data_1sy9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1sy9 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.301 0.572 . . . . 0.0 110.067 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 72.1 mt -57.88 -29.02 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.776 -0.577 . . . . 0.0 110.737 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.22 -39.13 89.09 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.233 -0.917 . . . . 0.0 110.194 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -59.98 -43.47 95.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.718 -0.614 . . . . 0.0 110.397 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -64.8 -20.77 66.56 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.844 -0.535 . . . . 0.0 111.395 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -69.96 -42.3 73.36 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.068 -1.02 . . . . 0.0 109.107 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -70.0 -26.65 64.17 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.119 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.15 -27.43 32.73 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.335 -0.853 . . . . 0.0 111.147 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.454 ' CB ' ' CE1' ' A' ' 65' ' ' PHE . 47.9 t80 -59.66 -41.32 90.31 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.576 -0.703 . . . . 0.0 111.673 -177.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.0 m -61.28 -38.36 86.5 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.233 -0.917 . . . . 0.0 109.974 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.7 tp -60.05 -41.21 91.84 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.816 -0.553 . . . . 0.0 110.0 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -74.22 -34.76 63.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.583 -0.698 . . . . 0.0 110.467 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -92.97 95.44 9.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.447 -0.783 . . . . 0.0 109.655 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -59.98 -32.1 70.51 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.426 -0.796 . . . . 0.0 111.155 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -79.44 -8.03 58.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.102 -0.999 . . . . 0.0 110.754 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.21 26.83 29.92 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -90.4 -4.82 56.78 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.686 -0.89 . . . . 0.0 111.326 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.97 2.41 58.26 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.634 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.0 p -146.71 144.18 29.25 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.353 1.576 . . . . 0.0 111.727 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 84.0 mt -107.72 133.14 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.71 -0.619 . . . . 0.0 109.97 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.2 p -111.04 145.84 37.78 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.552 -0.717 . . . . 0.0 110.626 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.412 ' CG2' ' CD1' ' A' ' 52' ' ' ILE . 53.6 p -43.81 -32.98 1.18 Allowed 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.667 -0.646 . . . . 0.0 111.858 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.06 -50.59 65.58 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.753 0.787 . . . . 0.0 109.533 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -59.99 -53.63 55.56 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.65 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.0 tt -60.02 -32.38 70.84 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.359 -0.838 . . . . 0.0 110.479 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.19 -31.34 33.8 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.314 -1.115 . . . . 0.0 110.314 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 93.7 m -63.83 -39.97 95.49 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.591 -0.946 . . . . 0.0 109.09 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.0 t -66.61 -39.98 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 96.8 mmm -59.97 -39.99 87.57 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.684 -0.635 . . . . 0.0 110.877 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.438 ' CG ' ' HB2' ' A' ' 42' ' ' ASN . 55.6 mtm180 -61.85 -42.62 99.26 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.152 -0.967 . . . . 0.0 109.552 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.3 t -63.72 -25.96 68.44 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.083 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.0 tp -85.77 -23.17 27.38 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.416 -0.803 . . . . 0.0 109.366 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.93 -58.77 0.17 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -160.56 176.26 11.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.544 -0.974 . . . . 0.0 111.415 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.438 ' HB2' ' CG ' ' A' ' 37' ' ' ARG . 38.9 t30 -99.61 131.84 24.1 Favored Pre-proline 0 N--CA 1.492 1.664 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.208 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -68.75 -147.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.111 0 N-CA-C 108.435 -1.41 . . . . 0.0 108.435 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.1 p -129.59 141.55 50.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.827 -1.171 . . . . 0.0 110.481 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -51.48 -25.77 7.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.642 -0.661 . . . . 0.0 111.322 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.57 -54.9 7.87 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.124 0.964 . . . . 0.0 108.546 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -66.86 -39.87 87.69 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.093 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 mt -56.0 -35.04 66.37 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.542 -0.724 . . . . 0.0 109.713 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.97 -37.16 81.19 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.152 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -65.22 -38.68 91.16 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.382 -0.823 . . . . 0.0 110.791 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 88.6 mmm -59.98 -45.97 90.97 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.659 -0.65 . . . . 0.0 110.206 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.412 ' CD1' ' CG2' ' A' ' 29' ' ' THR . 89.9 mt -67.89 -32.98 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.714 -0.616 . . . . 0.0 110.375 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -60.01 -43.29 95.33 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.246 -0.909 . . . . 0.0 110.669 -178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -67.9 -26.44 65.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.339 -0.851 . . . . 0.0 110.918 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.5 t -99.97 -8.84 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.483 -0.761 . . . . 0.0 111.482 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -71.23 103.16 2.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.109 -0.995 . . . . 0.0 110.897 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.25 -38.71 78.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.648 -0.658 . . . . 0.0 109.76 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -91.45 -30.64 16.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.615 -0.678 . . . . 0.0 110.537 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.2 20.99 40.01 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 120.36 -0.924 . . . . 0.0 110.905 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.6 p-10 -73.95 -32.86 63.67 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.39 -1.065 . . . . 0.0 110.323 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.7 -0.04 12.16 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.006 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 57.7 p -137.35 167.74 21.01 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.091 -1.24 . . . . 0.0 110.917 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.8 mt -104.58 120.67 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 121.317 0.58 . . . . 0.0 110.483 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -96.48 169.93 9.57 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.383 0.611 . . . . 0.0 110.585 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.454 ' CE1' ' CB ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -46.06 -50.35 36.86 Favored Pre-proline 0 N--CA 1.501 2.099 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -179.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.3 Cg_endo -72.37 -32.02 10.74 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.026 1.014 . . . . 0.0 111.771 -178.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -71.44 -40.03 70.65 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.216 -0.927 . . . . 0.0 110.251 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -61.52 -39.96 92.93 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.723 -0.611 . . . . 0.0 110.761 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.3 mt -67.76 -39.98 84.12 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.424 -0.798 . . . . 0.0 111.926 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.1 p -61.88 -40.08 94.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.356 -0.84 . . . . 0.0 110.748 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 60.5 ttp -67.71 -38.38 83.53 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.622 -0.674 . . . . 0.0 110.357 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.402 ' CE ' ' CG2' ' B' ' 166' ' ' VAL . 5.0 tpt -60.06 -49.51 77.39 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.611 -0.681 . . . . 0.0 111.076 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.09 -28.96 65.83 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.395 -0.816 . . . . 0.0 110.757 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -72.05 -40.79 68.1 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.498 -0.751 . . . . 0.0 110.608 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -69.15 -50.07 51.08 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.639 -0.663 . . . . 0.0 111.483 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 70.6 mtm -59.94 -40.03 87.56 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.429 -0.794 . . . . 0.0 111.104 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -60.74 -55.41 33.53 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.368 -0.832 . . . . 0.0 111.224 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -65.02 -19.98 66.27 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.456 -0.777 . . . . 0.0 110.161 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . 0.299 52.9 m -99.87 -175.11 2.87 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.815 -0.553 . . . . 0.0 109.648 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -121.74 140.82 51.85 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.223 -0.923 . . . . 0.0 109.084 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.6 t -55.76 -28.57 56.67 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.317 -0.864 . . . . 0.0 110.271 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.76 -34.32 77.63 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.677 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -71.42 -41.63 69.31 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.92 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -69.93 -29.49 66.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.117 -0.989 . . . . 0.0 110.414 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 95.9 mt -69.3 -46.31 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.536 -0.727 . . . . 0.0 109.699 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 63.2 mtt180 -59.81 -39.93 86.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.409 -0.807 . . . . 0.0 110.584 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.95 -44.45 80.55 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.535 -0.728 . . . . 0.0 110.927 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.4 -43.58 93.98 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.667 -0.646 . . . . 0.0 111.282 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -59.94 -47.99 83.54 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.763 0.792 . . . . 0.0 109.778 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -58.98 -33.42 70.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.914 -0.492 . . . . 0.0 110.473 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.5 t -70.04 -42.88 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.508 -0.745 . . . . 0.0 110.028 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -70.06 -39.13 75.84 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.446 -0.784 . . . . 0.0 110.628 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -79.75 73.32 6.48 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.575 -0.703 . . . . 0.0 109.653 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -64.82 -40.83 95.84 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.381 -0.824 . . . . 0.0 110.487 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -76.12 -16.59 59.86 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.459 -0.775 . . . . 0.0 110.958 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.18 61.58 7.34 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 21.5 p-10 -107.79 -10.6 15.55 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.581 -0.952 . . . . 0.0 111.377 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.4 -23.22 8.58 Favored Glycine 0 N--CA 1.498 2.815 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 14.6 p90 -142.79 176.16 9.27 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.483 -1.01 . . . . 0.0 108.708 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.4 mt -89.07 -129.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 119.801 -0.759 . . . . 0.0 109.248 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 168.71 159.87 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 O-C-N 120.529 -1.357 . . . . 0.0 108.321 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.3 -42.02 97.97 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.367 -0.833 . . . . 0.0 109.18 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.12 -30.67 67.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.837 -0.539 . . . . 0.0 110.094 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -69.97 -39.15 76.16 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.305 -0.872 . . . . 0.0 110.593 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.54 -47.24 70.44 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.481 -0.762 . . . . 0.0 110.21 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -61.21 -38.94 88.39 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.826 -0.546 . . . . 0.0 111.628 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -60.04 -39.95 87.71 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.218 -0.926 . . . . 0.0 111.163 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 96.5 t -74.08 -47.36 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 O-C-N 121.275 -0.891 . . . . 0.0 111.438 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 76.5 mtm -58.83 -42.96 90.46 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.156 -0.965 . . . . 0.0 110.267 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.2 m -67.27 -41.67 85.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.541 -0.724 . . . . 0.0 109.127 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -63.1 -31.91 73.17 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.5 mt -70.02 -35.09 74.08 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.697 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.94 21.14 2.95 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.667 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -119.98 138.32 53.55 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.215 -1.168 . . . . 0.0 110.024 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.7 mmmt -103.33 122.02 43.95 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.541 -0.725 . . . . 0.0 110.649 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 77.2 mt -135.05 156.48 48.95 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.64 -0.662 . . . . 0.0 109.502 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.77 159.39 29.07 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.558 -0.714 . . . . 0.0 109.677 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -58.75 -29.8 67.02 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -66.09 -29.97 70.39 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -37.31 86.13 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 94.5 t -70.05 -39.91 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.522 0.677 . . . . 0.0 110.151 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -60.04 -45.75 91.78 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.786 -0.571 . . . . 0.0 110.074 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -59.9 -40.05 87.46 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.597 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 10.2 mmt -55.39 -38.48 68.94 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.594 -0.842 . . . . 0.0 108.767 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.4 mm -66.31 -40.1 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.356 0.598 . . . . 0.0 109.749 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -57.86 -38.62 76.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.691 -0.631 . . . . 0.0 111.197 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.95 -39.77 86.73 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.68 -0.638 . . . . 0.0 111.16 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.93 4.45 34.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.321 -0.862 . . . . 0.0 111.558 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -88.14 69.9 9.25 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.035 -1.041 . . . . 0.0 110.425 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.7 mt -67.67 -40.74 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.464 -0.772 . . . . 0.0 110.481 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -72.59 -22.4 60.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.433 -0.792 . . . . 0.0 111.087 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.6 24.33 50.58 Favored Glycine 0 N--CA 1.496 2.688 0 C-N-CA 120.262 -0.971 . . . . 0.0 110.69 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -83.8 -10.78 57.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.389 -1.065 . . . . 0.0 111.086 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.35 0.84 79.33 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -137.81 149.26 46.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -1.117 . . . . 0.0 109.286 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.0 t -92.14 118.63 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.427 -0.796 . . . . 0.0 109.771 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -88.06 176.51 7.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.573 -0.705 . . . . 0.0 109.346 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -61.34 -47.47 85.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.743 -0.598 . . . . 0.0 110.498 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -59.95 -46.42 89.47 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.74 -0.6 . . . . 0.0 111.51 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -64.47 -37.04 86.15 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.806 0.813 . . . . 0.0 109.99 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.453 ' CZ ' ' CE ' ' A' ' 145' ' ' MET . 64.9 t80 -60.07 -48.88 79.89 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.283 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 89.0 t -70.0 -40.65 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.308 -0.87 . . . . 0.0 111.921 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -59.94 -48.8 80.22 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.308 -0.87 . . . . 0.0 111.477 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 55.2 ttp -59.99 -35.9 76.01 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.428 -0.795 . . . . 0.0 110.475 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.453 ' CE ' ' CZ ' ' A' ' 141' ' ' PHE . 37.3 mtt -70.65 -40.04 73.27 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.638 -0.664 . . . . 0.0 110.939 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.5 t -104.99 31.65 4.69 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.514 -0.741 . . . . 0.0 109.98 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.18 -42.45 95.04 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.626 -0.671 . . . . 0.0 110.153 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 30.2 mttt . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.969 179.563 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.374 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -92.64 146.23 18.04 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -59.95 -40.73 90.0 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.506 -0.997 . . . . 0.0 109.903 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 32.6 ttp85 -61.38 -40.45 94.4 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.699 -0.626 . . . . 0.0 110.22 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -60.14 -40.01 88.34 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.488 -0.757 . . . . 0.0 110.286 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 97.4 mt -66.68 -39.63 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.655 -0.653 . . . . 0.0 110.465 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.32 -37.11 76.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.521 -0.737 . . . . 0.0 110.372 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -60.13 -40.04 88.4 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.486 -0.759 . . . . 0.0 110.688 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 83.4 mt -70.04 -34.95 73.91 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.517 -0.739 . . . . 0.0 110.691 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 91.1 t -63.97 -39.96 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.595 -0.691 . . . . 0.0 109.932 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.14 -30.46 67.2 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . 0.402 ' CG2' ' CE ' ' A' ' 72' ' ' MET . 58.3 t -69.02 -33.56 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.628 -0.925 . . . . 0.0 110.959 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 91.6 mt -60.17 -46.55 89.3 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.372 -0.83 . . . . 0.0 111.711 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -70.07 -38.18 75.66 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.198 -0.939 . . . . 0.0 111.505 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -59.97 -40.06 87.77 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.287 -0.883 . . . . 0.0 110.629 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -59.95 -40.26 88.38 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.41 -0.806 . . . . 0.0 109.845 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.1 -20.45 59.46 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.578 -0.701 . . . . 0.0 110.514 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -60.03 -39.99 87.77 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.324 -0.86 . . . . 0.0 110.072 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.635 -0.666 . . . . 0.0 110.111 179.73 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 121.523 0.678 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.428 HG21 HD13 ' A' ' 9' ' ' ILE . 79.0 mt -60.58 -29.04 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.925 -0.484 . . . . 0.0 111.525 -178.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.67 86.6 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.157 -0.964 . . . . 0.0 110.063 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -60.03 -40.38 89.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.465 -0.772 . . . . 0.0 110.244 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -65.36 -20.75 66.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.724 -0.61 . . . . 0.0 110.917 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.448 ' HD3' ' CZ ' ' A' ' 65' ' ' PHE . 72.2 mmtt -69.94 -46.14 65.94 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.293 -0.879 . . . . 0.0 109.886 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -76.23 -24.82 54.61 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.45 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.22 -35.2 42.01 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.454 -0.779 . . . . 0.0 110.51 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -59.87 -39.99 87.13 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.853 -0.529 . . . . 0.0 111.549 -177.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.5 m -61.93 -39.64 92.77 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.25 -0.906 . . . . 0.0 109.946 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.7 tp -60.03 -40.09 88.16 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.693 -0.629 . . . . 0.0 109.406 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -77.39 -35.61 54.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.718 -0.614 . . . . 0.0 110.349 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -94.26 97.73 10.44 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.401 -0.812 . . . . 0.0 110.196 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -59.99 -34.81 73.81 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.527 -0.733 . . . . 0.0 111.728 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -80.1 -11.2 59.78 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.172 -0.955 . . . . 0.0 111.249 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.56 28.77 52.29 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -90.86 -6.13 54.62 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.725 -0.868 . . . . 0.0 111.262 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.42 0.25 56.87 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 120.158 -1.02 . . . . 0.0 111.617 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.5 p -144.86 143.02 30.38 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 119.284 1.542 . . . . 0.0 111.108 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.8 mt -107.04 130.07 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 121.766 0.793 . . . . 0.0 110.868 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.4 p -106.16 143.06 34.82 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.846 -0.533 . . . . 0.0 110.537 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 64.8 p -43.25 -29.03 0.36 Allowed 'General case' 0 N--CA 1.509 2.489 0 O-C-N 121.667 -0.646 . . . . 0.0 112.163 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -65.09 -50.21 66.99 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.804 0.811 . . . . 0.0 109.58 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -59.51 -53.35 59.13 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.695 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.441 ' CD2' ' CE2' ' B' ' 170' ' ' TRP . 54.4 tp -60.09 -30.47 69.26 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.253 -0.904 . . . . 0.0 110.119 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.49 -32.56 23.58 Favored Glycine 0 N--CA 1.5 2.959 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.6 m -65.38 -39.91 92.86 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.545 -0.974 . . . . 0.0 109.434 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.1 t -68.18 -39.99 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-O 121.492 0.663 . . . . 0.0 110.046 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 46.1 mtt -59.97 -39.96 87.42 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.698 -0.626 . . . . 0.0 111.104 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.446 ' CG ' ' HB2' ' A' ' 42' ' ' ASN . 55.8 mtt180 -60.73 -46.73 89.28 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.303 -0.873 . . . . 0.0 109.961 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -67.0 -23.36 65.92 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.903 -178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.7 tp -82.64 -30.5 29.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.94 . . . . 0.0 109.443 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.37 -39.61 0.19 Allowed Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.934 -1.127 . . . . 0.0 110.868 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -170.53 160.35 7.3 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.076 -1.249 . . . . 0.0 112.271 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.446 ' HB2' ' CG ' ' A' ' 37' ' ' ARG . 5.9 t-20 -105.88 111.22 64.59 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.699 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -61.15 -143.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.496 0 O-C-N 123.501 1.264 . . . . 0.0 109.683 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.2 p -131.41 149.93 52.35 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.218 -1.551 . . . . 0.0 112.131 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -51.1 -22.54 2.53 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.872 -0.517 . . . . 0.0 111.927 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.61 -55.76 8.05 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 122.284 1.04 . . . . 0.0 108.454 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -67.32 -37.17 82.88 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.718 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.416 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 4.1 mt -57.35 -36.19 70.89 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.551 -0.718 . . . . 0.0 109.772 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.25 -40.03 89.9 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.426 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -64.0 -36.58 84.43 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.452 -0.78 . . . . 0.0 111.046 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 64.6 mtt -60.03 -44.95 94.28 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.638 -0.663 . . . . 0.0 109.888 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.428 HD11 HG21 ' A' ' 52' ' ' ILE . 66.1 mt -68.32 -34.06 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.747 -0.596 . . . . 0.0 110.364 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -60.06 -42.56 94.78 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.32 -0.863 . . . . 0.0 111.051 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -69.1 -27.67 65.8 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.089 -1.007 . . . . 0.0 110.984 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 96.5 t -99.92 -7.67 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.591 -0.693 . . . . 0.0 111.239 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.7 100.02 2.73 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.163 -0.961 . . . . 0.0 112.004 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.09 -33.28 65.52 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -71.62 -40.09 70.0 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.407 0.622 . . . . 0.0 110.214 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.25 -1.44 73.27 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -73.7 -40.07 63.89 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.206 -1.173 . . . . 0.0 110.95 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 129.78 8.55 3.42 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 119.83 -1.176 . . . . 0.0 112.009 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 74.5 p -136.79 160.0 40.15 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.007 -1.29 . . . . 0.0 110.535 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.1 mt -104.93 120.03 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 120.039 -0.664 . . . . 0.0 111.273 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -96.22 171.17 8.76 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.505 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 19.4 t80 -49.37 -48.61 74.4 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.535 -0.728 . . . . 0.0 112.762 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 38.3 Cg_endo -63.94 -37.73 42.23 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 O-C-N 122.693 0.838 . . . . 0.0 111.56 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -69.65 -38.12 77.01 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.266 -0.896 . . . . 0.0 110.053 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -60.56 -42.27 96.25 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.546 -0.721 . . . . 0.0 110.158 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.437 HD12 ' CE2' ' A' ' 65' ' ' PHE . 89.4 mt -63.22 -40.5 97.64 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.5 -0.75 . . . . 0.0 111.854 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.7 p -61.66 -41.99 98.29 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.374 -0.829 . . . . 0.0 110.954 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 60.6 ttp -69.83 -40.02 76.13 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.562 -0.711 . . . . 0.0 111.475 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 97.2 mmm -62.71 -52.78 61.92 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.446 -0.784 . . . . 0.0 111.92 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.01 -31.54 71.3 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.661 -0.649 . . . . 0.0 110.313 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -71.83 -43.63 65.26 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.735 -0.603 . . . . 0.0 110.983 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -70.06 -42.22 73.12 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 45.9 mtm -59.91 -46.42 89.42 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.135 -0.978 . . . . 0.0 112.531 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -37.43 76.09 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.032 -1.043 . . . . 0.0 110.089 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -69.97 -20.03 63.33 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.712 -0.618 . . . . 0.0 111.252 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.7 t -111.34 -160.71 0.72 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.921 0.867 . . . . 0.0 111.94 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -120.49 138.39 53.85 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.463 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.6 t -65.73 -27.74 68.54 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.58 -0.7 . . . . 0.0 109.97 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.02 -31.0 69.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.61 -0.681 . . . . 0.0 109.844 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.62 -40.0 76.86 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.643 -0.661 . . . . 0.0 110.354 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.68 -38.59 87.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.527 -0.733 . . . . 0.0 110.379 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.57 -51.0 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.778 -0.577 . . . . 0.0 110.758 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.8 mtp85 -56.1 -38.41 70.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.265 -0.897 . . . . 0.0 110.481 -178.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -69.77 -39.9 76.39 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.804 -0.56 . . . . 0.0 110.789 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.62 -48.64 74.11 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.392 -0.818 . . . . 0.0 111.152 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -60.22 -43.01 96.38 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.725 0.774 . . . . 0.0 109.7 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -60.0 -36.44 77.2 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.411 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 90.4 t -69.43 -50.49 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.559 -0.713 . . . . 0.0 110.19 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.422 ' CZ ' HG13 ' A' ' 108' ' ' VAL . 28.2 m-85 -64.84 -40.04 94.54 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.397 -0.814 . . . . 0.0 110.952 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -78.5 65.05 3.7 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.475 -0.766 . . . . 0.0 110.686 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -60.67 -45.97 92.12 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.235 -0.916 . . . . 0.0 109.898 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 41.0 p-10 -69.99 -19.09 63.35 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.567 -0.708 . . . . 0.0 110.791 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.03 57.59 19.04 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -105.11 -3.24 23.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.278 -1.131 . . . . 0.0 110.525 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.43 -16.03 56.98 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -135.62 142.91 45.32 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.146 -1.208 . . . . 0.0 109.525 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.426 HG22 HD12 ' A' ' 100' ' ' ILE . 75.2 mt -88.97 124.55 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.482 -0.761 . . . . 0.0 110.021 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.2 m -84.52 169.38 14.52 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.353 0.597 . . . . 0.0 110.575 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.76 -40.57 97.68 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.77 -0.581 . . . . 0.0 110.096 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.77 -33.3 75.54 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.782 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -66.35 -40.02 89.55 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.426 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.7 tt -61.1 -48.87 79.68 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.331 -0.856 . . . . 0.0 109.841 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -62.66 -28.39 69.89 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.821 -0.549 . . . . 0.0 111.027 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -60.08 -40.01 88.05 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.186 -0.946 . . . . 0.0 109.978 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' CZ ' ' A' ' 92' ' ' PHE . 58.3 t -77.25 -33.11 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.528 -0.733 . . . . 0.0 110.256 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 16.9 mtt -59.99 -49.88 75.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.473 -0.767 . . . . 0.0 110.118 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 p -68.25 -40.87 81.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.621 -0.674 . . . . 0.0 109.703 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -60.05 -31.9 70.42 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.5 mt -69.94 -35.2 74.33 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.176 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 112.85 24.26 4.99 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -119.82 141.92 49.09 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.452 -1.028 . . . . 0.0 109.518 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -99.92 123.26 43.98 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.407 -0.808 . . . . 0.0 110.847 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.2 mp -138.72 154.52 48.56 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.579 -0.7 . . . . 0.0 110.206 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.0 m -87.81 170.2 11.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.637 -0.664 . . . . 0.0 109.344 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -63.5 -24.9 68.02 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.343 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -68.14 -36.36 79.57 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.716 0.769 . . . . 0.0 109.364 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -65.23 -38.38 90.21 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.594 0.711 . . . . 0.0 109.225 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 74.3 t -68.2 -39.96 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.03 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -59.96 -42.02 93.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.629 -0.67 . . . . 0.0 109.831 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -59.97 -40.94 90.8 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.654 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 10.5 mmt -54.22 -38.52 65.81 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 84.1 mt -66.03 -40.02 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.468 0.651 . . . . 0.0 110.082 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.5 ttt85 -57.35 -39.94 77.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.543 -0.723 . . . . 0.0 111.718 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -60.15 -37.93 81.6 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.572 -0.705 . . . . 0.0 111.465 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -109.39 -5.89 15.66 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.22 -0.925 . . . . 0.0 112.241 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -82.64 70.73 9.68 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.935 -1.103 . . . . 0.0 111.01 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.415 HD11 HG21 ' A' ' 130' ' ' ILE . 87.1 mt -67.99 -39.96 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.467 -0.771 . . . . 0.0 110.488 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.8 p-10 -70.51 -20.03 62.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.416 -0.802 . . . . 0.0 111.337 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.59 24.38 58.67 Favored Glycine 0 N--CA 1.496 2.646 0 C-N-CA 120.135 -1.031 . . . . 0.0 110.672 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -81.93 -11.61 58.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -1.173 . . . . 0.0 110.95 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.44 3.08 72.39 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -141.98 153.11 44.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -1.125 . . . . 0.0 109.784 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.0 t -96.22 109.97 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.609 -0.682 . . . . 0.0 109.611 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.0 p30 -81.93 -174.14 4.88 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.54 -0.725 . . . . 0.0 110.197 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -69.33 -42.86 74.79 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.056 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -62.45 -49.95 73.41 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.294 -0.879 . . . . 0.0 112.049 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.46 -35.5 81.09 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.445 -0.784 . . . . 0.0 110.456 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -59.94 -45.83 91.36 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.425 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.9 t -71.46 -40.51 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.294 -0.879 . . . . 0.0 111.777 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -59.96 -49.98 75.56 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.398 -0.814 . . . . 0.0 110.649 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 10.5 tmm? -59.97 -39.86 87.09 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.407 -0.808 . . . . 0.0 109.361 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 92.7 mmm -68.11 -39.86 82.7 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.216 0.531 . . . . 0.0 109.577 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 56.8 m -69.66 -17.8 63.52 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.714 -0.616 . . . . 0.0 110.446 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.94 139.99 57.02 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.381 -0.824 . . . . 0.0 110.454 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.2 mttm . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.105 -179.889 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -156.35 140.93 7.56 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -60.05 -39.92 87.61 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.644 -0.915 . . . . 0.0 110.064 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -60.02 -39.76 86.96 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.631 -0.668 . . . . 0.0 110.309 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -60.09 -39.95 87.87 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.576 -0.702 . . . . 0.0 110.592 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.65 -40.43 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.618 -0.676 . . . . 0.0 109.742 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.21 -39.53 93.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.691 -0.63 . . . . 0.0 110.736 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -64.11 -39.91 95.05 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.419 -0.801 . . . . 0.0 111.34 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 77.6 mt -70.05 -40.39 75.14 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.379 -0.826 . . . . 0.0 112.205 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 13.5 p -71.0 -31.96 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.073 -1.017 . . . . 0.0 110.673 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.73 -40.04 97.52 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 60.3 t -72.96 -27.94 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.696 -0.884 . . . . 0.0 112.0 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 90.6 mt -59.92 -48.13 82.95 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.117 -0.99 . . . . 0.0 111.019 -177.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -64.93 -39.98 94.33 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.26 -0.9 . . . . 0.0 110.885 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -60.32 -36.37 77.76 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.538 -0.726 . . . . 0.0 110.336 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 170' ' ' TRP . . . . . 0.441 ' CE2' ' CD2' ' A' ' 32' ' ' LEU . 3.0 t-105 -60.08 -40.02 88.09 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.578 -0.701 . . . . 0.0 109.782 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.12 -50.4 73.64 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.546 -0.721 . . . . 0.0 110.509 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -60.06 -34.1 72.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.368 -0.832 . . . . 0.0 109.876 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 . . . . . 0 N--CA 1.495 1.782 0 O-C-N 121.648 -0.658 . . . . 0.0 110.205 -179.863 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 121.768 0.794 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.88 -35.47 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.918 -0.489 . . . . 0.0 111.37 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.74 -27.15 68.1 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.045 -1.034 . . . . 0.0 111.184 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -69.44 -45.67 68.55 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.666 0.746 . . . . 0.0 110.094 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -69.44 -24.35 63.8 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.591 0.71 . . . . 0.0 109.169 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -70.86 -40.83 72.09 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.654 0.74 . . . . 0.0 109.605 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -70.62 -28.6 64.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.792 -0.568 . . . . 0.0 110.737 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.21 -27.46 35.29 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.486 -0.759 . . . . 0.0 110.609 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -60.0 -40.35 88.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.639 -0.663 . . . . 0.0 110.61 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.1 t -62.16 -39.48 92.8 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.432 -0.793 . . . . 0.0 109.499 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.3 tp -59.99 -40.65 89.91 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -77.55 -38.95 47.48 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.897 -0.502 . . . . 0.0 109.957 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -94.96 95.61 8.74 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.602 -0.686 . . . . 0.0 109.802 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -69.96 -26.95 64.35 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.44 -0.788 . . . . 0.0 111.548 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -80.97 -8.74 59.83 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.074 -1.016 . . . . 0.0 111.405 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.62 25.23 27.82 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -87.67 -6.62 58.15 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.548 -0.972 . . . . 0.0 110.718 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.17 0.9 58.33 Favored Glycine 0 N--CA 1.489 2.183 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.117 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.2 p -144.56 141.42 29.45 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 119.15 1.475 . . . . 0.0 111.292 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.5 mt -104.34 127.85 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.698 -0.626 . . . . 0.0 109.354 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.1 p -103.25 143.36 32.75 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.761 -0.587 . . . . 0.0 110.964 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.446 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 11.0 p -39.49 -34.32 0.21 Allowed 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -61.9 -46.05 91.05 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.921 0.867 . . . . 0.0 108.943 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -59.27 -53.29 59.95 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.276 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.49 -38.48 71.81 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.328 -0.857 . . . . 0.0 111.051 -178.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.85 -29.57 42.57 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.2 m -70.03 -39.45 75.76 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.644 -0.916 . . . . 0.0 110.491 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.6 t -61.24 -54.89 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.329 -0.857 . . . . 0.0 108.881 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.5 mtt -59.05 -29.31 67.2 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.656 -0.653 . . . . 0.0 109.382 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -59.49 -40.03 85.66 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.6 p -70.03 -16.97 63.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.972 -0.455 . . . . 0.0 110.744 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.6 tp -81.67 -31.17 32.4 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.354 -0.841 . . . . 0.0 109.663 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.25 -35.0 0.19 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -160.22 170.05 21.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.554 -0.968 . . . . 0.0 111.219 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -101.31 138.27 19.89 Favored Pre-proline 0 C--N 1.299 -1.607 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.733 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -67.18 -152.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.487 1.146 0 O-C-N 123.394 1.207 . . . . 0.0 109.427 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.4 p -139.97 144.7 37.15 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.191 -0.943 . . . . 0.0 111.123 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -49.72 -25.09 2.67 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.715 -0.616 . . . . 0.0 111.623 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.9 -54.87 9.84 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.185 0.993 . . . . 0.0 108.597 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -67.83 -39.87 83.83 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.764 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.446 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 8.5 mt -55.66 -37.01 67.71 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.676 0.751 . . . . 0.0 109.403 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.06 -40.04 96.53 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.775 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -63.83 -39.96 95.47 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.583 -0.698 . . . . 0.0 111.086 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 64.8 mtt -61.61 -41.76 97.91 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.633 -0.667 . . . . 0.0 109.919 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.4 mm -66.97 -39.99 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.781 -0.574 . . . . 0.0 110.467 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -61.32 -40.0 92.61 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.521 -0.737 . . . . 0.0 112.287 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -69.73 -29.72 67.16 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.995 -1.065 . . . . 0.0 110.723 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.6 t -99.99 -8.94 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.637 -0.664 . . . . 0.0 111.246 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.99 93.97 0.61 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.149 -0.969 . . . . 0.0 111.11 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.23 -38.49 91.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.655 -0.653 . . . . 0.0 109.504 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -91.72 -29.99 16.52 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.702 -0.624 . . . . 0.0 110.816 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.69 20.5 37.06 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -73.57 -39.1 64.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.372 -1.075 . . . . 0.0 110.42 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 129.05 -0.62 6.12 Favored Glycine 0 N--CA 1.497 2.744 0 C-N-CA 120.092 -1.051 . . . . 0.0 111.547 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.1 p -134.6 169.15 17.74 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.114 -1.227 . . . . 0.0 111.033 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.9 mt -102.68 118.9 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.813 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -98.79 170.01 9.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.533 -0.729 . . . . 0.0 110.766 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.463 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.8 t80 -47.53 -50.02 52.18 Favored Pre-proline 0 N--CA 1.499 1.984 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.2 Cg_endo -67.18 -34.9 26.6 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 O-C-N 122.884 0.939 . . . . 0.0 111.223 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.96 -40.02 75.66 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.307 -0.871 . . . . 0.0 110.353 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -62.81 -41.63 99.38 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.63 -0.669 . . . . 0.0 111.252 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 mp -67.86 -41.1 83.41 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.322 -0.861 . . . . 0.0 111.422 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.6 p -63.12 -39.99 96.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.542 -0.724 . . . . 0.0 110.879 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 48.8 ttp -68.61 -41.04 80.11 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.657 -0.652 . . . . 0.0 111.921 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 57.0 tpp -68.94 -42.53 76.62 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.257 -0.902 . . . . 0.0 111.772 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.0 -35.52 66.85 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.475 -0.766 . . . . 0.0 112.074 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.77 -55.01 5.69 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.432 -0.792 . . . . 0.0 111.421 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -59.94 -41.01 90.89 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.525 -0.735 . . . . 0.0 112.641 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 27.7 ptm -59.95 -34.49 73.32 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.283 -0.885 . . . . 0.0 111.877 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -63.25 -49.92 72.21 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.406 -0.809 . . . . 0.0 111.856 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -69.61 -10.31 57.67 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.176 -0.952 . . . . 0.0 111.019 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . 0.27 22.2 m -86.53 -175.03 5.29 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -129.98 138.57 50.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.132 -0.98 . . . . 0.0 109.404 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 24.4 p -61.15 -27.01 68.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.478 -0.764 . . . . 0.0 110.374 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.04 -37.01 78.56 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.716 0.769 . . . . 0.0 109.016 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.01 -40.02 75.5 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.316 0.579 . . . . 0.0 110.079 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -62.56 -39.98 95.37 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.783 -0.573 . . . . 0.0 110.7 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 89.6 mt -65.06 -49.75 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.533 -0.729 . . . . 0.0 110.849 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.77 -42.82 84.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.348 -0.845 . . . . 0.0 111.207 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -69.98 -39.64 75.82 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.405 -0.809 . . . . 0.0 111.773 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.405 ' HA ' ' CG1' ' B' ' 164' ' ' VAL . . . -64.77 -47.35 78.48 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.605 -0.684 . . . . 0.0 112.014 -178.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -67.26 -40.17 86.2 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.1 -1.0 . . . . 0.0 110.43 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -61.03 -39.94 91.69 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.694 -0.629 . . . . 0.0 111.738 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.421 HG21 ' N ' ' A' ' 92' ' ' PHE . 34.9 m -71.29 -40.06 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 0.0 111.112 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.421 ' N ' HG21 ' A' ' 91' ' ' VAL . 8.5 m-85 -72.39 -40.0 67.55 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.144 -0.973 . . . . 0.0 111.466 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -82.65 68.82 9.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.638 -0.664 . . . . 0.0 110.595 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.418 ' HE3' ' CD2' ' A' ' 107' ' ' HIS . 25.3 mttt -60.0 -42.72 94.87 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.19 -0.944 . . . . 0.0 110.001 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -74.52 -24.37 58.97 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.49 -0.757 . . . . 0.0 110.411 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.29 24.63 76.75 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -67.93 -16.69 64.18 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.334 -1.097 . . . . 0.0 111.262 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.47 -19.58 14.46 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.446 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 29.0 p90 -145.82 156.75 43.78 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.336 -1.096 . . . . 0.0 109.438 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 65.9 mt -89.14 122.04 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.668 0.747 . . . . 0.0 110.154 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 m -80.78 170.67 15.99 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.351 0.596 . . . . 0.0 110.624 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.73 -47.58 84.61 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.682 -0.636 . . . . 0.0 109.991 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.0 -37.97 81.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.744 -0.597 . . . . 0.0 109.855 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -61.05 -39.93 91.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.586 -0.696 . . . . 0.0 110.674 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.5 tt -60.54 -46.94 88.31 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.323 -0.861 . . . . 0.0 110.398 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -60.04 -34.91 74.03 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.698 -0.626 . . . . 0.0 111.919 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.418 ' CD2' ' HE3' ' A' ' 94' ' ' LYS . 48.4 t60 -59.97 -41.95 93.06 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.123 -0.986 . . . . 0.0 110.874 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.5 t -77.07 -37.05 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.429 -0.795 . . . . 0.0 111.183 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.7 mmt -60.05 -49.97 75.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.5 m -67.18 -43.69 81.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.725 -0.61 . . . . 0.0 109.809 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -61.82 -28.17 69.28 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.722 -0.611 . . . . 0.0 109.522 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.8 mt -70.03 -30.28 67.53 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.036 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 112.09 22.17 6.01 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -120.48 137.76 54.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.376 -1.073 . . . . 0.0 110.26 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -99.95 117.75 34.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.534 -0.729 . . . . 0.0 109.396 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 67.6 mt -131.24 156.85 44.68 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.458 -0.776 . . . . 0.0 110.15 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 m -82.51 165.8 19.85 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -63.39 -29.07 70.43 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -68.19 -32.83 73.35 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.508 0.67 . . . . 0.0 109.76 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -68.64 -35.07 76.79 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 78.0 t -69.98 -38.33 75.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-O 121.649 0.738 . . . . 0.0 109.028 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -60.0 -43.34 95.26 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.746 -0.596 . . . . 0.0 109.928 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -59.9 -40.18 87.93 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.356 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 13.7 mmt -54.58 -36.83 64.82 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.154 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 91.1 mt -67.75 -38.42 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 121.252 0.548 . . . . 0.0 109.825 178.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -60.03 -39.98 87.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.641 -0.662 . . . . 0.0 110.959 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -63.68 -39.83 95.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.545 -0.722 . . . . 0.0 111.403 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -98.98 -7.78 26.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.377 -0.827 . . . . 0.0 112.046 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -103.38 78.27 1.59 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.025 -1.047 . . . . 0.0 111.268 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 86.8 mt -66.99 -39.96 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.702 -0.624 . . . . 0.0 110.022 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 34.0 p-10 -59.03 -39.75 82.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.669 -0.644 . . . . 0.0 111.266 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 98.65 11.69 46.55 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.366 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -80.88 -16.7 52.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.943 -1.328 . . . . 0.0 110.151 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.68 5.18 71.94 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.747 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -132.34 133.41 43.96 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.237 -1.155 . . . . 0.0 110.035 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.7 t -90.88 114.58 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.442 -0.786 . . . . 0.0 109.936 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -87.7 -178.36 6.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.659 -0.651 . . . . 0.0 109.764 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -65.0 -41.33 95.47 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.613 -0.68 . . . . 0.0 110.092 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -61.69 -42.57 99.11 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.575 -0.703 . . . . 0.0 110.798 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -64.18 -39.45 94.02 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.831 0.824 . . . . 0.0 109.708 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.433 ' CZ ' ' CE ' ' A' ' 145' ' ' MET . 64.3 t80 -60.05 -46.82 88.27 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.426 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 99.3 t -65.13 -39.97 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.303 -0.873 . . . . 0.0 111.041 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -61.04 -39.97 91.83 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.516 -0.74 . . . . 0.0 110.381 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 49.9 mtp -60.59 -44.55 96.12 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.654 -0.654 . . . . 0.0 111.943 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.433 ' CE ' ' CZ ' ' A' ' 141' ' ' PHE . 42.9 mtt -73.24 -39.98 65.04 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.694 -0.629 . . . . 0.0 111.805 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.1 t -75.1 -8.16 55.77 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.41 -0.806 . . . . 0.0 111.262 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -92.83 120.04 32.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.203 -0.935 . . . . 0.0 110.363 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.6 pttm . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.608 179.788 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.56 -39.21 97.37 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -63.66 -40.25 96.37 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.56 -0.965 . . . . 0.0 111.368 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -64.32 -39.34 93.72 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.028 -1.045 . . . . 0.0 110.354 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -60.02 -49.85 76.04 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.663 -0.648 . . . . 0.0 111.737 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 19.7 tt -69.94 -26.01 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 120.987 -1.071 . . . . 0.0 110.727 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.92 90.89 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.372 -0.83 . . . . 0.0 110.919 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 25.8 ttm-85 -60.06 -41.01 91.42 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.517 -0.739 . . . . 0.0 110.759 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . 0.416 ' N ' ' CD2' ' B' ' 163' ' ' LEU . 4.6 mm? -61.92 -38.89 90.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.576 -0.702 . . . . 0.0 110.19 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . 0.405 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 97.2 t -64.53 -40.12 87.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.517 -0.739 . . . . 0.0 111.191 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.53 -44.12 93.91 Favored Glycine 0 N--CA 1.501 2.976 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 12.0 p -81.94 -11.64 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.687 -0.89 . . . . 0.0 111.455 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 9.2 tt -60.03 -50.02 75.35 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.188 -0.945 . . . . 0.0 110.434 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 30.0 mtp-105 -70.02 -31.09 68.58 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.588 -0.695 . . . . 0.0 110.538 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.97 -40.02 87.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.586 -0.696 . . . . 0.0 109.779 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -59.99 -41.29 91.73 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.671 -0.643 . . . . 0.0 109.928 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.1 -20.73 64.07 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.388 -0.82 . . . . 0.0 111.307 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -59.76 -39.9 86.4 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.318 -0.863 . . . . 0.0 110.319 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.538 -0.726 . . . . 0.0 110.219 179.622 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 . . . . . 0 N--CA 1.498 1.941 0 CA-C-O 121.484 0.659 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.9 mm -58.94 -50.02 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.708 -0.62 . . . . 0.0 111.046 -176.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.91 -20.04 63.35 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.225 -0.922 . . . . 0.0 110.688 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -68.21 -54.46 17.63 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.462 -0.774 . . . . 0.0 109.678 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -66.62 -21.67 66.12 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.462 0.648 . . . . 0.0 109.57 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -69.14 -44.06 73.08 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.415 0.626 . . . . 0.0 110.281 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -71.42 -24.46 62.05 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.751 -0.593 . . . . 0.0 111.299 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.7 -33.27 41.14 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.319 -0.863 . . . . 0.0 110.908 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.416 ' CB ' ' CE1' ' A' ' 65' ' ' PHE . 56.2 t80 -59.95 -37.5 79.74 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.695 -0.628 . . . . 0.0 111.255 -177.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 91.9 p -61.42 -38.79 88.4 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.243 -0.91 . . . . 0.0 110.087 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 46.3 tp -60.11 -40.19 88.84 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.541 -0.724 . . . . 0.0 109.758 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -78.77 -37.39 41.2 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.732 -0.605 . . . . 0.0 109.783 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -93.58 94.94 8.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.642 -0.661 . . . . 0.0 110.176 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -66.13 -30.11 70.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.468 -0.77 . . . . 0.0 111.393 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -79.96 -9.93 59.73 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.09 -1.006 . . . . 0.0 111.373 -177.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.79 26.71 58.12 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 57.9 p30 -89.96 -3.48 58.0 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.713 -0.875 . . . . 0.0 110.886 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.96 4.45 72.12 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.248 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 58.3 p -143.76 142.19 30.79 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 119.288 1.544 . . . . 0.0 111.945 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.4 mm -103.69 125.3 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.747 -0.596 . . . . 0.0 110.055 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.9 m -101.54 141.38 34.49 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.541 -0.725 . . . . 0.0 110.244 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 28.2 p -39.56 -34.79 0.25 Allowed 'General case' 0 N--CA 1.51 2.543 0 O-C-N 121.871 -0.518 . . . . 0.0 112.364 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -60.12 -49.36 77.94 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.327 -0.858 . . . . 0.0 109.11 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -57.58 -51.09 70.91 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.11 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.53 -38.81 67.01 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.154 -0.966 . . . . 0.0 111.002 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -51.61 -29.55 25.2 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.3 m -65.09 -40.01 93.98 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.528 -0.983 . . . . 0.0 110.074 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.6 t -68.3 -40.07 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-O 121.384 0.612 . . . . 0.0 109.775 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.401 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 13.4 mmt -59.93 -39.89 87.04 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.736 -0.602 . . . . 0.0 111.712 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -60.76 -40.01 90.88 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.757 0.789 . . . . 0.0 110.346 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.5 t -64.56 -24.84 67.74 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.766 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.77 -17.72 27.68 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.152 -0.968 . . . . 0.0 110.434 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.41 -51.44 0.22 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -166.73 176.47 7.14 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.59 -0.947 . . . . 0.0 111.197 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -99.17 133.47 22.08 Favored Pre-proline 0 N--CA 1.492 1.664 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.927 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.401 ' HD3' ' HB3' ' A' ' 36' ' ' MET . 52.1 Cg_endo -66.3 -147.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.306 0 O-C-N 123.207 1.109 . . . . 0.0 109.414 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.8 p -125.94 140.73 52.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.001 -1.062 . . . . 0.0 110.901 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -48.17 -24.69 1.21 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.713 -0.617 . . . . 0.0 112.039 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.25 -44.18 65.8 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.247 1.022 . . . . 0.0 108.461 176.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -69.96 -39.85 75.78 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.323 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 8.5 mt -55.88 -38.03 69.62 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.483 -0.76 . . . . 0.0 109.534 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -40.57 97.77 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.152 -178.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -64.43 -39.44 93.84 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.611 -0.681 . . . . 0.0 111.267 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 61.9 mtt -62.93 -39.98 96.25 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.679 -0.638 . . . . 0.0 109.917 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 52' ' ' ILE . 48.4 mm -69.23 -39.91 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.682 -0.636 . . . . 0.0 110.91 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -64.2 -40.09 95.36 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.447 -0.783 . . . . 0.0 112.519 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -69.93 -27.34 64.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.932 -1.105 . . . . 0.0 110.483 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.6 t -99.9 -10.01 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.658 -0.651 . . . . 0.0 110.917 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.12 99.01 1.06 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.188 -0.945 . . . . 0.0 110.962 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.79 -36.95 83.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.593 -0.692 . . . . 0.0 109.879 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -94.54 -26.11 16.55 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.654 -0.654 . . . . 0.0 110.84 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.7 20.01 49.32 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -73.9 -34.74 64.51 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.436 -1.038 . . . . 0.0 110.162 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.08 2.13 8.57 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 120.34 -0.933 . . . . 0.0 111.204 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 82.7 p -138.3 168.56 19.49 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.063 -1.257 . . . . 0.0 111.21 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.7 mt -103.69 121.0 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.288 0.566 . . . . 0.0 110.537 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -98.77 170.38 8.81 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.373 0.606 . . . . 0.0 110.47 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.461 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.5 OUTLIER -47.63 -50.0 53.21 Favored Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 121.626 -0.671 . . . . 0.0 112.533 -179.493 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.8 Cg_endo -67.87 -35.12 21.94 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 122.833 0.912 . . . . 0.0 111.237 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.99 -40.01 75.58 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.277 -0.889 . . . . 0.0 110.339 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -63.66 -40.77 97.67 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.548 -0.72 . . . . 0.0 110.933 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.3 mt -64.56 -39.96 94.69 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.433 -0.792 . . . . 0.0 111.346 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 68.8 p -60.6 -40.79 93.1 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.458 -0.776 . . . . 0.0 110.561 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.8 ttp -69.99 -39.96 75.59 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.561 -0.712 . . . . 0.0 111.708 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.6 tpt -60.05 -49.96 75.58 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.436 -0.79 . . . . 0.0 111.364 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.01 -29.27 66.29 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.455 -0.778 . . . . 0.0 111.369 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -72.87 -40.02 65.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.433 -0.792 . . . . 0.0 111.733 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -69.55 -46.58 66.12 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.355 -0.841 . . . . 0.0 112.24 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 77.0 mtm -60.01 -39.38 85.61 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.031 -1.043 . . . . 0.0 111.018 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -66.91 -51.27 57.39 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.549 -0.719 . . . . 0.0 110.816 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -69.09 -31.94 71.01 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.583 0.706 . . . . 0.0 110.134 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . 0.253 23.2 m -90.89 -174.64 4.1 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -123.81 144.56 49.64 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.099 -1.001 . . . . 0.0 110.055 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.2 p -61.59 -27.77 68.87 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.702 -0.624 . . . . 0.0 110.452 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -60.11 -37.87 81.29 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.627 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -70.04 -40.04 75.38 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.65 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -67.71 -37.75 82.67 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.455 -0.778 . . . . 0.0 110.28 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 71.0 mt -63.82 -49.86 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.736 -0.602 . . . . 0.0 110.002 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -57.58 -39.85 77.67 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.481 -0.762 . . . . 0.0 110.982 -178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.45 -42.09 75.38 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.514 -0.741 . . . . 0.0 111.655 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.56 -45.38 79.54 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.502 -0.748 . . . . 0.0 111.608 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.409 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 35.4 t80 -60.01 -47.07 87.33 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.469 -0.77 . . . . 0.0 109.542 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -60.09 -34.85 74.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.927 -0.483 . . . . 0.0 110.414 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.9 t -68.11 -47.77 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.373 -0.83 . . . . 0.0 109.795 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -64.25 -37.45 87.51 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.521 -0.737 . . . . 0.0 110.515 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -75.58 85.44 2.64 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.52 -0.737 . . . . 0.0 110.193 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -67.68 -41.11 84.18 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.374 -0.829 . . . . 0.0 110.209 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -81.28 -12.33 59.11 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.543 -0.723 . . . . 0.0 111.589 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 59.97 31.15 71.59 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -78.23 0.48 25.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.503 -0.998 . . . . 0.0 111.392 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.5 -10.06 75.66 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.607 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -137.58 137.25 38.35 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.08 -1.247 . . . . 0.0 109.979 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 74.6 mt -88.72 129.98 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.467 -0.771 . . . . 0.0 109.359 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.7 m -109.86 151.3 27.21 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.642 0.734 . . . . 0.0 111.103 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.26 -41.22 37.09 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.62 -0.675 . . . . 0.0 110.799 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.04 -34.32 73.23 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.408 -0.807 . . . . 0.0 108.834 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -74.82 -28.27 60.64 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.688 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.9 mp -65.04 -39.97 94.12 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.798 0.809 . . . . 0.0 109.121 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 48.1 ttt-85 -59.96 -34.99 74.02 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.151 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -60.09 -43.91 95.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.317 -0.865 . . . . 0.0 111.048 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 75.4 t -72.11 -40.38 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.442 -0.787 . . . . 0.0 111.244 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 67.6 mtt -58.07 -49.57 76.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.346 -0.846 . . . . 0.0 110.505 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.5 m -66.03 -42.78 89.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.62 -0.675 . . . . 0.0 109.774 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -62.53 -29.76 70.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.685 -0.634 . . . . 0.0 109.333 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 19.1 mt -69.94 -32.17 70.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.698 -0.626 . . . . 0.0 109.964 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 109.57 26.43 5.09 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -124.16 138.45 54.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.441 -1.035 . . . . 0.0 109.997 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -99.97 118.18 35.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.569 -0.707 . . . . 0.0 110.074 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 86.3 mt -131.68 157.3 44.11 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.6 -0.688 . . . . 0.0 109.667 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.88 162.08 22.91 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.611 -0.681 . . . . 0.0 109.555 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -58.8 -28.32 65.87 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.17 -32.57 73.74 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -39.9 95.25 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 73.0 t -70.03 -39.96 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 121.536 0.684 . . . . 0.0 110.567 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -60.04 -44.99 94.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.751 -0.593 . . . . 0.0 110.179 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -60.33 -40.98 92.59 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.645 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 86.6 mmm -55.2 -38.33 68.27 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 119.642 -0.823 . . . . 0.0 108.976 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 47.3 mm -66.84 -38.06 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-O 121.512 0.672 . . . . 0.0 109.65 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -59.07 -40.0 83.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.68 -0.638 . . . . 0.0 111.555 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.04 -39.87 87.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.619 -0.676 . . . . 0.0 111.043 -178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.99 0.01 34.44 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.377 -0.827 . . . . 0.0 111.572 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -87.55 71.23 9.8 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.019 -1.051 . . . . 0.0 110.679 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.403 HG22 HD13 ' A' ' 130' ' ' ILE . 87.5 mt -67.37 -42.26 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.358 -0.838 . . . . 0.0 110.532 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -71.33 -20.07 62.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.362 -0.836 . . . . 0.0 111.348 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.43 22.7 58.14 Favored Glycine 0 N--CA 1.496 2.682 0 C-N-CA 120.367 -0.921 . . . . 0.0 110.869 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -82.76 -12.5 57.48 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.29 -1.123 . . . . 0.0 111.152 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.0 1.73 75.81 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -139.5 152.1 46.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.267 -1.137 . . . . 0.0 109.459 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 70.7 t -92.46 118.26 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.56 -0.712 . . . . 0.0 110.168 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -84.82 175.51 9.09 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -65.05 -41.42 95.18 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.315 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -61.46 -45.86 92.51 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.703 -0.623 . . . . 0.0 111.025 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -66.0 -40.06 90.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.494 -0.754 . . . . 0.0 110.704 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.409 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 77.5 t80 -59.95 -44.22 94.52 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.981 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 89.6 t -69.56 -39.63 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.416 -0.802 . . . . 0.0 110.917 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -59.98 -47.66 84.89 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.528 -0.732 . . . . 0.0 110.684 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.1 tmm? -60.16 -39.65 87.17 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.41 -0.806 . . . . 0.0 110.693 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 97.5 mmm -69.63 -40.0 76.83 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.603 -0.685 . . . . 0.0 111.053 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.4 t -96.04 25.59 4.71 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.381 -0.824 . . . . 0.0 110.681 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -96.87 121.83 39.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.447 -0.783 . . . . 0.0 110.695 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 98.2 mttt . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.844 179.507 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -162.75 171.89 38.67 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -60.6 -39.94 89.97 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.648 -0.913 . . . . 0.0 110.476 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -60.04 -39.85 87.37 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.637 -0.664 . . . . 0.0 110.822 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -60.03 -40.0 87.85 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.398 -0.814 . . . . 0.0 110.617 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 85.4 mt -69.92 -40.03 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.375 -0.828 . . . . 0.0 110.813 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.46 -39.75 91.99 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.541 -0.725 . . . . 0.0 110.882 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -60.04 -39.95 87.69 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.583 -0.698 . . . . 0.0 110.468 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.99 -40.01 94.33 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.496 -0.753 . . . . 0.0 111.13 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 55.4 t -67.07 -40.0 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.381 -0.824 . . . . 0.0 110.971 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -53.72 -47.89 63.2 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 84.4 t -75.13 -22.65 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.693 -0.886 . . . . 0.0 110.569 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 5.7 tt -58.7 -49.97 75.6 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.338 -0.851 . . . . 0.0 110.593 -178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 30.4 ttt85 -65.07 -38.8 91.95 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.468 -0.77 . . . . 0.0 110.136 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.05 -31.46 70.0 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.58 -0.7 . . . . 0.0 109.902 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 4.0 t-105 -60.05 -45.42 92.92 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.697 -0.627 . . . . 0.0 109.883 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.58 -53.16 60.81 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.59 -0.694 . . . . 0.0 110.193 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -60.08 -40.01 88.06 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.508 -0.745 . . . . 0.0 110.732 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.494 -0.753 . . . . 0.0 110.289 179.855 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 121.366 0.603 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.4 HD11 HG22 ' A' ' 9' ' ' ILE . 92.7 mt -59.99 -28.2 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.72 -0.613 . . . . 0.0 111.395 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.15 -39.51 94.17 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.148 -0.97 . . . . 0.0 109.743 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -59.98 -40.07 87.84 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -64.29 -20.1 65.85 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.681 -0.637 . . . . 0.0 111.092 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HD3' ' CZ ' ' A' ' 65' ' ' PHE . 73.2 mmtt -69.08 -39.94 78.74 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.196 -0.94 . . . . 0.0 109.407 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -63.64 -59.66 4.31 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.453 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.1 -30.16 71.08 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.371 -0.83 . . . . 0.0 112.232 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.488 ' CG ' ' CE2' ' A' ' 65' ' ' PHE . 57.9 t80 -58.39 -49.97 75.35 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.167 -0.958 . . . . 0.0 110.745 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.0 m -66.15 -39.92 90.18 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.29 -0.881 . . . . 0.0 109.685 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 61.0 tp -62.79 -39.48 94.38 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.416 0.627 . . . . 0.0 109.431 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -74.15 -33.19 63.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.863 -0.523 . . . . 0.0 110.202 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -92.33 102.04 14.52 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.468 -0.77 . . . . 0.0 110.129 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -60.02 -39.2 85.02 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.482 -0.761 . . . . 0.0 111.486 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -80.03 -13.15 59.54 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.034 -1.041 . . . . 0.0 111.148 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.19 30.54 58.03 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -90.08 -2.88 58.17 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.714 -0.874 . . . . 0.0 110.84 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.61 3.95 62.4 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 120.22 -0.991 . . . . 0.0 111.432 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.0 p -145.8 142.41 28.84 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 119.197 1.498 . . . . 0.0 111.44 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.4 mt -100.68 122.68 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.3 m -95.82 139.47 31.99 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.48 -0.762 . . . . 0.0 110.151 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 65.0 p -42.39 -34.34 0.8 Allowed 'General case' 0 N--CA 1.51 2.571 0 O-C-N 121.961 -0.462 . . . . 0.0 111.588 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -64.31 -48.63 74.9 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.883 0.849 . . . . 0.0 109.136 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -60.0 -56.03 26.67 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.691 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.4 tt -61.09 -34.71 75.37 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.21 -0.931 . . . . 0.0 111.056 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.82 -32.57 59.1 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.4 m -70.01 -39.39 75.88 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.955 -0.733 . . . . 0.0 110.189 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.0 t -60.0 -57.29 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 94.7 mtp -59.98 -25.72 65.46 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.608 -0.682 . . . . 0.0 109.796 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -59.99 -46.02 90.82 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.736 0.779 . . . . 0.0 109.31 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.5 t -70.43 -16.98 63.0 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.821 -0.549 . . . . 0.0 111.14 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.88 -18.98 25.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.327 -0.858 . . . . 0.0 110.35 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.4 -50.37 0.2 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -168.01 172.17 9.08 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.645 -0.914 . . . . 0.0 110.674 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -120.61 138.85 27.99 Favored Pre-proline 0 C--N 1.299 -1.628 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.36 -148.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.224 1.118 . . . . 0.0 109.453 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 p -136.75 152.37 50.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.104 -0.997 . . . . 0.0 110.49 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -52.06 -22.41 4.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.53 -0.731 . . . . 0.0 112.033 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.1 -60.0 2.45 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.17 -0.956 . . . . 0.0 108.994 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -70.01 -33.75 72.42 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.734 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.9 mt -57.31 -36.88 71.66 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.526 -0.734 . . . . 0.0 109.449 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.44 -30.9 66.57 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.163 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -70.39 -45.08 66.72 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.563 -0.711 . . . . 0.0 111.707 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 79.2 mtm -63.27 -41.67 99.05 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.491 0.662 . . . . 0.0 109.298 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.6 mt -68.58 -31.92 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -58.04 -48.12 81.03 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.574 -0.704 . . . . 0.0 110.967 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -64.82 -24.24 67.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.341 -0.849 . . . . 0.0 110.11 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 67.2 t -98.17 -12.01 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.545 -0.722 . . . . 0.0 111.358 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -72.13 101.79 2.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.152 -0.967 . . . . 0.0 111.385 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.06 -39.98 90.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.558 -0.714 . . . . 0.0 109.445 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -88.26 -31.31 19.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.644 -0.66 . . . . 0.0 110.378 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.79 24.36 32.97 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -74.39 -31.96 62.54 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.459 -1.024 . . . . 0.0 110.465 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.68 -2.04 10.16 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.207 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 82.5 p -134.95 168.77 18.48 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.109 -1.23 . . . . 0.0 110.284 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.9 mt -104.49 120.37 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.714 -178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -98.56 170.25 8.94 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.488 0.661 . . . . 0.0 110.538 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.488 ' CE2' ' CG ' ' A' ' 16' ' ' PHE . 1.2 t80 -50.03 -48.56 78.58 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.4 Cg_endo -69.12 -36.57 12.24 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 O-C-N 122.768 0.878 . . . . 0.0 111.003 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.86 -39.94 76.07 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.484 -0.76 . . . . 0.0 109.223 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -59.89 -45.76 91.49 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.912 -0.493 . . . . 0.0 110.715 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.6 mt -63.57 -40.23 96.43 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.412 -0.805 . . . . 0.0 111.246 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.3 m -60.0 -44.04 94.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.441 -0.787 . . . . 0.0 110.719 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -39.98 93.51 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.708 -0.62 . . . . 0.0 111.039 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.407 ' O ' ' HG2' ' A' ' 76' ' ' MET . 57.2 tpp -59.95 -49.76 76.42 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.319 -0.863 . . . . 0.0 110.468 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.57 75.34 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.404 -0.81 . . . . 0.0 110.64 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -74.92 -37.75 61.96 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.458 -0.776 . . . . 0.0 111.119 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -70.04 -40.03 75.39 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.602 -0.686 . . . . 0.0 112.123 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.407 ' HG2' ' O ' ' A' ' 72' ' ' MET . 39.0 mmt -60.03 -47.29 86.47 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.244 -0.91 . . . . 0.0 112.322 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -68.48 -40.02 81.13 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.25 -0.906 . . . . 0.0 111.065 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -70.54 -20.96 62.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.484 -0.76 . . . . 0.0 111.56 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.6 t -107.29 -165.33 1.05 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.047 0.927 . . . . 0.0 111.803 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -130.01 136.54 49.52 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.894 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.6 t -60.58 -33.12 72.26 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.624 -0.672 . . . . 0.0 109.895 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -60.07 -34.44 73.45 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.397 0.618 . . . . 0.0 109.461 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -69.9 -40.08 75.84 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.348 0.594 . . . . 0.0 110.374 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -64.66 -34.24 77.83 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.591 -0.693 . . . . 0.0 111.29 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 87.8 mt -69.12 -43.89 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.484 -0.76 . . . . 0.0 110.133 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -59.93 -43.99 94.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.557 -0.714 . . . . 0.0 110.969 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -70.03 -39.9 75.48 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.348 -0.845 . . . . 0.0 110.993 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.73 -44.96 96.0 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.598 -0.689 . . . . 0.0 110.629 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -67.47 -39.27 85.28 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.428 -0.795 . . . . 0.0 110.359 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -60.45 -40.03 89.68 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.523 -0.736 . . . . 0.0 112.268 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.421 HG21 ' N ' ' A' ' 92' ' ' PHE . 34.7 m -71.17 -39.19 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.098 -1.002 . . . . 0.0 111.291 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.421 ' N ' HG21 ' A' ' 91' ' ' VAL . 11.8 m-85 -70.9 -37.15 72.95 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.114 -0.991 . . . . 0.0 110.669 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -79.79 69.04 6.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.681 -0.637 . . . . 0.0 110.806 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -59.94 -46.15 90.3 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.175 -0.953 . . . . 0.0 109.722 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.9 p-10 -69.89 -20.48 63.37 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.566 -0.709 . . . . 0.0 110.602 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.8 25.23 71.74 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -70.04 -9.76 56.42 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.285 -1.127 . . . . 0.0 111.31 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.11 -10.05 65.59 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -136.84 141.94 42.85 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.158 -1.201 . . . . 0.0 109.021 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 62.0 mt -89.49 120.45 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.407 -0.808 . . . . 0.0 109.929 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 m -84.06 168.56 15.78 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.267 0.555 . . . . 0.0 110.637 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.03 -41.17 91.28 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.621 -0.675 . . . . 0.0 109.552 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.53 -38.35 89.62 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.316 0.579 . . . . 0.0 109.44 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -61.17 -39.95 92.08 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.697 -0.627 . . . . 0.0 110.791 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 tt -63.6 -44.46 93.93 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.77 0.795 . . . . 0.0 109.35 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.9 ttt-85 -60.66 -32.69 71.86 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.853 -0.53 . . . . 0.0 111.356 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -60.01 -42.38 94.19 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.159 -0.963 . . . . 0.0 110.837 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 86.6 t -74.1 -40.02 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.27 -0.894 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 13.0 mmt -57.43 -49.18 77.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.4 -0.813 . . . . 0.0 110.067 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.6 m -64.64 -44.95 88.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.644 -0.66 . . . . 0.0 109.551 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -61.63 -29.31 69.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.7 -0.625 . . . . 0.0 109.567 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 11.7 mt -69.97 -30.79 68.22 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.216 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 111.13 25.62 4.98 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -122.84 136.78 54.98 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.454 -1.027 . . . . 0.0 109.727 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -99.94 119.96 39.05 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.548 -0.72 . . . . 0.0 110.674 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 71.3 mt -135.75 158.32 44.67 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.718 -0.614 . . . . 0.0 110.066 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.03 161.12 26.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.602 -0.686 . . . . 0.0 109.302 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -61.71 -27.9 69.04 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.71 -33.82 73.05 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.674 0.749 . . . . 0.0 109.379 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -67.53 -36.83 81.78 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.495 0.665 . . . . 0.0 109.226 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.1 t -69.98 -39.95 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.579 0.704 . . . . 0.0 109.78 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -60.0 -38.72 83.44 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.744 -0.597 . . . . 0.0 109.918 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -59.22 -39.72 83.58 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.378 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.9 mtt -55.34 -36.01 65.82 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 119.286 -0.965 . . . . 0.0 109.338 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.4 mm -67.31 -39.54 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.72 -0.613 . . . . 0.0 109.605 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -58.26 -38.24 76.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.606 -0.684 . . . . 0.0 110.734 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.97 -36.79 77.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.667 -0.646 . . . . 0.0 110.096 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.61 -4.33 23.99 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.563 -0.71 . . . . 0.0 111.307 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -82.49 71.1 9.56 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.959 -1.088 . . . . 0.0 110.24 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 85.3 mt -64.76 -46.88 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.525 -0.734 . . . . 0.0 110.682 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -70.49 -20.18 62.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.541 -0.724 . . . . 0.0 111.785 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.3 22.69 58.4 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -81.05 -10.32 59.7 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.366 -1.079 . . . . 0.0 110.804 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.03 0.63 71.07 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -141.42 156.49 45.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -1.193 . . . . 0.0 109.756 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 63.9 t -95.24 119.36 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.53 -0.731 . . . . 0.0 109.976 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -87.88 173.6 8.84 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -60.07 -50.03 75.34 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.649 -0.657 . . . . 0.0 110.054 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -60.66 -41.48 95.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.571 -0.706 . . . . 0.0 111.794 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -65.81 -36.35 83.27 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.2 -0.937 . . . . 0.0 109.882 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -62.14 -43.94 97.73 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.034 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.1 t -70.06 -45.24 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.4 -0.812 . . . . 0.0 111.693 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -60.32 -44.73 95.2 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.51 -0.744 . . . . 0.0 110.444 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -61.79 -39.99 93.63 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.697 -0.627 . . . . 0.0 109.945 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.2 mmt -67.71 -39.96 84.3 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.555 -0.715 . . . . 0.0 109.988 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 36.2 m -89.14 1.37 55.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.753 -0.592 . . . . 0.0 110.52 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.94 136.63 58.07 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.202 -0.936 . . . . 0.0 110.162 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 93.8 mttt . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.191 -179.795 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -146.09 125.38 2.25 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -67.94 -30.35 69.63 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.734 -0.863 . . . . 0.0 110.662 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -60.06 -40.03 88.03 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.383 -0.823 . . . . 0.0 110.139 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -68.36 -33.62 74.6 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.567 -0.708 . . . . 0.0 109.906 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 47.4 mm -59.94 -44.49 94.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.581 -0.699 . . . . 0.0 110.51 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.43 -39.93 92.7 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.541 -0.724 . . . . 0.0 111.299 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -61.48 -42.21 98.45 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.392 -0.818 . . . . 0.0 111.574 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 8.4 tt -70.05 -40.02 75.36 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.364 -0.835 . . . . 0.0 110.684 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 71.6 t -61.41 -39.98 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.628 -0.67 . . . . 0.0 110.644 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -52.48 -37.35 49.15 Favored Glycine 0 N--CA 1.501 2.996 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 89.7 t -78.18 -29.73 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.817 -0.814 . . . . 0.0 110.316 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 6.8 tt -59.3 -52.86 63.85 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.459 -0.776 . . . . 0.0 110.9 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -67.13 -39.93 86.68 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.343 -0.848 . . . . 0.0 110.727 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -59.95 -29.57 68.5 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.482 -0.761 . . . . 0.0 110.385 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -60.01 -47.2 86.83 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.486 -0.759 . . . . 0.0 109.549 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.12 -44.96 94.51 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.628 -0.67 . . . . 0.0 110.974 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -59.99 -40.02 87.72 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.384 -0.823 . . . . 0.0 110.781 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.467 -0.77 . . . . 0.0 110.316 -179.753 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 121.75 0.786 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 77.3 mt -58.59 -35.33 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.856 -0.527 . . . . 0.0 111.181 -178.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.467 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -62.65 -55.79 23.68 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.87 -1.144 . . . . 0.0 111.597 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -56.11 -38.52 70.87 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.564 -1.335 . . . . 0.0 111.025 -177.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -68.22 -30.11 69.1 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 20.7 ttpt -68.28 -38.49 81.76 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.386 0.613 . . . . 0.0 109.712 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.11 -59.22 5.76 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.431 0.634 . . . . 0.0 110.728 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.76 -33.16 75.04 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.844 -0.535 . . . . 0.0 112.426 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -58.26 -48.08 81.55 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.933 -1.104 . . . . 0.0 110.502 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.1 t -65.22 -37.83 88.5 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.223 -0.923 . . . . 0.0 108.842 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 64.3 tp -60.07 -40.01 88.03 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.154 0.502 . . . . 0.0 109.976 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -75.38 -30.62 60.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.663 -0.648 . . . . 0.0 110.37 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -93.0 103.4 15.72 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.545 -0.722 . . . . 0.0 109.201 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -59.97 -38.16 81.72 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.542 -0.724 . . . . 0.0 112.29 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -77.97 -11.78 59.93 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.825 -1.172 . . . . 0.0 111.09 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.77 27.7 50.44 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -89.63 -0.93 57.85 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.599 -0.942 . . . . 0.0 110.785 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.44 4.91 63.82 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 120.256 -0.974 . . . . 0.0 111.218 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.2 p -146.08 143.59 29.48 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 119.137 1.469 . . . . 0.0 111.768 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.8 mt -104.73 129.98 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.8 p -108.04 144.94 34.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.652 -0.655 . . . . 0.0 110.795 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.6 p -43.37 -32.29 0.81 Allowed 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.877 -0.515 . . . . 0.0 112.142 -178.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -65.39 -50.15 66.58 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.233 -0.917 . . . . 0.0 109.593 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -60.08 -54.52 45.02 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.936 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.429 HD11 ' CZ3' ' B' ' 170' ' ' TRP . 9.7 tt -60.01 -35.66 75.54 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.367 -0.833 . . . . 0.0 111.231 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.94 -31.3 17.21 Favored Glycine 0 N--CA 1.5 2.957 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.1 m -70.02 -39.87 75.53 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.576 -0.956 . . . . 0.0 110.372 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.74 -57.4 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.543 -0.723 . . . . 0.0 110.053 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 65.0 mtt -60.3 -31.54 70.35 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.493 -0.754 . . . . 0.0 110.78 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.99 -48.85 80.02 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.382 -0.824 . . . . 0.0 109.155 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 t -71.95 -12.86 61.44 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.884 -0.51 . . . . 0.0 110.2 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.4 tp -82.44 -33.7 28.45 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.354 -0.841 . . . . 0.0 109.81 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.07 -30.44 0.14 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -158.39 155.76 29.24 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.251 -1.146 . . . . 0.0 111.3 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -114.21 104.79 54.63 Favored Pre-proline 0 C--N 1.297 -1.712 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.167 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -62.23 -151.89 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.392 0 O-C-N 123.001 1.0 . . . . 0.0 109.82 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.1 p -140.04 154.57 47.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.995 -1.066 . . . . 0.0 111.925 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -52.57 -22.84 5.41 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.757 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.63 -60.02 2.44 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.938 0.875 . . . . 0.0 109.427 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.69 -32.63 71.35 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.404 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.2 mt -60.06 -34.08 72.94 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.628 0.728 . . . . 0.0 109.836 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.2 -32.49 66.83 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.259 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -69.86 -43.87 70.98 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.248 -0.907 . . . . 0.0 111.745 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 21.5 ptm -63.22 -39.16 93.83 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.789 -0.764 . . . . 0.0 109.241 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 71.4 mt -68.63 -33.61 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.676 -0.64 . . . . 0.0 110.235 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -60.01 -40.1 88.06 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.409 -0.807 . . . . 0.0 111.412 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -67.04 -27.22 67.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 110.527 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.8 t -100.09 -9.95 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.548 -0.72 . . . . 0.0 110.91 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.29 107.87 6.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.104 -0.998 . . . . 0.0 110.971 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -93.28 -20.24 20.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.742 -0.599 . . . . 0.0 109.657 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -75.36 -40.14 58.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.49 -0.756 . . . . 0.0 110.803 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.27 -4.48 62.39 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -74.64 -39.58 62.0 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.199 -1.177 . . . . 0.0 111.061 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 123.77 4.78 7.89 Favored Glycine 0 N--CA 1.496 2.634 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.317 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 76.4 p -135.4 162.7 31.88 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.129 -1.218 . . . . 0.0 110.284 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.8 mt -99.5 118.93 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.767 -177.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -93.59 171.22 9.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.667 -0.646 . . . . 0.0 109.945 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.457 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 16.4 t80 -46.1 -48.76 42.56 Favored Pre-proline 0 N--CA 1.498 1.967 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.5 Cg_endo -67.28 -32.55 32.87 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 122.747 0.867 . . . . 0.0 111.526 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -74.16 -41.1 62.05 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.214 -0.929 . . . . 0.0 110.346 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -60.21 -45.67 92.36 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.515 -0.74 . . . . 0.0 110.638 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.1 mp -66.34 -39.94 89.54 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.446 -0.784 . . . . 0.0 111.419 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.6 m -60.74 -43.07 98.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.541 -0.725 . . . . 0.0 110.616 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 57.6 ttp -66.63 -42.77 86.25 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.597 -0.69 . . . . 0.0 111.663 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 54.0 ttm -59.97 -49.86 76.01 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.432 -0.792 . . . . 0.0 111.165 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.68 -32.83 74.61 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.512 -0.743 . . . . 0.0 111.493 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -71.17 -40.01 71.52 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.394 -0.816 . . . . 0.0 111.127 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -69.53 -38.33 77.48 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.391 -0.818 . . . . 0.0 111.778 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.7 mtm -56.22 -48.21 76.9 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.318 -0.864 . . . . 0.0 111.871 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -69.82 -39.99 76.15 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.09 -1.006 . . . . 0.0 110.999 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -69.6 -34.05 73.56 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.459 -0.776 . . . . 0.0 110.635 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.0 m -97.59 -173.43 2.63 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.866 -0.521 . . . . 0.0 110.017 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -117.36 138.04 52.06 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.244 -0.91 . . . . 0.0 110.156 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 52.2 p -64.36 -27.32 68.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.598 -0.689 . . . . 0.0 110.153 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -60.06 -34.62 73.67 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.535 -0.728 . . . . 0.0 109.297 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.15 -39.57 78.74 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.348 0.594 . . . . 0.0 109.47 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.42 -37.75 88.63 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.704 -0.622 . . . . 0.0 110.827 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 98.2 mt -66.9 -48.29 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.524 -0.735 . . . . 0.0 110.923 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 41.9 mtp85 -59.99 -40.94 90.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.423 -0.798 . . . . 0.0 111.414 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.05 -40.73 74.95 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.32 -0.863 . . . . 0.0 111.51 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.35 -44.98 85.99 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.569 -0.707 . . . . 0.0 111.5 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -62.59 -40.92 98.43 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.826 0.822 . . . . 0.0 109.475 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -59.97 -36.6 77.48 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.953 -0.467 . . . . 0.0 111.027 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.8 t -69.58 -49.07 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.545 -0.722 . . . . 0.0 109.972 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.416 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 28.4 m-85 -66.65 -39.87 88.41 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.538 -0.726 . . . . 0.0 110.967 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -77.28 72.48 3.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.495 -0.753 . . . . 0.0 109.843 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -59.99 -44.44 94.5 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.541 -0.724 . . . . 0.0 109.967 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 36.0 p-10 -78.56 -24.8 45.37 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.649 -0.657 . . . . 0.0 110.692 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.44 29.85 73.13 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.6 p-10 -71.68 -13.96 61.89 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.455 -1.027 . . . . 0.0 111.773 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.89 -22.42 8.62 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 119.966 -1.111 . . . . 0.0 110.588 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 35.6 p90 -145.96 156.39 43.48 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.28 -1.13 . . . . 0.0 109.452 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 64.6 mt -89.3 126.56 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-O 121.822 0.82 . . . . 0.0 110.849 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.5 m -86.48 172.46 10.32 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.16 0.505 . . . . 0.0 110.518 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.78 -40.26 83.99 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.61 -0.681 . . . . 0.0 109.717 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.47 -38.59 91.55 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -60.58 -37.96 83.05 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.703 -0.623 . . . . 0.0 110.214 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.03 -41.36 92.05 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.608 0.718 . . . . 0.0 109.427 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 63.4 mtp180 -60.07 -35.64 75.6 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.815 -0.553 . . . . 0.0 112.277 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -60.06 -45.66 92.15 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.084 -1.01 . . . . 0.0 111.512 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.416 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 63.7 t -73.85 -37.79 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.374 -0.829 . . . . 0.0 111.379 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 14.2 mmt -59.92 -47.17 86.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.331 -0.856 . . . . 0.0 110.002 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.6 m -65.56 -40.86 93.3 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.691 -0.631 . . . . 0.0 109.462 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -60.6 -34.55 74.39 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.9 mt -69.94 -31.86 69.82 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.145 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.68 26.45 6.14 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -119.52 132.97 55.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.33 -1.1 . . . . 0.0 109.884 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -98.57 120.13 38.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.582 -0.699 . . . . 0.0 110.014 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 57.0 mt -130.18 159.96 35.25 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.474 -0.766 . . . . 0.0 110.489 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.2 p -83.14 163.34 20.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.811 -0.556 . . . . 0.0 109.659 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -63.22 -27.0 69.06 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -69.97 -37.31 75.75 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.582 0.706 . . . . 0.0 109.194 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -65.12 -36.67 85.02 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.536 0.684 . . . . 0.0 109.36 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 97.5 t -69.48 -39.41 78.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.694 0.759 . . . . 0.0 109.613 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -59.98 -40.21 88.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.794 -0.566 . . . . 0.0 110.287 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -60.0 -40.96 91.01 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.405 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 67.6 mtt -55.07 -35.83 64.96 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.459 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.5 mm -66.58 -39.09 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.789 -0.569 . . . . 0.0 110.066 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 50.0 ttt-85 -60.02 -40.02 87.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.494 -0.753 . . . . 0.0 111.742 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -60.12 -38.53 83.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.468 -0.77 . . . . 0.0 110.865 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.4 6.33 37.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.46 -0.775 . . . . 0.0 111.447 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -118.94 81.01 1.63 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.007 -1.058 . . . . 0.0 111.48 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 86.4 mt -66.79 -40.05 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.563 -0.711 . . . . 0.0 109.98 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.9 p30 -59.84 -39.32 84.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.626 -0.671 . . . . 0.0 111.136 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.54 15.96 44.72 Favored Glycine 0 N--CA 1.494 2.553 0 C-N-CA 120.149 -1.024 . . . . 0.0 111.24 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -80.01 -20.14 46.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.135 -1.215 . . . . 0.0 110.115 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.72 8.12 57.34 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.807 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -132.69 131.31 41.13 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.163 -1.198 . . . . 0.0 110.066 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.8 t -92.34 110.39 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.55 -0.719 . . . . 0.0 109.664 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -83.85 178.65 7.82 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.581 -0.699 . . . . 0.0 109.569 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -61.34 -44.89 96.43 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.747 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -61.76 -40.49 95.34 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.344 -0.847 . . . . 0.0 111.084 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -63.82 -39.62 94.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.325 -0.859 . . . . 0.0 109.629 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -60.0 -49.59 77.05 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.883 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 89.3 t -61.16 -41.38 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.317 -0.865 . . . . 0.0 110.919 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -60.0 -40.2 88.4 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.259 -0.9 . . . . 0.0 109.741 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 7.7 ttm -60.24 -42.04 94.46 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.701 -0.624 . . . . 0.0 110.609 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 98.4 mmm -69.93 -40.04 75.76 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.629 -0.669 . . . . 0.0 111.099 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.2 t -98.23 19.28 14.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.583 -0.698 . . . . 0.0 110.383 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.14 -39.96 92.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.51 -0.743 . . . . 0.0 109.829 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 44.1 mttp . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.045 179.95 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -116.09 136.51 12.96 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -64.41 -36.72 85.09 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.542 -0.975 . . . . 0.0 110.241 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -60.03 -39.15 84.88 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.691 -0.631 . . . . 0.0 110.095 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -60.02 -39.97 87.69 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.653 -0.654 . . . . 0.0 110.693 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . 0.413 HD11 HG23 ' B' ' 160' ' ' ILE . 97.2 mt -69.61 -39.94 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.307 -0.87 . . . . 0.0 110.526 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.37 -39.94 89.05 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.562 -0.711 . . . . 0.0 110.967 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -67.14 -39.97 86.65 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.443 -0.786 . . . . 0.0 110.821 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 88.6 mt -64.1 -40.04 95.35 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.472 -0.768 . . . . 0.0 111.192 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 83.4 t -70.03 -40.0 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.413 -0.804 . . . . 0.0 110.714 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.98 -50.01 69.81 Favored Glycine 0 N--CA 1.498 2.807 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 14.6 p -71.09 -28.44 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.604 -0.939 . . . . 0.0 110.461 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.04 -50.16 74.81 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.467 -0.77 . . . . 0.0 111.469 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -70.05 -39.99 75.37 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.466 -0.771 . . . . 0.0 110.655 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -60.38 -39.98 89.22 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.46 -0.775 . . . . 0.0 111.628 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 170' ' ' TRP . . . . . 0.429 ' CZ3' HD11 ' A' ' 32' ' ' LEU . 18.3 t90 -70.06 -31.36 68.94 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.373 -0.829 . . . . 0.0 110.458 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.43 -47.81 80.79 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.469 -0.769 . . . . 0.0 110.264 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -60.0 -33.78 72.44 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.538 -0.726 . . . . 0.0 110.104 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.764 -0.585 . . . . 0.0 110.384 -179.373 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 . . . . . 0 N--CA 1.497 1.915 0 CA-C-O 121.015 0.436 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.6 mm -62.97 -43.0 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.386 -0.821 . . . . 0.0 110.342 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.9 -31.21 72.22 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.732 -0.605 . . . . 0.0 111.105 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -62.56 -39.99 95.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.805 . . . . 0.0 109.719 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -64.26 -23.91 67.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.95 -0.469 . . . . 0.0 111.347 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HD3' ' CE1' ' A' ' 65' ' ' PHE . 73.9 mmtt -68.93 -40.0 79.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.193 -0.942 . . . . 0.0 110.271 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -77.76 -23.99 49.1 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.991 -0.443 . . . . 0.0 111.57 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.51 -38.36 34.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.3 -0.875 . . . . 0.0 111.175 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -56.76 -39.98 75.0 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.662 -0.649 . . . . 0.0 111.33 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 94.0 p -60.26 -39.33 86.4 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.188 -0.945 . . . . 0.0 110.055 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.1 tt -59.97 -44.45 94.44 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.62 -0.675 . . . . 0.0 109.381 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -70.02 -38.96 76.06 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.888 -0.508 . . . . 0.0 109.714 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -94.68 92.59 7.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.604 -0.685 . . . . 0.0 109.287 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -59.07 -22.5 60.87 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.228 -0.92 . . . . 0.0 111.653 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -81.23 -55.79 4.5 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.037 -1.039 . . . . 0.0 109.0 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.72 28.32 7.08 Favored Glycine 0 N--CA 1.482 1.748 0 N-CA-C 107.885 -2.086 . . . . 0.0 107.885 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -90.01 -1.23 57.93 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.666 -0.902 . . . . 0.0 110.526 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.04 -0.1 64.02 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 120.42 -0.895 . . . . 0.0 110.931 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.0 p -144.88 143.01 30.36 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 119.212 1.506 . . . . 0.0 111.547 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 83.8 mt -106.4 130.08 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.796 -0.565 . . . . 0.0 109.844 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.4 m -104.91 143.91 32.51 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.486 -0.758 . . . . 0.0 110.632 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 55.1 p -41.96 -35.71 0.93 Allowed 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.851 -0.531 . . . . 0.0 111.93 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.1 mttm -63.9 -48.17 77.68 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.35 -0.843 . . . . 0.0 109.325 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -58.96 -51.13 71.38 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.514 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.2 tp -59.93 -34.86 73.8 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.104 -0.997 . . . . 0.0 110.827 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.413 ' O ' ' CB ' ' A' ' 37' ' ' ARG . . . -48.52 -32.76 10.84 Favored Glycine 0 N--CA 1.5 2.963 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.1 m -70.06 -40.01 75.32 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 118.36 1.08 . . . . 0.0 110.3 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.1 t -69.11 -58.19 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.461 -0.774 . . . . 0.0 111.654 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 93.9 mmm -59.88 -37.26 78.85 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.258 -0.901 . . . . 0.0 110.849 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.413 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 5.9 tpt180 -60.01 -50.03 75.32 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.517 0.675 . . . . 0.0 109.736 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.1 p -71.75 -18.16 62.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.785 -0.572 . . . . 0.0 111.369 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.4 mt -91.86 -18.12 24.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.427 -0.796 . . . . 0.0 111.656 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.98 -40.47 0.2 Allowed Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.251 -1.452 . . . . 0.0 111.612 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -159.92 157.97 29.92 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 118.872 1.336 . . . . 0.0 112.128 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -118.01 103.72 49.6 Favored Pre-proline 0 N--CA 1.489 1.513 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.244 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -63.83 -148.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.335 0 O-C-N 123.309 1.163 . . . . 0.0 109.503 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.7 p -135.99 151.45 49.93 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.826 -1.171 . . . . 0.0 111.495 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -52.35 -24.52 7.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.652 -0.655 . . . . 0.0 111.449 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.16 -58.99 2.97 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 122.034 0.921 . . . . 0.0 108.729 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -65.43 -39.06 91.64 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.051 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 75.2 mt -58.04 -35.56 71.49 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.663 0.744 . . . . 0.0 110.01 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -40.03 82.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 122.01 -0.431 . . . . 0.0 111.491 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -65.22 -36.19 83.4 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.365 -0.834 . . . . 0.0 110.0 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 92.0 mmm -59.93 -45.61 92.03 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.447 0.642 . . . . 0.0 109.879 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.0 mt -67.74 -33.06 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.761 -0.587 . . . . 0.0 110.303 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -59.93 -40.01 87.44 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.537 -0.727 . . . . 0.0 110.766 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -66.93 -28.61 68.44 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.327 -0.858 . . . . 0.0 110.621 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.3 t -102.0 -7.17 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.613 -0.68 . . . . 0.0 111.081 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.82 105.53 1.98 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.2 -0.937 . . . . 0.0 110.72 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.54 -39.56 77.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.635 -0.666 . . . . 0.0 109.801 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -90.21 -27.66 19.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.612 -0.68 . . . . 0.0 110.531 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.82 21.61 46.07 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -74.32 -34.22 63.39 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.447 -1.031 . . . . 0.0 110.425 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.8 1.22 7.61 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.486 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 66.7 p -138.69 164.83 28.52 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.077 -1.249 . . . . 0.0 111.457 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.0 mt -100.84 122.1 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 121.34 0.59 . . . . 0.0 111.298 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -96.08 171.41 8.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.697 -0.627 . . . . 0.0 109.695 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.472 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 78.6 t80 -48.57 -49.95 61.74 Favored Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 121.435 -0.79 . . . . 0.0 112.56 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.4 Cg_endo -66.47 -33.91 35.64 Favored 'Trans proline' 0 N--CA 1.492 1.382 0 O-C-N 122.693 0.838 . . . . 0.0 111.255 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -70.44 -39.98 74.02 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.302 -0.874 . . . . 0.0 110.383 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -64.0 -40.02 95.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.712 -0.618 . . . . 0.0 110.67 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.422 ' N ' HD13 ' A' ' 69' ' ' LEU . 5.9 mp -66.66 -39.9 88.41 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.657 -0.652 . . . . 0.0 111.9 -178.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.7 p -60.24 -40.1 89.05 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.09 -1.006 . . . . 0.0 110.403 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 31.7 ttm -66.72 -54.36 23.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.643 -0.66 . . . . 0.0 111.979 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 57.8 ttm -61.74 -52.37 64.53 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.77 -38.19 86.09 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.561 -0.712 . . . . 0.0 112.536 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -71.42 -44.21 65.29 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.312 -0.867 . . . . 0.0 111.739 -178.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -71.81 -40.87 68.87 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.329 -0.857 . . . . 0.0 113.048 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 26.9 ptm -57.03 -20.3 23.72 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.178 -0.951 . . . . 0.0 111.326 -178.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -66.58 -54.27 25.38 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.327 -0.858 . . . . 0.0 110.495 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -70.0 -23.34 63.13 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.798 -0.563 . . . . 0.0 110.457 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.4 m -83.02 -173.05 4.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.633 -0.667 . . . . 0.0 110.006 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -128.14 140.37 51.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.311 -0.868 . . . . 0.0 109.945 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.2 t -70.03 -25.1 63.41 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.642 -0.661 . . . . 0.0 110.507 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -60.08 -37.07 78.81 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.897 0.856 . . . . 0.0 108.743 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -67.48 -39.89 85.27 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.421 0.629 . . . . 0.0 109.844 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -65.33 -33.82 76.88 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.694 -0.629 . . . . 0.0 110.519 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 78.9 mt -66.08 -46.76 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.655 -0.653 . . . . 0.0 110.071 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 62.1 mtt180 -60.01 -40.42 89.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.51 -0.744 . . . . 0.0 111.584 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -70.07 -40.18 75.2 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.203 -0.936 . . . . 0.0 111.548 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.18 -45.4 84.99 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.531 -0.73 . . . . 0.0 111.114 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -60.0 -47.41 85.94 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.529 0.68 . . . . 0.0 109.978 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -60.01 -36.62 77.62 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.791 -0.568 . . . . 0.0 111.192 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 72.0 t -69.19 -49.75 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.262 -0.899 . . . . 0.0 109.569 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -67.65 -39.99 84.57 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.315 -0.866 . . . . 0.0 109.877 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -79.83 79.66 6.32 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -69.03 -39.89 78.96 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.45 -0.781 . . . . 0.0 111.034 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -77.4 -21.42 53.17 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.465 -0.772 . . . . 0.0 110.839 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.18 28.95 74.07 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -72.91 -10.31 59.66 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.561 -0.964 . . . . 0.0 111.765 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.78 -20.98 12.86 Favored Glycine 0 N--CA 1.498 2.829 0 C-N-CA 120.025 -1.083 . . . . 0.0 110.608 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -144.66 152.44 40.46 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.388 -1.066 . . . . 0.0 109.236 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.419 ' CG2' ' CD2' ' A' ' 105' ' ' LEU . 18.5 mt -88.67 131.35 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.096 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.02 170.96 11.1 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.918 -0.489 . . . . 0.0 109.756 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.77 -39.33 73.27 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.57 -37.24 86.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.692 -0.63 . . . . 0.0 109.46 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -62.24 -34.34 76.33 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.555 0.693 . . . . 0.0 109.416 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.419 ' CD2' ' CG2' ' A' ' 100' ' ' ILE . 0.5 OUTLIER -69.16 -40.32 78.24 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.907 -0.496 . . . . 0.0 109.964 179.173 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -60.0 -38.75 83.53 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.533 -0.729 . . . . 0.0 111.352 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -60.1 -46.2 90.38 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.083 -1.011 . . . . 0.0 111.709 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 93.2 t -70.28 -39.99 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.203 -0.936 . . . . 0.0 111.183 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 16.0 mmt -59.64 -50.03 75.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.546 -0.721 . . . . 0.0 110.889 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 93.9 m -67.35 -43.09 82.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.543 -0.723 . . . . 0.0 109.955 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -61.63 -31.67 71.77 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.36 0.6 . . . . 0.0 109.432 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 19.9 mt -69.41 -34.93 75.21 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.917 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 119.66 26.1 2.44 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -126.13 149.62 48.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.385 -1.067 . . . . 0.0 109.782 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -116.48 126.0 52.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.515 -0.741 . . . . 0.0 110.415 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 60.4 mt -138.08 154.72 49.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.593 -0.692 . . . . 0.0 109.326 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.03 163.77 23.95 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -62.0 -27.45 68.88 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.016 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.55 -32.7 73.65 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.421 0.629 . . . . 0.0 109.869 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -68.34 -36.61 79.5 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 90.7 t -66.88 -39.75 84.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.837 0.827 . . . . 0.0 108.955 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -59.99 -47.69 84.77 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.498 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -60.05 -40.07 88.13 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.838 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 65.7 mtt -55.93 -38.53 70.43 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.443 -0.903 . . . . 0.0 109.096 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 47.9 mm -65.93 -39.3 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 121.452 0.644 . . . . 0.0 109.655 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.9 ttt-85 -57.78 -38.67 75.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.678 -0.639 . . . . 0.0 110.843 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -59.95 -37.51 79.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.699 -0.626 . . . . 0.0 110.628 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.14 -1.6 27.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.403 -0.81 . . . . 0.0 111.323 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -84.76 71.75 10.81 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.996 -1.065 . . . . 0.0 110.392 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.6 mt -67.16 -41.43 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.434 -0.792 . . . . 0.0 110.245 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.5 p-10 -72.56 -20.14 61.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.328 -0.858 . . . . 0.0 111.148 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.64 22.14 62.6 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 120.312 -0.947 . . . . 0.0 111.139 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -83.1 -10.04 58.9 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.214 -1.168 . . . . 0.0 111.064 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.21 0.71 76.66 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -137.57 148.17 45.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.208 -1.171 . . . . 0.0 109.648 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 85.9 t -90.06 117.75 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.429 -0.794 . . . . 0.0 110.348 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -89.26 175.33 7.39 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -61.79 -47.92 82.97 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.794 -0.566 . . . . 0.0 110.117 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -60.02 -49.3 78.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.731 -0.606 . . . . 0.0 111.851 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -63.3 -35.4 80.24 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.316 -0.865 . . . . 0.0 109.991 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -60.02 -45.14 93.76 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 91.8 t -70.01 -37.85 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.328 -0.857 . . . . 0.0 111.564 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -59.91 -47.13 87.01 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.207 -0.933 . . . . 0.0 110.395 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.4 tmm? -60.02 -39.24 85.17 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.511 -0.743 . . . . 0.0 109.925 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 96.2 mmm -65.74 -40.03 91.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.64 -0.662 . . . . 0.0 109.869 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.1 m -92.39 6.51 46.68 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.563 -0.711 . . . . 0.0 110.914 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -99.04 119.83 38.46 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.1 -1.0 . . . . 0.0 110.256 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.7 mtmt . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.266 -179.897 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.74 68.53 0.26 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -59.98 -44.1 94.7 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.584 -0.951 . . . . 0.0 110.241 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -60.02 -39.48 85.97 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.593 -0.692 . . . . 0.0 111.098 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -59.3 -39.98 84.76 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.301 -0.875 . . . . 0.0 110.256 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.8 -40.04 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.571 -0.706 . . . . 0.0 109.377 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.3 -31.01 72.05 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.621 -0.674 . . . . 0.0 110.42 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -60.03 -38.81 83.84 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.573 -0.704 . . . . 0.0 110.097 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 66.6 mt -60.01 -40.44 89.27 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.477 -0.764 . . . . 0.0 110.99 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 99.1 t -68.4 -40.0 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.558 -0.714 . . . . 0.0 110.466 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.75 -41.97 94.18 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 11.5 p -74.98 -12.24 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -1.101 . . . . 0.0 110.96 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 9.5 tt -60.01 -49.16 78.74 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.113 -0.992 . . . . 0.0 109.48 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -60.0 -41.05 91.26 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.653 -0.654 . . . . 0.0 110.32 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.07 -40.29 88.99 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.632 -0.668 . . . . 0.0 111.601 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 5.0 t-105 -61.43 -47.61 84.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.436 -0.79 . . . . 0.0 110.512 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.02 -43.62 95.14 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.542 -0.724 . . . . 0.0 111.007 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -60.01 -40.0 87.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.37 -0.831 . . . . 0.0 110.625 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 . . . . . 0 N--CA 1.495 1.794 0 O-C-N 121.413 -0.804 . . . . 0.0 110.4 -179.877 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 . . . . . 0 N--CA 1.5 2.073 0 CA-C-O 120.739 0.304 . . . . 0.0 111.448 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.5 mm -60.68 -50.03 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.369 -0.832 . . . . 0.0 110.891 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.04 -31.44 69.97 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.64 -0.662 . . . . 0.0 111.466 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -59.95 -43.04 95.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.927 . . . . 0.0 110.586 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.423 ' CG ' HD12 ' A' ' 69' ' ' LEU . 44.5 m-85 -65.23 -21.77 66.79 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.578 -0.701 . . . . 0.0 111.468 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.429 ' HD3' ' CZ ' ' A' ' 65' ' ' PHE . 32.5 mmtt -70.71 -43.92 67.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.083 -1.011 . . . . 0.0 110.391 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -75.16 -28.23 60.01 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.21 -30.27 22.54 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.144 -0.972 . . . . 0.0 111.851 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -59.99 -45.85 91.39 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.497 -0.752 . . . . 0.0 111.677 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.5 m -60.06 -39.48 86.17 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.221 -0.924 . . . . 0.0 109.604 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.6 tp -61.35 -43.47 98.82 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -69.95 -40.07 75.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.993 -0.442 . . . . 0.0 110.461 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -92.32 95.36 9.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.439 -0.788 . . . . 0.0 109.627 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -60.01 -34.52 73.47 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.381 -0.824 . . . . 0.0 110.859 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -80.03 -10.11 59.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.255 -0.903 . . . . 0.0 111.051 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.43 26.53 44.99 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -88.02 -7.88 56.41 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.64 -0.918 . . . . 0.0 111.035 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.77 1.77 58.64 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.542 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.8 p -144.02 141.57 30.19 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 119.192 1.496 . . . . 0.0 111.192 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 88.1 mt -104.23 128.45 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.714 -0.616 . . . . 0.0 109.492 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.5 p -100.5 139.62 35.93 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.61 -0.681 . . . . 0.0 110.2 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.1 p -42.38 -30.93 0.36 Allowed 'General case' 0 N--CA 1.511 2.603 0 O-C-N 121.796 -0.565 . . . . 0.0 111.645 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -65.66 -49.63 67.94 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.413 -0.804 . . . . 0.0 109.641 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.35 -53.9 52.95 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.71 -0.619 . . . . 0.0 111.165 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.454 ' CD2' ' CZ2' ' B' ' 170' ' ' TRP . 58.8 tp -59.99 -34.76 73.75 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.318 -0.864 . . . . 0.0 110.633 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.04 -31.47 10.85 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.4 m -70.14 -40.83 74.58 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.517 -0.99 . . . . 0.0 110.483 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.4 t -65.76 -51.24 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 121.361 -0.837 . . . . 0.0 109.982 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 98.1 mtp -60.06 -33.77 72.51 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.459 0.647 . . . . 0.0 109.496 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -49.12 78.94 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.618 0.723 . . . . 0.0 109.438 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.7 t -71.69 -16.22 62.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.908 -0.495 . . . . 0.0 110.804 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -90.29 -19.95 23.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.215 -0.928 . . . . 0.0 110.653 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.36 -43.57 0.2 Allowed Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.611 -1.281 . . . . 0.0 110.876 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -160.48 160.0 31.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.107 -1.231 . . . . 0.0 111.559 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -115.21 99.77 52.78 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -64.58 -151.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.278 0 O-C-N 123.321 1.169 . . . . 0.0 109.942 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.5 p -140.07 159.96 41.0 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.15 -0.969 . . . . 0.0 111.685 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -54.98 -21.2 11.05 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.811 -0.555 . . . . 0.0 111.645 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.43 -59.92 2.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.176 -0.953 . . . . 0.0 108.693 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -69.13 -35.97 76.96 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.677 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.7 mt -58.14 -33.04 68.75 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.456 0.646 . . . . 0.0 110.148 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.08 -31.59 68.01 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.57 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -70.62 -45.75 64.64 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.297 -0.877 . . . . 0.0 111.091 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 78.7 mtm -61.53 -42.05 98.25 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.572 0.701 . . . . 0.0 109.585 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 91.0 mt -69.02 -33.41 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.257 0.551 . . . . 0.0 110.147 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -59.96 -38.76 83.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.483 -0.761 . . . . 0.0 110.332 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -64.41 -27.41 68.98 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.546 -0.721 . . . . 0.0 110.297 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.6 t -104.64 -7.97 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.586 -0.696 . . . . 0.0 111.208 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -68.41 103.39 1.63 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.963 -1.086 . . . . 0.0 111.453 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.58 -39.98 94.72 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.713 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.6 p-10 -91.61 -30.67 16.23 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.637 -0.664 . . . . 0.0 111.041 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.26 23.38 44.49 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -73.37 -37.2 66.12 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.448 -1.03 . . . . 0.0 110.721 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.4 -0.84 7.56 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 120.303 -0.951 . . . . 0.0 110.965 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 49.8 p -134.73 169.72 16.91 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.171 -1.194 . . . . 0.0 110.07 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.0 mt -110.11 120.07 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.44 -177.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -96.25 170.34 9.32 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.408 0.623 . . . . 0.0 110.237 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.456 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 t80 -49.77 -48.09 78.05 Favored Pre-proline 0 N--CA 1.497 1.894 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.7 Cg_endo -67.7 -36.99 17.4 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 122.699 0.841 . . . . 0.0 111.683 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -70.03 -39.75 75.6 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.134 -0.979 . . . . 0.0 110.069 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -60.74 -50.01 75.21 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.484 -0.76 . . . . 0.0 111.317 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.423 HD12 ' CG ' ' A' ' 12' ' ' PHE . 3.1 tt -61.39 -41.69 97.52 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.362 -0.836 . . . . 0.0 111.56 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.0 p -63.02 -35.66 80.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.583 -0.698 . . . . 0.0 109.996 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 24.6 ttt -66.21 -43.55 86.41 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.838 -0.539 . . . . 0.0 111.852 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.1 ttt -60.06 -45.53 92.55 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.288 -0.882 . . . . 0.0 111.498 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.33 -32.0 71.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.451 -0.781 . . . . 0.0 110.564 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.7 mmm-85 -70.02 -40.04 75.44 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.622 -0.674 . . . . 0.0 111.124 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -73.09 -44.38 60.52 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.398 -0.814 . . . . 0.0 112.212 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 48.6 mtm -60.64 -39.94 90.15 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.297 -0.877 . . . . 0.0 113.096 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -67.25 -36.41 81.56 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.968 -1.082 . . . . 0.0 111.335 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -69.41 -17.85 63.7 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.509 -0.744 . . . . 0.0 111.056 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.5 t -117.97 -159.65 0.75 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.653 0.739 . . . . 0.0 111.272 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -122.55 140.02 53.25 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.143 0.497 . . . . 0.0 109.773 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.1 t -64.27 -24.57 67.71 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.636 -0.665 . . . . 0.0 110.678 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -64.4 -35.51 81.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.289 -0.882 . . . . 0.0 109.024 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -67.82 -42.48 81.42 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.994 -178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.95 -25.49 63.67 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.275 -0.891 . . . . 0.0 111.278 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.8 mt -69.61 -45.33 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.44 -0.787 . . . . 0.0 109.591 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 63.2 mtt180 -59.97 -37.98 81.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.555 -0.716 . . . . 0.0 110.572 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.54 -41.71 75.58 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.69 -0.631 . . . . 0.0 110.601 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.83 -43.83 87.37 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.53 -0.731 . . . . 0.0 111.331 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -60.1 -48.47 81.57 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.619 0.723 . . . . 0.0 109.682 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -58.74 -31.83 68.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.892 -0.505 . . . . 0.0 110.171 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.97 -41.35 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.499 -0.751 . . . . 0.0 110.044 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -68.57 -37.51 79.94 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.495 -0.753 . . . . 0.0 110.948 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -80.03 76.95 6.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.539 -0.726 . . . . 0.0 109.852 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.425 ' HD3' ' CD2' ' A' ' 107' ' ' HIS . 4.9 mtmp? -63.28 -44.84 93.93 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.399 -0.813 . . . . 0.0 110.193 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -75.65 -17.5 59.96 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.621 -0.674 . . . . 0.0 111.409 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.7 20.15 75.54 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -70.07 -10.05 57.43 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.18 -1.188 . . . . 0.0 111.124 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.71 -13.28 67.49 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.46 ' N ' ' CD1' ' A' ' 99' ' ' TYR . 41.0 m-85 -128.17 136.97 51.85 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.138 -1.213 . . . . 0.0 108.295 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 47.6 mt -89.09 120.6 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.907 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.8 m -84.56 169.43 14.43 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.407 0.622 . . . . 0.0 110.627 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.02 -39.97 87.15 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.647 -0.658 . . . . 0.0 109.305 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.73 -36.64 79.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.792 -0.568 . . . . 0.0 109.659 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -66.88 -40.02 87.69 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.642 -0.661 . . . . 0.0 110.674 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.62 -45.88 92.4 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.474 -0.767 . . . . 0.0 109.54 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -61.37 -33.74 74.17 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.848 -0.532 . . . . 0.0 111.066 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.425 ' CD2' ' HD3' ' A' ' 94' ' ' LYS . 75.6 t60 -59.95 -47.42 85.88 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.265 -0.897 . . . . 0.0 111.752 -177.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 63.2 t -72.74 -51.05 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 121.147 -0.97 . . . . 0.0 112.026 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.405 ' CE ' ' CD1' ' A' ' 116' ' ' LEU . 51.2 mtp -58.1 -39.89 79.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.078 -1.014 . . . . 0.0 110.598 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.5 m -67.17 -46.0 75.3 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.551 -0.718 . . . . 0.0 109.778 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -62.04 -31.26 71.64 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.351 0.596 . . . . 0.0 109.499 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.1 mt -69.58 -32.39 71.12 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.669 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.59 20.48 1.92 Allowed Glycine 0 N--CA 1.497 2.734 0 C-N-CA 119.868 -1.158 . . . . 0.0 111.22 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -121.85 138.98 54.18 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.101 -1.234 . . . . 0.0 110.386 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -103.05 120.03 39.92 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.528 -0.732 . . . . 0.0 109.901 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.405 ' CD1' ' CE ' ' A' ' 109' ' ' MET . 74.1 mt -133.2 157.91 44.19 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.418 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.59 172.14 8.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.817 -0.552 . . . . 0.0 109.852 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -64.98 -23.57 67.26 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -69.21 -38.73 78.74 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.607 -0.683 . . . . 0.0 109.764 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -64.7 -35.84 82.34 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.0 t -69.8 -39.1 77.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.467 0.651 . . . . 0.0 109.637 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -60.05 -46.36 89.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.749 -0.595 . . . . 0.0 110.09 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -59.95 -42.47 94.13 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.617 -0.677 . . . . 0.0 109.576 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 78.0 mmm -54.16 -39.31 66.45 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.414 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 85.5 mt -67.68 -38.61 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.217 0.532 . . . . 0.0 110.614 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -59.13 -39.99 84.08 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.576 -0.702 . . . . 0.0 112.11 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.05 -39.96 83.64 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.808 -0.557 . . . . 0.0 110.993 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.29 -1.76 26.56 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.193 -0.942 . . . . 0.0 111.655 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -83.4 70.5 10.2 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.997 -1.065 . . . . 0.0 110.48 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.71 -40.83 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.418 -0.801 . . . . 0.0 110.726 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -70.44 -18.8 63.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.386 -0.821 . . . . 0.0 111.343 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.57 22.0 63.07 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 120.239 -0.982 . . . . 0.0 110.73 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -83.01 -9.95 59.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -1.146 . . . . 0.0 110.988 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.49 0.69 84.22 Favored Glycine 0 N--CA 1.497 2.76 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -136.67 148.21 47.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.31 -1.112 . . . . 0.0 109.042 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.8 t -91.38 119.11 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.406 -0.809 . . . . 0.0 109.673 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.429 ' OD1' ' CE2' ' A' ' 99' ' ' TYR . 80.9 m-20 -89.02 175.24 7.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.584 -0.697 . . . . 0.0 109.929 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -60.87 -47.9 84.27 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.275 0.56 . . . . 0.0 110.524 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -59.99 -45.47 92.62 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.638 -0.663 . . . . 0.0 111.264 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -65.22 -35.9 82.51 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.797 0.808 . . . . 0.0 110.122 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.467 ' CZ ' ' CE ' ' A' ' 145' ' ' MET . 68.5 t80 -60.04 -47.29 86.47 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.32 -178.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.3 t -70.06 -39.72 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.288 -0.882 . . . . 0.0 111.366 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -59.94 -50.04 75.34 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.297 -0.877 . . . . 0.0 111.212 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.411 ' HE1' ' CD1' ' B' ' 157' ' ' PHE . 60.5 ttp -60.3 -36.83 78.8 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.371 -0.83 . . . . 0.0 110.534 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.467 ' CE ' ' CZ ' ' A' ' 141' ' ' PHE . 33.1 mtt -69.57 -39.96 77.03 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.635 -0.666 . . . . 0.0 110.664 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.1 t -99.0 22.8 9.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.542 -0.724 . . . . 0.0 110.633 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.01 -44.93 94.24 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.439 -0.788 . . . . 0.0 110.468 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 96.6 mttt . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.193 179.899 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 70.45 29.27 70.11 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . 0.411 ' CD1' ' HE1' ' A' ' 144' ' ' MET . 37.0 t80 -60.02 -39.96 87.66 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.506 -0.996 . . . . 0.0 109.395 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -66.07 -40.02 90.55 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.667 -0.646 . . . . 0.0 110.776 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -60.88 -45.97 92.47 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.331 -0.855 . . . . 0.0 111.457 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . 0.413 HG23 ' N ' ' B' ' 161' ' ' ALA . 18.2 tt -70.08 -35.49 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.353 -0.842 . . . . 0.0 111.171 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . 0.413 ' N ' HG23 ' B' ' 160' ' ' ILE . . . -60.15 -45.24 93.73 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.349 -0.844 . . . . 0.0 110.686 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -60.42 -40.08 89.72 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.48 -0.763 . . . . 0.0 110.488 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.76 -40.49 97.42 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.515 -0.741 . . . . 0.0 110.678 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 98.9 t -62.46 -40.0 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.431 -0.793 . . . . 0.0 109.563 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.44 -39.42 94.85 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 90.0 t -69.41 -35.38 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.673 -0.898 . . . . 0.0 111.307 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.98 -49.99 75.49 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.348 -0.845 . . . . 0.0 112.782 -177.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 -60.6 -39.91 89.88 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.992 -1.067 . . . . 0.0 110.804 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.41 -33.65 72.8 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.491 -0.756 . . . . 0.0 109.478 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 170' ' ' TRP . . . . . 0.454 ' CZ2' ' CD2' ' A' ' 32' ' ' LEU . 2.4 t90 -60.02 -49.25 78.39 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.823 -0.548 . . . . 0.0 110.023 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.41 94.51 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.501 -0.749 . . . . 0.0 110.853 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -59.98 -39.93 87.38 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.437 -0.79 . . . . 0.0 110.028 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.702 -0.624 . . . . 0.0 110.236 -179.524 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.299 0.571 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 80.2 mt -60.19 -29.11 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.713 -0.617 . . . . 0.0 111.023 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.63 -39.44 93.85 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.092 -1.005 . . . . 0.0 110.268 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -59.54 -41.76 90.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.513 -0.742 . . . . 0.0 109.916 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -64.29 -20.6 66.19 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.933 -0.479 . . . . 0.0 111.103 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -69.96 -44.17 70.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.132 -0.98 . . . . 0.0 110.077 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -60.07 -54.95 39.9 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.31 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.13 -25.0 64.17 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.089 -1.007 . . . . 0.0 111.577 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -49.98 -56.38 10.9 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 120.972 -1.08 . . . . 0.0 111.463 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.9 m -62.39 -36.84 83.59 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.384 -0.822 . . . . 0.0 109.829 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.5 tp -59.92 -40.78 90.04 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.71 -0.619 . . . . 0.0 109.894 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.15 -33.69 59.39 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.58 -0.7 . . . . 0.0 109.928 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -92.0 98.38 11.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.51 -0.744 . . . . 0.0 109.306 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -59.97 -38.55 82.83 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.625 -0.672 . . . . 0.0 111.503 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -78.44 -12.69 60.02 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.013 -1.054 . . . . 0.0 110.813 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.92 27.9 65.22 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -90.0 -2.08 58.08 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.611 -0.935 . . . . 0.0 110.768 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.24 3.82 63.14 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.704 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.3 p -147.12 145.36 29.56 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-N 119.268 1.534 . . . . 0.0 111.646 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 91.6 mt -103.37 127.89 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 121.412 0.625 . . . . 0.0 109.689 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.5 m -100.21 139.99 35.1 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.841 -0.537 . . . . 0.0 109.866 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.41 ' CG2' HG13 ' A' ' 52' ' ' ILE . 4.9 p -42.95 -30.49 0.41 Allowed 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.707 -0.621 . . . . 0.0 111.686 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -64.89 -49.54 70.06 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.847 0.832 . . . . 0.0 108.999 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -58.86 -53.71 55.29 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.902 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.7 tp -60.7 -32.84 72.06 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.297 -0.877 . . . . 0.0 110.285 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.76 -31.47 38.29 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.4 m -69.96 -37.74 75.88 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.516 -0.99 . . . . 0.0 109.903 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.39 -56.18 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-O 121.425 0.631 . . . . 0.0 109.725 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.437 ' CE ' ' CD1' ' B' ' 170' ' ' TRP . 60.6 mtt -59.9 -31.75 70.11 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.684 -0.635 . . . . 0.0 111.124 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -50.02 75.36 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.427 -0.796 . . . . 0.0 109.289 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.1 t -73.71 -18.69 60.97 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.776 -0.578 . . . . 0.0 110.439 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -97.38 -3.02 41.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.352 -0.843 . . . . 0.0 110.954 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.98 -71.59 0.11 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -162.95 171.35 16.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.475 -1.014 . . . . 0.0 111.055 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -106.98 119.66 50.56 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.784 -0.573 . . . . 0.0 109.893 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.38 -148.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.454 0 O-C-N 123.07 1.037 . . . . 0.0 109.982 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.1 p -138.1 153.15 49.3 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.935 -1.103 . . . . 0.0 111.596 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -52.49 -23.83 6.91 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.742 -0.599 . . . . 0.0 111.728 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.47 -59.96 2.55 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.177 0.989 . . . . 0.0 108.63 177.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -67.65 -37.61 82.64 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.735 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.408 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 14.3 mt -57.58 -35.12 69.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.608 -0.682 . . . . 0.0 109.856 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.88 -40.07 96.41 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.914 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -65.94 -40.02 90.99 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.526 -0.734 . . . . 0.0 111.133 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 49.2 mtt -59.98 -45.13 93.7 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.474 -0.766 . . . . 0.0 109.811 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.41 HG13 ' CG2' ' A' ' 29' ' ' THR . 47.5 mm -67.03 -35.81 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.766 -0.584 . . . . 0.0 110.546 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -60.0 -40.11 88.1 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.602 -0.686 . . . . 0.0 111.122 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -69.99 -28.51 65.58 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.28 -0.887 . . . . 0.0 110.998 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.4 t -98.15 -9.11 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.45 -0.781 . . . . 0.0 111.383 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.88 98.79 3.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.132 -0.98 . . . . 0.0 111.046 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.92 -38.5 88.84 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 109.44 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -90.13 -29.69 18.13 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.666 -0.646 . . . . 0.0 110.793 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.51 19.95 36.43 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -74.01 -37.87 64.25 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.447 -1.031 . . . . 0.0 110.747 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.16 3.75 7.33 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.196 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 81.1 p -136.17 169.12 18.14 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.127 -1.219 . . . . 0.0 111.101 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.6 mt -107.44 122.53 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.503 -177.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -103.35 170.06 8.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.597 -0.69 . . . . 0.0 110.642 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.472 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 62.5 t80 -47.15 -49.84 49.71 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.659 -0.65 . . . . 0.0 112.737 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.6 Cg_endo -65.97 -34.33 38.9 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 O-C-N 122.622 0.801 . . . . 0.0 111.703 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.62 -39.96 73.42 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.179 -0.95 . . . . 0.0 111.066 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -62.44 -43.93 97.65 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.358 -0.839 . . . . 0.0 110.675 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.46 -43.44 97.35 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.383 -0.823 . . . . 0.0 112.454 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.435 HG22 ' N ' ' A' ' 71' ' ' MET . 8.5 t -62.48 -33.93 75.83 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.197 -0.939 . . . . 0.0 110.926 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.435 ' N ' HG22 ' A' ' 70' ' ' THR . 15.9 ttm -67.33 -46.57 73.07 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.466 -0.771 . . . . 0.0 111.646 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 50.2 ttm -64.99 -43.87 91.16 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.322 -0.861 . . . . 0.0 112.017 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.54 -36.7 76.65 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.372 -0.83 . . . . 0.0 110.776 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -70.97 -39.95 72.21 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.696 -0.627 . . . . 0.0 111.306 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -72.08 -30.77 65.45 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 36.2 mmt -60.07 -45.16 93.79 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.932 -1.105 . . . . 0.0 112.547 -176.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.4 pttp -69.36 -35.68 76.1 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.118 -0.989 . . . . 0.0 111.682 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -71.23 -12.34 61.41 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.418 -0.802 . . . . 0.0 111.777 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.4 t -125.63 -164.32 1.29 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.319 -0.863 . . . . 0.0 111.965 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -120.04 133.44 55.53 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.824 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.5 t -60.34 -29.95 69.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.593 -0.692 . . . . 0.0 110.673 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.13 -31.63 70.26 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.461 -0.774 . . . . 0.0 109.617 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.01 -39.98 87.68 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.903 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.11 -37.49 85.29 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.64 -0.662 . . . . 0.0 110.854 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 86.8 mt -66.98 -47.98 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.667 -0.646 . . . . 0.0 110.84 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -60.03 -41.1 91.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.465 -0.772 . . . . 0.0 111.207 -178.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -70.06 -40.03 75.31 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.457 -0.777 . . . . 0.0 111.333 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.13 -46.05 75.3 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.772 -0.58 . . . . 0.0 111.824 -178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -59.96 -45.4 92.77 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.826 0.822 . . . . 0.0 109.338 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 29.6 ttm-85 -59.95 -37.08 78.51 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.421 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.93 -46.27 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.496 -0.752 . . . . 0.0 110.188 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -69.0 -36.88 78.33 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.492 -0.755 . . . . 0.0 110.536 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -78.03 78.84 4.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.53 -0.731 . . . . 0.0 109.096 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.99 -44.16 94.69 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.413 -0.804 . . . . 0.0 110.577 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -78.92 -19.42 51.84 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.576 -0.703 . . . . 0.0 110.667 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.64 28.26 72.26 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -71.73 -10.49 59.85 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.452 -1.028 . . . . 0.0 111.159 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.9 -20.09 44.73 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.414 ' CE2' ' OD1' ' A' ' 137' ' ' ASN . 59.0 m-85 -119.91 139.39 52.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.259 -1.142 . . . . 0.0 108.971 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.438 HD13 HG23 ' A' ' 100' ' ' ILE . 82.5 mt -92.6 120.0 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.465 -0.772 . . . . 0.0 110.452 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.1 m -91.36 170.37 10.03 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.432 0.634 . . . . 0.0 110.719 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.73 -37.67 73.49 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.643 -0.661 . . . . 0.0 109.577 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.11 -38.76 92.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.853 -0.529 . . . . 0.0 109.918 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.5 -39.99 94.81 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.513 -0.742 . . . . 0.0 110.423 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.43 ' CD2' ' CG2' ' A' ' 100' ' ' ILE . 1.2 mm? -64.29 -40.0 95.07 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.607 0.718 . . . . 0.0 109.662 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 69.4 ttp85 -62.87 -31.08 72.04 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.806 -0.558 . . . . 0.0 110.875 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -60.02 -46.2 90.29 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.233 -0.917 . . . . 0.0 110.68 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.0 t -75.03 -35.57 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.363 -0.836 . . . . 0.0 111.246 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.7 mmt -60.05 -48.94 79.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.385 -0.822 . . . . 0.0 110.428 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.4 m -69.37 -39.96 77.73 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.593 -0.692 . . . . 0.0 110.125 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -60.0 -35.79 75.8 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.4 mt -69.87 -33.94 72.91 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.206 0.526 . . . . 0.0 110.306 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.96 17.25 6.43 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -109.13 131.97 54.56 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.22 -1.165 . . . . 0.0 110.256 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -100.16 120.57 40.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.618 -0.676 . . . . 0.0 110.239 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 71.2 mt -135.8 156.32 48.98 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.425 -0.797 . . . . 0.0 110.95 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.67 159.9 25.17 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -61.87 -26.6 68.24 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -68.1 -31.74 71.56 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -67.24 -34.5 77.59 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.5 t -73.02 -38.63 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.992 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -60.03 -43.81 95.04 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.64 -0.663 . . . . 0.0 109.55 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -60.02 -42.36 94.19 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.458 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.0 mtt -54.84 -37.59 66.37 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.118 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 86.7 mt -65.36 -37.9 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -57.87 -37.89 74.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.816 -0.553 . . . . 0.0 111.663 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.09 -39.97 88.0 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.427 -0.796 . . . . 0.0 111.632 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -106.34 -0.14 24.54 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.271 -0.893 . . . . 0.0 111.69 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -98.67 74.86 2.11 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.128 -0.982 . . . . 0.0 111.329 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 84.3 mt -66.93 -39.97 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.457 -0.777 . . . . 0.0 109.779 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 30.7 p30 -58.52 -37.76 76.3 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.742 -0.599 . . . . 0.0 111.494 -179.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 92.84 18.75 39.35 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 120.28 -0.962 . . . . 0.0 111.233 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -82.43 -13.37 56.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.047 -1.266 . . . . 0.0 110.47 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.0 4.68 71.71 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.506 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -136.24 141.85 43.98 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.09 -1.241 . . . . 0.0 109.828 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.3 t -94.07 125.11 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.41 -0.806 . . . . 0.0 110.188 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.414 ' OD1' ' CE2' ' A' ' 99' ' ' TYR . 91.3 m-20 -97.39 179.66 4.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.569 -0.707 . . . . 0.0 109.659 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -63.09 -50.05 72.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.741 -0.599 . . . . 0.0 110.852 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.21 -44.21 95.96 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.374 -0.829 . . . . 0.0 111.342 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -66.81 -38.52 86.63 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.851 0.834 . . . . 0.0 109.81 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -59.97 -46.12 90.48 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.156 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 98.1 t -69.96 -39.31 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.374 -0.829 . . . . 0.0 111.101 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -59.96 -47.33 86.24 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.271 -0.893 . . . . 0.0 110.437 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.4 tmm? -59.94 -37.27 79.05 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.469 -0.769 . . . . 0.0 110.27 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 92.2 mtp -66.36 -40.03 89.52 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.902 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 50.2 m -86.21 2.83 45.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.792 -0.567 . . . . 0.0 111.125 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.06 138.76 57.8 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.051 -1.03 . . . . 0.0 110.235 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.4 mttp . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 117.944 -1.026 . . . . 0.0 110.174 -179.916 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.71 -19.96 50.15 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -67.88 -40.33 83.55 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.288 -1.125 . . . . 0.0 110.153 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 -70.0 -39.21 76.0 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.534 -0.729 . . . . 0.0 111.021 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -59.94 -40.06 87.67 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.585 -0.697 . . . . 0.0 110.719 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . 0.407 HG13 ' N ' ' B' ' 161' ' ' ALA . 24.8 pt -76.21 -27.56 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.479 -0.763 . . . . 0.0 110.791 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . 0.407 ' N ' HG13 ' B' ' 160' ' ' ILE . . . -66.27 -39.93 89.78 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.354 -0.841 . . . . 0.0 110.528 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -60.06 -40.64 90.18 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.572 -0.705 . . . . 0.0 111.031 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.58 -40.07 95.71 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.272 -0.892 . . . . 0.0 110.818 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 67.9 t -64.26 -40.1 87.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.524 -0.735 . . . . 0.0 110.896 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.24 -40.05 91.12 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 94.4 t -76.38 -14.8 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.459 -1.024 . . . . 0.0 111.344 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 10.1 tt -60.01 -50.01 75.43 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.177 -0.952 . . . . 0.0 111.416 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -68.46 -39.95 81.23 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.249 -0.907 . . . . 0.0 110.486 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.07 -31.01 69.61 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.393 -0.817 . . . . 0.0 110.078 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 170' ' ' TRP . . . . . 0.437 ' CD1' ' CE ' ' A' ' 36' ' ' MET . 5.2 t-105 -59.97 -46.31 89.85 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.67 -0.644 . . . . 0.0 110.271 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.0 -51.39 69.85 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.461 -0.774 . . . . 0.0 110.242 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -60.11 -36.87 78.42 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.519 -0.738 . . . . 0.0 110.216 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.591 -0.693 . . . . 0.0 110.151 179.723 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 121.33 0.586 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 89.7 mt -60.79 -29.02 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.706 -0.621 . . . . 0.0 111.513 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -61.25 -37.88 84.67 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.047 -1.033 . . . . 0.0 109.788 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.9 -47.63 84.98 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.534 -0.729 . . . . 0.0 110.194 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.401 ' CE1' ' HE3' ' A' ' 72' ' ' MET . 26.5 m-85 -67.53 -25.25 65.74 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.632 -0.667 . . . . 0.0 110.627 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 22.9 tptp -67.37 -53.44 29.39 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.59 0.71 . . . . 0.0 109.251 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.4 -48.03 77.74 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.891 -0.505 . . . . 0.0 110.696 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.04 -20.34 63.26 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.227 -0.92 . . . . 0.0 111.32 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -60.02 -48.21 82.67 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.181 -0.95 . . . . 0.0 110.789 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.0 m -63.88 -39.24 93.72 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.278 -0.889 . . . . 0.0 108.778 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.8 tp -63.82 -39.96 95.48 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.04 -34.2 72.95 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -92.13 94.68 9.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.685 -0.634 . . . . 0.0 109.516 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -59.9 -36.6 77.3 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.53 -0.731 . . . . 0.0 112.177 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -79.17 -9.76 59.65 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.06 -1.025 . . . . 0.0 111.392 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.96 22.37 57.54 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -85.4 -8.6 58.34 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.429 -1.042 . . . . 0.0 110.542 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.96 6.64 53.9 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.518 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.5 p -147.81 143.02 27.19 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 119.32 1.56 . . . . 0.0 112.03 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.3 mt -100.41 124.34 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.3 p -100.98 140.57 35.09 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.706 -0.621 . . . . 0.0 110.835 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 7.1 p -42.08 -32.68 0.48 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.902 -0.499 . . . . 0.0 112.159 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -65.33 -49.1 70.73 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.731 0.777 . . . . 0.0 109.626 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -59.87 -53.69 54.93 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.976 -0.452 . . . . 0.0 111.092 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.4 tp -61.53 -34.91 76.34 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.218 -0.926 . . . . 0.0 111.063 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.51 -32.16 60.8 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.6 m -75.96 -41.26 52.02 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.671 -0.899 . . . . 0.0 111.044 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.7 t -62.7 -59.14 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.431 -0.793 . . . . 0.0 109.658 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.4 ptm -57.72 -20.78 36.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.67 -0.644 . . . . 0.0 110.467 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.2 ttt85 -59.9 -40.0 87.27 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.348 -0.845 . . . . 0.0 109.378 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.7 t -69.84 -16.35 63.25 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.897 -0.502 . . . . 0.0 111.735 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.6 mp -93.6 -10.06 35.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.305 -0.872 . . . . 0.0 110.756 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.16 -61.52 0.17 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -167.33 172.46 9.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.447 -1.031 . . . . 0.0 110.943 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -119.46 137.14 25.09 Favored Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.65 -149.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.332 0 O-C-N 123.19 1.1 . . . . 0.0 109.819 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -137.08 160.61 38.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.05 -1.031 . . . . 0.0 110.2 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -52.38 -25.31 9.48 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.897 -0.502 . . . . 0.0 112.305 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.16 -60.06 2.52 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.208 1.004 . . . . 0.0 108.85 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -66.82 -37.6 84.83 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.542 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.423 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 6.3 mt -57.71 -35.12 70.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.639 -0.663 . . . . 0.0 109.908 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.51 -40.11 95.67 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.779 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -65.49 -39.92 92.47 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.607 -0.683 . . . . 0.0 111.252 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 65.0 mtt -60.02 -43.21 95.41 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.716 0.77 . . . . 0.0 109.443 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.9 mm -66.2 -37.64 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 121.21 0.528 . . . . 0.0 110.475 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -60.0 -40.78 90.4 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.506 -0.746 . . . . 0.0 111.212 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -67.43 -27.95 67.48 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.195 -0.94 . . . . 0.0 110.541 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 49.8 t -99.97 -10.07 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.565 -0.709 . . . . 0.0 111.557 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -71.05 95.04 1.16 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.088 -1.008 . . . . 0.0 111.542 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.06 93.22 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.71 -0.619 . . . . 0.0 109.563 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -92.58 -29.27 16.25 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.648 -0.657 . . . . 0.0 110.952 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.56 20.49 34.54 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.0 p-10 -74.74 -32.76 62.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.344 -1.092 . . . . 0.0 110.35 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 118.65 5.24 12.52 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 120.277 -0.963 . . . . 0.0 111.24 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 80.9 p -136.43 170.17 16.48 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.189 -1.183 . . . . 0.0 111.077 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.8 mt -105.06 120.55 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.286 0.565 . . . . 0.0 110.886 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -100.05 165.4 11.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.721 -0.612 . . . . 0.0 109.934 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.5 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 16.2 t80 -48.7 -49.27 66.85 Favored Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 121.486 -0.759 . . . . 0.0 112.499 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 38.7 Cg_endo -64.23 -35.54 51.36 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 O-C-N 122.766 0.877 . . . . 0.0 111.173 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.96 -40.03 75.65 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.165 -0.959 . . . . 0.0 110.322 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -61.99 -42.86 99.61 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.59 -0.693 . . . . 0.0 111.3 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.68 -42.97 94.97 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.395 -0.816 . . . . 0.0 111.205 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.1 m -61.97 -40.03 94.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.649 -0.657 . . . . 0.0 111.111 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 56.2 ttp -68.35 -40.96 81.36 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.473 -0.767 . . . . 0.0 112.148 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.401 ' HE3' ' CE1' ' A' ' 12' ' ' PHE . 92.6 mmm -61.53 -45.49 93.95 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.296 -0.877 . . . . 0.0 111.131 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.67 -32.43 73.49 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.856 -0.528 . . . . 0.0 110.982 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -72.04 -39.98 68.7 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.435 -0.791 . . . . 0.0 110.292 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -62.5 -39.98 95.22 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.617 -0.677 . . . . 0.0 112.362 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 35.9 mmt -57.82 -33.21 68.37 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.185 -0.947 . . . . 0.0 110.736 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -69.69 -56.75 6.36 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.554 0.693 . . . . 0.0 110.572 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -69.16 -35.86 76.76 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.525 0.679 . . . . 0.0 110.436 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.1 m -86.07 -174.68 5.21 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.858 -0.526 . . . . 0.0 110.224 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -134.0 149.94 51.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.321 -0.862 . . . . 0.0 109.964 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.3 t -65.82 -33.74 76.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.7 -0.625 . . . . 0.0 109.556 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -63.77 -33.87 76.62 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.644 0.735 . . . . 0.0 109.181 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.56 -39.98 77.05 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.332 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -63.83 -36.35 83.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.594 -0.691 . . . . 0.0 109.934 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 77.4 mt -64.48 -49.96 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.668 -0.645 . . . . 0.0 110.821 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -57.14 -39.94 76.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.176 -0.953 . . . . 0.0 111.019 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.0 -40.02 75.53 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.54 -0.725 . . . . 0.0 111.471 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.55 -49.25 69.57 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.423 -0.798 . . . . 0.0 112.244 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -60.37 -40.42 90.71 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.247 -0.908 . . . . 0.0 109.429 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -59.98 -37.57 80.0 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.666 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 94.1 t -69.75 -53.41 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.419 -0.801 . . . . 0.0 110.797 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -63.43 -39.76 95.36 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.355 -0.841 . . . . 0.0 110.882 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -80.98 72.02 7.98 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.531 -0.731 . . . . 0.0 110.006 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -61.83 -41.72 98.14 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.211 -0.93 . . . . 0.0 109.859 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.0 p-10 -73.16 -22.22 60.55 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.567 -0.708 . . . . 0.0 110.995 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.2 25.06 73.53 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -71.2 -12.49 61.5 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.322 -1.105 . . . . 0.0 111.541 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.85 -16.69 59.24 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.415 ' CD2' ' OD1' ' A' ' 137' ' ' ASN . 60.1 m-85 -123.18 136.36 54.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.19 -1.182 . . . . 0.0 109.148 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.436 ' CG2' ' CD2' ' A' ' 105' ' ' LEU . 61.4 mt -89.8 120.07 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.423 -0.798 . . . . 0.0 109.922 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.2 m -90.07 170.56 10.22 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.329 0.585 . . . . 0.0 110.686 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.73 -35.99 72.97 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.666 -0.646 . . . . 0.0 109.358 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.43 -35.57 79.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.735 -0.603 . . . . 0.0 109.584 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.22 -37.88 78.26 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.659 -0.65 . . . . 0.0 110.776 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.436 ' CD2' ' CG2' ' A' ' 100' ' ' ILE . 1.3 mm? -66.92 -41.66 86.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.552 -0.717 . . . . 0.0 110.279 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -60.06 -37.8 80.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.695 -0.628 . . . . 0.0 110.717 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -60.66 -42.79 97.72 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.456 -0.778 . . . . 0.0 112.419 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.3 t -74.04 -50.9 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 O-C-N 121.159 -0.963 . . . . 0.0 111.827 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 78.1 mtm -59.55 -40.21 86.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.116 -0.99 . . . . 0.0 110.205 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.2 m -64.72 -45.63 85.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.645 -0.659 . . . . 0.0 109.325 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -61.36 -33.63 73.97 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.6 mt -69.98 -36.12 74.96 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.141 0.496 . . . . 0.0 109.836 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.41 30.72 1.65 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -119.93 127.34 52.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.464 -1.021 . . . . 0.0 109.701 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -100.11 120.96 40.67 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.654 -0.654 . . . . 0.0 110.824 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.5 mp -137.72 155.39 49.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.567 -0.708 . . . . 0.0 110.051 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.38 166.92 16.97 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -64.65 -24.76 67.69 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.178 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -68.66 -35.87 77.8 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.683 0.754 . . . . 0.0 109.278 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -64.8 -36.11 83.27 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.6 t -70.04 -38.62 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-O 121.427 0.632 . . . . 0.0 110.178 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -59.79 -46.54 88.9 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.573 -0.705 . . . . 0.0 110.227 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -60.1 -39.97 88.0 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.805 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 67.6 mtt -54.7 -40.01 68.75 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.353 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.64 -38.04 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.716 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -59.38 -40.02 85.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.507 -0.746 . . . . 0.0 111.938 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.88 -40.0 91.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.448 -0.782 . . . . 0.0 112.012 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.14 -17.16 16.79 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.276 -0.89 . . . . 0.0 111.388 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -85.8 74.99 10.11 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.271 -0.893 . . . . 0.0 110.538 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.7 -40.04 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.725 -0.609 . . . . 0.0 109.841 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 27.9 p-10 -58.76 -38.92 79.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.551 -0.718 . . . . 0.0 110.766 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.86 16.05 40.29 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 120.224 -0.988 . . . . 0.0 111.073 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.59 -10.81 59.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.127 -1.219 . . . . 0.0 110.238 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.47 3.54 74.84 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.476 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -134.79 136.36 42.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.093 -1.24 . . . . 0.0 110.666 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.8 t -92.11 120.01 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.47 -0.768 . . . . 0.0 110.033 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.415 ' OD1' ' CD2' ' A' ' 99' ' ' TYR . 84.8 m-20 -96.41 -175.03 3.22 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.453 0.644 . . . . 0.0 110.381 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -60.0 -49.98 75.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.837 -0.539 . . . . 0.0 110.188 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -60.08 -44.75 94.55 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.374 -0.829 . . . . 0.0 111.279 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -62.32 -39.03 91.72 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.04 0.924 . . . . 0.0 109.353 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -60.01 -41.86 93.06 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.697 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 92.9 t -67.65 -40.05 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.378 -0.826 . . . . 0.0 110.844 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -59.97 -39.98 87.51 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.472 -0.767 . . . . 0.0 110.498 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 46.2 ttp -60.04 -40.55 89.79 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.66 -0.65 . . . . 0.0 110.588 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 61.1 mtt -76.72 -34.24 58.14 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.419 -0.801 . . . . 0.0 109.95 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.0 m -92.7 23.62 4.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.793 -0.567 . . . . 0.0 111.016 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.49 89.03 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.353 -0.842 . . . . 0.0 110.474 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.146 -179.847 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 82.2 7.15 88.11 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -60.05 -47.97 83.65 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.038 -1.272 . . . . 0.0 109.472 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -61.4 -38.78 88.32 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.856 -0.528 . . . . 0.0 111.136 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -60.09 -39.9 87.74 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.389 -0.819 . . . . 0.0 110.707 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 85.4 mt -69.07 -40.06 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.441 -0.787 . . . . 0.0 110.214 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.0 -44.47 94.53 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.616 -0.677 . . . . 0.0 110.969 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -60.49 -40.79 92.6 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.34 -0.85 . . . . 0.0 110.5 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 40.4 tp -61.27 -40.6 94.7 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.503 -0.748 . . . . 0.0 109.972 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 93.1 t -60.59 -40.0 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.697 -0.627 . . . . 0.0 109.871 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -53.91 -36.15 55.03 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 98.3 t -77.71 -29.87 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.606 -0.938 . . . . 0.0 110.33 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 3.7 tt -59.98 -50.72 72.62 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.512 -0.743 . . . . 0.0 111.515 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -60.27 -40.09 89.14 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.369 -0.832 . . . . 0.0 111.164 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -59.91 -35.32 74.62 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.49 -0.756 . . . . 0.0 110.695 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -59.69 -39.97 86.3 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.477 -0.765 . . . . 0.0 110.25 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.05 79.2 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.296 -0.878 . . . . 0.0 110.306 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -60.06 -39.64 86.69 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.337 -0.852 . . . . 0.0 109.347 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.286 0.565 . . . . 0.0 110.056 179.381 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 121.458 0.647 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 83.8 mt -57.11 -29.62 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.806 -0.559 . . . . 0.0 111.044 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.94 -39.54 94.39 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.194 -0.941 . . . . 0.0 110.419 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -60.07 -42.62 94.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.37 -0.831 . . . . 0.0 109.88 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -63.32 -20.88 65.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.865 -0.522 . . . . 0.0 111.068 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.429 ' HD3' ' CZ ' ' A' ' 65' ' ' PHE . 40.3 mmtt -66.87 -40.22 87.76 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.203 -0.936 . . . . 0.0 108.988 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -64.25 -58.31 6.93 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.976 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.86 -26.95 68.44 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.36 -0.837 . . . . 0.0 112.545 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -58.36 -48.31 81.01 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.753 -1.217 . . . . 0.0 111.013 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.4 p -62.33 -37.17 84.58 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.186 -0.947 . . . . 0.0 109.481 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.2 tp -60.09 -40.01 88.11 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.583 0.706 . . . . 0.0 109.499 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -74.81 -36.69 62.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.875 -0.516 . . . . 0.0 110.974 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -94.91 97.78 10.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.441 -0.787 . . . . 0.0 110.131 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -65.67 -31.98 73.29 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.499 -0.75 . . . . 0.0 111.077 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -80.04 -10.43 59.77 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.214 -0.929 . . . . 0.0 111.166 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.34 25.66 55.06 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -88.46 -8.08 55.51 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.543 -0.974 . . . . 0.0 110.902 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.31 2.72 56.71 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 120.054 -1.07 . . . . 0.0 111.751 178.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.8 p -143.4 141.5 30.9 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-N 119.464 1.632 . . . . 0.0 111.966 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 83.9 mt -100.88 121.32 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.737 -0.602 . . . . 0.0 109.458 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.1 m -102.33 141.86 34.48 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.59 -0.694 . . . . 0.0 110.389 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.41 ' CG2' HG13 ' A' ' 52' ' ' ILE . 40.6 p -41.96 -29.79 0.24 Allowed 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.643 -0.66 . . . . 0.0 112.211 -177.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -63.41 -52.08 63.09 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.333 -0.854 . . . . 0.0 109.364 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.04 -53.73 54.3 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.487 -178.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.0 tp -59.83 -36.49 76.93 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.092 -1.005 . . . . 0.0 110.672 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.77 -31.0 37.35 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.4 m -69.97 -40.1 75.57 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.616 -0.932 . . . . 0.0 110.24 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.22 -55.21 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.53 -0.731 . . . . 0.0 109.512 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.419 ' HE2' ' CG ' ' B' ' 170' ' ' TRP . 69.0 mtt -58.48 -30.46 67.0 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.333 0.587 . . . . 0.0 110.044 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -59.88 -50.04 75.34 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 t -70.76 -18.8 62.76 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.803 -0.561 . . . . 0.0 110.436 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.7 mt -84.96 -21.87 29.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.293 -0.88 . . . . 0.0 110.576 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.77 -45.46 0.19 Allowed Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.937 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -161.44 159.95 28.73 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.11 -1.229 . . . . 0.0 111.957 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -114.42 105.1 54.2 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -61.36 -149.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.503 0 O-C-N 123.306 1.161 . . . . 0.0 110.734 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.23 160.54 39.17 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.93 -1.106 . . . . 0.0 111.174 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -53.78 -22.02 8.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.936 -0.478 . . . . 0.0 111.939 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.01 -59.23 3.04 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -67.27 -38.67 85.46 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.553 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.2 mt -58.71 -33.17 69.88 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.865 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -40.0 94.78 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.497 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -64.79 -40.03 94.57 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.649 -0.657 . . . . 0.0 110.928 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 66.6 mtt -61.3 -43.41 98.91 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.685 -0.634 . . . . 0.0 109.748 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.41 HG13 ' CG2' ' A' ' 29' ' ' THR . 48.4 mm -66.88 -36.24 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.849 -0.532 . . . . 0.0 110.746 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -60.01 -41.95 93.24 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.391 -0.818 . . . . 0.0 110.633 -178.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -69.88 -27.69 65.02 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.226 -0.921 . . . . 0.0 111.355 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.2 t -99.21 -10.02 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.316 -0.865 . . . . 0.0 111.835 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -71.53 96.88 1.58 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.089 -1.007 . . . . 0.0 111.302 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.23 -37.43 80.82 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.406 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -90.58 -27.01 19.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.733 -0.604 . . . . 0.0 110.433 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.99 20.34 43.34 Favored Glycine 0 N--CA 1.495 2.567 0 C-N-CA 120.458 -0.877 . . . . 0.0 110.923 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -76.27 -28.62 57.12 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.449 -1.03 . . . . 0.0 110.565 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.35 2.06 23.2 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.174 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.3 p -134.1 167.78 20.01 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.152 -1.204 . . . . 0.0 110.527 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.7 mt -103.53 119.94 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.228 -178.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -97.71 167.56 10.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.666 -0.646 . . . . 0.0 109.889 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.481 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 10.5 t80 -48.27 -48.63 64.99 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.52 -0.737 . . . . 0.0 112.45 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.5 Cg_endo -67.0 -34.4 29.21 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 O-C-N 122.895 0.945 . . . . 0.0 111.088 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.9 -39.92 69.23 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.181 -0.95 . . . . 0.0 110.887 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -62.32 -40.43 96.29 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.451 -0.781 . . . . 0.0 111.422 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.41 HD13 ' CD1' ' A' ' 65' ' ' PHE . 4.6 mp -69.63 -40.01 76.8 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.221 -0.924 . . . . 0.0 111.611 -178.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.8 p -61.22 -40.03 92.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.364 -0.835 . . . . 0.0 110.853 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 50.7 ttp -67.49 -52.05 43.86 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.525 -0.734 . . . . 0.0 112.044 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 49.8 ttm -59.98 -49.71 76.6 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.314 -0.866 . . . . 0.0 111.948 -178.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.99 -36.02 76.27 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.547 -0.72 . . . . 0.0 110.341 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -77.23 -43.55 33.16 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.606 0.717 . . . . 0.0 110.14 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -61.01 -48.12 83.29 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.757 -0.589 . . . . 0.0 111.973 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 27.8 ptm -59.94 -36.12 76.37 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.261 -0.9 . . . . 0.0 110.679 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -68.17 -42.93 79.27 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.695 0.759 . . . . 0.0 109.299 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -68.43 -30.93 69.93 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.691 0.758 . . . . 0.0 109.273 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.2 m -94.53 -174.11 3.23 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -120.73 141.63 50.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.109 -0.995 . . . . 0.0 109.808 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.3 t -60.06 -29.57 68.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.65 -0.656 . . . . 0.0 110.173 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.0 -37.34 79.42 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.698 0.761 . . . . 0.0 109.192 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -70.06 -39.98 75.35 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.19 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -64.08 -39.75 94.75 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.704 -0.623 . . . . 0.0 110.767 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.92 -49.68 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.63 -0.669 . . . . 0.0 110.465 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -57.7 -40.09 78.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.336 -0.852 . . . . 0.0 111.16 -178.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.03 -39.99 75.44 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.336 -0.853 . . . . 0.0 111.666 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.52 -47.21 73.64 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.331 -0.856 . . . . 0.0 111.287 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -60.01 -47.52 85.51 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.587 -0.695 . . . . 0.0 110.138 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -59.93 -36.35 76.85 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.683 -0.636 . . . . 0.0 110.325 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.5 t -66.92 -46.39 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.568 -0.707 . . . . 0.0 109.699 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.422 ' CD1' HD23 ' A' ' 105' ' ' LEU . 14.3 m-85 -69.91 -38.58 76.3 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.461 -0.774 . . . . 0.0 111.324 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -75.34 78.33 2.42 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.51 -0.744 . . . . 0.0 110.571 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -59.92 -47.91 83.85 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.622 -0.674 . . . . 0.0 110.178 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -78.08 -18.57 55.59 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.505 -0.747 . . . . 0.0 111.239 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.98 28.58 72.27 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -73.91 -8.96 58.06 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.414 -1.05 . . . . 0.0 111.401 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.39 -17.61 50.48 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -129.99 138.44 50.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.315 -1.109 . . . . 0.0 108.87 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.429 ' CG2' ' CD2' ' A' ' 105' ' ' LEU . 32.9 mt -89.05 124.41 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.368 -0.833 . . . . 0.0 110.435 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.4 m -88.65 171.01 10.33 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.242 0.544 . . . . 0.0 110.384 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.84 -40.07 83.78 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.663 -0.648 . . . . 0.0 109.582 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.55 -38.51 91.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.76 -0.588 . . . . 0.0 109.604 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.85 -40.28 91.58 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.781 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.429 ' CD2' ' CG2' ' A' ' 100' ' ' ILE . 0.2 OUTLIER -63.1 -44.76 94.79 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.505 -0.747 . . . . 0.0 110.462 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -60.29 -30.9 69.77 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.633 -0.667 . . . . 0.0 110.385 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -60.18 -49.95 75.6 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.561 -0.712 . . . . 0.0 111.456 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.3 t -74.26 -52.32 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 O-C-N 121.234 -0.916 . . . . 0.0 112.168 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 99.4 mtp -56.56 -42.68 78.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.123 -0.986 . . . . 0.0 110.511 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.6 m -65.16 -46.7 79.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.707 -0.621 . . . . 0.0 109.668 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -62.01 -33.69 74.81 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.9 mt -70.03 -33.43 71.97 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.701 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.27 40.8 0.42 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -138.02 132.84 32.82 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.5 -1.0 . . . . 0.0 110.142 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -106.82 141.3 38.28 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.477 -0.764 . . . . 0.0 110.303 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -158.73 157.82 32.47 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.624 0.726 . . . . 0.0 110.769 179.231 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.3 p -85.66 167.57 15.2 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.632 -0.667 . . . . 0.0 109.802 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -65.47 -26.69 68.05 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -69.92 -37.34 75.91 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.909 0.862 . . . . 0.0 109.204 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -63.43 -40.02 96.03 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.44 1.114 . . . . 0.0 108.378 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.7 t -67.21 -39.97 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.033 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -60.07 -45.81 91.63 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.568 -0.707 . . . . 0.0 110.041 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -59.96 -40.09 87.86 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.724 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 66.7 mtt -56.24 -37.68 70.07 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.184 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 89.4 mt -65.21 -38.56 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.812 0.815 . . . . 0.0 109.047 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.4 ttt180 -58.51 -39.63 80.63 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.057 0.456 . . . . 0.0 111.391 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -60.06 -39.95 87.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.709 -0.619 . . . . 0.0 111.845 -178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.2 -10.45 15.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.208 -0.933 . . . . 0.0 112.011 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -74.25 69.94 1.61 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.1 -1.0 . . . . 0.0 110.414 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.0 mt -68.2 -40.0 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.587 -0.696 . . . . 0.0 110.503 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -69.3 -24.31 63.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.377 -0.827 . . . . 0.0 111.017 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.89 24.67 48.28 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.96 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -82.57 -10.0 59.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -1.125 . . . . 0.0 110.802 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.33 -1.39 79.5 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -138.23 150.39 46.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -1.105 . . . . 0.0 109.38 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.53 118.87 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.408 -0.807 . . . . 0.0 109.944 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -89.93 -170.73 2.9 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.682 0.754 . . . . 0.0 110.397 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -69.87 -40.03 75.98 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.502 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -60.15 -47.82 84.33 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.3 -0.875 . . . . 0.0 112.249 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -62.74 -37.74 87.77 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.927 0.87 . . . . 0.0 110.043 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -59.97 -50.04 75.32 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.37 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.411 HG22 ' N ' ' A' ' 143' ' ' GLN . 36.0 m -70.12 -41.05 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.411 ' N ' HG22 ' A' ' 142' ' ' VAL . 57.0 tt0 -59.97 -51.04 71.36 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.184 -0.947 . . . . 0.0 111.314 -178.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.9 ttp -62.38 -37.73 86.85 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.447 -0.783 . . . . 0.0 109.927 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 90.6 mmm -69.82 -39.35 76.53 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.848 -0.533 . . . . 0.0 109.967 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 71.4 p -82.56 0.39 42.94 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.499 -0.751 . . . . 0.0 111.039 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.94 -40.0 87.47 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.138 -0.976 . . . . 0.0 110.477 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.2 mttt . . . . . 0 N--CA 1.496 1.825 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.347 -179.781 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -77.0 141.4 26.13 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -60.05 -41.57 92.59 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.59 -0.947 . . . . 0.0 110.595 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 21.3 ptt-85 -60.04 -39.97 87.77 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.626 -0.671 . . . . 0.0 111.51 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 30.1 mtp-105 -61.62 -39.97 93.17 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.494 -0.754 . . . . 0.0 110.458 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 88.8 mt -66.39 -39.96 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.569 -0.707 . . . . 0.0 110.481 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.95 87.42 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.558 -0.714 . . . . 0.0 110.708 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -60.0 -42.31 93.98 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.547 -0.721 . . . . 0.0 111.457 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 42.6 tp -65.0 -40.9 95.62 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.3 -0.875 . . . . 0.0 110.83 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 66.9 t -61.09 -39.99 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.588 -0.695 . . . . 0.0 110.751 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.07 -40.15 82.08 Favored Glycine 0 N--CA 1.495 2.597 0 O-C-N 121.447 -0.783 . . . . 0.0 111.759 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 15.0 p -76.33 -24.46 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.096 -1.238 . . . . 0.0 112.53 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 85.7 mt -59.96 -49.09 79.03 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.953 -1.092 . . . . 0.0 110.969 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -61.72 -40.0 93.5 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.314 -0.866 . . . . 0.0 110.704 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.34 -26.01 68.21 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.473 -0.767 . . . . 0.0 109.872 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 170' ' ' TRP . . . . . 0.419 ' CG ' ' HE2' ' A' ' 36' ' ' MET . 2.2 t90 -59.99 -41.73 92.7 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.593 -0.692 . . . . 0.0 109.721 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.97 -50.5 73.5 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.461 -0.774 . . . . 0.0 110.78 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -60.16 -39.89 87.98 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.451 -0.781 . . . . 0.0 110.378 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 . . . . . 0 N--CA 1.495 1.778 0 O-C-N 121.611 -0.681 . . . . 0.0 110.127 -179.982 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 121.306 0.574 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.3 mt -59.93 -31.87 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.727 -0.608 . . . . 0.0 110.98 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.11 -39.38 86.02 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.249 -0.907 . . . . 0.0 110.287 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -60.04 -40.0 87.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.541 -0.725 . . . . 0.0 110.349 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -65.52 -22.83 66.76 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.486 -0.759 . . . . 0.0 110.841 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.428 ' HD3' ' CE1' ' A' ' 65' ' ' PHE . 46.7 mmtt -68.77 -39.99 79.96 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.84 -56.82 13.97 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 120.311 -0.555 . . . . 0.0 110.542 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.38 -25.89 67.48 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.295 -0.878 . . . . 0.0 112.19 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.517 ' CG ' ' CZ ' ' A' ' 65' ' ' PHE . 51.1 t80 -59.99 -43.61 95.03 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.112 -0.993 . . . . 0.0 110.714 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 98.4 p -62.13 -35.34 78.45 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.34 -0.85 . . . . 0.0 110.123 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.8 tt -66.7 -39.97 88.3 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -70.01 -40.06 75.49 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -91.59 88.75 6.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.782 -0.574 . . . . 0.0 110.139 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -59.98 -33.22 71.66 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.439 -0.788 . . . . 0.0 111.297 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -80.18 -10.07 59.74 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.113 -0.992 . . . . 0.0 111.236 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 58.02 26.07 57.7 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -88.07 -7.17 57.39 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.507 -0.996 . . . . 0.0 111.096 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.87 3.47 58.11 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.199 -1.001 . . . . 0.0 111.568 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.2 p -143.22 141.25 31.03 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 119.181 1.491 . . . . 0.0 111.484 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.5 mt -98.51 120.06 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.0 p -84.05 175.77 9.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.431 -0.793 . . . . 0.0 109.875 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 78.3 p -76.21 -32.34 58.9 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.592 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -67.84 -41.65 82.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.526 -0.734 . . . . 0.0 110.708 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -60.54 -57.46 12.65 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.605 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.5 tp -59.96 -39.19 84.78 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.368 -0.832 . . . . 0.0 111.057 -178.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -48.1 -29.79 6.96 Favored Glycine 0 N--CA 1.502 3.08 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.5 m -68.14 -40.0 82.52 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.442 -1.034 . . . . 0.0 108.928 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.5 t -64.13 -44.41 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 CA-C-O 121.306 0.574 . . . . 0.0 110.128 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 95.9 mtp -59.99 -39.99 87.65 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.604 -0.685 . . . . 0.0 110.554 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.408 ' HG2' ' HB2' ' A' ' 42' ' ' ASN . 1.1 mmt85 -61.02 -38.44 86.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.424 -0.797 . . . . 0.0 109.504 178.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.4 t -64.35 -26.7 68.59 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.887 -0.508 . . . . 0.0 110.613 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.3 mt -93.39 -16.1 24.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.298 -0.876 . . . . 0.0 110.228 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.05 -66.3 0.12 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -161.34 170.01 20.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.258 -1.142 . . . . 0.0 111.708 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.408 ' HB2' ' HG2' ' A' ' 37' ' ' ARG . 29.9 t30 -112.79 129.0 24.88 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.882 -0.511 . . . . 0.0 110.136 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.6 -143.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.264 0 O-C-N 123.142 1.075 . . . . 0.0 109.398 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.5 p -128.48 156.17 43.66 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.648 -1.282 . . . . 0.0 111.444 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -51.9 -22.59 3.95 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.78 -0.575 . . . . 0.0 111.844 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.13 -56.18 6.02 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 122.233 1.016 . . . . 0.0 108.523 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.4 -34.3 76.97 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.479 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 mt -57.22 -35.52 69.76 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.611 -0.681 . . . . 0.0 109.991 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -72.63 -30.29 64.18 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 120.191 -0.603 . . . . 0.0 111.708 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -69.14 -40.16 78.42 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.224 -0.923 . . . . 0.0 110.531 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 78.1 mtm -65.12 -40.02 93.88 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.682 0.754 . . . . 0.0 109.216 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 92.6 mt -67.38 -34.48 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.832 -0.543 . . . . 0.0 110.507 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -60.08 -39.98 87.96 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.233 -0.917 . . . . 0.0 112.073 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -66.03 -27.77 68.35 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.051 -1.031 . . . . 0.0 110.75 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -97.34 -9.33 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.598 -0.689 . . . . 0.0 110.55 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -69.44 97.63 1.01 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.283 -0.886 . . . . 0.0 110.603 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.08 -38.62 91.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.658 -0.651 . . . . 0.0 109.4 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -90.33 -31.58 16.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.726 -0.609 . . . . 0.0 110.812 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.6 21.58 36.75 Favored Glycine 0 N--CA 1.496 2.653 0 C-N-CA 120.336 -0.935 . . . . 0.0 110.832 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -73.93 -33.61 64.01 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.441 -1.035 . . . . 0.0 110.576 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.05 -2.31 7.86 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 120.437 -0.887 . . . . 0.0 110.957 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.8 p -136.19 167.33 21.48 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.014 -1.286 . . . . 0.0 110.621 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.413 HD11 HG22 ' A' ' 63' ' ' ILE . 7.9 mt -107.76 123.78 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 121.596 0.712 . . . . 0.0 111.464 -177.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -99.58 171.22 8.06 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.54 0.685 . . . . 0.0 111.044 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.517 ' CZ ' ' CG ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -47.65 -50.03 53.2 Favored Pre-proline 0 N--CA 1.503 2.184 0 O-C-N 121.653 -0.654 . . . . 0.0 112.519 -179.507 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.7 Cg_endo -69.52 -35.33 13.54 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 122.92 0.958 . . . . 0.0 111.671 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.99 -39.93 75.63 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.23 -0.919 . . . . 0.0 109.8 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -61.66 -41.67 97.85 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.205 0.526 . . . . 0.0 110.775 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.3 mt -65.34 -39.97 93.06 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.479 -0.763 . . . . 0.0 111.941 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.9 p -59.98 -39.96 87.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.249 -0.907 . . . . 0.0 110.614 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 61.3 ttp -67.36 -40.0 85.77 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.558 -0.714 . . . . 0.0 110.986 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -59.95 -50.15 74.9 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.53 -0.731 . . . . 0.0 111.928 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.84 -29.95 67.33 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.541 -0.725 . . . . 0.0 111.877 -178.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -69.97 -40.11 75.58 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.364 -0.835 . . . . 0.0 111.281 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -69.97 -27.18 64.51 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 38.8 mmt -59.33 -49.03 79.38 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.03 -1.044 . . . . 0.0 112.229 -177.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.6 pttt -69.24 -33.87 73.95 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.263 -0.898 . . . . 0.0 111.936 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -70.02 -19.96 63.29 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.462 -0.773 . . . . 0.0 111.341 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.3 t -118.2 -166.82 1.26 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.11 0.957 . . . . 0.0 112.427 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -128.52 137.97 52.03 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.639 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.9 t -60.7 -32.43 71.67 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.649 -0.657 . . . . 0.0 110.652 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -59.99 -33.8 72.45 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.561 -0.712 . . . . 0.0 110.127 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -69.96 -40.0 75.67 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.742 -0.599 . . . . 0.0 110.747 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -69.39 -33.26 72.76 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.503 -0.748 . . . . 0.0 110.469 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 91.9 mt -64.81 -49.62 79.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.724 -0.61 . . . . 0.0 110.407 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -57.87 -38.4 75.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.444 -0.785 . . . . 0.0 111.02 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.0 -42.06 73.54 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.66 -0.65 . . . . 0.0 111.617 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.3 -45.65 79.68 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.487 -0.758 . . . . 0.0 111.779 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -60.01 -45.99 90.96 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.382 -0.824 . . . . 0.0 109.449 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -59.99 -33.93 72.63 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.682 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 83.3 t -69.04 -47.87 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.441 -0.787 . . . . 0.0 109.829 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -70.02 -39.76 75.6 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.514 -0.741 . . . . 0.0 111.501 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -80.05 80.03 6.52 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.406 -0.809 . . . . 0.0 110.186 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -69.97 -42.07 73.64 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.413 -0.804 . . . . 0.0 110.932 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -72.78 -23.41 60.8 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.415 -0.803 . . . . 0.0 111.046 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.71 24.54 75.42 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -70.7 -9.73 57.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.504 -0.997 . . . . 0.0 111.131 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.69 -11.72 66.35 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -133.18 139.31 46.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.187 -1.184 . . . . 0.0 109.076 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.413 ' CG2' ' CD2' ' A' ' 105' ' ' LEU . 56.7 mt -89.37 123.25 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.532 -0.73 . . . . 0.0 110.042 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.4 m -86.96 170.14 11.85 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.405 0.621 . . . . 0.0 110.297 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.99 -39.91 75.63 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.632 -0.668 . . . . 0.0 109.749 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.25 -39.29 94.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.772 -0.58 . . . . 0.0 109.668 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -60.16 -39.89 87.97 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.606 -0.684 . . . . 0.0 110.386 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.413 ' CD2' ' CG2' ' A' ' 100' ' ' ILE . 0.5 OUTLIER -68.21 -41.23 81.63 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.484 0.659 . . . . 0.0 110.655 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -61.09 -37.03 81.27 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.656 -0.652 . . . . 0.0 111.746 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -59.97 -43.32 95.14 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.142 -0.974 . . . . 0.0 111.848 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.4 t -74.85 -44.24 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.237 -0.914 . . . . 0.0 111.631 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 94.5 mmm -58.25 -46.77 85.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.28 -0.888 . . . . 0.0 110.317 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.4 m -67.51 -41.07 85.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.46 -0.775 . . . . 0.0 109.202 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -61.55 -32.94 73.04 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.5 mt -68.52 -37.36 79.96 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.079 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 119.82 38.27 0.72 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -129.67 140.45 51.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.645 -0.915 . . . . 0.0 109.792 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -107.94 109.18 20.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.439 -0.788 . . . . 0.0 110.579 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 56.2 mt -131.59 156.2 46.18 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.598 -0.689 . . . . 0.0 109.753 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.3 m -84.0 164.76 19.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.626 -0.671 . . . . 0.0 109.744 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -61.13 -26.76 67.9 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.586 -0.696 . . . . 0.0 109.142 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.95 -31.85 73.0 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -37.34 87.26 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 73.1 t -70.64 -39.7 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.533 0.682 . . . . 0.0 110.201 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -59.89 -44.62 94.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.789 -0.57 . . . . 0.0 109.994 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -60.55 -41.33 94.34 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.579 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 67.6 mtt -55.6 -37.69 68.44 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 119.48 -0.888 . . . . 0.0 108.939 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.94 -39.93 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -58.64 -39.97 82.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.57 -0.706 . . . . 0.0 111.53 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -61.46 -40.0 92.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.398 -0.814 . . . . 0.0 111.86 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -102.93 -5.06 23.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.168 -0.957 . . . . 0.0 111.921 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -89.3 69.95 8.17 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.916 -1.115 . . . . 0.0 110.518 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.3 mt -70.03 -40.37 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.519 -0.738 . . . . 0.0 111.247 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -62.84 -39.96 95.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.357 -0.839 . . . . 0.0 111.207 -178.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 103.25 22.9 8.82 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.987 -1.102 . . . . 0.0 110.813 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -83.39 -7.71 59.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.33 -1.1 . . . . 0.0 110.767 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.05 -3.18 87.08 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -138.02 148.26 44.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.409 -1.053 . . . . 0.0 109.454 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 71.4 t -92.36 118.63 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.566 -0.709 . . . . 0.0 110.263 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -90.62 -174.32 4.05 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.361 -0.837 . . . . 0.0 110.823 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -69.98 -40.21 75.47 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.354 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.33 -50.11 74.94 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.181 -0.95 . . . . 0.0 111.383 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.47 -34.36 78.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.517 -0.739 . . . . 0.0 109.828 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.43 ' CZ ' ' HE3' ' A' ' 145' ' ' MET . 49.6 t80 -58.05 -49.3 77.37 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.038 0.447 . . . . 0.0 110.776 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 53.3 t -70.03 -39.08 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.365 -0.834 . . . . 0.0 111.211 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -57.6 -49.28 76.91 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.305 -0.872 . . . . 0.0 110.827 -178.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -59.35 -35.62 74.19 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.416 -0.802 . . . . 0.0 110.33 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.43 ' HE3' ' CZ ' ' A' ' 141' ' ' PHE . 58.5 mtt -73.8 -40.0 63.7 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.53 -0.731 . . . . 0.0 110.549 178.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 34.8 m -69.9 -19.88 63.39 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.715 -0.615 . . . . 0.0 110.86 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -107.64 137.32 45.87 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.402 -0.811 . . . . 0.0 110.484 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.3 mttm . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.025 179.951 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -99.28 146.56 18.08 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -60.04 -41.84 93.13 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.595 -0.944 . . . . 0.0 110.098 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -59.96 -40.05 87.73 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.597 -0.689 . . . . 0.0 110.186 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -59.98 -40.19 88.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.733 -0.604 . . . . 0.0 110.703 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . 0.476 HD13 HG22 ' B' ' 160' ' ' ILE . 95.3 mt -69.92 -40.41 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.396 -0.815 . . . . 0.0 111.973 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.14 -42.85 88.5 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.274 -0.892 . . . . 0.0 111.923 -178.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -68.68 -40.02 80.3 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.383 -0.823 . . . . 0.0 110.785 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 10.3 tt -59.93 -42.87 94.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.499 -0.75 . . . . 0.0 110.397 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 85.8 t -65.85 -40.03 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.581 -0.699 . . . . 0.0 110.011 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.57 -39.97 93.95 Favored Glycine 0 N--CA 1.498 2.83 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 84.8 t -64.56 -37.39 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.464 -1.021 . . . . 0.0 110.314 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.02 -45.35 93.08 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.52 -0.737 . . . . 0.0 110.919 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 168' ' ' ARG . . . . . 0.402 ' O ' ' CD2' ' B' ' 172' ' ' TYR . 21.5 mmt180 -59.94 -39.31 85.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.487 -0.758 . . . . 0.0 110.999 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -60.02 -37.95 81.26 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.446 -0.784 . . . . 0.0 109.747 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 3.2 t-105 -59.98 -43.32 95.19 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.688 -0.633 . . . . 0.0 109.72 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.98 -52.04 65.61 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.568 -0.707 . . . . 0.0 110.641 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 172' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' B' ' 168' ' ' ARG . 53.6 m-85 -60.01 -38.75 83.57 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.485 -0.76 . . . . 0.0 110.538 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.542 -0.724 . . . . 0.0 110.246 -179.883 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 121.698 0.761 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 94.3 mt -59.99 -32.4 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.817 -0.552 . . . . 0.0 111.53 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.6 -32.23 73.7 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.967 -1.083 . . . . 0.0 110.512 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -65.09 -45.54 84.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 109.946 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -69.99 -23.59 63.17 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.358 0.599 . . . . 0.0 110.09 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.1 tptp -66.61 -53.08 38.15 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.355 0.598 . . . . 0.0 109.562 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -57.09 -52.68 64.32 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.951 -0.699 . . . . 0.0 110.376 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.78 -26.39 68.69 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.352 -0.842 . . . . 0.0 111.105 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -58.25 -48.41 80.5 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.009 -1.057 . . . . 0.0 110.236 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.3 m -61.86 -39.85 93.31 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.306 -0.871 . . . . 0.0 109.143 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.5 tp -60.0 -39.98 87.64 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.351 0.596 . . . . 0.0 109.5 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -72.59 -35.49 67.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.727 -0.608 . . . . 0.0 110.392 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -95.4 98.96 10.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.471 -0.768 . . . . 0.0 110.371 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.2 mmtm -64.97 -32.04 73.57 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.377 -0.827 . . . . 0.0 111.192 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -79.83 -10.08 59.74 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.083 -1.011 . . . . 0.0 111.081 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.2 26.19 49.42 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -88.28 -3.29 58.88 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.605 -0.938 . . . . 0.0 110.637 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.57 5.46 64.94 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.297 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.9 p -145.1 142.39 29.64 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 119.166 1.483 . . . . 0.0 111.703 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 86.2 mt -103.86 128.0 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.3 p -102.05 141.22 35.23 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.619 -0.676 . . . . 0.0 110.628 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 65.7 p -40.82 -35.87 0.56 Allowed 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -65.72 -45.44 82.69 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.249 -0.907 . . . . 0.0 109.548 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -60.05 -54.05 50.59 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.8 -0.562 . . . . 0.0 111.304 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.6 tt -59.95 -35.86 75.86 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.291 -0.881 . . . . 0.0 111.321 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.22 -28.98 44.16 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.2 m -69.54 -39.98 77.12 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.471 -1.017 . . . . 0.0 110.701 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.9 t -63.58 -54.98 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.691 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 97.8 mmm -59.96 -29.52 68.48 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.731 -0.606 . . . . 0.0 110.788 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -60.39 -50.44 73.58 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.503 -0.748 . . . . 0.0 110.448 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.4 t -72.55 -18.17 61.66 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.692 -0.63 . . . . 0.0 111.02 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.8 mt -100.11 -5.04 28.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.424 -0.797 . . . . 0.0 111.518 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.29 -68.04 0.12 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -160.21 170.64 20.75 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.228 -1.16 . . . . 0.0 111.448 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -110.53 117.21 51.41 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.972 -0.455 . . . . 0.0 110.215 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -68.63 -150.37 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.324 0 N-CA-C 109.265 -1.091 . . . . 0.0 109.265 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 77.2 p -137.79 147.03 44.28 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.939 -1.101 . . . . 0.0 110.606 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -54.86 -21.1 10.32 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.55 -0.718 . . . . 0.0 111.46 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.53 -59.44 2.76 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.23 -38.43 85.21 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.832 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.5 mt -59.48 -33.71 71.65 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.666 0.746 . . . . 0.0 109.839 178.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.84 -39.01 83.89 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.022 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -65.93 -39.39 90.48 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.467 -0.771 . . . . 0.0 110.186 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 66.9 mtt -61.64 -43.39 98.94 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.415 0.626 . . . . 0.0 109.628 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 81.3 mt -68.02 -32.55 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.773 -0.579 . . . . 0.0 110.419 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -59.76 -40.04 86.83 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.384 -0.823 . . . . 0.0 110.292 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -64.07 -27.99 69.48 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.445 -0.785 . . . . 0.0 110.319 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.0 t -101.01 -10.11 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.443 -0.785 . . . . 0.0 110.803 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -67.25 100.5 0.81 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.136 -0.978 . . . . 0.0 111.163 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.0 -38.34 75.94 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -90.75 -30.45 17.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.756 -0.59 . . . . 0.0 110.622 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.6 22.42 43.5 Favored Glycine 0 N--CA 1.496 2.65 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.006 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -75.22 -31.89 61.0 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.342 -1.093 . . . . 0.0 110.657 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.4 1.1 12.48 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.334 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 77.8 p -133.49 170.01 16.13 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.116 -1.226 . . . . 0.0 110.429 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.0 mt -106.69 122.33 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.892 -177.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -98.5 170.03 9.11 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.521 0.676 . . . . 0.0 110.383 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.426 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 9.9 t80 -47.07 -48.77 53.1 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.586 -0.696 . . . . 0.0 112.802 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.2 Cg_endo -71.26 -32.27 13.07 Favored 'Trans proline' 0 N--CA 1.487 1.102 0 O-C-N 122.783 0.886 . . . . 0.0 111.596 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -72.4 -40.21 67.38 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.123 -0.986 . . . . 0.0 110.409 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -62.74 -45.43 92.74 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.781 -0.574 . . . . 0.0 110.544 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.05 -40.01 87.96 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.515 -0.74 . . . . 0.0 110.472 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 93.1 m -61.19 -40.75 95.09 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.721 -0.612 . . . . 0.0 111.029 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.9 ttm -69.14 -41.07 77.82 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.45 -0.781 . . . . 0.0 112.099 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -60.02 -50.0 75.44 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.335 -0.853 . . . . 0.0 111.226 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.59 -32.27 70.91 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.714 -0.616 . . . . 0.0 111.822 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.8 mmt85 -72.96 -43.51 62.2 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.33 -0.856 . . . . 0.0 111.819 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -73.4 -41.66 63.07 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.373 -0.829 . . . . 0.0 112.853 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 24.4 ptm -60.06 -29.77 68.77 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.162 -0.961 . . . . 0.0 111.538 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -63.19 -52.69 61.32 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.27 -0.894 . . . . 0.0 111.587 -178.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -69.84 -10.82 59.85 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.42 -0.8 . . . . 0.0 111.168 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . 0.268 23.4 m -86.06 -174.58 5.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.581 -0.699 . . . . 0.0 109.369 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -128.01 140.9 51.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.238 -0.914 . . . . 0.0 109.447 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.1 t -59.95 -35.05 74.13 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.633 -0.667 . . . . 0.0 110.152 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -61.08 -34.95 75.73 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.619 0.723 . . . . 0.0 109.471 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.99 -40.0 75.58 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.909 -0.494 . . . . 0.0 111.412 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.91 -40.0 79.34 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.443 -0.786 . . . . 0.0 111.062 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 82.8 mt -68.16 -51.82 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.45 -0.781 . . . . 0.0 110.984 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -60.01 -40.94 90.99 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.255 -0.903 . . . . 0.0 111.708 -178.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -70.52 -41.45 72.56 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.51 -0.744 . . . . 0.0 111.576 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.31 -43.61 94.16 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.526 -0.734 . . . . 0.0 110.716 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -61.96 -40.81 96.86 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.811 0.815 . . . . 0.0 108.899 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 29.6 ttt85 -59.95 -37.13 78.67 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.395 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 91.2 t -70.02 -50.03 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.509 -0.744 . . . . 0.0 110.153 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -67.67 -39.97 84.47 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.405 -0.809 . . . . 0.0 110.261 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -79.58 76.3 6.21 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.406 ' HE3' ' CD2' ' A' ' 107' ' ' HIS . 60.2 mttm -68.85 -40.48 79.33 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.505 -0.747 . . . . 0.0 110.276 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -74.5 -21.67 59.44 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.418 -0.801 . . . . 0.0 110.64 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.2 26.41 73.43 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -69.92 -12.66 61.78 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.535 -0.979 . . . . 0.0 111.464 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.11 -20.62 14.07 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -144.77 153.74 41.97 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.239 -1.154 . . . . 0.0 109.994 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 80.6 mt -88.88 131.58 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.887 0.851 . . . . 0.0 110.457 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.2 m -87.7 171.01 10.75 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.193 0.521 . . . . 0.0 110.367 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.68 -40.07 91.97 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.41 -38.49 89.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.748 -0.595 . . . . 0.0 109.5 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -61.84 -39.95 93.61 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.751 -0.593 . . . . 0.0 110.666 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.38 -45.61 93.63 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.44 -0.788 . . . . 0.0 109.761 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -64.42 -29.0 70.06 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.768 -0.582 . . . . 0.0 110.513 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.406 ' CD2' ' HE3' ' A' ' 94' ' ' LYS . 1.5 t-80 -61.59 -46.8 88.32 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.445 -0.785 . . . . 0.0 111.361 -178.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 66.5 t -73.38 -47.93 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.472 -0.768 . . . . 0.0 111.727 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 98.0 mtp -58.61 -39.95 81.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.222 -0.923 . . . . 0.0 110.544 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.4 m -66.58 -45.27 79.79 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -61.45 -33.41 73.68 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.2 mt -68.83 -38.74 80.06 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.922 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 119.97 39.88 0.62 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -123.32 136.01 54.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.664 -0.903 . . . . 0.0 109.991 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -96.71 126.41 41.86 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.519 -0.738 . . . . 0.0 109.701 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.45 ' N ' ' CD2' ' A' ' 116' ' ' LEU . 1.0 OUTLIER -152.52 153.77 34.12 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.513 -0.742 . . . . 0.0 111.443 -178.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.7 p -87.36 168.04 13.51 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 36.6 p-10 -64.46 -20.69 66.34 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.644 -0.823 . . . . 0.0 108.879 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -69.71 -37.93 76.76 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.973 0.892 . . . . 0.0 109.134 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -61.48 -39.98 92.88 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 122.131 0.967 . . . . 0.0 108.967 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 63.7 t -69.73 -39.85 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.663 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -59.79 -48.54 81.29 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.572 -0.705 . . . . 0.0 110.217 -178.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -59.99 -40.04 87.8 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.93 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 92.8 mmm -55.4 -38.16 68.55 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.136 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.41 -36.92 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 121.667 0.746 . . . . 0.0 109.154 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -58.14 -39.66 79.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.804 -0.56 . . . . 0.0 111.072 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.96 -39.31 85.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.549 -0.719 . . . . 0.0 111.297 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.91 -18.8 18.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.281 -0.887 . . . . 0.0 111.103 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -72.42 70.84 0.9 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.312 -0.867 . . . . 0.0 111.349 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 85.4 mt -67.8 -40.41 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.45 -0.781 . . . . 0.0 110.557 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -72.32 -18.26 61.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.438 -0.789 . . . . 0.0 111.581 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.23 22.48 60.68 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 120.136 -1.03 . . . . 0.0 110.853 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -82.6 -7.23 59.65 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.181 -1.188 . . . . 0.0 110.782 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.19 -0.83 89.52 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -138.52 149.5 45.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.327 -1.102 . . . . 0.0 109.246 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.6 t -92.98 110.85 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.356 -0.84 . . . . 0.0 110.7 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -80.0 172.77 13.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.493 -0.754 . . . . 0.0 109.647 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -67.94 -40.07 83.36 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.795 -0.566 . . . . 0.0 111.009 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -62.85 -52.29 63.69 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.252 -0.905 . . . . 0.0 111.988 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -69.12 -23.3 63.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -0.849 . . . . 0.0 111.122 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -60.08 -42.3 94.3 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.433 -0.792 . . . . 0.0 109.598 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 95.3 t -70.09 -37.67 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.726 -0.609 . . . . 0.0 111.047 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -59.94 -50.03 75.36 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.49 -0.757 . . . . 0.0 110.935 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.413 ' HE2' ' CD1' ' B' ' 157' ' ' PHE . 59.5 ttp -59.95 -37.73 80.4 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.261 -0.899 . . . . 0.0 110.299 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 94.2 mmm -67.1 -39.99 86.82 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.749 -0.594 . . . . 0.0 111.372 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 64.5 m -57.59 -26.12 61.04 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.292 -0.88 . . . . 0.0 110.543 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.78 135.0 41.72 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.47 -0.769 . . . . 0.0 110.21 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.141 179.969 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -133.87 140.36 11.72 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . 0.413 ' CD1' ' HE2' ' A' ' 144' ' ' MET . 36.0 t80 -61.96 -41.26 97.8 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.597 -0.943 . . . . 0.0 110.37 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -62.5 -40.04 95.43 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.561 -0.712 . . . . 0.0 110.585 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -61.66 -48.12 82.28 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.643 -0.661 . . . . 0.0 111.191 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 14.3 tt -69.95 -26.04 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.527 -0.733 . . . . 0.0 111.04 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.48 -35.34 77.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.504 -0.748 . . . . 0.0 109.661 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -59.97 -40.09 87.89 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.817 -0.552 . . . . 0.0 109.997 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 59.7 mt -63.27 -39.96 96.07 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.525 -0.734 . . . . 0.0 110.704 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 91.2 t -62.75 -40.4 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.455 -0.778 . . . . 0.0 110.414 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.05 -40.02 96.51 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 48.1 t -70.53 -22.53 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.613 -0.934 . . . . 0.0 110.833 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 9.6 tt -59.98 -41.93 93.1 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.3 -0.875 . . . . 0.0 110.076 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -69.48 -35.98 76.09 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.577 -0.702 . . . . 0.0 109.767 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -59.92 -36.65 77.46 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.665 -0.647 . . . . 0.0 110.235 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 4.9 t-105 -60.06 -40.91 91.12 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.671 -0.643 . . . . 0.0 110.722 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.06 -50.12 74.95 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.453 -0.78 . . . . 0.0 110.65 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -60.01 -39.99 87.72 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.417 -0.802 . . . . 0.0 110.354 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 71.2 mtt-85 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.615 -0.678 . . . . 0.0 110.277 -179.537 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.791 0.805 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 88.0 mt -62.99 -37.94 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.958 -0.464 . . . . 0.0 111.699 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.66 -39.77 89.61 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.206 -0.934 . . . . 0.0 110.344 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -60.06 -39.58 86.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.374 -0.829 . . . . 0.0 110.407 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -64.17 -22.1 66.81 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.682 -0.636 . . . . 0.0 110.885 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -69.52 -41.14 76.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.303 -0.873 . . . . 0.0 109.181 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -71.91 -23.76 61.53 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.133 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.05 -35.49 42.48 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.342 -0.849 . . . . 0.0 110.107 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.433 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 54.7 t80 -58.38 -38.13 76.68 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.899 -0.5 . . . . 0.0 110.914 -178.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.3 p -61.02 -37.15 81.54 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.35 -0.844 . . . . 0.0 109.92 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.98 -40.01 87.67 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.611 -0.681 . . . . 0.0 109.459 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -78.14 -36.25 48.01 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.629 -0.669 . . . . 0.0 110.266 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -93.19 95.8 9.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.581 -0.699 . . . . 0.0 109.967 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -61.74 -32.82 73.08 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.574 -0.704 . . . . 0.0 111.221 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -79.37 -10.43 59.81 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.234 -0.916 . . . . 0.0 111.565 -177.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.51 27.75 54.72 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -92.98 -2.54 55.67 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.616 -0.931 . . . . 0.0 111.0 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.38 2.67 63.58 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.787 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 76.2 p -142.05 141.11 32.76 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 119.559 1.68 . . . . 0.0 111.76 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.7 mt -105.39 130.14 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.792 -0.567 . . . . 0.0 110.428 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.3 p -113.01 146.6 38.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.599 -0.688 . . . . 0.0 110.779 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 40.7 p -42.4 -31.08 0.38 Allowed 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.744 -0.598 . . . . 0.0 112.378 -177.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -65.38 -48.98 71.04 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.569 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -60.43 -56.82 16.76 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.967 -0.458 . . . . 0.0 111.767 -178.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.6 tp -61.54 -32.79 72.87 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.105 -0.997 . . . . 0.0 110.632 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.79 -33.95 28.49 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.3 m -69.98 -40.03 75.59 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.691 -0.888 . . . . 0.0 110.244 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.2 t -63.45 -58.51 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.573 -0.704 . . . . 0.0 110.264 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 74.0 mtm -60.01 -30.04 68.88 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.574 -0.704 . . . . 0.0 110.447 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -60.77 -50.36 73.77 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.566 -0.709 . . . . 0.0 109.601 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.9 t -74.78 -20.06 59.95 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.872 -0.517 . . . . 0.0 110.33 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.4 mp -97.97 -1.48 42.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.393 -0.817 . . . . 0.0 111.352 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.07 -71.43 0.11 Allowed Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.898 -1.144 . . . . 0.0 110.374 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -162.04 161.01 28.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.183 -1.186 . . . . 0.0 111.316 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -111.65 103.4 55.07 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -61.78 -146.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 O-C-N 123.512 1.269 . . . . 0.0 110.402 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.8 p -132.86 157.54 44.79 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.619 -1.3 . . . . 0.0 112.122 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -52.64 -23.36 6.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.886 -0.509 . . . . 0.0 111.647 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.05 -59.94 2.6 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.149 0.976 . . . . 0.0 108.419 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -67.86 -36.2 79.88 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.589 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.4 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 8.8 mt -58.3 -35.02 71.22 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.605 0.717 . . . . 0.0 109.769 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -39.79 94.29 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.068 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -64.8 -40.02 94.55 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.542 -0.724 . . . . 0.0 111.192 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 64.5 mtt -60.04 -42.53 94.63 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.618 -0.676 . . . . 0.0 109.791 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.5 mm -68.33 -37.18 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.855 -0.528 . . . . 0.0 111.11 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -60.97 -40.04 91.89 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.484 -0.76 . . . . 0.0 111.511 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -69.99 -28.25 65.36 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.188 -0.945 . . . . 0.0 110.482 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.1 t -95.61 -9.96 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.648 -0.658 . . . . 0.0 111.229 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -74.71 97.45 3.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.176 -0.953 . . . . 0.0 110.766 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.01 -34.53 73.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.541 -0.724 . . . . 0.0 109.804 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -91.41 -26.3 18.93 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.556 -0.715 . . . . 0.0 110.774 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.14 20.17 50.4 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.035 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -76.13 -26.34 56.25 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.434 -1.039 . . . . 0.0 110.461 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 109.8 -2.09 30.37 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 77.0 p -130.71 170.89 13.74 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.187 -1.184 . . . . 0.0 110.625 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.4 mt -89.4 167.5 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.218 0.533 . . . . 0.0 110.007 -178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.42 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 81.6 m-20 -147.04 150.57 35.35 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.476 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.7 m-85 -42.98 -52.45 11.57 Favored Pre-proline 0 N--CA 1.506 2.344 0 O-C-N 121.702 -0.624 . . . . 0.0 111.71 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.4 Cg_endo -69.41 -29.85 24.87 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 O-C-N 123.269 1.142 . . . . 0.0 111.334 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -72.55 -45.46 59.19 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.014 -1.054 . . . . 0.0 110.067 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -60.47 -43.93 96.41 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.755 -0.59 . . . . 0.0 110.665 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.3 mt -67.13 -41.55 85.93 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.686 -0.633 . . . . 0.0 111.757 -178.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.0 p -62.71 -40.16 96.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.337 -0.852 . . . . 0.0 110.718 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.417 ' HE1' ' CE3' ' B' ' 170' ' ' TRP . 56.4 ttp -66.35 -46.57 76.32 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.79 -0.569 . . . . 0.0 111.315 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.7 ttm -60.06 -49.97 75.56 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.388 -0.82 . . . . 0.0 111.352 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.54 -33.52 72.78 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.487 -0.758 . . . . 0.0 110.58 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.6 ttp180 -69.98 -39.52 75.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.722 -0.611 . . . . 0.0 110.857 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -71.83 -18.25 62.09 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.455 -0.778 . . . . 0.0 112.086 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 26.9 mmt -58.96 -50.02 75.66 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.99 -1.069 . . . . 0.0 110.735 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.99 -32.7 71.04 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.692 -0.63 . . . . 0.0 111.121 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -70.67 -18.9 62.83 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.43 -0.794 . . . . 0.0 111.549 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.4 t -121.93 -162.94 1.02 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.879 0.847 . . . . 0.0 112.284 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -127.97 142.2 51.31 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.353 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.3 t -66.73 -32.51 73.86 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.83 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -60.08 -36.98 78.58 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.881 0.848 . . . . 0.0 109.199 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.86 -39.97 76.04 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.306 0.574 . . . . 0.0 110.389 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -61.63 -37.49 84.17 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.606 -0.684 . . . . 0.0 110.75 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 77.4 mt -67.73 -44.43 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.538 -0.726 . . . . 0.0 110.685 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -59.25 -39.96 84.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.417 -0.802 . . . . 0.0 110.561 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -70.02 -39.96 75.48 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.339 -0.851 . . . . 0.0 111.346 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.98 -46.26 85.41 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.466 -0.771 . . . . 0.0 111.317 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.42 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 52.2 t80 -62.39 -39.99 95.02 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.481 -0.762 . . . . 0.0 109.617 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 39.4 ttm-85 -59.99 -39.3 85.24 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.821 -0.55 . . . . 0.0 111.247 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.6 t -70.02 -43.89 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.482 -0.761 . . . . 0.0 110.354 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -68.62 -39.28 80.88 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.345 -0.847 . . . . 0.0 111.119 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -78.64 78.2 5.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.515 -0.74 . . . . 0.0 109.867 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -59.98 -45.39 92.88 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.487 -0.758 . . . . 0.0 110.358 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 33.3 p-10 -79.71 -19.59 48.51 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.641 -0.662 . . . . 0.0 110.869 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.18 62.5 6.28 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -105.74 -10.59 16.66 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.389 -1.065 . . . . 0.0 111.262 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 123.91 -25.62 6.09 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.419 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 27.5 p90 -145.75 152.49 39.65 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.483 -1.01 . . . . 0.0 109.42 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 77.4 mt -88.84 131.39 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.887 0.851 . . . . 0.0 110.197 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.97 171.84 10.02 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.269 0.557 . . . . 0.0 110.588 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.0 -41.57 97.44 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.603 -0.686 . . . . 0.0 109.304 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.96 -37.7 88.51 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -64.82 -40.08 94.62 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.607 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.29 -45.48 93.19 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.336 -0.852 . . . . 0.0 109.264 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.8 ttt-85 -62.54 -30.99 71.7 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.844 -0.535 . . . . 0.0 111.081 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -59.94 -46.12 90.42 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.164 -0.96 . . . . 0.0 110.417 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 90.2 t -74.96 -33.0 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.411 -0.806 . . . . 0.0 110.926 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.1 mmt -60.09 -49.12 78.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.454 -0.779 . . . . 0.0 110.323 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 76.8 m -68.6 -43.92 75.42 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.66 -0.65 . . . . 0.0 110.414 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -59.89 -29.32 68.26 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.56 -0.712 . . . . 0.0 109.501 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 27.4 mt -70.01 -29.65 66.78 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.694 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 112.21 18.98 7.38 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -122.03 145.03 48.54 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.248 -1.148 . . . . 0.0 110.35 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -105.53 123.6 48.16 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.539 -0.726 . . . . 0.0 110.666 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 72.2 mt -135.38 157.83 45.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.625 -0.672 . . . . 0.0 110.02 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.22 166.75 16.28 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.631 -0.668 . . . . 0.0 109.226 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -61.72 -26.37 68.01 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.94 -34.54 78.36 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.466 0.651 . . . . 0.0 109.57 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.33 -35.86 82.28 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.9 t -68.07 -39.98 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 121.507 0.67 . . . . 0.0 109.884 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -59.99 -49.85 76.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.733 -0.604 . . . . 0.0 110.511 -178.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -60.44 -42.04 95.31 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.494 -0.754 . . . . 0.0 110.423 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 86.8 mtp -55.18 -37.83 67.55 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.205 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 90.3 mt -63.69 -38.67 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.447 0.641 . . . . 0.0 109.509 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -53.85 -35.77 61.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.665 -0.647 . . . . 0.0 111.613 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -59.83 -40.04 87.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.488 -0.758 . . . . 0.0 111.207 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.81 -5.13 17.46 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.221 -0.924 . . . . 0.0 111.167 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -79.78 68.06 5.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.076 -1.015 . . . . 0.0 109.89 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 82.8 mt -68.13 -39.97 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.684 -0.635 . . . . 0.0 110.725 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 37.4 p-10 -70.02 -20.91 63.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.372 -0.83 . . . . 0.0 110.923 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.09 21.43 60.98 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.062 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -82.01 -10.09 59.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -1.133 . . . . 0.0 110.952 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.61 3.46 77.66 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -139.18 147.8 42.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -1.144 . . . . 0.0 109.875 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.6 t -93.17 114.78 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.417 -0.802 . . . . 0.0 110.071 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -82.77 172.0 13.35 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -60.09 -43.85 95.22 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.361 0.601 . . . . 0.0 109.518 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -62.47 -47.61 83.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.678 -0.638 . . . . 0.0 111.013 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -65.35 -33.21 75.42 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.471 -0.768 . . . . 0.0 110.213 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 89.0 t80 -60.05 -47.07 87.38 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.941 -0.474 . . . . 0.0 111.116 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 83.7 t -70.01 -39.14 77.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.257 -0.902 . . . . 0.0 111.193 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -59.97 -49.49 77.47 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.414 -0.804 . . . . 0.0 111.093 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -60.01 -38.09 81.65 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.438 -0.789 . . . . 0.0 110.947 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 97.5 mtp -66.4 -40.0 89.35 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.606 -0.684 . . . . 0.0 110.603 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 66.8 p -98.56 22.13 10.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.417 -0.802 . . . . 0.0 110.387 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.93 -48.22 82.58 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.434 -0.791 . . . . 0.0 110.817 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 90.7 mttt . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.436 -179.58 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -89.38 148.49 20.1 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -59.91 -44.52 94.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.637 -0.919 . . . . 0.0 110.264 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -60.95 -40.01 91.69 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.655 -0.653 . . . . 0.0 111.393 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -62.03 -39.94 94.04 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.372 -0.83 . . . . 0.0 111.521 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 90.6 mt -68.43 -40.05 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.429 -0.794 . . . . 0.0 110.873 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.47 -40.04 92.7 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.325 -0.859 . . . . 0.0 111.05 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -61.61 -41.03 96.87 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.379 -0.826 . . . . 0.0 110.966 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.75 -39.98 90.74 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.496 -0.752 . . . . 0.0 110.595 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 96.8 t -66.26 -40.01 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.604 -0.685 . . . . 0.0 110.022 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -54.46 -42.6 75.9 Favored Glycine 0 N--CA 1.5 2.947 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.69 -18.91 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.656 -0.908 . . . . 0.0 110.371 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 9.3 tt -59.95 -49.95 75.65 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.323 -0.86 . . . . 0.0 110.905 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -64.62 -39.96 94.63 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.455 -0.778 . . . . 0.0 109.762 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -62.33 -25.39 67.86 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.75 -0.594 . . . . 0.0 110.055 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 170' ' ' TRP . . . . . 0.417 ' CE3' ' HE1' ' A' ' 71' ' ' MET . 2.6 t-105 -59.88 -43.0 94.98 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.524 -0.735 . . . . 0.0 109.925 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.06 -46.92 87.96 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.543 -0.723 . . . . 0.0 110.538 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -60.05 -38.28 82.33 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.421 -0.799 . . . . 0.0 110.381 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 . . . . . 0 N--CA 1.494 1.737 0 O-C-N 121.593 -0.692 . . . . 0.0 110.283 -179.755 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 121.343 0.592 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.401 HD13 HG23 ' A' ' 9' ' ' ILE . 47.9 mm -57.9 -50.01 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.346 -0.846 . . . . 0.0 110.744 -177.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.16 -22.38 66.92 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.36 -0.838 . . . . 0.0 111.591 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -68.54 -53.62 21.9 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.333 -0.854 . . . . 0.0 109.448 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.408 ' CE1' ' HG2' ' A' ' 72' ' ' MET . 25.6 m-85 -67.9 -21.88 65.11 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.373 0.606 . . . . 0.0 109.44 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -66.99 -41.81 86.11 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.412 0.625 . . . . 0.0 109.951 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.33 -56.98 14.94 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.794 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.68 -33.95 76.11 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.261 -0.899 . . . . 0.0 111.438 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -58.04 -49.99 74.97 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.151 -0.968 . . . . 0.0 110.236 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.2 m -65.51 -38.63 90.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.313 -0.867 . . . . 0.0 108.761 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.4 tp -60.0 -37.63 80.27 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.29 0.567 . . . . 0.0 109.893 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -73.48 -28.64 62.04 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.648 -0.658 . . . . 0.0 110.569 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -96.31 102.03 13.75 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.348 -0.845 . . . . 0.0 109.682 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -67.07 -31.57 72.17 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.435 -0.79 . . . . 0.0 111.446 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -79.85 -9.58 59.68 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.122 -0.986 . . . . 0.0 111.148 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 64.14 24.64 68.97 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -79.77 -9.55 59.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.453 -1.028 . . . . 0.0 110.939 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.01 6.94 88.92 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -178.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 78.0 p -148.22 142.14 25.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.124 -1.221 . . . . 0.0 109.892 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.4 mt -103.49 123.38 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.748 -0.595 . . . . 0.0 110.096 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 65.5 p -98.82 143.84 28.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.862 -0.524 . . . . 0.0 109.716 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.5 p -40.5 -36.6 0.59 Allowed 'General case' 0 N--CA 1.512 2.646 0 O-C-N 121.806 -0.559 . . . . 0.0 112.195 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -63.51 -45.31 91.27 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.209 -0.932 . . . . 0.0 109.527 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -59.95 -52.82 63.75 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.752 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.408 HD22 ' CE2' ' B' ' 170' ' ' TRP . 64.1 tp -59.19 -37.4 77.32 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.131 -0.98 . . . . 0.0 110.846 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.92 -32.28 41.21 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.5 m -70.04 -39.96 75.42 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.603 -0.939 . . . . 0.0 110.483 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.3 t -63.99 -57.19 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.453 -0.779 . . . . 0.0 109.851 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 98.2 mtp -59.21 -28.33 66.56 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.622 -0.674 . . . . 0.0 110.037 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -59.97 -39.58 86.14 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.4 t -66.16 -17.24 64.6 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.849 -0.532 . . . . 0.0 110.861 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.7 tp -85.61 -28.38 24.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.295 -0.878 . . . . 0.0 109.22 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.65 -46.85 0.2 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -160.96 176.36 11.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.772 -0.84 . . . . 0.0 110.253 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -120.01 148.62 47.18 Favored Pre-proline 0 C--N 1.299 -1.602 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.754 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.48 -147.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.318 0 O-C-N 123.626 1.329 . . . . 0.0 109.627 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 57.8 p -136.42 149.4 48.25 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.905 -1.122 . . . . 0.0 111.431 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -52.62 -24.02 7.62 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.706 -0.621 . . . . 0.0 111.57 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.35 -59.5 2.73 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.092 0.949 . . . . 0.0 108.636 177.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -66.75 -37.74 85.22 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.907 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 39.6 mt -58.55 -35.18 71.93 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.774 0.797 . . . . 0.0 109.507 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.4 -39.27 78.04 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.062 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -66.41 -38.02 86.54 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.481 -0.762 . . . . 0.0 110.675 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 73.2 mmm -60.05 -44.67 94.54 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.633 0.73 . . . . 0.0 109.469 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.83 -34.59 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-O 121.173 0.511 . . . . 0.0 110.413 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -60.7 -40.99 94.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.441 -0.787 . . . . 0.0 110.659 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -70.69 -29.43 65.73 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.329 -0.857 . . . . 0.0 110.813 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.8 t -98.23 -8.15 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.68 -0.637 . . . . 0.0 111.862 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -71.98 107.44 4.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.012 -1.055 . . . . 0.0 111.106 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.52 -41.08 85.0 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.542 -0.723 . . . . 0.0 109.715 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -87.85 -29.94 20.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.631 -0.668 . . . . 0.0 110.309 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.08 21.16 46.96 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.609 -0.997 . . . . 0.0 110.609 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -72.22 -37.8 69.12 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.391 -1.064 . . . . 0.0 110.258 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.77 -6.43 5.5 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 120.197 -1.001 . . . . 0.0 111.114 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 81.1 p -135.36 170.08 16.5 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.078 -1.248 . . . . 0.0 110.588 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.0 mt -106.13 123.73 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-O 121.609 0.718 . . . . 0.0 111.204 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -101.68 172.03 7.2 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.701 0.763 . . . . 0.0 111.103 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.471 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -46.8 -49.96 45.76 Favored Pre-proline 0 N--CA 1.499 1.992 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 39.4 Cg_endo -65.73 -36.66 31.41 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 122.889 0.941 . . . . 0.0 111.795 -178.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -70.01 -39.95 75.55 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.24 -0.912 . . . . 0.0 110.455 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -61.55 -40.28 94.15 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.606 -0.683 . . . . 0.0 111.042 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.2 mt -68.87 -40.01 79.51 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.425 -0.797 . . . . 0.0 111.848 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 47.2 p -59.97 -45.68 91.91 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.164 -0.96 . . . . 0.0 111.161 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 56.3 ttp -68.77 -40.0 79.94 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.531 -0.73 . . . . 0.0 111.458 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.408 ' HG2' ' CE1' ' A' ' 12' ' ' PHE . 48.6 tpp -60.12 -49.61 76.96 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.445 -0.785 . . . . 0.0 111.279 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.49 -31.18 66.82 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.523 -0.736 . . . . 0.0 112.174 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -83.38 -50.73 8.04 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.336 -0.853 . . . . 0.0 111.907 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.403 ' CG ' ' CG ' ' B' ' 169' ' ' GLU . 60.1 tptt -66.4 -40.0 89.36 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.564 -0.71 . . . . 0.0 112.192 -178.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 28.1 ptm -55.13 -34.12 63.47 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.254 -0.904 . . . . 0.0 111.756 -177.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -67.88 -39.86 83.63 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.352 -0.843 . . . . 0.0 110.151 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -67.03 -20.05 65.79 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.594 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.1 m -79.56 -174.75 4.43 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.693 -0.629 . . . . 0.0 109.797 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -135.82 131.41 35.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.317 -0.865 . . . . 0.0 109.158 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.1 t -60.5 -34.55 74.23 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.444 -0.785 . . . . 0.0 110.071 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.04 -39.53 86.23 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.768 0.794 . . . . 0.0 109.542 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.97 -40.01 75.63 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.417 0.627 . . . . 0.0 111.075 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -66.28 -35.93 81.65 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.611 -0.68 . . . . 0.0 111.425 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 67.0 mt -67.28 -47.32 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.491 -0.756 . . . . 0.0 110.818 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -59.95 -41.92 92.91 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.329 -0.857 . . . . 0.0 112.104 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -73.95 -39.98 63.36 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.438 -0.788 . . . . 0.0 111.952 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.31 -47.15 80.55 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.389 -0.82 . . . . 0.0 111.378 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -60.06 -45.96 91.14 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.606 0.717 . . . . 0.0 109.862 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -60.01 -34.04 72.81 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.979 -0.45 . . . . 0.0 111.047 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 98.6 t -70.08 -53.51 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.243 -0.91 . . . . 0.0 110.254 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -63.27 -39.46 94.64 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.398 -0.814 . . . . 0.0 110.539 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -77.17 79.06 3.7 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -60.08 -41.0 91.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.407 -0.808 . . . . 0.0 111.034 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -84.11 -23.02 30.9 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.457 -0.777 . . . . 0.0 111.283 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.8 31.92 76.73 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.45 ' ND2' ' CE2' ' A' ' 99' ' ' TYR . 33.4 p-10 -76.09 -12.03 60.04 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.562 -0.963 . . . . 0.0 112.085 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.37 -20.92 10.2 Favored Glycine 0 N--CA 1.497 2.762 0 C-N-CA 119.919 -1.134 . . . . 0.0 110.45 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.45 ' CE2' ' ND2' ' A' ' 97' ' ' ASN . 27.7 p90 -145.25 150.04 35.97 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.224 -1.162 . . . . 0.0 108.783 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.435 ' CG2' ' CD2' ' A' ' 105' ' ' LEU . 20.8 mt -89.29 130.32 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.734 0.778 . . . . 0.0 111.396 -178.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.6 m -87.93 172.95 9.21 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.205 0.526 . . . . 0.0 109.999 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.08 -39.96 82.8 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.643 -0.661 . . . . 0.0 109.248 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.7 -40.04 93.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.804 -0.56 . . . . 0.0 109.835 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -61.96 -39.94 93.87 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.616 -0.678 . . . . 0.0 110.012 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.435 ' CD2' ' CG2' ' A' ' 100' ' ' ILE . 0.6 OUTLIER -63.65 -40.32 96.56 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.74 -0.6 . . . . 0.0 109.597 179.045 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 57.1 mtp85 -61.31 -31.82 71.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.551 -0.718 . . . . 0.0 110.954 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -59.96 -48.6 81.03 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.38 -0.825 . . . . 0.0 111.002 -178.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 85.3 t -69.92 -44.96 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 121.354 -0.841 . . . . 0.0 111.572 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 66.2 mtt -58.61 -46.78 86.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 0.0 111.356 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.0 m -66.09 -47.69 73.38 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.467 -0.771 . . . . 0.0 109.934 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -61.9 -31.5 71.8 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 19.1 mt -69.89 -40.04 75.89 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 120.176 -0.609 . . . . 0.0 110.301 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.22 35.34 1.49 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -133.9 132.29 40.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.557 -0.967 . . . . 0.0 109.86 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -102.82 127.89 49.81 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.52 -0.737 . . . . 0.0 110.787 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 42.6 mt -133.9 157.79 45.1 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.568 -0.708 . . . . 0.0 109.116 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.16 162.13 21.37 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.433 -0.792 . . . . 0.0 109.417 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -60.05 -26.91 66.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.413 -0.805 . . . . 0.0 108.852 178.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -69.38 -35.5 75.88 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -65.23 -39.94 93.4 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.395 0.617 . . . . 0.0 109.622 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.01 -40.0 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.208 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -60.02 -44.04 94.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.703 -0.623 . . . . 0.0 110.005 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -60.03 -41.33 92.0 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.53 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 65.6 mtt -56.56 -37.94 71.25 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 119.6 -0.84 . . . . 0.0 108.781 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 90.7 mt -65.75 -38.76 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 121.705 0.764 . . . . 0.0 109.093 178.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -57.27 -38.47 73.94 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.252 0.548 . . . . 0.0 110.578 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.0 -38.78 83.63 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.701 -0.624 . . . . 0.0 110.544 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.8 0.64 30.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.294 -0.879 . . . . 0.0 111.117 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -87.3 70.5 10.04 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.006 -1.059 . . . . 0.0 110.594 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.0 mt -67.06 -40.02 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.424 -0.797 . . . . 0.0 109.998 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -73.29 -20.22 60.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.565 -0.71 . . . . 0.0 111.151 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.49 23.39 60.59 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 120.215 -0.993 . . . . 0.0 110.83 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -82.17 -10.22 59.24 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.24 -1.153 . . . . 0.0 111.044 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.37 1.7 74.64 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.105 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -138.74 149.24 44.83 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.257 -1.143 . . . . 0.0 109.779 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 87.7 t -92.77 118.01 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.545 -0.722 . . . . 0.0 109.969 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -90.03 175.86 7.01 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.515 -0.741 . . . . 0.0 109.927 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -60.04 -49.01 79.33 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.264 0.554 . . . . 0.0 110.483 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -60.05 -46.07 90.76 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.725 -0.61 . . . . 0.0 111.72 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -63.02 -35.02 78.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.232 -0.918 . . . . 0.0 109.739 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.409 ' CZ ' ' HE1' ' A' ' 145' ' ' MET . 64.6 t80 -60.0 -39.96 87.54 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.258 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 92.1 t -70.02 -40.47 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.517 -0.74 . . . . 0.0 110.964 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -60.25 -41.08 92.44 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.388 -0.82 . . . . 0.0 110.627 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 56.2 ttp -59.96 -40.07 87.76 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.836 -0.54 . . . . 0.0 110.089 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.409 ' HE1' ' CZ ' ' A' ' 141' ' ' PHE . 40.9 mtt -70.02 -39.92 75.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.789 -0.57 . . . . 0.0 110.695 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.4 t -101.38 20.96 14.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.501 -0.749 . . . . 0.0 110.681 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -79.94 129.83 34.8 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.313 -0.867 . . . . 0.0 110.574 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.6 pttm . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.363 -179.988 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.27 -40.03 98.48 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -60.6 -40.0 90.16 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.547 -0.973 . . . . 0.0 110.453 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -66.23 -39.93 89.91 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.447 -0.783 . . . . 0.0 110.649 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -60.59 -46.03 91.77 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.612 -0.68 . . . . 0.0 110.641 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 15.5 tt -70.0 -29.49 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.504 -0.748 . . . . 0.0 111.034 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.17 -44.12 89.52 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.39 -0.819 . . . . 0.0 110.422 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 75.5 mmt-85 -61.44 -40.11 93.25 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.577 -0.702 . . . . 0.0 109.861 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.45 -37.26 86.92 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.67 -0.644 . . . . 0.0 111.076 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 67.7 t -60.03 -40.05 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.386 -0.821 . . . . 0.0 110.058 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.94 -34.89 85.14 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 23.5 t -74.35 -19.97 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.729 -0.866 . . . . 0.0 110.584 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 6.2 tt -59.99 -48.77 80.36 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.107 -0.995 . . . . 0.0 110.386 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 9.6 ptt85 -69.86 -28.62 65.81 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.351 -0.843 . . . . 0.0 109.848 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . 0.403 ' CG ' ' CG ' ' A' ' 75' ' ' LYS . 44.0 tt0 -60.02 -43.84 95.0 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.58 -0.7 . . . . 0.0 110.021 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 170' ' ' TRP . . . . . 0.408 ' CE2' HD22 ' A' ' 32' ' ' LEU . 7.4 t-105 -60.93 -40.0 91.55 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.754 -0.591 . . . . 0.0 110.065 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.9 -46.65 88.66 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.575 -0.703 . . . . 0.0 110.851 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -59.98 -40.01 87.67 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.315 -0.866 . . . . 0.0 110.769 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.519 -0.738 . . . . 0.0 110.131 -179.568 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 . . . . . 0 N--CA 1.499 1.983 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.5 mm -60.15 -53.31 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 120.988 -1.07 . . . . 0.0 109.873 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -61.08 -27.11 68.12 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.659 -0.651 . . . . 0.0 109.975 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -66.32 -39.96 89.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.457 -0.777 . . . . 0.0 110.037 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -69.7 -25.02 63.67 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.626 -0.671 . . . . 0.0 109.426 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 16.4 ttmt -69.98 -40.03 75.61 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -60.31 -54.1 49.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.956 -0.465 . . . . 0.0 110.783 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.05 -22.18 63.1 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.334 -0.854 . . . . 0.0 111.975 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -58.44 -47.39 84.14 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.088 -1.008 . . . . 0.0 110.243 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.7 m -62.16 -37.73 86.33 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.479 -0.763 . . . . 0.0 109.393 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.5 tp -65.96 -39.93 90.84 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -69.53 -38.12 77.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.962 -0.462 . . . . 0.0 109.869 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -91.77 97.64 11.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.566 -0.709 . . . . 0.0 109.848 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -59.93 -37.55 79.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.324 -0.86 . . . . 0.0 111.119 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -80.02 -10.92 59.81 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.263 -0.898 . . . . 0.0 111.03 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.29 27.66 58.09 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -87.63 -5.77 58.57 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.707 -0.878 . . . . 0.0 110.777 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.1 4.88 59.77 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 120.268 -0.968 . . . . 0.0 111.383 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.2 p -143.93 141.15 30.08 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 119.168 1.484 . . . . 0.0 111.594 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 86.0 mt -101.06 122.08 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.25 0.548 . . . . 0.0 109.528 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.0 m -98.41 137.98 36.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.724 -0.61 . . . . 0.0 109.781 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.7 p -42.65 -28.89 0.26 Allowed 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.707 -0.621 . . . . 0.0 112.179 -178.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.1 tttp -65.97 -50.47 64.22 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.833 0.825 . . . . 0.0 109.691 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -60.2 -56.38 22.32 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.932 -0.48 . . . . 0.0 111.798 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.95 -34.16 74.3 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.29 -0.882 . . . . 0.0 110.49 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.97 -31.56 17.87 Favored Glycine 0 N--CA 1.501 2.982 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.2 m -67.25 -40.13 86.21 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.393 -1.063 . . . . 0.0 109.399 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.5 t -64.38 -39.98 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 121.455 0.645 . . . . 0.0 109.422 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 98.0 mmm -60.06 -38.4 82.72 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.809 -0.557 . . . . 0.0 110.297 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -62.92 -40.05 96.41 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.414 -0.804 . . . . 0.0 110.659 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 t -59.28 -26.86 65.31 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.924 -0.485 . . . . 0.0 110.883 -178.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 36.3 tp -85.56 -24.92 27.04 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.415 -0.803 . . . . 0.0 109.109 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.23 -61.95 0.15 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -162.96 172.04 15.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.587 -0.949 . . . . 0.0 110.931 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -116.41 153.58 48.83 Favored Pre-proline 0 C--N 1.298 -1.664 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.171 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -66.08 -146.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.532 1.28 . . . . 0.0 109.642 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.1 p -125.68 166.79 16.11 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.048 -1.033 . . . . 0.0 110.845 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -59.0 -35.48 73.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.767 -0.583 . . . . 0.0 111.706 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.48 -47.82 45.67 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 122.298 1.047 . . . . 0.0 109.23 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.54 -36.09 80.34 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.302 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.2 mt -58.2 -35.91 72.33 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.757 0.789 . . . . 0.0 109.587 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -66.82 -39.73 87.8 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.17 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -65.56 -39.94 92.26 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.537 -0.727 . . . . 0.0 110.937 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 90.7 mtp -60.17 -47.13 87.24 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.763 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.7 mm -64.92 -35.77 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.806 -0.559 . . . . 0.0 110.311 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -60.26 -44.97 94.82 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.596 -0.69 . . . . 0.0 111.772 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -70.01 -28.39 65.47 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.191 -0.943 . . . . 0.0 111.09 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.44 -8.58 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.587 -0.696 . . . . 0.0 110.599 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -74.35 103.18 4.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.26 -0.9 . . . . 0.0 110.415 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.98 -36.4 75.16 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.617 -0.677 . . . . 0.0 109.693 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -92.35 -26.84 17.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.683 -0.635 . . . . 0.0 110.821 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.57 20.06 52.53 Favored Glycine 0 N--CA 1.496 2.638 0 C-N-CA 120.404 -0.903 . . . . 0.0 110.906 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -74.49 -32.88 62.68 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.37 -1.077 . . . . 0.0 110.254 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.94 1.06 17.12 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.002 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.2 p -137.66 169.84 17.09 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.125 -1.22 . . . . 0.0 110.488 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.3 mt -105.78 120.57 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.505 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -98.17 169.91 9.26 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.528 0.68 . . . . 0.0 110.582 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.407 ' HB3' ' HD3' ' A' ' 66' ' ' PRO . 8.1 t80 -47.86 -48.75 60.86 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' A' ' 65' ' ' PHE . 45.9 Cg_endo -71.83 -32.68 11.14 Favored 'Trans proline' 0 N--CA 1.487 1.089 0 O-C-N 122.711 0.848 . . . . 0.0 111.376 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -72.13 -39.98 68.41 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.261 -0.9 . . . . 0.0 110.268 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -63.21 -41.64 99.17 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.471 -0.768 . . . . 0.0 111.204 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.2 mt -69.59 -39.99 76.95 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.534 -0.729 . . . . 0.0 112.048 -178.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.5 p -60.02 -47.87 84.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.334 -0.854 . . . . 0.0 111.191 -178.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 8.6 tmm? -68.56 -38.89 81.13 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.6 -0.687 . . . . 0.0 111.682 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 57.6 tpp -59.99 -50.03 75.35 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.374 -0.828 . . . . 0.0 112.217 -178.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.98 -25.04 63.43 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.183 -0.948 . . . . 0.0 112.082 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.2 -57.81 3.63 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.404 -0.81 . . . . 0.0 112.978 -178.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -69.64 -40.05 76.75 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -177.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 22.0 mtm -53.87 -39.91 66.12 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.057 -1.027 . . . . 0.0 111.946 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.0 tttt -59.99 -49.05 79.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.283 -0.885 . . . . 0.0 110.664 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -63.21 -27.37 69.31 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.817 0.818 . . . . 0.0 109.866 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . 0.255 7.0 m -70.09 -173.42 0.66 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.807 -0.558 . . . . 0.0 109.918 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -129.24 139.72 51.73 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.153 -0.967 . . . . 0.0 109.547 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.1 t -70.02 -27.46 64.69 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.581 -0.699 . . . . 0.0 111.046 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.03 -36.26 76.89 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.481 -0.762 . . . . 0.0 109.838 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -70.06 -39.93 75.37 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.342 0.592 . . . . 0.0 110.361 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -61.64 -39.57 91.79 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.571 -0.705 . . . . 0.0 111.274 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 89.2 mt -67.12 -44.3 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.52 -0.738 . . . . 0.0 110.803 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -59.81 -40.14 87.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.527 -0.733 . . . . 0.0 111.783 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -76.04 -39.85 54.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.364 -0.835 . . . . 0.0 112.262 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.52 -46.7 81.79 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.271 -0.893 . . . . 0.0 111.317 -178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -61.75 -44.14 97.48 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.509 -0.744 . . . . 0.0 109.834 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.04 -36.9 78.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.746 -0.596 . . . . 0.0 110.939 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 95.1 t -69.82 -48.51 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.484 -0.76 . . . . 0.0 110.161 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -68.03 -39.6 83.06 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.471 -0.768 . . . . 0.0 111.013 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -80.45 71.98 7.31 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.382 -0.824 . . . . 0.0 110.126 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -60.06 -47.5 85.61 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.374 -0.828 . . . . 0.0 110.335 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -70.63 -24.36 62.71 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.539 -0.726 . . . . 0.0 110.929 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.67 21.97 77.94 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -67.12 -15.7 63.87 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.239 -1.154 . . . . 0.0 111.258 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.58 -13.06 54.16 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 81.5 m-85 -133.15 141.31 48.06 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.163 -1.198 . . . . 0.0 109.224 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 62.7 mt -89.15 121.15 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.111 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 m -84.92 168.87 14.62 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.217 0.532 . . . . 0.0 109.869 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.97 -37.12 75.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.6 -0.688 . . . . 0.0 109.211 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.92 -36.41 83.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.796 -0.565 . . . . 0.0 109.799 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -67.22 -40.12 86.34 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.524 -0.735 . . . . 0.0 110.645 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.42 -42.4 96.06 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.505 0.669 . . . . 0.0 110.051 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -62.93 -39.5 94.78 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.788 -0.57 . . . . 0.0 111.535 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -60.41 -48.61 81.0 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.216 -0.928 . . . . 0.0 112.161 -177.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 93.8 t -71.49 -50.37 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.136 -0.977 . . . . 0.0 111.452 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 73.9 mtp -55.42 -40.38 71.4 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.266 -0.896 . . . . 0.0 110.231 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.2 m -66.59 -45.4 79.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.482 -0.761 . . . . 0.0 109.077 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -66.72 -25.04 66.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.814 -0.554 . . . . 0.0 109.85 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.9 mt -69.06 -26.61 65.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.583 -0.698 . . . . 0.0 110.227 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.6 11.73 5.89 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -127.76 131.41 49.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.172 -1.193 . . . . 0.0 109.952 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -105.0 126.01 51.6 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.608 -0.683 . . . . 0.0 110.232 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.0 mt -130.02 160.88 32.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.698 -0.626 . . . . 0.0 110.44 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.32 163.1 23.15 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -60.26 -31.44 70.22 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -67.15 -33.07 74.65 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.389 0.614 . . . . 0.0 109.667 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -67.79 -36.15 79.93 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 69.1 t -70.06 -40.01 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.913 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -60.03 -45.79 91.66 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.665 -0.647 . . . . 0.0 110.071 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -60.0 -41.4 91.99 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.599 -0.688 . . . . 0.0 109.641 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 98.0 mtp -54.46 -37.08 64.78 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.012 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 93.0 mt -66.58 -37.48 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 50.2 ttt85 -58.13 -40.0 80.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.472 -0.768 . . . . 0.0 111.118 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -60.0 -39.12 84.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.582 -0.699 . . . . 0.0 111.039 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.88 -10.92 19.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.397 -0.815 . . . . 0.0 111.522 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -89.48 74.04 7.76 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.003 -1.06 . . . . 0.0 110.994 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 84.7 mt -66.49 -39.96 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.663 -0.648 . . . . 0.0 109.474 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -59.23 -39.58 83.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.656 -0.653 . . . . 0.0 110.89 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.33 15.17 42.09 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.146 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -81.95 -10.05 59.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.02 -1.282 . . . . 0.0 110.546 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.12 2.54 85.76 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.491 -0.756 . . . . 0.0 111.537 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -130.94 131.32 44.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.24 -1.153 . . . . 0.0 109.611 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.7 t -90.88 111.62 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.452 -0.78 . . . . 0.0 110.037 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -89.03 -168.88 2.32 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 121.742 -0.599 . . . . 0.0 110.276 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -69.65 -40.08 76.7 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.8 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -60.0 -46.36 89.74 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.299 -0.876 . . . . 0.0 111.454 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -65.94 -38.15 87.88 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.817 0.818 . . . . 0.0 110.339 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -59.73 -45.67 91.48 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.865 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 62.5 t -78.1 -40.05 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.232 -0.917 . . . . 0.0 112.577 -178.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -60.0 -51.68 68.63 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.976 -1.077 . . . . 0.0 111.693 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.404 ' HE3' ' CD1' ' B' ' 157' ' ' PHE . 59.4 ttp -60.53 -36.07 77.53 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.369 -0.832 . . . . 0.0 110.413 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 95.9 mtp -69.96 -40.03 75.64 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.799 -0.563 . . . . 0.0 110.673 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 39.7 m -97.5 15.82 22.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.486 -0.759 . . . . 0.0 111.086 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.06 -42.3 94.21 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.179 -0.951 . . . . 0.0 110.432 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 86.2 mttt . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.144 179.684 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.31 142.14 13.02 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . 0.404 ' CD1' ' HE3' ' A' ' 144' ' ' MET . 45.8 t80 -60.02 -43.43 95.26 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.49 -1.006 . . . . 0.0 110.236 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -60.03 -39.59 86.41 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.658 -0.651 . . . . 0.0 110.51 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -59.92 -40.07 87.63 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.434 -0.791 . . . . 0.0 110.665 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . 0.423 HD12 HG22 ' B' ' 160' ' ' ILE . 95.8 mt -67.74 -39.62 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.408 -0.807 . . . . 0.0 110.121 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.27 91.68 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.552 -0.717 . . . . 0.0 111.634 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -60.09 -40.04 88.23 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.106 -0.997 . . . . 0.0 110.747 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 9.6 tt -60.61 -40.11 90.64 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.433 -0.792 . . . . 0.0 109.95 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 89.2 t -62.71 -39.95 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.594 -0.691 . . . . 0.0 109.688 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.99 -36.64 90.91 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 94.9 t -60.07 -31.54 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.769 -0.842 . . . . 0.0 110.581 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 84.5 mt -60.03 -41.14 91.6 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.452 -0.78 . . . . 0.0 111.015 -178.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -61.03 -40.02 92.01 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.254 -0.904 . . . . 0.0 109.864 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -62.23 -40.56 96.54 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.658 -0.651 . . . . 0.0 110.86 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -60.08 -41.06 91.65 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.397 -0.814 . . . . 0.0 111.032 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.53 -41.24 76.24 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.414 -0.804 . . . . 0.0 110.855 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -60.01 -39.95 87.56 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.521 -0.737 . . . . 0.0 110.602 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 . . . . . 0 N--CA 1.496 1.87 0 O-C-N 121.392 -0.817 . . . . 0.0 110.301 -179.796 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 121.449 0.642 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.7 mt -59.93 -31.15 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.659 -0.651 . . . . 0.0 111.911 -178.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.95 -39.77 86.72 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.927 -1.108 . . . . 0.0 109.95 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -59.32 -41.46 89.13 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.268 0.556 . . . . 0.0 109.963 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -65.09 -21.51 66.82 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.613 -0.679 . . . . 0.0 111.111 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -70.03 -41.15 74.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.116 -0.99 . . . . 0.0 108.878 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.93 -51.78 68.24 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.013 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.06 -20.47 63.23 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.185 -0.947 . . . . 0.0 112.008 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.503 ' CD1' ' CZ ' ' A' ' 65' ' ' PHE . 60.2 t80 -58.05 -50.04 74.81 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.03 -1.044 . . . . 0.0 111.222 -177.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 97.6 p -66.76 -39.36 87.84 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.5 tp -60.08 -40.0 88.04 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.258 0.551 . . . . 0.0 109.816 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -77.44 -31.74 54.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.683 -0.635 . . . . 0.0 110.311 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -92.09 102.11 14.64 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.418 -0.801 . . . . 0.0 109.522 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -60.0 -39.64 86.46 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.609 -0.682 . . . . 0.0 112.308 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -80.08 -11.66 59.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.087 -1.008 . . . . 0.0 111.335 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.18 28.62 50.15 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -88.28 -5.6 58.26 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.637 -0.919 . . . . 0.0 110.788 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.53 1.39 57.77 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.938 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 54.3 p -144.2 141.81 30.13 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 119.116 1.458 . . . . 0.0 111.368 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 84.8 mt -101.08 123.77 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.79 -0.569 . . . . 0.0 109.611 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 34.4 p -99.96 140.0 34.81 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.539 -0.726 . . . . 0.0 110.046 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.6 p -43.19 -29.22 0.36 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.726 -0.609 . . . . 0.0 112.092 -178.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.11 -50.55 65.65 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.429 -0.794 . . . . 0.0 109.511 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -59.61 -53.82 53.59 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 121.253 0.549 . . . . 0.0 110.894 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.6 tt -60.02 -35.32 74.82 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.449 -0.782 . . . . 0.0 111.451 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.07 -30.82 17.39 Favored Glycine 0 N--CA 1.498 2.822 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.5 m -70.03 -39.98 75.44 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.564 -0.963 . . . . 0.0 110.503 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.27 -54.26 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.457 -0.777 . . . . 0.0 109.456 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 95.8 mtp -59.92 -31.34 69.75 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.614 -0.679 . . . . 0.0 110.012 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -61.55 -40.47 94.81 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.681 0.753 . . . . 0.0 109.102 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.8 p -70.06 -20.22 63.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.787 -0.57 . . . . 0.0 110.405 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.1 mt -88.61 -17.0 31.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.484 -0.76 . . . . 0.0 110.41 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.22 -62.87 0.15 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -156.45 169.47 24.56 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.281 -1.129 . . . . 0.0 111.468 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -104.7 129.53 24.78 Favored Pre-proline 0 N--CA 1.49 1.573 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.844 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -67.3 -150.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.228 0 O-C-N 123.132 1.069 . . . . 0.0 109.487 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.5 p -135.62 151.71 50.51 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.159 -0.963 . . . . 0.0 110.598 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -51.44 -24.75 5.31 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.779 -0.575 . . . . 0.0 111.805 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.05 -59.8 2.58 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 122.171 0.986 . . . . 0.0 108.776 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -66.86 -36.97 83.53 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.829 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.6 mt -58.12 -34.81 70.63 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.434 -0.791 . . . . 0.0 109.173 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.27 -40.02 96.22 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 120.484 -0.487 . . . . 0.0 110.43 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -64.58 -40.01 94.77 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.606 -0.684 . . . . 0.0 110.569 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 89.3 mtp -59.95 -44.57 94.33 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.463 0.649 . . . . 0.0 109.718 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.7 mm -65.87 -37.8 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.902 -0.499 . . . . 0.0 110.671 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -60.05 -39.95 87.74 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.437 -0.789 . . . . 0.0 111.523 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -68.88 -28.64 66.87 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.203 -0.935 . . . . 0.0 110.486 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.9 t -99.46 -9.94 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.64 -0.662 . . . . 0.0 111.183 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -70.74 95.56 1.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.143 -0.973 . . . . 0.0 111.265 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.56 -34.08 71.83 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.739 -0.601 . . . . 0.0 109.618 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.2 p-10 -95.43 -23.66 17.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.706 -0.621 . . . . 0.0 110.66 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.61 19.14 55.31 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.135 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.3 p-10 -75.63 -25.34 56.8 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.33 -1.1 . . . . 0.0 110.655 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 108.44 4.28 32.67 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.227 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 67.2 p -134.0 170.12 16.11 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.165 -1.197 . . . . 0.0 110.89 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.4 mt -101.83 119.99 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.909 -0.494 . . . . 0.0 110.434 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -102.51 168.17 9.47 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.59 0.71 . . . . 0.0 111.147 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.503 ' CZ ' ' CD1' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -43.13 -52.34 12.26 Favored Pre-proline 0 N--CA 1.504 2.269 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.2 Cg_endo -71.34 -30.27 15.79 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.042 1.022 . . . . 0.0 111.944 -178.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.25 -40.51 70.96 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.167 -0.958 . . . . 0.0 110.001 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -63.18 -42.38 99.37 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.655 -0.653 . . . . 0.0 110.968 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.4 mt -65.93 -41.75 90.97 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.523 -0.735 . . . . 0.0 111.152 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.3 p -63.53 -40.89 98.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.473 -0.767 . . . . 0.0 111.61 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 53.9 ttp -68.1 -40.04 82.7 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.442 -0.786 . . . . 0.0 110.674 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 7.5 mmt -61.86 -43.16 99.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.731 -0.606 . . . . 0.0 111.251 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.94 -30.55 67.96 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.59 -0.693 . . . . 0.0 110.523 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -70.22 -40.04 74.76 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.633 -0.667 . . . . 0.0 110.469 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -67.05 -55.44 14.33 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.532 -0.73 . . . . 0.0 111.898 -178.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 78.6 mtm -59.94 -32.53 70.88 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.457 -0.777 . . . . 0.0 110.973 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.9 tttt -66.38 -62.32 1.53 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.681 -0.637 . . . . 0.0 112.15 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -70.73 -10.06 58.62 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.47 -0.769 . . . . 0.0 112.046 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.5 t -101.07 -160.05 0.77 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.897 0.856 . . . . 0.0 112.035 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -129.98 139.49 51.06 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.358 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.0 t -63.36 -33.86 76.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.726 -0.609 . . . . 0.0 109.983 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.02 -33.23 71.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.692 -0.63 . . . . 0.0 109.662 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.34 -39.99 77.82 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.519 0.676 . . . . 0.0 109.639 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -63.06 -36.13 82.56 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.787 -0.57 . . . . 0.0 110.29 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.18 -44.38 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.741 -0.599 . . . . 0.0 109.977 179.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -59.39 -43.58 92.92 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.638 -0.664 . . . . 0.0 111.162 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -70.03 -40.08 75.4 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.588 -0.695 . . . . 0.0 111.729 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.6 -46.96 77.37 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.505 -0.747 . . . . 0.0 111.337 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.403 ' CE1' ' OD2' ' A' ' 93' ' ' ASP . 60.2 t80 -62.9 -42.84 99.92 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.524 -0.735 . . . . 0.0 109.861 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -59.95 -34.84 73.8 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.906 -0.496 . . . . 0.0 110.368 -179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 77.7 t -69.9 -50.1 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.502 -0.749 . . . . 0.0 109.774 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -69.94 -41.16 74.94 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.475 -0.765 . . . . 0.0 111.022 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.403 ' OD2' ' CE1' ' A' ' 89' ' ' PHE . 33.2 t0 -81.1 75.18 8.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.404 -0.81 . . . . 0.0 109.946 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -70.02 -40.01 75.48 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.425 -0.797 . . . . 0.0 110.258 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 37.5 p-10 -75.7 -26.43 57.55 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.787 -0.571 . . . . 0.0 110.92 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.85 26.22 69.75 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -69.12 -14.86 63.24 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.365 -1.079 . . . . 0.0 111.476 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.73 -17.95 17.55 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.411 ' CD2' ' HB3' ' A' ' 135' ' ' GLN . 31.5 p90 -148.19 158.94 44.37 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.194 -1.18 . . . . 0.0 109.06 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 40.5 mt -88.9 124.24 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.322 -0.861 . . . . 0.0 110.099 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 m -82.67 172.29 13.09 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.669 0.747 . . . . 0.0 111.305 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.74 -47.37 83.85 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.81 -0.557 . . . . 0.0 110.098 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.45 -36.68 81.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.699 -0.626 . . . . 0.0 109.643 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -61.34 -40.13 93.11 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.601 -0.687 . . . . 0.0 110.39 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.73 -44.3 90.64 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.442 -0.786 . . . . 0.0 109.992 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -61.2 -37.37 82.75 Favored 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 34.7 t60 -60.0 -48.48 81.55 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.202 -0.936 . . . . 0.0 110.852 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.4 t -70.04 -39.22 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.513 -0.742 . . . . 0.0 111.568 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 12.9 mmt -59.06 -51.01 71.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.298 -0.876 . . . . 0.0 110.762 -178.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.5 m -66.88 -40.74 87.89 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.468 -0.77 . . . . 0.0 109.857 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -61.23 -31.36 71.15 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 13.8 mt -69.16 -29.55 67.58 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.194 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.93 27.45 5.13 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -119.22 139.91 51.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.512 -0.993 . . . . 0.0 110.011 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -101.67 115.21 30.03 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.503 -0.748 . . . . 0.0 109.523 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 50.0 mt -132.83 153.69 51.04 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.459 -0.775 . . . . 0.0 109.949 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.97 164.96 19.02 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -62.1 -26.69 68.44 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.446 -0.784 . . . . 0.0 109.377 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.17 -35.44 76.3 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.639 0.733 . . . . 0.0 109.189 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -65.03 -37.78 88.73 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.382 0.61 . . . . 0.0 109.474 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 79.6 t -69.86 -39.14 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.564 0.697 . . . . 0.0 109.718 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -60.0 -40.04 87.85 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.777 -0.577 . . . . 0.0 109.832 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -59.96 -40.68 89.87 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.278 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 66.5 mtt -56.15 -37.02 68.95 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.394 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.01 -40.01 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.595 -0.691 . . . . 0.0 110.322 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 40.2 mtm-85 -59.99 -41.56 92.32 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.578 -0.701 . . . . 0.0 112.463 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.99 -39.97 87.56 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.705 -0.622 . . . . 0.0 111.329 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -98.33 -16.55 19.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.29 -0.881 . . . . 0.0 111.084 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -78.48 72.65 5.02 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.13 -0.981 . . . . 0.0 110.12 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 86.3 mt -65.06 -45.72 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.661 -0.649 . . . . 0.0 110.92 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -63.37 -40.06 96.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.358 -0.839 . . . . 0.0 111.175 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.56 20.64 9.94 Favored Glycine 0 N--CA 1.497 2.719 0 C-N-CA 120.058 -1.068 . . . . 0.0 111.198 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -82.16 -9.94 59.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.22 -1.165 . . . . 0.0 110.828 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.14 2.44 80.5 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.411 ' HB3' ' CD2' ' A' ' 99' ' ' TYR . 27.7 mt-30 -135.62 144.9 46.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.382 -1.069 . . . . 0.0 109.079 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.7 t -93.08 118.98 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.403 -0.811 . . . . 0.0 110.296 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -87.58 -179.51 6.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.557 -0.714 . . . . 0.0 109.374 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -69.46 -40.57 77.07 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.943 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -62.78 -44.05 97.2 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.548 -0.72 . . . . 0.0 110.784 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -65.78 -38.64 89.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.461 -0.774 . . . . 0.0 109.932 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -60.01 -44.11 94.78 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.083 0.468 . . . . 0.0 110.839 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 76.6 t -68.67 -39.96 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.485 -0.759 . . . . 0.0 110.726 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -60.24 -42.47 95.34 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.437 -0.79 . . . . 0.0 110.586 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.5 mmm -60.74 -40.02 90.83 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.633 -0.667 . . . . 0.0 110.631 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 95.2 mmm -70.07 -39.98 75.31 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.547 -0.721 . . . . 0.0 110.294 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.4 m -96.87 18.96 13.42 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.54 -0.725 . . . . 0.0 110.65 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.58 142.86 53.48 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.313 -0.867 . . . . 0.0 110.609 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.8 mttt . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.252 179.511 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -66.03 138.85 37.5 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -59.96 -42.79 94.86 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.614 -0.933 . . . . 0.0 110.351 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -60.04 -33.81 72.54 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.565 -0.71 . . . . 0.0 110.552 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -60.05 -42.69 95.04 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.746 -0.596 . . . . 0.0 111.013 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.05 -40.02 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.567 -0.708 . . . . 0.0 110.681 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.04 87.97 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.576 -0.703 . . . . 0.0 111.118 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -69.04 -39.99 78.84 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.401 -0.812 . . . . 0.0 110.926 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 9.8 tt -61.04 -45.86 93.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.601 -0.687 . . . . 0.0 110.824 -179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 10.2 p -69.96 -29.99 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.388 -0.82 . . . . 0.0 110.699 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.14 -40.94 97.87 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 87.5 t -79.99 -26.05 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.82 -0.812 . . . . 0.0 110.134 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 4.3 tt -54.43 -59.92 4.04 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.478 -0.764 . . . . 0.0 111.814 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -66.78 -35.15 79.4 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.379 -0.826 . . . . 0.0 111.934 -178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -59.96 -38.72 83.3 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.263 -0.898 . . . . 0.0 109.842 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -60.01 -39.98 87.65 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.81 -0.556 . . . . 0.0 110.283 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.62 -35.81 75.1 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.4 -0.812 . . . . 0.0 110.198 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -59.89 -36.38 76.81 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.501 -0.749 . . . . 0.0 110.052 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 . . . . . 0 N--CA 1.493 1.719 0 O-C-N 121.546 -0.721 . . . . 0.0 110.235 179.947 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 . . . . . 0 N--CA 1.497 1.902 0 CA-C-O 121.417 0.627 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.5 mm -59.97 -49.75 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.444 -0.785 . . . . 0.0 111.075 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.41 -24.15 67.24 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.486 -0.758 . . . . 0.0 111.602 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -66.54 -44.95 81.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.289 -0.882 . . . . 0.0 109.943 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -69.88 -24.13 63.36 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.541 0.686 . . . . 0.0 109.598 178.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -69.94 -40.07 75.72 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.452 0.644 . . . . 0.0 109.968 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.96 -52.19 66.44 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.737 -0.602 . . . . 0.0 111.735 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.99 -21.57 63.21 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.173 -0.954 . . . . 0.0 111.709 -178.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -59.41 -47.06 86.9 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.206 -0.934 . . . . 0.0 110.513 -178.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -62.07 -37.29 84.44 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.294 -0.879 . . . . 0.0 109.201 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.1 -39.48 94.83 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -69.97 -39.24 76.11 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.176 0.512 . . . . 0.0 110.027 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -97.86 98.65 10.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.67 -0.644 . . . . 0.0 109.825 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -69.22 -29.2 67.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.463 -0.773 . . . . 0.0 110.547 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -82.07 -10.05 59.34 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.369 -0.832 . . . . 0.0 111.611 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.64 25.07 66.89 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -178.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -78.6 -11.24 59.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.472 -1.016 . . . . 0.0 110.824 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.59 3.95 83.44 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.8 p -145.92 140.72 27.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.028 -1.277 . . . . 0.0 110.283 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.4 mt -101.52 122.73 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.751 -0.593 . . . . 0.0 109.549 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.2 m -97.92 141.16 31.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.75 -0.594 . . . . 0.0 109.992 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 27.7 p -39.07 -34.98 0.19 Allowed 'General case' 0 N--CA 1.51 2.546 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -66.71 -44.89 80.44 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.441 -0.787 . . . . 0.0 109.314 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -61.45 -58.26 8.88 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.946 -0.471 . . . . 0.0 111.339 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.43 HD23 ' CE2' ' B' ' 170' ' ' TRP . 54.6 tp -59.99 -36.04 76.32 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.273 -0.892 . . . . 0.0 111.061 -178.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.01 -29.99 15.48 Favored Glycine 0 N--CA 1.5 2.908 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.4 m -69.95 -39.98 75.74 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.634 -0.921 . . . . 0.0 110.453 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.1 t -63.54 -51.19 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 CA-C-O 121.621 0.724 . . . . 0.0 109.112 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 87.3 mtp -60.05 -33.04 71.49 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.277 0.56 . . . . 0.0 109.835 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -60.92 -42.46 98.17 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.411 0.624 . . . . 0.0 109.896 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.0 t -70.03 -16.38 63.15 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.637 -0.665 . . . . 0.0 110.415 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.4 tp -84.66 -24.42 29.02 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.355 -0.841 . . . . 0.0 109.383 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.42 -51.42 0.18 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.781 -1.727 . . . . 0.0 108.781 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -163.1 172.96 14.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.633 -0.922 . . . . 0.0 110.612 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -120.33 143.98 37.09 Favored Pre-proline 0 C--N 1.299 -1.62 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.057 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.69 -150.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 123.394 1.208 . . . . 0.0 109.881 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.89 161.54 36.35 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.082 -1.011 . . . . 0.0 110.098 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -52.23 -27.36 14.5 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.699 -0.626 . . . . 0.0 111.524 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.94 -58.31 3.55 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 122.078 0.942 . . . . 0.0 109.171 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.73 -39.62 91.32 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.086 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 13.1 mt -56.56 -33.75 66.45 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.48 -0.762 . . . . 0.0 110.111 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.9 -36.65 82.77 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.386 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -68.33 -41.89 80.14 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.573 -0.705 . . . . 0.0 111.233 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 64.4 mtt -61.92 -43.28 99.16 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.534 -0.729 . . . . 0.0 109.724 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.2 mm -66.74 -35.58 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.842 -0.536 . . . . 0.0 110.241 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -61.53 -40.96 96.51 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.616 -0.677 . . . . 0.0 111.918 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -69.97 -29.6 66.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.184 -0.948 . . . . 0.0 111.002 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.7 t -100.03 -8.8 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.51 -0.744 . . . . 0.0 111.397 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.48 100.29 1.38 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.09 -1.007 . . . . 0.0 111.241 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.13 -33.89 72.4 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.661 -0.649 . . . . 0.0 109.933 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -98.36 -21.97 16.33 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.609 -0.682 . . . . 0.0 110.879 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.34 19.7 61.88 Favored Glycine 0 N--CA 1.495 2.632 0 C-N-CA 120.402 -0.904 . . . . 0.0 110.956 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -74.48 -37.54 63.16 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.372 -1.075 . . . . 0.0 110.173 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.33 2.52 6.97 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.306 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 62.8 p -138.5 170.18 16.47 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.033 -1.275 . . . . 0.0 111.355 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.9 mt -102.37 120.93 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.168 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -100.75 170.03 8.61 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.458 0.647 . . . . 0.0 110.251 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.449 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 5.6 t80 -48.22 -48.88 64.06 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.561 -0.712 . . . . 0.0 112.651 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.9 Cg_endo -68.45 -35.86 16.87 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 O-C-N 122.75 0.868 . . . . 0.0 111.916 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.98 -40.03 75.6 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.092 -1.005 . . . . 0.0 110.467 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -61.46 -42.02 98.12 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.643 -0.661 . . . . 0.0 110.549 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.51 -41.95 96.1 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.394 -0.816 . . . . 0.0 111.695 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 72.0 p -62.36 -40.48 96.54 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.288 -0.882 . . . . 0.0 111.493 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.437 ' CE ' ' CZ3' ' B' ' 170' ' ' TRP . 59.3 ttp -69.74 -40.38 76.2 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.481 -0.762 . . . . 0.0 111.439 -178.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 88.8 mmm -60.77 -49.08 78.93 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.483 -0.761 . . . . 0.0 110.95 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.24 -31.99 73.43 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.785 -0.572 . . . . 0.0 111.291 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -70.04 -39.76 75.55 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.545 -0.722 . . . . 0.0 111.649 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -69.12 -31.59 70.38 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.274 -0.891 . . . . 0.0 112.569 -178.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 63.2 mtt -59.54 -48.2 82.59 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.173 -0.955 . . . . 0.0 112.395 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -69.06 -38.38 79.05 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.238 -0.914 . . . . 0.0 112.032 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -69.99 -20.06 63.31 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.33 -0.856 . . . . 0.0 111.197 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.2 t -112.22 -164.45 0.92 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.957 0.884 . . . . 0.0 111.709 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -130.27 147.0 51.94 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.899 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.6 p -67.09 -26.93 66.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.591 -0.693 . . . . 0.0 110.601 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.31 -35.39 77.23 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.566 0.698 . . . . 0.0 109.505 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.97 -39.99 83.22 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.563 0.697 . . . . 0.0 109.87 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -62.32 -38.66 90.31 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.793 -0.567 . . . . 0.0 111.456 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 67.7 mt -68.11 -45.3 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.405 -0.809 . . . . 0.0 110.672 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 64.1 mtp180 -58.09 -41.49 83.61 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.231 -0.918 . . . . 0.0 110.811 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.407 ' CG ' ' HD3' ' B' ' 168' ' ' ARG . 98.5 mt-10 -70.03 -39.98 75.44 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.663 -0.648 . . . . 0.0 111.484 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.38 -47.98 77.19 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.469 -0.769 . . . . 0.0 111.536 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -60.27 -42.15 94.81 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.408 -0.808 . . . . 0.0 109.992 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -60.07 -37.61 80.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.905 -0.497 . . . . 0.0 110.62 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.5 t -69.9 -55.59 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.317 -0.864 . . . . 0.0 110.521 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -60.6 -39.98 90.11 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.312 -0.868 . . . . 0.0 110.978 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -80.51 78.04 7.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.587 -0.696 . . . . 0.0 110.315 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -67.0 -41.43 86.75 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.385 -0.822 . . . . 0.0 109.904 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.6 p-10 -76.15 -21.32 56.71 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.626 -0.671 . . . . 0.0 111.212 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.22 24.45 74.77 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -70.02 -10.94 60.35 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.412 -1.052 . . . . 0.0 111.368 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.19 -15.62 58.93 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.418 ' CZ ' ' ND2' ' A' ' 137' ' ' ASN . 73.3 m-85 -133.55 141.02 47.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.246 -1.15 . . . . 0.0 109.331 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 77.8 mt -89.06 122.15 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.395 -0.816 . . . . 0.0 109.72 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.4 m -83.49 170.01 14.88 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.334 0.588 . . . . 0.0 110.819 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.05 -39.99 94.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.8 -0.562 . . . . 0.0 109.807 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.7 -31.55 72.76 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.57 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -69.92 -40.01 75.82 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.767 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.58 -47.02 87.4 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.289 -0.882 . . . . 0.0 109.328 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -64.14 -30.36 71.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.929 -0.482 . . . . 0.0 111.102 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -61.96 -49.02 77.79 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.375 -0.828 . . . . 0.0 111.806 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 72.6 t -70.03 -47.18 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.328 -0.858 . . . . 0.0 111.299 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 98.9 mtp -59.61 -39.99 86.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.318 -0.864 . . . . 0.0 110.489 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.2 m -64.5 -46.2 84.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.453 -0.779 . . . . 0.0 109.107 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -62.46 -32.73 73.66 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.7 mt -69.97 -33.69 72.42 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.341 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.43 34.49 1.43 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -125.08 136.69 53.91 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.524 -0.986 . . . . 0.0 110.078 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -101.91 130.54 48.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.509 -0.744 . . . . 0.0 109.639 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -148.3 152.22 36.73 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.673 -0.642 . . . . 0.0 110.848 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.1 p -80.94 162.02 24.07 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -61.42 -27.78 68.79 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -67.8 -34.94 77.76 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.822 0.82 . . . . 0.0 109.193 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -62.52 -40.09 95.63 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 75.5 t -66.22 -40.06 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.097 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -60.02 -45.95 91.11 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.648 -0.658 . . . . 0.0 110.558 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -59.97 -40.61 89.69 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.904 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 86.2 mmm -54.63 -38.14 66.47 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.029 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.23 -38.69 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.692 -0.63 . . . . 0.0 110.15 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -58.36 -39.99 81.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.552 -0.718 . . . . 0.0 111.959 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.11 -40.06 88.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.469 -0.77 . . . . 0.0 112.172 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -108.44 -5.62 16.55 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.189 -0.944 . . . . 0.0 112.317 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -90.29 73.06 7.11 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.889 -1.132 . . . . 0.0 111.06 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 86.5 mt -68.28 -40.05 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.49 -0.756 . . . . 0.0 110.116 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 36.5 p-10 -60.0 -39.94 87.5 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.528 -0.732 . . . . 0.0 111.043 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 92.38 24.92 22.84 Favored Glycine 0 N--CA 1.493 2.437 0 O-C-N 121.25 -0.907 . . . . 0.0 111.057 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -82.45 -8.02 59.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -1.178 . . . . 0.0 110.544 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 97.16 -1.5 60.81 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -140.84 159.65 41.76 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.16 -1.2 . . . . 0.0 109.722 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 94.3 t -87.89 118.24 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.394 -0.816 . . . . 0.0 109.078 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.418 ' ND2' ' CZ ' ' A' ' 99' ' ' TYR . 8.6 t-20 -87.36 170.03 11.75 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.997 0.903 . . . . 0.0 110.994 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -63.57 -50.01 71.16 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.278 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -62.35 -41.1 98.32 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.38 -0.825 . . . . 0.0 110.539 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.25 -37.27 85.1 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.13 0.967 . . . . 0.0 109.268 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -59.94 -41.9 92.86 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.008 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.8 t -74.2 -42.16 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.284 -0.885 . . . . 0.0 111.956 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -59.98 -50.37 74.01 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.41 -0.806 . . . . 0.0 112.157 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.408 ' HE1' ' CD1' ' B' ' 157' ' ' PHE . 55.1 ttp -61.37 -35.72 78.25 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.366 -0.834 . . . . 0.0 110.871 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 89.2 mtp -69.96 -39.91 75.72 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.792 -0.567 . . . . 0.0 110.244 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.3 m -98.97 22.45 10.24 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.579 -0.7 . . . . 0.0 110.459 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.38 -40.55 85.71 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.366 -0.834 . . . . 0.0 111.399 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 29.9 mttt . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.525 -179.102 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 70.07 32.16 69.41 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . 0.408 ' CD1' ' HE1' ' A' ' 144' ' ' MET . 37.9 t80 -60.04 -41.89 93.25 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.55 -0.97 . . . . 0.0 110.111 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -60.77 -40.13 91.37 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.664 -0.647 . . . . 0.0 110.984 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 43.1 mtm-85 -65.73 -39.99 91.73 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.355 -0.841 . . . . 0.0 111.158 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 93.5 mt -65.25 -40.03 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.394 -0.816 . . . . 0.0 110.231 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.55 -40.74 97.78 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.562 -0.711 . . . . 0.0 110.127 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 -62.21 -40.48 96.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.728 -0.607 . . . . 0.0 110.557 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 85.8 mt -64.86 -40.07 94.57 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.495 -0.753 . . . . 0.0 110.562 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 94.2 t -63.78 -40.11 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.552 -0.718 . . . . 0.0 110.023 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.03 -31.39 61.54 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 67.2 t -79.94 -28.95 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.722 -0.87 . . . . 0.0 111.363 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 79.0 mt -60.09 -49.95 75.63 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.195 -0.941 . . . . 0.0 111.707 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 168' ' ' ARG . . . . . 0.407 ' HD3' ' CG ' ' A' ' 87' ' ' GLU . 38.0 ttt-85 -66.4 -40.06 89.41 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.127 -0.983 . . . . 0.0 110.445 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -60.04 -29.88 68.81 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.571 -0.706 . . . . 0.0 110.627 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 170' ' ' TRP . . . . . 0.437 ' CZ3' ' CE ' ' A' ' 71' ' ' MET . 4.5 t-105 -60.17 -39.47 86.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.489 -0.757 . . . . 0.0 110.176 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.23 -39.97 76.59 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.491 -0.755 . . . . 0.0 111.046 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -60.03 -39.97 87.69 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.345 -0.847 . . . . 0.0 110.372 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 . . . . . 0 N--CA 1.494 1.741 0 O-C-N 121.496 -0.752 . . . . 0.0 109.986 179.905 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 . . . . . 0 N--CA 1.499 2.009 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.7 mm -61.42 -50.87 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.308 -0.87 . . . . 0.0 110.374 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.43 -35.86 78.73 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.771 -0.581 . . . . 0.0 110.941 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.94 -45.46 92.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.61 -0.681 . . . . 0.0 110.362 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.459 ' CE1' ' HG2' ' A' ' 72' ' ' MET . 24.7 m-85 -64.68 -22.84 67.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.619 -0.676 . . . . 0.0 111.234 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -68.63 -41.62 79.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.272 -0.892 . . . . 0.0 108.721 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -59.99 -52.54 64.95 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.618 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.25 -23.43 64.78 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.318 -0.864 . . . . 0.0 111.657 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -56.1 -47.67 77.63 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.978 -1.076 . . . . 0.0 109.991 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.3 m -60.75 -39.29 88.16 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.503 -0.748 . . . . 0.0 109.403 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 64.2 tp -63.8 -39.95 95.48 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.92 -39.57 76.08 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -95.19 97.3 9.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.631 -0.668 . . . . 0.0 110.036 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.8 mttt -64.37 -32.01 73.45 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.367 -0.833 . . . . 0.0 111.598 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -80.57 -10.02 59.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.209 -0.932 . . . . 0.0 111.506 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.23 25.08 46.81 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -87.23 -9.66 54.51 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.586 -0.949 . . . . 0.0 110.666 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.64 2.81 53.04 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.868 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.5 p -144.61 141.95 29.78 Favored 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 119.534 1.667 . . . . 0.0 112.1 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.3 mm -99.93 121.04 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.5 p -100.91 142.08 32.88 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.576 -0.703 . . . . 0.0 111.019 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.4 HG23 ' CD1' ' A' ' 52' ' ' ILE . 82.1 p -41.76 -33.14 0.46 Allowed 'General case' 0 N--CA 1.509 2.518 0 O-C-N 121.856 -0.528 . . . . 0.0 111.892 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -64.71 -51.06 64.43 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.797 0.808 . . . . 0.0 109.525 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -59.95 -54.75 42.41 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.577 -178.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.431 HD22 ' CE2' ' B' ' 170' ' ' TRP . 58.8 tp -60.04 -35.32 74.85 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.203 -0.936 . . . . 0.0 110.696 -178.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.05 -30.45 16.56 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.8 m -70.03 -39.97 75.44 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.569 -0.959 . . . . 0.0 110.363 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 79.0 t -64.89 -51.07 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.628 -0.67 . . . . 0.0 109.746 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 98.1 mtp -59.97 -33.03 71.39 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.741 -0.6 . . . . 0.0 109.521 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -61.57 -41.87 98.02 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.696 0.76 . . . . 0.0 109.084 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.9 t -72.02 -19.47 61.85 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.962 -0.461 . . . . 0.0 110.81 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.7 -16.99 29.18 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.272 -0.893 . . . . 0.0 110.504 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.16 -55.62 0.18 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -159.97 169.92 22.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.411 -1.053 . . . . 0.0 110.804 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -107.82 125.88 31.12 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.892 -0.505 . . . . 0.0 110.151 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.07 -148.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.07 0 N-CA-C 108.649 -1.327 . . . . 0.0 108.649 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 50.2 p -137.45 150.36 47.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.929 -1.107 . . . . 0.0 110.837 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -53.15 -23.65 8.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.636 -0.665 . . . . 0.0 111.467 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.49 -60.05 2.42 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.89 0.852 . . . . 0.0 109.128 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -67.71 -37.67 82.57 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.054 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.6 mt -57.1 -33.23 67.1 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.495 -0.753 . . . . 0.0 110.02 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -35.52 80.45 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.956 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -65.68 -39.96 91.85 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.45 -0.781 . . . . 0.0 110.832 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 67.2 mtt -60.02 -45.45 92.74 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.433 0.635 . . . . 0.0 109.93 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.4 ' CD1' HG23 ' A' ' 29' ' ' THR . 96.8 mt -67.95 -33.07 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.824 -0.547 . . . . 0.0 110.729 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -60.06 -40.05 88.12 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.327 -0.858 . . . . 0.0 110.115 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -67.11 -26.47 66.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.377 -0.827 . . . . 0.0 109.959 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 74.3 t -99.81 -9.99 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.598 -0.689 . . . . 0.0 110.864 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -72.27 99.71 2.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.118 -0.989 . . . . 0.0 111.126 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.54 -40.06 92.46 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.388 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -88.32 -28.34 21.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.714 -0.616 . . . . 0.0 110.563 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.02 22.95 43.16 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -74.22 -33.79 63.49 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.499 -1.001 . . . . 0.0 110.617 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.97 -0.43 10.81 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.294 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.0 p -132.67 170.08 15.74 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.017 -1.284 . . . . 0.0 110.391 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.6 mt -106.67 120.4 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.87 -0.519 . . . . 0.0 110.869 -177.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -100.68 169.44 9.03 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.572 0.701 . . . . 0.0 110.906 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.448 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -45.05 -52.73 18.68 Favored Pre-proline 0 N--CA 1.502 2.168 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.069 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.2 Cg_endo -67.39 -30.93 35.81 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 O-C-N 122.943 0.97 . . . . 0.0 111.514 -178.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -72.1 -40.91 67.85 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.448 -0.782 . . . . 0.0 110.425 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -66.08 -40.16 90.61 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.683 -0.636 . . . . 0.0 111.177 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.7 mt -66.23 -39.93 89.9 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.373 -0.83 . . . . 0.0 111.569 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 21.6 p -64.19 -41.39 97.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.555 -0.716 . . . . 0.0 111.333 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 58.9 ttp -68.07 -40.2 82.77 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.438 -0.788 . . . . 0.0 110.894 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.459 ' HG2' ' CE1' ' A' ' 12' ' ' PHE . 53.6 tpp -59.99 -45.11 93.79 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.493 -0.755 . . . . 0.0 110.462 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.8 -30.8 70.32 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.506 -0.746 . . . . 0.0 109.725 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.02 -39.67 75.65 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.706 -0.621 . . . . 0.0 111.059 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -65.79 -36.57 83.88 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.412 -0.805 . . . . 0.0 112.203 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 60.7 mtt -59.73 -50.09 75.18 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.214 -0.929 . . . . 0.0 111.684 -177.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -70.05 -38.96 75.96 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.308 -0.87 . . . . 0.0 110.835 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -68.66 -40.02 80.38 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.448 -0.782 . . . . 0.0 109.978 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.4 m -100.43 -172.59 2.23 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.985 -0.447 . . . . 0.0 110.196 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -129.53 147.22 51.31 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.42 -0.8 . . . . 0.0 109.904 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.4 t -59.95 -27.81 67.12 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.546 -0.721 . . . . 0.0 110.401 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.01 -36.72 77.85 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.368 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.98 -39.94 75.64 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.378 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.08 -37.47 75.45 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.694 -0.629 . . . . 0.0 110.558 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 67.7 mt -65.57 -53.83 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.635 -0.666 . . . . 0.0 111.028 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.403 ' HG3' ' N ' ' A' ' 87' ' ' GLU . 33.6 ptt180 -60.03 -39.97 87.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.383 -0.823 . . . . 0.0 111.392 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.403 ' N ' ' HG3' ' A' ' 86' ' ' ARG . 95.3 mt-10 -68.58 -40.76 80.38 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.506 -0.746 . . . . 0.0 110.742 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.19 -44.24 89.03 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.956 -0.465 . . . . 0.0 110.898 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -61.15 -41.28 96.47 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.879 0.847 . . . . 0.0 108.814 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -59.98 -38.14 81.69 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.821 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.3 -43.2 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.506 -0.746 . . . . 0.0 110.027 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -69.37 -39.1 78.25 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.497 -0.752 . . . . 0.0 111.451 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -79.55 77.23 6.15 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.32 -0.862 . . . . 0.0 110.508 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -59.98 -42.34 93.98 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.395 -0.816 . . . . 0.0 110.216 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 24.1 p-10 -81.92 -19.94 39.74 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.496 -0.752 . . . . 0.0 111.258 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.79 63.83 4.92 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -109.91 -10.77 14.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.457 -1.025 . . . . 0.0 111.52 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.25 -23.31 8.14 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 31.0 p90 -149.08 152.91 37.01 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.327 -1.102 . . . . 0.0 109.549 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 56.0 mt -89.34 125.2 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.742 0.782 . . . . 0.0 109.96 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 m -80.99 171.29 15.18 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.141 0.496 . . . . 0.0 110.31 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.04 -40.59 96.63 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.622 -0.674 . . . . 0.0 109.498 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.03 -38.48 91.24 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.496 0.665 . . . . 0.0 109.314 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -62.43 -39.43 93.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.741 -0.6 . . . . 0.0 111.285 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.4 tt -62.53 -43.74 98.06 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.133 -0.979 . . . . 0.0 109.468 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -60.05 -33.34 71.91 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.686 -0.634 . . . . 0.0 110.901 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -60.37 -45.37 93.76 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.159 -0.963 . . . . 0.0 111.614 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.9 t -72.92 -39.86 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.299 -0.876 . . . . 0.0 111.256 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 26.8 mmt -59.86 -48.65 80.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.46 -0.775 . . . . 0.0 110.293 -178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.1 m -67.26 -41.71 85.09 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.496 -0.752 . . . . 0.0 109.848 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -61.13 -31.46 71.17 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.3 mt -69.03 -32.79 72.55 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.713 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.61 29.14 4.83 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -121.43 130.03 53.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.581 -0.952 . . . . 0.0 109.734 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -92.43 117.64 30.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.532 -0.73 . . . . 0.0 110.132 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 60.8 mt -132.71 157.24 45.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.617 -0.677 . . . . 0.0 109.812 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 p -83.74 162.99 20.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.587 -0.696 . . . . 0.0 109.663 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.9 p-10 -60.06 -25.16 65.16 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -66.61 -34.63 78.32 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.42 -38.98 91.78 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.541 0.686 . . . . 0.0 109.233 179.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 74.9 t -68.88 -39.05 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.359 0.6 . . . . 0.0 110.124 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -59.28 -49.93 75.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.768 -0.582 . . . . 0.0 110.341 -178.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -60.27 -41.45 93.29 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.399 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 97.6 mtp -54.81 -39.7 68.75 Favored 'General case' 0 N--CA 1.504 2.24 0 C-N-CA 119.389 -0.924 . . . . 0.0 108.838 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 89.4 mt -63.75 -40.0 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.162 0.506 . . . . 0.0 109.963 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -60.0 -39.97 87.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.483 -0.76 . . . . 0.0 112.182 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -60.06 -39.94 87.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.116 -0.99 . . . . 0.0 111.773 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -99.05 -17.48 18.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.205 -0.934 . . . . 0.0 110.987 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.4 77.86 5.76 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.178 -0.951 . . . . 0.0 110.816 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 82.9 mt -64.14 -39.98 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.66 -0.65 . . . . 0.0 111.079 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -59.51 -38.53 81.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.403 -0.81 . . . . 0.0 111.12 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 98.59 11.93 45.98 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 120.115 -1.04 . . . . 0.0 111.417 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -81.31 -13.66 58.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.023 -1.281 . . . . 0.0 110.56 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.95 5.55 70.69 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.793 178.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -127.68 126.48 42.01 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.032 -1.275 . . . . 0.0 109.924 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.7 t -89.96 113.99 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.252 -0.905 . . . . 0.0 109.71 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -89.97 -179.38 5.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.507 -0.746 . . . . 0.0 109.884 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -62.24 -41.8 98.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.718 -0.614 . . . . 0.0 110.422 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -62.56 -44.85 95.32 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.199 -0.938 . . . . 0.0 111.463 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -63.44 -38.96 93.15 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.978 0.894 . . . . 0.0 109.454 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -59.87 -41.88 92.48 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.578 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.2 t -68.06 -40.11 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.493 -0.754 . . . . 0.0 110.945 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -60.78 -40.39 92.41 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.373 -0.829 . . . . 0.0 110.056 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 53.9 ttp -60.05 -41.2 91.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.779 -0.576 . . . . 0.0 110.752 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 44.3 mtt -82.06 -39.18 23.82 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.535 -0.728 . . . . 0.0 110.999 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 85.4 m -59.98 -26.81 66.33 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.695 -0.628 . . . . 0.0 110.459 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -80.78 119.12 22.95 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.434 -0.791 . . . . 0.0 110.601 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.7 mttm . . . . . 0 N--CA 1.5 2.026 0 CA-C-O 118.407 -0.806 . . . . 0.0 111.47 179.798 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 72.86 39.17 55.54 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -59.97 -47.47 85.66 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.451 -1.029 . . . . 0.0 109.464 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -60.73 -39.06 87.26 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.855 -0.528 . . . . 0.0 110.351 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -60.0 -40.0 87.72 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.522 -0.736 . . . . 0.0 109.853 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 86.7 mt -68.34 -39.99 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.681 -0.637 . . . . 0.0 110.369 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.04 -38.89 84.07 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.46 -0.775 . . . . 0.0 110.65 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 32.7 ttm-85 -60.04 -40.95 91.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.433 -0.792 . . . . 0.0 109.962 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 39.2 tp -64.24 -39.9 94.92 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.772 -0.58 . . . . 0.0 110.077 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 80.2 t -62.47 -39.94 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.517 -0.74 . . . . 0.0 110.347 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.52 -36.9 87.03 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 73.3 t -68.21 -39.19 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.913 -0.757 . . . . 0.0 110.457 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.97 -46.41 89.52 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.522 -0.736 . . . . 0.0 111.635 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -59.98 -40.0 87.64 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.27 -0.894 . . . . 0.0 110.269 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -60.09 -39.86 87.6 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.55 -0.719 . . . . 0.0 110.396 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 170' ' ' TRP . . . . . 0.431 ' CE2' HD22 ' A' ' 32' ' ' LEU . 5.0 t-105 -60.02 -45.64 92.14 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.695 -0.628 . . . . 0.0 110.404 -179.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.55 -40.63 97.45 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.519 -0.738 . . . . 0.0 110.152 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -59.98 -40.07 87.85 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.579 -0.7 . . . . 0.0 109.977 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.697 -0.627 . . . . 0.0 110.174 179.784 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 . . . . . 0 N--CA 1.497 1.887 0 CA-C-O 121.44 0.638 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.6 mt -60.06 -38.85 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.65 -0.656 . . . . 0.0 111.971 -178.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.87 -29.19 70.02 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.97 -1.081 . . . . 0.0 111.051 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.85 -40.48 97.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.291 -0.881 . . . . 0.0 109.865 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.448 ' CG ' ' CD2' ' A' ' 69' ' ' LEU . 77.5 m-85 -64.98 -22.22 66.97 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.816 -0.553 . . . . 0.0 111.438 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.408 ' HE2' ' CZ ' ' A' ' 65' ' ' PHE . 28.3 mmtp -65.31 -39.97 93.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.34 -0.85 . . . . 0.0 110.075 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -62.63 -58.5 7.3 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.705 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.03 -36.07 76.47 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.387 -0.821 . . . . 0.0 112.15 -178.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -54.95 -49.73 70.63 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.072 -1.017 . . . . 0.0 110.561 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.6 t -60.77 -35.43 76.4 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.519 -0.738 . . . . 0.0 110.06 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.83 -39.97 91.35 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -71.95 -40.62 68.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.909 -0.495 . . . . 0.0 110.668 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -94.19 95.21 8.81 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.363 -0.836 . . . . 0.0 110.82 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -66.76 -33.14 74.96 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.298 -0.876 . . . . 0.0 111.309 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -78.7 -10.91 59.93 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.116 -0.99 . . . . 0.0 111.281 -177.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.42 25.28 66.72 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 58.2 p-10 -89.5 -3.28 58.42 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.456 -1.026 . . . . 0.0 110.808 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.93 8.22 76.37 Favored Glycine 0 N--CA 1.489 2.232 0 O-C-N 121.217 -0.927 . . . . 0.0 111.271 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.9 p -145.73 143.06 29.51 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 119.335 1.568 . . . . 0.0 112.109 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.0 mt -101.21 121.84 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.69 -0.631 . . . . 0.0 109.411 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.6 p -99.15 143.45 29.41 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.49 -0.757 . . . . 0.0 110.607 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 80.6 p -41.88 -36.92 1.16 Allowed 'General case' 0 N--CA 1.507 2.401 0 O-C-N 121.983 -0.448 . . . . 0.0 112.2 -178.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -62.47 -47.86 82.14 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.112 -0.992 . . . . 0.0 109.346 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -60.04 -54.97 39.7 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.49 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 44.4 tp -59.98 -36.99 78.34 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.253 -0.904 . . . . 0.0 111.55 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.54 -31.39 14.46 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.5 m -70.92 -39.62 72.58 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.401 -1.058 . . . . 0.0 110.172 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.3 t -64.79 -54.1 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.517 -0.739 . . . . 0.0 110.06 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 92.6 mtp -60.03 -34.94 74.06 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.59 0.71 . . . . 0.0 110.064 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -60.05 -49.54 77.24 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.651 0.739 . . . . 0.0 110.007 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.9 t -69.96 -16.69 63.24 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.838 -0.539 . . . . 0.0 110.791 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 84.3 mt -87.9 -24.41 23.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.474 -0.766 . . . . 0.0 110.45 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.41 -38.43 0.22 Allowed Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.528 -1.32 . . . . 0.0 111.401 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -152.78 155.53 37.34 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 118.814 1.307 . . . . 0.0 112.196 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -116.97 99.96 53.16 Favored Pre-proline 0 N--CA 1.489 1.517 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.677 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -64.18 -148.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.282 0 O-C-N 123.246 1.129 . . . . 0.0 109.56 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.7 p -139.94 156.5 46.63 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.93 -1.106 . . . . 0.0 111.689 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -54.02 -20.58 6.58 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.801 -0.562 . . . . 0.0 111.602 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.94 -59.99 2.46 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.937 0.875 . . . . 0.0 108.942 177.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -68.73 -33.75 74.44 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.044 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.2 mt -58.8 -34.85 71.96 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.608 -0.683 . . . . 0.0 110.33 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.33 -32.12 69.71 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.535 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -70.08 -43.09 71.83 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.356 -0.84 . . . . 0.0 111.313 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 77.7 mtm -60.95 -41.85 97.12 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.632 0.73 . . . . 0.0 109.463 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.0 mt -69.82 -31.93 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.908 -0.495 . . . . 0.0 110.026 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -59.96 -41.53 92.11 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.593 -0.692 . . . . 0.0 110.821 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -67.99 -25.61 65.49 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.323 -0.861 . . . . 0.0 110.292 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.3 t -99.09 -9.46 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.607 -0.683 . . . . 0.0 111.116 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -71.96 106.53 4.29 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.123 -0.986 . . . . 0.0 111.68 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.92 -40.07 75.76 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.458 -0.776 . . . . 0.0 109.726 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -88.62 -29.74 19.74 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.635 -0.665 . . . . 0.0 110.266 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.92 24.61 44.4 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -74.3 -31.82 62.64 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.536 -0.979 . . . . 0.0 110.467 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 123.0 -3.91 9.78 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 120.361 -0.923 . . . . 0.0 111.033 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 82.0 p -133.43 170.01 16.12 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.065 -1.256 . . . . 0.0 110.364 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.1 mt -102.79 120.48 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.05 -178.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -98.38 169.51 9.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.523 -0.736 . . . . 0.0 110.617 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.452 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 25.7 t80 -49.01 -48.76 71.9 Favored Pre-proline 0 N--CA 1.497 1.915 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.7 Cg_endo -68.11 -33.54 24.87 Favored 'Trans proline' 0 N--CA 1.486 1.084 0 O-C-N 122.639 0.81 . . . . 0.0 110.863 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -71.13 -39.98 71.69 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.328 -0.857 . . . . 0.0 110.061 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -60.78 -49.96 75.4 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.522 -0.736 . . . . 0.0 110.893 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.448 ' CD2' ' CG ' ' A' ' 12' ' ' PHE . 85.2 mt -60.33 -41.89 94.49 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.509 -0.744 . . . . 0.0 111.515 -178.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 45.9 p -63.66 -37.17 86.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.44 -0.788 . . . . 0.0 111.395 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.8 ttt -65.76 -44.36 86.09 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.299 -0.876 . . . . 0.0 111.54 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 91.2 mtp -71.04 -60.08 2.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.346 -0.846 . . . . 0.0 112.146 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.74 -40.79 76.39 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.47 -0.768 . . . . 0.0 111.314 -178.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.8 tpt85 -70.0 -40.2 75.42 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.526 -0.734 . . . . 0.0 111.157 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -86.2 -39.1 16.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.397 -0.815 . . . . 0.0 111.986 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 43.9 mtm -60.02 -39.95 87.62 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.254 -0.904 . . . . 0.0 111.661 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -62.21 -44.27 96.96 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.189 -0.944 . . . . 0.0 109.66 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -74.74 -10.02 59.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.93 -0.481 . . . . 0.0 110.566 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.433 ' CG2' ' N ' ' A' ' 80' ' ' ASP . 0.6 OUTLIER -85.5 -162.5 0.73 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.252 -0.905 . . . . 0.0 111.328 -179.047 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.433 ' N ' ' CG2' ' A' ' 79' ' ' THR . 68.6 m-20 -130.06 135.43 48.23 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.804 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.0 t -69.97 -27.19 64.52 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.614 -0.678 . . . . 0.0 110.638 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -60.04 -36.62 77.68 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.556 -0.715 . . . . 0.0 110.023 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.98 -40.02 75.6 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.722 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -63.21 -40.05 96.37 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.475 -0.766 . . . . 0.0 110.729 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 85.8 mt -66.03 -46.89 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.673 -0.642 . . . . 0.0 110.148 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 -56.57 -40.42 75.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.532 -0.73 . . . . 0.0 110.903 -178.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -69.94 -40.05 75.73 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.421 -0.8 . . . . 0.0 111.721 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.1 -48.86 72.17 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.358 -0.839 . . . . 0.0 111.996 -178.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -61.23 -43.68 98.48 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.464 -0.772 . . . . 0.0 109.984 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -59.98 -38.41 82.46 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.874 -0.516 . . . . 0.0 110.997 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.0 t -69.82 -48.76 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.473 -0.767 . . . . 0.0 110.446 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -67.98 -40.06 83.19 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.47 -0.769 . . . . 0.0 111.01 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -74.96 69.93 1.94 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.528 -0.733 . . . . 0.0 110.337 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.7 tttp -59.95 -46.6 88.89 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.426 -0.796 . . . . 0.0 109.84 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.1 p-10 -73.9 -18.83 60.86 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.603 -0.685 . . . . 0.0 111.382 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.94 62.4 6.35 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.438 ' ND2' ' CE2' ' A' ' 99' ' ' TYR . 37.6 p-10 -109.23 -7.46 15.27 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.516 -0.991 . . . . 0.0 111.82 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.55 -22.6 11.76 Favored Glycine 0 N--CA 1.498 2.817 0 C-N-CA 119.989 -1.1 . . . . 0.0 110.439 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.438 ' CE2' ' ND2' ' A' ' 97' ' ' ASN . 35.5 p90 -143.77 154.55 43.56 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.392 -1.064 . . . . 0.0 109.635 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 81.9 mt -91.32 129.42 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 121.839 0.828 . . . . 0.0 110.126 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.03 172.36 9.6 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.211 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.26 -40.98 86.26 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.579 -0.701 . . . . 0.0 109.665 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.54 -37.75 88.51 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -61.16 -37.35 82.58 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.974 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.58 -42.73 95.42 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.682 0.753 . . . . 0.0 109.552 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -60.04 -38.53 83.02 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.883 -0.511 . . . . 0.0 111.556 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -59.97 -41.06 91.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.084 -1.01 . . . . 0.0 111.856 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 84.5 t -72.9 -50.13 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.239 -0.913 . . . . 0.0 111.594 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 41.8 mtt -59.07 -41.52 88.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.175 -0.953 . . . . 0.0 110.403 -178.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.7 m -64.37 -46.62 82.59 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.49 -0.756 . . . . 0.0 109.126 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -61.35 -33.57 73.85 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.2 mt -69.84 -30.51 68.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.95 -0.469 . . . . 0.0 109.999 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.16 31.62 3.03 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -122.19 137.0 54.98 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.539 -0.977 . . . . 0.0 110.028 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -109.52 124.87 51.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.532 -0.73 . . . . 0.0 110.212 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 73.0 mt -138.98 159.75 41.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.565 -0.709 . . . . 0.0 109.647 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.18 162.01 26.04 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -59.61 -29.55 68.07 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.355 -0.841 . . . . 0.0 109.084 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -68.44 -32.63 72.78 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.424 0.63 . . . . 0.0 109.61 178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -67.83 -37.97 82.61 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.522 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 97.5 t -69.74 -40.09 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.699 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -59.9 -42.03 92.92 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.295 0.569 . . . . 0.0 109.996 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -60.04 -41.4 92.2 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.026 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 6.3 mmt -54.64 -36.37 64.48 Favored 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.385 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.5 mm -68.47 -37.6 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.308 0.575 . . . . 0.0 109.826 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 46.6 ttt-85 -60.0 -40.08 87.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.574 -0.704 . . . . 0.0 111.239 -178.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -61.83 -39.46 91.89 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.648 -0.657 . . . . 0.0 111.222 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -99.34 -0.25 41.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.347 -0.846 . . . . 0.0 111.763 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -104.48 80.53 1.69 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.979 -1.076 . . . . 0.0 110.947 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.4 mt -67.84 -39.95 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.648 -0.658 . . . . 0.0 109.965 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 36.5 p-10 -60.02 -39.72 86.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.587 -0.696 . . . . 0.0 110.755 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.77 17.9 36.75 Favored Glycine 0 N--CA 1.497 2.727 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.385 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -81.0 -10.11 59.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.108 -1.231 . . . . 0.0 110.608 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.13 2.29 71.39 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.367 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -136.77 139.18 41.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.167 -1.196 . . . . 0.0 110.276 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 98.1 t -95.81 113.81 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.566 -0.709 . . . . 0.0 109.713 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 41.6 p30 -86.12 -166.95 1.68 Allowed 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.609 -0.682 . . . . 0.0 110.241 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -70.08 -43.72 70.56 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.842 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -61.3 -49.96 74.93 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.264 -0.897 . . . . 0.0 112.115 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.3 -37.63 88.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.503 -0.748 . . . . 0.0 110.499 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -60.09 -47.3 86.45 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.667 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 87.0 t -64.66 -39.96 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.485 -0.76 . . . . 0.0 110.695 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -59.98 -49.64 76.87 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.563 -0.711 . . . . 0.0 111.033 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.448 ' CE ' ' CD1' ' B' ' 157' ' ' PHE . 10.9 tmm? -60.66 -40.01 90.48 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.279 -0.888 . . . . 0.0 110.128 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 94.9 mmm -67.24 -38.78 85.77 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.749 -0.595 . . . . 0.0 109.944 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 91.6 m -58.85 -29.03 66.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.69 -0.631 . . . . 0.0 109.973 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.99 141.86 47.74 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.6 -0.688 . . . . 0.0 110.432 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 95.7 mttt . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.325 179.916 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -66.54 152.74 52.41 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . 0.448 ' CD1' ' CE ' ' A' ' 144' ' ' MET . 22.6 t80 -61.51 -42.2 98.44 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.488 -1.007 . . . . 0.0 110.332 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 63.0 mtt85 -60.02 -40.06 88.01 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.558 -0.714 . . . . 0.0 110.397 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -62.61 -39.92 95.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.494 -0.754 . . . . 0.0 110.364 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 73.0 mt -61.23 -45.09 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.516 -0.74 . . . . 0.0 110.041 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.9 -28.64 69.09 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.518 -0.739 . . . . 0.0 110.146 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -60.15 -39.92 88.03 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.572 -0.705 . . . . 0.0 109.503 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 89.0 mt -60.04 -40.08 88.14 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.724 -0.61 . . . . 0.0 110.413 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 94.0 t -65.22 -39.95 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.496 -0.753 . . . . 0.0 109.9 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -54.81 -37.15 61.17 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 85.0 t -60.0 -33.32 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.657 -0.907 . . . . 0.0 109.627 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 8.1 tt -56.24 -37.74 70.15 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.622 -0.674 . . . . 0.0 110.777 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -59.99 -39.99 87.65 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.416 -0.803 . . . . 0.0 110.224 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -63.76 -40.01 95.67 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.447 -0.783 . . . . 0.0 110.989 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -20.9 59.46 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.415 -0.803 . . . . 0.0 110.869 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.98 -32.31 70.46 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.268 -0.895 . . . . 0.0 110.965 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -59.98 -38.73 83.39 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.355 -0.841 . . . . 0.0 109.865 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 71.4 mtp85 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.734 -0.604 . . . . 0.0 110.318 179.99 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 121.037 0.446 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -81.4 98.92 8.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.516 -0.74 . . . . 0.0 109.927 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.69 176.88 1.79 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.52 0.676 . . . . 0.0 110.721 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 66.6 mt -111.85 -179.4 3.68 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.603 0.716 . . . . 0.0 110.604 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.94 19.78 18.68 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.881 -0.512 . . . . 0.0 110.237 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -61.27 -13.79 21.46 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.369 -0.832 . . . . 0.0 111.526 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -64.96 -45.18 86.79 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.248 -0.908 . . . . 0.0 109.4 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -66.54 -38.82 87.98 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.301 0.572 . . . . 0.0 110.067 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 72.1 mt -57.88 -29.02 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.776 -0.577 . . . . 0.0 110.737 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.22 -39.13 89.09 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.233 -0.917 . . . . 0.0 110.194 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -59.98 -43.47 95.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.718 -0.614 . . . . 0.0 110.397 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -64.8 -20.77 66.56 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.844 -0.535 . . . . 0.0 111.395 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -69.96 -42.3 73.36 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.068 -1.02 . . . . 0.0 109.107 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -70.0 -26.65 64.17 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.119 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.15 -27.43 32.73 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.335 -0.853 . . . . 0.0 111.147 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.454 ' CB ' ' CE1' ' A' ' 65' ' ' PHE . 47.9 t80 -59.66 -41.32 90.31 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.576 -0.703 . . . . 0.0 111.673 -177.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.0 m -61.28 -38.36 86.5 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.233 -0.917 . . . . 0.0 109.974 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.7 tp -60.05 -41.21 91.84 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.816 -0.553 . . . . 0.0 110.0 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -74.22 -34.76 63.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.583 -0.698 . . . . 0.0 110.467 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -92.97 95.44 9.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.447 -0.783 . . . . 0.0 109.655 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -59.98 -32.1 70.51 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.426 -0.796 . . . . 0.0 111.155 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -79.44 -8.03 58.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.102 -0.999 . . . . 0.0 110.754 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.21 26.83 29.92 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -90.4 -4.82 56.78 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.686 -0.89 . . . . 0.0 111.326 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.97 2.41 58.26 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.634 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.0 p -146.71 144.18 29.25 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.353 1.576 . . . . 0.0 111.727 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 84.0 mt -107.72 133.14 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.71 -0.619 . . . . 0.0 109.97 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.2 p -111.04 145.84 37.78 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.552 -0.717 . . . . 0.0 110.626 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.412 ' CG2' ' CD1' ' A' ' 52' ' ' ILE . 53.6 p -43.81 -32.98 1.18 Allowed 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.667 -0.646 . . . . 0.0 111.858 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.06 -50.59 65.58 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.753 0.787 . . . . 0.0 109.533 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -59.99 -53.63 55.56 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.65 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.0 tt -60.02 -32.38 70.84 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.359 -0.838 . . . . 0.0 110.479 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.19 -31.34 33.8 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.314 -1.115 . . . . 0.0 110.314 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 93.7 m -63.83 -39.97 95.49 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.591 -0.946 . . . . 0.0 109.09 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.0 t -66.61 -39.98 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 96.8 mmm -59.97 -39.99 87.57 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.684 -0.635 . . . . 0.0 110.877 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.438 ' CG ' ' HB2' ' A' ' 42' ' ' ASN . 55.6 mtm180 -61.85 -42.62 99.26 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.152 -0.967 . . . . 0.0 109.552 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.3 t -63.72 -25.96 68.44 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.083 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.0 tp -85.77 -23.17 27.38 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.416 -0.803 . . . . 0.0 109.366 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.93 -58.77 0.17 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -160.56 176.26 11.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.544 -0.974 . . . . 0.0 111.415 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.438 ' HB2' ' CG ' ' A' ' 37' ' ' ARG . 38.9 t30 -99.61 131.84 24.1 Favored Pre-proline 0 N--CA 1.492 1.664 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.208 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -68.75 -147.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.111 0 N-CA-C 108.435 -1.41 . . . . 0.0 108.435 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.1 p -129.59 141.55 50.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.827 -1.171 . . . . 0.0 110.481 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -51.48 -25.77 7.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.642 -0.661 . . . . 0.0 111.322 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.57 -54.9 7.87 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.124 0.964 . . . . 0.0 108.546 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -66.86 -39.87 87.69 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.093 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 mt -56.0 -35.04 66.37 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.542 -0.724 . . . . 0.0 109.713 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.97 -37.16 81.19 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.152 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -65.22 -38.68 91.16 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.382 -0.823 . . . . 0.0 110.791 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 88.6 mmm -59.98 -45.97 90.97 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.659 -0.65 . . . . 0.0 110.206 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.412 ' CD1' ' CG2' ' A' ' 29' ' ' THR . 89.9 mt -67.89 -32.98 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.714 -0.616 . . . . 0.0 110.375 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -60.01 -43.29 95.33 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.246 -0.909 . . . . 0.0 110.669 -178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -67.9 -26.44 65.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.339 -0.851 . . . . 0.0 110.918 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.5 t -99.97 -8.84 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.483 -0.761 . . . . 0.0 111.482 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -71.23 103.16 2.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.109 -0.995 . . . . 0.0 110.897 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.25 -38.71 78.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.648 -0.658 . . . . 0.0 109.76 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -91.45 -30.64 16.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.615 -0.678 . . . . 0.0 110.537 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.2 20.99 40.01 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 120.36 -0.924 . . . . 0.0 110.905 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.6 p-10 -73.95 -32.86 63.67 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.39 -1.065 . . . . 0.0 110.323 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.7 -0.04 12.16 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.006 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 57.7 p -137.35 167.74 21.01 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.091 -1.24 . . . . 0.0 110.917 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.8 mt -104.58 120.67 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 121.317 0.58 . . . . 0.0 110.483 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -96.48 169.93 9.57 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.383 0.611 . . . . 0.0 110.585 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.454 ' CE1' ' CB ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -46.06 -50.35 36.86 Favored Pre-proline 0 N--CA 1.501 2.099 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -179.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.3 Cg_endo -72.37 -32.02 10.74 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.026 1.014 . . . . 0.0 111.771 -178.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -71.44 -40.03 70.65 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.216 -0.927 . . . . 0.0 110.251 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -61.52 -39.96 92.93 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.723 -0.611 . . . . 0.0 110.761 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.3 mt -67.76 -39.98 84.12 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.424 -0.798 . . . . 0.0 111.926 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.1 p -61.88 -40.08 94.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.356 -0.84 . . . . 0.0 110.748 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 60.5 ttp -67.71 -38.38 83.53 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.622 -0.674 . . . . 0.0 110.357 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.402 ' CE ' ' CG2' ' B' ' 166' ' ' VAL . 5.0 tpt -60.06 -49.51 77.39 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.611 -0.681 . . . . 0.0 111.076 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.09 -28.96 65.83 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.395 -0.816 . . . . 0.0 110.757 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -72.05 -40.79 68.1 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.498 -0.751 . . . . 0.0 110.608 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -69.15 -50.07 51.08 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.639 -0.663 . . . . 0.0 111.483 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 70.6 mtm -59.94 -40.03 87.56 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.429 -0.794 . . . . 0.0 111.104 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -60.74 -55.41 33.53 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.368 -0.832 . . . . 0.0 111.224 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -65.02 -19.98 66.27 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.456 -0.777 . . . . 0.0 110.161 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . 0.299 52.9 m -99.87 -175.11 2.87 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.815 -0.553 . . . . 0.0 109.648 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -121.74 140.82 51.85 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.223 -0.923 . . . . 0.0 109.084 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.6 t -55.76 -28.57 56.67 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.317 -0.864 . . . . 0.0 110.271 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.76 -34.32 77.63 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.677 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -71.42 -41.63 69.31 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.92 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -69.93 -29.49 66.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.117 -0.989 . . . . 0.0 110.414 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 95.9 mt -69.3 -46.31 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.536 -0.727 . . . . 0.0 109.699 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 63.2 mtt180 -59.81 -39.93 86.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.409 -0.807 . . . . 0.0 110.584 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.95 -44.45 80.55 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.535 -0.728 . . . . 0.0 110.927 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.4 -43.58 93.98 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.667 -0.646 . . . . 0.0 111.282 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -59.94 -47.99 83.54 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.763 0.792 . . . . 0.0 109.778 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -58.98 -33.42 70.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.914 -0.492 . . . . 0.0 110.473 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.5 t -70.04 -42.88 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.508 -0.745 . . . . 0.0 110.028 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -70.06 -39.13 75.84 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.446 -0.784 . . . . 0.0 110.628 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -79.75 73.32 6.48 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.575 -0.703 . . . . 0.0 109.653 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -64.82 -40.83 95.84 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.381 -0.824 . . . . 0.0 110.487 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -76.12 -16.59 59.86 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.459 -0.775 . . . . 0.0 110.958 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.18 61.58 7.34 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 21.5 p-10 -107.79 -10.6 15.55 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.581 -0.952 . . . . 0.0 111.377 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.4 -23.22 8.58 Favored Glycine 0 N--CA 1.498 2.815 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 14.6 p90 -142.79 176.16 9.27 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.483 -1.01 . . . . 0.0 108.708 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.4 mt -89.07 -129.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 119.801 -0.759 . . . . 0.0 109.248 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 168.71 159.87 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 O-C-N 120.529 -1.357 . . . . 0.0 108.321 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.3 -42.02 97.97 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.367 -0.833 . . . . 0.0 109.18 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.12 -30.67 67.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.837 -0.539 . . . . 0.0 110.094 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -69.97 -39.15 76.16 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.305 -0.872 . . . . 0.0 110.593 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.54 -47.24 70.44 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.481 -0.762 . . . . 0.0 110.21 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -61.21 -38.94 88.39 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.826 -0.546 . . . . 0.0 111.628 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -60.04 -39.95 87.71 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.218 -0.926 . . . . 0.0 111.163 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 96.5 t -74.08 -47.36 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 O-C-N 121.275 -0.891 . . . . 0.0 111.438 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 76.5 mtm -58.83 -42.96 90.46 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.156 -0.965 . . . . 0.0 110.267 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.2 m -67.27 -41.67 85.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.541 -0.724 . . . . 0.0 109.127 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -63.1 -31.91 73.17 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.5 mt -70.02 -35.09 74.08 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.697 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.94 21.14 2.95 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.667 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -119.98 138.32 53.55 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.215 -1.168 . . . . 0.0 110.024 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.7 mmmt -103.33 122.02 43.95 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.541 -0.725 . . . . 0.0 110.649 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 77.2 mt -135.05 156.48 48.95 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.64 -0.662 . . . . 0.0 109.502 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.77 159.39 29.07 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.558 -0.714 . . . . 0.0 109.677 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -58.75 -29.8 67.02 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -66.09 -29.97 70.39 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -37.31 86.13 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 94.5 t -70.05 -39.91 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.522 0.677 . . . . 0.0 110.151 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -60.04 -45.75 91.78 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.786 -0.571 . . . . 0.0 110.074 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -59.9 -40.05 87.46 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.597 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 10.2 mmt -55.39 -38.48 68.94 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.594 -0.842 . . . . 0.0 108.767 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.4 mm -66.31 -40.1 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.356 0.598 . . . . 0.0 109.749 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -57.86 -38.62 76.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.691 -0.631 . . . . 0.0 111.197 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.95 -39.77 86.73 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.68 -0.638 . . . . 0.0 111.16 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.93 4.45 34.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.321 -0.862 . . . . 0.0 111.558 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -88.14 69.9 9.25 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.035 -1.041 . . . . 0.0 110.425 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.7 mt -67.67 -40.74 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.464 -0.772 . . . . 0.0 110.481 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -72.59 -22.4 60.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.433 -0.792 . . . . 0.0 111.087 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.6 24.33 50.58 Favored Glycine 0 N--CA 1.496 2.688 0 C-N-CA 120.262 -0.971 . . . . 0.0 110.69 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -83.8 -10.78 57.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.389 -1.065 . . . . 0.0 111.086 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.35 0.84 79.33 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -137.81 149.26 46.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -1.117 . . . . 0.0 109.286 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.0 t -92.14 118.63 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.427 -0.796 . . . . 0.0 109.771 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -88.06 176.51 7.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.573 -0.705 . . . . 0.0 109.346 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -61.34 -47.47 85.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.743 -0.598 . . . . 0.0 110.498 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -59.95 -46.42 89.47 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.74 -0.6 . . . . 0.0 111.51 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -64.47 -37.04 86.15 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.806 0.813 . . . . 0.0 109.99 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.453 ' CZ ' ' CE ' ' A' ' 145' ' ' MET . 64.9 t80 -60.07 -48.88 79.89 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.283 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 89.0 t -70.0 -40.65 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.308 -0.87 . . . . 0.0 111.921 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -59.94 -48.8 80.22 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.308 -0.87 . . . . 0.0 111.477 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 55.2 ttp -59.99 -35.9 76.01 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.428 -0.795 . . . . 0.0 110.475 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.453 ' CE ' ' CZ ' ' A' ' 141' ' ' PHE . 37.3 mtt -70.65 -40.04 73.27 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.638 -0.664 . . . . 0.0 110.939 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.5 t -104.99 31.65 4.69 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.514 -0.741 . . . . 0.0 109.98 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.18 -42.45 95.04 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.626 -0.671 . . . . 0.0 110.153 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 30.2 mttt . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.969 179.563 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.374 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -92.64 146.23 18.04 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -59.95 -40.73 90.0 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.506 -0.997 . . . . 0.0 109.903 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 32.6 ttp85 -61.38 -40.45 94.4 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.699 -0.626 . . . . 0.0 110.22 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -60.14 -40.01 88.34 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.488 -0.757 . . . . 0.0 110.286 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 97.4 mt -66.68 -39.63 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.655 -0.653 . . . . 0.0 110.465 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.32 -37.11 76.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.521 -0.737 . . . . 0.0 110.372 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -60.13 -40.04 88.4 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.486 -0.759 . . . . 0.0 110.688 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 83.4 mt -70.04 -34.95 73.91 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.517 -0.739 . . . . 0.0 110.691 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 91.1 t -63.97 -39.96 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.595 -0.691 . . . . 0.0 109.932 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.14 -30.46 67.2 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . 0.402 ' CG2' ' CE ' ' A' ' 72' ' ' MET . 58.3 t -69.02 -33.56 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.628 -0.925 . . . . 0.0 110.959 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 91.6 mt -60.17 -46.55 89.3 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.372 -0.83 . . . . 0.0 111.711 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -70.07 -38.18 75.66 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.198 -0.939 . . . . 0.0 111.505 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -59.97 -40.06 87.77 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.287 -0.883 . . . . 0.0 110.629 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -59.95 -40.26 88.38 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.41 -0.806 . . . . 0.0 109.845 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.1 -20.45 59.46 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.578 -0.701 . . . . 0.0 110.514 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -60.03 -39.99 87.77 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.324 -0.86 . . . . 0.0 110.072 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.635 -0.666 . . . . 0.0 110.111 179.73 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.146 0.498 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -133.47 37.83 3.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.726 -0.609 . . . . 0.0 110.284 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -61.67 -40.0 93.41 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.688 0.756 . . . . 0.0 110.341 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 77.2 mt -117.61 178.31 4.44 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.516 0.674 . . . . 0.0 110.583 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 p -143.78 106.13 4.41 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -92.62 -12.21 32.24 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.746 -0.596 . . . . 0.0 111.033 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -69.95 -42.14 73.62 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.271 -0.893 . . . . 0.0 109.879 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -68.01 -40.03 83.05 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.523 0.678 . . . . 0.0 110.818 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.428 HG21 HD13 ' A' ' 9' ' ' ILE . 79.0 mt -60.58 -29.04 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.925 -0.484 . . . . 0.0 111.525 -178.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.67 86.6 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.157 -0.964 . . . . 0.0 110.063 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -60.03 -40.38 89.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.465 -0.772 . . . . 0.0 110.244 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -65.36 -20.75 66.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.724 -0.61 . . . . 0.0 110.917 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.448 ' HD3' ' CZ ' ' A' ' 65' ' ' PHE . 72.2 mmtt -69.94 -46.14 65.94 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.293 -0.879 . . . . 0.0 109.886 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -76.23 -24.82 54.61 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.45 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.22 -35.2 42.01 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.454 -0.779 . . . . 0.0 110.51 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -59.87 -39.99 87.13 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.853 -0.529 . . . . 0.0 111.549 -177.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.5 m -61.93 -39.64 92.77 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.25 -0.906 . . . . 0.0 109.946 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.7 tp -60.03 -40.09 88.16 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.693 -0.629 . . . . 0.0 109.406 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -77.39 -35.61 54.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.718 -0.614 . . . . 0.0 110.349 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -94.26 97.73 10.44 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.401 -0.812 . . . . 0.0 110.196 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -59.99 -34.81 73.81 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.527 -0.733 . . . . 0.0 111.728 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -80.1 -11.2 59.78 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.172 -0.955 . . . . 0.0 111.249 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.56 28.77 52.29 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -90.86 -6.13 54.62 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.725 -0.868 . . . . 0.0 111.262 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.42 0.25 56.87 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 120.158 -1.02 . . . . 0.0 111.617 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.5 p -144.86 143.02 30.38 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 119.284 1.542 . . . . 0.0 111.108 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.8 mt -107.04 130.07 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 121.766 0.793 . . . . 0.0 110.868 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.4 p -106.16 143.06 34.82 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.846 -0.533 . . . . 0.0 110.537 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 64.8 p -43.25 -29.03 0.36 Allowed 'General case' 0 N--CA 1.509 2.489 0 O-C-N 121.667 -0.646 . . . . 0.0 112.163 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -65.09 -50.21 66.99 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.804 0.811 . . . . 0.0 109.58 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -59.51 -53.35 59.13 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.695 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.441 ' CD2' ' CE2' ' B' ' 170' ' ' TRP . 54.4 tp -60.09 -30.47 69.26 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.253 -0.904 . . . . 0.0 110.119 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.49 -32.56 23.58 Favored Glycine 0 N--CA 1.5 2.959 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.6 m -65.38 -39.91 92.86 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.545 -0.974 . . . . 0.0 109.434 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.1 t -68.18 -39.99 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-O 121.492 0.663 . . . . 0.0 110.046 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 46.1 mtt -59.97 -39.96 87.42 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.698 -0.626 . . . . 0.0 111.104 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.446 ' CG ' ' HB2' ' A' ' 42' ' ' ASN . 55.8 mtt180 -60.73 -46.73 89.28 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.303 -0.873 . . . . 0.0 109.961 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -67.0 -23.36 65.92 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.903 -178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.7 tp -82.64 -30.5 29.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.94 . . . . 0.0 109.443 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.37 -39.61 0.19 Allowed Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.934 -1.127 . . . . 0.0 110.868 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -170.53 160.35 7.3 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.076 -1.249 . . . . 0.0 112.271 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.446 ' HB2' ' CG ' ' A' ' 37' ' ' ARG . 5.9 t-20 -105.88 111.22 64.59 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.699 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -61.15 -143.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.496 0 O-C-N 123.501 1.264 . . . . 0.0 109.683 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.2 p -131.41 149.93 52.35 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.218 -1.551 . . . . 0.0 112.131 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -51.1 -22.54 2.53 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.872 -0.517 . . . . 0.0 111.927 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.61 -55.76 8.05 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 122.284 1.04 . . . . 0.0 108.454 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -67.32 -37.17 82.88 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.718 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.416 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 4.1 mt -57.35 -36.19 70.89 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.551 -0.718 . . . . 0.0 109.772 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.25 -40.03 89.9 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.426 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -64.0 -36.58 84.43 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.452 -0.78 . . . . 0.0 111.046 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 64.6 mtt -60.03 -44.95 94.28 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.638 -0.663 . . . . 0.0 109.888 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.428 HD11 HG21 ' A' ' 52' ' ' ILE . 66.1 mt -68.32 -34.06 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.747 -0.596 . . . . 0.0 110.364 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -60.06 -42.56 94.78 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.32 -0.863 . . . . 0.0 111.051 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -69.1 -27.67 65.8 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.089 -1.007 . . . . 0.0 110.984 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 96.5 t -99.92 -7.67 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.591 -0.693 . . . . 0.0 111.239 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.7 100.02 2.73 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.163 -0.961 . . . . 0.0 112.004 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.09 -33.28 65.52 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -71.62 -40.09 70.0 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.407 0.622 . . . . 0.0 110.214 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.25 -1.44 73.27 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -73.7 -40.07 63.89 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.206 -1.173 . . . . 0.0 110.95 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 129.78 8.55 3.42 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 119.83 -1.176 . . . . 0.0 112.009 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 74.5 p -136.79 160.0 40.15 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.007 -1.29 . . . . 0.0 110.535 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.1 mt -104.93 120.03 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 120.039 -0.664 . . . . 0.0 111.273 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -96.22 171.17 8.76 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.505 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 19.4 t80 -49.37 -48.61 74.4 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.535 -0.728 . . . . 0.0 112.762 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 38.3 Cg_endo -63.94 -37.73 42.23 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 O-C-N 122.693 0.838 . . . . 0.0 111.56 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -69.65 -38.12 77.01 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.266 -0.896 . . . . 0.0 110.053 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -60.56 -42.27 96.25 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.546 -0.721 . . . . 0.0 110.158 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.437 HD12 ' CE2' ' A' ' 65' ' ' PHE . 89.4 mt -63.22 -40.5 97.64 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.5 -0.75 . . . . 0.0 111.854 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.7 p -61.66 -41.99 98.29 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.374 -0.829 . . . . 0.0 110.954 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 60.6 ttp -69.83 -40.02 76.13 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.562 -0.711 . . . . 0.0 111.475 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 97.2 mmm -62.71 -52.78 61.92 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.446 -0.784 . . . . 0.0 111.92 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.01 -31.54 71.3 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.661 -0.649 . . . . 0.0 110.313 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -71.83 -43.63 65.26 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.735 -0.603 . . . . 0.0 110.983 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -70.06 -42.22 73.12 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 45.9 mtm -59.91 -46.42 89.42 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.135 -0.978 . . . . 0.0 112.531 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -37.43 76.09 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.032 -1.043 . . . . 0.0 110.089 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -69.97 -20.03 63.33 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.712 -0.618 . . . . 0.0 111.252 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.7 t -111.34 -160.71 0.72 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.921 0.867 . . . . 0.0 111.94 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -120.49 138.39 53.85 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.463 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.6 t -65.73 -27.74 68.54 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.58 -0.7 . . . . 0.0 109.97 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.02 -31.0 69.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.61 -0.681 . . . . 0.0 109.844 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.62 -40.0 76.86 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.643 -0.661 . . . . 0.0 110.354 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.68 -38.59 87.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.527 -0.733 . . . . 0.0 110.379 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.57 -51.0 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.778 -0.577 . . . . 0.0 110.758 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.8 mtp85 -56.1 -38.41 70.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.265 -0.897 . . . . 0.0 110.481 -178.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -69.77 -39.9 76.39 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.804 -0.56 . . . . 0.0 110.789 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.62 -48.64 74.11 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.392 -0.818 . . . . 0.0 111.152 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -60.22 -43.01 96.38 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.725 0.774 . . . . 0.0 109.7 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -60.0 -36.44 77.2 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.411 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 90.4 t -69.43 -50.49 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.559 -0.713 . . . . 0.0 110.19 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.422 ' CZ ' HG13 ' A' ' 108' ' ' VAL . 28.2 m-85 -64.84 -40.04 94.54 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.397 -0.814 . . . . 0.0 110.952 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -78.5 65.05 3.7 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.475 -0.766 . . . . 0.0 110.686 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -60.67 -45.97 92.12 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.235 -0.916 . . . . 0.0 109.898 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 41.0 p-10 -69.99 -19.09 63.35 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.567 -0.708 . . . . 0.0 110.791 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.03 57.59 19.04 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -105.11 -3.24 23.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.278 -1.131 . . . . 0.0 110.525 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.43 -16.03 56.98 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -135.62 142.91 45.32 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.146 -1.208 . . . . 0.0 109.525 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.426 HG22 HD12 ' A' ' 100' ' ' ILE . 75.2 mt -88.97 124.55 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.482 -0.761 . . . . 0.0 110.021 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.2 m -84.52 169.38 14.52 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.353 0.597 . . . . 0.0 110.575 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.76 -40.57 97.68 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.77 -0.581 . . . . 0.0 110.096 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.77 -33.3 75.54 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.782 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -66.35 -40.02 89.55 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.426 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.7 tt -61.1 -48.87 79.68 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.331 -0.856 . . . . 0.0 109.841 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -62.66 -28.39 69.89 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.821 -0.549 . . . . 0.0 111.027 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -60.08 -40.01 88.05 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.186 -0.946 . . . . 0.0 109.978 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.422 HG13 ' CZ ' ' A' ' 92' ' ' PHE . 58.3 t -77.25 -33.11 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.528 -0.733 . . . . 0.0 110.256 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 16.9 mtt -59.99 -49.88 75.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.473 -0.767 . . . . 0.0 110.118 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 p -68.25 -40.87 81.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.621 -0.674 . . . . 0.0 109.703 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -60.05 -31.9 70.42 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.5 mt -69.94 -35.2 74.33 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.176 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 112.85 24.26 4.99 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -119.82 141.92 49.09 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.452 -1.028 . . . . 0.0 109.518 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -99.92 123.26 43.98 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.407 -0.808 . . . . 0.0 110.847 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.2 mp -138.72 154.52 48.56 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.579 -0.7 . . . . 0.0 110.206 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.0 m -87.81 170.2 11.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.637 -0.664 . . . . 0.0 109.344 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -63.5 -24.9 68.02 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.343 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -68.14 -36.36 79.57 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.716 0.769 . . . . 0.0 109.364 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -65.23 -38.38 90.21 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.594 0.711 . . . . 0.0 109.225 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 74.3 t -68.2 -39.96 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.03 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -59.96 -42.02 93.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.629 -0.67 . . . . 0.0 109.831 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -59.97 -40.94 90.8 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.654 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 10.5 mmt -54.22 -38.52 65.81 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 84.1 mt -66.03 -40.02 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.468 0.651 . . . . 0.0 110.082 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.5 ttt85 -57.35 -39.94 77.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.543 -0.723 . . . . 0.0 111.718 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -60.15 -37.93 81.6 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.572 -0.705 . . . . 0.0 111.465 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -109.39 -5.89 15.66 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.22 -0.925 . . . . 0.0 112.241 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -82.64 70.73 9.68 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.935 -1.103 . . . . 0.0 111.01 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.415 HD11 HG21 ' A' ' 130' ' ' ILE . 87.1 mt -67.99 -39.96 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.467 -0.771 . . . . 0.0 110.488 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.8 p-10 -70.51 -20.03 62.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.416 -0.802 . . . . 0.0 111.337 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.59 24.38 58.67 Favored Glycine 0 N--CA 1.496 2.646 0 C-N-CA 120.135 -1.031 . . . . 0.0 110.672 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -81.93 -11.61 58.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -1.173 . . . . 0.0 110.95 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.44 3.08 72.39 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -141.98 153.11 44.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -1.125 . . . . 0.0 109.784 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.0 t -96.22 109.97 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.609 -0.682 . . . . 0.0 109.611 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.0 p30 -81.93 -174.14 4.88 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.54 -0.725 . . . . 0.0 110.197 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -69.33 -42.86 74.79 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.056 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -62.45 -49.95 73.41 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.294 -0.879 . . . . 0.0 112.049 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.46 -35.5 81.09 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.445 -0.784 . . . . 0.0 110.456 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -59.94 -45.83 91.36 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.425 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.9 t -71.46 -40.51 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.294 -0.879 . . . . 0.0 111.777 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -59.96 -49.98 75.56 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.398 -0.814 . . . . 0.0 110.649 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 10.5 tmm? -59.97 -39.86 87.09 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.407 -0.808 . . . . 0.0 109.361 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 92.7 mmm -68.11 -39.86 82.7 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.216 0.531 . . . . 0.0 109.577 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 56.8 m -69.66 -17.8 63.52 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.714 -0.616 . . . . 0.0 110.446 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.94 139.99 57.02 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.381 -0.824 . . . . 0.0 110.454 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.2 mttm . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.105 -179.889 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -156.35 140.93 7.56 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -60.05 -39.92 87.61 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.644 -0.915 . . . . 0.0 110.064 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -60.02 -39.76 86.96 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.631 -0.668 . . . . 0.0 110.309 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -60.09 -39.95 87.87 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.576 -0.702 . . . . 0.0 110.592 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.65 -40.43 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.618 -0.676 . . . . 0.0 109.742 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.21 -39.53 93.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.691 -0.63 . . . . 0.0 110.736 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -64.11 -39.91 95.05 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.419 -0.801 . . . . 0.0 111.34 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 77.6 mt -70.05 -40.39 75.14 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.379 -0.826 . . . . 0.0 112.205 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 13.5 p -71.0 -31.96 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.073 -1.017 . . . . 0.0 110.673 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.73 -40.04 97.52 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 60.3 t -72.96 -27.94 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.696 -0.884 . . . . 0.0 112.0 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 90.6 mt -59.92 -48.13 82.95 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.117 -0.99 . . . . 0.0 111.019 -177.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -64.93 -39.98 94.33 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.26 -0.9 . . . . 0.0 110.885 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -60.32 -36.37 77.76 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.538 -0.726 . . . . 0.0 110.336 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . 0.441 ' CE2' ' CD2' ' A' ' 32' ' ' LEU . 3.0 t-105 -60.08 -40.02 88.09 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.578 -0.701 . . . . 0.0 109.782 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.12 -50.4 73.64 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.546 -0.721 . . . . 0.0 110.509 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -60.06 -34.1 72.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.368 -0.832 . . . . 0.0 109.876 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 . . . . . 0 N--CA 1.495 1.782 0 O-C-N 121.648 -0.658 . . . . 0.0 110.205 -179.863 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 121.128 0.489 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -94.42 73.72 3.84 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.445 -0.784 . . . . 0.0 109.853 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -64.04 -39.03 93.19 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.579 0.704 . . . . 0.0 110.535 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.2 mt -59.95 -40.07 87.75 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.535 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 p -138.37 106.86 5.84 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -79.21 -12.67 59.97 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.775 -0.578 . . . . 0.0 110.397 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -70.61 -26.77 63.65 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.388 -0.82 . . . . 0.0 109.645 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -65.66 -31.27 72.2 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.768 0.794 . . . . 0.0 109.201 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.88 -35.47 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.918 -0.489 . . . . 0.0 111.37 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.74 -27.15 68.1 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.045 -1.034 . . . . 0.0 111.184 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -69.44 -45.67 68.55 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.666 0.746 . . . . 0.0 110.094 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -69.44 -24.35 63.8 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.591 0.71 . . . . 0.0 109.169 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -70.86 -40.83 72.09 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.654 0.74 . . . . 0.0 109.605 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -70.62 -28.6 64.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.792 -0.568 . . . . 0.0 110.737 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.21 -27.46 35.29 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.486 -0.759 . . . . 0.0 110.609 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -60.0 -40.35 88.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.639 -0.663 . . . . 0.0 110.61 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.1 t -62.16 -39.48 92.8 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.432 -0.793 . . . . 0.0 109.499 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.3 tp -59.99 -40.65 89.91 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -77.55 -38.95 47.48 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.897 -0.502 . . . . 0.0 109.957 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -94.96 95.61 8.74 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.602 -0.686 . . . . 0.0 109.802 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -69.96 -26.95 64.35 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.44 -0.788 . . . . 0.0 111.548 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -80.97 -8.74 59.83 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.074 -1.016 . . . . 0.0 111.405 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.62 25.23 27.82 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -87.67 -6.62 58.15 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.548 -0.972 . . . . 0.0 110.718 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.17 0.9 58.33 Favored Glycine 0 N--CA 1.489 2.183 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.117 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.2 p -144.56 141.42 29.45 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 119.15 1.475 . . . . 0.0 111.292 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.5 mt -104.34 127.85 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.698 -0.626 . . . . 0.0 109.354 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.1 p -103.25 143.36 32.75 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.761 -0.587 . . . . 0.0 110.964 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.446 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 11.0 p -39.49 -34.32 0.21 Allowed 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -61.9 -46.05 91.05 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.921 0.867 . . . . 0.0 108.943 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -59.27 -53.29 59.95 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.276 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.49 -38.48 71.81 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.328 -0.857 . . . . 0.0 111.051 -178.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.85 -29.57 42.57 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.2 m -70.03 -39.45 75.76 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.644 -0.916 . . . . 0.0 110.491 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.6 t -61.24 -54.89 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.329 -0.857 . . . . 0.0 108.881 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.5 mtt -59.05 -29.31 67.2 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.656 -0.653 . . . . 0.0 109.382 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -59.49 -40.03 85.66 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.6 p -70.03 -16.97 63.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.972 -0.455 . . . . 0.0 110.744 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.6 tp -81.67 -31.17 32.4 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.354 -0.841 . . . . 0.0 109.663 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.25 -35.0 0.19 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -160.22 170.05 21.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.554 -0.968 . . . . 0.0 111.219 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -101.31 138.27 19.89 Favored Pre-proline 0 C--N 1.299 -1.607 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.733 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -67.18 -152.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.487 1.146 0 O-C-N 123.394 1.207 . . . . 0.0 109.427 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.4 p -139.97 144.7 37.15 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.191 -0.943 . . . . 0.0 111.123 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -49.72 -25.09 2.67 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.715 -0.616 . . . . 0.0 111.623 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.9 -54.87 9.84 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.185 0.993 . . . . 0.0 108.597 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -67.83 -39.87 83.83 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.764 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.446 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 8.5 mt -55.66 -37.01 67.71 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.676 0.751 . . . . 0.0 109.403 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.06 -40.04 96.53 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.775 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -63.83 -39.96 95.47 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.583 -0.698 . . . . 0.0 111.086 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 64.8 mtt -61.61 -41.76 97.91 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.633 -0.667 . . . . 0.0 109.919 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.4 mm -66.97 -39.99 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.781 -0.574 . . . . 0.0 110.467 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -61.32 -40.0 92.61 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.521 -0.737 . . . . 0.0 112.287 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -69.73 -29.72 67.16 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.995 -1.065 . . . . 0.0 110.723 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.6 t -99.99 -8.94 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.637 -0.664 . . . . 0.0 111.246 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.99 93.97 0.61 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.149 -0.969 . . . . 0.0 111.11 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.23 -38.49 91.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.655 -0.653 . . . . 0.0 109.504 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -91.72 -29.99 16.52 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.702 -0.624 . . . . 0.0 110.816 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.69 20.5 37.06 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -73.57 -39.1 64.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.372 -1.075 . . . . 0.0 110.42 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 129.05 -0.62 6.12 Favored Glycine 0 N--CA 1.497 2.744 0 C-N-CA 120.092 -1.051 . . . . 0.0 111.547 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.1 p -134.6 169.15 17.74 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.114 -1.227 . . . . 0.0 111.033 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.9 mt -102.68 118.9 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.813 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -98.79 170.01 9.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.533 -0.729 . . . . 0.0 110.766 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.463 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.8 t80 -47.53 -50.02 52.18 Favored Pre-proline 0 N--CA 1.499 1.984 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.2 Cg_endo -67.18 -34.9 26.6 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 O-C-N 122.884 0.939 . . . . 0.0 111.223 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.96 -40.02 75.66 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.307 -0.871 . . . . 0.0 110.353 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -62.81 -41.63 99.38 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.63 -0.669 . . . . 0.0 111.252 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 mp -67.86 -41.1 83.41 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.322 -0.861 . . . . 0.0 111.422 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.6 p -63.12 -39.99 96.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.542 -0.724 . . . . 0.0 110.879 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 48.8 ttp -68.61 -41.04 80.11 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.657 -0.652 . . . . 0.0 111.921 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 57.0 tpp -68.94 -42.53 76.62 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.257 -0.902 . . . . 0.0 111.772 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.0 -35.52 66.85 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.475 -0.766 . . . . 0.0 112.074 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.77 -55.01 5.69 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.432 -0.792 . . . . 0.0 111.421 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -59.94 -41.01 90.89 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.525 -0.735 . . . . 0.0 112.641 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 27.7 ptm -59.95 -34.49 73.32 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.283 -0.885 . . . . 0.0 111.877 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -63.25 -49.92 72.21 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.406 -0.809 . . . . 0.0 111.856 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -69.61 -10.31 57.67 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.176 -0.952 . . . . 0.0 111.019 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . 0.27 22.2 m -86.53 -175.03 5.29 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -129.98 138.57 50.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.132 -0.98 . . . . 0.0 109.404 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 24.4 p -61.15 -27.01 68.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.478 -0.764 . . . . 0.0 110.374 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.04 -37.01 78.56 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.716 0.769 . . . . 0.0 109.016 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.01 -40.02 75.5 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.316 0.579 . . . . 0.0 110.079 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -62.56 -39.98 95.37 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.783 -0.573 . . . . 0.0 110.7 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 89.6 mt -65.06 -49.75 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.533 -0.729 . . . . 0.0 110.849 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.77 -42.82 84.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.348 -0.845 . . . . 0.0 111.207 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -69.98 -39.64 75.82 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.405 -0.809 . . . . 0.0 111.773 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.405 ' HA ' ' CG1' ' B' ' 164' ' ' VAL . . . -64.77 -47.35 78.48 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.605 -0.684 . . . . 0.0 112.014 -178.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -67.26 -40.17 86.2 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.1 -1.0 . . . . 0.0 110.43 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -61.03 -39.94 91.69 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.694 -0.629 . . . . 0.0 111.738 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.421 HG21 ' N ' ' A' ' 92' ' ' PHE . 34.9 m -71.29 -40.06 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 0.0 111.112 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.421 ' N ' HG21 ' A' ' 91' ' ' VAL . 8.5 m-85 -72.39 -40.0 67.55 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.144 -0.973 . . . . 0.0 111.466 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -82.65 68.82 9.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.638 -0.664 . . . . 0.0 110.595 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.418 ' HE3' ' CD2' ' A' ' 107' ' ' HIS . 25.3 mttt -60.0 -42.72 94.87 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.19 -0.944 . . . . 0.0 110.001 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -74.52 -24.37 58.97 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.49 -0.757 . . . . 0.0 110.411 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.29 24.63 76.75 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -67.93 -16.69 64.18 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.334 -1.097 . . . . 0.0 111.262 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.47 -19.58 14.46 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.446 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 29.0 p90 -145.82 156.75 43.78 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.336 -1.096 . . . . 0.0 109.438 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 65.9 mt -89.14 122.04 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.668 0.747 . . . . 0.0 110.154 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 m -80.78 170.67 15.99 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.351 0.596 . . . . 0.0 110.624 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.73 -47.58 84.61 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.682 -0.636 . . . . 0.0 109.991 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.0 -37.97 81.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.744 -0.597 . . . . 0.0 109.855 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -61.05 -39.93 91.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.586 -0.696 . . . . 0.0 110.674 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.5 tt -60.54 -46.94 88.31 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.323 -0.861 . . . . 0.0 110.398 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -60.04 -34.91 74.03 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.698 -0.626 . . . . 0.0 111.919 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.418 ' CD2' ' HE3' ' A' ' 94' ' ' LYS . 48.4 t60 -59.97 -41.95 93.06 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.123 -0.986 . . . . 0.0 110.874 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.5 t -77.07 -37.05 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.429 -0.795 . . . . 0.0 111.183 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.7 mmt -60.05 -49.97 75.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.5 m -67.18 -43.69 81.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.725 -0.61 . . . . 0.0 109.809 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -61.82 -28.17 69.28 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.722 -0.611 . . . . 0.0 109.522 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.8 mt -70.03 -30.28 67.53 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.036 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 112.09 22.17 6.01 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -120.48 137.76 54.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.376 -1.073 . . . . 0.0 110.26 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -99.95 117.75 34.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.534 -0.729 . . . . 0.0 109.396 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 67.6 mt -131.24 156.85 44.68 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.458 -0.776 . . . . 0.0 110.15 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 m -82.51 165.8 19.85 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -63.39 -29.07 70.43 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -68.19 -32.83 73.35 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.508 0.67 . . . . 0.0 109.76 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -68.64 -35.07 76.79 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 78.0 t -69.98 -38.33 75.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-O 121.649 0.738 . . . . 0.0 109.028 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -60.0 -43.34 95.26 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.746 -0.596 . . . . 0.0 109.928 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -59.9 -40.18 87.93 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.356 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 13.7 mmt -54.58 -36.83 64.82 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.154 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 91.1 mt -67.75 -38.42 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 121.252 0.548 . . . . 0.0 109.825 178.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -60.03 -39.98 87.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.641 -0.662 . . . . 0.0 110.959 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -63.68 -39.83 95.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.545 -0.722 . . . . 0.0 111.403 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -98.98 -7.78 26.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.377 -0.827 . . . . 0.0 112.046 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -103.38 78.27 1.59 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.025 -1.047 . . . . 0.0 111.268 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 86.8 mt -66.99 -39.96 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.702 -0.624 . . . . 0.0 110.022 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 34.0 p-10 -59.03 -39.75 82.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.669 -0.644 . . . . 0.0 111.266 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 98.65 11.69 46.55 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.366 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -80.88 -16.7 52.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.943 -1.328 . . . . 0.0 110.151 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.68 5.18 71.94 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.747 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -132.34 133.41 43.96 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.237 -1.155 . . . . 0.0 110.035 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.7 t -90.88 114.58 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.442 -0.786 . . . . 0.0 109.936 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -87.7 -178.36 6.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.659 -0.651 . . . . 0.0 109.764 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -65.0 -41.33 95.47 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.613 -0.68 . . . . 0.0 110.092 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -61.69 -42.57 99.11 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.575 -0.703 . . . . 0.0 110.798 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -64.18 -39.45 94.02 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.831 0.824 . . . . 0.0 109.708 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.433 ' CZ ' ' CE ' ' A' ' 145' ' ' MET . 64.3 t80 -60.05 -46.82 88.27 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.426 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 99.3 t -65.13 -39.97 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.303 -0.873 . . . . 0.0 111.041 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -61.04 -39.97 91.83 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.516 -0.74 . . . . 0.0 110.381 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 49.9 mtp -60.59 -44.55 96.12 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.654 -0.654 . . . . 0.0 111.943 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.433 ' CE ' ' CZ ' ' A' ' 141' ' ' PHE . 42.9 mtt -73.24 -39.98 65.04 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.694 -0.629 . . . . 0.0 111.805 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.1 t -75.1 -8.16 55.77 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.41 -0.806 . . . . 0.0 111.262 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -92.83 120.04 32.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.203 -0.935 . . . . 0.0 110.363 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.6 pttm . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.608 179.788 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.56 -39.21 97.37 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -63.66 -40.25 96.37 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.56 -0.965 . . . . 0.0 111.368 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -64.32 -39.34 93.72 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.028 -1.045 . . . . 0.0 110.354 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -60.02 -49.85 76.04 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.663 -0.648 . . . . 0.0 111.737 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 19.7 tt -69.94 -26.01 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 120.987 -1.071 . . . . 0.0 110.727 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.92 90.89 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.372 -0.83 . . . . 0.0 110.919 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 25.8 ttm-85 -60.06 -41.01 91.42 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.517 -0.739 . . . . 0.0 110.759 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . 0.416 ' N ' ' CD2' ' B' ' 163' ' ' LEU . 4.6 mm? -61.92 -38.89 90.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.576 -0.702 . . . . 0.0 110.19 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . 0.405 ' CG1' ' HA ' ' A' ' 88' ' ' ALA . 97.2 t -64.53 -40.12 87.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.517 -0.739 . . . . 0.0 111.191 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.53 -44.12 93.91 Favored Glycine 0 N--CA 1.501 2.976 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 12.0 p -81.94 -11.64 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.687 -0.89 . . . . 0.0 111.455 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 9.2 tt -60.03 -50.02 75.35 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.188 -0.945 . . . . 0.0 110.434 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 30.0 mtp-105 -70.02 -31.09 68.58 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.588 -0.695 . . . . 0.0 110.538 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.97 -40.02 87.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.586 -0.696 . . . . 0.0 109.779 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -59.99 -41.29 91.73 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.671 -0.643 . . . . 0.0 109.928 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.1 -20.73 64.07 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.388 -0.82 . . . . 0.0 111.307 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -59.76 -39.9 86.4 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.318 -0.863 . . . . 0.0 110.319 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.538 -0.726 . . . . 0.0 110.219 179.622 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.99 0 CA-C-O 121.196 0.522 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -112.85 27.06 9.95 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.563 -0.71 . . . . 0.0 110.407 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -59.98 -39.96 87.48 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.818 0.818 . . . . 0.0 110.029 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.57 156.47 34.98 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.402 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -133.35 106.77 7.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.578 -0.701 . . . . 0.0 109.957 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -80.02 -9.78 59.72 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 122.046 -0.409 . . . . 0.0 111.717 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -69.81 -26.68 64.37 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.035 -1.041 . . . . 0.0 110.185 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -70.23 -25.85 63.58 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.39 -0.819 . . . . 0.0 110.158 177.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.9 mm -58.94 -50.02 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.708 -0.62 . . . . 0.0 111.046 -176.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.91 -20.04 63.35 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.225 -0.922 . . . . 0.0 110.688 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -68.21 -54.46 17.63 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.462 -0.774 . . . . 0.0 109.678 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -66.62 -21.67 66.12 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.462 0.648 . . . . 0.0 109.57 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -69.14 -44.06 73.08 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.415 0.626 . . . . 0.0 110.281 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -71.42 -24.46 62.05 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.751 -0.593 . . . . 0.0 111.299 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.7 -33.27 41.14 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.319 -0.863 . . . . 0.0 110.908 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.416 ' CB ' ' CE1' ' A' ' 65' ' ' PHE . 56.2 t80 -59.95 -37.5 79.74 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.695 -0.628 . . . . 0.0 111.255 -177.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 91.9 p -61.42 -38.79 88.4 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.243 -0.91 . . . . 0.0 110.087 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 46.3 tp -60.11 -40.19 88.84 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.541 -0.724 . . . . 0.0 109.758 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -78.77 -37.39 41.2 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.732 -0.605 . . . . 0.0 109.783 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -93.58 94.94 8.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.642 -0.661 . . . . 0.0 110.176 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -66.13 -30.11 70.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.468 -0.77 . . . . 0.0 111.393 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -79.96 -9.93 59.73 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.09 -1.006 . . . . 0.0 111.373 -177.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.79 26.71 58.12 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 57.9 p30 -89.96 -3.48 58.0 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.713 -0.875 . . . . 0.0 110.886 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.96 4.45 72.12 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.248 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 58.3 p -143.76 142.19 30.79 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 119.288 1.544 . . . . 0.0 111.945 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.4 mm -103.69 125.3 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.747 -0.596 . . . . 0.0 110.055 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.9 m -101.54 141.38 34.49 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.541 -0.725 . . . . 0.0 110.244 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 28.2 p -39.56 -34.79 0.25 Allowed 'General case' 0 N--CA 1.51 2.543 0 O-C-N 121.871 -0.518 . . . . 0.0 112.364 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -60.12 -49.36 77.94 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.327 -0.858 . . . . 0.0 109.11 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -57.58 -51.09 70.91 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.11 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.53 -38.81 67.01 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.154 -0.966 . . . . 0.0 111.002 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -51.61 -29.55 25.2 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.3 m -65.09 -40.01 93.98 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.528 -0.983 . . . . 0.0 110.074 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.6 t -68.3 -40.07 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-O 121.384 0.612 . . . . 0.0 109.775 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.401 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 13.4 mmt -59.93 -39.89 87.04 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.736 -0.602 . . . . 0.0 111.712 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -60.76 -40.01 90.88 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.757 0.789 . . . . 0.0 110.346 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.5 t -64.56 -24.84 67.74 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.766 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.77 -17.72 27.68 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.152 -0.968 . . . . 0.0 110.434 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.41 -51.44 0.22 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -166.73 176.47 7.14 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.59 -0.947 . . . . 0.0 111.197 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -99.17 133.47 22.08 Favored Pre-proline 0 N--CA 1.492 1.664 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.927 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.401 ' HD3' ' HB3' ' A' ' 36' ' ' MET . 52.1 Cg_endo -66.3 -147.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.306 0 O-C-N 123.207 1.109 . . . . 0.0 109.414 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.8 p -125.94 140.73 52.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.001 -1.062 . . . . 0.0 110.901 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -48.17 -24.69 1.21 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.713 -0.617 . . . . 0.0 112.039 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.25 -44.18 65.8 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.247 1.022 . . . . 0.0 108.461 176.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -69.96 -39.85 75.78 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.323 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 8.5 mt -55.88 -38.03 69.62 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.483 -0.76 . . . . 0.0 109.534 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -40.57 97.77 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.152 -178.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -64.43 -39.44 93.84 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.611 -0.681 . . . . 0.0 111.267 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 61.9 mtt -62.93 -39.98 96.25 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.679 -0.638 . . . . 0.0 109.917 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 52' ' ' ILE . 48.4 mm -69.23 -39.91 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.682 -0.636 . . . . 0.0 110.91 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -64.2 -40.09 95.36 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.447 -0.783 . . . . 0.0 112.519 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -69.93 -27.34 64.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.932 -1.105 . . . . 0.0 110.483 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.6 t -99.9 -10.01 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.658 -0.651 . . . . 0.0 110.917 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.12 99.01 1.06 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.188 -0.945 . . . . 0.0 110.962 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.79 -36.95 83.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.593 -0.692 . . . . 0.0 109.879 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -94.54 -26.11 16.55 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.654 -0.654 . . . . 0.0 110.84 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.7 20.01 49.32 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -73.9 -34.74 64.51 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.436 -1.038 . . . . 0.0 110.162 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.08 2.13 8.57 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 120.34 -0.933 . . . . 0.0 111.204 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 82.7 p -138.3 168.56 19.49 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.063 -1.257 . . . . 0.0 111.21 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.7 mt -103.69 121.0 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.288 0.566 . . . . 0.0 110.537 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -98.77 170.38 8.81 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.373 0.606 . . . . 0.0 110.47 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.461 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.5 OUTLIER -47.63 -50.0 53.21 Favored Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 121.626 -0.671 . . . . 0.0 112.533 -179.493 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.8 Cg_endo -67.87 -35.12 21.94 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 122.833 0.912 . . . . 0.0 111.237 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.99 -40.01 75.58 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.277 -0.889 . . . . 0.0 110.339 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -63.66 -40.77 97.67 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.548 -0.72 . . . . 0.0 110.933 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.3 mt -64.56 -39.96 94.69 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.433 -0.792 . . . . 0.0 111.346 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 68.8 p -60.6 -40.79 93.1 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.458 -0.776 . . . . 0.0 110.561 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.8 ttp -69.99 -39.96 75.59 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.561 -0.712 . . . . 0.0 111.708 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.6 tpt -60.05 -49.96 75.58 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.436 -0.79 . . . . 0.0 111.364 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.01 -29.27 66.29 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.455 -0.778 . . . . 0.0 111.369 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -72.87 -40.02 65.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.433 -0.792 . . . . 0.0 111.733 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -69.55 -46.58 66.12 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.355 -0.841 . . . . 0.0 112.24 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 77.0 mtm -60.01 -39.38 85.61 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.031 -1.043 . . . . 0.0 111.018 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -66.91 -51.27 57.39 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.549 -0.719 . . . . 0.0 110.816 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -69.09 -31.94 71.01 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.583 0.706 . . . . 0.0 110.134 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . 0.253 23.2 m -90.89 -174.64 4.1 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -123.81 144.56 49.64 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.099 -1.001 . . . . 0.0 110.055 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.2 p -61.59 -27.77 68.87 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.702 -0.624 . . . . 0.0 110.452 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -60.11 -37.87 81.29 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.627 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -70.04 -40.04 75.38 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.65 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -67.71 -37.75 82.67 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.455 -0.778 . . . . 0.0 110.28 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 71.0 mt -63.82 -49.86 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.736 -0.602 . . . . 0.0 110.002 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -57.58 -39.85 77.67 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.481 -0.762 . . . . 0.0 110.982 -178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.45 -42.09 75.38 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.514 -0.741 . . . . 0.0 111.655 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.56 -45.38 79.54 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.502 -0.748 . . . . 0.0 111.608 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.409 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 35.4 t80 -60.01 -47.07 87.33 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.469 -0.77 . . . . 0.0 109.542 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -60.09 -34.85 74.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.927 -0.483 . . . . 0.0 110.414 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.9 t -68.11 -47.77 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.373 -0.83 . . . . 0.0 109.795 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -64.25 -37.45 87.51 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.521 -0.737 . . . . 0.0 110.515 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -75.58 85.44 2.64 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.52 -0.737 . . . . 0.0 110.193 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -67.68 -41.11 84.18 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.374 -0.829 . . . . 0.0 110.209 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -81.28 -12.33 59.11 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.543 -0.723 . . . . 0.0 111.589 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 59.97 31.15 71.59 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -78.23 0.48 25.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.503 -0.998 . . . . 0.0 111.392 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.5 -10.06 75.66 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.607 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -137.58 137.25 38.35 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.08 -1.247 . . . . 0.0 109.979 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 74.6 mt -88.72 129.98 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.467 -0.771 . . . . 0.0 109.359 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.7 m -109.86 151.3 27.21 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.642 0.734 . . . . 0.0 111.103 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.26 -41.22 37.09 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.62 -0.675 . . . . 0.0 110.799 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.04 -34.32 73.23 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.408 -0.807 . . . . 0.0 108.834 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -74.82 -28.27 60.64 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.688 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.9 mp -65.04 -39.97 94.12 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.798 0.809 . . . . 0.0 109.121 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 48.1 ttt-85 -59.96 -34.99 74.02 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.151 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -60.09 -43.91 95.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.317 -0.865 . . . . 0.0 111.048 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 75.4 t -72.11 -40.38 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.442 -0.787 . . . . 0.0 111.244 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 67.6 mtt -58.07 -49.57 76.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.346 -0.846 . . . . 0.0 110.505 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.5 m -66.03 -42.78 89.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.62 -0.675 . . . . 0.0 109.774 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -62.53 -29.76 70.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.685 -0.634 . . . . 0.0 109.333 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 19.1 mt -69.94 -32.17 70.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.698 -0.626 . . . . 0.0 109.964 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 109.57 26.43 5.09 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -124.16 138.45 54.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.441 -1.035 . . . . 0.0 109.997 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -99.97 118.18 35.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.569 -0.707 . . . . 0.0 110.074 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 86.3 mt -131.68 157.3 44.11 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.6 -0.688 . . . . 0.0 109.667 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.88 162.08 22.91 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.611 -0.681 . . . . 0.0 109.555 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -58.8 -28.32 65.87 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.17 -32.57 73.74 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -39.9 95.25 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 73.0 t -70.03 -39.96 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 121.536 0.684 . . . . 0.0 110.567 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -60.04 -44.99 94.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.751 -0.593 . . . . 0.0 110.179 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -60.33 -40.98 92.59 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.645 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 86.6 mmm -55.2 -38.33 68.27 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 119.642 -0.823 . . . . 0.0 108.976 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 47.3 mm -66.84 -38.06 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-O 121.512 0.672 . . . . 0.0 109.65 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -59.07 -40.0 83.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.68 -0.638 . . . . 0.0 111.555 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.04 -39.87 87.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.619 -0.676 . . . . 0.0 111.043 -178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.99 0.01 34.44 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.377 -0.827 . . . . 0.0 111.572 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -87.55 71.23 9.8 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.019 -1.051 . . . . 0.0 110.679 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.403 HG22 HD13 ' A' ' 130' ' ' ILE . 87.5 mt -67.37 -42.26 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.358 -0.838 . . . . 0.0 110.532 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -71.33 -20.07 62.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.362 -0.836 . . . . 0.0 111.348 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.43 22.7 58.14 Favored Glycine 0 N--CA 1.496 2.682 0 C-N-CA 120.367 -0.921 . . . . 0.0 110.869 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -82.76 -12.5 57.48 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.29 -1.123 . . . . 0.0 111.152 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.0 1.73 75.81 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -139.5 152.1 46.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.267 -1.137 . . . . 0.0 109.459 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 70.7 t -92.46 118.26 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.56 -0.712 . . . . 0.0 110.168 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -84.82 175.51 9.09 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -65.05 -41.42 95.18 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.315 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -61.46 -45.86 92.51 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.703 -0.623 . . . . 0.0 111.025 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -66.0 -40.06 90.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.494 -0.754 . . . . 0.0 110.704 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.409 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 77.5 t80 -59.95 -44.22 94.52 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.981 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 89.6 t -69.56 -39.63 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.416 -0.802 . . . . 0.0 110.917 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -59.98 -47.66 84.89 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.528 -0.732 . . . . 0.0 110.684 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.1 tmm? -60.16 -39.65 87.17 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.41 -0.806 . . . . 0.0 110.693 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 97.5 mmm -69.63 -40.0 76.83 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.603 -0.685 . . . . 0.0 111.053 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.4 t -96.04 25.59 4.71 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.381 -0.824 . . . . 0.0 110.681 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -96.87 121.83 39.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.447 -0.783 . . . . 0.0 110.695 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 98.2 mttt . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.844 179.507 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -162.75 171.89 38.67 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -60.6 -39.94 89.97 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.648 -0.913 . . . . 0.0 110.476 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -60.04 -39.85 87.37 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.637 -0.664 . . . . 0.0 110.822 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -60.03 -40.0 87.85 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.398 -0.814 . . . . 0.0 110.617 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 85.4 mt -69.92 -40.03 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.375 -0.828 . . . . 0.0 110.813 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.46 -39.75 91.99 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.541 -0.725 . . . . 0.0 110.882 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -60.04 -39.95 87.69 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.583 -0.698 . . . . 0.0 110.468 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.99 -40.01 94.33 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.496 -0.753 . . . . 0.0 111.13 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 55.4 t -67.07 -40.0 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.381 -0.824 . . . . 0.0 110.971 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -53.72 -47.89 63.2 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 84.4 t -75.13 -22.65 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.693 -0.886 . . . . 0.0 110.569 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 5.7 tt -58.7 -49.97 75.6 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.338 -0.851 . . . . 0.0 110.593 -178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 30.4 ttt85 -65.07 -38.8 91.95 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.468 -0.77 . . . . 0.0 110.136 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.05 -31.46 70.0 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.58 -0.7 . . . . 0.0 109.902 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 4.0 t-105 -60.05 -45.42 92.92 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.697 -0.627 . . . . 0.0 109.883 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.58 -53.16 60.81 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.59 -0.694 . . . . 0.0 110.193 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -60.08 -40.01 88.06 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.508 -0.745 . . . . 0.0 110.732 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.494 -0.753 . . . . 0.0 110.289 179.855 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 121.364 0.602 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -128.73 114.91 17.2 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -121.15 158.81 27.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.352 -0.842 . . . . 0.0 110.864 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 93.1 mt -77.68 -178.36 5.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.545 -0.722 . . . . 0.0 109.817 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -153.68 110.08 3.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.753 -0.592 . . . . 0.0 110.183 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -84.66 -8.64 58.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.763 -0.586 . . . . 0.0 110.926 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -67.82 -33.52 74.94 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.095 -1.003 . . . . 0.0 110.812 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -65.04 -39.35 93.22 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.517 -0.739 . . . . 0.0 110.744 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.4 HD11 HG22 ' A' ' 9' ' ' ILE . 92.7 mt -59.99 -28.2 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.72 -0.613 . . . . 0.0 111.395 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.15 -39.51 94.17 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.148 -0.97 . . . . 0.0 109.743 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -59.98 -40.07 87.84 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -64.29 -20.1 65.85 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.681 -0.637 . . . . 0.0 111.092 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HD3' ' CZ ' ' A' ' 65' ' ' PHE . 73.2 mmtt -69.08 -39.94 78.74 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.196 -0.94 . . . . 0.0 109.407 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -63.64 -59.66 4.31 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.453 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.1 -30.16 71.08 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.371 -0.83 . . . . 0.0 112.232 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.488 ' CG ' ' CE2' ' A' ' 65' ' ' PHE . 57.9 t80 -58.39 -49.97 75.35 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.167 -0.958 . . . . 0.0 110.745 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.0 m -66.15 -39.92 90.18 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.29 -0.881 . . . . 0.0 109.685 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 61.0 tp -62.79 -39.48 94.38 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.416 0.627 . . . . 0.0 109.431 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -74.15 -33.19 63.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.863 -0.523 . . . . 0.0 110.202 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -92.33 102.04 14.52 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.468 -0.77 . . . . 0.0 110.129 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -60.02 -39.2 85.02 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.482 -0.761 . . . . 0.0 111.486 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -80.03 -13.15 59.54 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.034 -1.041 . . . . 0.0 111.148 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.19 30.54 58.03 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -90.08 -2.88 58.17 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.714 -0.874 . . . . 0.0 110.84 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.61 3.95 62.4 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 120.22 -0.991 . . . . 0.0 111.432 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.0 p -145.8 142.41 28.84 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 119.197 1.498 . . . . 0.0 111.44 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.4 mt -100.68 122.68 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.3 m -95.82 139.47 31.99 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.48 -0.762 . . . . 0.0 110.151 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 65.0 p -42.39 -34.34 0.8 Allowed 'General case' 0 N--CA 1.51 2.571 0 O-C-N 121.961 -0.462 . . . . 0.0 111.588 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -64.31 -48.63 74.9 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.883 0.849 . . . . 0.0 109.136 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -60.0 -56.03 26.67 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.691 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.4 tt -61.09 -34.71 75.37 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.21 -0.931 . . . . 0.0 111.056 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.82 -32.57 59.1 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.4 m -70.01 -39.39 75.88 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.955 -0.733 . . . . 0.0 110.189 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.0 t -60.0 -57.29 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 94.7 mtp -59.98 -25.72 65.46 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.608 -0.682 . . . . 0.0 109.796 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -59.99 -46.02 90.82 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.736 0.779 . . . . 0.0 109.31 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.5 t -70.43 -16.98 63.0 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.821 -0.549 . . . . 0.0 111.14 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.88 -18.98 25.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.327 -0.858 . . . . 0.0 110.35 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.4 -50.37 0.2 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -168.01 172.17 9.08 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.645 -0.914 . . . . 0.0 110.674 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -120.61 138.85 27.99 Favored Pre-proline 0 C--N 1.299 -1.628 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -68.36 -148.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.224 1.118 . . . . 0.0 109.453 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 p -136.75 152.37 50.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.104 -0.997 . . . . 0.0 110.49 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -52.06 -22.41 4.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.53 -0.731 . . . . 0.0 112.033 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.1 -60.0 2.45 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.17 -0.956 . . . . 0.0 108.994 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -70.01 -33.75 72.42 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.734 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.9 mt -57.31 -36.88 71.66 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.526 -0.734 . . . . 0.0 109.449 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.44 -30.9 66.57 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.163 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -70.39 -45.08 66.72 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.563 -0.711 . . . . 0.0 111.707 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 79.2 mtm -63.27 -41.67 99.05 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.491 0.662 . . . . 0.0 109.298 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.6 mt -68.58 -31.92 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -58.04 -48.12 81.03 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.574 -0.704 . . . . 0.0 110.967 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -64.82 -24.24 67.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.341 -0.849 . . . . 0.0 110.11 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 67.2 t -98.17 -12.01 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.545 -0.722 . . . . 0.0 111.358 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -72.13 101.79 2.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.152 -0.967 . . . . 0.0 111.385 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.06 -39.98 90.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.558 -0.714 . . . . 0.0 109.445 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -88.26 -31.31 19.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.644 -0.66 . . . . 0.0 110.378 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.79 24.36 32.97 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -74.39 -31.96 62.54 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.459 -1.024 . . . . 0.0 110.465 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.68 -2.04 10.16 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.207 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 82.5 p -134.95 168.77 18.48 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.109 -1.23 . . . . 0.0 110.284 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.9 mt -104.49 120.37 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.714 -178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -98.56 170.25 8.94 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.488 0.661 . . . . 0.0 110.538 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.488 ' CE2' ' CG ' ' A' ' 16' ' ' PHE . 1.2 t80 -50.03 -48.56 78.58 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.4 Cg_endo -69.12 -36.57 12.24 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 O-C-N 122.768 0.878 . . . . 0.0 111.003 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.86 -39.94 76.07 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.484 -0.76 . . . . 0.0 109.223 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -59.89 -45.76 91.49 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.912 -0.493 . . . . 0.0 110.715 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.6 mt -63.57 -40.23 96.43 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.412 -0.805 . . . . 0.0 111.246 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.3 m -60.0 -44.04 94.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.441 -0.787 . . . . 0.0 110.719 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -39.98 93.51 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.708 -0.62 . . . . 0.0 111.039 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.407 ' O ' ' HG2' ' A' ' 76' ' ' MET . 57.2 tpp -59.95 -49.76 76.42 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.319 -0.863 . . . . 0.0 110.468 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.57 75.34 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.404 -0.81 . . . . 0.0 110.64 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -74.92 -37.75 61.96 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.458 -0.776 . . . . 0.0 111.119 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -70.04 -40.03 75.39 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.602 -0.686 . . . . 0.0 112.123 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.407 ' HG2' ' O ' ' A' ' 72' ' ' MET . 39.0 mmt -60.03 -47.29 86.47 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.244 -0.91 . . . . 0.0 112.322 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -68.48 -40.02 81.13 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.25 -0.906 . . . . 0.0 111.065 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -70.54 -20.96 62.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.484 -0.76 . . . . 0.0 111.56 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.6 t -107.29 -165.33 1.05 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.047 0.927 . . . . 0.0 111.803 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -130.01 136.54 49.52 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.894 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.6 t -60.58 -33.12 72.26 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.624 -0.672 . . . . 0.0 109.895 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -60.07 -34.44 73.45 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.397 0.618 . . . . 0.0 109.461 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -69.9 -40.08 75.84 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.348 0.594 . . . . 0.0 110.374 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -64.66 -34.24 77.83 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.591 -0.693 . . . . 0.0 111.29 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 87.8 mt -69.12 -43.89 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.484 -0.76 . . . . 0.0 110.133 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -59.93 -43.99 94.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.557 -0.714 . . . . 0.0 110.969 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -70.03 -39.9 75.48 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.348 -0.845 . . . . 0.0 110.993 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.73 -44.96 96.0 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.598 -0.689 . . . . 0.0 110.629 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -67.47 -39.27 85.28 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.428 -0.795 . . . . 0.0 110.359 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -60.45 -40.03 89.68 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.523 -0.736 . . . . 0.0 112.268 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.421 HG21 ' N ' ' A' ' 92' ' ' PHE . 34.7 m -71.17 -39.19 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.098 -1.002 . . . . 0.0 111.291 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.421 ' N ' HG21 ' A' ' 91' ' ' VAL . 11.8 m-85 -70.9 -37.15 72.95 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.114 -0.991 . . . . 0.0 110.669 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -79.79 69.04 6.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.681 -0.637 . . . . 0.0 110.806 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -59.94 -46.15 90.3 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.175 -0.953 . . . . 0.0 109.722 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.9 p-10 -69.89 -20.48 63.37 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.566 -0.709 . . . . 0.0 110.602 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.8 25.23 71.74 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -70.04 -9.76 56.42 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.285 -1.127 . . . . 0.0 111.31 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.11 -10.05 65.59 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -136.84 141.94 42.85 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.158 -1.201 . . . . 0.0 109.021 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 62.0 mt -89.49 120.45 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.407 -0.808 . . . . 0.0 109.929 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 m -84.06 168.56 15.78 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.267 0.555 . . . . 0.0 110.637 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.03 -41.17 91.28 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.621 -0.675 . . . . 0.0 109.552 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.53 -38.35 89.62 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.316 0.579 . . . . 0.0 109.44 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -61.17 -39.95 92.08 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.697 -0.627 . . . . 0.0 110.791 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 tt -63.6 -44.46 93.93 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.77 0.795 . . . . 0.0 109.35 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.9 ttt-85 -60.66 -32.69 71.86 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.853 -0.53 . . . . 0.0 111.356 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -60.01 -42.38 94.19 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.159 -0.963 . . . . 0.0 110.837 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 86.6 t -74.1 -40.02 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.27 -0.894 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 13.0 mmt -57.43 -49.18 77.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.4 -0.813 . . . . 0.0 110.067 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.6 m -64.64 -44.95 88.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.644 -0.66 . . . . 0.0 109.551 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -61.63 -29.31 69.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.7 -0.625 . . . . 0.0 109.567 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 11.7 mt -69.97 -30.79 68.22 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.216 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 111.13 25.62 4.98 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -122.84 136.78 54.98 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.454 -1.027 . . . . 0.0 109.727 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -99.94 119.96 39.05 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.548 -0.72 . . . . 0.0 110.674 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 71.3 mt -135.75 158.32 44.67 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.718 -0.614 . . . . 0.0 110.066 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.03 161.12 26.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.602 -0.686 . . . . 0.0 109.302 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -61.71 -27.9 69.04 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.71 -33.82 73.05 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.674 0.749 . . . . 0.0 109.379 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -67.53 -36.83 81.78 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.495 0.665 . . . . 0.0 109.226 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.1 t -69.98 -39.95 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.579 0.704 . . . . 0.0 109.78 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -60.0 -38.72 83.44 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.744 -0.597 . . . . 0.0 109.918 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -59.22 -39.72 83.58 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.378 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.9 mtt -55.34 -36.01 65.82 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 119.286 -0.965 . . . . 0.0 109.338 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.4 mm -67.31 -39.54 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.72 -0.613 . . . . 0.0 109.605 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -58.26 -38.24 76.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.606 -0.684 . . . . 0.0 110.734 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.97 -36.79 77.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.667 -0.646 . . . . 0.0 110.096 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.61 -4.33 23.99 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.563 -0.71 . . . . 0.0 111.307 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -82.49 71.1 9.56 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.959 -1.088 . . . . 0.0 110.24 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 85.3 mt -64.76 -46.88 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.525 -0.734 . . . . 0.0 110.682 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -70.49 -20.18 62.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.541 -0.724 . . . . 0.0 111.785 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.3 22.69 58.4 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -81.05 -10.32 59.7 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.366 -1.079 . . . . 0.0 110.804 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.03 0.63 71.07 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -141.42 156.49 45.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -1.193 . . . . 0.0 109.756 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 63.9 t -95.24 119.36 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.53 -0.731 . . . . 0.0 109.976 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -87.88 173.6 8.84 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -60.07 -50.03 75.34 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.649 -0.657 . . . . 0.0 110.054 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -60.66 -41.48 95.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.571 -0.706 . . . . 0.0 111.794 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -65.81 -36.35 83.27 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.2 -0.937 . . . . 0.0 109.882 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -62.14 -43.94 97.73 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.034 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.1 t -70.06 -45.24 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.4 -0.812 . . . . 0.0 111.693 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -60.32 -44.73 95.2 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.51 -0.744 . . . . 0.0 110.444 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -61.79 -39.99 93.63 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.697 -0.627 . . . . 0.0 109.945 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.2 mmt -67.71 -39.96 84.3 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.555 -0.715 . . . . 0.0 109.988 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 36.2 m -89.14 1.37 55.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.753 -0.592 . . . . 0.0 110.52 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.94 136.63 58.07 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.202 -0.936 . . . . 0.0 110.162 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 93.8 mttt . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.191 -179.795 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -146.09 125.38 2.25 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -67.94 -30.35 69.63 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.734 -0.863 . . . . 0.0 110.662 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -60.06 -40.03 88.03 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.383 -0.823 . . . . 0.0 110.139 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -68.36 -33.62 74.6 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.567 -0.708 . . . . 0.0 109.906 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 47.4 mm -59.94 -44.49 94.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.581 -0.699 . . . . 0.0 110.51 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.43 -39.93 92.7 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.541 -0.724 . . . . 0.0 111.299 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -61.48 -42.21 98.45 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.392 -0.818 . . . . 0.0 111.574 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 8.4 tt -70.05 -40.02 75.36 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.364 -0.835 . . . . 0.0 110.684 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 71.6 t -61.41 -39.98 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.628 -0.67 . . . . 0.0 110.644 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -52.48 -37.35 49.15 Favored Glycine 0 N--CA 1.501 2.996 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 89.7 t -78.18 -29.73 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.817 -0.814 . . . . 0.0 110.316 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 6.8 tt -59.3 -52.86 63.85 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.459 -0.776 . . . . 0.0 110.9 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -67.13 -39.93 86.68 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.343 -0.848 . . . . 0.0 110.727 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -59.95 -29.57 68.5 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.482 -0.761 . . . . 0.0 110.385 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -60.01 -47.2 86.83 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.486 -0.759 . . . . 0.0 109.549 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.12 -44.96 94.51 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.628 -0.67 . . . . 0.0 110.974 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -59.99 -40.02 87.72 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.384 -0.823 . . . . 0.0 110.781 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.467 -0.77 . . . . 0.0 110.316 -179.753 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.123 0.487 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.4 t0 51.69 60.96 3.48 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.848 0.833 . . . . 0.0 110.592 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -56.52 -159.71 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.568 0.699 . . . . 0.0 112.376 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 90.3 mt -117.78 -20.45 8.86 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.638 -0.664 . . . . 0.0 111.472 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.5 p -68.22 -10.64 55.9 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.343 -0.848 . . . . 0.0 111.802 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.401 ' HA ' ' CD1' ' A' ' 9' ' ' ILE . 97.5 mt-10 -54.77 -17.16 3.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.366 -0.834 . . . . 0.0 111.238 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -71.84 -44.58 63.6 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.24 -0.913 . . . . 0.0 109.308 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -69.0 -34.7 75.7 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.75 0.786 . . . . 0.0 109.671 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.401 ' CD1' ' HA ' ' A' ' 6' ' ' GLU . 77.3 mt -58.59 -35.33 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.856 -0.527 . . . . 0.0 111.181 -178.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.467 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -62.65 -55.79 23.68 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.87 -1.144 . . . . 0.0 111.597 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -56.11 -38.52 70.87 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.564 -1.335 . . . . 0.0 111.025 -177.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -68.22 -30.11 69.1 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 20.7 ttpt -68.28 -38.49 81.76 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.386 0.613 . . . . 0.0 109.712 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.11 -59.22 5.76 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.431 0.634 . . . . 0.0 110.728 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.76 -33.16 75.04 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.844 -0.535 . . . . 0.0 112.426 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -58.26 -48.08 81.55 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.933 -1.104 . . . . 0.0 110.502 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.1 t -65.22 -37.83 88.5 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.223 -0.923 . . . . 0.0 108.842 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 64.3 tp -60.07 -40.01 88.03 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.154 0.502 . . . . 0.0 109.976 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -75.38 -30.62 60.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.663 -0.648 . . . . 0.0 110.37 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -93.0 103.4 15.72 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.545 -0.722 . . . . 0.0 109.201 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -59.97 -38.16 81.72 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.542 -0.724 . . . . 0.0 112.29 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -77.97 -11.78 59.93 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.825 -1.172 . . . . 0.0 111.09 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.77 27.7 50.44 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -89.63 -0.93 57.85 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.599 -0.942 . . . . 0.0 110.785 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.44 4.91 63.82 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 120.256 -0.974 . . . . 0.0 111.218 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.2 p -146.08 143.59 29.48 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 119.137 1.469 . . . . 0.0 111.768 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.8 mt -104.73 129.98 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.8 p -108.04 144.94 34.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.652 -0.655 . . . . 0.0 110.795 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.6 p -43.37 -32.29 0.81 Allowed 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.877 -0.515 . . . . 0.0 112.142 -178.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -65.39 -50.15 66.58 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.233 -0.917 . . . . 0.0 109.593 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -60.08 -54.52 45.02 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.936 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.429 HD11 ' CZ3' ' B' ' 170' ' ' TRP . 9.7 tt -60.01 -35.66 75.54 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.367 -0.833 . . . . 0.0 111.231 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.94 -31.3 17.21 Favored Glycine 0 N--CA 1.5 2.957 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.1 m -70.02 -39.87 75.53 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.576 -0.956 . . . . 0.0 110.372 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.74 -57.4 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.543 -0.723 . . . . 0.0 110.053 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 65.0 mtt -60.3 -31.54 70.35 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.493 -0.754 . . . . 0.0 110.78 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.99 -48.85 80.02 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.382 -0.824 . . . . 0.0 109.155 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 t -71.95 -12.86 61.44 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.884 -0.51 . . . . 0.0 110.2 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.4 tp -82.44 -33.7 28.45 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.354 -0.841 . . . . 0.0 109.81 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.07 -30.44 0.14 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -158.39 155.76 29.24 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.251 -1.146 . . . . 0.0 111.3 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -114.21 104.79 54.63 Favored Pre-proline 0 C--N 1.297 -1.712 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.167 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -62.23 -151.89 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.392 0 O-C-N 123.001 1.0 . . . . 0.0 109.82 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.1 p -140.04 154.57 47.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.995 -1.066 . . . . 0.0 111.925 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -52.57 -22.84 5.41 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.757 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.63 -60.02 2.44 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.938 0.875 . . . . 0.0 109.427 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.69 -32.63 71.35 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.404 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.2 mt -60.06 -34.08 72.94 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.628 0.728 . . . . 0.0 109.836 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.2 -32.49 66.83 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.259 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -69.86 -43.87 70.98 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.248 -0.907 . . . . 0.0 111.745 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 21.5 ptm -63.22 -39.16 93.83 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.789 -0.764 . . . . 0.0 109.241 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 71.4 mt -68.63 -33.61 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.676 -0.64 . . . . 0.0 110.235 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -60.01 -40.1 88.06 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.409 -0.807 . . . . 0.0 111.412 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -67.04 -27.22 67.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 110.527 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.8 t -100.09 -9.95 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.548 -0.72 . . . . 0.0 110.91 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.29 107.87 6.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.104 -0.998 . . . . 0.0 110.971 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -93.28 -20.24 20.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.742 -0.599 . . . . 0.0 109.657 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -75.36 -40.14 58.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.49 -0.756 . . . . 0.0 110.803 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.27 -4.48 62.39 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -74.64 -39.58 62.0 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.199 -1.177 . . . . 0.0 111.061 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 123.77 4.78 7.89 Favored Glycine 0 N--CA 1.496 2.634 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.317 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 76.4 p -135.4 162.7 31.88 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.129 -1.218 . . . . 0.0 110.284 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.8 mt -99.5 118.93 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.767 -177.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -93.59 171.22 9.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.667 -0.646 . . . . 0.0 109.945 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.457 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 16.4 t80 -46.1 -48.76 42.56 Favored Pre-proline 0 N--CA 1.498 1.967 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.5 Cg_endo -67.28 -32.55 32.87 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 122.747 0.867 . . . . 0.0 111.526 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -74.16 -41.1 62.05 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.214 -0.929 . . . . 0.0 110.346 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -60.21 -45.67 92.36 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.515 -0.74 . . . . 0.0 110.638 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.1 mp -66.34 -39.94 89.54 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.446 -0.784 . . . . 0.0 111.419 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.6 m -60.74 -43.07 98.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.541 -0.725 . . . . 0.0 110.616 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 57.6 ttp -66.63 -42.77 86.25 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.597 -0.69 . . . . 0.0 111.663 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 54.0 ttm -59.97 -49.86 76.01 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.432 -0.792 . . . . 0.0 111.165 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.68 -32.83 74.61 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.512 -0.743 . . . . 0.0 111.493 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -71.17 -40.01 71.52 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.394 -0.816 . . . . 0.0 111.127 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -69.53 -38.33 77.48 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.391 -0.818 . . . . 0.0 111.778 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.7 mtm -56.22 -48.21 76.9 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.318 -0.864 . . . . 0.0 111.871 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -69.82 -39.99 76.15 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.09 -1.006 . . . . 0.0 110.999 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -69.6 -34.05 73.56 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.459 -0.776 . . . . 0.0 110.635 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.0 m -97.59 -173.43 2.63 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.866 -0.521 . . . . 0.0 110.017 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -117.36 138.04 52.06 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.244 -0.91 . . . . 0.0 110.156 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 52.2 p -64.36 -27.32 68.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.598 -0.689 . . . . 0.0 110.153 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -60.06 -34.62 73.67 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.535 -0.728 . . . . 0.0 109.297 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.15 -39.57 78.74 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.348 0.594 . . . . 0.0 109.47 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.42 -37.75 88.63 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.704 -0.622 . . . . 0.0 110.827 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 98.2 mt -66.9 -48.29 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.524 -0.735 . . . . 0.0 110.923 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 41.9 mtp85 -59.99 -40.94 90.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.423 -0.798 . . . . 0.0 111.414 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.05 -40.73 74.95 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.32 -0.863 . . . . 0.0 111.51 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.35 -44.98 85.99 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.569 -0.707 . . . . 0.0 111.5 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -62.59 -40.92 98.43 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.826 0.822 . . . . 0.0 109.475 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -59.97 -36.6 77.48 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.953 -0.467 . . . . 0.0 111.027 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.8 t -69.58 -49.07 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.545 -0.722 . . . . 0.0 109.972 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.416 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 28.4 m-85 -66.65 -39.87 88.41 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.538 -0.726 . . . . 0.0 110.967 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -77.28 72.48 3.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.495 -0.753 . . . . 0.0 109.843 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -59.99 -44.44 94.5 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.541 -0.724 . . . . 0.0 109.967 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 36.0 p-10 -78.56 -24.8 45.37 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.649 -0.657 . . . . 0.0 110.692 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.44 29.85 73.13 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.6 p-10 -71.68 -13.96 61.89 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.455 -1.027 . . . . 0.0 111.773 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.89 -22.42 8.62 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 119.966 -1.111 . . . . 0.0 110.588 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 35.6 p90 -145.96 156.39 43.48 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.28 -1.13 . . . . 0.0 109.452 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 64.6 mt -89.3 126.56 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-O 121.822 0.82 . . . . 0.0 110.849 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.5 m -86.48 172.46 10.32 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.16 0.505 . . . . 0.0 110.518 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.78 -40.26 83.99 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.61 -0.681 . . . . 0.0 109.717 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.47 -38.59 91.55 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -60.58 -37.96 83.05 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.703 -0.623 . . . . 0.0 110.214 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.03 -41.36 92.05 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.608 0.718 . . . . 0.0 109.427 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 63.4 mtp180 -60.07 -35.64 75.6 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.815 -0.553 . . . . 0.0 112.277 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -60.06 -45.66 92.15 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.084 -1.01 . . . . 0.0 111.512 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.416 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 63.7 t -73.85 -37.79 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.374 -0.829 . . . . 0.0 111.379 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 14.2 mmt -59.92 -47.17 86.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.331 -0.856 . . . . 0.0 110.002 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.6 m -65.56 -40.86 93.3 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.691 -0.631 . . . . 0.0 109.462 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -60.6 -34.55 74.39 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.9 mt -69.94 -31.86 69.82 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.145 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.68 26.45 6.14 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -119.52 132.97 55.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.33 -1.1 . . . . 0.0 109.884 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -98.57 120.13 38.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.582 -0.699 . . . . 0.0 110.014 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 57.0 mt -130.18 159.96 35.25 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.474 -0.766 . . . . 0.0 110.489 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.2 p -83.14 163.34 20.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.811 -0.556 . . . . 0.0 109.659 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -63.22 -27.0 69.06 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -69.97 -37.31 75.75 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.582 0.706 . . . . 0.0 109.194 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -65.12 -36.67 85.02 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.536 0.684 . . . . 0.0 109.36 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 97.5 t -69.48 -39.41 78.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.694 0.759 . . . . 0.0 109.613 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -59.98 -40.21 88.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.794 -0.566 . . . . 0.0 110.287 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -60.0 -40.96 91.01 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.405 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 67.6 mtt -55.07 -35.83 64.96 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.459 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.5 mm -66.58 -39.09 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.789 -0.569 . . . . 0.0 110.066 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 50.0 ttt-85 -60.02 -40.02 87.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.494 -0.753 . . . . 0.0 111.742 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -60.12 -38.53 83.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.468 -0.77 . . . . 0.0 110.865 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.4 6.33 37.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.46 -0.775 . . . . 0.0 111.447 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -118.94 81.01 1.63 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.007 -1.058 . . . . 0.0 111.48 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 86.4 mt -66.79 -40.05 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.563 -0.711 . . . . 0.0 109.98 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.9 p30 -59.84 -39.32 84.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.626 -0.671 . . . . 0.0 111.136 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.54 15.96 44.72 Favored Glycine 0 N--CA 1.494 2.553 0 C-N-CA 120.149 -1.024 . . . . 0.0 111.24 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -80.01 -20.14 46.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.135 -1.215 . . . . 0.0 110.115 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.72 8.12 57.34 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.807 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -132.69 131.31 41.13 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.163 -1.198 . . . . 0.0 110.066 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.8 t -92.34 110.39 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.55 -0.719 . . . . 0.0 109.664 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -83.85 178.65 7.82 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.581 -0.699 . . . . 0.0 109.569 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -61.34 -44.89 96.43 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.747 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -61.76 -40.49 95.34 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.344 -0.847 . . . . 0.0 111.084 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -63.82 -39.62 94.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.325 -0.859 . . . . 0.0 109.629 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -60.0 -49.59 77.05 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.883 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 89.3 t -61.16 -41.38 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.317 -0.865 . . . . 0.0 110.919 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -60.0 -40.2 88.4 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.259 -0.9 . . . . 0.0 109.741 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 7.7 ttm -60.24 -42.04 94.46 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.701 -0.624 . . . . 0.0 110.609 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 98.4 mmm -69.93 -40.04 75.76 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.629 -0.669 . . . . 0.0 111.099 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.2 t -98.23 19.28 14.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.583 -0.698 . . . . 0.0 110.383 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.14 -39.96 92.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.51 -0.743 . . . . 0.0 109.829 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 44.1 mttp . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.045 179.95 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -116.09 136.51 12.96 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -64.41 -36.72 85.09 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.542 -0.975 . . . . 0.0 110.241 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -60.03 -39.15 84.88 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.691 -0.631 . . . . 0.0 110.095 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -60.02 -39.97 87.69 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.653 -0.654 . . . . 0.0 110.693 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . 0.413 HD11 HG23 ' B' ' 160' ' ' ILE . 97.2 mt -69.61 -39.94 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.307 -0.87 . . . . 0.0 110.526 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.37 -39.94 89.05 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.562 -0.711 . . . . 0.0 110.967 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -67.14 -39.97 86.65 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.443 -0.786 . . . . 0.0 110.821 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 88.6 mt -64.1 -40.04 95.35 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.472 -0.768 . . . . 0.0 111.192 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 83.4 t -70.03 -40.0 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.413 -0.804 . . . . 0.0 110.714 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.98 -50.01 69.81 Favored Glycine 0 N--CA 1.498 2.807 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 14.6 p -71.09 -28.44 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.604 -0.939 . . . . 0.0 110.461 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.04 -50.16 74.81 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.467 -0.77 . . . . 0.0 111.469 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -70.05 -39.99 75.37 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.466 -0.771 . . . . 0.0 110.655 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -60.38 -39.98 89.22 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.46 -0.775 . . . . 0.0 111.628 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . 0.429 ' CZ3' HD11 ' A' ' 32' ' ' LEU . 18.3 t90 -70.06 -31.36 68.94 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.373 -0.829 . . . . 0.0 110.458 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.43 -47.81 80.79 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.469 -0.769 . . . . 0.0 110.264 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -60.0 -33.78 72.44 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.538 -0.726 . . . . 0.0 110.104 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.764 -0.585 . . . . 0.0 110.384 -179.373 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.073 0.463 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -60.14 -40.05 88.44 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.55 -0.719 . . . . 0.0 110.304 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -117.42 146.72 43.27 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.459 0.647 . . . . 0.0 110.247 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 92.1 mt -60.06 -46.5 89.35 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.587 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -144.57 106.2 4.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.569 -0.707 . . . . 0.0 109.662 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -86.33 -15.66 39.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.957 -0.464 . . . . 0.0 110.991 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -61.82 -38.01 86.56 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.299 -0.876 . . . . 0.0 110.529 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -69.98 -20.05 63.32 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.81 -0.556 . . . . 0.0 111.208 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.6 mm -62.97 -43.0 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.386 -0.821 . . . . 0.0 110.342 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.9 -31.21 72.22 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.732 -0.605 . . . . 0.0 111.105 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -62.56 -39.99 95.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.805 . . . . 0.0 109.719 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -64.26 -23.91 67.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.95 -0.469 . . . . 0.0 111.347 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HD3' ' CE1' ' A' ' 65' ' ' PHE . 73.9 mmtt -68.93 -40.0 79.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.193 -0.942 . . . . 0.0 110.271 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -77.76 -23.99 49.1 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.991 -0.443 . . . . 0.0 111.57 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.51 -38.36 34.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.3 -0.875 . . . . 0.0 111.175 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -56.76 -39.98 75.0 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.662 -0.649 . . . . 0.0 111.33 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 94.0 p -60.26 -39.33 86.4 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.188 -0.945 . . . . 0.0 110.055 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.1 tt -59.97 -44.45 94.44 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.62 -0.675 . . . . 0.0 109.381 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -70.02 -38.96 76.06 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.888 -0.508 . . . . 0.0 109.714 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -94.68 92.59 7.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.604 -0.685 . . . . 0.0 109.287 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -59.07 -22.5 60.87 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.228 -0.92 . . . . 0.0 111.653 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -81.23 -55.79 4.5 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.037 -1.039 . . . . 0.0 109.0 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.72 28.32 7.08 Favored Glycine 0 N--CA 1.482 1.748 0 N-CA-C 107.885 -2.086 . . . . 0.0 107.885 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -90.01 -1.23 57.93 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.666 -0.902 . . . . 0.0 110.526 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.04 -0.1 64.02 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 120.42 -0.895 . . . . 0.0 110.931 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.0 p -144.88 143.01 30.36 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 119.212 1.506 . . . . 0.0 111.547 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 83.8 mt -106.4 130.08 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.796 -0.565 . . . . 0.0 109.844 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.4 m -104.91 143.91 32.51 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.486 -0.758 . . . . 0.0 110.632 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 55.1 p -41.96 -35.71 0.93 Allowed 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.851 -0.531 . . . . 0.0 111.93 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.1 mttm -63.9 -48.17 77.68 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.35 -0.843 . . . . 0.0 109.325 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -58.96 -51.13 71.38 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.514 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.2 tp -59.93 -34.86 73.8 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.104 -0.997 . . . . 0.0 110.827 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.413 ' O ' ' CB ' ' A' ' 37' ' ' ARG . . . -48.52 -32.76 10.84 Favored Glycine 0 N--CA 1.5 2.963 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.1 m -70.06 -40.01 75.32 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 118.36 1.08 . . . . 0.0 110.3 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.1 t -69.11 -58.19 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.461 -0.774 . . . . 0.0 111.654 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 93.9 mmm -59.88 -37.26 78.85 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.258 -0.901 . . . . 0.0 110.849 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.413 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 5.9 tpt180 -60.01 -50.03 75.32 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.517 0.675 . . . . 0.0 109.736 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.1 p -71.75 -18.16 62.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.785 -0.572 . . . . 0.0 111.369 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.4 mt -91.86 -18.12 24.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.427 -0.796 . . . . 0.0 111.656 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.98 -40.47 0.2 Allowed Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.251 -1.452 . . . . 0.0 111.612 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -159.92 157.97 29.92 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 118.872 1.336 . . . . 0.0 112.128 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -118.01 103.72 49.6 Favored Pre-proline 0 N--CA 1.489 1.513 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.244 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -63.83 -148.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.335 0 O-C-N 123.309 1.163 . . . . 0.0 109.503 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.7 p -135.99 151.45 49.93 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.826 -1.171 . . . . 0.0 111.495 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -52.35 -24.52 7.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.652 -0.655 . . . . 0.0 111.449 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.16 -58.99 2.97 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 122.034 0.921 . . . . 0.0 108.729 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -65.43 -39.06 91.64 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.051 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 75.2 mt -58.04 -35.56 71.49 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.663 0.744 . . . . 0.0 110.01 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -40.03 82.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 122.01 -0.431 . . . . 0.0 111.491 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -65.22 -36.19 83.4 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.365 -0.834 . . . . 0.0 110.0 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 92.0 mmm -59.93 -45.61 92.03 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.447 0.642 . . . . 0.0 109.879 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.0 mt -67.74 -33.06 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.761 -0.587 . . . . 0.0 110.303 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -59.93 -40.01 87.44 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.537 -0.727 . . . . 0.0 110.766 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -66.93 -28.61 68.44 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.327 -0.858 . . . . 0.0 110.621 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.3 t -102.0 -7.17 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.613 -0.68 . . . . 0.0 111.081 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.82 105.53 1.98 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.2 -0.937 . . . . 0.0 110.72 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.54 -39.56 77.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.635 -0.666 . . . . 0.0 109.801 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -90.21 -27.66 19.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.612 -0.68 . . . . 0.0 110.531 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.82 21.61 46.07 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -74.32 -34.22 63.39 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.447 -1.031 . . . . 0.0 110.425 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.8 1.22 7.61 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.486 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 66.7 p -138.69 164.83 28.52 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.077 -1.249 . . . . 0.0 111.457 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.0 mt -100.84 122.1 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 121.34 0.59 . . . . 0.0 111.298 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -96.08 171.41 8.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.697 -0.627 . . . . 0.0 109.695 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.472 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 78.6 t80 -48.57 -49.95 61.74 Favored Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 121.435 -0.79 . . . . 0.0 112.56 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.4 Cg_endo -66.47 -33.91 35.64 Favored 'Trans proline' 0 N--CA 1.492 1.382 0 O-C-N 122.693 0.838 . . . . 0.0 111.255 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -70.44 -39.98 74.02 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.302 -0.874 . . . . 0.0 110.383 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -64.0 -40.02 95.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.712 -0.618 . . . . 0.0 110.67 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.422 ' N ' HD13 ' A' ' 69' ' ' LEU . 5.9 mp -66.66 -39.9 88.41 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.657 -0.652 . . . . 0.0 111.9 -178.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.7 p -60.24 -40.1 89.05 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.09 -1.006 . . . . 0.0 110.403 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 31.7 ttm -66.72 -54.36 23.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.643 -0.66 . . . . 0.0 111.979 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 57.8 ttm -61.74 -52.37 64.53 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.77 -38.19 86.09 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.561 -0.712 . . . . 0.0 112.536 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -71.42 -44.21 65.29 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.312 -0.867 . . . . 0.0 111.739 -178.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -71.81 -40.87 68.87 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.329 -0.857 . . . . 0.0 113.048 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 26.9 ptm -57.03 -20.3 23.72 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.178 -0.951 . . . . 0.0 111.326 -178.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -66.58 -54.27 25.38 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.327 -0.858 . . . . 0.0 110.495 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -70.0 -23.34 63.13 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.798 -0.563 . . . . 0.0 110.457 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.4 m -83.02 -173.05 4.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.633 -0.667 . . . . 0.0 110.006 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -128.14 140.37 51.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.311 -0.868 . . . . 0.0 109.945 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.2 t -70.03 -25.1 63.41 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.642 -0.661 . . . . 0.0 110.507 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -60.08 -37.07 78.81 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.897 0.856 . . . . 0.0 108.743 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -67.48 -39.89 85.27 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.421 0.629 . . . . 0.0 109.844 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -65.33 -33.82 76.88 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.694 -0.629 . . . . 0.0 110.519 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 78.9 mt -66.08 -46.76 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.655 -0.653 . . . . 0.0 110.071 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 62.1 mtt180 -60.01 -40.42 89.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.51 -0.744 . . . . 0.0 111.584 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -70.07 -40.18 75.2 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.203 -0.936 . . . . 0.0 111.548 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.18 -45.4 84.99 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.531 -0.73 . . . . 0.0 111.114 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -60.0 -47.41 85.94 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.529 0.68 . . . . 0.0 109.978 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -60.01 -36.62 77.62 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.791 -0.568 . . . . 0.0 111.192 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 72.0 t -69.19 -49.75 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.262 -0.899 . . . . 0.0 109.569 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -67.65 -39.99 84.57 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.315 -0.866 . . . . 0.0 109.877 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -79.83 79.66 6.32 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -69.03 -39.89 78.96 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.45 -0.781 . . . . 0.0 111.034 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -77.4 -21.42 53.17 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.465 -0.772 . . . . 0.0 110.839 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.18 28.95 74.07 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -72.91 -10.31 59.66 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.561 -0.964 . . . . 0.0 111.765 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.78 -20.98 12.86 Favored Glycine 0 N--CA 1.498 2.829 0 C-N-CA 120.025 -1.083 . . . . 0.0 110.608 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -144.66 152.44 40.46 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.388 -1.066 . . . . 0.0 109.236 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.419 ' CG2' ' CD2' ' A' ' 105' ' ' LEU . 18.5 mt -88.67 131.35 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.096 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.02 170.96 11.1 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.918 -0.489 . . . . 0.0 109.756 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.77 -39.33 73.27 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.57 -37.24 86.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.692 -0.63 . . . . 0.0 109.46 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -62.24 -34.34 76.33 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.555 0.693 . . . . 0.0 109.416 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.419 ' CD2' ' CG2' ' A' ' 100' ' ' ILE . 0.5 OUTLIER -69.16 -40.32 78.24 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.907 -0.496 . . . . 0.0 109.964 179.173 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -60.0 -38.75 83.53 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.533 -0.729 . . . . 0.0 111.352 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -60.1 -46.2 90.38 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.083 -1.011 . . . . 0.0 111.709 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 93.2 t -70.28 -39.99 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.203 -0.936 . . . . 0.0 111.183 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 16.0 mmt -59.64 -50.03 75.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.546 -0.721 . . . . 0.0 110.889 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 93.9 m -67.35 -43.09 82.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.543 -0.723 . . . . 0.0 109.955 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -61.63 -31.67 71.77 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.36 0.6 . . . . 0.0 109.432 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 19.9 mt -69.41 -34.93 75.21 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.917 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 119.66 26.1 2.44 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -126.13 149.62 48.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.385 -1.067 . . . . 0.0 109.782 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -116.48 126.0 52.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.515 -0.741 . . . . 0.0 110.415 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 60.4 mt -138.08 154.72 49.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.593 -0.692 . . . . 0.0 109.326 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.03 163.77 23.95 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -62.0 -27.45 68.88 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.016 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.55 -32.7 73.65 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.421 0.629 . . . . 0.0 109.869 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -68.34 -36.61 79.5 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 90.7 t -66.88 -39.75 84.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.837 0.827 . . . . 0.0 108.955 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -59.99 -47.69 84.77 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.498 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -60.05 -40.07 88.13 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.838 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 65.7 mtt -55.93 -38.53 70.43 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.443 -0.903 . . . . 0.0 109.096 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 47.9 mm -65.93 -39.3 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 121.452 0.644 . . . . 0.0 109.655 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.9 ttt-85 -57.78 -38.67 75.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.678 -0.639 . . . . 0.0 110.843 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -59.95 -37.51 79.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.699 -0.626 . . . . 0.0 110.628 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.14 -1.6 27.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.403 -0.81 . . . . 0.0 111.323 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -84.76 71.75 10.81 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.996 -1.065 . . . . 0.0 110.392 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.6 mt -67.16 -41.43 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.434 -0.792 . . . . 0.0 110.245 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.5 p-10 -72.56 -20.14 61.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.328 -0.858 . . . . 0.0 111.148 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.64 22.14 62.6 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 120.312 -0.947 . . . . 0.0 111.139 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -83.1 -10.04 58.9 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.214 -1.168 . . . . 0.0 111.064 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.21 0.71 76.66 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -137.57 148.17 45.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.208 -1.171 . . . . 0.0 109.648 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 85.9 t -90.06 117.75 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.429 -0.794 . . . . 0.0 110.348 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -89.26 175.33 7.39 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -61.79 -47.92 82.97 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.794 -0.566 . . . . 0.0 110.117 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -60.02 -49.3 78.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.731 -0.606 . . . . 0.0 111.851 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -63.3 -35.4 80.24 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.316 -0.865 . . . . 0.0 109.991 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -60.02 -45.14 93.76 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 91.8 t -70.01 -37.85 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.328 -0.857 . . . . 0.0 111.564 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -59.91 -47.13 87.01 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.207 -0.933 . . . . 0.0 110.395 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.4 tmm? -60.02 -39.24 85.17 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.511 -0.743 . . . . 0.0 109.925 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 96.2 mmm -65.74 -40.03 91.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.64 -0.662 . . . . 0.0 109.869 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.1 m -92.39 6.51 46.68 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.563 -0.711 . . . . 0.0 110.914 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -99.04 119.83 38.46 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.1 -1.0 . . . . 0.0 110.256 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.7 mtmt . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.266 -179.897 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.74 68.53 0.26 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -59.98 -44.1 94.7 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.584 -0.951 . . . . 0.0 110.241 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -60.02 -39.48 85.97 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.593 -0.692 . . . . 0.0 111.098 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -59.3 -39.98 84.76 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.301 -0.875 . . . . 0.0 110.256 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.8 -40.04 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.571 -0.706 . . . . 0.0 109.377 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.3 -31.01 72.05 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.621 -0.674 . . . . 0.0 110.42 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -60.03 -38.81 83.84 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.573 -0.704 . . . . 0.0 110.097 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 66.6 mt -60.01 -40.44 89.27 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.477 -0.764 . . . . 0.0 110.99 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 99.1 t -68.4 -40.0 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.558 -0.714 . . . . 0.0 110.466 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.75 -41.97 94.18 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 11.5 p -74.98 -12.24 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -1.101 . . . . 0.0 110.96 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 9.5 tt -60.01 -49.16 78.74 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.113 -0.992 . . . . 0.0 109.48 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -60.0 -41.05 91.26 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.653 -0.654 . . . . 0.0 110.32 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.07 -40.29 88.99 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.632 -0.668 . . . . 0.0 111.601 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 5.0 t-105 -61.43 -47.61 84.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.436 -0.79 . . . . 0.0 110.512 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.02 -43.62 95.14 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.542 -0.724 . . . . 0.0 111.007 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -60.01 -40.0 87.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.37 -0.831 . . . . 0.0 110.625 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 . . . . . 0 N--CA 1.495 1.794 0 O-C-N 121.413 -0.804 . . . . 0.0 110.4 -179.877 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 121.191 0.52 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -99.97 30.35 3.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.642 -0.661 . . . . 0.0 110.336 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -60.04 -39.65 86.68 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.781 0.801 . . . . 0.0 109.53 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 79.5 mt -102.41 -178.48 3.7 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.102 0.477 . . . . 0.0 109.793 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.3 p -138.37 103.99 5.05 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.563 -0.711 . . . . 0.0 109.572 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -77.92 -34.66 51.22 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.734 -0.604 . . . . 0.0 110.579 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.44 -40.94 88.41 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.555 -0.716 . . . . 0.0 111.794 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -69.47 -19.08 63.76 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.091 -1.005 . . . . 0.0 111.448 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.5 mm -60.68 -50.03 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.369 -0.832 . . . . 0.0 110.891 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.04 -31.44 69.97 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.64 -0.662 . . . . 0.0 111.466 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -59.95 -43.04 95.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.927 . . . . 0.0 110.586 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.423 ' CG ' HD12 ' A' ' 69' ' ' LEU . 44.5 m-85 -65.23 -21.77 66.79 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.578 -0.701 . . . . 0.0 111.468 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.429 ' HD3' ' CZ ' ' A' ' 65' ' ' PHE . 32.5 mmtt -70.71 -43.92 67.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.083 -1.011 . . . . 0.0 110.391 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -75.16 -28.23 60.01 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.21 -30.27 22.54 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.144 -0.972 . . . . 0.0 111.851 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -59.99 -45.85 91.39 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.497 -0.752 . . . . 0.0 111.677 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.5 m -60.06 -39.48 86.17 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.221 -0.924 . . . . 0.0 109.604 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.6 tp -61.35 -43.47 98.82 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -69.95 -40.07 75.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.993 -0.442 . . . . 0.0 110.461 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -92.32 95.36 9.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.439 -0.788 . . . . 0.0 109.627 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -60.01 -34.52 73.47 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.381 -0.824 . . . . 0.0 110.859 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -80.03 -10.11 59.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.255 -0.903 . . . . 0.0 111.051 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.43 26.53 44.99 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -88.02 -7.88 56.41 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.64 -0.918 . . . . 0.0 111.035 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.77 1.77 58.64 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.542 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.8 p -144.02 141.57 30.19 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 119.192 1.496 . . . . 0.0 111.192 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 88.1 mt -104.23 128.45 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.714 -0.616 . . . . 0.0 109.492 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.5 p -100.5 139.62 35.93 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.61 -0.681 . . . . 0.0 110.2 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.1 p -42.38 -30.93 0.36 Allowed 'General case' 0 N--CA 1.511 2.603 0 O-C-N 121.796 -0.565 . . . . 0.0 111.645 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -65.66 -49.63 67.94 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.413 -0.804 . . . . 0.0 109.641 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.35 -53.9 52.95 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.71 -0.619 . . . . 0.0 111.165 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.454 ' CD2' ' CZ2' ' B' ' 170' ' ' TRP . 58.8 tp -59.99 -34.76 73.75 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.318 -0.864 . . . . 0.0 110.633 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.04 -31.47 10.85 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.4 m -70.14 -40.83 74.58 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.517 -0.99 . . . . 0.0 110.483 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.4 t -65.76 -51.24 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 121.361 -0.837 . . . . 0.0 109.982 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 98.1 mtp -60.06 -33.77 72.51 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.459 0.647 . . . . 0.0 109.496 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -49.12 78.94 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.618 0.723 . . . . 0.0 109.438 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.7 t -71.69 -16.22 62.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.908 -0.495 . . . . 0.0 110.804 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -90.29 -19.95 23.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.215 -0.928 . . . . 0.0 110.653 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.36 -43.57 0.2 Allowed Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.611 -1.281 . . . . 0.0 110.876 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -160.48 160.0 31.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.107 -1.231 . . . . 0.0 111.559 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -115.21 99.77 52.78 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -64.58 -151.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.278 0 O-C-N 123.321 1.169 . . . . 0.0 109.942 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.5 p -140.07 159.96 41.0 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.15 -0.969 . . . . 0.0 111.685 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -54.98 -21.2 11.05 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.811 -0.555 . . . . 0.0 111.645 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.43 -59.92 2.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.176 -0.953 . . . . 0.0 108.693 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -69.13 -35.97 76.96 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.677 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.7 mt -58.14 -33.04 68.75 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.456 0.646 . . . . 0.0 110.148 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.08 -31.59 68.01 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.57 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -70.62 -45.75 64.64 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.297 -0.877 . . . . 0.0 111.091 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 78.7 mtm -61.53 -42.05 98.25 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.572 0.701 . . . . 0.0 109.585 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 91.0 mt -69.02 -33.41 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.257 0.551 . . . . 0.0 110.147 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -59.96 -38.76 83.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.483 -0.761 . . . . 0.0 110.332 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -64.41 -27.41 68.98 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.546 -0.721 . . . . 0.0 110.297 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.6 t -104.64 -7.97 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.586 -0.696 . . . . 0.0 111.208 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -68.41 103.39 1.63 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.963 -1.086 . . . . 0.0 111.453 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.58 -39.98 94.72 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.713 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.6 p-10 -91.61 -30.67 16.23 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.637 -0.664 . . . . 0.0 111.041 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.26 23.38 44.49 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -73.37 -37.2 66.12 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.448 -1.03 . . . . 0.0 110.721 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.4 -0.84 7.56 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 120.303 -0.951 . . . . 0.0 110.965 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 49.8 p -134.73 169.72 16.91 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.171 -1.194 . . . . 0.0 110.07 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.0 mt -110.11 120.07 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.44 -177.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -96.25 170.34 9.32 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.408 0.623 . . . . 0.0 110.237 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.456 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 t80 -49.77 -48.09 78.05 Favored Pre-proline 0 N--CA 1.497 1.894 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.7 Cg_endo -67.7 -36.99 17.4 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 122.699 0.841 . . . . 0.0 111.683 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -70.03 -39.75 75.6 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.134 -0.979 . . . . 0.0 110.069 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -60.74 -50.01 75.21 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.484 -0.76 . . . . 0.0 111.317 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.423 HD12 ' CG ' ' A' ' 12' ' ' PHE . 3.1 tt -61.39 -41.69 97.52 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.362 -0.836 . . . . 0.0 111.56 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.0 p -63.02 -35.66 80.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.583 -0.698 . . . . 0.0 109.996 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 24.6 ttt -66.21 -43.55 86.41 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.838 -0.539 . . . . 0.0 111.852 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.1 ttt -60.06 -45.53 92.55 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.288 -0.882 . . . . 0.0 111.498 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.33 -32.0 71.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.451 -0.781 . . . . 0.0 110.564 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.7 mmm-85 -70.02 -40.04 75.44 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.622 -0.674 . . . . 0.0 111.124 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -73.09 -44.38 60.52 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.398 -0.814 . . . . 0.0 112.212 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 48.6 mtm -60.64 -39.94 90.15 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.297 -0.877 . . . . 0.0 113.096 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -67.25 -36.41 81.56 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.968 -1.082 . . . . 0.0 111.335 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -69.41 -17.85 63.7 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.509 -0.744 . . . . 0.0 111.056 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.5 t -117.97 -159.65 0.75 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.653 0.739 . . . . 0.0 111.272 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -122.55 140.02 53.25 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.143 0.497 . . . . 0.0 109.773 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.1 t -64.27 -24.57 67.71 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.636 -0.665 . . . . 0.0 110.678 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -64.4 -35.51 81.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.289 -0.882 . . . . 0.0 109.024 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -67.82 -42.48 81.42 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.994 -178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.95 -25.49 63.67 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.275 -0.891 . . . . 0.0 111.278 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 80.8 mt -69.61 -45.33 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.44 -0.787 . . . . 0.0 109.591 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 63.2 mtt180 -59.97 -37.98 81.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.555 -0.716 . . . . 0.0 110.572 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.54 -41.71 75.58 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.69 -0.631 . . . . 0.0 110.601 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.83 -43.83 87.37 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.53 -0.731 . . . . 0.0 111.331 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -60.1 -48.47 81.57 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.619 0.723 . . . . 0.0 109.682 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -58.74 -31.83 68.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.892 -0.505 . . . . 0.0 110.171 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.97 -41.35 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.499 -0.751 . . . . 0.0 110.044 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -68.57 -37.51 79.94 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.495 -0.753 . . . . 0.0 110.948 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -80.03 76.95 6.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.539 -0.726 . . . . 0.0 109.852 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.425 ' HD3' ' CD2' ' A' ' 107' ' ' HIS . 4.9 mtmp? -63.28 -44.84 93.93 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.399 -0.813 . . . . 0.0 110.193 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -75.65 -17.5 59.96 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.621 -0.674 . . . . 0.0 111.409 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.7 20.15 75.54 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -70.07 -10.05 57.43 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.18 -1.188 . . . . 0.0 111.124 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.71 -13.28 67.49 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.46 ' N ' ' CD1' ' A' ' 99' ' ' TYR . 41.0 m-85 -128.17 136.97 51.85 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.138 -1.213 . . . . 0.0 108.295 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 47.6 mt -89.09 120.6 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.907 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.8 m -84.56 169.43 14.43 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.407 0.622 . . . . 0.0 110.627 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.02 -39.97 87.15 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.647 -0.658 . . . . 0.0 109.305 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.73 -36.64 79.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.792 -0.568 . . . . 0.0 109.659 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -66.88 -40.02 87.69 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.642 -0.661 . . . . 0.0 110.674 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.62 -45.88 92.4 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.474 -0.767 . . . . 0.0 109.54 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -61.37 -33.74 74.17 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.848 -0.532 . . . . 0.0 111.066 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.425 ' CD2' ' HD3' ' A' ' 94' ' ' LYS . 75.6 t60 -59.95 -47.42 85.88 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.265 -0.897 . . . . 0.0 111.752 -177.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 63.2 t -72.74 -51.05 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 121.147 -0.97 . . . . 0.0 112.026 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.405 ' CE ' ' CD1' ' A' ' 116' ' ' LEU . 51.2 mtp -58.1 -39.89 79.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.078 -1.014 . . . . 0.0 110.598 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.5 m -67.17 -46.0 75.3 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.551 -0.718 . . . . 0.0 109.778 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -62.04 -31.26 71.64 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.351 0.596 . . . . 0.0 109.499 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.1 mt -69.58 -32.39 71.12 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.669 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.59 20.48 1.92 Allowed Glycine 0 N--CA 1.497 2.734 0 C-N-CA 119.868 -1.158 . . . . 0.0 111.22 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -121.85 138.98 54.18 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.101 -1.234 . . . . 0.0 110.386 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -103.05 120.03 39.92 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.528 -0.732 . . . . 0.0 109.901 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.405 ' CD1' ' CE ' ' A' ' 109' ' ' MET . 74.1 mt -133.2 157.91 44.19 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.418 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.59 172.14 8.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.817 -0.552 . . . . 0.0 109.852 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -64.98 -23.57 67.26 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -69.21 -38.73 78.74 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.607 -0.683 . . . . 0.0 109.764 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -64.7 -35.84 82.34 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.0 t -69.8 -39.1 77.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.467 0.651 . . . . 0.0 109.637 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -60.05 -46.36 89.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.749 -0.595 . . . . 0.0 110.09 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -59.95 -42.47 94.13 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.617 -0.677 . . . . 0.0 109.576 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 78.0 mmm -54.16 -39.31 66.45 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.414 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 85.5 mt -67.68 -38.61 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.217 0.532 . . . . 0.0 110.614 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -59.13 -39.99 84.08 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.576 -0.702 . . . . 0.0 112.11 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.05 -39.96 83.64 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.808 -0.557 . . . . 0.0 110.993 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.29 -1.76 26.56 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.193 -0.942 . . . . 0.0 111.655 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -83.4 70.5 10.2 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.997 -1.065 . . . . 0.0 110.48 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.71 -40.83 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.418 -0.801 . . . . 0.0 110.726 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -70.44 -18.8 63.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.386 -0.821 . . . . 0.0 111.343 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.57 22.0 63.07 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 120.239 -0.982 . . . . 0.0 110.73 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -83.01 -9.95 59.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -1.146 . . . . 0.0 110.988 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.49 0.69 84.22 Favored Glycine 0 N--CA 1.497 2.76 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -136.67 148.21 47.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.31 -1.112 . . . . 0.0 109.042 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.8 t -91.38 119.11 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.406 -0.809 . . . . 0.0 109.673 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.429 ' OD1' ' CE2' ' A' ' 99' ' ' TYR . 80.9 m-20 -89.02 175.24 7.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.584 -0.697 . . . . 0.0 109.929 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -60.87 -47.9 84.27 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.275 0.56 . . . . 0.0 110.524 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -59.99 -45.47 92.62 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.638 -0.663 . . . . 0.0 111.264 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -65.22 -35.9 82.51 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.797 0.808 . . . . 0.0 110.122 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.467 ' CZ ' ' CE ' ' A' ' 145' ' ' MET . 68.5 t80 -60.04 -47.29 86.47 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.32 -178.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.3 t -70.06 -39.72 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.288 -0.882 . . . . 0.0 111.366 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -59.94 -50.04 75.34 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.297 -0.877 . . . . 0.0 111.212 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.411 ' HE1' ' CD1' ' B' ' 157' ' ' PHE . 60.5 ttp -60.3 -36.83 78.8 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.371 -0.83 . . . . 0.0 110.534 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.467 ' CE ' ' CZ ' ' A' ' 141' ' ' PHE . 33.1 mtt -69.57 -39.96 77.03 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.635 -0.666 . . . . 0.0 110.664 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.1 t -99.0 22.8 9.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.542 -0.724 . . . . 0.0 110.633 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.01 -44.93 94.24 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.439 -0.788 . . . . 0.0 110.468 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 96.6 mttt . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.193 179.899 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 70.45 29.27 70.11 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.411 ' CD1' ' HE1' ' A' ' 144' ' ' MET . 37.0 t80 -60.02 -39.96 87.66 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.506 -0.996 . . . . 0.0 109.395 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -66.07 -40.02 90.55 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.667 -0.646 . . . . 0.0 110.776 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -60.88 -45.97 92.47 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.331 -0.855 . . . . 0.0 111.457 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . 0.413 HG23 ' N ' ' B' ' 161' ' ' ALA . 18.2 tt -70.08 -35.49 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.353 -0.842 . . . . 0.0 111.171 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . 0.413 ' N ' HG23 ' B' ' 160' ' ' ILE . . . -60.15 -45.24 93.73 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.349 -0.844 . . . . 0.0 110.686 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -60.42 -40.08 89.72 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.48 -0.763 . . . . 0.0 110.488 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.76 -40.49 97.42 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.515 -0.741 . . . . 0.0 110.678 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 98.9 t -62.46 -40.0 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.431 -0.793 . . . . 0.0 109.563 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.44 -39.42 94.85 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 90.0 t -69.41 -35.38 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.673 -0.898 . . . . 0.0 111.307 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.98 -49.99 75.49 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.348 -0.845 . . . . 0.0 112.782 -177.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 -60.6 -39.91 89.88 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.992 -1.067 . . . . 0.0 110.804 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.41 -33.65 72.8 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.491 -0.756 . . . . 0.0 109.478 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . 0.454 ' CZ2' ' CD2' ' A' ' 32' ' ' LEU . 2.4 t90 -60.02 -49.25 78.39 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.823 -0.548 . . . . 0.0 110.023 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.41 94.51 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.501 -0.749 . . . . 0.0 110.853 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -59.98 -39.93 87.38 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.437 -0.79 . . . . 0.0 110.028 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.702 -0.624 . . . . 0.0 110.236 -179.524 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.162 0.506 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -89.44 79.17 7.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.538 -0.726 . . . . 0.0 109.738 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -60.07 -46.27 90.13 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.687 0.756 . . . . 0.0 110.279 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 74.2 mt -81.9 175.5 10.35 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.403 0.62 . . . . 0.0 110.073 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.78 114.34 6.77 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -93.13 -9.64 38.74 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.868 -0.52 . . . . 0.0 111.34 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.92 -40.05 91.1 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.215 -0.928 . . . . 0.0 109.63 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -64.88 -36.66 85.07 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.299 0.571 . . . . 0.0 110.309 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 80.2 mt -60.19 -29.11 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.713 -0.617 . . . . 0.0 111.023 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.63 -39.44 93.85 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.092 -1.005 . . . . 0.0 110.268 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -59.54 -41.76 90.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.513 -0.742 . . . . 0.0 109.916 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -64.29 -20.6 66.19 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.933 -0.479 . . . . 0.0 111.103 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -69.96 -44.17 70.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.132 -0.98 . . . . 0.0 110.077 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -60.07 -54.95 39.9 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.31 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.13 -25.0 64.17 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.089 -1.007 . . . . 0.0 111.577 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -49.98 -56.38 10.9 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 120.972 -1.08 . . . . 0.0 111.463 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.9 m -62.39 -36.84 83.59 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.384 -0.822 . . . . 0.0 109.829 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.5 tp -59.92 -40.78 90.04 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.71 -0.619 . . . . 0.0 109.894 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.15 -33.69 59.39 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.58 -0.7 . . . . 0.0 109.928 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -92.0 98.38 11.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.51 -0.744 . . . . 0.0 109.306 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -59.97 -38.55 82.83 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.625 -0.672 . . . . 0.0 111.503 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -78.44 -12.69 60.02 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.013 -1.054 . . . . 0.0 110.813 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.92 27.9 65.22 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -90.0 -2.08 58.08 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.611 -0.935 . . . . 0.0 110.768 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.24 3.82 63.14 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.704 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.3 p -147.12 145.36 29.56 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-N 119.268 1.534 . . . . 0.0 111.646 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 91.6 mt -103.37 127.89 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 121.412 0.625 . . . . 0.0 109.689 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.5 m -100.21 139.99 35.1 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.841 -0.537 . . . . 0.0 109.866 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.41 ' CG2' HG13 ' A' ' 52' ' ' ILE . 4.9 p -42.95 -30.49 0.41 Allowed 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.707 -0.621 . . . . 0.0 111.686 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -64.89 -49.54 70.06 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.847 0.832 . . . . 0.0 108.999 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -58.86 -53.71 55.29 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.902 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.7 tp -60.7 -32.84 72.06 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.297 -0.877 . . . . 0.0 110.285 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.76 -31.47 38.29 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.4 m -69.96 -37.74 75.88 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.516 -0.99 . . . . 0.0 109.903 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.39 -56.18 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-O 121.425 0.631 . . . . 0.0 109.725 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.437 ' CE ' ' CD1' ' B' ' 170' ' ' TRP . 60.6 mtt -59.9 -31.75 70.11 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.684 -0.635 . . . . 0.0 111.124 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -50.02 75.36 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.427 -0.796 . . . . 0.0 109.289 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.1 t -73.71 -18.69 60.97 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.776 -0.578 . . . . 0.0 110.439 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -97.38 -3.02 41.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.352 -0.843 . . . . 0.0 110.954 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.98 -71.59 0.11 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -162.95 171.35 16.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.475 -1.014 . . . . 0.0 111.055 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -106.98 119.66 50.56 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.784 -0.573 . . . . 0.0 109.893 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.38 -148.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.454 0 O-C-N 123.07 1.037 . . . . 0.0 109.982 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.1 p -138.1 153.15 49.3 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.935 -1.103 . . . . 0.0 111.596 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -52.49 -23.83 6.91 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.742 -0.599 . . . . 0.0 111.728 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.47 -59.96 2.55 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.177 0.989 . . . . 0.0 108.63 177.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -67.65 -37.61 82.64 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.735 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.408 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 14.3 mt -57.58 -35.12 69.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.608 -0.682 . . . . 0.0 109.856 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.88 -40.07 96.41 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.914 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -65.94 -40.02 90.99 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.526 -0.734 . . . . 0.0 111.133 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 49.2 mtt -59.98 -45.13 93.7 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.474 -0.766 . . . . 0.0 109.811 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.41 HG13 ' CG2' ' A' ' 29' ' ' THR . 47.5 mm -67.03 -35.81 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.766 -0.584 . . . . 0.0 110.546 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -60.0 -40.11 88.1 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.602 -0.686 . . . . 0.0 111.122 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -69.99 -28.51 65.58 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.28 -0.887 . . . . 0.0 110.998 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.4 t -98.15 -9.11 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.45 -0.781 . . . . 0.0 111.383 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.88 98.79 3.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.132 -0.98 . . . . 0.0 111.046 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.92 -38.5 88.84 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 109.44 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -90.13 -29.69 18.13 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.666 -0.646 . . . . 0.0 110.793 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.51 19.95 36.43 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -74.01 -37.87 64.25 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.447 -1.031 . . . . 0.0 110.747 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.16 3.75 7.33 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.196 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 81.1 p -136.17 169.12 18.14 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.127 -1.219 . . . . 0.0 111.101 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.6 mt -107.44 122.53 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.503 -177.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -103.35 170.06 8.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.597 -0.69 . . . . 0.0 110.642 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.472 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 62.5 t80 -47.15 -49.84 49.71 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.659 -0.65 . . . . 0.0 112.737 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.6 Cg_endo -65.97 -34.33 38.9 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 O-C-N 122.622 0.801 . . . . 0.0 111.703 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.62 -39.96 73.42 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.179 -0.95 . . . . 0.0 111.066 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -62.44 -43.93 97.65 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.358 -0.839 . . . . 0.0 110.675 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.46 -43.44 97.35 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.383 -0.823 . . . . 0.0 112.454 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.435 HG22 ' N ' ' A' ' 71' ' ' MET . 8.5 t -62.48 -33.93 75.83 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.197 -0.939 . . . . 0.0 110.926 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.435 ' N ' HG22 ' A' ' 70' ' ' THR . 15.9 ttm -67.33 -46.57 73.07 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.466 -0.771 . . . . 0.0 111.646 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 50.2 ttm -64.99 -43.87 91.16 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.322 -0.861 . . . . 0.0 112.017 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.54 -36.7 76.65 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.372 -0.83 . . . . 0.0 110.776 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -70.97 -39.95 72.21 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.696 -0.627 . . . . 0.0 111.306 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -72.08 -30.77 65.45 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 36.2 mmt -60.07 -45.16 93.79 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.932 -1.105 . . . . 0.0 112.547 -176.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.4 pttp -69.36 -35.68 76.1 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.118 -0.989 . . . . 0.0 111.682 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -71.23 -12.34 61.41 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.418 -0.802 . . . . 0.0 111.777 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.4 t -125.63 -164.32 1.29 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.319 -0.863 . . . . 0.0 111.965 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -120.04 133.44 55.53 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.824 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.5 t -60.34 -29.95 69.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.593 -0.692 . . . . 0.0 110.673 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.13 -31.63 70.26 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.461 -0.774 . . . . 0.0 109.617 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.01 -39.98 87.68 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.903 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.11 -37.49 85.29 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.64 -0.662 . . . . 0.0 110.854 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 86.8 mt -66.98 -47.98 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.667 -0.646 . . . . 0.0 110.84 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -60.03 -41.1 91.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.465 -0.772 . . . . 0.0 111.207 -178.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -70.06 -40.03 75.31 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.457 -0.777 . . . . 0.0 111.333 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.13 -46.05 75.3 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.772 -0.58 . . . . 0.0 111.824 -178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -59.96 -45.4 92.77 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.826 0.822 . . . . 0.0 109.338 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 29.6 ttm-85 -59.95 -37.08 78.51 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.421 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.93 -46.27 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.496 -0.752 . . . . 0.0 110.188 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -69.0 -36.88 78.33 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.492 -0.755 . . . . 0.0 110.536 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -78.03 78.84 4.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.53 -0.731 . . . . 0.0 109.096 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.99 -44.16 94.69 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.413 -0.804 . . . . 0.0 110.577 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -78.92 -19.42 51.84 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.576 -0.703 . . . . 0.0 110.667 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.64 28.26 72.26 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -71.73 -10.49 59.85 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.452 -1.028 . . . . 0.0 111.159 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.9 -20.09 44.73 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.414 ' CE2' ' OD1' ' A' ' 137' ' ' ASN . 59.0 m-85 -119.91 139.39 52.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.259 -1.142 . . . . 0.0 108.971 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.438 HD13 HG23 ' A' ' 100' ' ' ILE . 82.5 mt -92.6 120.0 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.465 -0.772 . . . . 0.0 110.452 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.1 m -91.36 170.37 10.03 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.432 0.634 . . . . 0.0 110.719 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.73 -37.67 73.49 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.643 -0.661 . . . . 0.0 109.577 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.11 -38.76 92.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.853 -0.529 . . . . 0.0 109.918 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.5 -39.99 94.81 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.513 -0.742 . . . . 0.0 110.423 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.43 ' CD2' ' CG2' ' A' ' 100' ' ' ILE . 1.2 mm? -64.29 -40.0 95.07 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.607 0.718 . . . . 0.0 109.662 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 69.4 ttp85 -62.87 -31.08 72.04 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.806 -0.558 . . . . 0.0 110.875 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -60.02 -46.2 90.29 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.233 -0.917 . . . . 0.0 110.68 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.0 t -75.03 -35.57 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.363 -0.836 . . . . 0.0 111.246 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.7 mmt -60.05 -48.94 79.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.385 -0.822 . . . . 0.0 110.428 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.4 m -69.37 -39.96 77.73 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.593 -0.692 . . . . 0.0 110.125 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -60.0 -35.79 75.8 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.4 mt -69.87 -33.94 72.91 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.206 0.526 . . . . 0.0 110.306 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.96 17.25 6.43 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -109.13 131.97 54.56 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.22 -1.165 . . . . 0.0 110.256 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -100.16 120.57 40.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.618 -0.676 . . . . 0.0 110.239 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 71.2 mt -135.8 156.32 48.98 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.425 -0.797 . . . . 0.0 110.95 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.67 159.9 25.17 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -61.87 -26.6 68.24 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -68.1 -31.74 71.56 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -67.24 -34.5 77.59 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.5 t -73.02 -38.63 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.992 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -60.03 -43.81 95.04 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.64 -0.663 . . . . 0.0 109.55 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -60.02 -42.36 94.19 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.458 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.0 mtt -54.84 -37.59 66.37 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.118 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 86.7 mt -65.36 -37.9 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -57.87 -37.89 74.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.816 -0.553 . . . . 0.0 111.663 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.09 -39.97 88.0 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.427 -0.796 . . . . 0.0 111.632 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -106.34 -0.14 24.54 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.271 -0.893 . . . . 0.0 111.69 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -98.67 74.86 2.11 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.128 -0.982 . . . . 0.0 111.329 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 84.3 mt -66.93 -39.97 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.457 -0.777 . . . . 0.0 109.779 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 30.7 p30 -58.52 -37.76 76.3 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.742 -0.599 . . . . 0.0 111.494 -179.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 92.84 18.75 39.35 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 120.28 -0.962 . . . . 0.0 111.233 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -82.43 -13.37 56.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.047 -1.266 . . . . 0.0 110.47 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.0 4.68 71.71 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.506 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -136.24 141.85 43.98 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.09 -1.241 . . . . 0.0 109.828 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.3 t -94.07 125.11 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.41 -0.806 . . . . 0.0 110.188 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.414 ' OD1' ' CE2' ' A' ' 99' ' ' TYR . 91.3 m-20 -97.39 179.66 4.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.569 -0.707 . . . . 0.0 109.659 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -63.09 -50.05 72.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.741 -0.599 . . . . 0.0 110.852 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.21 -44.21 95.96 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.374 -0.829 . . . . 0.0 111.342 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -66.81 -38.52 86.63 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.851 0.834 . . . . 0.0 109.81 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -59.97 -46.12 90.48 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.156 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 98.1 t -69.96 -39.31 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.374 -0.829 . . . . 0.0 111.101 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -59.96 -47.33 86.24 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.271 -0.893 . . . . 0.0 110.437 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.4 tmm? -59.94 -37.27 79.05 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.469 -0.769 . . . . 0.0 110.27 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 92.2 mtp -66.36 -40.03 89.52 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.902 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 50.2 m -86.21 2.83 45.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.792 -0.567 . . . . 0.0 111.125 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.06 138.76 57.8 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.051 -1.03 . . . . 0.0 110.235 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.4 mttp . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 117.944 -1.026 . . . . 0.0 110.174 -179.916 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.71 -19.96 50.15 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -67.88 -40.33 83.55 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.288 -1.125 . . . . 0.0 110.153 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 -70.0 -39.21 76.0 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.534 -0.729 . . . . 0.0 111.021 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -59.94 -40.06 87.67 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.585 -0.697 . . . . 0.0 110.719 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . 0.407 HG13 ' N ' ' B' ' 161' ' ' ALA . 24.8 pt -76.21 -27.56 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.479 -0.763 . . . . 0.0 110.791 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . 0.407 ' N ' HG13 ' B' ' 160' ' ' ILE . . . -66.27 -39.93 89.78 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.354 -0.841 . . . . 0.0 110.528 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -60.06 -40.64 90.18 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.572 -0.705 . . . . 0.0 111.031 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.58 -40.07 95.71 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.272 -0.892 . . . . 0.0 110.818 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 67.9 t -64.26 -40.1 87.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.524 -0.735 . . . . 0.0 110.896 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.24 -40.05 91.12 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 94.4 t -76.38 -14.8 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.459 -1.024 . . . . 0.0 111.344 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 10.1 tt -60.01 -50.01 75.43 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.177 -0.952 . . . . 0.0 111.416 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -68.46 -39.95 81.23 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.249 -0.907 . . . . 0.0 110.486 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.07 -31.01 69.61 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.393 -0.817 . . . . 0.0 110.078 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . 0.437 ' CD1' ' CE ' ' A' ' 36' ' ' MET . 5.2 t-105 -59.97 -46.31 89.85 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.67 -0.644 . . . . 0.0 110.271 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.0 -51.39 69.85 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.461 -0.774 . . . . 0.0 110.242 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -60.11 -36.87 78.42 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.519 -0.738 . . . . 0.0 110.216 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.591 -0.693 . . . . 0.0 110.151 179.723 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 120.985 0.422 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -86.86 79.93 8.63 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.417 -0.802 . . . . 0.0 110.404 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -63.64 -40.07 95.95 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.889 0.852 . . . . 0.0 109.593 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 68.0 mt -112.6 -176.84 3.0 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.787 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 p -115.65 100.91 8.39 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.552 0.691 . . . . 0.0 109.216 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -74.4 -10.72 59.85 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.938 -0.476 . . . . 0.0 111.717 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -60.52 -53.02 62.52 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.053 -1.029 . . . . 0.0 109.646 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -66.89 -38.53 86.45 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.33 0.586 . . . . 0.0 110.557 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 89.7 mt -60.79 -29.02 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.706 -0.621 . . . . 0.0 111.513 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -61.25 -37.88 84.67 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.047 -1.033 . . . . 0.0 109.788 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.9 -47.63 84.98 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.534 -0.729 . . . . 0.0 110.194 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.401 ' CE1' ' HE3' ' A' ' 72' ' ' MET . 26.5 m-85 -67.53 -25.25 65.74 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.632 -0.667 . . . . 0.0 110.627 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 22.9 tptp -67.37 -53.44 29.39 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.59 0.71 . . . . 0.0 109.251 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.4 -48.03 77.74 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.891 -0.505 . . . . 0.0 110.696 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.04 -20.34 63.26 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.227 -0.92 . . . . 0.0 111.32 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -60.02 -48.21 82.67 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.181 -0.95 . . . . 0.0 110.789 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.0 m -63.88 -39.24 93.72 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.278 -0.889 . . . . 0.0 108.778 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.8 tp -63.82 -39.96 95.48 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.04 -34.2 72.95 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -92.13 94.68 9.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.685 -0.634 . . . . 0.0 109.516 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -59.9 -36.6 77.3 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.53 -0.731 . . . . 0.0 112.177 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -79.17 -9.76 59.65 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.06 -1.025 . . . . 0.0 111.392 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.96 22.37 57.54 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -85.4 -8.6 58.34 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.429 -1.042 . . . . 0.0 110.542 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.96 6.64 53.9 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.518 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.5 p -147.81 143.02 27.19 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 119.32 1.56 . . . . 0.0 112.03 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.3 mt -100.41 124.34 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.3 p -100.98 140.57 35.09 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.706 -0.621 . . . . 0.0 110.835 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 7.1 p -42.08 -32.68 0.48 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.902 -0.499 . . . . 0.0 112.159 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -65.33 -49.1 70.73 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.731 0.777 . . . . 0.0 109.626 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -59.87 -53.69 54.93 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.976 -0.452 . . . . 0.0 111.092 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.4 tp -61.53 -34.91 76.34 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.218 -0.926 . . . . 0.0 111.063 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.51 -32.16 60.8 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.6 m -75.96 -41.26 52.02 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.671 -0.899 . . . . 0.0 111.044 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.7 t -62.7 -59.14 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.431 -0.793 . . . . 0.0 109.658 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.4 ptm -57.72 -20.78 36.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.67 -0.644 . . . . 0.0 110.467 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.2 ttt85 -59.9 -40.0 87.27 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.348 -0.845 . . . . 0.0 109.378 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.7 t -69.84 -16.35 63.25 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.897 -0.502 . . . . 0.0 111.735 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.6 mp -93.6 -10.06 35.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.305 -0.872 . . . . 0.0 110.756 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.16 -61.52 0.17 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -167.33 172.46 9.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.447 -1.031 . . . . 0.0 110.943 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -119.46 137.14 25.09 Favored Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.65 -149.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.332 0 O-C-N 123.19 1.1 . . . . 0.0 109.819 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -137.08 160.61 38.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.05 -1.031 . . . . 0.0 110.2 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -52.38 -25.31 9.48 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.897 -0.502 . . . . 0.0 112.305 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.16 -60.06 2.52 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.208 1.004 . . . . 0.0 108.85 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -66.82 -37.6 84.83 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.542 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.423 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 6.3 mt -57.71 -35.12 70.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.639 -0.663 . . . . 0.0 109.908 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.51 -40.11 95.67 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.779 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -65.49 -39.92 92.47 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.607 -0.683 . . . . 0.0 111.252 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 65.0 mtt -60.02 -43.21 95.41 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.716 0.77 . . . . 0.0 109.443 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.9 mm -66.2 -37.64 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 121.21 0.528 . . . . 0.0 110.475 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -60.0 -40.78 90.4 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.506 -0.746 . . . . 0.0 111.212 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -67.43 -27.95 67.48 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.195 -0.94 . . . . 0.0 110.541 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 49.8 t -99.97 -10.07 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.565 -0.709 . . . . 0.0 111.557 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -71.05 95.04 1.16 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.088 -1.008 . . . . 0.0 111.542 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.06 93.22 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.71 -0.619 . . . . 0.0 109.563 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -92.58 -29.27 16.25 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.648 -0.657 . . . . 0.0 110.952 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.56 20.49 34.54 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.0 p-10 -74.74 -32.76 62.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.344 -1.092 . . . . 0.0 110.35 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 118.65 5.24 12.52 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 120.277 -0.963 . . . . 0.0 111.24 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 80.9 p -136.43 170.17 16.48 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.189 -1.183 . . . . 0.0 111.077 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.8 mt -105.06 120.55 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.286 0.565 . . . . 0.0 110.886 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -100.05 165.4 11.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.721 -0.612 . . . . 0.0 109.934 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.5 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 16.2 t80 -48.7 -49.27 66.85 Favored Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 121.486 -0.759 . . . . 0.0 112.499 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 38.7 Cg_endo -64.23 -35.54 51.36 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 O-C-N 122.766 0.877 . . . . 0.0 111.173 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.96 -40.03 75.65 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.165 -0.959 . . . . 0.0 110.322 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -61.99 -42.86 99.61 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.59 -0.693 . . . . 0.0 111.3 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.68 -42.97 94.97 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.395 -0.816 . . . . 0.0 111.205 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.1 m -61.97 -40.03 94.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.649 -0.657 . . . . 0.0 111.111 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 56.2 ttp -68.35 -40.96 81.36 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.473 -0.767 . . . . 0.0 112.148 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.401 ' HE3' ' CE1' ' A' ' 12' ' ' PHE . 92.6 mmm -61.53 -45.49 93.95 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.296 -0.877 . . . . 0.0 111.131 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.67 -32.43 73.49 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.856 -0.528 . . . . 0.0 110.982 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -72.04 -39.98 68.7 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.435 -0.791 . . . . 0.0 110.292 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -62.5 -39.98 95.22 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.617 -0.677 . . . . 0.0 112.362 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 35.9 mmt -57.82 -33.21 68.37 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.185 -0.947 . . . . 0.0 110.736 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -69.69 -56.75 6.36 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.554 0.693 . . . . 0.0 110.572 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -69.16 -35.86 76.76 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.525 0.679 . . . . 0.0 110.436 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.1 m -86.07 -174.68 5.21 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.858 -0.526 . . . . 0.0 110.224 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -134.0 149.94 51.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.321 -0.862 . . . . 0.0 109.964 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.3 t -65.82 -33.74 76.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.7 -0.625 . . . . 0.0 109.556 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -63.77 -33.87 76.62 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.644 0.735 . . . . 0.0 109.181 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.56 -39.98 77.05 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.332 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -63.83 -36.35 83.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.594 -0.691 . . . . 0.0 109.934 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 77.4 mt -64.48 -49.96 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.668 -0.645 . . . . 0.0 110.821 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -57.14 -39.94 76.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.176 -0.953 . . . . 0.0 111.019 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.0 -40.02 75.53 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.54 -0.725 . . . . 0.0 111.471 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.55 -49.25 69.57 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.423 -0.798 . . . . 0.0 112.244 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -60.37 -40.42 90.71 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.247 -0.908 . . . . 0.0 109.429 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -59.98 -37.57 80.0 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.666 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 94.1 t -69.75 -53.41 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.419 -0.801 . . . . 0.0 110.797 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -63.43 -39.76 95.36 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.355 -0.841 . . . . 0.0 110.882 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -80.98 72.02 7.98 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.531 -0.731 . . . . 0.0 110.006 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -61.83 -41.72 98.14 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.211 -0.93 . . . . 0.0 109.859 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.0 p-10 -73.16 -22.22 60.55 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.567 -0.708 . . . . 0.0 110.995 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.2 25.06 73.53 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -71.2 -12.49 61.5 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.322 -1.105 . . . . 0.0 111.541 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.85 -16.69 59.24 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.415 ' CD2' ' OD1' ' A' ' 137' ' ' ASN . 60.1 m-85 -123.18 136.36 54.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.19 -1.182 . . . . 0.0 109.148 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.436 ' CG2' ' CD2' ' A' ' 105' ' ' LEU . 61.4 mt -89.8 120.07 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.423 -0.798 . . . . 0.0 109.922 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.2 m -90.07 170.56 10.22 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.329 0.585 . . . . 0.0 110.686 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.73 -35.99 72.97 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.666 -0.646 . . . . 0.0 109.358 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.43 -35.57 79.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.735 -0.603 . . . . 0.0 109.584 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.22 -37.88 78.26 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.659 -0.65 . . . . 0.0 110.776 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.436 ' CD2' ' CG2' ' A' ' 100' ' ' ILE . 1.3 mm? -66.92 -41.66 86.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.552 -0.717 . . . . 0.0 110.279 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -60.06 -37.8 80.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.695 -0.628 . . . . 0.0 110.717 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -60.66 -42.79 97.72 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.456 -0.778 . . . . 0.0 112.419 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 91.3 t -74.04 -50.9 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 O-C-N 121.159 -0.963 . . . . 0.0 111.827 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 78.1 mtm -59.55 -40.21 86.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.116 -0.99 . . . . 0.0 110.205 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.2 m -64.72 -45.63 85.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.645 -0.659 . . . . 0.0 109.325 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -61.36 -33.63 73.97 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.6 mt -69.98 -36.12 74.96 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.141 0.496 . . . . 0.0 109.836 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.41 30.72 1.65 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -119.93 127.34 52.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.464 -1.021 . . . . 0.0 109.701 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -100.11 120.96 40.67 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.654 -0.654 . . . . 0.0 110.824 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.5 mp -137.72 155.39 49.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.567 -0.708 . . . . 0.0 110.051 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.38 166.92 16.97 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -64.65 -24.76 67.69 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.178 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -68.66 -35.87 77.8 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.683 0.754 . . . . 0.0 109.278 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -64.8 -36.11 83.27 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.6 t -70.04 -38.62 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-O 121.427 0.632 . . . . 0.0 110.178 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -59.79 -46.54 88.9 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.573 -0.705 . . . . 0.0 110.227 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -60.1 -39.97 88.0 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.805 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 67.6 mtt -54.7 -40.01 68.75 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.353 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.64 -38.04 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.716 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -59.38 -40.02 85.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.507 -0.746 . . . . 0.0 111.938 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.88 -40.0 91.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.448 -0.782 . . . . 0.0 112.012 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.14 -17.16 16.79 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.276 -0.89 . . . . 0.0 111.388 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -85.8 74.99 10.11 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.271 -0.893 . . . . 0.0 110.538 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.7 -40.04 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.725 -0.609 . . . . 0.0 109.841 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 27.9 p-10 -58.76 -38.92 79.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.551 -0.718 . . . . 0.0 110.766 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.86 16.05 40.29 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 120.224 -0.988 . . . . 0.0 111.073 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.59 -10.81 59.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.127 -1.219 . . . . 0.0 110.238 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.47 3.54 74.84 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.476 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -134.79 136.36 42.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.093 -1.24 . . . . 0.0 110.666 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.8 t -92.11 120.01 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.47 -0.768 . . . . 0.0 110.033 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.415 ' OD1' ' CD2' ' A' ' 99' ' ' TYR . 84.8 m-20 -96.41 -175.03 3.22 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.453 0.644 . . . . 0.0 110.381 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -60.0 -49.98 75.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.837 -0.539 . . . . 0.0 110.188 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -60.08 -44.75 94.55 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.374 -0.829 . . . . 0.0 111.279 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -62.32 -39.03 91.72 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.04 0.924 . . . . 0.0 109.353 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -60.01 -41.86 93.06 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.697 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 92.9 t -67.65 -40.05 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.378 -0.826 . . . . 0.0 110.844 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -59.97 -39.98 87.51 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.472 -0.767 . . . . 0.0 110.498 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 46.2 ttp -60.04 -40.55 89.79 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.66 -0.65 . . . . 0.0 110.588 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 61.1 mtt -76.72 -34.24 58.14 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.419 -0.801 . . . . 0.0 109.95 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.0 m -92.7 23.62 4.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.793 -0.567 . . . . 0.0 111.016 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.49 89.03 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.353 -0.842 . . . . 0.0 110.474 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.146 -179.847 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 82.2 7.15 88.11 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -60.05 -47.97 83.65 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.038 -1.272 . . . . 0.0 109.472 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -61.4 -38.78 88.32 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.856 -0.528 . . . . 0.0 111.136 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -60.09 -39.9 87.74 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.389 -0.819 . . . . 0.0 110.707 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 85.4 mt -69.07 -40.06 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.441 -0.787 . . . . 0.0 110.214 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.0 -44.47 94.53 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.616 -0.677 . . . . 0.0 110.969 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -60.49 -40.79 92.6 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.34 -0.85 . . . . 0.0 110.5 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 40.4 tp -61.27 -40.6 94.7 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.503 -0.748 . . . . 0.0 109.972 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 93.1 t -60.59 -40.0 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.697 -0.627 . . . . 0.0 109.871 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -53.91 -36.15 55.03 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 98.3 t -77.71 -29.87 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.606 -0.938 . . . . 0.0 110.33 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 3.7 tt -59.98 -50.72 72.62 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.512 -0.743 . . . . 0.0 111.515 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -60.27 -40.09 89.14 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.369 -0.832 . . . . 0.0 111.164 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -59.91 -35.32 74.62 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.49 -0.756 . . . . 0.0 110.695 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -59.69 -39.97 86.3 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.477 -0.765 . . . . 0.0 110.25 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.05 79.2 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.296 -0.878 . . . . 0.0 110.306 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -60.06 -39.64 86.69 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.337 -0.852 . . . . 0.0 109.347 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.286 0.565 . . . . 0.0 110.056 179.381 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.272 0.558 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -67.77 -36.09 79.85 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.741 0.781 . . . . 0.0 110.547 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -59.98 -40.03 87.71 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.352 0.596 . . . . 0.0 110.665 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.1 mt -89.46 -178.98 5.72 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.745 -0.597 . . . . 0.0 110.503 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.77 25.88 11.22 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.715 -0.616 . . . . 0.0 109.823 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -55.13 -14.16 1.52 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.591 -0.693 . . . . 0.0 111.917 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' A' ' 8' ' ' GLN . 19.5 pt-20 -64.51 -41.17 96.58 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.916 -1.115 . . . . 0.0 109.999 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.408 ' N ' ' HG3' ' A' ' 7' ' ' GLU . 27.0 mt-30 -63.83 -36.46 83.97 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.464 -0.772 . . . . 0.0 109.77 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 83.8 mt -57.11 -29.62 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.806 -0.559 . . . . 0.0 111.044 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.94 -39.54 94.39 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.194 -0.941 . . . . 0.0 110.419 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -60.07 -42.62 94.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.37 -0.831 . . . . 0.0 109.88 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -63.32 -20.88 65.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.865 -0.522 . . . . 0.0 111.068 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.429 ' HD3' ' CZ ' ' A' ' 65' ' ' PHE . 40.3 mmtt -66.87 -40.22 87.76 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.203 -0.936 . . . . 0.0 108.988 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -64.25 -58.31 6.93 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.976 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.86 -26.95 68.44 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.36 -0.837 . . . . 0.0 112.545 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -58.36 -48.31 81.01 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.753 -1.217 . . . . 0.0 111.013 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.4 p -62.33 -37.17 84.58 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.186 -0.947 . . . . 0.0 109.481 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.2 tp -60.09 -40.01 88.11 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.583 0.706 . . . . 0.0 109.499 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -74.81 -36.69 62.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.875 -0.516 . . . . 0.0 110.974 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -94.91 97.78 10.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.441 -0.787 . . . . 0.0 110.131 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -65.67 -31.98 73.29 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.499 -0.75 . . . . 0.0 111.077 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -80.04 -10.43 59.77 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.214 -0.929 . . . . 0.0 111.166 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.34 25.66 55.06 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -88.46 -8.08 55.51 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.543 -0.974 . . . . 0.0 110.902 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.31 2.72 56.71 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 120.054 -1.07 . . . . 0.0 111.751 178.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.8 p -143.4 141.5 30.9 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-N 119.464 1.632 . . . . 0.0 111.966 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 83.9 mt -100.88 121.32 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.737 -0.602 . . . . 0.0 109.458 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.1 m -102.33 141.86 34.48 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.59 -0.694 . . . . 0.0 110.389 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.41 ' CG2' HG13 ' A' ' 52' ' ' ILE . 40.6 p -41.96 -29.79 0.24 Allowed 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.643 -0.66 . . . . 0.0 112.211 -177.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -63.41 -52.08 63.09 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.333 -0.854 . . . . 0.0 109.364 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.04 -53.73 54.3 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.487 -178.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.0 tp -59.83 -36.49 76.93 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.092 -1.005 . . . . 0.0 110.672 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.77 -31.0 37.35 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.4 m -69.97 -40.1 75.57 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.616 -0.932 . . . . 0.0 110.24 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.22 -55.21 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.53 -0.731 . . . . 0.0 109.512 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.419 ' HE2' ' CG ' ' B' ' 170' ' ' TRP . 69.0 mtt -58.48 -30.46 67.0 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.333 0.587 . . . . 0.0 110.044 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -59.88 -50.04 75.34 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 t -70.76 -18.8 62.76 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.803 -0.561 . . . . 0.0 110.436 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.7 mt -84.96 -21.87 29.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.293 -0.88 . . . . 0.0 110.576 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.77 -45.46 0.19 Allowed Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.937 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -161.44 159.95 28.73 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.11 -1.229 . . . . 0.0 111.957 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -114.42 105.1 54.2 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -61.36 -149.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.503 0 O-C-N 123.306 1.161 . . . . 0.0 110.734 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.23 160.54 39.17 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.93 -1.106 . . . . 0.0 111.174 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -53.78 -22.02 8.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.936 -0.478 . . . . 0.0 111.939 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.01 -59.23 3.04 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -67.27 -38.67 85.46 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.553 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.2 mt -58.71 -33.17 69.88 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.865 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -40.0 94.78 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.497 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -64.79 -40.03 94.57 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.649 -0.657 . . . . 0.0 110.928 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 66.6 mtt -61.3 -43.41 98.91 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.685 -0.634 . . . . 0.0 109.748 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.41 HG13 ' CG2' ' A' ' 29' ' ' THR . 48.4 mm -66.88 -36.24 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.849 -0.532 . . . . 0.0 110.746 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -60.01 -41.95 93.24 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.391 -0.818 . . . . 0.0 110.633 -178.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -69.88 -27.69 65.02 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.226 -0.921 . . . . 0.0 111.355 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.2 t -99.21 -10.02 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.316 -0.865 . . . . 0.0 111.835 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -71.53 96.88 1.58 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.089 -1.007 . . . . 0.0 111.302 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.23 -37.43 80.82 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.406 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -90.58 -27.01 19.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.733 -0.604 . . . . 0.0 110.433 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.99 20.34 43.34 Favored Glycine 0 N--CA 1.495 2.567 0 C-N-CA 120.458 -0.877 . . . . 0.0 110.923 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -76.27 -28.62 57.12 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.449 -1.03 . . . . 0.0 110.565 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.35 2.06 23.2 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.174 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.3 p -134.1 167.78 20.01 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.152 -1.204 . . . . 0.0 110.527 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.7 mt -103.53 119.94 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.228 -178.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -97.71 167.56 10.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.666 -0.646 . . . . 0.0 109.889 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.481 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 10.5 t80 -48.27 -48.63 64.99 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.52 -0.737 . . . . 0.0 112.45 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.5 Cg_endo -67.0 -34.4 29.21 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 O-C-N 122.895 0.945 . . . . 0.0 111.088 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.9 -39.92 69.23 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.181 -0.95 . . . . 0.0 110.887 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -62.32 -40.43 96.29 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.451 -0.781 . . . . 0.0 111.422 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.41 HD13 ' CD1' ' A' ' 65' ' ' PHE . 4.6 mp -69.63 -40.01 76.8 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.221 -0.924 . . . . 0.0 111.611 -178.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.8 p -61.22 -40.03 92.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.364 -0.835 . . . . 0.0 110.853 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 50.7 ttp -67.49 -52.05 43.86 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.525 -0.734 . . . . 0.0 112.044 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 49.8 ttm -59.98 -49.71 76.6 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.314 -0.866 . . . . 0.0 111.948 -178.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.99 -36.02 76.27 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.547 -0.72 . . . . 0.0 110.341 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -77.23 -43.55 33.16 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.606 0.717 . . . . 0.0 110.14 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -61.01 -48.12 83.29 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.757 -0.589 . . . . 0.0 111.973 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 27.8 ptm -59.94 -36.12 76.37 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.261 -0.9 . . . . 0.0 110.679 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -68.17 -42.93 79.27 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.695 0.759 . . . . 0.0 109.299 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -68.43 -30.93 69.93 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.691 0.758 . . . . 0.0 109.273 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.2 m -94.53 -174.11 3.23 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -120.73 141.63 50.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.109 -0.995 . . . . 0.0 109.808 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.3 t -60.06 -29.57 68.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.65 -0.656 . . . . 0.0 110.173 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.0 -37.34 79.42 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.698 0.761 . . . . 0.0 109.192 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -70.06 -39.98 75.35 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.19 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -64.08 -39.75 94.75 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.704 -0.623 . . . . 0.0 110.767 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.92 -49.68 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.63 -0.669 . . . . 0.0 110.465 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -57.7 -40.09 78.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.336 -0.852 . . . . 0.0 111.16 -178.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.03 -39.99 75.44 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.336 -0.853 . . . . 0.0 111.666 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.52 -47.21 73.64 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.331 -0.856 . . . . 0.0 111.287 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -60.01 -47.52 85.51 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.587 -0.695 . . . . 0.0 110.138 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -59.93 -36.35 76.85 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.683 -0.636 . . . . 0.0 110.325 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.5 t -66.92 -46.39 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.568 -0.707 . . . . 0.0 109.699 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.422 ' CD1' HD23 ' A' ' 105' ' ' LEU . 14.3 m-85 -69.91 -38.58 76.3 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.461 -0.774 . . . . 0.0 111.324 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -75.34 78.33 2.42 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.51 -0.744 . . . . 0.0 110.571 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -59.92 -47.91 83.85 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.622 -0.674 . . . . 0.0 110.178 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -78.08 -18.57 55.59 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.505 -0.747 . . . . 0.0 111.239 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.98 28.58 72.27 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -73.91 -8.96 58.06 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.414 -1.05 . . . . 0.0 111.401 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.39 -17.61 50.48 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -129.99 138.44 50.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.315 -1.109 . . . . 0.0 108.87 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.429 ' CG2' ' CD2' ' A' ' 105' ' ' LEU . 32.9 mt -89.05 124.41 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.368 -0.833 . . . . 0.0 110.435 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.4 m -88.65 171.01 10.33 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.242 0.544 . . . . 0.0 110.384 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.84 -40.07 83.78 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.663 -0.648 . . . . 0.0 109.582 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.55 -38.51 91.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.76 -0.588 . . . . 0.0 109.604 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.85 -40.28 91.58 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.781 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.429 ' CD2' ' CG2' ' A' ' 100' ' ' ILE . 0.2 OUTLIER -63.1 -44.76 94.79 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.505 -0.747 . . . . 0.0 110.462 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -60.29 -30.9 69.77 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.633 -0.667 . . . . 0.0 110.385 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -60.18 -49.95 75.6 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.561 -0.712 . . . . 0.0 111.456 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.3 t -74.26 -52.32 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 O-C-N 121.234 -0.916 . . . . 0.0 112.168 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 99.4 mtp -56.56 -42.68 78.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.123 -0.986 . . . . 0.0 110.511 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.6 m -65.16 -46.7 79.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.707 -0.621 . . . . 0.0 109.668 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -62.01 -33.69 74.81 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.9 mt -70.03 -33.43 71.97 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.701 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.27 40.8 0.42 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -138.02 132.84 32.82 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.5 -1.0 . . . . 0.0 110.142 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -106.82 141.3 38.28 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.477 -0.764 . . . . 0.0 110.303 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -158.73 157.82 32.47 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.624 0.726 . . . . 0.0 110.769 179.231 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.3 p -85.66 167.57 15.2 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.632 -0.667 . . . . 0.0 109.802 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -65.47 -26.69 68.05 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -69.92 -37.34 75.91 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.909 0.862 . . . . 0.0 109.204 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -63.43 -40.02 96.03 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.44 1.114 . . . . 0.0 108.378 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.7 t -67.21 -39.97 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.033 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -60.07 -45.81 91.63 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.568 -0.707 . . . . 0.0 110.041 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -59.96 -40.09 87.86 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.724 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 66.7 mtt -56.24 -37.68 70.07 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.184 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 89.4 mt -65.21 -38.56 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.812 0.815 . . . . 0.0 109.047 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.4 ttt180 -58.51 -39.63 80.63 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.057 0.456 . . . . 0.0 111.391 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -60.06 -39.95 87.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.709 -0.619 . . . . 0.0 111.845 -178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.2 -10.45 15.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.208 -0.933 . . . . 0.0 112.011 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -74.25 69.94 1.61 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.1 -1.0 . . . . 0.0 110.414 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.0 mt -68.2 -40.0 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.587 -0.696 . . . . 0.0 110.503 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -69.3 -24.31 63.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.377 -0.827 . . . . 0.0 111.017 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.89 24.67 48.28 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.96 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -82.57 -10.0 59.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -1.125 . . . . 0.0 110.802 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.33 -1.39 79.5 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -138.23 150.39 46.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -1.105 . . . . 0.0 109.38 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.53 118.87 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.408 -0.807 . . . . 0.0 109.944 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -89.93 -170.73 2.9 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.682 0.754 . . . . 0.0 110.397 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -69.87 -40.03 75.98 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.502 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -60.15 -47.82 84.33 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.3 -0.875 . . . . 0.0 112.249 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -62.74 -37.74 87.77 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.927 0.87 . . . . 0.0 110.043 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -59.97 -50.04 75.32 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.37 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.411 HG22 ' N ' ' A' ' 143' ' ' GLN . 36.0 m -70.12 -41.05 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.411 ' N ' HG22 ' A' ' 142' ' ' VAL . 57.0 tt0 -59.97 -51.04 71.36 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.184 -0.947 . . . . 0.0 111.314 -178.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.9 ttp -62.38 -37.73 86.85 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.447 -0.783 . . . . 0.0 109.927 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 90.6 mmm -69.82 -39.35 76.53 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.848 -0.533 . . . . 0.0 109.967 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 71.4 p -82.56 0.39 42.94 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.499 -0.751 . . . . 0.0 111.039 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.94 -40.0 87.47 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.138 -0.976 . . . . 0.0 110.477 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.2 mttt . . . . . 0 N--CA 1.496 1.825 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.347 -179.781 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -77.0 141.4 26.13 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -60.05 -41.57 92.59 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.59 -0.947 . . . . 0.0 110.595 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 21.3 ptt-85 -60.04 -39.97 87.77 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.626 -0.671 . . . . 0.0 111.51 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 30.1 mtp-105 -61.62 -39.97 93.17 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.494 -0.754 . . . . 0.0 110.458 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 88.8 mt -66.39 -39.96 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.569 -0.707 . . . . 0.0 110.481 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.95 87.42 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.558 -0.714 . . . . 0.0 110.708 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -60.0 -42.31 93.98 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.547 -0.721 . . . . 0.0 111.457 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 42.6 tp -65.0 -40.9 95.62 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.3 -0.875 . . . . 0.0 110.83 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 66.9 t -61.09 -39.99 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.588 -0.695 . . . . 0.0 110.751 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.07 -40.15 82.08 Favored Glycine 0 N--CA 1.495 2.597 0 O-C-N 121.447 -0.783 . . . . 0.0 111.759 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 15.0 p -76.33 -24.46 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.096 -1.238 . . . . 0.0 112.53 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 85.7 mt -59.96 -49.09 79.03 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.953 -1.092 . . . . 0.0 110.969 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -61.72 -40.0 93.5 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.314 -0.866 . . . . 0.0 110.704 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.34 -26.01 68.21 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.473 -0.767 . . . . 0.0 109.872 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . 0.419 ' CG ' ' HE2' ' A' ' 36' ' ' MET . 2.2 t90 -59.99 -41.73 92.7 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.593 -0.692 . . . . 0.0 109.721 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.97 -50.5 73.5 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.461 -0.774 . . . . 0.0 110.78 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -60.16 -39.89 87.98 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.451 -0.781 . . . . 0.0 110.378 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 . . . . . 0 N--CA 1.495 1.778 0 O-C-N 121.611 -0.681 . . . . 0.0 110.127 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.22 0.533 . . . . 0.0 109.851 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -108.06 14.58 25.05 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.525 -0.735 . . . . 0.0 111.071 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -64.85 -174.06 0.13 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.181 -0.949 . . . . 0.0 109.372 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.1 mt -131.57 177.02 7.82 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.325 -0.859 . . . . 0.0 111.03 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.5 p -140.11 105.37 5.04 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -87.04 -9.04 56.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.743 -0.598 . . . . 0.0 111.397 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -70.06 -35.6 74.36 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -0.927 . . . . 0.0 110.554 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -68.76 -37.57 79.47 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.397 -0.814 . . . . 0.0 110.182 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.3 mt -59.93 -31.87 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.727 -0.608 . . . . 0.0 110.98 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.11 -39.38 86.02 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.249 -0.907 . . . . 0.0 110.287 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -60.04 -40.0 87.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.541 -0.725 . . . . 0.0 110.349 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -65.52 -22.83 66.76 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.486 -0.759 . . . . 0.0 110.841 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.428 ' HD3' ' CE1' ' A' ' 65' ' ' PHE . 46.7 mmtt -68.77 -39.99 79.96 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.84 -56.82 13.97 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 120.311 -0.555 . . . . 0.0 110.542 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.38 -25.89 67.48 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.295 -0.878 . . . . 0.0 112.19 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.517 ' CG ' ' CZ ' ' A' ' 65' ' ' PHE . 51.1 t80 -59.99 -43.61 95.03 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.112 -0.993 . . . . 0.0 110.714 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 98.4 p -62.13 -35.34 78.45 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.34 -0.85 . . . . 0.0 110.123 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.8 tt -66.7 -39.97 88.3 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -70.01 -40.06 75.49 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -91.59 88.75 6.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.782 -0.574 . . . . 0.0 110.139 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -59.98 -33.22 71.66 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.439 -0.788 . . . . 0.0 111.297 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -80.18 -10.07 59.74 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.113 -0.992 . . . . 0.0 111.236 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 58.02 26.07 57.7 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -88.07 -7.17 57.39 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.507 -0.996 . . . . 0.0 111.096 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.87 3.47 58.11 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.199 -1.001 . . . . 0.0 111.568 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.2 p -143.22 141.25 31.03 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 119.181 1.491 . . . . 0.0 111.484 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.5 mt -98.51 120.06 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.0 p -84.05 175.77 9.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.431 -0.793 . . . . 0.0 109.875 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 78.3 p -76.21 -32.34 58.9 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.592 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -67.84 -41.65 82.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.526 -0.734 . . . . 0.0 110.708 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -60.54 -57.46 12.65 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.605 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.5 tp -59.96 -39.19 84.78 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.368 -0.832 . . . . 0.0 111.057 -178.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -48.1 -29.79 6.96 Favored Glycine 0 N--CA 1.502 3.08 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.5 m -68.14 -40.0 82.52 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.442 -1.034 . . . . 0.0 108.928 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.5 t -64.13 -44.41 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 CA-C-O 121.306 0.574 . . . . 0.0 110.128 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 95.9 mtp -59.99 -39.99 87.65 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.604 -0.685 . . . . 0.0 110.554 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.408 ' HG2' ' HB2' ' A' ' 42' ' ' ASN . 1.1 mmt85 -61.02 -38.44 86.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.424 -0.797 . . . . 0.0 109.504 178.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.4 t -64.35 -26.7 68.59 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.887 -0.508 . . . . 0.0 110.613 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.3 mt -93.39 -16.1 24.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.298 -0.876 . . . . 0.0 110.228 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.05 -66.3 0.12 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -161.34 170.01 20.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.258 -1.142 . . . . 0.0 111.708 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.408 ' HB2' ' HG2' ' A' ' 37' ' ' ARG . 29.9 t30 -112.79 129.0 24.88 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.882 -0.511 . . . . 0.0 110.136 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.6 -143.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.264 0 O-C-N 123.142 1.075 . . . . 0.0 109.398 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.5 p -128.48 156.17 43.66 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.648 -1.282 . . . . 0.0 111.444 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -51.9 -22.59 3.95 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.78 -0.575 . . . . 0.0 111.844 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.13 -56.18 6.02 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 122.233 1.016 . . . . 0.0 108.523 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.4 -34.3 76.97 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.479 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 mt -57.22 -35.52 69.76 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.611 -0.681 . . . . 0.0 109.991 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -72.63 -30.29 64.18 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 120.191 -0.603 . . . . 0.0 111.708 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -69.14 -40.16 78.42 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.224 -0.923 . . . . 0.0 110.531 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 78.1 mtm -65.12 -40.02 93.88 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.682 0.754 . . . . 0.0 109.216 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 92.6 mt -67.38 -34.48 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.832 -0.543 . . . . 0.0 110.507 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -60.08 -39.98 87.96 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.233 -0.917 . . . . 0.0 112.073 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -66.03 -27.77 68.35 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.051 -1.031 . . . . 0.0 110.75 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -97.34 -9.33 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.598 -0.689 . . . . 0.0 110.55 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -69.44 97.63 1.01 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.283 -0.886 . . . . 0.0 110.603 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.08 -38.62 91.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.658 -0.651 . . . . 0.0 109.4 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -90.33 -31.58 16.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.726 -0.609 . . . . 0.0 110.812 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.6 21.58 36.75 Favored Glycine 0 N--CA 1.496 2.653 0 C-N-CA 120.336 -0.935 . . . . 0.0 110.832 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -73.93 -33.61 64.01 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.441 -1.035 . . . . 0.0 110.576 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.05 -2.31 7.86 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 120.437 -0.887 . . . . 0.0 110.957 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.8 p -136.19 167.33 21.48 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.014 -1.286 . . . . 0.0 110.621 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.413 HD11 HG22 ' A' ' 63' ' ' ILE . 7.9 mt -107.76 123.78 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 121.596 0.712 . . . . 0.0 111.464 -177.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -99.58 171.22 8.06 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.54 0.685 . . . . 0.0 111.044 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.517 ' CZ ' ' CG ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -47.65 -50.03 53.2 Favored Pre-proline 0 N--CA 1.503 2.184 0 O-C-N 121.653 -0.654 . . . . 0.0 112.519 -179.507 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.7 Cg_endo -69.52 -35.33 13.54 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 122.92 0.958 . . . . 0.0 111.671 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.99 -39.93 75.63 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.23 -0.919 . . . . 0.0 109.8 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -61.66 -41.67 97.85 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.205 0.526 . . . . 0.0 110.775 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.3 mt -65.34 -39.97 93.06 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.479 -0.763 . . . . 0.0 111.941 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.9 p -59.98 -39.96 87.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.249 -0.907 . . . . 0.0 110.614 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 61.3 ttp -67.36 -40.0 85.77 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.558 -0.714 . . . . 0.0 110.986 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -59.95 -50.15 74.9 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.53 -0.731 . . . . 0.0 111.928 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.84 -29.95 67.33 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.541 -0.725 . . . . 0.0 111.877 -178.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -69.97 -40.11 75.58 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.364 -0.835 . . . . 0.0 111.281 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -69.97 -27.18 64.51 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 38.8 mmt -59.33 -49.03 79.38 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.03 -1.044 . . . . 0.0 112.229 -177.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.6 pttt -69.24 -33.87 73.95 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.263 -0.898 . . . . 0.0 111.936 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -70.02 -19.96 63.29 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.462 -0.773 . . . . 0.0 111.341 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.3 t -118.2 -166.82 1.26 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.11 0.957 . . . . 0.0 112.427 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -128.52 137.97 52.03 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.639 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.9 t -60.7 -32.43 71.67 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.649 -0.657 . . . . 0.0 110.652 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -59.99 -33.8 72.45 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.561 -0.712 . . . . 0.0 110.127 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -69.96 -40.0 75.67 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.742 -0.599 . . . . 0.0 110.747 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -69.39 -33.26 72.76 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.503 -0.748 . . . . 0.0 110.469 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 91.9 mt -64.81 -49.62 79.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.724 -0.61 . . . . 0.0 110.407 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -57.87 -38.4 75.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.444 -0.785 . . . . 0.0 111.02 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.0 -42.06 73.54 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.66 -0.65 . . . . 0.0 111.617 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.3 -45.65 79.68 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.487 -0.758 . . . . 0.0 111.779 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -60.01 -45.99 90.96 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.382 -0.824 . . . . 0.0 109.449 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -59.99 -33.93 72.63 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.682 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 83.3 t -69.04 -47.87 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.441 -0.787 . . . . 0.0 109.829 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -70.02 -39.76 75.6 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.514 -0.741 . . . . 0.0 111.501 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -80.05 80.03 6.52 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.406 -0.809 . . . . 0.0 110.186 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -69.97 -42.07 73.64 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.413 -0.804 . . . . 0.0 110.932 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -72.78 -23.41 60.8 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.415 -0.803 . . . . 0.0 111.046 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.71 24.54 75.42 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -70.7 -9.73 57.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.504 -0.997 . . . . 0.0 111.131 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.69 -11.72 66.35 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -133.18 139.31 46.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.187 -1.184 . . . . 0.0 109.076 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.413 ' CG2' ' CD2' ' A' ' 105' ' ' LEU . 56.7 mt -89.37 123.25 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.532 -0.73 . . . . 0.0 110.042 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.4 m -86.96 170.14 11.85 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.405 0.621 . . . . 0.0 110.297 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.99 -39.91 75.63 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.632 -0.668 . . . . 0.0 109.749 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.25 -39.29 94.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.772 -0.58 . . . . 0.0 109.668 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -60.16 -39.89 87.97 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.606 -0.684 . . . . 0.0 110.386 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.413 ' CD2' ' CG2' ' A' ' 100' ' ' ILE . 0.5 OUTLIER -68.21 -41.23 81.63 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.484 0.659 . . . . 0.0 110.655 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -61.09 -37.03 81.27 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.656 -0.652 . . . . 0.0 111.746 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -59.97 -43.32 95.14 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.142 -0.974 . . . . 0.0 111.848 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.4 t -74.85 -44.24 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.237 -0.914 . . . . 0.0 111.631 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 94.5 mmm -58.25 -46.77 85.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.28 -0.888 . . . . 0.0 110.317 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.4 m -67.51 -41.07 85.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.46 -0.775 . . . . 0.0 109.202 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -61.55 -32.94 73.04 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.5 mt -68.52 -37.36 79.96 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.079 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 119.82 38.27 0.72 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -129.67 140.45 51.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.645 -0.915 . . . . 0.0 109.792 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -107.94 109.18 20.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.439 -0.788 . . . . 0.0 110.579 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 56.2 mt -131.59 156.2 46.18 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.598 -0.689 . . . . 0.0 109.753 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.3 m -84.0 164.76 19.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.626 -0.671 . . . . 0.0 109.744 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -61.13 -26.76 67.9 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.586 -0.696 . . . . 0.0 109.142 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.95 -31.85 73.0 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -37.34 87.26 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 73.1 t -70.64 -39.7 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.533 0.682 . . . . 0.0 110.201 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -59.89 -44.62 94.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.789 -0.57 . . . . 0.0 109.994 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -60.55 -41.33 94.34 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.579 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 67.6 mtt -55.6 -37.69 68.44 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 119.48 -0.888 . . . . 0.0 108.939 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.94 -39.93 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -58.64 -39.97 82.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.57 -0.706 . . . . 0.0 111.53 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -61.46 -40.0 92.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.398 -0.814 . . . . 0.0 111.86 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -102.93 -5.06 23.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.168 -0.957 . . . . 0.0 111.921 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -89.3 69.95 8.17 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.916 -1.115 . . . . 0.0 110.518 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.3 mt -70.03 -40.37 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.519 -0.738 . . . . 0.0 111.247 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -62.84 -39.96 95.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.357 -0.839 . . . . 0.0 111.207 -178.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 103.25 22.9 8.82 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.987 -1.102 . . . . 0.0 110.813 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -83.39 -7.71 59.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.33 -1.1 . . . . 0.0 110.767 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.05 -3.18 87.08 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -138.02 148.26 44.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.409 -1.053 . . . . 0.0 109.454 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 71.4 t -92.36 118.63 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.566 -0.709 . . . . 0.0 110.263 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -90.62 -174.32 4.05 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.361 -0.837 . . . . 0.0 110.823 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -69.98 -40.21 75.47 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.354 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.33 -50.11 74.94 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.181 -0.95 . . . . 0.0 111.383 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.47 -34.36 78.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.517 -0.739 . . . . 0.0 109.828 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.43 ' CZ ' ' HE3' ' A' ' 145' ' ' MET . 49.6 t80 -58.05 -49.3 77.37 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.038 0.447 . . . . 0.0 110.776 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 53.3 t -70.03 -39.08 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.365 -0.834 . . . . 0.0 111.211 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -57.6 -49.28 76.91 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.305 -0.872 . . . . 0.0 110.827 -178.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -59.35 -35.62 74.19 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.416 -0.802 . . . . 0.0 110.33 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.43 ' HE3' ' CZ ' ' A' ' 141' ' ' PHE . 58.5 mtt -73.8 -40.0 63.7 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.53 -0.731 . . . . 0.0 110.549 178.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 34.8 m -69.9 -19.88 63.39 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.715 -0.615 . . . . 0.0 110.86 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -107.64 137.32 45.87 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.402 -0.811 . . . . 0.0 110.484 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.3 mttm . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.025 179.951 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -99.28 146.56 18.08 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -60.04 -41.84 93.13 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.595 -0.944 . . . . 0.0 110.098 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -59.96 -40.05 87.73 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.597 -0.689 . . . . 0.0 110.186 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -59.98 -40.19 88.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.733 -0.604 . . . . 0.0 110.703 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . 0.476 HD13 HG22 ' B' ' 160' ' ' ILE . 95.3 mt -69.92 -40.41 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.396 -0.815 . . . . 0.0 111.973 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.14 -42.85 88.5 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.274 -0.892 . . . . 0.0 111.923 -178.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -68.68 -40.02 80.3 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.383 -0.823 . . . . 0.0 110.785 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 10.3 tt -59.93 -42.87 94.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.499 -0.75 . . . . 0.0 110.397 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 85.8 t -65.85 -40.03 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.581 -0.699 . . . . 0.0 110.011 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.57 -39.97 93.95 Favored Glycine 0 N--CA 1.498 2.83 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 84.8 t -64.56 -37.39 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.464 -1.021 . . . . 0.0 110.314 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.02 -45.35 93.08 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.52 -0.737 . . . . 0.0 110.919 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 168' ' ' ARG . . . . . 0.402 ' O ' ' CD2' ' B' ' 172' ' ' TYR . 21.5 mmt180 -59.94 -39.31 85.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.487 -0.758 . . . . 0.0 110.999 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -60.02 -37.95 81.26 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.446 -0.784 . . . . 0.0 109.747 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 3.2 t-105 -59.98 -43.32 95.19 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.688 -0.633 . . . . 0.0 109.72 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.98 -52.04 65.61 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.568 -0.707 . . . . 0.0 110.641 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 172' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' B' ' 168' ' ' ARG . 53.6 m-85 -60.01 -38.75 83.57 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.485 -0.76 . . . . 0.0 110.538 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.542 -0.724 . . . . 0.0 110.246 -179.883 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.081 0.467 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -97.54 10.04 40.89 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.531 -0.731 . . . . 0.0 110.703 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -60.17 -37.09 79.1 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.375 -0.828 . . . . 0.0 111.403 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.03 -39.96 87.67 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.642 -0.661 . . . . 0.0 110.414 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.7 p -134.45 102.59 5.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.35 -0.844 . . . . 0.0 109.588 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -77.71 -10.05 59.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.878 -0.514 . . . . 0.0 111.427 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -68.51 -23.86 64.6 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.159 -0.963 . . . . 0.0 110.177 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -66.01 -36.91 84.56 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.415 -0.803 . . . . 0.0 109.539 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 94.3 mt -59.99 -32.4 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.817 -0.552 . . . . 0.0 111.53 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.6 -32.23 73.7 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.967 -1.083 . . . . 0.0 110.512 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -65.09 -45.54 84.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 109.946 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -69.99 -23.59 63.17 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.358 0.599 . . . . 0.0 110.09 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.1 tptp -66.61 -53.08 38.15 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.355 0.598 . . . . 0.0 109.562 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -57.09 -52.68 64.32 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.951 -0.699 . . . . 0.0 110.376 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.78 -26.39 68.69 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.352 -0.842 . . . . 0.0 111.105 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -58.25 -48.41 80.5 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.009 -1.057 . . . . 0.0 110.236 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.3 m -61.86 -39.85 93.31 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.306 -0.871 . . . . 0.0 109.143 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.5 tp -60.0 -39.98 87.64 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.351 0.596 . . . . 0.0 109.5 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -72.59 -35.49 67.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.727 -0.608 . . . . 0.0 110.392 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -95.4 98.96 10.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.471 -0.768 . . . . 0.0 110.371 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.2 mmtm -64.97 -32.04 73.57 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.377 -0.827 . . . . 0.0 111.192 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -79.83 -10.08 59.74 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.083 -1.011 . . . . 0.0 111.081 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.2 26.19 49.42 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -88.28 -3.29 58.88 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.605 -0.938 . . . . 0.0 110.637 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.57 5.46 64.94 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.297 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.9 p -145.1 142.39 29.64 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 119.166 1.483 . . . . 0.0 111.703 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 86.2 mt -103.86 128.0 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.3 p -102.05 141.22 35.23 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.619 -0.676 . . . . 0.0 110.628 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 65.7 p -40.82 -35.87 0.56 Allowed 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -65.72 -45.44 82.69 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.249 -0.907 . . . . 0.0 109.548 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -60.05 -54.05 50.59 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.8 -0.562 . . . . 0.0 111.304 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.6 tt -59.95 -35.86 75.86 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.291 -0.881 . . . . 0.0 111.321 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.22 -28.98 44.16 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.2 m -69.54 -39.98 77.12 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.471 -1.017 . . . . 0.0 110.701 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.9 t -63.58 -54.98 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.691 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 97.8 mmm -59.96 -29.52 68.48 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.731 -0.606 . . . . 0.0 110.788 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -60.39 -50.44 73.58 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.503 -0.748 . . . . 0.0 110.448 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.4 t -72.55 -18.17 61.66 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.692 -0.63 . . . . 0.0 111.02 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.8 mt -100.11 -5.04 28.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.424 -0.797 . . . . 0.0 111.518 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.29 -68.04 0.12 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -160.21 170.64 20.75 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.228 -1.16 . . . . 0.0 111.448 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -110.53 117.21 51.41 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.972 -0.455 . . . . 0.0 110.215 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -68.63 -150.37 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.324 0 N-CA-C 109.265 -1.091 . . . . 0.0 109.265 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 77.2 p -137.79 147.03 44.28 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.939 -1.101 . . . . 0.0 110.606 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -54.86 -21.1 10.32 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.55 -0.718 . . . . 0.0 111.46 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.53 -59.44 2.76 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.23 -38.43 85.21 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.832 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.5 mt -59.48 -33.71 71.65 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.666 0.746 . . . . 0.0 109.839 178.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.84 -39.01 83.89 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.022 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -65.93 -39.39 90.48 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.467 -0.771 . . . . 0.0 110.186 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 66.9 mtt -61.64 -43.39 98.94 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.415 0.626 . . . . 0.0 109.628 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 81.3 mt -68.02 -32.55 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.773 -0.579 . . . . 0.0 110.419 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -59.76 -40.04 86.83 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.384 -0.823 . . . . 0.0 110.292 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -64.07 -27.99 69.48 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.445 -0.785 . . . . 0.0 110.319 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.0 t -101.01 -10.11 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.443 -0.785 . . . . 0.0 110.803 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -67.25 100.5 0.81 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.136 -0.978 . . . . 0.0 111.163 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.0 -38.34 75.94 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -90.75 -30.45 17.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.756 -0.59 . . . . 0.0 110.622 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.6 22.42 43.5 Favored Glycine 0 N--CA 1.496 2.65 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.006 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -75.22 -31.89 61.0 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.342 -1.093 . . . . 0.0 110.657 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.4 1.1 12.48 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.334 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 77.8 p -133.49 170.01 16.13 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.116 -1.226 . . . . 0.0 110.429 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.0 mt -106.69 122.33 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.892 -177.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -98.5 170.03 9.11 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.521 0.676 . . . . 0.0 110.383 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.426 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 9.9 t80 -47.07 -48.77 53.1 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.586 -0.696 . . . . 0.0 112.802 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.2 Cg_endo -71.26 -32.27 13.07 Favored 'Trans proline' 0 N--CA 1.487 1.102 0 O-C-N 122.783 0.886 . . . . 0.0 111.596 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -72.4 -40.21 67.38 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.123 -0.986 . . . . 0.0 110.409 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -62.74 -45.43 92.74 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.781 -0.574 . . . . 0.0 110.544 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.05 -40.01 87.96 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.515 -0.74 . . . . 0.0 110.472 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 93.1 m -61.19 -40.75 95.09 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.721 -0.612 . . . . 0.0 111.029 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.9 ttm -69.14 -41.07 77.82 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.45 -0.781 . . . . 0.0 112.099 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -60.02 -50.0 75.44 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.335 -0.853 . . . . 0.0 111.226 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.59 -32.27 70.91 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.714 -0.616 . . . . 0.0 111.822 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.8 mmt85 -72.96 -43.51 62.2 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.33 -0.856 . . . . 0.0 111.819 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -73.4 -41.66 63.07 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.373 -0.829 . . . . 0.0 112.853 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 24.4 ptm -60.06 -29.77 68.77 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.162 -0.961 . . . . 0.0 111.538 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -63.19 -52.69 61.32 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.27 -0.894 . . . . 0.0 111.587 -178.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -69.84 -10.82 59.85 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.42 -0.8 . . . . 0.0 111.168 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . 0.268 23.4 m -86.06 -174.58 5.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.581 -0.699 . . . . 0.0 109.369 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -128.01 140.9 51.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.238 -0.914 . . . . 0.0 109.447 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.1 t -59.95 -35.05 74.13 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.633 -0.667 . . . . 0.0 110.152 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -61.08 -34.95 75.73 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.619 0.723 . . . . 0.0 109.471 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.99 -40.0 75.58 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.909 -0.494 . . . . 0.0 111.412 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.91 -40.0 79.34 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.443 -0.786 . . . . 0.0 111.062 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 82.8 mt -68.16 -51.82 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.45 -0.781 . . . . 0.0 110.984 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -60.01 -40.94 90.99 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.255 -0.903 . . . . 0.0 111.708 -178.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -70.52 -41.45 72.56 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.51 -0.744 . . . . 0.0 111.576 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.31 -43.61 94.16 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.526 -0.734 . . . . 0.0 110.716 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -61.96 -40.81 96.86 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.811 0.815 . . . . 0.0 108.899 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 29.6 ttt85 -59.95 -37.13 78.67 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.395 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 91.2 t -70.02 -50.03 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.509 -0.744 . . . . 0.0 110.153 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -67.67 -39.97 84.47 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.405 -0.809 . . . . 0.0 110.261 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -79.58 76.3 6.21 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.406 ' HE3' ' CD2' ' A' ' 107' ' ' HIS . 60.2 mttm -68.85 -40.48 79.33 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.505 -0.747 . . . . 0.0 110.276 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -74.5 -21.67 59.44 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.418 -0.801 . . . . 0.0 110.64 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.2 26.41 73.43 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -69.92 -12.66 61.78 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.535 -0.979 . . . . 0.0 111.464 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.11 -20.62 14.07 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -144.77 153.74 41.97 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.239 -1.154 . . . . 0.0 109.994 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 80.6 mt -88.88 131.58 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.887 0.851 . . . . 0.0 110.457 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.2 m -87.7 171.01 10.75 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.193 0.521 . . . . 0.0 110.367 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.68 -40.07 91.97 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.41 -38.49 89.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.748 -0.595 . . . . 0.0 109.5 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -61.84 -39.95 93.61 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.751 -0.593 . . . . 0.0 110.666 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.38 -45.61 93.63 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.44 -0.788 . . . . 0.0 109.761 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -64.42 -29.0 70.06 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.768 -0.582 . . . . 0.0 110.513 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.406 ' CD2' ' HE3' ' A' ' 94' ' ' LYS . 1.5 t-80 -61.59 -46.8 88.32 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.445 -0.785 . . . . 0.0 111.361 -178.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 66.5 t -73.38 -47.93 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.472 -0.768 . . . . 0.0 111.727 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 98.0 mtp -58.61 -39.95 81.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.222 -0.923 . . . . 0.0 110.544 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.4 m -66.58 -45.27 79.79 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -61.45 -33.41 73.68 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.2 mt -68.83 -38.74 80.06 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.922 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 119.97 39.88 0.62 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -123.32 136.01 54.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.664 -0.903 . . . . 0.0 109.991 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -96.71 126.41 41.86 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.519 -0.738 . . . . 0.0 109.701 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.45 ' N ' ' CD2' ' A' ' 116' ' ' LEU . 1.0 OUTLIER -152.52 153.77 34.12 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.513 -0.742 . . . . 0.0 111.443 -178.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.7 p -87.36 168.04 13.51 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 36.6 p-10 -64.46 -20.69 66.34 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.644 -0.823 . . . . 0.0 108.879 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -69.71 -37.93 76.76 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.973 0.892 . . . . 0.0 109.134 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -61.48 -39.98 92.88 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 122.131 0.967 . . . . 0.0 108.967 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 63.7 t -69.73 -39.85 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.663 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -59.79 -48.54 81.29 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.572 -0.705 . . . . 0.0 110.217 -178.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -59.99 -40.04 87.8 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.93 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 92.8 mmm -55.4 -38.16 68.55 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.136 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.41 -36.92 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 121.667 0.746 . . . . 0.0 109.154 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -58.14 -39.66 79.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.804 -0.56 . . . . 0.0 111.072 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.96 -39.31 85.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.549 -0.719 . . . . 0.0 111.297 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.91 -18.8 18.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.281 -0.887 . . . . 0.0 111.103 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -72.42 70.84 0.9 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.312 -0.867 . . . . 0.0 111.349 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 85.4 mt -67.8 -40.41 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.45 -0.781 . . . . 0.0 110.557 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -72.32 -18.26 61.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.438 -0.789 . . . . 0.0 111.581 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.23 22.48 60.68 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 120.136 -1.03 . . . . 0.0 110.853 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -82.6 -7.23 59.65 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.181 -1.188 . . . . 0.0 110.782 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.19 -0.83 89.52 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -138.52 149.5 45.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.327 -1.102 . . . . 0.0 109.246 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.6 t -92.98 110.85 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.356 -0.84 . . . . 0.0 110.7 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -80.0 172.77 13.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.493 -0.754 . . . . 0.0 109.647 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -67.94 -40.07 83.36 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.795 -0.566 . . . . 0.0 111.009 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -62.85 -52.29 63.69 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.252 -0.905 . . . . 0.0 111.988 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -69.12 -23.3 63.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -0.849 . . . . 0.0 111.122 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -60.08 -42.3 94.3 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.433 -0.792 . . . . 0.0 109.598 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 95.3 t -70.09 -37.67 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.726 -0.609 . . . . 0.0 111.047 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -59.94 -50.03 75.36 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.49 -0.757 . . . . 0.0 110.935 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.413 ' HE2' ' CD1' ' B' ' 157' ' ' PHE . 59.5 ttp -59.95 -37.73 80.4 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.261 -0.899 . . . . 0.0 110.299 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 94.2 mmm -67.1 -39.99 86.82 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.749 -0.594 . . . . 0.0 111.372 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 64.5 m -57.59 -26.12 61.04 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.292 -0.88 . . . . 0.0 110.543 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.78 135.0 41.72 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.47 -0.769 . . . . 0.0 110.21 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.141 179.969 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -133.87 140.36 11.72 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.413 ' CD1' ' HE2' ' A' ' 144' ' ' MET . 36.0 t80 -61.96 -41.26 97.8 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.597 -0.943 . . . . 0.0 110.37 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -62.5 -40.04 95.43 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.561 -0.712 . . . . 0.0 110.585 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -61.66 -48.12 82.28 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.643 -0.661 . . . . 0.0 111.191 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 14.3 tt -69.95 -26.04 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.527 -0.733 . . . . 0.0 111.04 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.48 -35.34 77.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.504 -0.748 . . . . 0.0 109.661 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -59.97 -40.09 87.89 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.817 -0.552 . . . . 0.0 109.997 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 59.7 mt -63.27 -39.96 96.07 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.525 -0.734 . . . . 0.0 110.704 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 91.2 t -62.75 -40.4 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.455 -0.778 . . . . 0.0 110.414 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.05 -40.02 96.51 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 48.1 t -70.53 -22.53 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.613 -0.934 . . . . 0.0 110.833 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 9.6 tt -59.98 -41.93 93.1 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.3 -0.875 . . . . 0.0 110.076 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -69.48 -35.98 76.09 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.577 -0.702 . . . . 0.0 109.767 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -59.92 -36.65 77.46 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.665 -0.647 . . . . 0.0 110.235 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 4.9 t-105 -60.06 -40.91 91.12 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.671 -0.643 . . . . 0.0 110.722 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.06 -50.12 74.95 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.453 -0.78 . . . . 0.0 110.65 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -60.01 -39.99 87.72 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.417 -0.802 . . . . 0.0 110.354 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 71.2 mtt-85 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.615 -0.678 . . . . 0.0 110.277 -179.537 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.269 0.557 . . . . 0.0 110.017 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -109.18 25.78 11.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.689 -0.632 . . . . 0.0 110.235 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -60.0 -40.05 87.89 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.559 -0.713 . . . . 0.0 110.344 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 76.1 mt -72.89 173.99 8.42 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.335 0.588 . . . . 0.0 110.01 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.96 117.0 7.26 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.388 0.613 . . . . 0.0 109.534 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -71.59 -26.56 62.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.912 -0.493 . . . . 0.0 110.645 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -64.03 -20.44 65.92 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.522 -0.736 . . . . 0.0 111.492 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -70.56 -38.67 74.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.265 -0.897 . . . . 0.0 109.542 177.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 88.0 mt -62.99 -37.94 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.958 -0.464 . . . . 0.0 111.699 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.66 -39.77 89.61 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.206 -0.934 . . . . 0.0 110.344 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -60.06 -39.58 86.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.374 -0.829 . . . . 0.0 110.407 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -64.17 -22.1 66.81 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.682 -0.636 . . . . 0.0 110.885 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -69.52 -41.14 76.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.303 -0.873 . . . . 0.0 109.181 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -71.91 -23.76 61.53 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.133 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.05 -35.49 42.48 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.342 -0.849 . . . . 0.0 110.107 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.433 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 54.7 t80 -58.38 -38.13 76.68 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.899 -0.5 . . . . 0.0 110.914 -178.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.3 p -61.02 -37.15 81.54 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.35 -0.844 . . . . 0.0 109.92 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.98 -40.01 87.67 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.611 -0.681 . . . . 0.0 109.459 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -78.14 -36.25 48.01 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.629 -0.669 . . . . 0.0 110.266 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -93.19 95.8 9.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.581 -0.699 . . . . 0.0 109.967 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -61.74 -32.82 73.08 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.574 -0.704 . . . . 0.0 111.221 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -79.37 -10.43 59.81 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.234 -0.916 . . . . 0.0 111.565 -177.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.51 27.75 54.72 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -92.98 -2.54 55.67 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.616 -0.931 . . . . 0.0 111.0 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.38 2.67 63.58 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.787 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 76.2 p -142.05 141.11 32.76 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 119.559 1.68 . . . . 0.0 111.76 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.7 mt -105.39 130.14 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.792 -0.567 . . . . 0.0 110.428 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.3 p -113.01 146.6 38.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.599 -0.688 . . . . 0.0 110.779 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 40.7 p -42.4 -31.08 0.38 Allowed 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.744 -0.598 . . . . 0.0 112.378 -177.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -65.38 -48.98 71.04 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.569 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -60.43 -56.82 16.76 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.967 -0.458 . . . . 0.0 111.767 -178.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.6 tp -61.54 -32.79 72.87 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.105 -0.997 . . . . 0.0 110.632 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.79 -33.95 28.49 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.3 m -69.98 -40.03 75.59 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.691 -0.888 . . . . 0.0 110.244 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.2 t -63.45 -58.51 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.573 -0.704 . . . . 0.0 110.264 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 74.0 mtm -60.01 -30.04 68.88 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.574 -0.704 . . . . 0.0 110.447 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -60.77 -50.36 73.77 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.566 -0.709 . . . . 0.0 109.601 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.9 t -74.78 -20.06 59.95 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.872 -0.517 . . . . 0.0 110.33 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.4 mp -97.97 -1.48 42.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.393 -0.817 . . . . 0.0 111.352 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.07 -71.43 0.11 Allowed Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.898 -1.144 . . . . 0.0 110.374 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -162.04 161.01 28.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.183 -1.186 . . . . 0.0 111.316 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -111.65 103.4 55.07 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -61.78 -146.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 O-C-N 123.512 1.269 . . . . 0.0 110.402 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.8 p -132.86 157.54 44.79 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.619 -1.3 . . . . 0.0 112.122 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -52.64 -23.36 6.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.886 -0.509 . . . . 0.0 111.647 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.05 -59.94 2.6 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.149 0.976 . . . . 0.0 108.419 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -67.86 -36.2 79.88 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.589 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.4 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 8.8 mt -58.3 -35.02 71.22 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.605 0.717 . . . . 0.0 109.769 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -39.79 94.29 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.068 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -64.8 -40.02 94.55 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.542 -0.724 . . . . 0.0 111.192 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 64.5 mtt -60.04 -42.53 94.63 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.618 -0.676 . . . . 0.0 109.791 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.5 mm -68.33 -37.18 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.855 -0.528 . . . . 0.0 111.11 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -60.97 -40.04 91.89 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.484 -0.76 . . . . 0.0 111.511 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -69.99 -28.25 65.36 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.188 -0.945 . . . . 0.0 110.482 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.1 t -95.61 -9.96 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.648 -0.658 . . . . 0.0 111.229 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -74.71 97.45 3.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.176 -0.953 . . . . 0.0 110.766 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.01 -34.53 73.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.541 -0.724 . . . . 0.0 109.804 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -91.41 -26.3 18.93 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.556 -0.715 . . . . 0.0 110.774 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.14 20.17 50.4 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.035 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -76.13 -26.34 56.25 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.434 -1.039 . . . . 0.0 110.461 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 109.8 -2.09 30.37 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 77.0 p -130.71 170.89 13.74 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.187 -1.184 . . . . 0.0 110.625 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.4 mt -89.4 167.5 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.218 0.533 . . . . 0.0 110.007 -178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.42 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 81.6 m-20 -147.04 150.57 35.35 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.476 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.7 m-85 -42.98 -52.45 11.57 Favored Pre-proline 0 N--CA 1.506 2.344 0 O-C-N 121.702 -0.624 . . . . 0.0 111.71 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.4 Cg_endo -69.41 -29.85 24.87 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 O-C-N 123.269 1.142 . . . . 0.0 111.334 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -72.55 -45.46 59.19 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.014 -1.054 . . . . 0.0 110.067 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -60.47 -43.93 96.41 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.755 -0.59 . . . . 0.0 110.665 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.3 mt -67.13 -41.55 85.93 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.686 -0.633 . . . . 0.0 111.757 -178.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.0 p -62.71 -40.16 96.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.337 -0.852 . . . . 0.0 110.718 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.417 ' HE1' ' CE3' ' B' ' 170' ' ' TRP . 56.4 ttp -66.35 -46.57 76.32 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.79 -0.569 . . . . 0.0 111.315 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.7 ttm -60.06 -49.97 75.56 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.388 -0.82 . . . . 0.0 111.352 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.54 -33.52 72.78 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.487 -0.758 . . . . 0.0 110.58 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.6 ttp180 -69.98 -39.52 75.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.722 -0.611 . . . . 0.0 110.857 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -71.83 -18.25 62.09 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.455 -0.778 . . . . 0.0 112.086 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 26.9 mmt -58.96 -50.02 75.66 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.99 -1.069 . . . . 0.0 110.735 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.99 -32.7 71.04 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.692 -0.63 . . . . 0.0 111.121 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -70.67 -18.9 62.83 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.43 -0.794 . . . . 0.0 111.549 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.4 t -121.93 -162.94 1.02 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.879 0.847 . . . . 0.0 112.284 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -127.97 142.2 51.31 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.353 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.3 t -66.73 -32.51 73.86 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.83 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -60.08 -36.98 78.58 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.881 0.848 . . . . 0.0 109.199 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.86 -39.97 76.04 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.306 0.574 . . . . 0.0 110.389 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -61.63 -37.49 84.17 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.606 -0.684 . . . . 0.0 110.75 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 77.4 mt -67.73 -44.43 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.538 -0.726 . . . . 0.0 110.685 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -59.25 -39.96 84.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.417 -0.802 . . . . 0.0 110.561 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -70.02 -39.96 75.48 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.339 -0.851 . . . . 0.0 111.346 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.98 -46.26 85.41 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.466 -0.771 . . . . 0.0 111.317 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.42 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 52.2 t80 -62.39 -39.99 95.02 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.481 -0.762 . . . . 0.0 109.617 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 39.4 ttm-85 -59.99 -39.3 85.24 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.821 -0.55 . . . . 0.0 111.247 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.6 t -70.02 -43.89 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.482 -0.761 . . . . 0.0 110.354 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -68.62 -39.28 80.88 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.345 -0.847 . . . . 0.0 111.119 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -78.64 78.2 5.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.515 -0.74 . . . . 0.0 109.867 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -59.98 -45.39 92.88 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.487 -0.758 . . . . 0.0 110.358 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 33.3 p-10 -79.71 -19.59 48.51 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.641 -0.662 . . . . 0.0 110.869 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.18 62.5 6.28 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -105.74 -10.59 16.66 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.389 -1.065 . . . . 0.0 111.262 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 123.91 -25.62 6.09 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.419 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 27.5 p90 -145.75 152.49 39.65 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.483 -1.01 . . . . 0.0 109.42 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 77.4 mt -88.84 131.39 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.887 0.851 . . . . 0.0 110.197 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.97 171.84 10.02 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.269 0.557 . . . . 0.0 110.588 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.0 -41.57 97.44 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.603 -0.686 . . . . 0.0 109.304 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.96 -37.7 88.51 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -64.82 -40.08 94.62 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.607 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.29 -45.48 93.19 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.336 -0.852 . . . . 0.0 109.264 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.8 ttt-85 -62.54 -30.99 71.7 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.844 -0.535 . . . . 0.0 111.081 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -59.94 -46.12 90.42 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.164 -0.96 . . . . 0.0 110.417 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 90.2 t -74.96 -33.0 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.411 -0.806 . . . . 0.0 110.926 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.1 mmt -60.09 -49.12 78.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.454 -0.779 . . . . 0.0 110.323 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 76.8 m -68.6 -43.92 75.42 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.66 -0.65 . . . . 0.0 110.414 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -59.89 -29.32 68.26 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.56 -0.712 . . . . 0.0 109.501 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 27.4 mt -70.01 -29.65 66.78 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.694 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 112.21 18.98 7.38 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -122.03 145.03 48.54 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.248 -1.148 . . . . 0.0 110.35 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -105.53 123.6 48.16 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.539 -0.726 . . . . 0.0 110.666 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 72.2 mt -135.38 157.83 45.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.625 -0.672 . . . . 0.0 110.02 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.22 166.75 16.28 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.631 -0.668 . . . . 0.0 109.226 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -61.72 -26.37 68.01 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.94 -34.54 78.36 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.466 0.651 . . . . 0.0 109.57 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.33 -35.86 82.28 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.9 t -68.07 -39.98 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 121.507 0.67 . . . . 0.0 109.884 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -59.99 -49.85 76.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.733 -0.604 . . . . 0.0 110.511 -178.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -60.44 -42.04 95.31 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.494 -0.754 . . . . 0.0 110.423 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 86.8 mtp -55.18 -37.83 67.55 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.205 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 90.3 mt -63.69 -38.67 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.447 0.641 . . . . 0.0 109.509 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -53.85 -35.77 61.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.665 -0.647 . . . . 0.0 111.613 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -59.83 -40.04 87.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.488 -0.758 . . . . 0.0 111.207 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.81 -5.13 17.46 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.221 -0.924 . . . . 0.0 111.167 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -79.78 68.06 5.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.076 -1.015 . . . . 0.0 109.89 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 82.8 mt -68.13 -39.97 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.684 -0.635 . . . . 0.0 110.725 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 37.4 p-10 -70.02 -20.91 63.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.372 -0.83 . . . . 0.0 110.923 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.09 21.43 60.98 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.062 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -82.01 -10.09 59.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -1.133 . . . . 0.0 110.952 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.61 3.46 77.66 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -139.18 147.8 42.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -1.144 . . . . 0.0 109.875 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.6 t -93.17 114.78 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.417 -0.802 . . . . 0.0 110.071 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -82.77 172.0 13.35 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -60.09 -43.85 95.22 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.361 0.601 . . . . 0.0 109.518 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -62.47 -47.61 83.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.678 -0.638 . . . . 0.0 111.013 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -65.35 -33.21 75.42 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.471 -0.768 . . . . 0.0 110.213 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 89.0 t80 -60.05 -47.07 87.38 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.941 -0.474 . . . . 0.0 111.116 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 83.7 t -70.01 -39.14 77.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.257 -0.902 . . . . 0.0 111.193 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -59.97 -49.49 77.47 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.414 -0.804 . . . . 0.0 111.093 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -60.01 -38.09 81.65 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.438 -0.789 . . . . 0.0 110.947 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 97.5 mtp -66.4 -40.0 89.35 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.606 -0.684 . . . . 0.0 110.603 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 66.8 p -98.56 22.13 10.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.417 -0.802 . . . . 0.0 110.387 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.93 -48.22 82.58 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.434 -0.791 . . . . 0.0 110.817 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 90.7 mttt . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.436 -179.58 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -89.38 148.49 20.1 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -59.91 -44.52 94.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.637 -0.919 . . . . 0.0 110.264 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -60.95 -40.01 91.69 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.655 -0.653 . . . . 0.0 111.393 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -62.03 -39.94 94.04 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.372 -0.83 . . . . 0.0 111.521 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 90.6 mt -68.43 -40.05 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.429 -0.794 . . . . 0.0 110.873 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.47 -40.04 92.7 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.325 -0.859 . . . . 0.0 111.05 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -61.61 -41.03 96.87 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.379 -0.826 . . . . 0.0 110.966 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.75 -39.98 90.74 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.496 -0.752 . . . . 0.0 110.595 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 96.8 t -66.26 -40.01 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.604 -0.685 . . . . 0.0 110.022 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -54.46 -42.6 75.9 Favored Glycine 0 N--CA 1.5 2.947 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.69 -18.91 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.656 -0.908 . . . . 0.0 110.371 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 9.3 tt -59.95 -49.95 75.65 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.323 -0.86 . . . . 0.0 110.905 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -64.62 -39.96 94.63 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.455 -0.778 . . . . 0.0 109.762 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -62.33 -25.39 67.86 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.75 -0.594 . . . . 0.0 110.055 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . 0.417 ' CE3' ' HE1' ' A' ' 71' ' ' MET . 2.6 t-105 -59.88 -43.0 94.98 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.524 -0.735 . . . . 0.0 109.925 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.06 -46.92 87.96 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.543 -0.723 . . . . 0.0 110.538 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -60.05 -38.28 82.33 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.421 -0.799 . . . . 0.0 110.381 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 . . . . . 0 N--CA 1.494 1.737 0 O-C-N 121.593 -0.692 . . . . 0.0 110.283 -179.755 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.188 0.518 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -104.01 16.15 26.93 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.476 -0.765 . . . . 0.0 111.059 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -59.94 -40.11 87.83 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.287 -0.883 . . . . 0.0 110.259 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 90.7 mt -111.44 -176.59 2.98 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.451 0.643 . . . . 0.0 110.688 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.45 106.44 5.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.701 -0.625 . . . . 0.0 109.651 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -83.39 -9.92 58.75 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.818 -0.551 . . . . 0.0 111.265 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -70.0 -34.63 73.57 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.184 -0.947 . . . . 0.0 110.123 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -69.85 -22.34 63.27 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.343 0.592 . . . . 0.0 110.278 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.401 HD13 HG23 ' A' ' 9' ' ' ILE . 47.9 mm -57.9 -50.01 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.346 -0.846 . . . . 0.0 110.744 -177.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.16 -22.38 66.92 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.36 -0.838 . . . . 0.0 111.591 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -68.54 -53.62 21.9 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.333 -0.854 . . . . 0.0 109.448 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.408 ' CE1' ' HG2' ' A' ' 72' ' ' MET . 25.6 m-85 -67.9 -21.88 65.11 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.373 0.606 . . . . 0.0 109.44 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -66.99 -41.81 86.11 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.412 0.625 . . . . 0.0 109.951 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.33 -56.98 14.94 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.794 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.68 -33.95 76.11 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.261 -0.899 . . . . 0.0 111.438 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -58.04 -49.99 74.97 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.151 -0.968 . . . . 0.0 110.236 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.2 m -65.51 -38.63 90.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.313 -0.867 . . . . 0.0 108.761 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.4 tp -60.0 -37.63 80.27 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.29 0.567 . . . . 0.0 109.893 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -73.48 -28.64 62.04 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.648 -0.658 . . . . 0.0 110.569 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -96.31 102.03 13.75 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.348 -0.845 . . . . 0.0 109.682 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -67.07 -31.57 72.17 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.435 -0.79 . . . . 0.0 111.446 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -79.85 -9.58 59.68 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.122 -0.986 . . . . 0.0 111.148 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 64.14 24.64 68.97 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -79.77 -9.55 59.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.453 -1.028 . . . . 0.0 110.939 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.01 6.94 88.92 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -178.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 78.0 p -148.22 142.14 25.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.124 -1.221 . . . . 0.0 109.892 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.4 mt -103.49 123.38 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.748 -0.595 . . . . 0.0 110.096 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 65.5 p -98.82 143.84 28.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.862 -0.524 . . . . 0.0 109.716 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.5 p -40.5 -36.6 0.59 Allowed 'General case' 0 N--CA 1.512 2.646 0 O-C-N 121.806 -0.559 . . . . 0.0 112.195 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -63.51 -45.31 91.27 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.209 -0.932 . . . . 0.0 109.527 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -59.95 -52.82 63.75 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.752 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.408 HD22 ' CE2' ' B' ' 170' ' ' TRP . 64.1 tp -59.19 -37.4 77.32 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.131 -0.98 . . . . 0.0 110.846 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.92 -32.28 41.21 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.5 m -70.04 -39.96 75.42 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.603 -0.939 . . . . 0.0 110.483 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.3 t -63.99 -57.19 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.453 -0.779 . . . . 0.0 109.851 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 98.2 mtp -59.21 -28.33 66.56 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.622 -0.674 . . . . 0.0 110.037 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -59.97 -39.58 86.14 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.4 t -66.16 -17.24 64.6 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.849 -0.532 . . . . 0.0 110.861 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.7 tp -85.61 -28.38 24.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.295 -0.878 . . . . 0.0 109.22 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.65 -46.85 0.2 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -160.96 176.36 11.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.772 -0.84 . . . . 0.0 110.253 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -120.01 148.62 47.18 Favored Pre-proline 0 C--N 1.299 -1.602 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.754 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.48 -147.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.318 0 O-C-N 123.626 1.329 . . . . 0.0 109.627 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 57.8 p -136.42 149.4 48.25 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.905 -1.122 . . . . 0.0 111.431 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -52.62 -24.02 7.62 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.706 -0.621 . . . . 0.0 111.57 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.35 -59.5 2.73 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.092 0.949 . . . . 0.0 108.636 177.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -66.75 -37.74 85.22 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.907 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 39.6 mt -58.55 -35.18 71.93 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.774 0.797 . . . . 0.0 109.507 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.4 -39.27 78.04 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.062 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -66.41 -38.02 86.54 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.481 -0.762 . . . . 0.0 110.675 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 73.2 mmm -60.05 -44.67 94.54 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.633 0.73 . . . . 0.0 109.469 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.83 -34.59 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-O 121.173 0.511 . . . . 0.0 110.413 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -60.7 -40.99 94.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.441 -0.787 . . . . 0.0 110.659 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -70.69 -29.43 65.73 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.329 -0.857 . . . . 0.0 110.813 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.8 t -98.23 -8.15 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.68 -0.637 . . . . 0.0 111.862 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -71.98 107.44 4.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.012 -1.055 . . . . 0.0 111.106 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.52 -41.08 85.0 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.542 -0.723 . . . . 0.0 109.715 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -87.85 -29.94 20.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.631 -0.668 . . . . 0.0 110.309 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.08 21.16 46.96 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.609 -0.997 . . . . 0.0 110.609 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -72.22 -37.8 69.12 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.391 -1.064 . . . . 0.0 110.258 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.77 -6.43 5.5 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 120.197 -1.001 . . . . 0.0 111.114 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 81.1 p -135.36 170.08 16.5 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.078 -1.248 . . . . 0.0 110.588 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.0 mt -106.13 123.73 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-O 121.609 0.718 . . . . 0.0 111.204 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -101.68 172.03 7.2 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.701 0.763 . . . . 0.0 111.103 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.471 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -46.8 -49.96 45.76 Favored Pre-proline 0 N--CA 1.499 1.992 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 39.4 Cg_endo -65.73 -36.66 31.41 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 122.889 0.941 . . . . 0.0 111.795 -178.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -70.01 -39.95 75.55 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.24 -0.912 . . . . 0.0 110.455 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -61.55 -40.28 94.15 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.606 -0.683 . . . . 0.0 111.042 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.2 mt -68.87 -40.01 79.51 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.425 -0.797 . . . . 0.0 111.848 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 47.2 p -59.97 -45.68 91.91 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.164 -0.96 . . . . 0.0 111.161 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 56.3 ttp -68.77 -40.0 79.94 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.531 -0.73 . . . . 0.0 111.458 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.408 ' HG2' ' CE1' ' A' ' 12' ' ' PHE . 48.6 tpp -60.12 -49.61 76.96 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.445 -0.785 . . . . 0.0 111.279 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.49 -31.18 66.82 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.523 -0.736 . . . . 0.0 112.174 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -83.38 -50.73 8.04 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.336 -0.853 . . . . 0.0 111.907 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.403 ' CG ' ' CG ' ' B' ' 169' ' ' GLU . 60.1 tptt -66.4 -40.0 89.36 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.564 -0.71 . . . . 0.0 112.192 -178.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 28.1 ptm -55.13 -34.12 63.47 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.254 -0.904 . . . . 0.0 111.756 -177.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -67.88 -39.86 83.63 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.352 -0.843 . . . . 0.0 110.151 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -67.03 -20.05 65.79 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.594 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.1 m -79.56 -174.75 4.43 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.693 -0.629 . . . . 0.0 109.797 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -135.82 131.41 35.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.317 -0.865 . . . . 0.0 109.158 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.1 t -60.5 -34.55 74.23 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.444 -0.785 . . . . 0.0 110.071 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.04 -39.53 86.23 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.768 0.794 . . . . 0.0 109.542 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.97 -40.01 75.63 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.417 0.627 . . . . 0.0 111.075 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -66.28 -35.93 81.65 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.611 -0.68 . . . . 0.0 111.425 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 67.0 mt -67.28 -47.32 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.491 -0.756 . . . . 0.0 110.818 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -59.95 -41.92 92.91 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.329 -0.857 . . . . 0.0 112.104 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -73.95 -39.98 63.36 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.438 -0.788 . . . . 0.0 111.952 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.31 -47.15 80.55 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.389 -0.82 . . . . 0.0 111.378 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -60.06 -45.96 91.14 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.606 0.717 . . . . 0.0 109.862 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -60.01 -34.04 72.81 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.979 -0.45 . . . . 0.0 111.047 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 98.6 t -70.08 -53.51 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.243 -0.91 . . . . 0.0 110.254 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -63.27 -39.46 94.64 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.398 -0.814 . . . . 0.0 110.539 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -77.17 79.06 3.7 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -60.08 -41.0 91.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.407 -0.808 . . . . 0.0 111.034 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -84.11 -23.02 30.9 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.457 -0.777 . . . . 0.0 111.283 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.8 31.92 76.73 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.45 ' ND2' ' CE2' ' A' ' 99' ' ' TYR . 33.4 p-10 -76.09 -12.03 60.04 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.562 -0.963 . . . . 0.0 112.085 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.37 -20.92 10.2 Favored Glycine 0 N--CA 1.497 2.762 0 C-N-CA 119.919 -1.134 . . . . 0.0 110.45 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.45 ' CE2' ' ND2' ' A' ' 97' ' ' ASN . 27.7 p90 -145.25 150.04 35.97 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.224 -1.162 . . . . 0.0 108.783 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.435 ' CG2' ' CD2' ' A' ' 105' ' ' LEU . 20.8 mt -89.29 130.32 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.734 0.778 . . . . 0.0 111.396 -178.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.6 m -87.93 172.95 9.21 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.205 0.526 . . . . 0.0 109.999 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.08 -39.96 82.8 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.643 -0.661 . . . . 0.0 109.248 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.7 -40.04 93.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.804 -0.56 . . . . 0.0 109.835 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -61.96 -39.94 93.87 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.616 -0.678 . . . . 0.0 110.012 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.435 ' CD2' ' CG2' ' A' ' 100' ' ' ILE . 0.6 OUTLIER -63.65 -40.32 96.56 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.74 -0.6 . . . . 0.0 109.597 179.045 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 57.1 mtp85 -61.31 -31.82 71.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.551 -0.718 . . . . 0.0 110.954 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -59.96 -48.6 81.03 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.38 -0.825 . . . . 0.0 111.002 -178.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 85.3 t -69.92 -44.96 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 121.354 -0.841 . . . . 0.0 111.572 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 66.2 mtt -58.61 -46.78 86.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 0.0 111.356 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.0 m -66.09 -47.69 73.38 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.467 -0.771 . . . . 0.0 109.934 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -61.9 -31.5 71.8 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 19.1 mt -69.89 -40.04 75.89 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 120.176 -0.609 . . . . 0.0 110.301 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.22 35.34 1.49 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -133.9 132.29 40.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.557 -0.967 . . . . 0.0 109.86 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -102.82 127.89 49.81 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.52 -0.737 . . . . 0.0 110.787 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 42.6 mt -133.9 157.79 45.1 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.568 -0.708 . . . . 0.0 109.116 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.16 162.13 21.37 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.433 -0.792 . . . . 0.0 109.417 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -60.05 -26.91 66.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.413 -0.805 . . . . 0.0 108.852 178.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -69.38 -35.5 75.88 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -65.23 -39.94 93.4 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.395 0.617 . . . . 0.0 109.622 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.01 -40.0 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.208 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -60.02 -44.04 94.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.703 -0.623 . . . . 0.0 110.005 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -60.03 -41.33 92.0 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.53 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 65.6 mtt -56.56 -37.94 71.25 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 119.6 -0.84 . . . . 0.0 108.781 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 90.7 mt -65.75 -38.76 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 121.705 0.764 . . . . 0.0 109.093 178.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -57.27 -38.47 73.94 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.252 0.548 . . . . 0.0 110.578 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.0 -38.78 83.63 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.701 -0.624 . . . . 0.0 110.544 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.8 0.64 30.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.294 -0.879 . . . . 0.0 111.117 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -87.3 70.5 10.04 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.006 -1.059 . . . . 0.0 110.594 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.0 mt -67.06 -40.02 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.424 -0.797 . . . . 0.0 109.998 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -73.29 -20.22 60.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.565 -0.71 . . . . 0.0 111.151 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.49 23.39 60.59 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 120.215 -0.993 . . . . 0.0 110.83 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -82.17 -10.22 59.24 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.24 -1.153 . . . . 0.0 111.044 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.37 1.7 74.64 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.105 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -138.74 149.24 44.83 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.257 -1.143 . . . . 0.0 109.779 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 87.7 t -92.77 118.01 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.545 -0.722 . . . . 0.0 109.969 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -90.03 175.86 7.01 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.515 -0.741 . . . . 0.0 109.927 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -60.04 -49.01 79.33 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.264 0.554 . . . . 0.0 110.483 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -60.05 -46.07 90.76 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.725 -0.61 . . . . 0.0 111.72 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -63.02 -35.02 78.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.232 -0.918 . . . . 0.0 109.739 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.409 ' CZ ' ' HE1' ' A' ' 145' ' ' MET . 64.6 t80 -60.0 -39.96 87.54 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.258 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 92.1 t -70.02 -40.47 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.517 -0.74 . . . . 0.0 110.964 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -60.25 -41.08 92.44 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.388 -0.82 . . . . 0.0 110.627 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 56.2 ttp -59.96 -40.07 87.76 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.836 -0.54 . . . . 0.0 110.089 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.409 ' HE1' ' CZ ' ' A' ' 141' ' ' PHE . 40.9 mtt -70.02 -39.92 75.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.789 -0.57 . . . . 0.0 110.695 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.4 t -101.38 20.96 14.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.501 -0.749 . . . . 0.0 110.681 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -79.94 129.83 34.8 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.313 -0.867 . . . . 0.0 110.574 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.6 pttm . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.363 -179.988 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.27 -40.03 98.48 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -60.6 -40.0 90.16 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.547 -0.973 . . . . 0.0 110.453 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -66.23 -39.93 89.91 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.447 -0.783 . . . . 0.0 110.649 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -60.59 -46.03 91.77 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.612 -0.68 . . . . 0.0 110.641 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 15.5 tt -70.0 -29.49 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.504 -0.748 . . . . 0.0 111.034 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.17 -44.12 89.52 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.39 -0.819 . . . . 0.0 110.422 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 75.5 mmt-85 -61.44 -40.11 93.25 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.577 -0.702 . . . . 0.0 109.861 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.45 -37.26 86.92 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.67 -0.644 . . . . 0.0 111.076 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 67.7 t -60.03 -40.05 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.386 -0.821 . . . . 0.0 110.058 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.94 -34.89 85.14 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 23.5 t -74.35 -19.97 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.729 -0.866 . . . . 0.0 110.584 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 6.2 tt -59.99 -48.77 80.36 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.107 -0.995 . . . . 0.0 110.386 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 9.6 ptt85 -69.86 -28.62 65.81 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.351 -0.843 . . . . 0.0 109.848 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . 0.403 ' CG ' ' CG ' ' A' ' 75' ' ' LYS . 44.0 tt0 -60.02 -43.84 95.0 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.58 -0.7 . . . . 0.0 110.021 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . 0.408 ' CE2' HD22 ' A' ' 32' ' ' LEU . 7.4 t-105 -60.93 -40.0 91.55 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.754 -0.591 . . . . 0.0 110.065 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.9 -46.65 88.66 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.575 -0.703 . . . . 0.0 110.851 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -59.98 -40.01 87.67 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.315 -0.866 . . . . 0.0 110.769 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.519 -0.738 . . . . 0.0 110.131 -179.568 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 120.882 0.372 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -60.73 -40.06 90.93 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.451 -0.781 . . . . 0.0 110.179 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -122.05 -89.96 0.59 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 122.052 -0.405 . . . . 0.0 110.038 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 92.0 mt -103.69 -78.01 0.56 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 109.714 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.3 p -153.14 107.53 3.12 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.516 -0.74 . . . . 0.0 110.371 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.09 -37.97 75.56 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.625 -0.672 . . . . 0.0 110.091 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -48.51 -60.59 2.57 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.648 -0.658 . . . . 0.0 111.193 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -56.23 -23.79 38.1 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.453 -0.78 . . . . 0.0 112.431 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.5 mm -60.15 -53.31 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 120.988 -1.07 . . . . 0.0 109.873 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -61.08 -27.11 68.12 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.659 -0.651 . . . . 0.0 109.975 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -66.32 -39.96 89.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.457 -0.777 . . . . 0.0 110.037 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -69.7 -25.02 63.67 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.626 -0.671 . . . . 0.0 109.426 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 16.4 ttmt -69.98 -40.03 75.61 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -60.31 -54.1 49.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.956 -0.465 . . . . 0.0 110.783 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.05 -22.18 63.1 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.334 -0.854 . . . . 0.0 111.975 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -58.44 -47.39 84.14 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.088 -1.008 . . . . 0.0 110.243 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.7 m -62.16 -37.73 86.33 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.479 -0.763 . . . . 0.0 109.393 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.5 tp -65.96 -39.93 90.84 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -69.53 -38.12 77.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.962 -0.462 . . . . 0.0 109.869 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -91.77 97.64 11.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.566 -0.709 . . . . 0.0 109.848 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -59.93 -37.55 79.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.324 -0.86 . . . . 0.0 111.119 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -80.02 -10.92 59.81 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.263 -0.898 . . . . 0.0 111.03 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.29 27.66 58.09 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -87.63 -5.77 58.57 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.707 -0.878 . . . . 0.0 110.777 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.1 4.88 59.77 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 120.268 -0.968 . . . . 0.0 111.383 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.2 p -143.93 141.15 30.08 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 119.168 1.484 . . . . 0.0 111.594 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 86.0 mt -101.06 122.08 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.25 0.548 . . . . 0.0 109.528 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.0 m -98.41 137.98 36.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.724 -0.61 . . . . 0.0 109.781 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.7 p -42.65 -28.89 0.26 Allowed 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.707 -0.621 . . . . 0.0 112.179 -178.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.1 tttp -65.97 -50.47 64.22 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.833 0.825 . . . . 0.0 109.691 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -60.2 -56.38 22.32 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.932 -0.48 . . . . 0.0 111.798 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.95 -34.16 74.3 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.29 -0.882 . . . . 0.0 110.49 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.97 -31.56 17.87 Favored Glycine 0 N--CA 1.501 2.982 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.2 m -67.25 -40.13 86.21 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.393 -1.063 . . . . 0.0 109.399 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.5 t -64.38 -39.98 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 121.455 0.645 . . . . 0.0 109.422 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 98.0 mmm -60.06 -38.4 82.72 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.809 -0.557 . . . . 0.0 110.297 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -62.92 -40.05 96.41 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.414 -0.804 . . . . 0.0 110.659 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 t -59.28 -26.86 65.31 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.924 -0.485 . . . . 0.0 110.883 -178.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 36.3 tp -85.56 -24.92 27.04 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.415 -0.803 . . . . 0.0 109.109 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.23 -61.95 0.15 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -162.96 172.04 15.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.587 -0.949 . . . . 0.0 110.931 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -116.41 153.58 48.83 Favored Pre-proline 0 C--N 1.298 -1.664 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.171 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -66.08 -146.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.532 1.28 . . . . 0.0 109.642 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.1 p -125.68 166.79 16.11 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.048 -1.033 . . . . 0.0 110.845 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -59.0 -35.48 73.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.767 -0.583 . . . . 0.0 111.706 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.48 -47.82 45.67 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 122.298 1.047 . . . . 0.0 109.23 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.54 -36.09 80.34 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.302 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.2 mt -58.2 -35.91 72.33 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.757 0.789 . . . . 0.0 109.587 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -66.82 -39.73 87.8 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.17 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -65.56 -39.94 92.26 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.537 -0.727 . . . . 0.0 110.937 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 90.7 mtp -60.17 -47.13 87.24 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.763 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.7 mm -64.92 -35.77 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.806 -0.559 . . . . 0.0 110.311 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -60.26 -44.97 94.82 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.596 -0.69 . . . . 0.0 111.772 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -70.01 -28.39 65.47 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.191 -0.943 . . . . 0.0 111.09 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.44 -8.58 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.587 -0.696 . . . . 0.0 110.599 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -74.35 103.18 4.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.26 -0.9 . . . . 0.0 110.415 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.98 -36.4 75.16 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.617 -0.677 . . . . 0.0 109.693 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -92.35 -26.84 17.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.683 -0.635 . . . . 0.0 110.821 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.57 20.06 52.53 Favored Glycine 0 N--CA 1.496 2.638 0 C-N-CA 120.404 -0.903 . . . . 0.0 110.906 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -74.49 -32.88 62.68 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.37 -1.077 . . . . 0.0 110.254 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.94 1.06 17.12 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.002 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.2 p -137.66 169.84 17.09 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.125 -1.22 . . . . 0.0 110.488 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.3 mt -105.78 120.57 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.505 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -98.17 169.91 9.26 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.528 0.68 . . . . 0.0 110.582 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.407 ' HB3' ' HD3' ' A' ' 66' ' ' PRO . 8.1 t80 -47.86 -48.75 60.86 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' A' ' 65' ' ' PHE . 45.9 Cg_endo -71.83 -32.68 11.14 Favored 'Trans proline' 0 N--CA 1.487 1.089 0 O-C-N 122.711 0.848 . . . . 0.0 111.376 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -72.13 -39.98 68.41 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.261 -0.9 . . . . 0.0 110.268 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -63.21 -41.64 99.17 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.471 -0.768 . . . . 0.0 111.204 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.2 mt -69.59 -39.99 76.95 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.534 -0.729 . . . . 0.0 112.048 -178.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.5 p -60.02 -47.87 84.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.334 -0.854 . . . . 0.0 111.191 -178.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 8.6 tmm? -68.56 -38.89 81.13 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.6 -0.687 . . . . 0.0 111.682 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 57.6 tpp -59.99 -50.03 75.35 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.374 -0.828 . . . . 0.0 112.217 -178.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.98 -25.04 63.43 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.183 -0.948 . . . . 0.0 112.082 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.2 -57.81 3.63 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.404 -0.81 . . . . 0.0 112.978 -178.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -69.64 -40.05 76.75 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -177.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 22.0 mtm -53.87 -39.91 66.12 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.057 -1.027 . . . . 0.0 111.946 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.0 tttt -59.99 -49.05 79.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.283 -0.885 . . . . 0.0 110.664 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -63.21 -27.37 69.31 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.817 0.818 . . . . 0.0 109.866 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . 0.255 7.0 m -70.09 -173.42 0.66 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.807 -0.558 . . . . 0.0 109.918 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -129.24 139.72 51.73 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.153 -0.967 . . . . 0.0 109.547 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.1 t -70.02 -27.46 64.69 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.581 -0.699 . . . . 0.0 111.046 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.03 -36.26 76.89 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.481 -0.762 . . . . 0.0 109.838 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -70.06 -39.93 75.37 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.342 0.592 . . . . 0.0 110.361 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -61.64 -39.57 91.79 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.571 -0.705 . . . . 0.0 111.274 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 89.2 mt -67.12 -44.3 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.52 -0.738 . . . . 0.0 110.803 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -59.81 -40.14 87.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.527 -0.733 . . . . 0.0 111.783 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -76.04 -39.85 54.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.364 -0.835 . . . . 0.0 112.262 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.52 -46.7 81.79 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.271 -0.893 . . . . 0.0 111.317 -178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -61.75 -44.14 97.48 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.509 -0.744 . . . . 0.0 109.834 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.04 -36.9 78.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.746 -0.596 . . . . 0.0 110.939 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 95.1 t -69.82 -48.51 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.484 -0.76 . . . . 0.0 110.161 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -68.03 -39.6 83.06 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.471 -0.768 . . . . 0.0 111.013 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -80.45 71.98 7.31 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.382 -0.824 . . . . 0.0 110.126 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -60.06 -47.5 85.61 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.374 -0.828 . . . . 0.0 110.335 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -70.63 -24.36 62.71 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.539 -0.726 . . . . 0.0 110.929 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.67 21.97 77.94 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -67.12 -15.7 63.87 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.239 -1.154 . . . . 0.0 111.258 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.58 -13.06 54.16 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 81.5 m-85 -133.15 141.31 48.06 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.163 -1.198 . . . . 0.0 109.224 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 62.7 mt -89.15 121.15 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.111 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 m -84.92 168.87 14.62 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.217 0.532 . . . . 0.0 109.869 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.97 -37.12 75.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.6 -0.688 . . . . 0.0 109.211 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.92 -36.41 83.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.796 -0.565 . . . . 0.0 109.799 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -67.22 -40.12 86.34 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.524 -0.735 . . . . 0.0 110.645 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.42 -42.4 96.06 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.505 0.669 . . . . 0.0 110.051 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -62.93 -39.5 94.78 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.788 -0.57 . . . . 0.0 111.535 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -60.41 -48.61 81.0 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.216 -0.928 . . . . 0.0 112.161 -177.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 93.8 t -71.49 -50.37 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.136 -0.977 . . . . 0.0 111.452 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 73.9 mtp -55.42 -40.38 71.4 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.266 -0.896 . . . . 0.0 110.231 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.2 m -66.59 -45.4 79.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.482 -0.761 . . . . 0.0 109.077 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -66.72 -25.04 66.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.814 -0.554 . . . . 0.0 109.85 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.9 mt -69.06 -26.61 65.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.583 -0.698 . . . . 0.0 110.227 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.6 11.73 5.89 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -127.76 131.41 49.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.172 -1.193 . . . . 0.0 109.952 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -105.0 126.01 51.6 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.608 -0.683 . . . . 0.0 110.232 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.0 mt -130.02 160.88 32.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.698 -0.626 . . . . 0.0 110.44 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.32 163.1 23.15 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -60.26 -31.44 70.22 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -67.15 -33.07 74.65 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.389 0.614 . . . . 0.0 109.667 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -67.79 -36.15 79.93 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 69.1 t -70.06 -40.01 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.913 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -60.03 -45.79 91.66 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.665 -0.647 . . . . 0.0 110.071 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -60.0 -41.4 91.99 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.599 -0.688 . . . . 0.0 109.641 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 98.0 mtp -54.46 -37.08 64.78 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.012 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 93.0 mt -66.58 -37.48 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 50.2 ttt85 -58.13 -40.0 80.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.472 -0.768 . . . . 0.0 111.118 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -60.0 -39.12 84.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.582 -0.699 . . . . 0.0 111.039 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.88 -10.92 19.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.397 -0.815 . . . . 0.0 111.522 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -89.48 74.04 7.76 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.003 -1.06 . . . . 0.0 110.994 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 84.7 mt -66.49 -39.96 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.663 -0.648 . . . . 0.0 109.474 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -59.23 -39.58 83.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.656 -0.653 . . . . 0.0 110.89 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.33 15.17 42.09 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.146 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -81.95 -10.05 59.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.02 -1.282 . . . . 0.0 110.546 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.12 2.54 85.76 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.491 -0.756 . . . . 0.0 111.537 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -130.94 131.32 44.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.24 -1.153 . . . . 0.0 109.611 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.7 t -90.88 111.62 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.452 -0.78 . . . . 0.0 110.037 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -89.03 -168.88 2.32 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 121.742 -0.599 . . . . 0.0 110.276 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -69.65 -40.08 76.7 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.8 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -60.0 -46.36 89.74 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.299 -0.876 . . . . 0.0 111.454 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -65.94 -38.15 87.88 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.817 0.818 . . . . 0.0 110.339 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -59.73 -45.67 91.48 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.865 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 62.5 t -78.1 -40.05 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.232 -0.917 . . . . 0.0 112.577 -178.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -60.0 -51.68 68.63 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.976 -1.077 . . . . 0.0 111.693 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.404 ' HE3' ' CD1' ' B' ' 157' ' ' PHE . 59.4 ttp -60.53 -36.07 77.53 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.369 -0.832 . . . . 0.0 110.413 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 95.9 mtp -69.96 -40.03 75.64 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.799 -0.563 . . . . 0.0 110.673 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 39.7 m -97.5 15.82 22.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.486 -0.759 . . . . 0.0 111.086 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.06 -42.3 94.21 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.179 -0.951 . . . . 0.0 110.432 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 86.2 mttt . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.144 179.684 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.31 142.14 13.02 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.404 ' CD1' ' HE3' ' A' ' 144' ' ' MET . 45.8 t80 -60.02 -43.43 95.26 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.49 -1.006 . . . . 0.0 110.236 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -60.03 -39.59 86.41 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.658 -0.651 . . . . 0.0 110.51 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -59.92 -40.07 87.63 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.434 -0.791 . . . . 0.0 110.665 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . 0.423 HD12 HG22 ' B' ' 160' ' ' ILE . 95.8 mt -67.74 -39.62 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.408 -0.807 . . . . 0.0 110.121 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.27 91.68 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.552 -0.717 . . . . 0.0 111.634 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -60.09 -40.04 88.23 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.106 -0.997 . . . . 0.0 110.747 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 9.6 tt -60.61 -40.11 90.64 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.433 -0.792 . . . . 0.0 109.95 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 89.2 t -62.71 -39.95 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.594 -0.691 . . . . 0.0 109.688 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.99 -36.64 90.91 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 94.9 t -60.07 -31.54 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.769 -0.842 . . . . 0.0 110.581 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 84.5 mt -60.03 -41.14 91.6 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.452 -0.78 . . . . 0.0 111.015 -178.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -61.03 -40.02 92.01 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.254 -0.904 . . . . 0.0 109.864 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -62.23 -40.56 96.54 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.658 -0.651 . . . . 0.0 110.86 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -60.08 -41.06 91.65 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.397 -0.814 . . . . 0.0 111.032 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.53 -41.24 76.24 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.414 -0.804 . . . . 0.0 110.855 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -60.01 -39.95 87.56 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.521 -0.737 . . . . 0.0 110.602 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 . . . . . 0 N--CA 1.496 1.87 0 O-C-N 121.392 -0.817 . . . . 0.0 110.301 -179.796 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.255 0.55 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 52.31 38.48 25.02 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.467 -0.771 . . . . 0.0 110.747 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -64.64 -41.18 96.31 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.684 0.754 . . . . 0.0 110.018 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.5 mt -114.28 -89.54 0.54 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 122.003 -0.436 . . . . 0.0 110.295 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.42 11.68 2.99 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.009 -1.057 . . . . 0.0 111.606 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -55.5 -15.33 2.66 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.159 -0.963 . . . . 0.0 112.245 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -64.26 -42.02 96.67 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.897 -1.127 . . . . 0.0 110.329 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -65.87 -39.28 90.56 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.442 -0.786 . . . . 0.0 110.846 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.7 mt -59.93 -31.15 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.659 -0.651 . . . . 0.0 111.911 -178.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.95 -39.77 86.72 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.927 -1.108 . . . . 0.0 109.95 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -59.32 -41.46 89.13 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.268 0.556 . . . . 0.0 109.963 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -65.09 -21.51 66.82 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.613 -0.679 . . . . 0.0 111.111 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -70.03 -41.15 74.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.116 -0.99 . . . . 0.0 108.878 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.93 -51.78 68.24 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.013 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.06 -20.47 63.23 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.185 -0.947 . . . . 0.0 112.008 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.503 ' CD1' ' CZ ' ' A' ' 65' ' ' PHE . 60.2 t80 -58.05 -50.04 74.81 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.03 -1.044 . . . . 0.0 111.222 -177.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 97.6 p -66.76 -39.36 87.84 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.5 tp -60.08 -40.0 88.04 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.258 0.551 . . . . 0.0 109.816 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -77.44 -31.74 54.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.683 -0.635 . . . . 0.0 110.311 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -92.09 102.11 14.64 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.418 -0.801 . . . . 0.0 109.522 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -60.0 -39.64 86.46 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.609 -0.682 . . . . 0.0 112.308 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -80.08 -11.66 59.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.087 -1.008 . . . . 0.0 111.335 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.18 28.62 50.15 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -88.28 -5.6 58.26 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.637 -0.919 . . . . 0.0 110.788 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.53 1.39 57.77 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.938 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 54.3 p -144.2 141.81 30.13 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 119.116 1.458 . . . . 0.0 111.368 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 84.8 mt -101.08 123.77 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.79 -0.569 . . . . 0.0 109.611 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 34.4 p -99.96 140.0 34.81 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.539 -0.726 . . . . 0.0 110.046 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.6 p -43.19 -29.22 0.36 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.726 -0.609 . . . . 0.0 112.092 -178.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.11 -50.55 65.65 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.429 -0.794 . . . . 0.0 109.511 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -59.61 -53.82 53.59 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 121.253 0.549 . . . . 0.0 110.894 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.6 tt -60.02 -35.32 74.82 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.449 -0.782 . . . . 0.0 111.451 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.07 -30.82 17.39 Favored Glycine 0 N--CA 1.498 2.822 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.5 m -70.03 -39.98 75.44 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.564 -0.963 . . . . 0.0 110.503 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.27 -54.26 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.457 -0.777 . . . . 0.0 109.456 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 95.8 mtp -59.92 -31.34 69.75 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.614 -0.679 . . . . 0.0 110.012 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -61.55 -40.47 94.81 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.681 0.753 . . . . 0.0 109.102 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.8 p -70.06 -20.22 63.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.787 -0.57 . . . . 0.0 110.405 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.1 mt -88.61 -17.0 31.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.484 -0.76 . . . . 0.0 110.41 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.22 -62.87 0.15 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -156.45 169.47 24.56 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.281 -1.129 . . . . 0.0 111.468 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -104.7 129.53 24.78 Favored Pre-proline 0 N--CA 1.49 1.573 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.844 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -67.3 -150.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.228 0 O-C-N 123.132 1.069 . . . . 0.0 109.487 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.5 p -135.62 151.71 50.51 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.159 -0.963 . . . . 0.0 110.598 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -51.44 -24.75 5.31 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.779 -0.575 . . . . 0.0 111.805 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.05 -59.8 2.58 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 122.171 0.986 . . . . 0.0 108.776 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -66.86 -36.97 83.53 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.829 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.6 mt -58.12 -34.81 70.63 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.434 -0.791 . . . . 0.0 109.173 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.27 -40.02 96.22 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 120.484 -0.487 . . . . 0.0 110.43 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -64.58 -40.01 94.77 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.606 -0.684 . . . . 0.0 110.569 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 89.3 mtp -59.95 -44.57 94.33 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.463 0.649 . . . . 0.0 109.718 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.7 mm -65.87 -37.8 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.902 -0.499 . . . . 0.0 110.671 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -60.05 -39.95 87.74 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.437 -0.789 . . . . 0.0 111.523 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -68.88 -28.64 66.87 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.203 -0.935 . . . . 0.0 110.486 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.9 t -99.46 -9.94 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.64 -0.662 . . . . 0.0 111.183 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -70.74 95.56 1.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.143 -0.973 . . . . 0.0 111.265 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.56 -34.08 71.83 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.739 -0.601 . . . . 0.0 109.618 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.2 p-10 -95.43 -23.66 17.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.706 -0.621 . . . . 0.0 110.66 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.61 19.14 55.31 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.135 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.3 p-10 -75.63 -25.34 56.8 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.33 -1.1 . . . . 0.0 110.655 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 108.44 4.28 32.67 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.227 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 67.2 p -134.0 170.12 16.11 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.165 -1.197 . . . . 0.0 110.89 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.4 mt -101.83 119.99 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.909 -0.494 . . . . 0.0 110.434 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -102.51 168.17 9.47 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.59 0.71 . . . . 0.0 111.147 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.503 ' CZ ' ' CD1' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -43.13 -52.34 12.26 Favored Pre-proline 0 N--CA 1.504 2.269 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.2 Cg_endo -71.34 -30.27 15.79 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.042 1.022 . . . . 0.0 111.944 -178.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.25 -40.51 70.96 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.167 -0.958 . . . . 0.0 110.001 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -63.18 -42.38 99.37 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.655 -0.653 . . . . 0.0 110.968 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.4 mt -65.93 -41.75 90.97 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.523 -0.735 . . . . 0.0 111.152 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.3 p -63.53 -40.89 98.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.473 -0.767 . . . . 0.0 111.61 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 53.9 ttp -68.1 -40.04 82.7 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.442 -0.786 . . . . 0.0 110.674 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 7.5 mmt -61.86 -43.16 99.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.731 -0.606 . . . . 0.0 111.251 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.94 -30.55 67.96 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.59 -0.693 . . . . 0.0 110.523 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -70.22 -40.04 74.76 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.633 -0.667 . . . . 0.0 110.469 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -67.05 -55.44 14.33 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.532 -0.73 . . . . 0.0 111.898 -178.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 78.6 mtm -59.94 -32.53 70.88 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.457 -0.777 . . . . 0.0 110.973 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.9 tttt -66.38 -62.32 1.53 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.681 -0.637 . . . . 0.0 112.15 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -70.73 -10.06 58.62 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.47 -0.769 . . . . 0.0 112.046 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.5 t -101.07 -160.05 0.77 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.897 0.856 . . . . 0.0 112.035 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -129.98 139.49 51.06 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.358 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.0 t -63.36 -33.86 76.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.726 -0.609 . . . . 0.0 109.983 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.02 -33.23 71.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.692 -0.63 . . . . 0.0 109.662 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.34 -39.99 77.82 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.519 0.676 . . . . 0.0 109.639 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -63.06 -36.13 82.56 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.787 -0.57 . . . . 0.0 110.29 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.18 -44.38 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.741 -0.599 . . . . 0.0 109.977 179.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -59.39 -43.58 92.92 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.638 -0.664 . . . . 0.0 111.162 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -70.03 -40.08 75.4 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.588 -0.695 . . . . 0.0 111.729 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.6 -46.96 77.37 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.505 -0.747 . . . . 0.0 111.337 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.403 ' CE1' ' OD2' ' A' ' 93' ' ' ASP . 60.2 t80 -62.9 -42.84 99.92 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.524 -0.735 . . . . 0.0 109.861 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -59.95 -34.84 73.8 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.906 -0.496 . . . . 0.0 110.368 -179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 77.7 t -69.9 -50.1 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.502 -0.749 . . . . 0.0 109.774 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -69.94 -41.16 74.94 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.475 -0.765 . . . . 0.0 111.022 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.403 ' OD2' ' CE1' ' A' ' 89' ' ' PHE . 33.2 t0 -81.1 75.18 8.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.404 -0.81 . . . . 0.0 109.946 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -70.02 -40.01 75.48 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.425 -0.797 . . . . 0.0 110.258 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 37.5 p-10 -75.7 -26.43 57.55 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.787 -0.571 . . . . 0.0 110.92 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.85 26.22 69.75 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -69.12 -14.86 63.24 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.365 -1.079 . . . . 0.0 111.476 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.73 -17.95 17.55 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.411 ' CD2' ' HB3' ' A' ' 135' ' ' GLN . 31.5 p90 -148.19 158.94 44.37 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.194 -1.18 . . . . 0.0 109.06 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 40.5 mt -88.9 124.24 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.322 -0.861 . . . . 0.0 110.099 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 m -82.67 172.29 13.09 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.669 0.747 . . . . 0.0 111.305 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.74 -47.37 83.85 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.81 -0.557 . . . . 0.0 110.098 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.45 -36.68 81.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.699 -0.626 . . . . 0.0 109.643 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -61.34 -40.13 93.11 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.601 -0.687 . . . . 0.0 110.39 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.73 -44.3 90.64 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.442 -0.786 . . . . 0.0 109.992 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -61.2 -37.37 82.75 Favored 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 34.7 t60 -60.0 -48.48 81.55 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.202 -0.936 . . . . 0.0 110.852 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.4 t -70.04 -39.22 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.513 -0.742 . . . . 0.0 111.568 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 12.9 mmt -59.06 -51.01 71.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.298 -0.876 . . . . 0.0 110.762 -178.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.5 m -66.88 -40.74 87.89 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.468 -0.77 . . . . 0.0 109.857 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -61.23 -31.36 71.15 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 13.8 mt -69.16 -29.55 67.58 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.194 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.93 27.45 5.13 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -119.22 139.91 51.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.512 -0.993 . . . . 0.0 110.011 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -101.67 115.21 30.03 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.503 -0.748 . . . . 0.0 109.523 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 50.0 mt -132.83 153.69 51.04 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.459 -0.775 . . . . 0.0 109.949 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.97 164.96 19.02 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -62.1 -26.69 68.44 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.446 -0.784 . . . . 0.0 109.377 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.17 -35.44 76.3 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.639 0.733 . . . . 0.0 109.189 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -65.03 -37.78 88.73 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.382 0.61 . . . . 0.0 109.474 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 79.6 t -69.86 -39.14 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.564 0.697 . . . . 0.0 109.718 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -60.0 -40.04 87.85 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.777 -0.577 . . . . 0.0 109.832 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -59.96 -40.68 89.87 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.278 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 66.5 mtt -56.15 -37.02 68.95 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.394 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.01 -40.01 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.595 -0.691 . . . . 0.0 110.322 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 40.2 mtm-85 -59.99 -41.56 92.32 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.578 -0.701 . . . . 0.0 112.463 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.99 -39.97 87.56 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.705 -0.622 . . . . 0.0 111.329 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -98.33 -16.55 19.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.29 -0.881 . . . . 0.0 111.084 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -78.48 72.65 5.02 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.13 -0.981 . . . . 0.0 110.12 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 86.3 mt -65.06 -45.72 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.661 -0.649 . . . . 0.0 110.92 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -63.37 -40.06 96.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.358 -0.839 . . . . 0.0 111.175 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.56 20.64 9.94 Favored Glycine 0 N--CA 1.497 2.719 0 C-N-CA 120.058 -1.068 . . . . 0.0 111.198 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -82.16 -9.94 59.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.22 -1.165 . . . . 0.0 110.828 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.14 2.44 80.5 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.411 ' HB3' ' CD2' ' A' ' 99' ' ' TYR . 27.7 mt-30 -135.62 144.9 46.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.382 -1.069 . . . . 0.0 109.079 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.7 t -93.08 118.98 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.403 -0.811 . . . . 0.0 110.296 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -87.58 -179.51 6.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.557 -0.714 . . . . 0.0 109.374 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -69.46 -40.57 77.07 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.943 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -62.78 -44.05 97.2 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.548 -0.72 . . . . 0.0 110.784 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -65.78 -38.64 89.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.461 -0.774 . . . . 0.0 109.932 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -60.01 -44.11 94.78 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.083 0.468 . . . . 0.0 110.839 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 76.6 t -68.67 -39.96 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.485 -0.759 . . . . 0.0 110.726 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -60.24 -42.47 95.34 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.437 -0.79 . . . . 0.0 110.586 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.5 mmm -60.74 -40.02 90.83 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.633 -0.667 . . . . 0.0 110.631 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 95.2 mmm -70.07 -39.98 75.31 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.547 -0.721 . . . . 0.0 110.294 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.4 m -96.87 18.96 13.42 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.54 -0.725 . . . . 0.0 110.65 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.58 142.86 53.48 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.313 -0.867 . . . . 0.0 110.609 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.8 mttt . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.252 179.511 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -66.03 138.85 37.5 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -59.96 -42.79 94.86 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.614 -0.933 . . . . 0.0 110.351 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -60.04 -33.81 72.54 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.565 -0.71 . . . . 0.0 110.552 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -60.05 -42.69 95.04 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.746 -0.596 . . . . 0.0 111.013 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.05 -40.02 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.567 -0.708 . . . . 0.0 110.681 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.04 87.97 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.576 -0.703 . . . . 0.0 111.118 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -69.04 -39.99 78.84 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.401 -0.812 . . . . 0.0 110.926 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 9.8 tt -61.04 -45.86 93.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.601 -0.687 . . . . 0.0 110.824 -179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 10.2 p -69.96 -29.99 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.388 -0.82 . . . . 0.0 110.699 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.14 -40.94 97.87 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 87.5 t -79.99 -26.05 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.82 -0.812 . . . . 0.0 110.134 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 4.3 tt -54.43 -59.92 4.04 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.478 -0.764 . . . . 0.0 111.814 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -66.78 -35.15 79.4 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.379 -0.826 . . . . 0.0 111.934 -178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -59.96 -38.72 83.3 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.263 -0.898 . . . . 0.0 109.842 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -60.01 -39.98 87.65 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.81 -0.556 . . . . 0.0 110.283 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.62 -35.81 75.1 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.4 -0.812 . . . . 0.0 110.198 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -59.89 -36.38 76.81 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.501 -0.749 . . . . 0.0 110.052 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 . . . . . 0 N--CA 1.493 1.719 0 O-C-N 121.546 -0.721 . . . . 0.0 110.235 179.947 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.194 0.521 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -69.94 -40.04 75.7 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.626 -0.671 . . . . 0.0 110.751 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.06 -40.02 94.11 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.573 0.701 . . . . 0.0 110.313 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 76.0 mt -101.75 176.47 5.21 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.259 0.552 . . . . 0.0 109.917 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.52 110.35 4.94 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.383 0.611 . . . . 0.0 109.591 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -75.49 -17.93 59.97 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.854 -0.529 . . . . 0.0 110.593 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -62.76 -27.19 69.12 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.36 -0.838 . . . . 0.0 111.178 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -70.93 -23.19 62.2 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.169 -0.957 . . . . 0.0 110.323 177.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.5 mm -59.97 -49.75 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.444 -0.785 . . . . 0.0 111.075 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.41 -24.15 67.24 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.486 -0.758 . . . . 0.0 111.602 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -66.54 -44.95 81.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.289 -0.882 . . . . 0.0 109.943 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -69.88 -24.13 63.36 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.541 0.686 . . . . 0.0 109.598 178.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -69.94 -40.07 75.72 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.452 0.644 . . . . 0.0 109.968 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.96 -52.19 66.44 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.737 -0.602 . . . . 0.0 111.735 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.99 -21.57 63.21 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.173 -0.954 . . . . 0.0 111.709 -178.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -59.41 -47.06 86.9 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.206 -0.934 . . . . 0.0 110.513 -178.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -62.07 -37.29 84.44 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.294 -0.879 . . . . 0.0 109.201 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.1 -39.48 94.83 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -69.97 -39.24 76.11 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.176 0.512 . . . . 0.0 110.027 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -97.86 98.65 10.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.67 -0.644 . . . . 0.0 109.825 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -69.22 -29.2 67.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.463 -0.773 . . . . 0.0 110.547 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -82.07 -10.05 59.34 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.369 -0.832 . . . . 0.0 111.611 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.64 25.07 66.89 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -178.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -78.6 -11.24 59.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.472 -1.016 . . . . 0.0 110.824 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.59 3.95 83.44 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.8 p -145.92 140.72 27.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.028 -1.277 . . . . 0.0 110.283 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.4 mt -101.52 122.73 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.751 -0.593 . . . . 0.0 109.549 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.2 m -97.92 141.16 31.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.75 -0.594 . . . . 0.0 109.992 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 27.7 p -39.07 -34.98 0.19 Allowed 'General case' 0 N--CA 1.51 2.546 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -66.71 -44.89 80.44 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.441 -0.787 . . . . 0.0 109.314 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -61.45 -58.26 8.88 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.946 -0.471 . . . . 0.0 111.339 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.43 HD23 ' CE2' ' B' ' 170' ' ' TRP . 54.6 tp -59.99 -36.04 76.32 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.273 -0.892 . . . . 0.0 111.061 -178.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.01 -29.99 15.48 Favored Glycine 0 N--CA 1.5 2.908 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.4 m -69.95 -39.98 75.74 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.634 -0.921 . . . . 0.0 110.453 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.1 t -63.54 -51.19 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 CA-C-O 121.621 0.724 . . . . 0.0 109.112 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 87.3 mtp -60.05 -33.04 71.49 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.277 0.56 . . . . 0.0 109.835 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -60.92 -42.46 98.17 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.411 0.624 . . . . 0.0 109.896 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.0 t -70.03 -16.38 63.15 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.637 -0.665 . . . . 0.0 110.415 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.4 tp -84.66 -24.42 29.02 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.355 -0.841 . . . . 0.0 109.383 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.42 -51.42 0.18 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.781 -1.727 . . . . 0.0 108.781 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -163.1 172.96 14.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.633 -0.922 . . . . 0.0 110.612 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -120.33 143.98 37.09 Favored Pre-proline 0 C--N 1.299 -1.62 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.057 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.69 -150.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 123.394 1.208 . . . . 0.0 109.881 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.89 161.54 36.35 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.082 -1.011 . . . . 0.0 110.098 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -52.23 -27.36 14.5 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.699 -0.626 . . . . 0.0 111.524 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.94 -58.31 3.55 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 122.078 0.942 . . . . 0.0 109.171 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.73 -39.62 91.32 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.086 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 13.1 mt -56.56 -33.75 66.45 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.48 -0.762 . . . . 0.0 110.111 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.9 -36.65 82.77 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.386 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -68.33 -41.89 80.14 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.573 -0.705 . . . . 0.0 111.233 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 64.4 mtt -61.92 -43.28 99.16 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.534 -0.729 . . . . 0.0 109.724 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.2 mm -66.74 -35.58 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.842 -0.536 . . . . 0.0 110.241 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -61.53 -40.96 96.51 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.616 -0.677 . . . . 0.0 111.918 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -69.97 -29.6 66.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.184 -0.948 . . . . 0.0 111.002 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.7 t -100.03 -8.8 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.51 -0.744 . . . . 0.0 111.397 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.48 100.29 1.38 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.09 -1.007 . . . . 0.0 111.241 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.13 -33.89 72.4 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.661 -0.649 . . . . 0.0 109.933 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -98.36 -21.97 16.33 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.609 -0.682 . . . . 0.0 110.879 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.34 19.7 61.88 Favored Glycine 0 N--CA 1.495 2.632 0 C-N-CA 120.402 -0.904 . . . . 0.0 110.956 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -74.48 -37.54 63.16 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.372 -1.075 . . . . 0.0 110.173 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.33 2.52 6.97 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.306 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 62.8 p -138.5 170.18 16.47 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.033 -1.275 . . . . 0.0 111.355 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.9 mt -102.37 120.93 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.168 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -100.75 170.03 8.61 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.458 0.647 . . . . 0.0 110.251 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.449 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 5.6 t80 -48.22 -48.88 64.06 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.561 -0.712 . . . . 0.0 112.651 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.9 Cg_endo -68.45 -35.86 16.87 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 O-C-N 122.75 0.868 . . . . 0.0 111.916 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.98 -40.03 75.6 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.092 -1.005 . . . . 0.0 110.467 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -61.46 -42.02 98.12 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.643 -0.661 . . . . 0.0 110.549 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.51 -41.95 96.1 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.394 -0.816 . . . . 0.0 111.695 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 72.0 p -62.36 -40.48 96.54 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.288 -0.882 . . . . 0.0 111.493 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.437 ' CE ' ' CZ3' ' B' ' 170' ' ' TRP . 59.3 ttp -69.74 -40.38 76.2 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.481 -0.762 . . . . 0.0 111.439 -178.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 88.8 mmm -60.77 -49.08 78.93 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.483 -0.761 . . . . 0.0 110.95 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.24 -31.99 73.43 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.785 -0.572 . . . . 0.0 111.291 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -70.04 -39.76 75.55 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.545 -0.722 . . . . 0.0 111.649 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -69.12 -31.59 70.38 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.274 -0.891 . . . . 0.0 112.569 -178.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 63.2 mtt -59.54 -48.2 82.59 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.173 -0.955 . . . . 0.0 112.395 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -69.06 -38.38 79.05 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.238 -0.914 . . . . 0.0 112.032 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -69.99 -20.06 63.31 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.33 -0.856 . . . . 0.0 111.197 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.2 t -112.22 -164.45 0.92 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.957 0.884 . . . . 0.0 111.709 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -130.27 147.0 51.94 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.899 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.6 p -67.09 -26.93 66.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.591 -0.693 . . . . 0.0 110.601 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.31 -35.39 77.23 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.566 0.698 . . . . 0.0 109.505 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.97 -39.99 83.22 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.563 0.697 . . . . 0.0 109.87 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -62.32 -38.66 90.31 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.793 -0.567 . . . . 0.0 111.456 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 67.7 mt -68.11 -45.3 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.405 -0.809 . . . . 0.0 110.672 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 64.1 mtp180 -58.09 -41.49 83.61 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.231 -0.918 . . . . 0.0 110.811 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.407 ' CG ' ' HD3' ' B' ' 168' ' ' ARG . 98.5 mt-10 -70.03 -39.98 75.44 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.663 -0.648 . . . . 0.0 111.484 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.38 -47.98 77.19 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.469 -0.769 . . . . 0.0 111.536 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -60.27 -42.15 94.81 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.408 -0.808 . . . . 0.0 109.992 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -60.07 -37.61 80.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.905 -0.497 . . . . 0.0 110.62 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.5 t -69.9 -55.59 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.317 -0.864 . . . . 0.0 110.521 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -60.6 -39.98 90.11 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.312 -0.868 . . . . 0.0 110.978 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -80.51 78.04 7.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.587 -0.696 . . . . 0.0 110.315 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -67.0 -41.43 86.75 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.385 -0.822 . . . . 0.0 109.904 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.6 p-10 -76.15 -21.32 56.71 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.626 -0.671 . . . . 0.0 111.212 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.22 24.45 74.77 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -70.02 -10.94 60.35 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.412 -1.052 . . . . 0.0 111.368 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.19 -15.62 58.93 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.418 ' CZ ' ' ND2' ' A' ' 137' ' ' ASN . 73.3 m-85 -133.55 141.02 47.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.246 -1.15 . . . . 0.0 109.331 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 77.8 mt -89.06 122.15 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.395 -0.816 . . . . 0.0 109.72 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.4 m -83.49 170.01 14.88 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.334 0.588 . . . . 0.0 110.819 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.05 -39.99 94.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.8 -0.562 . . . . 0.0 109.807 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.7 -31.55 72.76 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.57 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -69.92 -40.01 75.82 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.767 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.58 -47.02 87.4 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.289 -0.882 . . . . 0.0 109.328 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -64.14 -30.36 71.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.929 -0.482 . . . . 0.0 111.102 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -61.96 -49.02 77.79 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.375 -0.828 . . . . 0.0 111.806 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 72.6 t -70.03 -47.18 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.328 -0.858 . . . . 0.0 111.299 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 98.9 mtp -59.61 -39.99 86.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.318 -0.864 . . . . 0.0 110.489 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.2 m -64.5 -46.2 84.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.453 -0.779 . . . . 0.0 109.107 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -62.46 -32.73 73.66 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.7 mt -69.97 -33.69 72.42 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.341 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.43 34.49 1.43 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -125.08 136.69 53.91 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.524 -0.986 . . . . 0.0 110.078 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -101.91 130.54 48.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.509 -0.744 . . . . 0.0 109.639 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -148.3 152.22 36.73 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.673 -0.642 . . . . 0.0 110.848 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.1 p -80.94 162.02 24.07 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -61.42 -27.78 68.79 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -67.8 -34.94 77.76 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.822 0.82 . . . . 0.0 109.193 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -62.52 -40.09 95.63 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 75.5 t -66.22 -40.06 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.097 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -60.02 -45.95 91.11 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.648 -0.658 . . . . 0.0 110.558 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -59.97 -40.61 89.69 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.904 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 86.2 mmm -54.63 -38.14 66.47 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.029 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.23 -38.69 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.692 -0.63 . . . . 0.0 110.15 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -58.36 -39.99 81.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.552 -0.718 . . . . 0.0 111.959 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.11 -40.06 88.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.469 -0.77 . . . . 0.0 112.172 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -108.44 -5.62 16.55 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.189 -0.944 . . . . 0.0 112.317 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -90.29 73.06 7.11 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.889 -1.132 . . . . 0.0 111.06 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 86.5 mt -68.28 -40.05 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.49 -0.756 . . . . 0.0 110.116 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 36.5 p-10 -60.0 -39.94 87.5 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.528 -0.732 . . . . 0.0 111.043 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 92.38 24.92 22.84 Favored Glycine 0 N--CA 1.493 2.437 0 O-C-N 121.25 -0.907 . . . . 0.0 111.057 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -82.45 -8.02 59.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -1.178 . . . . 0.0 110.544 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 97.16 -1.5 60.81 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -140.84 159.65 41.76 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.16 -1.2 . . . . 0.0 109.722 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 94.3 t -87.89 118.24 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.394 -0.816 . . . . 0.0 109.078 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.418 ' ND2' ' CZ ' ' A' ' 99' ' ' TYR . 8.6 t-20 -87.36 170.03 11.75 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.997 0.903 . . . . 0.0 110.994 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -63.57 -50.01 71.16 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.278 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -62.35 -41.1 98.32 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.38 -0.825 . . . . 0.0 110.539 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.25 -37.27 85.1 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.13 0.967 . . . . 0.0 109.268 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -59.94 -41.9 92.86 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.008 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.8 t -74.2 -42.16 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.284 -0.885 . . . . 0.0 111.956 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -59.98 -50.37 74.01 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.41 -0.806 . . . . 0.0 112.157 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.408 ' HE1' ' CD1' ' B' ' 157' ' ' PHE . 55.1 ttp -61.37 -35.72 78.25 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.366 -0.834 . . . . 0.0 110.871 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 89.2 mtp -69.96 -39.91 75.72 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.792 -0.567 . . . . 0.0 110.244 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.3 m -98.97 22.45 10.24 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.579 -0.7 . . . . 0.0 110.459 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.38 -40.55 85.71 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.366 -0.834 . . . . 0.0 111.399 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 29.9 mttt . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.525 -179.102 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 70.07 32.16 69.41 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.408 ' CD1' ' HE1' ' A' ' 144' ' ' MET . 37.9 t80 -60.04 -41.89 93.25 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.55 -0.97 . . . . 0.0 110.111 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -60.77 -40.13 91.37 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.664 -0.647 . . . . 0.0 110.984 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 43.1 mtm-85 -65.73 -39.99 91.73 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.355 -0.841 . . . . 0.0 111.158 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 93.5 mt -65.25 -40.03 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.394 -0.816 . . . . 0.0 110.231 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.55 -40.74 97.78 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.562 -0.711 . . . . 0.0 110.127 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 -62.21 -40.48 96.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.728 -0.607 . . . . 0.0 110.557 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 85.8 mt -64.86 -40.07 94.57 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.495 -0.753 . . . . 0.0 110.562 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 94.2 t -63.78 -40.11 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.552 -0.718 . . . . 0.0 110.023 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.03 -31.39 61.54 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 67.2 t -79.94 -28.95 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.722 -0.87 . . . . 0.0 111.363 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 79.0 mt -60.09 -49.95 75.63 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.195 -0.941 . . . . 0.0 111.707 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 168' ' ' ARG . . . . . 0.407 ' HD3' ' CG ' ' A' ' 87' ' ' GLU . 38.0 ttt-85 -66.4 -40.06 89.41 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.127 -0.983 . . . . 0.0 110.445 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -60.04 -29.88 68.81 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.571 -0.706 . . . . 0.0 110.627 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . 0.437 ' CZ3' ' CE ' ' A' ' 71' ' ' MET . 4.5 t-105 -60.17 -39.47 86.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.489 -0.757 . . . . 0.0 110.176 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.23 -39.97 76.59 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.491 -0.755 . . . . 0.0 111.046 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -60.03 -39.97 87.69 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.345 -0.847 . . . . 0.0 110.372 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 . . . . . 0 N--CA 1.494 1.741 0 O-C-N 121.496 -0.752 . . . . 0.0 109.986 179.905 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 120.997 0.427 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -89.96 85.36 6.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.597 -0.689 . . . . 0.0 109.794 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -59.93 -39.45 85.55 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.787 0.803 . . . . 0.0 109.9 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 90.3 mt -59.97 -40.04 87.74 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.059 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 p -136.62 105.39 5.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 110.202 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -81.82 -15.34 54.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.92 -0.488 . . . . 0.0 110.69 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -52.85 -43.27 65.94 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.086 -1.009 . . . . 0.0 110.503 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -70.05 -21.08 63.2 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.606 -0.683 . . . . 0.0 111.975 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.7 mm -61.42 -50.87 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.308 -0.87 . . . . 0.0 110.374 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.43 -35.86 78.73 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.771 -0.581 . . . . 0.0 110.941 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.94 -45.46 92.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.61 -0.681 . . . . 0.0 110.362 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.459 ' CE1' ' HG2' ' A' ' 72' ' ' MET . 24.7 m-85 -64.68 -22.84 67.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.619 -0.676 . . . . 0.0 111.234 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -68.63 -41.62 79.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.272 -0.892 . . . . 0.0 108.721 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -59.99 -52.54 64.95 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.618 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.25 -23.43 64.78 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.318 -0.864 . . . . 0.0 111.657 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -56.1 -47.67 77.63 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.978 -1.076 . . . . 0.0 109.991 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.3 m -60.75 -39.29 88.16 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.503 -0.748 . . . . 0.0 109.403 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 64.2 tp -63.8 -39.95 95.48 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.92 -39.57 76.08 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -95.19 97.3 9.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.631 -0.668 . . . . 0.0 110.036 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.8 mttt -64.37 -32.01 73.45 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.367 -0.833 . . . . 0.0 111.598 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -80.57 -10.02 59.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.209 -0.932 . . . . 0.0 111.506 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.23 25.08 46.81 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -87.23 -9.66 54.51 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.586 -0.949 . . . . 0.0 110.666 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.64 2.81 53.04 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.868 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.5 p -144.61 141.95 29.78 Favored 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 119.534 1.667 . . . . 0.0 112.1 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.3 mm -99.93 121.04 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.5 p -100.91 142.08 32.88 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.576 -0.703 . . . . 0.0 111.019 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.4 HG23 ' CD1' ' A' ' 52' ' ' ILE . 82.1 p -41.76 -33.14 0.46 Allowed 'General case' 0 N--CA 1.509 2.518 0 O-C-N 121.856 -0.528 . . . . 0.0 111.892 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -64.71 -51.06 64.43 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.797 0.808 . . . . 0.0 109.525 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -59.95 -54.75 42.41 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.577 -178.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.431 HD22 ' CE2' ' B' ' 170' ' ' TRP . 58.8 tp -60.04 -35.32 74.85 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.203 -0.936 . . . . 0.0 110.696 -178.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.05 -30.45 16.56 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.8 m -70.03 -39.97 75.44 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.569 -0.959 . . . . 0.0 110.363 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 79.0 t -64.89 -51.07 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.628 -0.67 . . . . 0.0 109.746 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 98.1 mtp -59.97 -33.03 71.39 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.741 -0.6 . . . . 0.0 109.521 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -61.57 -41.87 98.02 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.696 0.76 . . . . 0.0 109.084 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.9 t -72.02 -19.47 61.85 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.962 -0.461 . . . . 0.0 110.81 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.7 -16.99 29.18 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.272 -0.893 . . . . 0.0 110.504 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.16 -55.62 0.18 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -159.97 169.92 22.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.411 -1.053 . . . . 0.0 110.804 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -107.82 125.88 31.12 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.892 -0.505 . . . . 0.0 110.151 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.07 -148.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.07 0 N-CA-C 108.649 -1.327 . . . . 0.0 108.649 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 50.2 p -137.45 150.36 47.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.929 -1.107 . . . . 0.0 110.837 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -53.15 -23.65 8.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.636 -0.665 . . . . 0.0 111.467 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.49 -60.05 2.42 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.89 0.852 . . . . 0.0 109.128 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -67.71 -37.67 82.57 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.054 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.6 mt -57.1 -33.23 67.1 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.495 -0.753 . . . . 0.0 110.02 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -35.52 80.45 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.956 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -65.68 -39.96 91.85 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.45 -0.781 . . . . 0.0 110.832 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 67.2 mtt -60.02 -45.45 92.74 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.433 0.635 . . . . 0.0 109.93 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.4 ' CD1' HG23 ' A' ' 29' ' ' THR . 96.8 mt -67.95 -33.07 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.824 -0.547 . . . . 0.0 110.729 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -60.06 -40.05 88.12 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.327 -0.858 . . . . 0.0 110.115 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -67.11 -26.47 66.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.377 -0.827 . . . . 0.0 109.959 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 74.3 t -99.81 -9.99 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.598 -0.689 . . . . 0.0 110.864 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -72.27 99.71 2.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.118 -0.989 . . . . 0.0 111.126 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.54 -40.06 92.46 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.388 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -88.32 -28.34 21.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.714 -0.616 . . . . 0.0 110.563 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.02 22.95 43.16 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -74.22 -33.79 63.49 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.499 -1.001 . . . . 0.0 110.617 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.97 -0.43 10.81 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.294 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.0 p -132.67 170.08 15.74 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.017 -1.284 . . . . 0.0 110.391 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.6 mt -106.67 120.4 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.87 -0.519 . . . . 0.0 110.869 -177.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -100.68 169.44 9.03 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.572 0.701 . . . . 0.0 110.906 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.448 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -45.05 -52.73 18.68 Favored Pre-proline 0 N--CA 1.502 2.168 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.069 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.2 Cg_endo -67.39 -30.93 35.81 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 O-C-N 122.943 0.97 . . . . 0.0 111.514 -178.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -72.1 -40.91 67.85 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.448 -0.782 . . . . 0.0 110.425 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -66.08 -40.16 90.61 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.683 -0.636 . . . . 0.0 111.177 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.7 mt -66.23 -39.93 89.9 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.373 -0.83 . . . . 0.0 111.569 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 21.6 p -64.19 -41.39 97.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.555 -0.716 . . . . 0.0 111.333 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 58.9 ttp -68.07 -40.2 82.77 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.438 -0.788 . . . . 0.0 110.894 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.459 ' HG2' ' CE1' ' A' ' 12' ' ' PHE . 53.6 tpp -59.99 -45.11 93.79 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.493 -0.755 . . . . 0.0 110.462 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.8 -30.8 70.32 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.506 -0.746 . . . . 0.0 109.725 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.02 -39.67 75.65 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.706 -0.621 . . . . 0.0 111.059 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -65.79 -36.57 83.88 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.412 -0.805 . . . . 0.0 112.203 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 60.7 mtt -59.73 -50.09 75.18 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.214 -0.929 . . . . 0.0 111.684 -177.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -70.05 -38.96 75.96 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.308 -0.87 . . . . 0.0 110.835 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -68.66 -40.02 80.38 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.448 -0.782 . . . . 0.0 109.978 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.4 m -100.43 -172.59 2.23 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.985 -0.447 . . . . 0.0 110.196 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -129.53 147.22 51.31 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.42 -0.8 . . . . 0.0 109.904 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.4 t -59.95 -27.81 67.12 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.546 -0.721 . . . . 0.0 110.401 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.01 -36.72 77.85 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.368 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.98 -39.94 75.64 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.378 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.08 -37.47 75.45 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.694 -0.629 . . . . 0.0 110.558 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 67.7 mt -65.57 -53.83 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.635 -0.666 . . . . 0.0 111.028 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.403 ' HG3' ' N ' ' A' ' 87' ' ' GLU . 33.6 ptt180 -60.03 -39.97 87.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.383 -0.823 . . . . 0.0 111.392 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.403 ' N ' ' HG3' ' A' ' 86' ' ' ARG . 95.3 mt-10 -68.58 -40.76 80.38 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.506 -0.746 . . . . 0.0 110.742 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.19 -44.24 89.03 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.956 -0.465 . . . . 0.0 110.898 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -61.15 -41.28 96.47 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.879 0.847 . . . . 0.0 108.814 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -59.98 -38.14 81.69 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.821 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.3 -43.2 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.506 -0.746 . . . . 0.0 110.027 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -69.37 -39.1 78.25 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.497 -0.752 . . . . 0.0 111.451 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -79.55 77.23 6.15 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.32 -0.862 . . . . 0.0 110.508 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -59.98 -42.34 93.98 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.395 -0.816 . . . . 0.0 110.216 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 24.1 p-10 -81.92 -19.94 39.74 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.496 -0.752 . . . . 0.0 111.258 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.79 63.83 4.92 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -109.91 -10.77 14.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.457 -1.025 . . . . 0.0 111.52 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.25 -23.31 8.14 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 31.0 p90 -149.08 152.91 37.01 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.327 -1.102 . . . . 0.0 109.549 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 56.0 mt -89.34 125.2 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.742 0.782 . . . . 0.0 109.96 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 m -80.99 171.29 15.18 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.141 0.496 . . . . 0.0 110.31 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.04 -40.59 96.63 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.622 -0.674 . . . . 0.0 109.498 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.03 -38.48 91.24 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.496 0.665 . . . . 0.0 109.314 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -62.43 -39.43 93.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.741 -0.6 . . . . 0.0 111.285 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.4 tt -62.53 -43.74 98.06 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.133 -0.979 . . . . 0.0 109.468 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -60.05 -33.34 71.91 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.686 -0.634 . . . . 0.0 110.901 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -60.37 -45.37 93.76 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.159 -0.963 . . . . 0.0 111.614 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.9 t -72.92 -39.86 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.299 -0.876 . . . . 0.0 111.256 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 26.8 mmt -59.86 -48.65 80.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.46 -0.775 . . . . 0.0 110.293 -178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.1 m -67.26 -41.71 85.09 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.496 -0.752 . . . . 0.0 109.848 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -61.13 -31.46 71.17 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.3 mt -69.03 -32.79 72.55 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.713 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.61 29.14 4.83 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -121.43 130.03 53.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.581 -0.952 . . . . 0.0 109.734 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -92.43 117.64 30.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.532 -0.73 . . . . 0.0 110.132 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 60.8 mt -132.71 157.24 45.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.617 -0.677 . . . . 0.0 109.812 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 p -83.74 162.99 20.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.587 -0.696 . . . . 0.0 109.663 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.9 p-10 -60.06 -25.16 65.16 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -66.61 -34.63 78.32 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.42 -38.98 91.78 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.541 0.686 . . . . 0.0 109.233 179.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 74.9 t -68.88 -39.05 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.359 0.6 . . . . 0.0 110.124 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -59.28 -49.93 75.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.768 -0.582 . . . . 0.0 110.341 -178.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -60.27 -41.45 93.29 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.399 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 97.6 mtp -54.81 -39.7 68.75 Favored 'General case' 0 N--CA 1.504 2.24 0 C-N-CA 119.389 -0.924 . . . . 0.0 108.838 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 89.4 mt -63.75 -40.0 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.162 0.506 . . . . 0.0 109.963 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -60.0 -39.97 87.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.483 -0.76 . . . . 0.0 112.182 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -60.06 -39.94 87.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.116 -0.99 . . . . 0.0 111.773 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -99.05 -17.48 18.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.205 -0.934 . . . . 0.0 110.987 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.4 77.86 5.76 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.178 -0.951 . . . . 0.0 110.816 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 82.9 mt -64.14 -39.98 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.66 -0.65 . . . . 0.0 111.079 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -59.51 -38.53 81.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.403 -0.81 . . . . 0.0 111.12 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 98.59 11.93 45.98 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 120.115 -1.04 . . . . 0.0 111.417 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -81.31 -13.66 58.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.023 -1.281 . . . . 0.0 110.56 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.95 5.55 70.69 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.793 178.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -127.68 126.48 42.01 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.032 -1.275 . . . . 0.0 109.924 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.7 t -89.96 113.99 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.252 -0.905 . . . . 0.0 109.71 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -89.97 -179.38 5.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.507 -0.746 . . . . 0.0 109.884 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -62.24 -41.8 98.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.718 -0.614 . . . . 0.0 110.422 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -62.56 -44.85 95.32 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.199 -0.938 . . . . 0.0 111.463 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -63.44 -38.96 93.15 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.978 0.894 . . . . 0.0 109.454 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -59.87 -41.88 92.48 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.578 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.2 t -68.06 -40.11 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.493 -0.754 . . . . 0.0 110.945 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -60.78 -40.39 92.41 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.373 -0.829 . . . . 0.0 110.056 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 53.9 ttp -60.05 -41.2 91.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.779 -0.576 . . . . 0.0 110.752 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 44.3 mtt -82.06 -39.18 23.82 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.535 -0.728 . . . . 0.0 110.999 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 85.4 m -59.98 -26.81 66.33 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.695 -0.628 . . . . 0.0 110.459 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -80.78 119.12 22.95 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.434 -0.791 . . . . 0.0 110.601 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.7 mttm . . . . . 0 N--CA 1.5 2.026 0 CA-C-O 118.407 -0.806 . . . . 0.0 111.47 179.798 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 72.86 39.17 55.54 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -59.97 -47.47 85.66 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.451 -1.029 . . . . 0.0 109.464 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -60.73 -39.06 87.26 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.855 -0.528 . . . . 0.0 110.351 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -60.0 -40.0 87.72 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.522 -0.736 . . . . 0.0 109.853 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 86.7 mt -68.34 -39.99 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.681 -0.637 . . . . 0.0 110.369 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.04 -38.89 84.07 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.46 -0.775 . . . . 0.0 110.65 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 32.7 ttm-85 -60.04 -40.95 91.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.433 -0.792 . . . . 0.0 109.962 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 39.2 tp -64.24 -39.9 94.92 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.772 -0.58 . . . . 0.0 110.077 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 80.2 t -62.47 -39.94 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.517 -0.74 . . . . 0.0 110.347 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.52 -36.9 87.03 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 73.3 t -68.21 -39.19 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.913 -0.757 . . . . 0.0 110.457 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.97 -46.41 89.52 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.522 -0.736 . . . . 0.0 111.635 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -59.98 -40.0 87.64 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.27 -0.894 . . . . 0.0 110.269 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -60.09 -39.86 87.6 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.55 -0.719 . . . . 0.0 110.396 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . 0.431 ' CE2' HD22 ' A' ' 32' ' ' LEU . 5.0 t-105 -60.02 -45.64 92.14 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.695 -0.628 . . . . 0.0 110.404 -179.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.55 -40.63 97.45 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.519 -0.738 . . . . 0.0 110.152 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -59.98 -40.07 87.85 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.579 -0.7 . . . . 0.0 109.977 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.697 -0.627 . . . . 0.0 110.174 179.784 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.006 0.431 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -94.18 115.96 28.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.456 -0.777 . . . . 0.0 109.86 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -114.4 155.54 26.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.654 -0.654 . . . . 0.0 110.238 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.2 mt -95.19 -178.84 4.59 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.62 -0.675 . . . . 0.0 110.453 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.1 p -127.07 104.35 7.94 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.669 0.747 . . . . 0.0 110.335 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -81.84 -7.52 59.61 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.898 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -70.07 -39.97 75.33 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.276 -0.89 . . . . 0.0 110.244 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -69.9 -34.81 74.0 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.44 0.638 . . . . 0.0 110.875 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.6 mt -60.06 -38.85 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.65 -0.656 . . . . 0.0 111.971 -178.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.87 -29.19 70.02 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.97 -1.081 . . . . 0.0 111.051 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.85 -40.48 97.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.291 -0.881 . . . . 0.0 109.865 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.448 ' CG ' ' CD2' ' A' ' 69' ' ' LEU . 77.5 m-85 -64.98 -22.22 66.97 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.816 -0.553 . . . . 0.0 111.438 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.408 ' HE2' ' CZ ' ' A' ' 65' ' ' PHE . 28.3 mmtp -65.31 -39.97 93.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.34 -0.85 . . . . 0.0 110.075 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -62.63 -58.5 7.3 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.705 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.03 -36.07 76.47 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.387 -0.821 . . . . 0.0 112.15 -178.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -54.95 -49.73 70.63 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.072 -1.017 . . . . 0.0 110.561 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.6 t -60.77 -35.43 76.4 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.519 -0.738 . . . . 0.0 110.06 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.83 -39.97 91.35 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -71.95 -40.62 68.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.909 -0.495 . . . . 0.0 110.668 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -94.19 95.21 8.81 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.363 -0.836 . . . . 0.0 110.82 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -66.76 -33.14 74.96 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.298 -0.876 . . . . 0.0 111.309 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -78.7 -10.91 59.93 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.116 -0.99 . . . . 0.0 111.281 -177.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.42 25.28 66.72 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 58.2 p-10 -89.5 -3.28 58.42 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.456 -1.026 . . . . 0.0 110.808 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.93 8.22 76.37 Favored Glycine 0 N--CA 1.489 2.232 0 O-C-N 121.217 -0.927 . . . . 0.0 111.271 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.9 p -145.73 143.06 29.51 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 119.335 1.568 . . . . 0.0 112.109 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.0 mt -101.21 121.84 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.69 -0.631 . . . . 0.0 109.411 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.6 p -99.15 143.45 29.41 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.49 -0.757 . . . . 0.0 110.607 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 80.6 p -41.88 -36.92 1.16 Allowed 'General case' 0 N--CA 1.507 2.401 0 O-C-N 121.983 -0.448 . . . . 0.0 112.2 -178.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -62.47 -47.86 82.14 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.112 -0.992 . . . . 0.0 109.346 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -60.04 -54.97 39.7 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.49 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 44.4 tp -59.98 -36.99 78.34 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.253 -0.904 . . . . 0.0 111.55 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.54 -31.39 14.46 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.5 m -70.92 -39.62 72.58 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.401 -1.058 . . . . 0.0 110.172 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.3 t -64.79 -54.1 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.517 -0.739 . . . . 0.0 110.06 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 92.6 mtp -60.03 -34.94 74.06 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.59 0.71 . . . . 0.0 110.064 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -60.05 -49.54 77.24 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.651 0.739 . . . . 0.0 110.007 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.9 t -69.96 -16.69 63.24 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.838 -0.539 . . . . 0.0 110.791 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 84.3 mt -87.9 -24.41 23.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.474 -0.766 . . . . 0.0 110.45 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.41 -38.43 0.22 Allowed Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.528 -1.32 . . . . 0.0 111.401 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -152.78 155.53 37.34 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 118.814 1.307 . . . . 0.0 112.196 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -116.97 99.96 53.16 Favored Pre-proline 0 N--CA 1.489 1.517 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.677 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -64.18 -148.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.282 0 O-C-N 123.246 1.129 . . . . 0.0 109.56 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.7 p -139.94 156.5 46.63 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.93 -1.106 . . . . 0.0 111.689 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -54.02 -20.58 6.58 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.801 -0.562 . . . . 0.0 111.602 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.94 -59.99 2.46 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.937 0.875 . . . . 0.0 108.942 177.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -68.73 -33.75 74.44 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.044 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 44.2 mt -58.8 -34.85 71.96 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.608 -0.683 . . . . 0.0 110.33 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.33 -32.12 69.71 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.535 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -70.08 -43.09 71.83 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.356 -0.84 . . . . 0.0 111.313 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 77.7 mtm -60.95 -41.85 97.12 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.632 0.73 . . . . 0.0 109.463 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.0 mt -69.82 -31.93 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.908 -0.495 . . . . 0.0 110.026 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -59.96 -41.53 92.11 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.593 -0.692 . . . . 0.0 110.821 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -67.99 -25.61 65.49 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.323 -0.861 . . . . 0.0 110.292 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.3 t -99.09 -9.46 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.607 -0.683 . . . . 0.0 111.116 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -71.96 106.53 4.29 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.123 -0.986 . . . . 0.0 111.68 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.92 -40.07 75.76 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.458 -0.776 . . . . 0.0 109.726 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -88.62 -29.74 19.74 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.635 -0.665 . . . . 0.0 110.266 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.92 24.61 44.4 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -74.3 -31.82 62.64 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.536 -0.979 . . . . 0.0 110.467 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 123.0 -3.91 9.78 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 120.361 -0.923 . . . . 0.0 111.033 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 82.0 p -133.43 170.01 16.12 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.065 -1.256 . . . . 0.0 110.364 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.1 mt -102.79 120.48 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.05 -178.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -98.38 169.51 9.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.523 -0.736 . . . . 0.0 110.617 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.452 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 25.7 t80 -49.01 -48.76 71.9 Favored Pre-proline 0 N--CA 1.497 1.915 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.7 Cg_endo -68.11 -33.54 24.87 Favored 'Trans proline' 0 N--CA 1.486 1.084 0 O-C-N 122.639 0.81 . . . . 0.0 110.863 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -71.13 -39.98 71.69 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.328 -0.857 . . . . 0.0 110.061 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -60.78 -49.96 75.4 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.522 -0.736 . . . . 0.0 110.893 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.448 ' CD2' ' CG ' ' A' ' 12' ' ' PHE . 85.2 mt -60.33 -41.89 94.49 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.509 -0.744 . . . . 0.0 111.515 -178.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 45.9 p -63.66 -37.17 86.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.44 -0.788 . . . . 0.0 111.395 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.8 ttt -65.76 -44.36 86.09 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.299 -0.876 . . . . 0.0 111.54 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 91.2 mtp -71.04 -60.08 2.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.346 -0.846 . . . . 0.0 112.146 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.74 -40.79 76.39 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.47 -0.768 . . . . 0.0 111.314 -178.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.8 tpt85 -70.0 -40.2 75.42 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.526 -0.734 . . . . 0.0 111.157 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -86.2 -39.1 16.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.397 -0.815 . . . . 0.0 111.986 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 43.9 mtm -60.02 -39.95 87.62 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.254 -0.904 . . . . 0.0 111.661 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -62.21 -44.27 96.96 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.189 -0.944 . . . . 0.0 109.66 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -74.74 -10.02 59.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.93 -0.481 . . . . 0.0 110.566 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.433 ' CG2' ' N ' ' A' ' 80' ' ' ASP . 0.6 OUTLIER -85.5 -162.5 0.73 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.252 -0.905 . . . . 0.0 111.328 -179.047 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.433 ' N ' ' CG2' ' A' ' 79' ' ' THR . 68.6 m-20 -130.06 135.43 48.23 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.804 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.0 t -69.97 -27.19 64.52 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.614 -0.678 . . . . 0.0 110.638 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -60.04 -36.62 77.68 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.556 -0.715 . . . . 0.0 110.023 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.98 -40.02 75.6 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.722 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -63.21 -40.05 96.37 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.475 -0.766 . . . . 0.0 110.729 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 85.8 mt -66.03 -46.89 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.673 -0.642 . . . . 0.0 110.148 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 -56.57 -40.42 75.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.532 -0.73 . . . . 0.0 110.903 -178.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -69.94 -40.05 75.73 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.421 -0.8 . . . . 0.0 111.721 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.1 -48.86 72.17 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.358 -0.839 . . . . 0.0 111.996 -178.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -61.23 -43.68 98.48 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.464 -0.772 . . . . 0.0 109.984 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -59.98 -38.41 82.46 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.874 -0.516 . . . . 0.0 110.997 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.0 t -69.82 -48.76 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.473 -0.767 . . . . 0.0 110.446 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -67.98 -40.06 83.19 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.47 -0.769 . . . . 0.0 111.01 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -74.96 69.93 1.94 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.528 -0.733 . . . . 0.0 110.337 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.7 tttp -59.95 -46.6 88.89 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.426 -0.796 . . . . 0.0 109.84 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.1 p-10 -73.9 -18.83 60.86 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.603 -0.685 . . . . 0.0 111.382 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.94 62.4 6.35 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.438 ' ND2' ' CE2' ' A' ' 99' ' ' TYR . 37.6 p-10 -109.23 -7.46 15.27 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.516 -0.991 . . . . 0.0 111.82 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.55 -22.6 11.76 Favored Glycine 0 N--CA 1.498 2.817 0 C-N-CA 119.989 -1.1 . . . . 0.0 110.439 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.438 ' CE2' ' ND2' ' A' ' 97' ' ' ASN . 35.5 p90 -143.77 154.55 43.56 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.392 -1.064 . . . . 0.0 109.635 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 81.9 mt -91.32 129.42 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 121.839 0.828 . . . . 0.0 110.126 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.03 172.36 9.6 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.211 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.26 -40.98 86.26 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.579 -0.701 . . . . 0.0 109.665 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.54 -37.75 88.51 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -61.16 -37.35 82.58 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.974 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.58 -42.73 95.42 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.682 0.753 . . . . 0.0 109.552 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -60.04 -38.53 83.02 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.883 -0.511 . . . . 0.0 111.556 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -59.97 -41.06 91.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.084 -1.01 . . . . 0.0 111.856 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 84.5 t -72.9 -50.13 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.239 -0.913 . . . . 0.0 111.594 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 41.8 mtt -59.07 -41.52 88.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.175 -0.953 . . . . 0.0 110.403 -178.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.7 m -64.37 -46.62 82.59 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.49 -0.756 . . . . 0.0 109.126 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -61.35 -33.57 73.85 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.2 mt -69.84 -30.51 68.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.95 -0.469 . . . . 0.0 109.999 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.16 31.62 3.03 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -122.19 137.0 54.98 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.539 -0.977 . . . . 0.0 110.028 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -109.52 124.87 51.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.532 -0.73 . . . . 0.0 110.212 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 73.0 mt -138.98 159.75 41.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.565 -0.709 . . . . 0.0 109.647 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.18 162.01 26.04 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -59.61 -29.55 68.07 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.355 -0.841 . . . . 0.0 109.084 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -68.44 -32.63 72.78 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.424 0.63 . . . . 0.0 109.61 178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -67.83 -37.97 82.61 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.522 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 97.5 t -69.74 -40.09 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.699 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -59.9 -42.03 92.92 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.295 0.569 . . . . 0.0 109.996 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -60.04 -41.4 92.2 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.026 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 6.3 mmt -54.64 -36.37 64.48 Favored 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.385 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.5 mm -68.47 -37.6 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.308 0.575 . . . . 0.0 109.826 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 46.6 ttt-85 -60.0 -40.08 87.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.574 -0.704 . . . . 0.0 111.239 -178.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -61.83 -39.46 91.89 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.648 -0.657 . . . . 0.0 111.222 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -99.34 -0.25 41.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.347 -0.846 . . . . 0.0 111.763 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -104.48 80.53 1.69 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.979 -1.076 . . . . 0.0 110.947 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.4 mt -67.84 -39.95 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.648 -0.658 . . . . 0.0 109.965 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 36.5 p-10 -60.02 -39.72 86.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.587 -0.696 . . . . 0.0 110.755 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.77 17.9 36.75 Favored Glycine 0 N--CA 1.497 2.727 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.385 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -81.0 -10.11 59.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.108 -1.231 . . . . 0.0 110.608 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.13 2.29 71.39 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.367 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -136.77 139.18 41.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.167 -1.196 . . . . 0.0 110.276 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 98.1 t -95.81 113.81 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.566 -0.709 . . . . 0.0 109.713 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 41.6 p30 -86.12 -166.95 1.68 Allowed 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.609 -0.682 . . . . 0.0 110.241 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -70.08 -43.72 70.56 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.842 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -61.3 -49.96 74.93 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.264 -0.897 . . . . 0.0 112.115 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.3 -37.63 88.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.503 -0.748 . . . . 0.0 110.499 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -60.09 -47.3 86.45 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.667 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 87.0 t -64.66 -39.96 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.485 -0.76 . . . . 0.0 110.695 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -59.98 -49.64 76.87 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.563 -0.711 . . . . 0.0 111.033 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.448 ' CE ' ' CD1' ' B' ' 157' ' ' PHE . 10.9 tmm? -60.66 -40.01 90.48 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.279 -0.888 . . . . 0.0 110.128 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 94.9 mmm -67.24 -38.78 85.77 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.749 -0.595 . . . . 0.0 109.944 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 91.6 m -58.85 -29.03 66.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.69 -0.631 . . . . 0.0 109.973 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.99 141.86 47.74 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.6 -0.688 . . . . 0.0 110.432 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 95.7 mttt . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.325 179.916 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -66.54 152.74 52.41 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . 0.448 ' CD1' ' CE ' ' A' ' 144' ' ' MET . 22.6 t80 -61.51 -42.2 98.44 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.488 -1.007 . . . . 0.0 110.332 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 63.0 mtt85 -60.02 -40.06 88.01 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.558 -0.714 . . . . 0.0 110.397 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -62.61 -39.92 95.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.494 -0.754 . . . . 0.0 110.364 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 73.0 mt -61.23 -45.09 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.516 -0.74 . . . . 0.0 110.041 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.9 -28.64 69.09 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.518 -0.739 . . . . 0.0 110.146 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -60.15 -39.92 88.03 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.572 -0.705 . . . . 0.0 109.503 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 89.0 mt -60.04 -40.08 88.14 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.724 -0.61 . . . . 0.0 110.413 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 94.0 t -65.22 -39.95 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.496 -0.753 . . . . 0.0 109.9 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -54.81 -37.15 61.17 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 85.0 t -60.0 -33.32 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.657 -0.907 . . . . 0.0 109.627 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 8.1 tt -56.24 -37.74 70.15 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.622 -0.674 . . . . 0.0 110.777 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -59.99 -39.99 87.65 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.416 -0.803 . . . . 0.0 110.224 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -63.76 -40.01 95.67 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.447 -0.783 . . . . 0.0 110.989 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -20.9 59.46 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.415 -0.803 . . . . 0.0 110.869 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.98 -32.31 70.46 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.268 -0.895 . . . . 0.0 110.965 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -59.98 -38.73 83.39 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.355 -0.841 . . . . 0.0 109.865 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 71.4 mtp85 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.734 -0.604 . . . . 0.0 110.318 179.99 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.301 0.572 . . . . 0.0 110.067 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 72.1 mt -57.88 -29.02 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.776 -0.577 . . . . 0.0 110.737 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.22 -39.13 89.09 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.233 -0.917 . . . . 0.0 110.194 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -59.98 -43.47 95.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.718 -0.614 . . . . 0.0 110.397 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.584 ' HB3' HD21 ' A' ' 69' ' ' LEU . 77.2 m-85 -64.8 -20.77 66.56 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.844 -0.535 . . . . 0.0 111.395 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -69.96 -42.3 73.36 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.068 -1.02 . . . . 0.0 109.107 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -70.0 -26.65 64.17 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.119 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.15 -27.43 32.73 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.335 -0.853 . . . . 0.0 111.147 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.454 ' CB ' ' CE1' ' A' ' 65' ' ' PHE . 47.9 t80 -59.66 -41.32 90.31 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.576 -0.703 . . . . 0.0 111.673 -177.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.0 m -61.28 -38.36 86.5 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.233 -0.917 . . . . 0.0 109.974 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.7 tp -60.05 -41.21 91.84 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.816 -0.553 . . . . 0.0 110.0 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -74.22 -34.76 63.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.583 -0.698 . . . . 0.0 110.467 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -92.97 95.44 9.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.447 -0.783 . . . . 0.0 109.655 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -59.98 -32.1 70.51 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.426 -0.796 . . . . 0.0 111.155 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -79.44 -8.03 58.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.102 -0.999 . . . . 0.0 110.754 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.21 26.83 29.92 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -90.4 -4.82 56.78 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.686 -0.89 . . . . 0.0 111.326 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.97 2.41 58.26 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.634 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.0 p -146.71 144.18 29.25 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.353 1.576 . . . . 0.0 111.727 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 84.0 mt -107.72 133.14 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.71 -0.619 . . . . 0.0 109.97 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.2 p -111.04 145.84 37.78 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.552 -0.717 . . . . 0.0 110.626 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.442 ' CG2' HD12 ' A' ' 52' ' ' ILE . 53.6 p -43.81 -32.98 1.18 Allowed 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.667 -0.646 . . . . 0.0 111.858 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.06 -50.59 65.58 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.753 0.787 . . . . 0.0 109.533 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -59.99 -53.63 55.56 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.65 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.559 HD13 ' CZ2' ' B' ' 170' ' ' TRP . 9.0 tt -60.02 -32.38 70.84 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.359 -0.838 . . . . 0.0 110.479 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.19 -31.34 33.8 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.314 -1.115 . . . . 0.0 110.314 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 93.7 m -63.83 -39.97 95.49 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.591 -0.946 . . . . 0.0 109.09 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.401 ' CG1' HD22 ' B' ' 167' ' ' LEU . 78.0 t -66.61 -39.98 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 96.8 mmm -59.97 -39.99 87.57 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.684 -0.635 . . . . 0.0 110.877 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.46 ' CG ' ' HB2' ' A' ' 42' ' ' ASN . 55.6 mtm180 -61.85 -42.62 99.26 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.152 -0.967 . . . . 0.0 109.552 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.3 t -63.72 -25.96 68.44 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.083 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.641 HD21 ' HD2' ' B' ' 168' ' ' ARG . 24.0 tp -85.77 -23.17 27.38 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.416 -0.803 . . . . 0.0 109.366 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.93 -58.77 0.17 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -160.56 176.26 11.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.544 -0.974 . . . . 0.0 111.415 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.46 ' HB2' ' CG ' ' A' ' 37' ' ' ARG . 38.9 t30 -99.61 131.84 24.1 Favored Pre-proline 0 N--CA 1.492 1.664 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.208 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -68.75 -147.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.111 0 N-CA-C 108.435 -1.41 . . . . 0.0 108.435 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.1 p -129.59 141.55 50.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.827 -1.171 . . . . 0.0 110.481 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -51.48 -25.77 7.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.642 -0.661 . . . . 0.0 111.322 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.57 -54.9 7.87 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.124 0.964 . . . . 0.0 108.546 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -66.86 -39.87 87.69 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.093 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.43 HD13 ' HB ' ' A' ' 29' ' ' THR . 1.4 mt -56.0 -35.04 66.37 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.542 -0.724 . . . . 0.0 109.713 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.97 -37.16 81.19 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.152 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -65.22 -38.68 91.16 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.382 -0.823 . . . . 0.0 110.791 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 88.6 mmm -59.98 -45.97 90.97 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.659 -0.65 . . . . 0.0 110.206 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.732 HG22 ' OD2' ' A' ' 56' ' ' ASP . 89.9 mt -67.89 -32.98 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.714 -0.616 . . . . 0.0 110.375 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -60.01 -43.29 95.33 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.246 -0.909 . . . . 0.0 110.669 -178.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -67.9 -26.44 65.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.339 -0.851 . . . . 0.0 110.918 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.505 HG21 ' SD ' ' A' ' 71' ' ' MET . 57.5 t -99.97 -8.84 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.483 -0.761 . . . . 0.0 111.482 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.732 ' OD2' HG22 ' A' ' 52' ' ' ILE . 3.6 m-20 -71.23 103.16 2.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.109 -0.995 . . . . 0.0 110.897 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.25 -38.71 78.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.648 -0.658 . . . . 0.0 109.76 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -91.45 -30.64 16.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.615 -0.678 . . . . 0.0 110.537 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.2 20.99 40.01 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 120.36 -0.924 . . . . 0.0 110.905 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.6 p-10 -73.95 -32.86 63.67 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.39 -1.065 . . . . 0.0 110.323 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.7 -0.04 12.16 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.006 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 57.7 p -137.35 167.74 21.01 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.091 -1.24 . . . . 0.0 110.917 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.8 mt -104.58 120.67 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 121.317 0.58 . . . . 0.0 110.483 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -96.48 169.93 9.57 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.383 0.611 . . . . 0.0 110.585 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.456 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -46.06 -50.35 36.86 Favored Pre-proline 0 N--CA 1.501 2.099 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -179.063 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.3 Cg_endo -72.37 -32.02 10.74 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.026 1.014 . . . . 0.0 111.771 -178.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -71.44 -40.03 70.65 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.216 -0.927 . . . . 0.0 110.251 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -61.52 -39.96 92.93 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.723 -0.611 . . . . 0.0 110.761 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.584 HD21 ' HB3' ' A' ' 12' ' ' PHE . 89.3 mt -67.76 -39.98 84.12 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.424 -0.798 . . . . 0.0 111.926 -178.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.1 p -61.88 -40.08 94.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.356 -0.84 . . . . 0.0 110.748 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.505 ' SD ' HG21 ' A' ' 55' ' ' VAL . 60.5 ttp -67.71 -38.38 83.53 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.622 -0.674 . . . . 0.0 110.357 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.402 ' CE ' ' CG2' ' B' ' 166' ' ' VAL . 5.0 tpt -60.06 -49.51 77.39 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.611 -0.681 . . . . 0.0 111.076 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.09 -28.96 65.83 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.395 -0.816 . . . . 0.0 110.757 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -72.05 -40.79 68.1 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.498 -0.751 . . . . 0.0 110.608 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -69.15 -50.07 51.08 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.639 -0.663 . . . . 0.0 111.483 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 70.6 mtm -59.94 -40.03 87.56 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.429 -0.794 . . . . 0.0 111.104 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -60.74 -55.41 33.53 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.368 -0.832 . . . . 0.0 111.224 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -65.02 -19.98 66.27 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.456 -0.777 . . . . 0.0 110.161 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.544 HG22 ' H ' ' A' ' 80' ' ' ASP 0.299 52.9 m -99.87 -175.11 2.87 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.815 -0.553 . . . . 0.0 109.648 -179.742 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.544 ' H ' HG22 ' A' ' 79' ' ' THR . 87.4 m-20 -121.74 140.82 51.85 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.223 -0.923 . . . . 0.0 109.084 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.4 ' HA ' ' HG2' ' A' ' 84' ' ' GLU . 33.6 t -55.76 -28.57 56.67 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.317 -0.864 . . . . 0.0 110.271 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.76 -34.32 77.63 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.677 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -71.42 -41.63 69.31 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.92 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.4 ' HG2' ' HA ' ' A' ' 81' ' ' SER . 9.5 pt-20 -69.93 -29.49 66.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.117 -0.989 . . . . 0.0 110.414 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 95.9 mt -69.3 -46.31 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.536 -0.727 . . . . 0.0 109.699 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 63.2 mtt180 -59.81 -39.93 86.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.409 -0.807 . . . . 0.0 110.584 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.62 ' O ' HG23 ' A' ' 91' ' ' VAL . 98.9 mt-10 -66.95 -44.45 80.55 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.535 -0.728 . . . . 0.0 110.927 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.494 ' HA ' HG12 ' B' ' 164' ' ' VAL . . . -64.4 -43.58 93.98 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.667 -0.646 . . . . 0.0 111.282 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -59.94 -47.99 83.54 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.763 0.792 . . . . 0.0 109.778 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -58.98 -33.42 70.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.914 -0.492 . . . . 0.0 110.473 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 87' ' ' GLU . 78.5 t -70.04 -42.88 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.508 -0.745 . . . . 0.0 110.028 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.41 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 13.0 m-85 -70.06 -39.13 75.84 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.446 -0.784 . . . . 0.0 110.628 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -79.75 73.32 6.48 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.575 -0.703 . . . . 0.0 109.653 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -64.82 -40.83 95.84 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.381 -0.824 . . . . 0.0 110.487 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -76.12 -16.59 59.86 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.459 -0.775 . . . . 0.0 110.958 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.18 61.58 7.34 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -107.79 -10.6 15.55 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.581 -0.952 . . . . 0.0 111.377 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.4 -23.22 8.58 Favored Glycine 0 N--CA 1.498 2.815 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 14.6 p90 -142.79 176.16 9.27 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.483 -1.01 . . . . 0.0 108.708 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.507 HG22 ' H ' ' A' ' 101' ' ' SER . 23.4 mt -89.07 -129.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 119.801 -0.759 . . . . 0.0 109.248 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.507 ' H ' HG22 ' A' ' 100' ' ' ILE . 0.3 OUTLIER 168.71 159.87 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 O-C-N 120.529 -1.357 . . . . 0.0 108.321 178.568 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.52 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -61.3 -42.02 97.97 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.367 -0.833 . . . . 0.0 109.18 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.12 -30.67 67.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.837 -0.539 . . . . 0.0 110.094 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.47 ' HB2' HG22 ' A' ' 100' ' ' ILE . 61.9 mt-10 -69.97 -39.15 76.16 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.305 -0.872 . . . . 0.0 110.593 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.752 ' HB3' HG13 ' A' ' 121' ' ' VAL . 0.9 OUTLIER -67.54 -47.24 70.44 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.481 -0.762 . . . . 0.0 110.21 179.676 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -61.21 -38.94 88.39 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.826 -0.546 . . . . 0.0 111.628 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -60.04 -39.95 87.71 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.218 -0.926 . . . . 0.0 111.163 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.41 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 96.5 t -74.08 -47.36 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 O-C-N 121.275 -0.891 . . . . 0.0 111.438 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.702 ' HE1' HG22 ' A' ' 121' ' ' VAL . 76.5 mtm -58.83 -42.96 90.46 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.156 -0.965 . . . . 0.0 110.267 -178.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.2 m -67.27 -41.67 85.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.541 -0.724 . . . . 0.0 109.127 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.526 ' C ' HD21 ' A' ' 111' ' ' ASN . 0.2 OUTLIER -63.1 -31.91 73.17 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 109' ' ' MET . 42.5 mt -70.02 -35.09 74.08 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.697 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.94 21.14 2.95 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.667 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -119.98 138.32 53.55 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.215 -1.168 . . . . 0.0 110.024 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.7 mmmt -103.33 122.02 43.95 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.541 -0.725 . . . . 0.0 110.649 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.511 HD12 ' SD ' ' A' ' 109' ' ' MET . 77.2 mt -135.05 156.48 48.95 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.64 -0.662 . . . . 0.0 109.502 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.77 159.39 29.07 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.558 -0.714 . . . . 0.0 109.677 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -58.75 -29.8 67.02 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -66.09 -29.97 70.39 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -37.31 86.13 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.752 HG13 ' HB3' ' A' ' 105' ' ' LEU . 94.5 t -70.05 -39.91 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.522 0.677 . . . . 0.0 110.151 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -60.04 -45.75 91.78 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.786 -0.571 . . . . 0.0 110.074 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -59.9 -40.05 87.46 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.597 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.548 ' HB3' HD11 ' A' ' 105' ' ' LEU . 10.2 mmt -55.39 -38.48 68.94 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.594 -0.842 . . . . 0.0 108.767 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 48.4 mm -66.31 -40.1 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.356 0.598 . . . . 0.0 109.749 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -57.86 -38.62 76.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.691 -0.631 . . . . 0.0 111.197 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.95 -39.77 86.73 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.68 -0.638 . . . . 0.0 111.16 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.93 4.45 34.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.321 -0.862 . . . . 0.0 111.558 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 62.7 t0 -88.14 69.9 9.25 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.035 -1.041 . . . . 0.0 110.425 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.7 mt -67.67 -40.74 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.464 -0.772 . . . . 0.0 110.481 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -72.59 -22.4 60.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.433 -0.792 . . . . 0.0 111.087 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.6 24.33 50.58 Favored Glycine 0 N--CA 1.496 2.688 0 C-N-CA 120.262 -0.971 . . . . 0.0 110.69 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -83.8 -10.78 57.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.389 -1.065 . . . . 0.0 111.086 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.35 0.84 79.33 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -137.81 149.26 46.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -1.117 . . . . 0.0 109.286 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.0 t -92.14 118.63 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.427 -0.796 . . . . 0.0 109.771 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -88.06 176.51 7.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.573 -0.705 . . . . 0.0 109.346 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -61.34 -47.47 85.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.743 -0.598 . . . . 0.0 110.498 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -59.95 -46.42 89.47 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.74 -0.6 . . . . 0.0 111.51 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -64.47 -37.04 86.15 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.806 0.813 . . . . 0.0 109.99 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.453 ' CZ ' ' CE ' ' A' ' 145' ' ' MET . 64.9 t80 -60.07 -48.88 79.89 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.283 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.859 ' O ' HG22 ' A' ' 146' ' ' THR . 89.0 t -70.0 -40.65 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.308 -0.87 . . . . 0.0 111.921 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -59.94 -48.8 80.22 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.308 -0.87 . . . . 0.0 111.477 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.43 ' HE1' ' CE1' ' B' ' 157' ' ' PHE . 55.2 ttp -59.99 -35.9 76.01 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.428 -0.795 . . . . 0.0 110.475 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.477 ' HE2' ' CB ' ' B' ' 161' ' ' ALA . 37.3 mtt -70.65 -40.04 73.27 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.638 -0.664 . . . . 0.0 110.939 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.859 HG22 ' O ' ' A' ' 142' ' ' VAL . 8.5 t -104.99 31.65 4.69 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.514 -0.741 . . . . 0.0 109.98 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.18 -42.45 95.04 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.626 -0.671 . . . . 0.0 110.153 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 30.2 mttt . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.969 179.563 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.374 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -92.64 146.23 18.04 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 157' ' ' PHE . . . . . 0.43 ' CE1' ' HE1' ' A' ' 144' ' ' MET . 51.4 t80 -59.95 -40.73 90.0 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.506 -0.997 . . . . 0.0 109.903 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 32.6 ttp85 -61.38 -40.45 94.4 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.699 -0.626 . . . . 0.0 110.22 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -60.14 -40.01 88.34 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.488 -0.757 . . . . 0.0 110.286 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 97.4 mt -66.68 -39.63 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.655 -0.653 . . . . 0.0 110.465 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 161' ' ' ALA . . . . . 0.477 ' CB ' ' HE2' ' A' ' 145' ' ' MET . . . -59.32 -37.11 76.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.521 -0.737 . . . . 0.0 110.372 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -60.13 -40.04 88.4 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.486 -0.759 . . . . 0.0 110.688 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 83.4 mt -70.04 -34.95 73.91 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.517 -0.739 . . . . 0.0 110.691 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 164' ' ' VAL . . . . . 0.494 HG12 ' HA ' ' A' ' 88' ' ' ALA . 91.1 t -63.97 -39.96 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.595 -0.691 . . . . 0.0 109.932 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.14 -30.46 67.2 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.402 ' CG2' ' CE ' ' A' ' 72' ' ' MET . 58.3 t -69.02 -33.56 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.628 -0.925 . . . . 0.0 110.959 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.401 HD22 ' CG1' ' A' ' 35' ' ' VAL . 91.6 mt -60.17 -46.55 89.3 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.372 -0.83 . . . . 0.0 111.711 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 168' ' ' ARG . . . . . 0.641 ' HD2' HD21 ' A' ' 39' ' ' LEU . 23.2 mmm180 -70.07 -38.18 75.66 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.198 -0.939 . . . . 0.0 111.505 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -59.97 -40.06 87.77 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.287 -0.883 . . . . 0.0 110.629 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 170' ' ' TRP . . . . . 0.559 ' CZ2' HD13 ' A' ' 32' ' ' LEU . 2.0 t-105 -59.95 -40.26 88.38 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.41 -0.806 . . . . 0.0 109.845 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.1 -20.45 59.46 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.578 -0.701 . . . . 0.0 110.514 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -60.03 -39.99 87.77 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.324 -0.86 . . . . 0.0 110.072 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.635 -0.666 . . . . 0.0 110.111 179.73 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 121.523 0.678 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 79.0 mt -60.58 -29.04 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.925 -0.484 . . . . 0.0 111.525 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.67 86.6 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.157 -0.964 . . . . 0.0 110.063 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -60.03 -40.38 89.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.465 -0.772 . . . . 0.0 110.244 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.415 ' CG ' HD21 ' A' ' 69' ' ' LEU . 66.0 m-85 -65.36 -20.75 66.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.724 -0.61 . . . . 0.0 110.917 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HD3' ' CZ ' ' A' ' 65' ' ' PHE . 72.2 mmtt -69.94 -46.14 65.94 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.293 -0.879 . . . . 0.0 109.886 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -76.23 -24.82 54.61 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.45 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.22 -35.2 42.01 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.454 -0.779 . . . . 0.0 110.51 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -59.87 -39.99 87.13 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.853 -0.529 . . . . 0.0 111.549 -177.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.5 m -61.93 -39.64 92.77 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.25 -0.906 . . . . 0.0 109.946 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.649 HD11 ' O ' ' A' ' 112' ' ' LEU . 59.7 tp -60.03 -40.09 88.16 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.693 -0.629 . . . . 0.0 109.406 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -77.39 -35.61 54.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.718 -0.614 . . . . 0.0 110.349 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -94.26 97.73 10.44 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.401 -0.812 . . . . 0.0 110.196 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -59.99 -34.81 73.81 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.527 -0.733 . . . . 0.0 111.728 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -80.1 -11.2 59.78 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.172 -0.955 . . . . 0.0 111.249 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.56 28.77 52.29 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -90.86 -6.13 54.62 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.725 -0.868 . . . . 0.0 111.262 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.42 0.25 56.87 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 120.158 -1.02 . . . . 0.0 111.617 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.5 p -144.86 143.02 30.38 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 119.284 1.542 . . . . 0.0 111.108 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.8 mt -107.04 130.07 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 121.766 0.793 . . . . 0.0 110.868 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.4 p -106.16 143.06 34.82 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.846 -0.533 . . . . 0.0 110.537 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.511 HG23 ' CD1' ' A' ' 52' ' ' ILE . 64.8 p -43.25 -29.03 0.36 Allowed 'General case' 0 N--CA 1.509 2.489 0 O-C-N 121.667 -0.646 . . . . 0.0 112.163 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -65.09 -50.21 66.99 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.804 0.811 . . . . 0.0 109.58 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -59.51 -53.35 59.13 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.695 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.441 ' CD2' ' CE2' ' B' ' 170' ' ' TRP . 54.4 tp -60.09 -30.47 69.26 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.253 -0.904 . . . . 0.0 110.119 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.49 -32.56 23.58 Favored Glycine 0 N--CA 1.5 2.959 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.6 m -65.38 -39.91 92.86 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.545 -0.974 . . . . 0.0 109.434 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.458 ' CG1' HD22 ' B' ' 167' ' ' LEU . 77.1 t -68.18 -39.99 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-O 121.492 0.663 . . . . 0.0 110.046 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 46.1 mtt -59.97 -39.96 87.42 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.698 -0.626 . . . . 0.0 111.104 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.471 ' CG ' ' HB2' ' A' ' 42' ' ' ASN . 55.8 mtt180 -60.73 -46.73 89.28 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.303 -0.873 . . . . 0.0 109.961 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -67.0 -23.36 65.92 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.903 -178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.7 tp -82.64 -30.5 29.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.94 . . . . 0.0 109.443 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.37 -39.61 0.19 Allowed Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.934 -1.127 . . . . 0.0 110.868 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -170.53 160.35 7.3 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.076 -1.249 . . . . 0.0 112.271 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.471 ' HB2' ' CG ' ' A' ' 37' ' ' ARG . 5.9 t-20 -105.88 111.22 64.59 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.699 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.467 ' HD2' ' HA ' ' A' ' 42' ' ' ASN . 41.3 Cg_endo -61.15 -143.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.496 0 O-C-N 123.501 1.264 . . . . 0.0 109.683 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.2 p -131.41 149.93 52.35 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.218 -1.551 . . . . 0.0 112.131 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -51.1 -22.54 2.53 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.872 -0.517 . . . . 0.0 111.927 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.61 -55.76 8.05 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 122.284 1.04 . . . . 0.0 108.454 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -67.32 -37.17 82.88 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.718 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.45 HD13 ' HB ' ' A' ' 29' ' ' THR . 4.1 mt -57.35 -36.19 70.89 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.551 -0.718 . . . . 0.0 109.772 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.25 -40.03 89.9 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.426 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -64.0 -36.58 84.43 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.452 -0.78 . . . . 0.0 111.046 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 64.6 mtt -60.03 -44.95 94.28 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.638 -0.663 . . . . 0.0 109.888 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.732 HG22 ' OD2' ' A' ' 56' ' ' ASP . 66.1 mt -68.32 -34.06 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.747 -0.596 . . . . 0.0 110.364 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -60.06 -42.56 94.78 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.32 -0.863 . . . . 0.0 111.051 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -69.1 -27.67 65.8 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.089 -1.007 . . . . 0.0 110.984 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.492 HG21 ' SD ' ' A' ' 71' ' ' MET . 96.5 t -99.92 -7.67 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.591 -0.693 . . . . 0.0 111.239 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.732 ' OD2' HG22 ' A' ' 52' ' ' ILE . 0.5 OUTLIER -72.7 100.02 2.73 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.163 -0.961 . . . . 0.0 112.004 -179.156 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.09 -33.28 65.52 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -71.62 -40.09 70.0 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.407 0.622 . . . . 0.0 110.214 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.25 -1.44 73.27 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -73.7 -40.07 63.89 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.206 -1.173 . . . . 0.0 110.95 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.566 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 129.78 8.55 3.42 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 119.83 -1.176 . . . . 0.0 112.009 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 74.5 p -136.79 160.0 40.15 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.007 -1.29 . . . . 0.0 110.535 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.1 mt -104.93 120.03 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 120.039 -0.664 . . . . 0.0 111.273 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -96.22 171.17 8.76 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.533 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 19.4 t80 -49.37 -48.61 74.4 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.535 -0.728 . . . . 0.0 112.762 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 38.3 Cg_endo -63.94 -37.73 42.23 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 O-C-N 122.693 0.838 . . . . 0.0 111.56 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -69.65 -38.12 77.01 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.266 -0.896 . . . . 0.0 110.053 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.414 ' CE1' ' HG3' ' A' ' 72' ' ' MET . 63.8 t80 -60.56 -42.27 96.25 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.546 -0.721 . . . . 0.0 110.158 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.519 HD11 ' CE2' ' A' ' 65' ' ' PHE . 89.4 mt -63.22 -40.5 97.64 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.5 -0.75 . . . . 0.0 111.854 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 66' ' ' PRO . 70.7 p -61.66 -41.99 98.29 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.374 -0.829 . . . . 0.0 110.954 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.492 ' SD ' HG21 ' A' ' 55' ' ' VAL . 60.6 ttp -69.83 -40.02 76.13 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.562 -0.711 . . . . 0.0 111.475 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.414 ' HG3' ' CE1' ' A' ' 68' ' ' PHE . 97.2 mmm -62.71 -52.78 61.92 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.446 -0.784 . . . . 0.0 111.92 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.01 -31.54 71.3 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.661 -0.649 . . . . 0.0 110.313 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.411 ' HD2' ' CE ' ' A' ' 77' ' ' LYS . 10.4 tpt180 -71.83 -43.63 65.26 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.735 -0.603 . . . . 0.0 110.983 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.642 ' O ' HG22 ' A' ' 79' ' ' THR . 66.0 mmtt -70.06 -42.22 73.12 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 45.9 mtm -59.91 -46.42 89.42 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.135 -0.978 . . . . 0.0 112.531 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.411 ' CE ' ' HD2' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -69.87 -37.43 76.09 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.032 -1.043 . . . . 0.0 110.089 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -69.97 -20.03 63.33 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.712 -0.618 . . . . 0.0 111.252 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.642 HG22 ' O ' ' A' ' 75' ' ' LYS . 12.7 t -111.34 -160.71 0.72 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.921 0.867 . . . . 0.0 111.94 -178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -120.49 138.39 53.85 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.463 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.6 t -65.73 -27.74 68.54 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.58 -0.7 . . . . 0.0 109.97 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.02 -31.0 69.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.61 -0.681 . . . . 0.0 109.844 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.62 -40.0 76.86 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.643 -0.661 . . . . 0.0 110.354 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.68 -38.59 87.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.527 -0.733 . . . . 0.0 110.379 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.713 HG23 ' HE1' ' A' ' 141' ' ' PHE . 95.5 mt -64.57 -51.0 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.778 -0.577 . . . . 0.0 110.758 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.8 mtp85 -56.1 -38.41 70.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.265 -0.897 . . . . 0.0 110.481 -178.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.722 ' O ' HG23 ' A' ' 91' ' ' VAL . 95.0 mt-10 -69.77 -39.9 76.39 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.804 -0.56 . . . . 0.0 110.789 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.62 -48.64 74.11 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.392 -0.818 . . . . 0.0 111.152 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -60.22 -43.01 96.38 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.725 0.774 . . . . 0.0 109.7 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -60.0 -36.44 77.2 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.411 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 87' ' ' GLU . 90.4 t -69.43 -50.49 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.559 -0.713 . . . . 0.0 110.19 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -64.84 -40.04 94.54 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.397 -0.814 . . . . 0.0 110.952 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -78.5 65.05 3.7 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.475 -0.766 . . . . 0.0 110.686 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -60.67 -45.97 92.12 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.235 -0.916 . . . . 0.0 109.898 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 41.0 p-10 -69.99 -19.09 63.35 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.567 -0.708 . . . . 0.0 110.791 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.03 57.59 19.04 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -105.11 -3.24 23.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.278 -1.131 . . . . 0.0 110.525 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.43 -16.03 56.98 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -135.62 142.91 45.32 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.146 -1.208 . . . . 0.0 109.525 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 75.2 mt -88.97 124.55 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.482 -0.761 . . . . 0.0 110.021 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.2 m -84.52 169.38 14.52 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.353 0.597 . . . . 0.0 110.575 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.76 -40.57 97.68 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.77 -0.581 . . . . 0.0 110.096 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.77 -33.3 75.54 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.782 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -66.35 -40.02 89.55 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.426 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.449 ' HB3' HG13 ' A' ' 121' ' ' VAL . 1.7 tt -61.1 -48.87 79.68 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.331 -0.856 . . . . 0.0 109.841 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -62.66 -28.39 69.89 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.821 -0.549 . . . . 0.0 111.027 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -60.08 -40.01 88.05 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.186 -0.946 . . . . 0.0 109.978 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.3 t -77.25 -33.11 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.528 -0.733 . . . . 0.0 110.256 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.471 ' SD ' HG22 ' A' ' 121' ' ' VAL . 16.9 mtt -59.99 -49.88 75.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.473 -0.767 . . . . 0.0 110.118 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 p -68.25 -40.87 81.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.621 -0.674 . . . . 0.0 109.703 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -60.05 -31.9 70.42 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.649 ' O ' HD11 ' A' ' 18' ' ' LEU . 21.5 mt -69.94 -35.2 74.33 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.176 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 112.85 24.26 4.99 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -119.82 141.92 49.09 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.452 -1.028 . . . . 0.0 109.518 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -99.92 123.26 43.98 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.407 -0.808 . . . . 0.0 110.847 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.623 HD23 ' OE2' ' A' ' 120' ' ' GLU . 4.2 mp -138.72 154.52 48.56 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.579 -0.7 . . . . 0.0 110.206 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.0 m -87.81 170.2 11.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.637 -0.664 . . . . 0.0 109.344 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -63.5 -24.9 68.02 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.343 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -68.14 -36.36 79.57 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.716 0.769 . . . . 0.0 109.364 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.623 ' OE2' HD23 ' A' ' 116' ' ' LEU . 12.1 mt-10 -65.23 -38.38 90.21 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.594 0.711 . . . . 0.0 109.225 178.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.471 HG22 ' SD ' ' A' ' 109' ' ' MET . 74.3 t -68.2 -39.96 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.03 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.573 ' HA ' HD12 ' A' ' 125' ' ' ILE . 65.7 t0 -59.96 -42.02 93.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.629 -0.67 . . . . 0.0 109.831 -178.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -59.97 -40.94 90.8 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.654 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 10.5 mmt -54.22 -38.52 65.81 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.573 HD12 ' HA ' ' A' ' 122' ' ' ASP . 84.1 mt -66.03 -40.02 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.468 0.651 . . . . 0.0 110.082 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.5 ttt85 -57.35 -39.94 77.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.543 -0.723 . . . . 0.0 111.718 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -60.15 -37.93 81.6 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.572 -0.705 . . . . 0.0 111.465 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -109.39 -5.89 15.66 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.22 -0.925 . . . . 0.0 112.241 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -82.64 70.73 9.68 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.935 -1.103 . . . . 0.0 111.01 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.1 mt -67.99 -39.96 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.467 -0.771 . . . . 0.0 110.488 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.8 p-10 -70.51 -20.03 62.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.416 -0.802 . . . . 0.0 111.337 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.59 24.38 58.67 Favored Glycine 0 N--CA 1.496 2.646 0 C-N-CA 120.135 -1.031 . . . . 0.0 110.672 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -81.93 -11.61 58.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -1.173 . . . . 0.0 110.95 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.44 3.08 72.39 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -141.98 153.11 44.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -1.125 . . . . 0.0 109.784 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.0 t -96.22 109.97 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.609 -0.682 . . . . 0.0 109.611 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.0 p30 -81.93 -174.14 4.88 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.54 -0.725 . . . . 0.0 110.197 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -69.33 -42.86 74.79 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.056 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -62.45 -49.95 73.41 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.294 -0.879 . . . . 0.0 112.049 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.46 -35.5 81.09 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.445 -0.784 . . . . 0.0 110.456 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.713 ' HE1' HG23 ' A' ' 85' ' ' ILE . 64.7 t80 -59.94 -45.83 91.36 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.425 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.9 t -71.46 -40.51 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.294 -0.879 . . . . 0.0 111.777 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -59.96 -49.98 75.56 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.398 -0.814 . . . . 0.0 110.649 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 10.5 tmm? -59.97 -39.86 87.09 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.407 -0.808 . . . . 0.0 109.361 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 92.7 mmm -68.11 -39.86 82.7 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.216 0.531 . . . . 0.0 109.577 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 56.8 m -69.66 -17.8 63.52 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.714 -0.616 . . . . 0.0 110.446 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.94 139.99 57.02 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.381 -0.824 . . . . 0.0 110.454 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.2 mttm . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.105 -179.889 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -156.35 140.93 7.56 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -60.05 -39.92 87.61 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.644 -0.915 . . . . 0.0 110.064 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -60.02 -39.76 86.96 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.631 -0.668 . . . . 0.0 110.309 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -60.09 -39.95 87.87 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.576 -0.702 . . . . 0.0 110.592 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.65 -40.43 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.618 -0.676 . . . . 0.0 109.742 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.21 -39.53 93.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.691 -0.63 . . . . 0.0 110.736 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -64.11 -39.91 95.05 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.419 -0.801 . . . . 0.0 111.34 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 77.6 mt -70.05 -40.39 75.14 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.379 -0.826 . . . . 0.0 112.205 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 164' ' ' VAL . . . . . 0.665 ' HA ' HD12 ' B' ' 167' ' ' LEU . 13.5 p -71.0 -31.96 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.073 -1.017 . . . . 0.0 110.673 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.73 -40.04 97.52 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 60.3 t -72.96 -27.94 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.696 -0.884 . . . . 0.0 112.0 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.665 HD12 ' HA ' ' B' ' 164' ' ' VAL . 90.6 mt -59.92 -48.13 82.95 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.117 -0.99 . . . . 0.0 111.019 -177.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -64.93 -39.98 94.33 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.26 -0.9 . . . . 0.0 110.885 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -60.32 -36.37 77.76 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.538 -0.726 . . . . 0.0 110.336 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 170' ' ' TRP . . . . . 0.441 ' CE2' ' CD2' ' A' ' 32' ' ' LEU . 3.0 t-105 -60.08 -40.02 88.09 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.578 -0.701 . . . . 0.0 109.782 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.12 -50.4 73.64 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.546 -0.721 . . . . 0.0 110.509 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -60.06 -34.1 72.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.368 -0.832 . . . . 0.0 109.876 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 . . . . . 0 N--CA 1.495 1.782 0 O-C-N 121.648 -0.658 . . . . 0.0 110.205 -179.863 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 121.768 0.794 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.88 -35.47 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.918 -0.489 . . . . 0.0 111.37 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.74 -27.15 68.1 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.045 -1.034 . . . . 0.0 111.184 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -69.44 -45.67 68.55 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.666 0.746 . . . . 0.0 110.094 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -69.44 -24.35 63.8 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.591 0.71 . . . . 0.0 109.169 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -70.86 -40.83 72.09 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.654 0.74 . . . . 0.0 109.605 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -70.62 -28.6 64.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.792 -0.568 . . . . 0.0 110.737 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.21 -27.46 35.29 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.486 -0.759 . . . . 0.0 110.609 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -60.0 -40.35 88.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.639 -0.663 . . . . 0.0 110.61 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.1 t -62.16 -39.48 92.8 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.432 -0.793 . . . . 0.0 109.499 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.3 tp -59.99 -40.65 89.91 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.426 ' HB3' HD13 ' A' ' 27' ' ' ILE . 15.4 m-85 -77.55 -38.95 47.48 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.897 -0.502 . . . . 0.0 109.957 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -94.96 95.61 8.74 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.602 -0.686 . . . . 0.0 109.802 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -69.96 -26.95 64.35 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.44 -0.788 . . . . 0.0 111.548 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -80.97 -8.74 59.83 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.074 -1.016 . . . . 0.0 111.405 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.62 25.23 27.82 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -87.67 -6.62 58.15 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.548 -0.972 . . . . 0.0 110.718 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.17 0.9 58.33 Favored Glycine 0 N--CA 1.489 2.183 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.117 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.2 p -144.56 141.42 29.45 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 119.15 1.475 . . . . 0.0 111.292 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.426 HD13 ' HB3' ' A' ' 19' ' ' PHE . 85.5 mt -104.34 127.85 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.698 -0.626 . . . . 0.0 109.354 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.1 p -103.25 143.36 32.75 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.761 -0.587 . . . . 0.0 110.964 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 11.0 p -39.49 -34.32 0.21 Allowed 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -61.9 -46.05 91.05 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.921 0.867 . . . . 0.0 108.943 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -59.27 -53.29 59.95 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.276 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.462 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -56.49 -38.48 71.81 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.328 -0.857 . . . . 0.0 111.051 -178.577 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.85 -29.57 42.57 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.2 m -70.03 -39.45 75.76 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.644 -0.916 . . . . 0.0 110.491 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.6 t -61.24 -54.89 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.329 -0.857 . . . . 0.0 108.881 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.405 ' HB2' ' HD3' ' A' ' 43' ' ' PRO . 67.5 mtt -59.05 -29.31 67.2 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.656 -0.653 . . . . 0.0 109.382 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -59.49 -40.03 85.66 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.6 p -70.03 -16.97 63.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.972 -0.455 . . . . 0.0 110.744 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.6 tp -81.67 -31.17 32.4 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.354 -0.841 . . . . 0.0 109.663 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.25 -35.0 0.19 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -160.22 170.05 21.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.554 -0.968 . . . . 0.0 111.219 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -101.31 138.27 19.89 Favored Pre-proline 0 C--N 1.299 -1.607 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.733 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.405 ' HD3' ' HB2' ' A' ' 36' ' ' MET . 53.5 Cg_endo -67.18 -152.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.487 1.146 0 O-C-N 123.394 1.207 . . . . 0.0 109.427 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.4 p -139.97 144.7 37.15 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.191 -0.943 . . . . 0.0 111.123 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -49.72 -25.09 2.67 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.715 -0.616 . . . . 0.0 111.623 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.9 -54.87 9.84 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.185 0.993 . . . . 0.0 108.597 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -67.83 -39.87 83.83 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.764 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.475 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 8.5 mt -55.66 -37.01 67.71 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.676 0.751 . . . . 0.0 109.403 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -63.06 -40.04 96.53 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.775 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -63.83 -39.96 95.47 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.583 -0.698 . . . . 0.0 111.086 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 64.8 mtt -61.61 -41.76 97.91 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.633 -0.667 . . . . 0.0 109.919 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.87 HG22 ' OD2' ' A' ' 56' ' ' ASP . 48.4 mm -66.97 -39.99 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.781 -0.574 . . . . 0.0 110.467 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -61.32 -40.0 92.61 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.521 -0.737 . . . . 0.0 112.287 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -69.73 -29.72 67.16 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.995 -1.065 . . . . 0.0 110.723 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.629 HG21 ' SD ' ' A' ' 71' ' ' MET . 87.6 t -99.99 -8.94 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.637 -0.664 . . . . 0.0 111.246 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.87 ' OD2' HG22 ' A' ' 52' ' ' ILE . 7.2 m-20 -68.99 93.97 0.61 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.149 -0.969 . . . . 0.0 111.11 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.23 -38.49 91.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.655 -0.653 . . . . 0.0 109.504 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -91.72 -29.99 16.52 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.702 -0.624 . . . . 0.0 110.816 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.403 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 91.69 20.5 37.06 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -73.57 -39.1 64.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.372 -1.075 . . . . 0.0 110.42 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.772 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 129.05 -0.62 6.12 Favored Glycine 0 N--CA 1.497 2.744 0 C-N-CA 120.092 -1.051 . . . . 0.0 111.547 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.1 p -134.6 169.15 17.74 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.114 -1.227 . . . . 0.0 111.033 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.504 HD11 HD13 ' A' ' 52' ' ' ILE . 5.9 mt -102.68 118.9 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.813 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -98.79 170.01 9.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.533 -0.729 . . . . 0.0 110.766 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.504 ' O ' HD13 ' A' ' 69' ' ' LEU . 2.8 t80 -47.53 -50.02 52.18 Favored Pre-proline 0 N--CA 1.499 1.984 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.2 Cg_endo -67.18 -34.9 26.6 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 O-C-N 122.884 0.939 . . . . 0.0 111.223 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.96 -40.02 75.66 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.307 -0.871 . . . . 0.0 110.353 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -62.81 -41.63 99.38 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.63 -0.669 . . . . 0.0 111.252 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 65' ' ' PHE . 4.5 mp -67.86 -41.1 83.41 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.322 -0.861 . . . . 0.0 111.422 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.6 p -63.12 -39.99 96.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.542 -0.724 . . . . 0.0 110.879 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.629 ' SD ' HG21 ' A' ' 55' ' ' VAL . 48.8 ttp -68.61 -41.04 80.11 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.657 -0.652 . . . . 0.0 111.921 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 57.0 tpp -68.94 -42.53 76.62 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.257 -0.902 . . . . 0.0 111.772 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.0 -35.52 66.85 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.475 -0.766 . . . . 0.0 112.074 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.77 -55.01 5.69 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.432 -0.792 . . . . 0.0 111.421 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.443 ' HA ' ' OD2' ' A' ' 78' ' ' ASP . 88.1 mttt -59.94 -41.01 90.89 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.525 -0.735 . . . . 0.0 112.641 -178.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 27.7 ptm -59.95 -34.49 73.32 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.283 -0.885 . . . . 0.0 111.877 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -63.25 -49.92 72.21 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.406 -0.809 . . . . 0.0 111.856 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.443 ' OD2' ' HA ' ' A' ' 75' ' ' LYS . 3.9 p30 -69.61 -10.31 57.67 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.176 -0.952 . . . . 0.0 111.019 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.589 HG22 ' H ' ' A' ' 80' ' ' ASP 0.27 22.2 m -86.53 -175.03 5.29 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.385 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.589 ' H ' HG22 ' A' ' 79' ' ' THR . 84.3 m-20 -129.98 138.57 50.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.132 -0.98 . . . . 0.0 109.404 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 24.4 p -61.15 -27.01 68.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.478 -0.764 . . . . 0.0 110.374 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.04 -37.01 78.56 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.716 0.769 . . . . 0.0 109.016 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.01 -40.02 75.5 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.316 0.579 . . . . 0.0 110.079 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -62.56 -39.98 95.37 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.783 -0.573 . . . . 0.0 110.7 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.448 HG23 ' HE1' ' A' ' 141' ' ' PHE . 89.6 mt -65.06 -49.75 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.533 -0.729 . . . . 0.0 110.849 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.77 -42.82 84.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.348 -0.845 . . . . 0.0 111.207 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.438 ' O ' HG13 ' A' ' 91' ' ' VAL . 95.3 mt-10 -69.98 -39.64 75.82 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.405 -0.809 . . . . 0.0 111.773 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.532 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -64.77 -47.35 78.48 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.605 -0.684 . . . . 0.0 112.014 -178.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -67.26 -40.17 86.2 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.1 -1.0 . . . . 0.0 110.43 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -61.03 -39.94 91.69 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.694 -0.629 . . . . 0.0 111.738 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.532 HG22 ' O ' ' A' ' 88' ' ' ALA . 34.9 m -71.29 -40.06 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 0.0 111.112 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -72.39 -40.0 67.55 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.144 -0.973 . . . . 0.0 111.466 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -82.65 68.82 9.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.638 -0.664 . . . . 0.0 110.595 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.445 ' HZ2' ' CD2' ' A' ' 107' ' ' HIS . 25.3 mttt -60.0 -42.72 94.87 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.19 -0.944 . . . . 0.0 110.001 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -74.52 -24.37 58.97 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.49 -0.757 . . . . 0.0 110.411 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.29 24.63 76.75 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -67.93 -16.69 64.18 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.334 -1.097 . . . . 0.0 111.262 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.47 -19.58 14.46 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.446 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 29.0 p90 -145.82 156.75 43.78 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.336 -1.096 . . . . 0.0 109.438 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 65.9 mt -89.14 122.04 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.668 0.747 . . . . 0.0 110.154 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 m -80.78 170.67 15.99 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.351 0.596 . . . . 0.0 110.624 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.73 -47.58 84.61 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.682 -0.636 . . . . 0.0 109.991 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.0 -37.97 81.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.744 -0.597 . . . . 0.0 109.855 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -61.05 -39.93 91.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.586 -0.696 . . . . 0.0 110.674 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.436 HD13 HG13 ' A' ' 121' ' ' VAL . 1.5 tt -60.54 -46.94 88.31 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.323 -0.861 . . . . 0.0 110.398 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.545 ' HG2' HG21 ' A' ' 121' ' ' VAL . 92.1 mtt180 -60.04 -34.91 74.03 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.698 -0.626 . . . . 0.0 111.919 -178.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.445 ' CD2' ' HZ2' ' A' ' 94' ' ' LYS . 48.4 t60 -59.97 -41.95 93.06 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.123 -0.986 . . . . 0.0 110.874 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.5 t -77.07 -37.05 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.429 -0.795 . . . . 0.0 111.183 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.7 mmt -60.05 -49.97 75.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.5 m -67.18 -43.69 81.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.725 -0.61 . . . . 0.0 109.809 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -61.82 -28.17 69.28 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.722 -0.611 . . . . 0.0 109.522 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.8 mt -70.03 -30.28 67.53 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.036 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 112.09 22.17 6.01 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -120.48 137.76 54.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.376 -1.073 . . . . 0.0 110.26 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -99.95 117.75 34.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.534 -0.729 . . . . 0.0 109.396 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 67.6 mt -131.24 156.85 44.68 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.458 -0.776 . . . . 0.0 110.15 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 m -82.51 165.8 19.85 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -63.39 -29.07 70.43 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -68.19 -32.83 73.35 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.508 0.67 . . . . 0.0 109.76 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -68.64 -35.07 76.79 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.545 HG21 ' HG2' ' A' ' 106' ' ' ARG . 78.0 t -69.98 -38.33 75.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-O 121.649 0.738 . . . . 0.0 109.028 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.421 ' HA ' HD12 ' A' ' 125' ' ' ILE . 56.4 t0 -60.0 -43.34 95.26 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.746 -0.596 . . . . 0.0 109.928 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -59.9 -40.18 87.93 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.356 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 13.7 mmt -54.58 -36.83 64.82 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.154 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 122' ' ' ASP . 91.1 mt -67.75 -38.42 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 121.252 0.548 . . . . 0.0 109.825 178.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -60.03 -39.98 87.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.641 -0.662 . . . . 0.0 110.959 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -63.68 -39.83 95.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.545 -0.722 . . . . 0.0 111.403 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.588 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -98.98 -7.78 26.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.377 -0.827 . . . . 0.0 112.046 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -103.38 78.27 1.59 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.025 -1.047 . . . . 0.0 111.268 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 86.8 mt -66.99 -39.96 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.702 -0.624 . . . . 0.0 110.022 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 34.0 p-10 -59.03 -39.75 82.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.669 -0.644 . . . . 0.0 111.266 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 98.65 11.69 46.55 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.366 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -80.88 -16.7 52.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.943 -1.328 . . . . 0.0 110.151 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.68 5.18 71.94 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.747 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -132.34 133.41 43.96 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.237 -1.155 . . . . 0.0 110.035 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.7 t -90.88 114.58 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.442 -0.786 . . . . 0.0 109.936 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -87.7 -178.36 6.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.659 -0.651 . . . . 0.0 109.764 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -65.0 -41.33 95.47 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.613 -0.68 . . . . 0.0 110.092 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -61.69 -42.57 99.11 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.575 -0.703 . . . . 0.0 110.798 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -64.18 -39.45 94.02 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.831 0.824 . . . . 0.0 109.708 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.448 ' HE1' HG23 ' A' ' 85' ' ' ILE . 64.3 t80 -60.05 -46.82 88.27 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.426 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.414 ' O ' HG22 ' A' ' 146' ' ' THR . 99.3 t -65.13 -39.97 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.303 -0.873 . . . . 0.0 111.041 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.405 ' HA ' HG22 ' A' ' 146' ' ' THR . 61.6 tt0 -61.04 -39.97 91.83 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.516 -0.74 . . . . 0.0 110.381 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.588 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 49.9 mtp -60.59 -44.55 96.12 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.654 -0.654 . . . . 0.0 111.943 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.433 ' CE ' ' CZ ' ' A' ' 141' ' ' PHE . 42.9 mtt -73.24 -39.98 65.04 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.694 -0.629 . . . . 0.0 111.805 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 142' ' ' VAL . 15.1 t -75.1 -8.16 55.77 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.41 -0.806 . . . . 0.0 111.262 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -92.83 120.04 32.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.203 -0.935 . . . . 0.0 110.363 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.6 pttm . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.608 179.788 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.56 -39.21 97.37 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -63.66 -40.25 96.37 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.56 -0.965 . . . . 0.0 111.368 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -64.32 -39.34 93.72 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.028 -1.045 . . . . 0.0 110.354 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -60.02 -49.85 76.04 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.663 -0.648 . . . . 0.0 111.737 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 19.7 tt -69.94 -26.01 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 120.987 -1.071 . . . . 0.0 110.727 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.92 90.89 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.372 -0.83 . . . . 0.0 110.919 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 25.8 ttm-85 -60.06 -41.01 91.42 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.517 -0.739 . . . . 0.0 110.759 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.473 ' N ' HD22 ' B' ' 163' ' ' LEU . 4.6 mm? -61.92 -38.89 90.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.576 -0.702 . . . . 0.0 110.19 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.53 -40.12 87.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.517 -0.739 . . . . 0.0 111.191 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.53 -44.12 93.91 Favored Glycine 0 N--CA 1.501 2.976 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 12.0 p -81.94 -11.64 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.687 -0.89 . . . . 0.0 111.455 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.548 HD23 ' C ' ' B' ' 167' ' ' LEU . 9.2 tt -60.03 -50.02 75.35 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.188 -0.945 . . . . 0.0 110.434 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 30.0 mtp-105 -70.02 -31.09 68.58 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.588 -0.695 . . . . 0.0 110.538 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.97 -40.02 87.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.586 -0.696 . . . . 0.0 109.779 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -59.99 -41.29 91.73 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.671 -0.643 . . . . 0.0 109.928 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.1 -20.73 64.07 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.388 -0.82 . . . . 0.0 111.307 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -59.76 -39.9 86.4 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.318 -0.863 . . . . 0.0 110.319 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.538 -0.726 . . . . 0.0 110.219 179.622 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 . . . . . 0 N--CA 1.498 1.941 0 CA-C-O 121.484 0.659 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.9 mm -58.94 -50.02 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.708 -0.62 . . . . 0.0 111.046 -176.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.91 -20.04 63.35 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.225 -0.922 . . . . 0.0 110.688 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -68.21 -54.46 17.63 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.462 -0.774 . . . . 0.0 109.678 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.575 ' CB ' HD21 ' A' ' 69' ' ' LEU . 51.9 m-85 -66.62 -21.67 66.12 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.462 0.648 . . . . 0.0 109.57 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -69.14 -44.06 73.08 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.415 0.626 . . . . 0.0 110.281 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -71.42 -24.46 62.05 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.751 -0.593 . . . . 0.0 111.299 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.7 -33.27 41.14 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.319 -0.863 . . . . 0.0 110.908 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.416 ' CB ' ' CE1' ' A' ' 65' ' ' PHE . 56.2 t80 -59.95 -37.5 79.74 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.695 -0.628 . . . . 0.0 111.255 -177.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 91.9 p -61.42 -38.79 88.4 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.243 -0.91 . . . . 0.0 110.087 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 46.3 tp -60.11 -40.19 88.84 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.541 -0.724 . . . . 0.0 109.758 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -78.77 -37.39 41.2 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.732 -0.605 . . . . 0.0 109.783 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.595 ' HB2' HD11 ' A' ' 27' ' ' ILE . 27.5 t0 -93.58 94.94 8.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.642 -0.661 . . . . 0.0 110.176 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -66.13 -30.11 70.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.468 -0.77 . . . . 0.0 111.393 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -79.96 -9.93 59.73 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.09 -1.006 . . . . 0.0 111.373 -177.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.79 26.71 58.12 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 57.9 p30 -89.96 -3.48 58.0 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.713 -0.875 . . . . 0.0 110.886 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.96 4.45 72.12 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.248 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 58.3 p -143.76 142.19 30.79 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 119.288 1.544 . . . . 0.0 111.945 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.595 HD11 ' HB2' ' A' ' 20' ' ' ASP . 49.4 mm -103.69 125.3 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.747 -0.596 . . . . 0.0 110.055 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.9 m -101.54 141.38 34.49 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.541 -0.725 . . . . 0.0 110.244 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.455 ' HB ' HD13 ' A' ' 48' ' ' LEU . 28.2 p -39.56 -34.79 0.25 Allowed 'General case' 0 N--CA 1.51 2.543 0 O-C-N 121.871 -0.518 . . . . 0.0 112.364 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -60.12 -49.36 77.94 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.327 -0.858 . . . . 0.0 109.11 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -57.58 -51.09 70.91 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.11 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.582 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -54.53 -38.81 67.01 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.154 -0.966 . . . . 0.0 111.002 -179.034 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -51.61 -29.55 25.2 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.3 m -65.09 -40.01 93.98 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.528 -0.983 . . . . 0.0 110.074 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.6 t -68.3 -40.07 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-O 121.384 0.612 . . . . 0.0 109.775 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.464 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 13.4 mmt -59.93 -39.89 87.04 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.736 -0.602 . . . . 0.0 111.712 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -60.76 -40.01 90.88 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.757 0.789 . . . . 0.0 110.346 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.5 t -64.56 -24.84 67.74 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.766 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.529 ' HG ' HD22 ' B' ' 167' ' ' LEU . 4.3 mm? -89.77 -17.72 27.68 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.152 -0.968 . . . . 0.0 110.434 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.41 -51.44 0.22 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -166.73 176.47 7.14 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.59 -0.947 . . . . 0.0 111.197 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -99.17 133.47 22.08 Favored Pre-proline 0 N--CA 1.492 1.664 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.927 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.464 ' HD3' ' HB3' ' A' ' 36' ' ' MET . 52.1 Cg_endo -66.3 -147.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.306 0 O-C-N 123.207 1.109 . . . . 0.0 109.414 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.8 p -125.94 140.73 52.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.001 -1.062 . . . . 0.0 110.901 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -48.17 -24.69 1.21 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.713 -0.617 . . . . 0.0 112.039 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.25 -44.18 65.8 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.247 1.022 . . . . 0.0 108.461 176.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -69.96 -39.85 75.78 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.323 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.455 HD13 ' HB ' ' A' ' 29' ' ' THR . 8.5 mt -55.88 -38.03 69.62 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.483 -0.76 . . . . 0.0 109.534 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -63.26 -40.57 97.77 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.152 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -64.43 -39.44 93.84 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.611 -0.681 . . . . 0.0 111.267 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 61.9 mtt -62.93 -39.98 96.25 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.679 -0.638 . . . . 0.0 109.917 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.845 HG22 ' OD2' ' A' ' 56' ' ' ASP . 48.4 mm -69.23 -39.91 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.682 -0.636 . . . . 0.0 110.91 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -64.2 -40.09 95.36 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.447 -0.783 . . . . 0.0 112.519 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.852 ' HG3' HG23 ' A' ' 55' ' ' VAL . 15.3 pt-20 -69.93 -27.34 64.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.932 -1.105 . . . . 0.0 110.483 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.852 HG23 ' HG3' ' A' ' 54' ' ' GLU . 48.6 t -99.9 -10.01 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.658 -0.651 . . . . 0.0 110.917 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.845 ' OD2' HG22 ' A' ' 52' ' ' ILE . 4.0 m-20 -69.12 99.01 1.06 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.188 -0.945 . . . . 0.0 110.962 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.79 -36.95 83.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.593 -0.692 . . . . 0.0 109.879 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -94.54 -26.11 16.55 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.654 -0.654 . . . . 0.0 110.84 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.7 20.01 49.32 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -73.9 -34.74 64.51 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.436 -1.038 . . . . 0.0 110.162 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.804 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 124.08 2.13 8.57 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 120.34 -0.933 . . . . 0.0 111.204 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 82.7 p -138.3 168.56 19.49 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.063 -1.257 . . . . 0.0 111.21 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.468 HD11 HD13 ' A' ' 52' ' ' ILE . 7.7 mt -103.69 121.0 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.288 0.566 . . . . 0.0 110.537 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -98.77 170.38 8.81 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.373 0.606 . . . . 0.0 110.47 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.488 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.5 OUTLIER -47.63 -50.0 53.21 Favored Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 121.626 -0.671 . . . . 0.0 112.533 -179.493 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.653 ' O ' HG23 ' A' ' 70' ' ' THR . 40.8 Cg_endo -67.87 -35.12 21.94 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 122.833 0.912 . . . . 0.0 111.237 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.99 -40.01 75.58 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.277 -0.889 . . . . 0.0 110.339 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -63.66 -40.77 97.67 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.548 -0.72 . . . . 0.0 110.933 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.575 HD21 ' CB ' ' A' ' 12' ' ' PHE . 84.3 mt -64.56 -39.96 94.69 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.433 -0.792 . . . . 0.0 111.346 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.653 HG23 ' O ' ' A' ' 66' ' ' PRO . 68.8 p -60.6 -40.79 93.1 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.458 -0.776 . . . . 0.0 110.561 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.8 ttp -69.99 -39.96 75.59 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.561 -0.712 . . . . 0.0 111.708 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.402 ' SD ' HG21 ' B' ' 166' ' ' VAL . 2.6 tpt -60.05 -49.96 75.58 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.436 -0.79 . . . . 0.0 111.364 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.01 -29.27 66.29 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.455 -0.778 . . . . 0.0 111.369 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -72.87 -40.02 65.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.433 -0.792 . . . . 0.0 111.733 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -69.55 -46.58 66.12 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.355 -0.841 . . . . 0.0 112.24 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 77.0 mtm -60.01 -39.38 85.61 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.031 -1.043 . . . . 0.0 111.018 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -66.91 -51.27 57.39 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.549 -0.719 . . . . 0.0 110.816 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -69.09 -31.94 71.01 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.583 0.706 . . . . 0.0 110.134 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.606 HG22 ' H ' ' A' ' 80' ' ' ASP 0.253 23.2 m -90.89 -174.64 4.1 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.606 ' H ' HG22 ' A' ' 79' ' ' THR . 81.6 m-20 -123.81 144.56 49.64 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.099 -1.001 . . . . 0.0 110.055 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.2 p -61.59 -27.77 68.87 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.702 -0.624 . . . . 0.0 110.452 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -60.11 -37.87 81.29 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.627 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -70.04 -40.04 75.38 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.65 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -67.71 -37.75 82.67 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.455 -0.778 . . . . 0.0 110.28 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 71.0 mt -63.82 -49.86 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.736 -0.602 . . . . 0.0 110.002 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -57.58 -39.85 77.67 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.481 -0.762 . . . . 0.0 110.982 -178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.783 ' O ' HG23 ' A' ' 91' ' ' VAL . 96.5 mt-10 -69.45 -42.09 75.38 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.514 -0.741 . . . . 0.0 111.655 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.438 ' HA ' HG11 ' B' ' 164' ' ' VAL . . . -66.56 -45.38 79.54 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.502 -0.748 . . . . 0.0 111.608 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.415 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 35.4 t80 -60.01 -47.07 87.33 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.469 -0.77 . . . . 0.0 109.542 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -60.09 -34.85 74.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.927 -0.483 . . . . 0.0 110.414 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 87' ' ' GLU . 84.9 t -68.11 -47.77 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.373 -0.83 . . . . 0.0 109.795 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.478 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 13.5 m-85 -64.25 -37.45 87.51 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.521 -0.737 . . . . 0.0 110.515 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -75.58 85.44 2.64 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.52 -0.737 . . . . 0.0 110.193 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -67.68 -41.11 84.18 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.374 -0.829 . . . . 0.0 110.209 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -81.28 -12.33 59.11 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.543 -0.723 . . . . 0.0 111.589 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 59.97 31.15 71.59 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -78.23 0.48 25.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.503 -0.998 . . . . 0.0 111.392 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.5 -10.06 75.66 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.607 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.631 ' HD2' HD21 ' A' ' 137' ' ' ASN . 89.1 m-85 -137.58 137.25 38.35 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.08 -1.247 . . . . 0.0 109.979 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.564 HG22 ' CD1' ' A' ' 105' ' ' LEU . 74.6 mt -88.72 129.98 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.467 -0.771 . . . . 0.0 109.359 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.7 m -109.86 151.3 27.21 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.642 0.734 . . . . 0.0 111.103 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.523 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -49.26 -41.22 37.09 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.62 -0.675 . . . . 0.0 110.799 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.04 -34.32 73.23 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.408 -0.807 . . . . 0.0 108.834 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -74.82 -28.27 60.64 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.688 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.601 ' HB3' HG13 ' A' ' 121' ' ' VAL . 5.9 mp -65.04 -39.97 94.12 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.798 0.809 . . . . 0.0 109.121 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 48.1 ttt-85 -59.96 -34.99 74.02 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.151 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -60.09 -43.91 95.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.317 -0.865 . . . . 0.0 111.048 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.478 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 75.4 t -72.11 -40.38 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.442 -0.787 . . . . 0.0 111.244 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.628 ' SD ' HG22 ' A' ' 121' ' ' VAL . 67.6 mtt -58.07 -49.57 76.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.346 -0.846 . . . . 0.0 110.505 -178.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.5 m -66.03 -42.78 89.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.62 -0.675 . . . . 0.0 109.774 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -62.53 -29.76 70.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.685 -0.634 . . . . 0.0 109.333 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 19.1 mt -69.94 -32.17 70.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.698 -0.626 . . . . 0.0 109.964 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 109.57 26.43 5.09 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -124.16 138.45 54.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.441 -1.035 . . . . 0.0 109.997 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -99.97 118.18 35.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.569 -0.707 . . . . 0.0 110.074 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 86.3 mt -131.68 157.3 44.11 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.6 -0.688 . . . . 0.0 109.667 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.88 162.08 22.91 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.611 -0.681 . . . . 0.0 109.555 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -58.8 -28.32 65.87 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.17 -32.57 73.74 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -39.9 95.25 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.628 HG22 ' SD ' ' A' ' 109' ' ' MET . 73.0 t -70.03 -39.96 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 121.536 0.684 . . . . 0.0 110.567 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -60.04 -44.99 94.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.751 -0.593 . . . . 0.0 110.179 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -60.33 -40.98 92.59 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.645 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 86.6 mmm -55.2 -38.33 68.27 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 119.642 -0.823 . . . . 0.0 108.976 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.402 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 47.3 mm -66.84 -38.06 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-O 121.512 0.672 . . . . 0.0 109.65 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -59.07 -40.0 83.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.68 -0.638 . . . . 0.0 111.555 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.04 -39.87 87.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.619 -0.676 . . . . 0.0 111.043 -178.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.99 0.01 34.44 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.377 -0.827 . . . . 0.0 111.572 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 57.8 t0 -87.55 71.23 9.8 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.019 -1.051 . . . . 0.0 110.679 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.5 mt -67.37 -42.26 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.358 -0.838 . . . . 0.0 110.532 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -71.33 -20.07 62.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.362 -0.836 . . . . 0.0 111.348 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.43 22.7 58.14 Favored Glycine 0 N--CA 1.496 2.682 0 C-N-CA 120.367 -0.921 . . . . 0.0 110.869 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -82.76 -12.5 57.48 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.29 -1.123 . . . . 0.0 111.152 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.4 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 90.0 1.73 75.81 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -139.5 152.1 46.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.267 -1.137 . . . . 0.0 109.459 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 70.7 t -92.46 118.26 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.56 -0.712 . . . . 0.0 110.168 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.631 HD21 ' HD2' ' A' ' 99' ' ' TYR . 30.2 m120 -84.82 175.51 9.09 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -65.05 -41.42 95.18 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.315 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -61.46 -45.86 92.51 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.703 -0.623 . . . . 0.0 111.025 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -66.0 -40.06 90.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.494 -0.754 . . . . 0.0 110.704 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.415 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 77.5 t80 -59.95 -44.22 94.52 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.981 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.758 ' O ' HG22 ' A' ' 146' ' ' THR . 89.6 t -69.56 -39.63 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.416 -0.802 . . . . 0.0 110.917 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 58.3 tt0 -59.98 -47.66 84.89 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.528 -0.732 . . . . 0.0 110.684 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.1 tmm? -60.16 -39.65 87.17 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.41 -0.806 . . . . 0.0 110.693 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 97.5 mmm -69.63 -40.0 76.83 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.603 -0.685 . . . . 0.0 111.053 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.758 HG22 ' O ' ' A' ' 142' ' ' VAL . 9.4 t -96.04 25.59 4.71 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.381 -0.824 . . . . 0.0 110.681 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -96.87 121.83 39.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.447 -0.783 . . . . 0.0 110.695 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 98.2 mttt . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.844 179.507 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -162.75 171.89 38.67 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -60.6 -39.94 89.97 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.648 -0.913 . . . . 0.0 110.476 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -60.04 -39.85 87.37 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.637 -0.664 . . . . 0.0 110.822 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -60.03 -40.0 87.85 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.398 -0.814 . . . . 0.0 110.617 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 85.4 mt -69.92 -40.03 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.375 -0.828 . . . . 0.0 110.813 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.46 -39.75 91.99 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.541 -0.725 . . . . 0.0 110.882 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -60.04 -39.95 87.69 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.583 -0.698 . . . . 0.0 110.468 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.99 -40.01 94.33 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.496 -0.753 . . . . 0.0 111.13 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 164' ' ' VAL . . . . . 0.438 HG11 ' HA ' ' A' ' 88' ' ' ALA . 55.4 t -67.07 -40.0 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.381 -0.824 . . . . 0.0 110.971 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -53.72 -47.89 63.2 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.402 HG21 ' SD ' ' A' ' 72' ' ' MET . 84.4 t -75.13 -22.65 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.693 -0.886 . . . . 0.0 110.569 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.539 HD23 ' C ' ' B' ' 167' ' ' LEU . 5.7 tt -58.7 -49.97 75.6 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.338 -0.851 . . . . 0.0 110.593 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 30.4 ttt85 -65.07 -38.8 91.95 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.468 -0.77 . . . . 0.0 110.136 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.05 -31.46 70.0 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.58 -0.7 . . . . 0.0 109.902 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 4.0 t-105 -60.05 -45.42 92.92 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.697 -0.627 . . . . 0.0 109.883 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.58 -53.16 60.81 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.59 -0.694 . . . . 0.0 110.193 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -60.08 -40.01 88.06 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.508 -0.745 . . . . 0.0 110.732 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.494 -0.753 . . . . 0.0 110.289 179.855 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 121.366 0.603 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 92.7 mt -59.99 -28.2 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.72 -0.613 . . . . 0.0 111.395 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.15 -39.51 94.17 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.148 -0.97 . . . . 0.0 109.743 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -59.98 -40.07 87.84 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.429 ' CG ' HD21 ' A' ' 69' ' ' LEU . 37.2 m-85 -64.29 -20.1 65.85 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.681 -0.637 . . . . 0.0 111.092 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HD3' ' CZ ' ' A' ' 65' ' ' PHE . 73.2 mmtt -69.08 -39.94 78.74 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.196 -0.94 . . . . 0.0 109.407 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -63.64 -59.66 4.31 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.453 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.1 -30.16 71.08 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.371 -0.83 . . . . 0.0 112.232 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.488 ' CG ' ' CE2' ' A' ' 65' ' ' PHE . 57.9 t80 -58.39 -49.97 75.35 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.167 -0.958 . . . . 0.0 110.745 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.0 m -66.15 -39.92 90.18 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.29 -0.881 . . . . 0.0 109.685 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 61.0 tp -62.79 -39.48 94.38 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.416 0.627 . . . . 0.0 109.431 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.536 ' HE2' HG21 ' A' ' 27' ' ' ILE . 32.2 t80 -74.15 -33.19 63.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.863 -0.523 . . . . 0.0 110.202 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -92.33 102.04 14.52 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.468 -0.77 . . . . 0.0 110.129 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -60.02 -39.2 85.02 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.482 -0.761 . . . . 0.0 111.486 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -80.03 -13.15 59.54 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.034 -1.041 . . . . 0.0 111.148 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.19 30.54 58.03 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -90.08 -2.88 58.17 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.714 -0.874 . . . . 0.0 110.84 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.61 3.95 62.4 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 120.22 -0.991 . . . . 0.0 111.432 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.0 p -145.8 142.41 28.84 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 119.197 1.498 . . . . 0.0 111.44 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.536 HG21 ' HE2' ' A' ' 19' ' ' PHE . 85.4 mt -100.68 122.68 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.3 m -95.82 139.47 31.99 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.48 -0.762 . . . . 0.0 110.151 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.626 HG22 ' CD1' ' A' ' 52' ' ' ILE . 65.0 p -42.39 -34.34 0.8 Allowed 'General case' 0 N--CA 1.51 2.571 0 O-C-N 121.961 -0.462 . . . . 0.0 111.588 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -64.31 -48.63 74.9 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.883 0.849 . . . . 0.0 109.136 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -60.0 -56.03 26.67 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.691 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.4 HD12 ' CE2' ' A' ' 19' ' ' PHE . 7.4 tt -61.09 -34.71 75.37 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.21 -0.931 . . . . 0.0 111.056 -178.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -55.82 -32.57 59.1 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.4 m -70.01 -39.39 75.88 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.955 -0.733 . . . . 0.0 110.189 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.0 t -60.0 -57.29 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 94.7 mtp -59.98 -25.72 65.46 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.608 -0.682 . . . . 0.0 109.796 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 43.2 ttt180 -59.99 -46.02 90.82 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.736 0.779 . . . . 0.0 109.31 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.5 t -70.43 -16.98 63.0 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.821 -0.549 . . . . 0.0 111.14 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 39' ' ' LEU . 4.3 mm? -89.88 -18.98 25.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.327 -0.858 . . . . 0.0 110.35 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.4 -50.37 0.2 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -168.01 172.17 9.08 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.645 -0.914 . . . . 0.0 110.674 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -120.61 138.85 27.99 Favored Pre-proline 0 C--N 1.299 -1.628 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.429 ' HG2' HD21 ' A' ' 48' ' ' LEU . 53.6 Cg_endo -68.36 -148.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.224 1.118 . . . . 0.0 109.453 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 p -136.75 152.37 50.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.104 -0.997 . . . . 0.0 110.49 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -52.06 -22.41 4.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.53 -0.731 . . . . 0.0 112.033 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.1 -60.0 2.45 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.17 -0.956 . . . . 0.0 108.994 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -70.01 -33.75 72.42 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.734 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.54 HD13 ' HB ' ' A' ' 29' ' ' THR . 12.9 mt -57.31 -36.88 71.66 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.526 -0.734 . . . . 0.0 109.449 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.44 -30.9 66.57 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.163 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -70.39 -45.08 66.72 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.563 -0.711 . . . . 0.0 111.707 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 79.2 mtm -63.27 -41.67 99.05 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.491 0.662 . . . . 0.0 109.298 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.803 HG22 ' OD2' ' A' ' 56' ' ' ASP . 97.6 mt -68.58 -31.92 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -58.04 -48.12 81.03 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.574 -0.704 . . . . 0.0 110.967 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -64.82 -24.24 67.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.341 -0.849 . . . . 0.0 110.11 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 67.2 t -98.17 -12.01 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.545 -0.722 . . . . 0.0 111.358 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.803 ' OD2' HG22 ' A' ' 52' ' ' ILE . 26.1 m-20 -72.13 101.79 2.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.152 -0.967 . . . . 0.0 111.385 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.06 -39.98 90.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.558 -0.714 . . . . 0.0 109.445 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -88.26 -31.31 19.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.644 -0.66 . . . . 0.0 110.378 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.79 24.36 32.97 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -74.39 -31.96 62.54 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.459 -1.024 . . . . 0.0 110.465 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.68 -2.04 10.16 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.207 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 82.5 p -134.95 168.77 18.48 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.109 -1.23 . . . . 0.0 110.284 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.709 HD11 HG12 ' A' ' 52' ' ' ILE . 6.9 mt -104.49 120.37 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.714 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -98.56 170.25 8.94 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.488 0.661 . . . . 0.0 110.538 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.488 ' CE2' ' CG ' ' A' ' 16' ' ' PHE . 1.2 t80 -50.03 -48.56 78.58 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.4 Cg_endo -69.12 -36.57 12.24 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 O-C-N 122.768 0.878 . . . . 0.0 111.003 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.86 -39.94 76.07 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.484 -0.76 . . . . 0.0 109.223 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -59.89 -45.76 91.49 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.912 -0.493 . . . . 0.0 110.715 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.429 HD21 ' CG ' ' A' ' 12' ' ' PHE . 84.6 mt -63.57 -40.23 96.43 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.412 -0.805 . . . . 0.0 111.246 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.3 m -60.0 -44.04 94.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.441 -0.787 . . . . 0.0 110.719 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -39.98 93.51 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.708 -0.62 . . . . 0.0 111.039 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.431 ' O ' ' HG2' ' A' ' 76' ' ' MET . 57.2 tpp -59.95 -49.76 76.42 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.319 -0.863 . . . . 0.0 110.468 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.57 75.34 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.404 -0.81 . . . . 0.0 110.64 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -74.92 -37.75 61.96 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.458 -0.776 . . . . 0.0 111.119 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.706 ' O ' HG22 ' A' ' 79' ' ' THR . 63.0 mmtt -70.04 -40.03 75.39 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.602 -0.686 . . . . 0.0 112.123 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' A' ' 72' ' ' MET . 39.0 mmt -60.03 -47.29 86.47 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.244 -0.91 . . . . 0.0 112.322 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -68.48 -40.02 81.13 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.25 -0.906 . . . . 0.0 111.065 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -70.54 -20.96 62.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.484 -0.76 . . . . 0.0 111.56 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.706 HG22 ' O ' ' A' ' 75' ' ' LYS . 14.6 t -107.29 -165.33 1.05 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.047 0.927 . . . . 0.0 111.803 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -130.01 136.54 49.52 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.894 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.6 t -60.58 -33.12 72.26 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.624 -0.672 . . . . 0.0 109.895 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -60.07 -34.44 73.45 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.397 0.618 . . . . 0.0 109.461 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -69.9 -40.08 75.84 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.348 0.594 . . . . 0.0 110.374 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -64.66 -34.24 77.83 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.591 -0.693 . . . . 0.0 111.29 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.665 HG23 ' HE2' ' A' ' 141' ' ' PHE . 87.8 mt -69.12 -43.89 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.484 -0.76 . . . . 0.0 110.133 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -59.93 -43.99 94.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.557 -0.714 . . . . 0.0 110.969 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -70.03 -39.9 75.48 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.348 -0.845 . . . . 0.0 110.993 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.518 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -60.73 -44.96 96.0 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.598 -0.689 . . . . 0.0 110.629 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -67.47 -39.27 85.28 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.428 -0.795 . . . . 0.0 110.359 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -60.45 -40.03 89.68 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.523 -0.736 . . . . 0.0 112.268 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 88' ' ' ALA . 34.7 m -71.17 -39.19 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.098 -1.002 . . . . 0.0 111.291 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.465 ' HE2' HG21 ' B' ' 164' ' ' VAL . 11.8 m-85 -70.9 -37.15 72.95 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.114 -0.991 . . . . 0.0 110.669 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -79.79 69.04 6.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.681 -0.637 . . . . 0.0 110.806 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -59.94 -46.15 90.3 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.175 -0.953 . . . . 0.0 109.722 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.9 p-10 -69.89 -20.48 63.37 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.566 -0.709 . . . . 0.0 110.602 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.8 25.23 71.74 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -70.04 -9.76 56.42 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.285 -1.127 . . . . 0.0 111.31 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.11 -10.05 65.59 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.502 ' HD2' HD21 ' A' ' 137' ' ' ASN . 83.1 m-85 -136.84 141.94 42.85 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.158 -1.201 . . . . 0.0 109.021 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 62.0 mt -89.49 120.45 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.407 -0.808 . . . . 0.0 109.929 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 m -84.06 168.56 15.78 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.267 0.555 . . . . 0.0 110.637 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.03 -41.17 91.28 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.621 -0.675 . . . . 0.0 109.552 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.53 -38.35 89.62 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.316 0.579 . . . . 0.0 109.44 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -61.17 -39.95 92.08 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.697 -0.627 . . . . 0.0 110.791 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.415 ' HB3' HG13 ' A' ' 121' ' ' VAL . 1.2 tt -63.6 -44.46 93.93 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.77 0.795 . . . . 0.0 109.35 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.9 ttt-85 -60.66 -32.69 71.86 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.853 -0.53 . . . . 0.0 111.356 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -60.01 -42.38 94.19 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.159 -0.963 . . . . 0.0 110.837 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.434 HG12 ' CD1' ' A' ' 112' ' ' LEU . 86.6 t -74.1 -40.02 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.27 -0.894 . . . . 0.0 110.851 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 13.0 mmt -57.43 -49.18 77.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.4 -0.813 . . . . 0.0 110.067 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.6 m -64.64 -44.95 88.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.644 -0.66 . . . . 0.0 109.551 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -61.63 -29.31 69.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.7 -0.625 . . . . 0.0 109.567 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.434 ' CD1' HG12 ' A' ' 108' ' ' VAL . 11.7 mt -69.97 -30.79 68.22 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.216 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 111.13 25.62 4.98 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -122.84 136.78 54.98 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.454 -1.027 . . . . 0.0 109.727 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -99.94 119.96 39.05 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.548 -0.72 . . . . 0.0 110.674 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 71.3 mt -135.75 158.32 44.67 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.718 -0.614 . . . . 0.0 110.066 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.03 161.12 26.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.602 -0.686 . . . . 0.0 109.302 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -61.71 -27.9 69.04 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.71 -33.82 73.05 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.674 0.749 . . . . 0.0 109.379 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -67.53 -36.83 81.78 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.495 0.665 . . . . 0.0 109.226 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.415 HG13 ' HB3' ' A' ' 105' ' ' LEU . 56.1 t -69.98 -39.95 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.579 0.704 . . . . 0.0 109.78 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -60.0 -38.72 83.44 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.744 -0.597 . . . . 0.0 109.918 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -59.22 -39.72 83.58 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.378 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.9 mtt -55.34 -36.01 65.82 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 119.286 -0.965 . . . . 0.0 109.338 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.4 mm -67.31 -39.54 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.72 -0.613 . . . . 0.0 109.605 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -58.26 -38.24 76.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.606 -0.684 . . . . 0.0 110.734 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.97 -36.79 77.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.667 -0.646 . . . . 0.0 110.096 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.501 ' HB3' HG22 ' A' ' 136' ' ' VAL . . . -103.61 -4.33 23.99 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.563 -0.71 . . . . 0.0 111.307 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -82.49 71.1 9.56 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.959 -1.088 . . . . 0.0 110.24 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 85.3 mt -64.76 -46.88 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.525 -0.734 . . . . 0.0 110.682 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -70.49 -20.18 62.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.541 -0.724 . . . . 0.0 111.785 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.3 22.69 58.4 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -81.05 -10.32 59.7 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.366 -1.079 . . . . 0.0 110.804 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.03 0.63 71.07 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -141.42 156.49 45.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -1.193 . . . . 0.0 109.756 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.501 HG22 ' HB3' ' A' ' 128' ' ' ALA . 63.9 t -95.24 119.36 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.53 -0.731 . . . . 0.0 109.976 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.502 HD21 ' HD2' ' A' ' 99' ' ' TYR . 32.6 m120 -87.88 173.6 8.84 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -60.07 -50.03 75.34 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.649 -0.657 . . . . 0.0 110.054 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -60.66 -41.48 95.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.571 -0.706 . . . . 0.0 111.794 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -65.81 -36.35 83.27 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.2 -0.937 . . . . 0.0 109.882 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.665 ' HE2' HG23 ' A' ' 85' ' ' ILE . 65.6 t80 -62.14 -43.94 97.73 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.034 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.1 t -70.06 -45.24 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.4 -0.812 . . . . 0.0 111.693 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -60.32 -44.73 95.2 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.51 -0.744 . . . . 0.0 110.444 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -61.79 -39.99 93.63 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.697 -0.627 . . . . 0.0 109.945 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.2 mmt -67.71 -39.96 84.3 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.555 -0.715 . . . . 0.0 109.988 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.429 ' O ' HG22 ' A' ' 146' ' ' THR . 36.2 m -89.14 1.37 55.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.753 -0.592 . . . . 0.0 110.52 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.94 136.63 58.07 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.202 -0.936 . . . . 0.0 110.162 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 93.8 mttt . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.191 -179.795 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -146.09 125.38 2.25 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -67.94 -30.35 69.63 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.734 -0.863 . . . . 0.0 110.662 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -60.06 -40.03 88.03 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.383 -0.823 . . . . 0.0 110.139 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -68.36 -33.62 74.6 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.567 -0.708 . . . . 0.0 109.906 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 160' ' ' ILE . . . . . 0.46 ' O ' HG23 ' B' ' 164' ' ' VAL . 47.4 mm -59.94 -44.49 94.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.581 -0.699 . . . . 0.0 110.51 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.43 -39.93 92.7 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.541 -0.724 . . . . 0.0 111.299 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -61.48 -42.21 98.45 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.392 -0.818 . . . . 0.0 111.574 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 8.4 tt -70.05 -40.02 75.36 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.364 -0.835 . . . . 0.0 110.684 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 164' ' ' VAL . . . . . 0.465 HG21 ' HE2' ' A' ' 92' ' ' PHE . 71.6 t -61.41 -39.98 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.628 -0.67 . . . . 0.0 110.644 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -52.48 -37.35 49.15 Favored Glycine 0 N--CA 1.501 2.996 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 89.7 t -78.18 -29.73 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.817 -0.814 . . . . 0.0 110.316 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.556 HD23 ' C ' ' B' ' 167' ' ' LEU . 6.8 tt -59.3 -52.86 63.85 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.459 -0.776 . . . . 0.0 110.9 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -67.13 -39.93 86.68 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.343 -0.848 . . . . 0.0 110.727 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -59.95 -29.57 68.5 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.482 -0.761 . . . . 0.0 110.385 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 170' ' ' TRP . . . . . 0.44 ' HH2' HD12 ' A' ' 63' ' ' ILE . 2.1 t90 -60.01 -47.2 86.83 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.486 -0.759 . . . . 0.0 109.549 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.12 -44.96 94.51 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.628 -0.67 . . . . 0.0 110.974 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -59.99 -40.02 87.72 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.384 -0.823 . . . . 0.0 110.781 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.467 -0.77 . . . . 0.0 110.316 -179.753 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 121.75 0.786 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 77.3 mt -58.59 -35.33 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.856 -0.527 . . . . 0.0 111.181 -178.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -62.65 -55.79 23.68 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.87 -1.144 . . . . 0.0 111.597 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -56.11 -38.52 70.87 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.564 -1.335 . . . . 0.0 111.025 -177.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -68.22 -30.11 69.1 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 20.7 ttpt -68.28 -38.49 81.76 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.386 0.613 . . . . 0.0 109.712 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.11 -59.22 5.76 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.431 0.634 . . . . 0.0 110.728 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.76 -33.16 75.04 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.844 -0.535 . . . . 0.0 112.426 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -58.26 -48.08 81.55 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.933 -1.104 . . . . 0.0 110.502 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.1 t -65.22 -37.83 88.5 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.223 -0.923 . . . . 0.0 108.842 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 64.3 tp -60.07 -40.01 88.03 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.154 0.502 . . . . 0.0 109.976 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -75.38 -30.62 60.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.663 -0.648 . . . . 0.0 110.37 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -93.0 103.4 15.72 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.545 -0.722 . . . . 0.0 109.201 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -59.97 -38.16 81.72 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.542 -0.724 . . . . 0.0 112.29 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -77.97 -11.78 59.93 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.825 -1.172 . . . . 0.0 111.09 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.77 27.7 50.44 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -89.63 -0.93 57.85 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.599 -0.942 . . . . 0.0 110.785 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.44 4.91 63.82 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 120.256 -0.974 . . . . 0.0 111.218 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.2 p -146.08 143.59 29.48 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 119.137 1.469 . . . . 0.0 111.768 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.8 mt -104.73 129.98 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.8 p -108.04 144.94 34.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.652 -0.655 . . . . 0.0 110.795 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.6 p -43.37 -32.29 0.81 Allowed 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.877 -0.515 . . . . 0.0 112.142 -178.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -65.39 -50.15 66.58 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.233 -0.917 . . . . 0.0 109.593 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -60.08 -54.52 45.02 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.936 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.667 HD21 ' SD ' ' A' ' 36' ' ' MET . 9.7 tt -60.01 -35.66 75.54 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.367 -0.833 . . . . 0.0 111.231 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.94 -31.3 17.21 Favored Glycine 0 N--CA 1.5 2.957 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.1 m -70.02 -39.87 75.53 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.576 -0.956 . . . . 0.0 110.372 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.74 -57.4 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.543 -0.723 . . . . 0.0 110.053 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.667 ' SD ' HD21 ' A' ' 32' ' ' LEU . 65.0 mtt -60.3 -31.54 70.35 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.493 -0.754 . . . . 0.0 110.78 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.99 -48.85 80.02 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.382 -0.824 . . . . 0.0 109.155 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 t -71.95 -12.86 61.44 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.884 -0.51 . . . . 0.0 110.2 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.801 HD22 ' CD1' ' B' ' 167' ' ' LEU . 18.4 tp -82.44 -33.7 28.45 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.354 -0.841 . . . . 0.0 109.81 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.07 -30.44 0.14 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -158.39 155.76 29.24 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.251 -1.146 . . . . 0.0 111.3 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.432 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 5.8 p-10 -114.21 104.79 54.63 Favored Pre-proline 0 C--N 1.297 -1.712 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.167 178.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.594 ' HG2' HD21 ' A' ' 48' ' ' LEU . 44.1 Cg_endo -62.23 -151.89 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.392 0 O-C-N 123.001 1.0 . . . . 0.0 109.82 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.1 p -140.04 154.57 47.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.995 -1.066 . . . . 0.0 111.925 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -52.57 -22.84 5.41 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.757 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.63 -60.02 2.44 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.938 0.875 . . . . 0.0 109.427 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.69 -32.63 71.35 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.404 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.594 HD21 ' HG2' ' A' ' 43' ' ' PRO . 44.2 mt -60.06 -34.08 72.94 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.628 0.728 . . . . 0.0 109.836 178.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.2 -32.49 66.83 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.259 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -69.86 -43.87 70.98 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.248 -0.907 . . . . 0.0 111.745 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.43 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 21.5 ptm -63.22 -39.16 93.83 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.789 -0.764 . . . . 0.0 109.241 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.617 HG22 ' OD2' ' A' ' 56' ' ' ASP . 71.4 mt -68.63 -33.61 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.676 -0.64 . . . . 0.0 110.235 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -60.01 -40.1 88.06 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.409 -0.807 . . . . 0.0 111.412 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -67.04 -27.22 67.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 110.527 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.8 t -100.09 -9.95 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.548 -0.72 . . . . 0.0 110.91 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.617 ' OD2' HG22 ' A' ' 52' ' ' ILE . 1.0 OUTLIER -74.29 107.87 6.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.104 -0.998 . . . . 0.0 110.971 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -93.28 -20.24 20.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.742 -0.599 . . . . 0.0 109.657 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -75.36 -40.14 58.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.49 -0.756 . . . . 0.0 110.803 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.27 -4.48 62.39 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -74.64 -39.58 62.0 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.199 -1.177 . . . . 0.0 111.061 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 123.77 4.78 7.89 Favored Glycine 0 N--CA 1.496 2.634 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.317 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 76.4 p -135.4 162.7 31.88 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.129 -1.218 . . . . 0.0 110.284 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.429 ' HA ' ' OE1' ' A' ' 67' ' ' GLU . 7.8 mt -99.5 118.93 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.767 -177.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -93.59 171.22 9.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.667 -0.646 . . . . 0.0 109.945 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.485 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 16.4 t80 -46.1 -48.76 42.56 Favored Pre-proline 0 N--CA 1.498 1.967 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.5 Cg_endo -67.28 -32.55 32.87 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 122.747 0.867 . . . . 0.0 111.526 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.429 ' OE1' ' HA ' ' A' ' 63' ' ' ILE . 80.1 mt-10 -74.16 -41.1 62.05 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.214 -0.929 . . . . 0.0 110.346 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -60.21 -45.67 92.36 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.515 -0.74 . . . . 0.0 110.638 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 65' ' ' PHE . 6.1 mp -66.34 -39.94 89.54 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.446 -0.784 . . . . 0.0 111.419 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.6 m -60.74 -43.07 98.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.541 -0.725 . . . . 0.0 110.616 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 57.6 ttp -66.63 -42.77 86.25 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.597 -0.69 . . . . 0.0 111.663 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 54.0 ttm -59.97 -49.86 76.01 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.432 -0.792 . . . . 0.0 111.165 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.68 -32.83 74.61 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.512 -0.743 . . . . 0.0 111.493 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -71.17 -40.01 71.52 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.394 -0.816 . . . . 0.0 111.127 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -69.53 -38.33 77.48 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.391 -0.818 . . . . 0.0 111.778 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.7 mtm -56.22 -48.21 76.9 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.318 -0.864 . . . . 0.0 111.871 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -69.82 -39.99 76.15 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.09 -1.006 . . . . 0.0 110.999 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -69.6 -34.05 73.56 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.459 -0.776 . . . . 0.0 110.635 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.621 HG22 ' H ' ' A' ' 80' ' ' ASP . 4.0 m -97.59 -173.43 2.63 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.866 -0.521 . . . . 0.0 110.017 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.621 ' H ' HG22 ' A' ' 79' ' ' THR . 91.5 m-20 -117.36 138.04 52.06 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.244 -0.91 . . . . 0.0 110.156 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 52.2 p -64.36 -27.32 68.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.598 -0.689 . . . . 0.0 110.153 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -60.06 -34.62 73.67 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.535 -0.728 . . . . 0.0 109.297 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.15 -39.57 78.74 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.348 0.594 . . . . 0.0 109.47 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.42 -37.75 88.63 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.704 -0.622 . . . . 0.0 110.827 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.593 HG23 ' HE2' ' A' ' 141' ' ' PHE . 98.2 mt -66.9 -48.29 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.524 -0.735 . . . . 0.0 110.923 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 41.9 mtp85 -59.99 -40.94 90.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.423 -0.798 . . . . 0.0 111.414 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.56 ' O ' HG23 ' A' ' 91' ' ' VAL . 98.9 mt-10 -70.05 -40.73 74.95 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.32 -0.863 . . . . 0.0 111.51 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.35 -44.98 85.99 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.569 -0.707 . . . . 0.0 111.5 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -62.59 -40.92 98.43 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.826 0.822 . . . . 0.0 109.475 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -59.97 -36.6 77.48 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.953 -0.467 . . . . 0.0 111.027 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 87' ' ' GLU . 87.8 t -69.58 -49.07 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.545 -0.722 . . . . 0.0 109.972 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.66 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 28.4 m-85 -66.65 -39.87 88.41 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.538 -0.726 . . . . 0.0 110.967 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -77.28 72.48 3.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.495 -0.753 . . . . 0.0 109.843 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -59.99 -44.44 94.5 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.541 -0.724 . . . . 0.0 109.967 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 36.0 p-10 -78.56 -24.8 45.37 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.649 -0.657 . . . . 0.0 110.692 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.44 29.85 73.13 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.6 p-10 -71.68 -13.96 61.89 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.455 -1.027 . . . . 0.0 111.773 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.89 -22.42 8.62 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 119.966 -1.111 . . . . 0.0 110.588 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 35.6 p90 -145.96 156.39 43.48 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.28 -1.13 . . . . 0.0 109.452 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 64.6 mt -89.3 126.56 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-O 121.822 0.82 . . . . 0.0 110.849 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.5 m -86.48 172.46 10.32 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.16 0.505 . . . . 0.0 110.518 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.78 -40.26 83.99 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.61 -0.681 . . . . 0.0 109.717 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.47 -38.59 91.55 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -60.58 -37.96 83.05 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.703 -0.623 . . . . 0.0 110.214 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.462 ' HB3' HG13 ' A' ' 121' ' ' VAL . 0.9 OUTLIER -60.03 -41.36 92.05 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.608 0.718 . . . . 0.0 109.427 179.18 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 63.4 mtp180 -60.07 -35.64 75.6 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.815 -0.553 . . . . 0.0 112.277 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -60.06 -45.66 92.15 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.084 -1.01 . . . . 0.0 111.512 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.66 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 63.7 t -73.85 -37.79 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.374 -0.829 . . . . 0.0 111.379 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 14.2 mmt -59.92 -47.17 86.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.331 -0.856 . . . . 0.0 110.002 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.6 m -65.56 -40.86 93.3 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.691 -0.631 . . . . 0.0 109.462 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -60.6 -34.55 74.39 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.9 mt -69.94 -31.86 69.82 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.145 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.68 26.45 6.14 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.416 ' OE2' HD21 ' A' ' 116' ' ' LEU . 88.8 tt0 -119.52 132.97 55.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.33 -1.1 . . . . 0.0 109.884 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -98.57 120.13 38.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.582 -0.699 . . . . 0.0 110.014 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.416 HD21 ' OE2' ' A' ' 114' ' ' GLU . 57.0 mt -130.18 159.96 35.25 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.474 -0.766 . . . . 0.0 110.489 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.2 p -83.14 163.34 20.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.811 -0.556 . . . . 0.0 109.659 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -63.22 -27.0 69.06 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -69.97 -37.31 75.75 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.582 0.706 . . . . 0.0 109.194 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -65.12 -36.67 85.02 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.536 0.684 . . . . 0.0 109.36 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.462 HG13 ' HB3' ' A' ' 105' ' ' LEU . 97.5 t -69.48 -39.41 78.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.694 0.759 . . . . 0.0 109.613 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -59.98 -40.21 88.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.794 -0.566 . . . . 0.0 110.287 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -60.0 -40.96 91.01 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.405 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.412 ' CB ' HD11 ' A' ' 105' ' ' LEU . 67.6 mtt -55.07 -35.83 64.96 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.459 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.5 mm -66.58 -39.09 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.789 -0.569 . . . . 0.0 110.066 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 50.0 ttt-85 -60.02 -40.02 87.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.494 -0.753 . . . . 0.0 111.742 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -60.12 -38.53 83.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.468 -0.77 . . . . 0.0 110.865 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.549 ' HB2' ' HE2' ' A' ' 144' ' ' MET . . . -103.4 6.33 37.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.46 -0.775 . . . . 0.0 111.447 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -118.94 81.01 1.63 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.007 -1.058 . . . . 0.0 111.48 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 86.4 mt -66.79 -40.05 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.563 -0.711 . . . . 0.0 109.98 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.9 p30 -59.84 -39.32 84.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.626 -0.671 . . . . 0.0 111.136 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.54 15.96 44.72 Favored Glycine 0 N--CA 1.494 2.553 0 C-N-CA 120.149 -1.024 . . . . 0.0 111.24 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -80.01 -20.14 46.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.135 -1.215 . . . . 0.0 110.115 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.72 8.12 57.34 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.807 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -132.69 131.31 41.13 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.163 -1.198 . . . . 0.0 110.066 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.8 t -92.34 110.39 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.55 -0.719 . . . . 0.0 109.664 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -83.85 178.65 7.82 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.581 -0.699 . . . . 0.0 109.569 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -61.34 -44.89 96.43 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.747 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -61.76 -40.49 95.34 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.344 -0.847 . . . . 0.0 111.084 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -63.82 -39.62 94.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.325 -0.859 . . . . 0.0 109.629 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.593 ' HE2' HG23 ' A' ' 85' ' ' ILE . 69.4 t80 -60.0 -49.59 77.05 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.883 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.67 ' O ' HG22 ' A' ' 146' ' ' THR . 89.3 t -61.16 -41.38 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.317 -0.865 . . . . 0.0 110.919 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -60.0 -40.2 88.4 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.259 -0.9 . . . . 0.0 109.741 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.549 ' HE2' ' HB2' ' A' ' 128' ' ' ALA . 7.7 ttm -60.24 -42.04 94.46 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.701 -0.624 . . . . 0.0 110.609 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 98.4 mmm -69.93 -40.04 75.76 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.629 -0.669 . . . . 0.0 111.099 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.67 HG22 ' O ' ' A' ' 142' ' ' VAL . 9.2 t -98.23 19.28 14.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.583 -0.698 . . . . 0.0 110.383 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.14 -39.96 92.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.51 -0.743 . . . . 0.0 109.829 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 44.1 mttp . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.045 179.95 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -116.09 136.51 12.96 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -64.41 -36.72 85.09 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.542 -0.975 . . . . 0.0 110.241 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -60.03 -39.15 84.88 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.691 -0.631 . . . . 0.0 110.095 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 159' ' ' ARG . . . . . 0.441 ' NH2' HD21 ' B' ' 163' ' ' LEU . 16.4 tpt180 -60.02 -39.97 87.69 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.653 -0.654 . . . . 0.0 110.693 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 97.2 mt -69.61 -39.94 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.307 -0.87 . . . . 0.0 110.526 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.37 -39.94 89.05 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.562 -0.711 . . . . 0.0 110.967 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -67.14 -39.97 86.65 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.443 -0.786 . . . . 0.0 110.821 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.441 HD21 ' NH2' ' B' ' 159' ' ' ARG . 88.6 mt -64.1 -40.04 95.35 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.472 -0.768 . . . . 0.0 111.192 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 83.4 t -70.03 -40.0 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.413 -0.804 . . . . 0.0 110.714 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.98 -50.01 69.81 Favored Glycine 0 N--CA 1.498 2.807 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 14.6 p -71.09 -28.44 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.604 -0.939 . . . . 0.0 110.461 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.801 ' CD1' HD22 ' A' ' 39' ' ' LEU . 2.7 tm? -60.04 -50.16 74.81 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.467 -0.77 . . . . 0.0 111.469 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -70.05 -39.99 75.37 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.466 -0.771 . . . . 0.0 110.655 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -60.38 -39.98 89.22 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.46 -0.775 . . . . 0.0 111.628 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 18.3 t90 -70.06 -31.36 68.94 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.373 -0.829 . . . . 0.0 110.458 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.43 -47.81 80.79 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.469 -0.769 . . . . 0.0 110.264 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -60.0 -33.78 72.44 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.538 -0.726 . . . . 0.0 110.104 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.764 -0.585 . . . . 0.0 110.384 -179.373 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 . . . . . 0 N--CA 1.497 1.915 0 CA-C-O 121.015 0.436 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.6 mm -62.97 -43.0 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.386 -0.821 . . . . 0.0 110.342 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.9 -31.21 72.22 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.732 -0.605 . . . . 0.0 111.105 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -62.56 -39.99 95.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.805 . . . . 0.0 109.719 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.463 ' HB3' HD11 ' A' ' 69' ' ' LEU . 17.4 m-85 -64.26 -23.91 67.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.95 -0.469 . . . . 0.0 111.347 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.43 ' HD3' ' CE1' ' A' ' 65' ' ' PHE . 73.9 mmtt -68.93 -40.0 79.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.193 -0.942 . . . . 0.0 110.271 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -77.76 -23.99 49.1 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.991 -0.443 . . . . 0.0 111.57 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.51 -38.36 34.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.3 -0.875 . . . . 0.0 111.175 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -56.76 -39.98 75.0 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.662 -0.649 . . . . 0.0 111.33 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 94.0 p -60.26 -39.33 86.4 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.188 -0.945 . . . . 0.0 110.055 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.594 HD11 HD22 ' A' ' 112' ' ' LEU . 7.1 tt -59.97 -44.45 94.44 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.62 -0.675 . . . . 0.0 109.381 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.419 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 0.9 OUTLIER -70.02 -38.96 76.06 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.888 -0.508 . . . . 0.0 109.714 178.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -94.68 92.59 7.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.604 -0.685 . . . . 0.0 109.287 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -59.07 -22.5 60.87 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.228 -0.92 . . . . 0.0 111.653 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -81.23 -55.79 4.5 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.037 -1.039 . . . . 0.0 109.0 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.72 28.32 7.08 Favored Glycine 0 N--CA 1.482 1.748 0 N-CA-C 107.885 -2.086 . . . . 0.0 107.885 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -90.01 -1.23 57.93 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.666 -0.902 . . . . 0.0 110.526 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.04 -0.1 64.02 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 120.42 -0.895 . . . . 0.0 110.931 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.0 p -144.88 143.01 30.36 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 119.212 1.506 . . . . 0.0 111.547 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.419 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 83.8 mt -106.4 130.08 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.796 -0.565 . . . . 0.0 109.844 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.4 m -104.91 143.91 32.51 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.486 -0.758 . . . . 0.0 110.632 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 55.1 p -41.96 -35.71 0.93 Allowed 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.851 -0.531 . . . . 0.0 111.93 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.1 mttm -63.9 -48.17 77.68 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.35 -0.843 . . . . 0.0 109.325 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -58.96 -51.13 71.38 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.514 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.2 tp -59.93 -34.86 73.8 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.104 -0.997 . . . . 0.0 110.827 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.413 ' O ' ' CB ' ' A' ' 37' ' ' ARG . . . -48.52 -32.76 10.84 Favored Glycine 0 N--CA 1.5 2.963 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.1 m -70.06 -40.01 75.32 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 118.36 1.08 . . . . 0.0 110.3 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.587 HG12 HD12 ' A' ' 39' ' ' LEU . 98.1 t -69.11 -58.19 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.461 -0.774 . . . . 0.0 111.654 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 93.9 mmm -59.88 -37.26 78.85 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.258 -0.901 . . . . 0.0 110.849 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.414 ' HD3' ' HB2' ' A' ' 42' ' ' ASN . 5.9 tpt180 -60.01 -50.03 75.32 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.517 0.675 . . . . 0.0 109.736 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.1 p -71.75 -18.16 62.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.785 -0.572 . . . . 0.0 111.369 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.587 HD12 HG12 ' A' ' 35' ' ' VAL . 15.4 mt -91.86 -18.12 24.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.427 -0.796 . . . . 0.0 111.656 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.98 -40.47 0.2 Allowed Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.251 -1.452 . . . . 0.0 111.612 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.407 ' HG2' ' N ' ' A' ' 42' ' ' ASN . 26.4 tt0 -159.92 157.97 29.92 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 118.872 1.336 . . . . 0.0 112.128 -178.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.428 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 53.4 t30 -118.01 103.72 49.6 Favored Pre-proline 0 N--CA 1.489 1.513 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.244 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.786 ' HG2' HD21 ' A' ' 48' ' ' LEU . 44.5 Cg_endo -63.83 -148.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.335 0 O-C-N 123.309 1.163 . . . . 0.0 109.503 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.7 p -135.99 151.45 49.93 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.826 -1.171 . . . . 0.0 111.495 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -52.35 -24.52 7.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.652 -0.655 . . . . 0.0 111.449 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.16 -58.99 2.97 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 122.034 0.921 . . . . 0.0 108.729 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -65.43 -39.06 91.64 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.051 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.786 HD21 ' HG2' ' A' ' 43' ' ' PRO . 75.2 mt -58.04 -35.56 71.49 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.663 0.744 . . . . 0.0 110.01 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -40.03 82.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 122.01 -0.431 . . . . 0.0 111.491 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -65.22 -36.19 83.4 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.365 -0.834 . . . . 0.0 110.0 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.545 ' HE1' ' O ' ' B' ' 170' ' ' TRP . 92.0 mmm -59.93 -45.61 92.03 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.447 0.642 . . . . 0.0 109.879 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.635 HG23 HG12 ' A' ' 63' ' ' ILE . 96.0 mt -67.74 -33.06 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.761 -0.587 . . . . 0.0 110.303 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -59.93 -40.01 87.44 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.537 -0.727 . . . . 0.0 110.766 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -66.93 -28.61 68.44 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.327 -0.858 . . . . 0.0 110.621 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.778 HG21 ' HE2' ' A' ' 71' ' ' MET . 57.3 t -102.0 -7.17 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.613 -0.68 . . . . 0.0 111.081 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.485 ' OD2' HG22 ' A' ' 52' ' ' ILE . 3.1 m-20 -67.82 105.53 1.98 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.2 -0.937 . . . . 0.0 110.72 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.54 -39.56 77.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.635 -0.666 . . . . 0.0 109.801 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -90.21 -27.66 19.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.612 -0.68 . . . . 0.0 110.531 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.82 21.61 46.07 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -74.32 -34.22 63.39 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.447 -1.031 . . . . 0.0 110.425 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.8 1.22 7.61 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.486 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 66.7 p -138.69 164.83 28.52 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.077 -1.249 . . . . 0.0 111.457 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.635 HG12 HG23 ' A' ' 52' ' ' ILE . 10.0 mt -100.84 122.1 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 121.34 0.59 . . . . 0.0 111.298 -177.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -96.08 171.41 8.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.697 -0.627 . . . . 0.0 109.695 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.642 ' O ' HD13 ' A' ' 69' ' ' LEU . 78.6 t80 -48.57 -49.95 61.74 Favored Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 121.435 -0.79 . . . . 0.0 112.56 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.4 Cg_endo -66.47 -33.91 35.64 Favored 'Trans proline' 0 N--CA 1.492 1.382 0 O-C-N 122.693 0.838 . . . . 0.0 111.255 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -70.44 -39.98 74.02 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.302 -0.874 . . . . 0.0 110.383 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -64.0 -40.02 95.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.712 -0.618 . . . . 0.0 110.67 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.642 HD13 ' O ' ' A' ' 65' ' ' PHE . 5.9 mp -66.66 -39.9 88.41 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.657 -0.652 . . . . 0.0 111.9 -178.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.7 p -60.24 -40.1 89.05 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.09 -1.006 . . . . 0.0 110.403 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.778 ' HE2' HG21 ' A' ' 55' ' ' VAL . 31.7 ttm -66.72 -54.36 23.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.643 -0.66 . . . . 0.0 111.979 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.599 ' HE2' HG11 ' B' ' 166' ' ' VAL . 57.8 ttm -61.74 -52.37 64.53 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -177.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.77 -38.19 86.09 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.561 -0.712 . . . . 0.0 112.536 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -71.42 -44.21 65.29 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.312 -0.867 . . . . 0.0 111.739 -178.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -71.81 -40.87 68.87 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.329 -0.857 . . . . 0.0 113.048 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 26.9 ptm -57.03 -20.3 23.72 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.178 -0.951 . . . . 0.0 111.326 -178.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -66.58 -54.27 25.38 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.327 -0.858 . . . . 0.0 110.495 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -70.0 -23.34 63.13 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.798 -0.563 . . . . 0.0 110.457 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.599 HG22 ' H ' ' A' ' 80' ' ' ASP . 2.4 m -83.02 -173.05 4.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.633 -0.667 . . . . 0.0 110.006 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.599 ' H ' HG22 ' A' ' 79' ' ' THR . 81.9 m-20 -128.14 140.37 51.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.311 -0.868 . . . . 0.0 109.945 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.2 t -70.03 -25.1 63.41 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.642 -0.661 . . . . 0.0 110.507 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.636 ' HA ' HD12 ' A' ' 85' ' ' ILE . 99.0 mt-10 -60.08 -37.07 78.81 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.897 0.856 . . . . 0.0 108.743 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -67.48 -39.89 85.27 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.421 0.629 . . . . 0.0 109.844 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -65.33 -33.82 76.88 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.694 -0.629 . . . . 0.0 110.519 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.636 HD12 ' HA ' ' A' ' 82' ' ' GLU . 78.9 mt -66.08 -46.76 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.655 -0.653 . . . . 0.0 110.071 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 62.1 mtt180 -60.01 -40.42 89.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.51 -0.744 . . . . 0.0 111.584 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.498 ' O ' HG23 ' A' ' 91' ' ' VAL . 97.9 mt-10 -70.07 -40.18 75.2 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.203 -0.936 . . . . 0.0 111.548 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.858 ' HA ' HG11 ' B' ' 164' ' ' VAL . . . -65.18 -45.4 84.99 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.531 -0.73 . . . . 0.0 111.114 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -60.0 -47.41 85.94 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.529 0.68 . . . . 0.0 109.978 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -60.01 -36.62 77.62 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.791 -0.568 . . . . 0.0 111.192 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 87' ' ' GLU . 72.0 t -69.19 -49.75 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.262 -0.899 . . . . 0.0 109.569 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -67.65 -39.99 84.57 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.315 -0.866 . . . . 0.0 109.877 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -79.83 79.66 6.32 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -69.03 -39.89 78.96 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.45 -0.781 . . . . 0.0 111.034 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -77.4 -21.42 53.17 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.465 -0.772 . . . . 0.0 110.839 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.18 28.95 74.07 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -72.91 -10.31 59.66 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.561 -0.964 . . . . 0.0 111.765 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.78 -20.98 12.86 Favored Glycine 0 N--CA 1.498 2.829 0 C-N-CA 120.025 -1.083 . . . . 0.0 110.608 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -144.66 152.44 40.46 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.388 -1.066 . . . . 0.0 109.236 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.617 ' CG2' HD23 ' A' ' 105' ' ' LEU . 18.5 mt -88.67 131.35 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.096 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.02 170.96 11.1 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.918 -0.489 . . . . 0.0 109.756 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.77 -39.33 73.27 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.57 -37.24 86.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.692 -0.63 . . . . 0.0 109.46 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -62.24 -34.34 76.33 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.555 0.693 . . . . 0.0 109.416 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.617 HD23 ' CG2' ' A' ' 100' ' ' ILE . 0.5 OUTLIER -69.16 -40.32 78.24 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.907 -0.496 . . . . 0.0 109.964 179.173 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -60.0 -38.75 83.53 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.533 -0.729 . . . . 0.0 111.352 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -60.1 -46.2 90.38 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.083 -1.011 . . . . 0.0 111.709 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.473 HG12 ' CD1' ' A' ' 112' ' ' LEU . 93.2 t -70.28 -39.99 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.203 -0.936 . . . . 0.0 111.183 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.614 ' CE ' HD13 ' B' ' 160' ' ' ILE . 16.0 mmt -59.64 -50.03 75.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.546 -0.721 . . . . 0.0 110.889 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 93.9 m -67.35 -43.09 82.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.543 -0.723 . . . . 0.0 109.955 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -61.63 -31.67 71.77 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.36 0.6 . . . . 0.0 109.432 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.594 HD22 HD11 ' A' ' 18' ' ' LEU . 19.9 mt -69.41 -34.93 75.21 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.917 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 119.66 26.1 2.44 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -126.13 149.62 48.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.385 -1.067 . . . . 0.0 109.782 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -116.48 126.0 52.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.515 -0.741 . . . . 0.0 110.415 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 60.4 mt -138.08 154.72 49.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.593 -0.692 . . . . 0.0 109.326 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.03 163.77 23.95 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -62.0 -27.45 68.88 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.016 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.55 -32.7 73.65 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.421 0.629 . . . . 0.0 109.869 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -68.34 -36.61 79.5 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 90.7 t -66.88 -39.75 84.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.837 0.827 . . . . 0.0 108.955 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -59.99 -47.69 84.77 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.498 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -60.05 -40.07 88.13 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.838 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 65.7 mtt -55.93 -38.53 70.43 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.443 -0.903 . . . . 0.0 109.096 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 47.9 mm -65.93 -39.3 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 121.452 0.644 . . . . 0.0 109.655 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.9 ttt-85 -57.78 -38.67 75.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.678 -0.639 . . . . 0.0 110.843 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -59.95 -37.51 79.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.699 -0.626 . . . . 0.0 110.628 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.14 -1.6 27.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.403 -0.81 . . . . 0.0 111.323 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -84.76 71.75 10.81 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.996 -1.065 . . . . 0.0 110.392 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.6 mt -67.16 -41.43 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.434 -0.792 . . . . 0.0 110.245 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.5 p-10 -72.56 -20.14 61.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.328 -0.858 . . . . 0.0 111.148 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.64 22.14 62.6 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 120.312 -0.947 . . . . 0.0 111.139 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -83.1 -10.04 58.9 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.214 -1.168 . . . . 0.0 111.064 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.21 0.71 76.66 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -137.57 148.17 45.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.208 -1.171 . . . . 0.0 109.648 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 85.9 t -90.06 117.75 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.429 -0.794 . . . . 0.0 110.348 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -89.26 175.33 7.39 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -61.79 -47.92 82.97 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.794 -0.566 . . . . 0.0 110.117 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -60.02 -49.3 78.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.731 -0.606 . . . . 0.0 111.851 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -63.3 -35.4 80.24 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.316 -0.865 . . . . 0.0 109.991 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.507 ' HE1' HG23 ' A' ' 85' ' ' ILE . 64.9 t80 -60.02 -45.14 93.76 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 91.8 t -70.01 -37.85 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.328 -0.857 . . . . 0.0 111.564 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 61.9 tt0 -59.91 -47.13 87.01 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.207 -0.933 . . . . 0.0 110.395 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.4 tmm? -60.02 -39.24 85.17 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.511 -0.743 . . . . 0.0 109.925 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 96.2 mmm -65.74 -40.03 91.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.64 -0.662 . . . . 0.0 109.869 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.1 m -92.39 6.51 46.68 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.563 -0.711 . . . . 0.0 110.914 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -99.04 119.83 38.46 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.1 -1.0 . . . . 0.0 110.256 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.7 mtmt . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.266 -179.897 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.74 68.53 0.26 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -59.98 -44.1 94.7 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.584 -0.951 . . . . 0.0 110.241 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -60.02 -39.48 85.97 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.593 -0.692 . . . . 0.0 111.098 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -59.3 -39.98 84.76 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.301 -0.875 . . . . 0.0 110.256 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 160' ' ' ILE . . . . . 0.614 HD13 ' CE ' ' A' ' 109' ' ' MET . 97.0 mt -62.8 -40.04 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.571 -0.706 . . . . 0.0 109.377 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.3 -31.01 72.05 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.621 -0.674 . . . . 0.0 110.42 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -60.03 -38.81 83.84 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.573 -0.704 . . . . 0.0 110.097 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.553 ' O ' HG12 ' B' ' 166' ' ' VAL . 66.6 mt -60.01 -40.44 89.27 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.477 -0.764 . . . . 0.0 110.99 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 164' ' ' VAL . . . . . 0.858 HG11 ' HA ' ' A' ' 88' ' ' ALA . 99.1 t -68.4 -40.0 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.558 -0.714 . . . . 0.0 110.466 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.75 -41.97 94.18 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.599 HG11 ' HE2' ' A' ' 72' ' ' MET . 11.5 p -74.98 -12.24 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -1.101 . . . . 0.0 110.96 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.506 HD23 ' C ' ' B' ' 167' ' ' LEU . 9.5 tt -60.01 -49.16 78.74 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.113 -0.992 . . . . 0.0 109.48 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -60.0 -41.05 91.26 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.653 -0.654 . . . . 0.0 110.32 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.07 -40.29 88.99 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.632 -0.668 . . . . 0.0 111.601 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 170' ' ' TRP . . . . . 0.545 ' O ' ' HE1' ' A' ' 51' ' ' MET . 5.0 t-105 -61.43 -47.61 84.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.436 -0.79 . . . . 0.0 110.512 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.02 -43.62 95.14 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.542 -0.724 . . . . 0.0 111.007 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -60.01 -40.0 87.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.37 -0.831 . . . . 0.0 110.625 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 . . . . . 0 N--CA 1.495 1.794 0 O-C-N 121.413 -0.804 . . . . 0.0 110.4 -179.877 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 . . . . . 0 N--CA 1.5 2.073 0 CA-C-O 120.739 0.304 . . . . 0.0 111.448 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.5 mm -60.68 -50.03 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.369 -0.832 . . . . 0.0 110.891 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.04 -31.44 69.97 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.64 -0.662 . . . . 0.0 111.466 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -59.95 -43.04 95.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.927 . . . . 0.0 110.586 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.426 ' CE2' ' HG ' ' A' ' 69' ' ' LEU . 44.5 m-85 -65.23 -21.77 66.79 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.578 -0.701 . . . . 0.0 111.468 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.43 ' HD3' ' CZ ' ' A' ' 65' ' ' PHE . 32.5 mmtt -70.71 -43.92 67.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.083 -1.011 . . . . 0.0 110.391 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -75.16 -28.23 60.01 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.21 -30.27 22.54 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.144 -0.972 . . . . 0.0 111.851 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -59.99 -45.85 91.39 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.497 -0.752 . . . . 0.0 111.677 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.5 m -60.06 -39.48 86.17 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.221 -0.924 . . . . 0.0 109.604 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.6 tp -61.35 -43.47 98.82 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.624 ' HZ ' HD21 ' B' ' 167' ' ' LEU . 1.3 m-85 -69.95 -40.07 75.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.993 -0.442 . . . . 0.0 110.461 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -92.32 95.36 9.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.439 -0.788 . . . . 0.0 109.627 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -60.01 -34.52 73.47 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.381 -0.824 . . . . 0.0 110.859 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -80.03 -10.11 59.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.255 -0.903 . . . . 0.0 111.051 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.43 26.53 44.99 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -88.02 -7.88 56.41 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.64 -0.918 . . . . 0.0 111.035 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.77 1.77 58.64 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.542 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.8 p -144.02 141.57 30.19 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 119.192 1.496 . . . . 0.0 111.192 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 88.1 mt -104.23 128.45 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.714 -0.616 . . . . 0.0 109.492 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.5 p -100.5 139.62 35.93 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.61 -0.681 . . . . 0.0 110.2 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.725 HG22 ' CD1' ' A' ' 52' ' ' ILE . 61.1 p -42.38 -30.93 0.36 Allowed 'General case' 0 N--CA 1.511 2.603 0 O-C-N 121.796 -0.565 . . . . 0.0 111.645 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -65.66 -49.63 67.94 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.413 -0.804 . . . . 0.0 109.641 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.35 -53.9 52.95 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.71 -0.619 . . . . 0.0 111.165 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.454 ' CD2' ' CZ2' ' B' ' 170' ' ' TRP . 58.8 tp -59.99 -34.76 73.75 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.318 -0.864 . . . . 0.0 110.633 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.04 -31.47 10.85 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.4 m -70.14 -40.83 74.58 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.517 -0.99 . . . . 0.0 110.483 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.4 t -65.76 -51.24 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 121.361 -0.837 . . . . 0.0 109.982 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 98.1 mtp -60.06 -33.77 72.51 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.459 0.647 . . . . 0.0 109.496 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -49.12 78.94 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.618 0.723 . . . . 0.0 109.438 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.7 t -71.69 -16.22 62.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.908 -0.495 . . . . 0.0 110.804 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.409 ' HA ' HD13 ' A' ' 39' ' ' LEU . 1.8 mm? -90.29 -19.95 23.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.215 -0.928 . . . . 0.0 110.653 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.36 -43.57 0.2 Allowed Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.611 -1.281 . . . . 0.0 110.876 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -160.48 160.0 31.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.107 -1.231 . . . . 0.0 111.559 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.409 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 32.1 t30 -115.21 99.77 52.78 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 42' ' ' ASN . 47.5 Cg_endo -64.58 -151.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.278 0 O-C-N 123.321 1.169 . . . . 0.0 109.942 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.5 p -140.07 159.96 41.0 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.15 -0.969 . . . . 0.0 111.685 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.405 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 98.2 mt-10 -54.98 -21.2 11.05 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.811 -0.555 . . . . 0.0 111.645 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.43 -59.92 2.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.176 -0.953 . . . . 0.0 108.693 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -69.13 -35.97 76.96 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.677 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.499 HD13 ' HB ' ' A' ' 29' ' ' THR . 22.7 mt -58.14 -33.04 68.75 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.456 0.646 . . . . 0.0 110.148 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.08 -31.59 68.01 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.57 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -70.62 -45.75 64.64 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.297 -0.877 . . . . 0.0 111.091 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 78.7 mtm -61.53 -42.05 98.25 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.572 0.701 . . . . 0.0 109.585 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.74 HG12 HD11 ' A' ' 63' ' ' ILE . 91.0 mt -69.02 -33.41 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.257 0.551 . . . . 0.0 110.147 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -59.96 -38.76 83.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.483 -0.761 . . . . 0.0 110.332 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -64.41 -27.41 68.98 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.546 -0.721 . . . . 0.0 110.297 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.529 HG11 ' HB2' ' A' ' 71' ' ' MET . 16.6 t -104.64 -7.97 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.586 -0.696 . . . . 0.0 111.208 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -68.41 103.39 1.63 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.963 -1.086 . . . . 0.0 111.453 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.58 -39.98 94.72 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.713 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.6 p-10 -91.61 -30.67 16.23 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.637 -0.664 . . . . 0.0 111.041 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.26 23.38 44.49 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -73.37 -37.2 66.12 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.448 -1.03 . . . . 0.0 110.721 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.4 -0.84 7.56 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 120.303 -0.951 . . . . 0.0 110.965 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 49.8 p -134.73 169.72 16.91 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.171 -1.194 . . . . 0.0 110.07 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.74 HD11 HG12 ' A' ' 52' ' ' ILE . 7.0 mt -110.11 120.07 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.44 -177.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -96.25 170.34 9.32 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.408 0.623 . . . . 0.0 110.237 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.485 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 t80 -49.77 -48.09 78.05 Favored Pre-proline 0 N--CA 1.497 1.894 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.7 Cg_endo -67.7 -36.99 17.4 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 122.699 0.841 . . . . 0.0 111.683 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -70.03 -39.75 75.6 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.134 -0.979 . . . . 0.0 110.069 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -60.74 -50.01 75.21 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.484 -0.76 . . . . 0.0 111.317 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.426 ' HG ' ' CE2' ' A' ' 12' ' ' PHE . 3.1 tt -61.39 -41.69 97.52 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.362 -0.836 . . . . 0.0 111.56 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.0 p -63.02 -35.66 80.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.583 -0.698 . . . . 0.0 109.996 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.529 ' HB2' HG11 ' A' ' 55' ' ' VAL . 24.6 ttt -66.21 -43.55 86.41 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.838 -0.539 . . . . 0.0 111.852 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.1 ttt -60.06 -45.53 92.55 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.288 -0.882 . . . . 0.0 111.498 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.33 -32.0 71.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.451 -0.781 . . . . 0.0 110.564 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 20.7 mmm-85 -70.02 -40.04 75.44 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.622 -0.674 . . . . 0.0 111.124 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -73.09 -44.38 60.52 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.398 -0.814 . . . . 0.0 112.212 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 48.6 mtm -60.64 -39.94 90.15 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.297 -0.877 . . . . 0.0 113.096 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 14.6 pttp -67.25 -36.41 81.56 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.968 -1.082 . . . . 0.0 111.335 -178.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -69.41 -17.85 63.7 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.509 -0.744 . . . . 0.0 111.056 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.5 t -117.97 -159.65 0.75 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.653 0.739 . . . . 0.0 111.272 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -122.55 140.02 53.25 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.143 0.497 . . . . 0.0 109.773 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.433 ' HA ' ' HG2' ' A' ' 84' ' ' GLU . 48.1 t -64.27 -24.57 67.71 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.636 -0.665 . . . . 0.0 110.678 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.511 ' HA ' HD12 ' A' ' 85' ' ' ILE . 46.6 mt-10 -64.4 -35.51 81.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.289 -0.882 . . . . 0.0 109.024 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -67.82 -42.48 81.42 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.994 -178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.433 ' HG2' ' HA ' ' A' ' 81' ' ' SER . 12.5 pt-20 -69.95 -25.49 63.67 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.275 -0.891 . . . . 0.0 111.278 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 82' ' ' GLU . 80.8 mt -69.61 -45.33 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.44 -0.787 . . . . 0.0 109.591 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 63.2 mtt180 -59.97 -37.98 81.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.555 -0.716 . . . . 0.0 110.572 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.63 ' O ' HG23 ' A' ' 91' ' ' VAL . 96.5 mt-10 -69.54 -41.71 75.58 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.69 -0.631 . . . . 0.0 110.601 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.83 -43.83 87.37 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.53 -0.731 . . . . 0.0 111.331 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -60.1 -48.47 81.57 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.619 0.723 . . . . 0.0 109.682 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -58.74 -31.83 68.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.892 -0.505 . . . . 0.0 110.171 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 87' ' ' GLU . 75.7 t -69.97 -41.35 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.499 -0.751 . . . . 0.0 110.044 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -68.57 -37.51 79.94 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.495 -0.753 . . . . 0.0 110.948 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -80.03 76.95 6.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.539 -0.726 . . . . 0.0 109.852 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -63.28 -44.84 93.93 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.399 -0.813 . . . . 0.0 110.193 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -75.65 -17.5 59.96 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.621 -0.674 . . . . 0.0 111.409 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.7 20.15 75.54 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -70.07 -10.05 57.43 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.18 -1.188 . . . . 0.0 111.124 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.71 -13.28 67.49 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 41.0 m-85 -128.17 136.97 51.85 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.138 -1.213 . . . . 0.0 108.295 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 47.6 mt -89.09 120.6 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.907 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.8 m -84.56 169.43 14.43 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.407 0.622 . . . . 0.0 110.627 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.02 -39.97 87.15 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.647 -0.658 . . . . 0.0 109.305 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.73 -36.64 79.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.792 -0.568 . . . . 0.0 109.659 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -66.88 -40.02 87.69 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.642 -0.661 . . . . 0.0 110.674 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.62 -45.88 92.4 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.474 -0.767 . . . . 0.0 109.54 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -61.37 -33.74 74.17 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.848 -0.532 . . . . 0.0 111.066 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -59.95 -47.42 85.88 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.265 -0.897 . . . . 0.0 111.752 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 63.2 t -72.74 -51.05 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 121.147 -0.97 . . . . 0.0 112.026 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.405 ' CE ' ' CD1' ' A' ' 116' ' ' LEU . 51.2 mtp -58.1 -39.89 79.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.078 -1.014 . . . . 0.0 110.598 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.5 m -67.17 -46.0 75.3 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.551 -0.718 . . . . 0.0 109.778 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -62.04 -31.26 71.64 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.351 0.596 . . . . 0.0 109.499 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.1 mt -69.58 -32.39 71.12 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.669 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.59 20.48 1.92 Allowed Glycine 0 N--CA 1.497 2.734 0 C-N-CA 119.868 -1.158 . . . . 0.0 111.22 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -121.85 138.98 54.18 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.101 -1.234 . . . . 0.0 110.386 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -103.05 120.03 39.92 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.528 -0.732 . . . . 0.0 109.901 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.405 ' CD1' ' CE ' ' A' ' 109' ' ' MET . 74.1 mt -133.2 157.91 44.19 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.418 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.59 172.14 8.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.817 -0.552 . . . . 0.0 109.852 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -64.98 -23.57 67.26 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -69.21 -38.73 78.74 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.607 -0.683 . . . . 0.0 109.764 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -64.7 -35.84 82.34 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.0 t -69.8 -39.1 77.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.467 0.651 . . . . 0.0 109.637 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -60.05 -46.36 89.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.749 -0.595 . . . . 0.0 110.09 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -59.95 -42.47 94.13 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.617 -0.677 . . . . 0.0 109.576 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.463 ' HE3' ' HA ' ' B' ' 157' ' ' PHE . 78.0 mmm -54.16 -39.31 66.45 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.414 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.493 HG21 ' O ' ' A' ' 134' ' ' GLY . 85.5 mt -67.68 -38.61 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.217 0.532 . . . . 0.0 110.614 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -59.13 -39.99 84.08 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.576 -0.702 . . . . 0.0 112.11 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.05 -39.96 83.64 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.808 -0.557 . . . . 0.0 110.993 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.454 ' HB2' ' CE ' ' A' ' 144' ' ' MET . . . -104.29 -1.76 26.56 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.193 -0.942 . . . . 0.0 111.655 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -83.4 70.5 10.2 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.997 -1.065 . . . . 0.0 110.48 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.71 -40.83 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.418 -0.801 . . . . 0.0 110.726 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -70.44 -18.8 63.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.386 -0.821 . . . . 0.0 111.343 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.57 22.0 63.07 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 120.239 -0.982 . . . . 0.0 110.73 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -83.01 -9.95 59.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -1.146 . . . . 0.0 110.988 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.493 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 87.49 0.69 84.22 Favored Glycine 0 N--CA 1.497 2.76 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -136.67 148.21 47.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.31 -1.112 . . . . 0.0 109.042 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.8 t -91.38 119.11 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.406 -0.809 . . . . 0.0 109.673 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.429 ' OD1' ' CE2' ' A' ' 99' ' ' TYR . 80.9 m-20 -89.02 175.24 7.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.584 -0.697 . . . . 0.0 109.929 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -60.87 -47.9 84.27 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.275 0.56 . . . . 0.0 110.524 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -59.99 -45.47 92.62 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.638 -0.663 . . . . 0.0 111.264 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -65.22 -35.9 82.51 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.797 0.808 . . . . 0.0 110.122 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.467 ' CZ ' ' CE ' ' A' ' 145' ' ' MET . 68.5 t80 -60.04 -47.29 86.47 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.32 -178.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.808 ' O ' HG22 ' A' ' 146' ' ' THR . 96.3 t -70.06 -39.72 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.288 -0.882 . . . . 0.0 111.366 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -59.94 -50.04 75.34 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.297 -0.877 . . . . 0.0 111.212 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.454 ' CE ' ' HB2' ' A' ' 128' ' ' ALA . 60.5 ttp -60.3 -36.83 78.8 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.371 -0.83 . . . . 0.0 110.534 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.585 ' CE ' ' HB1' ' B' ' 161' ' ' ALA . 33.1 mtt -69.57 -39.96 77.03 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.635 -0.666 . . . . 0.0 110.664 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.808 HG22 ' O ' ' A' ' 142' ' ' VAL . 10.1 t -99.0 22.8 9.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.542 -0.724 . . . . 0.0 110.633 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.01 -44.93 94.24 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.439 -0.788 . . . . 0.0 110.468 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 96.6 mttt . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.193 179.899 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 70.45 29.27 70.11 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 157' ' ' PHE . . . . . 0.463 ' HA ' ' HE3' ' A' ' 124' ' ' MET . 37.0 t80 -60.02 -39.96 87.66 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.506 -0.996 . . . . 0.0 109.395 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -66.07 -40.02 90.55 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.667 -0.646 . . . . 0.0 110.776 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -60.88 -45.97 92.47 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.331 -0.855 . . . . 0.0 111.457 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 160' ' ' ILE . . . . . 0.457 HG22 ' O ' ' B' ' 157' ' ' PHE . 18.2 tt -70.08 -35.49 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.353 -0.842 . . . . 0.0 111.171 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 161' ' ' ALA . . . . . 0.585 ' HB1' ' CE ' ' A' ' 145' ' ' MET . . . -60.15 -45.24 93.73 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.349 -0.844 . . . . 0.0 110.686 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -60.42 -40.08 89.72 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.48 -0.763 . . . . 0.0 110.488 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' B' ' 160' ' ' ILE . 85.9 mt -62.76 -40.49 97.42 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.515 -0.741 . . . . 0.0 110.678 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 164' ' ' VAL . . . . . 0.601 ' HA ' HD12 ' B' ' 167' ' ' LEU . 98.9 t -62.46 -40.0 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.431 -0.793 . . . . 0.0 109.563 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.44 -39.42 94.85 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 90.0 t -69.41 -35.38 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.673 -0.898 . . . . 0.0 111.307 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.624 HD21 ' HZ ' ' A' ' 19' ' ' PHE . 96.0 mt -59.98 -49.99 75.49 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.348 -0.845 . . . . 0.0 112.782 -177.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 168' ' ' ARG . . . . . 0.422 ' HD3' ' CG ' ' A' ' 87' ' ' GLU . 69.4 ttt-85 -60.6 -39.91 89.88 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.992 -1.067 . . . . 0.0 110.804 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.41 -33.65 72.8 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.491 -0.756 . . . . 0.0 109.478 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 170' ' ' TRP . . . . . 0.454 ' CZ2' ' CD2' ' A' ' 32' ' ' LEU . 2.4 t90 -60.02 -49.25 78.39 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.823 -0.548 . . . . 0.0 110.023 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.41 94.51 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.501 -0.749 . . . . 0.0 110.853 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -59.98 -39.93 87.38 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.437 -0.79 . . . . 0.0 110.028 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.702 -0.624 . . . . 0.0 110.236 -179.524 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.299 0.571 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 80.2 mt -60.19 -29.11 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.713 -0.617 . . . . 0.0 111.023 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.63 -39.44 93.85 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.092 -1.005 . . . . 0.0 110.268 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -59.54 -41.76 90.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.513 -0.742 . . . . 0.0 109.916 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -64.29 -20.6 66.19 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.933 -0.479 . . . . 0.0 111.103 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -69.96 -44.17 70.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.132 -0.98 . . . . 0.0 110.077 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -60.07 -54.95 39.9 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.31 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.13 -25.0 64.17 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.089 -1.007 . . . . 0.0 111.577 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -49.98 -56.38 10.9 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 120.972 -1.08 . . . . 0.0 111.463 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.9 m -62.39 -36.84 83.59 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.384 -0.822 . . . . 0.0 109.829 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.5 tp -59.92 -40.78 90.04 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.71 -0.619 . . . . 0.0 109.894 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.15 -33.69 59.39 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.58 -0.7 . . . . 0.0 109.928 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -92.0 98.38 11.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.51 -0.744 . . . . 0.0 109.306 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -59.97 -38.55 82.83 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.625 -0.672 . . . . 0.0 111.503 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -78.44 -12.69 60.02 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.013 -1.054 . . . . 0.0 110.813 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.92 27.9 65.22 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -90.0 -2.08 58.08 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.611 -0.935 . . . . 0.0 110.768 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.24 3.82 63.14 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.704 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.551 HG22 ' OD1' ' A' ' 64' ' ' ASP . 31.3 p -147.12 145.36 29.56 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-N 119.268 1.534 . . . . 0.0 111.646 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 91.6 mt -103.37 127.89 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 121.412 0.625 . . . . 0.0 109.689 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.5 m -100.21 139.99 35.1 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.841 -0.537 . . . . 0.0 109.866 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.632 HG23 HG13 ' A' ' 52' ' ' ILE . 4.9 p -42.95 -30.49 0.41 Allowed 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.707 -0.621 . . . . 0.0 111.686 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -64.89 -49.54 70.06 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.847 0.832 . . . . 0.0 108.999 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -58.86 -53.71 55.29 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.902 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.414 HD21 ' HE1' ' A' ' 36' ' ' MET . 56.7 tp -60.7 -32.84 72.06 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.297 -0.877 . . . . 0.0 110.285 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.76 -31.47 38.29 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.4 m -69.96 -37.74 75.88 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.516 -0.99 . . . . 0.0 109.903 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.39 -56.18 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-O 121.425 0.631 . . . . 0.0 109.725 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.51 ' HE1' ' CD1' ' B' ' 170' ' ' TRP . 60.6 mtt -59.9 -31.75 70.11 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.684 -0.635 . . . . 0.0 111.124 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -50.02 75.36 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.427 -0.796 . . . . 0.0 109.289 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.1 t -73.71 -18.69 60.97 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.776 -0.578 . . . . 0.0 110.439 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 39' ' ' LEU . 2.8 mm? -97.38 -3.02 41.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.352 -0.843 . . . . 0.0 110.954 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.98 -71.59 0.11 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -162.95 171.35 16.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.475 -1.014 . . . . 0.0 111.055 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -106.98 119.66 50.56 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.784 -0.573 . . . . 0.0 109.893 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.38 -148.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.454 0 O-C-N 123.07 1.037 . . . . 0.0 109.982 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.1 p -138.1 153.15 49.3 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.935 -1.103 . . . . 0.0 111.596 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -52.49 -23.83 6.91 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.742 -0.599 . . . . 0.0 111.728 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.47 -59.96 2.55 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.177 0.989 . . . . 0.0 108.63 177.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -67.65 -37.61 82.64 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.735 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.549 HD13 ' HB ' ' A' ' 29' ' ' THR . 14.3 mt -57.58 -35.12 69.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.608 -0.682 . . . . 0.0 109.856 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.88 -40.07 96.41 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.914 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -65.94 -40.02 90.99 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.526 -0.734 . . . . 0.0 111.133 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 49.2 mtt -59.98 -45.13 93.7 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.474 -0.766 . . . . 0.0 109.811 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.791 HG22 ' OD2' ' A' ' 56' ' ' ASP . 47.5 mm -67.03 -35.81 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.766 -0.584 . . . . 0.0 110.546 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -60.0 -40.11 88.1 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.602 -0.686 . . . . 0.0 111.122 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -69.99 -28.51 65.58 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.28 -0.887 . . . . 0.0 110.998 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.4 t -98.15 -9.11 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.45 -0.781 . . . . 0.0 111.383 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.791 ' OD2' HG22 ' A' ' 52' ' ' ILE . 4.0 m-20 -73.88 98.79 3.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.132 -0.98 . . . . 0.0 111.046 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.92 -38.5 88.84 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 109.44 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -90.13 -29.69 18.13 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.666 -0.646 . . . . 0.0 110.793 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.51 19.95 36.43 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -74.01 -37.87 64.25 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.447 -1.031 . . . . 0.0 110.747 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.576 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 125.16 3.75 7.33 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.196 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 81.1 p -136.17 169.12 18.14 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.127 -1.219 . . . . 0.0 111.101 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.603 HD11 ' CD1' ' A' ' 52' ' ' ILE . 10.6 mt -107.44 122.53 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.503 -177.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.551 ' OD1' HG22 ' A' ' 26' ' ' THR . 96.1 m-20 -103.35 170.06 8.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.597 -0.69 . . . . 0.0 110.642 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.52 ' CZ ' HD11 ' A' ' 69' ' ' LEU . 62.5 t80 -47.15 -49.84 49.71 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.659 -0.65 . . . . 0.0 112.737 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.6 Cg_endo -65.97 -34.33 38.9 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 O-C-N 122.622 0.801 . . . . 0.0 111.703 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.583 ' O ' HG22 ' A' ' 70' ' ' THR . 97.3 mt-10 -70.62 -39.96 73.42 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.179 -0.95 . . . . 0.0 111.066 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -62.44 -43.93 97.65 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.358 -0.839 . . . . 0.0 110.675 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.52 HD11 ' CZ ' ' A' ' 65' ' ' PHE . 84.5 mt -63.46 -43.44 97.35 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.383 -0.823 . . . . 0.0 112.454 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 67' ' ' GLU . 8.5 t -62.48 -33.93 75.83 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.197 -0.939 . . . . 0.0 110.926 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 15.9 ttm -67.33 -46.57 73.07 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.466 -0.771 . . . . 0.0 111.646 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 50.2 ttm -64.99 -43.87 91.16 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.322 -0.861 . . . . 0.0 112.017 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.54 -36.7 76.65 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.372 -0.83 . . . . 0.0 110.776 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -70.97 -39.95 72.21 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.696 -0.627 . . . . 0.0 111.306 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.593 ' O ' HG22 ' A' ' 79' ' ' THR . 42.0 mmtm -72.08 -30.77 65.45 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 36.2 mmt -60.07 -45.16 93.79 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.932 -1.105 . . . . 0.0 112.547 -176.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.4 pttp -69.36 -35.68 76.1 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.118 -0.989 . . . . 0.0 111.682 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -71.23 -12.34 61.41 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.418 -0.802 . . . . 0.0 111.777 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.593 HG22 ' O ' ' A' ' 75' ' ' LYS . 15.4 t -125.63 -164.32 1.29 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.319 -0.863 . . . . 0.0 111.965 -178.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -120.04 133.44 55.53 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.824 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.5 t -60.34 -29.95 69.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.593 -0.692 . . . . 0.0 110.673 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.538 ' HA ' HD12 ' A' ' 85' ' ' ILE . 98.8 mt-10 -60.13 -31.63 70.26 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.461 -0.774 . . . . 0.0 109.617 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.01 -39.98 87.68 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.903 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.11 -37.49 85.29 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.64 -0.662 . . . . 0.0 110.854 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.636 HG23 ' HE2' ' A' ' 141' ' ' PHE . 86.8 mt -66.98 -47.98 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.667 -0.646 . . . . 0.0 110.84 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -60.03 -41.1 91.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.465 -0.772 . . . . 0.0 111.207 -178.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.645 ' O ' HG23 ' A' ' 91' ' ' VAL . 99.9 mt-10 -70.06 -40.03 75.31 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.457 -0.777 . . . . 0.0 111.333 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.13 -46.05 75.3 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.772 -0.58 . . . . 0.0 111.824 -178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -59.96 -45.4 92.77 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.826 0.822 . . . . 0.0 109.338 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 29.6 ttm-85 -59.95 -37.08 78.51 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.421 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 87' ' ' GLU . 65.6 t -67.93 -46.27 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.496 -0.752 . . . . 0.0 110.188 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -69.0 -36.88 78.33 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.492 -0.755 . . . . 0.0 110.536 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -78.03 78.84 4.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.53 -0.731 . . . . 0.0 109.096 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.99 -44.16 94.69 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.413 -0.804 . . . . 0.0 110.577 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -78.92 -19.42 51.84 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.576 -0.703 . . . . 0.0 110.667 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.64 28.26 72.26 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -71.73 -10.49 59.85 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.452 -1.028 . . . . 0.0 111.159 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.9 -20.09 44.73 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.532 ' CE2' ' ND2' ' A' ' 137' ' ' ASN . 59.0 m-85 -119.91 139.39 52.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.259 -1.142 . . . . 0.0 108.971 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.501 ' CG2' HD23 ' A' ' 105' ' ' LEU . 82.5 mt -92.6 120.0 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.465 -0.772 . . . . 0.0 110.452 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.1 m -91.36 170.37 10.03 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.432 0.634 . . . . 0.0 110.719 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.73 -37.67 73.49 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.643 -0.661 . . . . 0.0 109.577 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.11 -38.76 92.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.853 -0.529 . . . . 0.0 109.918 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.5 -39.99 94.81 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.513 -0.742 . . . . 0.0 110.423 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.501 HD23 ' CG2' ' A' ' 100' ' ' ILE . 1.2 mm? -64.29 -40.0 95.07 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.607 0.718 . . . . 0.0 109.662 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 69.4 ttp85 -62.87 -31.08 72.04 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.806 -0.558 . . . . 0.0 110.875 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -60.02 -46.2 90.29 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.233 -0.917 . . . . 0.0 110.68 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.0 t -75.03 -35.57 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.363 -0.836 . . . . 0.0 111.246 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.7 mmt -60.05 -48.94 79.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.385 -0.822 . . . . 0.0 110.428 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.4 m -69.37 -39.96 77.73 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.593 -0.692 . . . . 0.0 110.125 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -60.0 -35.79 75.8 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.4 mt -69.87 -33.94 72.91 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.206 0.526 . . . . 0.0 110.306 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.96 17.25 6.43 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -109.13 131.97 54.56 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.22 -1.165 . . . . 0.0 110.256 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -100.16 120.57 40.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.618 -0.676 . . . . 0.0 110.239 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 71.2 mt -135.8 156.32 48.98 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.425 -0.797 . . . . 0.0 110.95 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.67 159.9 25.17 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -61.87 -26.6 68.24 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -68.1 -31.74 71.56 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -67.24 -34.5 77.59 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.5 t -73.02 -38.63 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.992 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.519 ' HA ' HD12 ' A' ' 125' ' ' ILE . 54.7 t0 -60.03 -43.81 95.04 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.64 -0.663 . . . . 0.0 109.55 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -60.02 -42.36 94.19 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.458 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.0 mtt -54.84 -37.59 66.37 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.118 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.519 HD12 ' HA ' ' A' ' 122' ' ' ASP . 86.7 mt -65.36 -37.9 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -57.87 -37.89 74.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.816 -0.553 . . . . 0.0 111.663 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.09 -39.97 88.0 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.427 -0.796 . . . . 0.0 111.632 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -106.34 -0.14 24.54 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.271 -0.893 . . . . 0.0 111.69 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 16.6 t70 -98.67 74.86 2.11 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.128 -0.982 . . . . 0.0 111.329 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 84.3 mt -66.93 -39.97 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.457 -0.777 . . . . 0.0 109.779 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 30.7 p30 -58.52 -37.76 76.3 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.742 -0.599 . . . . 0.0 111.494 -179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 92.84 18.75 39.35 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 120.28 -0.962 . . . . 0.0 111.233 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -82.43 -13.37 56.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.047 -1.266 . . . . 0.0 110.47 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.0 4.68 71.71 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.506 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -136.24 141.85 43.98 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.09 -1.241 . . . . 0.0 109.828 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.423 ' HB ' HD12 ' A' ' 100' ' ' ILE . 61.3 t -94.07 125.11 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.41 -0.806 . . . . 0.0 110.188 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.532 ' ND2' ' CE2' ' A' ' 99' ' ' TYR . 13.7 m120 -97.39 179.66 4.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.569 -0.707 . . . . 0.0 109.659 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -63.09 -50.05 72.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.741 -0.599 . . . . 0.0 110.852 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.21 -44.21 95.96 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.374 -0.829 . . . . 0.0 111.342 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -66.81 -38.52 86.63 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.851 0.834 . . . . 0.0 109.81 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.636 ' HE2' HG23 ' A' ' 85' ' ' ILE . 67.6 t80 -59.97 -46.12 90.48 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.156 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.609 HG22 HG21 ' A' ' 85' ' ' ILE . 98.1 t -69.96 -39.31 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.374 -0.829 . . . . 0.0 111.101 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -59.96 -47.33 86.24 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.271 -0.893 . . . . 0.0 110.437 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.443 ' HE1' ' CD1' ' B' ' 157' ' ' PHE . 12.4 tmm? -59.94 -37.27 79.05 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.469 -0.769 . . . . 0.0 110.27 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 92.2 mtp -66.36 -40.03 89.52 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.902 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.471 ' O ' HG22 ' A' ' 146' ' ' THR . 50.2 m -86.21 2.83 45.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.792 -0.567 . . . . 0.0 111.125 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.06 138.76 57.8 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.051 -1.03 . . . . 0.0 110.235 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.4 mttp . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 117.944 -1.026 . . . . 0.0 110.174 -179.916 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.71 -19.96 50.15 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 157' ' ' PHE . . . . . 0.443 ' CD1' ' HE1' ' A' ' 144' ' ' MET . 52.3 t80 -67.88 -40.33 83.55 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.288 -1.125 . . . . 0.0 110.153 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 -70.0 -39.21 76.0 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.534 -0.729 . . . . 0.0 111.021 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -59.94 -40.06 87.67 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.585 -0.697 . . . . 0.0 110.719 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 160' ' ' ILE . . . . . 0.42 HG13 ' N ' ' B' ' 161' ' ' ALA . 24.8 pt -76.21 -27.56 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.479 -0.763 . . . . 0.0 110.791 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 161' ' ' ALA . . . . . 0.42 ' N ' HG13 ' B' ' 160' ' ' ILE . . . -66.27 -39.93 89.78 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.354 -0.841 . . . . 0.0 110.528 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -60.06 -40.64 90.18 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.572 -0.705 . . . . 0.0 111.031 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.58 -40.07 95.71 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.272 -0.892 . . . . 0.0 110.818 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 67.9 t -64.26 -40.1 87.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.524 -0.735 . . . . 0.0 110.896 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.24 -40.05 91.12 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 94.4 t -76.38 -14.8 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.459 -1.024 . . . . 0.0 111.344 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.447 HD23 ' C ' ' B' ' 167' ' ' LEU . 10.1 tt -60.01 -50.01 75.43 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.177 -0.952 . . . . 0.0 111.416 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -68.46 -39.95 81.23 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.249 -0.907 . . . . 0.0 110.486 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.07 -31.01 69.61 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.393 -0.817 . . . . 0.0 110.078 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 170' ' ' TRP . . . . . 0.51 ' CD1' ' HE1' ' A' ' 36' ' ' MET . 5.2 t-105 -59.97 -46.31 89.85 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.67 -0.644 . . . . 0.0 110.271 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.0 -51.39 69.85 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.461 -0.774 . . . . 0.0 110.242 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -60.11 -36.87 78.42 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.519 -0.738 . . . . 0.0 110.216 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.591 -0.693 . . . . 0.0 110.151 179.723 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 121.33 0.586 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 89.7 mt -60.79 -29.02 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.706 -0.621 . . . . 0.0 111.513 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -61.25 -37.88 84.67 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.047 -1.033 . . . . 0.0 109.788 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.9 -47.63 84.98 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.534 -0.729 . . . . 0.0 110.194 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.448 ' CE1' ' HE2' ' A' ' 72' ' ' MET . 26.5 m-85 -67.53 -25.25 65.74 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.632 -0.667 . . . . 0.0 110.627 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 22.9 tptp -67.37 -53.44 29.39 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.59 0.71 . . . . 0.0 109.251 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.4 -48.03 77.74 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.891 -0.505 . . . . 0.0 110.696 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.04 -20.34 63.26 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.227 -0.92 . . . . 0.0 111.32 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -60.02 -48.21 82.67 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.181 -0.95 . . . . 0.0 110.789 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.0 m -63.88 -39.24 93.72 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.278 -0.889 . . . . 0.0 108.778 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.602 HD11 ' O ' ' A' ' 112' ' ' LEU . 47.8 tp -63.82 -39.96 95.48 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.4 ' HB3' HD11 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -70.04 -34.2 72.95 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.362 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -92.13 94.68 9.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.685 -0.634 . . . . 0.0 109.516 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -59.9 -36.6 77.3 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.53 -0.731 . . . . 0.0 112.177 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -79.17 -9.76 59.65 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.06 -1.025 . . . . 0.0 111.392 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.96 22.37 57.54 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -85.4 -8.6 58.34 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.429 -1.042 . . . . 0.0 110.542 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.415 ' C ' HG23 ' A' ' 26' ' ' THR . . . 99.96 6.64 53.9 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.518 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.415 HG23 ' C ' ' A' ' 25' ' ' GLY . 80.5 p -147.81 143.02 27.19 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 119.32 1.56 . . . . 0.0 112.03 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.4 HD11 ' HB3' ' A' ' 19' ' ' PHE . 87.3 mt -100.41 124.34 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.3 p -100.98 140.57 35.09 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.706 -0.621 . . . . 0.0 110.835 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.464 HG23 HG13 ' A' ' 52' ' ' ILE . 7.1 p -42.08 -32.68 0.48 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.902 -0.499 . . . . 0.0 112.159 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -65.33 -49.1 70.73 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.731 0.777 . . . . 0.0 109.626 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -59.87 -53.69 54.93 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.976 -0.452 . . . . 0.0 111.092 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.4 tp -61.53 -34.91 76.34 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.218 -0.926 . . . . 0.0 111.063 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.51 -32.16 60.8 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.6 m -75.96 -41.26 52.02 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.671 -0.899 . . . . 0.0 111.044 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.7 t -62.7 -59.14 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.431 -0.793 . . . . 0.0 109.658 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.4 ptm -57.72 -20.78 36.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.67 -0.644 . . . . 0.0 110.467 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.2 ttt85 -59.9 -40.0 87.27 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.348 -0.845 . . . . 0.0 109.378 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.7 t -69.84 -16.35 63.25 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.897 -0.502 . . . . 0.0 111.735 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.855 HD22 HD22 ' B' ' 167' ' ' LEU . 6.6 mp -93.6 -10.06 35.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.305 -0.872 . . . . 0.0 110.756 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.16 -61.52 0.17 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -167.33 172.46 9.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.447 -1.031 . . . . 0.0 110.943 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -119.46 137.14 25.09 Favored Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.65 -149.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.332 0 O-C-N 123.19 1.1 . . . . 0.0 109.819 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -137.08 160.61 38.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.05 -1.031 . . . . 0.0 110.2 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -52.38 -25.31 9.48 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.897 -0.502 . . . . 0.0 112.305 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.16 -60.06 2.52 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.208 1.004 . . . . 0.0 108.85 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -66.82 -37.6 84.83 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.542 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.446 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 6.3 mt -57.71 -35.12 70.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.639 -0.663 . . . . 0.0 109.908 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -62.51 -40.11 95.67 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.779 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -65.49 -39.92 92.47 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.607 -0.683 . . . . 0.0 111.252 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 65.0 mtt -60.02 -43.21 95.41 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.716 0.77 . . . . 0.0 109.443 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.767 HG22 ' OD2' ' A' ' 56' ' ' ASP . 47.9 mm -66.2 -37.64 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 121.21 0.528 . . . . 0.0 110.475 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -60.0 -40.78 90.4 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.506 -0.746 . . . . 0.0 111.212 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -67.43 -27.95 67.48 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.195 -0.94 . . . . 0.0 110.541 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.411 HG21 ' SD ' ' A' ' 71' ' ' MET . 49.8 t -99.97 -10.07 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.565 -0.709 . . . . 0.0 111.557 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.767 ' OD2' HG22 ' A' ' 52' ' ' ILE . 6.6 m-20 -71.05 95.04 1.16 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.088 -1.008 . . . . 0.0 111.542 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.06 93.22 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.71 -0.619 . . . . 0.0 109.563 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -92.58 -29.27 16.25 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.648 -0.657 . . . . 0.0 110.952 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.56 20.49 34.54 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.0 p-10 -74.74 -32.76 62.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.344 -1.092 . . . . 0.0 110.35 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.531 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 118.65 5.24 12.52 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 120.277 -0.963 . . . . 0.0 111.24 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 80.9 p -136.43 170.17 16.48 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.189 -1.183 . . . . 0.0 111.077 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.465 HD11 ' CD1' ' A' ' 52' ' ' ILE . 10.8 mt -105.06 120.55 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.286 0.565 . . . . 0.0 110.886 -177.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -100.05 165.4 11.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.721 -0.612 . . . . 0.0 109.934 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.524 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 16.2 t80 -48.7 -49.27 66.85 Favored Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 121.486 -0.759 . . . . 0.0 112.499 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 38.7 Cg_endo -64.23 -35.54 51.36 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 O-C-N 122.766 0.877 . . . . 0.0 111.173 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.96 -40.03 75.65 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.165 -0.959 . . . . 0.0 110.322 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -61.99 -42.86 99.61 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.59 -0.693 . . . . 0.0 111.3 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 69' ' ' LEU . 4.0 mm? -64.68 -42.97 94.97 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.395 -0.816 . . . . 0.0 111.205 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.1 m -61.97 -40.03 94.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.649 -0.657 . . . . 0.0 111.111 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.411 ' SD ' HG21 ' A' ' 55' ' ' VAL . 56.2 ttp -68.35 -40.96 81.36 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.473 -0.767 . . . . 0.0 112.148 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.478 ' SD ' HG11 ' B' ' 166' ' ' VAL . 92.6 mmm -61.53 -45.49 93.95 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.296 -0.877 . . . . 0.0 111.131 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.67 -32.43 73.49 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.856 -0.528 . . . . 0.0 110.982 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -72.04 -39.98 68.7 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.435 -0.791 . . . . 0.0 110.292 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -62.5 -39.98 95.22 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.617 -0.677 . . . . 0.0 112.362 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 35.9 mmt -57.82 -33.21 68.37 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.185 -0.947 . . . . 0.0 110.736 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -69.69 -56.75 6.36 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.554 0.693 . . . . 0.0 110.572 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -69.16 -35.86 76.76 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.525 0.679 . . . . 0.0 110.436 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.629 HG22 ' H ' ' A' ' 80' ' ' ASP . 8.1 m -86.07 -174.68 5.21 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.858 -0.526 . . . . 0.0 110.224 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.629 ' H ' HG22 ' A' ' 79' ' ' THR . 90.4 m-20 -134.0 149.94 51.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.321 -0.862 . . . . 0.0 109.964 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.3 t -65.82 -33.74 76.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.7 -0.625 . . . . 0.0 109.556 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -63.77 -33.87 76.62 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.644 0.735 . . . . 0.0 109.181 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.56 -39.98 77.05 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.332 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -63.83 -36.35 83.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.594 -0.691 . . . . 0.0 109.934 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.633 HG23 ' CE1' ' A' ' 141' ' ' PHE . 77.4 mt -64.48 -49.96 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.668 -0.645 . . . . 0.0 110.821 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -57.14 -39.94 76.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.176 -0.953 . . . . 0.0 111.019 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.666 ' O ' HG23 ' A' ' 91' ' ' VAL . 98.8 mt-10 -70.0 -40.02 75.53 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.54 -0.725 . . . . 0.0 111.471 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.55 -49.25 69.57 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.423 -0.798 . . . . 0.0 112.244 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -60.37 -40.42 90.71 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.247 -0.908 . . . . 0.0 109.429 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -59.98 -37.57 80.0 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.666 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 87' ' ' GLU . 94.1 t -69.75 -53.41 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.419 -0.801 . . . . 0.0 110.797 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.485 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 51.5 m-85 -63.43 -39.76 95.36 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.355 -0.841 . . . . 0.0 110.882 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -80.98 72.02 7.98 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.531 -0.731 . . . . 0.0 110.006 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -61.83 -41.72 98.14 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.211 -0.93 . . . . 0.0 109.859 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.0 p-10 -73.16 -22.22 60.55 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.567 -0.708 . . . . 0.0 110.995 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.2 25.06 73.53 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -71.2 -12.49 61.5 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.322 -1.105 . . . . 0.0 111.541 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.85 -16.69 59.24 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.5 ' CD2' ' ND2' ' A' ' 137' ' ' ASN . 60.1 m-85 -123.18 136.36 54.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.19 -1.182 . . . . 0.0 109.148 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.5 ' CG2' HD23 ' A' ' 105' ' ' LEU . 61.4 mt -89.8 120.07 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.423 -0.798 . . . . 0.0 109.922 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.2 m -90.07 170.56 10.22 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.329 0.585 . . . . 0.0 110.686 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.73 -35.99 72.97 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.666 -0.646 . . . . 0.0 109.358 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.43 -35.57 79.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.735 -0.603 . . . . 0.0 109.584 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.22 -37.88 78.26 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.659 -0.65 . . . . 0.0 110.776 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.5 HD23 ' CG2' ' A' ' 100' ' ' ILE . 1.3 mm? -66.92 -41.66 86.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.552 -0.717 . . . . 0.0 110.279 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -60.06 -37.8 80.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.695 -0.628 . . . . 0.0 110.717 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -60.66 -42.79 97.72 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.456 -0.778 . . . . 0.0 112.419 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.485 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 91.3 t -74.04 -50.9 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 O-C-N 121.159 -0.963 . . . . 0.0 111.827 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 78.1 mtm -59.55 -40.21 86.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.116 -0.99 . . . . 0.0 110.205 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.2 m -64.72 -45.63 85.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.645 -0.659 . . . . 0.0 109.325 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -61.36 -33.63 73.97 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.602 ' O ' HD11 ' A' ' 18' ' ' LEU . 35.6 mt -69.98 -36.12 74.96 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.141 0.496 . . . . 0.0 109.836 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.41 30.72 1.65 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -119.93 127.34 52.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.464 -1.021 . . . . 0.0 109.701 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -100.11 120.96 40.67 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.654 -0.654 . . . . 0.0 110.824 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.549 HD23 ' OE1' ' A' ' 120' ' ' GLU . 2.5 mp -137.72 155.39 49.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.567 -0.708 . . . . 0.0 110.051 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.38 166.92 16.97 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -64.65 -24.76 67.69 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.178 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -68.66 -35.87 77.8 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.683 0.754 . . . . 0.0 109.278 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.549 ' OE1' HD23 ' A' ' 116' ' ' LEU . 4.6 mt-10 -64.8 -36.11 83.27 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.6 t -70.04 -38.62 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-O 121.427 0.632 . . . . 0.0 110.178 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -59.79 -46.54 88.9 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.573 -0.705 . . . . 0.0 110.227 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -60.1 -39.97 88.0 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.805 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 67.6 mtt -54.7 -40.01 68.75 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.353 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.64 -38.04 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.716 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -59.38 -40.02 85.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.507 -0.746 . . . . 0.0 111.938 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.88 -40.0 91.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.448 -0.782 . . . . 0.0 112.012 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.14 -17.16 16.79 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.276 -0.89 . . . . 0.0 111.388 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -85.8 74.99 10.11 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.271 -0.893 . . . . 0.0 110.538 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.7 -40.04 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.725 -0.609 . . . . 0.0 109.841 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 27.9 p-10 -58.76 -38.92 79.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.551 -0.718 . . . . 0.0 110.766 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.86 16.05 40.29 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 120.224 -0.988 . . . . 0.0 111.073 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.59 -10.81 59.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.127 -1.219 . . . . 0.0 110.238 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.47 3.54 74.84 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.476 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -134.79 136.36 42.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.093 -1.24 . . . . 0.0 110.666 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.8 t -92.11 120.01 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.47 -0.768 . . . . 0.0 110.033 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.5 ' ND2' ' CD2' ' A' ' 99' ' ' TYR . 25.5 m120 -96.41 -175.03 3.22 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.453 0.644 . . . . 0.0 110.381 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -60.0 -49.98 75.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.837 -0.539 . . . . 0.0 110.188 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -60.08 -44.75 94.55 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.374 -0.829 . . . . 0.0 111.279 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -62.32 -39.03 91.72 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.04 0.924 . . . . 0.0 109.353 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.633 ' CE1' HG23 ' A' ' 85' ' ' ILE . 64.7 t80 -60.01 -41.86 93.06 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.697 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 92.9 t -67.65 -40.05 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.378 -0.826 . . . . 0.0 110.844 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -59.97 -39.98 87.51 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.472 -0.767 . . . . 0.0 110.498 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 46.2 ttp -60.04 -40.55 89.79 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.66 -0.65 . . . . 0.0 110.588 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 61.1 mtt -76.72 -34.24 58.14 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.419 -0.801 . . . . 0.0 109.95 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.514 ' O ' HG22 ' A' ' 146' ' ' THR . 25.0 m -92.7 23.62 4.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.793 -0.567 . . . . 0.0 111.016 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.49 89.03 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.353 -0.842 . . . . 0.0 110.474 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.146 -179.847 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 82.2 7.15 88.11 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -60.05 -47.97 83.65 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.038 -1.272 . . . . 0.0 109.472 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -61.4 -38.78 88.32 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.856 -0.528 . . . . 0.0 111.136 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -60.09 -39.9 87.74 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.389 -0.819 . . . . 0.0 110.707 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 85.4 mt -69.07 -40.06 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.441 -0.787 . . . . 0.0 110.214 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.0 -44.47 94.53 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.616 -0.677 . . . . 0.0 110.969 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -60.49 -40.79 92.6 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.34 -0.85 . . . . 0.0 110.5 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 40.4 tp -61.27 -40.6 94.7 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.503 -0.748 . . . . 0.0 109.972 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 93.1 t -60.59 -40.0 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.697 -0.627 . . . . 0.0 109.871 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -53.91 -36.15 55.03 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.478 HG11 ' SD ' ' A' ' 72' ' ' MET . 98.3 t -77.71 -29.87 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.606 -0.938 . . . . 0.0 110.33 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.855 HD22 HD22 ' A' ' 39' ' ' LEU . 3.7 tt -59.98 -50.72 72.62 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.512 -0.743 . . . . 0.0 111.515 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -60.27 -40.09 89.14 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.369 -0.832 . . . . 0.0 111.164 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -59.91 -35.32 74.62 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.49 -0.756 . . . . 0.0 110.695 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -59.69 -39.97 86.3 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.477 -0.765 . . . . 0.0 110.25 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.05 79.2 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.296 -0.878 . . . . 0.0 110.306 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -60.06 -39.64 86.69 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.337 -0.852 . . . . 0.0 109.347 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.286 0.565 . . . . 0.0 110.056 179.381 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 121.458 0.647 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.421 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 83.8 mt -57.11 -29.62 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.806 -0.559 . . . . 0.0 111.044 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.94 -39.54 94.39 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.194 -0.941 . . . . 0.0 110.419 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -60.07 -42.62 94.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.37 -0.831 . . . . 0.0 109.88 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -63.32 -20.88 65.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.865 -0.522 . . . . 0.0 111.068 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HD3' ' CZ ' ' A' ' 65' ' ' PHE . 40.3 mmtt -66.87 -40.22 87.76 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.203 -0.936 . . . . 0.0 108.988 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -64.25 -58.31 6.93 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.976 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.86 -26.95 68.44 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.36 -0.837 . . . . 0.0 112.545 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -58.36 -48.31 81.01 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.753 -1.217 . . . . 0.0 111.013 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.4 p -62.33 -37.17 84.58 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.186 -0.947 . . . . 0.0 109.481 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.2 tp -60.09 -40.01 88.11 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.583 0.706 . . . . 0.0 109.499 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.677 ' HE2' HD11 ' B' ' 163' ' ' LEU . 4.4 m-85 -74.81 -36.69 62.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.875 -0.516 . . . . 0.0 110.974 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -94.91 97.78 10.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.441 -0.787 . . . . 0.0 110.131 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -65.67 -31.98 73.29 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.499 -0.75 . . . . 0.0 111.077 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -80.04 -10.43 59.77 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.214 -0.929 . . . . 0.0 111.166 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.34 25.66 55.06 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -88.46 -8.08 55.51 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.543 -0.974 . . . . 0.0 110.902 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.31 2.72 56.71 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 120.054 -1.07 . . . . 0.0 111.751 178.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.8 p -143.4 141.5 30.9 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-N 119.464 1.632 . . . . 0.0 111.966 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 83.9 mt -100.88 121.32 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.737 -0.602 . . . . 0.0 109.458 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.1 m -102.33 141.86 34.48 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.59 -0.694 . . . . 0.0 110.389 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.44 ' CG2' HG13 ' A' ' 52' ' ' ILE . 40.6 p -41.96 -29.79 0.24 Allowed 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.643 -0.66 . . . . 0.0 112.211 -177.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -63.41 -52.08 63.09 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.333 -0.854 . . . . 0.0 109.364 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.04 -53.73 54.3 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.487 -178.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.561 HD21 ' CE ' ' A' ' 36' ' ' MET . 53.0 tp -59.83 -36.49 76.93 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.092 -1.005 . . . . 0.0 110.672 -178.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.77 -31.0 37.35 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.4 m -69.97 -40.1 75.57 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.616 -0.932 . . . . 0.0 110.24 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.22 -55.21 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.53 -0.731 . . . . 0.0 109.512 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.561 ' CE ' HD21 ' A' ' 32' ' ' LEU . 69.0 mtt -58.48 -30.46 67.0 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.333 0.587 . . . . 0.0 110.044 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -59.88 -50.04 75.34 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 t -70.76 -18.8 62.76 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.803 -0.561 . . . . 0.0 110.436 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.562 HD11 HD13 ' B' ' 167' ' ' LEU . 66.7 mt -84.96 -21.87 29.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.293 -0.88 . . . . 0.0 110.576 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.77 -45.46 0.19 Allowed Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.937 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -161.44 159.95 28.73 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.11 -1.229 . . . . 0.0 111.957 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.451 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 38.9 t30 -114.42 105.1 54.2 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 42' ' ' ASN . 42.5 Cg_endo -61.36 -149.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.503 0 O-C-N 123.306 1.161 . . . . 0.0 110.734 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.23 160.54 39.17 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.93 -1.106 . . . . 0.0 111.174 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.4 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 11.9 mm-40 -53.78 -22.02 8.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.936 -0.478 . . . . 0.0 111.939 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.01 -59.23 3.04 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -67.27 -38.67 85.46 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.553 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.402 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 6.2 mt -58.71 -33.17 69.88 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.865 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -64.56 -40.0 94.78 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.497 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -64.79 -40.03 94.57 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.649 -0.657 . . . . 0.0 110.928 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 66.6 mtt -61.3 -43.41 98.91 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.685 -0.634 . . . . 0.0 109.748 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.897 HG22 ' OD2' ' A' ' 56' ' ' ASP . 48.4 mm -66.88 -36.24 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.849 -0.532 . . . . 0.0 110.746 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -60.01 -41.95 93.24 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.391 -0.818 . . . . 0.0 110.633 -178.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -69.88 -27.69 65.02 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.226 -0.921 . . . . 0.0 111.355 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.497 HG21 ' SD ' ' A' ' 71' ' ' MET . 60.2 t -99.21 -10.02 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.316 -0.865 . . . . 0.0 111.835 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.897 ' OD2' HG22 ' A' ' 52' ' ' ILE . 19.5 m-20 -71.53 96.88 1.58 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.089 -1.007 . . . . 0.0 111.302 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.23 -37.43 80.82 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.406 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -90.58 -27.01 19.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.733 -0.604 . . . . 0.0 110.433 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.99 20.34 43.34 Favored Glycine 0 N--CA 1.495 2.567 0 C-N-CA 120.458 -0.877 . . . . 0.0 110.923 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -76.27 -28.62 57.12 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.449 -1.03 . . . . 0.0 110.565 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.76 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 114.35 2.06 23.2 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.174 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.3 p -134.1 167.78 20.01 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.152 -1.204 . . . . 0.0 110.527 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.51 HD11 HD13 ' A' ' 52' ' ' ILE . 8.7 mt -103.53 119.94 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.228 -178.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -97.71 167.56 10.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.666 -0.646 . . . . 0.0 109.889 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.508 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 10.5 t80 -48.27 -48.63 64.99 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.52 -0.737 . . . . 0.0 112.45 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.5 Cg_endo -67.0 -34.4 29.21 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 O-C-N 122.895 0.945 . . . . 0.0 111.088 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.9 -39.92 69.23 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.181 -0.95 . . . . 0.0 110.887 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -62.32 -40.43 96.29 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.451 -0.781 . . . . 0.0 111.422 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 65' ' ' PHE . 4.6 mp -69.63 -40.01 76.8 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.221 -0.924 . . . . 0.0 111.611 -178.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.8 p -61.22 -40.03 92.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.364 -0.835 . . . . 0.0 110.853 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.497 ' SD ' HG21 ' A' ' 55' ' ' VAL . 50.7 ttp -67.49 -52.05 43.86 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.525 -0.734 . . . . 0.0 112.044 -178.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.427 ' HE2' HG11 ' B' ' 166' ' ' VAL . 49.8 ttm -59.98 -49.71 76.6 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.314 -0.866 . . . . 0.0 111.948 -178.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.99 -36.02 76.27 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.547 -0.72 . . . . 0.0 110.341 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -77.23 -43.55 33.16 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.606 0.717 . . . . 0.0 110.14 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -61.01 -48.12 83.29 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.757 -0.589 . . . . 0.0 111.973 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 27.8 ptm -59.94 -36.12 76.37 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.261 -0.9 . . . . 0.0 110.679 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -68.17 -42.93 79.27 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.695 0.759 . . . . 0.0 109.299 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -68.43 -30.93 69.93 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.691 0.758 . . . . 0.0 109.273 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 80' ' ' ASP . 7.2 m -94.53 -174.11 3.23 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.61 ' H ' HG22 ' A' ' 79' ' ' THR . 65.6 m-20 -120.73 141.63 50.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.109 -0.995 . . . . 0.0 109.808 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.3 t -60.06 -29.57 68.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.65 -0.656 . . . . 0.0 110.173 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.0 -37.34 79.42 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.698 0.761 . . . . 0.0 109.192 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -70.06 -39.98 75.35 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.19 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -64.08 -39.75 94.75 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.704 -0.623 . . . . 0.0 110.767 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.772 HG23 ' CE1' ' A' ' 141' ' ' PHE . 96.5 mt -62.92 -49.68 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.63 -0.669 . . . . 0.0 110.465 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -57.7 -40.09 78.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.336 -0.852 . . . . 0.0 111.16 -178.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.693 ' O ' HG23 ' A' ' 91' ' ' VAL . 98.9 mt-10 -70.03 -39.99 75.44 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.336 -0.853 . . . . 0.0 111.666 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.52 -47.21 73.64 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.331 -0.856 . . . . 0.0 111.287 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -60.01 -47.52 85.51 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.587 -0.695 . . . . 0.0 110.138 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -59.93 -36.35 76.85 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.683 -0.636 . . . . 0.0 110.325 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 87' ' ' GLU . 70.5 t -66.92 -46.39 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.568 -0.707 . . . . 0.0 109.699 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.518 ' CD1' HD22 ' A' ' 105' ' ' LEU . 14.3 m-85 -69.91 -38.58 76.3 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.461 -0.774 . . . . 0.0 111.324 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -75.34 78.33 2.42 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.51 -0.744 . . . . 0.0 110.571 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -59.92 -47.91 83.85 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.622 -0.674 . . . . 0.0 110.178 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -78.08 -18.57 55.59 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.505 -0.747 . . . . 0.0 111.239 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.98 28.58 72.27 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -73.91 -8.96 58.06 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.414 -1.05 . . . . 0.0 111.401 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.39 -17.61 50.48 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -129.99 138.44 50.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.315 -1.109 . . . . 0.0 108.87 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.764 ' CG2' HD23 ' A' ' 105' ' ' LEU . 32.9 mt -89.05 124.41 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.368 -0.833 . . . . 0.0 110.435 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.4 m -88.65 171.01 10.33 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.242 0.544 . . . . 0.0 110.384 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.84 -40.07 83.78 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.663 -0.648 . . . . 0.0 109.582 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.55 -38.51 91.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.76 -0.588 . . . . 0.0 109.604 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.85 -40.28 91.58 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.781 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.764 HD23 ' CG2' ' A' ' 100' ' ' ILE . 0.2 OUTLIER -63.1 -44.76 94.79 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.505 -0.747 . . . . 0.0 110.462 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.406 ' CG ' HG21 ' A' ' 121' ' ' VAL . 77.6 mtp180 -60.29 -30.9 69.77 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.633 -0.667 . . . . 0.0 110.385 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -60.18 -49.95 75.6 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.561 -0.712 . . . . 0.0 111.456 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.47 HG12 ' CD1' ' A' ' 112' ' ' LEU . 61.3 t -74.26 -52.32 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 O-C-N 121.234 -0.916 . . . . 0.0 112.168 -178.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 99.4 mtp -56.56 -42.68 78.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.123 -0.986 . . . . 0.0 110.511 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.6 m -65.16 -46.7 79.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.707 -0.621 . . . . 0.0 109.668 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -62.01 -33.69 74.81 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.47 ' CD1' HG12 ' A' ' 108' ' ' VAL . 61.9 mt -70.03 -33.43 71.97 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.701 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.27 40.8 0.42 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -138.02 132.84 32.82 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.5 -1.0 . . . . 0.0 110.142 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.679 ' C ' HD13 ' A' ' 116' ' ' LEU . 68.4 mttm -106.82 141.3 38.28 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.477 -0.764 . . . . 0.0 110.303 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.679 HD13 ' C ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -158.73 157.82 32.47 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.624 0.726 . . . . 0.0 110.769 179.231 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.3 p -85.66 167.57 15.2 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.632 -0.667 . . . . 0.0 109.802 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -65.47 -26.69 68.05 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -69.92 -37.34 75.91 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.909 0.862 . . . . 0.0 109.204 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -63.43 -40.02 96.03 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.44 1.114 . . . . 0.0 108.378 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.406 HG21 ' CG ' ' A' ' 106' ' ' ARG . 53.7 t -67.21 -39.97 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.033 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.422 ' HA ' HD12 ' A' ' 125' ' ' ILE . 61.1 t0 -60.07 -45.81 91.63 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.568 -0.707 . . . . 0.0 110.041 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -59.96 -40.09 87.86 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.724 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 66.7 mtt -56.24 -37.68 70.07 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.184 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 122' ' ' ASP . 89.4 mt -65.21 -38.56 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.812 0.815 . . . . 0.0 109.047 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.4 ttt180 -58.51 -39.63 80.63 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.057 0.456 . . . . 0.0 111.391 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -60.06 -39.95 87.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.709 -0.619 . . . . 0.0 111.845 -178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.2 -10.45 15.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.208 -0.933 . . . . 0.0 112.011 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -74.25 69.94 1.61 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.1 -1.0 . . . . 0.0 110.414 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.0 mt -68.2 -40.0 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.587 -0.696 . . . . 0.0 110.503 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -69.3 -24.31 63.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.377 -0.827 . . . . 0.0 111.017 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.89 24.67 48.28 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.96 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -82.57 -10.0 59.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -1.125 . . . . 0.0 110.802 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.33 -1.39 79.5 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -138.23 150.39 46.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -1.105 . . . . 0.0 109.38 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.53 118.87 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.408 -0.807 . . . . 0.0 109.944 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -89.93 -170.73 2.9 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.682 0.754 . . . . 0.0 110.397 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -69.87 -40.03 75.98 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.502 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -60.15 -47.82 84.33 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.3 -0.875 . . . . 0.0 112.249 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -62.74 -37.74 87.77 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.927 0.87 . . . . 0.0 110.043 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.772 ' CE1' HG23 ' A' ' 85' ' ' ILE . 57.9 t80 -59.97 -50.04 75.32 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.37 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.562 HG12 HG21 ' A' ' 85' ' ' ILE . 36.0 m -70.12 -41.05 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -59.97 -51.04 71.36 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.184 -0.947 . . . . 0.0 111.314 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.9 ttp -62.38 -37.73 86.85 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.447 -0.783 . . . . 0.0 109.927 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 90.6 mmm -69.82 -39.35 76.53 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.848 -0.533 . . . . 0.0 109.967 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.491 HG23 ' O ' ' A' ' 142' ' ' VAL . 71.4 p -82.56 0.39 42.94 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.499 -0.751 . . . . 0.0 111.039 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.94 -40.0 87.47 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.138 -0.976 . . . . 0.0 110.477 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.2 mttt . . . . . 0 N--CA 1.496 1.825 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.347 -179.781 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -77.0 141.4 26.13 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -60.05 -41.57 92.59 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.59 -0.947 . . . . 0.0 110.595 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 21.3 ptt-85 -60.04 -39.97 87.77 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.626 -0.671 . . . . 0.0 111.51 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 30.1 mtp-105 -61.62 -39.97 93.17 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.494 -0.754 . . . . 0.0 110.458 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 88.8 mt -66.39 -39.96 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.569 -0.707 . . . . 0.0 110.481 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.95 87.42 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.558 -0.714 . . . . 0.0 110.708 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -60.0 -42.31 93.98 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.547 -0.721 . . . . 0.0 111.457 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.735 ' O ' HG12 ' B' ' 166' ' ' VAL . 42.6 tp -65.0 -40.9 95.62 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.3 -0.875 . . . . 0.0 110.83 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 164' ' ' VAL . . . . . 0.647 ' HA ' HD12 ' B' ' 167' ' ' LEU . 66.9 t -61.09 -39.99 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.588 -0.695 . . . . 0.0 110.751 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.07 -40.15 82.08 Favored Glycine 0 N--CA 1.495 2.597 0 O-C-N 121.447 -0.783 . . . . 0.0 111.759 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.735 HG12 ' O ' ' B' ' 163' ' ' LEU . 15.0 p -76.33 -24.46 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.096 -1.238 . . . . 0.0 112.53 -178.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.647 HD12 ' HA ' ' B' ' 164' ' ' VAL . 85.7 mt -59.96 -49.09 79.03 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.953 -1.092 . . . . 0.0 110.969 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -61.72 -40.0 93.5 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.314 -0.866 . . . . 0.0 110.704 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 169' ' ' GLU . . . . . 0.444 ' CD ' HG21 ' A' ' 79' ' ' THR . 97.6 mt-10 -62.34 -26.01 68.21 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.473 -0.767 . . . . 0.0 109.872 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -59.99 -41.73 92.7 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.593 -0.692 . . . . 0.0 109.721 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.97 -50.5 73.5 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.461 -0.774 . . . . 0.0 110.78 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -60.16 -39.89 87.98 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.451 -0.781 . . . . 0.0 110.378 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 . . . . . 0 N--CA 1.495 1.778 0 O-C-N 121.611 -0.681 . . . . 0.0 110.127 -179.982 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 121.306 0.574 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.3 mt -59.93 -31.87 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.727 -0.608 . . . . 0.0 110.98 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.11 -39.38 86.02 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.249 -0.907 . . . . 0.0 110.287 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -60.04 -40.0 87.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.541 -0.725 . . . . 0.0 110.349 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -65.52 -22.83 66.76 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.486 -0.759 . . . . 0.0 110.841 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.446 ' HD3' ' CE1' ' A' ' 65' ' ' PHE . 46.7 mmtt -68.77 -39.99 79.96 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.84 -56.82 13.97 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 120.311 -0.555 . . . . 0.0 110.542 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.38 -25.89 67.48 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.295 -0.878 . . . . 0.0 112.19 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.517 ' CG ' ' CZ ' ' A' ' 65' ' ' PHE . 51.1 t80 -59.99 -43.61 95.03 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.112 -0.993 . . . . 0.0 110.714 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 98.4 p -62.13 -35.34 78.45 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.34 -0.85 . . . . 0.0 110.123 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.8 tt -66.7 -39.97 88.3 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.449 ' HZ ' HD21 ' B' ' 167' ' ' LEU . 5.5 m-85 -70.01 -40.06 75.49 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -91.59 88.75 6.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.782 -0.574 . . . . 0.0 110.139 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -59.98 -33.22 71.66 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.439 -0.788 . . . . 0.0 111.297 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -80.18 -10.07 59.74 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.113 -0.992 . . . . 0.0 111.236 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 58.02 26.07 57.7 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -88.07 -7.17 57.39 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.507 -0.996 . . . . 0.0 111.096 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.87 3.47 58.11 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.199 -1.001 . . . . 0.0 111.568 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.2 p -143.22 141.25 31.03 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 119.181 1.491 . . . . 0.0 111.484 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.5 mt -98.51 120.06 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.0 p -84.05 175.77 9.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.431 -0.793 . . . . 0.0 109.875 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.735 HG22 HD11 ' A' ' 52' ' ' ILE . 78.3 p -76.21 -32.34 58.9 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.592 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -67.84 -41.65 82.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.526 -0.734 . . . . 0.0 110.708 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -60.54 -57.46 12.65 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.605 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.5 tp -59.96 -39.19 84.78 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.368 -0.832 . . . . 0.0 111.057 -178.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -48.1 -29.79 6.96 Favored Glycine 0 N--CA 1.502 3.08 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -178.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.5 m -68.14 -40.0 82.52 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.442 -1.034 . . . . 0.0 108.928 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.5 t -64.13 -44.41 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 CA-C-O 121.306 0.574 . . . . 0.0 110.128 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.483 ' HE2' ' HD3' ' A' ' 43' ' ' PRO . 95.9 mtp -59.99 -39.99 87.65 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.604 -0.685 . . . . 0.0 110.554 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.465 ' HG2' ' HB2' ' A' ' 42' ' ' ASN . 1.1 mmt85 -61.02 -38.44 86.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.424 -0.797 . . . . 0.0 109.504 178.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.4 t -64.35 -26.7 68.59 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.887 -0.508 . . . . 0.0 110.613 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.557 HD11 HD13 ' B' ' 167' ' ' LEU . 88.3 mt -93.39 -16.1 24.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.298 -0.876 . . . . 0.0 110.228 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.05 -66.3 0.12 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -161.34 170.01 20.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.258 -1.142 . . . . 0.0 111.708 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.465 ' HB2' ' HG2' ' A' ' 37' ' ' ARG . 29.9 t30 -112.79 129.0 24.88 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.882 -0.511 . . . . 0.0 110.136 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.483 ' HD3' ' HE2' ' A' ' 36' ' ' MET . 50.8 Cg_endo -68.6 -143.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.264 0 O-C-N 123.142 1.075 . . . . 0.0 109.398 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.5 p -128.48 156.17 43.66 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.648 -1.282 . . . . 0.0 111.444 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -51.9 -22.59 3.95 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.78 -0.575 . . . . 0.0 111.844 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.13 -56.18 6.02 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 122.233 1.016 . . . . 0.0 108.523 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.4 -34.3 76.97 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.479 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.415 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 1.2 mt -57.22 -35.52 69.76 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.611 -0.681 . . . . 0.0 109.991 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -72.63 -30.29 64.18 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 120.191 -0.603 . . . . 0.0 111.708 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -69.14 -40.16 78.42 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.224 -0.923 . . . . 0.0 110.531 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 78.1 mtm -65.12 -40.02 93.88 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.682 0.754 . . . . 0.0 109.216 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.735 HD11 HG22 ' A' ' 29' ' ' THR . 92.6 mt -67.38 -34.48 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.832 -0.543 . . . . 0.0 110.507 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -60.08 -39.98 87.96 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.233 -0.917 . . . . 0.0 112.073 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -66.03 -27.77 68.35 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.051 -1.031 . . . . 0.0 110.75 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.578 HG21 ' SD ' ' A' ' 71' ' ' MET . 60.1 t -97.34 -9.33 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.598 -0.689 . . . . 0.0 110.55 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.432 ' OD2' HG22 ' A' ' 52' ' ' ILE . 12.1 m-20 -69.44 97.63 1.01 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.283 -0.886 . . . . 0.0 110.603 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.08 -38.62 91.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.658 -0.651 . . . . 0.0 109.4 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -90.33 -31.58 16.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.726 -0.609 . . . . 0.0 110.812 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.6 21.58 36.75 Favored Glycine 0 N--CA 1.496 2.653 0 C-N-CA 120.336 -0.935 . . . . 0.0 110.832 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -73.93 -33.61 64.01 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.441 -1.035 . . . . 0.0 110.576 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.05 -2.31 7.86 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 120.437 -0.887 . . . . 0.0 110.957 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.8 p -136.19 167.33 21.48 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.014 -1.286 . . . . 0.0 110.621 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.61 HD12 ' HH2' ' B' ' 170' ' ' TRP . 7.9 mt -107.76 123.78 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 121.596 0.712 . . . . 0.0 111.464 -177.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -99.58 171.22 8.06 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.54 0.685 . . . . 0.0 111.044 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.517 ' CZ ' ' CG ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -47.65 -50.03 53.2 Favored Pre-proline 0 N--CA 1.503 2.184 0 O-C-N 121.653 -0.654 . . . . 0.0 112.519 -179.507 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.499 ' O ' HG23 ' A' ' 70' ' ' THR . 41.7 Cg_endo -69.52 -35.33 13.54 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 122.92 0.958 . . . . 0.0 111.671 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.99 -39.93 75.63 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.23 -0.919 . . . . 0.0 109.8 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -61.66 -41.67 97.85 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.205 0.526 . . . . 0.0 110.775 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.3 mt -65.34 -39.97 93.06 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.479 -0.763 . . . . 0.0 111.941 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 66' ' ' PRO . 77.9 p -59.98 -39.96 87.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.249 -0.907 . . . . 0.0 110.614 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.578 ' SD ' HG21 ' A' ' 55' ' ' VAL . 61.3 ttp -67.36 -40.0 85.77 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.558 -0.714 . . . . 0.0 110.986 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -59.95 -50.15 74.9 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.53 -0.731 . . . . 0.0 111.928 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.84 -29.95 67.33 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.541 -0.725 . . . . 0.0 111.877 -178.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -69.97 -40.11 75.58 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.364 -0.835 . . . . 0.0 111.281 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.643 ' O ' HG22 ' A' ' 79' ' ' THR . 43.9 mmtm -69.97 -27.18 64.51 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 38.8 mmt -59.33 -49.03 79.38 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.03 -1.044 . . . . 0.0 112.229 -177.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.6 pttt -69.24 -33.87 73.95 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.263 -0.898 . . . . 0.0 111.936 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -70.02 -19.96 63.29 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.462 -0.773 . . . . 0.0 111.341 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.643 HG22 ' O ' ' A' ' 75' ' ' LYS . 14.3 t -118.2 -166.82 1.26 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.11 0.957 . . . . 0.0 112.427 -178.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -128.52 137.97 52.03 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.639 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.9 t -60.7 -32.43 71.67 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.649 -0.657 . . . . 0.0 110.652 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.474 ' HA ' HD12 ' A' ' 85' ' ' ILE . 92.7 mt-10 -59.99 -33.8 72.45 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.561 -0.712 . . . . 0.0 110.127 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -69.96 -40.0 75.67 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.742 -0.599 . . . . 0.0 110.747 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -69.39 -33.26 72.76 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.503 -0.748 . . . . 0.0 110.469 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.744 HG23 ' HE1' ' A' ' 141' ' ' PHE . 91.9 mt -64.81 -49.62 79.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.724 -0.61 . . . . 0.0 110.407 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -57.87 -38.4 75.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.444 -0.785 . . . . 0.0 111.02 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.714 ' O ' HG23 ' A' ' 91' ' ' VAL . 98.8 mt-10 -70.0 -42.06 73.54 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.66 -0.65 . . . . 0.0 111.617 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.3 -45.65 79.68 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.487 -0.758 . . . . 0.0 111.779 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -60.01 -45.99 90.96 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.382 -0.824 . . . . 0.0 109.449 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -59.99 -33.93 72.63 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.682 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 87' ' ' GLU . 83.3 t -69.04 -47.87 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.441 -0.787 . . . . 0.0 109.829 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.504 ' HE2' HG21 ' B' ' 164' ' ' VAL . 28.3 m-85 -70.02 -39.76 75.6 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.514 -0.741 . . . . 0.0 111.501 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -80.05 80.03 6.52 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.406 -0.809 . . . . 0.0 110.186 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -69.97 -42.07 73.64 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.413 -0.804 . . . . 0.0 110.932 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -72.78 -23.41 60.8 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.415 -0.803 . . . . 0.0 111.046 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.71 24.54 75.42 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -70.7 -9.73 57.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.504 -0.997 . . . . 0.0 111.131 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.69 -11.72 66.35 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -133.18 139.31 46.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.187 -1.184 . . . . 0.0 109.076 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.674 ' CG2' HD23 ' A' ' 105' ' ' LEU . 56.7 mt -89.37 123.25 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.532 -0.73 . . . . 0.0 110.042 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.4 m -86.96 170.14 11.85 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.405 0.621 . . . . 0.0 110.297 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.99 -39.91 75.63 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.632 -0.668 . . . . 0.0 109.749 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.25 -39.29 94.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.772 -0.58 . . . . 0.0 109.668 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -60.16 -39.89 87.97 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.606 -0.684 . . . . 0.0 110.386 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.674 HD23 ' CG2' ' A' ' 100' ' ' ILE . 0.5 OUTLIER -68.21 -41.23 81.63 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.484 0.659 . . . . 0.0 110.655 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -61.09 -37.03 81.27 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.656 -0.652 . . . . 0.0 111.746 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -59.97 -43.32 95.14 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.142 -0.974 . . . . 0.0 111.848 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.456 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 94.4 t -74.85 -44.24 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.237 -0.914 . . . . 0.0 111.631 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 94.5 mmm -58.25 -46.77 85.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.28 -0.888 . . . . 0.0 110.317 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.4 m -67.51 -41.07 85.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.46 -0.775 . . . . 0.0 109.202 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -61.55 -32.94 73.04 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.5 mt -68.52 -37.36 79.96 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.079 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 119.82 38.27 0.72 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -129.67 140.45 51.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.645 -0.915 . . . . 0.0 109.792 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -107.94 109.18 20.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.439 -0.788 . . . . 0.0 110.579 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 56.2 mt -131.59 156.2 46.18 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.598 -0.689 . . . . 0.0 109.753 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.3 m -84.0 164.76 19.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.626 -0.671 . . . . 0.0 109.744 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -61.13 -26.76 67.9 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.586 -0.696 . . . . 0.0 109.142 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.95 -31.85 73.0 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -37.34 87.26 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 73.1 t -70.64 -39.7 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.533 0.682 . . . . 0.0 110.201 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.409 ' HA ' HD12 ' A' ' 125' ' ' ILE . 44.4 t0 -59.89 -44.62 94.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.789 -0.57 . . . . 0.0 109.994 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -60.55 -41.33 94.34 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.579 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 67.6 mtt -55.6 -37.69 68.44 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 119.48 -0.888 . . . . 0.0 108.939 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 122' ' ' ASP . 96.7 mt -64.94 -39.93 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -58.64 -39.97 82.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.57 -0.706 . . . . 0.0 111.53 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -61.46 -40.0 92.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.398 -0.814 . . . . 0.0 111.86 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -102.93 -5.06 23.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.168 -0.957 . . . . 0.0 111.921 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -89.3 69.95 8.17 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.916 -1.115 . . . . 0.0 110.518 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.3 mt -70.03 -40.37 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.519 -0.738 . . . . 0.0 111.247 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -62.84 -39.96 95.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.357 -0.839 . . . . 0.0 111.207 -178.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 103.25 22.9 8.82 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.987 -1.102 . . . . 0.0 110.813 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -83.39 -7.71 59.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.33 -1.1 . . . . 0.0 110.767 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.05 -3.18 87.08 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -138.02 148.26 44.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.409 -1.053 . . . . 0.0 109.454 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 71.4 t -92.36 118.63 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.566 -0.709 . . . . 0.0 110.263 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -90.62 -174.32 4.05 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.361 -0.837 . . . . 0.0 110.823 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -69.98 -40.21 75.47 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.354 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.33 -50.11 74.94 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.181 -0.95 . . . . 0.0 111.383 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.47 -34.36 78.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.517 -0.739 . . . . 0.0 109.828 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.744 ' HE1' HG23 ' A' ' 85' ' ' ILE . 49.6 t80 -58.05 -49.3 77.37 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.038 0.447 . . . . 0.0 110.776 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 53.3 t -70.03 -39.08 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.365 -0.834 . . . . 0.0 111.211 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -57.6 -49.28 76.91 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.305 -0.872 . . . . 0.0 110.827 -178.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -59.35 -35.62 74.19 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.416 -0.802 . . . . 0.0 110.33 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.529 ' CE ' ' HB1' ' B' ' 161' ' ' ALA . 58.5 mtt -73.8 -40.0 63.7 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.53 -0.731 . . . . 0.0 110.549 178.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 34.8 m -69.9 -19.88 63.39 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.715 -0.615 . . . . 0.0 110.86 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -107.64 137.32 45.87 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.402 -0.811 . . . . 0.0 110.484 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.3 mttm . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.025 179.951 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -99.28 146.56 18.08 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -60.04 -41.84 93.13 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.595 -0.944 . . . . 0.0 110.098 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -59.96 -40.05 87.73 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.597 -0.689 . . . . 0.0 110.186 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -59.98 -40.19 88.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.733 -0.604 . . . . 0.0 110.703 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 160' ' ' ILE . . . . . 0.411 ' O ' HG23 ' B' ' 164' ' ' VAL . 95.3 mt -69.92 -40.41 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.396 -0.815 . . . . 0.0 111.973 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 161' ' ' ALA . . . . . 0.529 ' HB1' ' CE ' ' A' ' 145' ' ' MET . . . -66.14 -42.85 88.5 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.274 -0.892 . . . . 0.0 111.923 -178.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -68.68 -40.02 80.3 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.383 -0.823 . . . . 0.0 110.785 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.467 HD23 ' C ' ' B' ' 163' ' ' LEU . 10.3 tt -59.93 -42.87 94.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.499 -0.75 . . . . 0.0 110.397 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 164' ' ' VAL . . . . . 0.516 ' HA ' HD12 ' B' ' 167' ' ' LEU . 85.8 t -65.85 -40.03 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.581 -0.699 . . . . 0.0 110.011 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.57 -39.97 93.95 Favored Glycine 0 N--CA 1.498 2.83 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 84.8 t -64.56 -37.39 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.464 -1.021 . . . . 0.0 110.314 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.557 HD13 HD11 ' A' ' 39' ' ' LEU . 95.7 mt -60.02 -45.35 93.08 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.52 -0.737 . . . . 0.0 110.919 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 168' ' ' ARG . . . . . 0.402 ' O ' ' CD2' ' B' ' 172' ' ' TYR . 21.5 mmt180 -59.94 -39.31 85.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.487 -0.758 . . . . 0.0 110.999 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -60.02 -37.95 81.26 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.446 -0.784 . . . . 0.0 109.747 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 170' ' ' TRP . . . . . 0.61 ' HH2' HD12 ' A' ' 63' ' ' ILE . 3.2 t-105 -59.98 -43.32 95.19 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.688 -0.633 . . . . 0.0 109.72 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.98 -52.04 65.61 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.568 -0.707 . . . . 0.0 110.641 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 172' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' B' ' 168' ' ' ARG . 53.6 m-85 -60.01 -38.75 83.57 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.485 -0.76 . . . . 0.0 110.538 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.542 -0.724 . . . . 0.0 110.246 -179.883 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 121.698 0.761 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 94.3 mt -59.99 -32.4 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.817 -0.552 . . . . 0.0 111.53 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -65.6 -32.23 73.7 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.967 -1.083 . . . . 0.0 110.512 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -65.09 -45.54 84.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 109.946 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -69.99 -23.59 63.17 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.358 0.599 . . . . 0.0 110.09 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 23.1 tptp -66.61 -53.08 38.15 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.355 0.598 . . . . 0.0 109.562 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -57.09 -52.68 64.32 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.951 -0.699 . . . . 0.0 110.376 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.78 -26.39 68.69 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.352 -0.842 . . . . 0.0 111.105 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -58.25 -48.41 80.5 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.009 -1.057 . . . . 0.0 110.236 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.3 m -61.86 -39.85 93.31 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.306 -0.871 . . . . 0.0 109.143 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.5 tp -60.0 -39.98 87.64 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.351 0.596 . . . . 0.0 109.5 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -72.59 -35.49 67.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.727 -0.608 . . . . 0.0 110.392 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -95.4 98.96 10.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.471 -0.768 . . . . 0.0 110.371 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.2 mmtm -64.97 -32.04 73.57 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.377 -0.827 . . . . 0.0 111.192 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -79.83 -10.08 59.74 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.083 -1.011 . . . . 0.0 111.081 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.2 26.19 49.42 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -88.28 -3.29 58.88 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.605 -0.938 . . . . 0.0 110.637 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.57 5.46 64.94 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.297 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.9 p -145.1 142.39 29.64 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 119.166 1.483 . . . . 0.0 111.703 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 86.2 mt -103.86 128.0 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.3 p -102.05 141.22 35.23 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.619 -0.676 . . . . 0.0 110.628 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.455 ' O ' HD13 ' A' ' 48' ' ' LEU . 65.7 p -40.82 -35.87 0.56 Allowed 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -65.72 -45.44 82.69 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.249 -0.907 . . . . 0.0 109.548 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -60.05 -54.05 50.59 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.8 -0.562 . . . . 0.0 111.304 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.6 tt -59.95 -35.86 75.86 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.291 -0.881 . . . . 0.0 111.321 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.22 -28.98 44.16 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.2 m -69.54 -39.98 77.12 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.471 -1.017 . . . . 0.0 110.701 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.9 t -63.58 -54.98 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.691 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 97.8 mmm -59.96 -29.52 68.48 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.731 -0.606 . . . . 0.0 110.788 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -60.39 -50.44 73.58 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.503 -0.748 . . . . 0.0 110.448 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.4 t -72.55 -18.17 61.66 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.692 -0.63 . . . . 0.0 111.02 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.482 HD13 ' CD1' ' B' ' 167' ' ' LEU . 81.8 mt -100.11 -5.04 28.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.424 -0.797 . . . . 0.0 111.518 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.29 -68.04 0.12 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -160.21 170.64 20.75 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.228 -1.16 . . . . 0.0 111.448 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -110.53 117.21 51.41 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.972 -0.455 . . . . 0.0 110.215 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.697 ' CG ' HD21 ' A' ' 48' ' ' LEU . 53.1 Cg_endo -68.63 -150.37 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.324 0 N-CA-C 109.265 -1.091 . . . . 0.0 109.265 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 77.2 p -137.79 147.03 44.28 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.939 -1.101 . . . . 0.0 110.606 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.406 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 17.8 pt-20 -54.86 -21.1 10.32 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.55 -0.718 . . . . 0.0 111.46 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.53 -59.44 2.76 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.23 -38.43 85.21 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.832 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.697 HD21 ' CG ' ' A' ' 43' ' ' PRO . 56.5 mt -59.48 -33.71 71.65 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.666 0.746 . . . . 0.0 109.839 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.84 -39.01 83.89 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.022 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -65.93 -39.39 90.48 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.467 -0.771 . . . . 0.0 110.186 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 66.9 mtt -61.64 -43.39 98.94 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.415 0.626 . . . . 0.0 109.628 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.786 HG12 HD11 ' A' ' 63' ' ' ILE . 81.3 mt -68.02 -32.55 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.773 -0.579 . . . . 0.0 110.419 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -59.76 -40.04 86.83 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.384 -0.823 . . . . 0.0 110.292 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -64.07 -27.99 69.48 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.445 -0.785 . . . . 0.0 110.319 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.535 HG21 ' HE2' ' A' ' 71' ' ' MET . 61.0 t -101.01 -10.11 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.443 -0.785 . . . . 0.0 110.803 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.546 ' OD2' HG22 ' A' ' 52' ' ' ILE . 22.0 m-20 -67.25 100.5 0.81 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.136 -0.978 . . . . 0.0 111.163 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.0 -38.34 75.94 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -90.75 -30.45 17.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.756 -0.59 . . . . 0.0 110.622 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.6 22.42 43.5 Favored Glycine 0 N--CA 1.496 2.65 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.006 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -75.22 -31.89 61.0 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.342 -1.093 . . . . 0.0 110.657 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.4 1.1 12.48 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.334 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 77.8 p -133.49 170.01 16.13 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.116 -1.226 . . . . 0.0 110.429 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.786 HD11 HG12 ' A' ' 52' ' ' ILE . 7.0 mt -106.69 122.33 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.892 -177.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -98.5 170.03 9.11 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.521 0.676 . . . . 0.0 110.383 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.45 ' HB3' ' HD3' ' A' ' 66' ' ' PRO . 9.9 t80 -47.07 -48.77 53.1 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.586 -0.696 . . . . 0.0 112.802 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 65' ' ' PHE . 45.2 Cg_endo -71.26 -32.27 13.07 Favored 'Trans proline' 0 N--CA 1.487 1.102 0 O-C-N 122.783 0.886 . . . . 0.0 111.596 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -72.4 -40.21 67.38 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.123 -0.986 . . . . 0.0 110.409 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -62.74 -45.43 92.74 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.781 -0.574 . . . . 0.0 110.544 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.05 -40.01 87.96 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.515 -0.74 . . . . 0.0 110.472 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 93.1 m -61.19 -40.75 95.09 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.721 -0.612 . . . . 0.0 111.029 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.535 ' HE2' HG21 ' A' ' 55' ' ' VAL . 12.9 ttm -69.14 -41.07 77.82 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.45 -0.781 . . . . 0.0 112.099 -178.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -60.02 -50.0 75.44 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.335 -0.853 . . . . 0.0 111.226 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.59 -32.27 70.91 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.714 -0.616 . . . . 0.0 111.822 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.8 mmt85 -72.96 -43.51 62.2 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.33 -0.856 . . . . 0.0 111.819 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -73.4 -41.66 63.07 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.373 -0.829 . . . . 0.0 112.853 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 24.4 ptm -60.06 -29.77 68.77 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.162 -0.961 . . . . 0.0 111.538 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -63.19 -52.69 61.32 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.27 -0.894 . . . . 0.0 111.587 -178.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -69.84 -10.82 59.85 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.42 -0.8 . . . . 0.0 111.168 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.586 HG22 ' H ' ' A' ' 80' ' ' ASP 0.268 23.4 m -86.06 -174.58 5.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.581 -0.699 . . . . 0.0 109.369 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.586 ' H ' HG22 ' A' ' 79' ' ' THR . 94.1 m-20 -128.01 140.9 51.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.238 -0.914 . . . . 0.0 109.447 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.1 t -59.95 -35.05 74.13 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.633 -0.667 . . . . 0.0 110.152 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -61.08 -34.95 75.73 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.619 0.723 . . . . 0.0 109.471 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.99 -40.0 75.58 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.909 -0.494 . . . . 0.0 111.412 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.91 -40.0 79.34 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.443 -0.786 . . . . 0.0 111.062 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.448 HG23 ' HE1' ' A' ' 141' ' ' PHE . 82.8 mt -68.16 -51.82 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.45 -0.781 . . . . 0.0 110.984 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -60.01 -40.94 90.99 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.255 -0.903 . . . . 0.0 111.708 -178.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.517 ' O ' HG23 ' A' ' 91' ' ' VAL . 97.6 mt-10 -70.52 -41.45 72.56 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.51 -0.744 . . . . 0.0 111.576 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.31 -43.61 94.16 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.526 -0.734 . . . . 0.0 110.716 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -61.96 -40.81 96.86 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.811 0.815 . . . . 0.0 108.899 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 29.6 ttt85 -59.95 -37.13 78.67 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.395 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 87' ' ' GLU . 91.2 t -70.02 -50.03 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.509 -0.744 . . . . 0.0 110.153 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.674 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 27.3 m-85 -67.67 -39.97 84.47 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.405 -0.809 . . . . 0.0 110.261 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -79.58 76.3 6.21 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.403 ' HE3' ' CD2' ' A' ' 107' ' ' HIS . 60.2 mttm -68.85 -40.48 79.33 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.505 -0.747 . . . . 0.0 110.276 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -74.5 -21.67 59.44 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.418 -0.801 . . . . 0.0 110.64 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.2 26.41 73.43 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -69.92 -12.66 61.78 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.535 -0.979 . . . . 0.0 111.464 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.11 -20.62 14.07 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -144.77 153.74 41.97 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.239 -1.154 . . . . 0.0 109.994 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 80.6 mt -88.88 131.58 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.887 0.851 . . . . 0.0 110.457 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.2 m -87.7 171.01 10.75 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.193 0.521 . . . . 0.0 110.367 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.499 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -65.68 -40.07 91.97 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.41 -38.49 89.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.748 -0.595 . . . . 0.0 109.5 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -61.84 -39.95 93.61 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.751 -0.593 . . . . 0.0 110.666 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.66 ' HB3' HG13 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -61.38 -45.61 93.63 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.44 -0.788 . . . . 0.0 109.761 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -64.42 -29.0 70.06 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.768 -0.582 . . . . 0.0 110.513 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.403 ' CD2' ' HE3' ' A' ' 94' ' ' LYS . 1.5 t-80 -61.59 -46.8 88.32 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.445 -0.785 . . . . 0.0 111.361 -178.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.674 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 66.5 t -73.38 -47.93 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.472 -0.768 . . . . 0.0 111.727 -178.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.468 ' HA ' HD12 ' A' ' 112' ' ' LEU . 98.0 mtp -58.61 -39.95 81.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.222 -0.923 . . . . 0.0 110.544 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.4 m -66.58 -45.27 79.79 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -61.45 -33.41 73.68 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 109' ' ' MET . 59.2 mt -68.83 -38.74 80.06 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.922 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 119.97 39.88 0.62 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -123.32 136.01 54.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.664 -0.903 . . . . 0.0 109.991 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -96.71 126.41 41.86 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.519 -0.738 . . . . 0.0 109.701 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.688 HD23 ' N ' ' A' ' 116' ' ' LEU . 1.0 OUTLIER -152.52 153.77 34.12 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.513 -0.742 . . . . 0.0 111.443 -178.813 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.7 p -87.36 168.04 13.51 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 36.6 p-10 -64.46 -20.69 66.34 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.644 -0.823 . . . . 0.0 108.879 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -69.71 -37.93 76.76 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.973 0.892 . . . . 0.0 109.134 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -61.48 -39.98 92.88 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 122.131 0.967 . . . . 0.0 108.967 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.66 HG13 ' HB3' ' A' ' 105' ' ' LEU . 63.7 t -69.73 -39.85 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.663 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -59.79 -48.54 81.29 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.572 -0.705 . . . . 0.0 110.217 -178.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -59.99 -40.04 87.8 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.93 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.451 ' HB3' HD11 ' A' ' 105' ' ' LEU . 92.8 mmm -55.4 -38.16 68.55 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.136 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.41 -36.92 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 121.667 0.746 . . . . 0.0 109.154 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -58.14 -39.66 79.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.804 -0.56 . . . . 0.0 111.072 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.96 -39.31 85.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.549 -0.719 . . . . 0.0 111.297 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.91 -18.8 18.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.281 -0.887 . . . . 0.0 111.103 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -72.42 70.84 0.9 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.312 -0.867 . . . . 0.0 111.349 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 85.4 mt -67.8 -40.41 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.45 -0.781 . . . . 0.0 110.557 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -72.32 -18.26 61.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.438 -0.789 . . . . 0.0 111.581 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.23 22.48 60.68 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 120.136 -1.03 . . . . 0.0 110.853 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -82.6 -7.23 59.65 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.181 -1.188 . . . . 0.0 110.782 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.19 -0.83 89.52 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -138.52 149.5 45.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.327 -1.102 . . . . 0.0 109.246 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.6 t -92.98 110.85 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.356 -0.84 . . . . 0.0 110.7 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -80.0 172.77 13.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.493 -0.754 . . . . 0.0 109.647 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -67.94 -40.07 83.36 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.795 -0.566 . . . . 0.0 111.009 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -62.85 -52.29 63.69 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.252 -0.905 . . . . 0.0 111.988 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -69.12 -23.3 63.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -0.849 . . . . 0.0 111.122 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.448 ' HE1' HG23 ' A' ' 85' ' ' ILE . 63.3 t80 -60.08 -42.3 94.3 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.433 -0.792 . . . . 0.0 109.598 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 95.3 t -70.09 -37.67 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.726 -0.609 . . . . 0.0 111.047 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -59.94 -50.03 75.36 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.49 -0.757 . . . . 0.0 110.935 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.476 ' HE1' ' CD1' ' B' ' 157' ' ' PHE . 59.5 ttp -59.95 -37.73 80.4 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.261 -0.899 . . . . 0.0 110.299 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 94.2 mmm -67.1 -39.99 86.82 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.749 -0.594 . . . . 0.0 111.372 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 64.5 m -57.59 -26.12 61.04 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.292 -0.88 . . . . 0.0 110.543 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.78 135.0 41.72 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.47 -0.769 . . . . 0.0 110.21 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.141 179.969 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -133.87 140.36 11.72 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 157' ' ' PHE . . . . . 0.48 ' O ' HG22 ' B' ' 160' ' ' ILE . 36.0 t80 -61.96 -41.26 97.8 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.597 -0.943 . . . . 0.0 110.37 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -62.5 -40.04 95.43 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.561 -0.712 . . . . 0.0 110.585 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -61.66 -48.12 82.28 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.643 -0.661 . . . . 0.0 111.191 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 160' ' ' ILE . . . . . 0.48 HG22 ' O ' ' B' ' 157' ' ' PHE . 14.3 tt -69.95 -26.04 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.527 -0.733 . . . . 0.0 111.04 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.48 -35.34 77.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.504 -0.748 . . . . 0.0 109.661 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -59.97 -40.09 87.89 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.817 -0.552 . . . . 0.0 109.997 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 59.7 mt -63.27 -39.96 96.07 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.525 -0.734 . . . . 0.0 110.704 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 91.2 t -62.75 -40.4 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.455 -0.778 . . . . 0.0 110.414 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.05 -40.02 96.51 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 48.1 t -70.53 -22.53 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.613 -0.934 . . . . 0.0 110.833 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.482 ' CD1' HD13 ' A' ' 39' ' ' LEU . 9.6 tt -59.98 -41.93 93.1 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.3 -0.875 . . . . 0.0 110.076 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -69.48 -35.98 76.09 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.577 -0.702 . . . . 0.0 109.767 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 169' ' ' GLU . . . . . 0.446 ' OE2' HG21 ' A' ' 79' ' ' THR . 89.8 mt-10 -59.92 -36.65 77.46 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.665 -0.647 . . . . 0.0 110.235 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 4.9 t-105 -60.06 -40.91 91.12 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.671 -0.643 . . . . 0.0 110.722 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.06 -50.12 74.95 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.453 -0.78 . . . . 0.0 110.65 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -60.01 -39.99 87.72 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.417 -0.802 . . . . 0.0 110.354 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 71.2 mtt-85 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.615 -0.678 . . . . 0.0 110.277 -179.537 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.791 0.805 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 88.0 mt -62.99 -37.94 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.958 -0.464 . . . . 0.0 111.699 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.66 -39.77 89.61 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.206 -0.934 . . . . 0.0 110.344 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -60.06 -39.58 86.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.374 -0.829 . . . . 0.0 110.407 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.588 ' HB3' HD21 ' A' ' 69' ' ' LEU . 47.2 m-85 -64.17 -22.1 66.81 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.682 -0.636 . . . . 0.0 110.885 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -69.52 -41.14 76.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.303 -0.873 . . . . 0.0 109.181 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -71.91 -23.76 61.53 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.133 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.05 -35.49 42.48 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.342 -0.849 . . . . 0.0 110.107 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.433 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 54.7 t80 -58.38 -38.13 76.68 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.899 -0.5 . . . . 0.0 110.914 -178.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.3 p -61.02 -37.15 81.54 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.35 -0.844 . . . . 0.0 109.92 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.643 HD13 ' O ' ' A' ' 18' ' ' LEU . 0.8 OUTLIER -59.98 -40.01 87.67 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.611 -0.681 . . . . 0.0 109.459 179.545 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -78.14 -36.25 48.01 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.629 -0.669 . . . . 0.0 110.266 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -93.19 95.8 9.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.581 -0.699 . . . . 0.0 109.967 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -61.74 -32.82 73.08 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.574 -0.704 . . . . 0.0 111.221 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -79.37 -10.43 59.81 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.234 -0.916 . . . . 0.0 111.565 -177.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.51 27.75 54.72 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -92.98 -2.54 55.67 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.616 -0.931 . . . . 0.0 111.0 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.38 2.67 63.58 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.787 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 76.2 p -142.05 141.11 32.76 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 119.559 1.68 . . . . 0.0 111.76 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.622 ' HB ' HD12 ' A' ' 63' ' ' ILE . 85.7 mt -105.39 130.14 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.792 -0.567 . . . . 0.0 110.428 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.3 p -113.01 146.6 38.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.599 -0.688 . . . . 0.0 110.779 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.432 HG23 HG13 ' A' ' 52' ' ' ILE . 40.7 p -42.4 -31.08 0.38 Allowed 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.744 -0.598 . . . . 0.0 112.378 -177.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -65.38 -48.98 71.04 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.569 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -60.43 -56.82 16.76 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.967 -0.458 . . . . 0.0 111.767 -178.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.6 tp -61.54 -32.79 72.87 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.105 -0.997 . . . . 0.0 110.632 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -50.79 -33.95 28.49 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.3 m -69.98 -40.03 75.59 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.691 -0.888 . . . . 0.0 110.244 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.2 t -63.45 -58.51 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.573 -0.704 . . . . 0.0 110.264 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.427 ' HG2' HD21 ' B' ' 167' ' ' LEU . 74.0 mtm -60.01 -30.04 68.88 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.574 -0.704 . . . . 0.0 110.447 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 1.6 tmm_? -60.77 -50.36 73.77 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.566 -0.709 . . . . 0.0 109.601 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.9 t -74.78 -20.06 59.95 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.872 -0.517 . . . . 0.0 110.33 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.516 HD22 ' CD1' ' B' ' 167' ' ' LEU . 5.4 mp -97.97 -1.48 42.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.393 -0.817 . . . . 0.0 111.352 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.07 -71.43 0.11 Allowed Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.898 -1.144 . . . . 0.0 110.374 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.411 ' HG2' ' N ' ' A' ' 42' ' ' ASN . 36.5 tt0 -162.04 161.01 28.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.183 -1.186 . . . . 0.0 111.316 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.411 ' N ' ' HG2' ' A' ' 41' ' ' GLN . 45.3 t30 -111.65 103.4 55.07 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -61.78 -146.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 O-C-N 123.512 1.269 . . . . 0.0 110.402 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.8 p -132.86 157.54 44.79 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.619 -1.3 . . . . 0.0 112.122 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.421 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 45.8 mt-10 -52.64 -23.36 6.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.886 -0.509 . . . . 0.0 111.647 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.05 -59.94 2.6 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.149 0.976 . . . . 0.0 108.419 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -67.86 -36.2 79.88 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.589 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 45' ' ' GLU . 8.8 mt -58.3 -35.02 71.22 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.605 0.717 . . . . 0.0 109.769 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -64.68 -39.79 94.29 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.068 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -64.8 -40.02 94.55 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.542 -0.724 . . . . 0.0 111.192 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 64.5 mtt -60.04 -42.53 94.63 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.618 -0.676 . . . . 0.0 109.791 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.827 HG22 ' OD2' ' A' ' 56' ' ' ASP . 48.5 mm -68.33 -37.18 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.855 -0.528 . . . . 0.0 111.11 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -60.97 -40.04 91.89 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.484 -0.76 . . . . 0.0 111.511 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -69.99 -28.25 65.36 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.188 -0.945 . . . . 0.0 110.482 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.1 t -95.61 -9.96 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.648 -0.658 . . . . 0.0 111.229 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.827 ' OD2' HG22 ' A' ' 52' ' ' ILE . 25.4 m-20 -74.71 97.45 3.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.176 -0.953 . . . . 0.0 110.766 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.01 -34.53 73.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.541 -0.724 . . . . 0.0 109.804 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -91.41 -26.3 18.93 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.556 -0.715 . . . . 0.0 110.774 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.14 20.17 50.4 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.035 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -76.13 -26.34 56.25 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.434 -1.039 . . . . 0.0 110.461 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.438 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 109.8 -2.09 30.37 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 77.0 p -130.71 170.89 13.74 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.187 -1.184 . . . . 0.0 110.625 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.622 HD12 ' HB ' ' A' ' 27' ' ' ILE . 6.4 mt -89.4 167.5 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.218 0.533 . . . . 0.0 110.007 -178.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.425 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 81.6 m-20 -147.04 150.57 35.35 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.496 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.7 m-85 -42.98 -52.45 11.57 Favored Pre-proline 0 N--CA 1.506 2.344 0 O-C-N 121.702 -0.624 . . . . 0.0 111.71 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.669 ' O ' HG23 ' A' ' 70' ' ' THR . 43.4 Cg_endo -69.41 -29.85 24.87 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 O-C-N 123.269 1.142 . . . . 0.0 111.334 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -72.55 -45.46 59.19 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.014 -1.054 . . . . 0.0 110.067 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -60.47 -43.93 96.41 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.755 -0.59 . . . . 0.0 110.665 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.588 HD21 ' HB3' ' A' ' 12' ' ' PHE . 78.3 mt -67.13 -41.55 85.93 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.686 -0.633 . . . . 0.0 111.757 -178.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.669 HG23 ' O ' ' A' ' 66' ' ' PRO . 43.0 p -62.71 -40.16 96.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.337 -0.852 . . . . 0.0 110.718 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.414 ' HE3' ' CE3' ' B' ' 170' ' ' TRP . 56.4 ttp -66.35 -46.57 76.32 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.79 -0.569 . . . . 0.0 111.315 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.7 ttm -60.06 -49.97 75.56 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.388 -0.82 . . . . 0.0 111.352 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.54 -33.52 72.78 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.487 -0.758 . . . . 0.0 110.58 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.6 ttp180 -69.98 -39.52 75.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.722 -0.611 . . . . 0.0 110.857 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.775 ' O ' HG22 ' A' ' 79' ' ' THR . 4.3 mptp? -71.83 -18.25 62.09 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.455 -0.778 . . . . 0.0 112.086 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 26.9 mmt -58.96 -50.02 75.66 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.99 -1.069 . . . . 0.0 110.735 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.99 -32.7 71.04 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.692 -0.63 . . . . 0.0 111.121 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -70.67 -18.9 62.83 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.43 -0.794 . . . . 0.0 111.549 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.775 HG22 ' O ' ' A' ' 75' ' ' LYS . 14.4 t -121.93 -162.94 1.02 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.879 0.847 . . . . 0.0 112.284 -178.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -127.97 142.2 51.31 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.353 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.3 t -66.73 -32.51 73.86 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.83 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -60.08 -36.98 78.58 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.881 0.848 . . . . 0.0 109.199 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.86 -39.97 76.04 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.306 0.574 . . . . 0.0 110.389 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -61.63 -37.49 84.17 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.606 -0.684 . . . . 0.0 110.75 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 77.4 mt -67.73 -44.43 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.538 -0.726 . . . . 0.0 110.685 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -59.25 -39.96 84.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.417 -0.802 . . . . 0.0 110.561 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -70.02 -39.96 75.48 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.339 -0.851 . . . . 0.0 111.346 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.434 ' HA ' HG11 ' B' ' 164' ' ' VAL . . . -63.98 -46.26 85.41 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.466 -0.771 . . . . 0.0 111.317 -178.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.423 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 52.2 t80 -62.39 -39.99 95.02 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.481 -0.762 . . . . 0.0 109.617 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 39.4 ttm-85 -59.99 -39.3 85.24 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.821 -0.55 . . . . 0.0 111.247 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.6 t -70.02 -43.89 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.482 -0.761 . . . . 0.0 110.354 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.548 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 16.2 m-85 -68.62 -39.28 80.88 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.345 -0.847 . . . . 0.0 111.119 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -78.64 78.2 5.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.515 -0.74 . . . . 0.0 109.867 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -59.98 -45.39 92.88 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.487 -0.758 . . . . 0.0 110.358 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 33.3 p-10 -79.71 -19.59 48.51 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.641 -0.662 . . . . 0.0 110.869 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.18 62.5 6.28 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -105.74 -10.59 16.66 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.389 -1.065 . . . . 0.0 111.262 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 123.91 -25.62 6.09 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.419 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 27.5 p90 -145.75 152.49 39.65 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.483 -1.01 . . . . 0.0 109.42 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 77.4 mt -88.84 131.39 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.887 0.851 . . . . 0.0 110.197 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.97 171.84 10.02 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.269 0.557 . . . . 0.0 110.588 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.0 -41.57 97.44 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.603 -0.686 . . . . 0.0 109.304 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.96 -37.7 88.51 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -64.82 -40.08 94.62 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.607 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.639 ' HB3' HG13 ' A' ' 121' ' ' VAL . 1.3 tt -60.29 -45.48 93.19 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.336 -0.852 . . . . 0.0 109.264 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.8 ttt-85 -62.54 -30.99 71.7 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.844 -0.535 . . . . 0.0 111.081 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -59.94 -46.12 90.42 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.164 -0.96 . . . . 0.0 110.417 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.548 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 90.2 t -74.96 -33.0 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.411 -0.806 . . . . 0.0 110.926 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.1 mmt -60.09 -49.12 78.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.454 -0.779 . . . . 0.0 110.323 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 76.8 m -68.6 -43.92 75.42 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.66 -0.65 . . . . 0.0 110.414 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -59.89 -29.32 68.26 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.56 -0.712 . . . . 0.0 109.501 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.492 HD11 HG12 ' A' ' 108' ' ' VAL . 27.4 mt -70.01 -29.65 66.78 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.694 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 112.21 18.98 7.38 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -122.03 145.03 48.54 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.248 -1.148 . . . . 0.0 110.35 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -105.53 123.6 48.16 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.539 -0.726 . . . . 0.0 110.666 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 72.2 mt -135.38 157.83 45.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.625 -0.672 . . . . 0.0 110.02 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.22 166.75 16.28 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.631 -0.668 . . . . 0.0 109.226 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -61.72 -26.37 68.01 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.94 -34.54 78.36 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.466 0.651 . . . . 0.0 109.57 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.33 -35.86 82.28 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.639 HG13 ' HB3' ' A' ' 105' ' ' LEU . 53.9 t -68.07 -39.98 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 121.507 0.67 . . . . 0.0 109.884 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.518 ' HA ' HD12 ' A' ' 125' ' ' ILE . 55.2 t0 -59.99 -49.85 76.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.733 -0.604 . . . . 0.0 110.511 -178.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -60.44 -42.04 95.31 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.494 -0.754 . . . . 0.0 110.423 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 86.8 mtp -55.18 -37.83 67.55 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.205 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 122' ' ' ASP . 90.3 mt -63.69 -38.67 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.447 0.641 . . . . 0.0 109.509 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -53.85 -35.77 61.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.665 -0.647 . . . . 0.0 111.613 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -59.83 -40.04 87.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.488 -0.758 . . . . 0.0 111.207 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.81 -5.13 17.46 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.221 -0.924 . . . . 0.0 111.167 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.444 ' HB2' HG22 ' A' ' 125' ' ' ILE . 65.4 t0 -79.78 68.06 5.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.076 -1.015 . . . . 0.0 109.89 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 82.8 mt -68.13 -39.97 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.684 -0.635 . . . . 0.0 110.725 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 37.4 p-10 -70.02 -20.91 63.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.372 -0.83 . . . . 0.0 110.923 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.09 21.43 60.98 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.062 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -82.01 -10.09 59.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -1.133 . . . . 0.0 110.952 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.61 3.46 77.66 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -139.18 147.8 42.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -1.144 . . . . 0.0 109.875 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.6 t -93.17 114.78 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.417 -0.802 . . . . 0.0 110.071 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -82.77 172.0 13.35 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -60.09 -43.85 95.22 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.361 0.601 . . . . 0.0 109.518 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -62.47 -47.61 83.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.678 -0.638 . . . . 0.0 111.013 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -65.35 -33.21 75.42 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.471 -0.768 . . . . 0.0 110.213 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 89.0 t80 -60.05 -47.07 87.38 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.941 -0.474 . . . . 0.0 111.116 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 83.7 t -70.01 -39.14 77.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.257 -0.902 . . . . 0.0 111.193 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -59.97 -49.49 77.47 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.414 -0.804 . . . . 0.0 111.093 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -60.01 -38.09 81.65 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.438 -0.789 . . . . 0.0 110.947 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 97.5 mtp -66.4 -40.0 89.35 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.606 -0.684 . . . . 0.0 110.603 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 66.8 p -98.56 22.13 10.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.417 -0.802 . . . . 0.0 110.387 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.93 -48.22 82.58 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.434 -0.791 . . . . 0.0 110.817 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 90.7 mttt . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.436 -179.58 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -89.38 148.49 20.1 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -59.91 -44.52 94.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.637 -0.919 . . . . 0.0 110.264 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -60.95 -40.01 91.69 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.655 -0.653 . . . . 0.0 111.393 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -62.03 -39.94 94.04 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.372 -0.83 . . . . 0.0 111.521 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 90.6 mt -68.43 -40.05 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.429 -0.794 . . . . 0.0 110.873 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.47 -40.04 92.7 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.325 -0.859 . . . . 0.0 111.05 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -61.61 -41.03 96.87 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.379 -0.826 . . . . 0.0 110.966 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.75 -39.98 90.74 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.496 -0.752 . . . . 0.0 110.595 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 164' ' ' VAL . . . . . 0.434 HG11 ' HA ' ' A' ' 88' ' ' ALA . 96.8 t -66.26 -40.01 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.604 -0.685 . . . . 0.0 110.022 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -54.46 -42.6 75.9 Favored Glycine 0 N--CA 1.5 2.947 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.69 -18.91 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.656 -0.908 . . . . 0.0 110.371 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.57 HD23 ' C ' ' B' ' 167' ' ' LEU . 9.3 tt -59.95 -49.95 75.65 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.323 -0.86 . . . . 0.0 110.905 -178.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -64.62 -39.96 94.63 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.455 -0.778 . . . . 0.0 109.762 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -62.33 -25.39 67.86 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.75 -0.594 . . . . 0.0 110.055 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 170' ' ' TRP . . . . . 0.414 ' CE3' ' HE3' ' A' ' 71' ' ' MET . 2.6 t-105 -59.88 -43.0 94.98 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.524 -0.735 . . . . 0.0 109.925 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.06 -46.92 87.96 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.543 -0.723 . . . . 0.0 110.538 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -60.05 -38.28 82.33 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.421 -0.799 . . . . 0.0 110.381 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 . . . . . 0 N--CA 1.494 1.737 0 O-C-N 121.593 -0.692 . . . . 0.0 110.283 -179.755 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 121.343 0.592 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.9 mm -57.9 -50.01 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.346 -0.846 . . . . 0.0 110.744 -177.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.16 -22.38 66.92 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.36 -0.838 . . . . 0.0 111.591 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -68.54 -53.62 21.9 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.333 -0.854 . . . . 0.0 109.448 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.427 ' CE1' ' HG2' ' A' ' 72' ' ' MET . 25.6 m-85 -67.9 -21.88 65.11 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.373 0.606 . . . . 0.0 109.44 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -66.99 -41.81 86.11 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.412 0.625 . . . . 0.0 109.951 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.33 -56.98 14.94 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.794 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.68 -33.95 76.11 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.261 -0.899 . . . . 0.0 111.438 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -58.04 -49.99 74.97 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.151 -0.968 . . . . 0.0 110.236 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.2 m -65.51 -38.63 90.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.313 -0.867 . . . . 0.0 108.761 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.4 tp -60.0 -37.63 80.27 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.29 0.567 . . . . 0.0 109.893 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -73.48 -28.64 62.04 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.648 -0.658 . . . . 0.0 110.569 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -96.31 102.03 13.75 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.348 -0.845 . . . . 0.0 109.682 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -67.07 -31.57 72.17 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.435 -0.79 . . . . 0.0 111.446 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -79.85 -9.58 59.68 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.122 -0.986 . . . . 0.0 111.148 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 64.14 24.64 68.97 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -79.77 -9.55 59.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.453 -1.028 . . . . 0.0 110.939 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.417 ' C ' HG23 ' A' ' 26' ' ' THR . . . 80.01 6.94 88.92 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -178.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.417 HG23 ' C ' ' A' ' 25' ' ' GLY . 78.0 p -148.22 142.14 25.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.124 -1.221 . . . . 0.0 109.892 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.4 mt -103.49 123.38 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.748 -0.595 . . . . 0.0 110.096 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 65.5 p -98.82 143.84 28.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.862 -0.524 . . . . 0.0 109.716 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.406 ' H ' HG23 ' A' ' 29' ' ' THR . 70.5 p -40.5 -36.6 0.59 Allowed 'General case' 0 N--CA 1.512 2.646 0 O-C-N 121.806 -0.559 . . . . 0.0 112.195 -177.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -63.51 -45.31 91.27 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.209 -0.932 . . . . 0.0 109.527 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -59.95 -52.82 63.75 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.752 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.412 HD21 ' NE1' ' B' ' 170' ' ' TRP . 64.1 tp -59.19 -37.4 77.32 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.131 -0.98 . . . . 0.0 110.846 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -52.92 -32.28 41.21 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.5 m -70.04 -39.96 75.42 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.603 -0.939 . . . . 0.0 110.483 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.3 t -63.99 -57.19 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.453 -0.779 . . . . 0.0 109.851 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 98.2 mtp -59.21 -28.33 66.56 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.622 -0.674 . . . . 0.0 110.037 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 3.8 tmt_? -59.97 -39.58 86.14 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.4 t -66.16 -17.24 64.6 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.849 -0.532 . . . . 0.0 110.861 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.688 HD22 HD21 ' B' ' 167' ' ' LEU . 33.7 tp -85.61 -28.38 24.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.295 -0.878 . . . . 0.0 109.22 179.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.65 -46.85 0.2 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -160.96 176.36 11.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.772 -0.84 . . . . 0.0 110.253 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -120.01 148.62 47.18 Favored Pre-proline 0 C--N 1.299 -1.602 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.754 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.689 ' HG2' HD21 ' A' ' 48' ' ' LEU . 54.6 Cg_endo -69.48 -147.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.318 0 O-C-N 123.626 1.329 . . . . 0.0 109.627 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 57.8 p -136.42 149.4 48.25 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.905 -1.122 . . . . 0.0 111.431 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -52.62 -24.02 7.62 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.706 -0.621 . . . . 0.0 111.57 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.35 -59.5 2.73 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.092 0.949 . . . . 0.0 108.636 177.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -66.75 -37.74 85.22 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.907 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.689 HD21 ' HG2' ' A' ' 43' ' ' PRO . 39.6 mt -58.55 -35.18 71.93 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.774 0.797 . . . . 0.0 109.507 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.4 -39.27 78.04 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.062 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -66.41 -38.02 86.54 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.481 -0.762 . . . . 0.0 110.675 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 73.2 mmm -60.05 -44.67 94.54 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.633 0.73 . . . . 0.0 109.469 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.879 HG22 ' OD2' ' A' ' 56' ' ' ASP . 96.7 mt -68.83 -34.59 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-O 121.173 0.511 . . . . 0.0 110.413 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -60.7 -40.99 94.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.441 -0.787 . . . . 0.0 110.659 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -70.69 -29.43 65.73 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.329 -0.857 . . . . 0.0 110.813 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.8 t -98.23 -8.15 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.68 -0.637 . . . . 0.0 111.862 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.879 ' OD2' HG22 ' A' ' 52' ' ' ILE . 9.1 m-20 -71.98 107.44 4.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.012 -1.055 . . . . 0.0 111.106 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.52 -41.08 85.0 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.542 -0.723 . . . . 0.0 109.715 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -87.85 -29.94 20.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.631 -0.668 . . . . 0.0 110.309 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.08 21.16 46.96 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.609 -0.997 . . . . 0.0 110.609 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -72.22 -37.8 69.12 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.391 -1.064 . . . . 0.0 110.258 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.77 -6.43 5.5 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 120.197 -1.001 . . . . 0.0 111.114 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 81.1 p -135.36 170.08 16.5 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.078 -1.248 . . . . 0.0 110.588 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.642 HD12 ' HH2' ' B' ' 170' ' ' TRP . 7.0 mt -106.13 123.73 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-O 121.609 0.718 . . . . 0.0 111.204 -177.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -101.68 172.03 7.2 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.701 0.763 . . . . 0.0 111.103 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.498 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -46.8 -49.96 45.76 Favored Pre-proline 0 N--CA 1.499 1.992 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 39.4 Cg_endo -65.73 -36.66 31.41 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 122.889 0.941 . . . . 0.0 111.795 -178.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -70.01 -39.95 75.55 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.24 -0.912 . . . . 0.0 110.455 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -61.55 -40.28 94.15 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.606 -0.683 . . . . 0.0 111.042 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.2 mt -68.87 -40.01 79.51 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.425 -0.797 . . . . 0.0 111.848 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 47.2 p -59.97 -45.68 91.91 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.164 -0.96 . . . . 0.0 111.161 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 56.3 ttp -68.77 -40.0 79.94 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.531 -0.73 . . . . 0.0 111.458 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.605 ' CE ' HG11 ' B' ' 166' ' ' VAL . 48.6 tpp -60.12 -49.61 76.96 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.445 -0.785 . . . . 0.0 111.279 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.49 -31.18 66.82 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.523 -0.736 . . . . 0.0 112.174 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -83.38 -50.73 8.04 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.336 -0.853 . . . . 0.0 111.907 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.403 ' CG ' ' CG ' ' B' ' 169' ' ' GLU . 60.1 tptt -66.4 -40.0 89.36 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.564 -0.71 . . . . 0.0 112.192 -178.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.4 ' HG3' ' N ' ' A' ' 77' ' ' LYS . 28.1 ptm -55.13 -34.12 63.47 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.254 -0.904 . . . . 0.0 111.756 -177.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.4 ' N ' ' HG3' ' A' ' 76' ' ' MET . 33.7 mtpt -67.88 -39.86 83.63 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.352 -0.843 . . . . 0.0 110.151 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -67.03 -20.05 65.79 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.594 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.658 HG23 ' NH2' ' B' ' 168' ' ' ARG . 4.1 m -79.56 -174.75 4.43 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.693 -0.629 . . . . 0.0 109.797 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.596 ' H ' HG22 ' A' ' 79' ' ' THR . 85.4 m-20 -135.82 131.41 35.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.317 -0.865 . . . . 0.0 109.158 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.1 t -60.5 -34.55 74.23 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.444 -0.785 . . . . 0.0 110.071 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.04 -39.53 86.23 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.768 0.794 . . . . 0.0 109.542 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.97 -40.01 75.63 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.417 0.627 . . . . 0.0 111.075 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -66.28 -35.93 81.65 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.611 -0.68 . . . . 0.0 111.425 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.561 HG23 ' HE1' ' A' ' 141' ' ' PHE . 67.0 mt -67.28 -47.32 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.491 -0.756 . . . . 0.0 110.818 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -59.95 -41.92 92.91 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.329 -0.857 . . . . 0.0 112.104 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.642 ' O ' HG23 ' A' ' 91' ' ' VAL . 72.7 mt-10 -73.95 -39.98 63.36 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.438 -0.788 . . . . 0.0 111.952 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.31 -47.15 80.55 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.389 -0.82 . . . . 0.0 111.378 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -60.06 -45.96 91.14 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.606 0.717 . . . . 0.0 109.862 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -60.01 -34.04 72.81 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.979 -0.45 . . . . 0.0 111.047 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 87' ' ' GLU . 98.6 t -70.08 -53.51 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.243 -0.91 . . . . 0.0 110.254 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -63.27 -39.46 94.64 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.398 -0.814 . . . . 0.0 110.539 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -77.17 79.06 3.7 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -60.08 -41.0 91.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.407 -0.808 . . . . 0.0 111.034 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -84.11 -23.02 30.9 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.457 -0.777 . . . . 0.0 111.283 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.8 31.92 76.73 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.45 ' ND2' ' CE2' ' A' ' 99' ' ' TYR . 33.4 p-10 -76.09 -12.03 60.04 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.562 -0.963 . . . . 0.0 112.085 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.37 -20.92 10.2 Favored Glycine 0 N--CA 1.497 2.762 0 C-N-CA 119.919 -1.134 . . . . 0.0 110.45 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.45 ' CE2' ' ND2' ' A' ' 97' ' ' ASN . 27.7 p90 -145.25 150.04 35.97 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.224 -1.162 . . . . 0.0 108.783 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.662 ' CG2' HD23 ' A' ' 105' ' ' LEU . 20.8 mt -89.29 130.32 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.734 0.778 . . . . 0.0 111.396 -178.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.6 m -87.93 172.95 9.21 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.205 0.526 . . . . 0.0 109.999 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.08 -39.96 82.8 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.643 -0.661 . . . . 0.0 109.248 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.7 -40.04 93.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.804 -0.56 . . . . 0.0 109.835 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -61.96 -39.94 93.87 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.616 -0.678 . . . . 0.0 110.012 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.662 HD23 ' CG2' ' A' ' 100' ' ' ILE . 0.6 OUTLIER -63.65 -40.32 96.56 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.74 -0.6 . . . . 0.0 109.597 179.045 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 57.1 mtp85 -61.31 -31.82 71.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.551 -0.718 . . . . 0.0 110.954 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -59.96 -48.6 81.03 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.38 -0.825 . . . . 0.0 111.002 -178.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.662 HG12 ' CD1' ' A' ' 112' ' ' LEU . 85.3 t -69.92 -44.96 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 121.354 -0.841 . . . . 0.0 111.572 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.778 ' SD ' HD12 ' A' ' 116' ' ' LEU . 66.2 mtt -58.61 -46.78 86.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 0.0 111.356 -177.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.0 m -66.09 -47.69 73.38 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.467 -0.771 . . . . 0.0 109.934 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -61.9 -31.5 71.8 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.662 ' CD1' HG12 ' A' ' 108' ' ' VAL . 19.1 mt -69.89 -40.04 75.89 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 120.176 -0.609 . . . . 0.0 110.301 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.22 35.34 1.49 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -133.9 132.29 40.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.557 -0.967 . . . . 0.0 109.86 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -102.82 127.89 49.81 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.52 -0.737 . . . . 0.0 110.787 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.778 HD12 ' SD ' ' A' ' 109' ' ' MET . 42.6 mt -133.9 157.79 45.1 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.568 -0.708 . . . . 0.0 109.116 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.16 162.13 21.37 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.433 -0.792 . . . . 0.0 109.417 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -60.05 -26.91 66.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.413 -0.805 . . . . 0.0 108.852 178.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -69.38 -35.5 75.88 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.591 ' OE2' HD22 ' A' ' 116' ' ' LEU . 15.1 mt-10 -65.23 -39.94 93.4 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.395 0.617 . . . . 0.0 109.622 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.01 -40.0 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.208 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.428 ' HA ' HD12 ' A' ' 125' ' ' ILE . 7.7 t70 -60.02 -44.04 94.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.703 -0.623 . . . . 0.0 110.005 -178.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -60.03 -41.33 92.0 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.53 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 65.6 mtt -56.56 -37.94 71.25 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 119.6 -0.84 . . . . 0.0 108.781 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.482 HG21 ' O ' ' A' ' 134' ' ' GLY . 90.7 mt -65.75 -38.76 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 121.705 0.764 . . . . 0.0 109.093 178.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -57.27 -38.47 73.94 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.252 0.548 . . . . 0.0 110.578 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.0 -38.78 83.63 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.701 -0.624 . . . . 0.0 110.544 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.503 ' HB3' HG22 ' A' ' 136' ' ' VAL . . . -103.8 0.64 30.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.294 -0.879 . . . . 0.0 111.117 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -87.3 70.5 10.04 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.006 -1.059 . . . . 0.0 110.594 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.0 mt -67.06 -40.02 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.424 -0.797 . . . . 0.0 109.998 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -73.29 -20.22 60.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.565 -0.71 . . . . 0.0 111.151 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.49 23.39 60.59 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 120.215 -0.993 . . . . 0.0 110.83 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -82.17 -10.22 59.24 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.24 -1.153 . . . . 0.0 111.044 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.482 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 90.37 1.7 74.64 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.105 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -138.74 149.24 44.83 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.257 -1.143 . . . . 0.0 109.779 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.503 HG22 ' HB3' ' A' ' 128' ' ' ALA . 87.7 t -92.77 118.01 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.545 -0.722 . . . . 0.0 109.969 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -90.03 175.86 7.01 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.515 -0.741 . . . . 0.0 109.927 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -60.04 -49.01 79.33 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.264 0.554 . . . . 0.0 110.483 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -60.05 -46.07 90.76 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.725 -0.61 . . . . 0.0 111.72 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -63.02 -35.02 78.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.232 -0.918 . . . . 0.0 109.739 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.561 ' HE1' HG23 ' A' ' 85' ' ' ILE . 64.6 t80 -60.0 -39.96 87.54 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.258 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.65 ' O ' HG22 ' A' ' 146' ' ' THR . 92.1 t -70.02 -40.47 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.517 -0.74 . . . . 0.0 110.964 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.576 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 76.9 mt-30 -60.25 -41.08 92.44 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.388 -0.82 . . . . 0.0 110.627 -179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 56.2 ttp -59.96 -40.07 87.76 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.836 -0.54 . . . . 0.0 110.089 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.401 ' CE ' ' CZ ' ' A' ' 141' ' ' PHE . 40.9 mtt -70.02 -39.92 75.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.789 -0.57 . . . . 0.0 110.695 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.65 HG22 ' O ' ' A' ' 142' ' ' VAL . 9.4 t -101.38 20.96 14.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.501 -0.749 . . . . 0.0 110.681 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -79.94 129.83 34.8 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.313 -0.867 . . . . 0.0 110.574 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.6 pttm . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.363 -179.988 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.27 -40.03 98.48 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 157' ' ' PHE . . . . . 0.507 ' O ' HG22 ' B' ' 160' ' ' ILE . 31.4 t80 -60.6 -40.0 90.16 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.547 -0.973 . . . . 0.0 110.453 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -66.23 -39.93 89.91 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.447 -0.783 . . . . 0.0 110.649 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -60.59 -46.03 91.77 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.612 -0.68 . . . . 0.0 110.641 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 160' ' ' ILE . . . . . 0.74 ' O ' HG23 ' B' ' 164' ' ' VAL . 15.5 tt -70.0 -29.49 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.504 -0.748 . . . . 0.0 111.034 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.17 -44.12 89.52 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.39 -0.819 . . . . 0.0 110.422 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 75.5 mmt-85 -61.44 -40.11 93.25 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.577 -0.702 . . . . 0.0 109.861 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.45 -37.26 86.92 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.67 -0.644 . . . . 0.0 111.076 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 164' ' ' VAL . . . . . 0.74 HG23 ' O ' ' B' ' 160' ' ' ILE . 67.7 t -60.03 -40.05 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.386 -0.821 . . . . 0.0 110.058 -178.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.94 -34.89 85.14 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.605 HG11 ' CE ' ' A' ' 72' ' ' MET . 23.5 t -74.35 -19.97 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.729 -0.866 . . . . 0.0 110.584 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.688 HD21 HD22 ' A' ' 39' ' ' LEU . 6.2 tt -59.99 -48.77 80.36 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.107 -0.995 . . . . 0.0 110.386 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 168' ' ' ARG . . . . . 0.658 ' NH2' HG23 ' A' ' 79' ' ' THR . 9.6 ptt85 -69.86 -28.62 65.81 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.351 -0.843 . . . . 0.0 109.848 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 169' ' ' GLU . . . . . 0.403 ' CG ' ' CG ' ' A' ' 75' ' ' LYS . 44.0 tt0 -60.02 -43.84 95.0 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.58 -0.7 . . . . 0.0 110.021 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 170' ' ' TRP . . . . . 0.642 ' HH2' HD12 ' A' ' 63' ' ' ILE . 7.4 t-105 -60.93 -40.0 91.55 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.754 -0.591 . . . . 0.0 110.065 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.9 -46.65 88.66 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.575 -0.703 . . . . 0.0 110.851 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -59.98 -40.01 87.67 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.315 -0.866 . . . . 0.0 110.769 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.519 -0.738 . . . . 0.0 110.131 -179.568 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 . . . . . 0 N--CA 1.499 1.983 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.5 mm -60.15 -53.31 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 120.988 -1.07 . . . . 0.0 109.873 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -61.08 -27.11 68.12 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.659 -0.651 . . . . 0.0 109.975 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -66.32 -39.96 89.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.457 -0.777 . . . . 0.0 110.037 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.548 ' HB3' HD21 ' A' ' 69' ' ' LEU . 50.5 m-85 -69.7 -25.02 63.67 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.626 -0.671 . . . . 0.0 109.426 178.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 16.4 ttmt -69.98 -40.03 75.61 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -60.31 -54.1 49.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.956 -0.465 . . . . 0.0 110.783 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.05 -22.18 63.1 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.334 -0.854 . . . . 0.0 111.975 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -58.44 -47.39 84.14 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.088 -1.008 . . . . 0.0 110.243 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.7 m -62.16 -37.73 86.33 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.479 -0.763 . . . . 0.0 109.393 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.5 tp -65.96 -39.93 90.84 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -69.53 -38.12 77.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.962 -0.462 . . . . 0.0 109.869 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -91.77 97.64 11.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.566 -0.709 . . . . 0.0 109.848 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -59.93 -37.55 79.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.324 -0.86 . . . . 0.0 111.119 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -80.02 -10.92 59.81 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.263 -0.898 . . . . 0.0 111.03 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.29 27.66 58.09 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -87.63 -5.77 58.57 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.707 -0.878 . . . . 0.0 110.777 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.1 4.88 59.77 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 120.268 -0.968 . . . . 0.0 111.383 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.2 p -143.93 141.15 30.08 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 119.168 1.484 . . . . 0.0 111.594 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 86.0 mt -101.06 122.08 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.25 0.548 . . . . 0.0 109.528 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.0 m -98.41 137.98 36.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.724 -0.61 . . . . 0.0 109.781 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.531 ' HB ' HD22 ' A' ' 48' ' ' LEU . 24.7 p -42.65 -28.89 0.26 Allowed 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.707 -0.621 . . . . 0.0 112.179 -178.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.1 tttp -65.97 -50.47 64.22 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.833 0.825 . . . . 0.0 109.691 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -60.2 -56.38 22.32 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.932 -0.48 . . . . 0.0 111.798 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.95 -34.16 74.3 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.29 -0.882 . . . . 0.0 110.49 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.97 -31.56 17.87 Favored Glycine 0 N--CA 1.501 2.982 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.2 m -67.25 -40.13 86.21 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.393 -1.063 . . . . 0.0 109.399 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.5 t -64.38 -39.98 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 121.455 0.645 . . . . 0.0 109.422 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 98.0 mmm -60.06 -38.4 82.72 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.809 -0.557 . . . . 0.0 110.297 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -62.92 -40.05 96.41 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.414 -0.804 . . . . 0.0 110.659 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 t -59.28 -26.86 65.31 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.924 -0.485 . . . . 0.0 110.883 -178.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.498 HD12 ' CG2' ' A' ' 91' ' ' VAL . 36.3 tp -85.56 -24.92 27.04 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.415 -0.803 . . . . 0.0 109.109 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.23 -61.95 0.15 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -162.96 172.04 15.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.587 -0.949 . . . . 0.0 110.931 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -116.41 153.58 48.83 Favored Pre-proline 0 C--N 1.298 -1.664 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.171 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -66.08 -146.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.532 1.28 . . . . 0.0 109.642 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.1 p -125.68 166.79 16.11 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.048 -1.033 . . . . 0.0 110.845 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -59.0 -35.48 73.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.767 -0.583 . . . . 0.0 111.706 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.48 -47.82 45.67 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 122.298 1.047 . . . . 0.0 109.23 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.54 -36.09 80.34 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.302 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.531 HD22 ' HB ' ' A' ' 29' ' ' THR . 12.2 mt -58.2 -35.91 72.33 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.757 0.789 . . . . 0.0 109.587 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -66.82 -39.73 87.8 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.17 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -65.56 -39.94 92.26 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.537 -0.727 . . . . 0.0 110.937 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 90.7 mtp -60.17 -47.13 87.24 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.763 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.865 HG22 ' OD2' ' A' ' 56' ' ' ASP . 46.7 mm -64.92 -35.77 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.806 -0.559 . . . . 0.0 110.311 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -60.26 -44.97 94.82 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.596 -0.69 . . . . 0.0 111.772 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -70.01 -28.39 65.47 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.191 -0.943 . . . . 0.0 111.09 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.44 -8.58 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.587 -0.696 . . . . 0.0 110.599 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.865 ' OD2' HG22 ' A' ' 52' ' ' ILE . 4.3 m-20 -74.35 103.18 4.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.26 -0.9 . . . . 0.0 110.415 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.98 -36.4 75.16 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.617 -0.677 . . . . 0.0 109.693 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -92.35 -26.84 17.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.683 -0.635 . . . . 0.0 110.821 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.57 20.06 52.53 Favored Glycine 0 N--CA 1.496 2.638 0 C-N-CA 120.404 -0.903 . . . . 0.0 110.906 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -74.49 -32.88 62.68 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.37 -1.077 . . . . 0.0 110.254 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.559 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 117.94 1.06 17.12 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.002 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.2 p -137.66 169.84 17.09 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.125 -1.22 . . . . 0.0 110.488 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.3 mt -105.78 120.57 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.505 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -98.17 169.91 9.26 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.528 0.68 . . . . 0.0 110.582 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.434 ' HB3' ' HD3' ' A' ' 66' ' ' PRO . 8.1 t80 -47.86 -48.75 60.86 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.434 ' HD3' ' HB3' ' A' ' 65' ' ' PHE . 45.9 Cg_endo -71.83 -32.68 11.14 Favored 'Trans proline' 0 N--CA 1.487 1.089 0 O-C-N 122.711 0.848 . . . . 0.0 111.376 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -72.13 -39.98 68.41 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.261 -0.9 . . . . 0.0 110.268 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.417 ' CE1' ' HE2' ' A' ' 72' ' ' MET . 40.5 t80 -63.21 -41.64 99.17 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.471 -0.768 . . . . 0.0 111.204 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.548 HD21 ' HB3' ' A' ' 12' ' ' PHE . 96.2 mt -69.59 -39.99 76.95 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.534 -0.729 . . . . 0.0 112.048 -178.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.5 p -60.02 -47.87 84.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.334 -0.854 . . . . 0.0 111.191 -178.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 8.6 tmm? -68.56 -38.89 81.13 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.6 -0.687 . . . . 0.0 111.682 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.417 ' HE2' ' CE1' ' A' ' 68' ' ' PHE . 57.6 tpp -59.99 -50.03 75.35 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.374 -0.828 . . . . 0.0 112.217 -178.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.98 -25.04 63.43 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.183 -0.948 . . . . 0.0 112.082 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.2 -57.81 3.63 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.404 -0.81 . . . . 0.0 112.978 -178.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -69.64 -40.05 76.75 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -177.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 22.0 mtm -53.87 -39.91 66.12 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.057 -1.027 . . . . 0.0 111.946 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.0 tttt -59.99 -49.05 79.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.283 -0.885 . . . . 0.0 110.664 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -63.21 -27.37 69.31 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.817 0.818 . . . . 0.0 109.866 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.628 HG22 ' H ' ' A' ' 80' ' ' ASP 0.255 7.0 m -70.09 -173.42 0.66 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.807 -0.558 . . . . 0.0 109.918 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.628 ' H ' HG22 ' A' ' 79' ' ' THR . 81.3 m-20 -129.24 139.72 51.73 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.153 -0.967 . . . . 0.0 109.547 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.1 t -70.02 -27.46 64.69 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.581 -0.699 . . . . 0.0 111.046 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.03 -36.26 76.89 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.481 -0.762 . . . . 0.0 109.838 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -70.06 -39.93 75.37 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.342 0.592 . . . . 0.0 110.361 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -61.64 -39.57 91.79 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.571 -0.705 . . . . 0.0 111.274 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.686 HG23 ' HE1' ' A' ' 141' ' ' PHE . 89.2 mt -67.12 -44.3 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.52 -0.738 . . . . 0.0 110.803 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -59.81 -40.14 87.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.527 -0.733 . . . . 0.0 111.783 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.687 ' O ' HG23 ' A' ' 91' ' ' VAL . 35.7 mt-10 -76.04 -39.85 54.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.364 -0.835 . . . . 0.0 112.262 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.663 ' HA ' HG11 ' B' ' 164' ' ' VAL . . . -64.52 -46.7 81.79 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.271 -0.893 . . . . 0.0 111.317 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -61.75 -44.14 97.48 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.509 -0.744 . . . . 0.0 109.834 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.04 -36.9 78.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.746 -0.596 . . . . 0.0 110.939 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 87' ' ' GLU . 95.1 t -69.82 -48.51 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.484 -0.76 . . . . 0.0 110.161 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -68.03 -39.6 83.06 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.471 -0.768 . . . . 0.0 111.013 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -80.45 71.98 7.31 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.382 -0.824 . . . . 0.0 110.126 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -60.06 -47.5 85.61 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.374 -0.828 . . . . 0.0 110.335 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -70.63 -24.36 62.71 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.539 -0.726 . . . . 0.0 110.929 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.67 21.97 77.94 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -67.12 -15.7 63.87 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.239 -1.154 . . . . 0.0 111.258 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.58 -13.06 54.16 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 81.5 m-85 -133.15 141.31 48.06 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.163 -1.198 . . . . 0.0 109.224 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.76 ' CG2' HD23 ' A' ' 105' ' ' LEU . 62.7 mt -89.15 121.15 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.111 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 m -84.92 168.87 14.62 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.217 0.532 . . . . 0.0 109.869 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.97 -37.12 75.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.6 -0.688 . . . . 0.0 109.211 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.92 -36.41 83.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.796 -0.565 . . . . 0.0 109.799 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -67.22 -40.12 86.34 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.524 -0.735 . . . . 0.0 110.645 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.76 HD23 ' CG2' ' A' ' 100' ' ' ILE . 0.3 OUTLIER -64.42 -42.4 96.06 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.505 0.669 . . . . 0.0 110.051 179.734 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -62.93 -39.5 94.78 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.788 -0.57 . . . . 0.0 111.535 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -60.41 -48.61 81.0 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.216 -0.928 . . . . 0.0 112.161 -177.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 93.8 t -71.49 -50.37 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.136 -0.977 . . . . 0.0 111.452 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.477 ' HA ' HD12 ' A' ' 112' ' ' LEU . 73.9 mtp -55.42 -40.38 71.4 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.266 -0.896 . . . . 0.0 110.231 -178.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.2 m -66.59 -45.4 79.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.482 -0.761 . . . . 0.0 109.077 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -66.72 -25.04 66.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.814 -0.554 . . . . 0.0 109.85 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 109' ' ' MET . 17.9 mt -69.06 -26.61 65.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.583 -0.698 . . . . 0.0 110.227 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.6 11.73 5.89 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -127.76 131.41 49.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.172 -1.193 . . . . 0.0 109.952 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -105.0 126.01 51.6 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.608 -0.683 . . . . 0.0 110.232 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.0 mt -130.02 160.88 32.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.698 -0.626 . . . . 0.0 110.44 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.32 163.1 23.15 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -60.26 -31.44 70.22 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -67.15 -33.07 74.65 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.389 0.614 . . . . 0.0 109.667 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -67.79 -36.15 79.93 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.41 HG13 ' HB3' ' A' ' 105' ' ' LEU . 69.1 t -70.06 -40.01 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.913 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -60.03 -45.79 91.66 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.665 -0.647 . . . . 0.0 110.071 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -60.0 -41.4 91.99 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.599 -0.688 . . . . 0.0 109.641 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 98.0 mtp -54.46 -37.08 64.78 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.012 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.615 HG23 HG23 ' A' ' 136' ' ' VAL . 93.0 mt -66.58 -37.48 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 50.2 ttt85 -58.13 -40.0 80.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.472 -0.768 . . . . 0.0 111.118 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -60.0 -39.12 84.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.582 -0.699 . . . . 0.0 111.039 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.88 -10.92 19.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.397 -0.815 . . . . 0.0 111.522 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -89.48 74.04 7.76 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.003 -1.06 . . . . 0.0 110.994 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 84.7 mt -66.49 -39.96 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.663 -0.648 . . . . 0.0 109.474 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -59.23 -39.58 83.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.656 -0.653 . . . . 0.0 110.89 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.33 15.17 42.09 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.146 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -81.95 -10.05 59.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.02 -1.282 . . . . 0.0 110.546 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.12 2.54 85.76 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.491 -0.756 . . . . 0.0 111.537 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -130.94 131.32 44.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.24 -1.153 . . . . 0.0 109.611 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.615 HG23 HG23 ' A' ' 125' ' ' ILE . 57.7 t -90.88 111.62 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.452 -0.78 . . . . 0.0 110.037 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -89.03 -168.88 2.32 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 121.742 -0.599 . . . . 0.0 110.276 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -69.65 -40.08 76.7 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.8 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -60.0 -46.36 89.74 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.299 -0.876 . . . . 0.0 111.454 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -65.94 -38.15 87.88 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.817 0.818 . . . . 0.0 110.339 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.686 ' HE1' HG23 ' A' ' 85' ' ' ILE . 58.1 t80 -59.73 -45.67 91.48 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.865 -177.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.443 HG22 HG21 ' A' ' 85' ' ' ILE . 62.5 t -78.1 -40.05 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.232 -0.917 . . . . 0.0 112.577 -178.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -60.0 -51.68 68.63 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.976 -1.077 . . . . 0.0 111.693 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 59.4 ttp -60.53 -36.07 77.53 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.369 -0.832 . . . . 0.0 110.413 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 95.9 mtp -69.96 -40.03 75.64 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.799 -0.563 . . . . 0.0 110.673 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.552 ' O ' HG22 ' A' ' 146' ' ' THR . 39.7 m -97.5 15.82 22.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.486 -0.759 . . . . 0.0 111.086 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.06 -42.3 94.21 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.179 -0.951 . . . . 0.0 110.432 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 86.2 mttt . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.144 179.684 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.31 142.14 13.02 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -60.02 -43.43 95.26 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.49 -1.006 . . . . 0.0 110.236 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -60.03 -39.59 86.41 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.658 -0.651 . . . . 0.0 110.51 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -59.92 -40.07 87.63 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.434 -0.791 . . . . 0.0 110.665 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 95.8 mt -67.74 -39.62 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.408 -0.807 . . . . 0.0 110.121 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.27 91.68 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.552 -0.717 . . . . 0.0 111.634 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 162' ' ' ARG . . . . . 0.44 ' O ' HG23 ' B' ' 166' ' ' VAL . 51.3 mtm180 -60.09 -40.04 88.23 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.106 -0.997 . . . . 0.0 110.747 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.519 HD23 ' C ' ' B' ' 163' ' ' LEU . 9.6 tt -60.61 -40.11 90.64 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.433 -0.792 . . . . 0.0 109.95 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 164' ' ' VAL . . . . . 0.663 HG11 ' HA ' ' A' ' 88' ' ' ALA . 89.2 t -62.71 -39.95 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.594 -0.691 . . . . 0.0 109.688 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.99 -36.64 90.91 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.44 HG23 ' O ' ' B' ' 162' ' ' ARG . 94.9 t -60.07 -31.54 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.769 -0.842 . . . . 0.0 110.581 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 84.5 mt -60.03 -41.14 91.6 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.452 -0.78 . . . . 0.0 111.015 -178.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -61.03 -40.02 92.01 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.254 -0.904 . . . . 0.0 109.864 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -62.23 -40.56 96.54 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.658 -0.651 . . . . 0.0 110.86 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -60.08 -41.06 91.65 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.397 -0.814 . . . . 0.0 111.032 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.53 -41.24 76.24 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.414 -0.804 . . . . 0.0 110.855 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -60.01 -39.95 87.56 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.521 -0.737 . . . . 0.0 110.602 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 . . . . . 0 N--CA 1.496 1.87 0 O-C-N 121.392 -0.817 . . . . 0.0 110.301 -179.796 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 121.449 0.642 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.7 mt -59.93 -31.15 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.659 -0.651 . . . . 0.0 111.911 -178.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.95 -39.77 86.72 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.927 -1.108 . . . . 0.0 109.95 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -59.32 -41.46 89.13 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.268 0.556 . . . . 0.0 109.963 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -65.09 -21.51 66.82 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.613 -0.679 . . . . 0.0 111.111 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -70.03 -41.15 74.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.116 -0.99 . . . . 0.0 108.878 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.93 -51.78 68.24 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.013 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.06 -20.47 63.23 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.185 -0.947 . . . . 0.0 112.008 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.503 ' CD1' ' CZ ' ' A' ' 65' ' ' PHE . 60.2 t80 -58.05 -50.04 74.81 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.03 -1.044 . . . . 0.0 111.222 -177.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 97.6 p -66.76 -39.36 87.84 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.605 HD21 ' OE2' ' A' ' 114' ' ' GLU . 40.5 tp -60.08 -40.0 88.04 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.258 0.551 . . . . 0.0 109.816 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -77.44 -31.74 54.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.683 -0.635 . . . . 0.0 110.311 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -92.09 102.11 14.64 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.418 -0.801 . . . . 0.0 109.522 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -60.0 -39.64 86.46 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.609 -0.682 . . . . 0.0 112.308 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -80.08 -11.66 59.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.087 -1.008 . . . . 0.0 111.335 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.18 28.62 50.15 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -88.28 -5.6 58.26 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.637 -0.919 . . . . 0.0 110.788 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.53 1.39 57.77 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.938 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 54.3 p -144.2 141.81 30.13 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 119.116 1.458 . . . . 0.0 111.368 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 84.8 mt -101.08 123.77 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.79 -0.569 . . . . 0.0 109.611 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 34.4 p -99.96 140.0 34.81 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.539 -0.726 . . . . 0.0 110.046 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.57 HG23 HG13 ' A' ' 52' ' ' ILE . 6.6 p -43.19 -29.22 0.36 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.726 -0.609 . . . . 0.0 112.092 -178.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.11 -50.55 65.65 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.429 -0.794 . . . . 0.0 109.511 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -59.61 -53.82 53.59 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 121.253 0.549 . . . . 0.0 110.894 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.608 HD21 ' SD ' ' A' ' 36' ' ' MET . 9.6 tt -60.02 -35.32 74.82 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.449 -0.782 . . . . 0.0 111.451 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.07 -30.82 17.39 Favored Glycine 0 N--CA 1.498 2.822 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.5 m -70.03 -39.98 75.44 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.564 -0.963 . . . . 0.0 110.503 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.27 -54.26 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.457 -0.777 . . . . 0.0 109.456 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.608 ' SD ' HD21 ' A' ' 32' ' ' LEU . 95.8 mtp -59.92 -31.34 69.75 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.614 -0.679 . . . . 0.0 110.012 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -61.55 -40.47 94.81 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.681 0.753 . . . . 0.0 109.102 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.8 p -70.06 -20.22 63.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.787 -0.57 . . . . 0.0 110.405 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.545 HD11 ' CD1' ' B' ' 167' ' ' LEU . 86.1 mt -88.61 -17.0 31.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.484 -0.76 . . . . 0.0 110.41 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.22 -62.87 0.15 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -156.45 169.47 24.56 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.281 -1.129 . . . . 0.0 111.468 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -104.7 129.53 24.78 Favored Pre-proline 0 N--CA 1.49 1.573 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.844 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -67.3 -150.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.228 0 O-C-N 123.132 1.069 . . . . 0.0 109.487 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.5 p -135.62 151.71 50.51 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.159 -0.963 . . . . 0.0 110.598 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -51.44 -24.75 5.31 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.779 -0.575 . . . . 0.0 111.805 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.05 -59.8 2.58 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 122.171 0.986 . . . . 0.0 108.776 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -66.86 -36.97 83.53 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.829 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.523 HD13 ' HB ' ' A' ' 29' ' ' THR . 5.6 mt -58.12 -34.81 70.63 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.434 -0.791 . . . . 0.0 109.173 178.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.27 -40.02 96.22 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 120.484 -0.487 . . . . 0.0 110.43 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -64.58 -40.01 94.77 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.606 -0.684 . . . . 0.0 110.569 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 89.3 mtp -59.95 -44.57 94.33 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.463 0.649 . . . . 0.0 109.718 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.893 HG22 ' OD2' ' A' ' 56' ' ' ASP . 47.7 mm -65.87 -37.8 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.902 -0.499 . . . . 0.0 110.671 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -60.05 -39.95 87.74 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.437 -0.789 . . . . 0.0 111.523 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -68.88 -28.64 66.87 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.203 -0.935 . . . . 0.0 110.486 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.467 HG21 ' SD ' ' A' ' 71' ' ' MET . 78.9 t -99.46 -9.94 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.64 -0.662 . . . . 0.0 111.183 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.893 ' OD2' HG22 ' A' ' 52' ' ' ILE . 20.5 m-20 -70.74 95.56 1.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.143 -0.973 . . . . 0.0 111.265 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.56 -34.08 71.83 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.739 -0.601 . . . . 0.0 109.618 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.2 p-10 -95.43 -23.66 17.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.706 -0.621 . . . . 0.0 110.66 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.61 19.14 55.31 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.135 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.3 p-10 -75.63 -25.34 56.8 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.33 -1.1 . . . . 0.0 110.655 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.776 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 108.44 4.28 32.67 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.227 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 67.2 p -134.0 170.12 16.11 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.165 -1.197 . . . . 0.0 110.89 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.4 mt -101.83 119.99 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.909 -0.494 . . . . 0.0 110.434 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -102.51 168.17 9.47 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.59 0.71 . . . . 0.0 111.147 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.503 ' CZ ' ' CD1' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -43.13 -52.34 12.26 Favored Pre-proline 0 N--CA 1.504 2.269 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.2 Cg_endo -71.34 -30.27 15.79 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.042 1.022 . . . . 0.0 111.944 -178.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.25 -40.51 70.96 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.167 -0.958 . . . . 0.0 110.001 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -63.18 -42.38 99.37 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.655 -0.653 . . . . 0.0 110.968 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.4 mt -65.93 -41.75 90.97 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.523 -0.735 . . . . 0.0 111.152 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 66' ' ' PRO . 39.3 p -63.53 -40.89 98.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.473 -0.767 . . . . 0.0 111.61 -179.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.467 ' SD ' HG21 ' A' ' 55' ' ' VAL . 53.9 ttp -68.1 -40.04 82.7 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.442 -0.786 . . . . 0.0 110.674 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 7.5 mmt -61.86 -43.16 99.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.731 -0.606 . . . . 0.0 111.251 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.94 -30.55 67.96 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.59 -0.693 . . . . 0.0 110.523 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -70.22 -40.04 74.76 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.633 -0.667 . . . . 0.0 110.469 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -67.05 -55.44 14.33 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.532 -0.73 . . . . 0.0 111.898 -178.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.512 ' HA ' HG22 ' A' ' 79' ' ' THR . 78.6 mtm -59.94 -32.53 70.88 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.457 -0.777 . . . . 0.0 110.973 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.9 tttt -66.38 -62.32 1.53 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.681 -0.637 . . . . 0.0 112.15 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -70.73 -10.06 58.62 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.47 -0.769 . . . . 0.0 112.046 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.512 HG22 ' HA ' ' A' ' 76' ' ' MET . 1.5 t -101.07 -160.05 0.77 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.897 0.856 . . . . 0.0 112.035 -178.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.491 ' N ' HG23 ' A' ' 79' ' ' THR . 84.6 m-20 -129.98 139.49 51.06 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.358 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.0 t -63.36 -33.86 76.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.726 -0.609 . . . . 0.0 109.983 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.02 -33.23 71.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.692 -0.63 . . . . 0.0 109.662 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.34 -39.99 77.82 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.519 0.676 . . . . 0.0 109.639 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -63.06 -36.13 82.56 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.787 -0.57 . . . . 0.0 110.29 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.541 HG23 ' HE1' ' A' ' 141' ' ' PHE . 96.7 mt -67.18 -44.38 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.741 -0.599 . . . . 0.0 109.977 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -59.39 -43.58 92.92 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.638 -0.664 . . . . 0.0 111.162 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.561 ' O ' HG23 ' A' ' 91' ' ' VAL . 99.3 mt-10 -70.03 -40.08 75.4 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.588 -0.695 . . . . 0.0 111.729 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.6 -46.96 77.37 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.505 -0.747 . . . . 0.0 111.337 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.403 ' CE1' ' OD2' ' A' ' 93' ' ' ASP . 60.2 t80 -62.9 -42.84 99.92 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.524 -0.735 . . . . 0.0 109.861 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -59.95 -34.84 73.8 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.906 -0.496 . . . . 0.0 110.368 -179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 87' ' ' GLU . 77.7 t -69.9 -50.1 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.502 -0.749 . . . . 0.0 109.774 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -69.94 -41.16 74.94 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.475 -0.765 . . . . 0.0 111.022 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.403 ' OD2' ' CE1' ' A' ' 89' ' ' PHE . 33.2 t0 -81.1 75.18 8.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.404 -0.81 . . . . 0.0 109.946 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -70.02 -40.01 75.48 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.425 -0.797 . . . . 0.0 110.258 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 37.5 p-10 -75.7 -26.43 57.55 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.787 -0.571 . . . . 0.0 110.92 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.85 26.22 69.75 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -69.12 -14.86 63.24 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.365 -1.079 . . . . 0.0 111.476 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.73 -17.95 17.55 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.426 ' CD2' ' HB3' ' A' ' 135' ' ' GLN . 31.5 p90 -148.19 158.94 44.37 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.194 -1.18 . . . . 0.0 109.06 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 40.5 mt -88.9 124.24 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.322 -0.861 . . . . 0.0 110.099 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 m -82.67 172.29 13.09 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.669 0.747 . . . . 0.0 111.305 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.44 ' HB1' ' NH2' ' A' ' 106' ' ' ARG . . . -62.74 -47.37 83.85 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.81 -0.557 . . . . 0.0 110.098 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.45 -36.68 81.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.699 -0.626 . . . . 0.0 109.643 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -61.34 -40.13 93.11 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.601 -0.687 . . . . 0.0 110.39 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.473 HD21 ' SD ' ' A' ' 124' ' ' MET . 0.8 OUTLIER -64.73 -44.3 90.64 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.442 -0.786 . . . . 0.0 109.992 179.565 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.44 ' NH2' ' HB1' ' A' ' 102' ' ' ALA . 88.7 mtt180 -61.2 -37.37 82.75 Favored 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -60.0 -48.48 81.55 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.202 -0.936 . . . . 0.0 110.852 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.4 t -70.04 -39.22 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.513 -0.742 . . . . 0.0 111.568 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 12.9 mmt -59.06 -51.01 71.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.298 -0.876 . . . . 0.0 110.762 -178.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.5 m -66.88 -40.74 87.89 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.468 -0.77 . . . . 0.0 109.857 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -61.23 -31.36 71.15 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 112' ' ' LEU . 13.8 mt -69.16 -29.55 67.58 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.194 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.93 27.45 5.13 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.605 ' OE2' HD21 ' A' ' 18' ' ' LEU . 95.9 mt-10 -119.22 139.91 51.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.512 -0.993 . . . . 0.0 110.011 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -101.67 115.21 30.03 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.503 -0.748 . . . . 0.0 109.523 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.443 HD22 ' OE2' ' A' ' 120' ' ' GLU . 50.0 mt -132.83 153.69 51.04 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.459 -0.775 . . . . 0.0 109.949 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.97 164.96 19.02 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -62.1 -26.69 68.44 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.446 -0.784 . . . . 0.0 109.377 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.17 -35.44 76.3 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.639 0.733 . . . . 0.0 109.189 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.443 ' OE2' HD22 ' A' ' 116' ' ' LEU . 7.3 mt-10 -65.03 -37.78 88.73 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.382 0.61 . . . . 0.0 109.474 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.426 HG13 ' HB3' ' A' ' 105' ' ' LEU . 79.6 t -69.86 -39.14 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.564 0.697 . . . . 0.0 109.718 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -60.0 -40.04 87.85 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.777 -0.577 . . . . 0.0 109.832 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -59.96 -40.68 89.87 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.278 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.473 ' SD ' HD21 ' A' ' 105' ' ' LEU . 66.5 mtt -56.15 -37.02 68.95 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.394 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.01 -40.01 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.595 -0.691 . . . . 0.0 110.322 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 40.2 mtm-85 -59.99 -41.56 92.32 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.578 -0.701 . . . . 0.0 112.463 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.99 -39.97 87.56 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.705 -0.622 . . . . 0.0 111.329 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -98.33 -16.55 19.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.29 -0.881 . . . . 0.0 111.084 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -78.48 72.65 5.02 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.13 -0.981 . . . . 0.0 110.12 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 86.3 mt -65.06 -45.72 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.661 -0.649 . . . . 0.0 110.92 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -63.37 -40.06 96.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.358 -0.839 . . . . 0.0 111.175 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.56 20.64 9.94 Favored Glycine 0 N--CA 1.497 2.719 0 C-N-CA 120.058 -1.068 . . . . 0.0 111.198 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -82.16 -9.94 59.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.22 -1.165 . . . . 0.0 110.828 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.14 2.44 80.5 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.426 ' HB3' ' CD2' ' A' ' 99' ' ' TYR . 27.7 mt-30 -135.62 144.9 46.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.382 -1.069 . . . . 0.0 109.079 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.7 t -93.08 118.98 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.403 -0.811 . . . . 0.0 110.296 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -87.58 -179.51 6.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.557 -0.714 . . . . 0.0 109.374 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -69.46 -40.57 77.07 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.943 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -62.78 -44.05 97.2 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.548 -0.72 . . . . 0.0 110.784 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -65.78 -38.64 89.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.461 -0.774 . . . . 0.0 109.932 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.541 ' HE1' HG23 ' A' ' 85' ' ' ILE . 63.6 t80 -60.01 -44.11 94.78 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.083 0.468 . . . . 0.0 110.839 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 76.6 t -68.67 -39.96 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.485 -0.759 . . . . 0.0 110.726 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -60.24 -42.47 95.34 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.437 -0.79 . . . . 0.0 110.586 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.5 mmm -60.74 -40.02 90.83 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.633 -0.667 . . . . 0.0 110.631 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 95.2 mmm -70.07 -39.98 75.31 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.547 -0.721 . . . . 0.0 110.294 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.475 ' O ' HG22 ' A' ' 146' ' ' THR . 22.4 m -96.87 18.96 13.42 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.54 -0.725 . . . . 0.0 110.65 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.58 142.86 53.48 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.313 -0.867 . . . . 0.0 110.609 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.8 mttt . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.252 179.511 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -66.03 138.85 37.5 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -59.96 -42.79 94.86 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.614 -0.933 . . . . 0.0 110.351 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -60.04 -33.81 72.54 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.565 -0.71 . . . . 0.0 110.552 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -60.05 -42.69 95.04 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.746 -0.596 . . . . 0.0 111.013 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.05 -40.02 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.567 -0.708 . . . . 0.0 110.681 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.04 87.97 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.576 -0.703 . . . . 0.0 111.118 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -69.04 -39.99 78.84 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.401 -0.812 . . . . 0.0 110.926 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.496 HD23 ' C ' ' B' ' 163' ' ' LEU . 9.8 tt -61.04 -45.86 93.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.601 -0.687 . . . . 0.0 110.824 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 164' ' ' VAL . . . . . 0.418 ' HA ' ' HB2' ' B' ' 167' ' ' LEU . 10.2 p -69.96 -29.99 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.388 -0.82 . . . . 0.0 110.699 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.14 -40.94 97.87 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 87.5 t -79.99 -26.05 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.82 -0.812 . . . . 0.0 110.134 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.545 ' CD1' HD11 ' A' ' 39' ' ' LEU . 4.3 tt -54.43 -59.92 4.04 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.478 -0.764 . . . . 0.0 111.814 -178.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -66.78 -35.15 79.4 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.379 -0.826 . . . . 0.0 111.934 -178.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -59.96 -38.72 83.3 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.263 -0.898 . . . . 0.0 109.842 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -60.01 -39.98 87.65 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.81 -0.556 . . . . 0.0 110.283 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.62 -35.81 75.1 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.4 -0.812 . . . . 0.0 110.198 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -59.89 -36.38 76.81 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.501 -0.749 . . . . 0.0 110.052 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 . . . . . 0 N--CA 1.493 1.719 0 O-C-N 121.546 -0.721 . . . . 0.0 110.235 179.947 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 . . . . . 0 N--CA 1.497 1.902 0 CA-C-O 121.417 0.627 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.5 mm -59.97 -49.75 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.444 -0.785 . . . . 0.0 111.075 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.41 -24.15 67.24 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.486 -0.758 . . . . 0.0 111.602 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -66.54 -44.95 81.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.289 -0.882 . . . . 0.0 109.943 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.411 ' CB ' HD11 ' A' ' 69' ' ' LEU . 43.3 m-85 -69.88 -24.13 63.36 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.541 0.686 . . . . 0.0 109.598 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -69.94 -40.07 75.72 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.452 0.644 . . . . 0.0 109.968 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.96 -52.19 66.44 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.737 -0.602 . . . . 0.0 111.735 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.99 -21.57 63.21 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.173 -0.954 . . . . 0.0 111.709 -178.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -59.41 -47.06 86.9 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.206 -0.934 . . . . 0.0 110.513 -178.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -62.07 -37.29 84.44 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.294 -0.879 . . . . 0.0 109.201 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.531 HD21 HD22 ' A' ' 112' ' ' LEU . 50.2 tp -63.1 -39.48 94.83 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -69.97 -39.24 76.11 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.176 0.512 . . . . 0.0 110.027 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -97.86 98.65 10.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.67 -0.644 . . . . 0.0 109.825 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -69.22 -29.2 67.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.463 -0.773 . . . . 0.0 110.547 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -82.07 -10.05 59.34 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.369 -0.832 . . . . 0.0 111.611 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.64 25.07 66.89 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -178.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -78.6 -11.24 59.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.472 -1.016 . . . . 0.0 110.824 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.59 3.95 83.44 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.8 p -145.92 140.72 27.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.028 -1.277 . . . . 0.0 110.283 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.4 mt -101.52 122.73 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.751 -0.593 . . . . 0.0 109.549 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.2 m -97.92 141.16 31.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.75 -0.594 . . . . 0.0 109.992 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.548 ' HB ' HD13 ' A' ' 48' ' ' LEU . 27.7 p -39.07 -34.98 0.19 Allowed 'General case' 0 N--CA 1.51 2.546 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -66.71 -44.89 80.44 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.441 -0.787 . . . . 0.0 109.314 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -61.45 -58.26 8.88 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.946 -0.471 . . . . 0.0 111.339 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.456 HD21 ' CE2' ' B' ' 170' ' ' TRP . 54.6 tp -59.99 -36.04 76.32 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.273 -0.892 . . . . 0.0 111.061 -178.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.01 -29.99 15.48 Favored Glycine 0 N--CA 1.5 2.908 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.4 m -69.95 -39.98 75.74 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.634 -0.921 . . . . 0.0 110.453 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.1 t -63.54 -51.19 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 CA-C-O 121.621 0.724 . . . . 0.0 109.112 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 87.3 mtp -60.05 -33.04 71.49 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.277 0.56 . . . . 0.0 109.835 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -60.92 -42.46 98.17 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.411 0.624 . . . . 0.0 109.896 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.0 t -70.03 -16.38 63.15 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.637 -0.665 . . . . 0.0 110.415 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.4 tp -84.66 -24.42 29.02 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.355 -0.841 . . . . 0.0 109.383 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.42 -51.42 0.18 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.781 -1.727 . . . . 0.0 108.781 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -163.1 172.96 14.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.633 -0.922 . . . . 0.0 110.612 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -120.33 143.98 37.09 Favored Pre-proline 0 C--N 1.299 -1.62 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.057 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.69 -150.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 123.394 1.208 . . . . 0.0 109.881 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.89 161.54 36.35 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.082 -1.011 . . . . 0.0 110.098 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -52.23 -27.36 14.5 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.699 -0.626 . . . . 0.0 111.524 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.94 -58.31 3.55 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 122.078 0.942 . . . . 0.0 109.171 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.73 -39.62 91.32 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.086 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.548 HD13 ' HB ' ' A' ' 29' ' ' THR . 13.1 mt -56.56 -33.75 66.45 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.48 -0.762 . . . . 0.0 110.111 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.9 -36.65 82.77 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.386 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -68.33 -41.89 80.14 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.573 -0.705 . . . . 0.0 111.233 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 64.4 mtt -61.92 -43.28 99.16 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.534 -0.729 . . . . 0.0 109.724 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.889 HG22 ' OD2' ' A' ' 56' ' ' ASP . 43.2 mm -66.74 -35.58 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.842 -0.536 . . . . 0.0 110.241 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -61.53 -40.96 96.51 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.616 -0.677 . . . . 0.0 111.918 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -69.97 -29.6 66.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.184 -0.948 . . . . 0.0 111.002 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.54 HG21 ' SD ' ' A' ' 71' ' ' MET . 84.7 t -100.03 -8.8 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.51 -0.744 . . . . 0.0 111.397 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.889 ' OD2' HG22 ' A' ' 52' ' ' ILE . 4.2 m-20 -69.48 100.29 1.38 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.09 -1.007 . . . . 0.0 111.241 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.13 -33.89 72.4 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.661 -0.649 . . . . 0.0 109.933 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -98.36 -21.97 16.33 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.609 -0.682 . . . . 0.0 110.879 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.34 19.7 61.88 Favored Glycine 0 N--CA 1.495 2.632 0 C-N-CA 120.402 -0.904 . . . . 0.0 110.956 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -74.48 -37.54 63.16 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.372 -1.075 . . . . 0.0 110.173 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.6 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 126.33 2.52 6.97 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.306 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 62.8 p -138.5 170.18 16.47 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.033 -1.275 . . . . 0.0 111.355 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.9 mt -102.37 120.93 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.168 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -100.75 170.03 8.61 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.458 0.647 . . . . 0.0 110.251 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.478 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 5.6 t80 -48.22 -48.88 64.06 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.561 -0.712 . . . . 0.0 112.651 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.9 Cg_endo -68.45 -35.86 16.87 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 O-C-N 122.75 0.868 . . . . 0.0 111.916 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.98 -40.03 75.6 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.092 -1.005 . . . . 0.0 110.467 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.429 ' HD2' HD22 ' A' ' 69' ' ' LEU . 64.7 t80 -61.46 -42.02 98.12 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.643 -0.661 . . . . 0.0 110.549 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.453 HD23 ' O ' ' A' ' 65' ' ' PHE . 3.8 mm? -64.51 -41.95 96.1 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.394 -0.816 . . . . 0.0 111.695 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 66' ' ' PRO . 72.0 p -62.36 -40.48 96.54 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.288 -0.882 . . . . 0.0 111.493 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.54 ' SD ' HG21 ' A' ' 55' ' ' VAL . 59.3 ttp -69.74 -40.38 76.2 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.481 -0.762 . . . . 0.0 111.439 -178.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.6 ' SD ' HG11 ' B' ' 166' ' ' VAL . 88.8 mmm -60.77 -49.08 78.93 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.483 -0.761 . . . . 0.0 110.95 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.24 -31.99 73.43 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.785 -0.572 . . . . 0.0 111.291 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -70.04 -39.76 75.55 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.545 -0.722 . . . . 0.0 111.649 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.753 ' O ' HG22 ' A' ' 79' ' ' THR . 91.6 mttt -69.12 -31.59 70.38 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.274 -0.891 . . . . 0.0 112.569 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 63.2 mtt -59.54 -48.2 82.59 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.173 -0.955 . . . . 0.0 112.395 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -69.06 -38.38 79.05 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.238 -0.914 . . . . 0.0 112.032 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -69.99 -20.06 63.31 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.33 -0.856 . . . . 0.0 111.197 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.753 HG22 ' O ' ' A' ' 75' ' ' LYS . 15.2 t -112.22 -164.45 0.92 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.957 0.884 . . . . 0.0 111.709 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -130.27 147.0 51.94 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.899 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.6 p -67.09 -26.93 66.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.591 -0.693 . . . . 0.0 110.601 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.31 -35.39 77.23 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.566 0.698 . . . . 0.0 109.505 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.97 -39.99 83.22 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.563 0.697 . . . . 0.0 109.87 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -62.32 -38.66 90.31 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.793 -0.567 . . . . 0.0 111.456 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.687 HG23 ' HE2' ' A' ' 141' ' ' PHE . 67.7 mt -68.11 -45.3 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.405 -0.809 . . . . 0.0 110.672 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 64.1 mtp180 -58.09 -41.49 83.61 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.231 -0.918 . . . . 0.0 110.811 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.655 ' O ' HG23 ' A' ' 91' ' ' VAL . 98.5 mt-10 -70.03 -39.98 75.44 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.663 -0.648 . . . . 0.0 111.484 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.38 -47.98 77.19 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.469 -0.769 . . . . 0.0 111.536 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -60.27 -42.15 94.81 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.408 -0.808 . . . . 0.0 109.992 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -60.07 -37.61 80.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.905 -0.497 . . . . 0.0 110.62 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 87' ' ' GLU . 58.5 t -69.9 -55.59 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.317 -0.864 . . . . 0.0 110.521 -179.071 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.67 ' HE2' HG21 ' B' ' 164' ' ' VAL . 44.4 m-85 -60.6 -39.98 90.11 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.312 -0.868 . . . . 0.0 110.978 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -80.51 78.04 7.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.587 -0.696 . . . . 0.0 110.315 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -67.0 -41.43 86.75 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.385 -0.822 . . . . 0.0 109.904 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.6 p-10 -76.15 -21.32 56.71 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.626 -0.671 . . . . 0.0 111.212 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.22 24.45 74.77 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -70.02 -10.94 60.35 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.412 -1.052 . . . . 0.0 111.368 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.19 -15.62 58.93 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -133.55 141.02 47.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.246 -1.15 . . . . 0.0 109.331 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 77.8 mt -89.06 122.15 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.395 -0.816 . . . . 0.0 109.72 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.4 m -83.49 170.01 14.88 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.334 0.588 . . . . 0.0 110.819 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.05 -39.99 94.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.8 -0.562 . . . . 0.0 109.807 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.7 -31.55 72.76 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.57 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -69.92 -40.01 75.82 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.767 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.593 ' HB3' HG13 ' A' ' 121' ' ' VAL . 0.9 OUTLIER -61.58 -47.02 87.4 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.289 -0.882 . . . . 0.0 109.328 179.233 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -64.14 -30.36 71.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.929 -0.482 . . . . 0.0 111.102 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -61.96 -49.02 77.79 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.375 -0.828 . . . . 0.0 111.806 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.604 HG12 ' CD1' ' A' ' 112' ' ' LEU . 72.6 t -70.03 -47.18 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.328 -0.858 . . . . 0.0 111.299 -178.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.479 ' HA ' HD12 ' A' ' 112' ' ' LEU . 98.9 mtp -59.61 -39.99 86.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.318 -0.864 . . . . 0.0 110.489 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.2 m -64.5 -46.2 84.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.453 -0.779 . . . . 0.0 109.107 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -62.46 -32.73 73.66 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.604 ' CD1' HG12 ' A' ' 108' ' ' VAL . 39.7 mt -69.97 -33.69 72.42 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.341 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.43 34.49 1.43 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -125.08 136.69 53.91 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.524 -0.986 . . . . 0.0 110.078 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -101.91 130.54 48.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.509 -0.744 . . . . 0.0 109.639 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.632 HD12 HG23 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -148.3 152.22 36.73 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.673 -0.642 . . . . 0.0 110.848 -179.289 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.1 p -80.94 162.02 24.07 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -61.42 -27.78 68.79 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -67.8 -34.94 77.76 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.822 0.82 . . . . 0.0 109.193 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -62.52 -40.09 95.63 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.632 HG23 HD12 ' A' ' 116' ' ' LEU . 75.5 t -66.22 -40.06 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.097 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -60.02 -45.95 91.11 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.648 -0.658 . . . . 0.0 110.558 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -59.97 -40.61 89.69 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.904 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 86.2 mmm -54.63 -38.14 66.47 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.029 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.23 -38.69 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.692 -0.63 . . . . 0.0 110.15 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -58.36 -39.99 81.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.552 -0.718 . . . . 0.0 111.959 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.11 -40.06 88.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.469 -0.77 . . . . 0.0 112.172 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -108.44 -5.62 16.55 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.189 -0.944 . . . . 0.0 112.317 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -90.29 73.06 7.11 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.889 -1.132 . . . . 0.0 111.06 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 86.5 mt -68.28 -40.05 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.49 -0.756 . . . . 0.0 110.116 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 36.5 p-10 -60.0 -39.94 87.5 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.528 -0.732 . . . . 0.0 111.043 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.418 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 92.38 24.92 22.84 Favored Glycine 0 N--CA 1.493 2.437 0 O-C-N 121.25 -0.907 . . . . 0.0 111.057 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -82.45 -8.02 59.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -1.178 . . . . 0.0 110.544 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 97.16 -1.5 60.81 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -140.84 159.65 41.76 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.16 -1.2 . . . . 0.0 109.722 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 94.3 t -87.89 118.24 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.394 -0.816 . . . . 0.0 109.078 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -87.36 170.03 11.75 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.997 0.903 . . . . 0.0 110.994 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -63.57 -50.01 71.16 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.278 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -62.35 -41.1 98.32 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.38 -0.825 . . . . 0.0 110.539 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.25 -37.27 85.1 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.13 0.967 . . . . 0.0 109.268 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.687 ' HE2' HG23 ' A' ' 85' ' ' ILE . 77.4 t80 -59.94 -41.9 92.86 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.008 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.434 HG22 HG21 ' A' ' 85' ' ' ILE . 70.8 t -74.2 -42.16 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.284 -0.885 . . . . 0.0 111.956 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -59.98 -50.37 74.01 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.41 -0.806 . . . . 0.0 112.157 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 55.1 ttp -61.37 -35.72 78.25 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.366 -0.834 . . . . 0.0 110.871 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 89.2 mtp -69.96 -39.91 75.72 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.792 -0.567 . . . . 0.0 110.244 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.428 ' O ' HG22 ' A' ' 146' ' ' THR . 13.3 m -98.97 22.45 10.24 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.579 -0.7 . . . . 0.0 110.459 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.38 -40.55 85.71 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.366 -0.834 . . . . 0.0 111.399 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 29.9 mttt . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.525 -179.102 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 70.07 32.16 69.41 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -60.04 -41.89 93.25 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.55 -0.97 . . . . 0.0 110.111 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -60.77 -40.13 91.37 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.664 -0.647 . . . . 0.0 110.984 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 43.1 mtm-85 -65.73 -39.99 91.73 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.355 -0.841 . . . . 0.0 111.158 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 93.5 mt -65.25 -40.03 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.394 -0.816 . . . . 0.0 110.231 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.55 -40.74 97.78 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.562 -0.711 . . . . 0.0 110.127 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 -62.21 -40.48 96.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.728 -0.607 . . . . 0.0 110.557 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 85.8 mt -64.86 -40.07 94.57 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.495 -0.753 . . . . 0.0 110.562 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 164' ' ' VAL . . . . . 0.67 HG21 ' HE2' ' A' ' 92' ' ' PHE . 94.2 t -63.78 -40.11 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.552 -0.718 . . . . 0.0 110.023 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.03 -31.39 61.54 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.6 HG11 ' SD ' ' A' ' 72' ' ' MET . 67.2 t -79.94 -28.95 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.722 -0.87 . . . . 0.0 111.363 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.522 HD12 ' HA ' ' B' ' 164' ' ' VAL . 79.0 mt -60.09 -49.95 75.63 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.195 -0.941 . . . . 0.0 111.707 -177.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 168' ' ' ARG . . . . . 0.429 ' HD3' ' CG ' ' A' ' 87' ' ' GLU . 38.0 ttt-85 -66.4 -40.06 89.41 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.127 -0.983 . . . . 0.0 110.445 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -60.04 -29.88 68.81 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.571 -0.706 . . . . 0.0 110.627 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 170' ' ' TRP . . . . . 0.479 ' CZ3' ' HE1' ' A' ' 71' ' ' MET . 4.5 t-105 -60.17 -39.47 86.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.489 -0.757 . . . . 0.0 110.176 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.23 -39.97 76.59 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.491 -0.755 . . . . 0.0 111.046 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -60.03 -39.97 87.69 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.345 -0.847 . . . . 0.0 110.372 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 . . . . . 0 N--CA 1.494 1.741 0 O-C-N 121.496 -0.752 . . . . 0.0 109.986 179.905 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 . . . . . 0 N--CA 1.499 2.009 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.7 mm -61.42 -50.87 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.308 -0.87 . . . . 0.0 110.374 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.43 -35.86 78.73 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.771 -0.581 . . . . 0.0 110.941 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.94 -45.46 92.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.61 -0.681 . . . . 0.0 110.362 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.478 ' CE1' ' HG2' ' A' ' 72' ' ' MET . 24.7 m-85 -64.68 -22.84 67.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.619 -0.676 . . . . 0.0 111.234 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -68.63 -41.62 79.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.272 -0.892 . . . . 0.0 108.721 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -59.99 -52.54 64.95 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.618 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.25 -23.43 64.78 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.318 -0.864 . . . . 0.0 111.657 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -56.1 -47.67 77.63 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.978 -1.076 . . . . 0.0 109.991 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.3 m -60.75 -39.29 88.16 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.503 -0.748 . . . . 0.0 109.403 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 64.2 tp -63.8 -39.95 95.48 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.92 -39.57 76.08 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.454 ' HB2' HD11 ' A' ' 27' ' ' ILE . 25.3 t0 -95.19 97.3 9.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.631 -0.668 . . . . 0.0 110.036 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.8 mttt -64.37 -32.01 73.45 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.367 -0.833 . . . . 0.0 111.598 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -80.57 -10.02 59.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.209 -0.932 . . . . 0.0 111.506 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.23 25.08 46.81 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -87.23 -9.66 54.51 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.586 -0.949 . . . . 0.0 110.666 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.64 2.81 53.04 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.868 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.5 p -144.61 141.95 29.78 Favored 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 119.534 1.667 . . . . 0.0 112.1 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.454 HD11 ' HB2' ' A' ' 20' ' ' ASP . 49.3 mm -99.93 121.04 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.5 p -100.91 142.08 32.88 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.576 -0.703 . . . . 0.0 111.019 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.424 ' CG2' ' HB3' ' A' ' 48' ' ' LEU . 82.1 p -41.76 -33.14 0.46 Allowed 'General case' 0 N--CA 1.509 2.518 0 O-C-N 121.856 -0.528 . . . . 0.0 111.892 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -64.71 -51.06 64.43 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.797 0.808 . . . . 0.0 109.525 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -59.95 -54.75 42.41 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.577 -178.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.448 HD21 ' CE2' ' B' ' 170' ' ' TRP . 58.8 tp -60.04 -35.32 74.85 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.203 -0.936 . . . . 0.0 110.696 -178.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.05 -30.45 16.56 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -178.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.8 m -70.03 -39.97 75.44 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.569 -0.959 . . . . 0.0 110.363 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 79.0 t -64.89 -51.07 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.628 -0.67 . . . . 0.0 109.746 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.403 ' HE2' ' HD3' ' A' ' 43' ' ' PRO . 98.1 mtp -59.97 -33.03 71.39 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.741 -0.6 . . . . 0.0 109.521 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -61.57 -41.87 98.02 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.696 0.76 . . . . 0.0 109.084 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.9 t -72.02 -19.47 61.85 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.962 -0.461 . . . . 0.0 110.81 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.7 -16.99 29.18 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.272 -0.893 . . . . 0.0 110.504 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.16 -55.62 0.18 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -159.97 169.92 22.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.411 -1.053 . . . . 0.0 110.804 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -107.82 125.88 31.12 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.892 -0.505 . . . . 0.0 110.151 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.427 ' HG2' HD21 ' A' ' 48' ' ' LEU . 52.9 Cg_endo -69.07 -148.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.07 0 N-CA-C 108.649 -1.327 . . . . 0.0 108.649 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 50.2 p -137.45 150.36 47.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.929 -1.107 . . . . 0.0 110.837 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -53.15 -23.65 8.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.636 -0.665 . . . . 0.0 111.467 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.49 -60.05 2.42 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.89 0.852 . . . . 0.0 109.128 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -67.71 -37.67 82.57 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.054 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.427 HD21 ' HG2' ' A' ' 43' ' ' PRO . 15.6 mt -57.1 -33.23 67.1 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.495 -0.753 . . . . 0.0 110.02 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -35.52 80.45 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.956 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -65.68 -39.96 91.85 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.45 -0.781 . . . . 0.0 110.832 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 67.2 mtt -60.02 -45.45 92.74 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.433 0.635 . . . . 0.0 109.93 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.795 HG22 ' OD2' ' A' ' 56' ' ' ASP . 96.8 mt -67.95 -33.07 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.824 -0.547 . . . . 0.0 110.729 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -60.06 -40.05 88.12 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.327 -0.858 . . . . 0.0 110.115 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -67.11 -26.47 66.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.377 -0.827 . . . . 0.0 109.959 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.535 HG21 ' SD ' ' A' ' 71' ' ' MET . 74.3 t -99.81 -9.99 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.598 -0.689 . . . . 0.0 110.864 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.795 ' OD2' HG22 ' A' ' 52' ' ' ILE . 25.6 m-20 -72.27 99.71 2.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.118 -0.989 . . . . 0.0 111.126 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.54 -40.06 92.46 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.388 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -88.32 -28.34 21.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.714 -0.616 . . . . 0.0 110.563 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.02 22.95 43.16 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -74.22 -33.79 63.49 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.499 -1.001 . . . . 0.0 110.617 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.97 -0.43 10.81 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.294 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.0 p -132.67 170.08 15.74 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.017 -1.284 . . . . 0.0 110.391 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.773 HD11 HG12 ' A' ' 52' ' ' ILE . 12.6 mt -106.67 120.4 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.87 -0.519 . . . . 0.0 110.869 -177.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -100.68 169.44 9.03 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.572 0.701 . . . . 0.0 110.906 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.47 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -45.05 -52.73 18.68 Favored Pre-proline 0 N--CA 1.502 2.168 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.069 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.2 Cg_endo -67.39 -30.93 35.81 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 O-C-N 122.943 0.97 . . . . 0.0 111.514 -178.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -72.1 -40.91 67.85 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.448 -0.782 . . . . 0.0 110.425 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -66.08 -40.16 90.61 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.683 -0.636 . . . . 0.0 111.177 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.7 mt -66.23 -39.93 89.9 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.373 -0.83 . . . . 0.0 111.569 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 21.6 p -64.19 -41.39 97.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.555 -0.716 . . . . 0.0 111.333 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.535 ' SD ' HG21 ' A' ' 55' ' ' VAL . 58.9 ttp -68.07 -40.2 82.77 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.438 -0.788 . . . . 0.0 110.894 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.478 ' HG2' ' CE1' ' A' ' 12' ' ' PHE . 53.6 tpp -59.99 -45.11 93.79 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.493 -0.755 . . . . 0.0 110.462 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.8 -30.8 70.32 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.506 -0.746 . . . . 0.0 109.725 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.4 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 0.2 OUTLIER -70.02 -39.67 75.65 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.706 -0.621 . . . . 0.0 111.059 179.824 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -65.79 -36.57 83.88 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.412 -0.805 . . . . 0.0 112.203 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 60.7 mtt -59.73 -50.09 75.18 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.214 -0.929 . . . . 0.0 111.684 -177.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 10.9 pttt -70.05 -38.96 75.96 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.308 -0.87 . . . . 0.0 110.835 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -68.66 -40.02 80.38 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.448 -0.782 . . . . 0.0 109.978 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.571 HG22 ' H ' ' A' ' 80' ' ' ASP . 1.4 m -100.43 -172.59 2.23 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.985 -0.447 . . . . 0.0 110.196 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.571 ' H ' HG22 ' A' ' 79' ' ' THR . 69.9 m-20 -129.53 147.22 51.31 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.42 -0.8 . . . . 0.0 109.904 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.4 t -59.95 -27.81 67.12 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.546 -0.721 . . . . 0.0 110.401 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.01 -36.72 77.85 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.368 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.98 -39.94 75.64 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.378 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.08 -37.47 75.45 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.694 -0.629 . . . . 0.0 110.558 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.474 HG23 ' SD ' ' A' ' 145' ' ' MET . 67.7 mt -65.57 -53.83 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.635 -0.666 . . . . 0.0 111.028 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.423 ' HG3' ' N ' ' A' ' 87' ' ' GLU . 33.6 ptt180 -60.03 -39.97 87.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.383 -0.823 . . . . 0.0 111.392 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.423 ' N ' ' HG3' ' A' ' 86' ' ' ARG . 95.3 mt-10 -68.58 -40.76 80.38 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.506 -0.746 . . . . 0.0 110.742 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.429 ' HA ' HG12 ' B' ' 164' ' ' VAL . . . -65.19 -44.24 89.03 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.956 -0.465 . . . . 0.0 110.898 -178.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -61.15 -41.28 96.47 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.879 0.847 . . . . 0.0 108.814 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -59.98 -38.14 81.69 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.821 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.3 -43.2 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.506 -0.746 . . . . 0.0 110.027 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.643 ' HE2' HG21 ' B' ' 164' ' ' VAL . 13.4 m-85 -69.37 -39.1 78.25 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.497 -0.752 . . . . 0.0 111.451 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -79.55 77.23 6.15 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.32 -0.862 . . . . 0.0 110.508 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -59.98 -42.34 93.98 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.395 -0.816 . . . . 0.0 110.216 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 24.1 p-10 -81.92 -19.94 39.74 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.496 -0.752 . . . . 0.0 111.258 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.79 63.83 4.92 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -109.91 -10.77 14.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.457 -1.025 . . . . 0.0 111.52 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.25 -23.31 8.14 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 31.0 p90 -149.08 152.91 37.01 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.327 -1.102 . . . . 0.0 109.549 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 56.0 mt -89.34 125.2 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.742 0.782 . . . . 0.0 109.96 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 m -80.99 171.29 15.18 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.141 0.496 . . . . 0.0 110.31 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.04 -40.59 96.63 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.622 -0.674 . . . . 0.0 109.498 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.03 -38.48 91.24 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.496 0.665 . . . . 0.0 109.314 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -62.43 -39.43 93.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.741 -0.6 . . . . 0.0 111.285 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.627 HD21 ' HE1' ' A' ' 124' ' ' MET . 1.4 tt -62.53 -43.74 98.06 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.133 -0.979 . . . . 0.0 109.468 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.449 ' HG2' HG21 ' A' ' 121' ' ' VAL . 88.1 mtt180 -60.05 -33.34 71.91 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.686 -0.634 . . . . 0.0 110.901 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -60.37 -45.37 93.76 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.159 -0.963 . . . . 0.0 111.614 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.535 HG11 ' CE1' ' A' ' 92' ' ' PHE . 95.9 t -72.92 -39.86 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.299 -0.876 . . . . 0.0 111.256 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 26.8 mmt -59.86 -48.65 80.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.46 -0.775 . . . . 0.0 110.293 -178.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.1 m -67.26 -41.71 85.09 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.496 -0.752 . . . . 0.0 109.848 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -61.13 -31.46 71.17 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.3 mt -69.03 -32.79 72.55 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.713 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.61 29.14 4.83 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -121.43 130.03 53.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.581 -0.952 . . . . 0.0 109.734 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -92.43 117.64 30.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.532 -0.73 . . . . 0.0 110.132 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.527 HD13 ' OE1' ' A' ' 120' ' ' GLU . 60.8 mt -132.71 157.24 45.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.617 -0.677 . . . . 0.0 109.812 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 p -83.74 162.99 20.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.587 -0.696 . . . . 0.0 109.663 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.9 p-10 -60.06 -25.16 65.16 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -66.61 -34.63 78.32 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.527 ' OE1' HD13 ' A' ' 116' ' ' LEU . 0.5 OUTLIER -62.42 -38.98 91.78 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.541 0.686 . . . . 0.0 109.233 179.15 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.543 HG13 HD13 ' A' ' 105' ' ' LEU . 74.9 t -68.88 -39.05 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.359 0.6 . . . . 0.0 110.124 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.493 ' HA ' HD12 ' A' ' 125' ' ' ILE . 45.2 t0 -59.28 -49.93 75.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.768 -0.582 . . . . 0.0 110.341 -178.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -60.27 -41.45 93.29 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.399 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.627 ' HE1' HD21 ' A' ' 105' ' ' LEU . 97.6 mtp -54.81 -39.7 68.75 Favored 'General case' 0 N--CA 1.504 2.24 0 C-N-CA 119.389 -0.924 . . . . 0.0 108.838 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.493 HD12 ' HA ' ' A' ' 122' ' ' ASP . 89.4 mt -63.75 -40.0 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.162 0.506 . . . . 0.0 109.963 178.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -60.0 -39.97 87.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.483 -0.76 . . . . 0.0 112.182 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -60.06 -39.94 87.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.116 -0.99 . . . . 0.0 111.773 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -99.05 -17.48 18.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.205 -0.934 . . . . 0.0 110.987 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.4 77.86 5.76 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.178 -0.951 . . . . 0.0 110.816 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 82.9 mt -64.14 -39.98 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.66 -0.65 . . . . 0.0 111.079 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -59.51 -38.53 81.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.403 -0.81 . . . . 0.0 111.12 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 98.59 11.93 45.98 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 120.115 -1.04 . . . . 0.0 111.417 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -81.31 -13.66 58.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.023 -1.281 . . . . 0.0 110.56 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.95 5.55 70.69 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.793 178.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -127.68 126.48 42.01 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.032 -1.275 . . . . 0.0 109.924 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.7 t -89.96 113.99 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.252 -0.905 . . . . 0.0 109.71 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -89.97 -179.38 5.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.507 -0.746 . . . . 0.0 109.884 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -62.24 -41.8 98.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.718 -0.614 . . . . 0.0 110.422 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -62.56 -44.85 95.32 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.199 -0.938 . . . . 0.0 111.463 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -63.44 -38.96 93.15 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.978 0.894 . . . . 0.0 109.454 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -59.87 -41.88 92.48 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.578 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.2 t -68.06 -40.11 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.493 -0.754 . . . . 0.0 110.945 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -60.78 -40.39 92.41 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.373 -0.829 . . . . 0.0 110.056 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 53.9 ttp -60.05 -41.2 91.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.779 -0.576 . . . . 0.0 110.752 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.474 ' SD ' HG23 ' A' ' 85' ' ' ILE . 44.3 mtt -82.06 -39.18 23.82 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.535 -0.728 . . . . 0.0 110.999 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 85.4 m -59.98 -26.81 66.33 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.695 -0.628 . . . . 0.0 110.459 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -80.78 119.12 22.95 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.434 -0.791 . . . . 0.0 110.601 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.7 mttm . . . . . 0 N--CA 1.5 2.026 0 CA-C-O 118.407 -0.806 . . . . 0.0 111.47 179.798 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 72.86 39.17 55.54 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -59.97 -47.47 85.66 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.451 -1.029 . . . . 0.0 109.464 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -60.73 -39.06 87.26 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.855 -0.528 . . . . 0.0 110.351 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -60.0 -40.0 87.72 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.522 -0.736 . . . . 0.0 109.853 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 86.7 mt -68.34 -39.99 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.681 -0.637 . . . . 0.0 110.369 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.04 -38.89 84.07 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.46 -0.775 . . . . 0.0 110.65 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 32.7 ttm-85 -60.04 -40.95 91.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.433 -0.792 . . . . 0.0 109.962 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 39.2 tp -64.24 -39.9 94.92 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.772 -0.58 . . . . 0.0 110.077 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 164' ' ' VAL . . . . . 0.643 HG21 ' HE2' ' A' ' 92' ' ' PHE . 80.2 t -62.47 -39.94 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.517 -0.74 . . . . 0.0 110.347 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.52 -36.9 87.03 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 73.3 t -68.21 -39.19 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.913 -0.757 . . . . 0.0 110.457 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.577 HD12 ' HA ' ' B' ' 164' ' ' VAL . 84.5 mt -59.97 -46.41 89.52 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.522 -0.736 . . . . 0.0 111.635 -178.185 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -59.98 -40.0 87.64 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.27 -0.894 . . . . 0.0 110.269 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -60.09 -39.86 87.6 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.55 -0.719 . . . . 0.0 110.396 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 170' ' ' TRP . . . . . 0.448 ' CE2' HD21 ' A' ' 32' ' ' LEU . 5.0 t-105 -60.02 -45.64 92.14 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.695 -0.628 . . . . 0.0 110.404 -179.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.55 -40.63 97.45 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.519 -0.738 . . . . 0.0 110.152 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -59.98 -40.07 87.85 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.579 -0.7 . . . . 0.0 109.977 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.697 -0.627 . . . . 0.0 110.174 179.784 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 . . . . . 0 N--CA 1.497 1.887 0 CA-C-O 121.44 0.638 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.6 mt -60.06 -38.85 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.65 -0.656 . . . . 0.0 111.971 -178.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.87 -29.19 70.02 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.97 -1.081 . . . . 0.0 111.051 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.85 -40.48 97.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.291 -0.881 . . . . 0.0 109.865 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.51 ' CB ' HD21 ' A' ' 69' ' ' LEU . 77.5 m-85 -64.98 -22.22 66.97 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.816 -0.553 . . . . 0.0 111.438 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.424 ' HE2' ' CZ ' ' A' ' 65' ' ' PHE . 28.3 mmtp -65.31 -39.97 93.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.34 -0.85 . . . . 0.0 110.075 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -62.63 -58.5 7.3 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.705 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.03 -36.07 76.47 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.387 -0.821 . . . . 0.0 112.15 -178.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -54.95 -49.73 70.63 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.072 -1.017 . . . . 0.0 110.561 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.6 t -60.77 -35.43 76.4 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.519 -0.738 . . . . 0.0 110.06 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.649 HD13 ' O ' ' A' ' 18' ' ' LEU . 2.1 tm? -65.83 -39.97 91.35 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -71.95 -40.62 68.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.909 -0.495 . . . . 0.0 110.668 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -94.19 95.21 8.81 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.363 -0.836 . . . . 0.0 110.82 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -66.76 -33.14 74.96 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.298 -0.876 . . . . 0.0 111.309 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -78.7 -10.91 59.93 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.116 -0.99 . . . . 0.0 111.281 -177.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.42 25.28 66.72 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 58.2 p-10 -89.5 -3.28 58.42 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.456 -1.026 . . . . 0.0 110.808 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.93 8.22 76.37 Favored Glycine 0 N--CA 1.489 2.232 0 O-C-N 121.217 -0.927 . . . . 0.0 111.271 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.9 p -145.73 143.06 29.51 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 119.335 1.568 . . . . 0.0 112.109 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.0 mt -101.21 121.84 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.69 -0.631 . . . . 0.0 109.411 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.6 p -99.15 143.45 29.41 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.49 -0.757 . . . . 0.0 110.607 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.416 ' O ' HD13 ' A' ' 48' ' ' LEU . 80.6 p -41.88 -36.92 1.16 Allowed 'General case' 0 N--CA 1.507 2.401 0 O-C-N 121.983 -0.448 . . . . 0.0 112.2 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -62.47 -47.86 82.14 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.112 -0.992 . . . . 0.0 109.346 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -60.04 -54.97 39.7 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.49 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 44.4 tp -59.98 -36.99 78.34 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.253 -0.904 . . . . 0.0 111.55 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.54 -31.39 14.46 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.5 m -70.92 -39.62 72.58 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.401 -1.058 . . . . 0.0 110.172 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.3 t -64.79 -54.1 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.517 -0.739 . . . . 0.0 110.06 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 92.6 mtp -60.03 -34.94 74.06 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.59 0.71 . . . . 0.0 110.064 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -60.05 -49.54 77.24 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.651 0.739 . . . . 0.0 110.007 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.9 t -69.96 -16.69 63.24 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.838 -0.539 . . . . 0.0 110.791 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.531 HD13 HD12 ' B' ' 167' ' ' LEU . 84.3 mt -87.9 -24.41 23.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.474 -0.766 . . . . 0.0 110.45 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.41 -38.43 0.22 Allowed Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.528 -1.32 . . . . 0.0 111.401 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -152.78 155.53 37.34 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 118.814 1.307 . . . . 0.0 112.196 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -116.97 99.96 53.16 Favored Pre-proline 0 N--CA 1.489 1.517 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.677 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.422 ' HG2' HD21 ' A' ' 48' ' ' LEU . 44.7 Cg_endo -64.18 -148.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.282 0 O-C-N 123.246 1.129 . . . . 0.0 109.56 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.7 p -139.94 156.5 46.63 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.93 -1.106 . . . . 0.0 111.689 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -54.02 -20.58 6.58 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.801 -0.562 . . . . 0.0 111.602 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.94 -59.99 2.46 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.937 0.875 . . . . 0.0 108.942 177.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -68.73 -33.75 74.44 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.044 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.422 HD21 ' HG2' ' A' ' 43' ' ' PRO . 44.2 mt -58.8 -34.85 71.96 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.608 -0.683 . . . . 0.0 110.33 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.33 -32.12 69.71 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.535 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -70.08 -43.09 71.83 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.356 -0.84 . . . . 0.0 111.313 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.422 ' CE ' HD23 ' A' ' 48' ' ' LEU . 77.7 mtm -60.95 -41.85 97.12 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.632 0.73 . . . . 0.0 109.463 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.579 HG22 ' OD2' ' A' ' 56' ' ' ASP . 97.0 mt -69.82 -31.93 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.908 -0.495 . . . . 0.0 110.026 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -59.96 -41.53 92.11 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.593 -0.692 . . . . 0.0 110.821 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -67.99 -25.61 65.49 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.323 -0.861 . . . . 0.0 110.292 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.3 t -99.09 -9.46 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.607 -0.683 . . . . 0.0 111.116 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.579 ' OD2' HG22 ' A' ' 52' ' ' ILE . 26.7 m-20 -71.96 106.53 4.29 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.123 -0.986 . . . . 0.0 111.68 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.92 -40.07 75.76 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.458 -0.776 . . . . 0.0 109.726 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -88.62 -29.74 19.74 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.635 -0.665 . . . . 0.0 110.266 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.92 24.61 44.4 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -74.3 -31.82 62.64 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.536 -0.979 . . . . 0.0 110.467 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 123.0 -3.91 9.78 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 120.361 -0.923 . . . . 0.0 111.033 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 82.0 p -133.43 170.01 16.12 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.065 -1.256 . . . . 0.0 110.364 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.57 HG12 HG23 ' A' ' 52' ' ' ILE . 9.1 mt -102.79 120.48 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.05 -178.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -98.38 169.51 9.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.523 -0.736 . . . . 0.0 110.617 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.476 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 25.7 t80 -49.01 -48.76 71.9 Favored Pre-proline 0 N--CA 1.497 1.915 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.7 Cg_endo -68.11 -33.54 24.87 Favored 'Trans proline' 0 N--CA 1.486 1.084 0 O-C-N 122.639 0.81 . . . . 0.0 110.863 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -71.13 -39.98 71.69 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.328 -0.857 . . . . 0.0 110.061 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -60.78 -49.96 75.4 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.522 -0.736 . . . . 0.0 110.893 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.51 HD21 ' CB ' ' A' ' 12' ' ' PHE . 85.2 mt -60.33 -41.89 94.49 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.509 -0.744 . . . . 0.0 111.515 -178.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 66' ' ' PRO . 45.9 p -63.66 -37.17 86.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.44 -0.788 . . . . 0.0 111.395 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.8 ttt -65.76 -44.36 86.09 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.299 -0.876 . . . . 0.0 111.54 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 91.2 mtp -71.04 -60.08 2.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.346 -0.846 . . . . 0.0 112.146 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.74 -40.79 76.39 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.47 -0.768 . . . . 0.0 111.314 -178.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.8 tpt85 -70.0 -40.2 75.42 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.526 -0.734 . . . . 0.0 111.157 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -86.2 -39.1 16.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.397 -0.815 . . . . 0.0 111.986 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.729 ' O ' HG22 ' A' ' 79' ' ' THR . 43.9 mtm -60.02 -39.95 87.62 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.254 -0.904 . . . . 0.0 111.661 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -62.21 -44.27 96.96 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.189 -0.944 . . . . 0.0 109.66 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -74.74 -10.02 59.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.93 -0.481 . . . . 0.0 110.566 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.729 HG22 ' O ' ' A' ' 76' ' ' MET . 0.6 OUTLIER -85.5 -162.5 0.73 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.252 -0.905 . . . . 0.0 111.328 -179.047 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.643 ' N ' HG23 ' A' ' 79' ' ' THR . 68.6 m-20 -130.06 135.43 48.23 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.804 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.0 t -69.97 -27.19 64.52 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.614 -0.678 . . . . 0.0 110.638 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -60.04 -36.62 77.68 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.556 -0.715 . . . . 0.0 110.023 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.98 -40.02 75.6 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.722 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -63.21 -40.05 96.37 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.475 -0.766 . . . . 0.0 110.729 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.624 HG23 ' HE2' ' A' ' 141' ' ' PHE . 85.8 mt -66.03 -46.89 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.673 -0.642 . . . . 0.0 110.148 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 -56.57 -40.42 75.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.532 -0.73 . . . . 0.0 110.903 -178.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.721 ' O ' HG23 ' A' ' 91' ' ' VAL . 99.0 mt-10 -69.94 -40.05 75.73 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.421 -0.8 . . . . 0.0 111.721 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.656 ' CA ' HG11 ' B' ' 164' ' ' VAL . . . -65.1 -48.86 72.17 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.358 -0.839 . . . . 0.0 111.996 -178.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -61.23 -43.68 98.48 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.464 -0.772 . . . . 0.0 109.984 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -59.98 -38.41 82.46 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.874 -0.516 . . . . 0.0 110.997 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 87' ' ' GLU . 99.0 t -69.82 -48.76 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.473 -0.767 . . . . 0.0 110.446 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.778 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 20.3 m-85 -67.98 -40.06 83.19 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.47 -0.769 . . . . 0.0 111.01 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -74.96 69.93 1.94 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.528 -0.733 . . . . 0.0 110.337 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.7 tttp -59.95 -46.6 88.89 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.426 -0.796 . . . . 0.0 109.84 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.1 p-10 -73.9 -18.83 60.86 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.603 -0.685 . . . . 0.0 111.382 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.94 62.4 6.35 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.438 ' ND2' ' CE2' ' A' ' 99' ' ' TYR . 37.6 p-10 -109.23 -7.46 15.27 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.516 -0.991 . . . . 0.0 111.82 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.55 -22.6 11.76 Favored Glycine 0 N--CA 1.498 2.817 0 C-N-CA 119.989 -1.1 . . . . 0.0 110.439 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.438 ' CE2' ' ND2' ' A' ' 97' ' ' ASN . 35.5 p90 -143.77 154.55 43.56 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.392 -1.064 . . . . 0.0 109.635 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 81.9 mt -91.32 129.42 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 121.839 0.828 . . . . 0.0 110.126 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.03 172.36 9.6 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.211 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.26 -40.98 86.26 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.579 -0.701 . . . . 0.0 109.665 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.54 -37.75 88.51 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -61.16 -37.35 82.58 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.974 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.591 ' HB3' HG13 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -64.58 -42.73 95.42 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.682 0.753 . . . . 0.0 109.552 179.033 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -60.04 -38.53 83.02 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.883 -0.511 . . . . 0.0 111.556 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -59.97 -41.06 91.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.084 -1.01 . . . . 0.0 111.856 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.778 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 84.5 t -72.9 -50.13 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.239 -0.913 . . . . 0.0 111.594 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.422 ' HA ' HD12 ' A' ' 112' ' ' LEU . 41.8 mtt -59.07 -41.52 88.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.175 -0.953 . . . . 0.0 110.403 -178.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.7 m -64.37 -46.62 82.59 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.49 -0.756 . . . . 0.0 109.126 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -61.35 -33.57 73.85 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.504 ' CD1' HG12 ' A' ' 108' ' ' VAL . 39.2 mt -69.84 -30.51 68.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.95 -0.469 . . . . 0.0 109.999 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.16 31.62 3.03 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -122.19 137.0 54.98 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.539 -0.977 . . . . 0.0 110.028 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -109.52 124.87 51.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.532 -0.73 . . . . 0.0 110.212 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.667 HD22 ' OE2' ' A' ' 120' ' ' GLU . 73.0 mt -138.98 159.75 41.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.565 -0.709 . . . . 0.0 109.647 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.18 162.01 26.04 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -59.61 -29.55 68.07 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.355 -0.841 . . . . 0.0 109.084 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -68.44 -32.63 72.78 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.424 0.63 . . . . 0.0 109.61 178.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.667 ' OE2' HD22 ' A' ' 116' ' ' LEU . 12.0 mt-10 -67.83 -37.97 82.61 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.522 178.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.591 HG13 ' HB3' ' A' ' 105' ' ' LEU . 97.5 t -69.74 -40.09 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.699 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -59.9 -42.03 92.92 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.295 0.569 . . . . 0.0 109.996 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -60.04 -41.4 92.2 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.026 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.485 ' HB3' HD11 ' A' ' 105' ' ' LEU . 6.3 mmt -54.64 -36.37 64.48 Favored 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.385 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.5 mm -68.47 -37.6 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.308 0.575 . . . . 0.0 109.826 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 46.6 ttt-85 -60.0 -40.08 87.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.574 -0.704 . . . . 0.0 111.239 -178.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -61.83 -39.46 91.89 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.648 -0.657 . . . . 0.0 111.222 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -99.34 -0.25 41.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.347 -0.846 . . . . 0.0 111.763 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -104.48 80.53 1.69 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.979 -1.076 . . . . 0.0 110.947 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.4 mt -67.84 -39.95 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.648 -0.658 . . . . 0.0 109.965 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 36.5 p-10 -60.02 -39.72 86.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.587 -0.696 . . . . 0.0 110.755 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.77 17.9 36.75 Favored Glycine 0 N--CA 1.497 2.727 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.385 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -81.0 -10.11 59.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.108 -1.231 . . . . 0.0 110.608 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.13 2.29 71.39 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.367 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -136.77 139.18 41.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.167 -1.196 . . . . 0.0 110.276 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 98.1 t -95.81 113.81 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.566 -0.709 . . . . 0.0 109.713 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 41.6 p30 -86.12 -166.95 1.68 Allowed 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.609 -0.682 . . . . 0.0 110.241 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -70.08 -43.72 70.56 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.842 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -61.3 -49.96 74.93 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.264 -0.897 . . . . 0.0 112.115 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.3 -37.63 88.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.503 -0.748 . . . . 0.0 110.499 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.624 ' HE2' HG23 ' A' ' 85' ' ' ILE . 68.5 t80 -60.09 -47.3 86.45 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.667 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 87.0 t -64.66 -39.96 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.485 -0.76 . . . . 0.0 110.695 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -59.98 -49.64 76.87 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.563 -0.711 . . . . 0.0 111.033 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.448 ' CE ' ' CD1' ' B' ' 157' ' ' PHE . 10.9 tmm? -60.66 -40.01 90.48 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.279 -0.888 . . . . 0.0 110.128 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 94.9 mmm -67.24 -38.78 85.77 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.749 -0.595 . . . . 0.0 109.944 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 91.6 m -58.85 -29.03 66.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.69 -0.631 . . . . 0.0 109.973 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.99 141.86 47.74 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.6 -0.688 . . . . 0.0 110.432 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 95.7 mttt . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.325 179.916 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -66.54 152.74 52.41 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 157' ' ' PHE . . . . . 0.531 ' HA ' HD12 ' B' ' 160' ' ' ILE . 22.6 t80 -61.51 -42.2 98.44 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.488 -1.007 . . . . 0.0 110.332 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 63.0 mtt85 -60.02 -40.06 88.01 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.558 -0.714 . . . . 0.0 110.397 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -62.61 -39.92 95.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.494 -0.754 . . . . 0.0 110.364 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 160' ' ' ILE . . . . . 0.531 HD12 ' HA ' ' B' ' 157' ' ' PHE . 73.0 mt -61.23 -45.09 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.516 -0.74 . . . . 0.0 110.041 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.9 -28.64 69.09 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.518 -0.739 . . . . 0.0 110.146 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -60.15 -39.92 88.03 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.572 -0.705 . . . . 0.0 109.503 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 89.0 mt -60.04 -40.08 88.14 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.724 -0.61 . . . . 0.0 110.413 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 164' ' ' VAL . . . . . 0.656 HG11 ' CA ' ' A' ' 88' ' ' ALA . 94.0 t -65.22 -39.95 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.496 -0.753 . . . . 0.0 109.9 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -54.81 -37.15 61.17 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 85.0 t -60.0 -33.32 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.657 -0.907 . . . . 0.0 109.627 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.577 HD23 ' O ' ' B' ' 167' ' ' LEU . 8.1 tt -56.24 -37.74 70.15 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.622 -0.674 . . . . 0.0 110.777 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -59.99 -39.99 87.65 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.416 -0.803 . . . . 0.0 110.224 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -63.76 -40.01 95.67 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.447 -0.783 . . . . 0.0 110.989 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -20.9 59.46 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.415 -0.803 . . . . 0.0 110.869 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.98 -32.31 70.46 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.268 -0.895 . . . . 0.0 110.965 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -59.98 -38.73 83.39 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.355 -0.841 . . . . 0.0 109.865 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 71.4 mtp85 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.734 -0.604 . . . . 0.0 110.318 179.99 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 121.037 0.446 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -81.4 98.92 8.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.516 -0.74 . . . . 0.0 109.927 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.69 176.88 1.79 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.52 0.676 . . . . 0.0 110.721 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 66.6 mt -111.85 -179.4 3.68 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.603 0.716 . . . . 0.0 110.604 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.94 19.78 18.68 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.881 -0.512 . . . . 0.0 110.237 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.635 ' HA ' HD12 ' A' ' 9' ' ' ILE . 95.3 mt-10 -61.27 -13.79 21.46 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.369 -0.832 . . . . 0.0 111.526 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -64.96 -45.18 86.79 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.248 -0.908 . . . . 0.0 109.4 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -66.54 -38.82 87.98 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.301 0.572 . . . . 0.0 110.067 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.635 HD12 ' HA ' ' A' ' 6' ' ' GLU . 72.1 mt -57.88 -29.02 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.776 -0.577 . . . . 0.0 110.737 -179.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.22 -39.13 89.09 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.233 -0.917 . . . . 0.0 110.194 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -59.98 -43.47 95.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.718 -0.614 . . . . 0.0 110.397 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.584 ' HB3' HD21 ' A' ' 69' ' ' LEU . 77.2 m-85 -64.8 -20.77 66.56 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.844 -0.535 . . . . 0.0 111.395 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -69.96 -42.3 73.36 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.068 -1.02 . . . . 0.0 109.107 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -70.0 -26.65 64.17 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.119 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.15 -27.43 32.73 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.335 -0.853 . . . . 0.0 111.147 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.454 ' CB ' ' CE1' ' A' ' 65' ' ' PHE . 47.9 t80 -59.66 -41.32 90.31 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.576 -0.703 . . . . 0.0 111.673 -177.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.0 m -61.28 -38.36 86.5 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.233 -0.917 . . . . 0.0 109.974 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.7 tp -60.05 -41.21 91.84 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.816 -0.553 . . . . 0.0 110.0 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -74.22 -34.76 63.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.583 -0.698 . . . . 0.0 110.467 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -92.97 95.44 9.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.447 -0.783 . . . . 0.0 109.655 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -59.98 -32.1 70.51 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.426 -0.796 . . . . 0.0 111.155 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -79.44 -8.03 58.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.102 -0.999 . . . . 0.0 110.754 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.21 26.83 29.92 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -90.4 -4.82 56.78 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.686 -0.89 . . . . 0.0 111.326 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.97 2.41 58.26 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.634 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.0 p -146.71 144.18 29.25 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.353 1.576 . . . . 0.0 111.727 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 84.0 mt -107.72 133.14 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.71 -0.619 . . . . 0.0 109.97 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.2 p -111.04 145.84 37.78 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.552 -0.717 . . . . 0.0 110.626 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.442 ' CG2' HD12 ' A' ' 52' ' ' ILE . 53.6 p -43.81 -32.98 1.18 Allowed 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.667 -0.646 . . . . 0.0 111.858 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.06 -50.59 65.58 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.753 0.787 . . . . 0.0 109.533 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -59.99 -53.63 55.56 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.65 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.559 HD13 ' CZ2' ' B' ' 170' ' ' TRP . 9.0 tt -60.02 -32.38 70.84 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.359 -0.838 . . . . 0.0 110.479 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.19 -31.34 33.8 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.314 -1.115 . . . . 0.0 110.314 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 93.7 m -63.83 -39.97 95.49 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.591 -0.946 . . . . 0.0 109.09 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.401 ' CG1' HD22 ' B' ' 167' ' ' LEU . 78.0 t -66.61 -39.98 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 96.8 mmm -59.97 -39.99 87.57 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.684 -0.635 . . . . 0.0 110.877 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.46 ' CG ' ' HB2' ' A' ' 42' ' ' ASN . 55.6 mtm180 -61.85 -42.62 99.26 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.152 -0.967 . . . . 0.0 109.552 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.3 t -63.72 -25.96 68.44 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.083 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.641 HD21 ' HD2' ' B' ' 168' ' ' ARG . 24.0 tp -85.77 -23.17 27.38 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.416 -0.803 . . . . 0.0 109.366 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.93 -58.77 0.17 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -160.56 176.26 11.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.544 -0.974 . . . . 0.0 111.415 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.46 ' HB2' ' CG ' ' A' ' 37' ' ' ARG . 38.9 t30 -99.61 131.84 24.1 Favored Pre-proline 0 N--CA 1.492 1.664 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.208 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -68.75 -147.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.111 0 N-CA-C 108.435 -1.41 . . . . 0.0 108.435 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.1 p -129.59 141.55 50.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.827 -1.171 . . . . 0.0 110.481 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -51.48 -25.77 7.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.642 -0.661 . . . . 0.0 111.322 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.57 -54.9 7.87 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.124 0.964 . . . . 0.0 108.546 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -66.86 -39.87 87.69 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.093 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.43 HD13 ' HB ' ' A' ' 29' ' ' THR . 1.4 mt -56.0 -35.04 66.37 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.542 -0.724 . . . . 0.0 109.713 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.97 -37.16 81.19 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.152 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -65.22 -38.68 91.16 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.382 -0.823 . . . . 0.0 110.791 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 88.6 mmm -59.98 -45.97 90.97 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.659 -0.65 . . . . 0.0 110.206 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.732 HG22 ' OD2' ' A' ' 56' ' ' ASP . 89.9 mt -67.89 -32.98 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.714 -0.616 . . . . 0.0 110.375 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -60.01 -43.29 95.33 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.246 -0.909 . . . . 0.0 110.669 -178.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -67.9 -26.44 65.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.339 -0.851 . . . . 0.0 110.918 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.505 HG21 ' SD ' ' A' ' 71' ' ' MET . 57.5 t -99.97 -8.84 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.483 -0.761 . . . . 0.0 111.482 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.732 ' OD2' HG22 ' A' ' 52' ' ' ILE . 3.6 m-20 -71.23 103.16 2.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.109 -0.995 . . . . 0.0 110.897 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.25 -38.71 78.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.648 -0.658 . . . . 0.0 109.76 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -91.45 -30.64 16.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.615 -0.678 . . . . 0.0 110.537 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.2 20.99 40.01 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 120.36 -0.924 . . . . 0.0 110.905 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.6 p-10 -73.95 -32.86 63.67 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.39 -1.065 . . . . 0.0 110.323 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.7 -0.04 12.16 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.006 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 57.7 p -137.35 167.74 21.01 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.091 -1.24 . . . . 0.0 110.917 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.8 mt -104.58 120.67 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 121.317 0.58 . . . . 0.0 110.483 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -96.48 169.93 9.57 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.383 0.611 . . . . 0.0 110.585 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.456 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -46.06 -50.35 36.86 Favored Pre-proline 0 N--CA 1.501 2.099 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -179.063 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.3 Cg_endo -72.37 -32.02 10.74 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.026 1.014 . . . . 0.0 111.771 -178.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -71.44 -40.03 70.65 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.216 -0.927 . . . . 0.0 110.251 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -61.52 -39.96 92.93 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.723 -0.611 . . . . 0.0 110.761 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.584 HD21 ' HB3' ' A' ' 12' ' ' PHE . 89.3 mt -67.76 -39.98 84.12 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.424 -0.798 . . . . 0.0 111.926 -178.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.1 p -61.88 -40.08 94.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.356 -0.84 . . . . 0.0 110.748 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.505 ' SD ' HG21 ' A' ' 55' ' ' VAL . 60.5 ttp -67.71 -38.38 83.53 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.622 -0.674 . . . . 0.0 110.357 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.402 ' CE ' ' CG2' ' B' ' 166' ' ' VAL . 5.0 tpt -60.06 -49.51 77.39 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.611 -0.681 . . . . 0.0 111.076 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.09 -28.96 65.83 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.395 -0.816 . . . . 0.0 110.757 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -72.05 -40.79 68.1 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.498 -0.751 . . . . 0.0 110.608 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -69.15 -50.07 51.08 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.639 -0.663 . . . . 0.0 111.483 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 70.6 mtm -59.94 -40.03 87.56 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.429 -0.794 . . . . 0.0 111.104 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -60.74 -55.41 33.53 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.368 -0.832 . . . . 0.0 111.224 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -65.02 -19.98 66.27 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.456 -0.777 . . . . 0.0 110.161 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.544 HG22 ' H ' ' A' ' 80' ' ' ASP 0.299 52.9 m -99.87 -175.11 2.87 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.815 -0.553 . . . . 0.0 109.648 -179.742 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.544 ' H ' HG22 ' A' ' 79' ' ' THR . 87.4 m-20 -121.74 140.82 51.85 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.223 -0.923 . . . . 0.0 109.084 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.4 ' HA ' ' HG2' ' A' ' 84' ' ' GLU . 33.6 t -55.76 -28.57 56.67 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.317 -0.864 . . . . 0.0 110.271 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.76 -34.32 77.63 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.677 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -71.42 -41.63 69.31 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.92 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.4 ' HG2' ' HA ' ' A' ' 81' ' ' SER . 9.5 pt-20 -69.93 -29.49 66.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.117 -0.989 . . . . 0.0 110.414 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 95.9 mt -69.3 -46.31 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.536 -0.727 . . . . 0.0 109.699 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 63.2 mtt180 -59.81 -39.93 86.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.409 -0.807 . . . . 0.0 110.584 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.62 ' O ' HG23 ' A' ' 91' ' ' VAL . 98.9 mt-10 -66.95 -44.45 80.55 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.535 -0.728 . . . . 0.0 110.927 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.494 ' HA ' HG12 ' B' ' 164' ' ' VAL . . . -64.4 -43.58 93.98 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.667 -0.646 . . . . 0.0 111.282 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -59.94 -47.99 83.54 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.763 0.792 . . . . 0.0 109.778 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -58.98 -33.42 70.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.914 -0.492 . . . . 0.0 110.473 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 87' ' ' GLU . 78.5 t -70.04 -42.88 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.508 -0.745 . . . . 0.0 110.028 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.41 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 13.0 m-85 -70.06 -39.13 75.84 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.446 -0.784 . . . . 0.0 110.628 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -79.75 73.32 6.48 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.575 -0.703 . . . . 0.0 109.653 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -64.82 -40.83 95.84 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.381 -0.824 . . . . 0.0 110.487 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -76.12 -16.59 59.86 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.459 -0.775 . . . . 0.0 110.958 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.18 61.58 7.34 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -107.79 -10.6 15.55 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.581 -0.952 . . . . 0.0 111.377 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.4 -23.22 8.58 Favored Glycine 0 N--CA 1.498 2.815 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 14.6 p90 -142.79 176.16 9.27 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.483 -1.01 . . . . 0.0 108.708 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.507 HG22 ' H ' ' A' ' 101' ' ' SER . 23.4 mt -89.07 -129.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 119.801 -0.759 . . . . 0.0 109.248 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.507 ' H ' HG22 ' A' ' 100' ' ' ILE . 0.3 OUTLIER 168.71 159.87 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 O-C-N 120.529 -1.357 . . . . 0.0 108.321 178.568 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.52 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -61.3 -42.02 97.97 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.367 -0.833 . . . . 0.0 109.18 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.12 -30.67 67.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.837 -0.539 . . . . 0.0 110.094 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.47 ' HB2' HG22 ' A' ' 100' ' ' ILE . 61.9 mt-10 -69.97 -39.15 76.16 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.305 -0.872 . . . . 0.0 110.593 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.752 ' HB3' HG13 ' A' ' 121' ' ' VAL . 0.9 OUTLIER -67.54 -47.24 70.44 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.481 -0.762 . . . . 0.0 110.21 179.676 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -61.21 -38.94 88.39 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.826 -0.546 . . . . 0.0 111.628 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -60.04 -39.95 87.71 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.218 -0.926 . . . . 0.0 111.163 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.41 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 96.5 t -74.08 -47.36 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 O-C-N 121.275 -0.891 . . . . 0.0 111.438 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.702 ' HE1' HG22 ' A' ' 121' ' ' VAL . 76.5 mtm -58.83 -42.96 90.46 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.156 -0.965 . . . . 0.0 110.267 -178.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.2 m -67.27 -41.67 85.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.541 -0.724 . . . . 0.0 109.127 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.526 ' C ' HD21 ' A' ' 111' ' ' ASN . 0.2 OUTLIER -63.1 -31.91 73.17 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 109' ' ' MET . 42.5 mt -70.02 -35.09 74.08 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.697 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.94 21.14 2.95 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.667 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -119.98 138.32 53.55 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.215 -1.168 . . . . 0.0 110.024 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.7 mmmt -103.33 122.02 43.95 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.541 -0.725 . . . . 0.0 110.649 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.511 HD12 ' SD ' ' A' ' 109' ' ' MET . 77.2 mt -135.05 156.48 48.95 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.64 -0.662 . . . . 0.0 109.502 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.77 159.39 29.07 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.558 -0.714 . . . . 0.0 109.677 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -58.75 -29.8 67.02 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -66.09 -29.97 70.39 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -37.31 86.13 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.752 HG13 ' HB3' ' A' ' 105' ' ' LEU . 94.5 t -70.05 -39.91 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.522 0.677 . . . . 0.0 110.151 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -60.04 -45.75 91.78 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.786 -0.571 . . . . 0.0 110.074 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -59.9 -40.05 87.46 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.597 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.548 ' HB3' HD11 ' A' ' 105' ' ' LEU . 10.2 mmt -55.39 -38.48 68.94 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.594 -0.842 . . . . 0.0 108.767 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 48.4 mm -66.31 -40.1 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.356 0.598 . . . . 0.0 109.749 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -57.86 -38.62 76.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.691 -0.631 . . . . 0.0 111.197 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.95 -39.77 86.73 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.68 -0.638 . . . . 0.0 111.16 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.93 4.45 34.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.321 -0.862 . . . . 0.0 111.558 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 62.7 t0 -88.14 69.9 9.25 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.035 -1.041 . . . . 0.0 110.425 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.7 mt -67.67 -40.74 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.464 -0.772 . . . . 0.0 110.481 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -72.59 -22.4 60.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.433 -0.792 . . . . 0.0 111.087 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.6 24.33 50.58 Favored Glycine 0 N--CA 1.496 2.688 0 C-N-CA 120.262 -0.971 . . . . 0.0 110.69 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -83.8 -10.78 57.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.389 -1.065 . . . . 0.0 111.086 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.35 0.84 79.33 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -137.81 149.26 46.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -1.117 . . . . 0.0 109.286 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.0 t -92.14 118.63 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.427 -0.796 . . . . 0.0 109.771 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -88.06 176.51 7.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.573 -0.705 . . . . 0.0 109.346 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -61.34 -47.47 85.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.743 -0.598 . . . . 0.0 110.498 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -59.95 -46.42 89.47 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.74 -0.6 . . . . 0.0 111.51 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -64.47 -37.04 86.15 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.806 0.813 . . . . 0.0 109.99 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.453 ' CZ ' ' CE ' ' A' ' 145' ' ' MET . 64.9 t80 -60.07 -48.88 79.89 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.283 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.859 ' O ' HG22 ' A' ' 146' ' ' THR . 89.0 t -70.0 -40.65 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.308 -0.87 . . . . 0.0 111.921 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -59.94 -48.8 80.22 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.308 -0.87 . . . . 0.0 111.477 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.43 ' HE1' ' CE1' ' B' ' 157' ' ' PHE . 55.2 ttp -59.99 -35.9 76.01 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.428 -0.795 . . . . 0.0 110.475 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.477 ' HE2' ' CB ' ' B' ' 161' ' ' ALA . 37.3 mtt -70.65 -40.04 73.27 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.638 -0.664 . . . . 0.0 110.939 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.859 HG22 ' O ' ' A' ' 142' ' ' VAL . 8.5 t -104.99 31.65 4.69 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.514 -0.741 . . . . 0.0 109.98 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.18 -42.45 95.04 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.626 -0.671 . . . . 0.0 110.153 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 30.2 mttt . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.969 179.563 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.374 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -92.64 146.23 18.04 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.43 ' CE1' ' HE1' ' A' ' 144' ' ' MET . 51.4 t80 -59.95 -40.73 90.0 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.506 -0.997 . . . . 0.0 109.903 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 32.6 ttp85 -61.38 -40.45 94.4 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.699 -0.626 . . . . 0.0 110.22 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -60.14 -40.01 88.34 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.488 -0.757 . . . . 0.0 110.286 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 97.4 mt -66.68 -39.63 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.655 -0.653 . . . . 0.0 110.465 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 161' ' ' ALA . . . . . 0.477 ' CB ' ' HE2' ' A' ' 145' ' ' MET . . . -59.32 -37.11 76.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.521 -0.737 . . . . 0.0 110.372 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -60.13 -40.04 88.4 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.486 -0.759 . . . . 0.0 110.688 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 83.4 mt -70.04 -34.95 73.91 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.517 -0.739 . . . . 0.0 110.691 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.494 HG12 ' HA ' ' A' ' 88' ' ' ALA . 91.1 t -63.97 -39.96 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.595 -0.691 . . . . 0.0 109.932 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.14 -30.46 67.2 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.402 ' CG2' ' CE ' ' A' ' 72' ' ' MET . 58.3 t -69.02 -33.56 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.628 -0.925 . . . . 0.0 110.959 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.401 HD22 ' CG1' ' A' ' 35' ' ' VAL . 91.6 mt -60.17 -46.55 89.3 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.372 -0.83 . . . . 0.0 111.711 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 168' ' ' ARG . . . . . 0.641 ' HD2' HD21 ' A' ' 39' ' ' LEU . 23.2 mmm180 -70.07 -38.18 75.66 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.198 -0.939 . . . . 0.0 111.505 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -59.97 -40.06 87.77 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.287 -0.883 . . . . 0.0 110.629 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 170' ' ' TRP . . . . . 0.559 ' CZ2' HD13 ' A' ' 32' ' ' LEU . 2.0 t-105 -59.95 -40.26 88.38 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.41 -0.806 . . . . 0.0 109.845 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.1 -20.45 59.46 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.578 -0.701 . . . . 0.0 110.514 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -60.03 -39.99 87.77 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.324 -0.86 . . . . 0.0 110.072 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.635 -0.666 . . . . 0.0 110.111 179.73 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.146 0.498 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -133.47 37.83 3.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.726 -0.609 . . . . 0.0 110.284 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -61.67 -40.0 93.41 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.688 0.756 . . . . 0.0 110.341 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 77.2 mt -117.61 178.31 4.44 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.516 0.674 . . . . 0.0 110.583 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 p -143.78 106.13 4.41 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.432 ' HA ' HD12 ' A' ' 9' ' ' ILE . 96.7 mt-10 -92.62 -12.21 32.24 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.746 -0.596 . . . . 0.0 111.033 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -69.95 -42.14 73.62 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.271 -0.893 . . . . 0.0 109.879 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -68.01 -40.03 83.05 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.523 0.678 . . . . 0.0 110.818 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.432 HD12 ' HA ' ' A' ' 6' ' ' GLU . 79.0 mt -60.58 -29.04 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.925 -0.484 . . . . 0.0 111.525 -178.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.67 86.6 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.157 -0.964 . . . . 0.0 110.063 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -60.03 -40.38 89.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.465 -0.772 . . . . 0.0 110.244 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.415 ' CG ' HD21 ' A' ' 69' ' ' LEU . 66.0 m-85 -65.36 -20.75 66.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.724 -0.61 . . . . 0.0 110.917 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HD3' ' CZ ' ' A' ' 65' ' ' PHE . 72.2 mmtt -69.94 -46.14 65.94 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.293 -0.879 . . . . 0.0 109.886 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -76.23 -24.82 54.61 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.45 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.22 -35.2 42.01 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.454 -0.779 . . . . 0.0 110.51 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -59.87 -39.99 87.13 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.853 -0.529 . . . . 0.0 111.549 -177.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.5 m -61.93 -39.64 92.77 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.25 -0.906 . . . . 0.0 109.946 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.649 HD11 ' O ' ' A' ' 112' ' ' LEU . 59.7 tp -60.03 -40.09 88.16 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.693 -0.629 . . . . 0.0 109.406 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -77.39 -35.61 54.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.718 -0.614 . . . . 0.0 110.349 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -94.26 97.73 10.44 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.401 -0.812 . . . . 0.0 110.196 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -59.99 -34.81 73.81 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.527 -0.733 . . . . 0.0 111.728 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -80.1 -11.2 59.78 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.172 -0.955 . . . . 0.0 111.249 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.56 28.77 52.29 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -90.86 -6.13 54.62 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.725 -0.868 . . . . 0.0 111.262 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.42 0.25 56.87 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 120.158 -1.02 . . . . 0.0 111.617 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.5 p -144.86 143.02 30.38 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 119.284 1.542 . . . . 0.0 111.108 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.8 mt -107.04 130.07 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 121.766 0.793 . . . . 0.0 110.868 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.4 p -106.16 143.06 34.82 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.846 -0.533 . . . . 0.0 110.537 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.511 HG23 ' CD1' ' A' ' 52' ' ' ILE . 64.8 p -43.25 -29.03 0.36 Allowed 'General case' 0 N--CA 1.509 2.489 0 O-C-N 121.667 -0.646 . . . . 0.0 112.163 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -65.09 -50.21 66.99 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.804 0.811 . . . . 0.0 109.58 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -59.51 -53.35 59.13 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.695 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.441 ' CD2' ' CE2' ' B' ' 170' ' ' TRP . 54.4 tp -60.09 -30.47 69.26 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.253 -0.904 . . . . 0.0 110.119 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.49 -32.56 23.58 Favored Glycine 0 N--CA 1.5 2.959 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.6 m -65.38 -39.91 92.86 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.545 -0.974 . . . . 0.0 109.434 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.458 ' CG1' HD22 ' B' ' 167' ' ' LEU . 77.1 t -68.18 -39.99 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-O 121.492 0.663 . . . . 0.0 110.046 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 46.1 mtt -59.97 -39.96 87.42 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.698 -0.626 . . . . 0.0 111.104 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.471 ' CG ' ' HB2' ' A' ' 42' ' ' ASN . 55.8 mtt180 -60.73 -46.73 89.28 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.303 -0.873 . . . . 0.0 109.961 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -67.0 -23.36 65.92 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.903 -178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.7 tp -82.64 -30.5 29.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.94 . . . . 0.0 109.443 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.37 -39.61 0.19 Allowed Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.934 -1.127 . . . . 0.0 110.868 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -170.53 160.35 7.3 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.076 -1.249 . . . . 0.0 112.271 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.471 ' HB2' ' CG ' ' A' ' 37' ' ' ARG . 5.9 t-20 -105.88 111.22 64.59 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.699 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.467 ' HD2' ' HA ' ' A' ' 42' ' ' ASN . 41.3 Cg_endo -61.15 -143.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.496 0 O-C-N 123.501 1.264 . . . . 0.0 109.683 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.2 p -131.41 149.93 52.35 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.218 -1.551 . . . . 0.0 112.131 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -51.1 -22.54 2.53 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.872 -0.517 . . . . 0.0 111.927 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.61 -55.76 8.05 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 122.284 1.04 . . . . 0.0 108.454 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -67.32 -37.17 82.88 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.718 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.45 HD13 ' HB ' ' A' ' 29' ' ' THR . 4.1 mt -57.35 -36.19 70.89 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.551 -0.718 . . . . 0.0 109.772 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.25 -40.03 89.9 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.426 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -64.0 -36.58 84.43 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.452 -0.78 . . . . 0.0 111.046 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 64.6 mtt -60.03 -44.95 94.28 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.638 -0.663 . . . . 0.0 109.888 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.732 HG22 ' OD2' ' A' ' 56' ' ' ASP . 66.1 mt -68.32 -34.06 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.747 -0.596 . . . . 0.0 110.364 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -60.06 -42.56 94.78 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.32 -0.863 . . . . 0.0 111.051 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -69.1 -27.67 65.8 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.089 -1.007 . . . . 0.0 110.984 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.492 HG21 ' SD ' ' A' ' 71' ' ' MET . 96.5 t -99.92 -7.67 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.591 -0.693 . . . . 0.0 111.239 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.732 ' OD2' HG22 ' A' ' 52' ' ' ILE . 0.5 OUTLIER -72.7 100.02 2.73 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.163 -0.961 . . . . 0.0 112.004 -179.156 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.09 -33.28 65.52 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -71.62 -40.09 70.0 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.407 0.622 . . . . 0.0 110.214 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.25 -1.44 73.27 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -73.7 -40.07 63.89 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.206 -1.173 . . . . 0.0 110.95 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.566 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 129.78 8.55 3.42 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 119.83 -1.176 . . . . 0.0 112.009 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 74.5 p -136.79 160.0 40.15 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.007 -1.29 . . . . 0.0 110.535 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.1 mt -104.93 120.03 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 120.039 -0.664 . . . . 0.0 111.273 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -96.22 171.17 8.76 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.533 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 19.4 t80 -49.37 -48.61 74.4 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.535 -0.728 . . . . 0.0 112.762 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 38.3 Cg_endo -63.94 -37.73 42.23 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 O-C-N 122.693 0.838 . . . . 0.0 111.56 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -69.65 -38.12 77.01 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.266 -0.896 . . . . 0.0 110.053 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.414 ' CE1' ' HG3' ' A' ' 72' ' ' MET . 63.8 t80 -60.56 -42.27 96.25 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.546 -0.721 . . . . 0.0 110.158 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.519 HD11 ' CE2' ' A' ' 65' ' ' PHE . 89.4 mt -63.22 -40.5 97.64 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.5 -0.75 . . . . 0.0 111.854 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 66' ' ' PRO . 70.7 p -61.66 -41.99 98.29 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.374 -0.829 . . . . 0.0 110.954 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.492 ' SD ' HG21 ' A' ' 55' ' ' VAL . 60.6 ttp -69.83 -40.02 76.13 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.562 -0.711 . . . . 0.0 111.475 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.414 ' HG3' ' CE1' ' A' ' 68' ' ' PHE . 97.2 mmm -62.71 -52.78 61.92 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.446 -0.784 . . . . 0.0 111.92 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.01 -31.54 71.3 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.661 -0.649 . . . . 0.0 110.313 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.411 ' HD2' ' CE ' ' A' ' 77' ' ' LYS . 10.4 tpt180 -71.83 -43.63 65.26 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.735 -0.603 . . . . 0.0 110.983 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.642 ' O ' HG22 ' A' ' 79' ' ' THR . 66.0 mmtt -70.06 -42.22 73.12 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 45.9 mtm -59.91 -46.42 89.42 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.135 -0.978 . . . . 0.0 112.531 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.411 ' CE ' ' HD2' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -69.87 -37.43 76.09 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.032 -1.043 . . . . 0.0 110.089 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -69.97 -20.03 63.33 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.712 -0.618 . . . . 0.0 111.252 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.642 HG22 ' O ' ' A' ' 75' ' ' LYS . 12.7 t -111.34 -160.71 0.72 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.921 0.867 . . . . 0.0 111.94 -178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -120.49 138.39 53.85 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.463 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.6 t -65.73 -27.74 68.54 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.58 -0.7 . . . . 0.0 109.97 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.02 -31.0 69.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.61 -0.681 . . . . 0.0 109.844 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.62 -40.0 76.86 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.643 -0.661 . . . . 0.0 110.354 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.68 -38.59 87.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.527 -0.733 . . . . 0.0 110.379 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.713 HG23 ' HE1' ' A' ' 141' ' ' PHE . 95.5 mt -64.57 -51.0 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.778 -0.577 . . . . 0.0 110.758 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.8 mtp85 -56.1 -38.41 70.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.265 -0.897 . . . . 0.0 110.481 -178.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.722 ' O ' HG23 ' A' ' 91' ' ' VAL . 95.0 mt-10 -69.77 -39.9 76.39 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.804 -0.56 . . . . 0.0 110.789 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.62 -48.64 74.11 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.392 -0.818 . . . . 0.0 111.152 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -60.22 -43.01 96.38 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.725 0.774 . . . . 0.0 109.7 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -60.0 -36.44 77.2 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.411 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 87' ' ' GLU . 90.4 t -69.43 -50.49 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.559 -0.713 . . . . 0.0 110.19 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -64.84 -40.04 94.54 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.397 -0.814 . . . . 0.0 110.952 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -78.5 65.05 3.7 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.475 -0.766 . . . . 0.0 110.686 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -60.67 -45.97 92.12 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.235 -0.916 . . . . 0.0 109.898 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 41.0 p-10 -69.99 -19.09 63.35 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.567 -0.708 . . . . 0.0 110.791 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.03 57.59 19.04 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -105.11 -3.24 23.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.278 -1.131 . . . . 0.0 110.525 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.43 -16.03 56.98 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -135.62 142.91 45.32 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.146 -1.208 . . . . 0.0 109.525 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 75.2 mt -88.97 124.55 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.482 -0.761 . . . . 0.0 110.021 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.2 m -84.52 169.38 14.52 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.353 0.597 . . . . 0.0 110.575 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.76 -40.57 97.68 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.77 -0.581 . . . . 0.0 110.096 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.77 -33.3 75.54 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.782 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -66.35 -40.02 89.55 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.426 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.449 ' HB3' HG13 ' A' ' 121' ' ' VAL . 1.7 tt -61.1 -48.87 79.68 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.331 -0.856 . . . . 0.0 109.841 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -62.66 -28.39 69.89 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.821 -0.549 . . . . 0.0 111.027 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -60.08 -40.01 88.05 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.186 -0.946 . . . . 0.0 109.978 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.3 t -77.25 -33.11 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.528 -0.733 . . . . 0.0 110.256 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.471 ' SD ' HG22 ' A' ' 121' ' ' VAL . 16.9 mtt -59.99 -49.88 75.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.473 -0.767 . . . . 0.0 110.118 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 p -68.25 -40.87 81.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.621 -0.674 . . . . 0.0 109.703 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -60.05 -31.9 70.42 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.649 ' O ' HD11 ' A' ' 18' ' ' LEU . 21.5 mt -69.94 -35.2 74.33 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.176 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 112.85 24.26 4.99 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -119.82 141.92 49.09 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.452 -1.028 . . . . 0.0 109.518 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -99.92 123.26 43.98 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.407 -0.808 . . . . 0.0 110.847 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.623 HD23 ' OE2' ' A' ' 120' ' ' GLU . 4.2 mp -138.72 154.52 48.56 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.579 -0.7 . . . . 0.0 110.206 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.0 m -87.81 170.2 11.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.637 -0.664 . . . . 0.0 109.344 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -63.5 -24.9 68.02 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.343 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -68.14 -36.36 79.57 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.716 0.769 . . . . 0.0 109.364 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.623 ' OE2' HD23 ' A' ' 116' ' ' LEU . 12.1 mt-10 -65.23 -38.38 90.21 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.594 0.711 . . . . 0.0 109.225 178.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.471 HG22 ' SD ' ' A' ' 109' ' ' MET . 74.3 t -68.2 -39.96 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.03 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.573 ' HA ' HD12 ' A' ' 125' ' ' ILE . 65.7 t0 -59.96 -42.02 93.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.629 -0.67 . . . . 0.0 109.831 -178.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -59.97 -40.94 90.8 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.654 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 10.5 mmt -54.22 -38.52 65.81 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.573 HD12 ' HA ' ' A' ' 122' ' ' ASP . 84.1 mt -66.03 -40.02 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.468 0.651 . . . . 0.0 110.082 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.5 ttt85 -57.35 -39.94 77.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.543 -0.723 . . . . 0.0 111.718 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -60.15 -37.93 81.6 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.572 -0.705 . . . . 0.0 111.465 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -109.39 -5.89 15.66 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.22 -0.925 . . . . 0.0 112.241 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -82.64 70.73 9.68 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.935 -1.103 . . . . 0.0 111.01 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.1 mt -67.99 -39.96 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.467 -0.771 . . . . 0.0 110.488 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.8 p-10 -70.51 -20.03 62.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.416 -0.802 . . . . 0.0 111.337 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.59 24.38 58.67 Favored Glycine 0 N--CA 1.496 2.646 0 C-N-CA 120.135 -1.031 . . . . 0.0 110.672 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -81.93 -11.61 58.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -1.173 . . . . 0.0 110.95 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.44 3.08 72.39 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -141.98 153.11 44.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -1.125 . . . . 0.0 109.784 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.0 t -96.22 109.97 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.609 -0.682 . . . . 0.0 109.611 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.0 p30 -81.93 -174.14 4.88 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.54 -0.725 . . . . 0.0 110.197 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -69.33 -42.86 74.79 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.056 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -62.45 -49.95 73.41 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.294 -0.879 . . . . 0.0 112.049 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.46 -35.5 81.09 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.445 -0.784 . . . . 0.0 110.456 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.713 ' HE1' HG23 ' A' ' 85' ' ' ILE . 64.7 t80 -59.94 -45.83 91.36 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.425 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.9 t -71.46 -40.51 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.294 -0.879 . . . . 0.0 111.777 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -59.96 -49.98 75.56 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.398 -0.814 . . . . 0.0 110.649 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 10.5 tmm? -59.97 -39.86 87.09 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.407 -0.808 . . . . 0.0 109.361 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 92.7 mmm -68.11 -39.86 82.7 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.216 0.531 . . . . 0.0 109.577 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 56.8 m -69.66 -17.8 63.52 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.714 -0.616 . . . . 0.0 110.446 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.94 139.99 57.02 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.381 -0.824 . . . . 0.0 110.454 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.2 mttm . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.105 -179.889 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -156.35 140.93 7.56 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -60.05 -39.92 87.61 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.644 -0.915 . . . . 0.0 110.064 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -60.02 -39.76 86.96 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.631 -0.668 . . . . 0.0 110.309 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -60.09 -39.95 87.87 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.576 -0.702 . . . . 0.0 110.592 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.65 -40.43 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.618 -0.676 . . . . 0.0 109.742 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.21 -39.53 93.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.691 -0.63 . . . . 0.0 110.736 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -64.11 -39.91 95.05 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.419 -0.801 . . . . 0.0 111.34 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 77.6 mt -70.05 -40.39 75.14 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.379 -0.826 . . . . 0.0 112.205 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.665 ' HA ' HD12 ' B' ' 167' ' ' LEU . 13.5 p -71.0 -31.96 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.073 -1.017 . . . . 0.0 110.673 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.73 -40.04 97.52 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 60.3 t -72.96 -27.94 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.696 -0.884 . . . . 0.0 112.0 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.665 HD12 ' HA ' ' B' ' 164' ' ' VAL . 90.6 mt -59.92 -48.13 82.95 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.117 -0.99 . . . . 0.0 111.019 -177.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -64.93 -39.98 94.33 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.26 -0.9 . . . . 0.0 110.885 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -60.32 -36.37 77.76 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.538 -0.726 . . . . 0.0 110.336 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 170' ' ' TRP . . . . . 0.441 ' CE2' ' CD2' ' A' ' 32' ' ' LEU . 3.0 t-105 -60.08 -40.02 88.09 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.578 -0.701 . . . . 0.0 109.782 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.12 -50.4 73.64 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.546 -0.721 . . . . 0.0 110.509 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -60.06 -34.1 72.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.368 -0.832 . . . . 0.0 109.876 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 . . . . . 0 N--CA 1.495 1.782 0 O-C-N 121.648 -0.658 . . . . 0.0 110.205 -179.863 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 121.128 0.489 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -94.42 73.72 3.84 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.445 -0.784 . . . . 0.0 109.853 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -64.04 -39.03 93.19 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.579 0.704 . . . . 0.0 110.535 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.2 mt -59.95 -40.07 87.75 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.535 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 p -138.37 106.86 5.84 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -79.21 -12.67 59.97 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.775 -0.578 . . . . 0.0 110.397 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -70.61 -26.77 63.65 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.388 -0.82 . . . . 0.0 109.645 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -65.66 -31.27 72.2 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.768 0.794 . . . . 0.0 109.201 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.88 -35.47 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.918 -0.489 . . . . 0.0 111.37 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.74 -27.15 68.1 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.045 -1.034 . . . . 0.0 111.184 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -69.44 -45.67 68.55 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.666 0.746 . . . . 0.0 110.094 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -69.44 -24.35 63.8 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.591 0.71 . . . . 0.0 109.169 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -70.86 -40.83 72.09 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.654 0.74 . . . . 0.0 109.605 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -70.62 -28.6 64.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.792 -0.568 . . . . 0.0 110.737 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.21 -27.46 35.29 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.486 -0.759 . . . . 0.0 110.609 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -60.0 -40.35 88.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.639 -0.663 . . . . 0.0 110.61 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.1 t -62.16 -39.48 92.8 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.432 -0.793 . . . . 0.0 109.499 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.3 tp -59.99 -40.65 89.91 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.426 ' HB3' HD13 ' A' ' 27' ' ' ILE . 15.4 m-85 -77.55 -38.95 47.48 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.897 -0.502 . . . . 0.0 109.957 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -94.96 95.61 8.74 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.602 -0.686 . . . . 0.0 109.802 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -69.96 -26.95 64.35 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.44 -0.788 . . . . 0.0 111.548 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -80.97 -8.74 59.83 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.074 -1.016 . . . . 0.0 111.405 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.62 25.23 27.82 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -87.67 -6.62 58.15 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.548 -0.972 . . . . 0.0 110.718 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.17 0.9 58.33 Favored Glycine 0 N--CA 1.489 2.183 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.117 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.2 p -144.56 141.42 29.45 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 119.15 1.475 . . . . 0.0 111.292 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.426 HD13 ' HB3' ' A' ' 19' ' ' PHE . 85.5 mt -104.34 127.85 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.698 -0.626 . . . . 0.0 109.354 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.1 p -103.25 143.36 32.75 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.761 -0.587 . . . . 0.0 110.964 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 11.0 p -39.49 -34.32 0.21 Allowed 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -61.9 -46.05 91.05 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.921 0.867 . . . . 0.0 108.943 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -59.27 -53.29 59.95 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.276 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.462 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -56.49 -38.48 71.81 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.328 -0.857 . . . . 0.0 111.051 -178.577 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.85 -29.57 42.57 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.2 m -70.03 -39.45 75.76 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.644 -0.916 . . . . 0.0 110.491 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.6 t -61.24 -54.89 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.329 -0.857 . . . . 0.0 108.881 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.405 ' HB2' ' HD3' ' A' ' 43' ' ' PRO . 67.5 mtt -59.05 -29.31 67.2 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.656 -0.653 . . . . 0.0 109.382 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -59.49 -40.03 85.66 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.6 p -70.03 -16.97 63.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.972 -0.455 . . . . 0.0 110.744 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.6 tp -81.67 -31.17 32.4 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.354 -0.841 . . . . 0.0 109.663 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.25 -35.0 0.19 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -160.22 170.05 21.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.554 -0.968 . . . . 0.0 111.219 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -101.31 138.27 19.89 Favored Pre-proline 0 C--N 1.299 -1.607 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.733 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.405 ' HD3' ' HB2' ' A' ' 36' ' ' MET . 53.5 Cg_endo -67.18 -152.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.487 1.146 0 O-C-N 123.394 1.207 . . . . 0.0 109.427 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.4 p -139.97 144.7 37.15 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.191 -0.943 . . . . 0.0 111.123 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -49.72 -25.09 2.67 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.715 -0.616 . . . . 0.0 111.623 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.9 -54.87 9.84 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.185 0.993 . . . . 0.0 108.597 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -67.83 -39.87 83.83 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.764 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.475 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 8.5 mt -55.66 -37.01 67.71 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.676 0.751 . . . . 0.0 109.403 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -63.06 -40.04 96.53 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.775 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -63.83 -39.96 95.47 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.583 -0.698 . . . . 0.0 111.086 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 64.8 mtt -61.61 -41.76 97.91 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.633 -0.667 . . . . 0.0 109.919 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.87 HG22 ' OD2' ' A' ' 56' ' ' ASP . 48.4 mm -66.97 -39.99 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.781 -0.574 . . . . 0.0 110.467 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -61.32 -40.0 92.61 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.521 -0.737 . . . . 0.0 112.287 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -69.73 -29.72 67.16 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.995 -1.065 . . . . 0.0 110.723 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.629 HG21 ' SD ' ' A' ' 71' ' ' MET . 87.6 t -99.99 -8.94 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.637 -0.664 . . . . 0.0 111.246 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.87 ' OD2' HG22 ' A' ' 52' ' ' ILE . 7.2 m-20 -68.99 93.97 0.61 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.149 -0.969 . . . . 0.0 111.11 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.23 -38.49 91.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.655 -0.653 . . . . 0.0 109.504 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -91.72 -29.99 16.52 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.702 -0.624 . . . . 0.0 110.816 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.403 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 91.69 20.5 37.06 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -73.57 -39.1 64.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.372 -1.075 . . . . 0.0 110.42 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.772 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 129.05 -0.62 6.12 Favored Glycine 0 N--CA 1.497 2.744 0 C-N-CA 120.092 -1.051 . . . . 0.0 111.547 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.1 p -134.6 169.15 17.74 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.114 -1.227 . . . . 0.0 111.033 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.504 HD11 HD13 ' A' ' 52' ' ' ILE . 5.9 mt -102.68 118.9 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.813 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -98.79 170.01 9.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.533 -0.729 . . . . 0.0 110.766 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.504 ' O ' HD13 ' A' ' 69' ' ' LEU . 2.8 t80 -47.53 -50.02 52.18 Favored Pre-proline 0 N--CA 1.499 1.984 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.2 Cg_endo -67.18 -34.9 26.6 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 O-C-N 122.884 0.939 . . . . 0.0 111.223 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.96 -40.02 75.66 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.307 -0.871 . . . . 0.0 110.353 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -62.81 -41.63 99.38 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.63 -0.669 . . . . 0.0 111.252 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 65' ' ' PHE . 4.5 mp -67.86 -41.1 83.41 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.322 -0.861 . . . . 0.0 111.422 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.6 p -63.12 -39.99 96.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.542 -0.724 . . . . 0.0 110.879 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.629 ' SD ' HG21 ' A' ' 55' ' ' VAL . 48.8 ttp -68.61 -41.04 80.11 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.657 -0.652 . . . . 0.0 111.921 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 57.0 tpp -68.94 -42.53 76.62 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.257 -0.902 . . . . 0.0 111.772 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.0 -35.52 66.85 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.475 -0.766 . . . . 0.0 112.074 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.77 -55.01 5.69 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.432 -0.792 . . . . 0.0 111.421 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.443 ' HA ' ' OD2' ' A' ' 78' ' ' ASP . 88.1 mttt -59.94 -41.01 90.89 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.525 -0.735 . . . . 0.0 112.641 -178.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 27.7 ptm -59.95 -34.49 73.32 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.283 -0.885 . . . . 0.0 111.877 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -63.25 -49.92 72.21 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.406 -0.809 . . . . 0.0 111.856 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.443 ' OD2' ' HA ' ' A' ' 75' ' ' LYS . 3.9 p30 -69.61 -10.31 57.67 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.176 -0.952 . . . . 0.0 111.019 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.589 HG22 ' H ' ' A' ' 80' ' ' ASP 0.27 22.2 m -86.53 -175.03 5.29 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.385 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.589 ' H ' HG22 ' A' ' 79' ' ' THR . 84.3 m-20 -129.98 138.57 50.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.132 -0.98 . . . . 0.0 109.404 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 24.4 p -61.15 -27.01 68.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.478 -0.764 . . . . 0.0 110.374 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.04 -37.01 78.56 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.716 0.769 . . . . 0.0 109.016 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.01 -40.02 75.5 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.316 0.579 . . . . 0.0 110.079 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -62.56 -39.98 95.37 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.783 -0.573 . . . . 0.0 110.7 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.448 HG23 ' HE1' ' A' ' 141' ' ' PHE . 89.6 mt -65.06 -49.75 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.533 -0.729 . . . . 0.0 110.849 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.77 -42.82 84.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.348 -0.845 . . . . 0.0 111.207 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.438 ' O ' HG13 ' A' ' 91' ' ' VAL . 95.3 mt-10 -69.98 -39.64 75.82 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.405 -0.809 . . . . 0.0 111.773 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.532 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -64.77 -47.35 78.48 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.605 -0.684 . . . . 0.0 112.014 -178.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -67.26 -40.17 86.2 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.1 -1.0 . . . . 0.0 110.43 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -61.03 -39.94 91.69 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.694 -0.629 . . . . 0.0 111.738 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.532 HG22 ' O ' ' A' ' 88' ' ' ALA . 34.9 m -71.29 -40.06 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 0.0 111.112 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -72.39 -40.0 67.55 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.144 -0.973 . . . . 0.0 111.466 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -82.65 68.82 9.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.638 -0.664 . . . . 0.0 110.595 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.445 ' HZ2' ' CD2' ' A' ' 107' ' ' HIS . 25.3 mttt -60.0 -42.72 94.87 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.19 -0.944 . . . . 0.0 110.001 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -74.52 -24.37 58.97 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.49 -0.757 . . . . 0.0 110.411 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.29 24.63 76.75 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -67.93 -16.69 64.18 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.334 -1.097 . . . . 0.0 111.262 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.47 -19.58 14.46 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.446 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 29.0 p90 -145.82 156.75 43.78 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.336 -1.096 . . . . 0.0 109.438 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 65.9 mt -89.14 122.04 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.668 0.747 . . . . 0.0 110.154 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 m -80.78 170.67 15.99 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.351 0.596 . . . . 0.0 110.624 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.73 -47.58 84.61 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.682 -0.636 . . . . 0.0 109.991 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.0 -37.97 81.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.744 -0.597 . . . . 0.0 109.855 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -61.05 -39.93 91.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.586 -0.696 . . . . 0.0 110.674 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.436 HD13 HG13 ' A' ' 121' ' ' VAL . 1.5 tt -60.54 -46.94 88.31 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.323 -0.861 . . . . 0.0 110.398 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.545 ' HG2' HG21 ' A' ' 121' ' ' VAL . 92.1 mtt180 -60.04 -34.91 74.03 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.698 -0.626 . . . . 0.0 111.919 -178.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.445 ' CD2' ' HZ2' ' A' ' 94' ' ' LYS . 48.4 t60 -59.97 -41.95 93.06 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.123 -0.986 . . . . 0.0 110.874 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.5 t -77.07 -37.05 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.429 -0.795 . . . . 0.0 111.183 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.7 mmt -60.05 -49.97 75.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.5 m -67.18 -43.69 81.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.725 -0.61 . . . . 0.0 109.809 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -61.82 -28.17 69.28 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.722 -0.611 . . . . 0.0 109.522 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.8 mt -70.03 -30.28 67.53 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.036 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 112.09 22.17 6.01 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -120.48 137.76 54.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.376 -1.073 . . . . 0.0 110.26 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -99.95 117.75 34.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.534 -0.729 . . . . 0.0 109.396 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 67.6 mt -131.24 156.85 44.68 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.458 -0.776 . . . . 0.0 110.15 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 m -82.51 165.8 19.85 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -63.39 -29.07 70.43 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -68.19 -32.83 73.35 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.508 0.67 . . . . 0.0 109.76 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -68.64 -35.07 76.79 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.545 HG21 ' HG2' ' A' ' 106' ' ' ARG . 78.0 t -69.98 -38.33 75.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-O 121.649 0.738 . . . . 0.0 109.028 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.421 ' HA ' HD12 ' A' ' 125' ' ' ILE . 56.4 t0 -60.0 -43.34 95.26 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.746 -0.596 . . . . 0.0 109.928 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -59.9 -40.18 87.93 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.356 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 13.7 mmt -54.58 -36.83 64.82 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.154 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 122' ' ' ASP . 91.1 mt -67.75 -38.42 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 121.252 0.548 . . . . 0.0 109.825 178.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -60.03 -39.98 87.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.641 -0.662 . . . . 0.0 110.959 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -63.68 -39.83 95.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.545 -0.722 . . . . 0.0 111.403 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.588 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -98.98 -7.78 26.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.377 -0.827 . . . . 0.0 112.046 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -103.38 78.27 1.59 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.025 -1.047 . . . . 0.0 111.268 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 86.8 mt -66.99 -39.96 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.702 -0.624 . . . . 0.0 110.022 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 34.0 p-10 -59.03 -39.75 82.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.669 -0.644 . . . . 0.0 111.266 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 98.65 11.69 46.55 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.366 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -80.88 -16.7 52.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.943 -1.328 . . . . 0.0 110.151 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.68 5.18 71.94 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.747 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -132.34 133.41 43.96 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.237 -1.155 . . . . 0.0 110.035 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.7 t -90.88 114.58 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.442 -0.786 . . . . 0.0 109.936 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -87.7 -178.36 6.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.659 -0.651 . . . . 0.0 109.764 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -65.0 -41.33 95.47 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.613 -0.68 . . . . 0.0 110.092 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -61.69 -42.57 99.11 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.575 -0.703 . . . . 0.0 110.798 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -64.18 -39.45 94.02 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.831 0.824 . . . . 0.0 109.708 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.448 ' HE1' HG23 ' A' ' 85' ' ' ILE . 64.3 t80 -60.05 -46.82 88.27 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.426 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.414 ' O ' HG22 ' A' ' 146' ' ' THR . 99.3 t -65.13 -39.97 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.303 -0.873 . . . . 0.0 111.041 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.405 ' HA ' HG22 ' A' ' 146' ' ' THR . 61.6 tt0 -61.04 -39.97 91.83 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.516 -0.74 . . . . 0.0 110.381 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.588 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 49.9 mtp -60.59 -44.55 96.12 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.654 -0.654 . . . . 0.0 111.943 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.433 ' CE ' ' CZ ' ' A' ' 141' ' ' PHE . 42.9 mtt -73.24 -39.98 65.04 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.694 -0.629 . . . . 0.0 111.805 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 142' ' ' VAL . 15.1 t -75.1 -8.16 55.77 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.41 -0.806 . . . . 0.0 111.262 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -92.83 120.04 32.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.203 -0.935 . . . . 0.0 110.363 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.6 pttm . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.608 179.788 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.56 -39.21 97.37 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -63.66 -40.25 96.37 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.56 -0.965 . . . . 0.0 111.368 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -64.32 -39.34 93.72 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.028 -1.045 . . . . 0.0 110.354 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -60.02 -49.85 76.04 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.663 -0.648 . . . . 0.0 111.737 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 19.7 tt -69.94 -26.01 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 120.987 -1.071 . . . . 0.0 110.727 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.92 90.89 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.372 -0.83 . . . . 0.0 110.919 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 25.8 ttm-85 -60.06 -41.01 91.42 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.517 -0.739 . . . . 0.0 110.759 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.473 ' N ' HD22 ' B' ' 163' ' ' LEU . 4.6 mm? -61.92 -38.89 90.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.576 -0.702 . . . . 0.0 110.19 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.53 -40.12 87.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.517 -0.739 . . . . 0.0 111.191 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.53 -44.12 93.91 Favored Glycine 0 N--CA 1.501 2.976 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 12.0 p -81.94 -11.64 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.687 -0.89 . . . . 0.0 111.455 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.548 HD23 ' C ' ' B' ' 167' ' ' LEU . 9.2 tt -60.03 -50.02 75.35 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.188 -0.945 . . . . 0.0 110.434 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 30.0 mtp-105 -70.02 -31.09 68.58 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.588 -0.695 . . . . 0.0 110.538 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.97 -40.02 87.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.586 -0.696 . . . . 0.0 109.779 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -59.99 -41.29 91.73 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.671 -0.643 . . . . 0.0 109.928 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.1 -20.73 64.07 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.388 -0.82 . . . . 0.0 111.307 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -59.76 -39.9 86.4 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.318 -0.863 . . . . 0.0 110.319 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.538 -0.726 . . . . 0.0 110.219 179.622 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.99 0 CA-C-O 121.196 0.522 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -112.85 27.06 9.95 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.563 -0.71 . . . . 0.0 110.407 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -59.98 -39.96 87.48 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.818 0.818 . . . . 0.0 110.029 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.57 156.47 34.98 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.402 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -133.35 106.77 7.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.578 -0.701 . . . . 0.0 109.957 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -80.02 -9.78 59.72 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 122.046 -0.409 . . . . 0.0 111.717 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -69.81 -26.68 64.37 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.035 -1.041 . . . . 0.0 110.185 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -70.23 -25.85 63.58 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.39 -0.819 . . . . 0.0 110.158 177.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.9 mm -58.94 -50.02 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.708 -0.62 . . . . 0.0 111.046 -176.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.91 -20.04 63.35 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.225 -0.922 . . . . 0.0 110.688 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -68.21 -54.46 17.63 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.462 -0.774 . . . . 0.0 109.678 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.575 ' CB ' HD21 ' A' ' 69' ' ' LEU . 51.9 m-85 -66.62 -21.67 66.12 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.462 0.648 . . . . 0.0 109.57 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -69.14 -44.06 73.08 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.415 0.626 . . . . 0.0 110.281 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -71.42 -24.46 62.05 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.751 -0.593 . . . . 0.0 111.299 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.7 -33.27 41.14 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.319 -0.863 . . . . 0.0 110.908 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.416 ' CB ' ' CE1' ' A' ' 65' ' ' PHE . 56.2 t80 -59.95 -37.5 79.74 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.695 -0.628 . . . . 0.0 111.255 -177.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 91.9 p -61.42 -38.79 88.4 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.243 -0.91 . . . . 0.0 110.087 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 46.3 tp -60.11 -40.19 88.84 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.541 -0.724 . . . . 0.0 109.758 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -78.77 -37.39 41.2 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.732 -0.605 . . . . 0.0 109.783 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.595 ' HB2' HD11 ' A' ' 27' ' ' ILE . 27.5 t0 -93.58 94.94 8.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.642 -0.661 . . . . 0.0 110.176 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -66.13 -30.11 70.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.468 -0.77 . . . . 0.0 111.393 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -79.96 -9.93 59.73 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.09 -1.006 . . . . 0.0 111.373 -177.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.79 26.71 58.12 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 57.9 p30 -89.96 -3.48 58.0 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.713 -0.875 . . . . 0.0 110.886 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.96 4.45 72.12 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.248 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 58.3 p -143.76 142.19 30.79 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 119.288 1.544 . . . . 0.0 111.945 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.595 HD11 ' HB2' ' A' ' 20' ' ' ASP . 49.4 mm -103.69 125.3 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.747 -0.596 . . . . 0.0 110.055 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.9 m -101.54 141.38 34.49 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.541 -0.725 . . . . 0.0 110.244 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.455 ' HB ' HD13 ' A' ' 48' ' ' LEU . 28.2 p -39.56 -34.79 0.25 Allowed 'General case' 0 N--CA 1.51 2.543 0 O-C-N 121.871 -0.518 . . . . 0.0 112.364 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -60.12 -49.36 77.94 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.327 -0.858 . . . . 0.0 109.11 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -57.58 -51.09 70.91 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.11 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.582 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -54.53 -38.81 67.01 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.154 -0.966 . . . . 0.0 111.002 -179.034 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -51.61 -29.55 25.2 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.3 m -65.09 -40.01 93.98 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.528 -0.983 . . . . 0.0 110.074 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.6 t -68.3 -40.07 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-O 121.384 0.612 . . . . 0.0 109.775 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.464 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 13.4 mmt -59.93 -39.89 87.04 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.736 -0.602 . . . . 0.0 111.712 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -60.76 -40.01 90.88 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.757 0.789 . . . . 0.0 110.346 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.5 t -64.56 -24.84 67.74 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.766 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.529 ' HG ' HD22 ' B' ' 167' ' ' LEU . 4.3 mm? -89.77 -17.72 27.68 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.152 -0.968 . . . . 0.0 110.434 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.41 -51.44 0.22 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -166.73 176.47 7.14 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.59 -0.947 . . . . 0.0 111.197 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -99.17 133.47 22.08 Favored Pre-proline 0 N--CA 1.492 1.664 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.927 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.464 ' HD3' ' HB3' ' A' ' 36' ' ' MET . 52.1 Cg_endo -66.3 -147.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.306 0 O-C-N 123.207 1.109 . . . . 0.0 109.414 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.8 p -125.94 140.73 52.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.001 -1.062 . . . . 0.0 110.901 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -48.17 -24.69 1.21 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.713 -0.617 . . . . 0.0 112.039 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.25 -44.18 65.8 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.247 1.022 . . . . 0.0 108.461 176.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -69.96 -39.85 75.78 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.323 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.455 HD13 ' HB ' ' A' ' 29' ' ' THR . 8.5 mt -55.88 -38.03 69.62 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.483 -0.76 . . . . 0.0 109.534 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -63.26 -40.57 97.77 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.152 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -64.43 -39.44 93.84 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.611 -0.681 . . . . 0.0 111.267 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 61.9 mtt -62.93 -39.98 96.25 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.679 -0.638 . . . . 0.0 109.917 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.845 HG22 ' OD2' ' A' ' 56' ' ' ASP . 48.4 mm -69.23 -39.91 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.682 -0.636 . . . . 0.0 110.91 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -64.2 -40.09 95.36 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.447 -0.783 . . . . 0.0 112.519 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.852 ' HG3' HG23 ' A' ' 55' ' ' VAL . 15.3 pt-20 -69.93 -27.34 64.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.932 -1.105 . . . . 0.0 110.483 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.852 HG23 ' HG3' ' A' ' 54' ' ' GLU . 48.6 t -99.9 -10.01 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.658 -0.651 . . . . 0.0 110.917 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.845 ' OD2' HG22 ' A' ' 52' ' ' ILE . 4.0 m-20 -69.12 99.01 1.06 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.188 -0.945 . . . . 0.0 110.962 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.79 -36.95 83.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.593 -0.692 . . . . 0.0 109.879 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -94.54 -26.11 16.55 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.654 -0.654 . . . . 0.0 110.84 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.7 20.01 49.32 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -73.9 -34.74 64.51 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.436 -1.038 . . . . 0.0 110.162 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.804 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 124.08 2.13 8.57 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 120.34 -0.933 . . . . 0.0 111.204 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 82.7 p -138.3 168.56 19.49 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.063 -1.257 . . . . 0.0 111.21 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.468 HD11 HD13 ' A' ' 52' ' ' ILE . 7.7 mt -103.69 121.0 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.288 0.566 . . . . 0.0 110.537 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -98.77 170.38 8.81 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.373 0.606 . . . . 0.0 110.47 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.488 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.5 OUTLIER -47.63 -50.0 53.21 Favored Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 121.626 -0.671 . . . . 0.0 112.533 -179.493 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.653 ' O ' HG23 ' A' ' 70' ' ' THR . 40.8 Cg_endo -67.87 -35.12 21.94 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 122.833 0.912 . . . . 0.0 111.237 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.99 -40.01 75.58 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.277 -0.889 . . . . 0.0 110.339 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -63.66 -40.77 97.67 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.548 -0.72 . . . . 0.0 110.933 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.575 HD21 ' CB ' ' A' ' 12' ' ' PHE . 84.3 mt -64.56 -39.96 94.69 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.433 -0.792 . . . . 0.0 111.346 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.653 HG23 ' O ' ' A' ' 66' ' ' PRO . 68.8 p -60.6 -40.79 93.1 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.458 -0.776 . . . . 0.0 110.561 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.8 ttp -69.99 -39.96 75.59 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.561 -0.712 . . . . 0.0 111.708 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.402 ' SD ' HG21 ' B' ' 166' ' ' VAL . 2.6 tpt -60.05 -49.96 75.58 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.436 -0.79 . . . . 0.0 111.364 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.01 -29.27 66.29 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.455 -0.778 . . . . 0.0 111.369 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -72.87 -40.02 65.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.433 -0.792 . . . . 0.0 111.733 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -69.55 -46.58 66.12 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.355 -0.841 . . . . 0.0 112.24 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 77.0 mtm -60.01 -39.38 85.61 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.031 -1.043 . . . . 0.0 111.018 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -66.91 -51.27 57.39 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.549 -0.719 . . . . 0.0 110.816 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -69.09 -31.94 71.01 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.583 0.706 . . . . 0.0 110.134 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.606 HG22 ' H ' ' A' ' 80' ' ' ASP 0.253 23.2 m -90.89 -174.64 4.1 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.606 ' H ' HG22 ' A' ' 79' ' ' THR . 81.6 m-20 -123.81 144.56 49.64 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.099 -1.001 . . . . 0.0 110.055 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.2 p -61.59 -27.77 68.87 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.702 -0.624 . . . . 0.0 110.452 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -60.11 -37.87 81.29 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.627 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -70.04 -40.04 75.38 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.65 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -67.71 -37.75 82.67 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.455 -0.778 . . . . 0.0 110.28 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 71.0 mt -63.82 -49.86 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.736 -0.602 . . . . 0.0 110.002 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -57.58 -39.85 77.67 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.481 -0.762 . . . . 0.0 110.982 -178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.783 ' O ' HG23 ' A' ' 91' ' ' VAL . 96.5 mt-10 -69.45 -42.09 75.38 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.514 -0.741 . . . . 0.0 111.655 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.438 ' HA ' HG11 ' B' ' 164' ' ' VAL . . . -66.56 -45.38 79.54 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.502 -0.748 . . . . 0.0 111.608 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.415 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 35.4 t80 -60.01 -47.07 87.33 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.469 -0.77 . . . . 0.0 109.542 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -60.09 -34.85 74.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.927 -0.483 . . . . 0.0 110.414 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 87' ' ' GLU . 84.9 t -68.11 -47.77 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.373 -0.83 . . . . 0.0 109.795 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.478 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 13.5 m-85 -64.25 -37.45 87.51 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.521 -0.737 . . . . 0.0 110.515 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -75.58 85.44 2.64 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.52 -0.737 . . . . 0.0 110.193 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -67.68 -41.11 84.18 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.374 -0.829 . . . . 0.0 110.209 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -81.28 -12.33 59.11 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.543 -0.723 . . . . 0.0 111.589 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 59.97 31.15 71.59 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -78.23 0.48 25.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.503 -0.998 . . . . 0.0 111.392 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.5 -10.06 75.66 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.607 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.631 ' HD2' HD21 ' A' ' 137' ' ' ASN . 89.1 m-85 -137.58 137.25 38.35 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.08 -1.247 . . . . 0.0 109.979 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.564 HG22 ' CD1' ' A' ' 105' ' ' LEU . 74.6 mt -88.72 129.98 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.467 -0.771 . . . . 0.0 109.359 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.7 m -109.86 151.3 27.21 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.642 0.734 . . . . 0.0 111.103 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.523 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -49.26 -41.22 37.09 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.62 -0.675 . . . . 0.0 110.799 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.04 -34.32 73.23 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.408 -0.807 . . . . 0.0 108.834 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -74.82 -28.27 60.64 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.688 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.601 ' HB3' HG13 ' A' ' 121' ' ' VAL . 5.9 mp -65.04 -39.97 94.12 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.798 0.809 . . . . 0.0 109.121 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 48.1 ttt-85 -59.96 -34.99 74.02 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.151 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -60.09 -43.91 95.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.317 -0.865 . . . . 0.0 111.048 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.478 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 75.4 t -72.11 -40.38 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.442 -0.787 . . . . 0.0 111.244 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.628 ' SD ' HG22 ' A' ' 121' ' ' VAL . 67.6 mtt -58.07 -49.57 76.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.346 -0.846 . . . . 0.0 110.505 -178.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.5 m -66.03 -42.78 89.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.62 -0.675 . . . . 0.0 109.774 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -62.53 -29.76 70.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.685 -0.634 . . . . 0.0 109.333 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 19.1 mt -69.94 -32.17 70.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.698 -0.626 . . . . 0.0 109.964 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 109.57 26.43 5.09 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -124.16 138.45 54.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.441 -1.035 . . . . 0.0 109.997 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -99.97 118.18 35.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.569 -0.707 . . . . 0.0 110.074 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 86.3 mt -131.68 157.3 44.11 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.6 -0.688 . . . . 0.0 109.667 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.88 162.08 22.91 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.611 -0.681 . . . . 0.0 109.555 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -58.8 -28.32 65.87 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.17 -32.57 73.74 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -39.9 95.25 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.628 HG22 ' SD ' ' A' ' 109' ' ' MET . 73.0 t -70.03 -39.96 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 121.536 0.684 . . . . 0.0 110.567 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -60.04 -44.99 94.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.751 -0.593 . . . . 0.0 110.179 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -60.33 -40.98 92.59 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.645 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 86.6 mmm -55.2 -38.33 68.27 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 119.642 -0.823 . . . . 0.0 108.976 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.402 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 47.3 mm -66.84 -38.06 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-O 121.512 0.672 . . . . 0.0 109.65 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -59.07 -40.0 83.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.68 -0.638 . . . . 0.0 111.555 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.04 -39.87 87.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.619 -0.676 . . . . 0.0 111.043 -178.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.99 0.01 34.44 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.377 -0.827 . . . . 0.0 111.572 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 57.8 t0 -87.55 71.23 9.8 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.019 -1.051 . . . . 0.0 110.679 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.5 mt -67.37 -42.26 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.358 -0.838 . . . . 0.0 110.532 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -71.33 -20.07 62.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.362 -0.836 . . . . 0.0 111.348 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.43 22.7 58.14 Favored Glycine 0 N--CA 1.496 2.682 0 C-N-CA 120.367 -0.921 . . . . 0.0 110.869 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -82.76 -12.5 57.48 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.29 -1.123 . . . . 0.0 111.152 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.4 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 90.0 1.73 75.81 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -139.5 152.1 46.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.267 -1.137 . . . . 0.0 109.459 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 70.7 t -92.46 118.26 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.56 -0.712 . . . . 0.0 110.168 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.631 HD21 ' HD2' ' A' ' 99' ' ' TYR . 30.2 m120 -84.82 175.51 9.09 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -65.05 -41.42 95.18 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.315 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -61.46 -45.86 92.51 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.703 -0.623 . . . . 0.0 111.025 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -66.0 -40.06 90.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.494 -0.754 . . . . 0.0 110.704 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.415 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 77.5 t80 -59.95 -44.22 94.52 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.981 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.758 ' O ' HG22 ' A' ' 146' ' ' THR . 89.6 t -69.56 -39.63 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.416 -0.802 . . . . 0.0 110.917 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 58.3 tt0 -59.98 -47.66 84.89 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.528 -0.732 . . . . 0.0 110.684 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.1 tmm? -60.16 -39.65 87.17 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.41 -0.806 . . . . 0.0 110.693 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 97.5 mmm -69.63 -40.0 76.83 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.603 -0.685 . . . . 0.0 111.053 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.758 HG22 ' O ' ' A' ' 142' ' ' VAL . 9.4 t -96.04 25.59 4.71 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.381 -0.824 . . . . 0.0 110.681 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -96.87 121.83 39.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.447 -0.783 . . . . 0.0 110.695 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 98.2 mttt . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.844 179.507 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -162.75 171.89 38.67 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -60.6 -39.94 89.97 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.648 -0.913 . . . . 0.0 110.476 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -60.04 -39.85 87.37 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.637 -0.664 . . . . 0.0 110.822 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -60.03 -40.0 87.85 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.398 -0.814 . . . . 0.0 110.617 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 85.4 mt -69.92 -40.03 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.375 -0.828 . . . . 0.0 110.813 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.46 -39.75 91.99 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.541 -0.725 . . . . 0.0 110.882 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -60.04 -39.95 87.69 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.583 -0.698 . . . . 0.0 110.468 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.99 -40.01 94.33 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.496 -0.753 . . . . 0.0 111.13 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.438 HG11 ' HA ' ' A' ' 88' ' ' ALA . 55.4 t -67.07 -40.0 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.381 -0.824 . . . . 0.0 110.971 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -53.72 -47.89 63.2 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.402 HG21 ' SD ' ' A' ' 72' ' ' MET . 84.4 t -75.13 -22.65 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.693 -0.886 . . . . 0.0 110.569 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.539 HD23 ' C ' ' B' ' 167' ' ' LEU . 5.7 tt -58.7 -49.97 75.6 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.338 -0.851 . . . . 0.0 110.593 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 30.4 ttt85 -65.07 -38.8 91.95 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.468 -0.77 . . . . 0.0 110.136 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.05 -31.46 70.0 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.58 -0.7 . . . . 0.0 109.902 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 4.0 t-105 -60.05 -45.42 92.92 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.697 -0.627 . . . . 0.0 109.883 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.58 -53.16 60.81 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.59 -0.694 . . . . 0.0 110.193 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -60.08 -40.01 88.06 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.508 -0.745 . . . . 0.0 110.732 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.494 -0.753 . . . . 0.0 110.289 179.855 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 121.364 0.602 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -128.73 114.91 17.2 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -121.15 158.81 27.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.352 -0.842 . . . . 0.0 110.864 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.442 ' O ' HG23 ' A' ' 5' ' ' THR . 93.1 mt -77.68 -178.36 5.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.545 -0.722 . . . . 0.0 109.817 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 4' ' ' LEU . 1.1 p -153.68 110.08 3.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.753 -0.592 . . . . 0.0 110.183 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -84.66 -8.64 58.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.763 -0.586 . . . . 0.0 110.926 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -67.82 -33.52 74.94 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.095 -1.003 . . . . 0.0 110.812 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -65.04 -39.35 93.22 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.517 -0.739 . . . . 0.0 110.744 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 92.7 mt -59.99 -28.2 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.72 -0.613 . . . . 0.0 111.395 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.15 -39.51 94.17 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.148 -0.97 . . . . 0.0 109.743 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -59.98 -40.07 87.84 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.429 ' CG ' HD21 ' A' ' 69' ' ' LEU . 37.2 m-85 -64.29 -20.1 65.85 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.681 -0.637 . . . . 0.0 111.092 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HD3' ' CZ ' ' A' ' 65' ' ' PHE . 73.2 mmtt -69.08 -39.94 78.74 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.196 -0.94 . . . . 0.0 109.407 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -63.64 -59.66 4.31 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.453 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.1 -30.16 71.08 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.371 -0.83 . . . . 0.0 112.232 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.488 ' CG ' ' CE2' ' A' ' 65' ' ' PHE . 57.9 t80 -58.39 -49.97 75.35 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.167 -0.958 . . . . 0.0 110.745 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.0 m -66.15 -39.92 90.18 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.29 -0.881 . . . . 0.0 109.685 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 61.0 tp -62.79 -39.48 94.38 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.416 0.627 . . . . 0.0 109.431 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.536 ' HE2' HG21 ' A' ' 27' ' ' ILE . 32.2 t80 -74.15 -33.19 63.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.863 -0.523 . . . . 0.0 110.202 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -92.33 102.04 14.52 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.468 -0.77 . . . . 0.0 110.129 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -60.02 -39.2 85.02 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.482 -0.761 . . . . 0.0 111.486 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -80.03 -13.15 59.54 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.034 -1.041 . . . . 0.0 111.148 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.19 30.54 58.03 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -90.08 -2.88 58.17 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.714 -0.874 . . . . 0.0 110.84 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.61 3.95 62.4 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 120.22 -0.991 . . . . 0.0 111.432 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.0 p -145.8 142.41 28.84 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 119.197 1.498 . . . . 0.0 111.44 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.536 HG21 ' HE2' ' A' ' 19' ' ' PHE . 85.4 mt -100.68 122.68 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.3 m -95.82 139.47 31.99 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.48 -0.762 . . . . 0.0 110.151 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.626 HG22 ' CD1' ' A' ' 52' ' ' ILE . 65.0 p -42.39 -34.34 0.8 Allowed 'General case' 0 N--CA 1.51 2.571 0 O-C-N 121.961 -0.462 . . . . 0.0 111.588 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -64.31 -48.63 74.9 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.883 0.849 . . . . 0.0 109.136 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -60.0 -56.03 26.67 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.691 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.4 HD12 ' CE2' ' A' ' 19' ' ' PHE . 7.4 tt -61.09 -34.71 75.37 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.21 -0.931 . . . . 0.0 111.056 -178.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -55.82 -32.57 59.1 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.4 m -70.01 -39.39 75.88 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.955 -0.733 . . . . 0.0 110.189 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.0 t -60.0 -57.29 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 94.7 mtp -59.98 -25.72 65.46 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.608 -0.682 . . . . 0.0 109.796 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 43.2 ttt180 -59.99 -46.02 90.82 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.736 0.779 . . . . 0.0 109.31 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.5 t -70.43 -16.98 63.0 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.821 -0.549 . . . . 0.0 111.14 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 39' ' ' LEU . 4.3 mm? -89.88 -18.98 25.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.327 -0.858 . . . . 0.0 110.35 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.4 -50.37 0.2 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -168.01 172.17 9.08 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.645 -0.914 . . . . 0.0 110.674 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -120.61 138.85 27.99 Favored Pre-proline 0 C--N 1.299 -1.628 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.429 ' HG2' HD21 ' A' ' 48' ' ' LEU . 53.6 Cg_endo -68.36 -148.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.224 1.118 . . . . 0.0 109.453 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 p -136.75 152.37 50.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.104 -0.997 . . . . 0.0 110.49 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -52.06 -22.41 4.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.53 -0.731 . . . . 0.0 112.033 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.1 -60.0 2.45 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.17 -0.956 . . . . 0.0 108.994 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -70.01 -33.75 72.42 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.734 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.54 HD13 ' HB ' ' A' ' 29' ' ' THR . 12.9 mt -57.31 -36.88 71.66 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.526 -0.734 . . . . 0.0 109.449 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.44 -30.9 66.57 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.163 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -70.39 -45.08 66.72 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.563 -0.711 . . . . 0.0 111.707 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 79.2 mtm -63.27 -41.67 99.05 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.491 0.662 . . . . 0.0 109.298 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.803 HG22 ' OD2' ' A' ' 56' ' ' ASP . 97.6 mt -68.58 -31.92 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -58.04 -48.12 81.03 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.574 -0.704 . . . . 0.0 110.967 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -64.82 -24.24 67.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.341 -0.849 . . . . 0.0 110.11 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 67.2 t -98.17 -12.01 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.545 -0.722 . . . . 0.0 111.358 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.803 ' OD2' HG22 ' A' ' 52' ' ' ILE . 26.1 m-20 -72.13 101.79 2.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.152 -0.967 . . . . 0.0 111.385 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.06 -39.98 90.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.558 -0.714 . . . . 0.0 109.445 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -88.26 -31.31 19.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.644 -0.66 . . . . 0.0 110.378 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.79 24.36 32.97 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -74.39 -31.96 62.54 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.459 -1.024 . . . . 0.0 110.465 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.68 -2.04 10.16 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.207 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 82.5 p -134.95 168.77 18.48 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.109 -1.23 . . . . 0.0 110.284 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.709 HD11 HG12 ' A' ' 52' ' ' ILE . 6.9 mt -104.49 120.37 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.714 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -98.56 170.25 8.94 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.488 0.661 . . . . 0.0 110.538 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.488 ' CE2' ' CG ' ' A' ' 16' ' ' PHE . 1.2 t80 -50.03 -48.56 78.58 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.4 Cg_endo -69.12 -36.57 12.24 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 O-C-N 122.768 0.878 . . . . 0.0 111.003 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.86 -39.94 76.07 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.484 -0.76 . . . . 0.0 109.223 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -59.89 -45.76 91.49 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.912 -0.493 . . . . 0.0 110.715 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.429 HD21 ' CG ' ' A' ' 12' ' ' PHE . 84.6 mt -63.57 -40.23 96.43 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.412 -0.805 . . . . 0.0 111.246 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.3 m -60.0 -44.04 94.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.441 -0.787 . . . . 0.0 110.719 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -39.98 93.51 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.708 -0.62 . . . . 0.0 111.039 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.431 ' O ' ' HG2' ' A' ' 76' ' ' MET . 57.2 tpp -59.95 -49.76 76.42 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.319 -0.863 . . . . 0.0 110.468 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.57 75.34 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.404 -0.81 . . . . 0.0 110.64 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -74.92 -37.75 61.96 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.458 -0.776 . . . . 0.0 111.119 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.706 ' O ' HG22 ' A' ' 79' ' ' THR . 63.0 mmtt -70.04 -40.03 75.39 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.602 -0.686 . . . . 0.0 112.123 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' A' ' 72' ' ' MET . 39.0 mmt -60.03 -47.29 86.47 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.244 -0.91 . . . . 0.0 112.322 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -68.48 -40.02 81.13 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.25 -0.906 . . . . 0.0 111.065 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -70.54 -20.96 62.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.484 -0.76 . . . . 0.0 111.56 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.706 HG22 ' O ' ' A' ' 75' ' ' LYS . 14.6 t -107.29 -165.33 1.05 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.047 0.927 . . . . 0.0 111.803 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -130.01 136.54 49.52 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.894 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.6 t -60.58 -33.12 72.26 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.624 -0.672 . . . . 0.0 109.895 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -60.07 -34.44 73.45 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.397 0.618 . . . . 0.0 109.461 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -69.9 -40.08 75.84 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.348 0.594 . . . . 0.0 110.374 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -64.66 -34.24 77.83 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.591 -0.693 . . . . 0.0 111.29 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.665 HG23 ' HE2' ' A' ' 141' ' ' PHE . 87.8 mt -69.12 -43.89 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.484 -0.76 . . . . 0.0 110.133 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -59.93 -43.99 94.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.557 -0.714 . . . . 0.0 110.969 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -70.03 -39.9 75.48 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.348 -0.845 . . . . 0.0 110.993 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.518 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -60.73 -44.96 96.0 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.598 -0.689 . . . . 0.0 110.629 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -67.47 -39.27 85.28 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.428 -0.795 . . . . 0.0 110.359 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -60.45 -40.03 89.68 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.523 -0.736 . . . . 0.0 112.268 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 88' ' ' ALA . 34.7 m -71.17 -39.19 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.098 -1.002 . . . . 0.0 111.291 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.465 ' HE2' HG21 ' B' ' 164' ' ' VAL . 11.8 m-85 -70.9 -37.15 72.95 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.114 -0.991 . . . . 0.0 110.669 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -79.79 69.04 6.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.681 -0.637 . . . . 0.0 110.806 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -59.94 -46.15 90.3 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.175 -0.953 . . . . 0.0 109.722 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.9 p-10 -69.89 -20.48 63.37 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.566 -0.709 . . . . 0.0 110.602 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.8 25.23 71.74 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -70.04 -9.76 56.42 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.285 -1.127 . . . . 0.0 111.31 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.11 -10.05 65.59 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.502 ' HD2' HD21 ' A' ' 137' ' ' ASN . 83.1 m-85 -136.84 141.94 42.85 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.158 -1.201 . . . . 0.0 109.021 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 62.0 mt -89.49 120.45 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.407 -0.808 . . . . 0.0 109.929 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 m -84.06 168.56 15.78 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.267 0.555 . . . . 0.0 110.637 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.03 -41.17 91.28 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.621 -0.675 . . . . 0.0 109.552 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.53 -38.35 89.62 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.316 0.579 . . . . 0.0 109.44 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -61.17 -39.95 92.08 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.697 -0.627 . . . . 0.0 110.791 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.415 ' HB3' HG13 ' A' ' 121' ' ' VAL . 1.2 tt -63.6 -44.46 93.93 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.77 0.795 . . . . 0.0 109.35 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.9 ttt-85 -60.66 -32.69 71.86 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.853 -0.53 . . . . 0.0 111.356 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -60.01 -42.38 94.19 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.159 -0.963 . . . . 0.0 110.837 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.434 HG12 ' CD1' ' A' ' 112' ' ' LEU . 86.6 t -74.1 -40.02 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.27 -0.894 . . . . 0.0 110.851 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 13.0 mmt -57.43 -49.18 77.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.4 -0.813 . . . . 0.0 110.067 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.6 m -64.64 -44.95 88.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.644 -0.66 . . . . 0.0 109.551 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -61.63 -29.31 69.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.7 -0.625 . . . . 0.0 109.567 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.434 ' CD1' HG12 ' A' ' 108' ' ' VAL . 11.7 mt -69.97 -30.79 68.22 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.216 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 111.13 25.62 4.98 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -122.84 136.78 54.98 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.454 -1.027 . . . . 0.0 109.727 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -99.94 119.96 39.05 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.548 -0.72 . . . . 0.0 110.674 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 71.3 mt -135.75 158.32 44.67 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.718 -0.614 . . . . 0.0 110.066 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.03 161.12 26.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.602 -0.686 . . . . 0.0 109.302 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -61.71 -27.9 69.04 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.71 -33.82 73.05 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.674 0.749 . . . . 0.0 109.379 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -67.53 -36.83 81.78 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.495 0.665 . . . . 0.0 109.226 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.415 HG13 ' HB3' ' A' ' 105' ' ' LEU . 56.1 t -69.98 -39.95 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.579 0.704 . . . . 0.0 109.78 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -60.0 -38.72 83.44 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.744 -0.597 . . . . 0.0 109.918 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -59.22 -39.72 83.58 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.378 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.9 mtt -55.34 -36.01 65.82 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 119.286 -0.965 . . . . 0.0 109.338 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.4 mm -67.31 -39.54 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.72 -0.613 . . . . 0.0 109.605 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -58.26 -38.24 76.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.606 -0.684 . . . . 0.0 110.734 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.97 -36.79 77.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.667 -0.646 . . . . 0.0 110.096 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.501 ' HB3' HG22 ' A' ' 136' ' ' VAL . . . -103.61 -4.33 23.99 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.563 -0.71 . . . . 0.0 111.307 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -82.49 71.1 9.56 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.959 -1.088 . . . . 0.0 110.24 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 85.3 mt -64.76 -46.88 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.525 -0.734 . . . . 0.0 110.682 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -70.49 -20.18 62.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.541 -0.724 . . . . 0.0 111.785 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.3 22.69 58.4 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -81.05 -10.32 59.7 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.366 -1.079 . . . . 0.0 110.804 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.03 0.63 71.07 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -141.42 156.49 45.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -1.193 . . . . 0.0 109.756 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.501 HG22 ' HB3' ' A' ' 128' ' ' ALA . 63.9 t -95.24 119.36 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.53 -0.731 . . . . 0.0 109.976 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.502 HD21 ' HD2' ' A' ' 99' ' ' TYR . 32.6 m120 -87.88 173.6 8.84 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -60.07 -50.03 75.34 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.649 -0.657 . . . . 0.0 110.054 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -60.66 -41.48 95.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.571 -0.706 . . . . 0.0 111.794 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -65.81 -36.35 83.27 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.2 -0.937 . . . . 0.0 109.882 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.665 ' HE2' HG23 ' A' ' 85' ' ' ILE . 65.6 t80 -62.14 -43.94 97.73 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.034 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.1 t -70.06 -45.24 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.4 -0.812 . . . . 0.0 111.693 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -60.32 -44.73 95.2 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.51 -0.744 . . . . 0.0 110.444 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -61.79 -39.99 93.63 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.697 -0.627 . . . . 0.0 109.945 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.2 mmt -67.71 -39.96 84.3 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.555 -0.715 . . . . 0.0 109.988 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.429 ' O ' HG22 ' A' ' 146' ' ' THR . 36.2 m -89.14 1.37 55.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.753 -0.592 . . . . 0.0 110.52 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.94 136.63 58.07 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.202 -0.936 . . . . 0.0 110.162 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 93.8 mttt . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.191 -179.795 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -146.09 125.38 2.25 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -67.94 -30.35 69.63 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.734 -0.863 . . . . 0.0 110.662 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -60.06 -40.03 88.03 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.383 -0.823 . . . . 0.0 110.139 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -68.36 -33.62 74.6 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.567 -0.708 . . . . 0.0 109.906 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 160' ' ' ILE . . . . . 0.46 ' O ' HG23 ' B' ' 164' ' ' VAL . 47.4 mm -59.94 -44.49 94.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.581 -0.699 . . . . 0.0 110.51 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.43 -39.93 92.7 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.541 -0.724 . . . . 0.0 111.299 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -61.48 -42.21 98.45 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.392 -0.818 . . . . 0.0 111.574 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 8.4 tt -70.05 -40.02 75.36 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.364 -0.835 . . . . 0.0 110.684 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.465 HG21 ' HE2' ' A' ' 92' ' ' PHE . 71.6 t -61.41 -39.98 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.628 -0.67 . . . . 0.0 110.644 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -52.48 -37.35 49.15 Favored Glycine 0 N--CA 1.501 2.996 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 89.7 t -78.18 -29.73 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.817 -0.814 . . . . 0.0 110.316 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.556 HD23 ' C ' ' B' ' 167' ' ' LEU . 6.8 tt -59.3 -52.86 63.85 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.459 -0.776 . . . . 0.0 110.9 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -67.13 -39.93 86.68 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.343 -0.848 . . . . 0.0 110.727 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -59.95 -29.57 68.5 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.482 -0.761 . . . . 0.0 110.385 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 170' ' ' TRP . . . . . 0.44 ' HH2' HD12 ' A' ' 63' ' ' ILE . 2.1 t90 -60.01 -47.2 86.83 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.486 -0.759 . . . . 0.0 109.549 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.12 -44.96 94.51 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.628 -0.67 . . . . 0.0 110.974 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -59.99 -40.02 87.72 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.384 -0.823 . . . . 0.0 110.781 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.467 -0.77 . . . . 0.0 110.316 -179.753 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.123 0.487 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.4 t0 51.69 60.96 3.48 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.848 0.833 . . . . 0.0 110.592 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -56.52 -159.71 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.568 0.699 . . . . 0.0 112.376 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 90.3 mt -117.78 -20.45 8.86 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.638 -0.664 . . . . 0.0 111.472 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.5 p -68.22 -10.64 55.9 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.343 -0.848 . . . . 0.0 111.802 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.797 ' HA ' HD12 ' A' ' 9' ' ' ILE . 97.5 mt-10 -54.77 -17.16 3.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.366 -0.834 . . . . 0.0 111.238 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -71.84 -44.58 63.6 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.24 -0.913 . . . . 0.0 109.308 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -69.0 -34.7 75.7 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.75 0.786 . . . . 0.0 109.671 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.797 HD12 ' HA ' ' A' ' 6' ' ' GLU . 77.3 mt -58.59 -35.33 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.856 -0.527 . . . . 0.0 111.181 -178.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -62.65 -55.79 23.68 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.87 -1.144 . . . . 0.0 111.597 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -56.11 -38.52 70.87 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.564 -1.335 . . . . 0.0 111.025 -177.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -68.22 -30.11 69.1 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 20.7 ttpt -68.28 -38.49 81.76 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.386 0.613 . . . . 0.0 109.712 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.11 -59.22 5.76 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.431 0.634 . . . . 0.0 110.728 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.76 -33.16 75.04 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.844 -0.535 . . . . 0.0 112.426 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -58.26 -48.08 81.55 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.933 -1.104 . . . . 0.0 110.502 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.1 t -65.22 -37.83 88.5 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.223 -0.923 . . . . 0.0 108.842 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 64.3 tp -60.07 -40.01 88.03 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.154 0.502 . . . . 0.0 109.976 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -75.38 -30.62 60.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.663 -0.648 . . . . 0.0 110.37 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -93.0 103.4 15.72 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.545 -0.722 . . . . 0.0 109.201 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -59.97 -38.16 81.72 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.542 -0.724 . . . . 0.0 112.29 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -77.97 -11.78 59.93 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.825 -1.172 . . . . 0.0 111.09 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.77 27.7 50.44 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -89.63 -0.93 57.85 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.599 -0.942 . . . . 0.0 110.785 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.44 4.91 63.82 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 120.256 -0.974 . . . . 0.0 111.218 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.2 p -146.08 143.59 29.48 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 119.137 1.469 . . . . 0.0 111.768 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.8 mt -104.73 129.98 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.8 p -108.04 144.94 34.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.652 -0.655 . . . . 0.0 110.795 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.6 p -43.37 -32.29 0.81 Allowed 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.877 -0.515 . . . . 0.0 112.142 -178.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -65.39 -50.15 66.58 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.233 -0.917 . . . . 0.0 109.593 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -60.08 -54.52 45.02 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.936 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.667 HD21 ' SD ' ' A' ' 36' ' ' MET . 9.7 tt -60.01 -35.66 75.54 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.367 -0.833 . . . . 0.0 111.231 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.94 -31.3 17.21 Favored Glycine 0 N--CA 1.5 2.957 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.1 m -70.02 -39.87 75.53 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.576 -0.956 . . . . 0.0 110.372 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.74 -57.4 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.543 -0.723 . . . . 0.0 110.053 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.667 ' SD ' HD21 ' A' ' 32' ' ' LEU . 65.0 mtt -60.3 -31.54 70.35 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.493 -0.754 . . . . 0.0 110.78 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.99 -48.85 80.02 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.382 -0.824 . . . . 0.0 109.155 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 t -71.95 -12.86 61.44 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.884 -0.51 . . . . 0.0 110.2 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.801 HD22 ' CD1' ' B' ' 167' ' ' LEU . 18.4 tp -82.44 -33.7 28.45 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.354 -0.841 . . . . 0.0 109.81 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.07 -30.44 0.14 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -158.39 155.76 29.24 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.251 -1.146 . . . . 0.0 111.3 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.432 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 5.8 p-10 -114.21 104.79 54.63 Favored Pre-proline 0 C--N 1.297 -1.712 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.167 178.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.594 ' HG2' HD21 ' A' ' 48' ' ' LEU . 44.1 Cg_endo -62.23 -151.89 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.392 0 O-C-N 123.001 1.0 . . . . 0.0 109.82 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.1 p -140.04 154.57 47.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.995 -1.066 . . . . 0.0 111.925 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -52.57 -22.84 5.41 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.757 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.63 -60.02 2.44 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.938 0.875 . . . . 0.0 109.427 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.69 -32.63 71.35 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.404 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.594 HD21 ' HG2' ' A' ' 43' ' ' PRO . 44.2 mt -60.06 -34.08 72.94 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.628 0.728 . . . . 0.0 109.836 178.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.2 -32.49 66.83 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.259 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -69.86 -43.87 70.98 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.248 -0.907 . . . . 0.0 111.745 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.43 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 21.5 ptm -63.22 -39.16 93.83 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.789 -0.764 . . . . 0.0 109.241 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.617 HG22 ' OD2' ' A' ' 56' ' ' ASP . 71.4 mt -68.63 -33.61 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.676 -0.64 . . . . 0.0 110.235 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -60.01 -40.1 88.06 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.409 -0.807 . . . . 0.0 111.412 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -67.04 -27.22 67.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 110.527 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.8 t -100.09 -9.95 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.548 -0.72 . . . . 0.0 110.91 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.617 ' OD2' HG22 ' A' ' 52' ' ' ILE . 1.0 OUTLIER -74.29 107.87 6.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.104 -0.998 . . . . 0.0 110.971 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -93.28 -20.24 20.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.742 -0.599 . . . . 0.0 109.657 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -75.36 -40.14 58.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.49 -0.756 . . . . 0.0 110.803 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.27 -4.48 62.39 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -74.64 -39.58 62.0 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.199 -1.177 . . . . 0.0 111.061 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 123.77 4.78 7.89 Favored Glycine 0 N--CA 1.496 2.634 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.317 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 76.4 p -135.4 162.7 31.88 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.129 -1.218 . . . . 0.0 110.284 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.429 ' HA ' ' OE1' ' A' ' 67' ' ' GLU . 7.8 mt -99.5 118.93 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.767 -177.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -93.59 171.22 9.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.667 -0.646 . . . . 0.0 109.945 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.485 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 16.4 t80 -46.1 -48.76 42.56 Favored Pre-proline 0 N--CA 1.498 1.967 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.5 Cg_endo -67.28 -32.55 32.87 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 122.747 0.867 . . . . 0.0 111.526 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.429 ' OE1' ' HA ' ' A' ' 63' ' ' ILE . 80.1 mt-10 -74.16 -41.1 62.05 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.214 -0.929 . . . . 0.0 110.346 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -60.21 -45.67 92.36 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.515 -0.74 . . . . 0.0 110.638 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 65' ' ' PHE . 6.1 mp -66.34 -39.94 89.54 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.446 -0.784 . . . . 0.0 111.419 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.6 m -60.74 -43.07 98.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.541 -0.725 . . . . 0.0 110.616 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 57.6 ttp -66.63 -42.77 86.25 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.597 -0.69 . . . . 0.0 111.663 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 54.0 ttm -59.97 -49.86 76.01 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.432 -0.792 . . . . 0.0 111.165 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.68 -32.83 74.61 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.512 -0.743 . . . . 0.0 111.493 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -71.17 -40.01 71.52 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.394 -0.816 . . . . 0.0 111.127 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -69.53 -38.33 77.48 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.391 -0.818 . . . . 0.0 111.778 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.7 mtm -56.22 -48.21 76.9 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.318 -0.864 . . . . 0.0 111.871 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -69.82 -39.99 76.15 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.09 -1.006 . . . . 0.0 110.999 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -69.6 -34.05 73.56 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.459 -0.776 . . . . 0.0 110.635 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.621 HG22 ' H ' ' A' ' 80' ' ' ASP . 4.0 m -97.59 -173.43 2.63 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.866 -0.521 . . . . 0.0 110.017 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.621 ' H ' HG22 ' A' ' 79' ' ' THR . 91.5 m-20 -117.36 138.04 52.06 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.244 -0.91 . . . . 0.0 110.156 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 52.2 p -64.36 -27.32 68.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.598 -0.689 . . . . 0.0 110.153 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -60.06 -34.62 73.67 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.535 -0.728 . . . . 0.0 109.297 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.15 -39.57 78.74 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.348 0.594 . . . . 0.0 109.47 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.42 -37.75 88.63 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.704 -0.622 . . . . 0.0 110.827 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.593 HG23 ' HE2' ' A' ' 141' ' ' PHE . 98.2 mt -66.9 -48.29 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.524 -0.735 . . . . 0.0 110.923 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 41.9 mtp85 -59.99 -40.94 90.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.423 -0.798 . . . . 0.0 111.414 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.56 ' O ' HG23 ' A' ' 91' ' ' VAL . 98.9 mt-10 -70.05 -40.73 74.95 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.32 -0.863 . . . . 0.0 111.51 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.35 -44.98 85.99 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.569 -0.707 . . . . 0.0 111.5 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -62.59 -40.92 98.43 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.826 0.822 . . . . 0.0 109.475 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -59.97 -36.6 77.48 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.953 -0.467 . . . . 0.0 111.027 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 87' ' ' GLU . 87.8 t -69.58 -49.07 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.545 -0.722 . . . . 0.0 109.972 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.66 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 28.4 m-85 -66.65 -39.87 88.41 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.538 -0.726 . . . . 0.0 110.967 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -77.28 72.48 3.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.495 -0.753 . . . . 0.0 109.843 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -59.99 -44.44 94.5 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.541 -0.724 . . . . 0.0 109.967 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 36.0 p-10 -78.56 -24.8 45.37 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.649 -0.657 . . . . 0.0 110.692 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.44 29.85 73.13 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.6 p-10 -71.68 -13.96 61.89 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.455 -1.027 . . . . 0.0 111.773 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.89 -22.42 8.62 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 119.966 -1.111 . . . . 0.0 110.588 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 35.6 p90 -145.96 156.39 43.48 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.28 -1.13 . . . . 0.0 109.452 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 64.6 mt -89.3 126.56 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-O 121.822 0.82 . . . . 0.0 110.849 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.5 m -86.48 172.46 10.32 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.16 0.505 . . . . 0.0 110.518 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.78 -40.26 83.99 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.61 -0.681 . . . . 0.0 109.717 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.47 -38.59 91.55 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -60.58 -37.96 83.05 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.703 -0.623 . . . . 0.0 110.214 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.462 ' HB3' HG13 ' A' ' 121' ' ' VAL . 0.9 OUTLIER -60.03 -41.36 92.05 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.608 0.718 . . . . 0.0 109.427 179.18 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 63.4 mtp180 -60.07 -35.64 75.6 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.815 -0.553 . . . . 0.0 112.277 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -60.06 -45.66 92.15 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.084 -1.01 . . . . 0.0 111.512 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.66 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 63.7 t -73.85 -37.79 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.374 -0.829 . . . . 0.0 111.379 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 14.2 mmt -59.92 -47.17 86.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.331 -0.856 . . . . 0.0 110.002 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.6 m -65.56 -40.86 93.3 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.691 -0.631 . . . . 0.0 109.462 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -60.6 -34.55 74.39 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.9 mt -69.94 -31.86 69.82 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.145 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.68 26.45 6.14 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.416 ' OE2' HD21 ' A' ' 116' ' ' LEU . 88.8 tt0 -119.52 132.97 55.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.33 -1.1 . . . . 0.0 109.884 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -98.57 120.13 38.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.582 -0.699 . . . . 0.0 110.014 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.416 HD21 ' OE2' ' A' ' 114' ' ' GLU . 57.0 mt -130.18 159.96 35.25 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.474 -0.766 . . . . 0.0 110.489 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.2 p -83.14 163.34 20.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.811 -0.556 . . . . 0.0 109.659 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -63.22 -27.0 69.06 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -69.97 -37.31 75.75 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.582 0.706 . . . . 0.0 109.194 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -65.12 -36.67 85.02 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.536 0.684 . . . . 0.0 109.36 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.462 HG13 ' HB3' ' A' ' 105' ' ' LEU . 97.5 t -69.48 -39.41 78.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.694 0.759 . . . . 0.0 109.613 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -59.98 -40.21 88.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.794 -0.566 . . . . 0.0 110.287 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -60.0 -40.96 91.01 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.405 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.412 ' CB ' HD11 ' A' ' 105' ' ' LEU . 67.6 mtt -55.07 -35.83 64.96 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.459 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.5 mm -66.58 -39.09 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.789 -0.569 . . . . 0.0 110.066 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 50.0 ttt-85 -60.02 -40.02 87.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.494 -0.753 . . . . 0.0 111.742 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -60.12 -38.53 83.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.468 -0.77 . . . . 0.0 110.865 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.549 ' HB2' ' HE2' ' A' ' 144' ' ' MET . . . -103.4 6.33 37.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.46 -0.775 . . . . 0.0 111.447 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -118.94 81.01 1.63 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.007 -1.058 . . . . 0.0 111.48 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 86.4 mt -66.79 -40.05 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.563 -0.711 . . . . 0.0 109.98 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.9 p30 -59.84 -39.32 84.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.626 -0.671 . . . . 0.0 111.136 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.54 15.96 44.72 Favored Glycine 0 N--CA 1.494 2.553 0 C-N-CA 120.149 -1.024 . . . . 0.0 111.24 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -80.01 -20.14 46.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.135 -1.215 . . . . 0.0 110.115 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.72 8.12 57.34 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.807 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -132.69 131.31 41.13 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.163 -1.198 . . . . 0.0 110.066 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.8 t -92.34 110.39 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.55 -0.719 . . . . 0.0 109.664 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -83.85 178.65 7.82 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.581 -0.699 . . . . 0.0 109.569 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -61.34 -44.89 96.43 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.747 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -61.76 -40.49 95.34 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.344 -0.847 . . . . 0.0 111.084 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -63.82 -39.62 94.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.325 -0.859 . . . . 0.0 109.629 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.593 ' HE2' HG23 ' A' ' 85' ' ' ILE . 69.4 t80 -60.0 -49.59 77.05 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.883 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.67 ' O ' HG22 ' A' ' 146' ' ' THR . 89.3 t -61.16 -41.38 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.317 -0.865 . . . . 0.0 110.919 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -60.0 -40.2 88.4 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.259 -0.9 . . . . 0.0 109.741 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.549 ' HE2' ' HB2' ' A' ' 128' ' ' ALA . 7.7 ttm -60.24 -42.04 94.46 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.701 -0.624 . . . . 0.0 110.609 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 98.4 mmm -69.93 -40.04 75.76 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.629 -0.669 . . . . 0.0 111.099 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.67 HG22 ' O ' ' A' ' 142' ' ' VAL . 9.2 t -98.23 19.28 14.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.583 -0.698 . . . . 0.0 110.383 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.14 -39.96 92.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.51 -0.743 . . . . 0.0 109.829 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 44.1 mttp . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.045 179.95 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -116.09 136.51 12.96 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -64.41 -36.72 85.09 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.542 -0.975 . . . . 0.0 110.241 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -60.03 -39.15 84.88 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.691 -0.631 . . . . 0.0 110.095 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 159' ' ' ARG . . . . . 0.441 ' NH2' HD21 ' B' ' 163' ' ' LEU . 16.4 tpt180 -60.02 -39.97 87.69 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.653 -0.654 . . . . 0.0 110.693 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 97.2 mt -69.61 -39.94 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.307 -0.87 . . . . 0.0 110.526 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.37 -39.94 89.05 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.562 -0.711 . . . . 0.0 110.967 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -67.14 -39.97 86.65 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.443 -0.786 . . . . 0.0 110.821 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.441 HD21 ' NH2' ' B' ' 159' ' ' ARG . 88.6 mt -64.1 -40.04 95.35 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.472 -0.768 . . . . 0.0 111.192 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 83.4 t -70.03 -40.0 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.413 -0.804 . . . . 0.0 110.714 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.98 -50.01 69.81 Favored Glycine 0 N--CA 1.498 2.807 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 14.6 p -71.09 -28.44 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.604 -0.939 . . . . 0.0 110.461 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.801 ' CD1' HD22 ' A' ' 39' ' ' LEU . 2.7 tm? -60.04 -50.16 74.81 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.467 -0.77 . . . . 0.0 111.469 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -70.05 -39.99 75.37 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.466 -0.771 . . . . 0.0 110.655 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -60.38 -39.98 89.22 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.46 -0.775 . . . . 0.0 111.628 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 18.3 t90 -70.06 -31.36 68.94 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.373 -0.829 . . . . 0.0 110.458 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.43 -47.81 80.79 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.469 -0.769 . . . . 0.0 110.264 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -60.0 -33.78 72.44 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.538 -0.726 . . . . 0.0 110.104 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.764 -0.585 . . . . 0.0 110.384 -179.373 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.073 0.463 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -60.14 -40.05 88.44 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.55 -0.719 . . . . 0.0 110.304 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -117.42 146.72 43.27 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.459 0.647 . . . . 0.0 110.247 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 92.1 mt -60.06 -46.5 89.35 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.587 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -144.57 106.2 4.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.569 -0.707 . . . . 0.0 109.662 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.414 ' HA ' HG12 ' A' ' 9' ' ' ILE . 97.8 mt-10 -86.33 -15.66 39.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.957 -0.464 . . . . 0.0 110.991 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -61.82 -38.01 86.56 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.299 -0.876 . . . . 0.0 110.529 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -69.98 -20.05 63.32 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.81 -0.556 . . . . 0.0 111.208 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.414 HG12 ' HA ' ' A' ' 6' ' ' GLU . 49.6 mm -62.97 -43.0 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.386 -0.821 . . . . 0.0 110.342 -179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.9 -31.21 72.22 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.732 -0.605 . . . . 0.0 111.105 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -62.56 -39.99 95.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.805 . . . . 0.0 109.719 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.463 ' HB3' HD11 ' A' ' 69' ' ' LEU . 17.4 m-85 -64.26 -23.91 67.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.95 -0.469 . . . . 0.0 111.347 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.43 ' HD3' ' CE1' ' A' ' 65' ' ' PHE . 73.9 mmtt -68.93 -40.0 79.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.193 -0.942 . . . . 0.0 110.271 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -77.76 -23.99 49.1 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.991 -0.443 . . . . 0.0 111.57 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.51 -38.36 34.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.3 -0.875 . . . . 0.0 111.175 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -56.76 -39.98 75.0 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.662 -0.649 . . . . 0.0 111.33 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 94.0 p -60.26 -39.33 86.4 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.188 -0.945 . . . . 0.0 110.055 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.594 HD11 HD22 ' A' ' 112' ' ' LEU . 7.1 tt -59.97 -44.45 94.44 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.62 -0.675 . . . . 0.0 109.381 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.419 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 0.9 OUTLIER -70.02 -38.96 76.06 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.888 -0.508 . . . . 0.0 109.714 178.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -94.68 92.59 7.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.604 -0.685 . . . . 0.0 109.287 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -59.07 -22.5 60.87 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.228 -0.92 . . . . 0.0 111.653 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -81.23 -55.79 4.5 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.037 -1.039 . . . . 0.0 109.0 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.72 28.32 7.08 Favored Glycine 0 N--CA 1.482 1.748 0 N-CA-C 107.885 -2.086 . . . . 0.0 107.885 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -90.01 -1.23 57.93 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.666 -0.902 . . . . 0.0 110.526 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.04 -0.1 64.02 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 120.42 -0.895 . . . . 0.0 110.931 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.0 p -144.88 143.01 30.36 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 119.212 1.506 . . . . 0.0 111.547 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.419 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 83.8 mt -106.4 130.08 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.796 -0.565 . . . . 0.0 109.844 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.4 m -104.91 143.91 32.51 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.486 -0.758 . . . . 0.0 110.632 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 55.1 p -41.96 -35.71 0.93 Allowed 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.851 -0.531 . . . . 0.0 111.93 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.1 mttm -63.9 -48.17 77.68 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.35 -0.843 . . . . 0.0 109.325 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -58.96 -51.13 71.38 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.514 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.2 tp -59.93 -34.86 73.8 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.104 -0.997 . . . . 0.0 110.827 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.413 ' O ' ' CB ' ' A' ' 37' ' ' ARG . . . -48.52 -32.76 10.84 Favored Glycine 0 N--CA 1.5 2.963 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.1 m -70.06 -40.01 75.32 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 118.36 1.08 . . . . 0.0 110.3 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.587 HG12 HD12 ' A' ' 39' ' ' LEU . 98.1 t -69.11 -58.19 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.461 -0.774 . . . . 0.0 111.654 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 93.9 mmm -59.88 -37.26 78.85 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.258 -0.901 . . . . 0.0 110.849 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.414 ' HD3' ' HB2' ' A' ' 42' ' ' ASN . 5.9 tpt180 -60.01 -50.03 75.32 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.517 0.675 . . . . 0.0 109.736 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.1 p -71.75 -18.16 62.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.785 -0.572 . . . . 0.0 111.369 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.587 HD12 HG12 ' A' ' 35' ' ' VAL . 15.4 mt -91.86 -18.12 24.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.427 -0.796 . . . . 0.0 111.656 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.98 -40.47 0.2 Allowed Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.251 -1.452 . . . . 0.0 111.612 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.407 ' HG2' ' N ' ' A' ' 42' ' ' ASN . 26.4 tt0 -159.92 157.97 29.92 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 118.872 1.336 . . . . 0.0 112.128 -178.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.428 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 53.4 t30 -118.01 103.72 49.6 Favored Pre-proline 0 N--CA 1.489 1.513 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.244 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.786 ' HG2' HD21 ' A' ' 48' ' ' LEU . 44.5 Cg_endo -63.83 -148.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.335 0 O-C-N 123.309 1.163 . . . . 0.0 109.503 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.7 p -135.99 151.45 49.93 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.826 -1.171 . . . . 0.0 111.495 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -52.35 -24.52 7.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.652 -0.655 . . . . 0.0 111.449 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.16 -58.99 2.97 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 122.034 0.921 . . . . 0.0 108.729 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -65.43 -39.06 91.64 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.051 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.786 HD21 ' HG2' ' A' ' 43' ' ' PRO . 75.2 mt -58.04 -35.56 71.49 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.663 0.744 . . . . 0.0 110.01 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -40.03 82.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 122.01 -0.431 . . . . 0.0 111.491 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -65.22 -36.19 83.4 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.365 -0.834 . . . . 0.0 110.0 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.545 ' HE1' ' O ' ' B' ' 170' ' ' TRP . 92.0 mmm -59.93 -45.61 92.03 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.447 0.642 . . . . 0.0 109.879 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.635 HG23 HG12 ' A' ' 63' ' ' ILE . 96.0 mt -67.74 -33.06 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.761 -0.587 . . . . 0.0 110.303 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -59.93 -40.01 87.44 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.537 -0.727 . . . . 0.0 110.766 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -66.93 -28.61 68.44 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.327 -0.858 . . . . 0.0 110.621 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.778 HG21 ' HE2' ' A' ' 71' ' ' MET . 57.3 t -102.0 -7.17 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.613 -0.68 . . . . 0.0 111.081 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.485 ' OD2' HG22 ' A' ' 52' ' ' ILE . 3.1 m-20 -67.82 105.53 1.98 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.2 -0.937 . . . . 0.0 110.72 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.54 -39.56 77.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.635 -0.666 . . . . 0.0 109.801 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -90.21 -27.66 19.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.612 -0.68 . . . . 0.0 110.531 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.82 21.61 46.07 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -74.32 -34.22 63.39 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.447 -1.031 . . . . 0.0 110.425 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.8 1.22 7.61 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.486 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 66.7 p -138.69 164.83 28.52 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.077 -1.249 . . . . 0.0 111.457 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.635 HG12 HG23 ' A' ' 52' ' ' ILE . 10.0 mt -100.84 122.1 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 121.34 0.59 . . . . 0.0 111.298 -177.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -96.08 171.41 8.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.697 -0.627 . . . . 0.0 109.695 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.642 ' O ' HD13 ' A' ' 69' ' ' LEU . 78.6 t80 -48.57 -49.95 61.74 Favored Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 121.435 -0.79 . . . . 0.0 112.56 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.4 Cg_endo -66.47 -33.91 35.64 Favored 'Trans proline' 0 N--CA 1.492 1.382 0 O-C-N 122.693 0.838 . . . . 0.0 111.255 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -70.44 -39.98 74.02 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.302 -0.874 . . . . 0.0 110.383 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -64.0 -40.02 95.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.712 -0.618 . . . . 0.0 110.67 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.642 HD13 ' O ' ' A' ' 65' ' ' PHE . 5.9 mp -66.66 -39.9 88.41 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.657 -0.652 . . . . 0.0 111.9 -178.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.7 p -60.24 -40.1 89.05 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.09 -1.006 . . . . 0.0 110.403 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.778 ' HE2' HG21 ' A' ' 55' ' ' VAL . 31.7 ttm -66.72 -54.36 23.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.643 -0.66 . . . . 0.0 111.979 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.599 ' HE2' HG11 ' B' ' 166' ' ' VAL . 57.8 ttm -61.74 -52.37 64.53 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -177.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.77 -38.19 86.09 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.561 -0.712 . . . . 0.0 112.536 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -71.42 -44.21 65.29 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.312 -0.867 . . . . 0.0 111.739 -178.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -71.81 -40.87 68.87 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.329 -0.857 . . . . 0.0 113.048 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 26.9 ptm -57.03 -20.3 23.72 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.178 -0.951 . . . . 0.0 111.326 -178.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -66.58 -54.27 25.38 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.327 -0.858 . . . . 0.0 110.495 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -70.0 -23.34 63.13 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.798 -0.563 . . . . 0.0 110.457 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.599 HG22 ' H ' ' A' ' 80' ' ' ASP . 2.4 m -83.02 -173.05 4.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.633 -0.667 . . . . 0.0 110.006 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.599 ' H ' HG22 ' A' ' 79' ' ' THR . 81.9 m-20 -128.14 140.37 51.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.311 -0.868 . . . . 0.0 109.945 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.2 t -70.03 -25.1 63.41 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.642 -0.661 . . . . 0.0 110.507 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.636 ' HA ' HD12 ' A' ' 85' ' ' ILE . 99.0 mt-10 -60.08 -37.07 78.81 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.897 0.856 . . . . 0.0 108.743 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -67.48 -39.89 85.27 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.421 0.629 . . . . 0.0 109.844 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -65.33 -33.82 76.88 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.694 -0.629 . . . . 0.0 110.519 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.636 HD12 ' HA ' ' A' ' 82' ' ' GLU . 78.9 mt -66.08 -46.76 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.655 -0.653 . . . . 0.0 110.071 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 62.1 mtt180 -60.01 -40.42 89.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.51 -0.744 . . . . 0.0 111.584 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.498 ' O ' HG23 ' A' ' 91' ' ' VAL . 97.9 mt-10 -70.07 -40.18 75.2 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.203 -0.936 . . . . 0.0 111.548 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.858 ' HA ' HG11 ' B' ' 164' ' ' VAL . . . -65.18 -45.4 84.99 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.531 -0.73 . . . . 0.0 111.114 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -60.0 -47.41 85.94 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.529 0.68 . . . . 0.0 109.978 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -60.01 -36.62 77.62 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.791 -0.568 . . . . 0.0 111.192 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 87' ' ' GLU . 72.0 t -69.19 -49.75 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.262 -0.899 . . . . 0.0 109.569 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -67.65 -39.99 84.57 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.315 -0.866 . . . . 0.0 109.877 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -79.83 79.66 6.32 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -69.03 -39.89 78.96 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.45 -0.781 . . . . 0.0 111.034 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -77.4 -21.42 53.17 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.465 -0.772 . . . . 0.0 110.839 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.18 28.95 74.07 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -72.91 -10.31 59.66 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.561 -0.964 . . . . 0.0 111.765 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.78 -20.98 12.86 Favored Glycine 0 N--CA 1.498 2.829 0 C-N-CA 120.025 -1.083 . . . . 0.0 110.608 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -144.66 152.44 40.46 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.388 -1.066 . . . . 0.0 109.236 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.617 ' CG2' HD23 ' A' ' 105' ' ' LEU . 18.5 mt -88.67 131.35 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.096 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.02 170.96 11.1 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.918 -0.489 . . . . 0.0 109.756 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.77 -39.33 73.27 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.57 -37.24 86.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.692 -0.63 . . . . 0.0 109.46 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -62.24 -34.34 76.33 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.555 0.693 . . . . 0.0 109.416 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.617 HD23 ' CG2' ' A' ' 100' ' ' ILE . 0.5 OUTLIER -69.16 -40.32 78.24 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.907 -0.496 . . . . 0.0 109.964 179.173 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -60.0 -38.75 83.53 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.533 -0.729 . . . . 0.0 111.352 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -60.1 -46.2 90.38 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.083 -1.011 . . . . 0.0 111.709 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.473 HG12 ' CD1' ' A' ' 112' ' ' LEU . 93.2 t -70.28 -39.99 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.203 -0.936 . . . . 0.0 111.183 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.614 ' CE ' HD13 ' B' ' 160' ' ' ILE . 16.0 mmt -59.64 -50.03 75.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.546 -0.721 . . . . 0.0 110.889 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 93.9 m -67.35 -43.09 82.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.543 -0.723 . . . . 0.0 109.955 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -61.63 -31.67 71.77 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.36 0.6 . . . . 0.0 109.432 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.594 HD22 HD11 ' A' ' 18' ' ' LEU . 19.9 mt -69.41 -34.93 75.21 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.917 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 119.66 26.1 2.44 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -126.13 149.62 48.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.385 -1.067 . . . . 0.0 109.782 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -116.48 126.0 52.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.515 -0.741 . . . . 0.0 110.415 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 60.4 mt -138.08 154.72 49.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.593 -0.692 . . . . 0.0 109.326 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.03 163.77 23.95 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -62.0 -27.45 68.88 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.016 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.55 -32.7 73.65 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.421 0.629 . . . . 0.0 109.869 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -68.34 -36.61 79.5 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 90.7 t -66.88 -39.75 84.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.837 0.827 . . . . 0.0 108.955 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -59.99 -47.69 84.77 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.498 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -60.05 -40.07 88.13 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.838 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 65.7 mtt -55.93 -38.53 70.43 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.443 -0.903 . . . . 0.0 109.096 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 47.9 mm -65.93 -39.3 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 121.452 0.644 . . . . 0.0 109.655 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.9 ttt-85 -57.78 -38.67 75.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.678 -0.639 . . . . 0.0 110.843 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -59.95 -37.51 79.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.699 -0.626 . . . . 0.0 110.628 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.14 -1.6 27.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.403 -0.81 . . . . 0.0 111.323 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -84.76 71.75 10.81 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.996 -1.065 . . . . 0.0 110.392 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.6 mt -67.16 -41.43 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.434 -0.792 . . . . 0.0 110.245 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.5 p-10 -72.56 -20.14 61.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.328 -0.858 . . . . 0.0 111.148 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.64 22.14 62.6 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 120.312 -0.947 . . . . 0.0 111.139 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -83.1 -10.04 58.9 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.214 -1.168 . . . . 0.0 111.064 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.21 0.71 76.66 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -137.57 148.17 45.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.208 -1.171 . . . . 0.0 109.648 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 85.9 t -90.06 117.75 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.429 -0.794 . . . . 0.0 110.348 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -89.26 175.33 7.39 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -61.79 -47.92 82.97 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.794 -0.566 . . . . 0.0 110.117 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -60.02 -49.3 78.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.731 -0.606 . . . . 0.0 111.851 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -63.3 -35.4 80.24 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.316 -0.865 . . . . 0.0 109.991 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.507 ' HE1' HG23 ' A' ' 85' ' ' ILE . 64.9 t80 -60.02 -45.14 93.76 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 91.8 t -70.01 -37.85 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.328 -0.857 . . . . 0.0 111.564 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 61.9 tt0 -59.91 -47.13 87.01 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.207 -0.933 . . . . 0.0 110.395 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.4 tmm? -60.02 -39.24 85.17 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.511 -0.743 . . . . 0.0 109.925 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 96.2 mmm -65.74 -40.03 91.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.64 -0.662 . . . . 0.0 109.869 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.1 m -92.39 6.51 46.68 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.563 -0.711 . . . . 0.0 110.914 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -99.04 119.83 38.46 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.1 -1.0 . . . . 0.0 110.256 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.7 mtmt . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.266 -179.897 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.74 68.53 0.26 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -59.98 -44.1 94.7 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.584 -0.951 . . . . 0.0 110.241 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -60.02 -39.48 85.97 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.593 -0.692 . . . . 0.0 111.098 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -59.3 -39.98 84.76 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.301 -0.875 . . . . 0.0 110.256 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 160' ' ' ILE . . . . . 0.614 HD13 ' CE ' ' A' ' 109' ' ' MET . 97.0 mt -62.8 -40.04 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.571 -0.706 . . . . 0.0 109.377 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.3 -31.01 72.05 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.621 -0.674 . . . . 0.0 110.42 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -60.03 -38.81 83.84 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.573 -0.704 . . . . 0.0 110.097 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.553 ' O ' HG12 ' B' ' 166' ' ' VAL . 66.6 mt -60.01 -40.44 89.27 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.477 -0.764 . . . . 0.0 110.99 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.858 HG11 ' HA ' ' A' ' 88' ' ' ALA . 99.1 t -68.4 -40.0 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.558 -0.714 . . . . 0.0 110.466 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.75 -41.97 94.18 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.599 HG11 ' HE2' ' A' ' 72' ' ' MET . 11.5 p -74.98 -12.24 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -1.101 . . . . 0.0 110.96 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.506 HD23 ' C ' ' B' ' 167' ' ' LEU . 9.5 tt -60.01 -49.16 78.74 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.113 -0.992 . . . . 0.0 109.48 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -60.0 -41.05 91.26 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.653 -0.654 . . . . 0.0 110.32 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.07 -40.29 88.99 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.632 -0.668 . . . . 0.0 111.601 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 170' ' ' TRP . . . . . 0.545 ' O ' ' HE1' ' A' ' 51' ' ' MET . 5.0 t-105 -61.43 -47.61 84.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.436 -0.79 . . . . 0.0 110.512 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.02 -43.62 95.14 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.542 -0.724 . . . . 0.0 111.007 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -60.01 -40.0 87.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.37 -0.831 . . . . 0.0 110.625 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 . . . . . 0 N--CA 1.495 1.794 0 O-C-N 121.413 -0.804 . . . . 0.0 110.4 -179.877 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.483 ' HB3' ' OE1' ' A' ' 3' ' ' GLN . . . . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 121.191 0.52 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -99.97 30.35 3.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.642 -0.661 . . . . 0.0 110.336 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.483 ' OE1' ' HB3' ' A' ' 1' ' ' ALA . 30.5 mt-30 -60.04 -39.65 86.68 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.781 0.801 . . . . 0.0 109.53 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 79.5 mt -102.41 -178.48 3.7 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.102 0.477 . . . . 0.0 109.793 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.3 p -138.37 103.99 5.05 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.563 -0.711 . . . . 0.0 109.572 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -77.92 -34.66 51.22 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.734 -0.604 . . . . 0.0 110.579 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.44 -40.94 88.41 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.555 -0.716 . . . . 0.0 111.794 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -69.47 -19.08 63.76 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.091 -1.005 . . . . 0.0 111.448 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.5 mm -60.68 -50.03 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.369 -0.832 . . . . 0.0 110.891 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.04 -31.44 69.97 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.64 -0.662 . . . . 0.0 111.466 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -59.95 -43.04 95.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.927 . . . . 0.0 110.586 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.426 ' CE2' ' HG ' ' A' ' 69' ' ' LEU . 44.5 m-85 -65.23 -21.77 66.79 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.578 -0.701 . . . . 0.0 111.468 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.43 ' HD3' ' CZ ' ' A' ' 65' ' ' PHE . 32.5 mmtt -70.71 -43.92 67.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.083 -1.011 . . . . 0.0 110.391 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -75.16 -28.23 60.01 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.21 -30.27 22.54 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.144 -0.972 . . . . 0.0 111.851 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -59.99 -45.85 91.39 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.497 -0.752 . . . . 0.0 111.677 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.5 m -60.06 -39.48 86.17 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.221 -0.924 . . . . 0.0 109.604 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.6 tp -61.35 -43.47 98.82 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.624 ' HZ ' HD21 ' B' ' 167' ' ' LEU . 1.3 m-85 -69.95 -40.07 75.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.993 -0.442 . . . . 0.0 110.461 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -92.32 95.36 9.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.439 -0.788 . . . . 0.0 109.627 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -60.01 -34.52 73.47 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.381 -0.824 . . . . 0.0 110.859 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -80.03 -10.11 59.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.255 -0.903 . . . . 0.0 111.051 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.43 26.53 44.99 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -88.02 -7.88 56.41 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.64 -0.918 . . . . 0.0 111.035 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.77 1.77 58.64 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.542 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.8 p -144.02 141.57 30.19 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 119.192 1.496 . . . . 0.0 111.192 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 88.1 mt -104.23 128.45 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.714 -0.616 . . . . 0.0 109.492 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.5 p -100.5 139.62 35.93 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.61 -0.681 . . . . 0.0 110.2 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.725 HG22 ' CD1' ' A' ' 52' ' ' ILE . 61.1 p -42.38 -30.93 0.36 Allowed 'General case' 0 N--CA 1.511 2.603 0 O-C-N 121.796 -0.565 . . . . 0.0 111.645 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -65.66 -49.63 67.94 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.413 -0.804 . . . . 0.0 109.641 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.35 -53.9 52.95 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.71 -0.619 . . . . 0.0 111.165 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.454 ' CD2' ' CZ2' ' B' ' 170' ' ' TRP . 58.8 tp -59.99 -34.76 73.75 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.318 -0.864 . . . . 0.0 110.633 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.04 -31.47 10.85 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.4 m -70.14 -40.83 74.58 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.517 -0.99 . . . . 0.0 110.483 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.4 t -65.76 -51.24 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 121.361 -0.837 . . . . 0.0 109.982 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 98.1 mtp -60.06 -33.77 72.51 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.459 0.647 . . . . 0.0 109.496 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -49.12 78.94 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.618 0.723 . . . . 0.0 109.438 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.7 t -71.69 -16.22 62.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.908 -0.495 . . . . 0.0 110.804 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.409 ' HA ' HD13 ' A' ' 39' ' ' LEU . 1.8 mm? -90.29 -19.95 23.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.215 -0.928 . . . . 0.0 110.653 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.36 -43.57 0.2 Allowed Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.611 -1.281 . . . . 0.0 110.876 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -160.48 160.0 31.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.107 -1.231 . . . . 0.0 111.559 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.409 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 32.1 t30 -115.21 99.77 52.78 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 42' ' ' ASN . 47.5 Cg_endo -64.58 -151.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.278 0 O-C-N 123.321 1.169 . . . . 0.0 109.942 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.5 p -140.07 159.96 41.0 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.15 -0.969 . . . . 0.0 111.685 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.405 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 98.2 mt-10 -54.98 -21.2 11.05 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.811 -0.555 . . . . 0.0 111.645 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.43 -59.92 2.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.176 -0.953 . . . . 0.0 108.693 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -69.13 -35.97 76.96 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.677 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.499 HD13 ' HB ' ' A' ' 29' ' ' THR . 22.7 mt -58.14 -33.04 68.75 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.456 0.646 . . . . 0.0 110.148 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.08 -31.59 68.01 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.57 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -70.62 -45.75 64.64 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.297 -0.877 . . . . 0.0 111.091 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 78.7 mtm -61.53 -42.05 98.25 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.572 0.701 . . . . 0.0 109.585 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.74 HG12 HD11 ' A' ' 63' ' ' ILE . 91.0 mt -69.02 -33.41 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.257 0.551 . . . . 0.0 110.147 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -59.96 -38.76 83.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.483 -0.761 . . . . 0.0 110.332 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -64.41 -27.41 68.98 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.546 -0.721 . . . . 0.0 110.297 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.529 HG11 ' HB2' ' A' ' 71' ' ' MET . 16.6 t -104.64 -7.97 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.586 -0.696 . . . . 0.0 111.208 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -68.41 103.39 1.63 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.963 -1.086 . . . . 0.0 111.453 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.58 -39.98 94.72 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.713 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.6 p-10 -91.61 -30.67 16.23 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.637 -0.664 . . . . 0.0 111.041 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.26 23.38 44.49 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -73.37 -37.2 66.12 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.448 -1.03 . . . . 0.0 110.721 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.4 -0.84 7.56 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 120.303 -0.951 . . . . 0.0 110.965 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 49.8 p -134.73 169.72 16.91 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.171 -1.194 . . . . 0.0 110.07 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.74 HD11 HG12 ' A' ' 52' ' ' ILE . 7.0 mt -110.11 120.07 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.44 -177.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -96.25 170.34 9.32 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.408 0.623 . . . . 0.0 110.237 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.485 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 t80 -49.77 -48.09 78.05 Favored Pre-proline 0 N--CA 1.497 1.894 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.7 Cg_endo -67.7 -36.99 17.4 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 122.699 0.841 . . . . 0.0 111.683 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -70.03 -39.75 75.6 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.134 -0.979 . . . . 0.0 110.069 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -60.74 -50.01 75.21 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.484 -0.76 . . . . 0.0 111.317 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.426 ' HG ' ' CE2' ' A' ' 12' ' ' PHE . 3.1 tt -61.39 -41.69 97.52 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.362 -0.836 . . . . 0.0 111.56 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.0 p -63.02 -35.66 80.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.583 -0.698 . . . . 0.0 109.996 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.529 ' HB2' HG11 ' A' ' 55' ' ' VAL . 24.6 ttt -66.21 -43.55 86.41 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.838 -0.539 . . . . 0.0 111.852 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.1 ttt -60.06 -45.53 92.55 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.288 -0.882 . . . . 0.0 111.498 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.33 -32.0 71.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.451 -0.781 . . . . 0.0 110.564 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 20.7 mmm-85 -70.02 -40.04 75.44 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.622 -0.674 . . . . 0.0 111.124 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -73.09 -44.38 60.52 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.398 -0.814 . . . . 0.0 112.212 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 48.6 mtm -60.64 -39.94 90.15 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.297 -0.877 . . . . 0.0 113.096 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 14.6 pttp -67.25 -36.41 81.56 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.968 -1.082 . . . . 0.0 111.335 -178.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -69.41 -17.85 63.7 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.509 -0.744 . . . . 0.0 111.056 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.5 t -117.97 -159.65 0.75 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.653 0.739 . . . . 0.0 111.272 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -122.55 140.02 53.25 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.143 0.497 . . . . 0.0 109.773 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.433 ' HA ' ' HG2' ' A' ' 84' ' ' GLU . 48.1 t -64.27 -24.57 67.71 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.636 -0.665 . . . . 0.0 110.678 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.511 ' HA ' HD12 ' A' ' 85' ' ' ILE . 46.6 mt-10 -64.4 -35.51 81.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.289 -0.882 . . . . 0.0 109.024 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -67.82 -42.48 81.42 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.994 -178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.433 ' HG2' ' HA ' ' A' ' 81' ' ' SER . 12.5 pt-20 -69.95 -25.49 63.67 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.275 -0.891 . . . . 0.0 111.278 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 82' ' ' GLU . 80.8 mt -69.61 -45.33 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.44 -0.787 . . . . 0.0 109.591 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 63.2 mtt180 -59.97 -37.98 81.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.555 -0.716 . . . . 0.0 110.572 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.63 ' O ' HG23 ' A' ' 91' ' ' VAL . 96.5 mt-10 -69.54 -41.71 75.58 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.69 -0.631 . . . . 0.0 110.601 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.83 -43.83 87.37 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.53 -0.731 . . . . 0.0 111.331 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -60.1 -48.47 81.57 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.619 0.723 . . . . 0.0 109.682 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -58.74 -31.83 68.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.892 -0.505 . . . . 0.0 110.171 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 87' ' ' GLU . 75.7 t -69.97 -41.35 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.499 -0.751 . . . . 0.0 110.044 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -68.57 -37.51 79.94 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.495 -0.753 . . . . 0.0 110.948 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -80.03 76.95 6.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.539 -0.726 . . . . 0.0 109.852 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -63.28 -44.84 93.93 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.399 -0.813 . . . . 0.0 110.193 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -75.65 -17.5 59.96 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.621 -0.674 . . . . 0.0 111.409 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.7 20.15 75.54 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -70.07 -10.05 57.43 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.18 -1.188 . . . . 0.0 111.124 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.71 -13.28 67.49 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 41.0 m-85 -128.17 136.97 51.85 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.138 -1.213 . . . . 0.0 108.295 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 47.6 mt -89.09 120.6 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.907 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.8 m -84.56 169.43 14.43 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.407 0.622 . . . . 0.0 110.627 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.02 -39.97 87.15 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.647 -0.658 . . . . 0.0 109.305 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.73 -36.64 79.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.792 -0.568 . . . . 0.0 109.659 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -66.88 -40.02 87.69 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.642 -0.661 . . . . 0.0 110.674 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.62 -45.88 92.4 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.474 -0.767 . . . . 0.0 109.54 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -61.37 -33.74 74.17 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.848 -0.532 . . . . 0.0 111.066 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -59.95 -47.42 85.88 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.265 -0.897 . . . . 0.0 111.752 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 63.2 t -72.74 -51.05 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 121.147 -0.97 . . . . 0.0 112.026 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.405 ' CE ' ' CD1' ' A' ' 116' ' ' LEU . 51.2 mtp -58.1 -39.89 79.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.078 -1.014 . . . . 0.0 110.598 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.5 m -67.17 -46.0 75.3 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.551 -0.718 . . . . 0.0 109.778 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -62.04 -31.26 71.64 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.351 0.596 . . . . 0.0 109.499 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.1 mt -69.58 -32.39 71.12 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.669 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.59 20.48 1.92 Allowed Glycine 0 N--CA 1.497 2.734 0 C-N-CA 119.868 -1.158 . . . . 0.0 111.22 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -121.85 138.98 54.18 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.101 -1.234 . . . . 0.0 110.386 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -103.05 120.03 39.92 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.528 -0.732 . . . . 0.0 109.901 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.405 ' CD1' ' CE ' ' A' ' 109' ' ' MET . 74.1 mt -133.2 157.91 44.19 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.418 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.59 172.14 8.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.817 -0.552 . . . . 0.0 109.852 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -64.98 -23.57 67.26 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -69.21 -38.73 78.74 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.607 -0.683 . . . . 0.0 109.764 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -64.7 -35.84 82.34 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.0 t -69.8 -39.1 77.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.467 0.651 . . . . 0.0 109.637 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -60.05 -46.36 89.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.749 -0.595 . . . . 0.0 110.09 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -59.95 -42.47 94.13 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.617 -0.677 . . . . 0.0 109.576 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.463 ' HE3' ' HA ' ' B' ' 157' ' ' PHE . 78.0 mmm -54.16 -39.31 66.45 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.414 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.493 HG21 ' O ' ' A' ' 134' ' ' GLY . 85.5 mt -67.68 -38.61 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.217 0.532 . . . . 0.0 110.614 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -59.13 -39.99 84.08 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.576 -0.702 . . . . 0.0 112.11 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.05 -39.96 83.64 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.808 -0.557 . . . . 0.0 110.993 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.454 ' HB2' ' CE ' ' A' ' 144' ' ' MET . . . -104.29 -1.76 26.56 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.193 -0.942 . . . . 0.0 111.655 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -83.4 70.5 10.2 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.997 -1.065 . . . . 0.0 110.48 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.71 -40.83 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.418 -0.801 . . . . 0.0 110.726 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -70.44 -18.8 63.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.386 -0.821 . . . . 0.0 111.343 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.57 22.0 63.07 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 120.239 -0.982 . . . . 0.0 110.73 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -83.01 -9.95 59.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -1.146 . . . . 0.0 110.988 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.493 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 87.49 0.69 84.22 Favored Glycine 0 N--CA 1.497 2.76 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -136.67 148.21 47.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.31 -1.112 . . . . 0.0 109.042 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.8 t -91.38 119.11 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.406 -0.809 . . . . 0.0 109.673 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.429 ' OD1' ' CE2' ' A' ' 99' ' ' TYR . 80.9 m-20 -89.02 175.24 7.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.584 -0.697 . . . . 0.0 109.929 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -60.87 -47.9 84.27 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.275 0.56 . . . . 0.0 110.524 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -59.99 -45.47 92.62 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.638 -0.663 . . . . 0.0 111.264 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -65.22 -35.9 82.51 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.797 0.808 . . . . 0.0 110.122 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.467 ' CZ ' ' CE ' ' A' ' 145' ' ' MET . 68.5 t80 -60.04 -47.29 86.47 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.32 -178.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.808 ' O ' HG22 ' A' ' 146' ' ' THR . 96.3 t -70.06 -39.72 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.288 -0.882 . . . . 0.0 111.366 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -59.94 -50.04 75.34 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.297 -0.877 . . . . 0.0 111.212 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.454 ' CE ' ' HB2' ' A' ' 128' ' ' ALA . 60.5 ttp -60.3 -36.83 78.8 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.371 -0.83 . . . . 0.0 110.534 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.585 ' CE ' ' HB1' ' B' ' 161' ' ' ALA . 33.1 mtt -69.57 -39.96 77.03 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.635 -0.666 . . . . 0.0 110.664 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.808 HG22 ' O ' ' A' ' 142' ' ' VAL . 10.1 t -99.0 22.8 9.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.542 -0.724 . . . . 0.0 110.633 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.01 -44.93 94.24 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.439 -0.788 . . . . 0.0 110.468 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 96.6 mttt . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.193 179.899 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 70.45 29.27 70.11 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.463 ' HA ' ' HE3' ' A' ' 124' ' ' MET . 37.0 t80 -60.02 -39.96 87.66 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.506 -0.996 . . . . 0.0 109.395 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -66.07 -40.02 90.55 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.667 -0.646 . . . . 0.0 110.776 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -60.88 -45.97 92.47 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.331 -0.855 . . . . 0.0 111.457 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 160' ' ' ILE . . . . . 0.457 HG22 ' O ' ' B' ' 157' ' ' PHE . 18.2 tt -70.08 -35.49 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.353 -0.842 . . . . 0.0 111.171 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 161' ' ' ALA . . . . . 0.585 ' HB1' ' CE ' ' A' ' 145' ' ' MET . . . -60.15 -45.24 93.73 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.349 -0.844 . . . . 0.0 110.686 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -60.42 -40.08 89.72 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.48 -0.763 . . . . 0.0 110.488 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' B' ' 160' ' ' ILE . 85.9 mt -62.76 -40.49 97.42 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.515 -0.741 . . . . 0.0 110.678 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.601 ' HA ' HD12 ' B' ' 167' ' ' LEU . 98.9 t -62.46 -40.0 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.431 -0.793 . . . . 0.0 109.563 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.44 -39.42 94.85 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 90.0 t -69.41 -35.38 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.673 -0.898 . . . . 0.0 111.307 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.624 HD21 ' HZ ' ' A' ' 19' ' ' PHE . 96.0 mt -59.98 -49.99 75.49 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.348 -0.845 . . . . 0.0 112.782 -177.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 168' ' ' ARG . . . . . 0.422 ' HD3' ' CG ' ' A' ' 87' ' ' GLU . 69.4 ttt-85 -60.6 -39.91 89.88 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.992 -1.067 . . . . 0.0 110.804 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.41 -33.65 72.8 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.491 -0.756 . . . . 0.0 109.478 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 170' ' ' TRP . . . . . 0.454 ' CZ2' ' CD2' ' A' ' 32' ' ' LEU . 2.4 t90 -60.02 -49.25 78.39 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.823 -0.548 . . . . 0.0 110.023 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.41 94.51 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.501 -0.749 . . . . 0.0 110.853 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -59.98 -39.93 87.38 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.437 -0.79 . . . . 0.0 110.028 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.702 -0.624 . . . . 0.0 110.236 -179.524 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.162 0.506 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -89.44 79.17 7.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.538 -0.726 . . . . 0.0 109.738 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -60.07 -46.27 90.13 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.687 0.756 . . . . 0.0 110.279 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 74.2 mt -81.9 175.5 10.35 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.403 0.62 . . . . 0.0 110.073 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.78 114.34 6.77 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.599 ' HA ' HD12 ' A' ' 9' ' ' ILE . 43.0 mt-10 -93.13 -9.64 38.74 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.868 -0.52 . . . . 0.0 111.34 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.92 -40.05 91.1 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.215 -0.928 . . . . 0.0 109.63 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -64.88 -36.66 85.07 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.299 0.571 . . . . 0.0 110.309 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.599 HD12 ' HA ' ' A' ' 6' ' ' GLU . 80.2 mt -60.19 -29.11 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.713 -0.617 . . . . 0.0 111.023 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.63 -39.44 93.85 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.092 -1.005 . . . . 0.0 110.268 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -59.54 -41.76 90.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.513 -0.742 . . . . 0.0 109.916 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -64.29 -20.6 66.19 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.933 -0.479 . . . . 0.0 111.103 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -69.96 -44.17 70.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.132 -0.98 . . . . 0.0 110.077 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -60.07 -54.95 39.9 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.31 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.13 -25.0 64.17 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.089 -1.007 . . . . 0.0 111.577 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -49.98 -56.38 10.9 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 120.972 -1.08 . . . . 0.0 111.463 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.9 m -62.39 -36.84 83.59 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.384 -0.822 . . . . 0.0 109.829 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.5 tp -59.92 -40.78 90.04 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.71 -0.619 . . . . 0.0 109.894 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.15 -33.69 59.39 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.58 -0.7 . . . . 0.0 109.928 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -92.0 98.38 11.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.51 -0.744 . . . . 0.0 109.306 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -59.97 -38.55 82.83 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.625 -0.672 . . . . 0.0 111.503 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -78.44 -12.69 60.02 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.013 -1.054 . . . . 0.0 110.813 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.92 27.9 65.22 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -90.0 -2.08 58.08 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.611 -0.935 . . . . 0.0 110.768 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.24 3.82 63.14 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.704 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.551 HG22 ' OD1' ' A' ' 64' ' ' ASP . 31.3 p -147.12 145.36 29.56 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-N 119.268 1.534 . . . . 0.0 111.646 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 91.6 mt -103.37 127.89 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 121.412 0.625 . . . . 0.0 109.689 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.5 m -100.21 139.99 35.1 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.841 -0.537 . . . . 0.0 109.866 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.632 HG23 HG13 ' A' ' 52' ' ' ILE . 4.9 p -42.95 -30.49 0.41 Allowed 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.707 -0.621 . . . . 0.0 111.686 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -64.89 -49.54 70.06 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.847 0.832 . . . . 0.0 108.999 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -58.86 -53.71 55.29 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.902 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.414 HD21 ' HE1' ' A' ' 36' ' ' MET . 56.7 tp -60.7 -32.84 72.06 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.297 -0.877 . . . . 0.0 110.285 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.76 -31.47 38.29 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.4 m -69.96 -37.74 75.88 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.516 -0.99 . . . . 0.0 109.903 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.39 -56.18 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-O 121.425 0.631 . . . . 0.0 109.725 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.51 ' HE1' ' CD1' ' B' ' 170' ' ' TRP . 60.6 mtt -59.9 -31.75 70.11 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.684 -0.635 . . . . 0.0 111.124 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -50.02 75.36 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.427 -0.796 . . . . 0.0 109.289 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.1 t -73.71 -18.69 60.97 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.776 -0.578 . . . . 0.0 110.439 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 39' ' ' LEU . 2.8 mm? -97.38 -3.02 41.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.352 -0.843 . . . . 0.0 110.954 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.98 -71.59 0.11 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -162.95 171.35 16.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.475 -1.014 . . . . 0.0 111.055 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -106.98 119.66 50.56 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.784 -0.573 . . . . 0.0 109.893 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.38 -148.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.454 0 O-C-N 123.07 1.037 . . . . 0.0 109.982 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.1 p -138.1 153.15 49.3 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.935 -1.103 . . . . 0.0 111.596 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -52.49 -23.83 6.91 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.742 -0.599 . . . . 0.0 111.728 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.47 -59.96 2.55 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.177 0.989 . . . . 0.0 108.63 177.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -67.65 -37.61 82.64 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.735 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.549 HD13 ' HB ' ' A' ' 29' ' ' THR . 14.3 mt -57.58 -35.12 69.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.608 -0.682 . . . . 0.0 109.856 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.88 -40.07 96.41 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.914 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -65.94 -40.02 90.99 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.526 -0.734 . . . . 0.0 111.133 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 49.2 mtt -59.98 -45.13 93.7 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.474 -0.766 . . . . 0.0 109.811 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.791 HG22 ' OD2' ' A' ' 56' ' ' ASP . 47.5 mm -67.03 -35.81 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.766 -0.584 . . . . 0.0 110.546 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -60.0 -40.11 88.1 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.602 -0.686 . . . . 0.0 111.122 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -69.99 -28.51 65.58 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.28 -0.887 . . . . 0.0 110.998 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.4 t -98.15 -9.11 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.45 -0.781 . . . . 0.0 111.383 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.791 ' OD2' HG22 ' A' ' 52' ' ' ILE . 4.0 m-20 -73.88 98.79 3.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.132 -0.98 . . . . 0.0 111.046 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.92 -38.5 88.84 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 109.44 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -90.13 -29.69 18.13 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.666 -0.646 . . . . 0.0 110.793 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.51 19.95 36.43 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -74.01 -37.87 64.25 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.447 -1.031 . . . . 0.0 110.747 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.576 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 125.16 3.75 7.33 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.196 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 81.1 p -136.17 169.12 18.14 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.127 -1.219 . . . . 0.0 111.101 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.603 HD11 ' CD1' ' A' ' 52' ' ' ILE . 10.6 mt -107.44 122.53 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.503 -177.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.551 ' OD1' HG22 ' A' ' 26' ' ' THR . 96.1 m-20 -103.35 170.06 8.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.597 -0.69 . . . . 0.0 110.642 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.52 ' CZ ' HD11 ' A' ' 69' ' ' LEU . 62.5 t80 -47.15 -49.84 49.71 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.659 -0.65 . . . . 0.0 112.737 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.6 Cg_endo -65.97 -34.33 38.9 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 O-C-N 122.622 0.801 . . . . 0.0 111.703 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.583 ' O ' HG22 ' A' ' 70' ' ' THR . 97.3 mt-10 -70.62 -39.96 73.42 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.179 -0.95 . . . . 0.0 111.066 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -62.44 -43.93 97.65 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.358 -0.839 . . . . 0.0 110.675 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.52 HD11 ' CZ ' ' A' ' 65' ' ' PHE . 84.5 mt -63.46 -43.44 97.35 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.383 -0.823 . . . . 0.0 112.454 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 67' ' ' GLU . 8.5 t -62.48 -33.93 75.83 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.197 -0.939 . . . . 0.0 110.926 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 15.9 ttm -67.33 -46.57 73.07 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.466 -0.771 . . . . 0.0 111.646 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 50.2 ttm -64.99 -43.87 91.16 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.322 -0.861 . . . . 0.0 112.017 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.54 -36.7 76.65 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.372 -0.83 . . . . 0.0 110.776 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -70.97 -39.95 72.21 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.696 -0.627 . . . . 0.0 111.306 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.593 ' O ' HG22 ' A' ' 79' ' ' THR . 42.0 mmtm -72.08 -30.77 65.45 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 36.2 mmt -60.07 -45.16 93.79 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.932 -1.105 . . . . 0.0 112.547 -176.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.4 pttp -69.36 -35.68 76.1 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.118 -0.989 . . . . 0.0 111.682 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -71.23 -12.34 61.41 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.418 -0.802 . . . . 0.0 111.777 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.593 HG22 ' O ' ' A' ' 75' ' ' LYS . 15.4 t -125.63 -164.32 1.29 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.319 -0.863 . . . . 0.0 111.965 -178.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -120.04 133.44 55.53 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.824 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.5 t -60.34 -29.95 69.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.593 -0.692 . . . . 0.0 110.673 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.538 ' HA ' HD12 ' A' ' 85' ' ' ILE . 98.8 mt-10 -60.13 -31.63 70.26 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.461 -0.774 . . . . 0.0 109.617 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.01 -39.98 87.68 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.903 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.11 -37.49 85.29 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.64 -0.662 . . . . 0.0 110.854 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.636 HG23 ' HE2' ' A' ' 141' ' ' PHE . 86.8 mt -66.98 -47.98 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.667 -0.646 . . . . 0.0 110.84 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -60.03 -41.1 91.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.465 -0.772 . . . . 0.0 111.207 -178.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.645 ' O ' HG23 ' A' ' 91' ' ' VAL . 99.9 mt-10 -70.06 -40.03 75.31 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.457 -0.777 . . . . 0.0 111.333 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.13 -46.05 75.3 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.772 -0.58 . . . . 0.0 111.824 -178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -59.96 -45.4 92.77 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.826 0.822 . . . . 0.0 109.338 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 29.6 ttm-85 -59.95 -37.08 78.51 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.421 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 87' ' ' GLU . 65.6 t -67.93 -46.27 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.496 -0.752 . . . . 0.0 110.188 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -69.0 -36.88 78.33 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.492 -0.755 . . . . 0.0 110.536 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -78.03 78.84 4.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.53 -0.731 . . . . 0.0 109.096 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.99 -44.16 94.69 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.413 -0.804 . . . . 0.0 110.577 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -78.92 -19.42 51.84 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.576 -0.703 . . . . 0.0 110.667 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.64 28.26 72.26 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -71.73 -10.49 59.85 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.452 -1.028 . . . . 0.0 111.159 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.9 -20.09 44.73 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.532 ' CE2' ' ND2' ' A' ' 137' ' ' ASN . 59.0 m-85 -119.91 139.39 52.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.259 -1.142 . . . . 0.0 108.971 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.501 ' CG2' HD23 ' A' ' 105' ' ' LEU . 82.5 mt -92.6 120.0 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.465 -0.772 . . . . 0.0 110.452 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.1 m -91.36 170.37 10.03 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.432 0.634 . . . . 0.0 110.719 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.73 -37.67 73.49 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.643 -0.661 . . . . 0.0 109.577 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.11 -38.76 92.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.853 -0.529 . . . . 0.0 109.918 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.5 -39.99 94.81 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.513 -0.742 . . . . 0.0 110.423 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.501 HD23 ' CG2' ' A' ' 100' ' ' ILE . 1.2 mm? -64.29 -40.0 95.07 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.607 0.718 . . . . 0.0 109.662 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 69.4 ttp85 -62.87 -31.08 72.04 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.806 -0.558 . . . . 0.0 110.875 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -60.02 -46.2 90.29 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.233 -0.917 . . . . 0.0 110.68 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.0 t -75.03 -35.57 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.363 -0.836 . . . . 0.0 111.246 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.7 mmt -60.05 -48.94 79.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.385 -0.822 . . . . 0.0 110.428 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.4 m -69.37 -39.96 77.73 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.593 -0.692 . . . . 0.0 110.125 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -60.0 -35.79 75.8 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.4 mt -69.87 -33.94 72.91 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.206 0.526 . . . . 0.0 110.306 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.96 17.25 6.43 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -109.13 131.97 54.56 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.22 -1.165 . . . . 0.0 110.256 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -100.16 120.57 40.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.618 -0.676 . . . . 0.0 110.239 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 71.2 mt -135.8 156.32 48.98 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.425 -0.797 . . . . 0.0 110.95 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.67 159.9 25.17 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -61.87 -26.6 68.24 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -68.1 -31.74 71.56 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -67.24 -34.5 77.59 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.5 t -73.02 -38.63 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.992 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.519 ' HA ' HD12 ' A' ' 125' ' ' ILE . 54.7 t0 -60.03 -43.81 95.04 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.64 -0.663 . . . . 0.0 109.55 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -60.02 -42.36 94.19 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.458 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.0 mtt -54.84 -37.59 66.37 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.118 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.519 HD12 ' HA ' ' A' ' 122' ' ' ASP . 86.7 mt -65.36 -37.9 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -57.87 -37.89 74.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.816 -0.553 . . . . 0.0 111.663 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.09 -39.97 88.0 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.427 -0.796 . . . . 0.0 111.632 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -106.34 -0.14 24.54 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.271 -0.893 . . . . 0.0 111.69 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 16.6 t70 -98.67 74.86 2.11 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.128 -0.982 . . . . 0.0 111.329 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 84.3 mt -66.93 -39.97 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.457 -0.777 . . . . 0.0 109.779 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 30.7 p30 -58.52 -37.76 76.3 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.742 -0.599 . . . . 0.0 111.494 -179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 92.84 18.75 39.35 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 120.28 -0.962 . . . . 0.0 111.233 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -82.43 -13.37 56.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.047 -1.266 . . . . 0.0 110.47 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.0 4.68 71.71 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.506 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -136.24 141.85 43.98 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.09 -1.241 . . . . 0.0 109.828 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.423 ' HB ' HD12 ' A' ' 100' ' ' ILE . 61.3 t -94.07 125.11 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.41 -0.806 . . . . 0.0 110.188 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.532 ' ND2' ' CE2' ' A' ' 99' ' ' TYR . 13.7 m120 -97.39 179.66 4.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.569 -0.707 . . . . 0.0 109.659 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -63.09 -50.05 72.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.741 -0.599 . . . . 0.0 110.852 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.21 -44.21 95.96 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.374 -0.829 . . . . 0.0 111.342 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -66.81 -38.52 86.63 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.851 0.834 . . . . 0.0 109.81 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.636 ' HE2' HG23 ' A' ' 85' ' ' ILE . 67.6 t80 -59.97 -46.12 90.48 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.156 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.609 HG22 HG21 ' A' ' 85' ' ' ILE . 98.1 t -69.96 -39.31 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.374 -0.829 . . . . 0.0 111.101 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -59.96 -47.33 86.24 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.271 -0.893 . . . . 0.0 110.437 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.443 ' HE1' ' CD1' ' B' ' 157' ' ' PHE . 12.4 tmm? -59.94 -37.27 79.05 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.469 -0.769 . . . . 0.0 110.27 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 92.2 mtp -66.36 -40.03 89.52 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.902 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.471 ' O ' HG22 ' A' ' 146' ' ' THR . 50.2 m -86.21 2.83 45.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.792 -0.567 . . . . 0.0 111.125 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.06 138.76 57.8 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.051 -1.03 . . . . 0.0 110.235 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.4 mttp . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 117.944 -1.026 . . . . 0.0 110.174 -179.916 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.71 -19.96 50.15 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.443 ' CD1' ' HE1' ' A' ' 144' ' ' MET . 52.3 t80 -67.88 -40.33 83.55 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.288 -1.125 . . . . 0.0 110.153 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 -70.0 -39.21 76.0 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.534 -0.729 . . . . 0.0 111.021 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -59.94 -40.06 87.67 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.585 -0.697 . . . . 0.0 110.719 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 160' ' ' ILE . . . . . 0.42 HG13 ' N ' ' B' ' 161' ' ' ALA . 24.8 pt -76.21 -27.56 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.479 -0.763 . . . . 0.0 110.791 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 161' ' ' ALA . . . . . 0.42 ' N ' HG13 ' B' ' 160' ' ' ILE . . . -66.27 -39.93 89.78 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.354 -0.841 . . . . 0.0 110.528 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -60.06 -40.64 90.18 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.572 -0.705 . . . . 0.0 111.031 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.58 -40.07 95.71 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.272 -0.892 . . . . 0.0 110.818 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 67.9 t -64.26 -40.1 87.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.524 -0.735 . . . . 0.0 110.896 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.24 -40.05 91.12 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 94.4 t -76.38 -14.8 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.459 -1.024 . . . . 0.0 111.344 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.447 HD23 ' C ' ' B' ' 167' ' ' LEU . 10.1 tt -60.01 -50.01 75.43 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.177 -0.952 . . . . 0.0 111.416 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -68.46 -39.95 81.23 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.249 -0.907 . . . . 0.0 110.486 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.07 -31.01 69.61 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.393 -0.817 . . . . 0.0 110.078 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 170' ' ' TRP . . . . . 0.51 ' CD1' ' HE1' ' A' ' 36' ' ' MET . 5.2 t-105 -59.97 -46.31 89.85 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.67 -0.644 . . . . 0.0 110.271 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.0 -51.39 69.85 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.461 -0.774 . . . . 0.0 110.242 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -60.11 -36.87 78.42 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.519 -0.738 . . . . 0.0 110.216 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.591 -0.693 . . . . 0.0 110.151 179.723 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 120.985 0.422 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -86.86 79.93 8.63 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.417 -0.802 . . . . 0.0 110.404 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -63.64 -40.07 95.95 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.889 0.852 . . . . 0.0 109.593 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 68.0 mt -112.6 -176.84 3.0 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.787 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 p -115.65 100.91 8.39 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.552 0.691 . . . . 0.0 109.216 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.63 ' HA ' HD12 ' A' ' 9' ' ' ILE . 99.3 mt-10 -74.4 -10.72 59.85 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.938 -0.476 . . . . 0.0 111.717 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -60.52 -53.02 62.52 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.053 -1.029 . . . . 0.0 109.646 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -66.89 -38.53 86.45 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.33 0.586 . . . . 0.0 110.557 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.63 HD12 ' HA ' ' A' ' 6' ' ' GLU . 89.7 mt -60.79 -29.02 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.706 -0.621 . . . . 0.0 111.513 -178.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -61.25 -37.88 84.67 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.047 -1.033 . . . . 0.0 109.788 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.9 -47.63 84.98 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.534 -0.729 . . . . 0.0 110.194 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.448 ' CE1' ' HE2' ' A' ' 72' ' ' MET . 26.5 m-85 -67.53 -25.25 65.74 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.632 -0.667 . . . . 0.0 110.627 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 22.9 tptp -67.37 -53.44 29.39 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.59 0.71 . . . . 0.0 109.251 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.4 -48.03 77.74 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.891 -0.505 . . . . 0.0 110.696 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.04 -20.34 63.26 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.227 -0.92 . . . . 0.0 111.32 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -60.02 -48.21 82.67 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.181 -0.95 . . . . 0.0 110.789 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.0 m -63.88 -39.24 93.72 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.278 -0.889 . . . . 0.0 108.778 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.602 HD11 ' O ' ' A' ' 112' ' ' LEU . 47.8 tp -63.82 -39.96 95.48 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.4 ' HB3' HD11 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -70.04 -34.2 72.95 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.362 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -92.13 94.68 9.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.685 -0.634 . . . . 0.0 109.516 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -59.9 -36.6 77.3 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.53 -0.731 . . . . 0.0 112.177 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -79.17 -9.76 59.65 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.06 -1.025 . . . . 0.0 111.392 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.96 22.37 57.54 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -85.4 -8.6 58.34 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.429 -1.042 . . . . 0.0 110.542 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.415 ' C ' HG23 ' A' ' 26' ' ' THR . . . 99.96 6.64 53.9 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.518 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.415 HG23 ' C ' ' A' ' 25' ' ' GLY . 80.5 p -147.81 143.02 27.19 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 119.32 1.56 . . . . 0.0 112.03 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.4 HD11 ' HB3' ' A' ' 19' ' ' PHE . 87.3 mt -100.41 124.34 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.3 p -100.98 140.57 35.09 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.706 -0.621 . . . . 0.0 110.835 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.464 HG23 HG13 ' A' ' 52' ' ' ILE . 7.1 p -42.08 -32.68 0.48 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.902 -0.499 . . . . 0.0 112.159 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -65.33 -49.1 70.73 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.731 0.777 . . . . 0.0 109.626 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -59.87 -53.69 54.93 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.976 -0.452 . . . . 0.0 111.092 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.4 tp -61.53 -34.91 76.34 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.218 -0.926 . . . . 0.0 111.063 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.51 -32.16 60.8 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.6 m -75.96 -41.26 52.02 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.671 -0.899 . . . . 0.0 111.044 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.7 t -62.7 -59.14 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.431 -0.793 . . . . 0.0 109.658 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.4 ptm -57.72 -20.78 36.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.67 -0.644 . . . . 0.0 110.467 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.2 ttt85 -59.9 -40.0 87.27 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.348 -0.845 . . . . 0.0 109.378 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.7 t -69.84 -16.35 63.25 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.897 -0.502 . . . . 0.0 111.735 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.855 HD22 HD22 ' B' ' 167' ' ' LEU . 6.6 mp -93.6 -10.06 35.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.305 -0.872 . . . . 0.0 110.756 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.16 -61.52 0.17 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -167.33 172.46 9.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.447 -1.031 . . . . 0.0 110.943 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -119.46 137.14 25.09 Favored Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.65 -149.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.332 0 O-C-N 123.19 1.1 . . . . 0.0 109.819 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -137.08 160.61 38.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.05 -1.031 . . . . 0.0 110.2 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -52.38 -25.31 9.48 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.897 -0.502 . . . . 0.0 112.305 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.16 -60.06 2.52 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.208 1.004 . . . . 0.0 108.85 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -66.82 -37.6 84.83 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.542 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.446 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 6.3 mt -57.71 -35.12 70.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.639 -0.663 . . . . 0.0 109.908 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -62.51 -40.11 95.67 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.779 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -65.49 -39.92 92.47 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.607 -0.683 . . . . 0.0 111.252 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 65.0 mtt -60.02 -43.21 95.41 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.716 0.77 . . . . 0.0 109.443 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.767 HG22 ' OD2' ' A' ' 56' ' ' ASP . 47.9 mm -66.2 -37.64 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 121.21 0.528 . . . . 0.0 110.475 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -60.0 -40.78 90.4 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.506 -0.746 . . . . 0.0 111.212 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -67.43 -27.95 67.48 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.195 -0.94 . . . . 0.0 110.541 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.411 HG21 ' SD ' ' A' ' 71' ' ' MET . 49.8 t -99.97 -10.07 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.565 -0.709 . . . . 0.0 111.557 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.767 ' OD2' HG22 ' A' ' 52' ' ' ILE . 6.6 m-20 -71.05 95.04 1.16 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.088 -1.008 . . . . 0.0 111.542 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.06 93.22 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.71 -0.619 . . . . 0.0 109.563 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -92.58 -29.27 16.25 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.648 -0.657 . . . . 0.0 110.952 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.56 20.49 34.54 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.0 p-10 -74.74 -32.76 62.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.344 -1.092 . . . . 0.0 110.35 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.531 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 118.65 5.24 12.52 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 120.277 -0.963 . . . . 0.0 111.24 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 80.9 p -136.43 170.17 16.48 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.189 -1.183 . . . . 0.0 111.077 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.465 HD11 ' CD1' ' A' ' 52' ' ' ILE . 10.8 mt -105.06 120.55 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.286 0.565 . . . . 0.0 110.886 -177.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -100.05 165.4 11.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.721 -0.612 . . . . 0.0 109.934 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.524 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 16.2 t80 -48.7 -49.27 66.85 Favored Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 121.486 -0.759 . . . . 0.0 112.499 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 38.7 Cg_endo -64.23 -35.54 51.36 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 O-C-N 122.766 0.877 . . . . 0.0 111.173 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.96 -40.03 75.65 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.165 -0.959 . . . . 0.0 110.322 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -61.99 -42.86 99.61 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.59 -0.693 . . . . 0.0 111.3 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 69' ' ' LEU . 4.0 mm? -64.68 -42.97 94.97 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.395 -0.816 . . . . 0.0 111.205 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.1 m -61.97 -40.03 94.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.649 -0.657 . . . . 0.0 111.111 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.411 ' SD ' HG21 ' A' ' 55' ' ' VAL . 56.2 ttp -68.35 -40.96 81.36 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.473 -0.767 . . . . 0.0 112.148 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.478 ' SD ' HG11 ' B' ' 166' ' ' VAL . 92.6 mmm -61.53 -45.49 93.95 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.296 -0.877 . . . . 0.0 111.131 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.67 -32.43 73.49 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.856 -0.528 . . . . 0.0 110.982 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -72.04 -39.98 68.7 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.435 -0.791 . . . . 0.0 110.292 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -62.5 -39.98 95.22 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.617 -0.677 . . . . 0.0 112.362 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 35.9 mmt -57.82 -33.21 68.37 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.185 -0.947 . . . . 0.0 110.736 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -69.69 -56.75 6.36 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.554 0.693 . . . . 0.0 110.572 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -69.16 -35.86 76.76 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.525 0.679 . . . . 0.0 110.436 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.629 HG22 ' H ' ' A' ' 80' ' ' ASP . 8.1 m -86.07 -174.68 5.21 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.858 -0.526 . . . . 0.0 110.224 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.629 ' H ' HG22 ' A' ' 79' ' ' THR . 90.4 m-20 -134.0 149.94 51.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.321 -0.862 . . . . 0.0 109.964 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.3 t -65.82 -33.74 76.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.7 -0.625 . . . . 0.0 109.556 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -63.77 -33.87 76.62 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.644 0.735 . . . . 0.0 109.181 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.56 -39.98 77.05 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.332 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -63.83 -36.35 83.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.594 -0.691 . . . . 0.0 109.934 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.633 HG23 ' CE1' ' A' ' 141' ' ' PHE . 77.4 mt -64.48 -49.96 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.668 -0.645 . . . . 0.0 110.821 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -57.14 -39.94 76.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.176 -0.953 . . . . 0.0 111.019 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.666 ' O ' HG23 ' A' ' 91' ' ' VAL . 98.8 mt-10 -70.0 -40.02 75.53 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.54 -0.725 . . . . 0.0 111.471 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.55 -49.25 69.57 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.423 -0.798 . . . . 0.0 112.244 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -60.37 -40.42 90.71 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.247 -0.908 . . . . 0.0 109.429 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -59.98 -37.57 80.0 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.666 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 87' ' ' GLU . 94.1 t -69.75 -53.41 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.419 -0.801 . . . . 0.0 110.797 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.485 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 51.5 m-85 -63.43 -39.76 95.36 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.355 -0.841 . . . . 0.0 110.882 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -80.98 72.02 7.98 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.531 -0.731 . . . . 0.0 110.006 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -61.83 -41.72 98.14 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.211 -0.93 . . . . 0.0 109.859 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.0 p-10 -73.16 -22.22 60.55 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.567 -0.708 . . . . 0.0 110.995 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.2 25.06 73.53 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -71.2 -12.49 61.5 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.322 -1.105 . . . . 0.0 111.541 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.85 -16.69 59.24 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.5 ' CD2' ' ND2' ' A' ' 137' ' ' ASN . 60.1 m-85 -123.18 136.36 54.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.19 -1.182 . . . . 0.0 109.148 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.5 ' CG2' HD23 ' A' ' 105' ' ' LEU . 61.4 mt -89.8 120.07 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.423 -0.798 . . . . 0.0 109.922 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.2 m -90.07 170.56 10.22 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.329 0.585 . . . . 0.0 110.686 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.73 -35.99 72.97 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.666 -0.646 . . . . 0.0 109.358 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.43 -35.57 79.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.735 -0.603 . . . . 0.0 109.584 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.22 -37.88 78.26 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.659 -0.65 . . . . 0.0 110.776 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.5 HD23 ' CG2' ' A' ' 100' ' ' ILE . 1.3 mm? -66.92 -41.66 86.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.552 -0.717 . . . . 0.0 110.279 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -60.06 -37.8 80.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.695 -0.628 . . . . 0.0 110.717 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -60.66 -42.79 97.72 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.456 -0.778 . . . . 0.0 112.419 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.485 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 91.3 t -74.04 -50.9 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 O-C-N 121.159 -0.963 . . . . 0.0 111.827 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 78.1 mtm -59.55 -40.21 86.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.116 -0.99 . . . . 0.0 110.205 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.2 m -64.72 -45.63 85.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.645 -0.659 . . . . 0.0 109.325 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -61.36 -33.63 73.97 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.602 ' O ' HD11 ' A' ' 18' ' ' LEU . 35.6 mt -69.98 -36.12 74.96 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.141 0.496 . . . . 0.0 109.836 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.41 30.72 1.65 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -119.93 127.34 52.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.464 -1.021 . . . . 0.0 109.701 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -100.11 120.96 40.67 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.654 -0.654 . . . . 0.0 110.824 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.549 HD23 ' OE1' ' A' ' 120' ' ' GLU . 2.5 mp -137.72 155.39 49.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.567 -0.708 . . . . 0.0 110.051 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.38 166.92 16.97 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -64.65 -24.76 67.69 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.178 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -68.66 -35.87 77.8 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.683 0.754 . . . . 0.0 109.278 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.549 ' OE1' HD23 ' A' ' 116' ' ' LEU . 4.6 mt-10 -64.8 -36.11 83.27 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.6 t -70.04 -38.62 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-O 121.427 0.632 . . . . 0.0 110.178 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -59.79 -46.54 88.9 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.573 -0.705 . . . . 0.0 110.227 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -60.1 -39.97 88.0 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.805 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 67.6 mtt -54.7 -40.01 68.75 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.353 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.64 -38.04 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.716 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -59.38 -40.02 85.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.507 -0.746 . . . . 0.0 111.938 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.88 -40.0 91.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.448 -0.782 . . . . 0.0 112.012 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.14 -17.16 16.79 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.276 -0.89 . . . . 0.0 111.388 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -85.8 74.99 10.11 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.271 -0.893 . . . . 0.0 110.538 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.7 -40.04 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.725 -0.609 . . . . 0.0 109.841 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 27.9 p-10 -58.76 -38.92 79.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.551 -0.718 . . . . 0.0 110.766 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.86 16.05 40.29 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 120.224 -0.988 . . . . 0.0 111.073 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.59 -10.81 59.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.127 -1.219 . . . . 0.0 110.238 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.47 3.54 74.84 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.476 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -134.79 136.36 42.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.093 -1.24 . . . . 0.0 110.666 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.8 t -92.11 120.01 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.47 -0.768 . . . . 0.0 110.033 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.5 ' ND2' ' CD2' ' A' ' 99' ' ' TYR . 25.5 m120 -96.41 -175.03 3.22 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.453 0.644 . . . . 0.0 110.381 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -60.0 -49.98 75.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.837 -0.539 . . . . 0.0 110.188 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -60.08 -44.75 94.55 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.374 -0.829 . . . . 0.0 111.279 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -62.32 -39.03 91.72 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.04 0.924 . . . . 0.0 109.353 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.633 ' CE1' HG23 ' A' ' 85' ' ' ILE . 64.7 t80 -60.01 -41.86 93.06 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.697 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 92.9 t -67.65 -40.05 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.378 -0.826 . . . . 0.0 110.844 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -59.97 -39.98 87.51 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.472 -0.767 . . . . 0.0 110.498 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 46.2 ttp -60.04 -40.55 89.79 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.66 -0.65 . . . . 0.0 110.588 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 61.1 mtt -76.72 -34.24 58.14 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.419 -0.801 . . . . 0.0 109.95 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.514 ' O ' HG22 ' A' ' 146' ' ' THR . 25.0 m -92.7 23.62 4.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.793 -0.567 . . . . 0.0 111.016 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.49 89.03 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.353 -0.842 . . . . 0.0 110.474 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.146 -179.847 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 82.2 7.15 88.11 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -60.05 -47.97 83.65 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.038 -1.272 . . . . 0.0 109.472 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -61.4 -38.78 88.32 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.856 -0.528 . . . . 0.0 111.136 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -60.09 -39.9 87.74 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.389 -0.819 . . . . 0.0 110.707 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 85.4 mt -69.07 -40.06 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.441 -0.787 . . . . 0.0 110.214 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.0 -44.47 94.53 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.616 -0.677 . . . . 0.0 110.969 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -60.49 -40.79 92.6 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.34 -0.85 . . . . 0.0 110.5 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 40.4 tp -61.27 -40.6 94.7 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.503 -0.748 . . . . 0.0 109.972 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 93.1 t -60.59 -40.0 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.697 -0.627 . . . . 0.0 109.871 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -53.91 -36.15 55.03 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.478 HG11 ' SD ' ' A' ' 72' ' ' MET . 98.3 t -77.71 -29.87 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.606 -0.938 . . . . 0.0 110.33 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.855 HD22 HD22 ' A' ' 39' ' ' LEU . 3.7 tt -59.98 -50.72 72.62 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.512 -0.743 . . . . 0.0 111.515 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -60.27 -40.09 89.14 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.369 -0.832 . . . . 0.0 111.164 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -59.91 -35.32 74.62 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.49 -0.756 . . . . 0.0 110.695 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -59.69 -39.97 86.3 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.477 -0.765 . . . . 0.0 110.25 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.05 79.2 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.296 -0.878 . . . . 0.0 110.306 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -60.06 -39.64 86.69 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.337 -0.852 . . . . 0.0 109.347 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.286 0.565 . . . . 0.0 110.056 179.381 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.272 0.558 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -67.77 -36.09 79.85 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.741 0.781 . . . . 0.0 110.547 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -59.98 -40.03 87.71 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.352 0.596 . . . . 0.0 110.665 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.1 mt -89.46 -178.98 5.72 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.745 -0.597 . . . . 0.0 110.503 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.77 25.88 11.22 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.715 -0.616 . . . . 0.0 109.823 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.754 ' HA ' HD12 ' A' ' 9' ' ' ILE . 98.8 mt-10 -55.13 -14.16 1.52 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.591 -0.693 . . . . 0.0 111.917 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.429 ' HG3' ' N ' ' A' ' 8' ' ' GLN . 19.5 pt-20 -64.51 -41.17 96.58 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.916 -1.115 . . . . 0.0 109.999 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.429 ' N ' ' HG3' ' A' ' 7' ' ' GLU . 97.3 mt-30 -63.83 -36.46 83.97 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.464 -0.772 . . . . 0.0 109.77 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.754 HD12 ' HA ' ' A' ' 6' ' ' GLU . 83.8 mt -57.11 -29.62 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.806 -0.559 . . . . 0.0 111.044 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.94 -39.54 94.39 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.194 -0.941 . . . . 0.0 110.419 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -60.07 -42.62 94.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.37 -0.831 . . . . 0.0 109.88 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -63.32 -20.88 65.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.865 -0.522 . . . . 0.0 111.068 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HD3' ' CZ ' ' A' ' 65' ' ' PHE . 40.3 mmtt -66.87 -40.22 87.76 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.203 -0.936 . . . . 0.0 108.988 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -64.25 -58.31 6.93 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.976 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.86 -26.95 68.44 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.36 -0.837 . . . . 0.0 112.545 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -58.36 -48.31 81.01 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.753 -1.217 . . . . 0.0 111.013 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.4 p -62.33 -37.17 84.58 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.186 -0.947 . . . . 0.0 109.481 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.2 tp -60.09 -40.01 88.11 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.583 0.706 . . . . 0.0 109.499 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.677 ' HE2' HD11 ' B' ' 163' ' ' LEU . 4.4 m-85 -74.81 -36.69 62.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.875 -0.516 . . . . 0.0 110.974 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -94.91 97.78 10.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.441 -0.787 . . . . 0.0 110.131 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -65.67 -31.98 73.29 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.499 -0.75 . . . . 0.0 111.077 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -80.04 -10.43 59.77 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.214 -0.929 . . . . 0.0 111.166 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.34 25.66 55.06 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -88.46 -8.08 55.51 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.543 -0.974 . . . . 0.0 110.902 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.31 2.72 56.71 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 120.054 -1.07 . . . . 0.0 111.751 178.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.8 p -143.4 141.5 30.9 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-N 119.464 1.632 . . . . 0.0 111.966 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 83.9 mt -100.88 121.32 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.737 -0.602 . . . . 0.0 109.458 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.1 m -102.33 141.86 34.48 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.59 -0.694 . . . . 0.0 110.389 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.44 ' CG2' HG13 ' A' ' 52' ' ' ILE . 40.6 p -41.96 -29.79 0.24 Allowed 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.643 -0.66 . . . . 0.0 112.211 -177.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -63.41 -52.08 63.09 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.333 -0.854 . . . . 0.0 109.364 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.04 -53.73 54.3 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.487 -178.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.561 HD21 ' CE ' ' A' ' 36' ' ' MET . 53.0 tp -59.83 -36.49 76.93 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.092 -1.005 . . . . 0.0 110.672 -178.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.77 -31.0 37.35 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.4 m -69.97 -40.1 75.57 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.616 -0.932 . . . . 0.0 110.24 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.22 -55.21 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.53 -0.731 . . . . 0.0 109.512 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.561 ' CE ' HD21 ' A' ' 32' ' ' LEU . 69.0 mtt -58.48 -30.46 67.0 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.333 0.587 . . . . 0.0 110.044 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -59.88 -50.04 75.34 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 t -70.76 -18.8 62.76 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.803 -0.561 . . . . 0.0 110.436 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.562 HD11 HD13 ' B' ' 167' ' ' LEU . 66.7 mt -84.96 -21.87 29.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.293 -0.88 . . . . 0.0 110.576 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.77 -45.46 0.19 Allowed Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.937 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -161.44 159.95 28.73 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.11 -1.229 . . . . 0.0 111.957 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.451 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 38.9 t30 -114.42 105.1 54.2 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 42' ' ' ASN . 42.5 Cg_endo -61.36 -149.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.503 0 O-C-N 123.306 1.161 . . . . 0.0 110.734 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.23 160.54 39.17 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.93 -1.106 . . . . 0.0 111.174 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.4 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 11.9 mm-40 -53.78 -22.02 8.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.936 -0.478 . . . . 0.0 111.939 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.01 -59.23 3.04 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -67.27 -38.67 85.46 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.553 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.402 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 6.2 mt -58.71 -33.17 69.88 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.865 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -64.56 -40.0 94.78 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.497 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -64.79 -40.03 94.57 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.649 -0.657 . . . . 0.0 110.928 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 66.6 mtt -61.3 -43.41 98.91 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.685 -0.634 . . . . 0.0 109.748 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.897 HG22 ' OD2' ' A' ' 56' ' ' ASP . 48.4 mm -66.88 -36.24 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.849 -0.532 . . . . 0.0 110.746 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -60.01 -41.95 93.24 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.391 -0.818 . . . . 0.0 110.633 -178.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -69.88 -27.69 65.02 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.226 -0.921 . . . . 0.0 111.355 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.497 HG21 ' SD ' ' A' ' 71' ' ' MET . 60.2 t -99.21 -10.02 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.316 -0.865 . . . . 0.0 111.835 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.897 ' OD2' HG22 ' A' ' 52' ' ' ILE . 19.5 m-20 -71.53 96.88 1.58 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.089 -1.007 . . . . 0.0 111.302 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.23 -37.43 80.82 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.406 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -90.58 -27.01 19.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.733 -0.604 . . . . 0.0 110.433 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.99 20.34 43.34 Favored Glycine 0 N--CA 1.495 2.567 0 C-N-CA 120.458 -0.877 . . . . 0.0 110.923 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -76.27 -28.62 57.12 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.449 -1.03 . . . . 0.0 110.565 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.76 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 114.35 2.06 23.2 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.174 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.3 p -134.1 167.78 20.01 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.152 -1.204 . . . . 0.0 110.527 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.51 HD11 HD13 ' A' ' 52' ' ' ILE . 8.7 mt -103.53 119.94 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.228 -178.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -97.71 167.56 10.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.666 -0.646 . . . . 0.0 109.889 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.508 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 10.5 t80 -48.27 -48.63 64.99 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.52 -0.737 . . . . 0.0 112.45 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.5 Cg_endo -67.0 -34.4 29.21 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 O-C-N 122.895 0.945 . . . . 0.0 111.088 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.9 -39.92 69.23 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.181 -0.95 . . . . 0.0 110.887 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -62.32 -40.43 96.29 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.451 -0.781 . . . . 0.0 111.422 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 65' ' ' PHE . 4.6 mp -69.63 -40.01 76.8 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.221 -0.924 . . . . 0.0 111.611 -178.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.8 p -61.22 -40.03 92.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.364 -0.835 . . . . 0.0 110.853 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.497 ' SD ' HG21 ' A' ' 55' ' ' VAL . 50.7 ttp -67.49 -52.05 43.86 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.525 -0.734 . . . . 0.0 112.044 -178.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.427 ' HE2' HG11 ' B' ' 166' ' ' VAL . 49.8 ttm -59.98 -49.71 76.6 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.314 -0.866 . . . . 0.0 111.948 -178.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.99 -36.02 76.27 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.547 -0.72 . . . . 0.0 110.341 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -77.23 -43.55 33.16 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.606 0.717 . . . . 0.0 110.14 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -61.01 -48.12 83.29 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.757 -0.589 . . . . 0.0 111.973 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 27.8 ptm -59.94 -36.12 76.37 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.261 -0.9 . . . . 0.0 110.679 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -68.17 -42.93 79.27 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.695 0.759 . . . . 0.0 109.299 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -68.43 -30.93 69.93 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.691 0.758 . . . . 0.0 109.273 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 80' ' ' ASP . 7.2 m -94.53 -174.11 3.23 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.61 ' H ' HG22 ' A' ' 79' ' ' THR . 65.6 m-20 -120.73 141.63 50.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.109 -0.995 . . . . 0.0 109.808 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.3 t -60.06 -29.57 68.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.65 -0.656 . . . . 0.0 110.173 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.0 -37.34 79.42 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.698 0.761 . . . . 0.0 109.192 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -70.06 -39.98 75.35 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.19 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -64.08 -39.75 94.75 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.704 -0.623 . . . . 0.0 110.767 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.772 HG23 ' CE1' ' A' ' 141' ' ' PHE . 96.5 mt -62.92 -49.68 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.63 -0.669 . . . . 0.0 110.465 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -57.7 -40.09 78.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.336 -0.852 . . . . 0.0 111.16 -178.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.693 ' O ' HG23 ' A' ' 91' ' ' VAL . 98.9 mt-10 -70.03 -39.99 75.44 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.336 -0.853 . . . . 0.0 111.666 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.52 -47.21 73.64 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.331 -0.856 . . . . 0.0 111.287 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -60.01 -47.52 85.51 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.587 -0.695 . . . . 0.0 110.138 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -59.93 -36.35 76.85 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.683 -0.636 . . . . 0.0 110.325 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 87' ' ' GLU . 70.5 t -66.92 -46.39 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.568 -0.707 . . . . 0.0 109.699 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.518 ' CD1' HD22 ' A' ' 105' ' ' LEU . 14.3 m-85 -69.91 -38.58 76.3 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.461 -0.774 . . . . 0.0 111.324 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -75.34 78.33 2.42 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.51 -0.744 . . . . 0.0 110.571 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -59.92 -47.91 83.85 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.622 -0.674 . . . . 0.0 110.178 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -78.08 -18.57 55.59 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.505 -0.747 . . . . 0.0 111.239 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.98 28.58 72.27 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -73.91 -8.96 58.06 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.414 -1.05 . . . . 0.0 111.401 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.39 -17.61 50.48 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -129.99 138.44 50.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.315 -1.109 . . . . 0.0 108.87 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.764 ' CG2' HD23 ' A' ' 105' ' ' LEU . 32.9 mt -89.05 124.41 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.368 -0.833 . . . . 0.0 110.435 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.4 m -88.65 171.01 10.33 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.242 0.544 . . . . 0.0 110.384 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.84 -40.07 83.78 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.663 -0.648 . . . . 0.0 109.582 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.55 -38.51 91.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.76 -0.588 . . . . 0.0 109.604 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.85 -40.28 91.58 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.781 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.764 HD23 ' CG2' ' A' ' 100' ' ' ILE . 0.2 OUTLIER -63.1 -44.76 94.79 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.505 -0.747 . . . . 0.0 110.462 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.406 ' CG ' HG21 ' A' ' 121' ' ' VAL . 77.6 mtp180 -60.29 -30.9 69.77 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.633 -0.667 . . . . 0.0 110.385 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -60.18 -49.95 75.6 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.561 -0.712 . . . . 0.0 111.456 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.47 HG12 ' CD1' ' A' ' 112' ' ' LEU . 61.3 t -74.26 -52.32 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 O-C-N 121.234 -0.916 . . . . 0.0 112.168 -178.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 99.4 mtp -56.56 -42.68 78.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.123 -0.986 . . . . 0.0 110.511 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.6 m -65.16 -46.7 79.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.707 -0.621 . . . . 0.0 109.668 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -62.01 -33.69 74.81 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.47 ' CD1' HG12 ' A' ' 108' ' ' VAL . 61.9 mt -70.03 -33.43 71.97 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.701 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.27 40.8 0.42 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -138.02 132.84 32.82 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.5 -1.0 . . . . 0.0 110.142 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.679 ' C ' HD13 ' A' ' 116' ' ' LEU . 68.4 mttm -106.82 141.3 38.28 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.477 -0.764 . . . . 0.0 110.303 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.679 HD13 ' C ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -158.73 157.82 32.47 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.624 0.726 . . . . 0.0 110.769 179.231 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.3 p -85.66 167.57 15.2 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.632 -0.667 . . . . 0.0 109.802 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -65.47 -26.69 68.05 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -69.92 -37.34 75.91 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.909 0.862 . . . . 0.0 109.204 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -63.43 -40.02 96.03 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.44 1.114 . . . . 0.0 108.378 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.406 HG21 ' CG ' ' A' ' 106' ' ' ARG . 53.7 t -67.21 -39.97 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.033 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.422 ' HA ' HD12 ' A' ' 125' ' ' ILE . 61.1 t0 -60.07 -45.81 91.63 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.568 -0.707 . . . . 0.0 110.041 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -59.96 -40.09 87.86 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.724 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 66.7 mtt -56.24 -37.68 70.07 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.184 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 122' ' ' ASP . 89.4 mt -65.21 -38.56 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.812 0.815 . . . . 0.0 109.047 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.4 ttt180 -58.51 -39.63 80.63 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.057 0.456 . . . . 0.0 111.391 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -60.06 -39.95 87.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.709 -0.619 . . . . 0.0 111.845 -178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.2 -10.45 15.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.208 -0.933 . . . . 0.0 112.011 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -74.25 69.94 1.61 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.1 -1.0 . . . . 0.0 110.414 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.0 mt -68.2 -40.0 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.587 -0.696 . . . . 0.0 110.503 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -69.3 -24.31 63.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.377 -0.827 . . . . 0.0 111.017 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.89 24.67 48.28 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.96 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -82.57 -10.0 59.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -1.125 . . . . 0.0 110.802 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.33 -1.39 79.5 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -138.23 150.39 46.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -1.105 . . . . 0.0 109.38 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.53 118.87 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.408 -0.807 . . . . 0.0 109.944 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -89.93 -170.73 2.9 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.682 0.754 . . . . 0.0 110.397 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -69.87 -40.03 75.98 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.502 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -60.15 -47.82 84.33 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.3 -0.875 . . . . 0.0 112.249 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -62.74 -37.74 87.77 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.927 0.87 . . . . 0.0 110.043 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.772 ' CE1' HG23 ' A' ' 85' ' ' ILE . 57.9 t80 -59.97 -50.04 75.32 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.37 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.562 HG12 HG21 ' A' ' 85' ' ' ILE . 36.0 m -70.12 -41.05 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -59.97 -51.04 71.36 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.184 -0.947 . . . . 0.0 111.314 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.9 ttp -62.38 -37.73 86.85 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.447 -0.783 . . . . 0.0 109.927 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 90.6 mmm -69.82 -39.35 76.53 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.848 -0.533 . . . . 0.0 109.967 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.491 HG23 ' O ' ' A' ' 142' ' ' VAL . 71.4 p -82.56 0.39 42.94 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.499 -0.751 . . . . 0.0 111.039 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.94 -40.0 87.47 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.138 -0.976 . . . . 0.0 110.477 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.2 mttt . . . . . 0 N--CA 1.496 1.825 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.347 -179.781 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -77.0 141.4 26.13 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -60.05 -41.57 92.59 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.59 -0.947 . . . . 0.0 110.595 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 21.3 ptt-85 -60.04 -39.97 87.77 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.626 -0.671 . . . . 0.0 111.51 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 30.1 mtp-105 -61.62 -39.97 93.17 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.494 -0.754 . . . . 0.0 110.458 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 88.8 mt -66.39 -39.96 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.569 -0.707 . . . . 0.0 110.481 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.95 87.42 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.558 -0.714 . . . . 0.0 110.708 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -60.0 -42.31 93.98 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.547 -0.721 . . . . 0.0 111.457 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.735 ' O ' HG12 ' B' ' 166' ' ' VAL . 42.6 tp -65.0 -40.9 95.62 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.3 -0.875 . . . . 0.0 110.83 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.647 ' HA ' HD12 ' B' ' 167' ' ' LEU . 66.9 t -61.09 -39.99 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.588 -0.695 . . . . 0.0 110.751 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.07 -40.15 82.08 Favored Glycine 0 N--CA 1.495 2.597 0 O-C-N 121.447 -0.783 . . . . 0.0 111.759 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.735 HG12 ' O ' ' B' ' 163' ' ' LEU . 15.0 p -76.33 -24.46 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.096 -1.238 . . . . 0.0 112.53 -178.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.647 HD12 ' HA ' ' B' ' 164' ' ' VAL . 85.7 mt -59.96 -49.09 79.03 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.953 -1.092 . . . . 0.0 110.969 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -61.72 -40.0 93.5 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.314 -0.866 . . . . 0.0 110.704 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 169' ' ' GLU . . . . . 0.444 ' CD ' HG21 ' A' ' 79' ' ' THR . 97.6 mt-10 -62.34 -26.01 68.21 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.473 -0.767 . . . . 0.0 109.872 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -59.99 -41.73 92.7 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.593 -0.692 . . . . 0.0 109.721 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.97 -50.5 73.5 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.461 -0.774 . . . . 0.0 110.78 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -60.16 -39.89 87.98 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.451 -0.781 . . . . 0.0 110.378 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 . . . . . 0 N--CA 1.495 1.778 0 O-C-N 121.611 -0.681 . . . . 0.0 110.127 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.22 0.533 . . . . 0.0 109.851 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -108.06 14.58 25.05 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.525 -0.735 . . . . 0.0 111.071 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -64.85 -174.06 0.13 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.181 -0.949 . . . . 0.0 109.372 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.1 mt -131.57 177.02 7.82 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.325 -0.859 . . . . 0.0 111.03 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.5 p -140.11 105.37 5.04 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.538 ' HA ' HD12 ' A' ' 9' ' ' ILE . 98.8 mt-10 -87.04 -9.04 56.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.743 -0.598 . . . . 0.0 111.397 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -70.06 -35.6 74.36 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -0.927 . . . . 0.0 110.554 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -68.76 -37.57 79.47 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.397 -0.814 . . . . 0.0 110.182 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 6' ' ' GLU . 82.3 mt -59.93 -31.87 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.727 -0.608 . . . . 0.0 110.98 -178.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.11 -39.38 86.02 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.249 -0.907 . . . . 0.0 110.287 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -60.04 -40.0 87.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.541 -0.725 . . . . 0.0 110.349 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -65.52 -22.83 66.76 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.486 -0.759 . . . . 0.0 110.841 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.446 ' HD3' ' CE1' ' A' ' 65' ' ' PHE . 46.7 mmtt -68.77 -39.99 79.96 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.84 -56.82 13.97 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 120.311 -0.555 . . . . 0.0 110.542 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.38 -25.89 67.48 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.295 -0.878 . . . . 0.0 112.19 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.517 ' CG ' ' CZ ' ' A' ' 65' ' ' PHE . 51.1 t80 -59.99 -43.61 95.03 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.112 -0.993 . . . . 0.0 110.714 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 98.4 p -62.13 -35.34 78.45 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.34 -0.85 . . . . 0.0 110.123 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.8 tt -66.7 -39.97 88.3 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.449 ' HZ ' HD21 ' B' ' 167' ' ' LEU . 5.5 m-85 -70.01 -40.06 75.49 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -91.59 88.75 6.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.782 -0.574 . . . . 0.0 110.139 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -59.98 -33.22 71.66 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.439 -0.788 . . . . 0.0 111.297 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -80.18 -10.07 59.74 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.113 -0.992 . . . . 0.0 111.236 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 58.02 26.07 57.7 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -88.07 -7.17 57.39 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.507 -0.996 . . . . 0.0 111.096 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.87 3.47 58.11 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.199 -1.001 . . . . 0.0 111.568 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.2 p -143.22 141.25 31.03 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 119.181 1.491 . . . . 0.0 111.484 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.5 mt -98.51 120.06 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.0 p -84.05 175.77 9.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.431 -0.793 . . . . 0.0 109.875 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.735 HG22 HD11 ' A' ' 52' ' ' ILE . 78.3 p -76.21 -32.34 58.9 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.592 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -67.84 -41.65 82.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.526 -0.734 . . . . 0.0 110.708 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -60.54 -57.46 12.65 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.605 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.5 tp -59.96 -39.19 84.78 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.368 -0.832 . . . . 0.0 111.057 -178.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -48.1 -29.79 6.96 Favored Glycine 0 N--CA 1.502 3.08 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -178.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.5 m -68.14 -40.0 82.52 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.442 -1.034 . . . . 0.0 108.928 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.5 t -64.13 -44.41 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 CA-C-O 121.306 0.574 . . . . 0.0 110.128 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.483 ' HE2' ' HD3' ' A' ' 43' ' ' PRO . 95.9 mtp -59.99 -39.99 87.65 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.604 -0.685 . . . . 0.0 110.554 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.465 ' HG2' ' HB2' ' A' ' 42' ' ' ASN . 1.1 mmt85 -61.02 -38.44 86.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.424 -0.797 . . . . 0.0 109.504 178.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.4 t -64.35 -26.7 68.59 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.887 -0.508 . . . . 0.0 110.613 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.557 HD11 HD13 ' B' ' 167' ' ' LEU . 88.3 mt -93.39 -16.1 24.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.298 -0.876 . . . . 0.0 110.228 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.05 -66.3 0.12 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -161.34 170.01 20.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.258 -1.142 . . . . 0.0 111.708 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.465 ' HB2' ' HG2' ' A' ' 37' ' ' ARG . 29.9 t30 -112.79 129.0 24.88 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.882 -0.511 . . . . 0.0 110.136 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.483 ' HD3' ' HE2' ' A' ' 36' ' ' MET . 50.8 Cg_endo -68.6 -143.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.264 0 O-C-N 123.142 1.075 . . . . 0.0 109.398 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.5 p -128.48 156.17 43.66 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.648 -1.282 . . . . 0.0 111.444 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -51.9 -22.59 3.95 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.78 -0.575 . . . . 0.0 111.844 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.13 -56.18 6.02 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 122.233 1.016 . . . . 0.0 108.523 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.4 -34.3 76.97 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.479 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.415 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 1.2 mt -57.22 -35.52 69.76 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.611 -0.681 . . . . 0.0 109.991 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -72.63 -30.29 64.18 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 120.191 -0.603 . . . . 0.0 111.708 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -69.14 -40.16 78.42 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.224 -0.923 . . . . 0.0 110.531 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 78.1 mtm -65.12 -40.02 93.88 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.682 0.754 . . . . 0.0 109.216 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.735 HD11 HG22 ' A' ' 29' ' ' THR . 92.6 mt -67.38 -34.48 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.832 -0.543 . . . . 0.0 110.507 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -60.08 -39.98 87.96 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.233 -0.917 . . . . 0.0 112.073 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -66.03 -27.77 68.35 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.051 -1.031 . . . . 0.0 110.75 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.578 HG21 ' SD ' ' A' ' 71' ' ' MET . 60.1 t -97.34 -9.33 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.598 -0.689 . . . . 0.0 110.55 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.432 ' OD2' HG22 ' A' ' 52' ' ' ILE . 12.1 m-20 -69.44 97.63 1.01 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.283 -0.886 . . . . 0.0 110.603 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.08 -38.62 91.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.658 -0.651 . . . . 0.0 109.4 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -90.33 -31.58 16.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.726 -0.609 . . . . 0.0 110.812 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.6 21.58 36.75 Favored Glycine 0 N--CA 1.496 2.653 0 C-N-CA 120.336 -0.935 . . . . 0.0 110.832 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -73.93 -33.61 64.01 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.441 -1.035 . . . . 0.0 110.576 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.05 -2.31 7.86 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 120.437 -0.887 . . . . 0.0 110.957 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.8 p -136.19 167.33 21.48 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.014 -1.286 . . . . 0.0 110.621 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.61 HD12 ' HH2' ' B' ' 170' ' ' TRP . 7.9 mt -107.76 123.78 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 121.596 0.712 . . . . 0.0 111.464 -177.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -99.58 171.22 8.06 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.54 0.685 . . . . 0.0 111.044 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.517 ' CZ ' ' CG ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -47.65 -50.03 53.2 Favored Pre-proline 0 N--CA 1.503 2.184 0 O-C-N 121.653 -0.654 . . . . 0.0 112.519 -179.507 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.499 ' O ' HG23 ' A' ' 70' ' ' THR . 41.7 Cg_endo -69.52 -35.33 13.54 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 122.92 0.958 . . . . 0.0 111.671 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.99 -39.93 75.63 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.23 -0.919 . . . . 0.0 109.8 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -61.66 -41.67 97.85 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.205 0.526 . . . . 0.0 110.775 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.3 mt -65.34 -39.97 93.06 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.479 -0.763 . . . . 0.0 111.941 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 66' ' ' PRO . 77.9 p -59.98 -39.96 87.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.249 -0.907 . . . . 0.0 110.614 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.578 ' SD ' HG21 ' A' ' 55' ' ' VAL . 61.3 ttp -67.36 -40.0 85.77 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.558 -0.714 . . . . 0.0 110.986 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -59.95 -50.15 74.9 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.53 -0.731 . . . . 0.0 111.928 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.84 -29.95 67.33 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.541 -0.725 . . . . 0.0 111.877 -178.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -69.97 -40.11 75.58 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.364 -0.835 . . . . 0.0 111.281 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.643 ' O ' HG22 ' A' ' 79' ' ' THR . 43.9 mmtm -69.97 -27.18 64.51 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 38.8 mmt -59.33 -49.03 79.38 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.03 -1.044 . . . . 0.0 112.229 -177.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.6 pttt -69.24 -33.87 73.95 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.263 -0.898 . . . . 0.0 111.936 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -70.02 -19.96 63.29 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.462 -0.773 . . . . 0.0 111.341 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.643 HG22 ' O ' ' A' ' 75' ' ' LYS . 14.3 t -118.2 -166.82 1.26 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.11 0.957 . . . . 0.0 112.427 -178.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -128.52 137.97 52.03 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.639 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.9 t -60.7 -32.43 71.67 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.649 -0.657 . . . . 0.0 110.652 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.474 ' HA ' HD12 ' A' ' 85' ' ' ILE . 92.7 mt-10 -59.99 -33.8 72.45 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.561 -0.712 . . . . 0.0 110.127 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -69.96 -40.0 75.67 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.742 -0.599 . . . . 0.0 110.747 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -69.39 -33.26 72.76 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.503 -0.748 . . . . 0.0 110.469 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.744 HG23 ' HE1' ' A' ' 141' ' ' PHE . 91.9 mt -64.81 -49.62 79.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.724 -0.61 . . . . 0.0 110.407 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -57.87 -38.4 75.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.444 -0.785 . . . . 0.0 111.02 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.714 ' O ' HG23 ' A' ' 91' ' ' VAL . 98.8 mt-10 -70.0 -42.06 73.54 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.66 -0.65 . . . . 0.0 111.617 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.3 -45.65 79.68 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.487 -0.758 . . . . 0.0 111.779 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -60.01 -45.99 90.96 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.382 -0.824 . . . . 0.0 109.449 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -59.99 -33.93 72.63 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.682 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 87' ' ' GLU . 83.3 t -69.04 -47.87 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.441 -0.787 . . . . 0.0 109.829 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.504 ' HE2' HG21 ' B' ' 164' ' ' VAL . 28.3 m-85 -70.02 -39.76 75.6 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.514 -0.741 . . . . 0.0 111.501 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -80.05 80.03 6.52 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.406 -0.809 . . . . 0.0 110.186 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -69.97 -42.07 73.64 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.413 -0.804 . . . . 0.0 110.932 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -72.78 -23.41 60.8 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.415 -0.803 . . . . 0.0 111.046 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.71 24.54 75.42 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -70.7 -9.73 57.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.504 -0.997 . . . . 0.0 111.131 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.69 -11.72 66.35 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -133.18 139.31 46.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.187 -1.184 . . . . 0.0 109.076 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.674 ' CG2' HD23 ' A' ' 105' ' ' LEU . 56.7 mt -89.37 123.25 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.532 -0.73 . . . . 0.0 110.042 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.4 m -86.96 170.14 11.85 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.405 0.621 . . . . 0.0 110.297 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.99 -39.91 75.63 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.632 -0.668 . . . . 0.0 109.749 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.25 -39.29 94.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.772 -0.58 . . . . 0.0 109.668 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -60.16 -39.89 87.97 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.606 -0.684 . . . . 0.0 110.386 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.674 HD23 ' CG2' ' A' ' 100' ' ' ILE . 0.5 OUTLIER -68.21 -41.23 81.63 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.484 0.659 . . . . 0.0 110.655 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -61.09 -37.03 81.27 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.656 -0.652 . . . . 0.0 111.746 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -59.97 -43.32 95.14 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.142 -0.974 . . . . 0.0 111.848 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.456 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 94.4 t -74.85 -44.24 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.237 -0.914 . . . . 0.0 111.631 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 94.5 mmm -58.25 -46.77 85.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.28 -0.888 . . . . 0.0 110.317 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.4 m -67.51 -41.07 85.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.46 -0.775 . . . . 0.0 109.202 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -61.55 -32.94 73.04 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.5 mt -68.52 -37.36 79.96 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.079 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 119.82 38.27 0.72 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -129.67 140.45 51.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.645 -0.915 . . . . 0.0 109.792 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -107.94 109.18 20.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.439 -0.788 . . . . 0.0 110.579 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 56.2 mt -131.59 156.2 46.18 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.598 -0.689 . . . . 0.0 109.753 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.3 m -84.0 164.76 19.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.626 -0.671 . . . . 0.0 109.744 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -61.13 -26.76 67.9 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.586 -0.696 . . . . 0.0 109.142 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.95 -31.85 73.0 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -37.34 87.26 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 73.1 t -70.64 -39.7 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.533 0.682 . . . . 0.0 110.201 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.409 ' HA ' HD12 ' A' ' 125' ' ' ILE . 44.4 t0 -59.89 -44.62 94.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.789 -0.57 . . . . 0.0 109.994 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -60.55 -41.33 94.34 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.579 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 67.6 mtt -55.6 -37.69 68.44 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 119.48 -0.888 . . . . 0.0 108.939 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 122' ' ' ASP . 96.7 mt -64.94 -39.93 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -58.64 -39.97 82.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.57 -0.706 . . . . 0.0 111.53 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -61.46 -40.0 92.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.398 -0.814 . . . . 0.0 111.86 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -102.93 -5.06 23.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.168 -0.957 . . . . 0.0 111.921 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -89.3 69.95 8.17 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.916 -1.115 . . . . 0.0 110.518 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.3 mt -70.03 -40.37 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.519 -0.738 . . . . 0.0 111.247 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -62.84 -39.96 95.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.357 -0.839 . . . . 0.0 111.207 -178.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 103.25 22.9 8.82 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.987 -1.102 . . . . 0.0 110.813 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -83.39 -7.71 59.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.33 -1.1 . . . . 0.0 110.767 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.05 -3.18 87.08 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -138.02 148.26 44.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.409 -1.053 . . . . 0.0 109.454 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 71.4 t -92.36 118.63 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.566 -0.709 . . . . 0.0 110.263 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -90.62 -174.32 4.05 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.361 -0.837 . . . . 0.0 110.823 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -69.98 -40.21 75.47 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.354 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.33 -50.11 74.94 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.181 -0.95 . . . . 0.0 111.383 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.47 -34.36 78.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.517 -0.739 . . . . 0.0 109.828 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.744 ' HE1' HG23 ' A' ' 85' ' ' ILE . 49.6 t80 -58.05 -49.3 77.37 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.038 0.447 . . . . 0.0 110.776 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 53.3 t -70.03 -39.08 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.365 -0.834 . . . . 0.0 111.211 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -57.6 -49.28 76.91 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.305 -0.872 . . . . 0.0 110.827 -178.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -59.35 -35.62 74.19 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.416 -0.802 . . . . 0.0 110.33 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.529 ' CE ' ' HB1' ' B' ' 161' ' ' ALA . 58.5 mtt -73.8 -40.0 63.7 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.53 -0.731 . . . . 0.0 110.549 178.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 34.8 m -69.9 -19.88 63.39 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.715 -0.615 . . . . 0.0 110.86 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -107.64 137.32 45.87 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.402 -0.811 . . . . 0.0 110.484 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.3 mttm . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.025 179.951 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -99.28 146.56 18.08 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -60.04 -41.84 93.13 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.595 -0.944 . . . . 0.0 110.098 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -59.96 -40.05 87.73 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.597 -0.689 . . . . 0.0 110.186 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -59.98 -40.19 88.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.733 -0.604 . . . . 0.0 110.703 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 160' ' ' ILE . . . . . 0.411 ' O ' HG23 ' B' ' 164' ' ' VAL . 95.3 mt -69.92 -40.41 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.396 -0.815 . . . . 0.0 111.973 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 161' ' ' ALA . . . . . 0.529 ' HB1' ' CE ' ' A' ' 145' ' ' MET . . . -66.14 -42.85 88.5 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.274 -0.892 . . . . 0.0 111.923 -178.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -68.68 -40.02 80.3 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.383 -0.823 . . . . 0.0 110.785 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.467 HD23 ' C ' ' B' ' 163' ' ' LEU . 10.3 tt -59.93 -42.87 94.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.499 -0.75 . . . . 0.0 110.397 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.516 ' HA ' HD12 ' B' ' 167' ' ' LEU . 85.8 t -65.85 -40.03 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.581 -0.699 . . . . 0.0 110.011 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.57 -39.97 93.95 Favored Glycine 0 N--CA 1.498 2.83 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 84.8 t -64.56 -37.39 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.464 -1.021 . . . . 0.0 110.314 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.557 HD13 HD11 ' A' ' 39' ' ' LEU . 95.7 mt -60.02 -45.35 93.08 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.52 -0.737 . . . . 0.0 110.919 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 168' ' ' ARG . . . . . 0.402 ' O ' ' CD2' ' B' ' 172' ' ' TYR . 21.5 mmt180 -59.94 -39.31 85.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.487 -0.758 . . . . 0.0 110.999 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -60.02 -37.95 81.26 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.446 -0.784 . . . . 0.0 109.747 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 170' ' ' TRP . . . . . 0.61 ' HH2' HD12 ' A' ' 63' ' ' ILE . 3.2 t-105 -59.98 -43.32 95.19 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.688 -0.633 . . . . 0.0 109.72 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.98 -52.04 65.61 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.568 -0.707 . . . . 0.0 110.641 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 172' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' B' ' 168' ' ' ARG . 53.6 m-85 -60.01 -38.75 83.57 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.485 -0.76 . . . . 0.0 110.538 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.542 -0.724 . . . . 0.0 110.246 -179.883 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.081 0.467 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -97.54 10.04 40.89 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.531 -0.731 . . . . 0.0 110.703 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -60.17 -37.09 79.1 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.375 -0.828 . . . . 0.0 111.403 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.03 -39.96 87.67 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.642 -0.661 . . . . 0.0 110.414 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.7 p -134.45 102.59 5.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.35 -0.844 . . . . 0.0 109.588 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -77.71 -10.05 59.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.878 -0.514 . . . . 0.0 111.427 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -68.51 -23.86 64.6 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.159 -0.963 . . . . 0.0 110.177 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -66.01 -36.91 84.56 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.415 -0.803 . . . . 0.0 109.539 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 94.3 mt -59.99 -32.4 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.817 -0.552 . . . . 0.0 111.53 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -65.6 -32.23 73.7 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.967 -1.083 . . . . 0.0 110.512 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -65.09 -45.54 84.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 109.946 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -69.99 -23.59 63.17 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.358 0.599 . . . . 0.0 110.09 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 23.1 tptp -66.61 -53.08 38.15 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.355 0.598 . . . . 0.0 109.562 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -57.09 -52.68 64.32 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.951 -0.699 . . . . 0.0 110.376 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.78 -26.39 68.69 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.352 -0.842 . . . . 0.0 111.105 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -58.25 -48.41 80.5 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.009 -1.057 . . . . 0.0 110.236 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.3 m -61.86 -39.85 93.31 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.306 -0.871 . . . . 0.0 109.143 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.5 tp -60.0 -39.98 87.64 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.351 0.596 . . . . 0.0 109.5 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -72.59 -35.49 67.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.727 -0.608 . . . . 0.0 110.392 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -95.4 98.96 10.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.471 -0.768 . . . . 0.0 110.371 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.2 mmtm -64.97 -32.04 73.57 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.377 -0.827 . . . . 0.0 111.192 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -79.83 -10.08 59.74 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.083 -1.011 . . . . 0.0 111.081 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.2 26.19 49.42 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -88.28 -3.29 58.88 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.605 -0.938 . . . . 0.0 110.637 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.57 5.46 64.94 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.297 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.9 p -145.1 142.39 29.64 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 119.166 1.483 . . . . 0.0 111.703 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 86.2 mt -103.86 128.0 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.3 p -102.05 141.22 35.23 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.619 -0.676 . . . . 0.0 110.628 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.455 ' O ' HD13 ' A' ' 48' ' ' LEU . 65.7 p -40.82 -35.87 0.56 Allowed 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -65.72 -45.44 82.69 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.249 -0.907 . . . . 0.0 109.548 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -60.05 -54.05 50.59 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.8 -0.562 . . . . 0.0 111.304 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.6 tt -59.95 -35.86 75.86 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.291 -0.881 . . . . 0.0 111.321 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.22 -28.98 44.16 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.2 m -69.54 -39.98 77.12 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.471 -1.017 . . . . 0.0 110.701 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.9 t -63.58 -54.98 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.691 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 97.8 mmm -59.96 -29.52 68.48 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.731 -0.606 . . . . 0.0 110.788 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -60.39 -50.44 73.58 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.503 -0.748 . . . . 0.0 110.448 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.4 t -72.55 -18.17 61.66 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.692 -0.63 . . . . 0.0 111.02 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.482 HD13 ' CD1' ' B' ' 167' ' ' LEU . 81.8 mt -100.11 -5.04 28.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.424 -0.797 . . . . 0.0 111.518 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.29 -68.04 0.12 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -160.21 170.64 20.75 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.228 -1.16 . . . . 0.0 111.448 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -110.53 117.21 51.41 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.972 -0.455 . . . . 0.0 110.215 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.697 ' CG ' HD21 ' A' ' 48' ' ' LEU . 53.1 Cg_endo -68.63 -150.37 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.324 0 N-CA-C 109.265 -1.091 . . . . 0.0 109.265 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 77.2 p -137.79 147.03 44.28 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.939 -1.101 . . . . 0.0 110.606 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.406 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 17.8 pt-20 -54.86 -21.1 10.32 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.55 -0.718 . . . . 0.0 111.46 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.53 -59.44 2.76 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.23 -38.43 85.21 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.832 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.697 HD21 ' CG ' ' A' ' 43' ' ' PRO . 56.5 mt -59.48 -33.71 71.65 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.666 0.746 . . . . 0.0 109.839 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.84 -39.01 83.89 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.022 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -65.93 -39.39 90.48 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.467 -0.771 . . . . 0.0 110.186 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 66.9 mtt -61.64 -43.39 98.94 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.415 0.626 . . . . 0.0 109.628 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.786 HG12 HD11 ' A' ' 63' ' ' ILE . 81.3 mt -68.02 -32.55 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.773 -0.579 . . . . 0.0 110.419 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -59.76 -40.04 86.83 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.384 -0.823 . . . . 0.0 110.292 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -64.07 -27.99 69.48 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.445 -0.785 . . . . 0.0 110.319 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.535 HG21 ' HE2' ' A' ' 71' ' ' MET . 61.0 t -101.01 -10.11 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.443 -0.785 . . . . 0.0 110.803 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.546 ' OD2' HG22 ' A' ' 52' ' ' ILE . 22.0 m-20 -67.25 100.5 0.81 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.136 -0.978 . . . . 0.0 111.163 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.0 -38.34 75.94 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -90.75 -30.45 17.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.756 -0.59 . . . . 0.0 110.622 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.6 22.42 43.5 Favored Glycine 0 N--CA 1.496 2.65 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.006 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -75.22 -31.89 61.0 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.342 -1.093 . . . . 0.0 110.657 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.4 1.1 12.48 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.334 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 77.8 p -133.49 170.01 16.13 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.116 -1.226 . . . . 0.0 110.429 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.786 HD11 HG12 ' A' ' 52' ' ' ILE . 7.0 mt -106.69 122.33 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.892 -177.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -98.5 170.03 9.11 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.521 0.676 . . . . 0.0 110.383 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.45 ' HB3' ' HD3' ' A' ' 66' ' ' PRO . 9.9 t80 -47.07 -48.77 53.1 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.586 -0.696 . . . . 0.0 112.802 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 65' ' ' PHE . 45.2 Cg_endo -71.26 -32.27 13.07 Favored 'Trans proline' 0 N--CA 1.487 1.102 0 O-C-N 122.783 0.886 . . . . 0.0 111.596 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -72.4 -40.21 67.38 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.123 -0.986 . . . . 0.0 110.409 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -62.74 -45.43 92.74 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.781 -0.574 . . . . 0.0 110.544 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.05 -40.01 87.96 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.515 -0.74 . . . . 0.0 110.472 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 93.1 m -61.19 -40.75 95.09 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.721 -0.612 . . . . 0.0 111.029 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.535 ' HE2' HG21 ' A' ' 55' ' ' VAL . 12.9 ttm -69.14 -41.07 77.82 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.45 -0.781 . . . . 0.0 112.099 -178.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -60.02 -50.0 75.44 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.335 -0.853 . . . . 0.0 111.226 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.59 -32.27 70.91 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.714 -0.616 . . . . 0.0 111.822 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.8 mmt85 -72.96 -43.51 62.2 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.33 -0.856 . . . . 0.0 111.819 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -73.4 -41.66 63.07 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.373 -0.829 . . . . 0.0 112.853 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 24.4 ptm -60.06 -29.77 68.77 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.162 -0.961 . . . . 0.0 111.538 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -63.19 -52.69 61.32 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.27 -0.894 . . . . 0.0 111.587 -178.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -69.84 -10.82 59.85 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.42 -0.8 . . . . 0.0 111.168 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.586 HG22 ' H ' ' A' ' 80' ' ' ASP 0.268 23.4 m -86.06 -174.58 5.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.581 -0.699 . . . . 0.0 109.369 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.586 ' H ' HG22 ' A' ' 79' ' ' THR . 94.1 m-20 -128.01 140.9 51.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.238 -0.914 . . . . 0.0 109.447 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.1 t -59.95 -35.05 74.13 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.633 -0.667 . . . . 0.0 110.152 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -61.08 -34.95 75.73 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.619 0.723 . . . . 0.0 109.471 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.99 -40.0 75.58 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.909 -0.494 . . . . 0.0 111.412 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.91 -40.0 79.34 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.443 -0.786 . . . . 0.0 111.062 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.448 HG23 ' HE1' ' A' ' 141' ' ' PHE . 82.8 mt -68.16 -51.82 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.45 -0.781 . . . . 0.0 110.984 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -60.01 -40.94 90.99 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.255 -0.903 . . . . 0.0 111.708 -178.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.517 ' O ' HG23 ' A' ' 91' ' ' VAL . 97.6 mt-10 -70.52 -41.45 72.56 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.51 -0.744 . . . . 0.0 111.576 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.31 -43.61 94.16 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.526 -0.734 . . . . 0.0 110.716 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -61.96 -40.81 96.86 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.811 0.815 . . . . 0.0 108.899 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 29.6 ttt85 -59.95 -37.13 78.67 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.395 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 87' ' ' GLU . 91.2 t -70.02 -50.03 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.509 -0.744 . . . . 0.0 110.153 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.674 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 27.3 m-85 -67.67 -39.97 84.47 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.405 -0.809 . . . . 0.0 110.261 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -79.58 76.3 6.21 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.403 ' HE3' ' CD2' ' A' ' 107' ' ' HIS . 60.2 mttm -68.85 -40.48 79.33 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.505 -0.747 . . . . 0.0 110.276 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -74.5 -21.67 59.44 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.418 -0.801 . . . . 0.0 110.64 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.2 26.41 73.43 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -69.92 -12.66 61.78 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.535 -0.979 . . . . 0.0 111.464 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.11 -20.62 14.07 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -144.77 153.74 41.97 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.239 -1.154 . . . . 0.0 109.994 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 80.6 mt -88.88 131.58 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.887 0.851 . . . . 0.0 110.457 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.2 m -87.7 171.01 10.75 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.193 0.521 . . . . 0.0 110.367 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.499 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -65.68 -40.07 91.97 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.41 -38.49 89.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.748 -0.595 . . . . 0.0 109.5 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -61.84 -39.95 93.61 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.751 -0.593 . . . . 0.0 110.666 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.66 ' HB3' HG13 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -61.38 -45.61 93.63 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.44 -0.788 . . . . 0.0 109.761 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -64.42 -29.0 70.06 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.768 -0.582 . . . . 0.0 110.513 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.403 ' CD2' ' HE3' ' A' ' 94' ' ' LYS . 1.5 t-80 -61.59 -46.8 88.32 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.445 -0.785 . . . . 0.0 111.361 -178.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.674 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 66.5 t -73.38 -47.93 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.472 -0.768 . . . . 0.0 111.727 -178.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.468 ' HA ' HD12 ' A' ' 112' ' ' LEU . 98.0 mtp -58.61 -39.95 81.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.222 -0.923 . . . . 0.0 110.544 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.4 m -66.58 -45.27 79.79 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -61.45 -33.41 73.68 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 109' ' ' MET . 59.2 mt -68.83 -38.74 80.06 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.922 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 119.97 39.88 0.62 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -123.32 136.01 54.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.664 -0.903 . . . . 0.0 109.991 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -96.71 126.41 41.86 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.519 -0.738 . . . . 0.0 109.701 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.688 HD23 ' N ' ' A' ' 116' ' ' LEU . 1.0 OUTLIER -152.52 153.77 34.12 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.513 -0.742 . . . . 0.0 111.443 -178.813 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.7 p -87.36 168.04 13.51 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 36.6 p-10 -64.46 -20.69 66.34 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.644 -0.823 . . . . 0.0 108.879 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -69.71 -37.93 76.76 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.973 0.892 . . . . 0.0 109.134 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -61.48 -39.98 92.88 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 122.131 0.967 . . . . 0.0 108.967 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.66 HG13 ' HB3' ' A' ' 105' ' ' LEU . 63.7 t -69.73 -39.85 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.663 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -59.79 -48.54 81.29 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.572 -0.705 . . . . 0.0 110.217 -178.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -59.99 -40.04 87.8 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.93 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.451 ' HB3' HD11 ' A' ' 105' ' ' LEU . 92.8 mmm -55.4 -38.16 68.55 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.136 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.41 -36.92 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 121.667 0.746 . . . . 0.0 109.154 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -58.14 -39.66 79.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.804 -0.56 . . . . 0.0 111.072 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.96 -39.31 85.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.549 -0.719 . . . . 0.0 111.297 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.91 -18.8 18.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.281 -0.887 . . . . 0.0 111.103 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -72.42 70.84 0.9 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.312 -0.867 . . . . 0.0 111.349 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 85.4 mt -67.8 -40.41 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.45 -0.781 . . . . 0.0 110.557 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -72.32 -18.26 61.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.438 -0.789 . . . . 0.0 111.581 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.23 22.48 60.68 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 120.136 -1.03 . . . . 0.0 110.853 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -82.6 -7.23 59.65 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.181 -1.188 . . . . 0.0 110.782 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.19 -0.83 89.52 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -138.52 149.5 45.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.327 -1.102 . . . . 0.0 109.246 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.6 t -92.98 110.85 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.356 -0.84 . . . . 0.0 110.7 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -80.0 172.77 13.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.493 -0.754 . . . . 0.0 109.647 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -67.94 -40.07 83.36 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.795 -0.566 . . . . 0.0 111.009 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -62.85 -52.29 63.69 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.252 -0.905 . . . . 0.0 111.988 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -69.12 -23.3 63.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -0.849 . . . . 0.0 111.122 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.448 ' HE1' HG23 ' A' ' 85' ' ' ILE . 63.3 t80 -60.08 -42.3 94.3 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.433 -0.792 . . . . 0.0 109.598 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 95.3 t -70.09 -37.67 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.726 -0.609 . . . . 0.0 111.047 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -59.94 -50.03 75.36 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.49 -0.757 . . . . 0.0 110.935 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.476 ' HE1' ' CD1' ' B' ' 157' ' ' PHE . 59.5 ttp -59.95 -37.73 80.4 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.261 -0.899 . . . . 0.0 110.299 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 94.2 mmm -67.1 -39.99 86.82 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.749 -0.594 . . . . 0.0 111.372 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 64.5 m -57.59 -26.12 61.04 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.292 -0.88 . . . . 0.0 110.543 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.78 135.0 41.72 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.47 -0.769 . . . . 0.0 110.21 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.141 179.969 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -133.87 140.36 11.72 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.48 ' O ' HG22 ' B' ' 160' ' ' ILE . 36.0 t80 -61.96 -41.26 97.8 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.597 -0.943 . . . . 0.0 110.37 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -62.5 -40.04 95.43 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.561 -0.712 . . . . 0.0 110.585 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -61.66 -48.12 82.28 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.643 -0.661 . . . . 0.0 111.191 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 160' ' ' ILE . . . . . 0.48 HG22 ' O ' ' B' ' 157' ' ' PHE . 14.3 tt -69.95 -26.04 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.527 -0.733 . . . . 0.0 111.04 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.48 -35.34 77.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.504 -0.748 . . . . 0.0 109.661 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -59.97 -40.09 87.89 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.817 -0.552 . . . . 0.0 109.997 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 59.7 mt -63.27 -39.96 96.07 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.525 -0.734 . . . . 0.0 110.704 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 91.2 t -62.75 -40.4 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.455 -0.778 . . . . 0.0 110.414 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.05 -40.02 96.51 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 48.1 t -70.53 -22.53 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.613 -0.934 . . . . 0.0 110.833 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.482 ' CD1' HD13 ' A' ' 39' ' ' LEU . 9.6 tt -59.98 -41.93 93.1 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.3 -0.875 . . . . 0.0 110.076 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -69.48 -35.98 76.09 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.577 -0.702 . . . . 0.0 109.767 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 169' ' ' GLU . . . . . 0.446 ' OE2' HG21 ' A' ' 79' ' ' THR . 89.8 mt-10 -59.92 -36.65 77.46 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.665 -0.647 . . . . 0.0 110.235 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 4.9 t-105 -60.06 -40.91 91.12 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.671 -0.643 . . . . 0.0 110.722 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.06 -50.12 74.95 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.453 -0.78 . . . . 0.0 110.65 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -60.01 -39.99 87.72 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.417 -0.802 . . . . 0.0 110.354 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 71.2 mtt-85 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.615 -0.678 . . . . 0.0 110.277 -179.537 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.269 0.557 . . . . 0.0 110.017 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -109.18 25.78 11.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.689 -0.632 . . . . 0.0 110.235 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -60.0 -40.05 87.89 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.559 -0.713 . . . . 0.0 110.344 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 76.1 mt -72.89 173.99 8.42 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.335 0.588 . . . . 0.0 110.01 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.96 117.0 7.26 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.388 0.613 . . . . 0.0 109.534 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -71.59 -26.56 62.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.912 -0.493 . . . . 0.0 110.645 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -64.03 -20.44 65.92 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.522 -0.736 . . . . 0.0 111.492 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -70.56 -38.67 74.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.265 -0.897 . . . . 0.0 109.542 177.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 88.0 mt -62.99 -37.94 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.958 -0.464 . . . . 0.0 111.699 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.66 -39.77 89.61 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.206 -0.934 . . . . 0.0 110.344 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -60.06 -39.58 86.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.374 -0.829 . . . . 0.0 110.407 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.588 ' HB3' HD21 ' A' ' 69' ' ' LEU . 47.2 m-85 -64.17 -22.1 66.81 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.682 -0.636 . . . . 0.0 110.885 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -69.52 -41.14 76.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.303 -0.873 . . . . 0.0 109.181 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -71.91 -23.76 61.53 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.133 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.05 -35.49 42.48 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.342 -0.849 . . . . 0.0 110.107 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.433 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 54.7 t80 -58.38 -38.13 76.68 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.899 -0.5 . . . . 0.0 110.914 -178.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.3 p -61.02 -37.15 81.54 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.35 -0.844 . . . . 0.0 109.92 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.643 HD13 ' O ' ' A' ' 18' ' ' LEU . 0.8 OUTLIER -59.98 -40.01 87.67 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.611 -0.681 . . . . 0.0 109.459 179.545 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -78.14 -36.25 48.01 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.629 -0.669 . . . . 0.0 110.266 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -93.19 95.8 9.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.581 -0.699 . . . . 0.0 109.967 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -61.74 -32.82 73.08 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.574 -0.704 . . . . 0.0 111.221 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -79.37 -10.43 59.81 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.234 -0.916 . . . . 0.0 111.565 -177.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.51 27.75 54.72 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -92.98 -2.54 55.67 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.616 -0.931 . . . . 0.0 111.0 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.38 2.67 63.58 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.787 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 76.2 p -142.05 141.11 32.76 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 119.559 1.68 . . . . 0.0 111.76 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.622 ' HB ' HD12 ' A' ' 63' ' ' ILE . 85.7 mt -105.39 130.14 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.792 -0.567 . . . . 0.0 110.428 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.3 p -113.01 146.6 38.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.599 -0.688 . . . . 0.0 110.779 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.432 HG23 HG13 ' A' ' 52' ' ' ILE . 40.7 p -42.4 -31.08 0.38 Allowed 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.744 -0.598 . . . . 0.0 112.378 -177.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -65.38 -48.98 71.04 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.569 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -60.43 -56.82 16.76 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.967 -0.458 . . . . 0.0 111.767 -178.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.6 tp -61.54 -32.79 72.87 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.105 -0.997 . . . . 0.0 110.632 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -50.79 -33.95 28.49 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.3 m -69.98 -40.03 75.59 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.691 -0.888 . . . . 0.0 110.244 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.2 t -63.45 -58.51 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.573 -0.704 . . . . 0.0 110.264 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.427 ' HG2' HD21 ' B' ' 167' ' ' LEU . 74.0 mtm -60.01 -30.04 68.88 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.574 -0.704 . . . . 0.0 110.447 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 1.6 tmm_? -60.77 -50.36 73.77 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.566 -0.709 . . . . 0.0 109.601 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.9 t -74.78 -20.06 59.95 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.872 -0.517 . . . . 0.0 110.33 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.516 HD22 ' CD1' ' B' ' 167' ' ' LEU . 5.4 mp -97.97 -1.48 42.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.393 -0.817 . . . . 0.0 111.352 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.07 -71.43 0.11 Allowed Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.898 -1.144 . . . . 0.0 110.374 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.411 ' HG2' ' N ' ' A' ' 42' ' ' ASN . 36.5 tt0 -162.04 161.01 28.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.183 -1.186 . . . . 0.0 111.316 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.411 ' N ' ' HG2' ' A' ' 41' ' ' GLN . 45.3 t30 -111.65 103.4 55.07 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -61.78 -146.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 O-C-N 123.512 1.269 . . . . 0.0 110.402 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.8 p -132.86 157.54 44.79 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.619 -1.3 . . . . 0.0 112.122 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.421 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 45.8 mt-10 -52.64 -23.36 6.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.886 -0.509 . . . . 0.0 111.647 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.05 -59.94 2.6 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.149 0.976 . . . . 0.0 108.419 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -67.86 -36.2 79.88 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.589 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 45' ' ' GLU . 8.8 mt -58.3 -35.02 71.22 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.605 0.717 . . . . 0.0 109.769 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -64.68 -39.79 94.29 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.068 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -64.8 -40.02 94.55 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.542 -0.724 . . . . 0.0 111.192 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 64.5 mtt -60.04 -42.53 94.63 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.618 -0.676 . . . . 0.0 109.791 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.827 HG22 ' OD2' ' A' ' 56' ' ' ASP . 48.5 mm -68.33 -37.18 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.855 -0.528 . . . . 0.0 111.11 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -60.97 -40.04 91.89 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.484 -0.76 . . . . 0.0 111.511 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -69.99 -28.25 65.36 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.188 -0.945 . . . . 0.0 110.482 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.1 t -95.61 -9.96 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.648 -0.658 . . . . 0.0 111.229 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.827 ' OD2' HG22 ' A' ' 52' ' ' ILE . 25.4 m-20 -74.71 97.45 3.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.176 -0.953 . . . . 0.0 110.766 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.01 -34.53 73.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.541 -0.724 . . . . 0.0 109.804 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -91.41 -26.3 18.93 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.556 -0.715 . . . . 0.0 110.774 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.14 20.17 50.4 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.035 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -76.13 -26.34 56.25 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.434 -1.039 . . . . 0.0 110.461 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.438 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 109.8 -2.09 30.37 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 77.0 p -130.71 170.89 13.74 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.187 -1.184 . . . . 0.0 110.625 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.622 HD12 ' HB ' ' A' ' 27' ' ' ILE . 6.4 mt -89.4 167.5 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.218 0.533 . . . . 0.0 110.007 -178.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.425 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 81.6 m-20 -147.04 150.57 35.35 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.496 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.7 m-85 -42.98 -52.45 11.57 Favored Pre-proline 0 N--CA 1.506 2.344 0 O-C-N 121.702 -0.624 . . . . 0.0 111.71 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.669 ' O ' HG23 ' A' ' 70' ' ' THR . 43.4 Cg_endo -69.41 -29.85 24.87 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 O-C-N 123.269 1.142 . . . . 0.0 111.334 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -72.55 -45.46 59.19 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.014 -1.054 . . . . 0.0 110.067 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -60.47 -43.93 96.41 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.755 -0.59 . . . . 0.0 110.665 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.588 HD21 ' HB3' ' A' ' 12' ' ' PHE . 78.3 mt -67.13 -41.55 85.93 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.686 -0.633 . . . . 0.0 111.757 -178.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.669 HG23 ' O ' ' A' ' 66' ' ' PRO . 43.0 p -62.71 -40.16 96.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.337 -0.852 . . . . 0.0 110.718 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.414 ' HE3' ' CE3' ' B' ' 170' ' ' TRP . 56.4 ttp -66.35 -46.57 76.32 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.79 -0.569 . . . . 0.0 111.315 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.7 ttm -60.06 -49.97 75.56 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.388 -0.82 . . . . 0.0 111.352 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.54 -33.52 72.78 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.487 -0.758 . . . . 0.0 110.58 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.6 ttp180 -69.98 -39.52 75.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.722 -0.611 . . . . 0.0 110.857 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.775 ' O ' HG22 ' A' ' 79' ' ' THR . 4.3 mptp? -71.83 -18.25 62.09 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.455 -0.778 . . . . 0.0 112.086 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 26.9 mmt -58.96 -50.02 75.66 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.99 -1.069 . . . . 0.0 110.735 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.99 -32.7 71.04 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.692 -0.63 . . . . 0.0 111.121 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -70.67 -18.9 62.83 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.43 -0.794 . . . . 0.0 111.549 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.775 HG22 ' O ' ' A' ' 75' ' ' LYS . 14.4 t -121.93 -162.94 1.02 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.879 0.847 . . . . 0.0 112.284 -178.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -127.97 142.2 51.31 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.353 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.3 t -66.73 -32.51 73.86 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.83 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -60.08 -36.98 78.58 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.881 0.848 . . . . 0.0 109.199 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.86 -39.97 76.04 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.306 0.574 . . . . 0.0 110.389 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -61.63 -37.49 84.17 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.606 -0.684 . . . . 0.0 110.75 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 77.4 mt -67.73 -44.43 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.538 -0.726 . . . . 0.0 110.685 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -59.25 -39.96 84.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.417 -0.802 . . . . 0.0 110.561 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -70.02 -39.96 75.48 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.339 -0.851 . . . . 0.0 111.346 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.434 ' HA ' HG11 ' B' ' 164' ' ' VAL . . . -63.98 -46.26 85.41 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.466 -0.771 . . . . 0.0 111.317 -178.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.423 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 52.2 t80 -62.39 -39.99 95.02 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.481 -0.762 . . . . 0.0 109.617 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 39.4 ttm-85 -59.99 -39.3 85.24 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.821 -0.55 . . . . 0.0 111.247 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.6 t -70.02 -43.89 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.482 -0.761 . . . . 0.0 110.354 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.548 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 16.2 m-85 -68.62 -39.28 80.88 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.345 -0.847 . . . . 0.0 111.119 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -78.64 78.2 5.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.515 -0.74 . . . . 0.0 109.867 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -59.98 -45.39 92.88 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.487 -0.758 . . . . 0.0 110.358 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 33.3 p-10 -79.71 -19.59 48.51 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.641 -0.662 . . . . 0.0 110.869 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.18 62.5 6.28 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -105.74 -10.59 16.66 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.389 -1.065 . . . . 0.0 111.262 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 123.91 -25.62 6.09 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.419 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 27.5 p90 -145.75 152.49 39.65 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.483 -1.01 . . . . 0.0 109.42 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 77.4 mt -88.84 131.39 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.887 0.851 . . . . 0.0 110.197 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.97 171.84 10.02 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.269 0.557 . . . . 0.0 110.588 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.0 -41.57 97.44 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.603 -0.686 . . . . 0.0 109.304 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.96 -37.7 88.51 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -64.82 -40.08 94.62 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.607 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.639 ' HB3' HG13 ' A' ' 121' ' ' VAL . 1.3 tt -60.29 -45.48 93.19 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.336 -0.852 . . . . 0.0 109.264 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.8 ttt-85 -62.54 -30.99 71.7 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.844 -0.535 . . . . 0.0 111.081 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -59.94 -46.12 90.42 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.164 -0.96 . . . . 0.0 110.417 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.548 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 90.2 t -74.96 -33.0 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.411 -0.806 . . . . 0.0 110.926 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.1 mmt -60.09 -49.12 78.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.454 -0.779 . . . . 0.0 110.323 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 76.8 m -68.6 -43.92 75.42 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.66 -0.65 . . . . 0.0 110.414 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -59.89 -29.32 68.26 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.56 -0.712 . . . . 0.0 109.501 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.492 HD11 HG12 ' A' ' 108' ' ' VAL . 27.4 mt -70.01 -29.65 66.78 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.694 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 112.21 18.98 7.38 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -122.03 145.03 48.54 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.248 -1.148 . . . . 0.0 110.35 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -105.53 123.6 48.16 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.539 -0.726 . . . . 0.0 110.666 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 72.2 mt -135.38 157.83 45.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.625 -0.672 . . . . 0.0 110.02 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.22 166.75 16.28 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.631 -0.668 . . . . 0.0 109.226 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -61.72 -26.37 68.01 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.94 -34.54 78.36 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.466 0.651 . . . . 0.0 109.57 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.33 -35.86 82.28 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.639 HG13 ' HB3' ' A' ' 105' ' ' LEU . 53.9 t -68.07 -39.98 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 121.507 0.67 . . . . 0.0 109.884 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.518 ' HA ' HD12 ' A' ' 125' ' ' ILE . 55.2 t0 -59.99 -49.85 76.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.733 -0.604 . . . . 0.0 110.511 -178.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -60.44 -42.04 95.31 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.494 -0.754 . . . . 0.0 110.423 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 86.8 mtp -55.18 -37.83 67.55 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.205 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 122' ' ' ASP . 90.3 mt -63.69 -38.67 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.447 0.641 . . . . 0.0 109.509 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -53.85 -35.77 61.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.665 -0.647 . . . . 0.0 111.613 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -59.83 -40.04 87.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.488 -0.758 . . . . 0.0 111.207 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.81 -5.13 17.46 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.221 -0.924 . . . . 0.0 111.167 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.444 ' HB2' HG22 ' A' ' 125' ' ' ILE . 65.4 t0 -79.78 68.06 5.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.076 -1.015 . . . . 0.0 109.89 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 82.8 mt -68.13 -39.97 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.684 -0.635 . . . . 0.0 110.725 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 37.4 p-10 -70.02 -20.91 63.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.372 -0.83 . . . . 0.0 110.923 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.09 21.43 60.98 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.062 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -82.01 -10.09 59.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -1.133 . . . . 0.0 110.952 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.61 3.46 77.66 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -139.18 147.8 42.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -1.144 . . . . 0.0 109.875 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.6 t -93.17 114.78 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.417 -0.802 . . . . 0.0 110.071 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -82.77 172.0 13.35 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -60.09 -43.85 95.22 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.361 0.601 . . . . 0.0 109.518 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -62.47 -47.61 83.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.678 -0.638 . . . . 0.0 111.013 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -65.35 -33.21 75.42 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.471 -0.768 . . . . 0.0 110.213 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 89.0 t80 -60.05 -47.07 87.38 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.941 -0.474 . . . . 0.0 111.116 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 83.7 t -70.01 -39.14 77.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.257 -0.902 . . . . 0.0 111.193 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -59.97 -49.49 77.47 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.414 -0.804 . . . . 0.0 111.093 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -60.01 -38.09 81.65 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.438 -0.789 . . . . 0.0 110.947 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 97.5 mtp -66.4 -40.0 89.35 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.606 -0.684 . . . . 0.0 110.603 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 66.8 p -98.56 22.13 10.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.417 -0.802 . . . . 0.0 110.387 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.93 -48.22 82.58 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.434 -0.791 . . . . 0.0 110.817 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 90.7 mttt . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.436 -179.58 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -89.38 148.49 20.1 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -59.91 -44.52 94.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.637 -0.919 . . . . 0.0 110.264 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -60.95 -40.01 91.69 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.655 -0.653 . . . . 0.0 111.393 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -62.03 -39.94 94.04 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.372 -0.83 . . . . 0.0 111.521 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 90.6 mt -68.43 -40.05 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.429 -0.794 . . . . 0.0 110.873 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.47 -40.04 92.7 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.325 -0.859 . . . . 0.0 111.05 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -61.61 -41.03 96.87 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.379 -0.826 . . . . 0.0 110.966 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.75 -39.98 90.74 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.496 -0.752 . . . . 0.0 110.595 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.434 HG11 ' HA ' ' A' ' 88' ' ' ALA . 96.8 t -66.26 -40.01 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.604 -0.685 . . . . 0.0 110.022 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -54.46 -42.6 75.9 Favored Glycine 0 N--CA 1.5 2.947 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.69 -18.91 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.656 -0.908 . . . . 0.0 110.371 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.57 HD23 ' C ' ' B' ' 167' ' ' LEU . 9.3 tt -59.95 -49.95 75.65 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.323 -0.86 . . . . 0.0 110.905 -178.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -64.62 -39.96 94.63 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.455 -0.778 . . . . 0.0 109.762 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -62.33 -25.39 67.86 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.75 -0.594 . . . . 0.0 110.055 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 170' ' ' TRP . . . . . 0.414 ' CE3' ' HE3' ' A' ' 71' ' ' MET . 2.6 t-105 -59.88 -43.0 94.98 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.524 -0.735 . . . . 0.0 109.925 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.06 -46.92 87.96 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.543 -0.723 . . . . 0.0 110.538 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -60.05 -38.28 82.33 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.421 -0.799 . . . . 0.0 110.381 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 . . . . . 0 N--CA 1.494 1.737 0 O-C-N 121.593 -0.692 . . . . 0.0 110.283 -179.755 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.188 0.518 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -104.01 16.15 26.93 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.476 -0.765 . . . . 0.0 111.059 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -59.94 -40.11 87.83 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.287 -0.883 . . . . 0.0 110.259 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 90.7 mt -111.44 -176.59 2.98 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.451 0.643 . . . . 0.0 110.688 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.45 106.44 5.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.701 -0.625 . . . . 0.0 109.651 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.449 ' HA ' HG12 ' A' ' 9' ' ' ILE . 50.6 mt-10 -83.39 -9.92 58.75 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.818 -0.551 . . . . 0.0 111.265 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -70.0 -34.63 73.57 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.184 -0.947 . . . . 0.0 110.123 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -69.85 -22.34 63.27 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.343 0.592 . . . . 0.0 110.278 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.449 HG12 ' HA ' ' A' ' 6' ' ' GLU . 47.9 mm -57.9 -50.01 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.346 -0.846 . . . . 0.0 110.744 -177.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.16 -22.38 66.92 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.36 -0.838 . . . . 0.0 111.591 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -68.54 -53.62 21.9 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.333 -0.854 . . . . 0.0 109.448 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.427 ' CE1' ' HG2' ' A' ' 72' ' ' MET . 25.6 m-85 -67.9 -21.88 65.11 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.373 0.606 . . . . 0.0 109.44 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -66.99 -41.81 86.11 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.412 0.625 . . . . 0.0 109.951 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.33 -56.98 14.94 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.794 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.68 -33.95 76.11 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.261 -0.899 . . . . 0.0 111.438 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -58.04 -49.99 74.97 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.151 -0.968 . . . . 0.0 110.236 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.2 m -65.51 -38.63 90.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.313 -0.867 . . . . 0.0 108.761 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.4 tp -60.0 -37.63 80.27 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.29 0.567 . . . . 0.0 109.893 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -73.48 -28.64 62.04 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.648 -0.658 . . . . 0.0 110.569 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -96.31 102.03 13.75 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.348 -0.845 . . . . 0.0 109.682 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -67.07 -31.57 72.17 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.435 -0.79 . . . . 0.0 111.446 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -79.85 -9.58 59.68 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.122 -0.986 . . . . 0.0 111.148 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 64.14 24.64 68.97 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -79.77 -9.55 59.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.453 -1.028 . . . . 0.0 110.939 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.417 ' C ' HG23 ' A' ' 26' ' ' THR . . . 80.01 6.94 88.92 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -178.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.417 HG23 ' C ' ' A' ' 25' ' ' GLY . 78.0 p -148.22 142.14 25.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.124 -1.221 . . . . 0.0 109.892 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.4 mt -103.49 123.38 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.748 -0.595 . . . . 0.0 110.096 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 65.5 p -98.82 143.84 28.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.862 -0.524 . . . . 0.0 109.716 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.406 ' H ' HG23 ' A' ' 29' ' ' THR . 70.5 p -40.5 -36.6 0.59 Allowed 'General case' 0 N--CA 1.512 2.646 0 O-C-N 121.806 -0.559 . . . . 0.0 112.195 -177.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -63.51 -45.31 91.27 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.209 -0.932 . . . . 0.0 109.527 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -59.95 -52.82 63.75 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.752 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.412 HD21 ' NE1' ' B' ' 170' ' ' TRP . 64.1 tp -59.19 -37.4 77.32 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.131 -0.98 . . . . 0.0 110.846 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -52.92 -32.28 41.21 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.5 m -70.04 -39.96 75.42 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.603 -0.939 . . . . 0.0 110.483 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.3 t -63.99 -57.19 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.453 -0.779 . . . . 0.0 109.851 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 98.2 mtp -59.21 -28.33 66.56 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.622 -0.674 . . . . 0.0 110.037 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 3.8 tmt_? -59.97 -39.58 86.14 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.4 t -66.16 -17.24 64.6 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.849 -0.532 . . . . 0.0 110.861 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.688 HD22 HD21 ' B' ' 167' ' ' LEU . 33.7 tp -85.61 -28.38 24.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.295 -0.878 . . . . 0.0 109.22 179.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.65 -46.85 0.2 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -160.96 176.36 11.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.772 -0.84 . . . . 0.0 110.253 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -120.01 148.62 47.18 Favored Pre-proline 0 C--N 1.299 -1.602 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.754 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.689 ' HG2' HD21 ' A' ' 48' ' ' LEU . 54.6 Cg_endo -69.48 -147.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.318 0 O-C-N 123.626 1.329 . . . . 0.0 109.627 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 57.8 p -136.42 149.4 48.25 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.905 -1.122 . . . . 0.0 111.431 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -52.62 -24.02 7.62 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.706 -0.621 . . . . 0.0 111.57 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.35 -59.5 2.73 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.092 0.949 . . . . 0.0 108.636 177.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -66.75 -37.74 85.22 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.907 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.689 HD21 ' HG2' ' A' ' 43' ' ' PRO . 39.6 mt -58.55 -35.18 71.93 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.774 0.797 . . . . 0.0 109.507 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.4 -39.27 78.04 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.062 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -66.41 -38.02 86.54 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.481 -0.762 . . . . 0.0 110.675 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 73.2 mmm -60.05 -44.67 94.54 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.633 0.73 . . . . 0.0 109.469 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.879 HG22 ' OD2' ' A' ' 56' ' ' ASP . 96.7 mt -68.83 -34.59 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-O 121.173 0.511 . . . . 0.0 110.413 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -60.7 -40.99 94.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.441 -0.787 . . . . 0.0 110.659 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -70.69 -29.43 65.73 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.329 -0.857 . . . . 0.0 110.813 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.8 t -98.23 -8.15 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.68 -0.637 . . . . 0.0 111.862 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.879 ' OD2' HG22 ' A' ' 52' ' ' ILE . 9.1 m-20 -71.98 107.44 4.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.012 -1.055 . . . . 0.0 111.106 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.52 -41.08 85.0 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.542 -0.723 . . . . 0.0 109.715 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -87.85 -29.94 20.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.631 -0.668 . . . . 0.0 110.309 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.08 21.16 46.96 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.609 -0.997 . . . . 0.0 110.609 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -72.22 -37.8 69.12 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.391 -1.064 . . . . 0.0 110.258 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.77 -6.43 5.5 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 120.197 -1.001 . . . . 0.0 111.114 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 81.1 p -135.36 170.08 16.5 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.078 -1.248 . . . . 0.0 110.588 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.642 HD12 ' HH2' ' B' ' 170' ' ' TRP . 7.0 mt -106.13 123.73 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-O 121.609 0.718 . . . . 0.0 111.204 -177.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -101.68 172.03 7.2 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.701 0.763 . . . . 0.0 111.103 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.498 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -46.8 -49.96 45.76 Favored Pre-proline 0 N--CA 1.499 1.992 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 39.4 Cg_endo -65.73 -36.66 31.41 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 122.889 0.941 . . . . 0.0 111.795 -178.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -70.01 -39.95 75.55 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.24 -0.912 . . . . 0.0 110.455 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -61.55 -40.28 94.15 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.606 -0.683 . . . . 0.0 111.042 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.2 mt -68.87 -40.01 79.51 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.425 -0.797 . . . . 0.0 111.848 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 47.2 p -59.97 -45.68 91.91 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.164 -0.96 . . . . 0.0 111.161 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 56.3 ttp -68.77 -40.0 79.94 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.531 -0.73 . . . . 0.0 111.458 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.605 ' CE ' HG11 ' B' ' 166' ' ' VAL . 48.6 tpp -60.12 -49.61 76.96 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.445 -0.785 . . . . 0.0 111.279 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.49 -31.18 66.82 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.523 -0.736 . . . . 0.0 112.174 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -83.38 -50.73 8.04 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.336 -0.853 . . . . 0.0 111.907 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.403 ' CG ' ' CG ' ' B' ' 169' ' ' GLU . 60.1 tptt -66.4 -40.0 89.36 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.564 -0.71 . . . . 0.0 112.192 -178.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.4 ' HG3' ' N ' ' A' ' 77' ' ' LYS . 28.1 ptm -55.13 -34.12 63.47 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.254 -0.904 . . . . 0.0 111.756 -177.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.4 ' N ' ' HG3' ' A' ' 76' ' ' MET . 33.7 mtpt -67.88 -39.86 83.63 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.352 -0.843 . . . . 0.0 110.151 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -67.03 -20.05 65.79 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.594 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.658 HG23 ' NH2' ' B' ' 168' ' ' ARG . 4.1 m -79.56 -174.75 4.43 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.693 -0.629 . . . . 0.0 109.797 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.596 ' H ' HG22 ' A' ' 79' ' ' THR . 85.4 m-20 -135.82 131.41 35.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.317 -0.865 . . . . 0.0 109.158 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.1 t -60.5 -34.55 74.23 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.444 -0.785 . . . . 0.0 110.071 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.04 -39.53 86.23 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.768 0.794 . . . . 0.0 109.542 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.97 -40.01 75.63 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.417 0.627 . . . . 0.0 111.075 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -66.28 -35.93 81.65 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.611 -0.68 . . . . 0.0 111.425 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.561 HG23 ' HE1' ' A' ' 141' ' ' PHE . 67.0 mt -67.28 -47.32 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.491 -0.756 . . . . 0.0 110.818 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -59.95 -41.92 92.91 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.329 -0.857 . . . . 0.0 112.104 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.642 ' O ' HG23 ' A' ' 91' ' ' VAL . 72.7 mt-10 -73.95 -39.98 63.36 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.438 -0.788 . . . . 0.0 111.952 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.31 -47.15 80.55 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.389 -0.82 . . . . 0.0 111.378 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -60.06 -45.96 91.14 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.606 0.717 . . . . 0.0 109.862 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -60.01 -34.04 72.81 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.979 -0.45 . . . . 0.0 111.047 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 87' ' ' GLU . 98.6 t -70.08 -53.51 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.243 -0.91 . . . . 0.0 110.254 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -63.27 -39.46 94.64 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.398 -0.814 . . . . 0.0 110.539 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -77.17 79.06 3.7 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -60.08 -41.0 91.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.407 -0.808 . . . . 0.0 111.034 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -84.11 -23.02 30.9 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.457 -0.777 . . . . 0.0 111.283 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.8 31.92 76.73 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.45 ' ND2' ' CE2' ' A' ' 99' ' ' TYR . 33.4 p-10 -76.09 -12.03 60.04 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.562 -0.963 . . . . 0.0 112.085 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.37 -20.92 10.2 Favored Glycine 0 N--CA 1.497 2.762 0 C-N-CA 119.919 -1.134 . . . . 0.0 110.45 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.45 ' CE2' ' ND2' ' A' ' 97' ' ' ASN . 27.7 p90 -145.25 150.04 35.97 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.224 -1.162 . . . . 0.0 108.783 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.662 ' CG2' HD23 ' A' ' 105' ' ' LEU . 20.8 mt -89.29 130.32 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.734 0.778 . . . . 0.0 111.396 -178.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.6 m -87.93 172.95 9.21 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.205 0.526 . . . . 0.0 109.999 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.08 -39.96 82.8 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.643 -0.661 . . . . 0.0 109.248 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.7 -40.04 93.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.804 -0.56 . . . . 0.0 109.835 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -61.96 -39.94 93.87 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.616 -0.678 . . . . 0.0 110.012 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.662 HD23 ' CG2' ' A' ' 100' ' ' ILE . 0.6 OUTLIER -63.65 -40.32 96.56 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.74 -0.6 . . . . 0.0 109.597 179.045 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 57.1 mtp85 -61.31 -31.82 71.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.551 -0.718 . . . . 0.0 110.954 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -59.96 -48.6 81.03 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.38 -0.825 . . . . 0.0 111.002 -178.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.662 HG12 ' CD1' ' A' ' 112' ' ' LEU . 85.3 t -69.92 -44.96 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 121.354 -0.841 . . . . 0.0 111.572 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.778 ' SD ' HD12 ' A' ' 116' ' ' LEU . 66.2 mtt -58.61 -46.78 86.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 0.0 111.356 -177.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.0 m -66.09 -47.69 73.38 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.467 -0.771 . . . . 0.0 109.934 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -61.9 -31.5 71.8 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.662 ' CD1' HG12 ' A' ' 108' ' ' VAL . 19.1 mt -69.89 -40.04 75.89 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 120.176 -0.609 . . . . 0.0 110.301 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.22 35.34 1.49 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -133.9 132.29 40.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.557 -0.967 . . . . 0.0 109.86 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -102.82 127.89 49.81 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.52 -0.737 . . . . 0.0 110.787 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.778 HD12 ' SD ' ' A' ' 109' ' ' MET . 42.6 mt -133.9 157.79 45.1 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.568 -0.708 . . . . 0.0 109.116 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.16 162.13 21.37 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.433 -0.792 . . . . 0.0 109.417 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -60.05 -26.91 66.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.413 -0.805 . . . . 0.0 108.852 178.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -69.38 -35.5 75.88 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.591 ' OE2' HD22 ' A' ' 116' ' ' LEU . 15.1 mt-10 -65.23 -39.94 93.4 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.395 0.617 . . . . 0.0 109.622 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.01 -40.0 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.208 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.428 ' HA ' HD12 ' A' ' 125' ' ' ILE . 7.7 t70 -60.02 -44.04 94.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.703 -0.623 . . . . 0.0 110.005 -178.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -60.03 -41.33 92.0 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.53 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 65.6 mtt -56.56 -37.94 71.25 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 119.6 -0.84 . . . . 0.0 108.781 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.482 HG21 ' O ' ' A' ' 134' ' ' GLY . 90.7 mt -65.75 -38.76 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 121.705 0.764 . . . . 0.0 109.093 178.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -57.27 -38.47 73.94 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.252 0.548 . . . . 0.0 110.578 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.0 -38.78 83.63 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.701 -0.624 . . . . 0.0 110.544 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.503 ' HB3' HG22 ' A' ' 136' ' ' VAL . . . -103.8 0.64 30.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.294 -0.879 . . . . 0.0 111.117 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -87.3 70.5 10.04 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.006 -1.059 . . . . 0.0 110.594 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.0 mt -67.06 -40.02 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.424 -0.797 . . . . 0.0 109.998 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -73.29 -20.22 60.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.565 -0.71 . . . . 0.0 111.151 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.49 23.39 60.59 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 120.215 -0.993 . . . . 0.0 110.83 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -82.17 -10.22 59.24 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.24 -1.153 . . . . 0.0 111.044 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.482 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 90.37 1.7 74.64 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.105 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -138.74 149.24 44.83 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.257 -1.143 . . . . 0.0 109.779 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.503 HG22 ' HB3' ' A' ' 128' ' ' ALA . 87.7 t -92.77 118.01 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.545 -0.722 . . . . 0.0 109.969 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -90.03 175.86 7.01 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.515 -0.741 . . . . 0.0 109.927 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -60.04 -49.01 79.33 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.264 0.554 . . . . 0.0 110.483 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -60.05 -46.07 90.76 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.725 -0.61 . . . . 0.0 111.72 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -63.02 -35.02 78.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.232 -0.918 . . . . 0.0 109.739 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.561 ' HE1' HG23 ' A' ' 85' ' ' ILE . 64.6 t80 -60.0 -39.96 87.54 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.258 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.65 ' O ' HG22 ' A' ' 146' ' ' THR . 92.1 t -70.02 -40.47 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.517 -0.74 . . . . 0.0 110.964 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.576 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 76.9 mt-30 -60.25 -41.08 92.44 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.388 -0.82 . . . . 0.0 110.627 -179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 56.2 ttp -59.96 -40.07 87.76 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.836 -0.54 . . . . 0.0 110.089 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.401 ' CE ' ' CZ ' ' A' ' 141' ' ' PHE . 40.9 mtt -70.02 -39.92 75.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.789 -0.57 . . . . 0.0 110.695 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.65 HG22 ' O ' ' A' ' 142' ' ' VAL . 9.4 t -101.38 20.96 14.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.501 -0.749 . . . . 0.0 110.681 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -79.94 129.83 34.8 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.313 -0.867 . . . . 0.0 110.574 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.6 pttm . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.363 -179.988 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.27 -40.03 98.48 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.507 ' O ' HG22 ' B' ' 160' ' ' ILE . 31.4 t80 -60.6 -40.0 90.16 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.547 -0.973 . . . . 0.0 110.453 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -66.23 -39.93 89.91 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.447 -0.783 . . . . 0.0 110.649 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -60.59 -46.03 91.77 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.612 -0.68 . . . . 0.0 110.641 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 160' ' ' ILE . . . . . 0.74 ' O ' HG23 ' B' ' 164' ' ' VAL . 15.5 tt -70.0 -29.49 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.504 -0.748 . . . . 0.0 111.034 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.17 -44.12 89.52 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.39 -0.819 . . . . 0.0 110.422 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 75.5 mmt-85 -61.44 -40.11 93.25 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.577 -0.702 . . . . 0.0 109.861 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.45 -37.26 86.92 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.67 -0.644 . . . . 0.0 111.076 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.74 HG23 ' O ' ' B' ' 160' ' ' ILE . 67.7 t -60.03 -40.05 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.386 -0.821 . . . . 0.0 110.058 -178.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.94 -34.89 85.14 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.605 HG11 ' CE ' ' A' ' 72' ' ' MET . 23.5 t -74.35 -19.97 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.729 -0.866 . . . . 0.0 110.584 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.688 HD21 HD22 ' A' ' 39' ' ' LEU . 6.2 tt -59.99 -48.77 80.36 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.107 -0.995 . . . . 0.0 110.386 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 168' ' ' ARG . . . . . 0.658 ' NH2' HG23 ' A' ' 79' ' ' THR . 9.6 ptt85 -69.86 -28.62 65.81 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.351 -0.843 . . . . 0.0 109.848 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 169' ' ' GLU . . . . . 0.403 ' CG ' ' CG ' ' A' ' 75' ' ' LYS . 44.0 tt0 -60.02 -43.84 95.0 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.58 -0.7 . . . . 0.0 110.021 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 170' ' ' TRP . . . . . 0.642 ' HH2' HD12 ' A' ' 63' ' ' ILE . 7.4 t-105 -60.93 -40.0 91.55 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.754 -0.591 . . . . 0.0 110.065 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.9 -46.65 88.66 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.575 -0.703 . . . . 0.0 110.851 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -59.98 -40.01 87.67 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.315 -0.866 . . . . 0.0 110.769 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.519 -0.738 . . . . 0.0 110.131 -179.568 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 120.882 0.372 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -60.73 -40.06 90.93 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.451 -0.781 . . . . 0.0 110.179 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -122.05 -89.96 0.59 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 122.052 -0.405 . . . . 0.0 110.038 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.471 ' C ' HG23 ' A' ' 5' ' ' THR . 92.0 mt -103.69 -78.01 0.56 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 109.714 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.471 HG23 ' C ' ' A' ' 4' ' ' LEU . 45.3 p -153.14 107.53 3.12 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.516 -0.74 . . . . 0.0 110.371 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.09 -37.97 75.56 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.625 -0.672 . . . . 0.0 110.091 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -48.51 -60.59 2.57 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.648 -0.658 . . . . 0.0 111.193 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -56.23 -23.79 38.1 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.453 -0.78 . . . . 0.0 112.431 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.5 mm -60.15 -53.31 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 120.988 -1.07 . . . . 0.0 109.873 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -61.08 -27.11 68.12 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.659 -0.651 . . . . 0.0 109.975 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -66.32 -39.96 89.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.457 -0.777 . . . . 0.0 110.037 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.548 ' HB3' HD21 ' A' ' 69' ' ' LEU . 50.5 m-85 -69.7 -25.02 63.67 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.626 -0.671 . . . . 0.0 109.426 178.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 16.4 ttmt -69.98 -40.03 75.61 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -60.31 -54.1 49.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.956 -0.465 . . . . 0.0 110.783 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.05 -22.18 63.1 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.334 -0.854 . . . . 0.0 111.975 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -58.44 -47.39 84.14 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.088 -1.008 . . . . 0.0 110.243 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.7 m -62.16 -37.73 86.33 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.479 -0.763 . . . . 0.0 109.393 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.5 tp -65.96 -39.93 90.84 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -69.53 -38.12 77.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.962 -0.462 . . . . 0.0 109.869 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -91.77 97.64 11.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.566 -0.709 . . . . 0.0 109.848 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -59.93 -37.55 79.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.324 -0.86 . . . . 0.0 111.119 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -80.02 -10.92 59.81 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.263 -0.898 . . . . 0.0 111.03 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.29 27.66 58.09 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -87.63 -5.77 58.57 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.707 -0.878 . . . . 0.0 110.777 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.1 4.88 59.77 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 120.268 -0.968 . . . . 0.0 111.383 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.2 p -143.93 141.15 30.08 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 119.168 1.484 . . . . 0.0 111.594 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 86.0 mt -101.06 122.08 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.25 0.548 . . . . 0.0 109.528 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.0 m -98.41 137.98 36.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.724 -0.61 . . . . 0.0 109.781 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.531 ' HB ' HD22 ' A' ' 48' ' ' LEU . 24.7 p -42.65 -28.89 0.26 Allowed 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.707 -0.621 . . . . 0.0 112.179 -178.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.1 tttp -65.97 -50.47 64.22 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.833 0.825 . . . . 0.0 109.691 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -60.2 -56.38 22.32 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.932 -0.48 . . . . 0.0 111.798 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.95 -34.16 74.3 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.29 -0.882 . . . . 0.0 110.49 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.97 -31.56 17.87 Favored Glycine 0 N--CA 1.501 2.982 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.2 m -67.25 -40.13 86.21 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.393 -1.063 . . . . 0.0 109.399 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.5 t -64.38 -39.98 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 121.455 0.645 . . . . 0.0 109.422 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 98.0 mmm -60.06 -38.4 82.72 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.809 -0.557 . . . . 0.0 110.297 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -62.92 -40.05 96.41 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.414 -0.804 . . . . 0.0 110.659 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 t -59.28 -26.86 65.31 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.924 -0.485 . . . . 0.0 110.883 -178.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.498 HD12 ' CG2' ' A' ' 91' ' ' VAL . 36.3 tp -85.56 -24.92 27.04 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.415 -0.803 . . . . 0.0 109.109 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.23 -61.95 0.15 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -162.96 172.04 15.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.587 -0.949 . . . . 0.0 110.931 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -116.41 153.58 48.83 Favored Pre-proline 0 C--N 1.298 -1.664 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.171 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -66.08 -146.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.532 1.28 . . . . 0.0 109.642 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.1 p -125.68 166.79 16.11 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.048 -1.033 . . . . 0.0 110.845 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -59.0 -35.48 73.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.767 -0.583 . . . . 0.0 111.706 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.48 -47.82 45.67 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 122.298 1.047 . . . . 0.0 109.23 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.54 -36.09 80.34 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.302 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.531 HD22 ' HB ' ' A' ' 29' ' ' THR . 12.2 mt -58.2 -35.91 72.33 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.757 0.789 . . . . 0.0 109.587 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -66.82 -39.73 87.8 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.17 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -65.56 -39.94 92.26 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.537 -0.727 . . . . 0.0 110.937 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 90.7 mtp -60.17 -47.13 87.24 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.763 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.865 HG22 ' OD2' ' A' ' 56' ' ' ASP . 46.7 mm -64.92 -35.77 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.806 -0.559 . . . . 0.0 110.311 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -60.26 -44.97 94.82 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.596 -0.69 . . . . 0.0 111.772 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -70.01 -28.39 65.47 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.191 -0.943 . . . . 0.0 111.09 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.44 -8.58 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.587 -0.696 . . . . 0.0 110.599 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.865 ' OD2' HG22 ' A' ' 52' ' ' ILE . 4.3 m-20 -74.35 103.18 4.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.26 -0.9 . . . . 0.0 110.415 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.98 -36.4 75.16 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.617 -0.677 . . . . 0.0 109.693 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -92.35 -26.84 17.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.683 -0.635 . . . . 0.0 110.821 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.57 20.06 52.53 Favored Glycine 0 N--CA 1.496 2.638 0 C-N-CA 120.404 -0.903 . . . . 0.0 110.906 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -74.49 -32.88 62.68 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.37 -1.077 . . . . 0.0 110.254 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.559 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 117.94 1.06 17.12 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.002 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.2 p -137.66 169.84 17.09 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.125 -1.22 . . . . 0.0 110.488 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.3 mt -105.78 120.57 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.505 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -98.17 169.91 9.26 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.528 0.68 . . . . 0.0 110.582 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.434 ' HB3' ' HD3' ' A' ' 66' ' ' PRO . 8.1 t80 -47.86 -48.75 60.86 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.434 ' HD3' ' HB3' ' A' ' 65' ' ' PHE . 45.9 Cg_endo -71.83 -32.68 11.14 Favored 'Trans proline' 0 N--CA 1.487 1.089 0 O-C-N 122.711 0.848 . . . . 0.0 111.376 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -72.13 -39.98 68.41 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.261 -0.9 . . . . 0.0 110.268 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.417 ' CE1' ' HE2' ' A' ' 72' ' ' MET . 40.5 t80 -63.21 -41.64 99.17 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.471 -0.768 . . . . 0.0 111.204 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.548 HD21 ' HB3' ' A' ' 12' ' ' PHE . 96.2 mt -69.59 -39.99 76.95 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.534 -0.729 . . . . 0.0 112.048 -178.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.5 p -60.02 -47.87 84.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.334 -0.854 . . . . 0.0 111.191 -178.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 8.6 tmm? -68.56 -38.89 81.13 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.6 -0.687 . . . . 0.0 111.682 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.417 ' HE2' ' CE1' ' A' ' 68' ' ' PHE . 57.6 tpp -59.99 -50.03 75.35 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.374 -0.828 . . . . 0.0 112.217 -178.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.98 -25.04 63.43 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.183 -0.948 . . . . 0.0 112.082 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.2 -57.81 3.63 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.404 -0.81 . . . . 0.0 112.978 -178.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -69.64 -40.05 76.75 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -177.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 22.0 mtm -53.87 -39.91 66.12 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.057 -1.027 . . . . 0.0 111.946 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.0 tttt -59.99 -49.05 79.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.283 -0.885 . . . . 0.0 110.664 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -63.21 -27.37 69.31 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.817 0.818 . . . . 0.0 109.866 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.628 HG22 ' H ' ' A' ' 80' ' ' ASP 0.255 7.0 m -70.09 -173.42 0.66 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.807 -0.558 . . . . 0.0 109.918 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.628 ' H ' HG22 ' A' ' 79' ' ' THR . 81.3 m-20 -129.24 139.72 51.73 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.153 -0.967 . . . . 0.0 109.547 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.1 t -70.02 -27.46 64.69 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.581 -0.699 . . . . 0.0 111.046 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.03 -36.26 76.89 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.481 -0.762 . . . . 0.0 109.838 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -70.06 -39.93 75.37 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.342 0.592 . . . . 0.0 110.361 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -61.64 -39.57 91.79 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.571 -0.705 . . . . 0.0 111.274 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.686 HG23 ' HE1' ' A' ' 141' ' ' PHE . 89.2 mt -67.12 -44.3 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.52 -0.738 . . . . 0.0 110.803 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -59.81 -40.14 87.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.527 -0.733 . . . . 0.0 111.783 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.687 ' O ' HG23 ' A' ' 91' ' ' VAL . 35.7 mt-10 -76.04 -39.85 54.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.364 -0.835 . . . . 0.0 112.262 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.663 ' HA ' HG11 ' B' ' 164' ' ' VAL . . . -64.52 -46.7 81.79 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.271 -0.893 . . . . 0.0 111.317 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -61.75 -44.14 97.48 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.509 -0.744 . . . . 0.0 109.834 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.04 -36.9 78.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.746 -0.596 . . . . 0.0 110.939 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 87' ' ' GLU . 95.1 t -69.82 -48.51 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.484 -0.76 . . . . 0.0 110.161 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -68.03 -39.6 83.06 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.471 -0.768 . . . . 0.0 111.013 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -80.45 71.98 7.31 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.382 -0.824 . . . . 0.0 110.126 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -60.06 -47.5 85.61 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.374 -0.828 . . . . 0.0 110.335 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -70.63 -24.36 62.71 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.539 -0.726 . . . . 0.0 110.929 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.67 21.97 77.94 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -67.12 -15.7 63.87 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.239 -1.154 . . . . 0.0 111.258 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.58 -13.06 54.16 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 81.5 m-85 -133.15 141.31 48.06 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.163 -1.198 . . . . 0.0 109.224 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.76 ' CG2' HD23 ' A' ' 105' ' ' LEU . 62.7 mt -89.15 121.15 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.111 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 m -84.92 168.87 14.62 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.217 0.532 . . . . 0.0 109.869 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.97 -37.12 75.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.6 -0.688 . . . . 0.0 109.211 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.92 -36.41 83.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.796 -0.565 . . . . 0.0 109.799 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -67.22 -40.12 86.34 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.524 -0.735 . . . . 0.0 110.645 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.76 HD23 ' CG2' ' A' ' 100' ' ' ILE . 0.3 OUTLIER -64.42 -42.4 96.06 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.505 0.669 . . . . 0.0 110.051 179.734 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -62.93 -39.5 94.78 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.788 -0.57 . . . . 0.0 111.535 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -60.41 -48.61 81.0 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.216 -0.928 . . . . 0.0 112.161 -177.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 93.8 t -71.49 -50.37 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.136 -0.977 . . . . 0.0 111.452 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.477 ' HA ' HD12 ' A' ' 112' ' ' LEU . 73.9 mtp -55.42 -40.38 71.4 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.266 -0.896 . . . . 0.0 110.231 -178.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.2 m -66.59 -45.4 79.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.482 -0.761 . . . . 0.0 109.077 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -66.72 -25.04 66.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.814 -0.554 . . . . 0.0 109.85 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 109' ' ' MET . 17.9 mt -69.06 -26.61 65.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.583 -0.698 . . . . 0.0 110.227 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.6 11.73 5.89 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -127.76 131.41 49.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.172 -1.193 . . . . 0.0 109.952 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -105.0 126.01 51.6 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.608 -0.683 . . . . 0.0 110.232 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.0 mt -130.02 160.88 32.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.698 -0.626 . . . . 0.0 110.44 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.32 163.1 23.15 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -60.26 -31.44 70.22 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -67.15 -33.07 74.65 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.389 0.614 . . . . 0.0 109.667 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -67.79 -36.15 79.93 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.41 HG13 ' HB3' ' A' ' 105' ' ' LEU . 69.1 t -70.06 -40.01 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.913 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -60.03 -45.79 91.66 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.665 -0.647 . . . . 0.0 110.071 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -60.0 -41.4 91.99 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.599 -0.688 . . . . 0.0 109.641 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 98.0 mtp -54.46 -37.08 64.78 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.012 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.615 HG23 HG23 ' A' ' 136' ' ' VAL . 93.0 mt -66.58 -37.48 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 50.2 ttt85 -58.13 -40.0 80.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.472 -0.768 . . . . 0.0 111.118 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -60.0 -39.12 84.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.582 -0.699 . . . . 0.0 111.039 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.88 -10.92 19.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.397 -0.815 . . . . 0.0 111.522 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -89.48 74.04 7.76 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.003 -1.06 . . . . 0.0 110.994 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 84.7 mt -66.49 -39.96 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.663 -0.648 . . . . 0.0 109.474 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -59.23 -39.58 83.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.656 -0.653 . . . . 0.0 110.89 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.33 15.17 42.09 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.146 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -81.95 -10.05 59.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.02 -1.282 . . . . 0.0 110.546 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.12 2.54 85.76 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.491 -0.756 . . . . 0.0 111.537 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -130.94 131.32 44.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.24 -1.153 . . . . 0.0 109.611 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.615 HG23 HG23 ' A' ' 125' ' ' ILE . 57.7 t -90.88 111.62 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.452 -0.78 . . . . 0.0 110.037 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -89.03 -168.88 2.32 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 121.742 -0.599 . . . . 0.0 110.276 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -69.65 -40.08 76.7 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.8 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -60.0 -46.36 89.74 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.299 -0.876 . . . . 0.0 111.454 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -65.94 -38.15 87.88 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.817 0.818 . . . . 0.0 110.339 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.686 ' HE1' HG23 ' A' ' 85' ' ' ILE . 58.1 t80 -59.73 -45.67 91.48 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.865 -177.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.443 HG22 HG21 ' A' ' 85' ' ' ILE . 62.5 t -78.1 -40.05 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.232 -0.917 . . . . 0.0 112.577 -178.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -60.0 -51.68 68.63 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.976 -1.077 . . . . 0.0 111.693 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 59.4 ttp -60.53 -36.07 77.53 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.369 -0.832 . . . . 0.0 110.413 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 95.9 mtp -69.96 -40.03 75.64 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.799 -0.563 . . . . 0.0 110.673 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.552 ' O ' HG22 ' A' ' 146' ' ' THR . 39.7 m -97.5 15.82 22.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.486 -0.759 . . . . 0.0 111.086 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.06 -42.3 94.21 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.179 -0.951 . . . . 0.0 110.432 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 86.2 mttt . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.144 179.684 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.31 142.14 13.02 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -60.02 -43.43 95.26 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.49 -1.006 . . . . 0.0 110.236 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -60.03 -39.59 86.41 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.658 -0.651 . . . . 0.0 110.51 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -59.92 -40.07 87.63 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.434 -0.791 . . . . 0.0 110.665 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 95.8 mt -67.74 -39.62 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.408 -0.807 . . . . 0.0 110.121 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.27 91.68 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.552 -0.717 . . . . 0.0 111.634 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 162' ' ' ARG . . . . . 0.44 ' O ' HG23 ' B' ' 166' ' ' VAL . 51.3 mtm180 -60.09 -40.04 88.23 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.106 -0.997 . . . . 0.0 110.747 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.519 HD23 ' C ' ' B' ' 163' ' ' LEU . 9.6 tt -60.61 -40.11 90.64 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.433 -0.792 . . . . 0.0 109.95 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.663 HG11 ' HA ' ' A' ' 88' ' ' ALA . 89.2 t -62.71 -39.95 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.594 -0.691 . . . . 0.0 109.688 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.99 -36.64 90.91 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.44 HG23 ' O ' ' B' ' 162' ' ' ARG . 94.9 t -60.07 -31.54 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.769 -0.842 . . . . 0.0 110.581 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 84.5 mt -60.03 -41.14 91.6 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.452 -0.78 . . . . 0.0 111.015 -178.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -61.03 -40.02 92.01 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.254 -0.904 . . . . 0.0 109.864 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -62.23 -40.56 96.54 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.658 -0.651 . . . . 0.0 110.86 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -60.08 -41.06 91.65 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.397 -0.814 . . . . 0.0 111.032 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.53 -41.24 76.24 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.414 -0.804 . . . . 0.0 110.855 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -60.01 -39.95 87.56 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.521 -0.737 . . . . 0.0 110.602 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 . . . . . 0 N--CA 1.496 1.87 0 O-C-N 121.392 -0.817 . . . . 0.0 110.301 -179.796 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.255 0.55 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 52.31 38.48 25.02 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.467 -0.771 . . . . 0.0 110.747 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -64.64 -41.18 96.31 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.684 0.754 . . . . 0.0 110.018 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.5 mt -114.28 -89.54 0.54 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 122.003 -0.436 . . . . 0.0 110.295 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.42 11.68 2.99 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.009 -1.057 . . . . 0.0 111.606 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.587 ' HA ' HD12 ' A' ' 9' ' ' ILE . 98.9 mt-10 -55.5 -15.33 2.66 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.159 -0.963 . . . . 0.0 112.245 -178.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 8' ' ' GLN . 12.7 pt-20 -64.26 -42.02 96.67 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.897 -1.127 . . . . 0.0 110.329 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.409 ' N ' ' HG3' ' A' ' 7' ' ' GLU . 45.0 mt-30 -65.87 -39.28 90.56 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.442 -0.786 . . . . 0.0 110.846 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.587 HD12 ' HA ' ' A' ' 6' ' ' GLU . 85.7 mt -59.93 -31.15 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.659 -0.651 . . . . 0.0 111.911 -178.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.95 -39.77 86.72 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.927 -1.108 . . . . 0.0 109.95 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -59.32 -41.46 89.13 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.268 0.556 . . . . 0.0 109.963 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -65.09 -21.51 66.82 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.613 -0.679 . . . . 0.0 111.111 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -70.03 -41.15 74.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.116 -0.99 . . . . 0.0 108.878 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.93 -51.78 68.24 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.013 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.06 -20.47 63.23 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.185 -0.947 . . . . 0.0 112.008 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.503 ' CD1' ' CZ ' ' A' ' 65' ' ' PHE . 60.2 t80 -58.05 -50.04 74.81 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.03 -1.044 . . . . 0.0 111.222 -177.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 97.6 p -66.76 -39.36 87.84 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.605 HD21 ' OE2' ' A' ' 114' ' ' GLU . 40.5 tp -60.08 -40.0 88.04 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.258 0.551 . . . . 0.0 109.816 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -77.44 -31.74 54.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.683 -0.635 . . . . 0.0 110.311 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -92.09 102.11 14.64 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.418 -0.801 . . . . 0.0 109.522 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -60.0 -39.64 86.46 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.609 -0.682 . . . . 0.0 112.308 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -80.08 -11.66 59.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.087 -1.008 . . . . 0.0 111.335 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.18 28.62 50.15 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -88.28 -5.6 58.26 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.637 -0.919 . . . . 0.0 110.788 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.53 1.39 57.77 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.938 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 54.3 p -144.2 141.81 30.13 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 119.116 1.458 . . . . 0.0 111.368 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 84.8 mt -101.08 123.77 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.79 -0.569 . . . . 0.0 109.611 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 34.4 p -99.96 140.0 34.81 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.539 -0.726 . . . . 0.0 110.046 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.57 HG23 HG13 ' A' ' 52' ' ' ILE . 6.6 p -43.19 -29.22 0.36 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.726 -0.609 . . . . 0.0 112.092 -178.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.11 -50.55 65.65 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.429 -0.794 . . . . 0.0 109.511 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -59.61 -53.82 53.59 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 121.253 0.549 . . . . 0.0 110.894 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.608 HD21 ' SD ' ' A' ' 36' ' ' MET . 9.6 tt -60.02 -35.32 74.82 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.449 -0.782 . . . . 0.0 111.451 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.07 -30.82 17.39 Favored Glycine 0 N--CA 1.498 2.822 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.5 m -70.03 -39.98 75.44 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.564 -0.963 . . . . 0.0 110.503 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.27 -54.26 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.457 -0.777 . . . . 0.0 109.456 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.608 ' SD ' HD21 ' A' ' 32' ' ' LEU . 95.8 mtp -59.92 -31.34 69.75 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.614 -0.679 . . . . 0.0 110.012 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -61.55 -40.47 94.81 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.681 0.753 . . . . 0.0 109.102 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.8 p -70.06 -20.22 63.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.787 -0.57 . . . . 0.0 110.405 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.545 HD11 ' CD1' ' B' ' 167' ' ' LEU . 86.1 mt -88.61 -17.0 31.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.484 -0.76 . . . . 0.0 110.41 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.22 -62.87 0.15 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -156.45 169.47 24.56 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.281 -1.129 . . . . 0.0 111.468 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -104.7 129.53 24.78 Favored Pre-proline 0 N--CA 1.49 1.573 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.844 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -67.3 -150.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.228 0 O-C-N 123.132 1.069 . . . . 0.0 109.487 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.5 p -135.62 151.71 50.51 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.159 -0.963 . . . . 0.0 110.598 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -51.44 -24.75 5.31 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.779 -0.575 . . . . 0.0 111.805 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.05 -59.8 2.58 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 122.171 0.986 . . . . 0.0 108.776 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -66.86 -36.97 83.53 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.829 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.523 HD13 ' HB ' ' A' ' 29' ' ' THR . 5.6 mt -58.12 -34.81 70.63 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.434 -0.791 . . . . 0.0 109.173 178.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.27 -40.02 96.22 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 120.484 -0.487 . . . . 0.0 110.43 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -64.58 -40.01 94.77 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.606 -0.684 . . . . 0.0 110.569 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 89.3 mtp -59.95 -44.57 94.33 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.463 0.649 . . . . 0.0 109.718 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.893 HG22 ' OD2' ' A' ' 56' ' ' ASP . 47.7 mm -65.87 -37.8 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.902 -0.499 . . . . 0.0 110.671 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -60.05 -39.95 87.74 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.437 -0.789 . . . . 0.0 111.523 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -68.88 -28.64 66.87 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.203 -0.935 . . . . 0.0 110.486 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.467 HG21 ' SD ' ' A' ' 71' ' ' MET . 78.9 t -99.46 -9.94 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.64 -0.662 . . . . 0.0 111.183 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.893 ' OD2' HG22 ' A' ' 52' ' ' ILE . 20.5 m-20 -70.74 95.56 1.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.143 -0.973 . . . . 0.0 111.265 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.56 -34.08 71.83 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.739 -0.601 . . . . 0.0 109.618 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.2 p-10 -95.43 -23.66 17.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.706 -0.621 . . . . 0.0 110.66 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.61 19.14 55.31 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.135 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.3 p-10 -75.63 -25.34 56.8 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.33 -1.1 . . . . 0.0 110.655 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.776 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 108.44 4.28 32.67 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.227 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 67.2 p -134.0 170.12 16.11 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.165 -1.197 . . . . 0.0 110.89 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.4 mt -101.83 119.99 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.909 -0.494 . . . . 0.0 110.434 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -102.51 168.17 9.47 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.59 0.71 . . . . 0.0 111.147 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.503 ' CZ ' ' CD1' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -43.13 -52.34 12.26 Favored Pre-proline 0 N--CA 1.504 2.269 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.2 Cg_endo -71.34 -30.27 15.79 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.042 1.022 . . . . 0.0 111.944 -178.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.25 -40.51 70.96 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.167 -0.958 . . . . 0.0 110.001 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -63.18 -42.38 99.37 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.655 -0.653 . . . . 0.0 110.968 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.4 mt -65.93 -41.75 90.97 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.523 -0.735 . . . . 0.0 111.152 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 66' ' ' PRO . 39.3 p -63.53 -40.89 98.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.473 -0.767 . . . . 0.0 111.61 -179.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.467 ' SD ' HG21 ' A' ' 55' ' ' VAL . 53.9 ttp -68.1 -40.04 82.7 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.442 -0.786 . . . . 0.0 110.674 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 7.5 mmt -61.86 -43.16 99.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.731 -0.606 . . . . 0.0 111.251 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.94 -30.55 67.96 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.59 -0.693 . . . . 0.0 110.523 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -70.22 -40.04 74.76 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.633 -0.667 . . . . 0.0 110.469 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -67.05 -55.44 14.33 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.532 -0.73 . . . . 0.0 111.898 -178.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.512 ' HA ' HG22 ' A' ' 79' ' ' THR . 78.6 mtm -59.94 -32.53 70.88 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.457 -0.777 . . . . 0.0 110.973 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.9 tttt -66.38 -62.32 1.53 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.681 -0.637 . . . . 0.0 112.15 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -70.73 -10.06 58.62 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.47 -0.769 . . . . 0.0 112.046 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.512 HG22 ' HA ' ' A' ' 76' ' ' MET . 1.5 t -101.07 -160.05 0.77 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.897 0.856 . . . . 0.0 112.035 -178.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.491 ' N ' HG23 ' A' ' 79' ' ' THR . 84.6 m-20 -129.98 139.49 51.06 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.358 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.0 t -63.36 -33.86 76.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.726 -0.609 . . . . 0.0 109.983 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.02 -33.23 71.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.692 -0.63 . . . . 0.0 109.662 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.34 -39.99 77.82 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.519 0.676 . . . . 0.0 109.639 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -63.06 -36.13 82.56 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.787 -0.57 . . . . 0.0 110.29 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.541 HG23 ' HE1' ' A' ' 141' ' ' PHE . 96.7 mt -67.18 -44.38 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.741 -0.599 . . . . 0.0 109.977 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -59.39 -43.58 92.92 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.638 -0.664 . . . . 0.0 111.162 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.561 ' O ' HG23 ' A' ' 91' ' ' VAL . 99.3 mt-10 -70.03 -40.08 75.4 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.588 -0.695 . . . . 0.0 111.729 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.6 -46.96 77.37 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.505 -0.747 . . . . 0.0 111.337 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.403 ' CE1' ' OD2' ' A' ' 93' ' ' ASP . 60.2 t80 -62.9 -42.84 99.92 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.524 -0.735 . . . . 0.0 109.861 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -59.95 -34.84 73.8 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.906 -0.496 . . . . 0.0 110.368 -179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 87' ' ' GLU . 77.7 t -69.9 -50.1 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.502 -0.749 . . . . 0.0 109.774 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -69.94 -41.16 74.94 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.475 -0.765 . . . . 0.0 111.022 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.403 ' OD2' ' CE1' ' A' ' 89' ' ' PHE . 33.2 t0 -81.1 75.18 8.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.404 -0.81 . . . . 0.0 109.946 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -70.02 -40.01 75.48 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.425 -0.797 . . . . 0.0 110.258 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 37.5 p-10 -75.7 -26.43 57.55 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.787 -0.571 . . . . 0.0 110.92 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.85 26.22 69.75 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -69.12 -14.86 63.24 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.365 -1.079 . . . . 0.0 111.476 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.73 -17.95 17.55 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.426 ' CD2' ' HB3' ' A' ' 135' ' ' GLN . 31.5 p90 -148.19 158.94 44.37 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.194 -1.18 . . . . 0.0 109.06 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 40.5 mt -88.9 124.24 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.322 -0.861 . . . . 0.0 110.099 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 m -82.67 172.29 13.09 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.669 0.747 . . . . 0.0 111.305 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.44 ' HB1' ' NH2' ' A' ' 106' ' ' ARG . . . -62.74 -47.37 83.85 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.81 -0.557 . . . . 0.0 110.098 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.45 -36.68 81.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.699 -0.626 . . . . 0.0 109.643 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -61.34 -40.13 93.11 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.601 -0.687 . . . . 0.0 110.39 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.473 HD21 ' SD ' ' A' ' 124' ' ' MET . 0.8 OUTLIER -64.73 -44.3 90.64 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.442 -0.786 . . . . 0.0 109.992 179.565 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.44 ' NH2' ' HB1' ' A' ' 102' ' ' ALA . 88.7 mtt180 -61.2 -37.37 82.75 Favored 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -60.0 -48.48 81.55 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.202 -0.936 . . . . 0.0 110.852 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.4 t -70.04 -39.22 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.513 -0.742 . . . . 0.0 111.568 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 12.9 mmt -59.06 -51.01 71.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.298 -0.876 . . . . 0.0 110.762 -178.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.5 m -66.88 -40.74 87.89 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.468 -0.77 . . . . 0.0 109.857 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -61.23 -31.36 71.15 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 112' ' ' LEU . 13.8 mt -69.16 -29.55 67.58 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.194 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.93 27.45 5.13 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.605 ' OE2' HD21 ' A' ' 18' ' ' LEU . 95.9 mt-10 -119.22 139.91 51.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.512 -0.993 . . . . 0.0 110.011 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -101.67 115.21 30.03 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.503 -0.748 . . . . 0.0 109.523 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.443 HD22 ' OE2' ' A' ' 120' ' ' GLU . 50.0 mt -132.83 153.69 51.04 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.459 -0.775 . . . . 0.0 109.949 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.97 164.96 19.02 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -62.1 -26.69 68.44 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.446 -0.784 . . . . 0.0 109.377 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.17 -35.44 76.3 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.639 0.733 . . . . 0.0 109.189 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.443 ' OE2' HD22 ' A' ' 116' ' ' LEU . 7.3 mt-10 -65.03 -37.78 88.73 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.382 0.61 . . . . 0.0 109.474 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.426 HG13 ' HB3' ' A' ' 105' ' ' LEU . 79.6 t -69.86 -39.14 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.564 0.697 . . . . 0.0 109.718 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -60.0 -40.04 87.85 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.777 -0.577 . . . . 0.0 109.832 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -59.96 -40.68 89.87 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.278 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.473 ' SD ' HD21 ' A' ' 105' ' ' LEU . 66.5 mtt -56.15 -37.02 68.95 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.394 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.01 -40.01 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.595 -0.691 . . . . 0.0 110.322 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 40.2 mtm-85 -59.99 -41.56 92.32 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.578 -0.701 . . . . 0.0 112.463 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.99 -39.97 87.56 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.705 -0.622 . . . . 0.0 111.329 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -98.33 -16.55 19.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.29 -0.881 . . . . 0.0 111.084 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -78.48 72.65 5.02 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.13 -0.981 . . . . 0.0 110.12 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 86.3 mt -65.06 -45.72 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.661 -0.649 . . . . 0.0 110.92 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -63.37 -40.06 96.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.358 -0.839 . . . . 0.0 111.175 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.56 20.64 9.94 Favored Glycine 0 N--CA 1.497 2.719 0 C-N-CA 120.058 -1.068 . . . . 0.0 111.198 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -82.16 -9.94 59.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.22 -1.165 . . . . 0.0 110.828 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.14 2.44 80.5 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.426 ' HB3' ' CD2' ' A' ' 99' ' ' TYR . 27.7 mt-30 -135.62 144.9 46.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.382 -1.069 . . . . 0.0 109.079 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.7 t -93.08 118.98 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.403 -0.811 . . . . 0.0 110.296 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -87.58 -179.51 6.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.557 -0.714 . . . . 0.0 109.374 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -69.46 -40.57 77.07 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.943 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -62.78 -44.05 97.2 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.548 -0.72 . . . . 0.0 110.784 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -65.78 -38.64 89.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.461 -0.774 . . . . 0.0 109.932 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.541 ' HE1' HG23 ' A' ' 85' ' ' ILE . 63.6 t80 -60.01 -44.11 94.78 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.083 0.468 . . . . 0.0 110.839 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 76.6 t -68.67 -39.96 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.485 -0.759 . . . . 0.0 110.726 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -60.24 -42.47 95.34 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.437 -0.79 . . . . 0.0 110.586 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.5 mmm -60.74 -40.02 90.83 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.633 -0.667 . . . . 0.0 110.631 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 95.2 mmm -70.07 -39.98 75.31 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.547 -0.721 . . . . 0.0 110.294 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.475 ' O ' HG22 ' A' ' 146' ' ' THR . 22.4 m -96.87 18.96 13.42 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.54 -0.725 . . . . 0.0 110.65 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.58 142.86 53.48 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.313 -0.867 . . . . 0.0 110.609 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.8 mttt . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.252 179.511 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -66.03 138.85 37.5 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -59.96 -42.79 94.86 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.614 -0.933 . . . . 0.0 110.351 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -60.04 -33.81 72.54 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.565 -0.71 . . . . 0.0 110.552 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -60.05 -42.69 95.04 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.746 -0.596 . . . . 0.0 111.013 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.05 -40.02 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.567 -0.708 . . . . 0.0 110.681 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.04 87.97 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.576 -0.703 . . . . 0.0 111.118 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -69.04 -39.99 78.84 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.401 -0.812 . . . . 0.0 110.926 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.496 HD23 ' C ' ' B' ' 163' ' ' LEU . 9.8 tt -61.04 -45.86 93.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.601 -0.687 . . . . 0.0 110.824 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.418 ' HA ' ' HB2' ' B' ' 167' ' ' LEU . 10.2 p -69.96 -29.99 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.388 -0.82 . . . . 0.0 110.699 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.14 -40.94 97.87 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 87.5 t -79.99 -26.05 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.82 -0.812 . . . . 0.0 110.134 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.545 ' CD1' HD11 ' A' ' 39' ' ' LEU . 4.3 tt -54.43 -59.92 4.04 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.478 -0.764 . . . . 0.0 111.814 -178.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -66.78 -35.15 79.4 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.379 -0.826 . . . . 0.0 111.934 -178.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -59.96 -38.72 83.3 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.263 -0.898 . . . . 0.0 109.842 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -60.01 -39.98 87.65 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.81 -0.556 . . . . 0.0 110.283 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.62 -35.81 75.1 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.4 -0.812 . . . . 0.0 110.198 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -59.89 -36.38 76.81 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.501 -0.749 . . . . 0.0 110.052 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 . . . . . 0 N--CA 1.493 1.719 0 O-C-N 121.546 -0.721 . . . . 0.0 110.235 179.947 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.194 0.521 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -69.94 -40.04 75.7 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.626 -0.671 . . . . 0.0 110.751 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.1 mp0 -65.06 -40.02 94.11 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.573 0.701 . . . . 0.0 110.313 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 76.0 mt -101.75 176.47 5.21 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.259 0.552 . . . . 0.0 109.917 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.52 110.35 4.94 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.383 0.611 . . . . 0.0 109.591 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -75.49 -17.93 59.97 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.854 -0.529 . . . . 0.0 110.593 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -62.76 -27.19 69.12 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.36 -0.838 . . . . 0.0 111.178 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -70.93 -23.19 62.2 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.169 -0.957 . . . . 0.0 110.323 177.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.5 mm -59.97 -49.75 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.444 -0.785 . . . . 0.0 111.075 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.41 -24.15 67.24 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.486 -0.758 . . . . 0.0 111.602 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -66.54 -44.95 81.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.289 -0.882 . . . . 0.0 109.943 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.411 ' CB ' HD11 ' A' ' 69' ' ' LEU . 43.3 m-85 -69.88 -24.13 63.36 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.541 0.686 . . . . 0.0 109.598 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -69.94 -40.07 75.72 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.452 0.644 . . . . 0.0 109.968 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.96 -52.19 66.44 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.737 -0.602 . . . . 0.0 111.735 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.99 -21.57 63.21 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.173 -0.954 . . . . 0.0 111.709 -178.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -59.41 -47.06 86.9 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.206 -0.934 . . . . 0.0 110.513 -178.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -62.07 -37.29 84.44 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.294 -0.879 . . . . 0.0 109.201 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.531 HD21 HD22 ' A' ' 112' ' ' LEU . 50.2 tp -63.1 -39.48 94.83 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -69.97 -39.24 76.11 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.176 0.512 . . . . 0.0 110.027 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -97.86 98.65 10.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.67 -0.644 . . . . 0.0 109.825 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -69.22 -29.2 67.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.463 -0.773 . . . . 0.0 110.547 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -82.07 -10.05 59.34 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.369 -0.832 . . . . 0.0 111.611 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.64 25.07 66.89 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -178.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -78.6 -11.24 59.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.472 -1.016 . . . . 0.0 110.824 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.59 3.95 83.44 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.8 p -145.92 140.72 27.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.028 -1.277 . . . . 0.0 110.283 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.4 mt -101.52 122.73 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.751 -0.593 . . . . 0.0 109.549 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.2 m -97.92 141.16 31.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.75 -0.594 . . . . 0.0 109.992 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.548 ' HB ' HD13 ' A' ' 48' ' ' LEU . 27.7 p -39.07 -34.98 0.19 Allowed 'General case' 0 N--CA 1.51 2.546 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -66.71 -44.89 80.44 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.441 -0.787 . . . . 0.0 109.314 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -61.45 -58.26 8.88 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.946 -0.471 . . . . 0.0 111.339 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.456 HD21 ' CE2' ' B' ' 170' ' ' TRP . 54.6 tp -59.99 -36.04 76.32 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.273 -0.892 . . . . 0.0 111.061 -178.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.01 -29.99 15.48 Favored Glycine 0 N--CA 1.5 2.908 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.4 m -69.95 -39.98 75.74 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.634 -0.921 . . . . 0.0 110.453 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.1 t -63.54 -51.19 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 CA-C-O 121.621 0.724 . . . . 0.0 109.112 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 87.3 mtp -60.05 -33.04 71.49 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.277 0.56 . . . . 0.0 109.835 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -60.92 -42.46 98.17 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.411 0.624 . . . . 0.0 109.896 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.0 t -70.03 -16.38 63.15 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.637 -0.665 . . . . 0.0 110.415 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.4 tp -84.66 -24.42 29.02 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.355 -0.841 . . . . 0.0 109.383 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.42 -51.42 0.18 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.781 -1.727 . . . . 0.0 108.781 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -163.1 172.96 14.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.633 -0.922 . . . . 0.0 110.612 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -120.33 143.98 37.09 Favored Pre-proline 0 C--N 1.299 -1.62 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.057 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.69 -150.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 123.394 1.208 . . . . 0.0 109.881 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.89 161.54 36.35 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.082 -1.011 . . . . 0.0 110.098 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -52.23 -27.36 14.5 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.699 -0.626 . . . . 0.0 111.524 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.94 -58.31 3.55 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 122.078 0.942 . . . . 0.0 109.171 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.73 -39.62 91.32 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.086 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.548 HD13 ' HB ' ' A' ' 29' ' ' THR . 13.1 mt -56.56 -33.75 66.45 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.48 -0.762 . . . . 0.0 110.111 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.9 -36.65 82.77 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.386 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -68.33 -41.89 80.14 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.573 -0.705 . . . . 0.0 111.233 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 64.4 mtt -61.92 -43.28 99.16 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.534 -0.729 . . . . 0.0 109.724 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.889 HG22 ' OD2' ' A' ' 56' ' ' ASP . 43.2 mm -66.74 -35.58 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.842 -0.536 . . . . 0.0 110.241 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -61.53 -40.96 96.51 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.616 -0.677 . . . . 0.0 111.918 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -69.97 -29.6 66.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.184 -0.948 . . . . 0.0 111.002 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.54 HG21 ' SD ' ' A' ' 71' ' ' MET . 84.7 t -100.03 -8.8 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.51 -0.744 . . . . 0.0 111.397 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.889 ' OD2' HG22 ' A' ' 52' ' ' ILE . 4.2 m-20 -69.48 100.29 1.38 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.09 -1.007 . . . . 0.0 111.241 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.13 -33.89 72.4 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.661 -0.649 . . . . 0.0 109.933 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -98.36 -21.97 16.33 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.609 -0.682 . . . . 0.0 110.879 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.34 19.7 61.88 Favored Glycine 0 N--CA 1.495 2.632 0 C-N-CA 120.402 -0.904 . . . . 0.0 110.956 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -74.48 -37.54 63.16 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.372 -1.075 . . . . 0.0 110.173 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.6 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 126.33 2.52 6.97 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.306 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 62.8 p -138.5 170.18 16.47 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.033 -1.275 . . . . 0.0 111.355 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.9 mt -102.37 120.93 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.168 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -100.75 170.03 8.61 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.458 0.647 . . . . 0.0 110.251 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.478 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 5.6 t80 -48.22 -48.88 64.06 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.561 -0.712 . . . . 0.0 112.651 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.9 Cg_endo -68.45 -35.86 16.87 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 O-C-N 122.75 0.868 . . . . 0.0 111.916 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.98 -40.03 75.6 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.092 -1.005 . . . . 0.0 110.467 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.429 ' HD2' HD22 ' A' ' 69' ' ' LEU . 64.7 t80 -61.46 -42.02 98.12 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.643 -0.661 . . . . 0.0 110.549 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.453 HD23 ' O ' ' A' ' 65' ' ' PHE . 3.8 mm? -64.51 -41.95 96.1 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.394 -0.816 . . . . 0.0 111.695 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 66' ' ' PRO . 72.0 p -62.36 -40.48 96.54 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.288 -0.882 . . . . 0.0 111.493 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.54 ' SD ' HG21 ' A' ' 55' ' ' VAL . 59.3 ttp -69.74 -40.38 76.2 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.481 -0.762 . . . . 0.0 111.439 -178.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.6 ' SD ' HG11 ' B' ' 166' ' ' VAL . 88.8 mmm -60.77 -49.08 78.93 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.483 -0.761 . . . . 0.0 110.95 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.24 -31.99 73.43 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.785 -0.572 . . . . 0.0 111.291 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -70.04 -39.76 75.55 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.545 -0.722 . . . . 0.0 111.649 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.753 ' O ' HG22 ' A' ' 79' ' ' THR . 91.6 mttt -69.12 -31.59 70.38 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.274 -0.891 . . . . 0.0 112.569 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 63.2 mtt -59.54 -48.2 82.59 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.173 -0.955 . . . . 0.0 112.395 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -69.06 -38.38 79.05 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.238 -0.914 . . . . 0.0 112.032 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -69.99 -20.06 63.31 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.33 -0.856 . . . . 0.0 111.197 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.753 HG22 ' O ' ' A' ' 75' ' ' LYS . 15.2 t -112.22 -164.45 0.92 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.957 0.884 . . . . 0.0 111.709 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -130.27 147.0 51.94 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.899 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.6 p -67.09 -26.93 66.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.591 -0.693 . . . . 0.0 110.601 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.31 -35.39 77.23 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.566 0.698 . . . . 0.0 109.505 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.97 -39.99 83.22 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.563 0.697 . . . . 0.0 109.87 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -62.32 -38.66 90.31 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.793 -0.567 . . . . 0.0 111.456 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.687 HG23 ' HE2' ' A' ' 141' ' ' PHE . 67.7 mt -68.11 -45.3 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.405 -0.809 . . . . 0.0 110.672 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 64.1 mtp180 -58.09 -41.49 83.61 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.231 -0.918 . . . . 0.0 110.811 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.655 ' O ' HG23 ' A' ' 91' ' ' VAL . 98.5 mt-10 -70.03 -39.98 75.44 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.663 -0.648 . . . . 0.0 111.484 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.38 -47.98 77.19 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.469 -0.769 . . . . 0.0 111.536 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -60.27 -42.15 94.81 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.408 -0.808 . . . . 0.0 109.992 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -60.07 -37.61 80.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.905 -0.497 . . . . 0.0 110.62 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 87' ' ' GLU . 58.5 t -69.9 -55.59 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.317 -0.864 . . . . 0.0 110.521 -179.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.67 ' HE2' HG21 ' B' ' 164' ' ' VAL . 44.4 m-85 -60.6 -39.98 90.11 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.312 -0.868 . . . . 0.0 110.978 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -80.51 78.04 7.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.587 -0.696 . . . . 0.0 110.315 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -67.0 -41.43 86.75 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.385 -0.822 . . . . 0.0 109.904 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.6 p-10 -76.15 -21.32 56.71 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.626 -0.671 . . . . 0.0 111.212 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.22 24.45 74.77 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -70.02 -10.94 60.35 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.412 -1.052 . . . . 0.0 111.368 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.19 -15.62 58.93 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -133.55 141.02 47.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.246 -1.15 . . . . 0.0 109.331 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 77.8 mt -89.06 122.15 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.395 -0.816 . . . . 0.0 109.72 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.4 m -83.49 170.01 14.88 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.334 0.588 . . . . 0.0 110.819 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.05 -39.99 94.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.8 -0.562 . . . . 0.0 109.807 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.7 -31.55 72.76 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.57 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -69.92 -40.01 75.82 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.767 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.593 ' HB3' HG13 ' A' ' 121' ' ' VAL . 0.9 OUTLIER -61.58 -47.02 87.4 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.289 -0.882 . . . . 0.0 109.328 179.233 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -64.14 -30.36 71.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.929 -0.482 . . . . 0.0 111.102 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -61.96 -49.02 77.79 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.375 -0.828 . . . . 0.0 111.806 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.604 HG12 ' CD1' ' A' ' 112' ' ' LEU . 72.6 t -70.03 -47.18 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.328 -0.858 . . . . 0.0 111.299 -178.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.479 ' HA ' HD12 ' A' ' 112' ' ' LEU . 98.9 mtp -59.61 -39.99 86.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.318 -0.864 . . . . 0.0 110.489 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.2 m -64.5 -46.2 84.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.453 -0.779 . . . . 0.0 109.107 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -62.46 -32.73 73.66 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.604 ' CD1' HG12 ' A' ' 108' ' ' VAL . 39.7 mt -69.97 -33.69 72.42 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.341 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.43 34.49 1.43 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -125.08 136.69 53.91 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.524 -0.986 . . . . 0.0 110.078 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -101.91 130.54 48.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.509 -0.744 . . . . 0.0 109.639 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.632 HD12 HG23 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -148.3 152.22 36.73 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.673 -0.642 . . . . 0.0 110.848 -179.289 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.1 p -80.94 162.02 24.07 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -61.42 -27.78 68.79 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -67.8 -34.94 77.76 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.822 0.82 . . . . 0.0 109.193 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -62.52 -40.09 95.63 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.632 HG23 HD12 ' A' ' 116' ' ' LEU . 75.5 t -66.22 -40.06 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.097 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -60.02 -45.95 91.11 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.648 -0.658 . . . . 0.0 110.558 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -59.97 -40.61 89.69 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.904 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 86.2 mmm -54.63 -38.14 66.47 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.029 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.23 -38.69 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.692 -0.63 . . . . 0.0 110.15 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -58.36 -39.99 81.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.552 -0.718 . . . . 0.0 111.959 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.11 -40.06 88.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.469 -0.77 . . . . 0.0 112.172 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -108.44 -5.62 16.55 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.189 -0.944 . . . . 0.0 112.317 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -90.29 73.06 7.11 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.889 -1.132 . . . . 0.0 111.06 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 86.5 mt -68.28 -40.05 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.49 -0.756 . . . . 0.0 110.116 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 36.5 p-10 -60.0 -39.94 87.5 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.528 -0.732 . . . . 0.0 111.043 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.418 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 92.38 24.92 22.84 Favored Glycine 0 N--CA 1.493 2.437 0 O-C-N 121.25 -0.907 . . . . 0.0 111.057 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -82.45 -8.02 59.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -1.178 . . . . 0.0 110.544 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 97.16 -1.5 60.81 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -140.84 159.65 41.76 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.16 -1.2 . . . . 0.0 109.722 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 94.3 t -87.89 118.24 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.394 -0.816 . . . . 0.0 109.078 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -87.36 170.03 11.75 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.997 0.903 . . . . 0.0 110.994 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -63.57 -50.01 71.16 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.278 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -62.35 -41.1 98.32 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.38 -0.825 . . . . 0.0 110.539 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.25 -37.27 85.1 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.13 0.967 . . . . 0.0 109.268 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.687 ' HE2' HG23 ' A' ' 85' ' ' ILE . 77.4 t80 -59.94 -41.9 92.86 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.008 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.434 HG22 HG21 ' A' ' 85' ' ' ILE . 70.8 t -74.2 -42.16 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.284 -0.885 . . . . 0.0 111.956 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -59.98 -50.37 74.01 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.41 -0.806 . . . . 0.0 112.157 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 55.1 ttp -61.37 -35.72 78.25 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.366 -0.834 . . . . 0.0 110.871 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 89.2 mtp -69.96 -39.91 75.72 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.792 -0.567 . . . . 0.0 110.244 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.428 ' O ' HG22 ' A' ' 146' ' ' THR . 13.3 m -98.97 22.45 10.24 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.579 -0.7 . . . . 0.0 110.459 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.38 -40.55 85.71 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.366 -0.834 . . . . 0.0 111.399 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 29.9 mttt . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.525 -179.102 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 70.07 32.16 69.41 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -60.04 -41.89 93.25 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.55 -0.97 . . . . 0.0 110.111 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -60.77 -40.13 91.37 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.664 -0.647 . . . . 0.0 110.984 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 43.1 mtm-85 -65.73 -39.99 91.73 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.355 -0.841 . . . . 0.0 111.158 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 93.5 mt -65.25 -40.03 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.394 -0.816 . . . . 0.0 110.231 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.55 -40.74 97.78 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.562 -0.711 . . . . 0.0 110.127 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 -62.21 -40.48 96.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.728 -0.607 . . . . 0.0 110.557 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 85.8 mt -64.86 -40.07 94.57 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.495 -0.753 . . . . 0.0 110.562 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.67 HG21 ' HE2' ' A' ' 92' ' ' PHE . 94.2 t -63.78 -40.11 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.552 -0.718 . . . . 0.0 110.023 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.03 -31.39 61.54 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.6 HG11 ' SD ' ' A' ' 72' ' ' MET . 67.2 t -79.94 -28.95 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.722 -0.87 . . . . 0.0 111.363 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.522 HD12 ' HA ' ' B' ' 164' ' ' VAL . 79.0 mt -60.09 -49.95 75.63 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.195 -0.941 . . . . 0.0 111.707 -177.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 168' ' ' ARG . . . . . 0.429 ' HD3' ' CG ' ' A' ' 87' ' ' GLU . 38.0 ttt-85 -66.4 -40.06 89.41 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.127 -0.983 . . . . 0.0 110.445 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -60.04 -29.88 68.81 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.571 -0.706 . . . . 0.0 110.627 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 170' ' ' TRP . . . . . 0.479 ' CZ3' ' HE1' ' A' ' 71' ' ' MET . 4.5 t-105 -60.17 -39.47 86.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.489 -0.757 . . . . 0.0 110.176 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.23 -39.97 76.59 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.491 -0.755 . . . . 0.0 111.046 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -60.03 -39.97 87.69 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.345 -0.847 . . . . 0.0 110.372 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 . . . . . 0 N--CA 1.494 1.741 0 O-C-N 121.496 -0.752 . . . . 0.0 109.986 179.905 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 120.997 0.427 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.48 ' H ' HD11 ' A' ' 9' ' ' ILE . 43.0 t0 -89.96 85.36 6.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.597 -0.689 . . . . 0.0 109.794 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -59.93 -39.45 85.55 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.787 0.803 . . . . 0.0 109.9 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 90.3 mt -59.97 -40.04 87.74 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.059 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 p -136.62 105.39 5.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 110.202 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.405 ' HA ' HG12 ' A' ' 9' ' ' ILE . 97.1 mt-10 -81.82 -15.34 54.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.92 -0.488 . . . . 0.0 110.69 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -52.85 -43.27 65.94 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.086 -1.009 . . . . 0.0 110.503 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -70.05 -21.08 63.2 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.606 -0.683 . . . . 0.0 111.975 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.48 HD11 ' H ' ' A' ' 2' ' ' ASP . 47.7 mm -61.42 -50.87 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.308 -0.87 . . . . 0.0 110.374 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.43 -35.86 78.73 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.771 -0.581 . . . . 0.0 110.941 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.94 -45.46 92.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.61 -0.681 . . . . 0.0 110.362 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.478 ' CE1' ' HG2' ' A' ' 72' ' ' MET . 24.7 m-85 -64.68 -22.84 67.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.619 -0.676 . . . . 0.0 111.234 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -68.63 -41.62 79.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.272 -0.892 . . . . 0.0 108.721 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -59.99 -52.54 64.95 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.618 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.25 -23.43 64.78 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.318 -0.864 . . . . 0.0 111.657 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -56.1 -47.67 77.63 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.978 -1.076 . . . . 0.0 109.991 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.3 m -60.75 -39.29 88.16 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.503 -0.748 . . . . 0.0 109.403 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 64.2 tp -63.8 -39.95 95.48 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.92 -39.57 76.08 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.454 ' HB2' HD11 ' A' ' 27' ' ' ILE . 25.3 t0 -95.19 97.3 9.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.631 -0.668 . . . . 0.0 110.036 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.8 mttt -64.37 -32.01 73.45 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.367 -0.833 . . . . 0.0 111.598 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -80.57 -10.02 59.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.209 -0.932 . . . . 0.0 111.506 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.23 25.08 46.81 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -87.23 -9.66 54.51 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.586 -0.949 . . . . 0.0 110.666 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.64 2.81 53.04 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.868 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.5 p -144.61 141.95 29.78 Favored 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 119.534 1.667 . . . . 0.0 112.1 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.454 HD11 ' HB2' ' A' ' 20' ' ' ASP . 49.3 mm -99.93 121.04 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.5 p -100.91 142.08 32.88 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.576 -0.703 . . . . 0.0 111.019 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.424 ' CG2' ' HB3' ' A' ' 48' ' ' LEU . 82.1 p -41.76 -33.14 0.46 Allowed 'General case' 0 N--CA 1.509 2.518 0 O-C-N 121.856 -0.528 . . . . 0.0 111.892 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -64.71 -51.06 64.43 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.797 0.808 . . . . 0.0 109.525 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -59.95 -54.75 42.41 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.577 -178.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.448 HD21 ' CE2' ' B' ' 170' ' ' TRP . 58.8 tp -60.04 -35.32 74.85 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.203 -0.936 . . . . 0.0 110.696 -178.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.05 -30.45 16.56 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -178.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.8 m -70.03 -39.97 75.44 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.569 -0.959 . . . . 0.0 110.363 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 79.0 t -64.89 -51.07 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.628 -0.67 . . . . 0.0 109.746 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.403 ' HE2' ' HD3' ' A' ' 43' ' ' PRO . 98.1 mtp -59.97 -33.03 71.39 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.741 -0.6 . . . . 0.0 109.521 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -61.57 -41.87 98.02 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.696 0.76 . . . . 0.0 109.084 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.9 t -72.02 -19.47 61.85 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.962 -0.461 . . . . 0.0 110.81 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.7 -16.99 29.18 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.272 -0.893 . . . . 0.0 110.504 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.16 -55.62 0.18 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -159.97 169.92 22.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.411 -1.053 . . . . 0.0 110.804 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -107.82 125.88 31.12 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.892 -0.505 . . . . 0.0 110.151 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.427 ' HG2' HD21 ' A' ' 48' ' ' LEU . 52.9 Cg_endo -69.07 -148.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.07 0 N-CA-C 108.649 -1.327 . . . . 0.0 108.649 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 50.2 p -137.45 150.36 47.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.929 -1.107 . . . . 0.0 110.837 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -53.15 -23.65 8.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.636 -0.665 . . . . 0.0 111.467 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.49 -60.05 2.42 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.89 0.852 . . . . 0.0 109.128 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -67.71 -37.67 82.57 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.054 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.427 HD21 ' HG2' ' A' ' 43' ' ' PRO . 15.6 mt -57.1 -33.23 67.1 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.495 -0.753 . . . . 0.0 110.02 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -35.52 80.45 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.956 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -65.68 -39.96 91.85 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.45 -0.781 . . . . 0.0 110.832 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 67.2 mtt -60.02 -45.45 92.74 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.433 0.635 . . . . 0.0 109.93 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.795 HG22 ' OD2' ' A' ' 56' ' ' ASP . 96.8 mt -67.95 -33.07 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.824 -0.547 . . . . 0.0 110.729 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -60.06 -40.05 88.12 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.327 -0.858 . . . . 0.0 110.115 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -67.11 -26.47 66.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.377 -0.827 . . . . 0.0 109.959 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.535 HG21 ' SD ' ' A' ' 71' ' ' MET . 74.3 t -99.81 -9.99 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.598 -0.689 . . . . 0.0 110.864 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.795 ' OD2' HG22 ' A' ' 52' ' ' ILE . 25.6 m-20 -72.27 99.71 2.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.118 -0.989 . . . . 0.0 111.126 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.54 -40.06 92.46 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.388 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -88.32 -28.34 21.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.714 -0.616 . . . . 0.0 110.563 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.02 22.95 43.16 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -74.22 -33.79 63.49 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.499 -1.001 . . . . 0.0 110.617 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.97 -0.43 10.81 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.294 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.0 p -132.67 170.08 15.74 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.017 -1.284 . . . . 0.0 110.391 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.773 HD11 HG12 ' A' ' 52' ' ' ILE . 12.6 mt -106.67 120.4 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.87 -0.519 . . . . 0.0 110.869 -177.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -100.68 169.44 9.03 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.572 0.701 . . . . 0.0 110.906 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.47 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -45.05 -52.73 18.68 Favored Pre-proline 0 N--CA 1.502 2.168 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.069 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.2 Cg_endo -67.39 -30.93 35.81 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 O-C-N 122.943 0.97 . . . . 0.0 111.514 -178.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -72.1 -40.91 67.85 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.448 -0.782 . . . . 0.0 110.425 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -66.08 -40.16 90.61 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.683 -0.636 . . . . 0.0 111.177 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.7 mt -66.23 -39.93 89.9 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.373 -0.83 . . . . 0.0 111.569 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 21.6 p -64.19 -41.39 97.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.555 -0.716 . . . . 0.0 111.333 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.535 ' SD ' HG21 ' A' ' 55' ' ' VAL . 58.9 ttp -68.07 -40.2 82.77 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.438 -0.788 . . . . 0.0 110.894 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.478 ' HG2' ' CE1' ' A' ' 12' ' ' PHE . 53.6 tpp -59.99 -45.11 93.79 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.493 -0.755 . . . . 0.0 110.462 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.8 -30.8 70.32 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.506 -0.746 . . . . 0.0 109.725 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.4 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 0.2 OUTLIER -70.02 -39.67 75.65 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.706 -0.621 . . . . 0.0 111.059 179.824 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -65.79 -36.57 83.88 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.412 -0.805 . . . . 0.0 112.203 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 60.7 mtt -59.73 -50.09 75.18 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.214 -0.929 . . . . 0.0 111.684 -177.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 10.9 pttt -70.05 -38.96 75.96 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.308 -0.87 . . . . 0.0 110.835 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -68.66 -40.02 80.38 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.448 -0.782 . . . . 0.0 109.978 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.571 HG22 ' H ' ' A' ' 80' ' ' ASP . 1.4 m -100.43 -172.59 2.23 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.985 -0.447 . . . . 0.0 110.196 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.571 ' H ' HG22 ' A' ' 79' ' ' THR . 69.9 m-20 -129.53 147.22 51.31 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.42 -0.8 . . . . 0.0 109.904 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.4 t -59.95 -27.81 67.12 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.546 -0.721 . . . . 0.0 110.401 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.01 -36.72 77.85 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.368 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.98 -39.94 75.64 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.378 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.08 -37.47 75.45 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.694 -0.629 . . . . 0.0 110.558 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.474 HG23 ' SD ' ' A' ' 145' ' ' MET . 67.7 mt -65.57 -53.83 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.635 -0.666 . . . . 0.0 111.028 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.423 ' HG3' ' N ' ' A' ' 87' ' ' GLU . 33.6 ptt180 -60.03 -39.97 87.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.383 -0.823 . . . . 0.0 111.392 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.423 ' N ' ' HG3' ' A' ' 86' ' ' ARG . 95.3 mt-10 -68.58 -40.76 80.38 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.506 -0.746 . . . . 0.0 110.742 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.429 ' HA ' HG12 ' B' ' 164' ' ' VAL . . . -65.19 -44.24 89.03 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.956 -0.465 . . . . 0.0 110.898 -178.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -61.15 -41.28 96.47 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.879 0.847 . . . . 0.0 108.814 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -59.98 -38.14 81.69 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.821 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.3 -43.2 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.506 -0.746 . . . . 0.0 110.027 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.643 ' HE2' HG21 ' B' ' 164' ' ' VAL . 13.4 m-85 -69.37 -39.1 78.25 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.497 -0.752 . . . . 0.0 111.451 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -79.55 77.23 6.15 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.32 -0.862 . . . . 0.0 110.508 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -59.98 -42.34 93.98 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.395 -0.816 . . . . 0.0 110.216 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 24.1 p-10 -81.92 -19.94 39.74 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.496 -0.752 . . . . 0.0 111.258 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.79 63.83 4.92 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -109.91 -10.77 14.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.457 -1.025 . . . . 0.0 111.52 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.25 -23.31 8.14 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 31.0 p90 -149.08 152.91 37.01 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.327 -1.102 . . . . 0.0 109.549 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 56.0 mt -89.34 125.2 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.742 0.782 . . . . 0.0 109.96 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 m -80.99 171.29 15.18 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.141 0.496 . . . . 0.0 110.31 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.04 -40.59 96.63 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.622 -0.674 . . . . 0.0 109.498 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.03 -38.48 91.24 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.496 0.665 . . . . 0.0 109.314 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -62.43 -39.43 93.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.741 -0.6 . . . . 0.0 111.285 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.627 HD21 ' HE1' ' A' ' 124' ' ' MET . 1.4 tt -62.53 -43.74 98.06 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.133 -0.979 . . . . 0.0 109.468 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.449 ' HG2' HG21 ' A' ' 121' ' ' VAL . 88.1 mtt180 -60.05 -33.34 71.91 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.686 -0.634 . . . . 0.0 110.901 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -60.37 -45.37 93.76 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.159 -0.963 . . . . 0.0 111.614 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.535 HG11 ' CE1' ' A' ' 92' ' ' PHE . 95.9 t -72.92 -39.86 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.299 -0.876 . . . . 0.0 111.256 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 26.8 mmt -59.86 -48.65 80.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.46 -0.775 . . . . 0.0 110.293 -178.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.1 m -67.26 -41.71 85.09 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.496 -0.752 . . . . 0.0 109.848 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -61.13 -31.46 71.17 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.3 mt -69.03 -32.79 72.55 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.713 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.61 29.14 4.83 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -121.43 130.03 53.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.581 -0.952 . . . . 0.0 109.734 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -92.43 117.64 30.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.532 -0.73 . . . . 0.0 110.132 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.527 HD13 ' OE1' ' A' ' 120' ' ' GLU . 60.8 mt -132.71 157.24 45.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.617 -0.677 . . . . 0.0 109.812 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 p -83.74 162.99 20.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.587 -0.696 . . . . 0.0 109.663 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.9 p-10 -60.06 -25.16 65.16 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -66.61 -34.63 78.32 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.527 ' OE1' HD13 ' A' ' 116' ' ' LEU . 0.5 OUTLIER -62.42 -38.98 91.78 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.541 0.686 . . . . 0.0 109.233 179.15 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.543 HG13 HD13 ' A' ' 105' ' ' LEU . 74.9 t -68.88 -39.05 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.359 0.6 . . . . 0.0 110.124 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.493 ' HA ' HD12 ' A' ' 125' ' ' ILE . 45.2 t0 -59.28 -49.93 75.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.768 -0.582 . . . . 0.0 110.341 -178.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -60.27 -41.45 93.29 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.399 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.627 ' HE1' HD21 ' A' ' 105' ' ' LEU . 97.6 mtp -54.81 -39.7 68.75 Favored 'General case' 0 N--CA 1.504 2.24 0 C-N-CA 119.389 -0.924 . . . . 0.0 108.838 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.493 HD12 ' HA ' ' A' ' 122' ' ' ASP . 89.4 mt -63.75 -40.0 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.162 0.506 . . . . 0.0 109.963 178.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -60.0 -39.97 87.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.483 -0.76 . . . . 0.0 112.182 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -60.06 -39.94 87.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.116 -0.99 . . . . 0.0 111.773 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -99.05 -17.48 18.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.205 -0.934 . . . . 0.0 110.987 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.4 77.86 5.76 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.178 -0.951 . . . . 0.0 110.816 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 82.9 mt -64.14 -39.98 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.66 -0.65 . . . . 0.0 111.079 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -59.51 -38.53 81.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.403 -0.81 . . . . 0.0 111.12 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 98.59 11.93 45.98 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 120.115 -1.04 . . . . 0.0 111.417 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -81.31 -13.66 58.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.023 -1.281 . . . . 0.0 110.56 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.95 5.55 70.69 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.793 178.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -127.68 126.48 42.01 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.032 -1.275 . . . . 0.0 109.924 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.7 t -89.96 113.99 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.252 -0.905 . . . . 0.0 109.71 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -89.97 -179.38 5.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.507 -0.746 . . . . 0.0 109.884 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -62.24 -41.8 98.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.718 -0.614 . . . . 0.0 110.422 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -62.56 -44.85 95.32 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.199 -0.938 . . . . 0.0 111.463 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -63.44 -38.96 93.15 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.978 0.894 . . . . 0.0 109.454 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -59.87 -41.88 92.48 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.578 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.2 t -68.06 -40.11 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.493 -0.754 . . . . 0.0 110.945 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -60.78 -40.39 92.41 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.373 -0.829 . . . . 0.0 110.056 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 53.9 ttp -60.05 -41.2 91.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.779 -0.576 . . . . 0.0 110.752 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.474 ' SD ' HG23 ' A' ' 85' ' ' ILE . 44.3 mtt -82.06 -39.18 23.82 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.535 -0.728 . . . . 0.0 110.999 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 85.4 m -59.98 -26.81 66.33 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.695 -0.628 . . . . 0.0 110.459 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -80.78 119.12 22.95 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.434 -0.791 . . . . 0.0 110.601 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.7 mttm . . . . . 0 N--CA 1.5 2.026 0 CA-C-O 118.407 -0.806 . . . . 0.0 111.47 179.798 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 72.86 39.17 55.54 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -59.97 -47.47 85.66 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.451 -1.029 . . . . 0.0 109.464 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -60.73 -39.06 87.26 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.855 -0.528 . . . . 0.0 110.351 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -60.0 -40.0 87.72 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.522 -0.736 . . . . 0.0 109.853 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 86.7 mt -68.34 -39.99 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.681 -0.637 . . . . 0.0 110.369 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.04 -38.89 84.07 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.46 -0.775 . . . . 0.0 110.65 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 32.7 ttm-85 -60.04 -40.95 91.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.433 -0.792 . . . . 0.0 109.962 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 39.2 tp -64.24 -39.9 94.92 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.772 -0.58 . . . . 0.0 110.077 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.643 HG21 ' HE2' ' A' ' 92' ' ' PHE . 80.2 t -62.47 -39.94 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.517 -0.74 . . . . 0.0 110.347 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.52 -36.9 87.03 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 73.3 t -68.21 -39.19 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.913 -0.757 . . . . 0.0 110.457 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.577 HD12 ' HA ' ' B' ' 164' ' ' VAL . 84.5 mt -59.97 -46.41 89.52 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.522 -0.736 . . . . 0.0 111.635 -178.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -59.98 -40.0 87.64 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.27 -0.894 . . . . 0.0 110.269 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -60.09 -39.86 87.6 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.55 -0.719 . . . . 0.0 110.396 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 170' ' ' TRP . . . . . 0.448 ' CE2' HD21 ' A' ' 32' ' ' LEU . 5.0 t-105 -60.02 -45.64 92.14 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.695 -0.628 . . . . 0.0 110.404 -179.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.55 -40.63 97.45 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.519 -0.738 . . . . 0.0 110.152 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -59.98 -40.07 87.85 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.579 -0.7 . . . . 0.0 109.977 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.697 -0.627 . . . . 0.0 110.174 179.784 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.006 0.431 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -94.18 115.96 28.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.456 -0.777 . . . . 0.0 109.86 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -114.4 155.54 26.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.654 -0.654 . . . . 0.0 110.238 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.2 mt -95.19 -178.84 4.59 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.62 -0.675 . . . . 0.0 110.453 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.1 p -127.07 104.35 7.94 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.669 0.747 . . . . 0.0 110.335 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.686 ' HA ' HD12 ' A' ' 9' ' ' ILE . 99.8 mt-10 -81.84 -7.52 59.61 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.898 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -70.07 -39.97 75.33 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.276 -0.89 . . . . 0.0 110.244 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -69.9 -34.81 74.0 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.44 0.638 . . . . 0.0 110.875 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.686 HD12 ' HA ' ' A' ' 6' ' ' GLU . 84.6 mt -60.06 -38.85 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.65 -0.656 . . . . 0.0 111.971 -178.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.87 -29.19 70.02 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.97 -1.081 . . . . 0.0 111.051 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.85 -40.48 97.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.291 -0.881 . . . . 0.0 109.865 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.51 ' CB ' HD21 ' A' ' 69' ' ' LEU . 77.5 m-85 -64.98 -22.22 66.97 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.816 -0.553 . . . . 0.0 111.438 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.424 ' HE2' ' CZ ' ' A' ' 65' ' ' PHE . 28.3 mmtp -65.31 -39.97 93.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.34 -0.85 . . . . 0.0 110.075 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -62.63 -58.5 7.3 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.705 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.03 -36.07 76.47 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.387 -0.821 . . . . 0.0 112.15 -178.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -54.95 -49.73 70.63 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.072 -1.017 . . . . 0.0 110.561 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.6 t -60.77 -35.43 76.4 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.519 -0.738 . . . . 0.0 110.06 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.649 HD13 ' O ' ' A' ' 18' ' ' LEU . 2.1 tm? -65.83 -39.97 91.35 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -71.95 -40.62 68.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.909 -0.495 . . . . 0.0 110.668 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -94.19 95.21 8.81 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.363 -0.836 . . . . 0.0 110.82 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -66.76 -33.14 74.96 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.298 -0.876 . . . . 0.0 111.309 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -78.7 -10.91 59.93 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.116 -0.99 . . . . 0.0 111.281 -177.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.42 25.28 66.72 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 58.2 p-10 -89.5 -3.28 58.42 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.456 -1.026 . . . . 0.0 110.808 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.93 8.22 76.37 Favored Glycine 0 N--CA 1.489 2.232 0 O-C-N 121.217 -0.927 . . . . 0.0 111.271 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.9 p -145.73 143.06 29.51 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 119.335 1.568 . . . . 0.0 112.109 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.0 mt -101.21 121.84 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.69 -0.631 . . . . 0.0 109.411 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.6 p -99.15 143.45 29.41 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.49 -0.757 . . . . 0.0 110.607 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.416 ' O ' HD13 ' A' ' 48' ' ' LEU . 80.6 p -41.88 -36.92 1.16 Allowed 'General case' 0 N--CA 1.507 2.401 0 O-C-N 121.983 -0.448 . . . . 0.0 112.2 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -62.47 -47.86 82.14 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.112 -0.992 . . . . 0.0 109.346 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -60.04 -54.97 39.7 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.49 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 44.4 tp -59.98 -36.99 78.34 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.253 -0.904 . . . . 0.0 111.55 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.54 -31.39 14.46 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.5 m -70.92 -39.62 72.58 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.401 -1.058 . . . . 0.0 110.172 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.3 t -64.79 -54.1 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.517 -0.739 . . . . 0.0 110.06 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 92.6 mtp -60.03 -34.94 74.06 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.59 0.71 . . . . 0.0 110.064 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -60.05 -49.54 77.24 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.651 0.739 . . . . 0.0 110.007 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.9 t -69.96 -16.69 63.24 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.838 -0.539 . . . . 0.0 110.791 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.531 HD13 HD12 ' B' ' 167' ' ' LEU . 84.3 mt -87.9 -24.41 23.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.474 -0.766 . . . . 0.0 110.45 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.41 -38.43 0.22 Allowed Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.528 -1.32 . . . . 0.0 111.401 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -152.78 155.53 37.34 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 118.814 1.307 . . . . 0.0 112.196 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -116.97 99.96 53.16 Favored Pre-proline 0 N--CA 1.489 1.517 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.677 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.422 ' HG2' HD21 ' A' ' 48' ' ' LEU . 44.7 Cg_endo -64.18 -148.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.282 0 O-C-N 123.246 1.129 . . . . 0.0 109.56 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.7 p -139.94 156.5 46.63 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.93 -1.106 . . . . 0.0 111.689 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -54.02 -20.58 6.58 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.801 -0.562 . . . . 0.0 111.602 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.94 -59.99 2.46 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.937 0.875 . . . . 0.0 108.942 177.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -68.73 -33.75 74.44 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.044 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.422 HD21 ' HG2' ' A' ' 43' ' ' PRO . 44.2 mt -58.8 -34.85 71.96 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.608 -0.683 . . . . 0.0 110.33 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.33 -32.12 69.71 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.535 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -70.08 -43.09 71.83 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.356 -0.84 . . . . 0.0 111.313 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.422 ' CE ' HD23 ' A' ' 48' ' ' LEU . 77.7 mtm -60.95 -41.85 97.12 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.632 0.73 . . . . 0.0 109.463 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.579 HG22 ' OD2' ' A' ' 56' ' ' ASP . 97.0 mt -69.82 -31.93 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.908 -0.495 . . . . 0.0 110.026 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -59.96 -41.53 92.11 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.593 -0.692 . . . . 0.0 110.821 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -67.99 -25.61 65.49 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.323 -0.861 . . . . 0.0 110.292 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.3 t -99.09 -9.46 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.607 -0.683 . . . . 0.0 111.116 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.579 ' OD2' HG22 ' A' ' 52' ' ' ILE . 26.7 m-20 -71.96 106.53 4.29 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.123 -0.986 . . . . 0.0 111.68 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.92 -40.07 75.76 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.458 -0.776 . . . . 0.0 109.726 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -88.62 -29.74 19.74 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.635 -0.665 . . . . 0.0 110.266 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.92 24.61 44.4 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -74.3 -31.82 62.64 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.536 -0.979 . . . . 0.0 110.467 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 123.0 -3.91 9.78 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 120.361 -0.923 . . . . 0.0 111.033 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 82.0 p -133.43 170.01 16.12 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.065 -1.256 . . . . 0.0 110.364 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.57 HG12 HG23 ' A' ' 52' ' ' ILE . 9.1 mt -102.79 120.48 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.05 -178.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -98.38 169.51 9.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.523 -0.736 . . . . 0.0 110.617 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.476 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 25.7 t80 -49.01 -48.76 71.9 Favored Pre-proline 0 N--CA 1.497 1.915 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.7 Cg_endo -68.11 -33.54 24.87 Favored 'Trans proline' 0 N--CA 1.486 1.084 0 O-C-N 122.639 0.81 . . . . 0.0 110.863 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -71.13 -39.98 71.69 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.328 -0.857 . . . . 0.0 110.061 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -60.78 -49.96 75.4 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.522 -0.736 . . . . 0.0 110.893 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.51 HD21 ' CB ' ' A' ' 12' ' ' PHE . 85.2 mt -60.33 -41.89 94.49 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.509 -0.744 . . . . 0.0 111.515 -178.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 66' ' ' PRO . 45.9 p -63.66 -37.17 86.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.44 -0.788 . . . . 0.0 111.395 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.8 ttt -65.76 -44.36 86.09 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.299 -0.876 . . . . 0.0 111.54 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 91.2 mtp -71.04 -60.08 2.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.346 -0.846 . . . . 0.0 112.146 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.74 -40.79 76.39 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.47 -0.768 . . . . 0.0 111.314 -178.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.8 tpt85 -70.0 -40.2 75.42 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.526 -0.734 . . . . 0.0 111.157 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -86.2 -39.1 16.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.397 -0.815 . . . . 0.0 111.986 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.729 ' O ' HG22 ' A' ' 79' ' ' THR . 43.9 mtm -60.02 -39.95 87.62 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.254 -0.904 . . . . 0.0 111.661 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -62.21 -44.27 96.96 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.189 -0.944 . . . . 0.0 109.66 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -74.74 -10.02 59.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.93 -0.481 . . . . 0.0 110.566 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.729 HG22 ' O ' ' A' ' 76' ' ' MET . 0.6 OUTLIER -85.5 -162.5 0.73 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.252 -0.905 . . . . 0.0 111.328 -179.047 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.643 ' N ' HG23 ' A' ' 79' ' ' THR . 68.6 m-20 -130.06 135.43 48.23 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.804 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.0 t -69.97 -27.19 64.52 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.614 -0.678 . . . . 0.0 110.638 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -60.04 -36.62 77.68 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.556 -0.715 . . . . 0.0 110.023 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.98 -40.02 75.6 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.722 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -63.21 -40.05 96.37 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.475 -0.766 . . . . 0.0 110.729 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.624 HG23 ' HE2' ' A' ' 141' ' ' PHE . 85.8 mt -66.03 -46.89 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.673 -0.642 . . . . 0.0 110.148 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 -56.57 -40.42 75.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.532 -0.73 . . . . 0.0 110.903 -178.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.721 ' O ' HG23 ' A' ' 91' ' ' VAL . 99.0 mt-10 -69.94 -40.05 75.73 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.421 -0.8 . . . . 0.0 111.721 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.656 ' CA ' HG11 ' B' ' 164' ' ' VAL . . . -65.1 -48.86 72.17 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.358 -0.839 . . . . 0.0 111.996 -178.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -61.23 -43.68 98.48 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.464 -0.772 . . . . 0.0 109.984 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -59.98 -38.41 82.46 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.874 -0.516 . . . . 0.0 110.997 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 87' ' ' GLU . 99.0 t -69.82 -48.76 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.473 -0.767 . . . . 0.0 110.446 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.778 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 20.3 m-85 -67.98 -40.06 83.19 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.47 -0.769 . . . . 0.0 111.01 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -74.96 69.93 1.94 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.528 -0.733 . . . . 0.0 110.337 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.7 tttp -59.95 -46.6 88.89 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.426 -0.796 . . . . 0.0 109.84 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.1 p-10 -73.9 -18.83 60.86 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.603 -0.685 . . . . 0.0 111.382 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.94 62.4 6.35 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.438 ' ND2' ' CE2' ' A' ' 99' ' ' TYR . 37.6 p-10 -109.23 -7.46 15.27 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.516 -0.991 . . . . 0.0 111.82 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.55 -22.6 11.76 Favored Glycine 0 N--CA 1.498 2.817 0 C-N-CA 119.989 -1.1 . . . . 0.0 110.439 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.438 ' CE2' ' ND2' ' A' ' 97' ' ' ASN . 35.5 p90 -143.77 154.55 43.56 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.392 -1.064 . . . . 0.0 109.635 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 81.9 mt -91.32 129.42 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 121.839 0.828 . . . . 0.0 110.126 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.03 172.36 9.6 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.211 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.26 -40.98 86.26 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.579 -0.701 . . . . 0.0 109.665 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.54 -37.75 88.51 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -61.16 -37.35 82.58 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.974 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.591 ' HB3' HG13 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -64.58 -42.73 95.42 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.682 0.753 . . . . 0.0 109.552 179.033 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -60.04 -38.53 83.02 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.883 -0.511 . . . . 0.0 111.556 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -59.97 -41.06 91.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.084 -1.01 . . . . 0.0 111.856 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.778 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 84.5 t -72.9 -50.13 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.239 -0.913 . . . . 0.0 111.594 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.422 ' HA ' HD12 ' A' ' 112' ' ' LEU . 41.8 mtt -59.07 -41.52 88.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.175 -0.953 . . . . 0.0 110.403 -178.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.7 m -64.37 -46.62 82.59 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.49 -0.756 . . . . 0.0 109.126 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -61.35 -33.57 73.85 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.504 ' CD1' HG12 ' A' ' 108' ' ' VAL . 39.2 mt -69.84 -30.51 68.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.95 -0.469 . . . . 0.0 109.999 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.16 31.62 3.03 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -122.19 137.0 54.98 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.539 -0.977 . . . . 0.0 110.028 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -109.52 124.87 51.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.532 -0.73 . . . . 0.0 110.212 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.667 HD22 ' OE2' ' A' ' 120' ' ' GLU . 73.0 mt -138.98 159.75 41.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.565 -0.709 . . . . 0.0 109.647 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.18 162.01 26.04 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -59.61 -29.55 68.07 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.355 -0.841 . . . . 0.0 109.084 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -68.44 -32.63 72.78 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.424 0.63 . . . . 0.0 109.61 178.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.667 ' OE2' HD22 ' A' ' 116' ' ' LEU . 12.0 mt-10 -67.83 -37.97 82.61 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.522 178.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.591 HG13 ' HB3' ' A' ' 105' ' ' LEU . 97.5 t -69.74 -40.09 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.699 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -59.9 -42.03 92.92 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.295 0.569 . . . . 0.0 109.996 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -60.04 -41.4 92.2 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.026 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.485 ' HB3' HD11 ' A' ' 105' ' ' LEU . 6.3 mmt -54.64 -36.37 64.48 Favored 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.385 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.5 mm -68.47 -37.6 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.308 0.575 . . . . 0.0 109.826 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 46.6 ttt-85 -60.0 -40.08 87.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.574 -0.704 . . . . 0.0 111.239 -178.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -61.83 -39.46 91.89 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.648 -0.657 . . . . 0.0 111.222 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -99.34 -0.25 41.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.347 -0.846 . . . . 0.0 111.763 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -104.48 80.53 1.69 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.979 -1.076 . . . . 0.0 110.947 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.4 mt -67.84 -39.95 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.648 -0.658 . . . . 0.0 109.965 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 36.5 p-10 -60.02 -39.72 86.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.587 -0.696 . . . . 0.0 110.755 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.77 17.9 36.75 Favored Glycine 0 N--CA 1.497 2.727 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.385 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -81.0 -10.11 59.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.108 -1.231 . . . . 0.0 110.608 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.13 2.29 71.39 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.367 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -136.77 139.18 41.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.167 -1.196 . . . . 0.0 110.276 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 98.1 t -95.81 113.81 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.566 -0.709 . . . . 0.0 109.713 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 41.6 p30 -86.12 -166.95 1.68 Allowed 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.609 -0.682 . . . . 0.0 110.241 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -70.08 -43.72 70.56 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.842 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -61.3 -49.96 74.93 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.264 -0.897 . . . . 0.0 112.115 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.3 -37.63 88.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.503 -0.748 . . . . 0.0 110.499 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.624 ' HE2' HG23 ' A' ' 85' ' ' ILE . 68.5 t80 -60.09 -47.3 86.45 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.667 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 87.0 t -64.66 -39.96 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.485 -0.76 . . . . 0.0 110.695 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -59.98 -49.64 76.87 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.563 -0.711 . . . . 0.0 111.033 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.448 ' CE ' ' CD1' ' B' ' 157' ' ' PHE . 10.9 tmm? -60.66 -40.01 90.48 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.279 -0.888 . . . . 0.0 110.128 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 94.9 mmm -67.24 -38.78 85.77 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.749 -0.595 . . . . 0.0 109.944 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 91.6 m -58.85 -29.03 66.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.69 -0.631 . . . . 0.0 109.973 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.99 141.86 47.74 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.6 -0.688 . . . . 0.0 110.432 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 95.7 mttt . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.325 179.916 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -66.54 152.74 52.41 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.531 ' HA ' HD12 ' B' ' 160' ' ' ILE . 22.6 t80 -61.51 -42.2 98.44 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.488 -1.007 . . . . 0.0 110.332 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 63.0 mtt85 -60.02 -40.06 88.01 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.558 -0.714 . . . . 0.0 110.397 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -62.61 -39.92 95.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.494 -0.754 . . . . 0.0 110.364 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 160' ' ' ILE . . . . . 0.531 HD12 ' HA ' ' B' ' 157' ' ' PHE . 73.0 mt -61.23 -45.09 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.516 -0.74 . . . . 0.0 110.041 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.9 -28.64 69.09 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.518 -0.739 . . . . 0.0 110.146 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -60.15 -39.92 88.03 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.572 -0.705 . . . . 0.0 109.503 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 89.0 mt -60.04 -40.08 88.14 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.724 -0.61 . . . . 0.0 110.413 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.656 HG11 ' CA ' ' A' ' 88' ' ' ALA . 94.0 t -65.22 -39.95 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.496 -0.753 . . . . 0.0 109.9 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -54.81 -37.15 61.17 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 85.0 t -60.0 -33.32 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.657 -0.907 . . . . 0.0 109.627 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.577 HD23 ' O ' ' B' ' 167' ' ' LEU . 8.1 tt -56.24 -37.74 70.15 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.622 -0.674 . . . . 0.0 110.777 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -59.99 -39.99 87.65 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.416 -0.803 . . . . 0.0 110.224 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -63.76 -40.01 95.67 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.447 -0.783 . . . . 0.0 110.989 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -20.9 59.46 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.415 -0.803 . . . . 0.0 110.869 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.98 -32.31 70.46 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.268 -0.895 . . . . 0.0 110.965 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -59.98 -38.73 83.39 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.355 -0.841 . . . . 0.0 109.865 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 71.4 mtp85 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.734 -0.604 . . . . 0.0 110.318 179.99 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.301 0.572 . . . . 0.0 110.067 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 72.1 mt -57.88 -29.02 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.776 -0.577 . . . . 0.0 110.737 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.22 -39.13 89.09 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.233 -0.917 . . . . 0.0 110.194 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -59.98 -43.47 95.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.718 -0.614 . . . . 0.0 110.397 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.584 ' HB3' HD21 ' A' ' 69' ' ' LEU . 77.2 m-85 -64.8 -20.77 66.56 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.844 -0.535 . . . . 0.0 111.395 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -69.96 -42.3 73.36 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.068 -1.02 . . . . 0.0 109.107 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -70.0 -26.65 64.17 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.119 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.15 -27.43 32.73 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.335 -0.853 . . . . 0.0 111.147 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.454 ' CB ' ' CE1' ' A' ' 65' ' ' PHE . 47.9 t80 -59.66 -41.32 90.31 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.576 -0.703 . . . . 0.0 111.673 -177.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.0 m -61.28 -38.36 86.5 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.233 -0.917 . . . . 0.0 109.974 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.7 tp -60.05 -41.21 91.84 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.816 -0.553 . . . . 0.0 110.0 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -74.22 -34.76 63.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.583 -0.698 . . . . 0.0 110.467 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -92.97 95.44 9.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.447 -0.783 . . . . 0.0 109.655 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -59.98 -32.1 70.51 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.426 -0.796 . . . . 0.0 111.155 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -79.44 -8.03 58.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.102 -0.999 . . . . 0.0 110.754 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.21 26.83 29.92 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -90.4 -4.82 56.78 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.686 -0.89 . . . . 0.0 111.326 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.97 2.41 58.26 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.634 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.0 p -146.71 144.18 29.25 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.353 1.576 . . . . 0.0 111.727 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 84.0 mt -107.72 133.14 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.71 -0.619 . . . . 0.0 109.97 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.2 p -111.04 145.84 37.78 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.552 -0.717 . . . . 0.0 110.626 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.442 ' CG2' HD12 ' A' ' 52' ' ' ILE . 53.6 p -43.81 -32.98 1.18 Allowed 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.667 -0.646 . . . . 0.0 111.858 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.06 -50.59 65.58 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.753 0.787 . . . . 0.0 109.533 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -59.99 -53.63 55.56 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.65 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.559 HD13 ' CZ2' ' B' ' 170' ' ' TRP . 9.0 tt -60.02 -32.38 70.84 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.359 -0.838 . . . . 0.0 110.479 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.19 -31.34 33.8 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.314 -1.115 . . . . 0.0 110.314 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 93.7 m -63.83 -39.97 95.49 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.591 -0.946 . . . . 0.0 109.09 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.401 ' CG1' HD22 ' B' ' 167' ' ' LEU . 78.0 t -66.61 -39.98 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 96.8 mmm -59.97 -39.99 87.57 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.684 -0.635 . . . . 0.0 110.877 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.46 ' CG ' ' HB2' ' A' ' 42' ' ' ASN . 55.6 mtm180 -61.85 -42.62 99.26 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.152 -0.967 . . . . 0.0 109.552 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.3 t -63.72 -25.96 68.44 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.083 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.641 HD21 ' HD2' ' B' ' 168' ' ' ARG . 24.0 tp -85.77 -23.17 27.38 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.416 -0.803 . . . . 0.0 109.366 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.93 -58.77 0.17 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -160.56 176.26 11.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.544 -0.974 . . . . 0.0 111.415 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.46 ' HB2' ' CG ' ' A' ' 37' ' ' ARG . 38.9 t30 -99.61 131.84 24.1 Favored Pre-proline 0 N--CA 1.492 1.664 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.208 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -68.75 -147.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.111 0 N-CA-C 108.435 -1.41 . . . . 0.0 108.435 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.1 p -129.59 141.55 50.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.827 -1.171 . . . . 0.0 110.481 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -51.48 -25.77 7.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.642 -0.661 . . . . 0.0 111.322 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.57 -54.9 7.87 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.124 0.964 . . . . 0.0 108.546 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -66.86 -39.87 87.69 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.093 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.43 HD13 ' HB ' ' A' ' 29' ' ' THR . 1.4 mt -56.0 -35.04 66.37 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.542 -0.724 . . . . 0.0 109.713 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.97 -37.16 81.19 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.152 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -65.22 -38.68 91.16 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.382 -0.823 . . . . 0.0 110.791 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 88.6 mmm -59.98 -45.97 90.97 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.659 -0.65 . . . . 0.0 110.206 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.732 HG22 ' OD2' ' A' ' 56' ' ' ASP . 89.9 mt -67.89 -32.98 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.714 -0.616 . . . . 0.0 110.375 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -60.01 -43.29 95.33 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.246 -0.909 . . . . 0.0 110.669 -178.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -67.9 -26.44 65.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.339 -0.851 . . . . 0.0 110.918 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.505 HG21 ' SD ' ' A' ' 71' ' ' MET . 57.5 t -99.97 -8.84 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.483 -0.761 . . . . 0.0 111.482 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.732 ' OD2' HG22 ' A' ' 52' ' ' ILE . 3.6 m-20 -71.23 103.16 2.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.109 -0.995 . . . . 0.0 110.897 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.25 -38.71 78.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.648 -0.658 . . . . 0.0 109.76 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -91.45 -30.64 16.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.615 -0.678 . . . . 0.0 110.537 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.2 20.99 40.01 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 120.36 -0.924 . . . . 0.0 110.905 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.6 p-10 -73.95 -32.86 63.67 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.39 -1.065 . . . . 0.0 110.323 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.7 -0.04 12.16 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.006 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 57.7 p -137.35 167.74 21.01 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.091 -1.24 . . . . 0.0 110.917 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.8 mt -104.58 120.67 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 121.317 0.58 . . . . 0.0 110.483 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -96.48 169.93 9.57 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.383 0.611 . . . . 0.0 110.585 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.456 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -46.06 -50.35 36.86 Favored Pre-proline 0 N--CA 1.501 2.099 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -179.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.3 Cg_endo -72.37 -32.02 10.74 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.026 1.014 . . . . 0.0 111.771 -178.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -71.44 -40.03 70.65 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.216 -0.927 . . . . 0.0 110.251 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -61.52 -39.96 92.93 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.723 -0.611 . . . . 0.0 110.761 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.584 HD21 ' HB3' ' A' ' 12' ' ' PHE . 89.3 mt -67.76 -39.98 84.12 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.424 -0.798 . . . . 0.0 111.926 -178.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.1 p -61.88 -40.08 94.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.356 -0.84 . . . . 0.0 110.748 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.505 ' SD ' HG21 ' A' ' 55' ' ' VAL . 60.5 ttp -67.71 -38.38 83.53 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.622 -0.674 . . . . 0.0 110.357 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.402 ' CE ' ' CG2' ' B' ' 166' ' ' VAL . 5.0 tpt -60.06 -49.51 77.39 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.611 -0.681 . . . . 0.0 111.076 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.09 -28.96 65.83 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.395 -0.816 . . . . 0.0 110.757 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -72.05 -40.79 68.1 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.498 -0.751 . . . . 0.0 110.608 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -69.15 -50.07 51.08 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.639 -0.663 . . . . 0.0 111.483 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 70.6 mtm -59.94 -40.03 87.56 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.429 -0.794 . . . . 0.0 111.104 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -60.74 -55.41 33.53 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.368 -0.832 . . . . 0.0 111.224 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -65.02 -19.98 66.27 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.456 -0.777 . . . . 0.0 110.161 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.544 HG22 ' H ' ' A' ' 80' ' ' ASP 0.299 52.9 m -99.87 -175.11 2.87 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.815 -0.553 . . . . 0.0 109.648 -179.742 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.544 ' H ' HG22 ' A' ' 79' ' ' THR . 87.4 m-20 -121.74 140.82 51.85 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.223 -0.923 . . . . 0.0 109.084 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.4 ' HA ' ' HG2' ' A' ' 84' ' ' GLU . 33.6 t -55.76 -28.57 56.67 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.317 -0.864 . . . . 0.0 110.271 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.76 -34.32 77.63 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.677 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -71.42 -41.63 69.31 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.92 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.4 ' HG2' ' HA ' ' A' ' 81' ' ' SER . 9.5 pt-20 -69.93 -29.49 66.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.117 -0.989 . . . . 0.0 110.414 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 95.9 mt -69.3 -46.31 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.536 -0.727 . . . . 0.0 109.699 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 63.2 mtt180 -59.81 -39.93 86.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.409 -0.807 . . . . 0.0 110.584 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.62 ' O ' HG23 ' A' ' 91' ' ' VAL . 98.9 mt-10 -66.95 -44.45 80.55 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.535 -0.728 . . . . 0.0 110.927 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.494 ' HA ' HG12 ' B' ' 164' ' ' VAL . . . -64.4 -43.58 93.98 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.667 -0.646 . . . . 0.0 111.282 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -59.94 -47.99 83.54 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.763 0.792 . . . . 0.0 109.778 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -58.98 -33.42 70.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.914 -0.492 . . . . 0.0 110.473 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 87' ' ' GLU . 78.5 t -70.04 -42.88 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.508 -0.745 . . . . 0.0 110.028 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.41 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 13.0 m-85 -70.06 -39.13 75.84 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.446 -0.784 . . . . 0.0 110.628 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -79.75 73.32 6.48 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.575 -0.703 . . . . 0.0 109.653 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -64.82 -40.83 95.84 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.381 -0.824 . . . . 0.0 110.487 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -76.12 -16.59 59.86 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.459 -0.775 . . . . 0.0 110.958 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.18 61.58 7.34 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -107.79 -10.6 15.55 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.581 -0.952 . . . . 0.0 111.377 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.4 -23.22 8.58 Favored Glycine 0 N--CA 1.498 2.815 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 14.6 p90 -142.79 176.16 9.27 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.483 -1.01 . . . . 0.0 108.708 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.507 HG22 ' H ' ' A' ' 101' ' ' SER . 23.4 mt -89.07 -129.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 119.801 -0.759 . . . . 0.0 109.248 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.507 ' H ' HG22 ' A' ' 100' ' ' ILE . 0.3 OUTLIER 168.71 159.87 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 O-C-N 120.529 -1.357 . . . . 0.0 108.321 178.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.52 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -61.3 -42.02 97.97 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.367 -0.833 . . . . 0.0 109.18 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.12 -30.67 67.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.837 -0.539 . . . . 0.0 110.094 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.47 ' HB2' HG22 ' A' ' 100' ' ' ILE . 61.9 mt-10 -69.97 -39.15 76.16 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.305 -0.872 . . . . 0.0 110.593 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.752 ' HB3' HG13 ' A' ' 121' ' ' VAL . 0.9 OUTLIER -67.54 -47.24 70.44 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.481 -0.762 . . . . 0.0 110.21 179.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -61.21 -38.94 88.39 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.826 -0.546 . . . . 0.0 111.628 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -60.04 -39.95 87.71 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.218 -0.926 . . . . 0.0 111.163 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.41 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 96.5 t -74.08 -47.36 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 O-C-N 121.275 -0.891 . . . . 0.0 111.438 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.702 ' HE1' HG22 ' A' ' 121' ' ' VAL . 76.5 mtm -58.83 -42.96 90.46 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.156 -0.965 . . . . 0.0 110.267 -178.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.2 m -67.27 -41.67 85.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.541 -0.724 . . . . 0.0 109.127 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -63.1 -31.91 73.17 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 109' ' ' MET . 42.5 mt -70.02 -35.09 74.08 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.697 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.94 21.14 2.95 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.667 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -119.98 138.32 53.55 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.215 -1.168 . . . . 0.0 110.024 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.7 mmmt -103.33 122.02 43.95 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.541 -0.725 . . . . 0.0 110.649 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.511 HD12 ' SD ' ' A' ' 109' ' ' MET . 77.2 mt -135.05 156.48 48.95 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.64 -0.662 . . . . 0.0 109.502 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.77 159.39 29.07 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.558 -0.714 . . . . 0.0 109.677 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -58.75 -29.8 67.02 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -66.09 -29.97 70.39 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -37.31 86.13 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.752 HG13 ' HB3' ' A' ' 105' ' ' LEU . 94.5 t -70.05 -39.91 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.522 0.677 . . . . 0.0 110.151 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -60.04 -45.75 91.78 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.786 -0.571 . . . . 0.0 110.074 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -59.9 -40.05 87.46 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.597 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.548 ' HB3' HD11 ' A' ' 105' ' ' LEU . 10.2 mmt -55.39 -38.48 68.94 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.594 -0.842 . . . . 0.0 108.767 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 48.4 mm -66.31 -40.1 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.356 0.598 . . . . 0.0 109.749 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -57.86 -38.62 76.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.691 -0.631 . . . . 0.0 111.197 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.95 -39.77 86.73 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.68 -0.638 . . . . 0.0 111.16 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.93 4.45 34.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.321 -0.862 . . . . 0.0 111.558 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 62.7 t0 -88.14 69.9 9.25 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.035 -1.041 . . . . 0.0 110.425 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.7 mt -67.67 -40.74 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.464 -0.772 . . . . 0.0 110.481 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -72.59 -22.4 60.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.433 -0.792 . . . . 0.0 111.087 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.6 24.33 50.58 Favored Glycine 0 N--CA 1.496 2.688 0 C-N-CA 120.262 -0.971 . . . . 0.0 110.69 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -83.8 -10.78 57.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.389 -1.065 . . . . 0.0 111.086 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.35 0.84 79.33 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -137.81 149.26 46.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -1.117 . . . . 0.0 109.286 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.0 t -92.14 118.63 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.427 -0.796 . . . . 0.0 109.771 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -88.06 176.51 7.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.573 -0.705 . . . . 0.0 109.346 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -61.34 -47.47 85.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.743 -0.598 . . . . 0.0 110.498 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -59.95 -46.42 89.47 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.74 -0.6 . . . . 0.0 111.51 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -64.47 -37.04 86.15 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.806 0.813 . . . . 0.0 109.99 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.453 ' CZ ' ' CE ' ' A' ' 145' ' ' MET . 64.9 t80 -60.07 -48.88 79.89 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.283 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.859 ' O ' HG22 ' A' ' 146' ' ' THR . 89.0 t -70.0 -40.65 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.308 -0.87 . . . . 0.0 111.921 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -59.94 -48.8 80.22 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.308 -0.87 . . . . 0.0 111.477 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.43 ' HE1' ' CE1' ' B' ' 157' ' ' PHE . 55.2 ttp -59.99 -35.9 76.01 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.428 -0.795 . . . . 0.0 110.475 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.477 ' HE2' ' CB ' ' B' ' 161' ' ' ALA . 37.3 mtt -70.65 -40.04 73.27 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.638 -0.664 . . . . 0.0 110.939 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.859 HG22 ' O ' ' A' ' 142' ' ' VAL . 8.5 t -104.99 31.65 4.69 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.514 -0.741 . . . . 0.0 109.98 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.18 -42.45 95.04 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.626 -0.671 . . . . 0.0 110.153 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 30.2 mttt . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.969 179.563 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.374 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -92.64 146.23 18.04 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . 0.43 ' CE1' ' HE1' ' A' ' 144' ' ' MET . 51.4 t80 -59.95 -40.73 90.0 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.506 -0.997 . . . . 0.0 109.903 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 32.6 ttp85 -61.38 -40.45 94.4 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.699 -0.626 . . . . 0.0 110.22 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -60.14 -40.01 88.34 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.488 -0.757 . . . . 0.0 110.286 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 97.4 mt -66.68 -39.63 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.655 -0.653 . . . . 0.0 110.465 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . 0.477 ' CB ' ' HE2' ' A' ' 145' ' ' MET . . . -59.32 -37.11 76.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.521 -0.737 . . . . 0.0 110.372 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -60.13 -40.04 88.4 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.486 -0.759 . . . . 0.0 110.688 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 83.4 mt -70.04 -34.95 73.91 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.517 -0.739 . . . . 0.0 110.691 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . 0.494 HG12 ' HA ' ' A' ' 88' ' ' ALA . 91.1 t -63.97 -39.96 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.595 -0.691 . . . . 0.0 109.932 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.14 -30.46 67.2 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.402 ' CG2' ' CE ' ' A' ' 72' ' ' MET . 58.3 t -69.02 -33.56 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.628 -0.925 . . . . 0.0 110.959 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.401 HD22 ' CG1' ' A' ' 35' ' ' VAL . 91.6 mt -60.17 -46.55 89.3 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.372 -0.83 . . . . 0.0 111.711 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 168' ' ' ARG . . . . . 0.641 ' HD2' HD21 ' A' ' 39' ' ' LEU . 23.2 mmm180 -70.07 -38.18 75.66 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.198 -0.939 . . . . 0.0 111.505 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -59.97 -40.06 87.77 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.287 -0.883 . . . . 0.0 110.629 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 170' ' ' TRP . . . . . 0.559 ' CZ2' HD13 ' A' ' 32' ' ' LEU . 2.0 t-105 -59.95 -40.26 88.38 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.41 -0.806 . . . . 0.0 109.845 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.1 -20.45 59.46 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.578 -0.701 . . . . 0.0 110.514 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -60.03 -39.99 87.77 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.324 -0.86 . . . . 0.0 110.072 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.635 -0.666 . . . . 0.0 110.111 179.73 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 121.523 0.678 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 79.0 mt -60.58 -29.04 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.925 -0.484 . . . . 0.0 111.525 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.67 86.6 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.157 -0.964 . . . . 0.0 110.063 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -60.03 -40.38 89.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.465 -0.772 . . . . 0.0 110.244 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.415 ' CG ' HD21 ' A' ' 69' ' ' LEU . 66.0 m-85 -65.36 -20.75 66.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.724 -0.61 . . . . 0.0 110.917 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HD3' ' CZ ' ' A' ' 65' ' ' PHE . 72.2 mmtt -69.94 -46.14 65.94 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.293 -0.879 . . . . 0.0 109.886 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -76.23 -24.82 54.61 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.45 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.22 -35.2 42.01 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.454 -0.779 . . . . 0.0 110.51 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -59.87 -39.99 87.13 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.853 -0.529 . . . . 0.0 111.549 -177.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.5 m -61.93 -39.64 92.77 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.25 -0.906 . . . . 0.0 109.946 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.649 HD11 ' O ' ' A' ' 112' ' ' LEU . 59.7 tp -60.03 -40.09 88.16 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.693 -0.629 . . . . 0.0 109.406 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -77.39 -35.61 54.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.718 -0.614 . . . . 0.0 110.349 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -94.26 97.73 10.44 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.401 -0.812 . . . . 0.0 110.196 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -59.99 -34.81 73.81 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.527 -0.733 . . . . 0.0 111.728 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -80.1 -11.2 59.78 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.172 -0.955 . . . . 0.0 111.249 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.56 28.77 52.29 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -90.86 -6.13 54.62 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.725 -0.868 . . . . 0.0 111.262 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.42 0.25 56.87 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 120.158 -1.02 . . . . 0.0 111.617 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.5 p -144.86 143.02 30.38 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 119.284 1.542 . . . . 0.0 111.108 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.8 mt -107.04 130.07 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 121.766 0.793 . . . . 0.0 110.868 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.4 p -106.16 143.06 34.82 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.846 -0.533 . . . . 0.0 110.537 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.511 HG23 ' CD1' ' A' ' 52' ' ' ILE . 64.8 p -43.25 -29.03 0.36 Allowed 'General case' 0 N--CA 1.509 2.489 0 O-C-N 121.667 -0.646 . . . . 0.0 112.163 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -65.09 -50.21 66.99 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.804 0.811 . . . . 0.0 109.58 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -59.51 -53.35 59.13 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.695 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.441 ' CD2' ' CE2' ' B' ' 170' ' ' TRP . 54.4 tp -60.09 -30.47 69.26 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.253 -0.904 . . . . 0.0 110.119 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.49 -32.56 23.58 Favored Glycine 0 N--CA 1.5 2.959 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.6 m -65.38 -39.91 92.86 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.545 -0.974 . . . . 0.0 109.434 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.458 ' CG1' HD22 ' B' ' 167' ' ' LEU . 77.1 t -68.18 -39.99 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-O 121.492 0.663 . . . . 0.0 110.046 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 46.1 mtt -59.97 -39.96 87.42 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.698 -0.626 . . . . 0.0 111.104 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.471 ' CG ' ' HB2' ' A' ' 42' ' ' ASN . 55.8 mtt180 -60.73 -46.73 89.28 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.303 -0.873 . . . . 0.0 109.961 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -67.0 -23.36 65.92 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.903 -178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.7 tp -82.64 -30.5 29.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.94 . . . . 0.0 109.443 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.37 -39.61 0.19 Allowed Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.934 -1.127 . . . . 0.0 110.868 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -170.53 160.35 7.3 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.076 -1.249 . . . . 0.0 112.271 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.471 ' HB2' ' CG ' ' A' ' 37' ' ' ARG . 5.9 t-20 -105.88 111.22 64.59 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.699 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.467 ' HD2' ' HA ' ' A' ' 42' ' ' ASN . 41.3 Cg_endo -61.15 -143.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.496 0 O-C-N 123.501 1.264 . . . . 0.0 109.683 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.2 p -131.41 149.93 52.35 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.218 -1.551 . . . . 0.0 112.131 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -51.1 -22.54 2.53 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.872 -0.517 . . . . 0.0 111.927 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.61 -55.76 8.05 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 122.284 1.04 . . . . 0.0 108.454 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -67.32 -37.17 82.88 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.718 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.45 HD13 ' HB ' ' A' ' 29' ' ' THR . 4.1 mt -57.35 -36.19 70.89 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.551 -0.718 . . . . 0.0 109.772 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.25 -40.03 89.9 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.426 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -64.0 -36.58 84.43 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.452 -0.78 . . . . 0.0 111.046 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 64.6 mtt -60.03 -44.95 94.28 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.638 -0.663 . . . . 0.0 109.888 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.732 HG22 ' OD2' ' A' ' 56' ' ' ASP . 66.1 mt -68.32 -34.06 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.747 -0.596 . . . . 0.0 110.364 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -60.06 -42.56 94.78 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.32 -0.863 . . . . 0.0 111.051 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -69.1 -27.67 65.8 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.089 -1.007 . . . . 0.0 110.984 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.492 HG21 ' SD ' ' A' ' 71' ' ' MET . 96.5 t -99.92 -7.67 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.591 -0.693 . . . . 0.0 111.239 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.732 ' OD2' HG22 ' A' ' 52' ' ' ILE . 0.5 OUTLIER -72.7 100.02 2.73 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.163 -0.961 . . . . 0.0 112.004 -179.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.09 -33.28 65.52 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -71.62 -40.09 70.0 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.407 0.622 . . . . 0.0 110.214 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.25 -1.44 73.27 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -73.7 -40.07 63.89 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.206 -1.173 . . . . 0.0 110.95 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.566 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 129.78 8.55 3.42 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 119.83 -1.176 . . . . 0.0 112.009 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 74.5 p -136.79 160.0 40.15 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.007 -1.29 . . . . 0.0 110.535 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.1 mt -104.93 120.03 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 120.039 -0.664 . . . . 0.0 111.273 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -96.22 171.17 8.76 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.533 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 19.4 t80 -49.37 -48.61 74.4 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.535 -0.728 . . . . 0.0 112.762 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 38.3 Cg_endo -63.94 -37.73 42.23 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 O-C-N 122.693 0.838 . . . . 0.0 111.56 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -69.65 -38.12 77.01 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.266 -0.896 . . . . 0.0 110.053 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.414 ' CE1' ' HG3' ' A' ' 72' ' ' MET . 63.8 t80 -60.56 -42.27 96.25 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.546 -0.721 . . . . 0.0 110.158 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.519 HD11 ' CE2' ' A' ' 65' ' ' PHE . 89.4 mt -63.22 -40.5 97.64 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.5 -0.75 . . . . 0.0 111.854 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 66' ' ' PRO . 70.7 p -61.66 -41.99 98.29 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.374 -0.829 . . . . 0.0 110.954 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.492 ' SD ' HG21 ' A' ' 55' ' ' VAL . 60.6 ttp -69.83 -40.02 76.13 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.562 -0.711 . . . . 0.0 111.475 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.414 ' HG3' ' CE1' ' A' ' 68' ' ' PHE . 97.2 mmm -62.71 -52.78 61.92 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.446 -0.784 . . . . 0.0 111.92 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.01 -31.54 71.3 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.661 -0.649 . . . . 0.0 110.313 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.411 ' HD2' ' CE ' ' A' ' 77' ' ' LYS . 10.4 tpt180 -71.83 -43.63 65.26 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.735 -0.603 . . . . 0.0 110.983 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.642 ' O ' HG22 ' A' ' 79' ' ' THR . 66.0 mmtt -70.06 -42.22 73.12 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 45.9 mtm -59.91 -46.42 89.42 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.135 -0.978 . . . . 0.0 112.531 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.411 ' CE ' ' HD2' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -69.87 -37.43 76.09 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.032 -1.043 . . . . 0.0 110.089 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -69.97 -20.03 63.33 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.712 -0.618 . . . . 0.0 111.252 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.642 HG22 ' O ' ' A' ' 75' ' ' LYS . 12.7 t -111.34 -160.71 0.72 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.921 0.867 . . . . 0.0 111.94 -178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -120.49 138.39 53.85 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.463 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.6 t -65.73 -27.74 68.54 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.58 -0.7 . . . . 0.0 109.97 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.02 -31.0 69.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.61 -0.681 . . . . 0.0 109.844 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.62 -40.0 76.86 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.643 -0.661 . . . . 0.0 110.354 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.68 -38.59 87.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.527 -0.733 . . . . 0.0 110.379 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.713 HG23 ' HE1' ' A' ' 141' ' ' PHE . 95.5 mt -64.57 -51.0 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.778 -0.577 . . . . 0.0 110.758 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.8 mtp85 -56.1 -38.41 70.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.265 -0.897 . . . . 0.0 110.481 -178.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.722 ' O ' HG23 ' A' ' 91' ' ' VAL . 95.0 mt-10 -69.77 -39.9 76.39 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.804 -0.56 . . . . 0.0 110.789 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.62 -48.64 74.11 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.392 -0.818 . . . . 0.0 111.152 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -60.22 -43.01 96.38 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.725 0.774 . . . . 0.0 109.7 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -60.0 -36.44 77.2 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.411 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 87' ' ' GLU . 90.4 t -69.43 -50.49 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.559 -0.713 . . . . 0.0 110.19 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -64.84 -40.04 94.54 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.397 -0.814 . . . . 0.0 110.952 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -78.5 65.05 3.7 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.475 -0.766 . . . . 0.0 110.686 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -60.67 -45.97 92.12 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.235 -0.916 . . . . 0.0 109.898 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 41.0 p-10 -69.99 -19.09 63.35 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.567 -0.708 . . . . 0.0 110.791 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.03 57.59 19.04 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -105.11 -3.24 23.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.278 -1.131 . . . . 0.0 110.525 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.43 -16.03 56.98 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -135.62 142.91 45.32 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.146 -1.208 . . . . 0.0 109.525 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 75.2 mt -88.97 124.55 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.482 -0.761 . . . . 0.0 110.021 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.2 m -84.52 169.38 14.52 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.353 0.597 . . . . 0.0 110.575 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.76 -40.57 97.68 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.77 -0.581 . . . . 0.0 110.096 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.77 -33.3 75.54 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.782 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -66.35 -40.02 89.55 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.426 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.449 ' HB3' HG13 ' A' ' 121' ' ' VAL . 1.7 tt -61.1 -48.87 79.68 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.331 -0.856 . . . . 0.0 109.841 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -62.66 -28.39 69.89 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.821 -0.549 . . . . 0.0 111.027 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -60.08 -40.01 88.05 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.186 -0.946 . . . . 0.0 109.978 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.3 t -77.25 -33.11 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.528 -0.733 . . . . 0.0 110.256 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.471 ' SD ' HG22 ' A' ' 121' ' ' VAL . 16.9 mtt -59.99 -49.88 75.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.473 -0.767 . . . . 0.0 110.118 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 p -68.25 -40.87 81.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.621 -0.674 . . . . 0.0 109.703 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -60.05 -31.9 70.42 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.649 ' O ' HD11 ' A' ' 18' ' ' LEU . 21.5 mt -69.94 -35.2 74.33 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.176 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 112.85 24.26 4.99 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -119.82 141.92 49.09 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.452 -1.028 . . . . 0.0 109.518 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -99.92 123.26 43.98 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.407 -0.808 . . . . 0.0 110.847 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.623 HD23 ' OE2' ' A' ' 120' ' ' GLU . 4.2 mp -138.72 154.52 48.56 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.579 -0.7 . . . . 0.0 110.206 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.0 m -87.81 170.2 11.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.637 -0.664 . . . . 0.0 109.344 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -63.5 -24.9 68.02 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.343 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -68.14 -36.36 79.57 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.716 0.769 . . . . 0.0 109.364 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.623 ' OE2' HD23 ' A' ' 116' ' ' LEU . 12.1 mt-10 -65.23 -38.38 90.21 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.594 0.711 . . . . 0.0 109.225 178.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.471 HG22 ' SD ' ' A' ' 109' ' ' MET . 74.3 t -68.2 -39.96 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.03 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.573 ' HA ' HD12 ' A' ' 125' ' ' ILE . 65.7 t0 -59.96 -42.02 93.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.629 -0.67 . . . . 0.0 109.831 -178.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -59.97 -40.94 90.8 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.654 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 10.5 mmt -54.22 -38.52 65.81 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.573 HD12 ' HA ' ' A' ' 122' ' ' ASP . 84.1 mt -66.03 -40.02 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.468 0.651 . . . . 0.0 110.082 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.5 ttt85 -57.35 -39.94 77.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.543 -0.723 . . . . 0.0 111.718 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -60.15 -37.93 81.6 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.572 -0.705 . . . . 0.0 111.465 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -109.39 -5.89 15.66 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.22 -0.925 . . . . 0.0 112.241 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -82.64 70.73 9.68 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.935 -1.103 . . . . 0.0 111.01 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.1 mt -67.99 -39.96 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.467 -0.771 . . . . 0.0 110.488 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.8 p-10 -70.51 -20.03 62.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.416 -0.802 . . . . 0.0 111.337 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.59 24.38 58.67 Favored Glycine 0 N--CA 1.496 2.646 0 C-N-CA 120.135 -1.031 . . . . 0.0 110.672 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -81.93 -11.61 58.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -1.173 . . . . 0.0 110.95 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.44 3.08 72.39 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -141.98 153.11 44.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -1.125 . . . . 0.0 109.784 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.0 t -96.22 109.97 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.609 -0.682 . . . . 0.0 109.611 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.0 p30 -81.93 -174.14 4.88 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.54 -0.725 . . . . 0.0 110.197 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -69.33 -42.86 74.79 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.056 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -62.45 -49.95 73.41 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.294 -0.879 . . . . 0.0 112.049 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.46 -35.5 81.09 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.445 -0.784 . . . . 0.0 110.456 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.713 ' HE1' HG23 ' A' ' 85' ' ' ILE . 64.7 t80 -59.94 -45.83 91.36 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.425 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.9 t -71.46 -40.51 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.294 -0.879 . . . . 0.0 111.777 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -59.96 -49.98 75.56 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.398 -0.814 . . . . 0.0 110.649 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 10.5 tmm? -59.97 -39.86 87.09 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.407 -0.808 . . . . 0.0 109.361 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 92.7 mmm -68.11 -39.86 82.7 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.216 0.531 . . . . 0.0 109.577 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 56.8 m -69.66 -17.8 63.52 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.714 -0.616 . . . . 0.0 110.446 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.94 139.99 57.02 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.381 -0.824 . . . . 0.0 110.454 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.2 mttm . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.105 -179.889 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -156.35 140.93 7.56 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -60.05 -39.92 87.61 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.644 -0.915 . . . . 0.0 110.064 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -60.02 -39.76 86.96 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.631 -0.668 . . . . 0.0 110.309 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -60.09 -39.95 87.87 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.576 -0.702 . . . . 0.0 110.592 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.65 -40.43 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.618 -0.676 . . . . 0.0 109.742 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.21 -39.53 93.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.691 -0.63 . . . . 0.0 110.736 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -64.11 -39.91 95.05 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.419 -0.801 . . . . 0.0 111.34 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 77.6 mt -70.05 -40.39 75.14 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.379 -0.826 . . . . 0.0 112.205 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . 0.665 ' HA ' HD12 ' B' ' 167' ' ' LEU . 13.5 p -71.0 -31.96 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.073 -1.017 . . . . 0.0 110.673 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.73 -40.04 97.52 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 60.3 t -72.96 -27.94 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.696 -0.884 . . . . 0.0 112.0 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.665 HD12 ' HA ' ' B' ' 164' ' ' VAL . 90.6 mt -59.92 -48.13 82.95 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.117 -0.99 . . . . 0.0 111.019 -177.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -64.93 -39.98 94.33 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.26 -0.9 . . . . 0.0 110.885 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -60.32 -36.37 77.76 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.538 -0.726 . . . . 0.0 110.336 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 170' ' ' TRP . . . . . 0.441 ' CE2' ' CD2' ' A' ' 32' ' ' LEU . 3.0 t-105 -60.08 -40.02 88.09 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.578 -0.701 . . . . 0.0 109.782 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.12 -50.4 73.64 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.546 -0.721 . . . . 0.0 110.509 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -60.06 -34.1 72.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.368 -0.832 . . . . 0.0 109.876 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 . . . . . 0 N--CA 1.495 1.782 0 O-C-N 121.648 -0.658 . . . . 0.0 110.205 -179.863 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 121.768 0.794 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.88 -35.47 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.918 -0.489 . . . . 0.0 111.37 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.74 -27.15 68.1 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.045 -1.034 . . . . 0.0 111.184 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -69.44 -45.67 68.55 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.666 0.746 . . . . 0.0 110.094 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -69.44 -24.35 63.8 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.591 0.71 . . . . 0.0 109.169 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -70.86 -40.83 72.09 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.654 0.74 . . . . 0.0 109.605 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -70.62 -28.6 64.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.792 -0.568 . . . . 0.0 110.737 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.21 -27.46 35.29 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.486 -0.759 . . . . 0.0 110.609 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -60.0 -40.35 88.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.639 -0.663 . . . . 0.0 110.61 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.1 t -62.16 -39.48 92.8 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.432 -0.793 . . . . 0.0 109.499 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.3 tp -59.99 -40.65 89.91 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.426 ' HB3' HD13 ' A' ' 27' ' ' ILE . 15.4 m-85 -77.55 -38.95 47.48 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.897 -0.502 . . . . 0.0 109.957 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -94.96 95.61 8.74 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.602 -0.686 . . . . 0.0 109.802 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -69.96 -26.95 64.35 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.44 -0.788 . . . . 0.0 111.548 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -80.97 -8.74 59.83 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.074 -1.016 . . . . 0.0 111.405 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.62 25.23 27.82 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -87.67 -6.62 58.15 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.548 -0.972 . . . . 0.0 110.718 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.17 0.9 58.33 Favored Glycine 0 N--CA 1.489 2.183 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.117 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.2 p -144.56 141.42 29.45 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 119.15 1.475 . . . . 0.0 111.292 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.426 HD13 ' HB3' ' A' ' 19' ' ' PHE . 85.5 mt -104.34 127.85 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.698 -0.626 . . . . 0.0 109.354 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.1 p -103.25 143.36 32.75 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.761 -0.587 . . . . 0.0 110.964 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 11.0 p -39.49 -34.32 0.21 Allowed 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -61.9 -46.05 91.05 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.921 0.867 . . . . 0.0 108.943 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -59.27 -53.29 59.95 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.276 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.462 HD13 ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -56.49 -38.48 71.81 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.328 -0.857 . . . . 0.0 111.051 -178.577 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.85 -29.57 42.57 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.2 m -70.03 -39.45 75.76 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.644 -0.916 . . . . 0.0 110.491 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.6 t -61.24 -54.89 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.329 -0.857 . . . . 0.0 108.881 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.405 ' HB2' ' HD3' ' A' ' 43' ' ' PRO . 67.5 mtt -59.05 -29.31 67.2 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.656 -0.653 . . . . 0.0 109.382 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -59.49 -40.03 85.66 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.6 p -70.03 -16.97 63.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.972 -0.455 . . . . 0.0 110.744 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.6 tp -81.67 -31.17 32.4 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.354 -0.841 . . . . 0.0 109.663 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.25 -35.0 0.19 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -160.22 170.05 21.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.554 -0.968 . . . . 0.0 111.219 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -101.31 138.27 19.89 Favored Pre-proline 0 C--N 1.299 -1.607 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.733 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.405 ' HD3' ' HB2' ' A' ' 36' ' ' MET . 53.5 Cg_endo -67.18 -152.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.487 1.146 0 O-C-N 123.394 1.207 . . . . 0.0 109.427 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.4 p -139.97 144.7 37.15 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.191 -0.943 . . . . 0.0 111.123 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -49.72 -25.09 2.67 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.715 -0.616 . . . . 0.0 111.623 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.9 -54.87 9.84 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.185 0.993 . . . . 0.0 108.597 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -67.83 -39.87 83.83 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.764 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.475 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 8.5 mt -55.66 -37.01 67.71 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.676 0.751 . . . . 0.0 109.403 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.06 -40.04 96.53 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.775 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -63.83 -39.96 95.47 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.583 -0.698 . . . . 0.0 111.086 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 64.8 mtt -61.61 -41.76 97.91 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.633 -0.667 . . . . 0.0 109.919 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.87 HG22 ' OD2' ' A' ' 56' ' ' ASP . 48.4 mm -66.97 -39.99 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.781 -0.574 . . . . 0.0 110.467 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -61.32 -40.0 92.61 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.521 -0.737 . . . . 0.0 112.287 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -69.73 -29.72 67.16 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.995 -1.065 . . . . 0.0 110.723 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.629 HG21 ' SD ' ' A' ' 71' ' ' MET . 87.6 t -99.99 -8.94 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.637 -0.664 . . . . 0.0 111.246 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.87 ' OD2' HG22 ' A' ' 52' ' ' ILE . 7.2 m-20 -68.99 93.97 0.61 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.149 -0.969 . . . . 0.0 111.11 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.23 -38.49 91.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.655 -0.653 . . . . 0.0 109.504 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -91.72 -29.99 16.52 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.702 -0.624 . . . . 0.0 110.816 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.403 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 91.69 20.5 37.06 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -73.57 -39.1 64.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.372 -1.075 . . . . 0.0 110.42 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.772 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 129.05 -0.62 6.12 Favored Glycine 0 N--CA 1.497 2.744 0 C-N-CA 120.092 -1.051 . . . . 0.0 111.547 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.1 p -134.6 169.15 17.74 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.114 -1.227 . . . . 0.0 111.033 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.504 HD11 HD13 ' A' ' 52' ' ' ILE . 5.9 mt -102.68 118.9 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.813 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -98.79 170.01 9.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.533 -0.729 . . . . 0.0 110.766 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.504 ' O ' HD13 ' A' ' 69' ' ' LEU . 2.8 t80 -47.53 -50.02 52.18 Favored Pre-proline 0 N--CA 1.499 1.984 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.2 Cg_endo -67.18 -34.9 26.6 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 O-C-N 122.884 0.939 . . . . 0.0 111.223 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.96 -40.02 75.66 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.307 -0.871 . . . . 0.0 110.353 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -62.81 -41.63 99.38 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.63 -0.669 . . . . 0.0 111.252 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 65' ' ' PHE . 4.5 mp -67.86 -41.1 83.41 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.322 -0.861 . . . . 0.0 111.422 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.6 p -63.12 -39.99 96.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.542 -0.724 . . . . 0.0 110.879 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.629 ' SD ' HG21 ' A' ' 55' ' ' VAL . 48.8 ttp -68.61 -41.04 80.11 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.657 -0.652 . . . . 0.0 111.921 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 57.0 tpp -68.94 -42.53 76.62 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.257 -0.902 . . . . 0.0 111.772 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.0 -35.52 66.85 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.475 -0.766 . . . . 0.0 112.074 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.77 -55.01 5.69 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.432 -0.792 . . . . 0.0 111.421 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.443 ' HA ' ' OD2' ' A' ' 78' ' ' ASP . 88.1 mttt -59.94 -41.01 90.89 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.525 -0.735 . . . . 0.0 112.641 -178.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 27.7 ptm -59.95 -34.49 73.32 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.283 -0.885 . . . . 0.0 111.877 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -63.25 -49.92 72.21 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.406 -0.809 . . . . 0.0 111.856 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.443 ' OD2' ' HA ' ' A' ' 75' ' ' LYS . 3.9 p30 -69.61 -10.31 57.67 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.176 -0.952 . . . . 0.0 111.019 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.589 HG22 ' H ' ' A' ' 80' ' ' ASP 0.27 22.2 m -86.53 -175.03 5.29 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.589 ' H ' HG22 ' A' ' 79' ' ' THR . 84.3 m-20 -129.98 138.57 50.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.132 -0.98 . . . . 0.0 109.404 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 24.4 p -61.15 -27.01 68.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.478 -0.764 . . . . 0.0 110.374 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.04 -37.01 78.56 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.716 0.769 . . . . 0.0 109.016 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.01 -40.02 75.5 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.316 0.579 . . . . 0.0 110.079 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -62.56 -39.98 95.37 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.783 -0.573 . . . . 0.0 110.7 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.448 HG23 ' HE1' ' A' ' 141' ' ' PHE . 89.6 mt -65.06 -49.75 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.533 -0.729 . . . . 0.0 110.849 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.77 -42.82 84.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.348 -0.845 . . . . 0.0 111.207 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.438 ' O ' HG13 ' A' ' 91' ' ' VAL . 95.3 mt-10 -69.98 -39.64 75.82 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.405 -0.809 . . . . 0.0 111.773 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.532 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -64.77 -47.35 78.48 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.605 -0.684 . . . . 0.0 112.014 -178.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -67.26 -40.17 86.2 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.1 -1.0 . . . . 0.0 110.43 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -61.03 -39.94 91.69 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.694 -0.629 . . . . 0.0 111.738 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.532 HG22 ' O ' ' A' ' 88' ' ' ALA . 34.9 m -71.29 -40.06 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 0.0 111.112 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -72.39 -40.0 67.55 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.144 -0.973 . . . . 0.0 111.466 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -82.65 68.82 9.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.638 -0.664 . . . . 0.0 110.595 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.445 ' HZ2' ' CD2' ' A' ' 107' ' ' HIS . 25.3 mttt -60.0 -42.72 94.87 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.19 -0.944 . . . . 0.0 110.001 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -74.52 -24.37 58.97 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.49 -0.757 . . . . 0.0 110.411 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.29 24.63 76.75 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -67.93 -16.69 64.18 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.334 -1.097 . . . . 0.0 111.262 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.47 -19.58 14.46 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.446 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 29.0 p90 -145.82 156.75 43.78 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.336 -1.096 . . . . 0.0 109.438 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 65.9 mt -89.14 122.04 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.668 0.747 . . . . 0.0 110.154 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 m -80.78 170.67 15.99 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.351 0.596 . . . . 0.0 110.624 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.73 -47.58 84.61 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.682 -0.636 . . . . 0.0 109.991 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.0 -37.97 81.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.744 -0.597 . . . . 0.0 109.855 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -61.05 -39.93 91.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.586 -0.696 . . . . 0.0 110.674 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.436 HD13 HG13 ' A' ' 121' ' ' VAL . 1.5 tt -60.54 -46.94 88.31 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.323 -0.861 . . . . 0.0 110.398 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.545 ' HG2' HG21 ' A' ' 121' ' ' VAL . 92.1 mtt180 -60.04 -34.91 74.03 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.698 -0.626 . . . . 0.0 111.919 -178.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.445 ' CD2' ' HZ2' ' A' ' 94' ' ' LYS . 48.4 t60 -59.97 -41.95 93.06 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.123 -0.986 . . . . 0.0 110.874 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.5 t -77.07 -37.05 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.429 -0.795 . . . . 0.0 111.183 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.7 mmt -60.05 -49.97 75.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.5 m -67.18 -43.69 81.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.725 -0.61 . . . . 0.0 109.809 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -61.82 -28.17 69.28 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.722 -0.611 . . . . 0.0 109.522 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.8 mt -70.03 -30.28 67.53 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.036 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 112.09 22.17 6.01 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -120.48 137.76 54.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.376 -1.073 . . . . 0.0 110.26 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -99.95 117.75 34.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.534 -0.729 . . . . 0.0 109.396 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 67.6 mt -131.24 156.85 44.68 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.458 -0.776 . . . . 0.0 110.15 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 m -82.51 165.8 19.85 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -63.39 -29.07 70.43 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -68.19 -32.83 73.35 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.508 0.67 . . . . 0.0 109.76 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -68.64 -35.07 76.79 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.545 HG21 ' HG2' ' A' ' 106' ' ' ARG . 78.0 t -69.98 -38.33 75.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-O 121.649 0.738 . . . . 0.0 109.028 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.421 ' HA ' HD12 ' A' ' 125' ' ' ILE . 56.4 t0 -60.0 -43.34 95.26 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.746 -0.596 . . . . 0.0 109.928 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -59.9 -40.18 87.93 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.356 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 13.7 mmt -54.58 -36.83 64.82 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.154 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 122' ' ' ASP . 91.1 mt -67.75 -38.42 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 121.252 0.548 . . . . 0.0 109.825 178.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -60.03 -39.98 87.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.641 -0.662 . . . . 0.0 110.959 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -63.68 -39.83 95.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.545 -0.722 . . . . 0.0 111.403 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.588 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -98.98 -7.78 26.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.377 -0.827 . . . . 0.0 112.046 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -103.38 78.27 1.59 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.025 -1.047 . . . . 0.0 111.268 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 86.8 mt -66.99 -39.96 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.702 -0.624 . . . . 0.0 110.022 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 34.0 p-10 -59.03 -39.75 82.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.669 -0.644 . . . . 0.0 111.266 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 98.65 11.69 46.55 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.366 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -80.88 -16.7 52.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.943 -1.328 . . . . 0.0 110.151 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.68 5.18 71.94 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.747 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -132.34 133.41 43.96 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.237 -1.155 . . . . 0.0 110.035 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.7 t -90.88 114.58 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.442 -0.786 . . . . 0.0 109.936 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -87.7 -178.36 6.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.659 -0.651 . . . . 0.0 109.764 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -65.0 -41.33 95.47 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.613 -0.68 . . . . 0.0 110.092 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -61.69 -42.57 99.11 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.575 -0.703 . . . . 0.0 110.798 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -64.18 -39.45 94.02 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.831 0.824 . . . . 0.0 109.708 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.448 ' HE1' HG23 ' A' ' 85' ' ' ILE . 64.3 t80 -60.05 -46.82 88.27 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.426 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.414 ' O ' HG22 ' A' ' 146' ' ' THR . 99.3 t -65.13 -39.97 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.303 -0.873 . . . . 0.0 111.041 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.405 ' HA ' HG22 ' A' ' 146' ' ' THR . 61.6 tt0 -61.04 -39.97 91.83 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.516 -0.74 . . . . 0.0 110.381 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.588 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 49.9 mtp -60.59 -44.55 96.12 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.654 -0.654 . . . . 0.0 111.943 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.433 ' CE ' ' CZ ' ' A' ' 141' ' ' PHE . 42.9 mtt -73.24 -39.98 65.04 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.694 -0.629 . . . . 0.0 111.805 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 142' ' ' VAL . 15.1 t -75.1 -8.16 55.77 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.41 -0.806 . . . . 0.0 111.262 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -92.83 120.04 32.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.203 -0.935 . . . . 0.0 110.363 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.6 pttm . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.608 179.788 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.56 -39.21 97.37 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -63.66 -40.25 96.37 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.56 -0.965 . . . . 0.0 111.368 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -64.32 -39.34 93.72 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.028 -1.045 . . . . 0.0 110.354 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -60.02 -49.85 76.04 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.663 -0.648 . . . . 0.0 111.737 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 19.7 tt -69.94 -26.01 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 120.987 -1.071 . . . . 0.0 110.727 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.92 90.89 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.372 -0.83 . . . . 0.0 110.919 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 25.8 ttm-85 -60.06 -41.01 91.42 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.517 -0.739 . . . . 0.0 110.759 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.473 HD22 ' N ' ' B' ' 163' ' ' LEU . 4.6 mm? -61.92 -38.89 90.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.576 -0.702 . . . . 0.0 110.19 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.53 -40.12 87.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.517 -0.739 . . . . 0.0 111.191 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.53 -44.12 93.91 Favored Glycine 0 N--CA 1.501 2.976 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 12.0 p -81.94 -11.64 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.687 -0.89 . . . . 0.0 111.455 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.548 HD23 ' C ' ' B' ' 167' ' ' LEU . 9.2 tt -60.03 -50.02 75.35 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.188 -0.945 . . . . 0.0 110.434 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 30.0 mtp-105 -70.02 -31.09 68.58 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.588 -0.695 . . . . 0.0 110.538 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.97 -40.02 87.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.586 -0.696 . . . . 0.0 109.779 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -59.99 -41.29 91.73 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.671 -0.643 . . . . 0.0 109.928 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.1 -20.73 64.07 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.388 -0.82 . . . . 0.0 111.307 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -59.76 -39.9 86.4 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.318 -0.863 . . . . 0.0 110.319 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.538 -0.726 . . . . 0.0 110.219 179.622 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 . . . . . 0 N--CA 1.498 1.941 0 CA-C-O 121.484 0.659 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.9 mm -58.94 -50.02 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.708 -0.62 . . . . 0.0 111.046 -176.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.91 -20.04 63.35 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.225 -0.922 . . . . 0.0 110.688 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -68.21 -54.46 17.63 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.462 -0.774 . . . . 0.0 109.678 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.575 ' CB ' HD21 ' A' ' 69' ' ' LEU . 51.9 m-85 -66.62 -21.67 66.12 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.462 0.648 . . . . 0.0 109.57 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -69.14 -44.06 73.08 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.415 0.626 . . . . 0.0 110.281 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -71.42 -24.46 62.05 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.751 -0.593 . . . . 0.0 111.299 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.7 -33.27 41.14 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.319 -0.863 . . . . 0.0 110.908 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.416 ' CB ' ' CE1' ' A' ' 65' ' ' PHE . 56.2 t80 -59.95 -37.5 79.74 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.695 -0.628 . . . . 0.0 111.255 -177.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 91.9 p -61.42 -38.79 88.4 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.243 -0.91 . . . . 0.0 110.087 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 46.3 tp -60.11 -40.19 88.84 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.541 -0.724 . . . . 0.0 109.758 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -78.77 -37.39 41.2 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.732 -0.605 . . . . 0.0 109.783 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.595 ' HB2' HD11 ' A' ' 27' ' ' ILE . 27.5 t0 -93.58 94.94 8.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.642 -0.661 . . . . 0.0 110.176 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -66.13 -30.11 70.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.468 -0.77 . . . . 0.0 111.393 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -79.96 -9.93 59.73 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.09 -1.006 . . . . 0.0 111.373 -177.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.79 26.71 58.12 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 57.9 p30 -89.96 -3.48 58.0 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.713 -0.875 . . . . 0.0 110.886 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.96 4.45 72.12 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.248 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 58.3 p -143.76 142.19 30.79 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 119.288 1.544 . . . . 0.0 111.945 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.595 HD11 ' HB2' ' A' ' 20' ' ' ASP . 49.4 mm -103.69 125.3 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.747 -0.596 . . . . 0.0 110.055 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.9 m -101.54 141.38 34.49 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.541 -0.725 . . . . 0.0 110.244 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.455 ' HB ' HD13 ' A' ' 48' ' ' LEU . 28.2 p -39.56 -34.79 0.25 Allowed 'General case' 0 N--CA 1.51 2.543 0 O-C-N 121.871 -0.518 . . . . 0.0 112.364 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -60.12 -49.36 77.94 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.327 -0.858 . . . . 0.0 109.11 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -57.58 -51.09 70.91 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.11 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.582 HD13 ' O ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -54.53 -38.81 67.01 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.154 -0.966 . . . . 0.0 111.002 -179.034 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -51.61 -29.55 25.2 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.3 m -65.09 -40.01 93.98 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.528 -0.983 . . . . 0.0 110.074 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.6 t -68.3 -40.07 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-O 121.384 0.612 . . . . 0.0 109.775 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.464 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 13.4 mmt -59.93 -39.89 87.04 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.736 -0.602 . . . . 0.0 111.712 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -60.76 -40.01 90.88 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.757 0.789 . . . . 0.0 110.346 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.5 t -64.56 -24.84 67.74 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.766 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.529 ' HG ' HD22 ' B' ' 167' ' ' LEU . 4.3 mm? -89.77 -17.72 27.68 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.152 -0.968 . . . . 0.0 110.434 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.41 -51.44 0.22 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -166.73 176.47 7.14 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.59 -0.947 . . . . 0.0 111.197 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -99.17 133.47 22.08 Favored Pre-proline 0 N--CA 1.492 1.664 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.927 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.464 ' HD3' ' HB3' ' A' ' 36' ' ' MET . 52.1 Cg_endo -66.3 -147.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.306 0 O-C-N 123.207 1.109 . . . . 0.0 109.414 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.8 p -125.94 140.73 52.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.001 -1.062 . . . . 0.0 110.901 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -48.17 -24.69 1.21 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.713 -0.617 . . . . 0.0 112.039 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.25 -44.18 65.8 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.247 1.022 . . . . 0.0 108.461 176.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -69.96 -39.85 75.78 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.323 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.455 HD13 ' HB ' ' A' ' 29' ' ' THR . 8.5 mt -55.88 -38.03 69.62 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.483 -0.76 . . . . 0.0 109.534 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -40.57 97.77 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.152 -178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -64.43 -39.44 93.84 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.611 -0.681 . . . . 0.0 111.267 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 61.9 mtt -62.93 -39.98 96.25 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.679 -0.638 . . . . 0.0 109.917 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.845 HG22 ' OD2' ' A' ' 56' ' ' ASP . 48.4 mm -69.23 -39.91 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.682 -0.636 . . . . 0.0 110.91 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -64.2 -40.09 95.36 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.447 -0.783 . . . . 0.0 112.519 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.852 ' HG3' HG23 ' A' ' 55' ' ' VAL . 15.3 pt-20 -69.93 -27.34 64.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.932 -1.105 . . . . 0.0 110.483 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.852 HG23 ' HG3' ' A' ' 54' ' ' GLU . 48.6 t -99.9 -10.01 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.658 -0.651 . . . . 0.0 110.917 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.845 ' OD2' HG22 ' A' ' 52' ' ' ILE . 4.0 m-20 -69.12 99.01 1.06 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.188 -0.945 . . . . 0.0 110.962 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.79 -36.95 83.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.593 -0.692 . . . . 0.0 109.879 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -94.54 -26.11 16.55 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.654 -0.654 . . . . 0.0 110.84 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.7 20.01 49.32 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -73.9 -34.74 64.51 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.436 -1.038 . . . . 0.0 110.162 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.804 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 124.08 2.13 8.57 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 120.34 -0.933 . . . . 0.0 111.204 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 82.7 p -138.3 168.56 19.49 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.063 -1.257 . . . . 0.0 111.21 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.468 HD11 HD13 ' A' ' 52' ' ' ILE . 7.7 mt -103.69 121.0 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.288 0.566 . . . . 0.0 110.537 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -98.77 170.38 8.81 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.373 0.606 . . . . 0.0 110.47 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.488 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.5 OUTLIER -47.63 -50.0 53.21 Favored Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 121.626 -0.671 . . . . 0.0 112.533 -179.493 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.653 ' O ' HG23 ' A' ' 70' ' ' THR . 40.8 Cg_endo -67.87 -35.12 21.94 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 122.833 0.912 . . . . 0.0 111.237 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.99 -40.01 75.58 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.277 -0.889 . . . . 0.0 110.339 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -63.66 -40.77 97.67 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.548 -0.72 . . . . 0.0 110.933 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.575 HD21 ' CB ' ' A' ' 12' ' ' PHE . 84.3 mt -64.56 -39.96 94.69 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.433 -0.792 . . . . 0.0 111.346 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.653 HG23 ' O ' ' A' ' 66' ' ' PRO . 68.8 p -60.6 -40.79 93.1 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.458 -0.776 . . . . 0.0 110.561 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.8 ttp -69.99 -39.96 75.59 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.561 -0.712 . . . . 0.0 111.708 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.402 ' SD ' HG21 ' B' ' 166' ' ' VAL . 2.6 tpt -60.05 -49.96 75.58 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.436 -0.79 . . . . 0.0 111.364 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.01 -29.27 66.29 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.455 -0.778 . . . . 0.0 111.369 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -72.87 -40.02 65.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.433 -0.792 . . . . 0.0 111.733 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -69.55 -46.58 66.12 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.355 -0.841 . . . . 0.0 112.24 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 77.0 mtm -60.01 -39.38 85.61 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.031 -1.043 . . . . 0.0 111.018 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -66.91 -51.27 57.39 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.549 -0.719 . . . . 0.0 110.816 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -69.09 -31.94 71.01 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.583 0.706 . . . . 0.0 110.134 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.606 HG22 ' H ' ' A' ' 80' ' ' ASP 0.253 23.2 m -90.89 -174.64 4.1 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.606 ' H ' HG22 ' A' ' 79' ' ' THR . 81.6 m-20 -123.81 144.56 49.64 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.099 -1.001 . . . . 0.0 110.055 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.2 p -61.59 -27.77 68.87 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.702 -0.624 . . . . 0.0 110.452 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -60.11 -37.87 81.29 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.627 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -70.04 -40.04 75.38 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.65 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -67.71 -37.75 82.67 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.455 -0.778 . . . . 0.0 110.28 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 71.0 mt -63.82 -49.86 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.736 -0.602 . . . . 0.0 110.002 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -57.58 -39.85 77.67 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.481 -0.762 . . . . 0.0 110.982 -178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.783 ' O ' HG23 ' A' ' 91' ' ' VAL . 96.5 mt-10 -69.45 -42.09 75.38 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.514 -0.741 . . . . 0.0 111.655 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.438 ' HA ' HG11 ' B' ' 164' ' ' VAL . . . -66.56 -45.38 79.54 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.502 -0.748 . . . . 0.0 111.608 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.415 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 35.4 t80 -60.01 -47.07 87.33 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.469 -0.77 . . . . 0.0 109.542 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -60.09 -34.85 74.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.927 -0.483 . . . . 0.0 110.414 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 87' ' ' GLU . 84.9 t -68.11 -47.77 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.373 -0.83 . . . . 0.0 109.795 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.478 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 13.5 m-85 -64.25 -37.45 87.51 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.521 -0.737 . . . . 0.0 110.515 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -75.58 85.44 2.64 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.52 -0.737 . . . . 0.0 110.193 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -67.68 -41.11 84.18 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.374 -0.829 . . . . 0.0 110.209 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -81.28 -12.33 59.11 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.543 -0.723 . . . . 0.0 111.589 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 59.97 31.15 71.59 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -78.23 0.48 25.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.503 -0.998 . . . . 0.0 111.392 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.5 -10.06 75.66 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.607 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -137.58 137.25 38.35 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.08 -1.247 . . . . 0.0 109.979 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.564 HG22 ' CD1' ' A' ' 105' ' ' LEU . 74.6 mt -88.72 129.98 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.467 -0.771 . . . . 0.0 109.359 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.7 m -109.86 151.3 27.21 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.642 0.734 . . . . 0.0 111.103 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.523 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -49.26 -41.22 37.09 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.62 -0.675 . . . . 0.0 110.799 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.04 -34.32 73.23 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.408 -0.807 . . . . 0.0 108.834 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -74.82 -28.27 60.64 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.688 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.601 ' HB3' HG13 ' A' ' 121' ' ' VAL . 5.9 mp -65.04 -39.97 94.12 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.798 0.809 . . . . 0.0 109.121 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 48.1 ttt-85 -59.96 -34.99 74.02 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.151 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -60.09 -43.91 95.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.317 -0.865 . . . . 0.0 111.048 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.478 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 75.4 t -72.11 -40.38 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.442 -0.787 . . . . 0.0 111.244 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.628 ' SD ' HG22 ' A' ' 121' ' ' VAL . 67.6 mtt -58.07 -49.57 76.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.346 -0.846 . . . . 0.0 110.505 -178.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.5 m -66.03 -42.78 89.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.62 -0.675 . . . . 0.0 109.774 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -62.53 -29.76 70.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.685 -0.634 . . . . 0.0 109.333 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 19.1 mt -69.94 -32.17 70.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.698 -0.626 . . . . 0.0 109.964 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 109.57 26.43 5.09 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -124.16 138.45 54.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.441 -1.035 . . . . 0.0 109.997 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -99.97 118.18 35.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.569 -0.707 . . . . 0.0 110.074 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 86.3 mt -131.68 157.3 44.11 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.6 -0.688 . . . . 0.0 109.667 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.88 162.08 22.91 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.611 -0.681 . . . . 0.0 109.555 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -58.8 -28.32 65.87 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.17 -32.57 73.74 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -39.9 95.25 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.628 HG22 ' SD ' ' A' ' 109' ' ' MET . 73.0 t -70.03 -39.96 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 121.536 0.684 . . . . 0.0 110.567 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -60.04 -44.99 94.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.751 -0.593 . . . . 0.0 110.179 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -60.33 -40.98 92.59 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.645 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 86.6 mmm -55.2 -38.33 68.27 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 119.642 -0.823 . . . . 0.0 108.976 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.402 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 47.3 mm -66.84 -38.06 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-O 121.512 0.672 . . . . 0.0 109.65 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -59.07 -40.0 83.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.68 -0.638 . . . . 0.0 111.555 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.04 -39.87 87.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.619 -0.676 . . . . 0.0 111.043 -178.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.99 0.01 34.44 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.377 -0.827 . . . . 0.0 111.572 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 57.8 t0 -87.55 71.23 9.8 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.019 -1.051 . . . . 0.0 110.679 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.5 mt -67.37 -42.26 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.358 -0.838 . . . . 0.0 110.532 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -71.33 -20.07 62.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.362 -0.836 . . . . 0.0 111.348 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.43 22.7 58.14 Favored Glycine 0 N--CA 1.496 2.682 0 C-N-CA 120.367 -0.921 . . . . 0.0 110.869 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -82.76 -12.5 57.48 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.29 -1.123 . . . . 0.0 111.152 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.4 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 90.0 1.73 75.81 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -139.5 152.1 46.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.267 -1.137 . . . . 0.0 109.459 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 70.7 t -92.46 118.26 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.56 -0.712 . . . . 0.0 110.168 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -84.82 175.51 9.09 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -65.05 -41.42 95.18 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.315 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -61.46 -45.86 92.51 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.703 -0.623 . . . . 0.0 111.025 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -66.0 -40.06 90.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.494 -0.754 . . . . 0.0 110.704 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.415 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 77.5 t80 -59.95 -44.22 94.52 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.981 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.758 ' O ' HG22 ' A' ' 146' ' ' THR . 89.6 t -69.56 -39.63 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.416 -0.802 . . . . 0.0 110.917 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 58.3 tt0 -59.98 -47.66 84.89 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.528 -0.732 . . . . 0.0 110.684 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.1 tmm? -60.16 -39.65 87.17 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.41 -0.806 . . . . 0.0 110.693 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 97.5 mmm -69.63 -40.0 76.83 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.603 -0.685 . . . . 0.0 111.053 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.758 HG22 ' O ' ' A' ' 142' ' ' VAL . 9.4 t -96.04 25.59 4.71 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.381 -0.824 . . . . 0.0 110.681 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -96.87 121.83 39.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.447 -0.783 . . . . 0.0 110.695 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 98.2 mttt . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.844 179.507 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -162.75 171.89 38.67 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -60.6 -39.94 89.97 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.648 -0.913 . . . . 0.0 110.476 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -60.04 -39.85 87.37 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.637 -0.664 . . . . 0.0 110.822 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -60.03 -40.0 87.85 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.398 -0.814 . . . . 0.0 110.617 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 85.4 mt -69.92 -40.03 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.375 -0.828 . . . . 0.0 110.813 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.46 -39.75 91.99 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.541 -0.725 . . . . 0.0 110.882 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -60.04 -39.95 87.69 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.583 -0.698 . . . . 0.0 110.468 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.99 -40.01 94.33 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.496 -0.753 . . . . 0.0 111.13 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . 0.438 HG11 ' HA ' ' A' ' 88' ' ' ALA . 55.4 t -67.07 -40.0 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.381 -0.824 . . . . 0.0 110.971 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -53.72 -47.89 63.2 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.402 HG21 ' SD ' ' A' ' 72' ' ' MET . 84.4 t -75.13 -22.65 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.693 -0.886 . . . . 0.0 110.569 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.539 HD23 ' C ' ' B' ' 167' ' ' LEU . 5.7 tt -58.7 -49.97 75.6 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.338 -0.851 . . . . 0.0 110.593 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 30.4 ttt85 -65.07 -38.8 91.95 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.468 -0.77 . . . . 0.0 110.136 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.05 -31.46 70.0 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.58 -0.7 . . . . 0.0 109.902 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 4.0 t-105 -60.05 -45.42 92.92 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.697 -0.627 . . . . 0.0 109.883 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.58 -53.16 60.81 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.59 -0.694 . . . . 0.0 110.193 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -60.08 -40.01 88.06 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.508 -0.745 . . . . 0.0 110.732 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.494 -0.753 . . . . 0.0 110.289 179.855 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 121.366 0.603 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 92.7 mt -59.99 -28.2 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.72 -0.613 . . . . 0.0 111.395 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.15 -39.51 94.17 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.148 -0.97 . . . . 0.0 109.743 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -59.98 -40.07 87.84 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.429 ' CG ' HD21 ' A' ' 69' ' ' LEU . 37.2 m-85 -64.29 -20.1 65.85 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.681 -0.637 . . . . 0.0 111.092 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HD3' ' CZ ' ' A' ' 65' ' ' PHE . 73.2 mmtt -69.08 -39.94 78.74 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.196 -0.94 . . . . 0.0 109.407 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -63.64 -59.66 4.31 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.453 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.1 -30.16 71.08 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.371 -0.83 . . . . 0.0 112.232 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.488 ' CG ' ' CE2' ' A' ' 65' ' ' PHE . 57.9 t80 -58.39 -49.97 75.35 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.167 -0.958 . . . . 0.0 110.745 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.0 m -66.15 -39.92 90.18 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.29 -0.881 . . . . 0.0 109.685 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 61.0 tp -62.79 -39.48 94.38 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.416 0.627 . . . . 0.0 109.431 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.536 ' HE2' HG21 ' A' ' 27' ' ' ILE . 32.2 t80 -74.15 -33.19 63.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.863 -0.523 . . . . 0.0 110.202 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -92.33 102.04 14.52 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.468 -0.77 . . . . 0.0 110.129 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -60.02 -39.2 85.02 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.482 -0.761 . . . . 0.0 111.486 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -80.03 -13.15 59.54 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.034 -1.041 . . . . 0.0 111.148 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.19 30.54 58.03 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -90.08 -2.88 58.17 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.714 -0.874 . . . . 0.0 110.84 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.61 3.95 62.4 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 120.22 -0.991 . . . . 0.0 111.432 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.0 p -145.8 142.41 28.84 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 119.197 1.498 . . . . 0.0 111.44 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.536 HG21 ' HE2' ' A' ' 19' ' ' PHE . 85.4 mt -100.68 122.68 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.3 m -95.82 139.47 31.99 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.48 -0.762 . . . . 0.0 110.151 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.626 HG22 ' CD1' ' A' ' 52' ' ' ILE . 65.0 p -42.39 -34.34 0.8 Allowed 'General case' 0 N--CA 1.51 2.571 0 O-C-N 121.961 -0.462 . . . . 0.0 111.588 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -64.31 -48.63 74.9 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.883 0.849 . . . . 0.0 109.136 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -60.0 -56.03 26.67 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.691 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.4 HD12 ' CE2' ' A' ' 19' ' ' PHE . 7.4 tt -61.09 -34.71 75.37 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.21 -0.931 . . . . 0.0 111.056 -178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -55.82 -32.57 59.1 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.4 m -70.01 -39.39 75.88 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.955 -0.733 . . . . 0.0 110.189 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.0 t -60.0 -57.29 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 94.7 mtp -59.98 -25.72 65.46 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.608 -0.682 . . . . 0.0 109.796 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 43.2 ttt180 -59.99 -46.02 90.82 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.736 0.779 . . . . 0.0 109.31 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.5 t -70.43 -16.98 63.0 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.821 -0.549 . . . . 0.0 111.14 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 39' ' ' LEU . 4.3 mm? -89.88 -18.98 25.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.327 -0.858 . . . . 0.0 110.35 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.4 -50.37 0.2 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -168.01 172.17 9.08 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.645 -0.914 . . . . 0.0 110.674 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -120.61 138.85 27.99 Favored Pre-proline 0 C--N 1.299 -1.628 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.429 ' HG2' HD21 ' A' ' 48' ' ' LEU . 53.6 Cg_endo -68.36 -148.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.224 1.118 . . . . 0.0 109.453 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 p -136.75 152.37 50.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.104 -0.997 . . . . 0.0 110.49 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -52.06 -22.41 4.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.53 -0.731 . . . . 0.0 112.033 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.1 -60.0 2.45 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.17 -0.956 . . . . 0.0 108.994 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -70.01 -33.75 72.42 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.734 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.54 HD13 ' HB ' ' A' ' 29' ' ' THR . 12.9 mt -57.31 -36.88 71.66 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.526 -0.734 . . . . 0.0 109.449 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.44 -30.9 66.57 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.163 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -70.39 -45.08 66.72 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.563 -0.711 . . . . 0.0 111.707 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 79.2 mtm -63.27 -41.67 99.05 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.491 0.662 . . . . 0.0 109.298 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.803 HG22 ' OD2' ' A' ' 56' ' ' ASP . 97.6 mt -68.58 -31.92 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -58.04 -48.12 81.03 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.574 -0.704 . . . . 0.0 110.967 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -64.82 -24.24 67.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.341 -0.849 . . . . 0.0 110.11 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 67.2 t -98.17 -12.01 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.545 -0.722 . . . . 0.0 111.358 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.803 ' OD2' HG22 ' A' ' 52' ' ' ILE . 26.1 m-20 -72.13 101.79 2.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.152 -0.967 . . . . 0.0 111.385 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.06 -39.98 90.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.558 -0.714 . . . . 0.0 109.445 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -88.26 -31.31 19.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.644 -0.66 . . . . 0.0 110.378 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.79 24.36 32.97 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -74.39 -31.96 62.54 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.459 -1.024 . . . . 0.0 110.465 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.68 -2.04 10.16 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.207 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 82.5 p -134.95 168.77 18.48 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.109 -1.23 . . . . 0.0 110.284 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.709 HD11 HG12 ' A' ' 52' ' ' ILE . 6.9 mt -104.49 120.37 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.714 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -98.56 170.25 8.94 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.488 0.661 . . . . 0.0 110.538 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.488 ' CE2' ' CG ' ' A' ' 16' ' ' PHE . 1.2 t80 -50.03 -48.56 78.58 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.4 Cg_endo -69.12 -36.57 12.24 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 O-C-N 122.768 0.878 . . . . 0.0 111.003 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.86 -39.94 76.07 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.484 -0.76 . . . . 0.0 109.223 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -59.89 -45.76 91.49 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.912 -0.493 . . . . 0.0 110.715 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.429 HD21 ' CG ' ' A' ' 12' ' ' PHE . 84.6 mt -63.57 -40.23 96.43 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.412 -0.805 . . . . 0.0 111.246 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.3 m -60.0 -44.04 94.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.441 -0.787 . . . . 0.0 110.719 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -39.98 93.51 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.708 -0.62 . . . . 0.0 111.039 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.431 ' O ' ' HG2' ' A' ' 76' ' ' MET . 57.2 tpp -59.95 -49.76 76.42 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.319 -0.863 . . . . 0.0 110.468 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.57 75.34 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.404 -0.81 . . . . 0.0 110.64 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -74.92 -37.75 61.96 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.458 -0.776 . . . . 0.0 111.119 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.706 ' O ' HG22 ' A' ' 79' ' ' THR . 63.0 mmtt -70.04 -40.03 75.39 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.602 -0.686 . . . . 0.0 112.123 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' A' ' 72' ' ' MET . 39.0 mmt -60.03 -47.29 86.47 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.244 -0.91 . . . . 0.0 112.322 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -68.48 -40.02 81.13 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.25 -0.906 . . . . 0.0 111.065 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -70.54 -20.96 62.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.484 -0.76 . . . . 0.0 111.56 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.706 HG22 ' O ' ' A' ' 75' ' ' LYS . 14.6 t -107.29 -165.33 1.05 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.047 0.927 . . . . 0.0 111.803 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -130.01 136.54 49.52 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.894 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.6 t -60.58 -33.12 72.26 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.624 -0.672 . . . . 0.0 109.895 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -60.07 -34.44 73.45 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.397 0.618 . . . . 0.0 109.461 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -69.9 -40.08 75.84 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.348 0.594 . . . . 0.0 110.374 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -64.66 -34.24 77.83 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.591 -0.693 . . . . 0.0 111.29 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.665 HG23 ' HE2' ' A' ' 141' ' ' PHE . 87.8 mt -69.12 -43.89 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.484 -0.76 . . . . 0.0 110.133 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -59.93 -43.99 94.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.557 -0.714 . . . . 0.0 110.969 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -70.03 -39.9 75.48 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.348 -0.845 . . . . 0.0 110.993 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.518 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -60.73 -44.96 96.0 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.598 -0.689 . . . . 0.0 110.629 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -67.47 -39.27 85.28 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.428 -0.795 . . . . 0.0 110.359 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -60.45 -40.03 89.68 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.523 -0.736 . . . . 0.0 112.268 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 88' ' ' ALA . 34.7 m -71.17 -39.19 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.098 -1.002 . . . . 0.0 111.291 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.465 ' HE2' HG21 ' B' ' 164' ' ' VAL . 11.8 m-85 -70.9 -37.15 72.95 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.114 -0.991 . . . . 0.0 110.669 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -79.79 69.04 6.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.681 -0.637 . . . . 0.0 110.806 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -59.94 -46.15 90.3 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.175 -0.953 . . . . 0.0 109.722 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.9 p-10 -69.89 -20.48 63.37 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.566 -0.709 . . . . 0.0 110.602 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.8 25.23 71.74 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -70.04 -9.76 56.42 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.285 -1.127 . . . . 0.0 111.31 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.11 -10.05 65.59 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -136.84 141.94 42.85 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.158 -1.201 . . . . 0.0 109.021 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 62.0 mt -89.49 120.45 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.407 -0.808 . . . . 0.0 109.929 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 m -84.06 168.56 15.78 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.267 0.555 . . . . 0.0 110.637 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.03 -41.17 91.28 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.621 -0.675 . . . . 0.0 109.552 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.53 -38.35 89.62 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.316 0.579 . . . . 0.0 109.44 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -61.17 -39.95 92.08 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.697 -0.627 . . . . 0.0 110.791 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.415 ' HB3' HG13 ' A' ' 121' ' ' VAL . 1.2 tt -63.6 -44.46 93.93 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.77 0.795 . . . . 0.0 109.35 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.9 ttt-85 -60.66 -32.69 71.86 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.853 -0.53 . . . . 0.0 111.356 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -60.01 -42.38 94.19 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.159 -0.963 . . . . 0.0 110.837 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.434 HG12 ' CD1' ' A' ' 112' ' ' LEU . 86.6 t -74.1 -40.02 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.27 -0.894 . . . . 0.0 110.851 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 13.0 mmt -57.43 -49.18 77.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.4 -0.813 . . . . 0.0 110.067 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.6 m -64.64 -44.95 88.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.644 -0.66 . . . . 0.0 109.551 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -61.63 -29.31 69.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.7 -0.625 . . . . 0.0 109.567 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.434 ' CD1' HG12 ' A' ' 108' ' ' VAL . 11.7 mt -69.97 -30.79 68.22 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.216 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 111.13 25.62 4.98 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -122.84 136.78 54.98 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.454 -1.027 . . . . 0.0 109.727 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -99.94 119.96 39.05 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.548 -0.72 . . . . 0.0 110.674 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 71.3 mt -135.75 158.32 44.67 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.718 -0.614 . . . . 0.0 110.066 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.03 161.12 26.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.602 -0.686 . . . . 0.0 109.302 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -61.71 -27.9 69.04 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.71 -33.82 73.05 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.674 0.749 . . . . 0.0 109.379 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -67.53 -36.83 81.78 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.495 0.665 . . . . 0.0 109.226 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.415 HG13 ' HB3' ' A' ' 105' ' ' LEU . 56.1 t -69.98 -39.95 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.579 0.704 . . . . 0.0 109.78 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -60.0 -38.72 83.44 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.744 -0.597 . . . . 0.0 109.918 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -59.22 -39.72 83.58 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.378 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.9 mtt -55.34 -36.01 65.82 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 119.286 -0.965 . . . . 0.0 109.338 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.4 mm -67.31 -39.54 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.72 -0.613 . . . . 0.0 109.605 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -58.26 -38.24 76.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.606 -0.684 . . . . 0.0 110.734 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.97 -36.79 77.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.667 -0.646 . . . . 0.0 110.096 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.501 ' HB3' HG22 ' A' ' 136' ' ' VAL . . . -103.61 -4.33 23.99 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.563 -0.71 . . . . 0.0 111.307 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -82.49 71.1 9.56 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.959 -1.088 . . . . 0.0 110.24 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 85.3 mt -64.76 -46.88 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.525 -0.734 . . . . 0.0 110.682 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -70.49 -20.18 62.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.541 -0.724 . . . . 0.0 111.785 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.3 22.69 58.4 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -81.05 -10.32 59.7 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.366 -1.079 . . . . 0.0 110.804 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.03 0.63 71.07 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -141.42 156.49 45.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -1.193 . . . . 0.0 109.756 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.501 HG22 ' HB3' ' A' ' 128' ' ' ALA . 63.9 t -95.24 119.36 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.53 -0.731 . . . . 0.0 109.976 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -87.88 173.6 8.84 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -60.07 -50.03 75.34 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.649 -0.657 . . . . 0.0 110.054 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -60.66 -41.48 95.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.571 -0.706 . . . . 0.0 111.794 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -65.81 -36.35 83.27 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.2 -0.937 . . . . 0.0 109.882 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.665 ' HE2' HG23 ' A' ' 85' ' ' ILE . 65.6 t80 -62.14 -43.94 97.73 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.034 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.1 t -70.06 -45.24 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.4 -0.812 . . . . 0.0 111.693 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -60.32 -44.73 95.2 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.51 -0.744 . . . . 0.0 110.444 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -61.79 -39.99 93.63 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.697 -0.627 . . . . 0.0 109.945 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.2 mmt -67.71 -39.96 84.3 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.555 -0.715 . . . . 0.0 109.988 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.429 ' O ' HG22 ' A' ' 146' ' ' THR . 36.2 m -89.14 1.37 55.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.753 -0.592 . . . . 0.0 110.52 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.94 136.63 58.07 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.202 -0.936 . . . . 0.0 110.162 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 93.8 mttt . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.191 -179.795 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -146.09 125.38 2.25 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -67.94 -30.35 69.63 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.734 -0.863 . . . . 0.0 110.662 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -60.06 -40.03 88.03 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.383 -0.823 . . . . 0.0 110.139 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -68.36 -33.62 74.6 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.567 -0.708 . . . . 0.0 109.906 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . 0.46 ' O ' HG23 ' B' ' 164' ' ' VAL . 47.4 mm -59.94 -44.49 94.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.581 -0.699 . . . . 0.0 110.51 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.43 -39.93 92.7 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.541 -0.724 . . . . 0.0 111.299 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -61.48 -42.21 98.45 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.392 -0.818 . . . . 0.0 111.574 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 8.4 tt -70.05 -40.02 75.36 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.364 -0.835 . . . . 0.0 110.684 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . 0.465 HG21 ' HE2' ' A' ' 92' ' ' PHE . 71.6 t -61.41 -39.98 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.628 -0.67 . . . . 0.0 110.644 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -52.48 -37.35 49.15 Favored Glycine 0 N--CA 1.501 2.996 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 89.7 t -78.18 -29.73 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.817 -0.814 . . . . 0.0 110.316 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.556 HD23 ' C ' ' B' ' 167' ' ' LEU . 6.8 tt -59.3 -52.86 63.85 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.459 -0.776 . . . . 0.0 110.9 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -67.13 -39.93 86.68 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.343 -0.848 . . . . 0.0 110.727 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -59.95 -29.57 68.5 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.482 -0.761 . . . . 0.0 110.385 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 170' ' ' TRP . . . . . 0.44 ' HH2' HD12 ' A' ' 63' ' ' ILE . 2.1 t90 -60.01 -47.2 86.83 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.486 -0.759 . . . . 0.0 109.549 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.12 -44.96 94.51 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.628 -0.67 . . . . 0.0 110.974 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -59.99 -40.02 87.72 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.384 -0.823 . . . . 0.0 110.781 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.467 -0.77 . . . . 0.0 110.316 -179.753 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 121.75 0.786 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 77.3 mt -58.59 -35.33 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.856 -0.527 . . . . 0.0 111.181 -178.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -62.65 -55.79 23.68 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.87 -1.144 . . . . 0.0 111.597 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -56.11 -38.52 70.87 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.564 -1.335 . . . . 0.0 111.025 -177.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -68.22 -30.11 69.1 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 20.7 ttpt -68.28 -38.49 81.76 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.386 0.613 . . . . 0.0 109.712 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.11 -59.22 5.76 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.431 0.634 . . . . 0.0 110.728 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.76 -33.16 75.04 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.844 -0.535 . . . . 0.0 112.426 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -58.26 -48.08 81.55 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.933 -1.104 . . . . 0.0 110.502 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.1 t -65.22 -37.83 88.5 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.223 -0.923 . . . . 0.0 108.842 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 64.3 tp -60.07 -40.01 88.03 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.154 0.502 . . . . 0.0 109.976 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -75.38 -30.62 60.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.663 -0.648 . . . . 0.0 110.37 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -93.0 103.4 15.72 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.545 -0.722 . . . . 0.0 109.201 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -59.97 -38.16 81.72 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.542 -0.724 . . . . 0.0 112.29 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -77.97 -11.78 59.93 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.825 -1.172 . . . . 0.0 111.09 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.77 27.7 50.44 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -89.63 -0.93 57.85 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.599 -0.942 . . . . 0.0 110.785 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.44 4.91 63.82 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 120.256 -0.974 . . . . 0.0 111.218 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.2 p -146.08 143.59 29.48 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 119.137 1.469 . . . . 0.0 111.768 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.8 mt -104.73 129.98 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.8 p -108.04 144.94 34.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.652 -0.655 . . . . 0.0 110.795 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.6 p -43.37 -32.29 0.81 Allowed 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.877 -0.515 . . . . 0.0 112.142 -178.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -65.39 -50.15 66.58 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.233 -0.917 . . . . 0.0 109.593 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -60.08 -54.52 45.02 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.936 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.667 HD21 ' SD ' ' A' ' 36' ' ' MET . 9.7 tt -60.01 -35.66 75.54 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.367 -0.833 . . . . 0.0 111.231 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.94 -31.3 17.21 Favored Glycine 0 N--CA 1.5 2.957 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.1 m -70.02 -39.87 75.53 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.576 -0.956 . . . . 0.0 110.372 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.74 -57.4 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.543 -0.723 . . . . 0.0 110.053 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.667 ' SD ' HD21 ' A' ' 32' ' ' LEU . 65.0 mtt -60.3 -31.54 70.35 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.493 -0.754 . . . . 0.0 110.78 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.99 -48.85 80.02 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.382 -0.824 . . . . 0.0 109.155 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 t -71.95 -12.86 61.44 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.884 -0.51 . . . . 0.0 110.2 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.801 HD22 ' CD1' ' B' ' 167' ' ' LEU . 18.4 tp -82.44 -33.7 28.45 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.354 -0.841 . . . . 0.0 109.81 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.07 -30.44 0.14 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -158.39 155.76 29.24 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.251 -1.146 . . . . 0.0 111.3 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.432 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 5.8 p-10 -114.21 104.79 54.63 Favored Pre-proline 0 C--N 1.297 -1.712 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.167 178.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.594 ' HG2' HD21 ' A' ' 48' ' ' LEU . 44.1 Cg_endo -62.23 -151.89 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.392 0 O-C-N 123.001 1.0 . . . . 0.0 109.82 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.1 p -140.04 154.57 47.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.995 -1.066 . . . . 0.0 111.925 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -52.57 -22.84 5.41 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.757 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.63 -60.02 2.44 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.938 0.875 . . . . 0.0 109.427 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.69 -32.63 71.35 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.404 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.594 HD21 ' HG2' ' A' ' 43' ' ' PRO . 44.2 mt -60.06 -34.08 72.94 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.628 0.728 . . . . 0.0 109.836 178.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.2 -32.49 66.83 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.259 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -69.86 -43.87 70.98 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.248 -0.907 . . . . 0.0 111.745 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.43 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 21.5 ptm -63.22 -39.16 93.83 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.789 -0.764 . . . . 0.0 109.241 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.617 HG22 ' OD2' ' A' ' 56' ' ' ASP . 71.4 mt -68.63 -33.61 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.676 -0.64 . . . . 0.0 110.235 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -60.01 -40.1 88.06 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.409 -0.807 . . . . 0.0 111.412 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -67.04 -27.22 67.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 110.527 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.8 t -100.09 -9.95 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.548 -0.72 . . . . 0.0 110.91 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.617 ' OD2' HG22 ' A' ' 52' ' ' ILE . 1.0 OUTLIER -74.29 107.87 6.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.104 -0.998 . . . . 0.0 110.971 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -93.28 -20.24 20.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.742 -0.599 . . . . 0.0 109.657 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -75.36 -40.14 58.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.49 -0.756 . . . . 0.0 110.803 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.27 -4.48 62.39 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -74.64 -39.58 62.0 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.199 -1.177 . . . . 0.0 111.061 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 123.77 4.78 7.89 Favored Glycine 0 N--CA 1.496 2.634 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.317 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 76.4 p -135.4 162.7 31.88 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.129 -1.218 . . . . 0.0 110.284 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.429 ' HA ' ' OE1' ' A' ' 67' ' ' GLU . 7.8 mt -99.5 118.93 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.767 -177.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -93.59 171.22 9.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.667 -0.646 . . . . 0.0 109.945 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.485 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 16.4 t80 -46.1 -48.76 42.56 Favored Pre-proline 0 N--CA 1.498 1.967 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.5 Cg_endo -67.28 -32.55 32.87 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 122.747 0.867 . . . . 0.0 111.526 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.429 ' OE1' ' HA ' ' A' ' 63' ' ' ILE . 80.1 mt-10 -74.16 -41.1 62.05 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.214 -0.929 . . . . 0.0 110.346 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -60.21 -45.67 92.36 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.515 -0.74 . . . . 0.0 110.638 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 65' ' ' PHE . 6.1 mp -66.34 -39.94 89.54 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.446 -0.784 . . . . 0.0 111.419 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.6 m -60.74 -43.07 98.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.541 -0.725 . . . . 0.0 110.616 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 57.6 ttp -66.63 -42.77 86.25 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.597 -0.69 . . . . 0.0 111.663 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 54.0 ttm -59.97 -49.86 76.01 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.432 -0.792 . . . . 0.0 111.165 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.68 -32.83 74.61 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.512 -0.743 . . . . 0.0 111.493 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -71.17 -40.01 71.52 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.394 -0.816 . . . . 0.0 111.127 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -69.53 -38.33 77.48 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.391 -0.818 . . . . 0.0 111.778 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.7 mtm -56.22 -48.21 76.9 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.318 -0.864 . . . . 0.0 111.871 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -69.82 -39.99 76.15 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.09 -1.006 . . . . 0.0 110.999 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -69.6 -34.05 73.56 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.459 -0.776 . . . . 0.0 110.635 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.621 HG22 ' H ' ' A' ' 80' ' ' ASP . 4.0 m -97.59 -173.43 2.63 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.866 -0.521 . . . . 0.0 110.017 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.621 ' H ' HG22 ' A' ' 79' ' ' THR . 91.5 m-20 -117.36 138.04 52.06 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.244 -0.91 . . . . 0.0 110.156 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 52.2 p -64.36 -27.32 68.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.598 -0.689 . . . . 0.0 110.153 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -60.06 -34.62 73.67 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.535 -0.728 . . . . 0.0 109.297 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.15 -39.57 78.74 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.348 0.594 . . . . 0.0 109.47 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.42 -37.75 88.63 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.704 -0.622 . . . . 0.0 110.827 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.593 HG23 ' HE2' ' A' ' 141' ' ' PHE . 98.2 mt -66.9 -48.29 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.524 -0.735 . . . . 0.0 110.923 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 41.9 mtp85 -59.99 -40.94 90.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.423 -0.798 . . . . 0.0 111.414 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.56 ' O ' HG23 ' A' ' 91' ' ' VAL . 98.9 mt-10 -70.05 -40.73 74.95 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.32 -0.863 . . . . 0.0 111.51 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.35 -44.98 85.99 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.569 -0.707 . . . . 0.0 111.5 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -62.59 -40.92 98.43 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.826 0.822 . . . . 0.0 109.475 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -59.97 -36.6 77.48 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.953 -0.467 . . . . 0.0 111.027 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 87' ' ' GLU . 87.8 t -69.58 -49.07 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.545 -0.722 . . . . 0.0 109.972 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.66 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 28.4 m-85 -66.65 -39.87 88.41 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.538 -0.726 . . . . 0.0 110.967 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -77.28 72.48 3.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.495 -0.753 . . . . 0.0 109.843 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -59.99 -44.44 94.5 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.541 -0.724 . . . . 0.0 109.967 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 36.0 p-10 -78.56 -24.8 45.37 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.649 -0.657 . . . . 0.0 110.692 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.44 29.85 73.13 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.6 p-10 -71.68 -13.96 61.89 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.455 -1.027 . . . . 0.0 111.773 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.89 -22.42 8.62 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 119.966 -1.111 . . . . 0.0 110.588 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 35.6 p90 -145.96 156.39 43.48 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.28 -1.13 . . . . 0.0 109.452 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 64.6 mt -89.3 126.56 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-O 121.822 0.82 . . . . 0.0 110.849 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.5 m -86.48 172.46 10.32 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.16 0.505 . . . . 0.0 110.518 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.78 -40.26 83.99 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.61 -0.681 . . . . 0.0 109.717 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.47 -38.59 91.55 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -60.58 -37.96 83.05 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.703 -0.623 . . . . 0.0 110.214 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.462 ' HB3' HG13 ' A' ' 121' ' ' VAL . 0.9 OUTLIER -60.03 -41.36 92.05 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.608 0.718 . . . . 0.0 109.427 179.18 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 63.4 mtp180 -60.07 -35.64 75.6 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.815 -0.553 . . . . 0.0 112.277 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -60.06 -45.66 92.15 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.084 -1.01 . . . . 0.0 111.512 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.66 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 63.7 t -73.85 -37.79 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.374 -0.829 . . . . 0.0 111.379 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 14.2 mmt -59.92 -47.17 86.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.331 -0.856 . . . . 0.0 110.002 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.6 m -65.56 -40.86 93.3 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.691 -0.631 . . . . 0.0 109.462 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -60.6 -34.55 74.39 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.9 mt -69.94 -31.86 69.82 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.145 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.68 26.45 6.14 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.416 ' OE2' HD21 ' A' ' 116' ' ' LEU . 88.8 tt0 -119.52 132.97 55.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.33 -1.1 . . . . 0.0 109.884 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -98.57 120.13 38.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.582 -0.699 . . . . 0.0 110.014 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.416 HD21 ' OE2' ' A' ' 114' ' ' GLU . 57.0 mt -130.18 159.96 35.25 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.474 -0.766 . . . . 0.0 110.489 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.2 p -83.14 163.34 20.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.811 -0.556 . . . . 0.0 109.659 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -63.22 -27.0 69.06 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -69.97 -37.31 75.75 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.582 0.706 . . . . 0.0 109.194 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -65.12 -36.67 85.02 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.536 0.684 . . . . 0.0 109.36 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.462 HG13 ' HB3' ' A' ' 105' ' ' LEU . 97.5 t -69.48 -39.41 78.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.694 0.759 . . . . 0.0 109.613 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -59.98 -40.21 88.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.794 -0.566 . . . . 0.0 110.287 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -60.0 -40.96 91.01 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.405 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.412 ' CB ' HD11 ' A' ' 105' ' ' LEU . 67.6 mtt -55.07 -35.83 64.96 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.459 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.5 mm -66.58 -39.09 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.789 -0.569 . . . . 0.0 110.066 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 50.0 ttt-85 -60.02 -40.02 87.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.494 -0.753 . . . . 0.0 111.742 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -60.12 -38.53 83.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.468 -0.77 . . . . 0.0 110.865 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.549 ' HB2' ' HE2' ' A' ' 144' ' ' MET . . . -103.4 6.33 37.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.46 -0.775 . . . . 0.0 111.447 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -118.94 81.01 1.63 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.007 -1.058 . . . . 0.0 111.48 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 86.4 mt -66.79 -40.05 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.563 -0.711 . . . . 0.0 109.98 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.9 p30 -59.84 -39.32 84.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.626 -0.671 . . . . 0.0 111.136 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.54 15.96 44.72 Favored Glycine 0 N--CA 1.494 2.553 0 C-N-CA 120.149 -1.024 . . . . 0.0 111.24 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -80.01 -20.14 46.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.135 -1.215 . . . . 0.0 110.115 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.72 8.12 57.34 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.807 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -132.69 131.31 41.13 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.163 -1.198 . . . . 0.0 110.066 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.8 t -92.34 110.39 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.55 -0.719 . . . . 0.0 109.664 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -83.85 178.65 7.82 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.581 -0.699 . . . . 0.0 109.569 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -61.34 -44.89 96.43 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.747 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -61.76 -40.49 95.34 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.344 -0.847 . . . . 0.0 111.084 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -63.82 -39.62 94.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.325 -0.859 . . . . 0.0 109.629 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.593 ' HE2' HG23 ' A' ' 85' ' ' ILE . 69.4 t80 -60.0 -49.59 77.05 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.883 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.67 ' O ' HG22 ' A' ' 146' ' ' THR . 89.3 t -61.16 -41.38 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.317 -0.865 . . . . 0.0 110.919 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -60.0 -40.2 88.4 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.259 -0.9 . . . . 0.0 109.741 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.549 ' HE2' ' HB2' ' A' ' 128' ' ' ALA . 7.7 ttm -60.24 -42.04 94.46 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.701 -0.624 . . . . 0.0 110.609 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 98.4 mmm -69.93 -40.04 75.76 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.629 -0.669 . . . . 0.0 111.099 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.67 HG22 ' O ' ' A' ' 142' ' ' VAL . 9.2 t -98.23 19.28 14.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.583 -0.698 . . . . 0.0 110.383 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.14 -39.96 92.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.51 -0.743 . . . . 0.0 109.829 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 44.1 mttp . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.045 179.95 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -116.09 136.51 12.96 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -64.41 -36.72 85.09 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.542 -0.975 . . . . 0.0 110.241 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -60.03 -39.15 84.88 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.691 -0.631 . . . . 0.0 110.095 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . 0.441 ' NH2' HD21 ' B' ' 163' ' ' LEU . 16.4 tpt180 -60.02 -39.97 87.69 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.653 -0.654 . . . . 0.0 110.693 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 97.2 mt -69.61 -39.94 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.307 -0.87 . . . . 0.0 110.526 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.37 -39.94 89.05 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.562 -0.711 . . . . 0.0 110.967 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -67.14 -39.97 86.65 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.443 -0.786 . . . . 0.0 110.821 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.441 HD21 ' NH2' ' B' ' 159' ' ' ARG . 88.6 mt -64.1 -40.04 95.35 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.472 -0.768 . . . . 0.0 111.192 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 83.4 t -70.03 -40.0 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.413 -0.804 . . . . 0.0 110.714 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.98 -50.01 69.81 Favored Glycine 0 N--CA 1.498 2.807 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 14.6 p -71.09 -28.44 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.604 -0.939 . . . . 0.0 110.461 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.801 ' CD1' HD22 ' A' ' 39' ' ' LEU . 2.7 tm? -60.04 -50.16 74.81 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.467 -0.77 . . . . 0.0 111.469 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -70.05 -39.99 75.37 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.466 -0.771 . . . . 0.0 110.655 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -60.38 -39.98 89.22 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.46 -0.775 . . . . 0.0 111.628 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 18.3 t90 -70.06 -31.36 68.94 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.373 -0.829 . . . . 0.0 110.458 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.43 -47.81 80.79 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.469 -0.769 . . . . 0.0 110.264 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -60.0 -33.78 72.44 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.538 -0.726 . . . . 0.0 110.104 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.764 -0.585 . . . . 0.0 110.384 -179.373 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 . . . . . 0 N--CA 1.497 1.915 0 CA-C-O 121.015 0.436 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.6 mm -62.97 -43.0 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.386 -0.821 . . . . 0.0 110.342 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.9 -31.21 72.22 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.732 -0.605 . . . . 0.0 111.105 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -62.56 -39.99 95.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.805 . . . . 0.0 109.719 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.463 ' HB3' HD11 ' A' ' 69' ' ' LEU . 17.4 m-85 -64.26 -23.91 67.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.95 -0.469 . . . . 0.0 111.347 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.43 ' HD3' ' CE1' ' A' ' 65' ' ' PHE . 73.9 mmtt -68.93 -40.0 79.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.193 -0.942 . . . . 0.0 110.271 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -77.76 -23.99 49.1 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.991 -0.443 . . . . 0.0 111.57 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.51 -38.36 34.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.3 -0.875 . . . . 0.0 111.175 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -56.76 -39.98 75.0 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.662 -0.649 . . . . 0.0 111.33 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 94.0 p -60.26 -39.33 86.4 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.188 -0.945 . . . . 0.0 110.055 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.594 HD11 HD22 ' A' ' 112' ' ' LEU . 7.1 tt -59.97 -44.45 94.44 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.62 -0.675 . . . . 0.0 109.381 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.419 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 0.9 OUTLIER -70.02 -38.96 76.06 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.888 -0.508 . . . . 0.0 109.714 178.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -94.68 92.59 7.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.604 -0.685 . . . . 0.0 109.287 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -59.07 -22.5 60.87 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.228 -0.92 . . . . 0.0 111.653 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -81.23 -55.79 4.5 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.037 -1.039 . . . . 0.0 109.0 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.72 28.32 7.08 Favored Glycine 0 N--CA 1.482 1.748 0 N-CA-C 107.885 -2.086 . . . . 0.0 107.885 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -90.01 -1.23 57.93 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.666 -0.902 . . . . 0.0 110.526 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.04 -0.1 64.02 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 120.42 -0.895 . . . . 0.0 110.931 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.0 p -144.88 143.01 30.36 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 119.212 1.506 . . . . 0.0 111.547 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.419 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 83.8 mt -106.4 130.08 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.796 -0.565 . . . . 0.0 109.844 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.4 m -104.91 143.91 32.51 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.486 -0.758 . . . . 0.0 110.632 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 55.1 p -41.96 -35.71 0.93 Allowed 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.851 -0.531 . . . . 0.0 111.93 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.1 mttm -63.9 -48.17 77.68 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.35 -0.843 . . . . 0.0 109.325 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -58.96 -51.13 71.38 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.514 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.2 tp -59.93 -34.86 73.8 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.104 -0.997 . . . . 0.0 110.827 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.413 ' O ' ' CB ' ' A' ' 37' ' ' ARG . . . -48.52 -32.76 10.84 Favored Glycine 0 N--CA 1.5 2.963 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.1 m -70.06 -40.01 75.32 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 118.36 1.08 . . . . 0.0 110.3 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.587 HG12 HD12 ' A' ' 39' ' ' LEU . 98.1 t -69.11 -58.19 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.461 -0.774 . . . . 0.0 111.654 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 93.9 mmm -59.88 -37.26 78.85 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.258 -0.901 . . . . 0.0 110.849 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.414 ' HD3' ' HB2' ' A' ' 42' ' ' ASN . 5.9 tpt180 -60.01 -50.03 75.32 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.517 0.675 . . . . 0.0 109.736 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.1 p -71.75 -18.16 62.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.785 -0.572 . . . . 0.0 111.369 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.587 HD12 HG12 ' A' ' 35' ' ' VAL . 15.4 mt -91.86 -18.12 24.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.427 -0.796 . . . . 0.0 111.656 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.98 -40.47 0.2 Allowed Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.251 -1.452 . . . . 0.0 111.612 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.407 ' HG2' ' N ' ' A' ' 42' ' ' ASN . 26.4 tt0 -159.92 157.97 29.92 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 118.872 1.336 . . . . 0.0 112.128 -178.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.428 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 53.4 t30 -118.01 103.72 49.6 Favored Pre-proline 0 N--CA 1.489 1.513 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.244 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.786 ' HG2' HD21 ' A' ' 48' ' ' LEU . 44.5 Cg_endo -63.83 -148.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.335 0 O-C-N 123.309 1.163 . . . . 0.0 109.503 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.7 p -135.99 151.45 49.93 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.826 -1.171 . . . . 0.0 111.495 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -52.35 -24.52 7.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.652 -0.655 . . . . 0.0 111.449 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.16 -58.99 2.97 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 122.034 0.921 . . . . 0.0 108.729 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -65.43 -39.06 91.64 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.051 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.786 HD21 ' HG2' ' A' ' 43' ' ' PRO . 75.2 mt -58.04 -35.56 71.49 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.663 0.744 . . . . 0.0 110.01 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -40.03 82.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 122.01 -0.431 . . . . 0.0 111.491 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -65.22 -36.19 83.4 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.365 -0.834 . . . . 0.0 110.0 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.545 ' HE1' ' O ' ' B' ' 170' ' ' TRP . 92.0 mmm -59.93 -45.61 92.03 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.447 0.642 . . . . 0.0 109.879 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.635 HG23 HG12 ' A' ' 63' ' ' ILE . 96.0 mt -67.74 -33.06 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.761 -0.587 . . . . 0.0 110.303 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -59.93 -40.01 87.44 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.537 -0.727 . . . . 0.0 110.766 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -66.93 -28.61 68.44 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.327 -0.858 . . . . 0.0 110.621 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.778 HG21 ' HE2' ' A' ' 71' ' ' MET . 57.3 t -102.0 -7.17 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.613 -0.68 . . . . 0.0 111.081 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.485 ' OD2' HG22 ' A' ' 52' ' ' ILE . 3.1 m-20 -67.82 105.53 1.98 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.2 -0.937 . . . . 0.0 110.72 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.54 -39.56 77.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.635 -0.666 . . . . 0.0 109.801 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -90.21 -27.66 19.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.612 -0.68 . . . . 0.0 110.531 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.82 21.61 46.07 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -74.32 -34.22 63.39 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.447 -1.031 . . . . 0.0 110.425 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.8 1.22 7.61 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.486 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 66.7 p -138.69 164.83 28.52 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.077 -1.249 . . . . 0.0 111.457 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.635 HG12 HG23 ' A' ' 52' ' ' ILE . 10.0 mt -100.84 122.1 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 121.34 0.59 . . . . 0.0 111.298 -177.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -96.08 171.41 8.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.697 -0.627 . . . . 0.0 109.695 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.642 ' O ' HD13 ' A' ' 69' ' ' LEU . 78.6 t80 -48.57 -49.95 61.74 Favored Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 121.435 -0.79 . . . . 0.0 112.56 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.4 Cg_endo -66.47 -33.91 35.64 Favored 'Trans proline' 0 N--CA 1.492 1.382 0 O-C-N 122.693 0.838 . . . . 0.0 111.255 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -70.44 -39.98 74.02 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.302 -0.874 . . . . 0.0 110.383 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -64.0 -40.02 95.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.712 -0.618 . . . . 0.0 110.67 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.642 HD13 ' O ' ' A' ' 65' ' ' PHE . 5.9 mp -66.66 -39.9 88.41 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.657 -0.652 . . . . 0.0 111.9 -178.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.7 p -60.24 -40.1 89.05 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.09 -1.006 . . . . 0.0 110.403 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.778 ' HE2' HG21 ' A' ' 55' ' ' VAL . 31.7 ttm -66.72 -54.36 23.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.643 -0.66 . . . . 0.0 111.979 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.599 ' HE2' HG11 ' B' ' 166' ' ' VAL . 57.8 ttm -61.74 -52.37 64.53 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -177.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.77 -38.19 86.09 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.561 -0.712 . . . . 0.0 112.536 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -71.42 -44.21 65.29 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.312 -0.867 . . . . 0.0 111.739 -178.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -71.81 -40.87 68.87 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.329 -0.857 . . . . 0.0 113.048 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 26.9 ptm -57.03 -20.3 23.72 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.178 -0.951 . . . . 0.0 111.326 -178.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -66.58 -54.27 25.38 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.327 -0.858 . . . . 0.0 110.495 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -70.0 -23.34 63.13 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.798 -0.563 . . . . 0.0 110.457 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.599 HG22 ' H ' ' A' ' 80' ' ' ASP . 2.4 m -83.02 -173.05 4.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.633 -0.667 . . . . 0.0 110.006 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.599 ' H ' HG22 ' A' ' 79' ' ' THR . 81.9 m-20 -128.14 140.37 51.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.311 -0.868 . . . . 0.0 109.945 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.2 t -70.03 -25.1 63.41 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.642 -0.661 . . . . 0.0 110.507 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.636 ' HA ' HD12 ' A' ' 85' ' ' ILE . 99.0 mt-10 -60.08 -37.07 78.81 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.897 0.856 . . . . 0.0 108.743 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -67.48 -39.89 85.27 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.421 0.629 . . . . 0.0 109.844 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -65.33 -33.82 76.88 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.694 -0.629 . . . . 0.0 110.519 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.636 HD12 ' HA ' ' A' ' 82' ' ' GLU . 78.9 mt -66.08 -46.76 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.655 -0.653 . . . . 0.0 110.071 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 62.1 mtt180 -60.01 -40.42 89.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.51 -0.744 . . . . 0.0 111.584 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.498 ' O ' HG23 ' A' ' 91' ' ' VAL . 97.9 mt-10 -70.07 -40.18 75.2 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.203 -0.936 . . . . 0.0 111.548 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.858 ' HA ' HG11 ' B' ' 164' ' ' VAL . . . -65.18 -45.4 84.99 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.531 -0.73 . . . . 0.0 111.114 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -60.0 -47.41 85.94 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.529 0.68 . . . . 0.0 109.978 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -60.01 -36.62 77.62 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.791 -0.568 . . . . 0.0 111.192 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 87' ' ' GLU . 72.0 t -69.19 -49.75 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.262 -0.899 . . . . 0.0 109.569 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -67.65 -39.99 84.57 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.315 -0.866 . . . . 0.0 109.877 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -79.83 79.66 6.32 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -69.03 -39.89 78.96 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.45 -0.781 . . . . 0.0 111.034 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -77.4 -21.42 53.17 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.465 -0.772 . . . . 0.0 110.839 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.18 28.95 74.07 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -72.91 -10.31 59.66 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.561 -0.964 . . . . 0.0 111.765 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.78 -20.98 12.86 Favored Glycine 0 N--CA 1.498 2.829 0 C-N-CA 120.025 -1.083 . . . . 0.0 110.608 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -144.66 152.44 40.46 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.388 -1.066 . . . . 0.0 109.236 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.617 ' CG2' HD23 ' A' ' 105' ' ' LEU . 18.5 mt -88.67 131.35 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.096 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.02 170.96 11.1 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.918 -0.489 . . . . 0.0 109.756 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.77 -39.33 73.27 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.57 -37.24 86.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.692 -0.63 . . . . 0.0 109.46 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -62.24 -34.34 76.33 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.555 0.693 . . . . 0.0 109.416 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.617 HD23 ' CG2' ' A' ' 100' ' ' ILE . 0.5 OUTLIER -69.16 -40.32 78.24 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.907 -0.496 . . . . 0.0 109.964 179.173 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -60.0 -38.75 83.53 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.533 -0.729 . . . . 0.0 111.352 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -60.1 -46.2 90.38 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.083 -1.011 . . . . 0.0 111.709 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.473 HG12 ' CD1' ' A' ' 112' ' ' LEU . 93.2 t -70.28 -39.99 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.203 -0.936 . . . . 0.0 111.183 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.614 ' CE ' HD13 ' B' ' 160' ' ' ILE . 16.0 mmt -59.64 -50.03 75.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.546 -0.721 . . . . 0.0 110.889 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 93.9 m -67.35 -43.09 82.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.543 -0.723 . . . . 0.0 109.955 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -61.63 -31.67 71.77 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.36 0.6 . . . . 0.0 109.432 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.594 HD22 HD11 ' A' ' 18' ' ' LEU . 19.9 mt -69.41 -34.93 75.21 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.917 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 119.66 26.1 2.44 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -126.13 149.62 48.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.385 -1.067 . . . . 0.0 109.782 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -116.48 126.0 52.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.515 -0.741 . . . . 0.0 110.415 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 60.4 mt -138.08 154.72 49.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.593 -0.692 . . . . 0.0 109.326 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.03 163.77 23.95 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -62.0 -27.45 68.88 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.016 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.55 -32.7 73.65 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.421 0.629 . . . . 0.0 109.869 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -68.34 -36.61 79.5 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 90.7 t -66.88 -39.75 84.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.837 0.827 . . . . 0.0 108.955 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -59.99 -47.69 84.77 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.498 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -60.05 -40.07 88.13 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.838 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 65.7 mtt -55.93 -38.53 70.43 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.443 -0.903 . . . . 0.0 109.096 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 47.9 mm -65.93 -39.3 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 121.452 0.644 . . . . 0.0 109.655 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.9 ttt-85 -57.78 -38.67 75.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.678 -0.639 . . . . 0.0 110.843 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -59.95 -37.51 79.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.699 -0.626 . . . . 0.0 110.628 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.14 -1.6 27.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.403 -0.81 . . . . 0.0 111.323 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -84.76 71.75 10.81 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.996 -1.065 . . . . 0.0 110.392 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.6 mt -67.16 -41.43 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.434 -0.792 . . . . 0.0 110.245 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.5 p-10 -72.56 -20.14 61.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.328 -0.858 . . . . 0.0 111.148 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.64 22.14 62.6 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 120.312 -0.947 . . . . 0.0 111.139 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -83.1 -10.04 58.9 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.214 -1.168 . . . . 0.0 111.064 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.21 0.71 76.66 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -137.57 148.17 45.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.208 -1.171 . . . . 0.0 109.648 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 85.9 t -90.06 117.75 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.429 -0.794 . . . . 0.0 110.348 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -89.26 175.33 7.39 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -61.79 -47.92 82.97 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.794 -0.566 . . . . 0.0 110.117 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -60.02 -49.3 78.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.731 -0.606 . . . . 0.0 111.851 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -63.3 -35.4 80.24 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.316 -0.865 . . . . 0.0 109.991 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.507 ' HE1' HG23 ' A' ' 85' ' ' ILE . 64.9 t80 -60.02 -45.14 93.76 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 91.8 t -70.01 -37.85 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.328 -0.857 . . . . 0.0 111.564 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 61.9 tt0 -59.91 -47.13 87.01 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.207 -0.933 . . . . 0.0 110.395 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.4 tmm? -60.02 -39.24 85.17 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.511 -0.743 . . . . 0.0 109.925 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 96.2 mmm -65.74 -40.03 91.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.64 -0.662 . . . . 0.0 109.869 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.1 m -92.39 6.51 46.68 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.563 -0.711 . . . . 0.0 110.914 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -99.04 119.83 38.46 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.1 -1.0 . . . . 0.0 110.256 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.7 mtmt . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.266 -179.897 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.74 68.53 0.26 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -59.98 -44.1 94.7 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.584 -0.951 . . . . 0.0 110.241 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -60.02 -39.48 85.97 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.593 -0.692 . . . . 0.0 111.098 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -59.3 -39.98 84.76 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.301 -0.875 . . . . 0.0 110.256 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . 0.614 HD13 ' CE ' ' A' ' 109' ' ' MET . 97.0 mt -62.8 -40.04 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.571 -0.706 . . . . 0.0 109.377 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.3 -31.01 72.05 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.621 -0.674 . . . . 0.0 110.42 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -60.03 -38.81 83.84 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.573 -0.704 . . . . 0.0 110.097 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.553 ' O ' HG12 ' B' ' 166' ' ' VAL . 66.6 mt -60.01 -40.44 89.27 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.477 -0.764 . . . . 0.0 110.99 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . 0.858 HG11 ' HA ' ' A' ' 88' ' ' ALA . 99.1 t -68.4 -40.0 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.558 -0.714 . . . . 0.0 110.466 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.75 -41.97 94.18 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.599 HG11 ' HE2' ' A' ' 72' ' ' MET . 11.5 p -74.98 -12.24 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -1.101 . . . . 0.0 110.96 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.506 HD23 ' C ' ' B' ' 167' ' ' LEU . 9.5 tt -60.01 -49.16 78.74 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.113 -0.992 . . . . 0.0 109.48 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -60.0 -41.05 91.26 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.653 -0.654 . . . . 0.0 110.32 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.07 -40.29 88.99 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.632 -0.668 . . . . 0.0 111.601 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 170' ' ' TRP . . . . . 0.545 ' O ' ' HE1' ' A' ' 51' ' ' MET . 5.0 t-105 -61.43 -47.61 84.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.436 -0.79 . . . . 0.0 110.512 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.02 -43.62 95.14 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.542 -0.724 . . . . 0.0 111.007 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -60.01 -40.0 87.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.37 -0.831 . . . . 0.0 110.625 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 . . . . . 0 N--CA 1.495 1.794 0 O-C-N 121.413 -0.804 . . . . 0.0 110.4 -179.877 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 . . . . . 0 N--CA 1.5 2.073 0 CA-C-O 120.739 0.304 . . . . 0.0 111.448 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.5 mm -60.68 -50.03 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.369 -0.832 . . . . 0.0 110.891 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.04 -31.44 69.97 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.64 -0.662 . . . . 0.0 111.466 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -59.95 -43.04 95.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.927 . . . . 0.0 110.586 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.426 ' CE2' ' HG ' ' A' ' 69' ' ' LEU . 44.5 m-85 -65.23 -21.77 66.79 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.578 -0.701 . . . . 0.0 111.468 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.43 ' HD3' ' CZ ' ' A' ' 65' ' ' PHE . 32.5 mmtt -70.71 -43.92 67.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.083 -1.011 . . . . 0.0 110.391 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -75.16 -28.23 60.01 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.21 -30.27 22.54 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.144 -0.972 . . . . 0.0 111.851 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -59.99 -45.85 91.39 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.497 -0.752 . . . . 0.0 111.677 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.5 m -60.06 -39.48 86.17 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.221 -0.924 . . . . 0.0 109.604 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.6 tp -61.35 -43.47 98.82 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.624 ' HZ ' HD21 ' B' ' 167' ' ' LEU . 1.3 m-85 -69.95 -40.07 75.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.993 -0.442 . . . . 0.0 110.461 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -92.32 95.36 9.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.439 -0.788 . . . . 0.0 109.627 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -60.01 -34.52 73.47 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.381 -0.824 . . . . 0.0 110.859 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -80.03 -10.11 59.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.255 -0.903 . . . . 0.0 111.051 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.43 26.53 44.99 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -88.02 -7.88 56.41 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.64 -0.918 . . . . 0.0 111.035 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.77 1.77 58.64 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.542 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.8 p -144.02 141.57 30.19 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 119.192 1.496 . . . . 0.0 111.192 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 88.1 mt -104.23 128.45 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.714 -0.616 . . . . 0.0 109.492 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.5 p -100.5 139.62 35.93 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.61 -0.681 . . . . 0.0 110.2 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.725 HG22 ' CD1' ' A' ' 52' ' ' ILE . 61.1 p -42.38 -30.93 0.36 Allowed 'General case' 0 N--CA 1.511 2.603 0 O-C-N 121.796 -0.565 . . . . 0.0 111.645 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -65.66 -49.63 67.94 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.413 -0.804 . . . . 0.0 109.641 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.35 -53.9 52.95 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.71 -0.619 . . . . 0.0 111.165 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.454 ' CD2' ' CZ2' ' B' ' 170' ' ' TRP . 58.8 tp -59.99 -34.76 73.75 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.318 -0.864 . . . . 0.0 110.633 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.04 -31.47 10.85 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.4 m -70.14 -40.83 74.58 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.517 -0.99 . . . . 0.0 110.483 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.4 t -65.76 -51.24 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 121.361 -0.837 . . . . 0.0 109.982 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 98.1 mtp -60.06 -33.77 72.51 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.459 0.647 . . . . 0.0 109.496 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -49.12 78.94 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.618 0.723 . . . . 0.0 109.438 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.7 t -71.69 -16.22 62.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.908 -0.495 . . . . 0.0 110.804 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.409 ' HA ' HD13 ' A' ' 39' ' ' LEU . 1.8 mm? -90.29 -19.95 23.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.215 -0.928 . . . . 0.0 110.653 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.36 -43.57 0.2 Allowed Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.611 -1.281 . . . . 0.0 110.876 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -160.48 160.0 31.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.107 -1.231 . . . . 0.0 111.559 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.409 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 3.2 t-20 -115.21 99.77 52.78 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 42' ' ' ASN . 47.5 Cg_endo -64.58 -151.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.278 0 O-C-N 123.321 1.169 . . . . 0.0 109.942 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.5 p -140.07 159.96 41.0 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.15 -0.969 . . . . 0.0 111.685 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.405 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 98.2 mt-10 -54.98 -21.2 11.05 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.811 -0.555 . . . . 0.0 111.645 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.43 -59.92 2.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.176 -0.953 . . . . 0.0 108.693 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -69.13 -35.97 76.96 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.677 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.499 HD13 ' HB ' ' A' ' 29' ' ' THR . 22.7 mt -58.14 -33.04 68.75 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.456 0.646 . . . . 0.0 110.148 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.08 -31.59 68.01 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.57 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -70.62 -45.75 64.64 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.297 -0.877 . . . . 0.0 111.091 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 78.7 mtm -61.53 -42.05 98.25 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.572 0.701 . . . . 0.0 109.585 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.74 HG12 HD11 ' A' ' 63' ' ' ILE . 91.0 mt -69.02 -33.41 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.257 0.551 . . . . 0.0 110.147 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -59.96 -38.76 83.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.483 -0.761 . . . . 0.0 110.332 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -64.41 -27.41 68.98 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.546 -0.721 . . . . 0.0 110.297 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.529 HG11 ' HB2' ' A' ' 71' ' ' MET . 16.6 t -104.64 -7.97 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.586 -0.696 . . . . 0.0 111.208 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -68.41 103.39 1.63 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.963 -1.086 . . . . 0.0 111.453 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.58 -39.98 94.72 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.713 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.6 p-10 -91.61 -30.67 16.23 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.637 -0.664 . . . . 0.0 111.041 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.26 23.38 44.49 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -73.37 -37.2 66.12 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.448 -1.03 . . . . 0.0 110.721 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.4 -0.84 7.56 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 120.303 -0.951 . . . . 0.0 110.965 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 49.8 p -134.73 169.72 16.91 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.171 -1.194 . . . . 0.0 110.07 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.74 HD11 HG12 ' A' ' 52' ' ' ILE . 7.0 mt -110.11 120.07 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.44 -177.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -96.25 170.34 9.32 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.408 0.623 . . . . 0.0 110.237 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.485 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 t80 -49.77 -48.09 78.05 Favored Pre-proline 0 N--CA 1.497 1.894 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.7 Cg_endo -67.7 -36.99 17.4 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 122.699 0.841 . . . . 0.0 111.683 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -70.03 -39.75 75.6 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.134 -0.979 . . . . 0.0 110.069 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -60.74 -50.01 75.21 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.484 -0.76 . . . . 0.0 111.317 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.426 ' HG ' ' CE2' ' A' ' 12' ' ' PHE . 3.1 tt -61.39 -41.69 97.52 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.362 -0.836 . . . . 0.0 111.56 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.0 p -63.02 -35.66 80.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.583 -0.698 . . . . 0.0 109.996 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.529 ' HB2' HG11 ' A' ' 55' ' ' VAL . 24.6 ttt -66.21 -43.55 86.41 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.838 -0.539 . . . . 0.0 111.852 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.1 ttt -60.06 -45.53 92.55 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.288 -0.882 . . . . 0.0 111.498 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.33 -32.0 71.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.451 -0.781 . . . . 0.0 110.564 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 20.7 mmm-85 -70.02 -40.04 75.44 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.622 -0.674 . . . . 0.0 111.124 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -73.09 -44.38 60.52 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.398 -0.814 . . . . 0.0 112.212 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 48.6 mtm -60.64 -39.94 90.15 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.297 -0.877 . . . . 0.0 113.096 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 14.6 pttp -67.25 -36.41 81.56 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.968 -1.082 . . . . 0.0 111.335 -178.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -69.41 -17.85 63.7 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.509 -0.744 . . . . 0.0 111.056 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.5 t -117.97 -159.65 0.75 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.653 0.739 . . . . 0.0 111.272 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -122.55 140.02 53.25 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.143 0.497 . . . . 0.0 109.773 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.433 ' HA ' ' HG2' ' A' ' 84' ' ' GLU . 48.1 t -64.27 -24.57 67.71 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.636 -0.665 . . . . 0.0 110.678 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.511 ' HA ' HD12 ' A' ' 85' ' ' ILE . 46.6 mt-10 -64.4 -35.51 81.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.289 -0.882 . . . . 0.0 109.024 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -67.82 -42.48 81.42 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.994 -178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.433 ' HG2' ' HA ' ' A' ' 81' ' ' SER . 12.5 pt-20 -69.95 -25.49 63.67 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.275 -0.891 . . . . 0.0 111.278 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 82' ' ' GLU . 80.8 mt -69.61 -45.33 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.44 -0.787 . . . . 0.0 109.591 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 63.2 mtt180 -59.97 -37.98 81.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.555 -0.716 . . . . 0.0 110.572 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.63 ' O ' HG23 ' A' ' 91' ' ' VAL . 96.5 mt-10 -69.54 -41.71 75.58 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.69 -0.631 . . . . 0.0 110.601 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.83 -43.83 87.37 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.53 -0.731 . . . . 0.0 111.331 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -60.1 -48.47 81.57 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.619 0.723 . . . . 0.0 109.682 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -58.74 -31.83 68.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.892 -0.505 . . . . 0.0 110.171 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 87' ' ' GLU . 75.7 t -69.97 -41.35 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.499 -0.751 . . . . 0.0 110.044 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -68.57 -37.51 79.94 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.495 -0.753 . . . . 0.0 110.948 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -80.03 76.95 6.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.539 -0.726 . . . . 0.0 109.852 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.451 ' HD3' ' CD2' ' A' ' 107' ' ' HIS . 4.9 mtmp? -63.28 -44.84 93.93 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.399 -0.813 . . . . 0.0 110.193 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -75.65 -17.5 59.96 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.621 -0.674 . . . . 0.0 111.409 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.7 20.15 75.54 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -70.07 -10.05 57.43 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.18 -1.188 . . . . 0.0 111.124 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.71 -13.28 67.49 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 41.0 m-85 -128.17 136.97 51.85 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.138 -1.213 . . . . 0.0 108.295 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 47.6 mt -89.09 120.6 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.907 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.8 m -84.56 169.43 14.43 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.407 0.622 . . . . 0.0 110.627 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.02 -39.97 87.15 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.647 -0.658 . . . . 0.0 109.305 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.73 -36.64 79.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.792 -0.568 . . . . 0.0 109.659 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -66.88 -40.02 87.69 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.642 -0.661 . . . . 0.0 110.674 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.62 -45.88 92.4 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.474 -0.767 . . . . 0.0 109.54 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -61.37 -33.74 74.17 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.848 -0.532 . . . . 0.0 111.066 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.451 ' CD2' ' HD3' ' A' ' 94' ' ' LYS . 75.6 t60 -59.95 -47.42 85.88 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.265 -0.897 . . . . 0.0 111.752 -177.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 63.2 t -72.74 -51.05 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 121.147 -0.97 . . . . 0.0 112.026 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.405 ' CE ' ' CD1' ' A' ' 116' ' ' LEU . 51.2 mtp -58.1 -39.89 79.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.078 -1.014 . . . . 0.0 110.598 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.5 m -67.17 -46.0 75.3 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.551 -0.718 . . . . 0.0 109.778 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -62.04 -31.26 71.64 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.351 0.596 . . . . 0.0 109.499 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.1 mt -69.58 -32.39 71.12 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.669 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.59 20.48 1.92 Allowed Glycine 0 N--CA 1.497 2.734 0 C-N-CA 119.868 -1.158 . . . . 0.0 111.22 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -121.85 138.98 54.18 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.101 -1.234 . . . . 0.0 110.386 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -103.05 120.03 39.92 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.528 -0.732 . . . . 0.0 109.901 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.405 ' CD1' ' CE ' ' A' ' 109' ' ' MET . 74.1 mt -133.2 157.91 44.19 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.418 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.59 172.14 8.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.817 -0.552 . . . . 0.0 109.852 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -64.98 -23.57 67.26 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -69.21 -38.73 78.74 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.607 -0.683 . . . . 0.0 109.764 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -64.7 -35.84 82.34 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.0 t -69.8 -39.1 77.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.467 0.651 . . . . 0.0 109.637 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -60.05 -46.36 89.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.749 -0.595 . . . . 0.0 110.09 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -59.95 -42.47 94.13 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.617 -0.677 . . . . 0.0 109.576 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.463 ' HE3' ' HA ' ' B' ' 157' ' ' PHE . 78.0 mmm -54.16 -39.31 66.45 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.414 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.493 HG21 ' O ' ' A' ' 134' ' ' GLY . 85.5 mt -67.68 -38.61 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.217 0.532 . . . . 0.0 110.614 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -59.13 -39.99 84.08 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.576 -0.702 . . . . 0.0 112.11 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.05 -39.96 83.64 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.808 -0.557 . . . . 0.0 110.993 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.454 ' HB2' ' CE ' ' A' ' 144' ' ' MET . . . -104.29 -1.76 26.56 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.193 -0.942 . . . . 0.0 111.655 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -83.4 70.5 10.2 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.997 -1.065 . . . . 0.0 110.48 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.71 -40.83 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.418 -0.801 . . . . 0.0 110.726 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -70.44 -18.8 63.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.386 -0.821 . . . . 0.0 111.343 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.57 22.0 63.07 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 120.239 -0.982 . . . . 0.0 110.73 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -83.01 -9.95 59.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -1.146 . . . . 0.0 110.988 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.493 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 87.49 0.69 84.22 Favored Glycine 0 N--CA 1.497 2.76 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -136.67 148.21 47.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.31 -1.112 . . . . 0.0 109.042 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.8 t -91.38 119.11 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.406 -0.809 . . . . 0.0 109.673 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.429 ' OD1' ' CE2' ' A' ' 99' ' ' TYR . 80.9 m-20 -89.02 175.24 7.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.584 -0.697 . . . . 0.0 109.929 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -60.87 -47.9 84.27 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.275 0.56 . . . . 0.0 110.524 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -59.99 -45.47 92.62 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.638 -0.663 . . . . 0.0 111.264 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -65.22 -35.9 82.51 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.797 0.808 . . . . 0.0 110.122 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.467 ' CZ ' ' CE ' ' A' ' 145' ' ' MET . 68.5 t80 -60.04 -47.29 86.47 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.32 -178.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.808 ' O ' HG22 ' A' ' 146' ' ' THR . 96.3 t -70.06 -39.72 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.288 -0.882 . . . . 0.0 111.366 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -59.94 -50.04 75.34 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.297 -0.877 . . . . 0.0 111.212 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.454 ' CE ' ' HB2' ' A' ' 128' ' ' ALA . 60.5 ttp -60.3 -36.83 78.8 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.371 -0.83 . . . . 0.0 110.534 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.585 ' CE ' ' HB1' ' B' ' 161' ' ' ALA . 33.1 mtt -69.57 -39.96 77.03 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.635 -0.666 . . . . 0.0 110.664 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.808 HG22 ' O ' ' A' ' 142' ' ' VAL . 10.1 t -99.0 22.8 9.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.542 -0.724 . . . . 0.0 110.633 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.01 -44.93 94.24 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.439 -0.788 . . . . 0.0 110.468 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 96.6 mttt . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.193 179.899 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 70.45 29.27 70.11 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . 0.463 ' HA ' ' HE3' ' A' ' 124' ' ' MET . 37.0 t80 -60.02 -39.96 87.66 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.506 -0.996 . . . . 0.0 109.395 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -66.07 -40.02 90.55 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.667 -0.646 . . . . 0.0 110.776 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -60.88 -45.97 92.47 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.331 -0.855 . . . . 0.0 111.457 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . 0.457 HG22 ' O ' ' B' ' 157' ' ' PHE . 18.2 tt -70.08 -35.49 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.353 -0.842 . . . . 0.0 111.171 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . 0.585 ' HB1' ' CE ' ' A' ' 145' ' ' MET . . . -60.15 -45.24 93.73 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.349 -0.844 . . . . 0.0 110.686 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -60.42 -40.08 89.72 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.48 -0.763 . . . . 0.0 110.488 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' B' ' 160' ' ' ILE . 85.9 mt -62.76 -40.49 97.42 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.515 -0.741 . . . . 0.0 110.678 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . 0.601 ' HA ' HD12 ' B' ' 167' ' ' LEU . 98.9 t -62.46 -40.0 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.431 -0.793 . . . . 0.0 109.563 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.44 -39.42 94.85 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 90.0 t -69.41 -35.38 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.673 -0.898 . . . . 0.0 111.307 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.624 HD21 ' HZ ' ' A' ' 19' ' ' PHE . 96.0 mt -59.98 -49.99 75.49 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.348 -0.845 . . . . 0.0 112.782 -177.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 168' ' ' ARG . . . . . 0.422 ' HD3' ' CG ' ' A' ' 87' ' ' GLU . 69.4 ttt-85 -60.6 -39.91 89.88 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.992 -1.067 . . . . 0.0 110.804 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.41 -33.65 72.8 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.491 -0.756 . . . . 0.0 109.478 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 170' ' ' TRP . . . . . 0.454 ' CZ2' ' CD2' ' A' ' 32' ' ' LEU . 2.4 t90 -60.02 -49.25 78.39 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.823 -0.548 . . . . 0.0 110.023 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.41 94.51 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.501 -0.749 . . . . 0.0 110.853 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -59.98 -39.93 87.38 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.437 -0.79 . . . . 0.0 110.028 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.702 -0.624 . . . . 0.0 110.236 -179.524 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.299 0.571 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 80.2 mt -60.19 -29.11 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.713 -0.617 . . . . 0.0 111.023 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.63 -39.44 93.85 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.092 -1.005 . . . . 0.0 110.268 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -59.54 -41.76 90.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.513 -0.742 . . . . 0.0 109.916 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -64.29 -20.6 66.19 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.933 -0.479 . . . . 0.0 111.103 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -69.96 -44.17 70.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.132 -0.98 . . . . 0.0 110.077 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -60.07 -54.95 39.9 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.31 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.13 -25.0 64.17 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.089 -1.007 . . . . 0.0 111.577 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -49.98 -56.38 10.9 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 120.972 -1.08 . . . . 0.0 111.463 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.9 m -62.39 -36.84 83.59 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.384 -0.822 . . . . 0.0 109.829 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.5 tp -59.92 -40.78 90.04 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.71 -0.619 . . . . 0.0 109.894 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.15 -33.69 59.39 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.58 -0.7 . . . . 0.0 109.928 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -92.0 98.38 11.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.51 -0.744 . . . . 0.0 109.306 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -59.97 -38.55 82.83 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.625 -0.672 . . . . 0.0 111.503 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -78.44 -12.69 60.02 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.013 -1.054 . . . . 0.0 110.813 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.92 27.9 65.22 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -90.0 -2.08 58.08 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.611 -0.935 . . . . 0.0 110.768 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.24 3.82 63.14 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.704 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.551 HG22 ' OD1' ' A' ' 64' ' ' ASP . 31.3 p -147.12 145.36 29.56 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-N 119.268 1.534 . . . . 0.0 111.646 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 91.6 mt -103.37 127.89 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 121.412 0.625 . . . . 0.0 109.689 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.5 m -100.21 139.99 35.1 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.841 -0.537 . . . . 0.0 109.866 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.632 HG23 HG13 ' A' ' 52' ' ' ILE . 4.9 p -42.95 -30.49 0.41 Allowed 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.707 -0.621 . . . . 0.0 111.686 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -64.89 -49.54 70.06 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.847 0.832 . . . . 0.0 108.999 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -58.86 -53.71 55.29 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.902 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.414 HD21 ' HE1' ' A' ' 36' ' ' MET . 56.7 tp -60.7 -32.84 72.06 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.297 -0.877 . . . . 0.0 110.285 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.76 -31.47 38.29 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.4 m -69.96 -37.74 75.88 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.516 -0.99 . . . . 0.0 109.903 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.39 -56.18 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-O 121.425 0.631 . . . . 0.0 109.725 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.51 ' HE1' ' CD1' ' B' ' 170' ' ' TRP . 60.6 mtt -59.9 -31.75 70.11 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.684 -0.635 . . . . 0.0 111.124 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -50.02 75.36 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.427 -0.796 . . . . 0.0 109.289 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.1 t -73.71 -18.69 60.97 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.776 -0.578 . . . . 0.0 110.439 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 39' ' ' LEU . 2.8 mm? -97.38 -3.02 41.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.352 -0.843 . . . . 0.0 110.954 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.98 -71.59 0.11 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -162.95 171.35 16.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.475 -1.014 . . . . 0.0 111.055 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -106.98 119.66 50.56 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.784 -0.573 . . . . 0.0 109.893 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.38 -148.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.454 0 O-C-N 123.07 1.037 . . . . 0.0 109.982 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.1 p -138.1 153.15 49.3 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.935 -1.103 . . . . 0.0 111.596 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -52.49 -23.83 6.91 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.742 -0.599 . . . . 0.0 111.728 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.47 -59.96 2.55 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.177 0.989 . . . . 0.0 108.63 177.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -67.65 -37.61 82.64 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.735 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.549 HD13 ' HB ' ' A' ' 29' ' ' THR . 14.3 mt -57.58 -35.12 69.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.608 -0.682 . . . . 0.0 109.856 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.88 -40.07 96.41 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.914 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -65.94 -40.02 90.99 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.526 -0.734 . . . . 0.0 111.133 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 49.2 mtt -59.98 -45.13 93.7 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.474 -0.766 . . . . 0.0 109.811 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.791 HG22 ' OD2' ' A' ' 56' ' ' ASP . 47.5 mm -67.03 -35.81 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.766 -0.584 . . . . 0.0 110.546 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -60.0 -40.11 88.1 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.602 -0.686 . . . . 0.0 111.122 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -69.99 -28.51 65.58 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.28 -0.887 . . . . 0.0 110.998 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.4 t -98.15 -9.11 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.45 -0.781 . . . . 0.0 111.383 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.791 ' OD2' HG22 ' A' ' 52' ' ' ILE . 4.0 m-20 -73.88 98.79 3.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.132 -0.98 . . . . 0.0 111.046 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.92 -38.5 88.84 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 109.44 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -90.13 -29.69 18.13 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.666 -0.646 . . . . 0.0 110.793 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.51 19.95 36.43 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -74.01 -37.87 64.25 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.447 -1.031 . . . . 0.0 110.747 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.576 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 125.16 3.75 7.33 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.196 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 81.1 p -136.17 169.12 18.14 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.127 -1.219 . . . . 0.0 111.101 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.603 HD11 ' CD1' ' A' ' 52' ' ' ILE . 10.6 mt -107.44 122.53 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.503 -177.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.551 ' OD1' HG22 ' A' ' 26' ' ' THR . 96.1 m-20 -103.35 170.06 8.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.597 -0.69 . . . . 0.0 110.642 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.52 ' CZ ' HD11 ' A' ' 69' ' ' LEU . 62.5 t80 -47.15 -49.84 49.71 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.659 -0.65 . . . . 0.0 112.737 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.6 Cg_endo -65.97 -34.33 38.9 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 O-C-N 122.622 0.801 . . . . 0.0 111.703 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.583 ' O ' HG22 ' A' ' 70' ' ' THR . 97.3 mt-10 -70.62 -39.96 73.42 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.179 -0.95 . . . . 0.0 111.066 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -62.44 -43.93 97.65 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.358 -0.839 . . . . 0.0 110.675 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.52 HD11 ' CZ ' ' A' ' 65' ' ' PHE . 84.5 mt -63.46 -43.44 97.35 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.383 -0.823 . . . . 0.0 112.454 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 67' ' ' GLU . 8.5 t -62.48 -33.93 75.83 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.197 -0.939 . . . . 0.0 110.926 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 15.9 ttm -67.33 -46.57 73.07 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.466 -0.771 . . . . 0.0 111.646 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 50.2 ttm -64.99 -43.87 91.16 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.322 -0.861 . . . . 0.0 112.017 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.54 -36.7 76.65 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.372 -0.83 . . . . 0.0 110.776 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -70.97 -39.95 72.21 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.696 -0.627 . . . . 0.0 111.306 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.593 ' O ' HG22 ' A' ' 79' ' ' THR . 42.0 mmtm -72.08 -30.77 65.45 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 36.2 mmt -60.07 -45.16 93.79 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.932 -1.105 . . . . 0.0 112.547 -176.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.4 pttp -69.36 -35.68 76.1 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.118 -0.989 . . . . 0.0 111.682 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -71.23 -12.34 61.41 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.418 -0.802 . . . . 0.0 111.777 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.593 HG22 ' O ' ' A' ' 75' ' ' LYS . 15.4 t -125.63 -164.32 1.29 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.319 -0.863 . . . . 0.0 111.965 -178.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -120.04 133.44 55.53 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.824 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.5 t -60.34 -29.95 69.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.593 -0.692 . . . . 0.0 110.673 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.538 ' HA ' HD12 ' A' ' 85' ' ' ILE . 98.8 mt-10 -60.13 -31.63 70.26 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.461 -0.774 . . . . 0.0 109.617 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.01 -39.98 87.68 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.903 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.11 -37.49 85.29 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.64 -0.662 . . . . 0.0 110.854 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.636 HG23 ' HE2' ' A' ' 141' ' ' PHE . 86.8 mt -66.98 -47.98 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.667 -0.646 . . . . 0.0 110.84 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -60.03 -41.1 91.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.465 -0.772 . . . . 0.0 111.207 -178.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.645 ' O ' HG23 ' A' ' 91' ' ' VAL . 99.9 mt-10 -70.06 -40.03 75.31 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.457 -0.777 . . . . 0.0 111.333 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.13 -46.05 75.3 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.772 -0.58 . . . . 0.0 111.824 -178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -59.96 -45.4 92.77 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.826 0.822 . . . . 0.0 109.338 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 29.6 ttm-85 -59.95 -37.08 78.51 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.421 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 87' ' ' GLU . 65.6 t -67.93 -46.27 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.496 -0.752 . . . . 0.0 110.188 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -69.0 -36.88 78.33 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.492 -0.755 . . . . 0.0 110.536 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -78.03 78.84 4.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.53 -0.731 . . . . 0.0 109.096 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.99 -44.16 94.69 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.413 -0.804 . . . . 0.0 110.577 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -78.92 -19.42 51.84 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.576 -0.703 . . . . 0.0 110.667 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.64 28.26 72.26 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -71.73 -10.49 59.85 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.452 -1.028 . . . . 0.0 111.159 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.9 -20.09 44.73 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.414 ' CE2' ' OD1' ' A' ' 137' ' ' ASN . 59.0 m-85 -119.91 139.39 52.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.259 -1.142 . . . . 0.0 108.971 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.501 ' CG2' HD23 ' A' ' 105' ' ' LEU . 82.5 mt -92.6 120.0 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.465 -0.772 . . . . 0.0 110.452 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.1 m -91.36 170.37 10.03 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.432 0.634 . . . . 0.0 110.719 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.73 -37.67 73.49 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.643 -0.661 . . . . 0.0 109.577 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.11 -38.76 92.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.853 -0.529 . . . . 0.0 109.918 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.5 -39.99 94.81 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.513 -0.742 . . . . 0.0 110.423 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.501 HD23 ' CG2' ' A' ' 100' ' ' ILE . 1.2 mm? -64.29 -40.0 95.07 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.607 0.718 . . . . 0.0 109.662 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 69.4 ttp85 -62.87 -31.08 72.04 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.806 -0.558 . . . . 0.0 110.875 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -60.02 -46.2 90.29 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.233 -0.917 . . . . 0.0 110.68 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.0 t -75.03 -35.57 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.363 -0.836 . . . . 0.0 111.246 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.7 mmt -60.05 -48.94 79.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.385 -0.822 . . . . 0.0 110.428 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.4 m -69.37 -39.96 77.73 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.593 -0.692 . . . . 0.0 110.125 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -60.0 -35.79 75.8 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.4 mt -69.87 -33.94 72.91 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.206 0.526 . . . . 0.0 110.306 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.96 17.25 6.43 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -109.13 131.97 54.56 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.22 -1.165 . . . . 0.0 110.256 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -100.16 120.57 40.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.618 -0.676 . . . . 0.0 110.239 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 71.2 mt -135.8 156.32 48.98 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.425 -0.797 . . . . 0.0 110.95 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.67 159.9 25.17 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -61.87 -26.6 68.24 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -68.1 -31.74 71.56 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -67.24 -34.5 77.59 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.5 t -73.02 -38.63 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.992 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.519 ' HA ' HD12 ' A' ' 125' ' ' ILE . 54.7 t0 -60.03 -43.81 95.04 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.64 -0.663 . . . . 0.0 109.55 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -60.02 -42.36 94.19 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.458 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.0 mtt -54.84 -37.59 66.37 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.118 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.519 HD12 ' HA ' ' A' ' 122' ' ' ASP . 86.7 mt -65.36 -37.9 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -57.87 -37.89 74.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.816 -0.553 . . . . 0.0 111.663 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.09 -39.97 88.0 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.427 -0.796 . . . . 0.0 111.632 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -106.34 -0.14 24.54 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.271 -0.893 . . . . 0.0 111.69 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 16.6 t70 -98.67 74.86 2.11 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.128 -0.982 . . . . 0.0 111.329 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 84.3 mt -66.93 -39.97 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.457 -0.777 . . . . 0.0 109.779 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 30.7 p30 -58.52 -37.76 76.3 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.742 -0.599 . . . . 0.0 111.494 -179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 92.84 18.75 39.35 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 120.28 -0.962 . . . . 0.0 111.233 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -82.43 -13.37 56.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.047 -1.266 . . . . 0.0 110.47 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.0 4.68 71.71 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.506 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -136.24 141.85 43.98 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.09 -1.241 . . . . 0.0 109.828 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.423 ' HB ' HD12 ' A' ' 100' ' ' ILE . 61.3 t -94.07 125.11 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.41 -0.806 . . . . 0.0 110.188 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.414 ' OD1' ' CE2' ' A' ' 99' ' ' TYR . 91.3 m-20 -97.39 179.66 4.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.569 -0.707 . . . . 0.0 109.659 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -63.09 -50.05 72.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.741 -0.599 . . . . 0.0 110.852 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.21 -44.21 95.96 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.374 -0.829 . . . . 0.0 111.342 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -66.81 -38.52 86.63 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.851 0.834 . . . . 0.0 109.81 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.636 ' HE2' HG23 ' A' ' 85' ' ' ILE . 67.6 t80 -59.97 -46.12 90.48 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.156 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.609 HG22 HG21 ' A' ' 85' ' ' ILE . 98.1 t -69.96 -39.31 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.374 -0.829 . . . . 0.0 111.101 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -59.96 -47.33 86.24 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.271 -0.893 . . . . 0.0 110.437 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.443 ' HE1' ' CD1' ' B' ' 157' ' ' PHE . 12.4 tmm? -59.94 -37.27 79.05 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.469 -0.769 . . . . 0.0 110.27 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 92.2 mtp -66.36 -40.03 89.52 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.902 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.471 ' O ' HG22 ' A' ' 146' ' ' THR . 50.2 m -86.21 2.83 45.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.792 -0.567 . . . . 0.0 111.125 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.06 138.76 57.8 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.051 -1.03 . . . . 0.0 110.235 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.4 mttp . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 117.944 -1.026 . . . . 0.0 110.174 -179.916 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.71 -19.96 50.15 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . 0.443 ' CD1' ' HE1' ' A' ' 144' ' ' MET . 52.3 t80 -67.88 -40.33 83.55 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.288 -1.125 . . . . 0.0 110.153 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 -70.0 -39.21 76.0 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.534 -0.729 . . . . 0.0 111.021 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -59.94 -40.06 87.67 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.585 -0.697 . . . . 0.0 110.719 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . 0.42 HG13 ' N ' ' B' ' 161' ' ' ALA . 24.8 pt -76.21 -27.56 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.479 -0.763 . . . . 0.0 110.791 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . 0.42 ' N ' HG13 ' B' ' 160' ' ' ILE . . . -66.27 -39.93 89.78 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.354 -0.841 . . . . 0.0 110.528 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -60.06 -40.64 90.18 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.572 -0.705 . . . . 0.0 111.031 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.58 -40.07 95.71 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.272 -0.892 . . . . 0.0 110.818 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 67.9 t -64.26 -40.1 87.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.524 -0.735 . . . . 0.0 110.896 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.24 -40.05 91.12 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 94.4 t -76.38 -14.8 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.459 -1.024 . . . . 0.0 111.344 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.447 HD23 ' C ' ' B' ' 167' ' ' LEU . 10.1 tt -60.01 -50.01 75.43 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.177 -0.952 . . . . 0.0 111.416 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -68.46 -39.95 81.23 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.249 -0.907 . . . . 0.0 110.486 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.07 -31.01 69.61 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.393 -0.817 . . . . 0.0 110.078 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 170' ' ' TRP . . . . . 0.51 ' CD1' ' HE1' ' A' ' 36' ' ' MET . 5.2 t-105 -59.97 -46.31 89.85 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.67 -0.644 . . . . 0.0 110.271 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.0 -51.39 69.85 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.461 -0.774 . . . . 0.0 110.242 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -60.11 -36.87 78.42 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.519 -0.738 . . . . 0.0 110.216 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.591 -0.693 . . . . 0.0 110.151 179.723 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 121.33 0.586 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 89.7 mt -60.79 -29.02 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.706 -0.621 . . . . 0.0 111.513 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -61.25 -37.88 84.67 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.047 -1.033 . . . . 0.0 109.788 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.9 -47.63 84.98 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.534 -0.729 . . . . 0.0 110.194 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.448 ' CE1' ' HE2' ' A' ' 72' ' ' MET . 26.5 m-85 -67.53 -25.25 65.74 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.632 -0.667 . . . . 0.0 110.627 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 22.9 tptp -67.37 -53.44 29.39 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.59 0.71 . . . . 0.0 109.251 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.4 -48.03 77.74 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.891 -0.505 . . . . 0.0 110.696 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.04 -20.34 63.26 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.227 -0.92 . . . . 0.0 111.32 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -60.02 -48.21 82.67 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.181 -0.95 . . . . 0.0 110.789 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.0 m -63.88 -39.24 93.72 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.278 -0.889 . . . . 0.0 108.778 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.602 HD11 ' O ' ' A' ' 112' ' ' LEU . 47.8 tp -63.82 -39.96 95.48 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.4 ' HB3' HD11 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -70.04 -34.2 72.95 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.362 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -92.13 94.68 9.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.685 -0.634 . . . . 0.0 109.516 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -59.9 -36.6 77.3 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.53 -0.731 . . . . 0.0 112.177 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -79.17 -9.76 59.65 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.06 -1.025 . . . . 0.0 111.392 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.96 22.37 57.54 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -85.4 -8.6 58.34 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.429 -1.042 . . . . 0.0 110.542 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.415 ' C ' HG23 ' A' ' 26' ' ' THR . . . 99.96 6.64 53.9 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.518 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.415 HG23 ' C ' ' A' ' 25' ' ' GLY . 80.5 p -147.81 143.02 27.19 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 119.32 1.56 . . . . 0.0 112.03 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.4 HD11 ' HB3' ' A' ' 19' ' ' PHE . 87.3 mt -100.41 124.34 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.3 p -100.98 140.57 35.09 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.706 -0.621 . . . . 0.0 110.835 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.464 HG23 HG13 ' A' ' 52' ' ' ILE . 7.1 p -42.08 -32.68 0.48 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.902 -0.499 . . . . 0.0 112.159 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -65.33 -49.1 70.73 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.731 0.777 . . . . 0.0 109.626 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -59.87 -53.69 54.93 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.976 -0.452 . . . . 0.0 111.092 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.4 tp -61.53 -34.91 76.34 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.218 -0.926 . . . . 0.0 111.063 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.51 -32.16 60.8 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.6 m -75.96 -41.26 52.02 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.671 -0.899 . . . . 0.0 111.044 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.7 t -62.7 -59.14 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.431 -0.793 . . . . 0.0 109.658 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.4 ptm -57.72 -20.78 36.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.67 -0.644 . . . . 0.0 110.467 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.2 ttt85 -59.9 -40.0 87.27 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.348 -0.845 . . . . 0.0 109.378 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.7 t -69.84 -16.35 63.25 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.897 -0.502 . . . . 0.0 111.735 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.855 HD22 HD22 ' B' ' 167' ' ' LEU . 6.6 mp -93.6 -10.06 35.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.305 -0.872 . . . . 0.0 110.756 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.16 -61.52 0.17 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -167.33 172.46 9.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.447 -1.031 . . . . 0.0 110.943 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -119.46 137.14 25.09 Favored Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.65 -149.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.332 0 O-C-N 123.19 1.1 . . . . 0.0 109.819 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -137.08 160.61 38.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.05 -1.031 . . . . 0.0 110.2 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -52.38 -25.31 9.48 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.897 -0.502 . . . . 0.0 112.305 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.16 -60.06 2.52 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.208 1.004 . . . . 0.0 108.85 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -66.82 -37.6 84.83 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.542 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.446 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 6.3 mt -57.71 -35.12 70.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.639 -0.663 . . . . 0.0 109.908 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.51 -40.11 95.67 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.779 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -65.49 -39.92 92.47 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.607 -0.683 . . . . 0.0 111.252 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 65.0 mtt -60.02 -43.21 95.41 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.716 0.77 . . . . 0.0 109.443 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.767 HG22 ' OD2' ' A' ' 56' ' ' ASP . 47.9 mm -66.2 -37.64 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 121.21 0.528 . . . . 0.0 110.475 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -60.0 -40.78 90.4 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.506 -0.746 . . . . 0.0 111.212 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -67.43 -27.95 67.48 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.195 -0.94 . . . . 0.0 110.541 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.411 HG21 ' SD ' ' A' ' 71' ' ' MET . 49.8 t -99.97 -10.07 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.565 -0.709 . . . . 0.0 111.557 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.767 ' OD2' HG22 ' A' ' 52' ' ' ILE . 6.6 m-20 -71.05 95.04 1.16 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.088 -1.008 . . . . 0.0 111.542 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.06 93.22 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.71 -0.619 . . . . 0.0 109.563 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -92.58 -29.27 16.25 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.648 -0.657 . . . . 0.0 110.952 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.56 20.49 34.54 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.0 p-10 -74.74 -32.76 62.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.344 -1.092 . . . . 0.0 110.35 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.531 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 118.65 5.24 12.52 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 120.277 -0.963 . . . . 0.0 111.24 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 80.9 p -136.43 170.17 16.48 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.189 -1.183 . . . . 0.0 111.077 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.465 HD11 ' CD1' ' A' ' 52' ' ' ILE . 10.8 mt -105.06 120.55 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.286 0.565 . . . . 0.0 110.886 -177.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -100.05 165.4 11.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.721 -0.612 . . . . 0.0 109.934 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.524 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 16.2 t80 -48.7 -49.27 66.85 Favored Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 121.486 -0.759 . . . . 0.0 112.499 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 38.7 Cg_endo -64.23 -35.54 51.36 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 O-C-N 122.766 0.877 . . . . 0.0 111.173 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.96 -40.03 75.65 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.165 -0.959 . . . . 0.0 110.322 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -61.99 -42.86 99.61 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.59 -0.693 . . . . 0.0 111.3 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 69' ' ' LEU . 4.0 mm? -64.68 -42.97 94.97 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.395 -0.816 . . . . 0.0 111.205 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.1 m -61.97 -40.03 94.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.649 -0.657 . . . . 0.0 111.111 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.411 ' SD ' HG21 ' A' ' 55' ' ' VAL . 56.2 ttp -68.35 -40.96 81.36 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.473 -0.767 . . . . 0.0 112.148 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.478 ' SD ' HG11 ' B' ' 166' ' ' VAL . 92.6 mmm -61.53 -45.49 93.95 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.296 -0.877 . . . . 0.0 111.131 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.67 -32.43 73.49 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.856 -0.528 . . . . 0.0 110.982 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -72.04 -39.98 68.7 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.435 -0.791 . . . . 0.0 110.292 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -62.5 -39.98 95.22 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.617 -0.677 . . . . 0.0 112.362 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 35.9 mmt -57.82 -33.21 68.37 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.185 -0.947 . . . . 0.0 110.736 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -69.69 -56.75 6.36 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.554 0.693 . . . . 0.0 110.572 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -69.16 -35.86 76.76 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.525 0.679 . . . . 0.0 110.436 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.629 HG22 ' H ' ' A' ' 80' ' ' ASP . 8.1 m -86.07 -174.68 5.21 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.858 -0.526 . . . . 0.0 110.224 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.629 ' H ' HG22 ' A' ' 79' ' ' THR . 90.4 m-20 -134.0 149.94 51.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.321 -0.862 . . . . 0.0 109.964 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.3 t -65.82 -33.74 76.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.7 -0.625 . . . . 0.0 109.556 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -63.77 -33.87 76.62 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.644 0.735 . . . . 0.0 109.181 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.56 -39.98 77.05 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.332 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -63.83 -36.35 83.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.594 -0.691 . . . . 0.0 109.934 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.633 HG23 ' CE1' ' A' ' 141' ' ' PHE . 77.4 mt -64.48 -49.96 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.668 -0.645 . . . . 0.0 110.821 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -57.14 -39.94 76.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.176 -0.953 . . . . 0.0 111.019 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.666 ' O ' HG23 ' A' ' 91' ' ' VAL . 98.8 mt-10 -70.0 -40.02 75.53 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.54 -0.725 . . . . 0.0 111.471 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.55 -49.25 69.57 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.423 -0.798 . . . . 0.0 112.244 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -60.37 -40.42 90.71 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.247 -0.908 . . . . 0.0 109.429 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -59.98 -37.57 80.0 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.666 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 87' ' ' GLU . 94.1 t -69.75 -53.41 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.419 -0.801 . . . . 0.0 110.797 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.485 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 51.5 m-85 -63.43 -39.76 95.36 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.355 -0.841 . . . . 0.0 110.882 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -80.98 72.02 7.98 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.531 -0.731 . . . . 0.0 110.006 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -61.83 -41.72 98.14 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.211 -0.93 . . . . 0.0 109.859 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.0 p-10 -73.16 -22.22 60.55 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.567 -0.708 . . . . 0.0 110.995 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.2 25.06 73.53 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -71.2 -12.49 61.5 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.322 -1.105 . . . . 0.0 111.541 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.85 -16.69 59.24 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.415 ' CD2' ' OD1' ' A' ' 137' ' ' ASN . 60.1 m-85 -123.18 136.36 54.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.19 -1.182 . . . . 0.0 109.148 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.5 ' CG2' HD23 ' A' ' 105' ' ' LEU . 61.4 mt -89.8 120.07 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.423 -0.798 . . . . 0.0 109.922 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.2 m -90.07 170.56 10.22 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.329 0.585 . . . . 0.0 110.686 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.73 -35.99 72.97 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.666 -0.646 . . . . 0.0 109.358 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.43 -35.57 79.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.735 -0.603 . . . . 0.0 109.584 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.22 -37.88 78.26 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.659 -0.65 . . . . 0.0 110.776 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.5 HD23 ' CG2' ' A' ' 100' ' ' ILE . 1.3 mm? -66.92 -41.66 86.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.552 -0.717 . . . . 0.0 110.279 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -60.06 -37.8 80.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.695 -0.628 . . . . 0.0 110.717 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -60.66 -42.79 97.72 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.456 -0.778 . . . . 0.0 112.419 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.485 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 91.3 t -74.04 -50.9 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 O-C-N 121.159 -0.963 . . . . 0.0 111.827 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 78.1 mtm -59.55 -40.21 86.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.116 -0.99 . . . . 0.0 110.205 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.2 m -64.72 -45.63 85.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.645 -0.659 . . . . 0.0 109.325 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -61.36 -33.63 73.97 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.602 ' O ' HD11 ' A' ' 18' ' ' LEU . 35.6 mt -69.98 -36.12 74.96 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.141 0.496 . . . . 0.0 109.836 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.41 30.72 1.65 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -119.93 127.34 52.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.464 -1.021 . . . . 0.0 109.701 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -100.11 120.96 40.67 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.654 -0.654 . . . . 0.0 110.824 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.549 HD23 ' OE1' ' A' ' 120' ' ' GLU . 2.5 mp -137.72 155.39 49.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.567 -0.708 . . . . 0.0 110.051 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.38 166.92 16.97 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -64.65 -24.76 67.69 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.178 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -68.66 -35.87 77.8 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.683 0.754 . . . . 0.0 109.278 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.549 ' OE1' HD23 ' A' ' 116' ' ' LEU . 4.6 mt-10 -64.8 -36.11 83.27 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.6 t -70.04 -38.62 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-O 121.427 0.632 . . . . 0.0 110.178 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -59.79 -46.54 88.9 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.573 -0.705 . . . . 0.0 110.227 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -60.1 -39.97 88.0 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.805 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 67.6 mtt -54.7 -40.01 68.75 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.353 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.64 -38.04 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.716 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -59.38 -40.02 85.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.507 -0.746 . . . . 0.0 111.938 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.88 -40.0 91.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.448 -0.782 . . . . 0.0 112.012 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.14 -17.16 16.79 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.276 -0.89 . . . . 0.0 111.388 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -85.8 74.99 10.11 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.271 -0.893 . . . . 0.0 110.538 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.7 -40.04 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.725 -0.609 . . . . 0.0 109.841 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 27.9 p-10 -58.76 -38.92 79.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.551 -0.718 . . . . 0.0 110.766 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.86 16.05 40.29 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 120.224 -0.988 . . . . 0.0 111.073 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.59 -10.81 59.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.127 -1.219 . . . . 0.0 110.238 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.47 3.54 74.84 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.476 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -134.79 136.36 42.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.093 -1.24 . . . . 0.0 110.666 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.8 t -92.11 120.01 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.47 -0.768 . . . . 0.0 110.033 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.415 ' OD1' ' CD2' ' A' ' 99' ' ' TYR . 84.8 m-20 -96.41 -175.03 3.22 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.453 0.644 . . . . 0.0 110.381 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -60.0 -49.98 75.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.837 -0.539 . . . . 0.0 110.188 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -60.08 -44.75 94.55 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.374 -0.829 . . . . 0.0 111.279 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -62.32 -39.03 91.72 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.04 0.924 . . . . 0.0 109.353 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.633 ' CE1' HG23 ' A' ' 85' ' ' ILE . 64.7 t80 -60.01 -41.86 93.06 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.697 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 92.9 t -67.65 -40.05 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.378 -0.826 . . . . 0.0 110.844 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -59.97 -39.98 87.51 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.472 -0.767 . . . . 0.0 110.498 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 46.2 ttp -60.04 -40.55 89.79 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.66 -0.65 . . . . 0.0 110.588 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 61.1 mtt -76.72 -34.24 58.14 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.419 -0.801 . . . . 0.0 109.95 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.514 ' O ' HG22 ' A' ' 146' ' ' THR . 25.0 m -92.7 23.62 4.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.793 -0.567 . . . . 0.0 111.016 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.49 89.03 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.353 -0.842 . . . . 0.0 110.474 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.146 -179.847 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 82.2 7.15 88.11 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -60.05 -47.97 83.65 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.038 -1.272 . . . . 0.0 109.472 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -61.4 -38.78 88.32 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.856 -0.528 . . . . 0.0 111.136 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -60.09 -39.9 87.74 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.389 -0.819 . . . . 0.0 110.707 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 85.4 mt -69.07 -40.06 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.441 -0.787 . . . . 0.0 110.214 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.0 -44.47 94.53 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.616 -0.677 . . . . 0.0 110.969 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -60.49 -40.79 92.6 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.34 -0.85 . . . . 0.0 110.5 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 40.4 tp -61.27 -40.6 94.7 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.503 -0.748 . . . . 0.0 109.972 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 93.1 t -60.59 -40.0 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.697 -0.627 . . . . 0.0 109.871 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -53.91 -36.15 55.03 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.478 HG11 ' SD ' ' A' ' 72' ' ' MET . 98.3 t -77.71 -29.87 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.606 -0.938 . . . . 0.0 110.33 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.855 HD22 HD22 ' A' ' 39' ' ' LEU . 3.7 tt -59.98 -50.72 72.62 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.512 -0.743 . . . . 0.0 111.515 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -60.27 -40.09 89.14 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.369 -0.832 . . . . 0.0 111.164 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -59.91 -35.32 74.62 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.49 -0.756 . . . . 0.0 110.695 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -59.69 -39.97 86.3 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.477 -0.765 . . . . 0.0 110.25 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.05 79.2 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.296 -0.878 . . . . 0.0 110.306 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -60.06 -39.64 86.69 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.337 -0.852 . . . . 0.0 109.347 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.286 0.565 . . . . 0.0 110.056 179.381 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 121.458 0.647 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.421 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 83.8 mt -57.11 -29.62 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.806 -0.559 . . . . 0.0 111.044 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.94 -39.54 94.39 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.194 -0.941 . . . . 0.0 110.419 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -60.07 -42.62 94.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.37 -0.831 . . . . 0.0 109.88 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -63.32 -20.88 65.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.865 -0.522 . . . . 0.0 111.068 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HD3' ' CZ ' ' A' ' 65' ' ' PHE . 40.3 mmtt -66.87 -40.22 87.76 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.203 -0.936 . . . . 0.0 108.988 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -64.25 -58.31 6.93 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.976 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.86 -26.95 68.44 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.36 -0.837 . . . . 0.0 112.545 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -58.36 -48.31 81.01 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.753 -1.217 . . . . 0.0 111.013 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.4 p -62.33 -37.17 84.58 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.186 -0.947 . . . . 0.0 109.481 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.2 tp -60.09 -40.01 88.11 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.583 0.706 . . . . 0.0 109.499 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.677 ' HE2' HD11 ' B' ' 163' ' ' LEU . 4.4 m-85 -74.81 -36.69 62.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.875 -0.516 . . . . 0.0 110.974 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -94.91 97.78 10.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.441 -0.787 . . . . 0.0 110.131 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -65.67 -31.98 73.29 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.499 -0.75 . . . . 0.0 111.077 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -80.04 -10.43 59.77 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.214 -0.929 . . . . 0.0 111.166 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.34 25.66 55.06 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -88.46 -8.08 55.51 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.543 -0.974 . . . . 0.0 110.902 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.31 2.72 56.71 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 120.054 -1.07 . . . . 0.0 111.751 178.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.8 p -143.4 141.5 30.9 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-N 119.464 1.632 . . . . 0.0 111.966 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 83.9 mt -100.88 121.32 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.737 -0.602 . . . . 0.0 109.458 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.1 m -102.33 141.86 34.48 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.59 -0.694 . . . . 0.0 110.389 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.44 ' CG2' HG13 ' A' ' 52' ' ' ILE . 40.6 p -41.96 -29.79 0.24 Allowed 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.643 -0.66 . . . . 0.0 112.211 -177.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -63.41 -52.08 63.09 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.333 -0.854 . . . . 0.0 109.364 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.04 -53.73 54.3 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.487 -178.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.561 HD21 ' CE ' ' A' ' 36' ' ' MET . 53.0 tp -59.83 -36.49 76.93 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.092 -1.005 . . . . 0.0 110.672 -178.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.77 -31.0 37.35 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.4 m -69.97 -40.1 75.57 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.616 -0.932 . . . . 0.0 110.24 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.22 -55.21 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.53 -0.731 . . . . 0.0 109.512 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.561 ' CE ' HD21 ' A' ' 32' ' ' LEU . 69.0 mtt -58.48 -30.46 67.0 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.333 0.587 . . . . 0.0 110.044 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -59.88 -50.04 75.34 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 t -70.76 -18.8 62.76 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.803 -0.561 . . . . 0.0 110.436 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.562 HD11 HD13 ' B' ' 167' ' ' LEU . 66.7 mt -84.96 -21.87 29.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.293 -0.88 . . . . 0.0 110.576 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.77 -45.46 0.19 Allowed Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.937 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -161.44 159.95 28.73 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.11 -1.229 . . . . 0.0 111.957 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.451 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 2.6 t-20 -114.42 105.1 54.2 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 42' ' ' ASN . 42.5 Cg_endo -61.36 -149.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.503 0 O-C-N 123.306 1.161 . . . . 0.0 110.734 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.23 160.54 39.17 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.93 -1.106 . . . . 0.0 111.174 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.4 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 11.9 mm-40 -53.78 -22.02 8.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.936 -0.478 . . . . 0.0 111.939 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.01 -59.23 3.04 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -67.27 -38.67 85.46 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.553 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.402 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 6.2 mt -58.71 -33.17 69.88 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.865 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -40.0 94.78 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.497 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -64.79 -40.03 94.57 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.649 -0.657 . . . . 0.0 110.928 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 66.6 mtt -61.3 -43.41 98.91 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.685 -0.634 . . . . 0.0 109.748 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.897 HG22 ' OD2' ' A' ' 56' ' ' ASP . 48.4 mm -66.88 -36.24 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.849 -0.532 . . . . 0.0 110.746 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -60.01 -41.95 93.24 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.391 -0.818 . . . . 0.0 110.633 -178.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -69.88 -27.69 65.02 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.226 -0.921 . . . . 0.0 111.355 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.497 HG21 ' SD ' ' A' ' 71' ' ' MET . 60.2 t -99.21 -10.02 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.316 -0.865 . . . . 0.0 111.835 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.897 ' OD2' HG22 ' A' ' 52' ' ' ILE . 19.5 m-20 -71.53 96.88 1.58 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.089 -1.007 . . . . 0.0 111.302 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.23 -37.43 80.82 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.406 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -90.58 -27.01 19.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.733 -0.604 . . . . 0.0 110.433 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.99 20.34 43.34 Favored Glycine 0 N--CA 1.495 2.567 0 C-N-CA 120.458 -0.877 . . . . 0.0 110.923 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -76.27 -28.62 57.12 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.449 -1.03 . . . . 0.0 110.565 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.76 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 114.35 2.06 23.2 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.174 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.3 p -134.1 167.78 20.01 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.152 -1.204 . . . . 0.0 110.527 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.51 HD11 HD13 ' A' ' 52' ' ' ILE . 8.7 mt -103.53 119.94 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.228 -178.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -97.71 167.56 10.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.666 -0.646 . . . . 0.0 109.889 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.508 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 10.5 t80 -48.27 -48.63 64.99 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.52 -0.737 . . . . 0.0 112.45 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.5 Cg_endo -67.0 -34.4 29.21 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 O-C-N 122.895 0.945 . . . . 0.0 111.088 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.9 -39.92 69.23 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.181 -0.95 . . . . 0.0 110.887 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -62.32 -40.43 96.29 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.451 -0.781 . . . . 0.0 111.422 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 65' ' ' PHE . 4.6 mp -69.63 -40.01 76.8 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.221 -0.924 . . . . 0.0 111.611 -178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.8 p -61.22 -40.03 92.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.364 -0.835 . . . . 0.0 110.853 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.497 ' SD ' HG21 ' A' ' 55' ' ' VAL . 50.7 ttp -67.49 -52.05 43.86 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.525 -0.734 . . . . 0.0 112.044 -178.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.427 ' HE2' HG11 ' B' ' 166' ' ' VAL . 49.8 ttm -59.98 -49.71 76.6 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.314 -0.866 . . . . 0.0 111.948 -178.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.99 -36.02 76.27 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.547 -0.72 . . . . 0.0 110.341 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -77.23 -43.55 33.16 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.606 0.717 . . . . 0.0 110.14 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -61.01 -48.12 83.29 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.757 -0.589 . . . . 0.0 111.973 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 27.8 ptm -59.94 -36.12 76.37 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.261 -0.9 . . . . 0.0 110.679 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -68.17 -42.93 79.27 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.695 0.759 . . . . 0.0 109.299 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -68.43 -30.93 69.93 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.691 0.758 . . . . 0.0 109.273 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 80' ' ' ASP . 7.2 m -94.53 -174.11 3.23 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.61 ' H ' HG22 ' A' ' 79' ' ' THR . 65.6 m-20 -120.73 141.63 50.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.109 -0.995 . . . . 0.0 109.808 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.3 t -60.06 -29.57 68.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.65 -0.656 . . . . 0.0 110.173 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.0 -37.34 79.42 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.698 0.761 . . . . 0.0 109.192 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -70.06 -39.98 75.35 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.19 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -64.08 -39.75 94.75 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.704 -0.623 . . . . 0.0 110.767 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.772 HG23 ' CE1' ' A' ' 141' ' ' PHE . 96.5 mt -62.92 -49.68 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.63 -0.669 . . . . 0.0 110.465 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -57.7 -40.09 78.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.336 -0.852 . . . . 0.0 111.16 -178.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.693 ' O ' HG23 ' A' ' 91' ' ' VAL . 98.9 mt-10 -70.03 -39.99 75.44 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.336 -0.853 . . . . 0.0 111.666 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.52 -47.21 73.64 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.331 -0.856 . . . . 0.0 111.287 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -60.01 -47.52 85.51 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.587 -0.695 . . . . 0.0 110.138 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -59.93 -36.35 76.85 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.683 -0.636 . . . . 0.0 110.325 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 87' ' ' GLU . 70.5 t -66.92 -46.39 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.568 -0.707 . . . . 0.0 109.699 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.518 ' CD1' HD22 ' A' ' 105' ' ' LEU . 14.3 m-85 -69.91 -38.58 76.3 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.461 -0.774 . . . . 0.0 111.324 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -75.34 78.33 2.42 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.51 -0.744 . . . . 0.0 110.571 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -59.92 -47.91 83.85 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.622 -0.674 . . . . 0.0 110.178 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -78.08 -18.57 55.59 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.505 -0.747 . . . . 0.0 111.239 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.98 28.58 72.27 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -73.91 -8.96 58.06 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.414 -1.05 . . . . 0.0 111.401 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.39 -17.61 50.48 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -129.99 138.44 50.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.315 -1.109 . . . . 0.0 108.87 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.764 ' CG2' HD23 ' A' ' 105' ' ' LEU . 32.9 mt -89.05 124.41 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.368 -0.833 . . . . 0.0 110.435 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.4 m -88.65 171.01 10.33 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.242 0.544 . . . . 0.0 110.384 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.84 -40.07 83.78 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.663 -0.648 . . . . 0.0 109.582 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.55 -38.51 91.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.76 -0.588 . . . . 0.0 109.604 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.85 -40.28 91.58 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.781 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.764 HD23 ' CG2' ' A' ' 100' ' ' ILE . 0.2 OUTLIER -63.1 -44.76 94.79 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.505 -0.747 . . . . 0.0 110.462 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.406 ' CG ' HG21 ' A' ' 121' ' ' VAL . 77.6 mtp180 -60.29 -30.9 69.77 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.633 -0.667 . . . . 0.0 110.385 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -60.18 -49.95 75.6 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.561 -0.712 . . . . 0.0 111.456 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.47 HG12 ' CD1' ' A' ' 112' ' ' LEU . 61.3 t -74.26 -52.32 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 O-C-N 121.234 -0.916 . . . . 0.0 112.168 -178.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 99.4 mtp -56.56 -42.68 78.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.123 -0.986 . . . . 0.0 110.511 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.6 m -65.16 -46.7 79.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.707 -0.621 . . . . 0.0 109.668 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -62.01 -33.69 74.81 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.47 ' CD1' HG12 ' A' ' 108' ' ' VAL . 61.9 mt -70.03 -33.43 71.97 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.701 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.27 40.8 0.42 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -138.02 132.84 32.82 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.5 -1.0 . . . . 0.0 110.142 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.679 ' C ' HD13 ' A' ' 116' ' ' LEU . 68.4 mttm -106.82 141.3 38.28 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.477 -0.764 . . . . 0.0 110.303 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.679 HD13 ' C ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -158.73 157.82 32.47 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.624 0.726 . . . . 0.0 110.769 179.231 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.3 p -85.66 167.57 15.2 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.632 -0.667 . . . . 0.0 109.802 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -65.47 -26.69 68.05 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -69.92 -37.34 75.91 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.909 0.862 . . . . 0.0 109.204 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -63.43 -40.02 96.03 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.44 1.114 . . . . 0.0 108.378 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.406 HG21 ' CG ' ' A' ' 106' ' ' ARG . 53.7 t -67.21 -39.97 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.033 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.422 ' HA ' HD12 ' A' ' 125' ' ' ILE . 61.1 t0 -60.07 -45.81 91.63 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.568 -0.707 . . . . 0.0 110.041 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -59.96 -40.09 87.86 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.724 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 66.7 mtt -56.24 -37.68 70.07 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.184 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 122' ' ' ASP . 89.4 mt -65.21 -38.56 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.812 0.815 . . . . 0.0 109.047 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.4 ttt180 -58.51 -39.63 80.63 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.057 0.456 . . . . 0.0 111.391 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -60.06 -39.95 87.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.709 -0.619 . . . . 0.0 111.845 -178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.2 -10.45 15.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.208 -0.933 . . . . 0.0 112.011 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -74.25 69.94 1.61 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.1 -1.0 . . . . 0.0 110.414 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.0 mt -68.2 -40.0 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.587 -0.696 . . . . 0.0 110.503 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -69.3 -24.31 63.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.377 -0.827 . . . . 0.0 111.017 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.89 24.67 48.28 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.96 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -82.57 -10.0 59.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -1.125 . . . . 0.0 110.802 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.33 -1.39 79.5 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -138.23 150.39 46.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -1.105 . . . . 0.0 109.38 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.53 118.87 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.408 -0.807 . . . . 0.0 109.944 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -89.93 -170.73 2.9 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.682 0.754 . . . . 0.0 110.397 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -69.87 -40.03 75.98 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.502 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -60.15 -47.82 84.33 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.3 -0.875 . . . . 0.0 112.249 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -62.74 -37.74 87.77 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.927 0.87 . . . . 0.0 110.043 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.772 ' CE1' HG23 ' A' ' 85' ' ' ILE . 57.9 t80 -59.97 -50.04 75.32 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.37 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.562 HG12 HG21 ' A' ' 85' ' ' ILE . 36.0 m -70.12 -41.05 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -59.97 -51.04 71.36 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.184 -0.947 . . . . 0.0 111.314 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.9 ttp -62.38 -37.73 86.85 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.447 -0.783 . . . . 0.0 109.927 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 90.6 mmm -69.82 -39.35 76.53 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.848 -0.533 . . . . 0.0 109.967 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.491 HG23 ' O ' ' A' ' 142' ' ' VAL . 71.4 p -82.56 0.39 42.94 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.499 -0.751 . . . . 0.0 111.039 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.94 -40.0 87.47 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.138 -0.976 . . . . 0.0 110.477 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.2 mttt . . . . . 0 N--CA 1.496 1.825 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.347 -179.781 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -77.0 141.4 26.13 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -60.05 -41.57 92.59 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.59 -0.947 . . . . 0.0 110.595 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 21.3 ptt-85 -60.04 -39.97 87.77 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.626 -0.671 . . . . 0.0 111.51 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 30.1 mtp-105 -61.62 -39.97 93.17 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.494 -0.754 . . . . 0.0 110.458 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 88.8 mt -66.39 -39.96 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.569 -0.707 . . . . 0.0 110.481 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.95 87.42 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.558 -0.714 . . . . 0.0 110.708 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -60.0 -42.31 93.98 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.547 -0.721 . . . . 0.0 111.457 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.735 ' O ' HG12 ' B' ' 166' ' ' VAL . 42.6 tp -65.0 -40.9 95.62 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.3 -0.875 . . . . 0.0 110.83 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . 0.647 ' HA ' HD12 ' B' ' 167' ' ' LEU . 66.9 t -61.09 -39.99 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.588 -0.695 . . . . 0.0 110.751 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.07 -40.15 82.08 Favored Glycine 0 N--CA 1.495 2.597 0 O-C-N 121.447 -0.783 . . . . 0.0 111.759 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.735 HG12 ' O ' ' B' ' 163' ' ' LEU . 15.0 p -76.33 -24.46 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.096 -1.238 . . . . 0.0 112.53 -178.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.647 HD12 ' HA ' ' B' ' 164' ' ' VAL . 85.7 mt -59.96 -49.09 79.03 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.953 -1.092 . . . . 0.0 110.969 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -61.72 -40.0 93.5 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.314 -0.866 . . . . 0.0 110.704 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . 0.444 ' CD ' HG21 ' A' ' 79' ' ' THR . 97.6 mt-10 -62.34 -26.01 68.21 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.473 -0.767 . . . . 0.0 109.872 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -59.99 -41.73 92.7 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.593 -0.692 . . . . 0.0 109.721 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.97 -50.5 73.5 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.461 -0.774 . . . . 0.0 110.78 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -60.16 -39.89 87.98 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.451 -0.781 . . . . 0.0 110.378 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 . . . . . 0 N--CA 1.495 1.778 0 O-C-N 121.611 -0.681 . . . . 0.0 110.127 -179.982 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 121.306 0.574 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.3 mt -59.93 -31.87 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.727 -0.608 . . . . 0.0 110.98 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.11 -39.38 86.02 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.249 -0.907 . . . . 0.0 110.287 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -60.04 -40.0 87.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.541 -0.725 . . . . 0.0 110.349 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -65.52 -22.83 66.76 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.486 -0.759 . . . . 0.0 110.841 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.446 ' HD3' ' CE1' ' A' ' 65' ' ' PHE . 46.7 mmtt -68.77 -39.99 79.96 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.84 -56.82 13.97 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 120.311 -0.555 . . . . 0.0 110.542 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.38 -25.89 67.48 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.295 -0.878 . . . . 0.0 112.19 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.517 ' CG ' ' CZ ' ' A' ' 65' ' ' PHE . 51.1 t80 -59.99 -43.61 95.03 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.112 -0.993 . . . . 0.0 110.714 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 98.4 p -62.13 -35.34 78.45 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.34 -0.85 . . . . 0.0 110.123 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.8 tt -66.7 -39.97 88.3 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.449 ' HZ ' HD21 ' B' ' 167' ' ' LEU . 5.5 m-85 -70.01 -40.06 75.49 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -91.59 88.75 6.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.782 -0.574 . . . . 0.0 110.139 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -59.98 -33.22 71.66 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.439 -0.788 . . . . 0.0 111.297 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -80.18 -10.07 59.74 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.113 -0.992 . . . . 0.0 111.236 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 58.02 26.07 57.7 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -88.07 -7.17 57.39 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.507 -0.996 . . . . 0.0 111.096 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.87 3.47 58.11 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.199 -1.001 . . . . 0.0 111.568 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.2 p -143.22 141.25 31.03 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 119.181 1.491 . . . . 0.0 111.484 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.5 mt -98.51 120.06 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.0 p -84.05 175.77 9.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.431 -0.793 . . . . 0.0 109.875 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.735 HG22 HD11 ' A' ' 52' ' ' ILE . 78.3 p -76.21 -32.34 58.9 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.592 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -67.84 -41.65 82.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.526 -0.734 . . . . 0.0 110.708 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -60.54 -57.46 12.65 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.605 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.5 tp -59.96 -39.19 84.78 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.368 -0.832 . . . . 0.0 111.057 -178.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -48.1 -29.79 6.96 Favored Glycine 0 N--CA 1.502 3.08 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -178.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.5 m -68.14 -40.0 82.52 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.442 -1.034 . . . . 0.0 108.928 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.5 t -64.13 -44.41 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 CA-C-O 121.306 0.574 . . . . 0.0 110.128 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.483 ' HE2' ' HD3' ' A' ' 43' ' ' PRO . 95.9 mtp -59.99 -39.99 87.65 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.604 -0.685 . . . . 0.0 110.554 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.465 ' HG2' ' HB2' ' A' ' 42' ' ' ASN . 1.1 mmt85 -61.02 -38.44 86.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.424 -0.797 . . . . 0.0 109.504 178.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.4 t -64.35 -26.7 68.59 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.887 -0.508 . . . . 0.0 110.613 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.557 HD11 HD13 ' B' ' 167' ' ' LEU . 88.3 mt -93.39 -16.1 24.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.298 -0.876 . . . . 0.0 110.228 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.05 -66.3 0.12 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -161.34 170.01 20.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.258 -1.142 . . . . 0.0 111.708 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.465 ' HB2' ' HG2' ' A' ' 37' ' ' ARG . 29.9 t30 -112.79 129.0 24.88 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.882 -0.511 . . . . 0.0 110.136 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.483 ' HD3' ' HE2' ' A' ' 36' ' ' MET . 50.8 Cg_endo -68.6 -143.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.264 0 O-C-N 123.142 1.075 . . . . 0.0 109.398 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.5 p -128.48 156.17 43.66 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.648 -1.282 . . . . 0.0 111.444 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -51.9 -22.59 3.95 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.78 -0.575 . . . . 0.0 111.844 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.13 -56.18 6.02 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 122.233 1.016 . . . . 0.0 108.523 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.4 -34.3 76.97 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.479 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.415 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 1.2 mt -57.22 -35.52 69.76 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.611 -0.681 . . . . 0.0 109.991 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -72.63 -30.29 64.18 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 120.191 -0.603 . . . . 0.0 111.708 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -69.14 -40.16 78.42 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.224 -0.923 . . . . 0.0 110.531 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 78.1 mtm -65.12 -40.02 93.88 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.682 0.754 . . . . 0.0 109.216 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.735 HD11 HG22 ' A' ' 29' ' ' THR . 92.6 mt -67.38 -34.48 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.832 -0.543 . . . . 0.0 110.507 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -60.08 -39.98 87.96 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.233 -0.917 . . . . 0.0 112.073 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -66.03 -27.77 68.35 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.051 -1.031 . . . . 0.0 110.75 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.578 HG21 ' SD ' ' A' ' 71' ' ' MET . 60.1 t -97.34 -9.33 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.598 -0.689 . . . . 0.0 110.55 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.432 ' OD2' HG22 ' A' ' 52' ' ' ILE . 12.1 m-20 -69.44 97.63 1.01 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.283 -0.886 . . . . 0.0 110.603 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.08 -38.62 91.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.658 -0.651 . . . . 0.0 109.4 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -90.33 -31.58 16.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.726 -0.609 . . . . 0.0 110.812 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.6 21.58 36.75 Favored Glycine 0 N--CA 1.496 2.653 0 C-N-CA 120.336 -0.935 . . . . 0.0 110.832 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -73.93 -33.61 64.01 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.441 -1.035 . . . . 0.0 110.576 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.05 -2.31 7.86 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 120.437 -0.887 . . . . 0.0 110.957 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.8 p -136.19 167.33 21.48 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.014 -1.286 . . . . 0.0 110.621 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.61 HD12 ' HH2' ' B' ' 170' ' ' TRP . 7.9 mt -107.76 123.78 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 121.596 0.712 . . . . 0.0 111.464 -177.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -99.58 171.22 8.06 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.54 0.685 . . . . 0.0 111.044 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.517 ' CZ ' ' CG ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -47.65 -50.03 53.2 Favored Pre-proline 0 N--CA 1.503 2.184 0 O-C-N 121.653 -0.654 . . . . 0.0 112.519 -179.507 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.499 ' O ' HG23 ' A' ' 70' ' ' THR . 41.7 Cg_endo -69.52 -35.33 13.54 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 122.92 0.958 . . . . 0.0 111.671 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.99 -39.93 75.63 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.23 -0.919 . . . . 0.0 109.8 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -61.66 -41.67 97.85 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.205 0.526 . . . . 0.0 110.775 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.3 mt -65.34 -39.97 93.06 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.479 -0.763 . . . . 0.0 111.941 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 66' ' ' PRO . 77.9 p -59.98 -39.96 87.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.249 -0.907 . . . . 0.0 110.614 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.578 ' SD ' HG21 ' A' ' 55' ' ' VAL . 61.3 ttp -67.36 -40.0 85.77 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.558 -0.714 . . . . 0.0 110.986 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -59.95 -50.15 74.9 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.53 -0.731 . . . . 0.0 111.928 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.84 -29.95 67.33 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.541 -0.725 . . . . 0.0 111.877 -178.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -69.97 -40.11 75.58 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.364 -0.835 . . . . 0.0 111.281 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.643 ' O ' HG22 ' A' ' 79' ' ' THR . 43.9 mmtm -69.97 -27.18 64.51 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 38.8 mmt -59.33 -49.03 79.38 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.03 -1.044 . . . . 0.0 112.229 -177.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.6 pttt -69.24 -33.87 73.95 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.263 -0.898 . . . . 0.0 111.936 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -70.02 -19.96 63.29 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.462 -0.773 . . . . 0.0 111.341 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.643 HG22 ' O ' ' A' ' 75' ' ' LYS . 14.3 t -118.2 -166.82 1.26 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.11 0.957 . . . . 0.0 112.427 -178.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -128.52 137.97 52.03 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.639 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.9 t -60.7 -32.43 71.67 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.649 -0.657 . . . . 0.0 110.652 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.474 ' HA ' HD12 ' A' ' 85' ' ' ILE . 92.7 mt-10 -59.99 -33.8 72.45 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.561 -0.712 . . . . 0.0 110.127 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -69.96 -40.0 75.67 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.742 -0.599 . . . . 0.0 110.747 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -69.39 -33.26 72.76 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.503 -0.748 . . . . 0.0 110.469 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.744 HG23 ' HE1' ' A' ' 141' ' ' PHE . 91.9 mt -64.81 -49.62 79.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.724 -0.61 . . . . 0.0 110.407 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -57.87 -38.4 75.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.444 -0.785 . . . . 0.0 111.02 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.714 ' O ' HG23 ' A' ' 91' ' ' VAL . 98.8 mt-10 -70.0 -42.06 73.54 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.66 -0.65 . . . . 0.0 111.617 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.3 -45.65 79.68 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.487 -0.758 . . . . 0.0 111.779 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -60.01 -45.99 90.96 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.382 -0.824 . . . . 0.0 109.449 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -59.99 -33.93 72.63 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.682 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 87' ' ' GLU . 83.3 t -69.04 -47.87 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.441 -0.787 . . . . 0.0 109.829 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.504 ' HE2' HG21 ' B' ' 164' ' ' VAL . 28.3 m-85 -70.02 -39.76 75.6 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.514 -0.741 . . . . 0.0 111.501 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -80.05 80.03 6.52 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.406 -0.809 . . . . 0.0 110.186 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -69.97 -42.07 73.64 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.413 -0.804 . . . . 0.0 110.932 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -72.78 -23.41 60.8 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.415 -0.803 . . . . 0.0 111.046 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.71 24.54 75.42 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -70.7 -9.73 57.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.504 -0.997 . . . . 0.0 111.131 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.69 -11.72 66.35 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -133.18 139.31 46.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.187 -1.184 . . . . 0.0 109.076 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.674 ' CG2' HD23 ' A' ' 105' ' ' LEU . 56.7 mt -89.37 123.25 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.532 -0.73 . . . . 0.0 110.042 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.4 m -86.96 170.14 11.85 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.405 0.621 . . . . 0.0 110.297 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.99 -39.91 75.63 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.632 -0.668 . . . . 0.0 109.749 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.25 -39.29 94.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.772 -0.58 . . . . 0.0 109.668 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -60.16 -39.89 87.97 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.606 -0.684 . . . . 0.0 110.386 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.674 HD23 ' CG2' ' A' ' 100' ' ' ILE . 0.5 OUTLIER -68.21 -41.23 81.63 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.484 0.659 . . . . 0.0 110.655 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -61.09 -37.03 81.27 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.656 -0.652 . . . . 0.0 111.746 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -59.97 -43.32 95.14 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.142 -0.974 . . . . 0.0 111.848 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.456 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 94.4 t -74.85 -44.24 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.237 -0.914 . . . . 0.0 111.631 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 94.5 mmm -58.25 -46.77 85.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.28 -0.888 . . . . 0.0 110.317 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.4 m -67.51 -41.07 85.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.46 -0.775 . . . . 0.0 109.202 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -61.55 -32.94 73.04 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.5 mt -68.52 -37.36 79.96 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.079 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 119.82 38.27 0.72 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -129.67 140.45 51.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.645 -0.915 . . . . 0.0 109.792 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -107.94 109.18 20.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.439 -0.788 . . . . 0.0 110.579 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 56.2 mt -131.59 156.2 46.18 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.598 -0.689 . . . . 0.0 109.753 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.3 m -84.0 164.76 19.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.626 -0.671 . . . . 0.0 109.744 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -61.13 -26.76 67.9 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.586 -0.696 . . . . 0.0 109.142 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.95 -31.85 73.0 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -37.34 87.26 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 73.1 t -70.64 -39.7 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.533 0.682 . . . . 0.0 110.201 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.409 ' HA ' HD12 ' A' ' 125' ' ' ILE . 44.4 t0 -59.89 -44.62 94.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.789 -0.57 . . . . 0.0 109.994 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -60.55 -41.33 94.34 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.579 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 67.6 mtt -55.6 -37.69 68.44 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 119.48 -0.888 . . . . 0.0 108.939 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 122' ' ' ASP . 96.7 mt -64.94 -39.93 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -58.64 -39.97 82.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.57 -0.706 . . . . 0.0 111.53 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -61.46 -40.0 92.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.398 -0.814 . . . . 0.0 111.86 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -102.93 -5.06 23.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.168 -0.957 . . . . 0.0 111.921 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -89.3 69.95 8.17 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.916 -1.115 . . . . 0.0 110.518 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.3 mt -70.03 -40.37 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.519 -0.738 . . . . 0.0 111.247 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -62.84 -39.96 95.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.357 -0.839 . . . . 0.0 111.207 -178.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 103.25 22.9 8.82 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.987 -1.102 . . . . 0.0 110.813 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -83.39 -7.71 59.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.33 -1.1 . . . . 0.0 110.767 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.05 -3.18 87.08 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -138.02 148.26 44.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.409 -1.053 . . . . 0.0 109.454 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 71.4 t -92.36 118.63 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.566 -0.709 . . . . 0.0 110.263 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -90.62 -174.32 4.05 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.361 -0.837 . . . . 0.0 110.823 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -69.98 -40.21 75.47 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.354 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.33 -50.11 74.94 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.181 -0.95 . . . . 0.0 111.383 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.47 -34.36 78.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.517 -0.739 . . . . 0.0 109.828 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.744 ' HE1' HG23 ' A' ' 85' ' ' ILE . 49.6 t80 -58.05 -49.3 77.37 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.038 0.447 . . . . 0.0 110.776 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 53.3 t -70.03 -39.08 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.365 -0.834 . . . . 0.0 111.211 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -57.6 -49.28 76.91 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.305 -0.872 . . . . 0.0 110.827 -178.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -59.35 -35.62 74.19 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.416 -0.802 . . . . 0.0 110.33 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.529 ' CE ' ' HB1' ' B' ' 161' ' ' ALA . 58.5 mtt -73.8 -40.0 63.7 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.53 -0.731 . . . . 0.0 110.549 178.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 34.8 m -69.9 -19.88 63.39 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.715 -0.615 . . . . 0.0 110.86 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -107.64 137.32 45.87 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.402 -0.811 . . . . 0.0 110.484 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.3 mttm . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.025 179.951 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -99.28 146.56 18.08 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -60.04 -41.84 93.13 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.595 -0.944 . . . . 0.0 110.098 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -59.96 -40.05 87.73 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.597 -0.689 . . . . 0.0 110.186 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -59.98 -40.19 88.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.733 -0.604 . . . . 0.0 110.703 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . 0.411 ' O ' HG23 ' B' ' 164' ' ' VAL . 95.3 mt -69.92 -40.41 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.396 -0.815 . . . . 0.0 111.973 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . 0.529 ' HB1' ' CE ' ' A' ' 145' ' ' MET . . . -66.14 -42.85 88.5 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.274 -0.892 . . . . 0.0 111.923 -178.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -68.68 -40.02 80.3 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.383 -0.823 . . . . 0.0 110.785 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.467 ' C ' HD23 ' B' ' 163' ' ' LEU . 10.3 tt -59.93 -42.87 94.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.499 -0.75 . . . . 0.0 110.397 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . 0.516 ' HA ' HD12 ' B' ' 167' ' ' LEU . 85.8 t -65.85 -40.03 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.581 -0.699 . . . . 0.0 110.011 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.57 -39.97 93.95 Favored Glycine 0 N--CA 1.498 2.83 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 84.8 t -64.56 -37.39 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.464 -1.021 . . . . 0.0 110.314 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.557 HD13 HD11 ' A' ' 39' ' ' LEU . 95.7 mt -60.02 -45.35 93.08 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.52 -0.737 . . . . 0.0 110.919 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 168' ' ' ARG . . . . . 0.402 ' O ' ' CD2' ' B' ' 172' ' ' TYR . 21.5 mmt180 -59.94 -39.31 85.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.487 -0.758 . . . . 0.0 110.999 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -60.02 -37.95 81.26 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.446 -0.784 . . . . 0.0 109.747 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 170' ' ' TRP . . . . . 0.61 ' HH2' HD12 ' A' ' 63' ' ' ILE . 3.2 t-105 -59.98 -43.32 95.19 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.688 -0.633 . . . . 0.0 109.72 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.98 -52.04 65.61 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.568 -0.707 . . . . 0.0 110.641 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 172' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' B' ' 168' ' ' ARG . 53.6 m-85 -60.01 -38.75 83.57 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.485 -0.76 . . . . 0.0 110.538 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.542 -0.724 . . . . 0.0 110.246 -179.883 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 121.698 0.761 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 94.3 mt -59.99 -32.4 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.817 -0.552 . . . . 0.0 111.53 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -65.6 -32.23 73.7 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.967 -1.083 . . . . 0.0 110.512 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -65.09 -45.54 84.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 109.946 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -69.99 -23.59 63.17 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.358 0.599 . . . . 0.0 110.09 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 23.1 tptp -66.61 -53.08 38.15 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.355 0.598 . . . . 0.0 109.562 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -57.09 -52.68 64.32 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.951 -0.699 . . . . 0.0 110.376 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.78 -26.39 68.69 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.352 -0.842 . . . . 0.0 111.105 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -58.25 -48.41 80.5 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.009 -1.057 . . . . 0.0 110.236 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.3 m -61.86 -39.85 93.31 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.306 -0.871 . . . . 0.0 109.143 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.5 tp -60.0 -39.98 87.64 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.351 0.596 . . . . 0.0 109.5 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -72.59 -35.49 67.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.727 -0.608 . . . . 0.0 110.392 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -95.4 98.96 10.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.471 -0.768 . . . . 0.0 110.371 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.2 mmtm -64.97 -32.04 73.57 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.377 -0.827 . . . . 0.0 111.192 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -79.83 -10.08 59.74 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.083 -1.011 . . . . 0.0 111.081 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.2 26.19 49.42 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -88.28 -3.29 58.88 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.605 -0.938 . . . . 0.0 110.637 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.57 5.46 64.94 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.297 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.9 p -145.1 142.39 29.64 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 119.166 1.483 . . . . 0.0 111.703 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 86.2 mt -103.86 128.0 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.3 p -102.05 141.22 35.23 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.619 -0.676 . . . . 0.0 110.628 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.455 ' O ' HD13 ' A' ' 48' ' ' LEU . 65.7 p -40.82 -35.87 0.56 Allowed 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -65.72 -45.44 82.69 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.249 -0.907 . . . . 0.0 109.548 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -60.05 -54.05 50.59 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.8 -0.562 . . . . 0.0 111.304 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.6 tt -59.95 -35.86 75.86 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.291 -0.881 . . . . 0.0 111.321 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.22 -28.98 44.16 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.2 m -69.54 -39.98 77.12 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.471 -1.017 . . . . 0.0 110.701 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.9 t -63.58 -54.98 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.691 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 97.8 mmm -59.96 -29.52 68.48 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.731 -0.606 . . . . 0.0 110.788 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -60.39 -50.44 73.58 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.503 -0.748 . . . . 0.0 110.448 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.4 t -72.55 -18.17 61.66 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.692 -0.63 . . . . 0.0 111.02 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.482 HD13 ' CD1' ' B' ' 167' ' ' LEU . 81.8 mt -100.11 -5.04 28.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.424 -0.797 . . . . 0.0 111.518 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.29 -68.04 0.12 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -160.21 170.64 20.75 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.228 -1.16 . . . . 0.0 111.448 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -110.53 117.21 51.41 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.972 -0.455 . . . . 0.0 110.215 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.697 ' CG ' HD21 ' A' ' 48' ' ' LEU . 53.1 Cg_endo -68.63 -150.37 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.324 0 N-CA-C 109.265 -1.091 . . . . 0.0 109.265 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 77.2 p -137.79 147.03 44.28 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.939 -1.101 . . . . 0.0 110.606 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.406 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 17.8 pt-20 -54.86 -21.1 10.32 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.55 -0.718 . . . . 0.0 111.46 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.53 -59.44 2.76 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.23 -38.43 85.21 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.832 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.697 HD21 ' CG ' ' A' ' 43' ' ' PRO . 56.5 mt -59.48 -33.71 71.65 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.666 0.746 . . . . 0.0 109.839 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.84 -39.01 83.89 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.022 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -65.93 -39.39 90.48 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.467 -0.771 . . . . 0.0 110.186 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 66.9 mtt -61.64 -43.39 98.94 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.415 0.626 . . . . 0.0 109.628 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.786 HG12 HD11 ' A' ' 63' ' ' ILE . 81.3 mt -68.02 -32.55 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.773 -0.579 . . . . 0.0 110.419 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -59.76 -40.04 86.83 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.384 -0.823 . . . . 0.0 110.292 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -64.07 -27.99 69.48 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.445 -0.785 . . . . 0.0 110.319 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.535 HG21 ' HE2' ' A' ' 71' ' ' MET . 61.0 t -101.01 -10.11 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.443 -0.785 . . . . 0.0 110.803 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.546 ' OD2' HG22 ' A' ' 52' ' ' ILE . 22.0 m-20 -67.25 100.5 0.81 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.136 -0.978 . . . . 0.0 111.163 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.0 -38.34 75.94 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -90.75 -30.45 17.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.756 -0.59 . . . . 0.0 110.622 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.6 22.42 43.5 Favored Glycine 0 N--CA 1.496 2.65 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.006 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -75.22 -31.89 61.0 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.342 -1.093 . . . . 0.0 110.657 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.4 1.1 12.48 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.334 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 77.8 p -133.49 170.01 16.13 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.116 -1.226 . . . . 0.0 110.429 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.786 HD11 HG12 ' A' ' 52' ' ' ILE . 7.0 mt -106.69 122.33 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.892 -177.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -98.5 170.03 9.11 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.521 0.676 . . . . 0.0 110.383 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.45 ' HB3' ' HD3' ' A' ' 66' ' ' PRO . 9.9 t80 -47.07 -48.77 53.1 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.586 -0.696 . . . . 0.0 112.802 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 65' ' ' PHE . 45.2 Cg_endo -71.26 -32.27 13.07 Favored 'Trans proline' 0 N--CA 1.487 1.102 0 O-C-N 122.783 0.886 . . . . 0.0 111.596 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -72.4 -40.21 67.38 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.123 -0.986 . . . . 0.0 110.409 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -62.74 -45.43 92.74 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.781 -0.574 . . . . 0.0 110.544 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.05 -40.01 87.96 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.515 -0.74 . . . . 0.0 110.472 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 93.1 m -61.19 -40.75 95.09 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.721 -0.612 . . . . 0.0 111.029 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.535 ' HE2' HG21 ' A' ' 55' ' ' VAL . 12.9 ttm -69.14 -41.07 77.82 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.45 -0.781 . . . . 0.0 112.099 -178.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -60.02 -50.0 75.44 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.335 -0.853 . . . . 0.0 111.226 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.59 -32.27 70.91 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.714 -0.616 . . . . 0.0 111.822 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.8 mmt85 -72.96 -43.51 62.2 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.33 -0.856 . . . . 0.0 111.819 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -73.4 -41.66 63.07 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.373 -0.829 . . . . 0.0 112.853 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 24.4 ptm -60.06 -29.77 68.77 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.162 -0.961 . . . . 0.0 111.538 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -63.19 -52.69 61.32 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.27 -0.894 . . . . 0.0 111.587 -178.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -69.84 -10.82 59.85 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.42 -0.8 . . . . 0.0 111.168 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.586 HG22 ' H ' ' A' ' 80' ' ' ASP 0.268 23.4 m -86.06 -174.58 5.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.581 -0.699 . . . . 0.0 109.369 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.586 ' H ' HG22 ' A' ' 79' ' ' THR . 94.1 m-20 -128.01 140.9 51.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.238 -0.914 . . . . 0.0 109.447 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.1 t -59.95 -35.05 74.13 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.633 -0.667 . . . . 0.0 110.152 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -61.08 -34.95 75.73 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.619 0.723 . . . . 0.0 109.471 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.99 -40.0 75.58 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.909 -0.494 . . . . 0.0 111.412 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.91 -40.0 79.34 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.443 -0.786 . . . . 0.0 111.062 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.448 HG23 ' HE1' ' A' ' 141' ' ' PHE . 82.8 mt -68.16 -51.82 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.45 -0.781 . . . . 0.0 110.984 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -60.01 -40.94 90.99 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.255 -0.903 . . . . 0.0 111.708 -178.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.517 ' O ' HG23 ' A' ' 91' ' ' VAL . 97.6 mt-10 -70.52 -41.45 72.56 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.51 -0.744 . . . . 0.0 111.576 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.31 -43.61 94.16 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.526 -0.734 . . . . 0.0 110.716 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -61.96 -40.81 96.86 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.811 0.815 . . . . 0.0 108.899 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 29.6 ttt85 -59.95 -37.13 78.67 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.395 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 87' ' ' GLU . 91.2 t -70.02 -50.03 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.509 -0.744 . . . . 0.0 110.153 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.674 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 27.3 m-85 -67.67 -39.97 84.47 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.405 -0.809 . . . . 0.0 110.261 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -79.58 76.3 6.21 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.403 ' HE3' ' CD2' ' A' ' 107' ' ' HIS . 60.2 mttm -68.85 -40.48 79.33 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.505 -0.747 . . . . 0.0 110.276 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -74.5 -21.67 59.44 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.418 -0.801 . . . . 0.0 110.64 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.2 26.41 73.43 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -69.92 -12.66 61.78 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.535 -0.979 . . . . 0.0 111.464 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.11 -20.62 14.07 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -144.77 153.74 41.97 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.239 -1.154 . . . . 0.0 109.994 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 80.6 mt -88.88 131.58 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.887 0.851 . . . . 0.0 110.457 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.2 m -87.7 171.01 10.75 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.193 0.521 . . . . 0.0 110.367 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.499 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -65.68 -40.07 91.97 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.41 -38.49 89.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.748 -0.595 . . . . 0.0 109.5 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -61.84 -39.95 93.61 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.751 -0.593 . . . . 0.0 110.666 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.66 ' HB3' HG13 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -61.38 -45.61 93.63 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.44 -0.788 . . . . 0.0 109.761 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -64.42 -29.0 70.06 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.768 -0.582 . . . . 0.0 110.513 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.403 ' CD2' ' HE3' ' A' ' 94' ' ' LYS . 1.5 t-80 -61.59 -46.8 88.32 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.445 -0.785 . . . . 0.0 111.361 -178.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.674 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 66.5 t -73.38 -47.93 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.472 -0.768 . . . . 0.0 111.727 -178.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.468 ' HA ' HD12 ' A' ' 112' ' ' LEU . 98.0 mtp -58.61 -39.95 81.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.222 -0.923 . . . . 0.0 110.544 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.4 m -66.58 -45.27 79.79 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -61.45 -33.41 73.68 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 109' ' ' MET . 59.2 mt -68.83 -38.74 80.06 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.922 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 119.97 39.88 0.62 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -123.32 136.01 54.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.664 -0.903 . . . . 0.0 109.991 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -96.71 126.41 41.86 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.519 -0.738 . . . . 0.0 109.701 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.688 HD23 ' N ' ' A' ' 116' ' ' LEU . 1.0 OUTLIER -152.52 153.77 34.12 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.513 -0.742 . . . . 0.0 111.443 -178.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.7 p -87.36 168.04 13.51 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 36.6 p-10 -64.46 -20.69 66.34 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.644 -0.823 . . . . 0.0 108.879 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -69.71 -37.93 76.76 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.973 0.892 . . . . 0.0 109.134 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -61.48 -39.98 92.88 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 122.131 0.967 . . . . 0.0 108.967 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.66 HG13 ' HB3' ' A' ' 105' ' ' LEU . 63.7 t -69.73 -39.85 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.663 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -59.79 -48.54 81.29 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.572 -0.705 . . . . 0.0 110.217 -178.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -59.99 -40.04 87.8 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.93 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.451 ' HB3' HD11 ' A' ' 105' ' ' LEU . 92.8 mmm -55.4 -38.16 68.55 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.136 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.41 -36.92 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 121.667 0.746 . . . . 0.0 109.154 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -58.14 -39.66 79.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.804 -0.56 . . . . 0.0 111.072 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.96 -39.31 85.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.549 -0.719 . . . . 0.0 111.297 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.91 -18.8 18.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.281 -0.887 . . . . 0.0 111.103 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -72.42 70.84 0.9 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.312 -0.867 . . . . 0.0 111.349 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 85.4 mt -67.8 -40.41 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.45 -0.781 . . . . 0.0 110.557 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -72.32 -18.26 61.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.438 -0.789 . . . . 0.0 111.581 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.23 22.48 60.68 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 120.136 -1.03 . . . . 0.0 110.853 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -82.6 -7.23 59.65 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.181 -1.188 . . . . 0.0 110.782 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.19 -0.83 89.52 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -138.52 149.5 45.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.327 -1.102 . . . . 0.0 109.246 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.6 t -92.98 110.85 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.356 -0.84 . . . . 0.0 110.7 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -80.0 172.77 13.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.493 -0.754 . . . . 0.0 109.647 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -67.94 -40.07 83.36 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.795 -0.566 . . . . 0.0 111.009 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -62.85 -52.29 63.69 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.252 -0.905 . . . . 0.0 111.988 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -69.12 -23.3 63.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -0.849 . . . . 0.0 111.122 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.448 ' HE1' HG23 ' A' ' 85' ' ' ILE . 63.3 t80 -60.08 -42.3 94.3 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.433 -0.792 . . . . 0.0 109.598 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 95.3 t -70.09 -37.67 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.726 -0.609 . . . . 0.0 111.047 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -59.94 -50.03 75.36 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.49 -0.757 . . . . 0.0 110.935 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.476 ' HE1' ' CD1' ' B' ' 157' ' ' PHE . 59.5 ttp -59.95 -37.73 80.4 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.261 -0.899 . . . . 0.0 110.299 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 94.2 mmm -67.1 -39.99 86.82 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.749 -0.594 . . . . 0.0 111.372 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 64.5 m -57.59 -26.12 61.04 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.292 -0.88 . . . . 0.0 110.543 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.78 135.0 41.72 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.47 -0.769 . . . . 0.0 110.21 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.141 179.969 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -133.87 140.36 11.72 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . 0.48 ' O ' HG22 ' B' ' 160' ' ' ILE . 36.0 t80 -61.96 -41.26 97.8 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.597 -0.943 . . . . 0.0 110.37 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -62.5 -40.04 95.43 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.561 -0.712 . . . . 0.0 110.585 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -61.66 -48.12 82.28 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.643 -0.661 . . . . 0.0 111.191 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . 0.48 HG22 ' O ' ' B' ' 157' ' ' PHE . 14.3 tt -69.95 -26.04 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.527 -0.733 . . . . 0.0 111.04 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.48 -35.34 77.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.504 -0.748 . . . . 0.0 109.661 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -59.97 -40.09 87.89 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.817 -0.552 . . . . 0.0 109.997 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 59.7 mt -63.27 -39.96 96.07 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.525 -0.734 . . . . 0.0 110.704 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 91.2 t -62.75 -40.4 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.455 -0.778 . . . . 0.0 110.414 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.05 -40.02 96.51 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 48.1 t -70.53 -22.53 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.613 -0.934 . . . . 0.0 110.833 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.482 ' CD1' HD13 ' A' ' 39' ' ' LEU . 9.6 tt -59.98 -41.93 93.1 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.3 -0.875 . . . . 0.0 110.076 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -69.48 -35.98 76.09 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.577 -0.702 . . . . 0.0 109.767 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . 0.446 ' OE2' HG21 ' A' ' 79' ' ' THR . 89.8 mt-10 -59.92 -36.65 77.46 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.665 -0.647 . . . . 0.0 110.235 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 4.9 t-105 -60.06 -40.91 91.12 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.671 -0.643 . . . . 0.0 110.722 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.06 -50.12 74.95 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.453 -0.78 . . . . 0.0 110.65 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -60.01 -39.99 87.72 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.417 -0.802 . . . . 0.0 110.354 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 71.2 mtt-85 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.615 -0.678 . . . . 0.0 110.277 -179.537 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.791 0.805 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 88.0 mt -62.99 -37.94 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.958 -0.464 . . . . 0.0 111.699 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.66 -39.77 89.61 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.206 -0.934 . . . . 0.0 110.344 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -60.06 -39.58 86.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.374 -0.829 . . . . 0.0 110.407 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.588 ' HB3' HD21 ' A' ' 69' ' ' LEU . 47.2 m-85 -64.17 -22.1 66.81 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.682 -0.636 . . . . 0.0 110.885 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -69.52 -41.14 76.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.303 -0.873 . . . . 0.0 109.181 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -71.91 -23.76 61.53 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.133 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.05 -35.49 42.48 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.342 -0.849 . . . . 0.0 110.107 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.433 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 54.7 t80 -58.38 -38.13 76.68 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.899 -0.5 . . . . 0.0 110.914 -178.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.3 p -61.02 -37.15 81.54 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.35 -0.844 . . . . 0.0 109.92 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.643 HD13 ' O ' ' A' ' 18' ' ' LEU . 0.8 OUTLIER -59.98 -40.01 87.67 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.611 -0.681 . . . . 0.0 109.459 179.545 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -78.14 -36.25 48.01 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.629 -0.669 . . . . 0.0 110.266 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -93.19 95.8 9.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.581 -0.699 . . . . 0.0 109.967 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -61.74 -32.82 73.08 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.574 -0.704 . . . . 0.0 111.221 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -79.37 -10.43 59.81 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.234 -0.916 . . . . 0.0 111.565 -177.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.51 27.75 54.72 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -92.98 -2.54 55.67 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.616 -0.931 . . . . 0.0 111.0 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.38 2.67 63.58 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.787 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 76.2 p -142.05 141.11 32.76 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 119.559 1.68 . . . . 0.0 111.76 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.622 ' HB ' HD12 ' A' ' 63' ' ' ILE . 85.7 mt -105.39 130.14 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.792 -0.567 . . . . 0.0 110.428 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.3 p -113.01 146.6 38.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.599 -0.688 . . . . 0.0 110.779 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.432 HG23 HG13 ' A' ' 52' ' ' ILE . 40.7 p -42.4 -31.08 0.38 Allowed 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.744 -0.598 . . . . 0.0 112.378 -177.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -65.38 -48.98 71.04 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.569 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -60.43 -56.82 16.76 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.967 -0.458 . . . . 0.0 111.767 -178.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.6 tp -61.54 -32.79 72.87 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.105 -0.997 . . . . 0.0 110.632 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -50.79 -33.95 28.49 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.3 m -69.98 -40.03 75.59 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.691 -0.888 . . . . 0.0 110.244 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.2 t -63.45 -58.51 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.573 -0.704 . . . . 0.0 110.264 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.427 ' HG2' HD21 ' B' ' 167' ' ' LEU . 74.0 mtm -60.01 -30.04 68.88 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.574 -0.704 . . . . 0.0 110.447 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 1.6 tmm_? -60.77 -50.36 73.77 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.566 -0.709 . . . . 0.0 109.601 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.9 t -74.78 -20.06 59.95 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.872 -0.517 . . . . 0.0 110.33 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.516 HD22 ' CD1' ' B' ' 167' ' ' LEU . 5.4 mp -97.97 -1.48 42.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.393 -0.817 . . . . 0.0 111.352 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.07 -71.43 0.11 Allowed Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.898 -1.144 . . . . 0.0 110.374 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.411 ' HG2' ' N ' ' A' ' 42' ' ' ASN . 36.5 tt0 -162.04 161.01 28.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.183 -1.186 . . . . 0.0 111.316 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.411 ' N ' ' HG2' ' A' ' 41' ' ' GLN . 45.3 t30 -111.65 103.4 55.07 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -61.78 -146.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 O-C-N 123.512 1.269 . . . . 0.0 110.402 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.8 p -132.86 157.54 44.79 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.619 -1.3 . . . . 0.0 112.122 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.421 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 45.8 mt-10 -52.64 -23.36 6.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.886 -0.509 . . . . 0.0 111.647 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.05 -59.94 2.6 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.149 0.976 . . . . 0.0 108.419 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -67.86 -36.2 79.88 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.589 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 45' ' ' GLU . 8.8 mt -58.3 -35.02 71.22 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.605 0.717 . . . . 0.0 109.769 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -39.79 94.29 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.068 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -64.8 -40.02 94.55 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.542 -0.724 . . . . 0.0 111.192 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 64.5 mtt -60.04 -42.53 94.63 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.618 -0.676 . . . . 0.0 109.791 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.827 HG22 ' OD2' ' A' ' 56' ' ' ASP . 48.5 mm -68.33 -37.18 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.855 -0.528 . . . . 0.0 111.11 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -60.97 -40.04 91.89 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.484 -0.76 . . . . 0.0 111.511 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -69.99 -28.25 65.36 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.188 -0.945 . . . . 0.0 110.482 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.1 t -95.61 -9.96 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.648 -0.658 . . . . 0.0 111.229 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.827 ' OD2' HG22 ' A' ' 52' ' ' ILE . 25.4 m-20 -74.71 97.45 3.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.176 -0.953 . . . . 0.0 110.766 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.01 -34.53 73.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.541 -0.724 . . . . 0.0 109.804 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -91.41 -26.3 18.93 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.556 -0.715 . . . . 0.0 110.774 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.14 20.17 50.4 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.035 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -76.13 -26.34 56.25 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.434 -1.039 . . . . 0.0 110.461 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.438 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 109.8 -2.09 30.37 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 77.0 p -130.71 170.89 13.74 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.187 -1.184 . . . . 0.0 110.625 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.622 HD12 ' HB ' ' A' ' 27' ' ' ILE . 6.4 mt -89.4 167.5 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.218 0.533 . . . . 0.0 110.007 -178.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.425 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 81.6 m-20 -147.04 150.57 35.35 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.496 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.7 m-85 -42.98 -52.45 11.57 Favored Pre-proline 0 N--CA 1.506 2.344 0 O-C-N 121.702 -0.624 . . . . 0.0 111.71 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.669 ' O ' HG23 ' A' ' 70' ' ' THR . 43.4 Cg_endo -69.41 -29.85 24.87 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 O-C-N 123.269 1.142 . . . . 0.0 111.334 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -72.55 -45.46 59.19 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.014 -1.054 . . . . 0.0 110.067 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -60.47 -43.93 96.41 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.755 -0.59 . . . . 0.0 110.665 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.588 HD21 ' HB3' ' A' ' 12' ' ' PHE . 78.3 mt -67.13 -41.55 85.93 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.686 -0.633 . . . . 0.0 111.757 -178.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.669 HG23 ' O ' ' A' ' 66' ' ' PRO . 43.0 p -62.71 -40.16 96.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.337 -0.852 . . . . 0.0 110.718 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.414 ' HE3' ' CE3' ' B' ' 170' ' ' TRP . 56.4 ttp -66.35 -46.57 76.32 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.79 -0.569 . . . . 0.0 111.315 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.7 ttm -60.06 -49.97 75.56 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.388 -0.82 . . . . 0.0 111.352 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.54 -33.52 72.78 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.487 -0.758 . . . . 0.0 110.58 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.6 ttp180 -69.98 -39.52 75.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.722 -0.611 . . . . 0.0 110.857 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.775 ' O ' HG22 ' A' ' 79' ' ' THR . 4.3 mptp? -71.83 -18.25 62.09 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.455 -0.778 . . . . 0.0 112.086 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 26.9 mmt -58.96 -50.02 75.66 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.99 -1.069 . . . . 0.0 110.735 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.99 -32.7 71.04 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.692 -0.63 . . . . 0.0 111.121 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -70.67 -18.9 62.83 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.43 -0.794 . . . . 0.0 111.549 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.775 HG22 ' O ' ' A' ' 75' ' ' LYS . 14.4 t -121.93 -162.94 1.02 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.879 0.847 . . . . 0.0 112.284 -178.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -127.97 142.2 51.31 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.353 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.3 t -66.73 -32.51 73.86 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.83 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -60.08 -36.98 78.58 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.881 0.848 . . . . 0.0 109.199 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.86 -39.97 76.04 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.306 0.574 . . . . 0.0 110.389 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -61.63 -37.49 84.17 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.606 -0.684 . . . . 0.0 110.75 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 77.4 mt -67.73 -44.43 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.538 -0.726 . . . . 0.0 110.685 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -59.25 -39.96 84.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.417 -0.802 . . . . 0.0 110.561 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -70.02 -39.96 75.48 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.339 -0.851 . . . . 0.0 111.346 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.434 ' HA ' HG11 ' B' ' 164' ' ' VAL . . . -63.98 -46.26 85.41 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.466 -0.771 . . . . 0.0 111.317 -178.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.423 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 52.2 t80 -62.39 -39.99 95.02 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.481 -0.762 . . . . 0.0 109.617 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 39.4 ttm-85 -59.99 -39.3 85.24 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.821 -0.55 . . . . 0.0 111.247 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.6 t -70.02 -43.89 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.482 -0.761 . . . . 0.0 110.354 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.548 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 16.2 m-85 -68.62 -39.28 80.88 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.345 -0.847 . . . . 0.0 111.119 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -78.64 78.2 5.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.515 -0.74 . . . . 0.0 109.867 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -59.98 -45.39 92.88 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.487 -0.758 . . . . 0.0 110.358 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 33.3 p-10 -79.71 -19.59 48.51 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.641 -0.662 . . . . 0.0 110.869 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.18 62.5 6.28 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -105.74 -10.59 16.66 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.389 -1.065 . . . . 0.0 111.262 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 123.91 -25.62 6.09 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.419 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 27.5 p90 -145.75 152.49 39.65 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.483 -1.01 . . . . 0.0 109.42 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 77.4 mt -88.84 131.39 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.887 0.851 . . . . 0.0 110.197 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.97 171.84 10.02 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.269 0.557 . . . . 0.0 110.588 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.0 -41.57 97.44 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.603 -0.686 . . . . 0.0 109.304 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.96 -37.7 88.51 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -64.82 -40.08 94.62 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.607 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.639 ' HB3' HG13 ' A' ' 121' ' ' VAL . 1.3 tt -60.29 -45.48 93.19 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.336 -0.852 . . . . 0.0 109.264 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.8 ttt-85 -62.54 -30.99 71.7 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.844 -0.535 . . . . 0.0 111.081 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -59.94 -46.12 90.42 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.164 -0.96 . . . . 0.0 110.417 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.548 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 90.2 t -74.96 -33.0 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.411 -0.806 . . . . 0.0 110.926 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.1 mmt -60.09 -49.12 78.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.454 -0.779 . . . . 0.0 110.323 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 76.8 m -68.6 -43.92 75.42 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.66 -0.65 . . . . 0.0 110.414 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -59.89 -29.32 68.26 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.56 -0.712 . . . . 0.0 109.501 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.492 HD11 HG12 ' A' ' 108' ' ' VAL . 27.4 mt -70.01 -29.65 66.78 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.694 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 112.21 18.98 7.38 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -122.03 145.03 48.54 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.248 -1.148 . . . . 0.0 110.35 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -105.53 123.6 48.16 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.539 -0.726 . . . . 0.0 110.666 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 72.2 mt -135.38 157.83 45.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.625 -0.672 . . . . 0.0 110.02 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.22 166.75 16.28 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.631 -0.668 . . . . 0.0 109.226 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -61.72 -26.37 68.01 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.94 -34.54 78.36 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.466 0.651 . . . . 0.0 109.57 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.33 -35.86 82.28 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.639 HG13 ' HB3' ' A' ' 105' ' ' LEU . 53.9 t -68.07 -39.98 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 121.507 0.67 . . . . 0.0 109.884 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.518 ' HA ' HD12 ' A' ' 125' ' ' ILE . 55.2 t0 -59.99 -49.85 76.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.733 -0.604 . . . . 0.0 110.511 -178.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -60.44 -42.04 95.31 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.494 -0.754 . . . . 0.0 110.423 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 86.8 mtp -55.18 -37.83 67.55 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.205 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 122' ' ' ASP . 90.3 mt -63.69 -38.67 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.447 0.641 . . . . 0.0 109.509 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -53.85 -35.77 61.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.665 -0.647 . . . . 0.0 111.613 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -59.83 -40.04 87.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.488 -0.758 . . . . 0.0 111.207 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.81 -5.13 17.46 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.221 -0.924 . . . . 0.0 111.167 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.444 ' HB2' HG22 ' A' ' 125' ' ' ILE . 65.4 t0 -79.78 68.06 5.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.076 -1.015 . . . . 0.0 109.89 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 82.8 mt -68.13 -39.97 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.684 -0.635 . . . . 0.0 110.725 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 37.4 p-10 -70.02 -20.91 63.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.372 -0.83 . . . . 0.0 110.923 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.09 21.43 60.98 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.062 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -82.01 -10.09 59.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -1.133 . . . . 0.0 110.952 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.61 3.46 77.66 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -139.18 147.8 42.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -1.144 . . . . 0.0 109.875 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.6 t -93.17 114.78 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.417 -0.802 . . . . 0.0 110.071 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -82.77 172.0 13.35 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -60.09 -43.85 95.22 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.361 0.601 . . . . 0.0 109.518 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -62.47 -47.61 83.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.678 -0.638 . . . . 0.0 111.013 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -65.35 -33.21 75.42 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.471 -0.768 . . . . 0.0 110.213 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 89.0 t80 -60.05 -47.07 87.38 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.941 -0.474 . . . . 0.0 111.116 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 83.7 t -70.01 -39.14 77.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.257 -0.902 . . . . 0.0 111.193 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -59.97 -49.49 77.47 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.414 -0.804 . . . . 0.0 111.093 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -60.01 -38.09 81.65 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.438 -0.789 . . . . 0.0 110.947 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 97.5 mtp -66.4 -40.0 89.35 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.606 -0.684 . . . . 0.0 110.603 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 66.8 p -98.56 22.13 10.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.417 -0.802 . . . . 0.0 110.387 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.93 -48.22 82.58 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.434 -0.791 . . . . 0.0 110.817 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 90.7 mttt . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.436 -179.58 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -89.38 148.49 20.1 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -59.91 -44.52 94.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.637 -0.919 . . . . 0.0 110.264 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -60.95 -40.01 91.69 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.655 -0.653 . . . . 0.0 111.393 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -62.03 -39.94 94.04 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.372 -0.83 . . . . 0.0 111.521 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 90.6 mt -68.43 -40.05 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.429 -0.794 . . . . 0.0 110.873 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.47 -40.04 92.7 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.325 -0.859 . . . . 0.0 111.05 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -61.61 -41.03 96.87 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.379 -0.826 . . . . 0.0 110.966 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.75 -39.98 90.74 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.496 -0.752 . . . . 0.0 110.595 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . 0.434 HG11 ' HA ' ' A' ' 88' ' ' ALA . 96.8 t -66.26 -40.01 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.604 -0.685 . . . . 0.0 110.022 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -54.46 -42.6 75.9 Favored Glycine 0 N--CA 1.5 2.947 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.69 -18.91 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.656 -0.908 . . . . 0.0 110.371 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.57 HD23 ' C ' ' B' ' 167' ' ' LEU . 9.3 tt -59.95 -49.95 75.65 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.323 -0.86 . . . . 0.0 110.905 -178.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -64.62 -39.96 94.63 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.455 -0.778 . . . . 0.0 109.762 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -62.33 -25.39 67.86 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.75 -0.594 . . . . 0.0 110.055 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 170' ' ' TRP . . . . . 0.414 ' CE3' ' HE3' ' A' ' 71' ' ' MET . 2.6 t-105 -59.88 -43.0 94.98 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.524 -0.735 . . . . 0.0 109.925 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.06 -46.92 87.96 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.543 -0.723 . . . . 0.0 110.538 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -60.05 -38.28 82.33 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.421 -0.799 . . . . 0.0 110.381 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 . . . . . 0 N--CA 1.494 1.737 0 O-C-N 121.593 -0.692 . . . . 0.0 110.283 -179.755 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 121.343 0.592 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.9 mm -57.9 -50.01 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.346 -0.846 . . . . 0.0 110.744 -177.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.16 -22.38 66.92 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.36 -0.838 . . . . 0.0 111.591 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -68.54 -53.62 21.9 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.333 -0.854 . . . . 0.0 109.448 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.427 ' CE1' ' HG2' ' A' ' 72' ' ' MET . 25.6 m-85 -67.9 -21.88 65.11 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.373 0.606 . . . . 0.0 109.44 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -66.99 -41.81 86.11 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.412 0.625 . . . . 0.0 109.951 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.33 -56.98 14.94 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.794 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.68 -33.95 76.11 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.261 -0.899 . . . . 0.0 111.438 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -58.04 -49.99 74.97 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.151 -0.968 . . . . 0.0 110.236 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.2 m -65.51 -38.63 90.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.313 -0.867 . . . . 0.0 108.761 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.4 tp -60.0 -37.63 80.27 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.29 0.567 . . . . 0.0 109.893 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -73.48 -28.64 62.04 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.648 -0.658 . . . . 0.0 110.569 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -96.31 102.03 13.75 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.348 -0.845 . . . . 0.0 109.682 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -67.07 -31.57 72.17 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.435 -0.79 . . . . 0.0 111.446 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -79.85 -9.58 59.68 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.122 -0.986 . . . . 0.0 111.148 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 64.14 24.64 68.97 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -79.77 -9.55 59.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.453 -1.028 . . . . 0.0 110.939 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.417 ' C ' HG23 ' A' ' 26' ' ' THR . . . 80.01 6.94 88.92 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -178.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.417 HG23 ' C ' ' A' ' 25' ' ' GLY . 78.0 p -148.22 142.14 25.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.124 -1.221 . . . . 0.0 109.892 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.4 mt -103.49 123.38 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.748 -0.595 . . . . 0.0 110.096 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 65.5 p -98.82 143.84 28.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.862 -0.524 . . . . 0.0 109.716 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.406 ' H ' HG23 ' A' ' 29' ' ' THR . 70.5 p -40.5 -36.6 0.59 Allowed 'General case' 0 N--CA 1.512 2.646 0 O-C-N 121.806 -0.559 . . . . 0.0 112.195 -177.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -63.51 -45.31 91.27 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.209 -0.932 . . . . 0.0 109.527 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -59.95 -52.82 63.75 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.752 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.412 HD21 ' NE1' ' B' ' 170' ' ' TRP . 64.1 tp -59.19 -37.4 77.32 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.131 -0.98 . . . . 0.0 110.846 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -52.92 -32.28 41.21 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.5 m -70.04 -39.96 75.42 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.603 -0.939 . . . . 0.0 110.483 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.3 t -63.99 -57.19 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.453 -0.779 . . . . 0.0 109.851 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 98.2 mtp -59.21 -28.33 66.56 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.622 -0.674 . . . . 0.0 110.037 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 3.8 tmt_? -59.97 -39.58 86.14 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.4 t -66.16 -17.24 64.6 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.849 -0.532 . . . . 0.0 110.861 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.688 HD22 HD21 ' B' ' 167' ' ' LEU . 33.7 tp -85.61 -28.38 24.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.295 -0.878 . . . . 0.0 109.22 179.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.65 -46.85 0.2 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -160.96 176.36 11.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.772 -0.84 . . . . 0.0 110.253 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -120.01 148.62 47.18 Favored Pre-proline 0 C--N 1.299 -1.602 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.754 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.689 ' HG2' HD21 ' A' ' 48' ' ' LEU . 54.6 Cg_endo -69.48 -147.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.318 0 O-C-N 123.626 1.329 . . . . 0.0 109.627 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 57.8 p -136.42 149.4 48.25 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.905 -1.122 . . . . 0.0 111.431 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -52.62 -24.02 7.62 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.706 -0.621 . . . . 0.0 111.57 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.35 -59.5 2.73 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.092 0.949 . . . . 0.0 108.636 177.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -66.75 -37.74 85.22 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.907 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.689 HD21 ' HG2' ' A' ' 43' ' ' PRO . 39.6 mt -58.55 -35.18 71.93 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.774 0.797 . . . . 0.0 109.507 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.4 -39.27 78.04 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.062 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -66.41 -38.02 86.54 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.481 -0.762 . . . . 0.0 110.675 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 73.2 mmm -60.05 -44.67 94.54 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.633 0.73 . . . . 0.0 109.469 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.879 HG22 ' OD2' ' A' ' 56' ' ' ASP . 96.7 mt -68.83 -34.59 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-O 121.173 0.511 . . . . 0.0 110.413 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -60.7 -40.99 94.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.441 -0.787 . . . . 0.0 110.659 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -70.69 -29.43 65.73 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.329 -0.857 . . . . 0.0 110.813 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.8 t -98.23 -8.15 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.68 -0.637 . . . . 0.0 111.862 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.879 ' OD2' HG22 ' A' ' 52' ' ' ILE . 9.1 m-20 -71.98 107.44 4.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.012 -1.055 . . . . 0.0 111.106 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.52 -41.08 85.0 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.542 -0.723 . . . . 0.0 109.715 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -87.85 -29.94 20.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.631 -0.668 . . . . 0.0 110.309 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.08 21.16 46.96 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.609 -0.997 . . . . 0.0 110.609 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -72.22 -37.8 69.12 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.391 -1.064 . . . . 0.0 110.258 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.77 -6.43 5.5 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 120.197 -1.001 . . . . 0.0 111.114 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 81.1 p -135.36 170.08 16.5 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.078 -1.248 . . . . 0.0 110.588 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.642 HD12 ' HH2' ' B' ' 170' ' ' TRP . 7.0 mt -106.13 123.73 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-O 121.609 0.718 . . . . 0.0 111.204 -177.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -101.68 172.03 7.2 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.701 0.763 . . . . 0.0 111.103 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.498 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -46.8 -49.96 45.76 Favored Pre-proline 0 N--CA 1.499 1.992 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 39.4 Cg_endo -65.73 -36.66 31.41 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 122.889 0.941 . . . . 0.0 111.795 -178.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -70.01 -39.95 75.55 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.24 -0.912 . . . . 0.0 110.455 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -61.55 -40.28 94.15 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.606 -0.683 . . . . 0.0 111.042 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.2 mt -68.87 -40.01 79.51 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.425 -0.797 . . . . 0.0 111.848 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 47.2 p -59.97 -45.68 91.91 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.164 -0.96 . . . . 0.0 111.161 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 56.3 ttp -68.77 -40.0 79.94 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.531 -0.73 . . . . 0.0 111.458 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.605 ' CE ' HG11 ' B' ' 166' ' ' VAL . 48.6 tpp -60.12 -49.61 76.96 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.445 -0.785 . . . . 0.0 111.279 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.49 -31.18 66.82 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.523 -0.736 . . . . 0.0 112.174 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -83.38 -50.73 8.04 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.336 -0.853 . . . . 0.0 111.907 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.403 ' CG ' ' CG ' ' B' ' 169' ' ' GLU . 60.1 tptt -66.4 -40.0 89.36 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.564 -0.71 . . . . 0.0 112.192 -178.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.4 ' HG3' ' N ' ' A' ' 77' ' ' LYS . 28.1 ptm -55.13 -34.12 63.47 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.254 -0.904 . . . . 0.0 111.756 -177.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.4 ' N ' ' HG3' ' A' ' 76' ' ' MET . 33.7 mtpt -67.88 -39.86 83.63 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.352 -0.843 . . . . 0.0 110.151 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -67.03 -20.05 65.79 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.594 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.658 HG23 ' NH2' ' B' ' 168' ' ' ARG . 4.1 m -79.56 -174.75 4.43 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.693 -0.629 . . . . 0.0 109.797 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.596 ' H ' HG22 ' A' ' 79' ' ' THR . 85.4 m-20 -135.82 131.41 35.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.317 -0.865 . . . . 0.0 109.158 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.1 t -60.5 -34.55 74.23 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.444 -0.785 . . . . 0.0 110.071 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.04 -39.53 86.23 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.768 0.794 . . . . 0.0 109.542 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.97 -40.01 75.63 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.417 0.627 . . . . 0.0 111.075 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -66.28 -35.93 81.65 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.611 -0.68 . . . . 0.0 111.425 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.561 HG23 ' HE1' ' A' ' 141' ' ' PHE . 67.0 mt -67.28 -47.32 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.491 -0.756 . . . . 0.0 110.818 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -59.95 -41.92 92.91 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.329 -0.857 . . . . 0.0 112.104 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.642 ' O ' HG23 ' A' ' 91' ' ' VAL . 72.7 mt-10 -73.95 -39.98 63.36 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.438 -0.788 . . . . 0.0 111.952 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.31 -47.15 80.55 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.389 -0.82 . . . . 0.0 111.378 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -60.06 -45.96 91.14 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.606 0.717 . . . . 0.0 109.862 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -60.01 -34.04 72.81 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.979 -0.45 . . . . 0.0 111.047 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 87' ' ' GLU . 98.6 t -70.08 -53.51 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.243 -0.91 . . . . 0.0 110.254 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -63.27 -39.46 94.64 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.398 -0.814 . . . . 0.0 110.539 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -77.17 79.06 3.7 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -60.08 -41.0 91.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.407 -0.808 . . . . 0.0 111.034 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -84.11 -23.02 30.9 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.457 -0.777 . . . . 0.0 111.283 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.8 31.92 76.73 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.45 ' ND2' ' CE2' ' A' ' 99' ' ' TYR . 33.4 p-10 -76.09 -12.03 60.04 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.562 -0.963 . . . . 0.0 112.085 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.37 -20.92 10.2 Favored Glycine 0 N--CA 1.497 2.762 0 C-N-CA 119.919 -1.134 . . . . 0.0 110.45 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.45 ' CE2' ' ND2' ' A' ' 97' ' ' ASN . 27.7 p90 -145.25 150.04 35.97 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.224 -1.162 . . . . 0.0 108.783 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.662 ' CG2' HD23 ' A' ' 105' ' ' LEU . 20.8 mt -89.29 130.32 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.734 0.778 . . . . 0.0 111.396 -178.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.6 m -87.93 172.95 9.21 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.205 0.526 . . . . 0.0 109.999 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.08 -39.96 82.8 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.643 -0.661 . . . . 0.0 109.248 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.7 -40.04 93.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.804 -0.56 . . . . 0.0 109.835 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -61.96 -39.94 93.87 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.616 -0.678 . . . . 0.0 110.012 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.662 HD23 ' CG2' ' A' ' 100' ' ' ILE . 0.6 OUTLIER -63.65 -40.32 96.56 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.74 -0.6 . . . . 0.0 109.597 179.045 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 57.1 mtp85 -61.31 -31.82 71.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.551 -0.718 . . . . 0.0 110.954 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -59.96 -48.6 81.03 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.38 -0.825 . . . . 0.0 111.002 -178.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.662 HG12 ' CD1' ' A' ' 112' ' ' LEU . 85.3 t -69.92 -44.96 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 121.354 -0.841 . . . . 0.0 111.572 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.778 ' SD ' HD12 ' A' ' 116' ' ' LEU . 66.2 mtt -58.61 -46.78 86.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 0.0 111.356 -177.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.0 m -66.09 -47.69 73.38 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.467 -0.771 . . . . 0.0 109.934 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -61.9 -31.5 71.8 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.662 ' CD1' HG12 ' A' ' 108' ' ' VAL . 19.1 mt -69.89 -40.04 75.89 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 120.176 -0.609 . . . . 0.0 110.301 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.22 35.34 1.49 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -133.9 132.29 40.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.557 -0.967 . . . . 0.0 109.86 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -102.82 127.89 49.81 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.52 -0.737 . . . . 0.0 110.787 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.778 HD12 ' SD ' ' A' ' 109' ' ' MET . 42.6 mt -133.9 157.79 45.1 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.568 -0.708 . . . . 0.0 109.116 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.16 162.13 21.37 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.433 -0.792 . . . . 0.0 109.417 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -60.05 -26.91 66.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.413 -0.805 . . . . 0.0 108.852 178.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -69.38 -35.5 75.88 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.591 ' OE2' HD22 ' A' ' 116' ' ' LEU . 15.1 mt-10 -65.23 -39.94 93.4 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.395 0.617 . . . . 0.0 109.622 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.01 -40.0 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.208 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.428 ' HA ' HD12 ' A' ' 125' ' ' ILE . 7.7 t70 -60.02 -44.04 94.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.703 -0.623 . . . . 0.0 110.005 -178.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -60.03 -41.33 92.0 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.53 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 65.6 mtt -56.56 -37.94 71.25 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 119.6 -0.84 . . . . 0.0 108.781 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.482 HG21 ' O ' ' A' ' 134' ' ' GLY . 90.7 mt -65.75 -38.76 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 121.705 0.764 . . . . 0.0 109.093 178.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -57.27 -38.47 73.94 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.252 0.548 . . . . 0.0 110.578 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.0 -38.78 83.63 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.701 -0.624 . . . . 0.0 110.544 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.503 ' HB3' HG22 ' A' ' 136' ' ' VAL . . . -103.8 0.64 30.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.294 -0.879 . . . . 0.0 111.117 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -87.3 70.5 10.04 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.006 -1.059 . . . . 0.0 110.594 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.0 mt -67.06 -40.02 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.424 -0.797 . . . . 0.0 109.998 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -73.29 -20.22 60.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.565 -0.71 . . . . 0.0 111.151 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.49 23.39 60.59 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 120.215 -0.993 . . . . 0.0 110.83 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -82.17 -10.22 59.24 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.24 -1.153 . . . . 0.0 111.044 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.482 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 90.37 1.7 74.64 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.105 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -138.74 149.24 44.83 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.257 -1.143 . . . . 0.0 109.779 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.503 HG22 ' HB3' ' A' ' 128' ' ' ALA . 87.7 t -92.77 118.01 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.545 -0.722 . . . . 0.0 109.969 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -90.03 175.86 7.01 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.515 -0.741 . . . . 0.0 109.927 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -60.04 -49.01 79.33 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.264 0.554 . . . . 0.0 110.483 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -60.05 -46.07 90.76 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.725 -0.61 . . . . 0.0 111.72 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -63.02 -35.02 78.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.232 -0.918 . . . . 0.0 109.739 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.561 ' HE1' HG23 ' A' ' 85' ' ' ILE . 64.6 t80 -60.0 -39.96 87.54 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.258 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.65 ' O ' HG22 ' A' ' 146' ' ' THR . 92.1 t -70.02 -40.47 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.517 -0.74 . . . . 0.0 110.964 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.576 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 76.9 mt-30 -60.25 -41.08 92.44 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.388 -0.82 . . . . 0.0 110.627 -179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 56.2 ttp -59.96 -40.07 87.76 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.836 -0.54 . . . . 0.0 110.089 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.401 ' CE ' ' CZ ' ' A' ' 141' ' ' PHE . 40.9 mtt -70.02 -39.92 75.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.789 -0.57 . . . . 0.0 110.695 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.65 HG22 ' O ' ' A' ' 142' ' ' VAL . 9.4 t -101.38 20.96 14.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.501 -0.749 . . . . 0.0 110.681 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -79.94 129.83 34.8 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.313 -0.867 . . . . 0.0 110.574 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.6 pttm . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.363 -179.988 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.27 -40.03 98.48 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . 0.507 ' O ' HG22 ' B' ' 160' ' ' ILE . 31.4 t80 -60.6 -40.0 90.16 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.547 -0.973 . . . . 0.0 110.453 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -66.23 -39.93 89.91 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.447 -0.783 . . . . 0.0 110.649 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -60.59 -46.03 91.77 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.612 -0.68 . . . . 0.0 110.641 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . 0.74 ' O ' HG23 ' B' ' 164' ' ' VAL . 15.5 tt -70.0 -29.49 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.504 -0.748 . . . . 0.0 111.034 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.17 -44.12 89.52 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.39 -0.819 . . . . 0.0 110.422 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 75.5 mmt-85 -61.44 -40.11 93.25 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.577 -0.702 . . . . 0.0 109.861 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.45 -37.26 86.92 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.67 -0.644 . . . . 0.0 111.076 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . 0.74 HG23 ' O ' ' B' ' 160' ' ' ILE . 67.7 t -60.03 -40.05 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.386 -0.821 . . . . 0.0 110.058 -178.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.94 -34.89 85.14 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.605 HG11 ' CE ' ' A' ' 72' ' ' MET . 23.5 t -74.35 -19.97 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.729 -0.866 . . . . 0.0 110.584 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.688 HD21 HD22 ' A' ' 39' ' ' LEU . 6.2 tt -59.99 -48.77 80.36 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.107 -0.995 . . . . 0.0 110.386 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 168' ' ' ARG . . . . . 0.658 ' NH2' HG23 ' A' ' 79' ' ' THR . 9.6 ptt85 -69.86 -28.62 65.81 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.351 -0.843 . . . . 0.0 109.848 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . 0.403 ' CG ' ' CG ' ' A' ' 75' ' ' LYS . 44.0 tt0 -60.02 -43.84 95.0 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.58 -0.7 . . . . 0.0 110.021 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 170' ' ' TRP . . . . . 0.642 ' HH2' HD12 ' A' ' 63' ' ' ILE . 7.4 t-105 -60.93 -40.0 91.55 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.754 -0.591 . . . . 0.0 110.065 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.9 -46.65 88.66 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.575 -0.703 . . . . 0.0 110.851 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -59.98 -40.01 87.67 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.315 -0.866 . . . . 0.0 110.769 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.519 -0.738 . . . . 0.0 110.131 -179.568 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 . . . . . 0 N--CA 1.499 1.983 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.5 mm -60.15 -53.31 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 120.988 -1.07 . . . . 0.0 109.873 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -61.08 -27.11 68.12 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.659 -0.651 . . . . 0.0 109.975 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -66.32 -39.96 89.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.457 -0.777 . . . . 0.0 110.037 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.548 ' HB3' HD21 ' A' ' 69' ' ' LEU . 50.5 m-85 -69.7 -25.02 63.67 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.626 -0.671 . . . . 0.0 109.426 178.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 16.4 ttmt -69.98 -40.03 75.61 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -60.31 -54.1 49.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.956 -0.465 . . . . 0.0 110.783 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.05 -22.18 63.1 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.334 -0.854 . . . . 0.0 111.975 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -58.44 -47.39 84.14 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.088 -1.008 . . . . 0.0 110.243 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.7 m -62.16 -37.73 86.33 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.479 -0.763 . . . . 0.0 109.393 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.5 tp -65.96 -39.93 90.84 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -69.53 -38.12 77.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.962 -0.462 . . . . 0.0 109.869 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -91.77 97.64 11.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.566 -0.709 . . . . 0.0 109.848 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -59.93 -37.55 79.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.324 -0.86 . . . . 0.0 111.119 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -80.02 -10.92 59.81 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.263 -0.898 . . . . 0.0 111.03 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.29 27.66 58.09 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -87.63 -5.77 58.57 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.707 -0.878 . . . . 0.0 110.777 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.1 4.88 59.77 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 120.268 -0.968 . . . . 0.0 111.383 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.2 p -143.93 141.15 30.08 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 119.168 1.484 . . . . 0.0 111.594 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 86.0 mt -101.06 122.08 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.25 0.548 . . . . 0.0 109.528 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.0 m -98.41 137.98 36.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.724 -0.61 . . . . 0.0 109.781 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.531 ' HB ' HD22 ' A' ' 48' ' ' LEU . 24.7 p -42.65 -28.89 0.26 Allowed 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.707 -0.621 . . . . 0.0 112.179 -178.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.1 tttp -65.97 -50.47 64.22 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.833 0.825 . . . . 0.0 109.691 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -60.2 -56.38 22.32 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.932 -0.48 . . . . 0.0 111.798 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.95 -34.16 74.3 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.29 -0.882 . . . . 0.0 110.49 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.97 -31.56 17.87 Favored Glycine 0 N--CA 1.501 2.982 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.2 m -67.25 -40.13 86.21 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.393 -1.063 . . . . 0.0 109.399 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.5 t -64.38 -39.98 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 121.455 0.645 . . . . 0.0 109.422 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 98.0 mmm -60.06 -38.4 82.72 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.809 -0.557 . . . . 0.0 110.297 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -62.92 -40.05 96.41 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.414 -0.804 . . . . 0.0 110.659 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 t -59.28 -26.86 65.31 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.924 -0.485 . . . . 0.0 110.883 -178.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.498 HD12 ' CG2' ' A' ' 91' ' ' VAL . 36.3 tp -85.56 -24.92 27.04 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.415 -0.803 . . . . 0.0 109.109 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.23 -61.95 0.15 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -162.96 172.04 15.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.587 -0.949 . . . . 0.0 110.931 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -116.41 153.58 48.83 Favored Pre-proline 0 C--N 1.298 -1.664 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.171 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -66.08 -146.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.532 1.28 . . . . 0.0 109.642 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.1 p -125.68 166.79 16.11 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.048 -1.033 . . . . 0.0 110.845 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -59.0 -35.48 73.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.767 -0.583 . . . . 0.0 111.706 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.48 -47.82 45.67 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 122.298 1.047 . . . . 0.0 109.23 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.54 -36.09 80.34 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.302 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.531 HD22 ' HB ' ' A' ' 29' ' ' THR . 12.2 mt -58.2 -35.91 72.33 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.757 0.789 . . . . 0.0 109.587 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -66.82 -39.73 87.8 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.17 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -65.56 -39.94 92.26 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.537 -0.727 . . . . 0.0 110.937 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 90.7 mtp -60.17 -47.13 87.24 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.763 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.865 HG22 ' OD2' ' A' ' 56' ' ' ASP . 46.7 mm -64.92 -35.77 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.806 -0.559 . . . . 0.0 110.311 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -60.26 -44.97 94.82 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.596 -0.69 . . . . 0.0 111.772 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -70.01 -28.39 65.47 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.191 -0.943 . . . . 0.0 111.09 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.44 -8.58 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.587 -0.696 . . . . 0.0 110.599 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.865 ' OD2' HG22 ' A' ' 52' ' ' ILE . 4.3 m-20 -74.35 103.18 4.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.26 -0.9 . . . . 0.0 110.415 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.98 -36.4 75.16 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.617 -0.677 . . . . 0.0 109.693 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -92.35 -26.84 17.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.683 -0.635 . . . . 0.0 110.821 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.57 20.06 52.53 Favored Glycine 0 N--CA 1.496 2.638 0 C-N-CA 120.404 -0.903 . . . . 0.0 110.906 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -74.49 -32.88 62.68 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.37 -1.077 . . . . 0.0 110.254 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.559 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 117.94 1.06 17.12 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.002 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.2 p -137.66 169.84 17.09 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.125 -1.22 . . . . 0.0 110.488 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.3 mt -105.78 120.57 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.505 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -98.17 169.91 9.26 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.528 0.68 . . . . 0.0 110.582 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.434 ' HB3' ' HD3' ' A' ' 66' ' ' PRO . 8.1 t80 -47.86 -48.75 60.86 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.434 ' HD3' ' HB3' ' A' ' 65' ' ' PHE . 45.9 Cg_endo -71.83 -32.68 11.14 Favored 'Trans proline' 0 N--CA 1.487 1.089 0 O-C-N 122.711 0.848 . . . . 0.0 111.376 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -72.13 -39.98 68.41 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.261 -0.9 . . . . 0.0 110.268 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.417 ' CE1' ' HE2' ' A' ' 72' ' ' MET . 40.5 t80 -63.21 -41.64 99.17 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.471 -0.768 . . . . 0.0 111.204 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.548 HD21 ' HB3' ' A' ' 12' ' ' PHE . 96.2 mt -69.59 -39.99 76.95 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.534 -0.729 . . . . 0.0 112.048 -178.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.5 p -60.02 -47.87 84.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.334 -0.854 . . . . 0.0 111.191 -178.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 8.6 tmm? -68.56 -38.89 81.13 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.6 -0.687 . . . . 0.0 111.682 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.417 ' HE2' ' CE1' ' A' ' 68' ' ' PHE . 57.6 tpp -59.99 -50.03 75.35 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.374 -0.828 . . . . 0.0 112.217 -178.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.98 -25.04 63.43 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.183 -0.948 . . . . 0.0 112.082 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.2 -57.81 3.63 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.404 -0.81 . . . . 0.0 112.978 -178.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -69.64 -40.05 76.75 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -177.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 22.0 mtm -53.87 -39.91 66.12 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.057 -1.027 . . . . 0.0 111.946 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.0 tttt -59.99 -49.05 79.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.283 -0.885 . . . . 0.0 110.664 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -63.21 -27.37 69.31 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.817 0.818 . . . . 0.0 109.866 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.628 HG22 ' H ' ' A' ' 80' ' ' ASP 0.255 7.0 m -70.09 -173.42 0.66 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.807 -0.558 . . . . 0.0 109.918 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.628 ' H ' HG22 ' A' ' 79' ' ' THR . 81.3 m-20 -129.24 139.72 51.73 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.153 -0.967 . . . . 0.0 109.547 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.1 t -70.02 -27.46 64.69 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.581 -0.699 . . . . 0.0 111.046 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.03 -36.26 76.89 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.481 -0.762 . . . . 0.0 109.838 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -70.06 -39.93 75.37 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.342 0.592 . . . . 0.0 110.361 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -61.64 -39.57 91.79 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.571 -0.705 . . . . 0.0 111.274 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.686 HG23 ' HE1' ' A' ' 141' ' ' PHE . 89.2 mt -67.12 -44.3 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.52 -0.738 . . . . 0.0 110.803 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -59.81 -40.14 87.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.527 -0.733 . . . . 0.0 111.783 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.687 ' O ' HG23 ' A' ' 91' ' ' VAL . 35.7 mt-10 -76.04 -39.85 54.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.364 -0.835 . . . . 0.0 112.262 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.663 ' HA ' HG11 ' B' ' 164' ' ' VAL . . . -64.52 -46.7 81.79 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.271 -0.893 . . . . 0.0 111.317 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -61.75 -44.14 97.48 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.509 -0.744 . . . . 0.0 109.834 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.04 -36.9 78.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.746 -0.596 . . . . 0.0 110.939 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 87' ' ' GLU . 95.1 t -69.82 -48.51 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.484 -0.76 . . . . 0.0 110.161 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -68.03 -39.6 83.06 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.471 -0.768 . . . . 0.0 111.013 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -80.45 71.98 7.31 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.382 -0.824 . . . . 0.0 110.126 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -60.06 -47.5 85.61 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.374 -0.828 . . . . 0.0 110.335 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -70.63 -24.36 62.71 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.539 -0.726 . . . . 0.0 110.929 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.67 21.97 77.94 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -67.12 -15.7 63.87 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.239 -1.154 . . . . 0.0 111.258 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.58 -13.06 54.16 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 81.5 m-85 -133.15 141.31 48.06 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.163 -1.198 . . . . 0.0 109.224 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.76 ' CG2' HD23 ' A' ' 105' ' ' LEU . 62.7 mt -89.15 121.15 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.111 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 m -84.92 168.87 14.62 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.217 0.532 . . . . 0.0 109.869 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.97 -37.12 75.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.6 -0.688 . . . . 0.0 109.211 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.92 -36.41 83.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.796 -0.565 . . . . 0.0 109.799 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -67.22 -40.12 86.34 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.524 -0.735 . . . . 0.0 110.645 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.76 HD23 ' CG2' ' A' ' 100' ' ' ILE . 0.3 OUTLIER -64.42 -42.4 96.06 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.505 0.669 . . . . 0.0 110.051 179.734 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -62.93 -39.5 94.78 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.788 -0.57 . . . . 0.0 111.535 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -60.41 -48.61 81.0 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.216 -0.928 . . . . 0.0 112.161 -177.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 93.8 t -71.49 -50.37 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.136 -0.977 . . . . 0.0 111.452 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.477 ' HA ' HD12 ' A' ' 112' ' ' LEU . 73.9 mtp -55.42 -40.38 71.4 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.266 -0.896 . . . . 0.0 110.231 -178.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.2 m -66.59 -45.4 79.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.482 -0.761 . . . . 0.0 109.077 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -66.72 -25.04 66.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.814 -0.554 . . . . 0.0 109.85 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 109' ' ' MET . 17.9 mt -69.06 -26.61 65.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.583 -0.698 . . . . 0.0 110.227 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.6 11.73 5.89 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -127.76 131.41 49.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.172 -1.193 . . . . 0.0 109.952 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -105.0 126.01 51.6 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.608 -0.683 . . . . 0.0 110.232 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.0 mt -130.02 160.88 32.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.698 -0.626 . . . . 0.0 110.44 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.32 163.1 23.15 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -60.26 -31.44 70.22 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -67.15 -33.07 74.65 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.389 0.614 . . . . 0.0 109.667 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -67.79 -36.15 79.93 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.41 HG13 ' HB3' ' A' ' 105' ' ' LEU . 69.1 t -70.06 -40.01 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.913 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -60.03 -45.79 91.66 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.665 -0.647 . . . . 0.0 110.071 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -60.0 -41.4 91.99 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.599 -0.688 . . . . 0.0 109.641 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 98.0 mtp -54.46 -37.08 64.78 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.012 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.615 HG23 HG23 ' A' ' 136' ' ' VAL . 93.0 mt -66.58 -37.48 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 50.2 ttt85 -58.13 -40.0 80.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.472 -0.768 . . . . 0.0 111.118 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -60.0 -39.12 84.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.582 -0.699 . . . . 0.0 111.039 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.88 -10.92 19.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.397 -0.815 . . . . 0.0 111.522 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -89.48 74.04 7.76 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.003 -1.06 . . . . 0.0 110.994 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 84.7 mt -66.49 -39.96 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.663 -0.648 . . . . 0.0 109.474 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -59.23 -39.58 83.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.656 -0.653 . . . . 0.0 110.89 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.33 15.17 42.09 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.146 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -81.95 -10.05 59.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.02 -1.282 . . . . 0.0 110.546 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.12 2.54 85.76 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.491 -0.756 . . . . 0.0 111.537 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -130.94 131.32 44.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.24 -1.153 . . . . 0.0 109.611 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.615 HG23 HG23 ' A' ' 125' ' ' ILE . 57.7 t -90.88 111.62 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.452 -0.78 . . . . 0.0 110.037 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -89.03 -168.88 2.32 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 121.742 -0.599 . . . . 0.0 110.276 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -69.65 -40.08 76.7 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.8 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -60.0 -46.36 89.74 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.299 -0.876 . . . . 0.0 111.454 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -65.94 -38.15 87.88 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.817 0.818 . . . . 0.0 110.339 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.686 ' HE1' HG23 ' A' ' 85' ' ' ILE . 58.1 t80 -59.73 -45.67 91.48 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.865 -177.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.443 HG22 HG21 ' A' ' 85' ' ' ILE . 62.5 t -78.1 -40.05 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.232 -0.917 . . . . 0.0 112.577 -178.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -60.0 -51.68 68.63 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.976 -1.077 . . . . 0.0 111.693 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 59.4 ttp -60.53 -36.07 77.53 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.369 -0.832 . . . . 0.0 110.413 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 95.9 mtp -69.96 -40.03 75.64 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.799 -0.563 . . . . 0.0 110.673 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.552 ' O ' HG22 ' A' ' 146' ' ' THR . 39.7 m -97.5 15.82 22.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.486 -0.759 . . . . 0.0 111.086 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.06 -42.3 94.21 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.179 -0.951 . . . . 0.0 110.432 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 86.2 mttt . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.144 179.684 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.31 142.14 13.02 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -60.02 -43.43 95.26 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.49 -1.006 . . . . 0.0 110.236 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -60.03 -39.59 86.41 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.658 -0.651 . . . . 0.0 110.51 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -59.92 -40.07 87.63 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.434 -0.791 . . . . 0.0 110.665 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 95.8 mt -67.74 -39.62 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.408 -0.807 . . . . 0.0 110.121 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.27 91.68 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.552 -0.717 . . . . 0.0 111.634 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . 0.44 ' O ' HG23 ' B' ' 166' ' ' VAL . 51.3 mtm180 -60.09 -40.04 88.23 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.106 -0.997 . . . . 0.0 110.747 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.519 ' C ' HD23 ' B' ' 163' ' ' LEU . 9.6 tt -60.61 -40.11 90.64 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.433 -0.792 . . . . 0.0 109.95 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . 0.663 HG11 ' HA ' ' A' ' 88' ' ' ALA . 89.2 t -62.71 -39.95 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.594 -0.691 . . . . 0.0 109.688 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.99 -36.64 90.91 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.44 HG23 ' O ' ' B' ' 162' ' ' ARG . 94.9 t -60.07 -31.54 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.769 -0.842 . . . . 0.0 110.581 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 84.5 mt -60.03 -41.14 91.6 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.452 -0.78 . . . . 0.0 111.015 -178.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -61.03 -40.02 92.01 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.254 -0.904 . . . . 0.0 109.864 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -62.23 -40.56 96.54 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.658 -0.651 . . . . 0.0 110.86 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -60.08 -41.06 91.65 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.397 -0.814 . . . . 0.0 111.032 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.53 -41.24 76.24 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.414 -0.804 . . . . 0.0 110.855 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -60.01 -39.95 87.56 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.521 -0.737 . . . . 0.0 110.602 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 . . . . . 0 N--CA 1.496 1.87 0 O-C-N 121.392 -0.817 . . . . 0.0 110.301 -179.796 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 121.449 0.642 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.7 mt -59.93 -31.15 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.659 -0.651 . . . . 0.0 111.911 -178.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.95 -39.77 86.72 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.927 -1.108 . . . . 0.0 109.95 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -59.32 -41.46 89.13 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.268 0.556 . . . . 0.0 109.963 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -65.09 -21.51 66.82 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.613 -0.679 . . . . 0.0 111.111 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -70.03 -41.15 74.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.116 -0.99 . . . . 0.0 108.878 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.93 -51.78 68.24 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.013 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.06 -20.47 63.23 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.185 -0.947 . . . . 0.0 112.008 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.503 ' CD1' ' CZ ' ' A' ' 65' ' ' PHE . 60.2 t80 -58.05 -50.04 74.81 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.03 -1.044 . . . . 0.0 111.222 -177.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 97.6 p -66.76 -39.36 87.84 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.605 HD21 ' OE2' ' A' ' 114' ' ' GLU . 40.5 tp -60.08 -40.0 88.04 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.258 0.551 . . . . 0.0 109.816 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -77.44 -31.74 54.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.683 -0.635 . . . . 0.0 110.311 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -92.09 102.11 14.64 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.418 -0.801 . . . . 0.0 109.522 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -60.0 -39.64 86.46 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.609 -0.682 . . . . 0.0 112.308 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -80.08 -11.66 59.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.087 -1.008 . . . . 0.0 111.335 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.18 28.62 50.15 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -88.28 -5.6 58.26 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.637 -0.919 . . . . 0.0 110.788 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.53 1.39 57.77 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.938 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 54.3 p -144.2 141.81 30.13 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 119.116 1.458 . . . . 0.0 111.368 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 84.8 mt -101.08 123.77 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.79 -0.569 . . . . 0.0 109.611 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 34.4 p -99.96 140.0 34.81 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.539 -0.726 . . . . 0.0 110.046 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.57 HG23 HG13 ' A' ' 52' ' ' ILE . 6.6 p -43.19 -29.22 0.36 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.726 -0.609 . . . . 0.0 112.092 -178.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.11 -50.55 65.65 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.429 -0.794 . . . . 0.0 109.511 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -59.61 -53.82 53.59 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 121.253 0.549 . . . . 0.0 110.894 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.608 HD21 ' SD ' ' A' ' 36' ' ' MET . 9.6 tt -60.02 -35.32 74.82 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.449 -0.782 . . . . 0.0 111.451 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.07 -30.82 17.39 Favored Glycine 0 N--CA 1.498 2.822 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.5 m -70.03 -39.98 75.44 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.564 -0.963 . . . . 0.0 110.503 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.27 -54.26 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.457 -0.777 . . . . 0.0 109.456 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.608 ' SD ' HD21 ' A' ' 32' ' ' LEU . 95.8 mtp -59.92 -31.34 69.75 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.614 -0.679 . . . . 0.0 110.012 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -61.55 -40.47 94.81 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.681 0.753 . . . . 0.0 109.102 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.8 p -70.06 -20.22 63.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.787 -0.57 . . . . 0.0 110.405 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.545 HD11 ' CD1' ' B' ' 167' ' ' LEU . 86.1 mt -88.61 -17.0 31.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.484 -0.76 . . . . 0.0 110.41 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.22 -62.87 0.15 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -156.45 169.47 24.56 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.281 -1.129 . . . . 0.0 111.468 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -104.7 129.53 24.78 Favored Pre-proline 0 N--CA 1.49 1.573 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.844 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -67.3 -150.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.228 0 O-C-N 123.132 1.069 . . . . 0.0 109.487 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.5 p -135.62 151.71 50.51 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.159 -0.963 . . . . 0.0 110.598 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -51.44 -24.75 5.31 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.779 -0.575 . . . . 0.0 111.805 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.05 -59.8 2.58 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 122.171 0.986 . . . . 0.0 108.776 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -66.86 -36.97 83.53 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.829 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.523 HD13 ' HB ' ' A' ' 29' ' ' THR . 5.6 mt -58.12 -34.81 70.63 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.434 -0.791 . . . . 0.0 109.173 178.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.27 -40.02 96.22 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 120.484 -0.487 . . . . 0.0 110.43 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -64.58 -40.01 94.77 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.606 -0.684 . . . . 0.0 110.569 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 89.3 mtp -59.95 -44.57 94.33 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.463 0.649 . . . . 0.0 109.718 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.893 HG22 ' OD2' ' A' ' 56' ' ' ASP . 47.7 mm -65.87 -37.8 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.902 -0.499 . . . . 0.0 110.671 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -60.05 -39.95 87.74 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.437 -0.789 . . . . 0.0 111.523 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -68.88 -28.64 66.87 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.203 -0.935 . . . . 0.0 110.486 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.467 HG21 ' SD ' ' A' ' 71' ' ' MET . 78.9 t -99.46 -9.94 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.64 -0.662 . . . . 0.0 111.183 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.893 ' OD2' HG22 ' A' ' 52' ' ' ILE . 20.5 m-20 -70.74 95.56 1.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.143 -0.973 . . . . 0.0 111.265 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.56 -34.08 71.83 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.739 -0.601 . . . . 0.0 109.618 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.2 p-10 -95.43 -23.66 17.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.706 -0.621 . . . . 0.0 110.66 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.61 19.14 55.31 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.135 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.3 p-10 -75.63 -25.34 56.8 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.33 -1.1 . . . . 0.0 110.655 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.776 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 108.44 4.28 32.67 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.227 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 67.2 p -134.0 170.12 16.11 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.165 -1.197 . . . . 0.0 110.89 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.4 mt -101.83 119.99 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.909 -0.494 . . . . 0.0 110.434 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -102.51 168.17 9.47 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.59 0.71 . . . . 0.0 111.147 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.503 ' CZ ' ' CD1' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -43.13 -52.34 12.26 Favored Pre-proline 0 N--CA 1.504 2.269 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.2 Cg_endo -71.34 -30.27 15.79 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.042 1.022 . . . . 0.0 111.944 -178.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.25 -40.51 70.96 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.167 -0.958 . . . . 0.0 110.001 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -63.18 -42.38 99.37 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.655 -0.653 . . . . 0.0 110.968 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.4 mt -65.93 -41.75 90.97 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.523 -0.735 . . . . 0.0 111.152 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 66' ' ' PRO . 39.3 p -63.53 -40.89 98.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.473 -0.767 . . . . 0.0 111.61 -179.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.467 ' SD ' HG21 ' A' ' 55' ' ' VAL . 53.9 ttp -68.1 -40.04 82.7 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.442 -0.786 . . . . 0.0 110.674 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 7.5 mmt -61.86 -43.16 99.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.731 -0.606 . . . . 0.0 111.251 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.94 -30.55 67.96 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.59 -0.693 . . . . 0.0 110.523 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -70.22 -40.04 74.76 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.633 -0.667 . . . . 0.0 110.469 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -67.05 -55.44 14.33 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.532 -0.73 . . . . 0.0 111.898 -178.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.512 ' HA ' HG22 ' A' ' 79' ' ' THR . 78.6 mtm -59.94 -32.53 70.88 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.457 -0.777 . . . . 0.0 110.973 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.9 tttt -66.38 -62.32 1.53 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.681 -0.637 . . . . 0.0 112.15 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -70.73 -10.06 58.62 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.47 -0.769 . . . . 0.0 112.046 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.512 HG22 ' HA ' ' A' ' 76' ' ' MET . 1.5 t -101.07 -160.05 0.77 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.897 0.856 . . . . 0.0 112.035 -178.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.491 ' N ' HG23 ' A' ' 79' ' ' THR . 84.6 m-20 -129.98 139.49 51.06 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.358 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.0 t -63.36 -33.86 76.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.726 -0.609 . . . . 0.0 109.983 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.02 -33.23 71.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.692 -0.63 . . . . 0.0 109.662 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.34 -39.99 77.82 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.519 0.676 . . . . 0.0 109.639 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -63.06 -36.13 82.56 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.787 -0.57 . . . . 0.0 110.29 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.541 HG23 ' HE1' ' A' ' 141' ' ' PHE . 96.7 mt -67.18 -44.38 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.741 -0.599 . . . . 0.0 109.977 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -59.39 -43.58 92.92 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.638 -0.664 . . . . 0.0 111.162 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.561 ' O ' HG23 ' A' ' 91' ' ' VAL . 99.3 mt-10 -70.03 -40.08 75.4 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.588 -0.695 . . . . 0.0 111.729 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.6 -46.96 77.37 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.505 -0.747 . . . . 0.0 111.337 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.403 ' CE1' ' OD2' ' A' ' 93' ' ' ASP . 60.2 t80 -62.9 -42.84 99.92 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.524 -0.735 . . . . 0.0 109.861 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -59.95 -34.84 73.8 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.906 -0.496 . . . . 0.0 110.368 -179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 87' ' ' GLU . 77.7 t -69.9 -50.1 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.502 -0.749 . . . . 0.0 109.774 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -69.94 -41.16 74.94 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.475 -0.765 . . . . 0.0 111.022 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.403 ' OD2' ' CE1' ' A' ' 89' ' ' PHE . 33.2 t0 -81.1 75.18 8.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.404 -0.81 . . . . 0.0 109.946 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -70.02 -40.01 75.48 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.425 -0.797 . . . . 0.0 110.258 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 37.5 p-10 -75.7 -26.43 57.55 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.787 -0.571 . . . . 0.0 110.92 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.85 26.22 69.75 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -69.12 -14.86 63.24 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.365 -1.079 . . . . 0.0 111.476 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.73 -17.95 17.55 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.426 ' CD2' ' HB3' ' A' ' 135' ' ' GLN . 31.5 p90 -148.19 158.94 44.37 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.194 -1.18 . . . . 0.0 109.06 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 40.5 mt -88.9 124.24 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.322 -0.861 . . . . 0.0 110.099 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 m -82.67 172.29 13.09 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.669 0.747 . . . . 0.0 111.305 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.44 ' HB1' ' NH2' ' A' ' 106' ' ' ARG . . . -62.74 -47.37 83.85 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.81 -0.557 . . . . 0.0 110.098 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.45 -36.68 81.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.699 -0.626 . . . . 0.0 109.643 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -61.34 -40.13 93.11 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.601 -0.687 . . . . 0.0 110.39 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.473 HD21 ' SD ' ' A' ' 124' ' ' MET . 0.8 OUTLIER -64.73 -44.3 90.64 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.442 -0.786 . . . . 0.0 109.992 179.565 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.44 ' NH2' ' HB1' ' A' ' 102' ' ' ALA . 88.7 mtt180 -61.2 -37.37 82.75 Favored 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 34.7 t60 -60.0 -48.48 81.55 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.202 -0.936 . . . . 0.0 110.852 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.4 t -70.04 -39.22 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.513 -0.742 . . . . 0.0 111.568 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 12.9 mmt -59.06 -51.01 71.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.298 -0.876 . . . . 0.0 110.762 -178.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.5 m -66.88 -40.74 87.89 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.468 -0.77 . . . . 0.0 109.857 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -61.23 -31.36 71.15 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 112' ' ' LEU . 13.8 mt -69.16 -29.55 67.58 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.194 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.93 27.45 5.13 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.605 ' OE2' HD21 ' A' ' 18' ' ' LEU . 95.9 mt-10 -119.22 139.91 51.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.512 -0.993 . . . . 0.0 110.011 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -101.67 115.21 30.03 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.503 -0.748 . . . . 0.0 109.523 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.443 HD22 ' OE2' ' A' ' 120' ' ' GLU . 50.0 mt -132.83 153.69 51.04 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.459 -0.775 . . . . 0.0 109.949 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.97 164.96 19.02 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -62.1 -26.69 68.44 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.446 -0.784 . . . . 0.0 109.377 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.17 -35.44 76.3 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.639 0.733 . . . . 0.0 109.189 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.443 ' OE2' HD22 ' A' ' 116' ' ' LEU . 7.3 mt-10 -65.03 -37.78 88.73 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.382 0.61 . . . . 0.0 109.474 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.426 HG13 ' HB3' ' A' ' 105' ' ' LEU . 79.6 t -69.86 -39.14 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.564 0.697 . . . . 0.0 109.718 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -60.0 -40.04 87.85 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.777 -0.577 . . . . 0.0 109.832 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -59.96 -40.68 89.87 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.278 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.473 ' SD ' HD21 ' A' ' 105' ' ' LEU . 66.5 mtt -56.15 -37.02 68.95 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.394 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.01 -40.01 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.595 -0.691 . . . . 0.0 110.322 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 40.2 mtm-85 -59.99 -41.56 92.32 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.578 -0.701 . . . . 0.0 112.463 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.99 -39.97 87.56 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.705 -0.622 . . . . 0.0 111.329 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -98.33 -16.55 19.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.29 -0.881 . . . . 0.0 111.084 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -78.48 72.65 5.02 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.13 -0.981 . . . . 0.0 110.12 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 86.3 mt -65.06 -45.72 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.661 -0.649 . . . . 0.0 110.92 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -63.37 -40.06 96.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.358 -0.839 . . . . 0.0 111.175 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.56 20.64 9.94 Favored Glycine 0 N--CA 1.497 2.719 0 C-N-CA 120.058 -1.068 . . . . 0.0 111.198 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -82.16 -9.94 59.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.22 -1.165 . . . . 0.0 110.828 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.14 2.44 80.5 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.426 ' HB3' ' CD2' ' A' ' 99' ' ' TYR . 27.7 mt-30 -135.62 144.9 46.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.382 -1.069 . . . . 0.0 109.079 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.7 t -93.08 118.98 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.403 -0.811 . . . . 0.0 110.296 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -87.58 -179.51 6.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.557 -0.714 . . . . 0.0 109.374 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -69.46 -40.57 77.07 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.943 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -62.78 -44.05 97.2 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.548 -0.72 . . . . 0.0 110.784 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -65.78 -38.64 89.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.461 -0.774 . . . . 0.0 109.932 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.541 ' HE1' HG23 ' A' ' 85' ' ' ILE . 63.6 t80 -60.01 -44.11 94.78 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.083 0.468 . . . . 0.0 110.839 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 76.6 t -68.67 -39.96 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.485 -0.759 . . . . 0.0 110.726 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -60.24 -42.47 95.34 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.437 -0.79 . . . . 0.0 110.586 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.5 mmm -60.74 -40.02 90.83 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.633 -0.667 . . . . 0.0 110.631 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 95.2 mmm -70.07 -39.98 75.31 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.547 -0.721 . . . . 0.0 110.294 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.475 ' O ' HG22 ' A' ' 146' ' ' THR . 22.4 m -96.87 18.96 13.42 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.54 -0.725 . . . . 0.0 110.65 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.58 142.86 53.48 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.313 -0.867 . . . . 0.0 110.609 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.8 mttt . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.252 179.511 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -66.03 138.85 37.5 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -59.96 -42.79 94.86 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.614 -0.933 . . . . 0.0 110.351 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -60.04 -33.81 72.54 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.565 -0.71 . . . . 0.0 110.552 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -60.05 -42.69 95.04 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.746 -0.596 . . . . 0.0 111.013 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.05 -40.02 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.567 -0.708 . . . . 0.0 110.681 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.04 87.97 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.576 -0.703 . . . . 0.0 111.118 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -69.04 -39.99 78.84 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.401 -0.812 . . . . 0.0 110.926 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.496 ' C ' HD23 ' B' ' 163' ' ' LEU . 9.8 tt -61.04 -45.86 93.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.601 -0.687 . . . . 0.0 110.824 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . 0.418 ' HA ' ' HB2' ' B' ' 167' ' ' LEU . 10.2 p -69.96 -29.99 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.388 -0.82 . . . . 0.0 110.699 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.14 -40.94 97.87 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 87.5 t -79.99 -26.05 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.82 -0.812 . . . . 0.0 110.134 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.545 ' CD1' HD11 ' A' ' 39' ' ' LEU . 4.3 tt -54.43 -59.92 4.04 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.478 -0.764 . . . . 0.0 111.814 -178.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -66.78 -35.15 79.4 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.379 -0.826 . . . . 0.0 111.934 -178.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -59.96 -38.72 83.3 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.263 -0.898 . . . . 0.0 109.842 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -60.01 -39.98 87.65 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.81 -0.556 . . . . 0.0 110.283 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.62 -35.81 75.1 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.4 -0.812 . . . . 0.0 110.198 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -59.89 -36.38 76.81 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.501 -0.749 . . . . 0.0 110.052 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 . . . . . 0 N--CA 1.493 1.719 0 O-C-N 121.546 -0.721 . . . . 0.0 110.235 179.947 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 . . . . . 0 N--CA 1.497 1.902 0 CA-C-O 121.417 0.627 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.5 mm -59.97 -49.75 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.444 -0.785 . . . . 0.0 111.075 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.41 -24.15 67.24 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.486 -0.758 . . . . 0.0 111.602 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -66.54 -44.95 81.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.289 -0.882 . . . . 0.0 109.943 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.411 ' CB ' HD11 ' A' ' 69' ' ' LEU . 43.3 m-85 -69.88 -24.13 63.36 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.541 0.686 . . . . 0.0 109.598 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -69.94 -40.07 75.72 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.452 0.644 . . . . 0.0 109.968 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.96 -52.19 66.44 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.737 -0.602 . . . . 0.0 111.735 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.99 -21.57 63.21 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.173 -0.954 . . . . 0.0 111.709 -178.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -59.41 -47.06 86.9 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.206 -0.934 . . . . 0.0 110.513 -178.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -62.07 -37.29 84.44 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.294 -0.879 . . . . 0.0 109.201 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.531 HD21 HD22 ' A' ' 112' ' ' LEU . 50.2 tp -63.1 -39.48 94.83 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -69.97 -39.24 76.11 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.176 0.512 . . . . 0.0 110.027 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -97.86 98.65 10.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.67 -0.644 . . . . 0.0 109.825 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -69.22 -29.2 67.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.463 -0.773 . . . . 0.0 110.547 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -82.07 -10.05 59.34 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.369 -0.832 . . . . 0.0 111.611 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.64 25.07 66.89 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -178.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -78.6 -11.24 59.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.472 -1.016 . . . . 0.0 110.824 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.59 3.95 83.44 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.8 p -145.92 140.72 27.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.028 -1.277 . . . . 0.0 110.283 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.4 mt -101.52 122.73 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.751 -0.593 . . . . 0.0 109.549 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.2 m -97.92 141.16 31.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.75 -0.594 . . . . 0.0 109.992 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.548 ' HB ' HD13 ' A' ' 48' ' ' LEU . 27.7 p -39.07 -34.98 0.19 Allowed 'General case' 0 N--CA 1.51 2.546 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -66.71 -44.89 80.44 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.441 -0.787 . . . . 0.0 109.314 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -61.45 -58.26 8.88 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.946 -0.471 . . . . 0.0 111.339 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.456 HD21 ' CE2' ' B' ' 170' ' ' TRP . 54.6 tp -59.99 -36.04 76.32 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.273 -0.892 . . . . 0.0 111.061 -178.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.01 -29.99 15.48 Favored Glycine 0 N--CA 1.5 2.908 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.4 m -69.95 -39.98 75.74 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.634 -0.921 . . . . 0.0 110.453 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.1 t -63.54 -51.19 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 CA-C-O 121.621 0.724 . . . . 0.0 109.112 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 87.3 mtp -60.05 -33.04 71.49 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.277 0.56 . . . . 0.0 109.835 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -60.92 -42.46 98.17 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.411 0.624 . . . . 0.0 109.896 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.0 t -70.03 -16.38 63.15 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.637 -0.665 . . . . 0.0 110.415 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.4 tp -84.66 -24.42 29.02 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.355 -0.841 . . . . 0.0 109.383 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.42 -51.42 0.18 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.781 -1.727 . . . . 0.0 108.781 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -163.1 172.96 14.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.633 -0.922 . . . . 0.0 110.612 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -120.33 143.98 37.09 Favored Pre-proline 0 C--N 1.299 -1.62 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.057 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.69 -150.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 123.394 1.208 . . . . 0.0 109.881 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.89 161.54 36.35 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.082 -1.011 . . . . 0.0 110.098 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -52.23 -27.36 14.5 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.699 -0.626 . . . . 0.0 111.524 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.94 -58.31 3.55 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 122.078 0.942 . . . . 0.0 109.171 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.73 -39.62 91.32 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.086 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.548 HD13 ' HB ' ' A' ' 29' ' ' THR . 13.1 mt -56.56 -33.75 66.45 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.48 -0.762 . . . . 0.0 110.111 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.9 -36.65 82.77 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.386 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -68.33 -41.89 80.14 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.573 -0.705 . . . . 0.0 111.233 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 64.4 mtt -61.92 -43.28 99.16 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.534 -0.729 . . . . 0.0 109.724 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.889 HG22 ' OD2' ' A' ' 56' ' ' ASP . 43.2 mm -66.74 -35.58 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.842 -0.536 . . . . 0.0 110.241 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -61.53 -40.96 96.51 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.616 -0.677 . . . . 0.0 111.918 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -69.97 -29.6 66.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.184 -0.948 . . . . 0.0 111.002 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.54 HG21 ' SD ' ' A' ' 71' ' ' MET . 84.7 t -100.03 -8.8 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.51 -0.744 . . . . 0.0 111.397 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.889 ' OD2' HG22 ' A' ' 52' ' ' ILE . 4.2 m-20 -69.48 100.29 1.38 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.09 -1.007 . . . . 0.0 111.241 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.13 -33.89 72.4 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.661 -0.649 . . . . 0.0 109.933 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -98.36 -21.97 16.33 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.609 -0.682 . . . . 0.0 110.879 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.34 19.7 61.88 Favored Glycine 0 N--CA 1.495 2.632 0 C-N-CA 120.402 -0.904 . . . . 0.0 110.956 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -74.48 -37.54 63.16 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.372 -1.075 . . . . 0.0 110.173 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.6 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 126.33 2.52 6.97 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.306 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 62.8 p -138.5 170.18 16.47 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.033 -1.275 . . . . 0.0 111.355 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.9 mt -102.37 120.93 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.168 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -100.75 170.03 8.61 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.458 0.647 . . . . 0.0 110.251 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.478 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 5.6 t80 -48.22 -48.88 64.06 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.561 -0.712 . . . . 0.0 112.651 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.9 Cg_endo -68.45 -35.86 16.87 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 O-C-N 122.75 0.868 . . . . 0.0 111.916 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.98 -40.03 75.6 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.092 -1.005 . . . . 0.0 110.467 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.429 ' HD2' HD22 ' A' ' 69' ' ' LEU . 64.7 t80 -61.46 -42.02 98.12 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.643 -0.661 . . . . 0.0 110.549 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.453 HD23 ' O ' ' A' ' 65' ' ' PHE . 3.8 mm? -64.51 -41.95 96.1 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.394 -0.816 . . . . 0.0 111.695 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 66' ' ' PRO . 72.0 p -62.36 -40.48 96.54 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.288 -0.882 . . . . 0.0 111.493 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.54 ' SD ' HG21 ' A' ' 55' ' ' VAL . 59.3 ttp -69.74 -40.38 76.2 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.481 -0.762 . . . . 0.0 111.439 -178.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.6 ' SD ' HG11 ' B' ' 166' ' ' VAL . 88.8 mmm -60.77 -49.08 78.93 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.483 -0.761 . . . . 0.0 110.95 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.24 -31.99 73.43 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.785 -0.572 . . . . 0.0 111.291 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -70.04 -39.76 75.55 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.545 -0.722 . . . . 0.0 111.649 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.753 ' O ' HG22 ' A' ' 79' ' ' THR . 91.6 mttt -69.12 -31.59 70.38 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.274 -0.891 . . . . 0.0 112.569 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 63.2 mtt -59.54 -48.2 82.59 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.173 -0.955 . . . . 0.0 112.395 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -69.06 -38.38 79.05 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.238 -0.914 . . . . 0.0 112.032 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -69.99 -20.06 63.31 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.33 -0.856 . . . . 0.0 111.197 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.753 HG22 ' O ' ' A' ' 75' ' ' LYS . 15.2 t -112.22 -164.45 0.92 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.957 0.884 . . . . 0.0 111.709 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -130.27 147.0 51.94 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.899 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.6 p -67.09 -26.93 66.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.591 -0.693 . . . . 0.0 110.601 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.31 -35.39 77.23 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.566 0.698 . . . . 0.0 109.505 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.97 -39.99 83.22 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.563 0.697 . . . . 0.0 109.87 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -62.32 -38.66 90.31 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.793 -0.567 . . . . 0.0 111.456 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.687 HG23 ' HE2' ' A' ' 141' ' ' PHE . 67.7 mt -68.11 -45.3 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.405 -0.809 . . . . 0.0 110.672 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 64.1 mtp180 -58.09 -41.49 83.61 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.231 -0.918 . . . . 0.0 110.811 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.655 ' O ' HG23 ' A' ' 91' ' ' VAL . 98.5 mt-10 -70.03 -39.98 75.44 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.663 -0.648 . . . . 0.0 111.484 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.38 -47.98 77.19 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.469 -0.769 . . . . 0.0 111.536 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -60.27 -42.15 94.81 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.408 -0.808 . . . . 0.0 109.992 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -60.07 -37.61 80.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.905 -0.497 . . . . 0.0 110.62 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 87' ' ' GLU . 58.5 t -69.9 -55.59 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.317 -0.864 . . . . 0.0 110.521 -179.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.67 ' HE2' HG21 ' B' ' 164' ' ' VAL . 44.4 m-85 -60.6 -39.98 90.11 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.312 -0.868 . . . . 0.0 110.978 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -80.51 78.04 7.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.587 -0.696 . . . . 0.0 110.315 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -67.0 -41.43 86.75 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.385 -0.822 . . . . 0.0 109.904 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.6 p-10 -76.15 -21.32 56.71 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.626 -0.671 . . . . 0.0 111.212 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.22 24.45 74.77 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -70.02 -10.94 60.35 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.412 -1.052 . . . . 0.0 111.368 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.19 -15.62 58.93 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.418 ' CZ ' ' ND2' ' A' ' 137' ' ' ASN . 73.3 m-85 -133.55 141.02 47.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.246 -1.15 . . . . 0.0 109.331 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 77.8 mt -89.06 122.15 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.395 -0.816 . . . . 0.0 109.72 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.4 m -83.49 170.01 14.88 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.334 0.588 . . . . 0.0 110.819 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.05 -39.99 94.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.8 -0.562 . . . . 0.0 109.807 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.7 -31.55 72.76 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.57 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -69.92 -40.01 75.82 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.767 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.593 ' HB3' HG13 ' A' ' 121' ' ' VAL . 0.9 OUTLIER -61.58 -47.02 87.4 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.289 -0.882 . . . . 0.0 109.328 179.233 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -64.14 -30.36 71.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.929 -0.482 . . . . 0.0 111.102 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -61.96 -49.02 77.79 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.375 -0.828 . . . . 0.0 111.806 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.604 HG12 ' CD1' ' A' ' 112' ' ' LEU . 72.6 t -70.03 -47.18 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.328 -0.858 . . . . 0.0 111.299 -178.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.479 ' HA ' HD12 ' A' ' 112' ' ' LEU . 98.9 mtp -59.61 -39.99 86.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.318 -0.864 . . . . 0.0 110.489 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.2 m -64.5 -46.2 84.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.453 -0.779 . . . . 0.0 109.107 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -62.46 -32.73 73.66 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.604 ' CD1' HG12 ' A' ' 108' ' ' VAL . 39.7 mt -69.97 -33.69 72.42 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.341 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.43 34.49 1.43 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -125.08 136.69 53.91 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.524 -0.986 . . . . 0.0 110.078 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -101.91 130.54 48.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.509 -0.744 . . . . 0.0 109.639 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.632 HD12 HG23 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -148.3 152.22 36.73 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.673 -0.642 . . . . 0.0 110.848 -179.289 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.1 p -80.94 162.02 24.07 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -61.42 -27.78 68.79 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -67.8 -34.94 77.76 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.822 0.82 . . . . 0.0 109.193 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -62.52 -40.09 95.63 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.632 HG23 HD12 ' A' ' 116' ' ' LEU . 75.5 t -66.22 -40.06 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.097 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -60.02 -45.95 91.11 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.648 -0.658 . . . . 0.0 110.558 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -59.97 -40.61 89.69 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.904 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 86.2 mmm -54.63 -38.14 66.47 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.029 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.23 -38.69 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.692 -0.63 . . . . 0.0 110.15 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -58.36 -39.99 81.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.552 -0.718 . . . . 0.0 111.959 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.11 -40.06 88.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.469 -0.77 . . . . 0.0 112.172 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -108.44 -5.62 16.55 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.189 -0.944 . . . . 0.0 112.317 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -90.29 73.06 7.11 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.889 -1.132 . . . . 0.0 111.06 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 86.5 mt -68.28 -40.05 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.49 -0.756 . . . . 0.0 110.116 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 36.5 p-10 -60.0 -39.94 87.5 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.528 -0.732 . . . . 0.0 111.043 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.418 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 92.38 24.92 22.84 Favored Glycine 0 N--CA 1.493 2.437 0 O-C-N 121.25 -0.907 . . . . 0.0 111.057 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -82.45 -8.02 59.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -1.178 . . . . 0.0 110.544 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 97.16 -1.5 60.81 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -140.84 159.65 41.76 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.16 -1.2 . . . . 0.0 109.722 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 94.3 t -87.89 118.24 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.394 -0.816 . . . . 0.0 109.078 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.418 ' ND2' ' CZ ' ' A' ' 99' ' ' TYR . 8.6 t-20 -87.36 170.03 11.75 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.997 0.903 . . . . 0.0 110.994 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -63.57 -50.01 71.16 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.278 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -62.35 -41.1 98.32 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.38 -0.825 . . . . 0.0 110.539 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.25 -37.27 85.1 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.13 0.967 . . . . 0.0 109.268 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.687 ' HE2' HG23 ' A' ' 85' ' ' ILE . 77.4 t80 -59.94 -41.9 92.86 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.008 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.434 HG22 HG21 ' A' ' 85' ' ' ILE . 70.8 t -74.2 -42.16 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.284 -0.885 . . . . 0.0 111.956 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -59.98 -50.37 74.01 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.41 -0.806 . . . . 0.0 112.157 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 55.1 ttp -61.37 -35.72 78.25 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.366 -0.834 . . . . 0.0 110.871 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 89.2 mtp -69.96 -39.91 75.72 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.792 -0.567 . . . . 0.0 110.244 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.428 ' O ' HG22 ' A' ' 146' ' ' THR . 13.3 m -98.97 22.45 10.24 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.579 -0.7 . . . . 0.0 110.459 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.38 -40.55 85.71 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.366 -0.834 . . . . 0.0 111.399 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 29.9 mttt . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.525 -179.102 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 70.07 32.16 69.41 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -60.04 -41.89 93.25 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.55 -0.97 . . . . 0.0 110.111 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -60.77 -40.13 91.37 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.664 -0.647 . . . . 0.0 110.984 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 43.1 mtm-85 -65.73 -39.99 91.73 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.355 -0.841 . . . . 0.0 111.158 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 93.5 mt -65.25 -40.03 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.394 -0.816 . . . . 0.0 110.231 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.55 -40.74 97.78 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.562 -0.711 . . . . 0.0 110.127 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 -62.21 -40.48 96.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.728 -0.607 . . . . 0.0 110.557 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 85.8 mt -64.86 -40.07 94.57 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.495 -0.753 . . . . 0.0 110.562 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . 0.67 HG21 ' HE2' ' A' ' 92' ' ' PHE . 94.2 t -63.78 -40.11 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.552 -0.718 . . . . 0.0 110.023 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.03 -31.39 61.54 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.6 HG11 ' SD ' ' A' ' 72' ' ' MET . 67.2 t -79.94 -28.95 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.722 -0.87 . . . . 0.0 111.363 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.522 HD12 ' HA ' ' B' ' 164' ' ' VAL . 79.0 mt -60.09 -49.95 75.63 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.195 -0.941 . . . . 0.0 111.707 -177.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 168' ' ' ARG . . . . . 0.429 ' HD3' ' CG ' ' A' ' 87' ' ' GLU . 38.0 ttt-85 -66.4 -40.06 89.41 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.127 -0.983 . . . . 0.0 110.445 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -60.04 -29.88 68.81 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.571 -0.706 . . . . 0.0 110.627 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 170' ' ' TRP . . . . . 0.479 ' CZ3' ' HE1' ' A' ' 71' ' ' MET . 4.5 t-105 -60.17 -39.47 86.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.489 -0.757 . . . . 0.0 110.176 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.23 -39.97 76.59 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.491 -0.755 . . . . 0.0 111.046 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -60.03 -39.97 87.69 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.345 -0.847 . . . . 0.0 110.372 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 . . . . . 0 N--CA 1.494 1.741 0 O-C-N 121.496 -0.752 . . . . 0.0 109.986 179.905 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 . . . . . 0 N--CA 1.499 2.009 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.7 mm -61.42 -50.87 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.308 -0.87 . . . . 0.0 110.374 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.43 -35.86 78.73 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.771 -0.581 . . . . 0.0 110.941 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.94 -45.46 92.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.61 -0.681 . . . . 0.0 110.362 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.478 ' CE1' ' HG2' ' A' ' 72' ' ' MET . 24.7 m-85 -64.68 -22.84 67.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.619 -0.676 . . . . 0.0 111.234 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -68.63 -41.62 79.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.272 -0.892 . . . . 0.0 108.721 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -59.99 -52.54 64.95 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.618 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.25 -23.43 64.78 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.318 -0.864 . . . . 0.0 111.657 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -56.1 -47.67 77.63 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.978 -1.076 . . . . 0.0 109.991 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.3 m -60.75 -39.29 88.16 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.503 -0.748 . . . . 0.0 109.403 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 64.2 tp -63.8 -39.95 95.48 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.92 -39.57 76.08 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.454 ' HB2' HD11 ' A' ' 27' ' ' ILE . 25.3 t0 -95.19 97.3 9.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.631 -0.668 . . . . 0.0 110.036 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.8 mttt -64.37 -32.01 73.45 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.367 -0.833 . . . . 0.0 111.598 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -80.57 -10.02 59.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.209 -0.932 . . . . 0.0 111.506 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.23 25.08 46.81 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -87.23 -9.66 54.51 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.586 -0.949 . . . . 0.0 110.666 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.64 2.81 53.04 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.868 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.5 p -144.61 141.95 29.78 Favored 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 119.534 1.667 . . . . 0.0 112.1 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.454 HD11 ' HB2' ' A' ' 20' ' ' ASP . 49.3 mm -99.93 121.04 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.5 p -100.91 142.08 32.88 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.576 -0.703 . . . . 0.0 111.019 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.424 ' CG2' ' HB3' ' A' ' 48' ' ' LEU . 82.1 p -41.76 -33.14 0.46 Allowed 'General case' 0 N--CA 1.509 2.518 0 O-C-N 121.856 -0.528 . . . . 0.0 111.892 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -64.71 -51.06 64.43 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.797 0.808 . . . . 0.0 109.525 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -59.95 -54.75 42.41 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.577 -178.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.448 HD21 ' CE2' ' B' ' 170' ' ' TRP . 58.8 tp -60.04 -35.32 74.85 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.203 -0.936 . . . . 0.0 110.696 -178.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.05 -30.45 16.56 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -178.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.8 m -70.03 -39.97 75.44 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.569 -0.959 . . . . 0.0 110.363 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 79.0 t -64.89 -51.07 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.628 -0.67 . . . . 0.0 109.746 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.403 ' HE2' ' HD3' ' A' ' 43' ' ' PRO . 98.1 mtp -59.97 -33.03 71.39 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.741 -0.6 . . . . 0.0 109.521 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -61.57 -41.87 98.02 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.696 0.76 . . . . 0.0 109.084 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.9 t -72.02 -19.47 61.85 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.962 -0.461 . . . . 0.0 110.81 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.7 -16.99 29.18 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.272 -0.893 . . . . 0.0 110.504 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.16 -55.62 0.18 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -159.97 169.92 22.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.411 -1.053 . . . . 0.0 110.804 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -107.82 125.88 31.12 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.892 -0.505 . . . . 0.0 110.151 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.427 ' HG2' HD21 ' A' ' 48' ' ' LEU . 52.9 Cg_endo -69.07 -148.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.07 0 N-CA-C 108.649 -1.327 . . . . 0.0 108.649 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 50.2 p -137.45 150.36 47.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.929 -1.107 . . . . 0.0 110.837 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -53.15 -23.65 8.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.636 -0.665 . . . . 0.0 111.467 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.49 -60.05 2.42 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.89 0.852 . . . . 0.0 109.128 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -67.71 -37.67 82.57 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.054 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.427 HD21 ' HG2' ' A' ' 43' ' ' PRO . 15.6 mt -57.1 -33.23 67.1 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.495 -0.753 . . . . 0.0 110.02 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -35.52 80.45 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.956 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -65.68 -39.96 91.85 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.45 -0.781 . . . . 0.0 110.832 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 67.2 mtt -60.02 -45.45 92.74 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.433 0.635 . . . . 0.0 109.93 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.795 HG22 ' OD2' ' A' ' 56' ' ' ASP . 96.8 mt -67.95 -33.07 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.824 -0.547 . . . . 0.0 110.729 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -60.06 -40.05 88.12 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.327 -0.858 . . . . 0.0 110.115 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -67.11 -26.47 66.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.377 -0.827 . . . . 0.0 109.959 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.535 HG21 ' SD ' ' A' ' 71' ' ' MET . 74.3 t -99.81 -9.99 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.598 -0.689 . . . . 0.0 110.864 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.795 ' OD2' HG22 ' A' ' 52' ' ' ILE . 25.6 m-20 -72.27 99.71 2.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.118 -0.989 . . . . 0.0 111.126 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.54 -40.06 92.46 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.388 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -88.32 -28.34 21.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.714 -0.616 . . . . 0.0 110.563 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.02 22.95 43.16 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -74.22 -33.79 63.49 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.499 -1.001 . . . . 0.0 110.617 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.97 -0.43 10.81 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.294 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.0 p -132.67 170.08 15.74 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.017 -1.284 . . . . 0.0 110.391 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.773 HD11 HG12 ' A' ' 52' ' ' ILE . 12.6 mt -106.67 120.4 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.87 -0.519 . . . . 0.0 110.869 -177.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -100.68 169.44 9.03 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.572 0.701 . . . . 0.0 110.906 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.47 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -45.05 -52.73 18.68 Favored Pre-proline 0 N--CA 1.502 2.168 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.069 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.2 Cg_endo -67.39 -30.93 35.81 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 O-C-N 122.943 0.97 . . . . 0.0 111.514 -178.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -72.1 -40.91 67.85 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.448 -0.782 . . . . 0.0 110.425 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -66.08 -40.16 90.61 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.683 -0.636 . . . . 0.0 111.177 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.7 mt -66.23 -39.93 89.9 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.373 -0.83 . . . . 0.0 111.569 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 21.6 p -64.19 -41.39 97.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.555 -0.716 . . . . 0.0 111.333 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.535 ' SD ' HG21 ' A' ' 55' ' ' VAL . 58.9 ttp -68.07 -40.2 82.77 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.438 -0.788 . . . . 0.0 110.894 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.478 ' HG2' ' CE1' ' A' ' 12' ' ' PHE . 53.6 tpp -59.99 -45.11 93.79 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.493 -0.755 . . . . 0.0 110.462 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.8 -30.8 70.32 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.506 -0.746 . . . . 0.0 109.725 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.4 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 0.2 OUTLIER -70.02 -39.67 75.65 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.706 -0.621 . . . . 0.0 111.059 179.824 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -65.79 -36.57 83.88 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.412 -0.805 . . . . 0.0 112.203 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 60.7 mtt -59.73 -50.09 75.18 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.214 -0.929 . . . . 0.0 111.684 -177.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 10.9 pttt -70.05 -38.96 75.96 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.308 -0.87 . . . . 0.0 110.835 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -68.66 -40.02 80.38 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.448 -0.782 . . . . 0.0 109.978 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.571 HG22 ' H ' ' A' ' 80' ' ' ASP . 1.4 m -100.43 -172.59 2.23 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.985 -0.447 . . . . 0.0 110.196 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.571 ' H ' HG22 ' A' ' 79' ' ' THR . 69.9 m-20 -129.53 147.22 51.31 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.42 -0.8 . . . . 0.0 109.904 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.4 t -59.95 -27.81 67.12 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.546 -0.721 . . . . 0.0 110.401 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.01 -36.72 77.85 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.368 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.98 -39.94 75.64 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.378 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.08 -37.47 75.45 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.694 -0.629 . . . . 0.0 110.558 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.474 HG23 ' SD ' ' A' ' 145' ' ' MET . 67.7 mt -65.57 -53.83 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.635 -0.666 . . . . 0.0 111.028 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.423 ' HG3' ' N ' ' A' ' 87' ' ' GLU . 33.6 ptt180 -60.03 -39.97 87.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.383 -0.823 . . . . 0.0 111.392 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.423 ' N ' ' HG3' ' A' ' 86' ' ' ARG . 95.3 mt-10 -68.58 -40.76 80.38 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.506 -0.746 . . . . 0.0 110.742 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.429 ' HA ' HG12 ' B' ' 164' ' ' VAL . . . -65.19 -44.24 89.03 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.956 -0.465 . . . . 0.0 110.898 -178.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -61.15 -41.28 96.47 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.879 0.847 . . . . 0.0 108.814 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -59.98 -38.14 81.69 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.821 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.3 -43.2 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.506 -0.746 . . . . 0.0 110.027 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.643 ' HE2' HG21 ' B' ' 164' ' ' VAL . 13.4 m-85 -69.37 -39.1 78.25 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.497 -0.752 . . . . 0.0 111.451 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -79.55 77.23 6.15 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.32 -0.862 . . . . 0.0 110.508 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -59.98 -42.34 93.98 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.395 -0.816 . . . . 0.0 110.216 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 24.1 p-10 -81.92 -19.94 39.74 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.496 -0.752 . . . . 0.0 111.258 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.79 63.83 4.92 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -109.91 -10.77 14.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.457 -1.025 . . . . 0.0 111.52 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.25 -23.31 8.14 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 31.0 p90 -149.08 152.91 37.01 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.327 -1.102 . . . . 0.0 109.549 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 56.0 mt -89.34 125.2 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.742 0.782 . . . . 0.0 109.96 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 m -80.99 171.29 15.18 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.141 0.496 . . . . 0.0 110.31 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.04 -40.59 96.63 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.622 -0.674 . . . . 0.0 109.498 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.03 -38.48 91.24 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.496 0.665 . . . . 0.0 109.314 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -62.43 -39.43 93.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.741 -0.6 . . . . 0.0 111.285 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.627 HD21 ' HE1' ' A' ' 124' ' ' MET . 1.4 tt -62.53 -43.74 98.06 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.133 -0.979 . . . . 0.0 109.468 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.449 ' HG2' HG21 ' A' ' 121' ' ' VAL . 88.1 mtt180 -60.05 -33.34 71.91 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.686 -0.634 . . . . 0.0 110.901 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -60.37 -45.37 93.76 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.159 -0.963 . . . . 0.0 111.614 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.535 HG11 ' CE1' ' A' ' 92' ' ' PHE . 95.9 t -72.92 -39.86 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.299 -0.876 . . . . 0.0 111.256 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 26.8 mmt -59.86 -48.65 80.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.46 -0.775 . . . . 0.0 110.293 -178.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.1 m -67.26 -41.71 85.09 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.496 -0.752 . . . . 0.0 109.848 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -61.13 -31.46 71.17 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.3 mt -69.03 -32.79 72.55 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.713 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.61 29.14 4.83 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -121.43 130.03 53.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.581 -0.952 . . . . 0.0 109.734 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -92.43 117.64 30.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.532 -0.73 . . . . 0.0 110.132 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.527 HD13 ' OE1' ' A' ' 120' ' ' GLU . 60.8 mt -132.71 157.24 45.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.617 -0.677 . . . . 0.0 109.812 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 p -83.74 162.99 20.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.587 -0.696 . . . . 0.0 109.663 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.9 p-10 -60.06 -25.16 65.16 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -66.61 -34.63 78.32 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.527 ' OE1' HD13 ' A' ' 116' ' ' LEU . 0.5 OUTLIER -62.42 -38.98 91.78 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.541 0.686 . . . . 0.0 109.233 179.15 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.543 HG13 HD13 ' A' ' 105' ' ' LEU . 74.9 t -68.88 -39.05 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.359 0.6 . . . . 0.0 110.124 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.493 ' HA ' HD12 ' A' ' 125' ' ' ILE . 45.2 t0 -59.28 -49.93 75.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.768 -0.582 . . . . 0.0 110.341 -178.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -60.27 -41.45 93.29 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.399 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.627 ' HE1' HD21 ' A' ' 105' ' ' LEU . 97.6 mtp -54.81 -39.7 68.75 Favored 'General case' 0 N--CA 1.504 2.24 0 C-N-CA 119.389 -0.924 . . . . 0.0 108.838 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.493 HD12 ' HA ' ' A' ' 122' ' ' ASP . 89.4 mt -63.75 -40.0 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.162 0.506 . . . . 0.0 109.963 178.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -60.0 -39.97 87.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.483 -0.76 . . . . 0.0 112.182 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -60.06 -39.94 87.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.116 -0.99 . . . . 0.0 111.773 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -99.05 -17.48 18.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.205 -0.934 . . . . 0.0 110.987 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.4 77.86 5.76 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.178 -0.951 . . . . 0.0 110.816 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 82.9 mt -64.14 -39.98 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.66 -0.65 . . . . 0.0 111.079 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -59.51 -38.53 81.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.403 -0.81 . . . . 0.0 111.12 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 98.59 11.93 45.98 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 120.115 -1.04 . . . . 0.0 111.417 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -81.31 -13.66 58.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.023 -1.281 . . . . 0.0 110.56 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.95 5.55 70.69 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.793 178.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -127.68 126.48 42.01 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.032 -1.275 . . . . 0.0 109.924 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.7 t -89.96 113.99 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.252 -0.905 . . . . 0.0 109.71 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -89.97 -179.38 5.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.507 -0.746 . . . . 0.0 109.884 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -62.24 -41.8 98.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.718 -0.614 . . . . 0.0 110.422 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -62.56 -44.85 95.32 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.199 -0.938 . . . . 0.0 111.463 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -63.44 -38.96 93.15 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.978 0.894 . . . . 0.0 109.454 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -59.87 -41.88 92.48 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.578 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.2 t -68.06 -40.11 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.493 -0.754 . . . . 0.0 110.945 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -60.78 -40.39 92.41 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.373 -0.829 . . . . 0.0 110.056 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 53.9 ttp -60.05 -41.2 91.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.779 -0.576 . . . . 0.0 110.752 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.474 ' SD ' HG23 ' A' ' 85' ' ' ILE . 44.3 mtt -82.06 -39.18 23.82 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.535 -0.728 . . . . 0.0 110.999 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 85.4 m -59.98 -26.81 66.33 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.695 -0.628 . . . . 0.0 110.459 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -80.78 119.12 22.95 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.434 -0.791 . . . . 0.0 110.601 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.7 mttm . . . . . 0 N--CA 1.5 2.026 0 CA-C-O 118.407 -0.806 . . . . 0.0 111.47 179.798 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 72.86 39.17 55.54 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -59.97 -47.47 85.66 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.451 -1.029 . . . . 0.0 109.464 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -60.73 -39.06 87.26 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.855 -0.528 . . . . 0.0 110.351 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -60.0 -40.0 87.72 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.522 -0.736 . . . . 0.0 109.853 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 86.7 mt -68.34 -39.99 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.681 -0.637 . . . . 0.0 110.369 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.04 -38.89 84.07 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.46 -0.775 . . . . 0.0 110.65 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 32.7 ttm-85 -60.04 -40.95 91.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.433 -0.792 . . . . 0.0 109.962 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 39.2 tp -64.24 -39.9 94.92 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.772 -0.58 . . . . 0.0 110.077 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . 0.643 HG21 ' HE2' ' A' ' 92' ' ' PHE . 80.2 t -62.47 -39.94 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.517 -0.74 . . . . 0.0 110.347 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.52 -36.9 87.03 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 73.3 t -68.21 -39.19 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.913 -0.757 . . . . 0.0 110.457 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.577 HD12 ' HA ' ' B' ' 164' ' ' VAL . 84.5 mt -59.97 -46.41 89.52 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.522 -0.736 . . . . 0.0 111.635 -178.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -59.98 -40.0 87.64 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.27 -0.894 . . . . 0.0 110.269 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -60.09 -39.86 87.6 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.55 -0.719 . . . . 0.0 110.396 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 170' ' ' TRP . . . . . 0.448 ' CE2' HD21 ' A' ' 32' ' ' LEU . 5.0 t-105 -60.02 -45.64 92.14 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.695 -0.628 . . . . 0.0 110.404 -179.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.55 -40.63 97.45 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.519 -0.738 . . . . 0.0 110.152 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -59.98 -40.07 87.85 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.579 -0.7 . . . . 0.0 109.977 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.697 -0.627 . . . . 0.0 110.174 179.784 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 . . . . . 0 N--CA 1.497 1.887 0 CA-C-O 121.44 0.638 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.6 mt -60.06 -38.85 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.65 -0.656 . . . . 0.0 111.971 -178.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.87 -29.19 70.02 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.97 -1.081 . . . . 0.0 111.051 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.85 -40.48 97.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.291 -0.881 . . . . 0.0 109.865 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.51 ' CB ' HD21 ' A' ' 69' ' ' LEU . 77.5 m-85 -64.98 -22.22 66.97 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.816 -0.553 . . . . 0.0 111.438 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.424 ' HE2' ' CZ ' ' A' ' 65' ' ' PHE . 28.3 mmtp -65.31 -39.97 93.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.34 -0.85 . . . . 0.0 110.075 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -62.63 -58.5 7.3 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.705 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.03 -36.07 76.47 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.387 -0.821 . . . . 0.0 112.15 -178.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -54.95 -49.73 70.63 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.072 -1.017 . . . . 0.0 110.561 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.6 t -60.77 -35.43 76.4 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.519 -0.738 . . . . 0.0 110.06 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.649 HD13 ' O ' ' A' ' 18' ' ' LEU . 2.1 tm? -65.83 -39.97 91.35 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -71.95 -40.62 68.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.909 -0.495 . . . . 0.0 110.668 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -94.19 95.21 8.81 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.363 -0.836 . . . . 0.0 110.82 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -66.76 -33.14 74.96 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.298 -0.876 . . . . 0.0 111.309 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -78.7 -10.91 59.93 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.116 -0.99 . . . . 0.0 111.281 -177.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.42 25.28 66.72 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 58.2 p-10 -89.5 -3.28 58.42 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.456 -1.026 . . . . 0.0 110.808 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.93 8.22 76.37 Favored Glycine 0 N--CA 1.489 2.232 0 O-C-N 121.217 -0.927 . . . . 0.0 111.271 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.9 p -145.73 143.06 29.51 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 119.335 1.568 . . . . 0.0 112.109 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.0 mt -101.21 121.84 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.69 -0.631 . . . . 0.0 109.411 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.6 p -99.15 143.45 29.41 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.49 -0.757 . . . . 0.0 110.607 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.416 ' O ' HD13 ' A' ' 48' ' ' LEU . 80.6 p -41.88 -36.92 1.16 Allowed 'General case' 0 N--CA 1.507 2.401 0 O-C-N 121.983 -0.448 . . . . 0.0 112.2 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -62.47 -47.86 82.14 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.112 -0.992 . . . . 0.0 109.346 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -60.04 -54.97 39.7 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.49 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 44.4 tp -59.98 -36.99 78.34 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.253 -0.904 . . . . 0.0 111.55 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.54 -31.39 14.46 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.5 m -70.92 -39.62 72.58 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.401 -1.058 . . . . 0.0 110.172 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.3 t -64.79 -54.1 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.517 -0.739 . . . . 0.0 110.06 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 92.6 mtp -60.03 -34.94 74.06 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.59 0.71 . . . . 0.0 110.064 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -60.05 -49.54 77.24 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.651 0.739 . . . . 0.0 110.007 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.9 t -69.96 -16.69 63.24 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.838 -0.539 . . . . 0.0 110.791 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.531 HD13 HD12 ' B' ' 167' ' ' LEU . 84.3 mt -87.9 -24.41 23.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.474 -0.766 . . . . 0.0 110.45 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.41 -38.43 0.22 Allowed Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.528 -1.32 . . . . 0.0 111.401 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -152.78 155.53 37.34 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 118.814 1.307 . . . . 0.0 112.196 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -116.97 99.96 53.16 Favored Pre-proline 0 N--CA 1.489 1.517 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.677 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.422 ' HG2' HD21 ' A' ' 48' ' ' LEU . 44.7 Cg_endo -64.18 -148.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.282 0 O-C-N 123.246 1.129 . . . . 0.0 109.56 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.7 p -139.94 156.5 46.63 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.93 -1.106 . . . . 0.0 111.689 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -54.02 -20.58 6.58 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.801 -0.562 . . . . 0.0 111.602 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.94 -59.99 2.46 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.937 0.875 . . . . 0.0 108.942 177.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -68.73 -33.75 74.44 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.044 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.422 HD21 ' HG2' ' A' ' 43' ' ' PRO . 44.2 mt -58.8 -34.85 71.96 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.608 -0.683 . . . . 0.0 110.33 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.33 -32.12 69.71 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.535 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -70.08 -43.09 71.83 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.356 -0.84 . . . . 0.0 111.313 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.422 ' CE ' HD23 ' A' ' 48' ' ' LEU . 77.7 mtm -60.95 -41.85 97.12 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.632 0.73 . . . . 0.0 109.463 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.579 HG22 ' OD2' ' A' ' 56' ' ' ASP . 97.0 mt -69.82 -31.93 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.908 -0.495 . . . . 0.0 110.026 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -59.96 -41.53 92.11 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.593 -0.692 . . . . 0.0 110.821 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -67.99 -25.61 65.49 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.323 -0.861 . . . . 0.0 110.292 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.3 t -99.09 -9.46 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.607 -0.683 . . . . 0.0 111.116 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.579 ' OD2' HG22 ' A' ' 52' ' ' ILE . 26.7 m-20 -71.96 106.53 4.29 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.123 -0.986 . . . . 0.0 111.68 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.92 -40.07 75.76 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.458 -0.776 . . . . 0.0 109.726 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -88.62 -29.74 19.74 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.635 -0.665 . . . . 0.0 110.266 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.92 24.61 44.4 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -74.3 -31.82 62.64 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.536 -0.979 . . . . 0.0 110.467 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 123.0 -3.91 9.78 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 120.361 -0.923 . . . . 0.0 111.033 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 82.0 p -133.43 170.01 16.12 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.065 -1.256 . . . . 0.0 110.364 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.57 HG12 HG23 ' A' ' 52' ' ' ILE . 9.1 mt -102.79 120.48 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.05 -178.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -98.38 169.51 9.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.523 -0.736 . . . . 0.0 110.617 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.476 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 25.7 t80 -49.01 -48.76 71.9 Favored Pre-proline 0 N--CA 1.497 1.915 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.7 Cg_endo -68.11 -33.54 24.87 Favored 'Trans proline' 0 N--CA 1.486 1.084 0 O-C-N 122.639 0.81 . . . . 0.0 110.863 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -71.13 -39.98 71.69 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.328 -0.857 . . . . 0.0 110.061 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -60.78 -49.96 75.4 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.522 -0.736 . . . . 0.0 110.893 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.51 HD21 ' CB ' ' A' ' 12' ' ' PHE . 85.2 mt -60.33 -41.89 94.49 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.509 -0.744 . . . . 0.0 111.515 -178.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 66' ' ' PRO . 45.9 p -63.66 -37.17 86.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.44 -0.788 . . . . 0.0 111.395 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.8 ttt -65.76 -44.36 86.09 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.299 -0.876 . . . . 0.0 111.54 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 91.2 mtp -71.04 -60.08 2.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.346 -0.846 . . . . 0.0 112.146 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.74 -40.79 76.39 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.47 -0.768 . . . . 0.0 111.314 -178.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.8 tpt85 -70.0 -40.2 75.42 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.526 -0.734 . . . . 0.0 111.157 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -86.2 -39.1 16.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.397 -0.815 . . . . 0.0 111.986 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.729 ' O ' HG22 ' A' ' 79' ' ' THR . 43.9 mtm -60.02 -39.95 87.62 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.254 -0.904 . . . . 0.0 111.661 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -62.21 -44.27 96.96 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.189 -0.944 . . . . 0.0 109.66 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -74.74 -10.02 59.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.93 -0.481 . . . . 0.0 110.566 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.729 HG22 ' O ' ' A' ' 76' ' ' MET . 0.6 OUTLIER -85.5 -162.5 0.73 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.252 -0.905 . . . . 0.0 111.328 -179.047 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.643 ' N ' HG23 ' A' ' 79' ' ' THR . 68.6 m-20 -130.06 135.43 48.23 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.804 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.0 t -69.97 -27.19 64.52 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.614 -0.678 . . . . 0.0 110.638 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -60.04 -36.62 77.68 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.556 -0.715 . . . . 0.0 110.023 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.98 -40.02 75.6 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.722 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -63.21 -40.05 96.37 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.475 -0.766 . . . . 0.0 110.729 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.624 HG23 ' HE2' ' A' ' 141' ' ' PHE . 85.8 mt -66.03 -46.89 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.673 -0.642 . . . . 0.0 110.148 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 -56.57 -40.42 75.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.532 -0.73 . . . . 0.0 110.903 -178.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.721 ' O ' HG23 ' A' ' 91' ' ' VAL . 99.0 mt-10 -69.94 -40.05 75.73 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.421 -0.8 . . . . 0.0 111.721 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.656 ' CA ' HG11 ' B' ' 164' ' ' VAL . . . -65.1 -48.86 72.17 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.358 -0.839 . . . . 0.0 111.996 -178.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -61.23 -43.68 98.48 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.464 -0.772 . . . . 0.0 109.984 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -59.98 -38.41 82.46 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.874 -0.516 . . . . 0.0 110.997 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 87' ' ' GLU . 99.0 t -69.82 -48.76 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.473 -0.767 . . . . 0.0 110.446 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.778 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 20.3 m-85 -67.98 -40.06 83.19 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.47 -0.769 . . . . 0.0 111.01 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -74.96 69.93 1.94 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.528 -0.733 . . . . 0.0 110.337 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.7 tttp -59.95 -46.6 88.89 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.426 -0.796 . . . . 0.0 109.84 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.1 p-10 -73.9 -18.83 60.86 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.603 -0.685 . . . . 0.0 111.382 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.94 62.4 6.35 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.438 ' ND2' ' CE2' ' A' ' 99' ' ' TYR . 37.6 p-10 -109.23 -7.46 15.27 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.516 -0.991 . . . . 0.0 111.82 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.55 -22.6 11.76 Favored Glycine 0 N--CA 1.498 2.817 0 C-N-CA 119.989 -1.1 . . . . 0.0 110.439 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.438 ' CE2' ' ND2' ' A' ' 97' ' ' ASN . 35.5 p90 -143.77 154.55 43.56 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.392 -1.064 . . . . 0.0 109.635 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 81.9 mt -91.32 129.42 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 121.839 0.828 . . . . 0.0 110.126 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.03 172.36 9.6 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.211 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.26 -40.98 86.26 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.579 -0.701 . . . . 0.0 109.665 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.54 -37.75 88.51 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -61.16 -37.35 82.58 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.974 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.591 ' HB3' HG13 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -64.58 -42.73 95.42 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.682 0.753 . . . . 0.0 109.552 179.033 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -60.04 -38.53 83.02 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.883 -0.511 . . . . 0.0 111.556 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -59.97 -41.06 91.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.084 -1.01 . . . . 0.0 111.856 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.778 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 84.5 t -72.9 -50.13 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.239 -0.913 . . . . 0.0 111.594 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.422 ' HA ' HD12 ' A' ' 112' ' ' LEU . 41.8 mtt -59.07 -41.52 88.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.175 -0.953 . . . . 0.0 110.403 -178.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.7 m -64.37 -46.62 82.59 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.49 -0.756 . . . . 0.0 109.126 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -61.35 -33.57 73.85 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.504 ' CD1' HG12 ' A' ' 108' ' ' VAL . 39.2 mt -69.84 -30.51 68.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.95 -0.469 . . . . 0.0 109.999 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.16 31.62 3.03 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -122.19 137.0 54.98 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.539 -0.977 . . . . 0.0 110.028 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -109.52 124.87 51.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.532 -0.73 . . . . 0.0 110.212 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.667 HD22 ' OE2' ' A' ' 120' ' ' GLU . 73.0 mt -138.98 159.75 41.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.565 -0.709 . . . . 0.0 109.647 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.18 162.01 26.04 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -59.61 -29.55 68.07 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.355 -0.841 . . . . 0.0 109.084 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -68.44 -32.63 72.78 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.424 0.63 . . . . 0.0 109.61 178.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.667 ' OE2' HD22 ' A' ' 116' ' ' LEU . 12.0 mt-10 -67.83 -37.97 82.61 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.522 178.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.591 HG13 ' HB3' ' A' ' 105' ' ' LEU . 97.5 t -69.74 -40.09 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.699 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -59.9 -42.03 92.92 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.295 0.569 . . . . 0.0 109.996 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -60.04 -41.4 92.2 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.026 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.485 ' HB3' HD11 ' A' ' 105' ' ' LEU . 6.3 mmt -54.64 -36.37 64.48 Favored 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.385 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.5 mm -68.47 -37.6 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.308 0.575 . . . . 0.0 109.826 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 46.6 ttt-85 -60.0 -40.08 87.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.574 -0.704 . . . . 0.0 111.239 -178.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -61.83 -39.46 91.89 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.648 -0.657 . . . . 0.0 111.222 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -99.34 -0.25 41.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.347 -0.846 . . . . 0.0 111.763 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -104.48 80.53 1.69 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.979 -1.076 . . . . 0.0 110.947 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.4 mt -67.84 -39.95 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.648 -0.658 . . . . 0.0 109.965 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 36.5 p-10 -60.02 -39.72 86.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.587 -0.696 . . . . 0.0 110.755 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.77 17.9 36.75 Favored Glycine 0 N--CA 1.497 2.727 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.385 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -81.0 -10.11 59.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.108 -1.231 . . . . 0.0 110.608 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.13 2.29 71.39 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.367 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -136.77 139.18 41.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.167 -1.196 . . . . 0.0 110.276 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 98.1 t -95.81 113.81 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.566 -0.709 . . . . 0.0 109.713 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 41.6 p30 -86.12 -166.95 1.68 Allowed 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.609 -0.682 . . . . 0.0 110.241 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -70.08 -43.72 70.56 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.842 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -61.3 -49.96 74.93 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.264 -0.897 . . . . 0.0 112.115 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.3 -37.63 88.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.503 -0.748 . . . . 0.0 110.499 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.624 ' HE2' HG23 ' A' ' 85' ' ' ILE . 68.5 t80 -60.09 -47.3 86.45 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.667 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 87.0 t -64.66 -39.96 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.485 -0.76 . . . . 0.0 110.695 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -59.98 -49.64 76.87 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.563 -0.711 . . . . 0.0 111.033 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.448 ' CE ' ' CD1' ' B' ' 157' ' ' PHE . 10.9 tmm? -60.66 -40.01 90.48 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.279 -0.888 . . . . 0.0 110.128 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 94.9 mmm -67.24 -38.78 85.77 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.749 -0.595 . . . . 0.0 109.944 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 91.6 m -58.85 -29.03 66.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.69 -0.631 . . . . 0.0 109.973 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.99 141.86 47.74 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.6 -0.688 . . . . 0.0 110.432 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 95.7 mttt . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.325 179.916 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -66.54 152.74 52.41 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . 0.531 ' HA ' HD12 ' B' ' 160' ' ' ILE . 22.6 t80 -61.51 -42.2 98.44 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.488 -1.007 . . . . 0.0 110.332 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 63.0 mtt85 -60.02 -40.06 88.01 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.558 -0.714 . . . . 0.0 110.397 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -62.61 -39.92 95.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.494 -0.754 . . . . 0.0 110.364 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . 0.531 HD12 ' HA ' ' B' ' 157' ' ' PHE . 73.0 mt -61.23 -45.09 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.516 -0.74 . . . . 0.0 110.041 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.9 -28.64 69.09 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.518 -0.739 . . . . 0.0 110.146 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -60.15 -39.92 88.03 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.572 -0.705 . . . . 0.0 109.503 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 89.0 mt -60.04 -40.08 88.14 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.724 -0.61 . . . . 0.0 110.413 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . 0.656 HG11 ' CA ' ' A' ' 88' ' ' ALA . 94.0 t -65.22 -39.95 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.496 -0.753 . . . . 0.0 109.9 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -54.81 -37.15 61.17 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 85.0 t -60.0 -33.32 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.657 -0.907 . . . . 0.0 109.627 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.577 ' O ' HD23 ' B' ' 167' ' ' LEU . 8.1 tt -56.24 -37.74 70.15 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.622 -0.674 . . . . 0.0 110.777 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -59.99 -39.99 87.65 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.416 -0.803 . . . . 0.0 110.224 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -63.76 -40.01 95.67 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.447 -0.783 . . . . 0.0 110.989 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -20.9 59.46 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.415 -0.803 . . . . 0.0 110.869 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.98 -32.31 70.46 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.268 -0.895 . . . . 0.0 110.965 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -59.98 -38.73 83.39 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.355 -0.841 . . . . 0.0 109.865 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 71.4 mtp85 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.734 -0.604 . . . . 0.0 110.318 179.99 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 121.037 0.446 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -81.4 98.92 8.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.516 -0.74 . . . . 0.0 109.927 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.69 176.88 1.79 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.52 0.676 . . . . 0.0 110.721 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 66.6 mt -111.85 -179.4 3.68 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.603 0.716 . . . . 0.0 110.604 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.94 19.78 18.68 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.881 -0.512 . . . . 0.0 110.237 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.635 ' HA ' HD12 ' A' ' 9' ' ' ILE . 95.3 mt-10 -61.27 -13.79 21.46 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.369 -0.832 . . . . 0.0 111.526 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -64.96 -45.18 86.79 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.248 -0.908 . . . . 0.0 109.4 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -66.54 -38.82 87.98 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.301 0.572 . . . . 0.0 110.067 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.635 HD12 ' HA ' ' A' ' 6' ' ' GLU . 72.1 mt -57.88 -29.02 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.776 -0.577 . . . . 0.0 110.737 -179.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.22 -39.13 89.09 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.233 -0.917 . . . . 0.0 110.194 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -59.98 -43.47 95.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.718 -0.614 . . . . 0.0 110.397 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.584 ' HB3' HD21 ' A' ' 69' ' ' LEU . 77.2 m-85 -64.8 -20.77 66.56 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.844 -0.535 . . . . 0.0 111.395 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -69.96 -42.3 73.36 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.068 -1.02 . . . . 0.0 109.107 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -70.0 -26.65 64.17 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.119 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.15 -27.43 32.73 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.335 -0.853 . . . . 0.0 111.147 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.454 ' CB ' ' CE1' ' A' ' 65' ' ' PHE . 47.9 t80 -59.66 -41.32 90.31 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.576 -0.703 . . . . 0.0 111.673 -177.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.0 m -61.28 -38.36 86.5 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.233 -0.917 . . . . 0.0 109.974 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.7 tp -60.05 -41.21 91.84 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.816 -0.553 . . . . 0.0 110.0 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -74.22 -34.76 63.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.583 -0.698 . . . . 0.0 110.467 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -92.97 95.44 9.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.447 -0.783 . . . . 0.0 109.655 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -59.98 -32.1 70.51 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.426 -0.796 . . . . 0.0 111.155 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -79.44 -8.03 58.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.102 -0.999 . . . . 0.0 110.754 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.21 26.83 29.92 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -90.4 -4.82 56.78 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.686 -0.89 . . . . 0.0 111.326 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.97 2.41 58.26 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.634 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.0 p -146.71 144.18 29.25 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.353 1.576 . . . . 0.0 111.727 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 84.0 mt -107.72 133.14 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.71 -0.619 . . . . 0.0 109.97 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.2 p -111.04 145.84 37.78 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.552 -0.717 . . . . 0.0 110.626 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.442 ' CG2' HD12 ' A' ' 52' ' ' ILE . 53.6 p -43.81 -32.98 1.18 Allowed 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.667 -0.646 . . . . 0.0 111.858 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.06 -50.59 65.58 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.753 0.787 . . . . 0.0 109.533 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -59.99 -53.63 55.56 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.65 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.559 HD13 ' CZ2' ' B' ' 170' ' ' TRP . 9.0 tt -60.02 -32.38 70.84 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.359 -0.838 . . . . 0.0 110.479 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.19 -31.34 33.8 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.314 -1.115 . . . . 0.0 110.314 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 93.7 m -63.83 -39.97 95.49 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.591 -0.946 . . . . 0.0 109.09 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.401 ' CG1' HD22 ' B' ' 167' ' ' LEU . 78.0 t -66.61 -39.98 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 96.8 mmm -59.97 -39.99 87.57 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.684 -0.635 . . . . 0.0 110.877 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.46 ' CG ' ' HB2' ' A' ' 42' ' ' ASN . 55.6 mtm180 -61.85 -42.62 99.26 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.152 -0.967 . . . . 0.0 109.552 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.3 t -63.72 -25.96 68.44 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.083 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.641 HD21 ' HD2' ' B' ' 168' ' ' ARG . 24.0 tp -85.77 -23.17 27.38 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.416 -0.803 . . . . 0.0 109.366 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.93 -58.77 0.17 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -160.56 176.26 11.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.544 -0.974 . . . . 0.0 111.415 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.46 ' HB2' ' CG ' ' A' ' 37' ' ' ARG . 38.9 t30 -99.61 131.84 24.1 Favored Pre-proline 0 N--CA 1.492 1.664 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.208 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -68.75 -147.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.111 0 N-CA-C 108.435 -1.41 . . . . 0.0 108.435 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.1 p -129.59 141.55 50.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.827 -1.171 . . . . 0.0 110.481 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -51.48 -25.77 7.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.642 -0.661 . . . . 0.0 111.322 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.57 -54.9 7.87 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.124 0.964 . . . . 0.0 108.546 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -66.86 -39.87 87.69 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.093 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.43 HD13 ' HB ' ' A' ' 29' ' ' THR . 1.4 mt -56.0 -35.04 66.37 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.542 -0.724 . . . . 0.0 109.713 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.97 -37.16 81.19 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.152 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -65.22 -38.68 91.16 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.382 -0.823 . . . . 0.0 110.791 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 88.6 mmm -59.98 -45.97 90.97 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.659 -0.65 . . . . 0.0 110.206 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.732 HG22 ' OD2' ' A' ' 56' ' ' ASP . 89.9 mt -67.89 -32.98 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.714 -0.616 . . . . 0.0 110.375 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -60.01 -43.29 95.33 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.246 -0.909 . . . . 0.0 110.669 -178.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -67.9 -26.44 65.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.339 -0.851 . . . . 0.0 110.918 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.505 HG21 ' SD ' ' A' ' 71' ' ' MET . 57.5 t -99.97 -8.84 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.483 -0.761 . . . . 0.0 111.482 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.732 ' OD2' HG22 ' A' ' 52' ' ' ILE . 3.6 m-20 -71.23 103.16 2.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.109 -0.995 . . . . 0.0 110.897 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.25 -38.71 78.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.648 -0.658 . . . . 0.0 109.76 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -91.45 -30.64 16.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.615 -0.678 . . . . 0.0 110.537 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.2 20.99 40.01 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 120.36 -0.924 . . . . 0.0 110.905 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.6 p-10 -73.95 -32.86 63.67 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.39 -1.065 . . . . 0.0 110.323 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.7 -0.04 12.16 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.006 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 57.7 p -137.35 167.74 21.01 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.091 -1.24 . . . . 0.0 110.917 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.8 mt -104.58 120.67 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 121.317 0.58 . . . . 0.0 110.483 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -96.48 169.93 9.57 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.383 0.611 . . . . 0.0 110.585 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.456 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -46.06 -50.35 36.86 Favored Pre-proline 0 N--CA 1.501 2.099 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -179.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 45.3 Cg_endo -72.37 -32.02 10.74 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.026 1.014 . . . . 0.0 111.771 -178.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -71.44 -40.03 70.65 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.216 -0.927 . . . . 0.0 110.251 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -61.52 -39.96 92.93 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.723 -0.611 . . . . 0.0 110.761 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.584 HD21 ' HB3' ' A' ' 12' ' ' PHE . 89.3 mt -67.76 -39.98 84.12 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.424 -0.798 . . . . 0.0 111.926 -178.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.1 p -61.88 -40.08 94.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.356 -0.84 . . . . 0.0 110.748 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.505 ' SD ' HG21 ' A' ' 55' ' ' VAL . 60.5 ttp -67.71 -38.38 83.53 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.622 -0.674 . . . . 0.0 110.357 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.402 ' CE ' ' CG2' ' B' ' 166' ' ' VAL . 5.0 tpt -60.06 -49.51 77.39 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.611 -0.681 . . . . 0.0 111.076 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.09 -28.96 65.83 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.395 -0.816 . . . . 0.0 110.757 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -72.05 -40.79 68.1 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.498 -0.751 . . . . 0.0 110.608 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -69.15 -50.07 51.08 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.639 -0.663 . . . . 0.0 111.483 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 70.6 mtm -59.94 -40.03 87.56 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.429 -0.794 . . . . 0.0 111.104 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -60.74 -55.41 33.53 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.368 -0.832 . . . . 0.0 111.224 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -65.02 -19.98 66.27 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.456 -0.777 . . . . 0.0 110.161 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.544 HG22 ' H ' ' A' ' 80' ' ' ASP 0.299 52.9 m -99.87 -175.11 2.87 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.815 -0.553 . . . . 0.0 109.648 -179.742 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.544 ' H ' HG22 ' A' ' 79' ' ' THR . 87.4 m-20 -121.74 140.82 51.85 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.223 -0.923 . . . . 0.0 109.084 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.4 ' HA ' ' HG2' ' A' ' 84' ' ' GLU . 33.6 t -55.76 -28.57 56.67 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.317 -0.864 . . . . 0.0 110.271 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.76 -34.32 77.63 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.677 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -71.42 -41.63 69.31 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.92 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.4 ' HG2' ' HA ' ' A' ' 81' ' ' SER . 9.5 pt-20 -69.93 -29.49 66.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.117 -0.989 . . . . 0.0 110.414 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 95.9 mt -69.3 -46.31 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.536 -0.727 . . . . 0.0 109.699 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 63.2 mtt180 -59.81 -39.93 86.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.409 -0.807 . . . . 0.0 110.584 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.62 ' O ' HG23 ' A' ' 91' ' ' VAL . 98.9 mt-10 -66.95 -44.45 80.55 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.535 -0.728 . . . . 0.0 110.927 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.494 ' HA ' HG12 ' B' ' 164' ' ' VAL . . . -64.4 -43.58 93.98 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.667 -0.646 . . . . 0.0 111.282 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -59.94 -47.99 83.54 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.763 0.792 . . . . 0.0 109.778 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -58.98 -33.42 70.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.914 -0.492 . . . . 0.0 110.473 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 87' ' ' GLU . 78.5 t -70.04 -42.88 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.508 -0.745 . . . . 0.0 110.028 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.41 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 13.0 m-85 -70.06 -39.13 75.84 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.446 -0.784 . . . . 0.0 110.628 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -79.75 73.32 6.48 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.575 -0.703 . . . . 0.0 109.653 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -64.82 -40.83 95.84 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.381 -0.824 . . . . 0.0 110.487 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -76.12 -16.59 59.86 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.459 -0.775 . . . . 0.0 110.958 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.18 61.58 7.34 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -107.79 -10.6 15.55 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.581 -0.952 . . . . 0.0 111.377 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.4 -23.22 8.58 Favored Glycine 0 N--CA 1.498 2.815 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 14.6 p90 -142.79 176.16 9.27 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.483 -1.01 . . . . 0.0 108.708 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.507 HG22 ' H ' ' A' ' 101' ' ' SER . 23.4 mt -89.07 -129.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 119.801 -0.759 . . . . 0.0 109.248 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.507 ' H ' HG22 ' A' ' 100' ' ' ILE . 0.3 OUTLIER 168.71 159.87 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 O-C-N 120.529 -1.357 . . . . 0.0 108.321 178.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.52 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -61.3 -42.02 97.97 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.367 -0.833 . . . . 0.0 109.18 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.12 -30.67 67.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.837 -0.539 . . . . 0.0 110.094 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.47 ' HB2' HG22 ' A' ' 100' ' ' ILE . 61.9 mt-10 -69.97 -39.15 76.16 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.305 -0.872 . . . . 0.0 110.593 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.752 ' HB3' HG13 ' A' ' 121' ' ' VAL . 0.9 OUTLIER -67.54 -47.24 70.44 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.481 -0.762 . . . . 0.0 110.21 179.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -61.21 -38.94 88.39 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.826 -0.546 . . . . 0.0 111.628 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -60.04 -39.95 87.71 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.218 -0.926 . . . . 0.0 111.163 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.41 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 96.5 t -74.08 -47.36 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 O-C-N 121.275 -0.891 . . . . 0.0 111.438 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.702 ' HE1' HG22 ' A' ' 121' ' ' VAL . 76.5 mtm -58.83 -42.96 90.46 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.156 -0.965 . . . . 0.0 110.267 -178.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.2 m -67.27 -41.67 85.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.541 -0.724 . . . . 0.0 109.127 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -63.1 -31.91 73.17 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 109' ' ' MET . 42.5 mt -70.02 -35.09 74.08 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.697 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.94 21.14 2.95 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.667 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -119.98 138.32 53.55 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.215 -1.168 . . . . 0.0 110.024 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.7 mmmt -103.33 122.02 43.95 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.541 -0.725 . . . . 0.0 110.649 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.511 HD12 ' SD ' ' A' ' 109' ' ' MET . 77.2 mt -135.05 156.48 48.95 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.64 -0.662 . . . . 0.0 109.502 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.77 159.39 29.07 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.558 -0.714 . . . . 0.0 109.677 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -58.75 -29.8 67.02 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -66.09 -29.97 70.39 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -37.31 86.13 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.752 HG13 ' HB3' ' A' ' 105' ' ' LEU . 94.5 t -70.05 -39.91 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.522 0.677 . . . . 0.0 110.151 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -60.04 -45.75 91.78 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.786 -0.571 . . . . 0.0 110.074 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -59.9 -40.05 87.46 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.597 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.548 ' HB3' HD11 ' A' ' 105' ' ' LEU . 10.2 mmt -55.39 -38.48 68.94 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.594 -0.842 . . . . 0.0 108.767 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 48.4 mm -66.31 -40.1 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.356 0.598 . . . . 0.0 109.749 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -57.86 -38.62 76.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.691 -0.631 . . . . 0.0 111.197 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.95 -39.77 86.73 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.68 -0.638 . . . . 0.0 111.16 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.93 4.45 34.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.321 -0.862 . . . . 0.0 111.558 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 62.7 t0 -88.14 69.9 9.25 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.035 -1.041 . . . . 0.0 110.425 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.7 mt -67.67 -40.74 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.464 -0.772 . . . . 0.0 110.481 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -72.59 -22.4 60.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.433 -0.792 . . . . 0.0 111.087 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.6 24.33 50.58 Favored Glycine 0 N--CA 1.496 2.688 0 C-N-CA 120.262 -0.971 . . . . 0.0 110.69 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -83.8 -10.78 57.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.389 -1.065 . . . . 0.0 111.086 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.35 0.84 79.33 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -137.81 149.26 46.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -1.117 . . . . 0.0 109.286 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.0 t -92.14 118.63 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.427 -0.796 . . . . 0.0 109.771 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -88.06 176.51 7.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.573 -0.705 . . . . 0.0 109.346 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -61.34 -47.47 85.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.743 -0.598 . . . . 0.0 110.498 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -59.95 -46.42 89.47 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.74 -0.6 . . . . 0.0 111.51 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -64.47 -37.04 86.15 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.806 0.813 . . . . 0.0 109.99 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.453 ' CZ ' ' CE ' ' A' ' 145' ' ' MET . 64.9 t80 -60.07 -48.88 79.89 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.283 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.859 ' O ' HG22 ' A' ' 146' ' ' THR . 89.0 t -70.0 -40.65 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.308 -0.87 . . . . 0.0 111.921 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -59.94 -48.8 80.22 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.308 -0.87 . . . . 0.0 111.477 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.43 ' HE1' ' CE1' ' B' ' 157' ' ' PHE . 55.2 ttp -59.99 -35.9 76.01 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.428 -0.795 . . . . 0.0 110.475 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.477 ' HE2' ' CB ' ' B' ' 161' ' ' ALA . 37.3 mtt -70.65 -40.04 73.27 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.638 -0.664 . . . . 0.0 110.939 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.859 HG22 ' O ' ' A' ' 142' ' ' VAL . 8.5 t -104.99 31.65 4.69 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.514 -0.741 . . . . 0.0 109.98 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.18 -42.45 95.04 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.626 -0.671 . . . . 0.0 110.153 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 30.2 mttt . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.969 179.563 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.374 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -92.64 146.23 18.04 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.43 ' CE1' ' HE1' ' A' ' 144' ' ' MET . 51.4 t80 -59.95 -40.73 90.0 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.506 -0.997 . . . . 0.0 109.903 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 32.6 ttp85 -61.38 -40.45 94.4 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.699 -0.626 . . . . 0.0 110.22 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -60.14 -40.01 88.34 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.488 -0.757 . . . . 0.0 110.286 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 97.4 mt -66.68 -39.63 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.655 -0.653 . . . . 0.0 110.465 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . 0.477 ' CB ' ' HE2' ' A' ' 145' ' ' MET . . . -59.32 -37.11 76.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.521 -0.737 . . . . 0.0 110.372 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -60.13 -40.04 88.4 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.486 -0.759 . . . . 0.0 110.688 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 83.4 mt -70.04 -34.95 73.91 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.517 -0.739 . . . . 0.0 110.691 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.494 HG12 ' HA ' ' A' ' 88' ' ' ALA . 91.1 t -63.97 -39.96 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.595 -0.691 . . . . 0.0 109.932 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.14 -30.46 67.2 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.402 ' CG2' ' CE ' ' A' ' 72' ' ' MET . 58.3 t -69.02 -33.56 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.628 -0.925 . . . . 0.0 110.959 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.401 HD22 ' CG1' ' A' ' 35' ' ' VAL . 91.6 mt -60.17 -46.55 89.3 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.372 -0.83 . . . . 0.0 111.711 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' ARG . . . . . 0.641 ' HD2' HD21 ' A' ' 39' ' ' LEU . 23.2 mmm180 -70.07 -38.18 75.66 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.198 -0.939 . . . . 0.0 111.505 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -59.97 -40.06 87.77 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.287 -0.883 . . . . 0.0 110.629 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . 0.559 ' CZ2' HD13 ' A' ' 32' ' ' LEU . 2.0 t-105 -59.95 -40.26 88.38 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.41 -0.806 . . . . 0.0 109.845 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.1 -20.45 59.46 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.578 -0.701 . . . . 0.0 110.514 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -60.03 -39.99 87.77 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.324 -0.86 . . . . 0.0 110.072 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.635 -0.666 . . . . 0.0 110.111 179.73 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.146 0.498 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -133.47 37.83 3.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.726 -0.609 . . . . 0.0 110.284 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -61.67 -40.0 93.41 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.688 0.756 . . . . 0.0 110.341 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 77.2 mt -117.61 178.31 4.44 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.516 0.674 . . . . 0.0 110.583 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 p -143.78 106.13 4.41 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.432 ' HA ' HD12 ' A' ' 9' ' ' ILE . 96.7 mt-10 -92.62 -12.21 32.24 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.746 -0.596 . . . . 0.0 111.033 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -69.95 -42.14 73.62 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.271 -0.893 . . . . 0.0 109.879 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -68.01 -40.03 83.05 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.523 0.678 . . . . 0.0 110.818 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.432 HD12 ' HA ' ' A' ' 6' ' ' GLU . 79.0 mt -60.58 -29.04 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.925 -0.484 . . . . 0.0 111.525 -178.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.67 86.6 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.157 -0.964 . . . . 0.0 110.063 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -60.03 -40.38 89.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.465 -0.772 . . . . 0.0 110.244 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.415 ' CG ' HD21 ' A' ' 69' ' ' LEU . 66.0 m-85 -65.36 -20.75 66.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.724 -0.61 . . . . 0.0 110.917 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HD3' ' CZ ' ' A' ' 65' ' ' PHE . 72.2 mmtt -69.94 -46.14 65.94 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.293 -0.879 . . . . 0.0 109.886 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -76.23 -24.82 54.61 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.45 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.22 -35.2 42.01 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.454 -0.779 . . . . 0.0 110.51 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -59.87 -39.99 87.13 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.853 -0.529 . . . . 0.0 111.549 -177.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.5 m -61.93 -39.64 92.77 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.25 -0.906 . . . . 0.0 109.946 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.649 HD11 ' O ' ' A' ' 112' ' ' LEU . 59.7 tp -60.03 -40.09 88.16 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.693 -0.629 . . . . 0.0 109.406 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -77.39 -35.61 54.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.718 -0.614 . . . . 0.0 110.349 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -94.26 97.73 10.44 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.401 -0.812 . . . . 0.0 110.196 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -59.99 -34.81 73.81 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.527 -0.733 . . . . 0.0 111.728 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -80.1 -11.2 59.78 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.172 -0.955 . . . . 0.0 111.249 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.56 28.77 52.29 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -90.86 -6.13 54.62 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.725 -0.868 . . . . 0.0 111.262 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.42 0.25 56.87 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 120.158 -1.02 . . . . 0.0 111.617 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.5 p -144.86 143.02 30.38 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 119.284 1.542 . . . . 0.0 111.108 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.8 mt -107.04 130.07 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 121.766 0.793 . . . . 0.0 110.868 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.4 p -106.16 143.06 34.82 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.846 -0.533 . . . . 0.0 110.537 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.511 HG23 ' CD1' ' A' ' 52' ' ' ILE . 64.8 p -43.25 -29.03 0.36 Allowed 'General case' 0 N--CA 1.509 2.489 0 O-C-N 121.667 -0.646 . . . . 0.0 112.163 -178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -65.09 -50.21 66.99 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.804 0.811 . . . . 0.0 109.58 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -59.51 -53.35 59.13 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.695 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.441 ' CD2' ' CE2' ' B' ' 170' ' ' TRP . 54.4 tp -60.09 -30.47 69.26 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.253 -0.904 . . . . 0.0 110.119 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.49 -32.56 23.58 Favored Glycine 0 N--CA 1.5 2.959 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.6 m -65.38 -39.91 92.86 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.545 -0.974 . . . . 0.0 109.434 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.458 ' CG1' HD22 ' B' ' 167' ' ' LEU . 77.1 t -68.18 -39.99 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-O 121.492 0.663 . . . . 0.0 110.046 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 46.1 mtt -59.97 -39.96 87.42 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.698 -0.626 . . . . 0.0 111.104 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.471 ' CG ' ' HB2' ' A' ' 42' ' ' ASN . 55.8 mtt180 -60.73 -46.73 89.28 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.303 -0.873 . . . . 0.0 109.961 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -67.0 -23.36 65.92 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.903 -178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.7 tp -82.64 -30.5 29.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.94 . . . . 0.0 109.443 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.37 -39.61 0.19 Allowed Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.934 -1.127 . . . . 0.0 110.868 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -170.53 160.35 7.3 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.076 -1.249 . . . . 0.0 112.271 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.471 ' HB2' ' CG ' ' A' ' 37' ' ' ARG . 5.9 t-20 -105.88 111.22 64.59 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.699 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.467 ' HD2' ' HA ' ' A' ' 42' ' ' ASN . 41.3 Cg_endo -61.15 -143.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.496 0 O-C-N 123.501 1.264 . . . . 0.0 109.683 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.2 p -131.41 149.93 52.35 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.218 -1.551 . . . . 0.0 112.131 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -51.1 -22.54 2.53 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.872 -0.517 . . . . 0.0 111.927 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.61 -55.76 8.05 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 122.284 1.04 . . . . 0.0 108.454 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -67.32 -37.17 82.88 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.718 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.45 HD13 ' HB ' ' A' ' 29' ' ' THR . 4.1 mt -57.35 -36.19 70.89 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.551 -0.718 . . . . 0.0 109.772 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.25 -40.03 89.9 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.426 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -64.0 -36.58 84.43 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.452 -0.78 . . . . 0.0 111.046 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 64.6 mtt -60.03 -44.95 94.28 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.638 -0.663 . . . . 0.0 109.888 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.732 HG22 ' OD2' ' A' ' 56' ' ' ASP . 66.1 mt -68.32 -34.06 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.747 -0.596 . . . . 0.0 110.364 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -60.06 -42.56 94.78 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.32 -0.863 . . . . 0.0 111.051 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -69.1 -27.67 65.8 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.089 -1.007 . . . . 0.0 110.984 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.492 HG21 ' SD ' ' A' ' 71' ' ' MET . 96.5 t -99.92 -7.67 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.591 -0.693 . . . . 0.0 111.239 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.732 ' OD2' HG22 ' A' ' 52' ' ' ILE . 0.5 OUTLIER -72.7 100.02 2.73 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.163 -0.961 . . . . 0.0 112.004 -179.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.09 -33.28 65.52 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -71.62 -40.09 70.0 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.407 0.622 . . . . 0.0 110.214 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.25 -1.44 73.27 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -73.7 -40.07 63.89 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.206 -1.173 . . . . 0.0 110.95 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.566 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 129.78 8.55 3.42 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 119.83 -1.176 . . . . 0.0 112.009 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 74.5 p -136.79 160.0 40.15 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.007 -1.29 . . . . 0.0 110.535 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.1 mt -104.93 120.03 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 120.039 -0.664 . . . . 0.0 111.273 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -96.22 171.17 8.76 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.533 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 19.4 t80 -49.37 -48.61 74.4 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.535 -0.728 . . . . 0.0 112.762 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 38.3 Cg_endo -63.94 -37.73 42.23 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 O-C-N 122.693 0.838 . . . . 0.0 111.56 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -69.65 -38.12 77.01 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.266 -0.896 . . . . 0.0 110.053 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.414 ' CE1' ' HG3' ' A' ' 72' ' ' MET . 63.8 t80 -60.56 -42.27 96.25 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.546 -0.721 . . . . 0.0 110.158 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.519 HD11 ' CE2' ' A' ' 65' ' ' PHE . 89.4 mt -63.22 -40.5 97.64 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.5 -0.75 . . . . 0.0 111.854 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 66' ' ' PRO . 70.7 p -61.66 -41.99 98.29 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.374 -0.829 . . . . 0.0 110.954 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.492 ' SD ' HG21 ' A' ' 55' ' ' VAL . 60.6 ttp -69.83 -40.02 76.13 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.562 -0.711 . . . . 0.0 111.475 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.414 ' HG3' ' CE1' ' A' ' 68' ' ' PHE . 97.2 mmm -62.71 -52.78 61.92 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.446 -0.784 . . . . 0.0 111.92 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.01 -31.54 71.3 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.661 -0.649 . . . . 0.0 110.313 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.411 ' HD2' ' CE ' ' A' ' 77' ' ' LYS . 10.4 tpt180 -71.83 -43.63 65.26 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.735 -0.603 . . . . 0.0 110.983 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.642 ' O ' HG22 ' A' ' 79' ' ' THR . 66.0 mmtt -70.06 -42.22 73.12 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 45.9 mtm -59.91 -46.42 89.42 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.135 -0.978 . . . . 0.0 112.531 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.411 ' CE ' ' HD2' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -69.87 -37.43 76.09 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.032 -1.043 . . . . 0.0 110.089 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -69.97 -20.03 63.33 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.712 -0.618 . . . . 0.0 111.252 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.642 HG22 ' O ' ' A' ' 75' ' ' LYS . 12.7 t -111.34 -160.71 0.72 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.921 0.867 . . . . 0.0 111.94 -178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -120.49 138.39 53.85 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.463 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.6 t -65.73 -27.74 68.54 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.58 -0.7 . . . . 0.0 109.97 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.02 -31.0 69.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.61 -0.681 . . . . 0.0 109.844 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.62 -40.0 76.86 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.643 -0.661 . . . . 0.0 110.354 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.68 -38.59 87.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.527 -0.733 . . . . 0.0 110.379 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.713 HG23 ' HE1' ' A' ' 141' ' ' PHE . 95.5 mt -64.57 -51.0 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.778 -0.577 . . . . 0.0 110.758 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.8 mtp85 -56.1 -38.41 70.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.265 -0.897 . . . . 0.0 110.481 -178.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.722 ' O ' HG23 ' A' ' 91' ' ' VAL . 95.0 mt-10 -69.77 -39.9 76.39 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.804 -0.56 . . . . 0.0 110.789 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.62 -48.64 74.11 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.392 -0.818 . . . . 0.0 111.152 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -60.22 -43.01 96.38 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.725 0.774 . . . . 0.0 109.7 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -60.0 -36.44 77.2 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.411 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 87' ' ' GLU . 90.4 t -69.43 -50.49 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.559 -0.713 . . . . 0.0 110.19 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -64.84 -40.04 94.54 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.397 -0.814 . . . . 0.0 110.952 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -78.5 65.05 3.7 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.475 -0.766 . . . . 0.0 110.686 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -60.67 -45.97 92.12 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.235 -0.916 . . . . 0.0 109.898 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 41.0 p-10 -69.99 -19.09 63.35 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.567 -0.708 . . . . 0.0 110.791 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.03 57.59 19.04 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -105.11 -3.24 23.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.278 -1.131 . . . . 0.0 110.525 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.43 -16.03 56.98 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -135.62 142.91 45.32 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.146 -1.208 . . . . 0.0 109.525 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 75.2 mt -88.97 124.55 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.482 -0.761 . . . . 0.0 110.021 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.2 m -84.52 169.38 14.52 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.353 0.597 . . . . 0.0 110.575 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.76 -40.57 97.68 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.77 -0.581 . . . . 0.0 110.096 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.77 -33.3 75.54 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.782 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -66.35 -40.02 89.55 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.426 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.449 ' HB3' HG13 ' A' ' 121' ' ' VAL . 1.7 tt -61.1 -48.87 79.68 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.331 -0.856 . . . . 0.0 109.841 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -62.66 -28.39 69.89 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.821 -0.549 . . . . 0.0 111.027 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -60.08 -40.01 88.05 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.186 -0.946 . . . . 0.0 109.978 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.3 t -77.25 -33.11 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.528 -0.733 . . . . 0.0 110.256 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.471 ' SD ' HG22 ' A' ' 121' ' ' VAL . 16.9 mtt -59.99 -49.88 75.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.473 -0.767 . . . . 0.0 110.118 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 p -68.25 -40.87 81.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.621 -0.674 . . . . 0.0 109.703 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -60.05 -31.9 70.42 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.649 ' O ' HD11 ' A' ' 18' ' ' LEU . 21.5 mt -69.94 -35.2 74.33 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.176 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 112.85 24.26 4.99 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -119.82 141.92 49.09 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.452 -1.028 . . . . 0.0 109.518 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -99.92 123.26 43.98 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.407 -0.808 . . . . 0.0 110.847 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.623 HD23 ' OE2' ' A' ' 120' ' ' GLU . 4.2 mp -138.72 154.52 48.56 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.579 -0.7 . . . . 0.0 110.206 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.0 m -87.81 170.2 11.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.637 -0.664 . . . . 0.0 109.344 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -63.5 -24.9 68.02 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.343 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -68.14 -36.36 79.57 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.716 0.769 . . . . 0.0 109.364 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.623 ' OE2' HD23 ' A' ' 116' ' ' LEU . 12.1 mt-10 -65.23 -38.38 90.21 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.594 0.711 . . . . 0.0 109.225 178.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.471 HG22 ' SD ' ' A' ' 109' ' ' MET . 74.3 t -68.2 -39.96 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.03 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.573 ' HA ' HD12 ' A' ' 125' ' ' ILE . 65.7 t0 -59.96 -42.02 93.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.629 -0.67 . . . . 0.0 109.831 -178.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -59.97 -40.94 90.8 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.654 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 10.5 mmt -54.22 -38.52 65.81 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.573 HD12 ' HA ' ' A' ' 122' ' ' ASP . 84.1 mt -66.03 -40.02 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.468 0.651 . . . . 0.0 110.082 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.5 ttt85 -57.35 -39.94 77.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.543 -0.723 . . . . 0.0 111.718 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -60.15 -37.93 81.6 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.572 -0.705 . . . . 0.0 111.465 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -109.39 -5.89 15.66 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.22 -0.925 . . . . 0.0 112.241 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -82.64 70.73 9.68 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.935 -1.103 . . . . 0.0 111.01 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.1 mt -67.99 -39.96 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.467 -0.771 . . . . 0.0 110.488 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.8 p-10 -70.51 -20.03 62.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.416 -0.802 . . . . 0.0 111.337 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.59 24.38 58.67 Favored Glycine 0 N--CA 1.496 2.646 0 C-N-CA 120.135 -1.031 . . . . 0.0 110.672 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -81.93 -11.61 58.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -1.173 . . . . 0.0 110.95 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.44 3.08 72.39 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -141.98 153.11 44.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -1.125 . . . . 0.0 109.784 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.0 t -96.22 109.97 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.609 -0.682 . . . . 0.0 109.611 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.0 p30 -81.93 -174.14 4.88 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.54 -0.725 . . . . 0.0 110.197 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -69.33 -42.86 74.79 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.056 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -62.45 -49.95 73.41 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.294 -0.879 . . . . 0.0 112.049 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.46 -35.5 81.09 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.445 -0.784 . . . . 0.0 110.456 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.713 ' HE1' HG23 ' A' ' 85' ' ' ILE . 64.7 t80 -59.94 -45.83 91.36 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.425 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.9 t -71.46 -40.51 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.294 -0.879 . . . . 0.0 111.777 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -59.96 -49.98 75.56 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.398 -0.814 . . . . 0.0 110.649 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 10.5 tmm? -59.97 -39.86 87.09 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.407 -0.808 . . . . 0.0 109.361 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 92.7 mmm -68.11 -39.86 82.7 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.216 0.531 . . . . 0.0 109.577 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 56.8 m -69.66 -17.8 63.52 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.714 -0.616 . . . . 0.0 110.446 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.94 139.99 57.02 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.381 -0.824 . . . . 0.0 110.454 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.2 mttm . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.105 -179.889 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -156.35 140.93 7.56 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -60.05 -39.92 87.61 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.644 -0.915 . . . . 0.0 110.064 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -60.02 -39.76 86.96 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.631 -0.668 . . . . 0.0 110.309 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -60.09 -39.95 87.87 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.576 -0.702 . . . . 0.0 110.592 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.65 -40.43 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.618 -0.676 . . . . 0.0 109.742 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.21 -39.53 93.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.691 -0.63 . . . . 0.0 110.736 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -64.11 -39.91 95.05 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.419 -0.801 . . . . 0.0 111.34 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 77.6 mt -70.05 -40.39 75.14 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.379 -0.826 . . . . 0.0 112.205 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.665 ' HA ' HD12 ' B' ' 167' ' ' LEU . 13.5 p -71.0 -31.96 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.073 -1.017 . . . . 0.0 110.673 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.73 -40.04 97.52 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 60.3 t -72.96 -27.94 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.696 -0.884 . . . . 0.0 112.0 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.665 HD12 ' HA ' ' B' ' 164' ' ' VAL . 90.6 mt -59.92 -48.13 82.95 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.117 -0.99 . . . . 0.0 111.019 -177.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -64.93 -39.98 94.33 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.26 -0.9 . . . . 0.0 110.885 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -60.32 -36.37 77.76 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.538 -0.726 . . . . 0.0 110.336 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . 0.441 ' CE2' ' CD2' ' A' ' 32' ' ' LEU . 3.0 t-105 -60.08 -40.02 88.09 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.578 -0.701 . . . . 0.0 109.782 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.12 -50.4 73.64 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.546 -0.721 . . . . 0.0 110.509 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -60.06 -34.1 72.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.368 -0.832 . . . . 0.0 109.876 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 . . . . . 0 N--CA 1.495 1.782 0 O-C-N 121.648 -0.658 . . . . 0.0 110.205 -179.863 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 121.128 0.489 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -94.42 73.72 3.84 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.445 -0.784 . . . . 0.0 109.853 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -64.04 -39.03 93.19 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.579 0.704 . . . . 0.0 110.535 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.2 mt -59.95 -40.07 87.75 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.535 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 p -138.37 106.86 5.84 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -79.21 -12.67 59.97 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.775 -0.578 . . . . 0.0 110.397 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -70.61 -26.77 63.65 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.388 -0.82 . . . . 0.0 109.645 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -65.66 -31.27 72.2 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.768 0.794 . . . . 0.0 109.201 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.88 -35.47 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.918 -0.489 . . . . 0.0 111.37 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.74 -27.15 68.1 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.045 -1.034 . . . . 0.0 111.184 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -69.44 -45.67 68.55 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.666 0.746 . . . . 0.0 110.094 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -69.44 -24.35 63.8 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.591 0.71 . . . . 0.0 109.169 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -70.86 -40.83 72.09 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.654 0.74 . . . . 0.0 109.605 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -70.62 -28.6 64.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.792 -0.568 . . . . 0.0 110.737 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.21 -27.46 35.29 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.486 -0.759 . . . . 0.0 110.609 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -60.0 -40.35 88.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.639 -0.663 . . . . 0.0 110.61 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.1 t -62.16 -39.48 92.8 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.432 -0.793 . . . . 0.0 109.499 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.3 tp -59.99 -40.65 89.91 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.426 ' HB3' HD13 ' A' ' 27' ' ' ILE . 15.4 m-85 -77.55 -38.95 47.48 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.897 -0.502 . . . . 0.0 109.957 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -94.96 95.61 8.74 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.602 -0.686 . . . . 0.0 109.802 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -69.96 -26.95 64.35 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.44 -0.788 . . . . 0.0 111.548 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -80.97 -8.74 59.83 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.074 -1.016 . . . . 0.0 111.405 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.62 25.23 27.82 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -87.67 -6.62 58.15 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.548 -0.972 . . . . 0.0 110.718 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.17 0.9 58.33 Favored Glycine 0 N--CA 1.489 2.183 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.117 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.2 p -144.56 141.42 29.45 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 119.15 1.475 . . . . 0.0 111.292 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.426 HD13 ' HB3' ' A' ' 19' ' ' PHE . 85.5 mt -104.34 127.85 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.698 -0.626 . . . . 0.0 109.354 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.1 p -103.25 143.36 32.75 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.761 -0.587 . . . . 0.0 110.964 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 11.0 p -39.49 -34.32 0.21 Allowed 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -61.9 -46.05 91.05 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.921 0.867 . . . . 0.0 108.943 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -59.27 -53.29 59.95 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.276 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.462 HD13 ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -56.49 -38.48 71.81 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.328 -0.857 . . . . 0.0 111.051 -178.577 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.85 -29.57 42.57 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.2 m -70.03 -39.45 75.76 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.644 -0.916 . . . . 0.0 110.491 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.6 t -61.24 -54.89 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.329 -0.857 . . . . 0.0 108.881 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.405 ' HB2' ' HD3' ' A' ' 43' ' ' PRO . 67.5 mtt -59.05 -29.31 67.2 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.656 -0.653 . . . . 0.0 109.382 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -59.49 -40.03 85.66 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.6 p -70.03 -16.97 63.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.972 -0.455 . . . . 0.0 110.744 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.6 tp -81.67 -31.17 32.4 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.354 -0.841 . . . . 0.0 109.663 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.25 -35.0 0.19 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -160.22 170.05 21.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.554 -0.968 . . . . 0.0 111.219 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -101.31 138.27 19.89 Favored Pre-proline 0 C--N 1.299 -1.607 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.733 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.405 ' HD3' ' HB2' ' A' ' 36' ' ' MET . 53.5 Cg_endo -67.18 -152.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.487 1.146 0 O-C-N 123.394 1.207 . . . . 0.0 109.427 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.4 p -139.97 144.7 37.15 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.191 -0.943 . . . . 0.0 111.123 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -49.72 -25.09 2.67 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.715 -0.616 . . . . 0.0 111.623 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.9 -54.87 9.84 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.185 0.993 . . . . 0.0 108.597 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -67.83 -39.87 83.83 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.764 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.475 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 8.5 mt -55.66 -37.01 67.71 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.676 0.751 . . . . 0.0 109.403 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.06 -40.04 96.53 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.775 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -63.83 -39.96 95.47 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.583 -0.698 . . . . 0.0 111.086 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 64.8 mtt -61.61 -41.76 97.91 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.633 -0.667 . . . . 0.0 109.919 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.87 HG22 ' OD2' ' A' ' 56' ' ' ASP . 48.4 mm -66.97 -39.99 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.781 -0.574 . . . . 0.0 110.467 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -61.32 -40.0 92.61 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.521 -0.737 . . . . 0.0 112.287 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -69.73 -29.72 67.16 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.995 -1.065 . . . . 0.0 110.723 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.629 HG21 ' SD ' ' A' ' 71' ' ' MET . 87.6 t -99.99 -8.94 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.637 -0.664 . . . . 0.0 111.246 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.87 ' OD2' HG22 ' A' ' 52' ' ' ILE . 7.2 m-20 -68.99 93.97 0.61 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.149 -0.969 . . . . 0.0 111.11 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.23 -38.49 91.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.655 -0.653 . . . . 0.0 109.504 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -91.72 -29.99 16.52 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.702 -0.624 . . . . 0.0 110.816 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.403 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 91.69 20.5 37.06 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -73.57 -39.1 64.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.372 -1.075 . . . . 0.0 110.42 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.772 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 129.05 -0.62 6.12 Favored Glycine 0 N--CA 1.497 2.744 0 C-N-CA 120.092 -1.051 . . . . 0.0 111.547 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.1 p -134.6 169.15 17.74 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.114 -1.227 . . . . 0.0 111.033 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.504 HD11 HD13 ' A' ' 52' ' ' ILE . 5.9 mt -102.68 118.9 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.813 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -98.79 170.01 9.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.533 -0.729 . . . . 0.0 110.766 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.504 ' O ' HD13 ' A' ' 69' ' ' LEU . 2.8 t80 -47.53 -50.02 52.18 Favored Pre-proline 0 N--CA 1.499 1.984 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.2 Cg_endo -67.18 -34.9 26.6 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 O-C-N 122.884 0.939 . . . . 0.0 111.223 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.96 -40.02 75.66 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.307 -0.871 . . . . 0.0 110.353 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -62.81 -41.63 99.38 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.63 -0.669 . . . . 0.0 111.252 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 65' ' ' PHE . 4.5 mp -67.86 -41.1 83.41 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.322 -0.861 . . . . 0.0 111.422 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.6 p -63.12 -39.99 96.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.542 -0.724 . . . . 0.0 110.879 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.629 ' SD ' HG21 ' A' ' 55' ' ' VAL . 48.8 ttp -68.61 -41.04 80.11 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.657 -0.652 . . . . 0.0 111.921 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 57.0 tpp -68.94 -42.53 76.62 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.257 -0.902 . . . . 0.0 111.772 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.0 -35.52 66.85 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.475 -0.766 . . . . 0.0 112.074 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.77 -55.01 5.69 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.432 -0.792 . . . . 0.0 111.421 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.443 ' HA ' ' OD2' ' A' ' 78' ' ' ASP . 88.1 mttt -59.94 -41.01 90.89 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.525 -0.735 . . . . 0.0 112.641 -178.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 27.7 ptm -59.95 -34.49 73.32 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.283 -0.885 . . . . 0.0 111.877 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -63.25 -49.92 72.21 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.406 -0.809 . . . . 0.0 111.856 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.443 ' OD2' ' HA ' ' A' ' 75' ' ' LYS . 3.9 p30 -69.61 -10.31 57.67 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.176 -0.952 . . . . 0.0 111.019 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.589 HG22 ' H ' ' A' ' 80' ' ' ASP 0.27 22.2 m -86.53 -175.03 5.29 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.589 ' H ' HG22 ' A' ' 79' ' ' THR . 84.3 m-20 -129.98 138.57 50.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.132 -0.98 . . . . 0.0 109.404 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 24.4 p -61.15 -27.01 68.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.478 -0.764 . . . . 0.0 110.374 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.04 -37.01 78.56 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.716 0.769 . . . . 0.0 109.016 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.01 -40.02 75.5 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.316 0.579 . . . . 0.0 110.079 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -62.56 -39.98 95.37 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.783 -0.573 . . . . 0.0 110.7 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.448 HG23 ' HE1' ' A' ' 141' ' ' PHE . 89.6 mt -65.06 -49.75 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.533 -0.729 . . . . 0.0 110.849 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.77 -42.82 84.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.348 -0.845 . . . . 0.0 111.207 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.438 ' O ' HG13 ' A' ' 91' ' ' VAL . 95.3 mt-10 -69.98 -39.64 75.82 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.405 -0.809 . . . . 0.0 111.773 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.532 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -64.77 -47.35 78.48 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.605 -0.684 . . . . 0.0 112.014 -178.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -67.26 -40.17 86.2 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.1 -1.0 . . . . 0.0 110.43 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -61.03 -39.94 91.69 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.694 -0.629 . . . . 0.0 111.738 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.532 HG22 ' O ' ' A' ' 88' ' ' ALA . 34.9 m -71.29 -40.06 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 0.0 111.112 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -72.39 -40.0 67.55 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.144 -0.973 . . . . 0.0 111.466 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -82.65 68.82 9.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.638 -0.664 . . . . 0.0 110.595 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.445 ' HZ2' ' CD2' ' A' ' 107' ' ' HIS . 25.3 mttt -60.0 -42.72 94.87 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.19 -0.944 . . . . 0.0 110.001 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -74.52 -24.37 58.97 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.49 -0.757 . . . . 0.0 110.411 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.29 24.63 76.75 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -67.93 -16.69 64.18 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.334 -1.097 . . . . 0.0 111.262 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.47 -19.58 14.46 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.446 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 29.0 p90 -145.82 156.75 43.78 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.336 -1.096 . . . . 0.0 109.438 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 65.9 mt -89.14 122.04 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.668 0.747 . . . . 0.0 110.154 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 m -80.78 170.67 15.99 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.351 0.596 . . . . 0.0 110.624 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.73 -47.58 84.61 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.682 -0.636 . . . . 0.0 109.991 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.0 -37.97 81.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.744 -0.597 . . . . 0.0 109.855 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -61.05 -39.93 91.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.586 -0.696 . . . . 0.0 110.674 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.436 HD13 HG13 ' A' ' 121' ' ' VAL . 1.5 tt -60.54 -46.94 88.31 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.323 -0.861 . . . . 0.0 110.398 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.545 ' HG2' HG21 ' A' ' 121' ' ' VAL . 92.1 mtt180 -60.04 -34.91 74.03 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.698 -0.626 . . . . 0.0 111.919 -178.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.445 ' CD2' ' HZ2' ' A' ' 94' ' ' LYS . 48.4 t60 -59.97 -41.95 93.06 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.123 -0.986 . . . . 0.0 110.874 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.5 t -77.07 -37.05 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.429 -0.795 . . . . 0.0 111.183 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.7 mmt -60.05 -49.97 75.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.5 m -67.18 -43.69 81.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.725 -0.61 . . . . 0.0 109.809 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -61.82 -28.17 69.28 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.722 -0.611 . . . . 0.0 109.522 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.8 mt -70.03 -30.28 67.53 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.036 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 112.09 22.17 6.01 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -120.48 137.76 54.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.376 -1.073 . . . . 0.0 110.26 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -99.95 117.75 34.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.534 -0.729 . . . . 0.0 109.396 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 67.6 mt -131.24 156.85 44.68 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.458 -0.776 . . . . 0.0 110.15 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 m -82.51 165.8 19.85 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -63.39 -29.07 70.43 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -68.19 -32.83 73.35 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.508 0.67 . . . . 0.0 109.76 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -68.64 -35.07 76.79 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.545 HG21 ' HG2' ' A' ' 106' ' ' ARG . 78.0 t -69.98 -38.33 75.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-O 121.649 0.738 . . . . 0.0 109.028 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.421 ' HA ' HD12 ' A' ' 125' ' ' ILE . 56.4 t0 -60.0 -43.34 95.26 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.746 -0.596 . . . . 0.0 109.928 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -59.9 -40.18 87.93 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.356 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 13.7 mmt -54.58 -36.83 64.82 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.154 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 122' ' ' ASP . 91.1 mt -67.75 -38.42 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 121.252 0.548 . . . . 0.0 109.825 178.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -60.03 -39.98 87.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.641 -0.662 . . . . 0.0 110.959 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -63.68 -39.83 95.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.545 -0.722 . . . . 0.0 111.403 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.588 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -98.98 -7.78 26.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.377 -0.827 . . . . 0.0 112.046 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -103.38 78.27 1.59 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.025 -1.047 . . . . 0.0 111.268 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 86.8 mt -66.99 -39.96 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.702 -0.624 . . . . 0.0 110.022 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 34.0 p-10 -59.03 -39.75 82.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.669 -0.644 . . . . 0.0 111.266 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 98.65 11.69 46.55 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.366 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -80.88 -16.7 52.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.943 -1.328 . . . . 0.0 110.151 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.68 5.18 71.94 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.747 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -132.34 133.41 43.96 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.237 -1.155 . . . . 0.0 110.035 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.7 t -90.88 114.58 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.442 -0.786 . . . . 0.0 109.936 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -87.7 -178.36 6.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.659 -0.651 . . . . 0.0 109.764 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -65.0 -41.33 95.47 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.613 -0.68 . . . . 0.0 110.092 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -61.69 -42.57 99.11 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.575 -0.703 . . . . 0.0 110.798 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -64.18 -39.45 94.02 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.831 0.824 . . . . 0.0 109.708 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.448 ' HE1' HG23 ' A' ' 85' ' ' ILE . 64.3 t80 -60.05 -46.82 88.27 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.426 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.414 ' O ' HG22 ' A' ' 146' ' ' THR . 99.3 t -65.13 -39.97 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.303 -0.873 . . . . 0.0 111.041 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.405 ' HA ' HG22 ' A' ' 146' ' ' THR . 61.6 tt0 -61.04 -39.97 91.83 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.516 -0.74 . . . . 0.0 110.381 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.588 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 49.9 mtp -60.59 -44.55 96.12 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.654 -0.654 . . . . 0.0 111.943 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.433 ' CE ' ' CZ ' ' A' ' 141' ' ' PHE . 42.9 mtt -73.24 -39.98 65.04 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.694 -0.629 . . . . 0.0 111.805 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 142' ' ' VAL . 15.1 t -75.1 -8.16 55.77 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.41 -0.806 . . . . 0.0 111.262 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -92.83 120.04 32.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.203 -0.935 . . . . 0.0 110.363 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.6 pttm . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.608 179.788 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -63.56 -39.21 97.37 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -63.66 -40.25 96.37 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.56 -0.965 . . . . 0.0 111.368 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -64.32 -39.34 93.72 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.028 -1.045 . . . . 0.0 110.354 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -60.02 -49.85 76.04 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.663 -0.648 . . . . 0.0 111.737 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 19.7 tt -69.94 -26.01 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 120.987 -1.071 . . . . 0.0 110.727 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.92 90.89 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.372 -0.83 . . . . 0.0 110.919 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 25.8 ttm-85 -60.06 -41.01 91.42 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.517 -0.739 . . . . 0.0 110.759 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.473 HD22 ' N ' ' B' ' 163' ' ' LEU . 4.6 mm? -61.92 -38.89 90.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.576 -0.702 . . . . 0.0 110.19 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.53 -40.12 87.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.517 -0.739 . . . . 0.0 111.191 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.53 -44.12 93.91 Favored Glycine 0 N--CA 1.501 2.976 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 12.0 p -81.94 -11.64 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.687 -0.89 . . . . 0.0 111.455 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.548 HD23 ' C ' ' B' ' 167' ' ' LEU . 9.2 tt -60.03 -50.02 75.35 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.188 -0.945 . . . . 0.0 110.434 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 30.0 mtp-105 -70.02 -31.09 68.58 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.588 -0.695 . . . . 0.0 110.538 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.97 -40.02 87.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.586 -0.696 . . . . 0.0 109.779 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -59.99 -41.29 91.73 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.671 -0.643 . . . . 0.0 109.928 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.1 -20.73 64.07 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.388 -0.82 . . . . 0.0 111.307 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -59.76 -39.9 86.4 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.318 -0.863 . . . . 0.0 110.319 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.538 -0.726 . . . . 0.0 110.219 179.622 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.438 ' HB3' ' NE2' ' A' ' 3' ' ' GLN . . . . . . . . 0 N--CA 1.499 1.99 0 CA-C-O 121.196 0.522 . . . . 0.0 110.047 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -112.85 27.06 9.95 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.563 -0.71 . . . . 0.0 110.407 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.438 ' NE2' ' HB3' ' A' ' 1' ' ' ALA . 6.7 mt-30 -59.98 -39.96 87.48 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.818 0.818 . . . . 0.0 110.029 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.57 156.47 34.98 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.402 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -133.35 106.77 7.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.578 -0.701 . . . . 0.0 109.957 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -80.02 -9.78 59.72 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 122.046 -0.409 . . . . 0.0 111.717 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -69.81 -26.68 64.37 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.035 -1.041 . . . . 0.0 110.185 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -70.23 -25.85 63.58 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.39 -0.819 . . . . 0.0 110.158 177.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.9 mm -58.94 -50.02 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.708 -0.62 . . . . 0.0 111.046 -176.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.91 -20.04 63.35 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.225 -0.922 . . . . 0.0 110.688 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -68.21 -54.46 17.63 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.462 -0.774 . . . . 0.0 109.678 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.575 ' CB ' HD21 ' A' ' 69' ' ' LEU . 51.9 m-85 -66.62 -21.67 66.12 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.462 0.648 . . . . 0.0 109.57 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -69.14 -44.06 73.08 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.415 0.626 . . . . 0.0 110.281 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -71.42 -24.46 62.05 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.751 -0.593 . . . . 0.0 111.299 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.7 -33.27 41.14 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.319 -0.863 . . . . 0.0 110.908 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.416 ' CB ' ' CE1' ' A' ' 65' ' ' PHE . 56.2 t80 -59.95 -37.5 79.74 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.695 -0.628 . . . . 0.0 111.255 -177.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 91.9 p -61.42 -38.79 88.4 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.243 -0.91 . . . . 0.0 110.087 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 46.3 tp -60.11 -40.19 88.84 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.541 -0.724 . . . . 0.0 109.758 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -78.77 -37.39 41.2 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.732 -0.605 . . . . 0.0 109.783 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.595 ' HB2' HD11 ' A' ' 27' ' ' ILE . 27.5 t0 -93.58 94.94 8.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.642 -0.661 . . . . 0.0 110.176 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -66.13 -30.11 70.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.468 -0.77 . . . . 0.0 111.393 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -79.96 -9.93 59.73 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.09 -1.006 . . . . 0.0 111.373 -177.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.79 26.71 58.12 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 57.9 p30 -89.96 -3.48 58.0 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.713 -0.875 . . . . 0.0 110.886 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.96 4.45 72.12 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.248 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 58.3 p -143.76 142.19 30.79 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 119.288 1.544 . . . . 0.0 111.945 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.595 HD11 ' HB2' ' A' ' 20' ' ' ASP . 49.4 mm -103.69 125.3 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.747 -0.596 . . . . 0.0 110.055 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.9 m -101.54 141.38 34.49 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.541 -0.725 . . . . 0.0 110.244 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.455 ' HB ' HD13 ' A' ' 48' ' ' LEU . 28.2 p -39.56 -34.79 0.25 Allowed 'General case' 0 N--CA 1.51 2.543 0 O-C-N 121.871 -0.518 . . . . 0.0 112.364 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -60.12 -49.36 77.94 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.327 -0.858 . . . . 0.0 109.11 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -57.58 -51.09 70.91 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.11 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.582 HD13 ' O ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -54.53 -38.81 67.01 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.154 -0.966 . . . . 0.0 111.002 -179.034 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -51.61 -29.55 25.2 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.3 m -65.09 -40.01 93.98 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.528 -0.983 . . . . 0.0 110.074 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.6 t -68.3 -40.07 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-O 121.384 0.612 . . . . 0.0 109.775 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.464 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 13.4 mmt -59.93 -39.89 87.04 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.736 -0.602 . . . . 0.0 111.712 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -60.76 -40.01 90.88 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.757 0.789 . . . . 0.0 110.346 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.5 t -64.56 -24.84 67.74 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.766 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.529 ' HG ' HD22 ' B' ' 167' ' ' LEU . 4.3 mm? -89.77 -17.72 27.68 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.152 -0.968 . . . . 0.0 110.434 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.41 -51.44 0.22 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -166.73 176.47 7.14 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.59 -0.947 . . . . 0.0 111.197 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -99.17 133.47 22.08 Favored Pre-proline 0 N--CA 1.492 1.664 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.927 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.464 ' HD3' ' HB3' ' A' ' 36' ' ' MET . 52.1 Cg_endo -66.3 -147.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.306 0 O-C-N 123.207 1.109 . . . . 0.0 109.414 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.8 p -125.94 140.73 52.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.001 -1.062 . . . . 0.0 110.901 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -48.17 -24.69 1.21 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.713 -0.617 . . . . 0.0 112.039 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.25 -44.18 65.8 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.247 1.022 . . . . 0.0 108.461 176.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -69.96 -39.85 75.78 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.323 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.455 HD13 ' HB ' ' A' ' 29' ' ' THR . 8.5 mt -55.88 -38.03 69.62 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.483 -0.76 . . . . 0.0 109.534 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -40.57 97.77 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.152 -178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -64.43 -39.44 93.84 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.611 -0.681 . . . . 0.0 111.267 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 61.9 mtt -62.93 -39.98 96.25 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.679 -0.638 . . . . 0.0 109.917 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.845 HG22 ' OD2' ' A' ' 56' ' ' ASP . 48.4 mm -69.23 -39.91 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.682 -0.636 . . . . 0.0 110.91 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -64.2 -40.09 95.36 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.447 -0.783 . . . . 0.0 112.519 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.852 ' HG3' HG23 ' A' ' 55' ' ' VAL . 15.3 pt-20 -69.93 -27.34 64.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.932 -1.105 . . . . 0.0 110.483 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.852 HG23 ' HG3' ' A' ' 54' ' ' GLU . 48.6 t -99.9 -10.01 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.658 -0.651 . . . . 0.0 110.917 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.845 ' OD2' HG22 ' A' ' 52' ' ' ILE . 4.0 m-20 -69.12 99.01 1.06 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.188 -0.945 . . . . 0.0 110.962 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.79 -36.95 83.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.593 -0.692 . . . . 0.0 109.879 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -94.54 -26.11 16.55 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.654 -0.654 . . . . 0.0 110.84 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.7 20.01 49.32 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -73.9 -34.74 64.51 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.436 -1.038 . . . . 0.0 110.162 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.804 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 124.08 2.13 8.57 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 120.34 -0.933 . . . . 0.0 111.204 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 82.7 p -138.3 168.56 19.49 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.063 -1.257 . . . . 0.0 111.21 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.468 HD11 HD13 ' A' ' 52' ' ' ILE . 7.7 mt -103.69 121.0 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.288 0.566 . . . . 0.0 110.537 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -98.77 170.38 8.81 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.373 0.606 . . . . 0.0 110.47 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.488 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.5 OUTLIER -47.63 -50.0 53.21 Favored Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 121.626 -0.671 . . . . 0.0 112.533 -179.493 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.653 ' O ' HG23 ' A' ' 70' ' ' THR . 40.8 Cg_endo -67.87 -35.12 21.94 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 122.833 0.912 . . . . 0.0 111.237 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.99 -40.01 75.58 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.277 -0.889 . . . . 0.0 110.339 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -63.66 -40.77 97.67 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.548 -0.72 . . . . 0.0 110.933 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.575 HD21 ' CB ' ' A' ' 12' ' ' PHE . 84.3 mt -64.56 -39.96 94.69 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.433 -0.792 . . . . 0.0 111.346 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.653 HG23 ' O ' ' A' ' 66' ' ' PRO . 68.8 p -60.6 -40.79 93.1 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.458 -0.776 . . . . 0.0 110.561 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 51.8 ttp -69.99 -39.96 75.59 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.561 -0.712 . . . . 0.0 111.708 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.402 ' SD ' HG21 ' B' ' 166' ' ' VAL . 2.6 tpt -60.05 -49.96 75.58 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.436 -0.79 . . . . 0.0 111.364 -178.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.01 -29.27 66.29 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.455 -0.778 . . . . 0.0 111.369 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -72.87 -40.02 65.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.433 -0.792 . . . . 0.0 111.733 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -69.55 -46.58 66.12 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.355 -0.841 . . . . 0.0 112.24 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 77.0 mtm -60.01 -39.38 85.61 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.031 -1.043 . . . . 0.0 111.018 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -66.91 -51.27 57.39 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.549 -0.719 . . . . 0.0 110.816 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -69.09 -31.94 71.01 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.583 0.706 . . . . 0.0 110.134 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.606 HG22 ' H ' ' A' ' 80' ' ' ASP 0.253 23.2 m -90.89 -174.64 4.1 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.606 ' H ' HG22 ' A' ' 79' ' ' THR . 81.6 m-20 -123.81 144.56 49.64 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.099 -1.001 . . . . 0.0 110.055 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.2 p -61.59 -27.77 68.87 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.702 -0.624 . . . . 0.0 110.452 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -60.11 -37.87 81.29 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.627 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -70.04 -40.04 75.38 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.65 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -67.71 -37.75 82.67 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.455 -0.778 . . . . 0.0 110.28 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 71.0 mt -63.82 -49.86 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.736 -0.602 . . . . 0.0 110.002 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -57.58 -39.85 77.67 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.481 -0.762 . . . . 0.0 110.982 -178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.783 ' O ' HG23 ' A' ' 91' ' ' VAL . 96.5 mt-10 -69.45 -42.09 75.38 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.514 -0.741 . . . . 0.0 111.655 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.438 ' HA ' HG11 ' B' ' 164' ' ' VAL . . . -66.56 -45.38 79.54 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.502 -0.748 . . . . 0.0 111.608 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.415 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 35.4 t80 -60.01 -47.07 87.33 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.469 -0.77 . . . . 0.0 109.542 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -60.09 -34.85 74.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.927 -0.483 . . . . 0.0 110.414 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 87' ' ' GLU . 84.9 t -68.11 -47.77 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.373 -0.83 . . . . 0.0 109.795 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.478 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 13.5 m-85 -64.25 -37.45 87.51 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.521 -0.737 . . . . 0.0 110.515 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -75.58 85.44 2.64 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.52 -0.737 . . . . 0.0 110.193 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -67.68 -41.11 84.18 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.374 -0.829 . . . . 0.0 110.209 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -81.28 -12.33 59.11 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.543 -0.723 . . . . 0.0 111.589 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 59.97 31.15 71.59 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -78.23 0.48 25.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.503 -0.998 . . . . 0.0 111.392 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.5 -10.06 75.66 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.607 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -137.58 137.25 38.35 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.08 -1.247 . . . . 0.0 109.979 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.564 HG22 ' CD1' ' A' ' 105' ' ' LEU . 74.6 mt -88.72 129.98 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.467 -0.771 . . . . 0.0 109.359 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.7 m -109.86 151.3 27.21 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.642 0.734 . . . . 0.0 111.103 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.523 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -49.26 -41.22 37.09 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.62 -0.675 . . . . 0.0 110.799 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.04 -34.32 73.23 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.408 -0.807 . . . . 0.0 108.834 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -74.82 -28.27 60.64 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.688 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.601 ' HB3' HG13 ' A' ' 121' ' ' VAL . 5.9 mp -65.04 -39.97 94.12 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.798 0.809 . . . . 0.0 109.121 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 48.1 ttt-85 -59.96 -34.99 74.02 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.151 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -60.09 -43.91 95.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.317 -0.865 . . . . 0.0 111.048 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.478 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 75.4 t -72.11 -40.38 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.442 -0.787 . . . . 0.0 111.244 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.628 ' SD ' HG22 ' A' ' 121' ' ' VAL . 67.6 mtt -58.07 -49.57 76.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.346 -0.846 . . . . 0.0 110.505 -178.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.5 m -66.03 -42.78 89.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.62 -0.675 . . . . 0.0 109.774 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -62.53 -29.76 70.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.685 -0.634 . . . . 0.0 109.333 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 19.1 mt -69.94 -32.17 70.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.698 -0.626 . . . . 0.0 109.964 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 109.57 26.43 5.09 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -124.16 138.45 54.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.441 -1.035 . . . . 0.0 109.997 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -99.97 118.18 35.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.569 -0.707 . . . . 0.0 110.074 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 86.3 mt -131.68 157.3 44.11 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.6 -0.688 . . . . 0.0 109.667 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.88 162.08 22.91 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.611 -0.681 . . . . 0.0 109.555 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -58.8 -28.32 65.87 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.17 -32.57 73.74 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -39.9 95.25 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.628 HG22 ' SD ' ' A' ' 109' ' ' MET . 73.0 t -70.03 -39.96 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 121.536 0.684 . . . . 0.0 110.567 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -60.04 -44.99 94.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.751 -0.593 . . . . 0.0 110.179 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -60.33 -40.98 92.59 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.645 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 86.6 mmm -55.2 -38.33 68.27 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 119.642 -0.823 . . . . 0.0 108.976 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.402 ' O ' ' HB2' ' A' ' 129' ' ' ASP . 47.3 mm -66.84 -38.06 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-O 121.512 0.672 . . . . 0.0 109.65 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -59.07 -40.0 83.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.68 -0.638 . . . . 0.0 111.555 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.04 -39.87 87.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.619 -0.676 . . . . 0.0 111.043 -178.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.99 0.01 34.44 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.377 -0.827 . . . . 0.0 111.572 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 57.8 t0 -87.55 71.23 9.8 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.019 -1.051 . . . . 0.0 110.679 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.5 mt -67.37 -42.26 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.358 -0.838 . . . . 0.0 110.532 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -71.33 -20.07 62.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.362 -0.836 . . . . 0.0 111.348 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.43 22.7 58.14 Favored Glycine 0 N--CA 1.496 2.682 0 C-N-CA 120.367 -0.921 . . . . 0.0 110.869 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -82.76 -12.5 57.48 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.29 -1.123 . . . . 0.0 111.152 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.4 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 90.0 1.73 75.81 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -139.5 152.1 46.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.267 -1.137 . . . . 0.0 109.459 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 70.7 t -92.46 118.26 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.56 -0.712 . . . . 0.0 110.168 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -84.82 175.51 9.09 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -65.05 -41.42 95.18 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.315 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -61.46 -45.86 92.51 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.703 -0.623 . . . . 0.0 111.025 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -66.0 -40.06 90.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.494 -0.754 . . . . 0.0 110.704 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.415 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 77.5 t80 -59.95 -44.22 94.52 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.981 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.758 ' O ' HG22 ' A' ' 146' ' ' THR . 89.6 t -69.56 -39.63 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.416 -0.802 . . . . 0.0 110.917 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 58.3 tt0 -59.98 -47.66 84.89 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.528 -0.732 . . . . 0.0 110.684 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.1 tmm? -60.16 -39.65 87.17 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.41 -0.806 . . . . 0.0 110.693 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 97.5 mmm -69.63 -40.0 76.83 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.603 -0.685 . . . . 0.0 111.053 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.758 HG22 ' O ' ' A' ' 142' ' ' VAL . 9.4 t -96.04 25.59 4.71 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.381 -0.824 . . . . 0.0 110.681 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -96.87 121.83 39.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.447 -0.783 . . . . 0.0 110.695 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 98.2 mttt . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.844 179.507 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -162.75 171.89 38.67 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -60.6 -39.94 89.97 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.648 -0.913 . . . . 0.0 110.476 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -60.04 -39.85 87.37 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.637 -0.664 . . . . 0.0 110.822 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -60.03 -40.0 87.85 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.398 -0.814 . . . . 0.0 110.617 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 85.4 mt -69.92 -40.03 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.375 -0.828 . . . . 0.0 110.813 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.46 -39.75 91.99 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.541 -0.725 . . . . 0.0 110.882 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -60.04 -39.95 87.69 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.583 -0.698 . . . . 0.0 110.468 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.99 -40.01 94.33 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.496 -0.753 . . . . 0.0 111.13 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.438 HG11 ' HA ' ' A' ' 88' ' ' ALA . 55.4 t -67.07 -40.0 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.381 -0.824 . . . . 0.0 110.971 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -53.72 -47.89 63.2 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.402 HG21 ' SD ' ' A' ' 72' ' ' MET . 84.4 t -75.13 -22.65 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.693 -0.886 . . . . 0.0 110.569 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.539 HD23 ' C ' ' B' ' 167' ' ' LEU . 5.7 tt -58.7 -49.97 75.6 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.338 -0.851 . . . . 0.0 110.593 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 30.4 ttt85 -65.07 -38.8 91.95 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.468 -0.77 . . . . 0.0 110.136 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.05 -31.46 70.0 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.58 -0.7 . . . . 0.0 109.902 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 4.0 t-105 -60.05 -45.42 92.92 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.697 -0.627 . . . . 0.0 109.883 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.58 -53.16 60.81 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.59 -0.694 . . . . 0.0 110.193 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -60.08 -40.01 88.06 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.508 -0.745 . . . . 0.0 110.732 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 . . . . . 0 N--CA 1.496 1.837 0 O-C-N 121.494 -0.753 . . . . 0.0 110.289 179.855 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 121.364 0.602 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -128.73 114.91 17.2 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -121.15 158.81 27.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.352 -0.842 . . . . 0.0 110.864 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.442 ' O ' HG23 ' A' ' 5' ' ' THR . 93.1 mt -77.68 -178.36 5.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.545 -0.722 . . . . 0.0 109.817 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 4' ' ' LEU . 1.1 p -153.68 110.08 3.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.753 -0.592 . . . . 0.0 110.183 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -84.66 -8.64 58.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.763 -0.586 . . . . 0.0 110.926 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -67.82 -33.52 74.94 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.095 -1.003 . . . . 0.0 110.812 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -65.04 -39.35 93.22 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.517 -0.739 . . . . 0.0 110.744 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 92.7 mt -59.99 -28.2 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.72 -0.613 . . . . 0.0 111.395 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.15 -39.51 94.17 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.148 -0.97 . . . . 0.0 109.743 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -59.98 -40.07 87.84 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.429 ' CG ' HD21 ' A' ' 69' ' ' LEU . 37.2 m-85 -64.29 -20.1 65.85 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.681 -0.637 . . . . 0.0 111.092 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HD3' ' CZ ' ' A' ' 65' ' ' PHE . 73.2 mmtt -69.08 -39.94 78.74 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.196 -0.94 . . . . 0.0 109.407 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -63.64 -59.66 4.31 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.453 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.1 -30.16 71.08 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.371 -0.83 . . . . 0.0 112.232 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.488 ' CG ' ' CE2' ' A' ' 65' ' ' PHE . 57.9 t80 -58.39 -49.97 75.35 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.167 -0.958 . . . . 0.0 110.745 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.0 m -66.15 -39.92 90.18 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.29 -0.881 . . . . 0.0 109.685 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 61.0 tp -62.79 -39.48 94.38 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.416 0.627 . . . . 0.0 109.431 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.536 ' HE2' HG21 ' A' ' 27' ' ' ILE . 32.2 t80 -74.15 -33.19 63.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.863 -0.523 . . . . 0.0 110.202 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -92.33 102.04 14.52 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.468 -0.77 . . . . 0.0 110.129 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -60.02 -39.2 85.02 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.482 -0.761 . . . . 0.0 111.486 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -80.03 -13.15 59.54 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.034 -1.041 . . . . 0.0 111.148 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.19 30.54 58.03 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -90.08 -2.88 58.17 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.714 -0.874 . . . . 0.0 110.84 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.61 3.95 62.4 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 120.22 -0.991 . . . . 0.0 111.432 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.0 p -145.8 142.41 28.84 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 119.197 1.498 . . . . 0.0 111.44 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.536 HG21 ' HE2' ' A' ' 19' ' ' PHE . 85.4 mt -100.68 122.68 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.3 m -95.82 139.47 31.99 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.48 -0.762 . . . . 0.0 110.151 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.626 HG22 ' CD1' ' A' ' 52' ' ' ILE . 65.0 p -42.39 -34.34 0.8 Allowed 'General case' 0 N--CA 1.51 2.571 0 O-C-N 121.961 -0.462 . . . . 0.0 111.588 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -64.31 -48.63 74.9 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.883 0.849 . . . . 0.0 109.136 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -60.0 -56.03 26.67 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.691 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.4 HD12 ' CE2' ' A' ' 19' ' ' PHE . 7.4 tt -61.09 -34.71 75.37 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.21 -0.931 . . . . 0.0 111.056 -178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -55.82 -32.57 59.1 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.4 m -70.01 -39.39 75.88 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.955 -0.733 . . . . 0.0 110.189 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.0 t -60.0 -57.29 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 94.7 mtp -59.98 -25.72 65.46 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.608 -0.682 . . . . 0.0 109.796 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 43.2 ttt180 -59.99 -46.02 90.82 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.736 0.779 . . . . 0.0 109.31 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.5 t -70.43 -16.98 63.0 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.821 -0.549 . . . . 0.0 111.14 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 39' ' ' LEU . 4.3 mm? -89.88 -18.98 25.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.327 -0.858 . . . . 0.0 110.35 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.4 -50.37 0.2 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -168.01 172.17 9.08 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.645 -0.914 . . . . 0.0 110.674 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -120.61 138.85 27.99 Favored Pre-proline 0 C--N 1.299 -1.628 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.429 ' HG2' HD21 ' A' ' 48' ' ' LEU . 53.6 Cg_endo -68.36 -148.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.224 1.118 . . . . 0.0 109.453 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 p -136.75 152.37 50.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.104 -0.997 . . . . 0.0 110.49 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -52.06 -22.41 4.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.53 -0.731 . . . . 0.0 112.033 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.1 -60.0 2.45 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.17 -0.956 . . . . 0.0 108.994 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -70.01 -33.75 72.42 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.734 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.54 HD13 ' HB ' ' A' ' 29' ' ' THR . 12.9 mt -57.31 -36.88 71.66 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.526 -0.734 . . . . 0.0 109.449 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.44 -30.9 66.57 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.163 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -70.39 -45.08 66.72 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.563 -0.711 . . . . 0.0 111.707 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 79.2 mtm -63.27 -41.67 99.05 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.491 0.662 . . . . 0.0 109.298 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.803 HG22 ' OD2' ' A' ' 56' ' ' ASP . 97.6 mt -68.58 -31.92 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -58.04 -48.12 81.03 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.574 -0.704 . . . . 0.0 110.967 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -64.82 -24.24 67.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.341 -0.849 . . . . 0.0 110.11 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 67.2 t -98.17 -12.01 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.545 -0.722 . . . . 0.0 111.358 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.803 ' OD2' HG22 ' A' ' 52' ' ' ILE . 26.1 m-20 -72.13 101.79 2.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.152 -0.967 . . . . 0.0 111.385 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.06 -39.98 90.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.558 -0.714 . . . . 0.0 109.445 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -88.26 -31.31 19.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.644 -0.66 . . . . 0.0 110.378 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.79 24.36 32.97 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -74.39 -31.96 62.54 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.459 -1.024 . . . . 0.0 110.465 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.68 -2.04 10.16 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.207 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 82.5 p -134.95 168.77 18.48 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.109 -1.23 . . . . 0.0 110.284 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.709 HD11 HG12 ' A' ' 52' ' ' ILE . 6.9 mt -104.49 120.37 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.714 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -98.56 170.25 8.94 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.488 0.661 . . . . 0.0 110.538 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.488 ' CE2' ' CG ' ' A' ' 16' ' ' PHE . 1.2 t80 -50.03 -48.56 78.58 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.4 Cg_endo -69.12 -36.57 12.24 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 O-C-N 122.768 0.878 . . . . 0.0 111.003 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.86 -39.94 76.07 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.484 -0.76 . . . . 0.0 109.223 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -59.89 -45.76 91.49 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.912 -0.493 . . . . 0.0 110.715 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.429 HD21 ' CG ' ' A' ' 12' ' ' PHE . 84.6 mt -63.57 -40.23 96.43 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.412 -0.805 . . . . 0.0 111.246 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.3 m -60.0 -44.04 94.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.441 -0.787 . . . . 0.0 110.719 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -39.98 93.51 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.708 -0.62 . . . . 0.0 111.039 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.431 ' O ' ' HG2' ' A' ' 76' ' ' MET . 57.2 tpp -59.95 -49.76 76.42 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.319 -0.863 . . . . 0.0 110.468 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.57 75.34 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.404 -0.81 . . . . 0.0 110.64 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -74.92 -37.75 61.96 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.458 -0.776 . . . . 0.0 111.119 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.706 ' O ' HG22 ' A' ' 79' ' ' THR . 63.0 mmtt -70.04 -40.03 75.39 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.602 -0.686 . . . . 0.0 112.123 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' A' ' 72' ' ' MET . 39.0 mmt -60.03 -47.29 86.47 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.244 -0.91 . . . . 0.0 112.322 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -68.48 -40.02 81.13 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.25 -0.906 . . . . 0.0 111.065 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -70.54 -20.96 62.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.484 -0.76 . . . . 0.0 111.56 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.706 HG22 ' O ' ' A' ' 75' ' ' LYS . 14.6 t -107.29 -165.33 1.05 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.047 0.927 . . . . 0.0 111.803 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -130.01 136.54 49.52 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.894 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.6 t -60.58 -33.12 72.26 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.624 -0.672 . . . . 0.0 109.895 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -60.07 -34.44 73.45 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.397 0.618 . . . . 0.0 109.461 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -69.9 -40.08 75.84 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.348 0.594 . . . . 0.0 110.374 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -64.66 -34.24 77.83 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.591 -0.693 . . . . 0.0 111.29 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.665 HG23 ' HE2' ' A' ' 141' ' ' PHE . 87.8 mt -69.12 -43.89 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.484 -0.76 . . . . 0.0 110.133 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -59.93 -43.99 94.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.557 -0.714 . . . . 0.0 110.969 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -70.03 -39.9 75.48 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.348 -0.845 . . . . 0.0 110.993 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.518 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -60.73 -44.96 96.0 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.598 -0.689 . . . . 0.0 110.629 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -67.47 -39.27 85.28 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.428 -0.795 . . . . 0.0 110.359 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -60.45 -40.03 89.68 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.523 -0.736 . . . . 0.0 112.268 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 88' ' ' ALA . 34.7 m -71.17 -39.19 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.098 -1.002 . . . . 0.0 111.291 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.465 ' HE2' HG21 ' B' ' 164' ' ' VAL . 11.8 m-85 -70.9 -37.15 72.95 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.114 -0.991 . . . . 0.0 110.669 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -79.79 69.04 6.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.681 -0.637 . . . . 0.0 110.806 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -59.94 -46.15 90.3 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.175 -0.953 . . . . 0.0 109.722 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.9 p-10 -69.89 -20.48 63.37 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.566 -0.709 . . . . 0.0 110.602 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.8 25.23 71.74 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -70.04 -9.76 56.42 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.285 -1.127 . . . . 0.0 111.31 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.11 -10.05 65.59 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -136.84 141.94 42.85 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.158 -1.201 . . . . 0.0 109.021 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 62.0 mt -89.49 120.45 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.407 -0.808 . . . . 0.0 109.929 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 m -84.06 168.56 15.78 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.267 0.555 . . . . 0.0 110.637 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.03 -41.17 91.28 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.621 -0.675 . . . . 0.0 109.552 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.53 -38.35 89.62 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.316 0.579 . . . . 0.0 109.44 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -61.17 -39.95 92.08 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.697 -0.627 . . . . 0.0 110.791 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.415 ' HB3' HG13 ' A' ' 121' ' ' VAL . 1.2 tt -63.6 -44.46 93.93 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.77 0.795 . . . . 0.0 109.35 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.9 ttt-85 -60.66 -32.69 71.86 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.853 -0.53 . . . . 0.0 111.356 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -60.01 -42.38 94.19 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.159 -0.963 . . . . 0.0 110.837 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.434 HG12 ' CD1' ' A' ' 112' ' ' LEU . 86.6 t -74.1 -40.02 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.27 -0.894 . . . . 0.0 110.851 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 13.0 mmt -57.43 -49.18 77.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.4 -0.813 . . . . 0.0 110.067 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.6 m -64.64 -44.95 88.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.644 -0.66 . . . . 0.0 109.551 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -61.63 -29.31 69.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.7 -0.625 . . . . 0.0 109.567 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.434 ' CD1' HG12 ' A' ' 108' ' ' VAL . 11.7 mt -69.97 -30.79 68.22 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.216 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 111.13 25.62 4.98 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -122.84 136.78 54.98 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.454 -1.027 . . . . 0.0 109.727 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -99.94 119.96 39.05 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.548 -0.72 . . . . 0.0 110.674 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 71.3 mt -135.75 158.32 44.67 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.718 -0.614 . . . . 0.0 110.066 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.03 161.12 26.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.602 -0.686 . . . . 0.0 109.302 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -61.71 -27.9 69.04 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.71 -33.82 73.05 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.674 0.749 . . . . 0.0 109.379 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -67.53 -36.83 81.78 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.495 0.665 . . . . 0.0 109.226 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.415 HG13 ' HB3' ' A' ' 105' ' ' LEU . 56.1 t -69.98 -39.95 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.579 0.704 . . . . 0.0 109.78 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -60.0 -38.72 83.44 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.744 -0.597 . . . . 0.0 109.918 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -59.22 -39.72 83.58 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.378 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 55.9 mtt -55.34 -36.01 65.82 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 119.286 -0.965 . . . . 0.0 109.338 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.4 mm -67.31 -39.54 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.72 -0.613 . . . . 0.0 109.605 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -58.26 -38.24 76.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.606 -0.684 . . . . 0.0 110.734 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.97 -36.79 77.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.667 -0.646 . . . . 0.0 110.096 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.501 ' HB3' HG22 ' A' ' 136' ' ' VAL . . . -103.61 -4.33 23.99 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.563 -0.71 . . . . 0.0 111.307 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -82.49 71.1 9.56 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.959 -1.088 . . . . 0.0 110.24 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 85.3 mt -64.76 -46.88 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.525 -0.734 . . . . 0.0 110.682 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -70.49 -20.18 62.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.541 -0.724 . . . . 0.0 111.785 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.3 22.69 58.4 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -81.05 -10.32 59.7 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.366 -1.079 . . . . 0.0 110.804 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.03 0.63 71.07 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -141.42 156.49 45.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -1.193 . . . . 0.0 109.756 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.501 HG22 ' HB3' ' A' ' 128' ' ' ALA . 63.9 t -95.24 119.36 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.53 -0.731 . . . . 0.0 109.976 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -87.88 173.6 8.84 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -60.07 -50.03 75.34 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.649 -0.657 . . . . 0.0 110.054 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -60.66 -41.48 95.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.571 -0.706 . . . . 0.0 111.794 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -65.81 -36.35 83.27 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.2 -0.937 . . . . 0.0 109.882 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.665 ' HE2' HG23 ' A' ' 85' ' ' ILE . 65.6 t80 -62.14 -43.94 97.73 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.034 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.1 t -70.06 -45.24 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.4 -0.812 . . . . 0.0 111.693 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -60.32 -44.73 95.2 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.51 -0.744 . . . . 0.0 110.444 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -61.79 -39.99 93.63 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.697 -0.627 . . . . 0.0 109.945 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.2 mmt -67.71 -39.96 84.3 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.555 -0.715 . . . . 0.0 109.988 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.429 ' O ' HG22 ' A' ' 146' ' ' THR . 36.2 m -89.14 1.37 55.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.753 -0.592 . . . . 0.0 110.52 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.94 136.63 58.07 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.202 -0.936 . . . . 0.0 110.162 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 93.8 mttt . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.191 -179.795 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -146.09 125.38 2.25 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -67.94 -30.35 69.63 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.734 -0.863 . . . . 0.0 110.662 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -60.06 -40.03 88.03 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.383 -0.823 . . . . 0.0 110.139 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -68.36 -33.62 74.6 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.567 -0.708 . . . . 0.0 109.906 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . 0.46 ' O ' HG23 ' B' ' 164' ' ' VAL . 47.4 mm -59.94 -44.49 94.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.581 -0.699 . . . . 0.0 110.51 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.43 -39.93 92.7 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.541 -0.724 . . . . 0.0 111.299 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -61.48 -42.21 98.45 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.392 -0.818 . . . . 0.0 111.574 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 8.4 tt -70.05 -40.02 75.36 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.364 -0.835 . . . . 0.0 110.684 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.465 HG21 ' HE2' ' A' ' 92' ' ' PHE . 71.6 t -61.41 -39.98 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.628 -0.67 . . . . 0.0 110.644 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -52.48 -37.35 49.15 Favored Glycine 0 N--CA 1.501 2.996 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 89.7 t -78.18 -29.73 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.817 -0.814 . . . . 0.0 110.316 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.556 HD23 ' C ' ' B' ' 167' ' ' LEU . 6.8 tt -59.3 -52.86 63.85 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.459 -0.776 . . . . 0.0 110.9 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -67.13 -39.93 86.68 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.343 -0.848 . . . . 0.0 110.727 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -59.95 -29.57 68.5 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.482 -0.761 . . . . 0.0 110.385 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . 0.44 ' HH2' HD12 ' A' ' 63' ' ' ILE . 2.1 t90 -60.01 -47.2 86.83 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.486 -0.759 . . . . 0.0 109.549 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.12 -44.96 94.51 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.628 -0.67 . . . . 0.0 110.974 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -59.99 -40.02 87.72 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.384 -0.823 . . . . 0.0 110.781 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.467 -0.77 . . . . 0.0 110.316 -179.753 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.123 0.487 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.4 t0 51.69 60.96 3.48 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.848 0.833 . . . . 0.0 110.592 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -56.52 -159.71 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.568 0.699 . . . . 0.0 112.376 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 90.3 mt -117.78 -20.45 8.86 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.638 -0.664 . . . . 0.0 111.472 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.5 p -68.22 -10.64 55.9 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.343 -0.848 . . . . 0.0 111.802 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.797 ' HA ' HD12 ' A' ' 9' ' ' ILE . 97.5 mt-10 -54.77 -17.16 3.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.366 -0.834 . . . . 0.0 111.238 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -71.84 -44.58 63.6 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.24 -0.913 . . . . 0.0 109.308 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -69.0 -34.7 75.7 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.75 0.786 . . . . 0.0 109.671 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.797 HD12 ' HA ' ' A' ' 6' ' ' GLU . 77.3 mt -58.59 -35.33 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.856 -0.527 . . . . 0.0 111.181 -178.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -62.65 -55.79 23.68 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.87 -1.144 . . . . 0.0 111.597 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -56.11 -38.52 70.87 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.564 -1.335 . . . . 0.0 111.025 -177.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -68.22 -30.11 69.1 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 20.7 ttpt -68.28 -38.49 81.76 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.386 0.613 . . . . 0.0 109.712 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.11 -59.22 5.76 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.431 0.634 . . . . 0.0 110.728 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.76 -33.16 75.04 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.844 -0.535 . . . . 0.0 112.426 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -58.26 -48.08 81.55 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.933 -1.104 . . . . 0.0 110.502 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.1 t -65.22 -37.83 88.5 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.223 -0.923 . . . . 0.0 108.842 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 64.3 tp -60.07 -40.01 88.03 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.154 0.502 . . . . 0.0 109.976 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -75.38 -30.62 60.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.663 -0.648 . . . . 0.0 110.37 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -93.0 103.4 15.72 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.545 -0.722 . . . . 0.0 109.201 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -59.97 -38.16 81.72 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.542 -0.724 . . . . 0.0 112.29 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -77.97 -11.78 59.93 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.825 -1.172 . . . . 0.0 111.09 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.77 27.7 50.44 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -89.63 -0.93 57.85 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.599 -0.942 . . . . 0.0 110.785 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.44 4.91 63.82 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 120.256 -0.974 . . . . 0.0 111.218 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.2 p -146.08 143.59 29.48 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 119.137 1.469 . . . . 0.0 111.768 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.8 mt -104.73 129.98 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.8 p -108.04 144.94 34.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.652 -0.655 . . . . 0.0 110.795 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.6 p -43.37 -32.29 0.81 Allowed 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.877 -0.515 . . . . 0.0 112.142 -178.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -65.39 -50.15 66.58 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.233 -0.917 . . . . 0.0 109.593 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -60.08 -54.52 45.02 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.936 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.667 HD21 ' SD ' ' A' ' 36' ' ' MET . 9.7 tt -60.01 -35.66 75.54 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.367 -0.833 . . . . 0.0 111.231 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.94 -31.3 17.21 Favored Glycine 0 N--CA 1.5 2.957 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.1 m -70.02 -39.87 75.53 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.576 -0.956 . . . . 0.0 110.372 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.74 -57.4 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.543 -0.723 . . . . 0.0 110.053 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.667 ' SD ' HD21 ' A' ' 32' ' ' LEU . 65.0 mtt -60.3 -31.54 70.35 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.493 -0.754 . . . . 0.0 110.78 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.99 -48.85 80.02 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.382 -0.824 . . . . 0.0 109.155 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 t -71.95 -12.86 61.44 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.884 -0.51 . . . . 0.0 110.2 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.801 HD22 ' CD1' ' B' ' 167' ' ' LEU . 18.4 tp -82.44 -33.7 28.45 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.354 -0.841 . . . . 0.0 109.81 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.07 -30.44 0.14 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -158.39 155.76 29.24 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.251 -1.146 . . . . 0.0 111.3 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.432 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 5.8 p-10 -114.21 104.79 54.63 Favored Pre-proline 0 C--N 1.297 -1.712 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.167 178.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.594 ' HG2' HD21 ' A' ' 48' ' ' LEU . 44.1 Cg_endo -62.23 -151.89 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.392 0 O-C-N 123.001 1.0 . . . . 0.0 109.82 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.1 p -140.04 154.57 47.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.995 -1.066 . . . . 0.0 111.925 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -52.57 -22.84 5.41 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.757 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.63 -60.02 2.44 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.938 0.875 . . . . 0.0 109.427 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.69 -32.63 71.35 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.404 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.594 HD21 ' HG2' ' A' ' 43' ' ' PRO . 44.2 mt -60.06 -34.08 72.94 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.628 0.728 . . . . 0.0 109.836 178.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.2 -32.49 66.83 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.259 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -69.86 -43.87 70.98 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.248 -0.907 . . . . 0.0 111.745 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.43 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 21.5 ptm -63.22 -39.16 93.83 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.789 -0.764 . . . . 0.0 109.241 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.617 HG22 ' OD2' ' A' ' 56' ' ' ASP . 71.4 mt -68.63 -33.61 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.676 -0.64 . . . . 0.0 110.235 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -60.01 -40.1 88.06 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.409 -0.807 . . . . 0.0 111.412 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -67.04 -27.22 67.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 110.527 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.8 t -100.09 -9.95 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.548 -0.72 . . . . 0.0 110.91 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.617 ' OD2' HG22 ' A' ' 52' ' ' ILE . 1.0 OUTLIER -74.29 107.87 6.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.104 -0.998 . . . . 0.0 110.971 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -93.28 -20.24 20.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.742 -0.599 . . . . 0.0 109.657 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -75.36 -40.14 58.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.49 -0.756 . . . . 0.0 110.803 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.27 -4.48 62.39 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -74.64 -39.58 62.0 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.199 -1.177 . . . . 0.0 111.061 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 123.77 4.78 7.89 Favored Glycine 0 N--CA 1.496 2.634 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.317 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 76.4 p -135.4 162.7 31.88 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.129 -1.218 . . . . 0.0 110.284 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.429 ' HA ' ' OE1' ' A' ' 67' ' ' GLU . 7.8 mt -99.5 118.93 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.767 -177.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -93.59 171.22 9.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.667 -0.646 . . . . 0.0 109.945 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.485 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 16.4 t80 -46.1 -48.76 42.56 Favored Pre-proline 0 N--CA 1.498 1.967 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.5 Cg_endo -67.28 -32.55 32.87 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 O-C-N 122.747 0.867 . . . . 0.0 111.526 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.429 ' OE1' ' HA ' ' A' ' 63' ' ' ILE . 80.1 mt-10 -74.16 -41.1 62.05 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.214 -0.929 . . . . 0.0 110.346 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -60.21 -45.67 92.36 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.515 -0.74 . . . . 0.0 110.638 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 65' ' ' PHE . 6.1 mp -66.34 -39.94 89.54 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.446 -0.784 . . . . 0.0 111.419 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.6 m -60.74 -43.07 98.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.541 -0.725 . . . . 0.0 110.616 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 57.6 ttp -66.63 -42.77 86.25 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.597 -0.69 . . . . 0.0 111.663 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 54.0 ttm -59.97 -49.86 76.01 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.432 -0.792 . . . . 0.0 111.165 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.68 -32.83 74.61 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.512 -0.743 . . . . 0.0 111.493 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -71.17 -40.01 71.52 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.394 -0.816 . . . . 0.0 111.127 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -69.53 -38.33 77.48 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.391 -0.818 . . . . 0.0 111.778 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.7 mtm -56.22 -48.21 76.9 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.318 -0.864 . . . . 0.0 111.871 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -69.82 -39.99 76.15 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.09 -1.006 . . . . 0.0 110.999 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -69.6 -34.05 73.56 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.459 -0.776 . . . . 0.0 110.635 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.621 HG22 ' H ' ' A' ' 80' ' ' ASP . 4.0 m -97.59 -173.43 2.63 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.866 -0.521 . . . . 0.0 110.017 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.621 ' H ' HG22 ' A' ' 79' ' ' THR . 91.5 m-20 -117.36 138.04 52.06 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.244 -0.91 . . . . 0.0 110.156 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 52.2 p -64.36 -27.32 68.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.598 -0.689 . . . . 0.0 110.153 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -60.06 -34.62 73.67 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.535 -0.728 . . . . 0.0 109.297 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.15 -39.57 78.74 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.348 0.594 . . . . 0.0 109.47 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.42 -37.75 88.63 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.704 -0.622 . . . . 0.0 110.827 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.593 HG23 ' HE2' ' A' ' 141' ' ' PHE . 98.2 mt -66.9 -48.29 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.524 -0.735 . . . . 0.0 110.923 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 41.9 mtp85 -59.99 -40.94 90.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.423 -0.798 . . . . 0.0 111.414 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.56 ' O ' HG23 ' A' ' 91' ' ' VAL . 98.9 mt-10 -70.05 -40.73 74.95 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.32 -0.863 . . . . 0.0 111.51 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.35 -44.98 85.99 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.569 -0.707 . . . . 0.0 111.5 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -62.59 -40.92 98.43 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.826 0.822 . . . . 0.0 109.475 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -59.97 -36.6 77.48 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.953 -0.467 . . . . 0.0 111.027 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 87' ' ' GLU . 87.8 t -69.58 -49.07 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.545 -0.722 . . . . 0.0 109.972 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.66 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 28.4 m-85 -66.65 -39.87 88.41 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.538 -0.726 . . . . 0.0 110.967 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -77.28 72.48 3.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.495 -0.753 . . . . 0.0 109.843 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -59.99 -44.44 94.5 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.541 -0.724 . . . . 0.0 109.967 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 36.0 p-10 -78.56 -24.8 45.37 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.649 -0.657 . . . . 0.0 110.692 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.44 29.85 73.13 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.6 p-10 -71.68 -13.96 61.89 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.455 -1.027 . . . . 0.0 111.773 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.89 -22.42 8.62 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 119.966 -1.111 . . . . 0.0 110.588 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 35.6 p90 -145.96 156.39 43.48 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.28 -1.13 . . . . 0.0 109.452 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 64.6 mt -89.3 126.56 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-O 121.822 0.82 . . . . 0.0 110.849 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.5 m -86.48 172.46 10.32 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.16 0.505 . . . . 0.0 110.518 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.78 -40.26 83.99 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.61 -0.681 . . . . 0.0 109.717 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.47 -38.59 91.55 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -60.58 -37.96 83.05 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.703 -0.623 . . . . 0.0 110.214 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.462 ' HB3' HG13 ' A' ' 121' ' ' VAL . 0.9 OUTLIER -60.03 -41.36 92.05 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.608 0.718 . . . . 0.0 109.427 179.18 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 63.4 mtp180 -60.07 -35.64 75.6 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.815 -0.553 . . . . 0.0 112.277 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -60.06 -45.66 92.15 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.084 -1.01 . . . . 0.0 111.512 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.66 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 63.7 t -73.85 -37.79 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.374 -0.829 . . . . 0.0 111.379 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 14.2 mmt -59.92 -47.17 86.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.331 -0.856 . . . . 0.0 110.002 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.6 m -65.56 -40.86 93.3 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.691 -0.631 . . . . 0.0 109.462 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -60.6 -34.55 74.39 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.9 mt -69.94 -31.86 69.82 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.145 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.68 26.45 6.14 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.416 ' OE2' HD21 ' A' ' 116' ' ' LEU . 88.8 tt0 -119.52 132.97 55.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.33 -1.1 . . . . 0.0 109.884 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -98.57 120.13 38.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.582 -0.699 . . . . 0.0 110.014 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.416 HD21 ' OE2' ' A' ' 114' ' ' GLU . 57.0 mt -130.18 159.96 35.25 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.474 -0.766 . . . . 0.0 110.489 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.2 p -83.14 163.34 20.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.811 -0.556 . . . . 0.0 109.659 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -63.22 -27.0 69.06 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -69.97 -37.31 75.75 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.582 0.706 . . . . 0.0 109.194 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -65.12 -36.67 85.02 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.536 0.684 . . . . 0.0 109.36 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.462 HG13 ' HB3' ' A' ' 105' ' ' LEU . 97.5 t -69.48 -39.41 78.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.694 0.759 . . . . 0.0 109.613 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -59.98 -40.21 88.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.794 -0.566 . . . . 0.0 110.287 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -60.0 -40.96 91.01 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.405 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.412 ' CB ' HD11 ' A' ' 105' ' ' LEU . 67.6 mtt -55.07 -35.83 64.96 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.459 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.5 mm -66.58 -39.09 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.789 -0.569 . . . . 0.0 110.066 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 50.0 ttt-85 -60.02 -40.02 87.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.494 -0.753 . . . . 0.0 111.742 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -60.12 -38.53 83.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.468 -0.77 . . . . 0.0 110.865 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.549 ' HB2' ' HE2' ' A' ' 144' ' ' MET . . . -103.4 6.33 37.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.46 -0.775 . . . . 0.0 111.447 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -118.94 81.01 1.63 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.007 -1.058 . . . . 0.0 111.48 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 86.4 mt -66.79 -40.05 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.563 -0.711 . . . . 0.0 109.98 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.9 p30 -59.84 -39.32 84.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.626 -0.671 . . . . 0.0 111.136 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.54 15.96 44.72 Favored Glycine 0 N--CA 1.494 2.553 0 C-N-CA 120.149 -1.024 . . . . 0.0 111.24 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -80.01 -20.14 46.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.135 -1.215 . . . . 0.0 110.115 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.72 8.12 57.34 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.807 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -132.69 131.31 41.13 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.163 -1.198 . . . . 0.0 110.066 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.8 t -92.34 110.39 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.55 -0.719 . . . . 0.0 109.664 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -83.85 178.65 7.82 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.581 -0.699 . . . . 0.0 109.569 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -61.34 -44.89 96.43 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.747 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -61.76 -40.49 95.34 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.344 -0.847 . . . . 0.0 111.084 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -63.82 -39.62 94.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.325 -0.859 . . . . 0.0 109.629 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.593 ' HE2' HG23 ' A' ' 85' ' ' ILE . 69.4 t80 -60.0 -49.59 77.05 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.883 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.67 ' O ' HG22 ' A' ' 146' ' ' THR . 89.3 t -61.16 -41.38 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.317 -0.865 . . . . 0.0 110.919 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -60.0 -40.2 88.4 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.259 -0.9 . . . . 0.0 109.741 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.549 ' HE2' ' HB2' ' A' ' 128' ' ' ALA . 7.7 ttm -60.24 -42.04 94.46 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.701 -0.624 . . . . 0.0 110.609 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 98.4 mmm -69.93 -40.04 75.76 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.629 -0.669 . . . . 0.0 111.099 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.67 HG22 ' O ' ' A' ' 142' ' ' VAL . 9.2 t -98.23 19.28 14.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.583 -0.698 . . . . 0.0 110.383 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.14 -39.96 92.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.51 -0.743 . . . . 0.0 109.829 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 44.1 mttp . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.045 179.95 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -116.09 136.51 12.96 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -64.41 -36.72 85.09 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.542 -0.975 . . . . 0.0 110.241 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -60.03 -39.15 84.88 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.691 -0.631 . . . . 0.0 110.095 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . 0.441 ' NH2' HD21 ' B' ' 163' ' ' LEU . 16.4 tpt180 -60.02 -39.97 87.69 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.653 -0.654 . . . . 0.0 110.693 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 97.2 mt -69.61 -39.94 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.307 -0.87 . . . . 0.0 110.526 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.37 -39.94 89.05 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.562 -0.711 . . . . 0.0 110.967 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -67.14 -39.97 86.65 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.443 -0.786 . . . . 0.0 110.821 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.441 HD21 ' NH2' ' B' ' 159' ' ' ARG . 88.6 mt -64.1 -40.04 95.35 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.472 -0.768 . . . . 0.0 111.192 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 83.4 t -70.03 -40.0 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.413 -0.804 . . . . 0.0 110.714 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.98 -50.01 69.81 Favored Glycine 0 N--CA 1.498 2.807 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 14.6 p -71.09 -28.44 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.604 -0.939 . . . . 0.0 110.461 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.801 ' CD1' HD22 ' A' ' 39' ' ' LEU . 2.7 tm? -60.04 -50.16 74.81 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.467 -0.77 . . . . 0.0 111.469 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -70.05 -39.99 75.37 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.466 -0.771 . . . . 0.0 110.655 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -60.38 -39.98 89.22 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.46 -0.775 . . . . 0.0 111.628 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 18.3 t90 -70.06 -31.36 68.94 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.373 -0.829 . . . . 0.0 110.458 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.43 -47.81 80.79 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.469 -0.769 . . . . 0.0 110.264 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -60.0 -33.78 72.44 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.538 -0.726 . . . . 0.0 110.104 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.764 -0.585 . . . . 0.0 110.384 -179.373 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.073 0.463 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -60.14 -40.05 88.44 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.55 -0.719 . . . . 0.0 110.304 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -117.42 146.72 43.27 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.459 0.647 . . . . 0.0 110.247 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 92.1 mt -60.06 -46.5 89.35 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.587 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -144.57 106.2 4.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.569 -0.707 . . . . 0.0 109.662 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.414 ' HA ' HG12 ' A' ' 9' ' ' ILE . 97.8 mt-10 -86.33 -15.66 39.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.957 -0.464 . . . . 0.0 110.991 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -61.82 -38.01 86.56 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.299 -0.876 . . . . 0.0 110.529 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -69.98 -20.05 63.32 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.81 -0.556 . . . . 0.0 111.208 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.414 HG12 ' HA ' ' A' ' 6' ' ' GLU . 49.6 mm -62.97 -43.0 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.386 -0.821 . . . . 0.0 110.342 -179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.9 -31.21 72.22 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.732 -0.605 . . . . 0.0 111.105 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -62.56 -39.99 95.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.805 . . . . 0.0 109.719 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.463 ' HB3' HD11 ' A' ' 69' ' ' LEU . 17.4 m-85 -64.26 -23.91 67.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.95 -0.469 . . . . 0.0 111.347 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.43 ' HD3' ' CE1' ' A' ' 65' ' ' PHE . 73.9 mmtt -68.93 -40.0 79.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.193 -0.942 . . . . 0.0 110.271 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -77.76 -23.99 49.1 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.991 -0.443 . . . . 0.0 111.57 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.51 -38.36 34.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.3 -0.875 . . . . 0.0 111.175 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -56.76 -39.98 75.0 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.662 -0.649 . . . . 0.0 111.33 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 94.0 p -60.26 -39.33 86.4 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.188 -0.945 . . . . 0.0 110.055 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.594 HD11 HD22 ' A' ' 112' ' ' LEU . 7.1 tt -59.97 -44.45 94.44 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.62 -0.675 . . . . 0.0 109.381 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.419 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 0.9 OUTLIER -70.02 -38.96 76.06 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.888 -0.508 . . . . 0.0 109.714 178.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -94.68 92.59 7.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.604 -0.685 . . . . 0.0 109.287 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -59.07 -22.5 60.87 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.228 -0.92 . . . . 0.0 111.653 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -81.23 -55.79 4.5 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.037 -1.039 . . . . 0.0 109.0 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.72 28.32 7.08 Favored Glycine 0 N--CA 1.482 1.748 0 N-CA-C 107.885 -2.086 . . . . 0.0 107.885 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -90.01 -1.23 57.93 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.666 -0.902 . . . . 0.0 110.526 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.04 -0.1 64.02 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 120.42 -0.895 . . . . 0.0 110.931 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.0 p -144.88 143.01 30.36 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 119.212 1.506 . . . . 0.0 111.547 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.419 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 83.8 mt -106.4 130.08 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.796 -0.565 . . . . 0.0 109.844 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.4 m -104.91 143.91 32.51 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.486 -0.758 . . . . 0.0 110.632 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 55.1 p -41.96 -35.71 0.93 Allowed 'General case' 0 N--CA 1.509 2.503 0 O-C-N 121.851 -0.531 . . . . 0.0 111.93 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.1 mttm -63.9 -48.17 77.68 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.35 -0.843 . . . . 0.0 109.325 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -58.96 -51.13 71.38 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.514 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.2 tp -59.93 -34.86 73.8 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.104 -0.997 . . . . 0.0 110.827 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.413 ' O ' ' CB ' ' A' ' 37' ' ' ARG . . . -48.52 -32.76 10.84 Favored Glycine 0 N--CA 1.5 2.963 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.1 m -70.06 -40.01 75.32 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 118.36 1.08 . . . . 0.0 110.3 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.587 HG12 HD12 ' A' ' 39' ' ' LEU . 98.1 t -69.11 -58.19 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.461 -0.774 . . . . 0.0 111.654 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 93.9 mmm -59.88 -37.26 78.85 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.258 -0.901 . . . . 0.0 110.849 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.414 ' HD3' ' HB2' ' A' ' 42' ' ' ASN . 5.9 tpt180 -60.01 -50.03 75.32 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.517 0.675 . . . . 0.0 109.736 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.1 p -71.75 -18.16 62.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.785 -0.572 . . . . 0.0 111.369 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.587 HD12 HG12 ' A' ' 35' ' ' VAL . 15.4 mt -91.86 -18.12 24.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.427 -0.796 . . . . 0.0 111.656 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.98 -40.47 0.2 Allowed Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.251 -1.452 . . . . 0.0 111.612 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.407 ' HG2' ' N ' ' A' ' 42' ' ' ASN . 26.4 tt0 -159.92 157.97 29.92 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 118.872 1.336 . . . . 0.0 112.128 -178.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.428 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 53.4 t30 -118.01 103.72 49.6 Favored Pre-proline 0 N--CA 1.489 1.513 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.244 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.786 ' HG2' HD21 ' A' ' 48' ' ' LEU . 44.5 Cg_endo -63.83 -148.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.335 0 O-C-N 123.309 1.163 . . . . 0.0 109.503 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.7 p -135.99 151.45 49.93 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.826 -1.171 . . . . 0.0 111.495 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -52.35 -24.52 7.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.652 -0.655 . . . . 0.0 111.449 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.16 -58.99 2.97 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 122.034 0.921 . . . . 0.0 108.729 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -65.43 -39.06 91.64 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.051 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.786 HD21 ' HG2' ' A' ' 43' ' ' PRO . 75.2 mt -58.04 -35.56 71.49 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.663 0.744 . . . . 0.0 110.01 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -40.03 82.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 122.01 -0.431 . . . . 0.0 111.491 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -65.22 -36.19 83.4 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.365 -0.834 . . . . 0.0 110.0 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.545 ' HE1' ' O ' ' B' ' 170' ' ' TRP . 92.0 mmm -59.93 -45.61 92.03 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.447 0.642 . . . . 0.0 109.879 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.635 HG23 HG12 ' A' ' 63' ' ' ILE . 96.0 mt -67.74 -33.06 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.761 -0.587 . . . . 0.0 110.303 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -59.93 -40.01 87.44 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.537 -0.727 . . . . 0.0 110.766 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -66.93 -28.61 68.44 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.327 -0.858 . . . . 0.0 110.621 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.778 HG21 ' HE2' ' A' ' 71' ' ' MET . 57.3 t -102.0 -7.17 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.613 -0.68 . . . . 0.0 111.081 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.485 ' OD2' HG22 ' A' ' 52' ' ' ILE . 3.1 m-20 -67.82 105.53 1.98 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.2 -0.937 . . . . 0.0 110.72 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.54 -39.56 77.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.635 -0.666 . . . . 0.0 109.801 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -90.21 -27.66 19.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.612 -0.68 . . . . 0.0 110.531 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.82 21.61 46.07 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -74.32 -34.22 63.39 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.447 -1.031 . . . . 0.0 110.425 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.8 1.22 7.61 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.486 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 66.7 p -138.69 164.83 28.52 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.077 -1.249 . . . . 0.0 111.457 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.635 HG12 HG23 ' A' ' 52' ' ' ILE . 10.0 mt -100.84 122.1 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 121.34 0.59 . . . . 0.0 111.298 -177.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -96.08 171.41 8.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.697 -0.627 . . . . 0.0 109.695 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.642 ' O ' HD13 ' A' ' 69' ' ' LEU . 78.6 t80 -48.57 -49.95 61.74 Favored Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 121.435 -0.79 . . . . 0.0 112.56 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.4 Cg_endo -66.47 -33.91 35.64 Favored 'Trans proline' 0 N--CA 1.492 1.382 0 O-C-N 122.693 0.838 . . . . 0.0 111.255 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -70.44 -39.98 74.02 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.302 -0.874 . . . . 0.0 110.383 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -64.0 -40.02 95.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.712 -0.618 . . . . 0.0 110.67 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.642 HD13 ' O ' ' A' ' 65' ' ' PHE . 5.9 mp -66.66 -39.9 88.41 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.657 -0.652 . . . . 0.0 111.9 -178.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.7 p -60.24 -40.1 89.05 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.09 -1.006 . . . . 0.0 110.403 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.778 ' HE2' HG21 ' A' ' 55' ' ' VAL . 31.7 ttm -66.72 -54.36 23.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.643 -0.66 . . . . 0.0 111.979 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.599 ' HE2' HG11 ' B' ' 166' ' ' VAL . 57.8 ttm -61.74 -52.37 64.53 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -177.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.77 -38.19 86.09 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.561 -0.712 . . . . 0.0 112.536 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -71.42 -44.21 65.29 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.312 -0.867 . . . . 0.0 111.739 -178.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -71.81 -40.87 68.87 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.329 -0.857 . . . . 0.0 113.048 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 26.9 ptm -57.03 -20.3 23.72 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.178 -0.951 . . . . 0.0 111.326 -178.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -66.58 -54.27 25.38 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.327 -0.858 . . . . 0.0 110.495 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -70.0 -23.34 63.13 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.798 -0.563 . . . . 0.0 110.457 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.599 HG22 ' H ' ' A' ' 80' ' ' ASP . 2.4 m -83.02 -173.05 4.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.633 -0.667 . . . . 0.0 110.006 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.599 ' H ' HG22 ' A' ' 79' ' ' THR . 81.9 m-20 -128.14 140.37 51.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.311 -0.868 . . . . 0.0 109.945 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.2 t -70.03 -25.1 63.41 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.642 -0.661 . . . . 0.0 110.507 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.636 ' HA ' HD12 ' A' ' 85' ' ' ILE . 99.0 mt-10 -60.08 -37.07 78.81 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.897 0.856 . . . . 0.0 108.743 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -67.48 -39.89 85.27 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.421 0.629 . . . . 0.0 109.844 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -65.33 -33.82 76.88 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.694 -0.629 . . . . 0.0 110.519 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.636 HD12 ' HA ' ' A' ' 82' ' ' GLU . 78.9 mt -66.08 -46.76 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.655 -0.653 . . . . 0.0 110.071 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 62.1 mtt180 -60.01 -40.42 89.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.51 -0.744 . . . . 0.0 111.584 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.498 ' O ' HG23 ' A' ' 91' ' ' VAL . 97.9 mt-10 -70.07 -40.18 75.2 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.203 -0.936 . . . . 0.0 111.548 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.858 ' HA ' HG11 ' B' ' 164' ' ' VAL . . . -65.18 -45.4 84.99 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.531 -0.73 . . . . 0.0 111.114 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -60.0 -47.41 85.94 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.529 0.68 . . . . 0.0 109.978 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -60.01 -36.62 77.62 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.791 -0.568 . . . . 0.0 111.192 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 87' ' ' GLU . 72.0 t -69.19 -49.75 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.262 -0.899 . . . . 0.0 109.569 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -67.65 -39.99 84.57 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.315 -0.866 . . . . 0.0 109.877 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -79.83 79.66 6.32 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -69.03 -39.89 78.96 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.45 -0.781 . . . . 0.0 111.034 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -77.4 -21.42 53.17 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.465 -0.772 . . . . 0.0 110.839 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.18 28.95 74.07 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -72.91 -10.31 59.66 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.561 -0.964 . . . . 0.0 111.765 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.78 -20.98 12.86 Favored Glycine 0 N--CA 1.498 2.829 0 C-N-CA 120.025 -1.083 . . . . 0.0 110.608 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -144.66 152.44 40.46 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.388 -1.066 . . . . 0.0 109.236 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.617 ' CG2' HD23 ' A' ' 105' ' ' LEU . 18.5 mt -88.67 131.35 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.096 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.02 170.96 11.1 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.918 -0.489 . . . . 0.0 109.756 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.77 -39.33 73.27 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.57 -37.24 86.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.692 -0.63 . . . . 0.0 109.46 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -62.24 -34.34 76.33 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.555 0.693 . . . . 0.0 109.416 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.617 HD23 ' CG2' ' A' ' 100' ' ' ILE . 0.5 OUTLIER -69.16 -40.32 78.24 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.907 -0.496 . . . . 0.0 109.964 179.173 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -60.0 -38.75 83.53 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.533 -0.729 . . . . 0.0 111.352 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -60.1 -46.2 90.38 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.083 -1.011 . . . . 0.0 111.709 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.473 HG12 ' CD1' ' A' ' 112' ' ' LEU . 93.2 t -70.28 -39.99 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.203 -0.936 . . . . 0.0 111.183 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.614 ' CE ' HD13 ' B' ' 160' ' ' ILE . 16.0 mmt -59.64 -50.03 75.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.546 -0.721 . . . . 0.0 110.889 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 93.9 m -67.35 -43.09 82.38 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.543 -0.723 . . . . 0.0 109.955 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -61.63 -31.67 71.77 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.36 0.6 . . . . 0.0 109.432 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.594 HD22 HD11 ' A' ' 18' ' ' LEU . 19.9 mt -69.41 -34.93 75.21 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.917 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 119.66 26.1 2.44 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -126.13 149.62 48.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.385 -1.067 . . . . 0.0 109.782 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -116.48 126.0 52.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.515 -0.741 . . . . 0.0 110.415 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 60.4 mt -138.08 154.72 49.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.593 -0.692 . . . . 0.0 109.326 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.03 163.77 23.95 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -62.0 -27.45 68.88 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.016 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.55 -32.7 73.65 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.421 0.629 . . . . 0.0 109.869 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -68.34 -36.61 79.5 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 90.7 t -66.88 -39.75 84.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.837 0.827 . . . . 0.0 108.955 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -59.99 -47.69 84.77 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.498 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -60.05 -40.07 88.13 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.838 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 65.7 mtt -55.93 -38.53 70.43 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.443 -0.903 . . . . 0.0 109.096 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 47.9 mm -65.93 -39.3 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 121.452 0.644 . . . . 0.0 109.655 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.9 ttt-85 -57.78 -38.67 75.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.678 -0.639 . . . . 0.0 110.843 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -59.95 -37.51 79.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.699 -0.626 . . . . 0.0 110.628 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.14 -1.6 27.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.403 -0.81 . . . . 0.0 111.323 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -84.76 71.75 10.81 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.996 -1.065 . . . . 0.0 110.392 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.6 mt -67.16 -41.43 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.434 -0.792 . . . . 0.0 110.245 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.5 p-10 -72.56 -20.14 61.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.328 -0.858 . . . . 0.0 111.148 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.64 22.14 62.6 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 120.312 -0.947 . . . . 0.0 111.139 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -83.1 -10.04 58.9 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.214 -1.168 . . . . 0.0 111.064 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.21 0.71 76.66 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -137.57 148.17 45.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.208 -1.171 . . . . 0.0 109.648 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 85.9 t -90.06 117.75 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.429 -0.794 . . . . 0.0 110.348 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -89.26 175.33 7.39 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -61.79 -47.92 82.97 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.794 -0.566 . . . . 0.0 110.117 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -60.02 -49.3 78.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.731 -0.606 . . . . 0.0 111.851 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -63.3 -35.4 80.24 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.316 -0.865 . . . . 0.0 109.991 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.507 ' HE1' HG23 ' A' ' 85' ' ' ILE . 64.9 t80 -60.02 -45.14 93.76 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 91.8 t -70.01 -37.85 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.328 -0.857 . . . . 0.0 111.564 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 61.9 tt0 -59.91 -47.13 87.01 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.207 -0.933 . . . . 0.0 110.395 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.4 tmm? -60.02 -39.24 85.17 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.511 -0.743 . . . . 0.0 109.925 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 96.2 mmm -65.74 -40.03 91.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.64 -0.662 . . . . 0.0 109.869 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.1 m -92.39 6.51 46.68 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.563 -0.711 . . . . 0.0 110.914 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -99.04 119.83 38.46 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.1 -1.0 . . . . 0.0 110.256 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.7 mtmt . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.266 -179.897 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.74 68.53 0.26 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -59.98 -44.1 94.7 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.584 -0.951 . . . . 0.0 110.241 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -60.02 -39.48 85.97 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.593 -0.692 . . . . 0.0 111.098 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -59.3 -39.98 84.76 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.301 -0.875 . . . . 0.0 110.256 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . 0.614 HD13 ' CE ' ' A' ' 109' ' ' MET . 97.0 mt -62.8 -40.04 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.571 -0.706 . . . . 0.0 109.377 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.3 -31.01 72.05 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.621 -0.674 . . . . 0.0 110.42 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -60.03 -38.81 83.84 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.573 -0.704 . . . . 0.0 110.097 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.553 ' O ' HG12 ' B' ' 166' ' ' VAL . 66.6 mt -60.01 -40.44 89.27 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.477 -0.764 . . . . 0.0 110.99 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.858 HG11 ' HA ' ' A' ' 88' ' ' ALA . 99.1 t -68.4 -40.0 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.558 -0.714 . . . . 0.0 110.466 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.75 -41.97 94.18 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.599 HG11 ' HE2' ' A' ' 72' ' ' MET . 11.5 p -74.98 -12.24 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -1.101 . . . . 0.0 110.96 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.506 HD23 ' C ' ' B' ' 167' ' ' LEU . 9.5 tt -60.01 -49.16 78.74 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.113 -0.992 . . . . 0.0 109.48 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -60.0 -41.05 91.26 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.653 -0.654 . . . . 0.0 110.32 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.07 -40.29 88.99 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.632 -0.668 . . . . 0.0 111.601 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . 0.545 ' O ' ' HE1' ' A' ' 51' ' ' MET . 5.0 t-105 -61.43 -47.61 84.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.436 -0.79 . . . . 0.0 110.512 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.02 -43.62 95.14 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.542 -0.724 . . . . 0.0 111.007 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -60.01 -40.0 87.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.37 -0.831 . . . . 0.0 110.625 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 . . . . . 0 N--CA 1.495 1.794 0 O-C-N 121.413 -0.804 . . . . 0.0 110.4 -179.877 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.633 ' HB3' ' NE2' ' A' ' 3' ' ' GLN . . . . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 121.191 0.52 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -99.97 30.35 3.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.642 -0.661 . . . . 0.0 110.336 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.633 ' NE2' ' HB3' ' A' ' 1' ' ' ALA . 12.3 mt-30 -60.04 -39.65 86.68 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.781 0.801 . . . . 0.0 109.53 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 79.5 mt -102.41 -178.48 3.7 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.102 0.477 . . . . 0.0 109.793 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.3 p -138.37 103.99 5.05 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.563 -0.711 . . . . 0.0 109.572 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -77.92 -34.66 51.22 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.734 -0.604 . . . . 0.0 110.579 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.44 -40.94 88.41 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.555 -0.716 . . . . 0.0 111.794 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -69.47 -19.08 63.76 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.091 -1.005 . . . . 0.0 111.448 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.5 mm -60.68 -50.03 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.369 -0.832 . . . . 0.0 110.891 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.04 -31.44 69.97 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.64 -0.662 . . . . 0.0 111.466 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -59.95 -43.04 95.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.927 . . . . 0.0 110.586 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.426 ' CE2' ' HG ' ' A' ' 69' ' ' LEU . 44.5 m-85 -65.23 -21.77 66.79 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.578 -0.701 . . . . 0.0 111.468 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.43 ' HD3' ' CZ ' ' A' ' 65' ' ' PHE . 32.5 mmtt -70.71 -43.92 67.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.083 -1.011 . . . . 0.0 110.391 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -75.16 -28.23 60.01 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.21 -30.27 22.54 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.144 -0.972 . . . . 0.0 111.851 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -59.99 -45.85 91.39 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.497 -0.752 . . . . 0.0 111.677 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.5 m -60.06 -39.48 86.17 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.221 -0.924 . . . . 0.0 109.604 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.6 tp -61.35 -43.47 98.82 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.624 ' HZ ' HD21 ' B' ' 167' ' ' LEU . 1.3 m-85 -69.95 -40.07 75.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.993 -0.442 . . . . 0.0 110.461 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -92.32 95.36 9.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.439 -0.788 . . . . 0.0 109.627 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -60.01 -34.52 73.47 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.381 -0.824 . . . . 0.0 110.859 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -80.03 -10.11 59.74 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.255 -0.903 . . . . 0.0 111.051 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.43 26.53 44.99 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -88.02 -7.88 56.41 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.64 -0.918 . . . . 0.0 111.035 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.77 1.77 58.64 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.542 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.8 p -144.02 141.57 30.19 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 119.192 1.496 . . . . 0.0 111.192 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 88.1 mt -104.23 128.45 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.714 -0.616 . . . . 0.0 109.492 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.5 p -100.5 139.62 35.93 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.61 -0.681 . . . . 0.0 110.2 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.725 HG22 ' CD1' ' A' ' 52' ' ' ILE . 61.1 p -42.38 -30.93 0.36 Allowed 'General case' 0 N--CA 1.511 2.603 0 O-C-N 121.796 -0.565 . . . . 0.0 111.645 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -65.66 -49.63 67.94 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.413 -0.804 . . . . 0.0 109.641 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.35 -53.9 52.95 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.71 -0.619 . . . . 0.0 111.165 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.454 ' CD2' ' CZ2' ' B' ' 170' ' ' TRP . 58.8 tp -59.99 -34.76 73.75 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.318 -0.864 . . . . 0.0 110.633 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.04 -31.47 10.85 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.4 m -70.14 -40.83 74.58 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.517 -0.99 . . . . 0.0 110.483 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.4 t -65.76 -51.24 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 121.361 -0.837 . . . . 0.0 109.982 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 98.1 mtp -60.06 -33.77 72.51 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.459 0.647 . . . . 0.0 109.496 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -49.12 78.94 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.618 0.723 . . . . 0.0 109.438 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.7 t -71.69 -16.22 62.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.908 -0.495 . . . . 0.0 110.804 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.409 ' HA ' HD13 ' A' ' 39' ' ' LEU . 1.8 mm? -90.29 -19.95 23.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.215 -0.928 . . . . 0.0 110.653 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.36 -43.57 0.2 Allowed Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.611 -1.281 . . . . 0.0 110.876 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -160.48 160.0 31.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.107 -1.231 . . . . 0.0 111.559 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.409 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 3.2 t-20 -115.21 99.77 52.78 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 42' ' ' ASN . 47.5 Cg_endo -64.58 -151.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.278 0 O-C-N 123.321 1.169 . . . . 0.0 109.942 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.5 p -140.07 159.96 41.0 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.15 -0.969 . . . . 0.0 111.685 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.405 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 98.2 mt-10 -54.98 -21.2 11.05 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.811 -0.555 . . . . 0.0 111.645 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.43 -59.92 2.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.176 -0.953 . . . . 0.0 108.693 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -69.13 -35.97 76.96 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.677 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.499 HD13 ' HB ' ' A' ' 29' ' ' THR . 22.7 mt -58.14 -33.04 68.75 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.456 0.646 . . . . 0.0 110.148 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.08 -31.59 68.01 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.57 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -70.62 -45.75 64.64 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.297 -0.877 . . . . 0.0 111.091 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 78.7 mtm -61.53 -42.05 98.25 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.572 0.701 . . . . 0.0 109.585 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.74 HG12 HD11 ' A' ' 63' ' ' ILE . 91.0 mt -69.02 -33.41 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.257 0.551 . . . . 0.0 110.147 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -59.96 -38.76 83.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.483 -0.761 . . . . 0.0 110.332 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -64.41 -27.41 68.98 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.546 -0.721 . . . . 0.0 110.297 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.529 HG11 ' HB2' ' A' ' 71' ' ' MET . 16.6 t -104.64 -7.97 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.586 -0.696 . . . . 0.0 111.208 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -68.41 103.39 1.63 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.963 -1.086 . . . . 0.0 111.453 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.58 -39.98 94.72 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.713 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.6 p-10 -91.61 -30.67 16.23 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.637 -0.664 . . . . 0.0 111.041 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.26 23.38 44.49 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -73.37 -37.2 66.12 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.448 -1.03 . . . . 0.0 110.721 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.4 -0.84 7.56 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 120.303 -0.951 . . . . 0.0 110.965 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 49.8 p -134.73 169.72 16.91 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.171 -1.194 . . . . 0.0 110.07 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.74 HD11 HG12 ' A' ' 52' ' ' ILE . 7.0 mt -110.11 120.07 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.44 -177.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -96.25 170.34 9.32 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.408 0.623 . . . . 0.0 110.237 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.485 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 t80 -49.77 -48.09 78.05 Favored Pre-proline 0 N--CA 1.497 1.894 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.7 Cg_endo -67.7 -36.99 17.4 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 122.699 0.841 . . . . 0.0 111.683 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -70.03 -39.75 75.6 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.134 -0.979 . . . . 0.0 110.069 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -60.74 -50.01 75.21 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.484 -0.76 . . . . 0.0 111.317 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.426 ' HG ' ' CE2' ' A' ' 12' ' ' PHE . 3.1 tt -61.39 -41.69 97.52 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.362 -0.836 . . . . 0.0 111.56 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.0 p -63.02 -35.66 80.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.583 -0.698 . . . . 0.0 109.996 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.529 ' HB2' HG11 ' A' ' 55' ' ' VAL . 24.6 ttt -66.21 -43.55 86.41 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.838 -0.539 . . . . 0.0 111.852 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.1 ttt -60.06 -45.53 92.55 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.288 -0.882 . . . . 0.0 111.498 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.33 -32.0 71.81 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.451 -0.781 . . . . 0.0 110.564 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 20.7 mmm-85 -70.02 -40.04 75.44 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.622 -0.674 . . . . 0.0 111.124 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -73.09 -44.38 60.52 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.398 -0.814 . . . . 0.0 112.212 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 48.6 mtm -60.64 -39.94 90.15 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.297 -0.877 . . . . 0.0 113.096 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 14.6 pttp -67.25 -36.41 81.56 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.968 -1.082 . . . . 0.0 111.335 -178.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -69.41 -17.85 63.7 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.509 -0.744 . . . . 0.0 111.056 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.5 t -117.97 -159.65 0.75 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.653 0.739 . . . . 0.0 111.272 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -122.55 140.02 53.25 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.143 0.497 . . . . 0.0 109.773 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.433 ' HA ' ' HG2' ' A' ' 84' ' ' GLU . 48.1 t -64.27 -24.57 67.71 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.636 -0.665 . . . . 0.0 110.678 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.511 ' HA ' HD12 ' A' ' 85' ' ' ILE . 46.6 mt-10 -64.4 -35.51 81.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.289 -0.882 . . . . 0.0 109.024 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -67.82 -42.48 81.42 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.994 -178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.433 ' HG2' ' HA ' ' A' ' 81' ' ' SER . 12.5 pt-20 -69.95 -25.49 63.67 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.275 -0.891 . . . . 0.0 111.278 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 82' ' ' GLU . 80.8 mt -69.61 -45.33 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.44 -0.787 . . . . 0.0 109.591 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 63.2 mtt180 -59.97 -37.98 81.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.555 -0.716 . . . . 0.0 110.572 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.63 ' O ' HG23 ' A' ' 91' ' ' VAL . 96.5 mt-10 -69.54 -41.71 75.58 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.69 -0.631 . . . . 0.0 110.601 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.83 -43.83 87.37 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.53 -0.731 . . . . 0.0 111.331 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -60.1 -48.47 81.57 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.619 0.723 . . . . 0.0 109.682 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -58.74 -31.83 68.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.892 -0.505 . . . . 0.0 110.171 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 87' ' ' GLU . 75.7 t -69.97 -41.35 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.499 -0.751 . . . . 0.0 110.044 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -68.57 -37.51 79.94 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.495 -0.753 . . . . 0.0 110.948 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -80.03 76.95 6.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.539 -0.726 . . . . 0.0 109.852 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.451 ' HD3' ' CD2' ' A' ' 107' ' ' HIS . 4.9 mtmp? -63.28 -44.84 93.93 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.399 -0.813 . . . . 0.0 110.193 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -75.65 -17.5 59.96 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.621 -0.674 . . . . 0.0 111.409 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.7 20.15 75.54 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -70.07 -10.05 57.43 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.18 -1.188 . . . . 0.0 111.124 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.71 -13.28 67.49 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 41.0 m-85 -128.17 136.97 51.85 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.138 -1.213 . . . . 0.0 108.295 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 47.6 mt -89.09 120.6 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.907 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.8 m -84.56 169.43 14.43 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.407 0.622 . . . . 0.0 110.627 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.02 -39.97 87.15 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.647 -0.658 . . . . 0.0 109.305 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.73 -36.64 79.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.792 -0.568 . . . . 0.0 109.659 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -66.88 -40.02 87.69 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.642 -0.661 . . . . 0.0 110.674 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.62 -45.88 92.4 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.474 -0.767 . . . . 0.0 109.54 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -61.37 -33.74 74.17 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.848 -0.532 . . . . 0.0 111.066 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.451 ' CD2' ' HD3' ' A' ' 94' ' ' LYS . 75.6 t60 -59.95 -47.42 85.88 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.265 -0.897 . . . . 0.0 111.752 -177.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 63.2 t -72.74 -51.05 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 O-C-N 121.147 -0.97 . . . . 0.0 112.026 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.405 ' CE ' ' CD1' ' A' ' 116' ' ' LEU . 51.2 mtp -58.1 -39.89 79.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.078 -1.014 . . . . 0.0 110.598 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.5 m -67.17 -46.0 75.3 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.551 -0.718 . . . . 0.0 109.778 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -62.04 -31.26 71.64 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.351 0.596 . . . . 0.0 109.499 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.1 mt -69.58 -32.39 71.12 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.669 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.59 20.48 1.92 Allowed Glycine 0 N--CA 1.497 2.734 0 C-N-CA 119.868 -1.158 . . . . 0.0 111.22 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -121.85 138.98 54.18 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.101 -1.234 . . . . 0.0 110.386 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -103.05 120.03 39.92 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.528 -0.732 . . . . 0.0 109.901 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.405 ' CD1' ' CE ' ' A' ' 109' ' ' MET . 74.1 mt -133.2 157.91 44.19 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.418 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.59 172.14 8.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.817 -0.552 . . . . 0.0 109.852 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -64.98 -23.57 67.26 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -69.21 -38.73 78.74 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.607 -0.683 . . . . 0.0 109.764 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -64.7 -35.84 82.34 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.0 t -69.8 -39.1 77.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.467 0.651 . . . . 0.0 109.637 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -60.05 -46.36 89.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.749 -0.595 . . . . 0.0 110.09 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -59.95 -42.47 94.13 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.617 -0.677 . . . . 0.0 109.576 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.463 ' HE3' ' HA ' ' B' ' 157' ' ' PHE . 78.0 mmm -54.16 -39.31 66.45 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.414 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.493 HG21 ' O ' ' A' ' 134' ' ' GLY . 85.5 mt -67.68 -38.61 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.217 0.532 . . . . 0.0 110.614 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -59.13 -39.99 84.08 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.576 -0.702 . . . . 0.0 112.11 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.05 -39.96 83.64 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.808 -0.557 . . . . 0.0 110.993 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.454 ' HB2' ' CE ' ' A' ' 144' ' ' MET . . . -104.29 -1.76 26.56 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.193 -0.942 . . . . 0.0 111.655 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -83.4 70.5 10.2 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.997 -1.065 . . . . 0.0 110.48 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.71 -40.83 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.418 -0.801 . . . . 0.0 110.726 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -70.44 -18.8 63.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.386 -0.821 . . . . 0.0 111.343 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.57 22.0 63.07 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 120.239 -0.982 . . . . 0.0 110.73 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -83.01 -9.95 59.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -1.146 . . . . 0.0 110.988 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.493 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 87.49 0.69 84.22 Favored Glycine 0 N--CA 1.497 2.76 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -136.67 148.21 47.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.31 -1.112 . . . . 0.0 109.042 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.8 t -91.38 119.11 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.406 -0.809 . . . . 0.0 109.673 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.429 ' OD1' ' CE2' ' A' ' 99' ' ' TYR . 80.9 m-20 -89.02 175.24 7.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.584 -0.697 . . . . 0.0 109.929 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -60.87 -47.9 84.27 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.275 0.56 . . . . 0.0 110.524 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -59.99 -45.47 92.62 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.638 -0.663 . . . . 0.0 111.264 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -65.22 -35.9 82.51 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.797 0.808 . . . . 0.0 110.122 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.467 ' CZ ' ' CE ' ' A' ' 145' ' ' MET . 68.5 t80 -60.04 -47.29 86.47 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.32 -178.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.808 ' O ' HG22 ' A' ' 146' ' ' THR . 96.3 t -70.06 -39.72 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.288 -0.882 . . . . 0.0 111.366 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -59.94 -50.04 75.34 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.297 -0.877 . . . . 0.0 111.212 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.454 ' CE ' ' HB2' ' A' ' 128' ' ' ALA . 60.5 ttp -60.3 -36.83 78.8 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.371 -0.83 . . . . 0.0 110.534 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.585 ' CE ' ' HB1' ' B' ' 161' ' ' ALA . 33.1 mtt -69.57 -39.96 77.03 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.635 -0.666 . . . . 0.0 110.664 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.808 HG22 ' O ' ' A' ' 142' ' ' VAL . 10.1 t -99.0 22.8 9.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.542 -0.724 . . . . 0.0 110.633 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.01 -44.93 94.24 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.439 -0.788 . . . . 0.0 110.468 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 96.6 mttt . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.193 179.899 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 70.45 29.27 70.11 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.463 ' HA ' ' HE3' ' A' ' 124' ' ' MET . 37.0 t80 -60.02 -39.96 87.66 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.506 -0.996 . . . . 0.0 109.395 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -66.07 -40.02 90.55 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.667 -0.646 . . . . 0.0 110.776 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -60.88 -45.97 92.47 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.331 -0.855 . . . . 0.0 111.457 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . 0.457 HG22 ' O ' ' B' ' 157' ' ' PHE . 18.2 tt -70.08 -35.49 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.353 -0.842 . . . . 0.0 111.171 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . 0.585 ' HB1' ' CE ' ' A' ' 145' ' ' MET . . . -60.15 -45.24 93.73 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.349 -0.844 . . . . 0.0 110.686 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -60.42 -40.08 89.72 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.48 -0.763 . . . . 0.0 110.488 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' B' ' 160' ' ' ILE . 85.9 mt -62.76 -40.49 97.42 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.515 -0.741 . . . . 0.0 110.678 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.601 ' HA ' HD12 ' B' ' 167' ' ' LEU . 98.9 t -62.46 -40.0 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.431 -0.793 . . . . 0.0 109.563 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.44 -39.42 94.85 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 90.0 t -69.41 -35.38 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.673 -0.898 . . . . 0.0 111.307 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.624 HD21 ' HZ ' ' A' ' 19' ' ' PHE . 96.0 mt -59.98 -49.99 75.49 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.348 -0.845 . . . . 0.0 112.782 -177.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' ARG . . . . . 0.422 ' HD3' ' CG ' ' A' ' 87' ' ' GLU . 69.4 ttt-85 -60.6 -39.91 89.88 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.992 -1.067 . . . . 0.0 110.804 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.41 -33.65 72.8 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.491 -0.756 . . . . 0.0 109.478 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . 0.454 ' CZ2' ' CD2' ' A' ' 32' ' ' LEU . 2.4 t90 -60.02 -49.25 78.39 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.823 -0.548 . . . . 0.0 110.023 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.41 94.51 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.501 -0.749 . . . . 0.0 110.853 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -59.98 -39.93 87.38 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.437 -0.79 . . . . 0.0 110.028 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.702 -0.624 . . . . 0.0 110.236 -179.524 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.162 0.506 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -89.44 79.17 7.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.538 -0.726 . . . . 0.0 109.738 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -60.07 -46.27 90.13 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.687 0.756 . . . . 0.0 110.279 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 74.2 mt -81.9 175.5 10.35 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.403 0.62 . . . . 0.0 110.073 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.78 114.34 6.77 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.599 ' HA ' HD12 ' A' ' 9' ' ' ILE . 43.0 mt-10 -93.13 -9.64 38.74 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.868 -0.52 . . . . 0.0 111.34 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.92 -40.05 91.1 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.215 -0.928 . . . . 0.0 109.63 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -64.88 -36.66 85.07 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.299 0.571 . . . . 0.0 110.309 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.599 HD12 ' HA ' ' A' ' 6' ' ' GLU . 80.2 mt -60.19 -29.11 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.713 -0.617 . . . . 0.0 111.023 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.63 -39.44 93.85 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.092 -1.005 . . . . 0.0 110.268 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -59.54 -41.76 90.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.513 -0.742 . . . . 0.0 109.916 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -64.29 -20.6 66.19 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.933 -0.479 . . . . 0.0 111.103 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -69.96 -44.17 70.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.132 -0.98 . . . . 0.0 110.077 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -60.07 -54.95 39.9 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.31 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.13 -25.0 64.17 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.089 -1.007 . . . . 0.0 111.577 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -49.98 -56.38 10.9 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 120.972 -1.08 . . . . 0.0 111.463 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.9 m -62.39 -36.84 83.59 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.384 -0.822 . . . . 0.0 109.829 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.5 tp -59.92 -40.78 90.04 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.71 -0.619 . . . . 0.0 109.894 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.15 -33.69 59.39 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.58 -0.7 . . . . 0.0 109.928 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -92.0 98.38 11.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.51 -0.744 . . . . 0.0 109.306 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -59.97 -38.55 82.83 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.625 -0.672 . . . . 0.0 111.503 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -78.44 -12.69 60.02 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.013 -1.054 . . . . 0.0 110.813 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.92 27.9 65.22 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -90.0 -2.08 58.08 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.611 -0.935 . . . . 0.0 110.768 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.24 3.82 63.14 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.704 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.551 HG22 ' OD1' ' A' ' 64' ' ' ASP . 31.3 p -147.12 145.36 29.56 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-N 119.268 1.534 . . . . 0.0 111.646 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 91.6 mt -103.37 127.89 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 121.412 0.625 . . . . 0.0 109.689 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.5 m -100.21 139.99 35.1 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.841 -0.537 . . . . 0.0 109.866 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.632 HG23 HG13 ' A' ' 52' ' ' ILE . 4.9 p -42.95 -30.49 0.41 Allowed 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.707 -0.621 . . . . 0.0 111.686 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -64.89 -49.54 70.06 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.847 0.832 . . . . 0.0 108.999 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -58.86 -53.71 55.29 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.902 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.414 HD21 ' HE1' ' A' ' 36' ' ' MET . 56.7 tp -60.7 -32.84 72.06 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.297 -0.877 . . . . 0.0 110.285 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.76 -31.47 38.29 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 86.4 m -69.96 -37.74 75.88 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.516 -0.99 . . . . 0.0 109.903 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.39 -56.18 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-O 121.425 0.631 . . . . 0.0 109.725 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.51 ' HE1' ' CD1' ' B' ' 170' ' ' TRP . 60.6 mtt -59.9 -31.75 70.11 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.684 -0.635 . . . . 0.0 111.124 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -50.02 75.36 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.427 -0.796 . . . . 0.0 109.289 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.1 t -73.71 -18.69 60.97 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.776 -0.578 . . . . 0.0 110.439 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 39' ' ' LEU . 2.8 mm? -97.38 -3.02 41.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.352 -0.843 . . . . 0.0 110.954 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.98 -71.59 0.11 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -162.95 171.35 16.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.475 -1.014 . . . . 0.0 111.055 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -106.98 119.66 50.56 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.784 -0.573 . . . . 0.0 109.893 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.38 -148.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.454 0 O-C-N 123.07 1.037 . . . . 0.0 109.982 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.1 p -138.1 153.15 49.3 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.935 -1.103 . . . . 0.0 111.596 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -52.49 -23.83 6.91 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.742 -0.599 . . . . 0.0 111.728 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.47 -59.96 2.55 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.177 0.989 . . . . 0.0 108.63 177.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -67.65 -37.61 82.64 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.735 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.549 HD13 ' HB ' ' A' ' 29' ' ' THR . 14.3 mt -57.58 -35.12 69.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.608 -0.682 . . . . 0.0 109.856 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.88 -40.07 96.41 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.914 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -65.94 -40.02 90.99 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.526 -0.734 . . . . 0.0 111.133 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 49.2 mtt -59.98 -45.13 93.7 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.474 -0.766 . . . . 0.0 109.811 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.791 HG22 ' OD2' ' A' ' 56' ' ' ASP . 47.5 mm -67.03 -35.81 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.766 -0.584 . . . . 0.0 110.546 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -60.0 -40.11 88.1 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.602 -0.686 . . . . 0.0 111.122 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -69.99 -28.51 65.58 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.28 -0.887 . . . . 0.0 110.998 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.4 t -98.15 -9.11 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.45 -0.781 . . . . 0.0 111.383 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.791 ' OD2' HG22 ' A' ' 52' ' ' ILE . 4.0 m-20 -73.88 98.79 3.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.132 -0.98 . . . . 0.0 111.046 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.92 -38.5 88.84 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.553 -0.717 . . . . 0.0 109.44 179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -90.13 -29.69 18.13 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.666 -0.646 . . . . 0.0 110.793 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.51 19.95 36.43 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -74.01 -37.87 64.25 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.447 -1.031 . . . . 0.0 110.747 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.576 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 125.16 3.75 7.33 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.196 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 81.1 p -136.17 169.12 18.14 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.127 -1.219 . . . . 0.0 111.101 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.603 HD11 ' CD1' ' A' ' 52' ' ' ILE . 10.6 mt -107.44 122.53 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.503 -177.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.551 ' OD1' HG22 ' A' ' 26' ' ' THR . 96.1 m-20 -103.35 170.06 8.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.597 -0.69 . . . . 0.0 110.642 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.52 ' CZ ' HD11 ' A' ' 69' ' ' LEU . 62.5 t80 -47.15 -49.84 49.71 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.659 -0.65 . . . . 0.0 112.737 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 40.6 Cg_endo -65.97 -34.33 38.9 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 O-C-N 122.622 0.801 . . . . 0.0 111.703 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.583 ' O ' HG22 ' A' ' 70' ' ' THR . 97.3 mt-10 -70.62 -39.96 73.42 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.179 -0.95 . . . . 0.0 111.066 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -62.44 -43.93 97.65 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.358 -0.839 . . . . 0.0 110.675 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.52 HD11 ' CZ ' ' A' ' 65' ' ' PHE . 84.5 mt -63.46 -43.44 97.35 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.383 -0.823 . . . . 0.0 112.454 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 67' ' ' GLU . 8.5 t -62.48 -33.93 75.83 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.197 -0.939 . . . . 0.0 110.926 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 15.9 ttm -67.33 -46.57 73.07 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.466 -0.771 . . . . 0.0 111.646 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 50.2 ttm -64.99 -43.87 91.16 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.322 -0.861 . . . . 0.0 112.017 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.54 -36.7 76.65 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.372 -0.83 . . . . 0.0 110.776 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -70.97 -39.95 72.21 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.696 -0.627 . . . . 0.0 111.306 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.593 ' O ' HG22 ' A' ' 79' ' ' THR . 42.0 mmtm -72.08 -30.77 65.45 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 36.2 mmt -60.07 -45.16 93.79 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.932 -1.105 . . . . 0.0 112.547 -176.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.4 pttp -69.36 -35.68 76.1 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.118 -0.989 . . . . 0.0 111.682 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -71.23 -12.34 61.41 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.418 -0.802 . . . . 0.0 111.777 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.593 HG22 ' O ' ' A' ' 75' ' ' LYS . 15.4 t -125.63 -164.32 1.29 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.319 -0.863 . . . . 0.0 111.965 -178.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -120.04 133.44 55.53 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.824 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.5 t -60.34 -29.95 69.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.593 -0.692 . . . . 0.0 110.673 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.538 ' HA ' HD12 ' A' ' 85' ' ' ILE . 98.8 mt-10 -60.13 -31.63 70.26 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.461 -0.774 . . . . 0.0 109.617 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.01 -39.98 87.68 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.903 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.11 -37.49 85.29 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.64 -0.662 . . . . 0.0 110.854 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.636 HG23 ' HE2' ' A' ' 141' ' ' PHE . 86.8 mt -66.98 -47.98 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.667 -0.646 . . . . 0.0 110.84 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -60.03 -41.1 91.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.465 -0.772 . . . . 0.0 111.207 -178.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.645 ' O ' HG23 ' A' ' 91' ' ' VAL . 99.9 mt-10 -70.06 -40.03 75.31 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.457 -0.777 . . . . 0.0 111.333 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.13 -46.05 75.3 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.772 -0.58 . . . . 0.0 111.824 -178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -59.96 -45.4 92.77 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.826 0.822 . . . . 0.0 109.338 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 29.6 ttm-85 -59.95 -37.08 78.51 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.421 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 87' ' ' GLU . 65.6 t -67.93 -46.27 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.496 -0.752 . . . . 0.0 110.188 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -69.0 -36.88 78.33 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.492 -0.755 . . . . 0.0 110.536 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -78.03 78.84 4.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.53 -0.731 . . . . 0.0 109.096 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.99 -44.16 94.69 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.413 -0.804 . . . . 0.0 110.577 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -78.92 -19.42 51.84 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.576 -0.703 . . . . 0.0 110.667 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 63.64 28.26 72.26 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -71.73 -10.49 59.85 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.452 -1.028 . . . . 0.0 111.159 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.9 -20.09 44.73 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.414 ' CE2' ' OD1' ' A' ' 137' ' ' ASN . 59.0 m-85 -119.91 139.39 52.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.259 -1.142 . . . . 0.0 108.971 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.501 ' CG2' HD23 ' A' ' 105' ' ' LEU . 82.5 mt -92.6 120.0 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.465 -0.772 . . . . 0.0 110.452 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.1 m -91.36 170.37 10.03 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.432 0.634 . . . . 0.0 110.719 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.73 -37.67 73.49 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.643 -0.661 . . . . 0.0 109.577 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.11 -38.76 92.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.853 -0.529 . . . . 0.0 109.918 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.5 -39.99 94.81 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.513 -0.742 . . . . 0.0 110.423 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.501 HD23 ' CG2' ' A' ' 100' ' ' ILE . 1.2 mm? -64.29 -40.0 95.07 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.607 0.718 . . . . 0.0 109.662 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 69.4 ttp85 -62.87 -31.08 72.04 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.806 -0.558 . . . . 0.0 110.875 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -60.02 -46.2 90.29 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.233 -0.917 . . . . 0.0 110.68 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.0 t -75.03 -35.57 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.363 -0.836 . . . . 0.0 111.246 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.7 mmt -60.05 -48.94 79.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.385 -0.822 . . . . 0.0 110.428 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.4 m -69.37 -39.96 77.73 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.593 -0.692 . . . . 0.0 110.125 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -60.0 -35.79 75.8 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.4 mt -69.87 -33.94 72.91 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.206 0.526 . . . . 0.0 110.306 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.96 17.25 6.43 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -109.13 131.97 54.56 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.22 -1.165 . . . . 0.0 110.256 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -100.16 120.57 40.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.618 -0.676 . . . . 0.0 110.239 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 71.2 mt -135.8 156.32 48.98 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.425 -0.797 . . . . 0.0 110.95 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.67 159.9 25.17 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -61.87 -26.6 68.24 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -68.1 -31.74 71.56 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -67.24 -34.5 77.59 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.5 t -73.02 -38.63 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.992 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.519 ' HA ' HD12 ' A' ' 125' ' ' ILE . 54.7 t0 -60.03 -43.81 95.04 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.64 -0.663 . . . . 0.0 109.55 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -60.02 -42.36 94.19 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.458 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.0 mtt -54.84 -37.59 66.37 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.118 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.519 HD12 ' HA ' ' A' ' 122' ' ' ASP . 86.7 mt -65.36 -37.9 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -57.87 -37.89 74.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.816 -0.553 . . . . 0.0 111.663 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.09 -39.97 88.0 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.427 -0.796 . . . . 0.0 111.632 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -106.34 -0.14 24.54 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.271 -0.893 . . . . 0.0 111.69 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 125' ' ' ILE . 16.6 t70 -98.67 74.86 2.11 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.128 -0.982 . . . . 0.0 111.329 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 84.3 mt -66.93 -39.97 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.457 -0.777 . . . . 0.0 109.779 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 30.7 p30 -58.52 -37.76 76.3 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.742 -0.599 . . . . 0.0 111.494 -179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 92.84 18.75 39.35 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 120.28 -0.962 . . . . 0.0 111.233 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -82.43 -13.37 56.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.047 -1.266 . . . . 0.0 110.47 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.0 4.68 71.71 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.506 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -136.24 141.85 43.98 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.09 -1.241 . . . . 0.0 109.828 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.423 ' HB ' HD12 ' A' ' 100' ' ' ILE . 61.3 t -94.07 125.11 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.41 -0.806 . . . . 0.0 110.188 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.414 ' OD1' ' CE2' ' A' ' 99' ' ' TYR . 91.3 m-20 -97.39 179.66 4.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.569 -0.707 . . . . 0.0 109.659 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -63.09 -50.05 72.05 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.741 -0.599 . . . . 0.0 110.852 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.21 -44.21 95.96 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.374 -0.829 . . . . 0.0 111.342 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -66.81 -38.52 86.63 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.851 0.834 . . . . 0.0 109.81 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.636 ' HE2' HG23 ' A' ' 85' ' ' ILE . 67.6 t80 -59.97 -46.12 90.48 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.156 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.609 HG22 HG21 ' A' ' 85' ' ' ILE . 98.1 t -69.96 -39.31 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.374 -0.829 . . . . 0.0 111.101 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -59.96 -47.33 86.24 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.271 -0.893 . . . . 0.0 110.437 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.443 ' HE1' ' CD1' ' B' ' 157' ' ' PHE . 12.4 tmm? -59.94 -37.27 79.05 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.469 -0.769 . . . . 0.0 110.27 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 92.2 mtp -66.36 -40.03 89.52 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.902 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.471 ' O ' HG22 ' A' ' 146' ' ' THR . 50.2 m -86.21 2.83 45.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.792 -0.567 . . . . 0.0 111.125 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.06 138.76 57.8 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.051 -1.03 . . . . 0.0 110.235 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.4 mttp . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 117.944 -1.026 . . . . 0.0 110.174 -179.916 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.71 -19.96 50.15 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.443 ' CD1' ' HE1' ' A' ' 144' ' ' MET . 52.3 t80 -67.88 -40.33 83.55 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.288 -1.125 . . . . 0.0 110.153 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 -70.0 -39.21 76.0 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.534 -0.729 . . . . 0.0 111.021 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -59.94 -40.06 87.67 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.585 -0.697 . . . . 0.0 110.719 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . 0.42 HG13 ' N ' ' B' ' 161' ' ' ALA . 24.8 pt -76.21 -27.56 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.479 -0.763 . . . . 0.0 110.791 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . 0.42 ' N ' HG13 ' B' ' 160' ' ' ILE . . . -66.27 -39.93 89.78 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.354 -0.841 . . . . 0.0 110.528 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -60.06 -40.64 90.18 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.572 -0.705 . . . . 0.0 111.031 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.58 -40.07 95.71 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.272 -0.892 . . . . 0.0 110.818 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 67.9 t -64.26 -40.1 87.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.524 -0.735 . . . . 0.0 110.896 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.24 -40.05 91.12 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 94.4 t -76.38 -14.8 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.459 -1.024 . . . . 0.0 111.344 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.447 HD23 ' C ' ' B' ' 167' ' ' LEU . 10.1 tt -60.01 -50.01 75.43 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.177 -0.952 . . . . 0.0 111.416 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -68.46 -39.95 81.23 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.249 -0.907 . . . . 0.0 110.486 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.07 -31.01 69.61 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.393 -0.817 . . . . 0.0 110.078 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . 0.51 ' CD1' ' HE1' ' A' ' 36' ' ' MET . 5.2 t-105 -59.97 -46.31 89.85 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.67 -0.644 . . . . 0.0 110.271 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.0 -51.39 69.85 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.461 -0.774 . . . . 0.0 110.242 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -60.11 -36.87 78.42 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.519 -0.738 . . . . 0.0 110.216 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.591 -0.693 . . . . 0.0 110.151 179.723 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 120.985 0.422 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -86.86 79.93 8.63 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.417 -0.802 . . . . 0.0 110.404 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -63.64 -40.07 95.95 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.889 0.852 . . . . 0.0 109.593 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 68.0 mt -112.6 -176.84 3.0 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.787 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 p -115.65 100.91 8.39 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.552 0.691 . . . . 0.0 109.216 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.63 ' HA ' HD12 ' A' ' 9' ' ' ILE . 99.3 mt-10 -74.4 -10.72 59.85 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.938 -0.476 . . . . 0.0 111.717 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -60.52 -53.02 62.52 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.053 -1.029 . . . . 0.0 109.646 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -66.89 -38.53 86.45 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.33 0.586 . . . . 0.0 110.557 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.63 HD12 ' HA ' ' A' ' 6' ' ' GLU . 89.7 mt -60.79 -29.02 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.706 -0.621 . . . . 0.0 111.513 -178.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -61.25 -37.88 84.67 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.047 -1.033 . . . . 0.0 109.788 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.9 -47.63 84.98 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.534 -0.729 . . . . 0.0 110.194 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.448 ' CE1' ' HE2' ' A' ' 72' ' ' MET . 26.5 m-85 -67.53 -25.25 65.74 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.632 -0.667 . . . . 0.0 110.627 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 22.9 tptp -67.37 -53.44 29.39 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.59 0.71 . . . . 0.0 109.251 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.4 -48.03 77.74 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.891 -0.505 . . . . 0.0 110.696 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.04 -20.34 63.26 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.227 -0.92 . . . . 0.0 111.32 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -60.02 -48.21 82.67 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.181 -0.95 . . . . 0.0 110.789 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.0 m -63.88 -39.24 93.72 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.278 -0.889 . . . . 0.0 108.778 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.602 HD11 ' O ' ' A' ' 112' ' ' LEU . 47.8 tp -63.82 -39.96 95.48 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.4 ' HB3' HD11 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -70.04 -34.2 72.95 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.362 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -92.13 94.68 9.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.685 -0.634 . . . . 0.0 109.516 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -59.9 -36.6 77.3 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.53 -0.731 . . . . 0.0 112.177 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -79.17 -9.76 59.65 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.06 -1.025 . . . . 0.0 111.392 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.96 22.37 57.54 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -85.4 -8.6 58.34 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.429 -1.042 . . . . 0.0 110.542 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.415 ' C ' HG23 ' A' ' 26' ' ' THR . . . 99.96 6.64 53.9 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.518 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.415 HG23 ' C ' ' A' ' 25' ' ' GLY . 80.5 p -147.81 143.02 27.19 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 119.32 1.56 . . . . 0.0 112.03 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.4 HD11 ' HB3' ' A' ' 19' ' ' PHE . 87.3 mt -100.41 124.34 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.3 p -100.98 140.57 35.09 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.706 -0.621 . . . . 0.0 110.835 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.464 HG23 HG13 ' A' ' 52' ' ' ILE . 7.1 p -42.08 -32.68 0.48 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.902 -0.499 . . . . 0.0 112.159 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -65.33 -49.1 70.73 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.731 0.777 . . . . 0.0 109.626 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -59.87 -53.69 54.93 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.976 -0.452 . . . . 0.0 111.092 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.4 tp -61.53 -34.91 76.34 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.218 -0.926 . . . . 0.0 111.063 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.51 -32.16 60.8 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 89.6 m -75.96 -41.26 52.02 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.671 -0.899 . . . . 0.0 111.044 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.7 t -62.7 -59.14 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.431 -0.793 . . . . 0.0 109.658 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.4 ptm -57.72 -20.78 36.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.67 -0.644 . . . . 0.0 110.467 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.2 ttt85 -59.9 -40.0 87.27 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.348 -0.845 . . . . 0.0 109.378 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.7 t -69.84 -16.35 63.25 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.897 -0.502 . . . . 0.0 111.735 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.855 HD22 HD22 ' B' ' 167' ' ' LEU . 6.6 mp -93.6 -10.06 35.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.305 -0.872 . . . . 0.0 110.756 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.16 -61.52 0.17 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -167.33 172.46 9.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.447 -1.031 . . . . 0.0 110.943 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -119.46 137.14 25.09 Favored Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.65 -149.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.332 0 O-C-N 123.19 1.1 . . . . 0.0 109.819 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -137.08 160.61 38.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.05 -1.031 . . . . 0.0 110.2 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -52.38 -25.31 9.48 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.897 -0.502 . . . . 0.0 112.305 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.16 -60.06 2.52 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.208 1.004 . . . . 0.0 108.85 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -66.82 -37.6 84.83 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.542 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.446 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 6.3 mt -57.71 -35.12 70.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.639 -0.663 . . . . 0.0 109.908 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.51 -40.11 95.67 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.779 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -65.49 -39.92 92.47 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.607 -0.683 . . . . 0.0 111.252 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 65.0 mtt -60.02 -43.21 95.41 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.716 0.77 . . . . 0.0 109.443 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.767 HG22 ' OD2' ' A' ' 56' ' ' ASP . 47.9 mm -66.2 -37.64 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 121.21 0.528 . . . . 0.0 110.475 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -60.0 -40.78 90.4 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.506 -0.746 . . . . 0.0 111.212 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -67.43 -27.95 67.48 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.195 -0.94 . . . . 0.0 110.541 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.411 HG21 ' SD ' ' A' ' 71' ' ' MET . 49.8 t -99.97 -10.07 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.565 -0.709 . . . . 0.0 111.557 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.767 ' OD2' HG22 ' A' ' 52' ' ' ILE . 6.6 m-20 -71.05 95.04 1.16 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.088 -1.008 . . . . 0.0 111.542 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.06 93.22 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.71 -0.619 . . . . 0.0 109.563 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -92.58 -29.27 16.25 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.648 -0.657 . . . . 0.0 110.952 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.56 20.49 34.54 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.0 p-10 -74.74 -32.76 62.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.344 -1.092 . . . . 0.0 110.35 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.531 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 118.65 5.24 12.52 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 120.277 -0.963 . . . . 0.0 111.24 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 80.9 p -136.43 170.17 16.48 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.189 -1.183 . . . . 0.0 111.077 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.465 HD11 ' CD1' ' A' ' 52' ' ' ILE . 10.8 mt -105.06 120.55 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.286 0.565 . . . . 0.0 110.886 -177.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -100.05 165.4 11.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.721 -0.612 . . . . 0.0 109.934 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.524 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 16.2 t80 -48.7 -49.27 66.85 Favored Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 121.486 -0.759 . . . . 0.0 112.499 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 38.7 Cg_endo -64.23 -35.54 51.36 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 O-C-N 122.766 0.877 . . . . 0.0 111.173 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.96 -40.03 75.65 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.165 -0.959 . . . . 0.0 110.322 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -61.99 -42.86 99.61 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.59 -0.693 . . . . 0.0 111.3 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 69' ' ' LEU . 4.0 mm? -64.68 -42.97 94.97 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.395 -0.816 . . . . 0.0 111.205 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.1 m -61.97 -40.03 94.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.649 -0.657 . . . . 0.0 111.111 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.411 ' SD ' HG21 ' A' ' 55' ' ' VAL . 56.2 ttp -68.35 -40.96 81.36 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.473 -0.767 . . . . 0.0 112.148 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.478 ' SD ' HG11 ' B' ' 166' ' ' VAL . 92.6 mmm -61.53 -45.49 93.95 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.296 -0.877 . . . . 0.0 111.131 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.67 -32.43 73.49 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.856 -0.528 . . . . 0.0 110.982 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -72.04 -39.98 68.7 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.435 -0.791 . . . . 0.0 110.292 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -62.5 -39.98 95.22 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.617 -0.677 . . . . 0.0 112.362 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 35.9 mmt -57.82 -33.21 68.37 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.185 -0.947 . . . . 0.0 110.736 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -69.69 -56.75 6.36 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.554 0.693 . . . . 0.0 110.572 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -69.16 -35.86 76.76 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.525 0.679 . . . . 0.0 110.436 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.629 HG22 ' H ' ' A' ' 80' ' ' ASP . 8.1 m -86.07 -174.68 5.21 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.858 -0.526 . . . . 0.0 110.224 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.629 ' H ' HG22 ' A' ' 79' ' ' THR . 90.4 m-20 -134.0 149.94 51.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.321 -0.862 . . . . 0.0 109.964 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.3 t -65.82 -33.74 76.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.7 -0.625 . . . . 0.0 109.556 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -63.77 -33.87 76.62 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.644 0.735 . . . . 0.0 109.181 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.56 -39.98 77.05 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.332 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -63.83 -36.35 83.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.594 -0.691 . . . . 0.0 109.934 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.633 HG23 ' CE1' ' A' ' 141' ' ' PHE . 77.4 mt -64.48 -49.96 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.668 -0.645 . . . . 0.0 110.821 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -57.14 -39.94 76.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.176 -0.953 . . . . 0.0 111.019 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.666 ' O ' HG23 ' A' ' 91' ' ' VAL . 98.8 mt-10 -70.0 -40.02 75.53 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.54 -0.725 . . . . 0.0 111.471 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.55 -49.25 69.57 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.423 -0.798 . . . . 0.0 112.244 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -60.37 -40.42 90.71 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.247 -0.908 . . . . 0.0 109.429 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -59.98 -37.57 80.0 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.666 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 87' ' ' GLU . 94.1 t -69.75 -53.41 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.419 -0.801 . . . . 0.0 110.797 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.485 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 51.5 m-85 -63.43 -39.76 95.36 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.355 -0.841 . . . . 0.0 110.882 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -80.98 72.02 7.98 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.531 -0.731 . . . . 0.0 110.006 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -61.83 -41.72 98.14 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.211 -0.93 . . . . 0.0 109.859 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.0 p-10 -73.16 -22.22 60.55 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.567 -0.708 . . . . 0.0 110.995 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.2 25.06 73.53 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -71.2 -12.49 61.5 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.322 -1.105 . . . . 0.0 111.541 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.85 -16.69 59.24 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.415 ' CD2' ' OD1' ' A' ' 137' ' ' ASN . 60.1 m-85 -123.18 136.36 54.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.19 -1.182 . . . . 0.0 109.148 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.5 ' CG2' HD23 ' A' ' 105' ' ' LEU . 61.4 mt -89.8 120.07 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.423 -0.798 . . . . 0.0 109.922 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.2 m -90.07 170.56 10.22 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.329 0.585 . . . . 0.0 110.686 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.73 -35.99 72.97 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.666 -0.646 . . . . 0.0 109.358 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.43 -35.57 79.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.735 -0.603 . . . . 0.0 109.584 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.22 -37.88 78.26 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.659 -0.65 . . . . 0.0 110.776 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.5 HD23 ' CG2' ' A' ' 100' ' ' ILE . 1.3 mm? -66.92 -41.66 86.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.552 -0.717 . . . . 0.0 110.279 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -60.06 -37.8 80.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.695 -0.628 . . . . 0.0 110.717 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -60.66 -42.79 97.72 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.456 -0.778 . . . . 0.0 112.419 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.485 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 91.3 t -74.04 -50.9 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 O-C-N 121.159 -0.963 . . . . 0.0 111.827 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 78.1 mtm -59.55 -40.21 86.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.116 -0.99 . . . . 0.0 110.205 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.2 m -64.72 -45.63 85.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.645 -0.659 . . . . 0.0 109.325 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -61.36 -33.63 73.97 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.602 ' O ' HD11 ' A' ' 18' ' ' LEU . 35.6 mt -69.98 -36.12 74.96 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.141 0.496 . . . . 0.0 109.836 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.41 30.72 1.65 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -119.93 127.34 52.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.464 -1.021 . . . . 0.0 109.701 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -100.11 120.96 40.67 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.654 -0.654 . . . . 0.0 110.824 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.549 HD23 ' OE1' ' A' ' 120' ' ' GLU . 2.5 mp -137.72 155.39 49.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.567 -0.708 . . . . 0.0 110.051 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.38 166.92 16.97 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -64.65 -24.76 67.69 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.178 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -68.66 -35.87 77.8 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.683 0.754 . . . . 0.0 109.278 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.549 ' OE1' HD23 ' A' ' 116' ' ' LEU . 4.6 mt-10 -64.8 -36.11 83.27 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.6 t -70.04 -38.62 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-O 121.427 0.632 . . . . 0.0 110.178 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -59.79 -46.54 88.9 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.573 -0.705 . . . . 0.0 110.227 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -60.1 -39.97 88.0 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.826 -0.75 . . . . 0.0 109.805 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 67.6 mtt -54.7 -40.01 68.75 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.353 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.64 -38.04 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.716 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -59.38 -40.02 85.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.507 -0.746 . . . . 0.0 111.938 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.88 -40.0 91.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.448 -0.782 . . . . 0.0 112.012 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.14 -17.16 16.79 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.276 -0.89 . . . . 0.0 111.388 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -85.8 74.99 10.11 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.271 -0.893 . . . . 0.0 110.538 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.7 -40.04 87.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.725 -0.609 . . . . 0.0 109.841 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 27.9 p-10 -58.76 -38.92 79.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.551 -0.718 . . . . 0.0 110.766 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.86 16.05 40.29 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 120.224 -0.988 . . . . 0.0 111.073 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.59 -10.81 59.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.127 -1.219 . . . . 0.0 110.238 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.47 3.54 74.84 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.476 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -134.79 136.36 42.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.093 -1.24 . . . . 0.0 110.666 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.8 t -92.11 120.01 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.47 -0.768 . . . . 0.0 110.033 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.415 ' OD1' ' CD2' ' A' ' 99' ' ' TYR . 84.8 m-20 -96.41 -175.03 3.22 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.453 0.644 . . . . 0.0 110.381 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -60.0 -49.98 75.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.837 -0.539 . . . . 0.0 110.188 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -60.08 -44.75 94.55 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.374 -0.829 . . . . 0.0 111.279 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -62.32 -39.03 91.72 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.04 0.924 . . . . 0.0 109.353 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.633 ' CE1' HG23 ' A' ' 85' ' ' ILE . 64.7 t80 -60.01 -41.86 93.06 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.697 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 92.9 t -67.65 -40.05 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.378 -0.826 . . . . 0.0 110.844 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -59.97 -39.98 87.51 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.472 -0.767 . . . . 0.0 110.498 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 46.2 ttp -60.04 -40.55 89.79 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.66 -0.65 . . . . 0.0 110.588 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 61.1 mtt -76.72 -34.24 58.14 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.419 -0.801 . . . . 0.0 109.95 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.514 ' O ' HG22 ' A' ' 146' ' ' THR . 25.0 m -92.7 23.62 4.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.793 -0.567 . . . . 0.0 111.016 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.49 89.03 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.353 -0.842 . . . . 0.0 110.474 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.146 -179.847 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 82.2 7.15 88.11 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -60.05 -47.97 83.65 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.038 -1.272 . . . . 0.0 109.472 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -61.4 -38.78 88.32 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.856 -0.528 . . . . 0.0 111.136 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -60.09 -39.9 87.74 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.389 -0.819 . . . . 0.0 110.707 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 85.4 mt -69.07 -40.06 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.441 -0.787 . . . . 0.0 110.214 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.0 -44.47 94.53 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.616 -0.677 . . . . 0.0 110.969 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -60.49 -40.79 92.6 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.34 -0.85 . . . . 0.0 110.5 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 40.4 tp -61.27 -40.6 94.7 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.503 -0.748 . . . . 0.0 109.972 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 93.1 t -60.59 -40.0 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.697 -0.627 . . . . 0.0 109.871 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -53.91 -36.15 55.03 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.478 HG11 ' SD ' ' A' ' 72' ' ' MET . 98.3 t -77.71 -29.87 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.606 -0.938 . . . . 0.0 110.33 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.855 HD22 HD22 ' A' ' 39' ' ' LEU . 3.7 tt -59.98 -50.72 72.62 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.512 -0.743 . . . . 0.0 111.515 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -60.27 -40.09 89.14 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.369 -0.832 . . . . 0.0 111.164 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -59.91 -35.32 74.62 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.49 -0.756 . . . . 0.0 110.695 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -59.69 -39.97 86.3 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.477 -0.765 . . . . 0.0 110.25 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.05 79.2 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.296 -0.878 . . . . 0.0 110.306 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -60.06 -39.64 86.69 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.337 -0.852 . . . . 0.0 109.347 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.286 0.565 . . . . 0.0 110.056 179.381 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.272 0.558 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -67.77 -36.09 79.85 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.741 0.781 . . . . 0.0 110.547 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -59.98 -40.03 87.71 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.352 0.596 . . . . 0.0 110.665 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.1 mt -89.46 -178.98 5.72 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.745 -0.597 . . . . 0.0 110.503 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.77 25.88 11.22 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.715 -0.616 . . . . 0.0 109.823 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.754 ' HA ' HD12 ' A' ' 9' ' ' ILE . 98.8 mt-10 -55.13 -14.16 1.52 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.591 -0.693 . . . . 0.0 111.917 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.429 ' HG3' ' N ' ' A' ' 8' ' ' GLN . 19.5 pt-20 -64.51 -41.17 96.58 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.916 -1.115 . . . . 0.0 109.999 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.429 ' N ' ' HG3' ' A' ' 7' ' ' GLU . 27.0 mt-30 -63.83 -36.46 83.97 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.464 -0.772 . . . . 0.0 109.77 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.754 HD12 ' HA ' ' A' ' 6' ' ' GLU . 83.8 mt -57.11 -29.62 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.806 -0.559 . . . . 0.0 111.044 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.94 -39.54 94.39 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.194 -0.941 . . . . 0.0 110.419 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -60.07 -42.62 94.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.37 -0.831 . . . . 0.0 109.88 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -63.32 -20.88 65.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.865 -0.522 . . . . 0.0 111.068 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HD3' ' CZ ' ' A' ' 65' ' ' PHE . 40.3 mmtt -66.87 -40.22 87.76 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.203 -0.936 . . . . 0.0 108.988 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -64.25 -58.31 6.93 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.976 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.86 -26.95 68.44 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.36 -0.837 . . . . 0.0 112.545 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -58.36 -48.31 81.01 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.753 -1.217 . . . . 0.0 111.013 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.4 p -62.33 -37.17 84.58 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.186 -0.947 . . . . 0.0 109.481 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.2 tp -60.09 -40.01 88.11 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.583 0.706 . . . . 0.0 109.499 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.677 ' HE2' HD11 ' B' ' 163' ' ' LEU . 4.4 m-85 -74.81 -36.69 62.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.875 -0.516 . . . . 0.0 110.974 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -94.91 97.78 10.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.441 -0.787 . . . . 0.0 110.131 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -65.67 -31.98 73.29 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.499 -0.75 . . . . 0.0 111.077 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -80.04 -10.43 59.77 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.214 -0.929 . . . . 0.0 111.166 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.34 25.66 55.06 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -88.46 -8.08 55.51 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.543 -0.974 . . . . 0.0 110.902 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.31 2.72 56.71 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 120.054 -1.07 . . . . 0.0 111.751 178.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.8 p -143.4 141.5 30.9 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-N 119.464 1.632 . . . . 0.0 111.966 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 83.9 mt -100.88 121.32 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.737 -0.602 . . . . 0.0 109.458 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.1 m -102.33 141.86 34.48 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.59 -0.694 . . . . 0.0 110.389 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.44 ' CG2' HG13 ' A' ' 52' ' ' ILE . 40.6 p -41.96 -29.79 0.24 Allowed 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.643 -0.66 . . . . 0.0 112.211 -177.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -63.41 -52.08 63.09 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.333 -0.854 . . . . 0.0 109.364 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.04 -53.73 54.3 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.487 -178.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.561 HD21 ' CE ' ' A' ' 36' ' ' MET . 53.0 tp -59.83 -36.49 76.93 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.092 -1.005 . . . . 0.0 110.672 -178.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.77 -31.0 37.35 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.4 m -69.97 -40.1 75.57 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.616 -0.932 . . . . 0.0 110.24 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.22 -55.21 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.53 -0.731 . . . . 0.0 109.512 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.561 ' CE ' HD21 ' A' ' 32' ' ' LEU . 69.0 mtt -58.48 -30.46 67.0 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.333 0.587 . . . . 0.0 110.044 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -59.88 -50.04 75.34 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 t -70.76 -18.8 62.76 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.803 -0.561 . . . . 0.0 110.436 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.562 HD11 HD13 ' B' ' 167' ' ' LEU . 66.7 mt -84.96 -21.87 29.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.293 -0.88 . . . . 0.0 110.576 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.77 -45.46 0.19 Allowed Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.937 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -161.44 159.95 28.73 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.11 -1.229 . . . . 0.0 111.957 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.451 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 2.6 t-20 -114.42 105.1 54.2 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 42' ' ' ASN . 42.5 Cg_endo -61.36 -149.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.503 0 O-C-N 123.306 1.161 . . . . 0.0 110.734 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.23 160.54 39.17 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.93 -1.106 . . . . 0.0 111.174 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.4 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 11.9 mm-40 -53.78 -22.02 8.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.936 -0.478 . . . . 0.0 111.939 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.01 -59.23 3.04 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -67.27 -38.67 85.46 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.553 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.402 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 6.2 mt -58.71 -33.17 69.88 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.572 -0.705 . . . . 0.0 109.865 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -40.0 94.78 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.497 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -64.79 -40.03 94.57 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.649 -0.657 . . . . 0.0 110.928 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 66.6 mtt -61.3 -43.41 98.91 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.685 -0.634 . . . . 0.0 109.748 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.897 HG22 ' OD2' ' A' ' 56' ' ' ASP . 48.4 mm -66.88 -36.24 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.849 -0.532 . . . . 0.0 110.746 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -60.01 -41.95 93.24 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.391 -0.818 . . . . 0.0 110.633 -178.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -69.88 -27.69 65.02 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.226 -0.921 . . . . 0.0 111.355 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.497 HG21 ' SD ' ' A' ' 71' ' ' MET . 60.2 t -99.21 -10.02 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.316 -0.865 . . . . 0.0 111.835 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.897 ' OD2' HG22 ' A' ' 52' ' ' ILE . 19.5 m-20 -71.53 96.88 1.58 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.089 -1.007 . . . . 0.0 111.302 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.23 -37.43 80.82 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.406 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -90.58 -27.01 19.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.733 -0.604 . . . . 0.0 110.433 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.99 20.34 43.34 Favored Glycine 0 N--CA 1.495 2.567 0 C-N-CA 120.458 -0.877 . . . . 0.0 110.923 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -76.27 -28.62 57.12 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.449 -1.03 . . . . 0.0 110.565 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.76 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 114.35 2.06 23.2 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.174 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.3 p -134.1 167.78 20.01 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.152 -1.204 . . . . 0.0 110.527 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.51 HD11 HD13 ' A' ' 52' ' ' ILE . 8.7 mt -103.53 119.94 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.228 -178.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -97.71 167.56 10.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.666 -0.646 . . . . 0.0 109.889 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.508 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 10.5 t80 -48.27 -48.63 64.99 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.52 -0.737 . . . . 0.0 112.45 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 41.5 Cg_endo -67.0 -34.4 29.21 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 O-C-N 122.895 0.945 . . . . 0.0 111.088 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.9 -39.92 69.23 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.181 -0.95 . . . . 0.0 110.887 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -62.32 -40.43 96.29 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.451 -0.781 . . . . 0.0 111.422 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 65' ' ' PHE . 4.6 mp -69.63 -40.01 76.8 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.221 -0.924 . . . . 0.0 111.611 -178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.8 p -61.22 -40.03 92.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.364 -0.835 . . . . 0.0 110.853 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.497 ' SD ' HG21 ' A' ' 55' ' ' VAL . 50.7 ttp -67.49 -52.05 43.86 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.525 -0.734 . . . . 0.0 112.044 -178.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.427 ' HE2' HG11 ' B' ' 166' ' ' VAL . 49.8 ttm -59.98 -49.71 76.6 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.314 -0.866 . . . . 0.0 111.948 -178.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.99 -36.02 76.27 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.547 -0.72 . . . . 0.0 110.341 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -77.23 -43.55 33.16 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.606 0.717 . . . . 0.0 110.14 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -61.01 -48.12 83.29 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.757 -0.589 . . . . 0.0 111.973 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 27.8 ptm -59.94 -36.12 76.37 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.261 -0.9 . . . . 0.0 110.679 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -68.17 -42.93 79.27 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.695 0.759 . . . . 0.0 109.299 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -68.43 -30.93 69.93 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.691 0.758 . . . . 0.0 109.273 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 80' ' ' ASP . 7.2 m -94.53 -174.11 3.23 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.61 ' H ' HG22 ' A' ' 79' ' ' THR . 65.6 m-20 -120.73 141.63 50.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.109 -0.995 . . . . 0.0 109.808 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.3 t -60.06 -29.57 68.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.65 -0.656 . . . . 0.0 110.173 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.0 -37.34 79.42 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.698 0.761 . . . . 0.0 109.192 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -70.06 -39.98 75.35 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.19 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -64.08 -39.75 94.75 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.704 -0.623 . . . . 0.0 110.767 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.772 HG23 ' CE1' ' A' ' 141' ' ' PHE . 96.5 mt -62.92 -49.68 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.63 -0.669 . . . . 0.0 110.465 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -57.7 -40.09 78.67 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.336 -0.852 . . . . 0.0 111.16 -178.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.693 ' O ' HG23 ' A' ' 91' ' ' VAL . 98.9 mt-10 -70.03 -39.99 75.44 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.336 -0.853 . . . . 0.0 111.666 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.52 -47.21 73.64 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.331 -0.856 . . . . 0.0 111.287 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -60.01 -47.52 85.51 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.587 -0.695 . . . . 0.0 110.138 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -59.93 -36.35 76.85 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.683 -0.636 . . . . 0.0 110.325 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 87' ' ' GLU . 70.5 t -66.92 -46.39 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.568 -0.707 . . . . 0.0 109.699 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.518 ' CD1' HD22 ' A' ' 105' ' ' LEU . 14.3 m-85 -69.91 -38.58 76.3 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.461 -0.774 . . . . 0.0 111.324 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -75.34 78.33 2.42 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.51 -0.744 . . . . 0.0 110.571 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -59.92 -47.91 83.85 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.622 -0.674 . . . . 0.0 110.178 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -78.08 -18.57 55.59 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.505 -0.747 . . . . 0.0 111.239 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 62.98 28.58 72.27 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -73.91 -8.96 58.06 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.414 -1.05 . . . . 0.0 111.401 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.39 -17.61 50.48 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -129.99 138.44 50.81 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.315 -1.109 . . . . 0.0 108.87 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.764 ' CG2' HD23 ' A' ' 105' ' ' LEU . 32.9 mt -89.05 124.41 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.368 -0.833 . . . . 0.0 110.435 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.4 m -88.65 171.01 10.33 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.242 0.544 . . . . 0.0 110.384 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.84 -40.07 83.78 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.663 -0.648 . . . . 0.0 109.582 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.55 -38.51 91.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.76 -0.588 . . . . 0.0 109.604 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.85 -40.28 91.58 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.781 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.764 HD23 ' CG2' ' A' ' 100' ' ' ILE . 0.2 OUTLIER -63.1 -44.76 94.79 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.505 -0.747 . . . . 0.0 110.462 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.406 ' CG ' HG21 ' A' ' 121' ' ' VAL . 77.6 mtp180 -60.29 -30.9 69.77 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.633 -0.667 . . . . 0.0 110.385 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -60.18 -49.95 75.6 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.561 -0.712 . . . . 0.0 111.456 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.47 HG12 ' CD1' ' A' ' 112' ' ' LEU . 61.3 t -74.26 -52.32 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 O-C-N 121.234 -0.916 . . . . 0.0 112.168 -178.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 99.4 mtp -56.56 -42.68 78.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.123 -0.986 . . . . 0.0 110.511 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.6 m -65.16 -46.7 79.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.707 -0.621 . . . . 0.0 109.668 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -62.01 -33.69 74.81 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.47 ' CD1' HG12 ' A' ' 108' ' ' VAL . 61.9 mt -70.03 -33.43 71.97 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.701 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.27 40.8 0.42 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -138.02 132.84 32.82 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.5 -1.0 . . . . 0.0 110.142 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.679 ' C ' HD13 ' A' ' 116' ' ' LEU . 68.4 mttm -106.82 141.3 38.28 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.477 -0.764 . . . . 0.0 110.303 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.679 HD13 ' C ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -158.73 157.82 32.47 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.624 0.726 . . . . 0.0 110.769 179.231 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.3 p -85.66 167.57 15.2 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.632 -0.667 . . . . 0.0 109.802 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -65.47 -26.69 68.05 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -69.92 -37.34 75.91 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.909 0.862 . . . . 0.0 109.204 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -63.43 -40.02 96.03 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.44 1.114 . . . . 0.0 108.378 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.406 HG21 ' CG ' ' A' ' 106' ' ' ARG . 53.7 t -67.21 -39.97 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.033 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.422 ' HA ' HD12 ' A' ' 125' ' ' ILE . 61.1 t0 -60.07 -45.81 91.63 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.568 -0.707 . . . . 0.0 110.041 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -59.96 -40.09 87.86 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.724 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 66.7 mtt -56.24 -37.68 70.07 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.184 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 122' ' ' ASP . 89.4 mt -65.21 -38.56 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.812 0.815 . . . . 0.0 109.047 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.4 ttt180 -58.51 -39.63 80.63 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.057 0.456 . . . . 0.0 111.391 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -60.06 -39.95 87.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.709 -0.619 . . . . 0.0 111.845 -178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.2 -10.45 15.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.208 -0.933 . . . . 0.0 112.011 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -74.25 69.94 1.61 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.1 -1.0 . . . . 0.0 110.414 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.0 mt -68.2 -40.0 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.587 -0.696 . . . . 0.0 110.503 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -69.3 -24.31 63.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.377 -0.827 . . . . 0.0 111.017 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.89 24.67 48.28 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.96 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -82.57 -10.0 59.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -1.125 . . . . 0.0 110.802 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.33 -1.39 79.5 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -138.23 150.39 46.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -1.105 . . . . 0.0 109.38 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.53 118.87 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.408 -0.807 . . . . 0.0 109.944 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -89.93 -170.73 2.9 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.682 0.754 . . . . 0.0 110.397 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -69.87 -40.03 75.98 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.502 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -60.15 -47.82 84.33 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.3 -0.875 . . . . 0.0 112.249 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -62.74 -37.74 87.77 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.927 0.87 . . . . 0.0 110.043 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.772 ' CE1' HG23 ' A' ' 85' ' ' ILE . 57.9 t80 -59.97 -50.04 75.32 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.37 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.562 HG12 HG21 ' A' ' 85' ' ' ILE . 36.0 m -70.12 -41.05 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -59.97 -51.04 71.36 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.184 -0.947 . . . . 0.0 111.314 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.9 ttp -62.38 -37.73 86.85 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.447 -0.783 . . . . 0.0 109.927 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 90.6 mmm -69.82 -39.35 76.53 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.848 -0.533 . . . . 0.0 109.967 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.491 HG23 ' O ' ' A' ' 142' ' ' VAL . 71.4 p -82.56 0.39 42.94 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.499 -0.751 . . . . 0.0 111.039 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.94 -40.0 87.47 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.138 -0.976 . . . . 0.0 110.477 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.2 mttt . . . . . 0 N--CA 1.496 1.825 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.347 -179.781 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -77.0 141.4 26.13 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -60.05 -41.57 92.59 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.59 -0.947 . . . . 0.0 110.595 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 21.3 ptt-85 -60.04 -39.97 87.77 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.626 -0.671 . . . . 0.0 111.51 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 30.1 mtp-105 -61.62 -39.97 93.17 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.494 -0.754 . . . . 0.0 110.458 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 88.8 mt -66.39 -39.96 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.569 -0.707 . . . . 0.0 110.481 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.95 87.42 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.558 -0.714 . . . . 0.0 110.708 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -60.0 -42.31 93.98 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.547 -0.721 . . . . 0.0 111.457 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.735 ' O ' HG12 ' B' ' 166' ' ' VAL . 42.6 tp -65.0 -40.9 95.62 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.3 -0.875 . . . . 0.0 110.83 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.647 ' HA ' HD12 ' B' ' 167' ' ' LEU . 66.9 t -61.09 -39.99 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.588 -0.695 . . . . 0.0 110.751 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.07 -40.15 82.08 Favored Glycine 0 N--CA 1.495 2.597 0 O-C-N 121.447 -0.783 . . . . 0.0 111.759 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.735 HG12 ' O ' ' B' ' 163' ' ' LEU . 15.0 p -76.33 -24.46 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.096 -1.238 . . . . 0.0 112.53 -178.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.647 HD12 ' HA ' ' B' ' 164' ' ' VAL . 85.7 mt -59.96 -49.09 79.03 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.953 -1.092 . . . . 0.0 110.969 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -61.72 -40.0 93.5 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.314 -0.866 . . . . 0.0 110.704 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . 0.444 ' CD ' HG21 ' A' ' 79' ' ' THR . 97.6 mt-10 -62.34 -26.01 68.21 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.473 -0.767 . . . . 0.0 109.872 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -59.99 -41.73 92.7 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.593 -0.692 . . . . 0.0 109.721 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.97 -50.5 73.5 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.461 -0.774 . . . . 0.0 110.78 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -60.16 -39.89 87.98 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.451 -0.781 . . . . 0.0 110.378 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 . . . . . 0 N--CA 1.495 1.778 0 O-C-N 121.611 -0.681 . . . . 0.0 110.127 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.22 0.533 . . . . 0.0 109.851 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -108.06 14.58 25.05 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.525 -0.735 . . . . 0.0 111.071 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -64.85 -174.06 0.13 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.181 -0.949 . . . . 0.0 109.372 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.1 mt -131.57 177.02 7.82 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.325 -0.859 . . . . 0.0 111.03 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.5 p -140.11 105.37 5.04 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.538 ' HA ' HD12 ' A' ' 9' ' ' ILE . 98.8 mt-10 -87.04 -9.04 56.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.743 -0.598 . . . . 0.0 111.397 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -70.06 -35.6 74.36 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -0.927 . . . . 0.0 110.554 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -68.76 -37.57 79.47 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.397 -0.814 . . . . 0.0 110.182 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 6' ' ' GLU . 82.3 mt -59.93 -31.87 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.727 -0.608 . . . . 0.0 110.98 -178.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.11 -39.38 86.02 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.249 -0.907 . . . . 0.0 110.287 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -60.04 -40.0 87.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.541 -0.725 . . . . 0.0 110.349 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -65.52 -22.83 66.76 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.486 -0.759 . . . . 0.0 110.841 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.446 ' HD3' ' CE1' ' A' ' 65' ' ' PHE . 46.7 mmtt -68.77 -39.99 79.96 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.84 -56.82 13.97 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 120.311 -0.555 . . . . 0.0 110.542 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.38 -25.89 67.48 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.295 -0.878 . . . . 0.0 112.19 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.517 ' CG ' ' CZ ' ' A' ' 65' ' ' PHE . 51.1 t80 -59.99 -43.61 95.03 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.112 -0.993 . . . . 0.0 110.714 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 98.4 p -62.13 -35.34 78.45 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.34 -0.85 . . . . 0.0 110.123 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.8 tt -66.7 -39.97 88.3 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.449 ' HZ ' HD21 ' B' ' 167' ' ' LEU . 5.5 m-85 -70.01 -40.06 75.49 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -91.59 88.75 6.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.782 -0.574 . . . . 0.0 110.139 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -59.98 -33.22 71.66 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.439 -0.788 . . . . 0.0 111.297 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -80.18 -10.07 59.74 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.113 -0.992 . . . . 0.0 111.236 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 58.02 26.07 57.7 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -88.07 -7.17 57.39 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.507 -0.996 . . . . 0.0 111.096 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.87 3.47 58.11 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.199 -1.001 . . . . 0.0 111.568 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.2 p -143.22 141.25 31.03 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 119.181 1.491 . . . . 0.0 111.484 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.5 mt -98.51 120.06 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.0 p -84.05 175.77 9.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.431 -0.793 . . . . 0.0 109.875 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.735 HG22 HD11 ' A' ' 52' ' ' ILE . 78.3 p -76.21 -32.34 58.9 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.592 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -67.84 -41.65 82.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.526 -0.734 . . . . 0.0 110.708 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -60.54 -57.46 12.65 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.605 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.5 tp -59.96 -39.19 84.78 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.368 -0.832 . . . . 0.0 111.057 -178.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -48.1 -29.79 6.96 Favored Glycine 0 N--CA 1.502 3.08 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -178.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.5 m -68.14 -40.0 82.52 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.442 -1.034 . . . . 0.0 108.928 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.5 t -64.13 -44.41 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 CA-C-O 121.306 0.574 . . . . 0.0 110.128 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.483 ' HE2' ' HD3' ' A' ' 43' ' ' PRO . 95.9 mtp -59.99 -39.99 87.65 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.604 -0.685 . . . . 0.0 110.554 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.465 ' HG2' ' HB2' ' A' ' 42' ' ' ASN . 1.1 mmt85 -61.02 -38.44 86.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.424 -0.797 . . . . 0.0 109.504 178.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.4 t -64.35 -26.7 68.59 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.887 -0.508 . . . . 0.0 110.613 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.557 HD11 HD13 ' B' ' 167' ' ' LEU . 88.3 mt -93.39 -16.1 24.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.298 -0.876 . . . . 0.0 110.228 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.05 -66.3 0.12 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -161.34 170.01 20.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.258 -1.142 . . . . 0.0 111.708 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.465 ' HB2' ' HG2' ' A' ' 37' ' ' ARG . 29.9 t30 -112.79 129.0 24.88 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.882 -0.511 . . . . 0.0 110.136 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.483 ' HD3' ' HE2' ' A' ' 36' ' ' MET . 50.8 Cg_endo -68.6 -143.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.264 0 O-C-N 123.142 1.075 . . . . 0.0 109.398 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.5 p -128.48 156.17 43.66 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.648 -1.282 . . . . 0.0 111.444 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -51.9 -22.59 3.95 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.78 -0.575 . . . . 0.0 111.844 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.13 -56.18 6.02 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 122.233 1.016 . . . . 0.0 108.523 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.4 -34.3 76.97 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.479 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.415 ' HB3' ' HB ' ' A' ' 29' ' ' THR . 1.2 mt -57.22 -35.52 69.76 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.611 -0.681 . . . . 0.0 109.991 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -72.63 -30.29 64.18 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 120.191 -0.603 . . . . 0.0 111.708 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -69.14 -40.16 78.42 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.224 -0.923 . . . . 0.0 110.531 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 78.1 mtm -65.12 -40.02 93.88 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.682 0.754 . . . . 0.0 109.216 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.735 HD11 HG22 ' A' ' 29' ' ' THR . 92.6 mt -67.38 -34.48 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.832 -0.543 . . . . 0.0 110.507 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -60.08 -39.98 87.96 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.233 -0.917 . . . . 0.0 112.073 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -66.03 -27.77 68.35 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.051 -1.031 . . . . 0.0 110.75 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.578 HG21 ' SD ' ' A' ' 71' ' ' MET . 60.1 t -97.34 -9.33 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.598 -0.689 . . . . 0.0 110.55 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.432 ' OD2' HG22 ' A' ' 52' ' ' ILE . 12.1 m-20 -69.44 97.63 1.01 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.283 -0.886 . . . . 0.0 110.603 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.08 -38.62 91.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.658 -0.651 . . . . 0.0 109.4 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -90.33 -31.58 16.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.726 -0.609 . . . . 0.0 110.812 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.6 21.58 36.75 Favored Glycine 0 N--CA 1.496 2.653 0 C-N-CA 120.336 -0.935 . . . . 0.0 110.832 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -73.93 -33.61 64.01 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.441 -1.035 . . . . 0.0 110.576 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.05 -2.31 7.86 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 120.437 -0.887 . . . . 0.0 110.957 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.8 p -136.19 167.33 21.48 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.014 -1.286 . . . . 0.0 110.621 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.61 HD12 ' HH2' ' B' ' 170' ' ' TRP . 7.9 mt -107.76 123.78 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 121.596 0.712 . . . . 0.0 111.464 -177.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -99.58 171.22 8.06 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.54 0.685 . . . . 0.0 111.044 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.517 ' CZ ' ' CG ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -47.65 -50.03 53.2 Favored Pre-proline 0 N--CA 1.503 2.184 0 O-C-N 121.653 -0.654 . . . . 0.0 112.519 -179.507 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.499 ' O ' HG23 ' A' ' 70' ' ' THR . 41.7 Cg_endo -69.52 -35.33 13.54 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 122.92 0.958 . . . . 0.0 111.671 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.99 -39.93 75.63 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.23 -0.919 . . . . 0.0 109.8 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -61.66 -41.67 97.85 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.205 0.526 . . . . 0.0 110.775 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.3 mt -65.34 -39.97 93.06 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.479 -0.763 . . . . 0.0 111.941 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 66' ' ' PRO . 77.9 p -59.98 -39.96 87.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.249 -0.907 . . . . 0.0 110.614 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.578 ' SD ' HG21 ' A' ' 55' ' ' VAL . 61.3 ttp -67.36 -40.0 85.77 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.558 -0.714 . . . . 0.0 110.986 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -59.95 -50.15 74.9 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.53 -0.731 . . . . 0.0 111.928 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.84 -29.95 67.33 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.541 -0.725 . . . . 0.0 111.877 -178.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -69.97 -40.11 75.58 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.364 -0.835 . . . . 0.0 111.281 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.643 ' O ' HG22 ' A' ' 79' ' ' THR . 43.9 mmtm -69.97 -27.18 64.51 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 38.8 mmt -59.33 -49.03 79.38 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.03 -1.044 . . . . 0.0 112.229 -177.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.6 pttt -69.24 -33.87 73.95 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.263 -0.898 . . . . 0.0 111.936 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -70.02 -19.96 63.29 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.462 -0.773 . . . . 0.0 111.341 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.643 HG22 ' O ' ' A' ' 75' ' ' LYS . 14.3 t -118.2 -166.82 1.26 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.11 0.957 . . . . 0.0 112.427 -178.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -128.52 137.97 52.03 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.639 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.9 t -60.7 -32.43 71.67 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.649 -0.657 . . . . 0.0 110.652 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.474 ' HA ' HD12 ' A' ' 85' ' ' ILE . 92.7 mt-10 -59.99 -33.8 72.45 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.561 -0.712 . . . . 0.0 110.127 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -69.96 -40.0 75.67 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.742 -0.599 . . . . 0.0 110.747 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -69.39 -33.26 72.76 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.503 -0.748 . . . . 0.0 110.469 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.744 HG23 ' HE1' ' A' ' 141' ' ' PHE . 91.9 mt -64.81 -49.62 79.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.724 -0.61 . . . . 0.0 110.407 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -57.87 -38.4 75.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.444 -0.785 . . . . 0.0 111.02 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.714 ' O ' HG23 ' A' ' 91' ' ' VAL . 98.8 mt-10 -70.0 -42.06 73.54 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.66 -0.65 . . . . 0.0 111.617 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.3 -45.65 79.68 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.487 -0.758 . . . . 0.0 111.779 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -60.01 -45.99 90.96 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.382 -0.824 . . . . 0.0 109.449 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -59.99 -33.93 72.63 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.682 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 87' ' ' GLU . 83.3 t -69.04 -47.87 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.441 -0.787 . . . . 0.0 109.829 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.504 ' HE2' HG21 ' B' ' 164' ' ' VAL . 28.3 m-85 -70.02 -39.76 75.6 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.514 -0.741 . . . . 0.0 111.501 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -80.05 80.03 6.52 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.406 -0.809 . . . . 0.0 110.186 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -69.97 -42.07 73.64 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.413 -0.804 . . . . 0.0 110.932 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -72.78 -23.41 60.8 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.415 -0.803 . . . . 0.0 111.046 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.71 24.54 75.42 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -70.7 -9.73 57.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.504 -0.997 . . . . 0.0 111.131 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.69 -11.72 66.35 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -133.18 139.31 46.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.187 -1.184 . . . . 0.0 109.076 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.674 ' CG2' HD23 ' A' ' 105' ' ' LEU . 56.7 mt -89.37 123.25 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.532 -0.73 . . . . 0.0 110.042 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.4 m -86.96 170.14 11.85 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.405 0.621 . . . . 0.0 110.297 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.99 -39.91 75.63 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.632 -0.668 . . . . 0.0 109.749 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.25 -39.29 94.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.772 -0.58 . . . . 0.0 109.668 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -60.16 -39.89 87.97 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.606 -0.684 . . . . 0.0 110.386 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.674 HD23 ' CG2' ' A' ' 100' ' ' ILE . 0.5 OUTLIER -68.21 -41.23 81.63 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.484 0.659 . . . . 0.0 110.655 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -61.09 -37.03 81.27 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.656 -0.652 . . . . 0.0 111.746 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -59.97 -43.32 95.14 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.142 -0.974 . . . . 0.0 111.848 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.456 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 94.4 t -74.85 -44.24 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.237 -0.914 . . . . 0.0 111.631 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 94.5 mmm -58.25 -46.77 85.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.28 -0.888 . . . . 0.0 110.317 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.4 m -67.51 -41.07 85.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.46 -0.775 . . . . 0.0 109.202 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -61.55 -32.94 73.04 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.5 mt -68.52 -37.36 79.96 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.079 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 119.82 38.27 0.72 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -129.67 140.45 51.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.645 -0.915 . . . . 0.0 109.792 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -107.94 109.18 20.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.439 -0.788 . . . . 0.0 110.579 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 56.2 mt -131.59 156.2 46.18 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.598 -0.689 . . . . 0.0 109.753 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.3 m -84.0 164.76 19.12 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.626 -0.671 . . . . 0.0 109.744 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -61.13 -26.76 67.9 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.586 -0.696 . . . . 0.0 109.142 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.95 -31.85 73.0 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -37.34 87.26 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 73.1 t -70.64 -39.7 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.533 0.682 . . . . 0.0 110.201 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.409 ' HA ' HD12 ' A' ' 125' ' ' ILE . 44.4 t0 -59.89 -44.62 94.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.789 -0.57 . . . . 0.0 109.994 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -60.55 -41.33 94.34 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.579 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 67.6 mtt -55.6 -37.69 68.44 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 119.48 -0.888 . . . . 0.0 108.939 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 122' ' ' ASP . 96.7 mt -64.94 -39.93 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -58.64 -39.97 82.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.57 -0.706 . . . . 0.0 111.53 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -61.46 -40.0 92.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.398 -0.814 . . . . 0.0 111.86 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -102.93 -5.06 23.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.168 -0.957 . . . . 0.0 111.921 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -89.3 69.95 8.17 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.916 -1.115 . . . . 0.0 110.518 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.3 mt -70.03 -40.37 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.519 -0.738 . . . . 0.0 111.247 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -62.84 -39.96 95.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.357 -0.839 . . . . 0.0 111.207 -178.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 103.25 22.9 8.82 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.987 -1.102 . . . . 0.0 110.813 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -83.39 -7.71 59.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.33 -1.1 . . . . 0.0 110.767 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.05 -3.18 87.08 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -138.02 148.26 44.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.409 -1.053 . . . . 0.0 109.454 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 71.4 t -92.36 118.63 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.566 -0.709 . . . . 0.0 110.263 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -90.62 -174.32 4.05 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.361 -0.837 . . . . 0.0 110.823 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -69.98 -40.21 75.47 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.354 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.33 -50.11 74.94 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.181 -0.95 . . . . 0.0 111.383 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.47 -34.36 78.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.517 -0.739 . . . . 0.0 109.828 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.744 ' HE1' HG23 ' A' ' 85' ' ' ILE . 49.6 t80 -58.05 -49.3 77.37 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.038 0.447 . . . . 0.0 110.776 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 53.3 t -70.03 -39.08 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.365 -0.834 . . . . 0.0 111.211 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -57.6 -49.28 76.91 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.305 -0.872 . . . . 0.0 110.827 -178.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -59.35 -35.62 74.19 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.416 -0.802 . . . . 0.0 110.33 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.529 ' CE ' ' HB1' ' B' ' 161' ' ' ALA . 58.5 mtt -73.8 -40.0 63.7 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.53 -0.731 . . . . 0.0 110.549 178.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 34.8 m -69.9 -19.88 63.39 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.715 -0.615 . . . . 0.0 110.86 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -107.64 137.32 45.87 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.402 -0.811 . . . . 0.0 110.484 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.3 mttm . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.025 179.951 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -99.28 146.56 18.08 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -60.04 -41.84 93.13 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.595 -0.944 . . . . 0.0 110.098 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -59.96 -40.05 87.73 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.597 -0.689 . . . . 0.0 110.186 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -59.98 -40.19 88.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.733 -0.604 . . . . 0.0 110.703 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . 0.411 ' O ' HG23 ' B' ' 164' ' ' VAL . 95.3 mt -69.92 -40.41 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.396 -0.815 . . . . 0.0 111.973 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . 0.529 ' HB1' ' CE ' ' A' ' 145' ' ' MET . . . -66.14 -42.85 88.5 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.274 -0.892 . . . . 0.0 111.923 -178.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -68.68 -40.02 80.3 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.383 -0.823 . . . . 0.0 110.785 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.467 ' C ' HD23 ' B' ' 163' ' ' LEU . 10.3 tt -59.93 -42.87 94.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.499 -0.75 . . . . 0.0 110.397 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.516 ' HA ' HD12 ' B' ' 167' ' ' LEU . 85.8 t -65.85 -40.03 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.581 -0.699 . . . . 0.0 110.011 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.57 -39.97 93.95 Favored Glycine 0 N--CA 1.498 2.83 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 84.8 t -64.56 -37.39 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.464 -1.021 . . . . 0.0 110.314 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.557 HD13 HD11 ' A' ' 39' ' ' LEU . 95.7 mt -60.02 -45.35 93.08 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.52 -0.737 . . . . 0.0 110.919 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 168' ' ' ARG . . . . . 0.402 ' O ' ' CD2' ' B' ' 172' ' ' TYR . 21.5 mmt180 -59.94 -39.31 85.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.487 -0.758 . . . . 0.0 110.999 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -60.02 -37.95 81.26 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.446 -0.784 . . . . 0.0 109.747 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . 0.61 ' HH2' HD12 ' A' ' 63' ' ' ILE . 3.2 t-105 -59.98 -43.32 95.19 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.688 -0.633 . . . . 0.0 109.72 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.98 -52.04 65.61 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.568 -0.707 . . . . 0.0 110.641 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 172' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' B' ' 168' ' ' ARG . 53.6 m-85 -60.01 -38.75 83.57 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.485 -0.76 . . . . 0.0 110.538 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.542 -0.724 . . . . 0.0 110.246 -179.883 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.081 0.467 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -97.54 10.04 40.89 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.531 -0.731 . . . . 0.0 110.703 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -60.17 -37.09 79.1 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.375 -0.828 . . . . 0.0 111.403 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.03 -39.96 87.67 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.642 -0.661 . . . . 0.0 110.414 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.7 p -134.45 102.59 5.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.35 -0.844 . . . . 0.0 109.588 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -77.71 -10.05 59.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.878 -0.514 . . . . 0.0 111.427 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -68.51 -23.86 64.6 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.159 -0.963 . . . . 0.0 110.177 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -66.01 -36.91 84.56 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.415 -0.803 . . . . 0.0 109.539 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 94.3 mt -59.99 -32.4 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.817 -0.552 . . . . 0.0 111.53 -178.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -65.6 -32.23 73.7 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.967 -1.083 . . . . 0.0 110.512 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -65.09 -45.54 84.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 109.946 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -69.99 -23.59 63.17 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.358 0.599 . . . . 0.0 110.09 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 23.1 tptp -66.61 -53.08 38.15 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.355 0.598 . . . . 0.0 109.562 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -57.09 -52.68 64.32 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.951 -0.699 . . . . 0.0 110.376 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.78 -26.39 68.69 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.352 -0.842 . . . . 0.0 111.105 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -58.25 -48.41 80.5 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.009 -1.057 . . . . 0.0 110.236 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.3 m -61.86 -39.85 93.31 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.306 -0.871 . . . . 0.0 109.143 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.5 tp -60.0 -39.98 87.64 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.351 0.596 . . . . 0.0 109.5 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -72.59 -35.49 67.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.727 -0.608 . . . . 0.0 110.392 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -95.4 98.96 10.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.471 -0.768 . . . . 0.0 110.371 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.2 mmtm -64.97 -32.04 73.57 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.377 -0.827 . . . . 0.0 111.192 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -79.83 -10.08 59.74 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.083 -1.011 . . . . 0.0 111.081 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.2 26.19 49.42 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -88.28 -3.29 58.88 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.605 -0.938 . . . . 0.0 110.637 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.57 5.46 64.94 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.297 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.9 p -145.1 142.39 29.64 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 119.166 1.483 . . . . 0.0 111.703 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 86.2 mt -103.86 128.0 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.3 p -102.05 141.22 35.23 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.619 -0.676 . . . . 0.0 110.628 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.455 ' O ' HD13 ' A' ' 48' ' ' LEU . 65.7 p -40.82 -35.87 0.56 Allowed 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -65.72 -45.44 82.69 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.249 -0.907 . . . . 0.0 109.548 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -60.05 -54.05 50.59 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.8 -0.562 . . . . 0.0 111.304 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.6 tt -59.95 -35.86 75.86 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.291 -0.881 . . . . 0.0 111.321 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.22 -28.98 44.16 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.2 m -69.54 -39.98 77.12 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.471 -1.017 . . . . 0.0 110.701 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.9 t -63.58 -54.98 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.691 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 97.8 mmm -59.96 -29.52 68.48 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.731 -0.606 . . . . 0.0 110.788 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -60.39 -50.44 73.58 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.503 -0.748 . . . . 0.0 110.448 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.4 t -72.55 -18.17 61.66 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.692 -0.63 . . . . 0.0 111.02 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.482 HD13 ' CD1' ' B' ' 167' ' ' LEU . 81.8 mt -100.11 -5.04 28.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.424 -0.797 . . . . 0.0 111.518 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.29 -68.04 0.12 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -160.21 170.64 20.75 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.228 -1.16 . . . . 0.0 111.448 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -110.53 117.21 51.41 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.972 -0.455 . . . . 0.0 110.215 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.697 ' CG ' HD21 ' A' ' 48' ' ' LEU . 53.1 Cg_endo -68.63 -150.37 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.324 0 N-CA-C 109.265 -1.091 . . . . 0.0 109.265 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 77.2 p -137.79 147.03 44.28 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.939 -1.101 . . . . 0.0 110.606 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.406 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 17.8 pt-20 -54.86 -21.1 10.32 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.55 -0.718 . . . . 0.0 111.46 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.53 -59.44 2.76 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.23 -38.43 85.21 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.832 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.697 HD21 ' CG ' ' A' ' 43' ' ' PRO . 56.5 mt -59.48 -33.71 71.65 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.666 0.746 . . . . 0.0 109.839 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.84 -39.01 83.89 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.022 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -65.93 -39.39 90.48 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.467 -0.771 . . . . 0.0 110.186 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 66.9 mtt -61.64 -43.39 98.94 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.415 0.626 . . . . 0.0 109.628 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.786 HG12 HD11 ' A' ' 63' ' ' ILE . 81.3 mt -68.02 -32.55 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.773 -0.579 . . . . 0.0 110.419 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -59.76 -40.04 86.83 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.384 -0.823 . . . . 0.0 110.292 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -64.07 -27.99 69.48 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.445 -0.785 . . . . 0.0 110.319 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.535 HG21 ' HE2' ' A' ' 71' ' ' MET . 61.0 t -101.01 -10.11 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.443 -0.785 . . . . 0.0 110.803 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.546 ' OD2' HG22 ' A' ' 52' ' ' ILE . 22.0 m-20 -67.25 100.5 0.81 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.136 -0.978 . . . . 0.0 111.163 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.0 -38.34 75.94 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -90.75 -30.45 17.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.756 -0.59 . . . . 0.0 110.622 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.6 22.42 43.5 Favored Glycine 0 N--CA 1.496 2.65 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.006 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -75.22 -31.89 61.0 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.342 -1.093 . . . . 0.0 110.657 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.4 1.1 12.48 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.334 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 77.8 p -133.49 170.01 16.13 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.116 -1.226 . . . . 0.0 110.429 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.786 HD11 HG12 ' A' ' 52' ' ' ILE . 7.0 mt -106.69 122.33 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.892 -177.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -98.5 170.03 9.11 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.521 0.676 . . . . 0.0 110.383 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.45 ' HB3' ' HD3' ' A' ' 66' ' ' PRO . 9.9 t80 -47.07 -48.77 53.1 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.586 -0.696 . . . . 0.0 112.802 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 65' ' ' PHE . 45.2 Cg_endo -71.26 -32.27 13.07 Favored 'Trans proline' 0 N--CA 1.487 1.102 0 O-C-N 122.783 0.886 . . . . 0.0 111.596 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -72.4 -40.21 67.38 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.123 -0.986 . . . . 0.0 110.409 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -62.74 -45.43 92.74 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.781 -0.574 . . . . 0.0 110.544 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.05 -40.01 87.96 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.515 -0.74 . . . . 0.0 110.472 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 93.1 m -61.19 -40.75 95.09 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.721 -0.612 . . . . 0.0 111.029 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.535 ' HE2' HG21 ' A' ' 55' ' ' VAL . 12.9 ttm -69.14 -41.07 77.82 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.45 -0.781 . . . . 0.0 112.099 -178.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -60.02 -50.0 75.44 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.335 -0.853 . . . . 0.0 111.226 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.59 -32.27 70.91 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.714 -0.616 . . . . 0.0 111.822 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.8 mmt85 -72.96 -43.51 62.2 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.33 -0.856 . . . . 0.0 111.819 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -73.4 -41.66 63.07 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.373 -0.829 . . . . 0.0 112.853 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 24.4 ptm -60.06 -29.77 68.77 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.162 -0.961 . . . . 0.0 111.538 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -63.19 -52.69 61.32 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.27 -0.894 . . . . 0.0 111.587 -178.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -69.84 -10.82 59.85 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.42 -0.8 . . . . 0.0 111.168 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.586 HG22 ' H ' ' A' ' 80' ' ' ASP 0.268 23.4 m -86.06 -174.58 5.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.581 -0.699 . . . . 0.0 109.369 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.586 ' H ' HG22 ' A' ' 79' ' ' THR . 94.1 m-20 -128.01 140.9 51.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.238 -0.914 . . . . 0.0 109.447 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.1 t -59.95 -35.05 74.13 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.633 -0.667 . . . . 0.0 110.152 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -61.08 -34.95 75.73 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.619 0.723 . . . . 0.0 109.471 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.99 -40.0 75.58 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.909 -0.494 . . . . 0.0 111.412 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.91 -40.0 79.34 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.443 -0.786 . . . . 0.0 111.062 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.448 HG23 ' HE1' ' A' ' 141' ' ' PHE . 82.8 mt -68.16 -51.82 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.45 -0.781 . . . . 0.0 110.984 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -60.01 -40.94 90.99 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.255 -0.903 . . . . 0.0 111.708 -178.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.517 ' O ' HG23 ' A' ' 91' ' ' VAL . 97.6 mt-10 -70.52 -41.45 72.56 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.51 -0.744 . . . . 0.0 111.576 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.31 -43.61 94.16 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.526 -0.734 . . . . 0.0 110.716 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -61.96 -40.81 96.86 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.811 0.815 . . . . 0.0 108.899 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 29.6 ttt85 -59.95 -37.13 78.67 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.395 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 87' ' ' GLU . 91.2 t -70.02 -50.03 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.509 -0.744 . . . . 0.0 110.153 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.674 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 27.3 m-85 -67.67 -39.97 84.47 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.405 -0.809 . . . . 0.0 110.261 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -79.58 76.3 6.21 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.403 ' HE3' ' CD2' ' A' ' 107' ' ' HIS . 60.2 mttm -68.85 -40.48 79.33 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.505 -0.747 . . . . 0.0 110.276 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -74.5 -21.67 59.44 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.418 -0.801 . . . . 0.0 110.64 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.2 26.41 73.43 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -69.92 -12.66 61.78 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.535 -0.979 . . . . 0.0 111.464 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.11 -20.62 14.07 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -144.77 153.74 41.97 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.239 -1.154 . . . . 0.0 109.994 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 80.6 mt -88.88 131.58 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.887 0.851 . . . . 0.0 110.457 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.2 m -87.7 171.01 10.75 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.193 0.521 . . . . 0.0 110.367 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.499 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -65.68 -40.07 91.97 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.41 -38.49 89.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.748 -0.595 . . . . 0.0 109.5 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -61.84 -39.95 93.61 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.751 -0.593 . . . . 0.0 110.666 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.66 ' HB3' HG13 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -61.38 -45.61 93.63 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.44 -0.788 . . . . 0.0 109.761 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -64.42 -29.0 70.06 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.768 -0.582 . . . . 0.0 110.513 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.403 ' CD2' ' HE3' ' A' ' 94' ' ' LYS . 1.5 t-80 -61.59 -46.8 88.32 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.445 -0.785 . . . . 0.0 111.361 -178.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.674 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 66.5 t -73.38 -47.93 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.472 -0.768 . . . . 0.0 111.727 -178.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.468 ' HA ' HD12 ' A' ' 112' ' ' LEU . 98.0 mtp -58.61 -39.95 81.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.222 -0.923 . . . . 0.0 110.544 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.4 m -66.58 -45.27 79.79 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -61.45 -33.41 73.68 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 109' ' ' MET . 59.2 mt -68.83 -38.74 80.06 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.922 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 119.97 39.88 0.62 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -123.32 136.01 54.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.664 -0.903 . . . . 0.0 109.991 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -96.71 126.41 41.86 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.519 -0.738 . . . . 0.0 109.701 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.688 HD23 ' N ' ' A' ' 116' ' ' LEU . 1.0 OUTLIER -152.52 153.77 34.12 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.513 -0.742 . . . . 0.0 111.443 -178.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.7 p -87.36 168.04 13.51 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 36.6 p-10 -64.46 -20.69 66.34 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.644 -0.823 . . . . 0.0 108.879 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -69.71 -37.93 76.76 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.973 0.892 . . . . 0.0 109.134 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -61.48 -39.98 92.88 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 122.131 0.967 . . . . 0.0 108.967 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.66 HG13 ' HB3' ' A' ' 105' ' ' LEU . 63.7 t -69.73 -39.85 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.663 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -59.79 -48.54 81.29 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.572 -0.705 . . . . 0.0 110.217 -178.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -59.99 -40.04 87.8 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.93 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.451 ' HB3' HD11 ' A' ' 105' ' ' LEU . 92.8 mmm -55.4 -38.16 68.55 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.136 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.41 -36.92 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 121.667 0.746 . . . . 0.0 109.154 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -58.14 -39.66 79.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.804 -0.56 . . . . 0.0 111.072 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.96 -39.31 85.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.549 -0.719 . . . . 0.0 111.297 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.91 -18.8 18.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.281 -0.887 . . . . 0.0 111.103 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -72.42 70.84 0.9 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.312 -0.867 . . . . 0.0 111.349 -178.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 85.4 mt -67.8 -40.41 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.45 -0.781 . . . . 0.0 110.557 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -72.32 -18.26 61.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.438 -0.789 . . . . 0.0 111.581 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.23 22.48 60.68 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 120.136 -1.03 . . . . 0.0 110.853 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -82.6 -7.23 59.65 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.181 -1.188 . . . . 0.0 110.782 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.19 -0.83 89.52 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -138.52 149.5 45.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.327 -1.102 . . . . 0.0 109.246 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.6 t -92.98 110.85 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.356 -0.84 . . . . 0.0 110.7 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -80.0 172.77 13.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.493 -0.754 . . . . 0.0 109.647 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -67.94 -40.07 83.36 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.795 -0.566 . . . . 0.0 111.009 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -62.85 -52.29 63.69 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.252 -0.905 . . . . 0.0 111.988 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -69.12 -23.3 63.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -0.849 . . . . 0.0 111.122 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.448 ' HE1' HG23 ' A' ' 85' ' ' ILE . 63.3 t80 -60.08 -42.3 94.3 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.433 -0.792 . . . . 0.0 109.598 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 95.3 t -70.09 -37.67 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.726 -0.609 . . . . 0.0 111.047 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -59.94 -50.03 75.36 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.49 -0.757 . . . . 0.0 110.935 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.476 ' HE1' ' CD1' ' B' ' 157' ' ' PHE . 59.5 ttp -59.95 -37.73 80.4 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.261 -0.899 . . . . 0.0 110.299 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 94.2 mmm -67.1 -39.99 86.82 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.749 -0.594 . . . . 0.0 111.372 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 64.5 m -57.59 -26.12 61.04 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.292 -0.88 . . . . 0.0 110.543 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.78 135.0 41.72 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.47 -0.769 . . . . 0.0 110.21 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.141 179.969 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -133.87 140.36 11.72 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.48 ' O ' HG22 ' B' ' 160' ' ' ILE . 36.0 t80 -61.96 -41.26 97.8 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.597 -0.943 . . . . 0.0 110.37 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -62.5 -40.04 95.43 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.561 -0.712 . . . . 0.0 110.585 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -61.66 -48.12 82.28 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.643 -0.661 . . . . 0.0 111.191 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . 0.48 HG22 ' O ' ' B' ' 157' ' ' PHE . 14.3 tt -69.95 -26.04 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.527 -0.733 . . . . 0.0 111.04 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.48 -35.34 77.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.504 -0.748 . . . . 0.0 109.661 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -59.97 -40.09 87.89 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.817 -0.552 . . . . 0.0 109.997 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 59.7 mt -63.27 -39.96 96.07 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.525 -0.734 . . . . 0.0 110.704 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 91.2 t -62.75 -40.4 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.455 -0.778 . . . . 0.0 110.414 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.05 -40.02 96.51 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 48.1 t -70.53 -22.53 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.613 -0.934 . . . . 0.0 110.833 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.482 ' CD1' HD13 ' A' ' 39' ' ' LEU . 9.6 tt -59.98 -41.93 93.1 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.3 -0.875 . . . . 0.0 110.076 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -69.48 -35.98 76.09 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.577 -0.702 . . . . 0.0 109.767 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . 0.446 ' OE2' HG21 ' A' ' 79' ' ' THR . 89.8 mt-10 -59.92 -36.65 77.46 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.665 -0.647 . . . . 0.0 110.235 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 4.9 t-105 -60.06 -40.91 91.12 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.671 -0.643 . . . . 0.0 110.722 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.06 -50.12 74.95 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.453 -0.78 . . . . 0.0 110.65 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -60.01 -39.99 87.72 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.417 -0.802 . . . . 0.0 110.354 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 71.2 mtt-85 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.615 -0.678 . . . . 0.0 110.277 -179.537 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.269 0.557 . . . . 0.0 110.017 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -109.18 25.78 11.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.689 -0.632 . . . . 0.0 110.235 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -60.0 -40.05 87.89 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.559 -0.713 . . . . 0.0 110.344 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 76.1 mt -72.89 173.99 8.42 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.335 0.588 . . . . 0.0 110.01 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.96 117.0 7.26 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.388 0.613 . . . . 0.0 109.534 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -71.59 -26.56 62.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.912 -0.493 . . . . 0.0 110.645 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -64.03 -20.44 65.92 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.522 -0.736 . . . . 0.0 111.492 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -70.56 -38.67 74.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.265 -0.897 . . . . 0.0 109.542 177.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 88.0 mt -62.99 -37.94 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.958 -0.464 . . . . 0.0 111.699 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.66 -39.77 89.61 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.206 -0.934 . . . . 0.0 110.344 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -60.06 -39.58 86.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.374 -0.829 . . . . 0.0 110.407 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.588 ' HB3' HD21 ' A' ' 69' ' ' LEU . 47.2 m-85 -64.17 -22.1 66.81 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.682 -0.636 . . . . 0.0 110.885 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -69.52 -41.14 76.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.303 -0.873 . . . . 0.0 109.181 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -71.91 -23.76 61.53 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.133 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.05 -35.49 42.48 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.342 -0.849 . . . . 0.0 110.107 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.433 ' CG ' ' CE1' ' A' ' 65' ' ' PHE . 54.7 t80 -58.38 -38.13 76.68 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.899 -0.5 . . . . 0.0 110.914 -178.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.3 p -61.02 -37.15 81.54 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.35 -0.844 . . . . 0.0 109.92 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.643 HD13 ' O ' ' A' ' 18' ' ' LEU . 0.8 OUTLIER -59.98 -40.01 87.67 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.611 -0.681 . . . . 0.0 109.459 179.545 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -78.14 -36.25 48.01 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.629 -0.669 . . . . 0.0 110.266 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -93.19 95.8 9.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.581 -0.699 . . . . 0.0 109.967 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -61.74 -32.82 73.08 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.574 -0.704 . . . . 0.0 111.221 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -79.37 -10.43 59.81 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.234 -0.916 . . . . 0.0 111.565 -177.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.51 27.75 54.72 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -92.98 -2.54 55.67 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.616 -0.931 . . . . 0.0 111.0 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.38 2.67 63.58 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.787 178.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 76.2 p -142.05 141.11 32.76 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 119.559 1.68 . . . . 0.0 111.76 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.622 ' HB ' HD12 ' A' ' 63' ' ' ILE . 85.7 mt -105.39 130.14 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.792 -0.567 . . . . 0.0 110.428 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.3 p -113.01 146.6 38.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.599 -0.688 . . . . 0.0 110.779 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.432 HG23 HG13 ' A' ' 52' ' ' ILE . 40.7 p -42.4 -31.08 0.38 Allowed 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.744 -0.598 . . . . 0.0 112.378 -177.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -65.38 -48.98 71.04 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.569 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -60.43 -56.82 16.76 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.967 -0.458 . . . . 0.0 111.767 -178.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.6 tp -61.54 -32.79 72.87 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.105 -0.997 . . . . 0.0 110.632 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -50.79 -33.95 28.49 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.3 m -69.98 -40.03 75.59 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.691 -0.888 . . . . 0.0 110.244 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.2 t -63.45 -58.51 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.573 -0.704 . . . . 0.0 110.264 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.427 ' HG2' HD21 ' B' ' 167' ' ' LEU . 74.0 mtm -60.01 -30.04 68.88 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.574 -0.704 . . . . 0.0 110.447 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 1.6 tmm_? -60.77 -50.36 73.77 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.566 -0.709 . . . . 0.0 109.601 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.9 t -74.78 -20.06 59.95 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.872 -0.517 . . . . 0.0 110.33 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.516 HD22 ' CD1' ' B' ' 167' ' ' LEU . 5.4 mp -97.97 -1.48 42.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.393 -0.817 . . . . 0.0 111.352 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.07 -71.43 0.11 Allowed Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.898 -1.144 . . . . 0.0 110.374 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.411 ' HG2' ' N ' ' A' ' 42' ' ' ASN . 36.5 tt0 -162.04 161.01 28.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.183 -1.186 . . . . 0.0 111.316 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.411 ' N ' ' HG2' ' A' ' 41' ' ' GLN . 45.3 t30 -111.65 103.4 55.07 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -61.78 -146.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 O-C-N 123.512 1.269 . . . . 0.0 110.402 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.8 p -132.86 157.54 44.79 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.619 -1.3 . . . . 0.0 112.122 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.421 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 45.8 mt-10 -52.64 -23.36 6.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.886 -0.509 . . . . 0.0 111.647 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.05 -59.94 2.6 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.149 0.976 . . . . 0.0 108.419 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -67.86 -36.2 79.88 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.589 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 45' ' ' GLU . 8.8 mt -58.3 -35.02 71.22 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.605 0.717 . . . . 0.0 109.769 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -39.79 94.29 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.068 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -64.8 -40.02 94.55 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.542 -0.724 . . . . 0.0 111.192 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 64.5 mtt -60.04 -42.53 94.63 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.618 -0.676 . . . . 0.0 109.791 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.827 HG22 ' OD2' ' A' ' 56' ' ' ASP . 48.5 mm -68.33 -37.18 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.855 -0.528 . . . . 0.0 111.11 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -60.97 -40.04 91.89 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.484 -0.76 . . . . 0.0 111.511 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -69.99 -28.25 65.36 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.188 -0.945 . . . . 0.0 110.482 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.1 t -95.61 -9.96 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.648 -0.658 . . . . 0.0 111.229 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.827 ' OD2' HG22 ' A' ' 52' ' ' ILE . 25.4 m-20 -74.71 97.45 3.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.176 -0.953 . . . . 0.0 110.766 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.01 -34.53 73.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.541 -0.724 . . . . 0.0 109.804 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -91.41 -26.3 18.93 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.556 -0.715 . . . . 0.0 110.774 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.14 20.17 50.4 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.035 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -76.13 -26.34 56.25 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.434 -1.039 . . . . 0.0 110.461 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.438 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 109.8 -2.09 30.37 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 77.0 p -130.71 170.89 13.74 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.187 -1.184 . . . . 0.0 110.625 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.622 HD12 ' HB ' ' A' ' 27' ' ' ILE . 6.4 mt -89.4 167.5 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.218 0.533 . . . . 0.0 110.007 -178.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.425 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 81.6 m-20 -147.04 150.57 35.35 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.496 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.7 m-85 -42.98 -52.45 11.57 Favored Pre-proline 0 N--CA 1.506 2.344 0 O-C-N 121.702 -0.624 . . . . 0.0 111.71 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.669 ' O ' HG23 ' A' ' 70' ' ' THR . 43.4 Cg_endo -69.41 -29.85 24.87 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 O-C-N 123.269 1.142 . . . . 0.0 111.334 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -72.55 -45.46 59.19 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.014 -1.054 . . . . 0.0 110.067 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -60.47 -43.93 96.41 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.755 -0.59 . . . . 0.0 110.665 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.588 HD21 ' HB3' ' A' ' 12' ' ' PHE . 78.3 mt -67.13 -41.55 85.93 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.686 -0.633 . . . . 0.0 111.757 -178.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.669 HG23 ' O ' ' A' ' 66' ' ' PRO . 43.0 p -62.71 -40.16 96.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.337 -0.852 . . . . 0.0 110.718 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.414 ' HE3' ' CE3' ' B' ' 170' ' ' TRP . 56.4 ttp -66.35 -46.57 76.32 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.79 -0.569 . . . . 0.0 111.315 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 59.7 ttm -60.06 -49.97 75.56 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.388 -0.82 . . . . 0.0 111.352 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.54 -33.52 72.78 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.487 -0.758 . . . . 0.0 110.58 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.6 ttp180 -69.98 -39.52 75.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.722 -0.611 . . . . 0.0 110.857 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.775 ' O ' HG22 ' A' ' 79' ' ' THR . 4.3 mptp? -71.83 -18.25 62.09 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.455 -0.778 . . . . 0.0 112.086 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 26.9 mmt -58.96 -50.02 75.66 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.99 -1.069 . . . . 0.0 110.735 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.99 -32.7 71.04 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.692 -0.63 . . . . 0.0 111.121 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -70.67 -18.9 62.83 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.43 -0.794 . . . . 0.0 111.549 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.775 HG22 ' O ' ' A' ' 75' ' ' LYS . 14.4 t -121.93 -162.94 1.02 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.879 0.847 . . . . 0.0 112.284 -178.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -127.97 142.2 51.31 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.353 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.3 t -66.73 -32.51 73.86 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.83 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -60.08 -36.98 78.58 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.881 0.848 . . . . 0.0 109.199 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.86 -39.97 76.04 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.306 0.574 . . . . 0.0 110.389 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -61.63 -37.49 84.17 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.606 -0.684 . . . . 0.0 110.75 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 77.4 mt -67.73 -44.43 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.538 -0.726 . . . . 0.0 110.685 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -59.25 -39.96 84.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.417 -0.802 . . . . 0.0 110.561 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -70.02 -39.96 75.48 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.339 -0.851 . . . . 0.0 111.346 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.434 ' HA ' HG11 ' B' ' 164' ' ' VAL . . . -63.98 -46.26 85.41 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.466 -0.771 . . . . 0.0 111.317 -178.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.423 ' HB2' ' CE2' ' A' ' 141' ' ' PHE . 52.2 t80 -62.39 -39.99 95.02 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.481 -0.762 . . . . 0.0 109.617 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 39.4 ttm-85 -59.99 -39.3 85.24 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.821 -0.55 . . . . 0.0 111.247 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.6 t -70.02 -43.89 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.482 -0.761 . . . . 0.0 110.354 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.548 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 16.2 m-85 -68.62 -39.28 80.88 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.345 -0.847 . . . . 0.0 111.119 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -78.64 78.2 5.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.515 -0.74 . . . . 0.0 109.867 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -59.98 -45.39 92.88 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.487 -0.758 . . . . 0.0 110.358 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 33.3 p-10 -79.71 -19.59 48.51 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.641 -0.662 . . . . 0.0 110.869 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.18 62.5 6.28 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -105.74 -10.59 16.66 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.389 -1.065 . . . . 0.0 111.262 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 123.91 -25.62 6.09 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.419 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 27.5 p90 -145.75 152.49 39.65 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.483 -1.01 . . . . 0.0 109.42 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 77.4 mt -88.84 131.39 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.887 0.851 . . . . 0.0 110.197 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.97 171.84 10.02 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.269 0.557 . . . . 0.0 110.588 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.0 -41.57 97.44 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.603 -0.686 . . . . 0.0 109.304 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.96 -37.7 88.51 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -64.82 -40.08 94.62 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.607 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.639 ' HB3' HG13 ' A' ' 121' ' ' VAL . 1.3 tt -60.29 -45.48 93.19 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.336 -0.852 . . . . 0.0 109.264 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.8 ttt-85 -62.54 -30.99 71.7 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.844 -0.535 . . . . 0.0 111.081 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -59.94 -46.12 90.42 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.164 -0.96 . . . . 0.0 110.417 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.548 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 90.2 t -74.96 -33.0 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.411 -0.806 . . . . 0.0 110.926 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.1 mmt -60.09 -49.12 78.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.454 -0.779 . . . . 0.0 110.323 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 76.8 m -68.6 -43.92 75.42 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.66 -0.65 . . . . 0.0 110.414 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -59.89 -29.32 68.26 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.56 -0.712 . . . . 0.0 109.501 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.492 HD11 HG12 ' A' ' 108' ' ' VAL . 27.4 mt -70.01 -29.65 66.78 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.694 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 112.21 18.98 7.38 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -122.03 145.03 48.54 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.248 -1.148 . . . . 0.0 110.35 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -105.53 123.6 48.16 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.539 -0.726 . . . . 0.0 110.666 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 72.2 mt -135.38 157.83 45.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.625 -0.672 . . . . 0.0 110.02 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.22 166.75 16.28 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.631 -0.668 . . . . 0.0 109.226 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -61.72 -26.37 68.01 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.94 -34.54 78.36 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.466 0.651 . . . . 0.0 109.57 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.33 -35.86 82.28 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.639 HG13 ' HB3' ' A' ' 105' ' ' LEU . 53.9 t -68.07 -39.98 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 121.507 0.67 . . . . 0.0 109.884 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.518 ' HA ' HD12 ' A' ' 125' ' ' ILE . 55.2 t0 -59.99 -49.85 76.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.733 -0.604 . . . . 0.0 110.511 -178.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -60.44 -42.04 95.31 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.494 -0.754 . . . . 0.0 110.423 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 86.8 mtp -55.18 -37.83 67.55 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.205 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 122' ' ' ASP . 90.3 mt -63.69 -38.67 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.447 0.641 . . . . 0.0 109.509 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -53.85 -35.77 61.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.665 -0.647 . . . . 0.0 111.613 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -59.83 -40.04 87.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.488 -0.758 . . . . 0.0 111.207 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.81 -5.13 17.46 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.221 -0.924 . . . . 0.0 111.167 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.444 ' HB2' HG22 ' A' ' 125' ' ' ILE . 65.4 t0 -79.78 68.06 5.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.076 -1.015 . . . . 0.0 109.89 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 82.8 mt -68.13 -39.97 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.684 -0.635 . . . . 0.0 110.725 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 37.4 p-10 -70.02 -20.91 63.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.372 -0.83 . . . . 0.0 110.923 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.09 21.43 60.98 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.062 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -82.01 -10.09 59.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -1.133 . . . . 0.0 110.952 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.61 3.46 77.66 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -139.18 147.8 42.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -1.144 . . . . 0.0 109.875 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.6 t -93.17 114.78 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.417 -0.802 . . . . 0.0 110.071 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -82.77 172.0 13.35 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -60.09 -43.85 95.22 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.361 0.601 . . . . 0.0 109.518 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -62.47 -47.61 83.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.678 -0.638 . . . . 0.0 111.013 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -65.35 -33.21 75.42 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.471 -0.768 . . . . 0.0 110.213 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 89.0 t80 -60.05 -47.07 87.38 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.941 -0.474 . . . . 0.0 111.116 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 83.7 t -70.01 -39.14 77.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.257 -0.902 . . . . 0.0 111.193 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -59.97 -49.49 77.47 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.414 -0.804 . . . . 0.0 111.093 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -60.01 -38.09 81.65 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.438 -0.789 . . . . 0.0 110.947 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 97.5 mtp -66.4 -40.0 89.35 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.606 -0.684 . . . . 0.0 110.603 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 66.8 p -98.56 22.13 10.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.417 -0.802 . . . . 0.0 110.387 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.93 -48.22 82.58 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.434 -0.791 . . . . 0.0 110.817 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 90.7 mttt . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.436 -179.58 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -89.38 148.49 20.1 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -59.91 -44.52 94.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.637 -0.919 . . . . 0.0 110.264 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -60.95 -40.01 91.69 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.655 -0.653 . . . . 0.0 111.393 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -62.03 -39.94 94.04 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.372 -0.83 . . . . 0.0 111.521 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 90.6 mt -68.43 -40.05 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.429 -0.794 . . . . 0.0 110.873 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.47 -40.04 92.7 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.325 -0.859 . . . . 0.0 111.05 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -61.61 -41.03 96.87 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.379 -0.826 . . . . 0.0 110.966 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.75 -39.98 90.74 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.496 -0.752 . . . . 0.0 110.595 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.434 HG11 ' HA ' ' A' ' 88' ' ' ALA . 96.8 t -66.26 -40.01 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.604 -0.685 . . . . 0.0 110.022 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -54.46 -42.6 75.9 Favored Glycine 0 N--CA 1.5 2.947 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.69 -18.91 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.656 -0.908 . . . . 0.0 110.371 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.57 HD23 ' C ' ' B' ' 167' ' ' LEU . 9.3 tt -59.95 -49.95 75.65 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.323 -0.86 . . . . 0.0 110.905 -178.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -64.62 -39.96 94.63 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.455 -0.778 . . . . 0.0 109.762 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -62.33 -25.39 67.86 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.75 -0.594 . . . . 0.0 110.055 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . 0.414 ' CE3' ' HE3' ' A' ' 71' ' ' MET . 2.6 t-105 -59.88 -43.0 94.98 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.524 -0.735 . . . . 0.0 109.925 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.06 -46.92 87.96 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.543 -0.723 . . . . 0.0 110.538 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -60.05 -38.28 82.33 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.421 -0.799 . . . . 0.0 110.381 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 . . . . . 0 N--CA 1.494 1.737 0 O-C-N 121.593 -0.692 . . . . 0.0 110.283 -179.755 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.188 0.518 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -104.01 16.15 26.93 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.476 -0.765 . . . . 0.0 111.059 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -59.94 -40.11 87.83 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.287 -0.883 . . . . 0.0 110.259 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 90.7 mt -111.44 -176.59 2.98 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.451 0.643 . . . . 0.0 110.688 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.45 106.44 5.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.701 -0.625 . . . . 0.0 109.651 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.449 ' HA ' HG12 ' A' ' 9' ' ' ILE . 50.6 mt-10 -83.39 -9.92 58.75 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.818 -0.551 . . . . 0.0 111.265 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -70.0 -34.63 73.57 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.184 -0.947 . . . . 0.0 110.123 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -69.85 -22.34 63.27 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.343 0.592 . . . . 0.0 110.278 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.449 HG12 ' HA ' ' A' ' 6' ' ' GLU . 47.9 mm -57.9 -50.01 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.346 -0.846 . . . . 0.0 110.744 -177.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.16 -22.38 66.92 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.36 -0.838 . . . . 0.0 111.591 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -68.54 -53.62 21.9 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.333 -0.854 . . . . 0.0 109.448 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.427 ' CE1' ' HG2' ' A' ' 72' ' ' MET . 25.6 m-85 -67.9 -21.88 65.11 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.373 0.606 . . . . 0.0 109.44 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -66.99 -41.81 86.11 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.412 0.625 . . . . 0.0 109.951 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.33 -56.98 14.94 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.794 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.68 -33.95 76.11 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.261 -0.899 . . . . 0.0 111.438 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -58.04 -49.99 74.97 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.151 -0.968 . . . . 0.0 110.236 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.2 m -65.51 -38.63 90.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.313 -0.867 . . . . 0.0 108.761 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.4 tp -60.0 -37.63 80.27 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.29 0.567 . . . . 0.0 109.893 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -73.48 -28.64 62.04 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.648 -0.658 . . . . 0.0 110.569 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -96.31 102.03 13.75 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.348 -0.845 . . . . 0.0 109.682 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -67.07 -31.57 72.17 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.435 -0.79 . . . . 0.0 111.446 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -79.85 -9.58 59.68 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.122 -0.986 . . . . 0.0 111.148 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 64.14 24.64 68.97 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -79.77 -9.55 59.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.453 -1.028 . . . . 0.0 110.939 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.417 ' C ' HG23 ' A' ' 26' ' ' THR . . . 80.01 6.94 88.92 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -178.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.417 HG23 ' C ' ' A' ' 25' ' ' GLY . 78.0 p -148.22 142.14 25.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.124 -1.221 . . . . 0.0 109.892 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.4 mt -103.49 123.38 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.748 -0.595 . . . . 0.0 110.096 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 65.5 p -98.82 143.84 28.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.862 -0.524 . . . . 0.0 109.716 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.406 ' H ' HG23 ' A' ' 29' ' ' THR . 70.5 p -40.5 -36.6 0.59 Allowed 'General case' 0 N--CA 1.512 2.646 0 O-C-N 121.806 -0.559 . . . . 0.0 112.195 -177.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -63.51 -45.31 91.27 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.209 -0.932 . . . . 0.0 109.527 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -59.95 -52.82 63.75 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.752 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.412 HD21 ' NE1' ' B' ' 170' ' ' TRP . 64.1 tp -59.19 -37.4 77.32 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.131 -0.98 . . . . 0.0 110.846 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . -52.92 -32.28 41.21 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.5 m -70.04 -39.96 75.42 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.603 -0.939 . . . . 0.0 110.483 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.3 t -63.99 -57.19 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.453 -0.779 . . . . 0.0 109.851 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 98.2 mtp -59.21 -28.33 66.56 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.622 -0.674 . . . . 0.0 110.037 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 3.8 tmt_? -59.97 -39.58 86.14 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.4 t -66.16 -17.24 64.6 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.849 -0.532 . . . . 0.0 110.861 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.688 HD22 HD21 ' B' ' 167' ' ' LEU . 33.7 tp -85.61 -28.38 24.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.295 -0.878 . . . . 0.0 109.22 179.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.65 -46.85 0.2 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -160.96 176.36 11.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.772 -0.84 . . . . 0.0 110.253 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -120.01 148.62 47.18 Favored Pre-proline 0 C--N 1.299 -1.602 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.754 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.689 ' HG2' HD21 ' A' ' 48' ' ' LEU . 54.6 Cg_endo -69.48 -147.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.318 0 O-C-N 123.626 1.329 . . . . 0.0 109.627 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 57.8 p -136.42 149.4 48.25 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.905 -1.122 . . . . 0.0 111.431 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -52.62 -24.02 7.62 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.706 -0.621 . . . . 0.0 111.57 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.35 -59.5 2.73 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.092 0.949 . . . . 0.0 108.636 177.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -66.75 -37.74 85.22 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.907 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.689 HD21 ' HG2' ' A' ' 43' ' ' PRO . 39.6 mt -58.55 -35.18 71.93 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.774 0.797 . . . . 0.0 109.507 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.4 -39.27 78.04 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.062 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -66.41 -38.02 86.54 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.481 -0.762 . . . . 0.0 110.675 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 73.2 mmm -60.05 -44.67 94.54 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.633 0.73 . . . . 0.0 109.469 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.879 HG22 ' OD2' ' A' ' 56' ' ' ASP . 96.7 mt -68.83 -34.59 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-O 121.173 0.511 . . . . 0.0 110.413 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -60.7 -40.99 94.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.441 -0.787 . . . . 0.0 110.659 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -70.69 -29.43 65.73 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.329 -0.857 . . . . 0.0 110.813 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.8 t -98.23 -8.15 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.68 -0.637 . . . . 0.0 111.862 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.879 ' OD2' HG22 ' A' ' 52' ' ' ILE . 9.1 m-20 -71.98 107.44 4.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.012 -1.055 . . . . 0.0 111.106 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.52 -41.08 85.0 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.542 -0.723 . . . . 0.0 109.715 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -87.85 -29.94 20.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.631 -0.668 . . . . 0.0 110.309 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.08 21.16 46.96 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.609 -0.997 . . . . 0.0 110.609 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -72.22 -37.8 69.12 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.391 -1.064 . . . . 0.0 110.258 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.77 -6.43 5.5 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 120.197 -1.001 . . . . 0.0 111.114 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 81.1 p -135.36 170.08 16.5 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.078 -1.248 . . . . 0.0 110.588 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.642 HD12 ' HH2' ' B' ' 170' ' ' TRP . 7.0 mt -106.13 123.73 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-O 121.609 0.718 . . . . 0.0 111.204 -177.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -101.68 172.03 7.2 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.701 0.763 . . . . 0.0 111.103 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.498 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -46.8 -49.96 45.76 Favored Pre-proline 0 N--CA 1.499 1.992 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 39.4 Cg_endo -65.73 -36.66 31.41 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 122.889 0.941 . . . . 0.0 111.795 -178.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -70.01 -39.95 75.55 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.24 -0.912 . . . . 0.0 110.455 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -61.55 -40.28 94.15 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.606 -0.683 . . . . 0.0 111.042 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.2 mt -68.87 -40.01 79.51 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.425 -0.797 . . . . 0.0 111.848 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 47.2 p -59.97 -45.68 91.91 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.164 -0.96 . . . . 0.0 111.161 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 56.3 ttp -68.77 -40.0 79.94 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.531 -0.73 . . . . 0.0 111.458 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.605 ' CE ' HG11 ' B' ' 166' ' ' VAL . 48.6 tpp -60.12 -49.61 76.96 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.445 -0.785 . . . . 0.0 111.279 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.49 -31.18 66.82 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.523 -0.736 . . . . 0.0 112.174 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -83.38 -50.73 8.04 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.336 -0.853 . . . . 0.0 111.907 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.403 ' CG ' ' CG ' ' B' ' 169' ' ' GLU . 60.1 tptt -66.4 -40.0 89.36 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.564 -0.71 . . . . 0.0 112.192 -178.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.4 ' HG3' ' N ' ' A' ' 77' ' ' LYS . 28.1 ptm -55.13 -34.12 63.47 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.254 -0.904 . . . . 0.0 111.756 -177.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.4 ' N ' ' HG3' ' A' ' 76' ' ' MET . 33.7 mtpt -67.88 -39.86 83.63 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.352 -0.843 . . . . 0.0 110.151 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -67.03 -20.05 65.79 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.594 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.658 HG23 ' NH2' ' B' ' 168' ' ' ARG . 4.1 m -79.56 -174.75 4.43 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.693 -0.629 . . . . 0.0 109.797 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.596 ' H ' HG22 ' A' ' 79' ' ' THR . 85.4 m-20 -135.82 131.41 35.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.317 -0.865 . . . . 0.0 109.158 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.1 t -60.5 -34.55 74.23 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.444 -0.785 . . . . 0.0 110.071 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.04 -39.53 86.23 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.768 0.794 . . . . 0.0 109.542 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.97 -40.01 75.63 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.417 0.627 . . . . 0.0 111.075 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -66.28 -35.93 81.65 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.611 -0.68 . . . . 0.0 111.425 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.561 HG23 ' HE1' ' A' ' 141' ' ' PHE . 67.0 mt -67.28 -47.32 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.491 -0.756 . . . . 0.0 110.818 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -59.95 -41.92 92.91 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.329 -0.857 . . . . 0.0 112.104 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.642 ' O ' HG23 ' A' ' 91' ' ' VAL . 72.7 mt-10 -73.95 -39.98 63.36 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.438 -0.788 . . . . 0.0 111.952 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.31 -47.15 80.55 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.389 -0.82 . . . . 0.0 111.378 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -60.06 -45.96 91.14 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.606 0.717 . . . . 0.0 109.862 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -60.01 -34.04 72.81 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.979 -0.45 . . . . 0.0 111.047 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 87' ' ' GLU . 98.6 t -70.08 -53.51 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.243 -0.91 . . . . 0.0 110.254 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -63.27 -39.46 94.64 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.398 -0.814 . . . . 0.0 110.539 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -77.17 79.06 3.7 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -60.08 -41.0 91.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.407 -0.808 . . . . 0.0 111.034 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -84.11 -23.02 30.9 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.457 -0.777 . . . . 0.0 111.283 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.8 31.92 76.73 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.45 ' ND2' ' CE2' ' A' ' 99' ' ' TYR . 33.4 p-10 -76.09 -12.03 60.04 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.562 -0.963 . . . . 0.0 112.085 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.37 -20.92 10.2 Favored Glycine 0 N--CA 1.497 2.762 0 C-N-CA 119.919 -1.134 . . . . 0.0 110.45 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.45 ' CE2' ' ND2' ' A' ' 97' ' ' ASN . 27.7 p90 -145.25 150.04 35.97 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.224 -1.162 . . . . 0.0 108.783 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.662 ' CG2' HD23 ' A' ' 105' ' ' LEU . 20.8 mt -89.29 130.32 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.734 0.778 . . . . 0.0 111.396 -178.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.6 m -87.93 172.95 9.21 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.205 0.526 . . . . 0.0 109.999 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.08 -39.96 82.8 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.643 -0.661 . . . . 0.0 109.248 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.7 -40.04 93.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.804 -0.56 . . . . 0.0 109.835 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -61.96 -39.94 93.87 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.616 -0.678 . . . . 0.0 110.012 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.662 HD23 ' CG2' ' A' ' 100' ' ' ILE . 0.6 OUTLIER -63.65 -40.32 96.56 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.74 -0.6 . . . . 0.0 109.597 179.045 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 57.1 mtp85 -61.31 -31.82 71.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.551 -0.718 . . . . 0.0 110.954 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -59.96 -48.6 81.03 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.38 -0.825 . . . . 0.0 111.002 -178.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.662 HG12 ' CD1' ' A' ' 112' ' ' LEU . 85.3 t -69.92 -44.96 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 121.354 -0.841 . . . . 0.0 111.572 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.778 ' SD ' HD12 ' A' ' 116' ' ' LEU . 66.2 mtt -58.61 -46.78 86.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 0.0 111.356 -177.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.0 m -66.09 -47.69 73.38 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.467 -0.771 . . . . 0.0 109.934 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -61.9 -31.5 71.8 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.662 ' CD1' HG12 ' A' ' 108' ' ' VAL . 19.1 mt -69.89 -40.04 75.89 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 120.176 -0.609 . . . . 0.0 110.301 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 114.22 35.34 1.49 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -133.9 132.29 40.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.557 -0.967 . . . . 0.0 109.86 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -102.82 127.89 49.81 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.52 -0.737 . . . . 0.0 110.787 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.778 HD12 ' SD ' ' A' ' 109' ' ' MET . 42.6 mt -133.9 157.79 45.1 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.568 -0.708 . . . . 0.0 109.116 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.16 162.13 21.37 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.433 -0.792 . . . . 0.0 109.417 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -60.05 -26.91 66.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.413 -0.805 . . . . 0.0 108.852 178.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -69.38 -35.5 75.88 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.591 ' OE2' HD22 ' A' ' 116' ' ' LEU . 15.1 mt-10 -65.23 -39.94 93.4 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.395 0.617 . . . . 0.0 109.622 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.01 -40.0 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.208 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.428 ' HA ' HD12 ' A' ' 125' ' ' ILE . 7.7 t70 -60.02 -44.04 94.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.703 -0.623 . . . . 0.0 110.005 -178.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -60.03 -41.33 92.0 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.53 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 65.6 mtt -56.56 -37.94 71.25 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 119.6 -0.84 . . . . 0.0 108.781 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.482 HG21 ' O ' ' A' ' 134' ' ' GLY . 90.7 mt -65.75 -38.76 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 121.705 0.764 . . . . 0.0 109.093 178.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -57.27 -38.47 73.94 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.252 0.548 . . . . 0.0 110.578 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.0 -38.78 83.63 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.701 -0.624 . . . . 0.0 110.544 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.503 ' HB3' HG22 ' A' ' 136' ' ' VAL . . . -103.8 0.64 30.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.294 -0.879 . . . . 0.0 111.117 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -87.3 70.5 10.04 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.006 -1.059 . . . . 0.0 110.594 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 87.0 mt -67.06 -40.02 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.424 -0.797 . . . . 0.0 109.998 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -73.29 -20.22 60.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.565 -0.71 . . . . 0.0 111.151 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.49 23.39 60.59 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 120.215 -0.993 . . . . 0.0 110.83 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -82.17 -10.22 59.24 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.24 -1.153 . . . . 0.0 111.044 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.482 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 90.37 1.7 74.64 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.105 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -138.74 149.24 44.83 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.257 -1.143 . . . . 0.0 109.779 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.503 HG22 ' HB3' ' A' ' 128' ' ' ALA . 87.7 t -92.77 118.01 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.545 -0.722 . . . . 0.0 109.969 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -90.03 175.86 7.01 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.515 -0.741 . . . . 0.0 109.927 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -60.04 -49.01 79.33 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.264 0.554 . . . . 0.0 110.483 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -60.05 -46.07 90.76 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.725 -0.61 . . . . 0.0 111.72 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -63.02 -35.02 78.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.232 -0.918 . . . . 0.0 109.739 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.561 ' HE1' HG23 ' A' ' 85' ' ' ILE . 64.6 t80 -60.0 -39.96 87.54 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.258 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.65 ' O ' HG22 ' A' ' 146' ' ' THR . 92.1 t -70.02 -40.47 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.517 -0.74 . . . . 0.0 110.964 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.576 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 76.9 mt-30 -60.25 -41.08 92.44 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.388 -0.82 . . . . 0.0 110.627 -179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 56.2 ttp -59.96 -40.07 87.76 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.836 -0.54 . . . . 0.0 110.089 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.401 ' CE ' ' CZ ' ' A' ' 141' ' ' PHE . 40.9 mtt -70.02 -39.92 75.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.789 -0.57 . . . . 0.0 110.695 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.65 HG22 ' O ' ' A' ' 142' ' ' VAL . 9.4 t -101.38 20.96 14.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.501 -0.749 . . . . 0.0 110.681 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -79.94 129.83 34.8 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.313 -0.867 . . . . 0.0 110.574 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.6 pttm . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.363 -179.988 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -62.27 -40.03 98.48 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.507 ' O ' HG22 ' B' ' 160' ' ' ILE . 31.4 t80 -60.6 -40.0 90.16 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.547 -0.973 . . . . 0.0 110.453 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -66.23 -39.93 89.91 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.447 -0.783 . . . . 0.0 110.649 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -60.59 -46.03 91.77 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.612 -0.68 . . . . 0.0 110.641 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . 0.74 ' O ' HG23 ' B' ' 164' ' ' VAL . 15.5 tt -70.0 -29.49 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.504 -0.748 . . . . 0.0 111.034 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.17 -44.12 89.52 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.39 -0.819 . . . . 0.0 110.422 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 75.5 mmt-85 -61.44 -40.11 93.25 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.577 -0.702 . . . . 0.0 109.861 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.45 -37.26 86.92 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.67 -0.644 . . . . 0.0 111.076 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.74 HG23 ' O ' ' B' ' 160' ' ' ILE . 67.7 t -60.03 -40.05 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.386 -0.821 . . . . 0.0 110.058 -178.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.94 -34.89 85.14 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.605 HG11 ' CE ' ' A' ' 72' ' ' MET . 23.5 t -74.35 -19.97 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.729 -0.866 . . . . 0.0 110.584 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.688 HD21 HD22 ' A' ' 39' ' ' LEU . 6.2 tt -59.99 -48.77 80.36 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.107 -0.995 . . . . 0.0 110.386 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 168' ' ' ARG . . . . . 0.658 ' NH2' HG23 ' A' ' 79' ' ' THR . 9.6 ptt85 -69.86 -28.62 65.81 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.351 -0.843 . . . . 0.0 109.848 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . 0.403 ' CG ' ' CG ' ' A' ' 75' ' ' LYS . 44.0 tt0 -60.02 -43.84 95.0 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.58 -0.7 . . . . 0.0 110.021 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . 0.642 ' HH2' HD12 ' A' ' 63' ' ' ILE . 7.4 t-105 -60.93 -40.0 91.55 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.754 -0.591 . . . . 0.0 110.065 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.9 -46.65 88.66 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.575 -0.703 . . . . 0.0 110.851 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -59.98 -40.01 87.67 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.315 -0.866 . . . . 0.0 110.769 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.519 -0.738 . . . . 0.0 110.131 -179.568 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 120.882 0.372 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -60.73 -40.06 90.93 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.451 -0.781 . . . . 0.0 110.179 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -122.05 -89.96 0.59 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 122.052 -0.405 . . . . 0.0 110.038 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.471 ' C ' HG23 ' A' ' 5' ' ' THR . 92.0 mt -103.69 -78.01 0.56 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 109.714 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.471 HG23 ' C ' ' A' ' 4' ' ' LEU . 45.3 p -153.14 107.53 3.12 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.516 -0.74 . . . . 0.0 110.371 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.09 -37.97 75.56 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.625 -0.672 . . . . 0.0 110.091 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -48.51 -60.59 2.57 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.648 -0.658 . . . . 0.0 111.193 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -56.23 -23.79 38.1 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.453 -0.78 . . . . 0.0 112.431 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.5 mm -60.15 -53.31 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 120.988 -1.07 . . . . 0.0 109.873 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' ' 13' ' ' LYS . . . -61.08 -27.11 68.12 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.659 -0.651 . . . . 0.0 109.975 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -66.32 -39.96 89.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.457 -0.777 . . . . 0.0 110.037 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.548 ' HB3' HD21 ' A' ' 69' ' ' LEU . 50.5 m-85 -69.7 -25.02 63.67 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.626 -0.671 . . . . 0.0 109.426 178.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 16.4 ttmt -69.98 -40.03 75.61 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -60.31 -54.1 49.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.956 -0.465 . . . . 0.0 110.783 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.05 -22.18 63.1 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.334 -0.854 . . . . 0.0 111.975 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -58.44 -47.39 84.14 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.088 -1.008 . . . . 0.0 110.243 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.7 m -62.16 -37.73 86.33 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.479 -0.763 . . . . 0.0 109.393 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.5 tp -65.96 -39.93 90.84 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -69.53 -38.12 77.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.962 -0.462 . . . . 0.0 109.869 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -91.77 97.64 11.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.566 -0.709 . . . . 0.0 109.848 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -59.93 -37.55 79.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.324 -0.86 . . . . 0.0 111.119 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -80.02 -10.92 59.81 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.263 -0.898 . . . . 0.0 111.03 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.29 27.66 58.09 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -87.63 -5.77 58.57 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.707 -0.878 . . . . 0.0 110.777 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.1 4.88 59.77 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 120.268 -0.968 . . . . 0.0 111.383 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.2 p -143.93 141.15 30.08 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 119.168 1.484 . . . . 0.0 111.594 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 86.0 mt -101.06 122.08 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.25 0.548 . . . . 0.0 109.528 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.0 m -98.41 137.98 36.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.724 -0.61 . . . . 0.0 109.781 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.531 ' HB ' HD22 ' A' ' 48' ' ' LEU . 24.7 p -42.65 -28.89 0.26 Allowed 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.707 -0.621 . . . . 0.0 112.179 -178.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.1 tttp -65.97 -50.47 64.22 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.833 0.825 . . . . 0.0 109.691 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -60.2 -56.38 22.32 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.932 -0.48 . . . . 0.0 111.798 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.95 -34.16 74.3 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.29 -0.882 . . . . 0.0 110.49 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.97 -31.56 17.87 Favored Glycine 0 N--CA 1.501 2.982 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.2 m -67.25 -40.13 86.21 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.393 -1.063 . . . . 0.0 109.399 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.5 t -64.38 -39.98 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 121.455 0.645 . . . . 0.0 109.422 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 98.0 mmm -60.06 -38.4 82.72 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.809 -0.557 . . . . 0.0 110.297 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -62.92 -40.05 96.41 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.414 -0.804 . . . . 0.0 110.659 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 t -59.28 -26.86 65.31 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.924 -0.485 . . . . 0.0 110.883 -178.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.498 HD12 ' CG2' ' A' ' 91' ' ' VAL . 36.3 tp -85.56 -24.92 27.04 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.415 -0.803 . . . . 0.0 109.109 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.23 -61.95 0.15 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -162.96 172.04 15.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.587 -0.949 . . . . 0.0 110.931 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -116.41 153.58 48.83 Favored Pre-proline 0 C--N 1.298 -1.664 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.171 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -66.08 -146.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.532 1.28 . . . . 0.0 109.642 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.1 p -125.68 166.79 16.11 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.048 -1.033 . . . . 0.0 110.845 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -59.0 -35.48 73.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.767 -0.583 . . . . 0.0 111.706 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.48 -47.82 45.67 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 122.298 1.047 . . . . 0.0 109.23 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.54 -36.09 80.34 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.302 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.531 HD22 ' HB ' ' A' ' 29' ' ' THR . 12.2 mt -58.2 -35.91 72.33 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.757 0.789 . . . . 0.0 109.587 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -66.82 -39.73 87.8 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.17 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -65.56 -39.94 92.26 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.537 -0.727 . . . . 0.0 110.937 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 90.7 mtp -60.17 -47.13 87.24 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.763 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.865 HG22 ' OD2' ' A' ' 56' ' ' ASP . 46.7 mm -64.92 -35.77 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.806 -0.559 . . . . 0.0 110.311 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -60.26 -44.97 94.82 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.596 -0.69 . . . . 0.0 111.772 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -70.01 -28.39 65.47 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.191 -0.943 . . . . 0.0 111.09 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.44 -8.58 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.587 -0.696 . . . . 0.0 110.599 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.865 ' OD2' HG22 ' A' ' 52' ' ' ILE . 4.3 m-20 -74.35 103.18 4.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.26 -0.9 . . . . 0.0 110.415 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.98 -36.4 75.16 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.617 -0.677 . . . . 0.0 109.693 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -92.35 -26.84 17.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.683 -0.635 . . . . 0.0 110.821 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.57 20.06 52.53 Favored Glycine 0 N--CA 1.496 2.638 0 C-N-CA 120.404 -0.903 . . . . 0.0 110.906 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -74.49 -32.88 62.68 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.37 -1.077 . . . . 0.0 110.254 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.559 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 117.94 1.06 17.12 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.002 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.2 p -137.66 169.84 17.09 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.125 -1.22 . . . . 0.0 110.488 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.3 mt -105.78 120.57 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.505 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -98.17 169.91 9.26 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.528 0.68 . . . . 0.0 110.582 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.434 ' HB3' ' HD3' ' A' ' 66' ' ' PRO . 8.1 t80 -47.86 -48.75 60.86 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.434 ' HD3' ' HB3' ' A' ' 65' ' ' PHE . 45.9 Cg_endo -71.83 -32.68 11.14 Favored 'Trans proline' 0 N--CA 1.487 1.089 0 O-C-N 122.711 0.848 . . . . 0.0 111.376 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -72.13 -39.98 68.41 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.261 -0.9 . . . . 0.0 110.268 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.417 ' CE1' ' HE2' ' A' ' 72' ' ' MET . 40.5 t80 -63.21 -41.64 99.17 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.471 -0.768 . . . . 0.0 111.204 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.548 HD21 ' HB3' ' A' ' 12' ' ' PHE . 96.2 mt -69.59 -39.99 76.95 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.534 -0.729 . . . . 0.0 112.048 -178.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.5 p -60.02 -47.87 84.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.334 -0.854 . . . . 0.0 111.191 -178.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 8.6 tmm? -68.56 -38.89 81.13 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.6 -0.687 . . . . 0.0 111.682 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.417 ' HE2' ' CE1' ' A' ' 68' ' ' PHE . 57.6 tpp -59.99 -50.03 75.35 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.374 -0.828 . . . . 0.0 112.217 -178.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.98 -25.04 63.43 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.183 -0.948 . . . . 0.0 112.082 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.2 -57.81 3.63 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.404 -0.81 . . . . 0.0 112.978 -178.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -69.64 -40.05 76.75 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -177.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 22.0 mtm -53.87 -39.91 66.12 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.057 -1.027 . . . . 0.0 111.946 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.0 tttt -59.99 -49.05 79.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.283 -0.885 . . . . 0.0 110.664 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -63.21 -27.37 69.31 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.817 0.818 . . . . 0.0 109.866 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.628 HG22 ' H ' ' A' ' 80' ' ' ASP 0.255 7.0 m -70.09 -173.42 0.66 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.807 -0.558 . . . . 0.0 109.918 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.628 ' H ' HG22 ' A' ' 79' ' ' THR . 81.3 m-20 -129.24 139.72 51.73 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.153 -0.967 . . . . 0.0 109.547 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.1 t -70.02 -27.46 64.69 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.581 -0.699 . . . . 0.0 111.046 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.03 -36.26 76.89 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.481 -0.762 . . . . 0.0 109.838 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -70.06 -39.93 75.37 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.342 0.592 . . . . 0.0 110.361 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -61.64 -39.57 91.79 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.571 -0.705 . . . . 0.0 111.274 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.686 HG23 ' HE1' ' A' ' 141' ' ' PHE . 89.2 mt -67.12 -44.3 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.52 -0.738 . . . . 0.0 110.803 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -59.81 -40.14 87.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.527 -0.733 . . . . 0.0 111.783 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.687 ' O ' HG23 ' A' ' 91' ' ' VAL . 35.7 mt-10 -76.04 -39.85 54.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.364 -0.835 . . . . 0.0 112.262 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.663 ' HA ' HG11 ' B' ' 164' ' ' VAL . . . -64.52 -46.7 81.79 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.271 -0.893 . . . . 0.0 111.317 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -61.75 -44.14 97.48 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.509 -0.744 . . . . 0.0 109.834 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.04 -36.9 78.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.746 -0.596 . . . . 0.0 110.939 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 87' ' ' GLU . 95.1 t -69.82 -48.51 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.484 -0.76 . . . . 0.0 110.161 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -68.03 -39.6 83.06 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.471 -0.768 . . . . 0.0 111.013 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -80.45 71.98 7.31 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.382 -0.824 . . . . 0.0 110.126 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -60.06 -47.5 85.61 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.374 -0.828 . . . . 0.0 110.335 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -70.63 -24.36 62.71 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.539 -0.726 . . . . 0.0 110.929 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.67 21.97 77.94 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -67.12 -15.7 63.87 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.239 -1.154 . . . . 0.0 111.258 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.58 -13.06 54.16 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 81.5 m-85 -133.15 141.31 48.06 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.163 -1.198 . . . . 0.0 109.224 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.76 ' CG2' HD23 ' A' ' 105' ' ' LEU . 62.7 mt -89.15 121.15 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.111 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 m -84.92 168.87 14.62 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.217 0.532 . . . . 0.0 109.869 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.97 -37.12 75.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.6 -0.688 . . . . 0.0 109.211 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.92 -36.41 83.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.796 -0.565 . . . . 0.0 109.799 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -67.22 -40.12 86.34 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.524 -0.735 . . . . 0.0 110.645 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.76 HD23 ' CG2' ' A' ' 100' ' ' ILE . 0.3 OUTLIER -64.42 -42.4 96.06 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.505 0.669 . . . . 0.0 110.051 179.734 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -62.93 -39.5 94.78 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.788 -0.57 . . . . 0.0 111.535 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -60.41 -48.61 81.0 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.216 -0.928 . . . . 0.0 112.161 -177.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 93.8 t -71.49 -50.37 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.136 -0.977 . . . . 0.0 111.452 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.477 ' HA ' HD12 ' A' ' 112' ' ' LEU . 73.9 mtp -55.42 -40.38 71.4 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.266 -0.896 . . . . 0.0 110.231 -178.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.2 m -66.59 -45.4 79.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.482 -0.761 . . . . 0.0 109.077 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -66.72 -25.04 66.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.814 -0.554 . . . . 0.0 109.85 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 109' ' ' MET . 17.9 mt -69.06 -26.61 65.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.583 -0.698 . . . . 0.0 110.227 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.6 11.73 5.89 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -127.76 131.41 49.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.172 -1.193 . . . . 0.0 109.952 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -105.0 126.01 51.6 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.608 -0.683 . . . . 0.0 110.232 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.0 mt -130.02 160.88 32.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.698 -0.626 . . . . 0.0 110.44 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.32 163.1 23.15 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -60.26 -31.44 70.22 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -67.15 -33.07 74.65 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.389 0.614 . . . . 0.0 109.667 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -67.79 -36.15 79.93 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.41 HG13 ' HB3' ' A' ' 105' ' ' LEU . 69.1 t -70.06 -40.01 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.913 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -60.03 -45.79 91.66 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.665 -0.647 . . . . 0.0 110.071 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -60.0 -41.4 91.99 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.599 -0.688 . . . . 0.0 109.641 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 98.0 mtp -54.46 -37.08 64.78 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.012 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.615 HG23 HG23 ' A' ' 136' ' ' VAL . 93.0 mt -66.58 -37.48 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 50.2 ttt85 -58.13 -40.0 80.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.472 -0.768 . . . . 0.0 111.118 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -60.0 -39.12 84.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.582 -0.699 . . . . 0.0 111.039 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.88 -10.92 19.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.397 -0.815 . . . . 0.0 111.522 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -89.48 74.04 7.76 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.003 -1.06 . . . . 0.0 110.994 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 84.7 mt -66.49 -39.96 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.663 -0.648 . . . . 0.0 109.474 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -59.23 -39.58 83.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.656 -0.653 . . . . 0.0 110.89 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.33 15.17 42.09 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.146 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -81.95 -10.05 59.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.02 -1.282 . . . . 0.0 110.546 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.12 2.54 85.76 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.491 -0.756 . . . . 0.0 111.537 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -130.94 131.32 44.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.24 -1.153 . . . . 0.0 109.611 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.615 HG23 HG23 ' A' ' 125' ' ' ILE . 57.7 t -90.88 111.62 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.452 -0.78 . . . . 0.0 110.037 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -89.03 -168.88 2.32 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 121.742 -0.599 . . . . 0.0 110.276 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -69.65 -40.08 76.7 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.8 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -60.0 -46.36 89.74 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.299 -0.876 . . . . 0.0 111.454 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -65.94 -38.15 87.88 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.817 0.818 . . . . 0.0 110.339 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.686 ' HE1' HG23 ' A' ' 85' ' ' ILE . 58.1 t80 -59.73 -45.67 91.48 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.865 -177.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.443 HG22 HG21 ' A' ' 85' ' ' ILE . 62.5 t -78.1 -40.05 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.232 -0.917 . . . . 0.0 112.577 -178.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -60.0 -51.68 68.63 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.976 -1.077 . . . . 0.0 111.693 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 59.4 ttp -60.53 -36.07 77.53 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.369 -0.832 . . . . 0.0 110.413 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 95.9 mtp -69.96 -40.03 75.64 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.799 -0.563 . . . . 0.0 110.673 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.552 ' O ' HG22 ' A' ' 146' ' ' THR . 39.7 m -97.5 15.82 22.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.486 -0.759 . . . . 0.0 111.086 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.06 -42.3 94.21 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.179 -0.951 . . . . 0.0 110.432 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 86.2 mttt . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.144 179.684 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.31 142.14 13.02 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -60.02 -43.43 95.26 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.49 -1.006 . . . . 0.0 110.236 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -60.03 -39.59 86.41 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.658 -0.651 . . . . 0.0 110.51 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -59.92 -40.07 87.63 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.434 -0.791 . . . . 0.0 110.665 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 95.8 mt -67.74 -39.62 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.408 -0.807 . . . . 0.0 110.121 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.27 91.68 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.552 -0.717 . . . . 0.0 111.634 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . 0.44 ' O ' HG23 ' B' ' 166' ' ' VAL . 51.3 mtm180 -60.09 -40.04 88.23 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.106 -0.997 . . . . 0.0 110.747 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.519 ' C ' HD23 ' B' ' 163' ' ' LEU . 9.6 tt -60.61 -40.11 90.64 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.433 -0.792 . . . . 0.0 109.95 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.663 HG11 ' HA ' ' A' ' 88' ' ' ALA . 89.2 t -62.71 -39.95 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.594 -0.691 . . . . 0.0 109.688 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -59.99 -36.64 90.91 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.44 HG23 ' O ' ' B' ' 162' ' ' ARG . 94.9 t -60.07 -31.54 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.769 -0.842 . . . . 0.0 110.581 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 84.5 mt -60.03 -41.14 91.6 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.452 -0.78 . . . . 0.0 111.015 -178.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -61.03 -40.02 92.01 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.254 -0.904 . . . . 0.0 109.864 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -62.23 -40.56 96.54 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.658 -0.651 . . . . 0.0 110.86 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -60.08 -41.06 91.65 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.397 -0.814 . . . . 0.0 111.032 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.53 -41.24 76.24 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.414 -0.804 . . . . 0.0 110.855 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -60.01 -39.95 87.56 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.521 -0.737 . . . . 0.0 110.602 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 . . . . . 0 N--CA 1.496 1.87 0 O-C-N 121.392 -0.817 . . . . 0.0 110.301 -179.796 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.255 0.55 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 52.31 38.48 25.02 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.467 -0.771 . . . . 0.0 110.747 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -64.64 -41.18 96.31 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.684 0.754 . . . . 0.0 110.018 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.5 mt -114.28 -89.54 0.54 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 122.003 -0.436 . . . . 0.0 110.295 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.42 11.68 2.99 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.009 -1.057 . . . . 0.0 111.606 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.587 ' HA ' HD12 ' A' ' 9' ' ' ILE . 98.9 mt-10 -55.5 -15.33 2.66 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.159 -0.963 . . . . 0.0 112.245 -178.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 8' ' ' GLN . 12.7 pt-20 -64.26 -42.02 96.67 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.897 -1.127 . . . . 0.0 110.329 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.409 ' N ' ' HG3' ' A' ' 7' ' ' GLU . 45.0 mt-30 -65.87 -39.28 90.56 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.442 -0.786 . . . . 0.0 110.846 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.587 HD12 ' HA ' ' A' ' 6' ' ' GLU . 85.7 mt -59.93 -31.15 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.659 -0.651 . . . . 0.0 111.911 -178.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.95 -39.77 86.72 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.927 -1.108 . . . . 0.0 109.95 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -59.32 -41.46 89.13 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.268 0.556 . . . . 0.0 109.963 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -65.09 -21.51 66.82 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.613 -0.679 . . . . 0.0 111.111 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -70.03 -41.15 74.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.116 -0.99 . . . . 0.0 108.878 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.93 -51.78 68.24 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.013 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.06 -20.47 63.23 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.185 -0.947 . . . . 0.0 112.008 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.503 ' CD1' ' CZ ' ' A' ' 65' ' ' PHE . 60.2 t80 -58.05 -50.04 74.81 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.03 -1.044 . . . . 0.0 111.222 -177.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 97.6 p -66.76 -39.36 87.84 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.605 HD21 ' OE2' ' A' ' 114' ' ' GLU . 40.5 tp -60.08 -40.0 88.04 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.258 0.551 . . . . 0.0 109.816 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -77.44 -31.74 54.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.683 -0.635 . . . . 0.0 110.311 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -92.09 102.11 14.64 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.418 -0.801 . . . . 0.0 109.522 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -60.0 -39.64 86.46 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.609 -0.682 . . . . 0.0 112.308 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -80.08 -11.66 59.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.087 -1.008 . . . . 0.0 111.335 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.18 28.62 50.15 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -88.28 -5.6 58.26 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.637 -0.919 . . . . 0.0 110.788 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.53 1.39 57.77 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.938 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 54.3 p -144.2 141.81 30.13 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 119.116 1.458 . . . . 0.0 111.368 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 84.8 mt -101.08 123.77 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.79 -0.569 . . . . 0.0 109.611 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 34.4 p -99.96 140.0 34.81 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.539 -0.726 . . . . 0.0 110.046 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.57 HG23 HG13 ' A' ' 52' ' ' ILE . 6.6 p -43.19 -29.22 0.36 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.726 -0.609 . . . . 0.0 112.092 -178.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.11 -50.55 65.65 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.429 -0.794 . . . . 0.0 109.511 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -59.61 -53.82 53.59 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 121.253 0.549 . . . . 0.0 110.894 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.608 HD21 ' SD ' ' A' ' 36' ' ' MET . 9.6 tt -60.02 -35.32 74.82 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.449 -0.782 . . . . 0.0 111.451 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.07 -30.82 17.39 Favored Glycine 0 N--CA 1.498 2.822 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.5 m -70.03 -39.98 75.44 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.564 -0.963 . . . . 0.0 110.503 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.27 -54.26 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.457 -0.777 . . . . 0.0 109.456 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.608 ' SD ' HD21 ' A' ' 32' ' ' LEU . 95.8 mtp -59.92 -31.34 69.75 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.614 -0.679 . . . . 0.0 110.012 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -61.55 -40.47 94.81 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.681 0.753 . . . . 0.0 109.102 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.8 p -70.06 -20.22 63.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.787 -0.57 . . . . 0.0 110.405 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.545 HD11 ' CD1' ' B' ' 167' ' ' LEU . 86.1 mt -88.61 -17.0 31.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.484 -0.76 . . . . 0.0 110.41 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.22 -62.87 0.15 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -156.45 169.47 24.56 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.281 -1.129 . . . . 0.0 111.468 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -104.7 129.53 24.78 Favored Pre-proline 0 N--CA 1.49 1.573 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.844 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -67.3 -150.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.228 0 O-C-N 123.132 1.069 . . . . 0.0 109.487 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.5 p -135.62 151.71 50.51 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.159 -0.963 . . . . 0.0 110.598 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -51.44 -24.75 5.31 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.779 -0.575 . . . . 0.0 111.805 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.05 -59.8 2.58 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 122.171 0.986 . . . . 0.0 108.776 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -66.86 -36.97 83.53 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.829 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.523 HD13 ' HB ' ' A' ' 29' ' ' THR . 5.6 mt -58.12 -34.81 70.63 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.434 -0.791 . . . . 0.0 109.173 178.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.27 -40.02 96.22 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 120.484 -0.487 . . . . 0.0 110.43 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -64.58 -40.01 94.77 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.606 -0.684 . . . . 0.0 110.569 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 89.3 mtp -59.95 -44.57 94.33 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.463 0.649 . . . . 0.0 109.718 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.893 HG22 ' OD2' ' A' ' 56' ' ' ASP . 47.7 mm -65.87 -37.8 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.902 -0.499 . . . . 0.0 110.671 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -60.05 -39.95 87.74 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.437 -0.789 . . . . 0.0 111.523 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -68.88 -28.64 66.87 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.203 -0.935 . . . . 0.0 110.486 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.467 HG21 ' SD ' ' A' ' 71' ' ' MET . 78.9 t -99.46 -9.94 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.64 -0.662 . . . . 0.0 111.183 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.893 ' OD2' HG22 ' A' ' 52' ' ' ILE . 20.5 m-20 -70.74 95.56 1.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.143 -0.973 . . . . 0.0 111.265 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.56 -34.08 71.83 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.739 -0.601 . . . . 0.0 109.618 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.2 p-10 -95.43 -23.66 17.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.706 -0.621 . . . . 0.0 110.66 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.61 19.14 55.31 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.135 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.3 p-10 -75.63 -25.34 56.8 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.33 -1.1 . . . . 0.0 110.655 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.776 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 108.44 4.28 32.67 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.227 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 67.2 p -134.0 170.12 16.11 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.165 -1.197 . . . . 0.0 110.89 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.4 mt -101.83 119.99 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.909 -0.494 . . . . 0.0 110.434 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -102.51 168.17 9.47 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.59 0.71 . . . . 0.0 111.147 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.503 ' CZ ' ' CD1' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -43.13 -52.34 12.26 Favored Pre-proline 0 N--CA 1.504 2.269 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 43.2 Cg_endo -71.34 -30.27 15.79 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.042 1.022 . . . . 0.0 111.944 -178.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.25 -40.51 70.96 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.167 -0.958 . . . . 0.0 110.001 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -63.18 -42.38 99.37 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.655 -0.653 . . . . 0.0 110.968 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.4 mt -65.93 -41.75 90.97 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.523 -0.735 . . . . 0.0 111.152 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 66' ' ' PRO . 39.3 p -63.53 -40.89 98.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.473 -0.767 . . . . 0.0 111.61 -179.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.467 ' SD ' HG21 ' A' ' 55' ' ' VAL . 53.9 ttp -68.1 -40.04 82.7 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.442 -0.786 . . . . 0.0 110.674 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 7.5 mmt -61.86 -43.16 99.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.731 -0.606 . . . . 0.0 111.251 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.94 -30.55 67.96 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.59 -0.693 . . . . 0.0 110.523 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -70.22 -40.04 74.76 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.633 -0.667 . . . . 0.0 110.469 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -67.05 -55.44 14.33 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.532 -0.73 . . . . 0.0 111.898 -178.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.512 ' HA ' HG22 ' A' ' 79' ' ' THR . 78.6 mtm -59.94 -32.53 70.88 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.457 -0.777 . . . . 0.0 110.973 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.9 tttt -66.38 -62.32 1.53 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.681 -0.637 . . . . 0.0 112.15 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -70.73 -10.06 58.62 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.47 -0.769 . . . . 0.0 112.046 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.512 HG22 ' HA ' ' A' ' 76' ' ' MET . 1.5 t -101.07 -160.05 0.77 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.897 0.856 . . . . 0.0 112.035 -178.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.491 ' N ' HG23 ' A' ' 79' ' ' THR . 84.6 m-20 -129.98 139.49 51.06 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.358 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.0 t -63.36 -33.86 76.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.726 -0.609 . . . . 0.0 109.983 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.02 -33.23 71.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.692 -0.63 . . . . 0.0 109.662 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.34 -39.99 77.82 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.519 0.676 . . . . 0.0 109.639 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -63.06 -36.13 82.56 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.787 -0.57 . . . . 0.0 110.29 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.541 HG23 ' HE1' ' A' ' 141' ' ' PHE . 96.7 mt -67.18 -44.38 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.741 -0.599 . . . . 0.0 109.977 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -59.39 -43.58 92.92 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.638 -0.664 . . . . 0.0 111.162 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.561 ' O ' HG23 ' A' ' 91' ' ' VAL . 99.3 mt-10 -70.03 -40.08 75.4 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.588 -0.695 . . . . 0.0 111.729 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.6 -46.96 77.37 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.505 -0.747 . . . . 0.0 111.337 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.403 ' CE1' ' OD2' ' A' ' 93' ' ' ASP . 60.2 t80 -62.9 -42.84 99.92 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.524 -0.735 . . . . 0.0 109.861 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -59.95 -34.84 73.8 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.906 -0.496 . . . . 0.0 110.368 -179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 87' ' ' GLU . 77.7 t -69.9 -50.1 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.502 -0.749 . . . . 0.0 109.774 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -69.94 -41.16 74.94 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.475 -0.765 . . . . 0.0 111.022 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.403 ' OD2' ' CE1' ' A' ' 89' ' ' PHE . 33.2 t0 -81.1 75.18 8.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.404 -0.81 . . . . 0.0 109.946 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -70.02 -40.01 75.48 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.425 -0.797 . . . . 0.0 110.258 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 37.5 p-10 -75.7 -26.43 57.55 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.787 -0.571 . . . . 0.0 110.92 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.85 26.22 69.75 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -69.12 -14.86 63.24 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.365 -1.079 . . . . 0.0 111.476 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.73 -17.95 17.55 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.426 ' CD2' ' HB3' ' A' ' 135' ' ' GLN . 31.5 p90 -148.19 158.94 44.37 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.194 -1.18 . . . . 0.0 109.06 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 40.5 mt -88.9 124.24 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.322 -0.861 . . . . 0.0 110.099 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 m -82.67 172.29 13.09 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.669 0.747 . . . . 0.0 111.305 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.44 ' HB1' ' NH2' ' A' ' 106' ' ' ARG . . . -62.74 -47.37 83.85 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.81 -0.557 . . . . 0.0 110.098 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.45 -36.68 81.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.699 -0.626 . . . . 0.0 109.643 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -61.34 -40.13 93.11 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.601 -0.687 . . . . 0.0 110.39 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.473 HD21 ' SD ' ' A' ' 124' ' ' MET . 0.8 OUTLIER -64.73 -44.3 90.64 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.442 -0.786 . . . . 0.0 109.992 179.565 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.44 ' NH2' ' HB1' ' A' ' 102' ' ' ALA . 88.7 mtt180 -61.2 -37.37 82.75 Favored 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 34.7 t60 -60.0 -48.48 81.55 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.202 -0.936 . . . . 0.0 110.852 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.4 t -70.04 -39.22 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.513 -0.742 . . . . 0.0 111.568 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 12.9 mmt -59.06 -51.01 71.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.298 -0.876 . . . . 0.0 110.762 -178.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.5 m -66.88 -40.74 87.89 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.468 -0.77 . . . . 0.0 109.857 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -61.23 -31.36 71.15 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 112' ' ' LEU . 13.8 mt -69.16 -29.55 67.58 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.194 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.93 27.45 5.13 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.605 ' OE2' HD21 ' A' ' 18' ' ' LEU . 95.9 mt-10 -119.22 139.91 51.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.512 -0.993 . . . . 0.0 110.011 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -101.67 115.21 30.03 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.503 -0.748 . . . . 0.0 109.523 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.443 HD22 ' OE2' ' A' ' 120' ' ' GLU . 50.0 mt -132.83 153.69 51.04 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.459 -0.775 . . . . 0.0 109.949 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.97 164.96 19.02 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -62.1 -26.69 68.44 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.446 -0.784 . . . . 0.0 109.377 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.17 -35.44 76.3 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.639 0.733 . . . . 0.0 109.189 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.443 ' OE2' HD22 ' A' ' 116' ' ' LEU . 7.3 mt-10 -65.03 -37.78 88.73 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.382 0.61 . . . . 0.0 109.474 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.426 HG13 ' HB3' ' A' ' 105' ' ' LEU . 79.6 t -69.86 -39.14 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.564 0.697 . . . . 0.0 109.718 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -60.0 -40.04 87.85 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.777 -0.577 . . . . 0.0 109.832 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -59.96 -40.68 89.87 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.278 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.473 ' SD ' HD21 ' A' ' 105' ' ' LEU . 66.5 mtt -56.15 -37.02 68.95 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.394 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.01 -40.01 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.595 -0.691 . . . . 0.0 110.322 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 40.2 mtm-85 -59.99 -41.56 92.32 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.578 -0.701 . . . . 0.0 112.463 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.99 -39.97 87.56 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.705 -0.622 . . . . 0.0 111.329 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -98.33 -16.55 19.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.29 -0.881 . . . . 0.0 111.084 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -78.48 72.65 5.02 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.13 -0.981 . . . . 0.0 110.12 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 86.3 mt -65.06 -45.72 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.661 -0.649 . . . . 0.0 110.92 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -63.37 -40.06 96.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.358 -0.839 . . . . 0.0 111.175 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.56 20.64 9.94 Favored Glycine 0 N--CA 1.497 2.719 0 C-N-CA 120.058 -1.068 . . . . 0.0 111.198 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -82.16 -9.94 59.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.22 -1.165 . . . . 0.0 110.828 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.14 2.44 80.5 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.426 ' HB3' ' CD2' ' A' ' 99' ' ' TYR . 27.7 mt-30 -135.62 144.9 46.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.382 -1.069 . . . . 0.0 109.079 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.7 t -93.08 118.98 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.403 -0.811 . . . . 0.0 110.296 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -87.58 -179.51 6.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.557 -0.714 . . . . 0.0 109.374 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -69.46 -40.57 77.07 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.943 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -62.78 -44.05 97.2 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.548 -0.72 . . . . 0.0 110.784 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -65.78 -38.64 89.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.461 -0.774 . . . . 0.0 109.932 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.541 ' HE1' HG23 ' A' ' 85' ' ' ILE . 63.6 t80 -60.01 -44.11 94.78 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.083 0.468 . . . . 0.0 110.839 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 76.6 t -68.67 -39.96 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.485 -0.759 . . . . 0.0 110.726 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -60.24 -42.47 95.34 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.437 -0.79 . . . . 0.0 110.586 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.5 mmm -60.74 -40.02 90.83 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.633 -0.667 . . . . 0.0 110.631 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 95.2 mmm -70.07 -39.98 75.31 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.547 -0.721 . . . . 0.0 110.294 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.475 ' O ' HG22 ' A' ' 146' ' ' THR . 22.4 m -96.87 18.96 13.42 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.54 -0.725 . . . . 0.0 110.65 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.58 142.86 53.48 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.313 -0.867 . . . . 0.0 110.609 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.8 mttt . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.252 179.511 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -66.03 138.85 37.5 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -59.96 -42.79 94.86 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.614 -0.933 . . . . 0.0 110.351 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -60.04 -33.81 72.54 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.565 -0.71 . . . . 0.0 110.552 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -60.05 -42.69 95.04 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.746 -0.596 . . . . 0.0 111.013 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.05 -40.02 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.567 -0.708 . . . . 0.0 110.681 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.04 87.97 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.576 -0.703 . . . . 0.0 111.118 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -69.04 -39.99 78.84 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.401 -0.812 . . . . 0.0 110.926 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.496 ' C ' HD23 ' B' ' 163' ' ' LEU . 9.8 tt -61.04 -45.86 93.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.601 -0.687 . . . . 0.0 110.824 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.418 ' HA ' ' HB2' ' B' ' 167' ' ' LEU . 10.2 p -69.96 -29.99 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.388 -0.82 . . . . 0.0 110.699 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.14 -40.94 97.87 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 87.5 t -79.99 -26.05 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.82 -0.812 . . . . 0.0 110.134 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.545 ' CD1' HD11 ' A' ' 39' ' ' LEU . 4.3 tt -54.43 -59.92 4.04 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.478 -0.764 . . . . 0.0 111.814 -178.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -66.78 -35.15 79.4 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.379 -0.826 . . . . 0.0 111.934 -178.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -59.96 -38.72 83.3 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.263 -0.898 . . . . 0.0 109.842 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -60.01 -39.98 87.65 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.81 -0.556 . . . . 0.0 110.283 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.62 -35.81 75.1 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.4 -0.812 . . . . 0.0 110.198 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -59.89 -36.38 76.81 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.501 -0.749 . . . . 0.0 110.052 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 . . . . . 0 N--CA 1.493 1.719 0 O-C-N 121.546 -0.721 . . . . 0.0 110.235 179.947 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.194 0.521 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -69.94 -40.04 75.7 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.626 -0.671 . . . . 0.0 110.751 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.06 -40.02 94.11 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.573 0.701 . . . . 0.0 110.313 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 76.0 mt -101.75 176.47 5.21 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.259 0.552 . . . . 0.0 109.917 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.52 110.35 4.94 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.383 0.611 . . . . 0.0 109.591 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -75.49 -17.93 59.97 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.854 -0.529 . . . . 0.0 110.593 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -62.76 -27.19 69.12 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.36 -0.838 . . . . 0.0 111.178 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -70.93 -23.19 62.2 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.169 -0.957 . . . . 0.0 110.323 177.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.5 mm -59.97 -49.75 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.444 -0.785 . . . . 0.0 111.075 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.41 -24.15 67.24 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.486 -0.758 . . . . 0.0 111.602 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -66.54 -44.95 81.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.289 -0.882 . . . . 0.0 109.943 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.411 ' CB ' HD11 ' A' ' 69' ' ' LEU . 43.3 m-85 -69.88 -24.13 63.36 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.541 0.686 . . . . 0.0 109.598 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -69.94 -40.07 75.72 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.452 0.644 . . . . 0.0 109.968 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.96 -52.19 66.44 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.737 -0.602 . . . . 0.0 111.735 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.99 -21.57 63.21 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.173 -0.954 . . . . 0.0 111.709 -178.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -59.41 -47.06 86.9 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.206 -0.934 . . . . 0.0 110.513 -178.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.1 p -62.07 -37.29 84.44 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.294 -0.879 . . . . 0.0 109.201 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.531 HD21 HD22 ' A' ' 112' ' ' LEU . 50.2 tp -63.1 -39.48 94.83 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -69.97 -39.24 76.11 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.176 0.512 . . . . 0.0 110.027 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -97.86 98.65 10.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.67 -0.644 . . . . 0.0 109.825 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -69.22 -29.2 67.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.463 -0.773 . . . . 0.0 110.547 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -82.07 -10.05 59.34 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.369 -0.832 . . . . 0.0 111.611 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.64 25.07 66.89 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -178.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -78.6 -11.24 59.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.472 -1.016 . . . . 0.0 110.824 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.59 3.95 83.44 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.8 p -145.92 140.72 27.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.028 -1.277 . . . . 0.0 110.283 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.4 mt -101.52 122.73 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.751 -0.593 . . . . 0.0 109.549 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.2 m -97.92 141.16 31.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.75 -0.594 . . . . 0.0 109.992 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.548 ' HB ' HD13 ' A' ' 48' ' ' LEU . 27.7 p -39.07 -34.98 0.19 Allowed 'General case' 0 N--CA 1.51 2.546 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -66.71 -44.89 80.44 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.441 -0.787 . . . . 0.0 109.314 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -61.45 -58.26 8.88 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.946 -0.471 . . . . 0.0 111.339 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.456 HD21 ' CE2' ' B' ' 170' ' ' TRP . 54.6 tp -59.99 -36.04 76.32 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.273 -0.892 . . . . 0.0 111.061 -178.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.01 -29.99 15.48 Favored Glycine 0 N--CA 1.5 2.908 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.4 m -69.95 -39.98 75.74 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.634 -0.921 . . . . 0.0 110.453 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.1 t -63.54 -51.19 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 CA-C-O 121.621 0.724 . . . . 0.0 109.112 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 87.3 mtp -60.05 -33.04 71.49 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.277 0.56 . . . . 0.0 109.835 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -60.92 -42.46 98.17 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.411 0.624 . . . . 0.0 109.896 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.0 t -70.03 -16.38 63.15 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.637 -0.665 . . . . 0.0 110.415 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.4 tp -84.66 -24.42 29.02 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.355 -0.841 . . . . 0.0 109.383 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.42 -51.42 0.18 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.781 -1.727 . . . . 0.0 108.781 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -163.1 172.96 14.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.633 -0.922 . . . . 0.0 110.612 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -120.33 143.98 37.09 Favored Pre-proline 0 C--N 1.299 -1.62 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.057 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.69 -150.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 123.394 1.208 . . . . 0.0 109.881 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.89 161.54 36.35 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.082 -1.011 . . . . 0.0 110.098 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -52.23 -27.36 14.5 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.699 -0.626 . . . . 0.0 111.524 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.94 -58.31 3.55 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 122.078 0.942 . . . . 0.0 109.171 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.73 -39.62 91.32 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.086 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.548 HD13 ' HB ' ' A' ' 29' ' ' THR . 13.1 mt -56.56 -33.75 66.45 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.48 -0.762 . . . . 0.0 110.111 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.9 -36.65 82.77 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.386 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -68.33 -41.89 80.14 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.573 -0.705 . . . . 0.0 111.233 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 64.4 mtt -61.92 -43.28 99.16 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.534 -0.729 . . . . 0.0 109.724 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.889 HG22 ' OD2' ' A' ' 56' ' ' ASP . 43.2 mm -66.74 -35.58 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.842 -0.536 . . . . 0.0 110.241 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -61.53 -40.96 96.51 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.616 -0.677 . . . . 0.0 111.918 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -69.97 -29.6 66.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.184 -0.948 . . . . 0.0 111.002 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.54 HG21 ' SD ' ' A' ' 71' ' ' MET . 84.7 t -100.03 -8.8 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.51 -0.744 . . . . 0.0 111.397 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.889 ' OD2' HG22 ' A' ' 52' ' ' ILE . 4.2 m-20 -69.48 100.29 1.38 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.09 -1.007 . . . . 0.0 111.241 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.13 -33.89 72.4 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.661 -0.649 . . . . 0.0 109.933 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -98.36 -21.97 16.33 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.609 -0.682 . . . . 0.0 110.879 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.34 19.7 61.88 Favored Glycine 0 N--CA 1.495 2.632 0 C-N-CA 120.402 -0.904 . . . . 0.0 110.956 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -74.48 -37.54 63.16 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.372 -1.075 . . . . 0.0 110.173 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.6 ' O ' HG21 ' A' ' 52' ' ' ILE . . . 126.33 2.52 6.97 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.306 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 62.8 p -138.5 170.18 16.47 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.033 -1.275 . . . . 0.0 111.355 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.9 mt -102.37 120.93 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.168 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -100.75 170.03 8.61 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.458 0.647 . . . . 0.0 110.251 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.478 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 5.6 t80 -48.22 -48.88 64.06 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.561 -0.712 . . . . 0.0 112.651 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.9 Cg_endo -68.45 -35.86 16.87 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 O-C-N 122.75 0.868 . . . . 0.0 111.916 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.98 -40.03 75.6 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.092 -1.005 . . . . 0.0 110.467 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.429 ' HD2' HD22 ' A' ' 69' ' ' LEU . 64.7 t80 -61.46 -42.02 98.12 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.643 -0.661 . . . . 0.0 110.549 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.453 HD23 ' O ' ' A' ' 65' ' ' PHE . 3.8 mm? -64.51 -41.95 96.1 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.394 -0.816 . . . . 0.0 111.695 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 66' ' ' PRO . 72.0 p -62.36 -40.48 96.54 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.288 -0.882 . . . . 0.0 111.493 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.54 ' SD ' HG21 ' A' ' 55' ' ' VAL . 59.3 ttp -69.74 -40.38 76.2 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.481 -0.762 . . . . 0.0 111.439 -178.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.6 ' SD ' HG11 ' B' ' 166' ' ' VAL . 88.8 mmm -60.77 -49.08 78.93 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.483 -0.761 . . . . 0.0 110.95 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.24 -31.99 73.43 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.785 -0.572 . . . . 0.0 111.291 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -70.04 -39.76 75.55 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.545 -0.722 . . . . 0.0 111.649 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.753 ' O ' HG22 ' A' ' 79' ' ' THR . 91.6 mttt -69.12 -31.59 70.38 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.274 -0.891 . . . . 0.0 112.569 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 63.2 mtt -59.54 -48.2 82.59 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.173 -0.955 . . . . 0.0 112.395 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -69.06 -38.38 79.05 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.238 -0.914 . . . . 0.0 112.032 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -69.99 -20.06 63.31 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.33 -0.856 . . . . 0.0 111.197 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.753 HG22 ' O ' ' A' ' 75' ' ' LYS . 15.2 t -112.22 -164.45 0.92 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.957 0.884 . . . . 0.0 111.709 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -130.27 147.0 51.94 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.899 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.6 p -67.09 -26.93 66.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.591 -0.693 . . . . 0.0 110.601 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.31 -35.39 77.23 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.566 0.698 . . . . 0.0 109.505 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.97 -39.99 83.22 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.563 0.697 . . . . 0.0 109.87 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -62.32 -38.66 90.31 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.793 -0.567 . . . . 0.0 111.456 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.687 HG23 ' HE2' ' A' ' 141' ' ' PHE . 67.7 mt -68.11 -45.3 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.405 -0.809 . . . . 0.0 110.672 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 64.1 mtp180 -58.09 -41.49 83.61 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.231 -0.918 . . . . 0.0 110.811 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.655 ' O ' HG23 ' A' ' 91' ' ' VAL . 98.5 mt-10 -70.03 -39.98 75.44 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.663 -0.648 . . . . 0.0 111.484 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.38 -47.98 77.19 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.469 -0.769 . . . . 0.0 111.536 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -60.27 -42.15 94.81 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.408 -0.808 . . . . 0.0 109.992 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -60.07 -37.61 80.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.905 -0.497 . . . . 0.0 110.62 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 87' ' ' GLU . 58.5 t -69.9 -55.59 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.317 -0.864 . . . . 0.0 110.521 -179.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.67 ' HE2' HG21 ' B' ' 164' ' ' VAL . 44.4 m-85 -60.6 -39.98 90.11 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.312 -0.868 . . . . 0.0 110.978 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -80.51 78.04 7.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.587 -0.696 . . . . 0.0 110.315 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -67.0 -41.43 86.75 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.385 -0.822 . . . . 0.0 109.904 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.6 p-10 -76.15 -21.32 56.71 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.626 -0.671 . . . . 0.0 111.212 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.22 24.45 74.77 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -70.02 -10.94 60.35 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.412 -1.052 . . . . 0.0 111.368 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.19 -15.62 58.93 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.418 ' CZ ' ' ND2' ' A' ' 137' ' ' ASN . 73.3 m-85 -133.55 141.02 47.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.246 -1.15 . . . . 0.0 109.331 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 77.8 mt -89.06 122.15 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.395 -0.816 . . . . 0.0 109.72 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.4 m -83.49 170.01 14.88 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.334 0.588 . . . . 0.0 110.819 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.05 -39.99 94.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.8 -0.562 . . . . 0.0 109.807 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.7 -31.55 72.76 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.57 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -69.92 -40.01 75.82 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.767 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.593 ' HB3' HG13 ' A' ' 121' ' ' VAL . 0.9 OUTLIER -61.58 -47.02 87.4 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.289 -0.882 . . . . 0.0 109.328 179.233 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -64.14 -30.36 71.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.929 -0.482 . . . . 0.0 111.102 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -61.96 -49.02 77.79 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.375 -0.828 . . . . 0.0 111.806 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.604 HG12 ' CD1' ' A' ' 112' ' ' LEU . 72.6 t -70.03 -47.18 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.328 -0.858 . . . . 0.0 111.299 -178.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.479 ' HA ' HD12 ' A' ' 112' ' ' LEU . 98.9 mtp -59.61 -39.99 86.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.318 -0.864 . . . . 0.0 110.489 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.2 m -64.5 -46.2 84.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.453 -0.779 . . . . 0.0 109.107 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -62.46 -32.73 73.66 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.604 ' CD1' HG12 ' A' ' 108' ' ' VAL . 39.7 mt -69.97 -33.69 72.42 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.341 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.43 34.49 1.43 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -125.08 136.69 53.91 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.524 -0.986 . . . . 0.0 110.078 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -101.91 130.54 48.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.509 -0.744 . . . . 0.0 109.639 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.632 HD12 HG23 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -148.3 152.22 36.73 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.673 -0.642 . . . . 0.0 110.848 -179.289 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.1 p -80.94 162.02 24.07 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -61.42 -27.78 68.79 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -67.8 -34.94 77.76 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.822 0.82 . . . . 0.0 109.193 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -62.52 -40.09 95.63 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.632 HG23 HD12 ' A' ' 116' ' ' LEU . 75.5 t -66.22 -40.06 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.097 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -60.02 -45.95 91.11 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.648 -0.658 . . . . 0.0 110.558 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -59.97 -40.61 89.69 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.904 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 86.2 mmm -54.63 -38.14 66.47 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.029 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.23 -38.69 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.692 -0.63 . . . . 0.0 110.15 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -58.36 -39.99 81.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.552 -0.718 . . . . 0.0 111.959 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.11 -40.06 88.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.469 -0.77 . . . . 0.0 112.172 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -108.44 -5.62 16.55 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.189 -0.944 . . . . 0.0 112.317 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -90.29 73.06 7.11 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.889 -1.132 . . . . 0.0 111.06 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 86.5 mt -68.28 -40.05 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.49 -0.756 . . . . 0.0 110.116 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 36.5 p-10 -60.0 -39.94 87.5 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.528 -0.732 . . . . 0.0 111.043 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.418 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . 92.38 24.92 22.84 Favored Glycine 0 N--CA 1.493 2.437 0 O-C-N 121.25 -0.907 . . . . 0.0 111.057 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -82.45 -8.02 59.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -1.178 . . . . 0.0 110.544 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 97.16 -1.5 60.81 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -140.84 159.65 41.76 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.16 -1.2 . . . . 0.0 109.722 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 94.3 t -87.89 118.24 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.394 -0.816 . . . . 0.0 109.078 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.418 ' ND2' ' CZ ' ' A' ' 99' ' ' TYR . 8.6 t-20 -87.36 170.03 11.75 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.997 0.903 . . . . 0.0 110.994 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -63.57 -50.01 71.16 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.278 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -62.35 -41.1 98.32 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.38 -0.825 . . . . 0.0 110.539 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.25 -37.27 85.1 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.13 0.967 . . . . 0.0 109.268 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.687 ' HE2' HG23 ' A' ' 85' ' ' ILE . 77.4 t80 -59.94 -41.9 92.86 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.008 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.434 HG22 HG21 ' A' ' 85' ' ' ILE . 70.8 t -74.2 -42.16 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.284 -0.885 . . . . 0.0 111.956 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -59.98 -50.37 74.01 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.41 -0.806 . . . . 0.0 112.157 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 55.1 ttp -61.37 -35.72 78.25 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.366 -0.834 . . . . 0.0 110.871 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 89.2 mtp -69.96 -39.91 75.72 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.792 -0.567 . . . . 0.0 110.244 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.428 ' O ' HG22 ' A' ' 146' ' ' THR . 13.3 m -98.97 22.45 10.24 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.579 -0.7 . . . . 0.0 110.459 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.38 -40.55 85.71 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.366 -0.834 . . . . 0.0 111.399 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 29.9 mttt . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.525 -179.102 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 70.07 32.16 69.41 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -60.04 -41.89 93.25 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.55 -0.97 . . . . 0.0 110.111 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -60.77 -40.13 91.37 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.664 -0.647 . . . . 0.0 110.984 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 43.1 mtm-85 -65.73 -39.99 91.73 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.355 -0.841 . . . . 0.0 111.158 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 93.5 mt -65.25 -40.03 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.394 -0.816 . . . . 0.0 110.231 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.55 -40.74 97.78 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.562 -0.711 . . . . 0.0 110.127 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 -62.21 -40.48 96.25 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.728 -0.607 . . . . 0.0 110.557 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 85.8 mt -64.86 -40.07 94.57 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.495 -0.753 . . . . 0.0 110.562 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.67 HG21 ' HE2' ' A' ' 92' ' ' PHE . 94.2 t -63.78 -40.11 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.552 -0.718 . . . . 0.0 110.023 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.03 -31.39 61.54 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.6 HG11 ' SD ' ' A' ' 72' ' ' MET . 67.2 t -79.94 -28.95 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.722 -0.87 . . . . 0.0 111.363 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.522 HD12 ' HA ' ' B' ' 164' ' ' VAL . 79.0 mt -60.09 -49.95 75.63 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.195 -0.941 . . . . 0.0 111.707 -177.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 168' ' ' ARG . . . . . 0.429 ' HD3' ' CG ' ' A' ' 87' ' ' GLU . 38.0 ttt-85 -66.4 -40.06 89.41 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.127 -0.983 . . . . 0.0 110.445 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -60.04 -29.88 68.81 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.571 -0.706 . . . . 0.0 110.627 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . 0.479 ' CZ3' ' HE1' ' A' ' 71' ' ' MET . 4.5 t-105 -60.17 -39.47 86.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.489 -0.757 . . . . 0.0 110.176 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.23 -39.97 76.59 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.491 -0.755 . . . . 0.0 111.046 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -60.03 -39.97 87.69 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.345 -0.847 . . . . 0.0 110.372 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 . . . . . 0 N--CA 1.494 1.741 0 O-C-N 121.496 -0.752 . . . . 0.0 109.986 179.905 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 120.997 0.427 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.48 ' H ' HD11 ' A' ' 9' ' ' ILE . 43.0 t0 -89.96 85.36 6.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.597 -0.689 . . . . 0.0 109.794 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -59.93 -39.45 85.55 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.787 0.803 . . . . 0.0 109.9 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 90.3 mt -59.97 -40.04 87.74 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.059 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 p -136.62 105.39 5.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 110.202 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.405 ' HA ' HG12 ' A' ' 9' ' ' ILE . 97.1 mt-10 -81.82 -15.34 54.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.92 -0.488 . . . . 0.0 110.69 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -52.85 -43.27 65.94 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.086 -1.009 . . . . 0.0 110.503 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -70.05 -21.08 63.2 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.606 -0.683 . . . . 0.0 111.975 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.48 HD11 ' H ' ' A' ' 2' ' ' ASP . 47.7 mm -61.42 -50.87 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.308 -0.87 . . . . 0.0 110.374 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.43 -35.86 78.73 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.771 -0.581 . . . . 0.0 110.941 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.94 -45.46 92.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.61 -0.681 . . . . 0.0 110.362 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.478 ' CE1' ' HG2' ' A' ' 72' ' ' MET . 24.7 m-85 -64.68 -22.84 67.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.619 -0.676 . . . . 0.0 111.234 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -68.63 -41.62 79.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.272 -0.892 . . . . 0.0 108.721 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -59.99 -52.54 64.95 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.618 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.25 -23.43 64.78 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.318 -0.864 . . . . 0.0 111.657 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -56.1 -47.67 77.63 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.978 -1.076 . . . . 0.0 109.991 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.3 m -60.75 -39.29 88.16 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.503 -0.748 . . . . 0.0 109.403 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 64.2 tp -63.8 -39.95 95.48 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.92 -39.57 76.08 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.454 ' HB2' HD11 ' A' ' 27' ' ' ILE . 25.3 t0 -95.19 97.3 9.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.631 -0.668 . . . . 0.0 110.036 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.8 mttt -64.37 -32.01 73.45 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.367 -0.833 . . . . 0.0 111.598 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -80.57 -10.02 59.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.209 -0.932 . . . . 0.0 111.506 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.23 25.08 46.81 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -87.23 -9.66 54.51 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.586 -0.949 . . . . 0.0 110.666 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.64 2.81 53.04 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.868 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.5 p -144.61 141.95 29.78 Favored 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 119.534 1.667 . . . . 0.0 112.1 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.454 HD11 ' HB2' ' A' ' 20' ' ' ASP . 49.3 mm -99.93 121.04 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.5 p -100.91 142.08 32.88 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.576 -0.703 . . . . 0.0 111.019 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.424 ' CG2' ' HB3' ' A' ' 48' ' ' LEU . 82.1 p -41.76 -33.14 0.46 Allowed 'General case' 0 N--CA 1.509 2.518 0 O-C-N 121.856 -0.528 . . . . 0.0 111.892 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -64.71 -51.06 64.43 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.797 0.808 . . . . 0.0 109.525 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -59.95 -54.75 42.41 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.577 -178.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.448 HD21 ' CE2' ' B' ' 170' ' ' TRP . 58.8 tp -60.04 -35.32 74.85 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.203 -0.936 . . . . 0.0 110.696 -178.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.05 -30.45 16.56 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -178.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.8 m -70.03 -39.97 75.44 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.569 -0.959 . . . . 0.0 110.363 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 79.0 t -64.89 -51.07 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.628 -0.67 . . . . 0.0 109.746 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.403 ' HE2' ' HD3' ' A' ' 43' ' ' PRO . 98.1 mtp -59.97 -33.03 71.39 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.741 -0.6 . . . . 0.0 109.521 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -61.57 -41.87 98.02 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.696 0.76 . . . . 0.0 109.084 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.9 t -72.02 -19.47 61.85 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.962 -0.461 . . . . 0.0 110.81 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.7 -16.99 29.18 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.272 -0.893 . . . . 0.0 110.504 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.16 -55.62 0.18 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -159.97 169.92 22.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.411 -1.053 . . . . 0.0 110.804 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -107.82 125.88 31.12 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.892 -0.505 . . . . 0.0 110.151 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.427 ' HG2' HD21 ' A' ' 48' ' ' LEU . 52.9 Cg_endo -69.07 -148.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.07 0 N-CA-C 108.649 -1.327 . . . . 0.0 108.649 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 50.2 p -137.45 150.36 47.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.929 -1.107 . . . . 0.0 110.837 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -53.15 -23.65 8.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.636 -0.665 . . . . 0.0 111.467 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.49 -60.05 2.42 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.89 0.852 . . . . 0.0 109.128 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -67.71 -37.67 82.57 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.054 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.427 HD21 ' HG2' ' A' ' 43' ' ' PRO . 15.6 mt -57.1 -33.23 67.1 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.495 -0.753 . . . . 0.0 110.02 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -35.52 80.45 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.956 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -65.68 -39.96 91.85 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.45 -0.781 . . . . 0.0 110.832 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 67.2 mtt -60.02 -45.45 92.74 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.433 0.635 . . . . 0.0 109.93 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.795 HG22 ' OD2' ' A' ' 56' ' ' ASP . 96.8 mt -67.95 -33.07 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.824 -0.547 . . . . 0.0 110.729 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -60.06 -40.05 88.12 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.327 -0.858 . . . . 0.0 110.115 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -67.11 -26.47 66.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.377 -0.827 . . . . 0.0 109.959 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.535 HG21 ' SD ' ' A' ' 71' ' ' MET . 74.3 t -99.81 -9.99 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.598 -0.689 . . . . 0.0 110.864 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.795 ' OD2' HG22 ' A' ' 52' ' ' ILE . 25.6 m-20 -72.27 99.71 2.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.118 -0.989 . . . . 0.0 111.126 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.54 -40.06 92.46 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.388 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -88.32 -28.34 21.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.714 -0.616 . . . . 0.0 110.563 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.02 22.95 43.16 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -74.22 -33.79 63.49 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.499 -1.001 . . . . 0.0 110.617 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.97 -0.43 10.81 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.294 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.0 p -132.67 170.08 15.74 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.017 -1.284 . . . . 0.0 110.391 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.773 HD11 HG12 ' A' ' 52' ' ' ILE . 12.6 mt -106.67 120.4 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.87 -0.519 . . . . 0.0 110.869 -177.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -100.68 169.44 9.03 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.572 0.701 . . . . 0.0 110.906 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.47 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -45.05 -52.73 18.68 Favored Pre-proline 0 N--CA 1.502 2.168 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.069 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.2 Cg_endo -67.39 -30.93 35.81 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 O-C-N 122.943 0.97 . . . . 0.0 111.514 -178.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -72.1 -40.91 67.85 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.448 -0.782 . . . . 0.0 110.425 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -66.08 -40.16 90.61 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.683 -0.636 . . . . 0.0 111.177 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.7 mt -66.23 -39.93 89.9 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.373 -0.83 . . . . 0.0 111.569 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 21.6 p -64.19 -41.39 97.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.555 -0.716 . . . . 0.0 111.333 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.535 ' SD ' HG21 ' A' ' 55' ' ' VAL . 58.9 ttp -68.07 -40.2 82.77 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.438 -0.788 . . . . 0.0 110.894 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.478 ' HG2' ' CE1' ' A' ' 12' ' ' PHE . 53.6 tpp -59.99 -45.11 93.79 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.493 -0.755 . . . . 0.0 110.462 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.8 -30.8 70.32 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.506 -0.746 . . . . 0.0 109.725 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.4 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 0.2 OUTLIER -70.02 -39.67 75.65 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.706 -0.621 . . . . 0.0 111.059 179.824 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -65.79 -36.57 83.88 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.412 -0.805 . . . . 0.0 112.203 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 60.7 mtt -59.73 -50.09 75.18 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.214 -0.929 . . . . 0.0 111.684 -177.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 74' ' ' ARG . 10.9 pttt -70.05 -38.96 75.96 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.308 -0.87 . . . . 0.0 110.835 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -68.66 -40.02 80.38 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.448 -0.782 . . . . 0.0 109.978 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.571 HG22 ' H ' ' A' ' 80' ' ' ASP . 1.4 m -100.43 -172.59 2.23 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.985 -0.447 . . . . 0.0 110.196 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.571 ' H ' HG22 ' A' ' 79' ' ' THR . 69.9 m-20 -129.53 147.22 51.31 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.42 -0.8 . . . . 0.0 109.904 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.4 t -59.95 -27.81 67.12 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.546 -0.721 . . . . 0.0 110.401 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.01 -36.72 77.85 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.368 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.98 -39.94 75.64 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.378 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.08 -37.47 75.45 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.694 -0.629 . . . . 0.0 110.558 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.474 HG23 ' SD ' ' A' ' 145' ' ' MET . 67.7 mt -65.57 -53.83 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.635 -0.666 . . . . 0.0 111.028 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.423 ' HG3' ' N ' ' A' ' 87' ' ' GLU . 33.6 ptt180 -60.03 -39.97 87.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.383 -0.823 . . . . 0.0 111.392 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.423 ' N ' ' HG3' ' A' ' 86' ' ' ARG . 95.3 mt-10 -68.58 -40.76 80.38 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.506 -0.746 . . . . 0.0 110.742 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.429 ' HA ' HG12 ' B' ' 164' ' ' VAL . . . -65.19 -44.24 89.03 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.956 -0.465 . . . . 0.0 110.898 -178.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -61.15 -41.28 96.47 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.879 0.847 . . . . 0.0 108.814 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -59.98 -38.14 81.69 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.821 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.3 -43.2 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.506 -0.746 . . . . 0.0 110.027 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.643 ' HE2' HG21 ' B' ' 164' ' ' VAL . 13.4 m-85 -69.37 -39.1 78.25 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.497 -0.752 . . . . 0.0 111.451 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -79.55 77.23 6.15 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.32 -0.862 . . . . 0.0 110.508 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -59.98 -42.34 93.98 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.395 -0.816 . . . . 0.0 110.216 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 24.1 p-10 -81.92 -19.94 39.74 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.496 -0.752 . . . . 0.0 111.258 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.79 63.83 4.92 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -109.91 -10.77 14.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.457 -1.025 . . . . 0.0 111.52 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.25 -23.31 8.14 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 99' ' ' TYR . 31.0 p90 -149.08 152.91 37.01 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.327 -1.102 . . . . 0.0 109.549 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 56.0 mt -89.34 125.2 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.742 0.782 . . . . 0.0 109.96 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 m -80.99 171.29 15.18 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.141 0.496 . . . . 0.0 110.31 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.04 -40.59 96.63 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.622 -0.674 . . . . 0.0 109.498 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.03 -38.48 91.24 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.496 0.665 . . . . 0.0 109.314 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -62.43 -39.43 93.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.741 -0.6 . . . . 0.0 111.285 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.627 HD21 ' HE1' ' A' ' 124' ' ' MET . 1.4 tt -62.53 -43.74 98.06 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.133 -0.979 . . . . 0.0 109.468 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.449 ' HG2' HG21 ' A' ' 121' ' ' VAL . 88.1 mtt180 -60.05 -33.34 71.91 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.686 -0.634 . . . . 0.0 110.901 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -60.37 -45.37 93.76 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.159 -0.963 . . . . 0.0 111.614 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.535 HG11 ' CE1' ' A' ' 92' ' ' PHE . 95.9 t -72.92 -39.86 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.299 -0.876 . . . . 0.0 111.256 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 26.8 mmt -59.86 -48.65 80.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.46 -0.775 . . . . 0.0 110.293 -178.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.1 m -67.26 -41.71 85.09 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.496 -0.752 . . . . 0.0 109.848 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -61.13 -31.46 71.17 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.3 mt -69.03 -32.79 72.55 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.713 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.61 29.14 4.83 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -121.43 130.03 53.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.581 -0.952 . . . . 0.0 109.734 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -92.43 117.64 30.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.532 -0.73 . . . . 0.0 110.132 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.527 HD13 ' OE1' ' A' ' 120' ' ' GLU . 60.8 mt -132.71 157.24 45.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.617 -0.677 . . . . 0.0 109.812 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 p -83.74 162.99 20.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.587 -0.696 . . . . 0.0 109.663 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.9 p-10 -60.06 -25.16 65.16 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -66.61 -34.63 78.32 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.527 ' OE1' HD13 ' A' ' 116' ' ' LEU . 0.5 OUTLIER -62.42 -38.98 91.78 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.541 0.686 . . . . 0.0 109.233 179.15 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.543 HG13 HD13 ' A' ' 105' ' ' LEU . 74.9 t -68.88 -39.05 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.359 0.6 . . . . 0.0 110.124 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.493 ' HA ' HD12 ' A' ' 125' ' ' ILE . 45.2 t0 -59.28 -49.93 75.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.768 -0.582 . . . . 0.0 110.341 -178.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -60.27 -41.45 93.29 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.399 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.627 ' HE1' HD21 ' A' ' 105' ' ' LEU . 97.6 mtp -54.81 -39.7 68.75 Favored 'General case' 0 N--CA 1.504 2.24 0 C-N-CA 119.389 -0.924 . . . . 0.0 108.838 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.493 HD12 ' HA ' ' A' ' 122' ' ' ASP . 89.4 mt -63.75 -40.0 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.162 0.506 . . . . 0.0 109.963 178.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -60.0 -39.97 87.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.483 -0.76 . . . . 0.0 112.182 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -60.06 -39.94 87.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.116 -0.99 . . . . 0.0 111.773 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -99.05 -17.48 18.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.205 -0.934 . . . . 0.0 110.987 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.4 77.86 5.76 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.178 -0.951 . . . . 0.0 110.816 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 82.9 mt -64.14 -39.98 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.66 -0.65 . . . . 0.0 111.079 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -59.51 -38.53 81.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.403 -0.81 . . . . 0.0 111.12 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 98.59 11.93 45.98 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 120.115 -1.04 . . . . 0.0 111.417 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -81.31 -13.66 58.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.023 -1.281 . . . . 0.0 110.56 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.95 5.55 70.69 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.793 178.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -127.68 126.48 42.01 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.032 -1.275 . . . . 0.0 109.924 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.7 t -89.96 113.99 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.252 -0.905 . . . . 0.0 109.71 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -89.97 -179.38 5.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.507 -0.746 . . . . 0.0 109.884 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -62.24 -41.8 98.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.718 -0.614 . . . . 0.0 110.422 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -62.56 -44.85 95.32 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.199 -0.938 . . . . 0.0 111.463 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -63.44 -38.96 93.15 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.978 0.894 . . . . 0.0 109.454 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -59.87 -41.88 92.48 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.578 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.2 t -68.06 -40.11 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.493 -0.754 . . . . 0.0 110.945 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -60.78 -40.39 92.41 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.373 -0.829 . . . . 0.0 110.056 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 53.9 ttp -60.05 -41.2 91.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.779 -0.576 . . . . 0.0 110.752 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.474 ' SD ' HG23 ' A' ' 85' ' ' ILE . 44.3 mtt -82.06 -39.18 23.82 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.535 -0.728 . . . . 0.0 110.999 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 85.4 m -59.98 -26.81 66.33 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.695 -0.628 . . . . 0.0 110.459 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -80.78 119.12 22.95 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.434 -0.791 . . . . 0.0 110.601 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.7 mttm . . . . . 0 N--CA 1.5 2.026 0 CA-C-O 118.407 -0.806 . . . . 0.0 111.47 179.798 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 72.86 39.17 55.54 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -59.97 -47.47 85.66 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.451 -1.029 . . . . 0.0 109.464 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -60.73 -39.06 87.26 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.855 -0.528 . . . . 0.0 110.351 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -60.0 -40.0 87.72 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.522 -0.736 . . . . 0.0 109.853 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 86.7 mt -68.34 -39.99 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.681 -0.637 . . . . 0.0 110.369 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.04 -38.89 84.07 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.46 -0.775 . . . . 0.0 110.65 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 32.7 ttm-85 -60.04 -40.95 91.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.433 -0.792 . . . . 0.0 109.962 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 39.2 tp -64.24 -39.9 94.92 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.772 -0.58 . . . . 0.0 110.077 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.643 HG21 ' HE2' ' A' ' 92' ' ' PHE . 80.2 t -62.47 -39.94 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.517 -0.74 . . . . 0.0 110.347 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.52 -36.9 87.03 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 73.3 t -68.21 -39.19 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.913 -0.757 . . . . 0.0 110.457 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.577 HD12 ' HA ' ' B' ' 164' ' ' VAL . 84.5 mt -59.97 -46.41 89.52 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.522 -0.736 . . . . 0.0 111.635 -178.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -59.98 -40.0 87.64 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.27 -0.894 . . . . 0.0 110.269 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -60.09 -39.86 87.6 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.55 -0.719 . . . . 0.0 110.396 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . 0.448 ' CE2' HD21 ' A' ' 32' ' ' LEU . 5.0 t-105 -60.02 -45.64 92.14 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.695 -0.628 . . . . 0.0 110.404 -179.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -62.55 -40.63 97.45 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.519 -0.738 . . . . 0.0 110.152 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -59.98 -40.07 87.85 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.579 -0.7 . . . . 0.0 109.977 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.697 -0.627 . . . . 0.0 110.174 179.784 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.006 0.431 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -94.18 115.96 28.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.456 -0.777 . . . . 0.0 109.86 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -114.4 155.54 26.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.654 -0.654 . . . . 0.0 110.238 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.2 mt -95.19 -178.84 4.59 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.62 -0.675 . . . . 0.0 110.453 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.1 p -127.07 104.35 7.94 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.669 0.747 . . . . 0.0 110.335 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.686 ' HA ' HD12 ' A' ' 9' ' ' ILE . 99.8 mt-10 -81.84 -7.52 59.61 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.898 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -70.07 -39.97 75.33 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.276 -0.89 . . . . 0.0 110.244 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -69.9 -34.81 74.0 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.44 0.638 . . . . 0.0 110.875 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.686 HD12 ' HA ' ' A' ' 6' ' ' GLU . 84.6 mt -60.06 -38.85 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.65 -0.656 . . . . 0.0 111.971 -178.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.87 -29.19 70.02 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.97 -1.081 . . . . 0.0 111.051 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.85 -40.48 97.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.291 -0.881 . . . . 0.0 109.865 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.51 ' CB ' HD21 ' A' ' 69' ' ' LEU . 77.5 m-85 -64.98 -22.22 66.97 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.816 -0.553 . . . . 0.0 111.438 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.424 ' HE2' ' CZ ' ' A' ' 65' ' ' PHE . 28.3 mmtp -65.31 -39.97 93.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.34 -0.85 . . . . 0.0 110.075 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -62.63 -58.5 7.3 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.705 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.03 -36.07 76.47 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.387 -0.821 . . . . 0.0 112.15 -178.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -54.95 -49.73 70.63 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.072 -1.017 . . . . 0.0 110.561 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.6 t -60.77 -35.43 76.4 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.519 -0.738 . . . . 0.0 110.06 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.649 HD13 ' O ' ' A' ' 18' ' ' LEU . 2.1 tm? -65.83 -39.97 91.35 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -71.95 -40.62 68.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.909 -0.495 . . . . 0.0 110.668 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -94.19 95.21 8.81 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.363 -0.836 . . . . 0.0 110.82 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -66.76 -33.14 74.96 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.298 -0.876 . . . . 0.0 111.309 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -78.7 -10.91 59.93 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.116 -0.99 . . . . 0.0 111.281 -177.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.42 25.28 66.72 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 58.2 p-10 -89.5 -3.28 58.42 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.456 -1.026 . . . . 0.0 110.808 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.93 8.22 76.37 Favored Glycine 0 N--CA 1.489 2.232 0 O-C-N 121.217 -0.927 . . . . 0.0 111.271 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.9 p -145.73 143.06 29.51 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 119.335 1.568 . . . . 0.0 112.109 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 85.0 mt -101.21 121.84 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.69 -0.631 . . . . 0.0 109.411 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.6 p -99.15 143.45 29.41 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.49 -0.757 . . . . 0.0 110.607 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.416 ' O ' HD13 ' A' ' 48' ' ' LEU . 80.6 p -41.88 -36.92 1.16 Allowed 'General case' 0 N--CA 1.507 2.401 0 O-C-N 121.983 -0.448 . . . . 0.0 112.2 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -62.47 -47.86 82.14 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.112 -0.992 . . . . 0.0 109.346 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -60.04 -54.97 39.7 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.49 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 44.4 tp -59.98 -36.99 78.34 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.253 -0.904 . . . . 0.0 111.55 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -49.54 -31.39 14.46 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.5 m -70.92 -39.62 72.58 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.401 -1.058 . . . . 0.0 110.172 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.3 t -64.79 -54.1 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.517 -0.739 . . . . 0.0 110.06 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 92.6 mtp -60.03 -34.94 74.06 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.59 0.71 . . . . 0.0 110.064 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -60.05 -49.54 77.24 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.651 0.739 . . . . 0.0 110.007 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.9 t -69.96 -16.69 63.24 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.838 -0.539 . . . . 0.0 110.791 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.531 HD13 HD12 ' B' ' 167' ' ' LEU . 84.3 mt -87.9 -24.41 23.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.474 -0.766 . . . . 0.0 110.45 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.41 -38.43 0.22 Allowed Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.528 -1.32 . . . . 0.0 111.401 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -152.78 155.53 37.34 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 118.814 1.307 . . . . 0.0 112.196 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -116.97 99.96 53.16 Favored Pre-proline 0 N--CA 1.489 1.517 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.677 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.422 ' HG2' HD21 ' A' ' 48' ' ' LEU . 44.7 Cg_endo -64.18 -148.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.282 0 O-C-N 123.246 1.129 . . . . 0.0 109.56 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.7 p -139.94 156.5 46.63 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.93 -1.106 . . . . 0.0 111.689 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -54.02 -20.58 6.58 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.801 -0.562 . . . . 0.0 111.602 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.94 -59.99 2.46 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.937 0.875 . . . . 0.0 108.942 177.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -68.73 -33.75 74.44 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.044 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.422 HD21 ' HG2' ' A' ' 43' ' ' PRO . 44.2 mt -58.8 -34.85 71.96 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.608 -0.683 . . . . 0.0 110.33 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.33 -32.12 69.71 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.535 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -70.08 -43.09 71.83 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.356 -0.84 . . . . 0.0 111.313 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.422 ' CE ' HD23 ' A' ' 48' ' ' LEU . 77.7 mtm -60.95 -41.85 97.12 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.632 0.73 . . . . 0.0 109.463 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.579 HG22 ' OD2' ' A' ' 56' ' ' ASP . 97.0 mt -69.82 -31.93 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.908 -0.495 . . . . 0.0 110.026 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -59.96 -41.53 92.11 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.593 -0.692 . . . . 0.0 110.821 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -67.99 -25.61 65.49 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.323 -0.861 . . . . 0.0 110.292 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.3 t -99.09 -9.46 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.607 -0.683 . . . . 0.0 111.116 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.579 ' OD2' HG22 ' A' ' 52' ' ' ILE . 26.7 m-20 -71.96 106.53 4.29 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.123 -0.986 . . . . 0.0 111.68 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.92 -40.07 75.76 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.458 -0.776 . . . . 0.0 109.726 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -88.62 -29.74 19.74 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.635 -0.665 . . . . 0.0 110.266 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.92 24.61 44.4 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -74.3 -31.82 62.64 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.536 -0.979 . . . . 0.0 110.467 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 123.0 -3.91 9.78 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 120.361 -0.923 . . . . 0.0 111.033 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 82.0 p -133.43 170.01 16.12 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.065 -1.256 . . . . 0.0 110.364 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.57 HG12 HG23 ' A' ' 52' ' ' ILE . 9.1 mt -102.79 120.48 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.05 -178.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -98.38 169.51 9.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.523 -0.736 . . . . 0.0 110.617 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.476 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 25.7 t80 -49.01 -48.76 71.9 Favored Pre-proline 0 N--CA 1.497 1.915 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 42.7 Cg_endo -68.11 -33.54 24.87 Favored 'Trans proline' 0 N--CA 1.486 1.084 0 O-C-N 122.639 0.81 . . . . 0.0 110.863 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -71.13 -39.98 71.69 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.328 -0.857 . . . . 0.0 110.061 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -60.78 -49.96 75.4 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.522 -0.736 . . . . 0.0 110.893 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.51 HD21 ' CB ' ' A' ' 12' ' ' PHE . 85.2 mt -60.33 -41.89 94.49 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.509 -0.744 . . . . 0.0 111.515 -178.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 66' ' ' PRO . 45.9 p -63.66 -37.17 86.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.44 -0.788 . . . . 0.0 111.395 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 26.8 ttt -65.76 -44.36 86.09 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.299 -0.876 . . . . 0.0 111.54 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 91.2 mtp -71.04 -60.08 2.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.346 -0.846 . . . . 0.0 112.146 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.74 -40.79 76.39 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.47 -0.768 . . . . 0.0 111.314 -178.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.8 tpt85 -70.0 -40.2 75.42 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.526 -0.734 . . . . 0.0 111.157 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -86.2 -39.1 16.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.397 -0.815 . . . . 0.0 111.986 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.729 ' O ' HG22 ' A' ' 79' ' ' THR . 43.9 mtm -60.02 -39.95 87.62 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.254 -0.904 . . . . 0.0 111.661 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -62.21 -44.27 96.96 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.189 -0.944 . . . . 0.0 109.66 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -74.74 -10.02 59.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.93 -0.481 . . . . 0.0 110.566 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.729 HG22 ' O ' ' A' ' 76' ' ' MET . 0.6 OUTLIER -85.5 -162.5 0.73 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.252 -0.905 . . . . 0.0 111.328 -179.047 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.643 ' N ' HG23 ' A' ' 79' ' ' THR . 68.6 m-20 -130.06 135.43 48.23 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.804 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.0 t -69.97 -27.19 64.52 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.614 -0.678 . . . . 0.0 110.638 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -60.04 -36.62 77.68 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.556 -0.715 . . . . 0.0 110.023 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.98 -40.02 75.6 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.722 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -63.21 -40.05 96.37 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.475 -0.766 . . . . 0.0 110.729 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.624 HG23 ' HE2' ' A' ' 141' ' ' PHE . 85.8 mt -66.03 -46.89 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.673 -0.642 . . . . 0.0 110.148 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 -56.57 -40.42 75.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.532 -0.73 . . . . 0.0 110.903 -178.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.721 ' O ' HG23 ' A' ' 91' ' ' VAL . 99.0 mt-10 -69.94 -40.05 75.73 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.421 -0.8 . . . . 0.0 111.721 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.656 ' CA ' HG11 ' B' ' 164' ' ' VAL . . . -65.1 -48.86 72.17 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.358 -0.839 . . . . 0.0 111.996 -178.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -61.23 -43.68 98.48 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.464 -0.772 . . . . 0.0 109.984 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -59.98 -38.41 82.46 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.874 -0.516 . . . . 0.0 110.997 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 87' ' ' GLU . 99.0 t -69.82 -48.76 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.473 -0.767 . . . . 0.0 110.446 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.778 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 20.3 m-85 -67.98 -40.06 83.19 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.47 -0.769 . . . . 0.0 111.01 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -74.96 69.93 1.94 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.528 -0.733 . . . . 0.0 110.337 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.7 tttp -59.95 -46.6 88.89 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.426 -0.796 . . . . 0.0 109.84 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.1 p-10 -73.9 -18.83 60.86 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.603 -0.685 . . . . 0.0 111.382 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 57.94 62.4 6.35 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.438 ' ND2' ' CE2' ' A' ' 99' ' ' TYR . 37.6 p-10 -109.23 -7.46 15.27 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.516 -0.991 . . . . 0.0 111.82 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.55 -22.6 11.76 Favored Glycine 0 N--CA 1.498 2.817 0 C-N-CA 119.989 -1.1 . . . . 0.0 110.439 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.438 ' CE2' ' ND2' ' A' ' 97' ' ' ASN . 35.5 p90 -143.77 154.55 43.56 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.392 -1.064 . . . . 0.0 109.635 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 81.9 mt -91.32 129.42 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 121.839 0.828 . . . . 0.0 110.126 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.03 172.36 9.6 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.211 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.26 -40.98 86.26 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.579 -0.701 . . . . 0.0 109.665 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.54 -37.75 88.51 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -61.16 -37.35 82.58 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.974 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.591 ' HB3' HG13 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -64.58 -42.73 95.42 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.682 0.753 . . . . 0.0 109.552 179.033 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -60.04 -38.53 83.02 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.883 -0.511 . . . . 0.0 111.556 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -59.97 -41.06 91.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.084 -1.01 . . . . 0.0 111.856 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.778 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 84.5 t -72.9 -50.13 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.239 -0.913 . . . . 0.0 111.594 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.422 ' HA ' HD12 ' A' ' 112' ' ' LEU . 41.8 mtt -59.07 -41.52 88.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.175 -0.953 . . . . 0.0 110.403 -178.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.7 m -64.37 -46.62 82.59 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.49 -0.756 . . . . 0.0 109.126 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -61.35 -33.57 73.85 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.504 ' CD1' HG12 ' A' ' 108' ' ' VAL . 39.2 mt -69.84 -30.51 68.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.95 -0.469 . . . . 0.0 109.999 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.16 31.62 3.03 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -122.19 137.0 54.98 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.539 -0.977 . . . . 0.0 110.028 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -109.52 124.87 51.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.532 -0.73 . . . . 0.0 110.212 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.667 HD22 ' OE2' ' A' ' 120' ' ' GLU . 73.0 mt -138.98 159.75 41.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.565 -0.709 . . . . 0.0 109.647 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.18 162.01 26.04 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -59.61 -29.55 68.07 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.355 -0.841 . . . . 0.0 109.084 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -68.44 -32.63 72.78 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.424 0.63 . . . . 0.0 109.61 178.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.667 ' OE2' HD22 ' A' ' 116' ' ' LEU . 12.0 mt-10 -67.83 -37.97 82.61 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.522 178.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.591 HG13 ' HB3' ' A' ' 105' ' ' LEU . 97.5 t -69.74 -40.09 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.699 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -59.9 -42.03 92.92 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.295 0.569 . . . . 0.0 109.996 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -60.04 -41.4 92.2 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.026 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.485 ' HB3' HD11 ' A' ' 105' ' ' LEU . 6.3 mmt -54.64 -36.37 64.48 Favored 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.385 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.5 mm -68.47 -37.6 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.308 0.575 . . . . 0.0 109.826 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 46.6 ttt-85 -60.0 -40.08 87.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.574 -0.704 . . . . 0.0 111.239 -178.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -61.83 -39.46 91.89 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.648 -0.657 . . . . 0.0 111.222 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -99.34 -0.25 41.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.347 -0.846 . . . . 0.0 111.763 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -104.48 80.53 1.69 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.979 -1.076 . . . . 0.0 110.947 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.4 mt -67.84 -39.95 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.648 -0.658 . . . . 0.0 109.965 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 36.5 p-10 -60.02 -39.72 86.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.587 -0.696 . . . . 0.0 110.755 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.77 17.9 36.75 Favored Glycine 0 N--CA 1.497 2.727 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.385 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -81.0 -10.11 59.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.108 -1.231 . . . . 0.0 110.608 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.13 2.29 71.39 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.367 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -136.77 139.18 41.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.167 -1.196 . . . . 0.0 110.276 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 98.1 t -95.81 113.81 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.566 -0.709 . . . . 0.0 109.713 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 41.6 p30 -86.12 -166.95 1.68 Allowed 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.609 -0.682 . . . . 0.0 110.241 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -70.08 -43.72 70.56 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.842 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -61.3 -49.96 74.93 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.264 -0.897 . . . . 0.0 112.115 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.3 -37.63 88.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.503 -0.748 . . . . 0.0 110.499 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.624 ' HE2' HG23 ' A' ' 85' ' ' ILE . 68.5 t80 -60.09 -47.3 86.45 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.667 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 87.0 t -64.66 -39.96 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.485 -0.76 . . . . 0.0 110.695 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -59.98 -49.64 76.87 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.563 -0.711 . . . . 0.0 111.033 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.448 ' CE ' ' CD1' ' B' ' 157' ' ' PHE . 10.9 tmm? -60.66 -40.01 90.48 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.279 -0.888 . . . . 0.0 110.128 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 94.9 mmm -67.24 -38.78 85.77 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.749 -0.595 . . . . 0.0 109.944 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 91.6 m -58.85 -29.03 66.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.69 -0.631 . . . . 0.0 109.973 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.99 141.86 47.74 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.6 -0.688 . . . . 0.0 110.432 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 95.7 mttt . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.325 179.916 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -66.54 152.74 52.41 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.531 ' HA ' HD12 ' B' ' 160' ' ' ILE . 22.6 t80 -61.51 -42.2 98.44 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.488 -1.007 . . . . 0.0 110.332 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 63.0 mtt85 -60.02 -40.06 88.01 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.558 -0.714 . . . . 0.0 110.397 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -62.61 -39.92 95.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.494 -0.754 . . . . 0.0 110.364 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . 0.531 HD12 ' HA ' ' B' ' 157' ' ' PHE . 73.0 mt -61.23 -45.09 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.516 -0.74 . . . . 0.0 110.041 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.9 -28.64 69.09 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.518 -0.739 . . . . 0.0 110.146 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -60.15 -39.92 88.03 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.572 -0.705 . . . . 0.0 109.503 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 89.0 mt -60.04 -40.08 88.14 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.724 -0.61 . . . . 0.0 110.413 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.656 HG11 ' CA ' ' A' ' 88' ' ' ALA . 94.0 t -65.22 -39.95 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.496 -0.753 . . . . 0.0 109.9 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . -54.81 -37.15 61.17 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 85.0 t -60.0 -33.32 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.657 -0.907 . . . . 0.0 109.627 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.577 ' O ' HD23 ' B' ' 167' ' ' LEU . 8.1 tt -56.24 -37.74 70.15 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.622 -0.674 . . . . 0.0 110.777 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 168' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -59.99 -39.99 87.65 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.416 -0.803 . . . . 0.0 110.224 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -63.76 -40.01 95.67 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.447 -0.783 . . . . 0.0 110.989 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -20.9 59.46 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.415 -0.803 . . . . 0.0 110.869 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.98 -32.31 70.46 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.268 -0.895 . . . . 0.0 110.965 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 172' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -59.98 -38.73 83.39 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.355 -0.841 . . . . 0.0 109.865 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 173' ' ' ARG . . . . . . . . . . . . . 71.4 mtp85 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.734 -0.604 . . . . 0.0 110.318 179.99 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_